PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Iimura, Y; Agata, U; Takeda, S; Kobayashi, Y; Yoshida, S; Ezawa, I; Omi, N				Iimura, Yuki; Agata, Umon; Takeda, Satoko; Kobayashi, Yuki; Yoshida, Shigeki; Ezawa, Ikuko; Omi, Naomi			The protective effect of lycopene intake on bone loss in ovariectomized rats	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Bone loss; Bone resorption; Lycopene; Oxidative stress; Ovariectomized rats	OXIDATIVE STRESS; PROINFLAMMATORY CYTOKINE; POSTMENOPAUSAL WOMEN; ESTROGEN-DEFICIENCY; CRUCIAL ROLE; ANTIOXIDANTS; RESORPTION; SUPPLEMENTATION; OSTEOPOROSIS; INHIBITION	Antioxidant lycopene supplementation has been shown to decrease oxidative stress and have beneficial effects on bone health. However, it remains unclear whether lycopene exerts its beneficial effect on bone metabolism through mitigation of oxidative stress in vivo. The aim of this study was to investigate whether lycopene intake protects against bone loss by reducing oxidative stress in ovariectomized rats. Female Sprague-Dawley 6-week-old rats were ovariectomized and randomly divided into four groups according to the lycopene content of their diet: 0, 50, 100, and 200 ppm. The tibial bone mineral density (BMD) in the 50, 100, and 200 ppm groups was significantly higher than that in the 0 ppm group. Serum and urinary bone resorption marker levels were significantly lower in the 50, 100, and 200 ppm groups than in the 0 ppm group. There was no significant difference in systemic oxidative stress markers among all groups. However, systemic oxidative stress levels were inversely correlated with the tibial BMD. Our findings suggest that lycopene intake significantly inhibits bone loss by suppressing bone resorption in ovariectomized rats. Further studies are necessary to clarify the effect of lycopene on oxidative stress in local tissues such as bone tissue.	[Iimura, Yuki; Agata, Umon; Takeda, Satoko; Kobayashi, Yuki; Omi, Naomi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Hlth & Sport Sci, Tsukuba, Ibaraki 3058574, Japan; [Yoshida, Shigeki] Univ Tsukuba, Grad Sch Life & Environm Sci, Dept Life Sci & Bioengn, Tsukuba, Ibaraki 3058572, Japan; [Ezawa, Ikuko] Japan Womens Univ, Sch Home Econ, Dept Food & Nutr, Bunkyo Ku, Tokyo 1128681, Japan; [Omi, Naomi] Univ Tsukuba, Hlth Phys Educ & Sport Sci, Tsukuba, Ibaraki 3058574, Japan	Omi, N (reprint author), Univ Tsukuba, Hlth Phys Educ & Sport Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058574, Japan.	ominaomi@taiiku.tsukuba.ac.jp					Al-Malki AL, 2011, TOXICOL IND HEALTH, V28, P542; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Mackinnon ES, 2011, OSTEOPOROSIS INT, V22, P1091, DOI 10.1007/s00198-010-1308-0; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Kotani K, 2012, J INT MED RES, V40, P1074; Lee CM, 1999, J NUTR, V129, P2271; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Palozza P, 2011, J NUTR BIOCHEM, V22, P259, DOI 10.1016/j.jnutbio.2010.02.003; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Batra N, 2012, BBA-BIOMEMBRANES, V1818, P1909, DOI 10.1016/j.bbamem.2011.09.018; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Jagger CJ, 2005, ENDOCRINOLOGY, V146, P113, DOI 10.1210/en.2004-1058; Maggio D, 2006, BONE, V38, P244, DOI 10.1016/j.bone.2005.08.003; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Ceribasi AO, 2010, BASIC CLIN PHARMACOL, V107, P730, DOI 10.1111/j.1742-7843.2010.00571.x; Cesarone MR, 1999, INT ANGIOL, V18, P127; De Zwart LL, 1999, FREE RADICAL BIO MED, V26, P202, DOI 10.1016/S0891-5849(98)00196-8; Kitade Y, 2002, HEPATOL RES, V22, P196, DOI 10.1016/S1386-6346(01)00132-2; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Porrini M, 1998, BRIT J NUTR, V80, P353, DOI 10.1079/096582198388300; OMI N, 1994, J NUTR SCI VITAMINOL, V40, P443; ROBINS SP, 1994, J BONE MINER RES, V9, P1643; Banifi G, 2008, CLIN CHEM LAB MED, V46, P1550; Bednarek-Tupikowska G, 2006, CLIN ENDOCRINOL, V64, P463, DOI 10.1111/j.1365-2265.2006.02494.x; DHEM A, 1984, FOOD CHEM TOXICOL, V22, P199, DOI 10.1016/0278-6915(84)90127-3; Ezawa I, 1979, J JPN SOC FOOD NUTR, V32, P329; Ferreira ALA, 2000, J NUTR, V130, P1256; Ferreira ALD, 2004, J NUTR BIOCHEM, V15, P493, DOI 10.1016/S0955-2863(03)001074-4; Fraser JHE, 1996, BONE, V19, P223, DOI 10.1016/8756-3282(96)00177-9; Gouranton E, 2011, J NUTR BIOCHEM, V22, P642, DOI 10.1016/j.jnutbio.2010.04.016; Grassi F, 2007, P NATL ACAD SCI USA, V104, P15087, DOI 10.1073/pnas.0703610104; Hernandez I, 2000, AM J PHYSIOL-REG I, V279, P1599; Iimura Y, 2014, J NUTR SCI IN PRESS, V60; Kim DJ, 1997, CANCER LETT, V120, P15; Kim Linda, 2003, Journal of Medicinal Food, V6, P79, DOI 10.1089/109662003322233468; Kneissel M, 2005, BONE, V36, P202, DOI 10.1016/j.bone.2004.11.006; Liang HD, 2012, MOLECULES, V17, P7093, DOI 10.3390/molecules17067093; Lind T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082388; Moselhy SS, 2008, MOL CELL BIOCHEM, V319, P175, DOI 10.1007/s11010-008-9890-6; Nagatomo F, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/381763; Omi N, 2011, JPN SOC EXERC SPORTS, V18, P11; Rao Leticia G., 2003, Journal of Medicinal Food, V6, P69, DOI 10.1089/109662003322233459; Sthal W, 1996, ARCH BIOCHEM BIOPHYS, V336, P1; Topcuoglu A, 2009, CLIN INVEST MED, V32, P133	47	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAY	2015	33	3					270	278		10.1007/s00774-014-0596-4		9	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CH8OH	WOS:000354295200004		
J	Saita, Y; Ishijima, M; Mogami, A; Kubota, M; Baba, T; Kaketa, T; Nagao, M; Sakamoto, Y; Sakai, K; Homma, Y; Kato, R; Nagura, N; Miyagawa, K; Wada, T; Liu, LZ; Matsuoka, J; Obayashi, O; Shitoto, K; Nozawa, M; Kajihara, H; Gen, H; Kaneko, K				Saita, Yoshitomo; Ishijima, Muneaki; Mogami, Atsuhiko; Kubota, Mitsuaki; Baba, Tomonori; Kaketa, Takefumi; Nagao, Masashi; Sakamoto, Yuko; Sakai, Kensuke; Homma, Yasuhiro; Kato, Rui; Nagura, Nana; Miyagawa, Kei; Wada, Tomoki; Liu, Lizu; Matsuoka, Joe; Obayashi, Osamu; Shitoto, Katsuo; Nozawa, Masahiko; Kajihara, Hajime; Gen, Hogaku; Kaneko, Kazuo			The incidence of and risk factors for developing atypical femoral fractures in Japan	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Atypical femoral fracture (AFF); Osteoporosis; Bisphosphonate; Glucocorticoid; Collagen disease	SUPPRESSED BONE TURNOVER; BISPHOSPHONATE USE; SHAFT FRACTURES; ALENDRONATE THERAPY; DIAPHYSEAL FEMUR; TRABECULAR BONE; OSTEOPOROSIS; WOMEN; MICROARCHITECTURE; DERMATOMYOSITIS	The long-term treatment with anti-resorptive drugs for osteoporotic patients is suggested to be associated with an increase in atypical femoral fractures (AFFs). However, their incidence, patient characteristics, and risk factors have not been fully elucidated especially in Asian countries. This retrospective observational cohort study found fourteen AFFs in ten patients (four bilateral fractures) among 2,238 hip and femoral shaft fractures treated in our associated hospitals between 2005 and 2010; this incidence (0.63 %) was similar to Caucasians. Of the ten patients with AFFs, nine (90 %) and six (60 %) were using bisphosphonates (BPs) and glucocorticoids (GCs), respectively, compared to 14.3 and 8.6 % for patients with typical femoral fractures who were using these agents. As comorbid conditions, five patients had collagen disease (CD) and two had diabetes. A fracture location-, age- and gender-matched (1:3) case-control study revealed that administration of BPs, GCs, and suffering from collagen disease (CD) were significant risk factors for developing AFFs [odds ratios 36.0 (95 % confidence intervals 3.8-342.2), 13.0 (2.3-74.1) and 9.0 (1.6-50.3), respectively]. Interestingly, all of the patients with atypical subtrochanteric femoral fractures, defined as those within 5 cm of the lesser trochanter, were taking GCs due to CD, and the age of these patients (average of 54.8 years) was significantly younger than those with atypical diaphyseal femoral fractures (average of 77.2 years, p < 0.05). In conclusion, the incidence of AFFs in the Japanese population was similar to that of Caucasians, and taking BPs and GCs and suffering from CD were risk factors for developing AFFs.	[Saita, Yoshitomo; Ishijima, Muneaki; Kubota, Mitsuaki; Kaketa, Takefumi; Liu, Lizu; Kaneko, Kazuo] Juntendo Univ, Fac Med, Dept Orthopaed, Tokyo 1138421, Japan; [Ishijima, Muneaki] Juntendo Univ, Grad Sch Med, Dept Med Orthopaed & Motor Organ, Bunkyo Ku, Tokyo 1138421, Japan; [Mogami, Atsuhiko; Homma, Yasuhiro; Nagura, Nana; Wada, Tomoki; Obayashi, Osamu] Juntendo Urayasu Hosp, Dept Orthopaed Surg, Shizuoka, Japan; [Baba, Tomonori; Shitoto, Katsuo] Juntendo Nerima Hosp, Dept Orthopaed Surg, Chiba, Japan; [Nagao, Masashi; Sakamoto, Yuko; Sakai, Kensuke; Nozawa, Masahiko] Juntendo Nerima Hosp, Dept Orthopaed Surg, Tokyo, Japan; [Kato, Rui; Kajihara, Hajime] Koto Hosp, Dept Orthopaed Surg, Tokyo, Japan; [Miyagawa, Kei; Gen, Hogaku] Chiba Cent Med Ctr, Dept Orthopaed Surg, Chiba, Japan; [Matsuoka, Joe] Juntendo Univ, Juntendo Clin Res Ctr, Tokyo, Japan	Ishijima, M (reprint author), Juntendo Univ, Grad Sch Med, Dept Med Orthopaed & Motor Organ, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ishijima@juntendo.ac.jp					Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Weinstein RS, 2000, J BONE MINER RES, V15, P621, DOI 10.1359/jbmr.2000.15.4.621; Girgis CM, 2010, NEW ENGL J MED, V362, P1848, DOI 10.1056/NEJMc0910389; Giusti A, 2010, BONE, V47, P169, DOI 10.1016/j.bone.2010.05.019; Ioannidis G, 2009, CAN MED ASSOC J, V181, P265, DOI 10.1503/cmaj.081720; Recker R, 2005, CURR MED RES OPIN, V21, P185, DOI 10.1185/030079904X20259; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Yoneda T, 2010, J BONE MINER METAB, V28, P365, DOI 10.1007/s00774-010-0162-7; Rizzoli R, 2011, OSTEOPOROSIS INT, V22, P373, DOI 10.1007/s00198-010-1453-5; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Meier RPH, 2012, ARCH INTERN MED, V172, P930, DOI 10.1001/archinternmed.2012.1796; Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/jbmr.081247, 10.1359/JBMR.081247]; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Thompson RN, 2012, J BONE JOINT SURG BR, V94B, P385, DOI 10.1302/0301-620X.94B3.27999; Goh SK, 2007, J BONE JOINT SURG BR, V89B, P349, DOI 10.1302/0301-620X.89B3.18146; Mashiba T, 2000, J BONE MINER RES, V15, P613, DOI 10.1359/jbmr.2000.15.4.613; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Saito M, 2008, OSTEOPOROSIS INT, V19, P1343, DOI 10.1007/s00198-008-0585-3; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Schilcher J, 2009, ACTA ORTHOP, V80, P413, DOI 10.3109/17453670903139914; Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P703, DOI 10.1007/s00198-008-0743-7; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Bottai V, 2013, OSTEOPOROSIS INT, V25, P993; Frost HM, 1963, INTRO BIOMECHANICS; Ishijima M, 2009, CALCIFIED TISSUE INT, V85, P398, DOI 10.1007/s00223-009-9295-x; Nakatsuka K, 2004, J BONE MINER METAB, V22, P153, DOI 10.1007/s00774-003-0464-0; Nieves JW, 2010, OSTEOPOROSIS INT, V21, P399; Nutter J, 1922, J BONE JT SURG AM, V4, P25; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Stevenson JC, 2011, NEW ENGL J MED, V365, P377, DOI 10.1056/NEJMc1106551#SA1; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2	35	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAY	2015	33	3					311	318		10.1007/s00774-014-0591-9		8	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CH8OH	WOS:000354295200009		
J	Yamazaki, M; Kawai, M; Miyagawa, K; Ohata, Y; Tachikawa, K; Kinoshita, S; Nishino, J; Ozono, K; Michigami, T				Yamazaki, Miwa; Kawai, Masanobu; Miyagawa, Kazuaki; Ohata, Yasuhisa; Tachikawa, Kanako; Kinoshita, Saori; Nishino, Jin; Ozono, Keiichi; Michigami, Toshimi			Interleukin-1-induced acute bone resorption facilitates the secretion of fibroblast growth factor 23 into the circulation	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						FGF23; IL-1 beta; Osteocytes; Osteoclasts; Bone resorption	VITAMIN-D METABOLISM; PHOSPHATE HOMEOSTASIS; TUMORAL CALCINOSIS; MINERAL METABOLISM; DIETARY PHOSPHATE; TARGETED ABLATION; FGF23; FIBROBLAST-GROWTH-FACTOR-23; MICE; OSTEOCYTES	Fibroblast growth factor 23 (FGF23), a central regulator of phosphate and vitamin D metabolism, is mainly produced by osteocytes in bone and exerts its effects on distant organs. Despite its endocrine function, the mechanism controlling serum FGF23 levels is not fully understood. Here we tested the hypothesis that osteoclastic bone resorption may play a role in regulating circulating levels of FGF23, using a mouse model where injections of interleukin (IL)-1 beta into the subcutaneous tissue over the calvaria induced rapid bone resorption. A significant amount of FGF23 was detected in the extracts from mouse bones, which supports the idea that FGF23 stays in bone for a while after its production. IL-1 beta-induced bone resorption was associated with elevated serum FGF23 levels, an effect abolished by pre-treatment with pamidronate. Fgf23 expression was not increased in either the calvariae or tibiae of IL-1 beta-injected mice, which suggests that IL-1 beta facilitated the entry of FGF23 protein into circulation by accelerating bone resorption rather than increasing its gene expression. The direct effect of IL-1 beta on bone was confirmed when it increased FGF23 levels in the conditioned media of mouse calvariae in organ culture. Repeated treatment of the cultured calvariae with IL-1 beta led to a refractory phase, where FGF23 was not mobilized by IL-1 beta anymore. Consistent with the in vivo results, treatment with IL-1 beta failed to increase Fgf23 mRNA in isolated primary osteocytes and osteoblasts. These results suggest that FGF23 produced by osteocytes remains in bone, and that rapid bone resorption facilitates its entry into the bloodstream.	[Yamazaki, Miwa; Kawai, Masanobu; Miyagawa, Kazuaki; Ohata, Yasuhisa; Tachikawa, Kanako; Kinoshita, Saori; Nishino, Jin; Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi, Osaka 5941101, Japan; [Yamazaki, Miwa; Kawai, Masanobu; Miyagawa, Kazuaki; Ohata, Yasuhisa; Tachikawa, Kanako; Kinoshita, Saori; Nishino, Jin; Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan; [Miyagawa, Kazuaki; Nishino, Jin] Osaka Univ, Grad Sch Dent, Dept Oral Surg 1, Suita, Osaka 5650871, Japan; [Ohata, Yasuhisa; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan	Michigami, T (reprint author), Osaka Med Ctr, Dept Bone & Mineral Res, Izumi, Osaka 5941101, Japan.	michigami@mch.pref.osaka.jp			Ministry of Education, Science, and Culture of Japan; Ministry of Health, Labour, and Welfare of Japan; Novo Nordisk Pharma. Ltd.	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (to M.Y. and T.M.), Ministry of Health, Labour, and Welfare of Japan (to T.M.), and funds from Novo Nordisk Pharma. Ltd. (to T.M.).	ADHR Consortium, 2000, Nature Genetics, V26, P345; Ito N, 2007, J BONE MINER METAB, V25, P419, DOI 10.1007/s00774-007-0779-3; Goetz R, 2012, J BIOL CHEM, V287, P29134, DOI 10.1074/jbc.M112.342980; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Endo I, 2008, BONE, V42, P1235, DOI 10.1016/j.bone.2008.02.014; Kulkarni RN, 2012, BIOCHEM BIOPH RES CO, V420, P11, DOI 10.1016/j.bbrc.2012.02.099; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Segawa H, 2003, PFLUG ARCH EUR J PHY, V446, P585, DOI 10.1007/s00424-003-1084-1; Morony S, 1999, J BONE MINER RES, V14, P1478, DOI 10.1359/jbmr.1999.14.9.1478; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Araya K, 2005, J CLIN ENDOCR METAB, V90, P5523, DOI 10.1210/jc.2005-0301; Larsson T, 2005, J CLIN ENDOCR METAB, V90, P2424, DOI 10.1210/jc.2004-2238; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; BOYCE BF, 1989, ENDOCRINOLOGY, V125, P1142; Igwe JC, 2011, CONNECT TISSUE RES, V52, P401, DOI 10.3109/03008207.2010.546536; Kitaoka T, 2011, J BONE MINER METAB, V29, P598, DOI 10.1007/s00774-011-0262-z; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; MIKUNITAKAGAKI Y, 1995, J BONE MINER RES, V10, P231; Miyagawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093840; Onuchic L, 2012, J CLIN ENDOCR METAB, V97, P1098, DOI 10.1210/jc.2011-3082	36	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAY	2015	33	3					342	354		10.1007/s00774-014-0598-2		13	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CH8OH	WOS:000354295200013		
J	Kinoshita, T; Asai, T; Suzuki, T				Kinoshita, Takeshi; Asai, Tohru; Suzuki, Tomoaki			Reoperative Median Sternotomy Following the Use of a Right Internal Mammary Artery Pedicle Graft Crossing the Midline to the Left Anterior Descending Artery	JOURNAL OF CARDIAC SURGERY			English	Article							COMPOSITE	Background and aimThe purpose of the present study was to examine the outcomes of cardiac reoperations for the patients with a previously placed pedicled graft of the right internal thoracic artery (RITA) to the left anterior descending artery (LAD). MethodsOf 1002 consecutive patients who underwent isolated coronary bypass surgery, 612 patients received pedicled grafts of skeletonized RITA to the LAD crossing the midline over the aorta. Of this cohort, seven patients underwent cardiac reoperations via a median resternotomy including aortic valve replacement, mitral valve plasty, and total arch replacement. Covering the RITA with pericardium and mediastinal tissue had been routinely performed in the initial operation. ResultsPreoperative computed tomography (CT) angiography showed the RITA at a safe distance from the sternum in six patients. No graft injury occurred during dissection. The patient who underwent emergent total arch replacement died from global brain ischemia at postoperative day 11. The remaining six patients recovered well without major complication and survived at 7.54.5 years after reoperations. ConclusionsCardiac reoperation via a median sternotomy can be performed at acceptable risk in patients with the RITA graft crossing the midline. Specific maneuvers should be applied in the first coronary artery bypass grafting to keep the RITA at the level of the aortic plane and prevent migration toward the sternum. Preoperative CT angiography is an important tool to understand the surgical anatomy and determine the safety of reoperation. doi: 10.1111/jocs.12535 (J Card Surg 2015;30:396-399)	[Kinoshita, Takeshi; Asai, Tohru; Suzuki, Tomoaki] Shiga Univ Med Sci, Div Cardiovasc Surg, Otsu, Shiga 52021, Japan	Kinoshita, T (reprint author), Shiga Univ Med Sci, Div Cardiovasc Surg, Otsu, Shiga 52021, Japan.	kinotake@belle.shiga-med.ac.jp					Kinoshita T, 2010, ANN THORAC SURG, V90, P1173, DOI 10.1016/j.athoracsur.2010.05.048; Manabe S, 2010, ANN THORAC SURG, V89, P683, DOI 10.1016/j.athoracsur.2009.11.053; Asai Tohru, 2013, Ann Cardiothorac Surg, V2, P235, DOI 10.3978/j.issn.2225-319X.2013.03.08; Calafiore AM, 1999, ANN THORAC SURG, V67, P1637, DOI 10.1016/S0003-4975(99)00282-9; Farhat F, 2005, ANN THORAC SURG, V80, P1532, DOI 10.1016/j.athoracsur.2004.04.075; Hirose H, 2004, ANN THORAC SURG, V78, P782, DOI 10.1016/j.athoracsur.2004.02.035; JOYCE FS, 1994, ANN THORAC SURG, V58, P80; Lev-Ran O, 2004, J CARDIAC SURG, V19, P151, DOI 10.1111/j.0886-0440.2004.04029.x; Lev-Ran O, 2002, ANN THORAC SURG, V74, P704, DOI 10.1016/S0003-4975(02)03791-8	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	MAY	2015	30	5					396	399		10.1111/jocs.12535		4	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CH4BC	WOS:000353974900003		
J	Minakata, K; Tanaka, S; Takahara, Y; Kaneko, T; Usui, A; Shimamoto, M; Okawa, Y; Yaku, H; Yamanaka, K; Tamura, N; Sakata, R				Minakata, Kenji; Tanaka, Shiro; Takahara, Yoshiharu; Kaneko, Tatsuo; Usui, Akihiko; Shimamoto, Mitsuomi; Okawa, Yohei; Yaku, Hitoshi; Yamanaka, Kazuo; Tamura, Nobushige; Sakata, Ryuzo			Long-Term Durability of Pericardial Valves in the Aortic Position in Younger Patients: When Does Reoperation Become Necessary?	JOURNAL OF CARDIAC SURGERY			English	Article							VALVULAR HEART-DISEASE; HANCOCK II BIOPROSTHESIS; JAPANESE PATIENTS; REPLACEMENT; GUIDELINES; EXPERIENCE; MANAGEMENT; TRANSCATHETER; AGE; IMPLANTATION	BackgroundWe sought to assess the long-term durability of pericardial valves in patients at age <65 years undergoing aortic valve replacement (AVR), and to determine the timing of redo operations due to structural valve deterioration (SVD). MethodsFrom 1986 to 2001, a total of 574 adult patients underwent AVR with pericardial valves in nine hospitals in Japan. Of these, 53 patients were at age <65 years (group Y). These patients were compared with those of age 65 (group O, n=521). ResultsThe mean follow-up duration was 9.5 years in group Y and 8.1 years in group O. Freedom from reoperation due to SVD was 100% at five years, 90.8% at 10 years, and 47.2% at 15 years in group Y, and 99.3% at five years, 97.4% at 10 years, and 94.4% at 15 years in group O (log-rank test, p<0.01). In those who required redo AVR in group Y (n=12), the mean time from initial operation to reoperation was 12.1 years. The reoperation-free survival curve started to decline after eight years postoperation in group Y. ConclusionsRedo AVR started to become necessary eight years after surgery in the patients who underwent AVR with pericardial valve at age <65 years. In addition, approximately half of those patients required reoperation due to SVD by 15 years postoperatively. doi: 10.1111/jocs.12537 (J Card Surg 2015;30:405-413)	[Minakata, Kenji; Sakata, Ryuzo] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Kyoto 6068507, Japan; [Tanaka, Shiro] Kyoto Univ, Dept Pharmacoepidemiol, Grad Sch Med & Publ Hlth, Kyoto 6068507, Japan; [Takahara, Yoshiharu] Funabashi Municipal Med Ctr, Dept Cardiovasc Surg, Funabashi, Chiba, Japan; [Kaneko, Tatsuo] Gunma Prefectural Cardiovasc Ctr, Div Cardiovasc Surg, Maebashi, Gumma, Japan; [Usui, Akihiko] Nagoya Univ, Grad Sch Med, Dept Cardiac Surg, Nagoya, Aichi 4648601, Japan; [Shimamoto, Mitsuomi] Shizuoka City Shizuoka Hosp, Div Cardiovasc Surg, Shizuoka, Japan; [Okawa, Yohei] Hokkaido Ohno Hosp, Div Cardiovasc Surg, Cardiovasc Ctr, Sapporo, Hokkaido, Japan; [Yaku, Hitoshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kyoto, Japan; [Yamanaka, Kazuo] Tenri Hosp, Dept Cardiovasc Surg, Tenri, Nara 632, Japan; [Tamura, Nobushige] Kumamoto City Hosp, Div Cardiovasc Surg, Kumamoto, Japan	Minakata, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	minakata@kuhp.kyoto-u.ac.jp	Usui, Akihiko/I-7251-2014		Research Institute for Production Development, Kyoto, Japan	Grant sponsor: Research Institute for Production Development, Kyoto, Japan	Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Minakata K, 2014, CIRC J, V78, P882, DOI 10.1253/circj.CJ-13-1068; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Gao GQ, 2004, J AM COLL CARDIOL, V44, P384, DOI 10.1016/j.jacc.2004.01.053; Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2; Walther T, 2007, J AM COLL CARDIOL, V50, P56, DOI 10.1016/j.jacc.2007.03.030; McClure RS, 2010, ANN THORAC SURG, V89, P1410, DOI 10.1016/j.athoracsur.2010.01.046; Weber A, 2012, J THORAC CARDIOV SUR, V144, P1075, DOI 10.1016/j.jtcvs.2012.01.024; Svensson LG, 2013, ANN THORAC SURG, V95, pS1, DOI 10.1016/j.athoracsur.2013.01.083; Forcillo J, 2013, ANN THORAC SURG, V96, P486, DOI 10.1016/j.athoracsur.2013.03.032; Akins CW, 2008, ANN THORAC SURG, V85, P1490, DOI 10.1016/j.athoracsur.2007.12.082; Said SM, 2012, ANN THORAC SURG, V93, P1868, DOI 10.1016/j.athoracsur.2012.01.061; Suri RM, 2013, CIRCULATION, V128, P1372, DOI 10.1161/CIRCULATIONAHA.113.001681; David TE, 2010, ANN THORAC SURG, V90, P775, DOI 10.1016/j.athoracsur.2010.05.034; Banbury MK, 2001, ANN THORAC SURG, V72, P753, DOI 10.1016/S0003-4975(01)02992-7; Aupart MR, 2006, J HEART VALVE DIS, V15, P768; Chikwe Joanna, 2011, Semin Thorac Cardiovasc Surg, V23, P18, DOI 10.1053/j.semtcvs.2011.04.008; Dvir D, 2014, JAMA-J AM MED ASSOC, V312, P162, DOI 10.1001/jama.2014.7246; Fann JI, 1996, ANN THORAC SURG, V62, P1301, DOI 10.1016/0003-4975(96)00629-7; Jamieson WRE, 1998, ANN THORAC SURG, V66, pS49, DOI 10.1016/S0003-4975(98)01127-8; Nishida Takahiro, 2013, Gen Thorac Cardiovasc Surg, V61, P182, DOI 10.1007/s11748-013-0202-z; Nishida T, 2014, CIRC J, V78, P2688, DOI 10.1253/circj.CJ-14-0466; Poirier NC, 1998, ANN THORAC SURG, V66, pS57, DOI 10.1016/S0003-4975(98)01110-2; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Une D, 2014, EUR J CARDIO-THORAC, V46, P825, DOI 10.1093/ejcts/ezu014; Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	MAY	2015	30	5					405	413		10.1111/jocs.12537		9	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CH4BC	WOS:000353974900005		
J	Hattori, R; Uchiyama, H				Hattori, Reiji; Uchiyama, Hirotomo			Single Patch Multilayer Aortic Annular Repair for Destructive Infective Endocarditis	JOURNAL OF CARDIAC SURGERY			English	Article							ROOT	Active infective endocarditis may progress to annular abscess formation. We describe a patch annuloplasty technique to treat the fragile aortic root tissue in these patients. doi: 10.1111/jocs.12485 (J Card Surg 2015;30:424-426)	[Hattori, Reiji; Uchiyama, Hirotomo] Grace Fdn Osaka Saiseikai Noe Hosp, Dept Cardiovasc Surg, Osaka 5360001, Japan	Hattori, R (reprint author), Grace Fdn Osaka Saiseikai Noe Hosp, Dept Cardiovasc Surg, Joto Ku, 3-25 Furuichi 1 Chome, Osaka 5360001, Japan.	hattorireiji@yahoo.co.jp					DAVID TE, 1989, CIRCULATION, V80, P269; Imran Maria A, 1995, J AM COLL CARDIOL, V25, P137; Leyh RG, 2004, J THORAC CARDIOV SUR, V127, P1416, DOI 10.1016/j.jtcvs.2003.08.047	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	MAY	2015	30	5					424	426		10.1111/jocs.12485		3	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CH4BC	WOS:000353974900009		
J	Kataoka, G; Nakano, K; Asano, R; Sato, A; Kodera, K; Tatsuishi, W				Kataoka, Go; Nakano, Kiyoharu; Asano, Ryota; Sato, Atsuhiko; Kodera, Kojiro; Tatsuishi, Wataru			Purulent Pericardial Effusion and Mycotic Pseudoaneurysm Following Insertion of a Bare Metal Stent	JOURNAL OF CARDIAC SURGERY			English	Article							CORONARY-ARTERY	A 65-year-old male was diagnosed with purulent pericarditis, caused by Staphylococcus aureus five weeks after bare metal stenting for a 90% stenosis of the right coronary artery ostium. Subsequently, he developed a pseudoaneurysm in the right coronary sinus of Valsalva (CSV) requiring surgical intervention during the treatment of the pericarditis. Bacteremia after percutaneous coronary intervention (PCI) occurs in <1% of patients and usually has insignificant clinical sequelae. We present an infected coronary bare metal stent of the proximal right coronary artery after PCI that resulted in a purulent pericardial effusion and mycotic pseudoaneurysm of the right coronary sinus of Valsalva (CSV). The patient successfully underwent surgical treatment. doi: 10.1111/jocs.12530 (J Card Surg 2015;30:433-435)	[Kataoka, Go; Nakano, Kiyoharu; Asano, Ryota; Sato, Atsuhiko; Kodera, Kojiro; Tatsuishi, Wataru] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Med Ctr East, Tokyo 1168567, Japan	Kataoka, G (reprint author), Tokyo Womens Med Univ, Dept Cardiovasc Surg, Med Ctr East, Arakawa Ku, 2-1-10 Nishiogu, Tokyo 1168567, Japan.	kataokago@yahoo.co.jp					Samore MH, 1997, AM J CARDIOL, V79, P873; Patel AJ, 2013, ANN THORAC SURG, V95, P1791, DOI 10.1016/j.athoracsur.2012.09.045; Furtado AD, 2011, INTERACT CARDIOV TH, V12, P636, DOI 10.1510/icvts.2010.257337; Le MQ, 2007, CATHETER CARDIO INTE, V69, P508, DOI 10.1002/ccd.21014; Lim CP, 2011, ANN THORAC SURG, V91, pE17, DOI 10.1016/j.athoracsur.2010.10.075	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	MAY	2015	30	5					433	435		10.1111/jocs.12530		3	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CH4BC	WOS:000353974900012		
J	Suzuki, S; Ichimiya, S; Kanashiro, M; Okamoto, H; Ishii, H; Murohara, T				Suzuki, Susumu; Ichimiya, Satoshi; Kanashiro, Masaaki; Okamoto, Hiroshi; Ishii, Hideki; Murohara, Toyoaki			Acute Thrombotic Occlusion of a Giant Right Coronary Artery Aneurysm	JOURNAL OF CARDIAC SURGERY			English	Editorial Material									[Suzuki, Susumu; Ichimiya, Satoshi; Kanashiro, Masaaki] Yokkaichi Municipal Hosp, Dept Cardiol, Yokaichi, Japan; [Suzuki, Susumu; Ishii, Hideki; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Okamoto, Hiroshi] Yokkaichi Municipal Hosp, Dept Cardiovasc Surg, Yokaichi, Japan	Suzuki, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sususu0531@yahoo.co.jp	Murohara, Toyoaki/M-4958-2014					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	MAY	2015	30	5					436	437		10.1111/jocs.12380		2	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CH4BC	WOS:000353974900013		
J	Kamiguchi, S; Seki, Y; Satake, A; Okumura, K; Nagashima, S; Chihara, T				Kamiguchi, Satoshi; Seki, Yasunari; Satake, Akiharu; Okumura, Kazu; Nagashima, Sayoko; Chihara, Teiji			Catalytic Cracking of Methyl tert-Butyl Ether to Isobutene over Bronsted and Lewis Acid Sites on Solid-state Molybdenum Sulfide Clusters with an Octahedral Metal Framework	JOURNAL OF CLUSTER SCIENCE			English	Article						Molybdenum sulfide cluster; Chevrel phase; MTBE cracking catalyst; Bronsted and Lewis acid; Bifunctional catalyst	DECOMPOSITION; ISOMERIZATION; OXIDE	Solid-state molybdenum sulfide clusters with an octahedral metal framework, the Chevrel phases, are applied to the catalytic cracking of methyl tert-butyl ether (MTBE) to yield isobutene. The copper salt of the nonstoichiometric sulfur-deficient cluster, Cu (x) Mo6S8-delta (x = 2.94 and delta a parts per thousand 0.3), after storing in air, is thermally activated in a hydrogen stream, followed by the reaction with MTBE. Two kinds of catalytically active sites develop depending on the activation temperature: one developed at 100-200 A degrees C is a Bronsted-acidic hydroxo ligand on the copper cation while the other developed at 350-400 A degrees C is a Lewis-acidic coordinatively unsaturated molybdenum atom with a sulfur-deficient site. A nonstoichiometric sulfur-deficient neutral cluster Mo6S8-delta (delta a parts per thousand 0.4) also catalyzes the cracking reaction when activated at 400 A degrees C.	[Kamiguchi, Satoshi] RIKEN, Adv Catalysis Res Grp, Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan; [Kamiguchi, Satoshi] RIKEN, Organometall Chem Lab, Wako, Saitama 3510198, Japan; [Seki, Yasunari; Satake, Akiharu] Tokyo Univ Sci, Fac Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Okumura, Kazu] Kogakuin Univ, Fac Engn, Hachioji, Tokyo 1920015, Japan; [Nagashima, Sayoko; Chihara, Teiji] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama, Saitama 3388570, Japan	Kamiguchi, S (reprint author), RIKEN, Organometall Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kamigu@riken.jp			Ministry of Education, Science, and Culture [25410079]	This work was supported by a Grant-in-Aid (25410079) for Scientific Research (C) from the Ministry of Education, Science, and Culture.	Akhmanova M. V., 1978, RUSS J INORG CHEM, V23, P18; Bricker JC, 2012, TOP CATAL, V55, P1309, DOI 10.1007/s11244-012-9912-1; CHEVREL R, 1971, J SOLID STATE CHEM, V3, P515, DOI 10.1016/0022-4596(71)90095-8; GOCKE E, 1987, INORG CHEM, V26, P1805, DOI 10.1021/ic00258a034; Paskach TJ, 2002, J CATAL, V211, P285, DOI 10.1006/jcat.2002.3684; Kopilevich S, 2012, J AM CHEM SOC, V134, P13082, DOI 10.1021/ja304513t; MCCARTY KF, 1984, IND ENG CHEM PROD RD, V23, P519, DOI 10.1021/i300016a002; WAKIHARA M, 1992, SOLID STATE IONICS, V53, P413, DOI 10.1016/0167-2738(92)90408-H; Harel-Michaud V, 2001, J ALLOY COMPD, V317, P195, DOI 10.1016/S0925-8388(00)01324-4; RABILLERBAUDRY M, 1991, MATER RES BULL, V26, P519, DOI 10.1016/0025-5408(91)90192-O; Kamiguchi S, 2013, J CLUST SCI, V24, P559, DOI 10.1007/s10876-012-0534-3; CHEVREL R, 1974, MATER RES BULL, V9, P1487, DOI 10.1016/0025-5408(74)90095-6; Kamiguchi S, 2003, J MOL CATAL A-CHEM, V195, P159, DOI 10.1016/S1381-1169(02)00546-0; BERAN S, 1984, REACT KINET CATAL L, V26, P437, DOI 10.1007/BF02067878; Fischer O., 1982, TOPICS CURRENT PHYS, V32; Maple M.B., 1982, TOPICS CURRENT PHYS, V34; Nakamoto K., 1997, INFRARED RAMAN SPE B, V5th, P53; Seo G, 2005, CATAL SURV ASIA, V9, P139, DOI 10.1007/s10563-005-7550-3; SONG IK, 1993, APPL CATAL A-GEN, V96, P53, DOI 10.1016/0926-860X(93)80006-C; Taylor JD, 2001, IND ENG CHEM RES, V40, P67, DOI 10.1021/ie0006357; USHIKUBO T, 1995, APPL CATAL A-GEN, V124, P19, DOI 10.1016/0926-860X(94)00262-2; Voorhoeve R. J. H., 1977, ADV MAT CATALYSIS, P129	22	3	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1040-7278	1572-8862		J CLUST SCI	J. Clust. Sci.	MAY	2015	26	3					653	660		10.1007/s10876-014-0781-6		8	Chemistry, Inorganic & Nuclear	Chemistry	CH5GV	WOS:000354064400002		
J	Azhikodan, G; Yokoyama, K				Azhikodan, Gubash; Yokoyama, Katsuhide			Temporal and Spatial Variation of Mixing and Movement of Suspended Sediment in the Macrotidal Chikugo River Estuary	JOURNAL OF COASTAL RESEARCH			English	Article						Mixing strength; ETM process; flow ratio; macrotidal estuary; synchronism of data acquisition; tidal cycle	MAXIMUM COMPARATIVE OBSERVATIONS; TURBIDITY MAXIMUM; SOUTHWESTERN JAPAN; KUMA RIVERS; TIDAL BORE; DYNAMICS; TRANSPORT; TURBULENCE; MATTER; AUSTRALIA	The effect of mixing on the movement of the estuarine turbidity maximum (ETM) was examined in the highly turbid Chikugo River estuary, Japan, in consideration of four significant issues: semidiurnal and semilunar tidal variations, spatial distribution, and synchronism of data acquisition. Vertical profiles of salinity and turbidity were measured for 2 weeks at 1 km intervals from the river mouth (0 km) to 17 km upstream, with a short duration for every cruise. Spring-neap transition and the spatial variation of mixing, and suspended sediment concentration (SSC) was found during the semilunar tidal cycle. The estuary gradually changed from a vertically well-mixed condition during spring tide to a stratified condition during the neap tide via a partially mixed condition during the intermediate half tides. The relationship between the flow ratio and the SSC showed that ETM growth was dominated by both tidal forcing and freshwater flow. SSC was high when the salinity was 0.5 practical salinity units (psu) in the upper estuary and 10 psu in the lower estuary. For the same mixing strength (MS), SSC in the lower estuary was greater than that in the upper estuary. Based on flow ratio, salinity, and MS, the occurrence of the ETM and its development at the macrotidal estuary was a consequence of three processes: bed-sediment erosion by seawater in the lower estuary, sediment transport in the estuarine channel by the tidal current and freshwater flow, and sediment accumulation at the salinity front in the upper estuary.	[Azhikodan, Gubash; Yokoyama, Katsuhide] Tokyo Metropolitan Univ, Dept Civil & Environm Engn, Tokyo 1920397, Japan	Yokoyama, K (reprint author), Tokyo Metropolitan Univ, Dept Civil & Environm Engn, Tokyo 1920397, Japan.	k-yoko@tmu.ac.jp			River Fund of the Foundation of River and Watershed Environment Management (FOREM), Japan; JSPS KAKENHI [22560520]; Tokyo Metropolitan Government	This research was supported in part by the River Fund of the Foundation of River and Watershed Environment Management (FOREM), Japan. This work was also supported by JSPS KAKENHI grant 22560520. The authors express special gratitude to the Tokyo Metropolitan Government for supporting the Ph.D study of Gubash Azhikodan through the Asian Human Resource Fund Scholarship.	Andersen TJ, 2007, ESTUAR COAST SHELF S, V75, P327, DOI 10.1016/j.ecss.2007.04.039; Suzuki KW, 2008, ESTUAR COAST SHELF S, V78, P541, DOI 10.1016/j.ecss.2008.01.014; SCHUBEL JR, 1968, SCIENCE, V161, P1013, DOI 10.1126/science.161.3845.1013; CLOERN JE, 1987, CONT SHELF RES, V7, P1367, DOI 10.1016/0278-4343(87)90042-2; Wolanski E, 2001, ESTUAR COAST SHELF S, V53, P717, DOI 10.1006/ecss.2001.0799; Capo S, 2006, MAR GEOL, V230, P199, DOI 10.1016/j.margeo.2006.05.003; GELFENBAUM G, 1983, MAR GEOL, V52, P39, DOI 10.1016/0025-3227(83)90020-8; Kitheka JU, 2005, ESTUAR COAST SHELF S, V63, P455, DOI 10.1016/j.ecss.2004.11.011; Muylaert K, 2005, HYDROBIOLOGIA, V540, P127, DOI 10.1007/s10750-004-7128-5; Byun DS, 2007, J MARINE SYST, V67, P102, DOI 10.1016/j.jmarsys.2006.10.003; Uncles RJ, 2010, ESTUAR COAST SHELF S, V87, P213, DOI 10.1016/j.ecss.2009.03.041; Chen MS, 2005, HYDROBIOLOGIA, V540, P79, DOI 10.1007/s10750-004-7122-y; Ji ZG, 2007, ESTUAR COAST SHELF S, V73, P188, DOI 10.1016/j.ecs.2006.12.016; Grabemann I, 1997, ESTUAR COAST SHELF S, V45, P235, DOI 10.1006/ecss.1996.0178; Wolanski E, 2004, ESTUAR COAST SHELF S, V60, P629, DOI 10.1016/j.ecss.2004.03.001; Mitchell SB, 2013, OCEAN COAST MANAGE, V79, P62, DOI 10.1016/j.ocecoaman.2012.05.030; ALLEN GP, 1980, SEDIMENT GEOL, V26, P69, DOI 10.1016/0037-0738(80)90006-8; FESTA JF, 1978, ESTUAR COAST MAR SCI, V7, P347, DOI 10.1016/0302-3524(78)90087-7; Jago CF, 2006, ESTUARIES COASTS, V29, P197, DOI 10.1007/BF02781989; Cook TL, 2007, ESTUAR COAST SHELF S, V72, P235, DOI 10.1016/j.ecss.2006.10.014; Davies J. L., 1964, Z GEOMORPHOL, V8, P127; Deloffre J, 2007, MAR GEOL, V241, P19, DOI 10.1016/j.margeo.2007.02.011; DOBEREINER C, 1983, CAN J FISH AQUAT SCI, V40, P117; Domingues RB, 2012, SCI TOTAL ENVIRON, V416, P300, DOI 10.1016/j.scitotenv.2011.11.043; Dyer K, 1986, COASTAL ESTUARINE SE; Dyer KR, 1997, ESTUARIES PHYS INTRO; Hir P.L., 2007, CONTINENTAL SHELF RE, V27, P1116; Patchineelam SM, 2004, ESTUAR COAST SHELF S, V59, P307, DOI 10.1016/j.ecss.2003.09.011; Peterson O.H., 1984, COASTAL SHELF SCI, V19, P563; Simmons H.B, 1955, P AM SOC CIVIL ENG, P792; Sottolichio A, 2011, CONT SHELF RES, V31, pS36, DOI 10.1016/j.csr.2011.03.016; Suzuki KW, 2013, J OCEANOGR, V69, P15, DOI 10.1007/s10872-012-0151-7; Suzuki KW, 2009, ESTUAR COAST SHELF S, V83, P516, DOI 10.1016/j.ecss.2009.04.023; Suzuki KW, 2012, J OCEANOGR, V68, P453, DOI 10.1007/s10872-012-0109-9; Tolhurst TJ, 2002, PROCEED MARINE SCI, V5, P409; Trevethan M, 2007, ESTUAR COAST SHELF S, V73, P341, DOI 10.1016/j.ecss.2007.01.014; Uncles RJ, 2006, MAR GEOL, V235, P213, DOI 10.1016/j.margeo.2006.10.015; Uncles RJ, 2002, ESTUAR COAST SHELF S, V55, P829, DOI 10.1006/ecss.2002.1032; WOLANSKI E, 1995, ESTUAR COAST SHELF S, V40, P321, DOI 10.1016/S0272-7714(05)80013-7; Xie DF, 2013, J HYDRODYN, V25, P903, DOI 10.1016/S1001-6058(13)60439-4; Yokoyama K, 2013, P HYDR 2013 INT IIT, P441	41	0	0	COASTAL EDUCATION & RESEARCH FOUNDATION	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	0749-0208	1551-5036		J COASTAL RES	J. Coast. Res.	MAY	2015	31	3					680	689		10.2112/JCOASTRES-D-14-00097.1		10	Environmental Sciences; Geography, Physical; Geosciences, Multidisciplinary	Environmental Sciences & Ecology; Physical Geography; Geology	CH5KL	WOS:000354074400016		
J	Tsushima, M; Hamai, K				Tsushima, Masahiro; Hamai, Koichi			Public Cooperation With the Police in Japan: Testing the Legitimacy Model	JOURNAL OF CONTEMPORARY CRIMINAL JUSTICE			English	Article						police legitimacy; trust in police; public cooperation; Japan	PROCEDURAL JUSTICE; PERCEPTIONS	The purpose of this study of public cooperation with the police in Japan is twofold: First, it draws on the legitimacy model to investigate the causal relationship between trust in and cooperation with the police in Japan, and explores how well the model fits the sample data. Second, it seeks to identify the determinant factors of public cooperation with the police in Japan. The key finding of the first analysis is that the legitimacy model does not seem to be sufficiently applicable to the Japanese data. The effects of the two key elements of police legitimacy-perceived duty toward and moral alignment with the police-on cooperation with the police were not significant. The findings of the second analysis show, rather, that gender, age, education, marital status, years of residence, and perceived sanctions are determinants of cooperation with the police. Among the findings, marital status and years of residence are worth our attention, given the results of the gender-specific analyses. Possible reasons for these results are discussed in consideration of various aspects of Japanese society, such as traditional gender role expectations.	[Tsushima, Masahiro] Ryukoku Univ, Dept Sociol, Otsu, Shiga 5202194, Japan; [Hamai, Koichi] Ryukoku Univ, Sch Law, Kyoto, Japan	Tsushima, M (reprint author), Ryukoku Univ, Dept Sociol, 1-5 Yokotani,Seta Oe Cho, Otsu, Shiga 5202194, Japan.	mtsushim@soc.ryukoku.ac.jp			JSPS KAKENHI Grant [22243006]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work is supported by JSPS KAKENHI Grant 22243006.	Ames W. L., 1981, POLICE COMMUNITY JAP; Tankebe J, 2009, CRIMINOLOGY, V47, P1265, DOI 10.1111/j.1745-9125.2009.00175.x; Mazerolle L, 2013, CRIMINOLOGY, V51, P33, DOI 10.1111/j.1745-9125.2012.00289.x; Sunshine J, 2003, SOC PSYCHOL QUART, V66, P153, DOI 10.2307/1519845; Tankebe J, 2013, CRIMINOLOGY, V51, P103, DOI 10.1111/j.1745-9125.2012.00291.x; Sunshine J, 2003, LAW SOC REV, V37, P513, DOI 10.1111/1540-5893.3703002; Kochel TR, 2013, JUSTICE Q, V30, P895, DOI 10.1080/07418825.2011.633544; [Anonymous], 2013, THE JAPAN NEWS  0608, P3; Bayley D. H., 1976, FORCES ORDER POLICE; Beetham D, 1991, LEGITIMACY POWER; Bellah R. N., 1985, HABITS HEART INDIVID; Blunch N. J., 2013, INTRO STRUCTURAL EQU; Braithwaite J., 1989, CRIME SHAME REINTEGR; Grace-Martin K., 2010, 2 REOMMENDED SOLUTIO; Haley J.O., 1991, AUTHORITY POWER LAW; Hough M., 2010, POLICING, V4, P241; Hough M, 2013, J POLICING INTELLIGE, V8, P144; IBM, 2011, AMOS STAT SOM MOD VA; Jackson J., 2009, ESS5 TRUST JUSTICE M; Jackson J., 2012, ESS COUNTRY SPECIFIC; Kline R. B., 2005, PRINCIPLES PRACTICE; Kobayashi Y., 2013, KEISATSUGAKU RONSHU, V66, P1; Kobayashi Y., 2013, CHAKUNIN JI NO SHOKU; National Police Agency, 2014, WHIT PAP POL 2013; Newsom J. T., 2012, IMPROPER SOLUTIONS S; Research and Training Institute Ministry of Justice Japan, 2004, WHIT PAP CRIM 2003; Sato M., 2013, KYOSEI KOZA, V33, P13; Shakai seikatsu to komyunikeishon kenkyukai, 2001, TOSH KOM NIOK JYUM N; Tyler T. R., 1997, SOCIAL JUSTICE DIVER; Tyler Tom R, 2006, WHY PEOPLE OBEY LAW	30	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1043-9862	1552-5406		J CONTEMP CRIM JUST	J. Contemp. Crim. Justice	MAY	2015	31	2			SI		212	228		10.1177/1043986214568836		17	Criminology & Penology	Criminology & Penology	CH4DZ	WOS:000353983800006		
J	Narisawa, Y; Koba, S; Inoue, T; Nagase, K				Narisawa, Yutaka; Koba, Shinichi; Inoue, Takuya; Nagase, Kotaro			Histogenesis of pure and combined Merkel cell carcinomas: An immunohistochemical study of 14 cases	JOURNAL OF DERMATOLOGY			English	Article						bulge; CD200; Merkel cell; Merkel cell carcinoma; stem cell	ADULT HUMAN SCALP; HAIR FOLLICLE; STEM-CELLS; NEUROENDOCRINE CARCINOMAS; POLYOMAVIRUS INFECTION; HUMAN FETAL; IN-VITRO; SKIN; DIFFERENTIATION; TUMOR	The histogenesis of Merkel cell carcinoma (MCC) has remained unresolved. Moreover, one of the questions is whether pure MCC and combined MCC represent the same histogenesis and entity. The existence of combined MCC suggests that MCC likely arise from pluripotent stem cells. Merkel cells (MC) localize within the bulge area, which is populated by hair follicle stem cells. We used hair follicle stem cell markers to investigate whether MCC share certain characteristics of these stem cells. Fourteen MCC specimens were examined histologically and immunohistochemically. There were six pure MCC and eight combined MCC. In six combined MCC, both MCC components and squamous components at least focally shared the expression of one or more of cytokeratin (CK)15, CK19 and CD200, which are hair follicle stem cell markers. On the other hand, four cases of pure MCC showed partially distinct CK19 expression, but did not show CK15 and/or CD200 expression. There was a distinct difference between pure MCC and combined MCC on the expression of hair follicle stem cell markers. The normal skin expressed CK15, CK19 and CD200 in the bulge area, whereas CK15 and CD200 were absent in the MC-rich glabrous skin and touch domes. The results led us to hypothesize that combined MCC originate from the hair follicle stem cells. We postulate that combined MCC undergo multidirectional differentiation into squamous, glandular, mesenchymal and Merkel cells. Further investigation is warranted to confirm the histogenesis of pure MCC and combined MCC.	[Narisawa, Yutaka; Koba, Shinichi; Inoue, Takuya; Nagase, Kotaro] Saga Univ, Div Dermatol, Dept Internal Med, Fac Med, Saga, Saga 8498501, Japan	Narisawa, Y (reprint author), Saga Univ, Div Dermatol, Dept Internal Med, Fac Med, 5-1-1 Nabeshima, Saga, Saga 8498501, Japan.	narisawa@cc.saga-u.ac.jp					Sellheyer K, 2011, J CUTAN PATHOL, V38, P460, DOI 10.1111/j.1600-0560.2010.01671.x; Koba S, 2011, J DERMATOL SCI, V64, P77, DOI 10.1016/j.jdermsci.2011.06.011; DEWOLFPEETERS C, 1980, CANCER, V46, P1810, DOI 10.1002/1097-0142(19801015)46:8<1810::AID-CNCR2820460819>3.0.CO;2-7; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; GOMEZ LG, 1983, AM J SURG PATHOL, V7, P171, DOI 10.1097/00000478-198303000-00007; Walsh NMG, 2001, HUM PATHOL, V32, P680, DOI 10.1053/hupa.2001.25904; Bichakjian CK, 2007, CANCER, V110, P1, DOI 10.1002/cncr.22765; Martin B, 2013, HISTOPATHOLOGY, V62, P711, DOI 10.1111/his.12091; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Ishida M, 2013, J CUTAN PATHOL, V40, P839, DOI 10.1111/cup.12176; McNiff JM, 2005, J CUTAN PATHOL, V32, P541, DOI 10.1111/j.0303-6987.2005.00378.x; Moll I, 2005, EUR J CELL BIOL, V84, P259, DOI 10.1016/j.ejcb.2004.12.023; Wright GJ, 2003, J IMMUNOL, V171, P3034; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595; Paik JY, 2011, HUM PATHOL, V42, P1385, DOI 10.1016/j.humpath.2010.12.013; Pontiggia L, 2009, J INVEST DERMATOL, V129, P480, DOI 10.1038/jid.2008.254; Kuwamoto S, 2011, HUM PATHOL, V42, P632, DOI 10.1016/j.humpath.2010.09.011; Ito M, 2008, J INVEST DERMATOL, V128, P1059, DOI 10.1038/jid.2008.86; Kuwamoto S, 2011, HUM PATHOL, V42, P1063, DOI 10.1016/j.humpath.2011.01.020; Michel M, 1996, J CELL SCI, V109, P1017; Busam KJ, 2009, AM J SURG PATHOL, V33, P1378, DOI 10.1097/PAS.0b013e3181aa30a5; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Cormack D., 1987, HAMS HISTOLOGY; Dadzie O, 2009, INT J DERMATOL, V48, P91, DOI 10.1111/j.1365-4632.2009.03840.x; Eispert AC, 2009, HISTOCHEM CELL BIOL, V132, P83, DOI 10.1007/s00418-009-0578-0; Higaki-Mori H, 2012, HUM PATHOL, V43, P2282, DOI 10.1016/j.humpath.2012.04.002; ISIMBALDI G, 1993, AM J DERMATOPATH, V15, P260, DOI 10.1097/00000372-199306000-00012; Iwasaki T, 2013, HUM PATHOL, V44, P1912, DOI 10.1016/j.humpath.2013.01.026; Koba S, 2015, AM J DERMATOPATH, V37, pE31, DOI 10.1097/DAD.0000000000000064; Koba S, 2014, J CUTAN PATHOL, V41, P469, DOI 10.1111/cup.12289; LEONG ASY, 1986, PATHOLOGY, V18, P256; Moll I, 2012, J SKIN CANC, V2012; Narisawa Y, 1994, J DERMATOL SCI, V7, P13; NARISAWA Y, 1992, J INVEST DERMATOL, V98, P171, DOI 10.1111/1523-1747.ep12555813; NARISAWA Y, 1994, J INVEST DERMATOL, V102, P506, DOI 10.1111/1523-1747.ep12373164; NARISAWA Y, 1992, J HISTOCHEM CYTOCHEM, V40, P65; NARISAWA Y, 1995, ARCH DERMATOL RES, V287, P599, DOI 10.1007/BF00374083; SMITH KJ, 1993, AM J DERMATOPATH, V15, P528, DOI 10.1097/00000372-199312000-00002; STENN KS, 1988, J INVEST DERMATOL, V90, P409, DOI 10.1111/1523-1747.ep12456517; Wong HH, 2010, ARCH PATHOL LAB MED, V134, P1711, DOI 10.1043/2009-0165-RSR2.1	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					445	452		10.1111/1346-8138.12808		8	Dermatology	Dermatology	CH3VW	WOS:000353959700001		
J	Aoki, T; Fukuzumi, T				Aoki, Toshiyuki; Fukuzumi, Takayuki			Atopy-related skin rash in a normal population of infants: Distribution and rates for 50 separate skin regions: Cohort study from 4 months to 3.5 years	JOURNAL OF DERMATOLOGY			English	Article						atopic dermatitis; distribution; infants; population surveillance; skin rash	STRATUM-CORNEUM; BARRIER FUNCTION; DERMATITIS; HYDRATION; LIFE; ADULT; AGE; PH	Analysis of the rash in a normal population of infants may give new information that is different from clinical observation of atopic dermatitis (AD). For this purpose, a cohort study was undertaken on infants at 4months, 10months and 3.5years. Infants who attended the local health center for health check were the subjects. Rash related to AD, dryness, scaling, erythema, papules, exudation and crusts was recorded in 50 skin regions and divided into three degrees. Examination was performed twice a month for a year at each age. The 777 infants who attended all three examinations were analyzed in this report. Rash-positive regions were 14.7% on average at 4months and decreased with age. Prevalence of rash-positive infants was 93.6% at 4months and also decreased with age. The main findings are as follows. First, rash was more frequent and more severe in younger infants. This seems to suggest that AD in early infancy is initiated and developed by immune immaturity, and is resolved by its maturation. Second, rash involved preferentially air-exposed and air-closed skin in younger infants. This seems to be evidence that the epidermis of young infants is easily responsive to both dryness and wetness. Third, some regions did not show age-dependent reduction of rash rate in younger infants. Those regions are probably irritated by saliva and urine or rubbing and scratching.	[Aoki, Toshiyuki] Aoki Skin & Allergy Clin Itchy Dis, Osaka 5430052, Japan; [Fukuzumi, Takayuki] Fukuzumi Allergy Skin Clin, Osaka, Japan	Aoki, T (reprint author), Aoki Skin & Allergy Clin Itchy Dis, Tennoji Ku, 8-15 Daido 1 Chome, Osaka 5430052, Japan.	toshiyuki.aoki@nifty.ne.jp					SAIJO S, 1991, PEDIATR DERMATOL, V8, P155, DOI 10.1111/j.1525-1470.1991.tb00308.x; Stamatas GN, 2010, PEDIATR DERMATOL, V27, P125, DOI 10.1111/j.1525-1470.2009.00973.x; Giusti F, 2001, PEDIATR DERMATOL, V18, P93, DOI 10.1046/j.1525-1470.2001.018002093.x; Denda M, 1998, J INVEST DERMATOL, V111, P858, DOI 10.1046/j.1523-1747.1998.00333.x; [Anonymous], 1980, ACTA DERM-VENEREOL S; Warner RR, 2003, J INVEST DERMATOL, V120, P275, DOI 10.1046/j.1523-1747.2003.12046.x; Nikolovski J, 2008, J INVEST DERMATOL, V128, P1728, DOI 10.1038/sj.jid.5701239; Hoeger PH, 2002, PEDIATR DERMATOL, V19, P256, DOI 10.1046/j.1525-1470.2002.00082.x; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Chiou YB, 2004, SKIN PHARMACOL PHYSI, V17, P57, DOI 10.1159/000076015; Halkjaer LB, 2006, ARCH DERMATOL, V142, P561, DOI 10.1001/archderm.142.5.561; AOKI T, 1992, ACTA DERM-VENEREOL, P19; Archer CB, 2000, ATOPIC DERMATITIS EP, V1st, P25, DOI 10.1017/CBO9780511545771.004; Cork MJ, 2008, TXB ATOPIC DERMATITI, P35; Fukuzumi Takayuki, 2005, Arerugi, V54, P455; Gfatter R, 1997, DERMATOLOGY, V195, P258; Heine RG, 2008, TXB ATOPIC DERMATITI, P85; Katayama I, 2014, ALLERGOL INT, V63, P380; Kunz B, 2002, TXB PEDIAT DERMATOLO, P199; Leung DYM, 2008, TXB ATOPIC DERMATITI, P59; Novak N, 2008, TXB ATOPIC DERMATITI, P25; Shibuya Noriko, 2013, Arerugi, V62, P1598; Sumikawa Yasuyuki, 2007, Arerugi, V56, P1270; Williams HC, 2000, ATOPIC DERMATITIS EP, V1st, P41, DOI 10.1017/CBO9780511545771.005; Williams HC, 2000, ATOPIC DERMATITIS EP, V1st, P3, DOI 10.1017/CBO9780511545771.003; Zhai HB, 2001, SKIN PHARMACOL APPL, V14, P1, DOI 10.1159/000056328	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					453	460		10.1111/1346-8138.12834		8	Dermatology	Dermatology	CH3VW	WOS:000353959700002		
J	Miura, S; Asano, Y; Saigusa, R; Yamashita, T; Taniguchi, T; Takahashi, T; Ichimura, Y; Toyama, T; Tamaki, Z; Tada, Y; Sugaya, M; Sato, S; Kadono, T				Miura, Shunsuke; Asano, Yoshihide; Saigusa, Ryosuke; Yamashita, Takashi; Taniguchi, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Tamaki, Zenshiro; Tada, Yayoi; Sugaya, Makoto; Sato, Shinichi; Kadono, Takafumi			Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis	JOURNAL OF DERMATOLOGY			English	Article						omentin; pulmonary arterial hypertension; systemic sclerosis; vascular inflammation; vasodilation	FLOW-MEDIATED DILATION; CLINICAL-SIGNIFICANCE; ADIPONECTIN LEVELS; ENDOTHELIAL-CELLS; SKIN SCLEROSIS; ADIPOSE-TISSUE; NITRIC-OXIDE; T-CELLS; SCLERODERMA; FIBROBLASTS	Adipokines have been shown to be potentially involved in various pathological processes of systemic sclerosis (SSc), including inflammation, vasculopathy and fibrosis, through their pleiotropic effects. Omentin is a member of the adipokines, and has a protective effect against vascular inflammation and pathological remodeling leading to atherosclerosis as well as a vasodilatory effect. To assess the potential role of omentin in the development of SSc, we determined serum omentin levels by enzyme-linked immunosorbent assay in 66 SSc and 21 control subjects and evaluated their clinical correlation. Serum omentin levels were significantly decreased in diffuse cutaneous SSc patients compared with limited cutaneous SSc patients, while comparable between total SSc patients and healthy controls. In diffuse cutaneous (dc)SSc, patients with a disease duration of 5years or less had serum omentin levels significantly lower than those with a disease duration of more than 5years. In total SSc, serum omentin levels were significantly higher in patients with elevated right ventricular systolic pressure than in the others, while serum omentin levels did not correlate with fibrotic and systemic inflammatory parameters. These results suggest that a loss of omentin-dependent protection against vascular inflammation and remodeling may be related to pathological vascular events of early dcSSc. The elevation of serum omentin levels may serve as a marker of vascular involvement leading to pulmonary arterial hypertension in SSc, which is possibly due to the compensatory induction of omentin against the increased pulmonary vascular tone.	[Miura, Shunsuke; Asano, Yoshihide; Saigusa, Ryosuke; Yamashita, Takashi; Taniguchi, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Tamaki, Zenshiro; Tada, Yayoi; Sugaya, Makoto; Sato, Shinichi; Kadono, Takafumi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp; kadono-der@h.u-tokyo.ac.jp			Ministry of Health, Labor and Welfare of Japan	This work was supported by a grant for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan.	Altorok N, 2014, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2014-205303, DOI 10.1136/ANNRHEUMDIS-2014-205303]; Amiya E, 2013, INT J CARDIOL, V168, P3125, DOI 10.1016/j.ijcard.2013.04.046; Wolf SI, 2013, VASC PHARMACOL, V59, P19, DOI 10.1016/j.vph.2013.05.002; LEROY EC, 1988, J RHEUMATOL, V15, P202; Toyama T, 2013, J EUR ACAD DERMATOL, V27, P337, DOI 10.1111/j.1468-3083.2011.04413.x; Masui Y, 2013, MOD RHEUMATOL, V23, P323, DOI 10.1007/s10165-012-0660-7; Sgonc R, 2000, ARTHRITIS RHEUM-US, V43, P2550, DOI 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H; Abraham DJ, 2009, RHEUMATOLOGY, V48, P3, DOI 10.1093/rheumatology/ken481; Prats-Puig A, 2011, OBESITY, V19, P1905, DOI 10.1038/oby.2011.198; Kahaleh MB, 1999, CLIN IMMUNOL, V91, P188, DOI 10.1006/clim.1999.4694; Aozasa N, 2013, J EUR ACAD DERMATOL, V27, P37, DOI 10.1111/j.1468-3083.2011.04354.x; Alcelik A, 2012, KIDNEY BLOOD PRESS R, V35, P511, DOI 10.1159/000338796; ROSENBAUM J, 1988, CLIN EXP IMMUNOL, V72, P450; Komiya T, 1998, BIOCHEM BIOPH RES CO, V251, P759, DOI 10.1006/bbrc.1998.9513; Masui Y, 2012, J EUR ACAD DERMATOL, V26, P354, DOI 10.1111/j.1468-3083.2011.04077.x; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Matouk CC, 2008, CIRC RES, V102, P873, DOI 10.1161/CIRCRESAHA.107.171025; Maruyama S, 2012, J BIOL CHEM, V287, P408, DOI 10.1074/jbc.M111.261818; Giacomelli R, 1998, ARTHRITIS RHEUM, V41, P327, DOI 10.1002/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S; JOANNIDES R, 1995, CIRCULATION, V91, P1314; Luo YY, 2013, J AUTOIMMUN, V41, P161, DOI 10.1016/j.jaut.2013.01.012; CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892; Schaffler A, 2005, BBA-GENE STRUCT EXPR, V1732, P96, DOI 10.1016/j.bbaexp.2005.11.005; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977; Masui Y, 2014, RHEUMATOL INT, V34, P1165, DOI 10.1007/s00296-013-2880-3; Levey AS, 1999, ANN INTERN MED, V130, P461; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Kazama K, 2012, EUR J PHARMACOL, V686, P116, DOI 10.1016/j.ejphar.2012.04.033; Takahashi T, 2014, MOD RHEUMATOL, V24, P106, DOI 10.3109/14397595.2013.854064; Yamawaki H, 2010, BIOCHEM BIOPH RES CO, V393, P668, DOI 10.1016/j.bbrc.2010.02.053; Kazama K, 2014, AM J PHYSIOL-HEART C, V306, pH1714, DOI 10.1152/ajpheart.00048.2014; Salojin KV, 1997, AM J MED, V102, P178; Tan BK, 2010, TRENDS CARDIOVAS MED, V20, P143, DOI 10.1016/j.tcm.2010.12.002; Moreno-Navarrete JM, 2011, OBESITY, V19, P1552, DOI 10.1038/oby.2010.351; Wang YQ, 2006, ARTHRITIS RHEUM, V54, P2271, DOI 10.1002/art.21948; Masui Y, 2013, RHEUMATOLOGY, V52, P1239, DOI 10.1093/rheumatology/ket010; Hill MB, 1996, CLIN EXP IMMUNOL, V106, P491, DOI 10.1046/j.1365-2249.1996.d01-867.x; Fang F, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4070; Lakota K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3827; Takahashi T, 2012, MOD RHEUMATOL, V22, P598, DOI 10.1007/s10165-011-0545-1; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					461	466		10.1111/1346-8138.12824		6	Dermatology	Dermatology	CH3VW	WOS:000353959700003		
J	Oyama, S; Funasaka, Y; Watanabe, A; Takizawa, T; Kawana, S; Saeki, H				Oyama, Satomi; Funasaka, Yoko; Watanabe, Atsushi; Takizawa, Toshihiro; Kawana, Seiji; Saeki, Hidehisa			BRAF, KIT and NRAS mutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients	JOURNAL OF DERMATOLOGY			English	Article						BRAF; KIT; melanoma; phosphorylated AKT; phosphorylated extracellular signal-regulated kinase	ACTIVATED PROTEIN-KINASE; PRIMARY CUTANEOUS MELANOMA; MELANOCYTIC NEVI; MALIGNANT-MELANOMA; ERK ACTIVATION; GENE MUTATION; PATHWAY; SITES; THERAPEUTICS; ASSOCIATION	To clarify the status of gene mutation and activation of growth signal in melanoma of Japanese patients in vivo, we analyzed the mutation of BRAF exon 15, NRAS exon 2, and KIT exons 9, 11, 13, 17 and 18 in melanoma cells obtained by laser capture microdissection, and performed direct sequencing in 20 cases of acral lentiginous melanoma (ALM) and 17 cases of superficial spreading melanoma (SSM). In the study of the mutation of BRAF, pyrosequencing was also done. To examine the cell proliferation signaling, immunohistochemistry for phosphorylated extracellular signal-regulated kinase (pERK), phosphorylated AKT (phosphorylated AKT) and c-KIT was done. The mutation of BRAF p.V600E was detected in 13 cases of ALM (65.0%) and 12 cases of SSM (70.6%). No NRAS mutation was found in all cases. The mutation in exons 9, 11, and 18 of KIT was detected in nine cases. The mutation of BRAF and KIT showed no correlation with clinical stage, lymph node metastasis, tumor thickness, ulceration and histology. pERK and pAKT was observed in small population of melanoma cells and there was no correlation with gene mutation. Our results indicate that the mutations of BRAF and KIT exist in Japanese melanoma patients, however, the cell growth signaling may be regulated by not only these mutated genes, but by other unknown regulatory factors, which may affect the prognosis of melanoma.	[Oyama, Satomi; Funasaka, Yoko; Kawana, Seiji; Saeki, Hidehisa] Nippon Med Sch, Grad Sch Med, Dept Dermatol, Tokyo 1138602, Japan; [Watanabe, Atsushi] Nippon Med Sch, Grad Sch Med, Mol & Med Genet, Tokyo 1138602, Japan; [Takizawa, Toshihiro] Nippon Med Sch, Grad Sch Med, Mol Med & Anat, Tokyo 1138602, Japan	Funasaka, Y (reprint author), Nippon Med Sch, Dept Dermatol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	funasaka@nms.ac.jp					Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Antonescu CR, 2003, CLIN CANCER RES, V9, P3329; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Ellerhorst JA, 2006, ONCOGENE, V25, P3956, DOI 10.1038/sj.onc.1209419; Poynter JN, 2006, MELANOMA RES, V16, P267, DOI 10.1097/01.cmr.0000222600.73179.f3; Woodman SE, 2010, BIOCHEM PHARMACOL, V80, P568, DOI 10.1016/j.bcp.2010.04.032; Ashida A, 2012, J DERMATOL SCI, V66, P240, DOI 10.1016/j.jdermsci.2012.03.005; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Tsao H, 2003, ARCH DERMATOL, V139, P282, DOI 10.1001/archderm.139.3.282; Dai B, 2013, HUM PATHOL, V44, P1472, DOI 10.1016/j.humpath.2013.01.007; Omholt K, 2011, CLIN CANCER RES, V17, P3933, DOI 10.1158/1078-0432.CCR-10-2917; Si L, 2012, EUR J CANCER, V48, P94, DOI 10.1016/j.ejca.2011.06.056; Saldanha G, 2006, CLIN CANCER RES, V12, P4499, DOI 10.1158/1078-0432.CCR-05-2447; Uribe P, 2006, J INVEST DERMATOL, V126, P161, DOI 10.1038/sj.jid.5700011; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; VANTVEER LJ, 1989, MOL CELL BIOL, V9, P3114; Eggermont AMM, 2014, LANCET, V383, P816, DOI 10.1016/S0140-6736(13)60802-8; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Ohashi A, 1996, MELANOMA RES, V6, P25, DOI 10.1097/00008390-199602000-00004; Ni SJ, 2012, HUM PATHOL, V43, P801, DOI 10.1016/j.humpath.2011.08.005; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Kong Y, 2011, CLIN CANCER RES, V17, P1684, DOI 10.1158/1078-0432.CCR-10-2346; Ellerhorst JA, 2011, CLIN CANCER RES, V17, P229, DOI 10.1158/1078-0432.CCR-10-2276; FUNASAKA Y, 1992, MOL BIOL CELL, V3, P197; Garbe C, 2004, ARCH DERMATOL, V140, P127; HALABAN R, 1991, ANN NY ACAD SCI, V638, P232, DOI 10.1111/j.1749-6632.1991.tb49034.x; HALABAN R, 1992, J IMMUNOTHER, V12, P154, DOI 10.1097/00002371-199210000-00002; Houben R, 2008, J INVEST DERMATOL, V128, P2003, DOI 10.1038/jid.2008.30; Jin Sun A, 2013, J Invest Dermatol, V133, P579, DOI 10.1038/jid.2012.338; Jovanovic B, 2008, J INVEST DERMATOL, V128, P2696, DOI 10.1038/jid.2008.134; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Sasaki Y, 2004, J INVEST DERMATOL, V123, P177, DOI 10.1111/j.0022-202X.2004.22722.x; Takata M, 2005, J INVEST DERMATOL, V125, P318, DOI 10.1111/j.0022-202X.2005.23812.x; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336; Yazdi AS, 2010, EUR J DERMATOL, V20, P575, DOI 10.1684/ejd.2010.1011; Zebary A, 2013, J DERMATOL SCI, V72, P284, DOI 10.1016/j.jdermsci.2013.07.013; Zhuang L, 2005, J CLIN PATHOL, V58, P1163, DOI 10.1136/jcp.2005.025957	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					477	484		10.1111/1346-8138.12822		8	Dermatology	Dermatology	CH3VW	WOS:000353959700005		
J	Fujimoto, N; Nakanishi, G; Kabuto, M; Nakano, T; Eto, H; Nakajima, H; Sano, S; Tanaka, T				Fujimoto, Noriki; Nakanishi, Gen; Kabuto, Miho; Nakano, Toshiaki; Eto, Hikaru; Nakajima, Hideki; Sano, Shigetoshi; Tanaka, Toshihiro			Merkel cell carcinoma showing regression after biopsy: Evaluation of programmed cell death 1-positive cells	JOURNAL OF DERMATOLOGY			English	Article						biopsy; Merkel cell carcinoma; programmed cell death 1; polyomavirus; regression	RESPONSES	We present a cases of Merkel cell carcinoma (MCC) with Merkel cell polyomavirus that showed complete regression after biopsy. The exact mechanism of regression in MCC has remained unclear. It has been reported that apoptosis caused by T-cell immunity was implicated in the regression, and programmed cell death 1 (PD-1), an inhibitory receptor, was expressed in approximately half of tumor-infiltrating T cells in MCC. However, the contribution of PD-1-positive cells for the regression of MCC has not been evaluated. We examined the rate of PD-1-positive cells among the peritumoral mononuclear cells, which showed that the percentage of PD-1-positive cells in the case was significantly lower compared with in MCC without regression. We propose that PD-1-positive cells suppress tumor immunity for MCC, and that reduction of PD-1-positive cells may be associated with tumor regression.	[Fujimoto, Noriki; Nakanishi, Gen; Kabuto, Miho; Tanaka, Toshihiro] Shiga Univ Med Sci, Dept Dermatol, Otsu, Shiga 5202192, Japan; [Nakano, Toshiaki; Eto, Hikaru] St Lukes Hosp, Dept Dermatol, Tokyo, Japan; [Nakajima, Hideki; Sano, Shigetoshi] Kochi Univ, Kochi Med Sch, Dept Dermatol, Kochi 780, Japan	Fujimoto, N (reprint author), Shiga Univ Med Sci, Dept Dermatol, Otsu, Shiga 5202192, Japan.	noriki@belle.shiga-med.ac.jp					Dowlatshahi M, 2013, J INVEST DERMATOL, V133, P1879, DOI 10.1038/jid.2013.75; Nicolaidou E, 2012, BRIT J DERMATOL, V166, P16, DOI 10.1111/j.1365-2133.2011.10562.x; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Sais G, 2002, J EUR ACAD DERMATOL, V16, P82, DOI 10.1046/j.1468-3083.2002.374_2.x; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Koba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041465; Paulson KG, 2011, J CLIN ONCOL, V29, P1539, DOI 10.1200/JCO.2010.30.6308; Takenaka H, 1997, AM J DERMATOPATH, V19, P614, DOI 10.1097/00000372-199712000-00012; Triozzi Pierre L, 2013, Cancers (Basel), V5, P234, DOI 10.3390/cancers5010234; Val-Bernal JF, 2011, ADV ANAT PATHOL, V18, P174, DOI 10.1097/PAP.0b013e31820ce11f; Yagi Y, 2009, J DERMATOL, V36, P312, DOI 10.1111/j.1346-8138.2009.00645.x	11	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					496	499		10.1111/1346-8138.12805		4	Dermatology	Dermatology	CH3VW	WOS:000353959700007		
J	Yasukochi, Y; Nakahara, T; Koike, A; Ichikawa, R; Koga, T; Furue, M				Yasukochi, Yumi; Nakahara, Takeshi; Koike, Akihiro; Ichikawa, Ryutaro; Koga, Tetsuya; Furue, Masutaka			Radiation-induced skin ulcer and rib fractures following percutaneous coronary intervention (PCI): A case of right back skin ulcer and adjacent rib fractures after single PCI	JOURNAL OF DERMATOLOGY			English	Article						interventional radiology; percutaneous coronary intervention; radiation dermatitis; rib fracture; skin ulcer	FLUOROSCOPICALLY GUIDED PROCEDURES; INJURIES	We experienced a 75-year-old male patient with a refractory and severely painful skin ulcer on the right back. He had suffered from ischemic heart disease and undergone percutaneous coronary intervention 5months prior to the consultation with us. The characteristic clinical appearance, location of the lesion and his past medical history led us to the diagnosis of radiation-induced skin ulcer. Magnetic resonance imaging, computed tomography as well as bone scintigraphy showed fractures of the right back rib adjacent to the ulcer, which was thought to be attributable to bone damage due to X-ray radiation and/or persistent secondary inflammation of the chronic ulcer. In the published work, there are no other reports of bone fractures associated with radiation dermatitis after coronary interventional radiology.	[Yasukochi, Yumi; Koga, Tetsuya] Fukuoka Higashi Med Ctr, Dept Dermatol, Fukuoka, Japan; [Yasukochi, Yumi; Nakahara, Takeshi; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 8128582, Japan; [Koike, Akihiro] Fukuoka Higashi Med Ctr, Dept Cardiol, Fukuoka, Japan; [Ichikawa, Ryutaro] Ichikawa Dermatol Clin, Fukuoka, Japan	Yasukochi, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Higashi Ku, 3-1-1 Maedashi, Fukuoka 8128582, Japan.	yummy@dermatol.med.kyushu-u.ac.jp					Koenig TR, 2001, AM J ROENTGENOL, V177, P13; Pettersson N, 2009, RADIOTHER ONCOL, V91, P360, DOI 10.1016/j.radonc.2009.03.022; Asai K, 2012, INT J RADIAT ONCOL, V84, P768, DOI 10.1016/j.ijrobp.2012.01.027; Koenig TR, 2001, AM J ROENTGENOL, V177, P3; Voroney JPJ, 2009, J THORAC ONCOL, V4, P1035, DOI 10.1097/JTO.0b013e3181ae2962; Glazier JJ, 2012, QJM-INT J MED, V105, P571, DOI 10.1093/qjmed/hcr089; Nagai R, 2013, CIRC J, V77, P519, DOI 10.1253/circj.CJ-66-0056; Lichtenstein DA, 1996, ARCH DERMATOL, V132, P663, DOI 10.1001/archderm.132.6.663; Monaco JoAn L, 2003, J Invasive Cardiol, V15, P451	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					508	510		10.1111/1346-8138.12839		3	Dermatology	Dermatology	CH3VW	WOS:000353959700010		
J	Sakiyama, T; Kubo, A; Sasaki, T; Yamada, T; Yabe, N; Matsumoto, K; Futei, Y				Sakiyama, Tomo; Kubo, Akiharu; Sasaki, Takashi; Yamada, Taketo; Yabe, Nobushige; Matsumoto, Ken-ichi; Futei, Yuko			Recurrent gastrointestinal perforation in a patient with Ehlers-Danlos syndrome due to tenascin-X deficiency	JOURNAL OF DERMATOLOGY			English	Article						customized targeted exome sequencing; Ehlers-Danlos syndrome; gastrointestinal perforation; next-generation sequencer; tenascin-X	EXPRESSION; TNXB	Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous disorder. Using a customized targeted exome-sequencing system we identified nonsense mutations in TNXB in a patient who had recurrent gastrointestinal perforation due to tissue fragility. This case highlights the utility of targeted exome sequencing for the diagnosis of congenital diseases showing genetic heterogeneity, and the importance of attention to gastrointestinal perforation in patients with tenascin-X deficient type EDS.	[Sakiyama, Tomo; Futei, Yuko] Ogikubo Hosp, Div Dermatol, Tokyo, Japan; [Sakiyama, Tomo; Kubo, Akiharu; Sasaki, Takashi] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan; [Sasaki, Takashi] Keio Univ, Sch Med, KOSE Endowed Program Skin Care & Allergy Prevent, Tokyo 1608582, Japan; [Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan; [Yamada, Taketo] Saitama Med Univ, Dept Pathol, Saitama, Japan; [Yabe, Nobushige] Ogikubo Hosp, Div Surg, Tokyo, Japan; [Matsumoto, Ken-ichi] Shimane Univ, Interdisciplinary Ctr Sci Res, Org Res, Dept Biosignaling & Radioisotope Expt, Matsue, Shimane, Japan	Kubo, A (reprint author), Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	akiharu@a5.keio.jp	Kubo, Akiharu/I-2711-2014		Ministry of Health, Labour and Welfare of Japan	This work was supported in parts by grants from the Ministry of Health, Labour and Welfare of Japan.	Minamitani T, 2004, EXP CELL RES, V297, P49, DOI 10.1016/j.yexcr.2004.03.002; Zweers MC, 2004, J INVEST DERMATOL, V122, P885, DOI 10.1111/j.0022-202X.2004.22401.x; Zweers MC, 2003, AM J HUM GENET, V73, P214, DOI 10.1086/376564; Penisson-Besnier I, 2013, NEUROMUSCULAR DISORD, V23, P664, DOI 10.1016/j.nmd.2013.04.009; Lindor NM, 2005, AM J MED GENET A, V135A, P75, DOI 10.1002/ajmg.a.30671; Egging DF, 2007, FEBS J, V274, P1280, DOI 10.1111/j.1742-4658.2007.05671.x; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Burcharth J, 2012, DIGEST SURG, V29, P349, DOI 10.1159/000343738; MATSUMOTO K, 1994, J CELL BIOL, V125, P483, DOI 10.1083/jcb.125.2.483; Satoh K, 2010, BIOL PHARM BULL, V33, P1898; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; Voermans NC, 2009, ANN NEUROL, V65, P687, DOI 10.1002/ana.21643	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					511	514		10.1111/1346-8138.12829		4	Dermatology	Dermatology	CH3VW	WOS:000353959700011		
J	Fukuda, H; Takahashi, M; Kato, K; Oharaseki, T; Mukai, H				Fukuda, Hidetsugu; Takahashi, Misaki; Kato, Keiichi; Oharaseki, Toshiaki; Mukai, Hideki			Multiple primary syphilis on the lip, nipple-areola and penis: An immunohistochemical examination of Treponema pallidum localization using an anti-T. pallidum antibody	JOURNAL OF DERMATOLOGY			English	Article						hard chancre; initial sclerosis; primary syphilis; syphilis; Treponema pallidum	HIV	Primary syphilis caused by Treponema pallidum usually develops after sexual contact as an initial solitary sclerosis or hard chancre in the genital region. We describe a case of primary syphilis at three sites in genital and extragenital regions of a man who had sex with men. A 29-year-old man visited our hospital for skin lesions on his lower lip, nipple-areola and penis. A positive syphilis serological test for rapid plasma reagin had a titer of 1:16; the patient also tested positive for specific antibodies against T.pallidum, with a cut-off index of 39.0. Histopathological examination of a nipple-areola biopsy specimen revealed a thickened epidermis and dense infiltration of inflammatory cells extending from the upper dermal layers to the deep dermis. The inflammatory cells were composed of abundant lymphocytes, plasma cells, histiocytes and neutrophils. Immunohistochemical staining for T.pallidum using an anti-T.pallidum antibody showed numerous spirochetes in the lower portion of the epidermis, scattered inside inflammatory cell infiltrate and perivascular sites throughout the dermis. Based on these findings, the patient was diagnosed with primary syphilis. Treatment with oral amoxicillin hydrate was started. Five days after starting treatment, a diffuse maculopapular rash (syphilitic roseola) occurred on his trunk and extremities. Perivascular cuffing due to T.pallidum was present throughout the dermis in the biopsy specimen of a localized lesion of primary syphilis. Moreover, syphilitic roseola, which indicates generalized dissemination of T.pallidum, developed during the course of treatment for primary syphilis. Therefore, we considered perivascular cuffing to be indicative of the dissemination phase.	[Fukuda, Hidetsugu; Takahashi, Misaki; Kato, Keiichi; Mukai, Hideki] Toho Univ, Ohashi Med Ctr, Dept Dermatol, Tokyo 1538515, Japan; [Oharaseki, Toshiaki] Toho Univ, Ohashi Med Ctr, Dept Pathol, Tokyo 1538515, Japan	Fukuda, H (reprint author), Toho Univ, Ohashi Med Ctr, Dept Dermatol, Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.	h-fukuda@med.toho-u.ac.jp					Andrade P, 2013, ACTA DERM-VENEREOL, V93, P236, DOI 10.2340/00015555-1355; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427; Quatresooz P, 2009, APPL IMMUNOHISTO M M, V17, P47, DOI 10.1097/PAI.0b013e3181788186; Quatresooz P, 2009, DERMATOLOGY, V219, P259, DOI 10.1159/000239970; Dourmishev LA, 2005, CLIN DERMATOL, V23, P555, DOI 10.1016/j.clindermatol.2005.01.015; Zheng S, 2014, ACTA DERM-VENEREOL, V94, P617, DOI 10.2340/00015555-1786	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					515	517		10.1111/1346-8138.12818		3	Dermatology	Dermatology	CH3VW	WOS:000353959700012		
J	Noguchi, H; Hiruma, M; Inoue, Y; Miyata, K; Tanaka, M; Ihn, H				Noguchi, Hiromitsu; Hiruma, Masataro; Inoue, Yuji; Miyata, Keishi; Tanaka, Masaru; Ihn, Hironobu			Tinea nigra showing a parallel ridge pattern on dermoscopy	JOURNAL OF DERMATOLOGY			English	Article						dermoscopy; Hortaea werneckii; palm; parallel ridge pattern; tinea nigra		An 18-year-old healthy female student noticed a brown macule measuring 21mm in diameter on the left palm and visited our clinic concerned about a cancerous mole. Dermoscopic examination revealed a brown, fine-dotted and granule-like structure overlapping an amorphous light brown macule. However, unlike previous cases, analysis of the high dynamic range-converted image revealed the parallel ridge pattern frequently observed in malignant melanomas. Brown mycelia were detected on direct microscopic examination; black colonies were isolated on fungal culture and the fungus was identified as Hortaea werneckii. The lesion was treated with topical ketoconazole cream, and it diminished 1month later.	[Noguchi, Hiromitsu] Noguchi Dermatol Clin, Kashima, Kumamoto 8613101, Japan; [Noguchi, Hiromitsu; Miyata, Keishi] Kumamoto Univ, Dept Immunol Allergy & Vasc Biol, Kumamoto, Japan; [Hiruma, Masataro] Ochanomizu Inst Med Mycol & Allergol, Tokyo, Japan; [Inoue, Yuji] Kumamoto City Hosp, Div Dermatol, Dept Immunol, Kumamoto, Japan; [Tanaka, Masaru] Tokyo Womens Med Univ Med Ctr East, Dept Dermatol, Tokyo, Japan; [Ihn, Hironobu] Kumamoto Univ, Dept Dermatol & Plast Surg, Kumamoto, Japan	Noguchi, H (reprint author), Noguchi Dermatol Clin, 1834-1 Namazu, Kashima, Kumamoto 8613101, Japan.	derma@nogcli.jp			Health and Sciences Research Grants for Research on Emerging and Re-emerging Infectious Diseases from Japanese Government, Ministry of Health, Labor and Welfare [H25-shinko-ippan-006]	This study was partly supported by Health and Sciences Research Grants for Research on Emerging and Re-emerging Infectious Diseases (H25-shinko-ippan-006) from the Japanese Government, Ministry of Health, Labor and Welfare.	Gupta G, 1997, BRIT J DERMATOL, V137, P483, DOI 10.1111/j.1365-2133.1997.tb03775.x; Uezato H, 2006, J DERMATOL, V33, P23, DOI 10.1111/j.1346-8138.2006.00004.x; Piliouras P, 2011, AUSTRALAS J DERMATOL, V52, P191, DOI 10.1111/j.1440-0960.2011.00790.x; Hay RJ, 2010, ROOKS TXB DERMATOLOG, V36, P14; Sato Toshitsugu, 2014, Dermatol Pract Concept, V4, P57, DOI 10.5826/dpc.0404a10; Sato T, 2013, JPN J DERMATOL, V123, P121; [Society of Japanese Pharmacopoeia The Minister of Health Labour and Welfare], 2011, JAP PHARM, V16th, P2220; Stocker T. F., 2013, CLIMATE CHANGE 2013, P1, DOI DOI 10.7930/J0Z31WJ2; Tanabe H, 2005, JPN J DERMATOL, V115, P2234	9	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					518	520		10.1111/1346-8138.12830		3	Dermatology	Dermatology	CH3VW	WOS:000353959700013		
J	Saigusa, R; Asano, Y; Nakamura, K; Miura, S; Ichimura, Y; Takahashi, T; Toyama, T; Taniguchi, T; Noda, S; Aozasa, N; Akamata, K; Sumida, H; Miyazaki, M; Tamaki, Z; Yanaba, K; Kuwano, Y; Sato, S				Saigusa, Ryosuke; Asano, Yoshihide; Nakamura, Kouki; Miura, Shunsuke; Ichimura, Yohei; Takahashi, Takehiro; Toyama, Tetsuo; Taniguchi, Takashi; Noda, Shinji; Aozasa, Naohiko; Akamata, Kaname; Sumida, Hayakazu; Miyazaki, Miki; Tamaki, Zenshiro; Yanaba, Koichi; Kuwano, Yoshihiro; Sato, Shinichi			Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis	JOURNAL OF DERMATOLOGY			English	Article						anti-RNA polymerase III antibody; Japanese; malignancy; synchronous onset; systemic sclerosis	POPULATION-BASED COHORT; CANCER; SCLERODERMA; DISEASE	Patients with systemic sclerosis (SSc) have an increased risk of malignancy compared with the general population. Recently, SSc patients with anti-RNA polymerase III antibody have been reported to have an increased risk of malignancy as compared with those with other disease-specific autoantibodies in US, European and Australian populations. Therefore, we studied the relationship between disease-specific autoantibodies and malignancy in 261 Japanese SSc patients. The prevalence of malignancy was significantly higher in patients with anti-RNA polymerase III antibody (7/22, 31.8%) than in those with anti-topoisomerase I antibody (2/82, 2.4%) and in those with anticentromere antibody (8/137, 5.8%). Importantly, among seven patients with anti-RNA polymerase III antibody and malignancy, three patients (42.9%) developed malignancy from 6months before to 12months after SSc onset. Thus, malignancy complication in Japanese SSc patients with anti-RNA polymerase III antibody is as high as that in other races, suggesting that SSc patients with anti-RNA polymerase III antibody share the same pathological process among different ethnic groups.	[Saigusa, Ryosuke; Asano, Yoshihide; Nakamura, Kouki; Miura, Shunsuke; Ichimura, Yohei; Takahashi, Takehiro; Toyama, Tetsuo; Taniguchi, Takashi; Noda, Shinji; Aozasa, Naohiko; Akamata, Kaname; Sumida, Hayakazu; Miyazaki, Miki; Tamaki, Zenshiro; Yanaba, Koichi; Kuwano, Yoshihiro; Sato, Shinichi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp					van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI 10.1136/annrheumdis-2013-204424; Joseph CG, 2014, SCIENCE, V343, P152, DOI 10.1126/science.1246886; Olesen AB, 2010, BRIT J DERMATOL, V163, P800, DOI 10.1111/j.1365-2133.2010.09861.x; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Buchbinder R, 2001, ANN INTERN MED, V134, P1087; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Shah AA, 2010, ARTHRITIS RHEUM-US, V62, P2787, DOI 10.1002/art.27549; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Airo' P, 2011, J RHEUMATOL, V38, P1329, DOI 10.3899/jrheum.101144; Moinzadeh P, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4486; Nikpour M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3544; ROSENTHAL AK, 1995, CANCER, V76, P910, DOI 10.1002/1097-0142(19950901)76:5<910::AID-CNCR2820760528>3.0.CO;2-T; Tatsis E, 1999, ARTHRITIS RHEUM, V42, P751, DOI 10.1002/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					524	527		10.1111/1346-8138.12827		4	Dermatology	Dermatology	CH3VW	WOS:000353959700015		
J	Miura, S; Asano, Y; Saigusa, R; Yamashita, T; Taniguchi, T; Takahashi, T; Ichimura, Y; Toyama, T; Tamaki, Z; Tada, Y; Sugaya, M; Sato, S; Kadono, T				Miura, Shunsuke; Asano, Yoshihide; Saigusa, Ryosuke; Yamashita, Takashi; Taniguchi, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Tamaki, Zenshiro; Tada, Yayoi; Sugaya, Makoto; Sato, Shinichi; Kadono, Takafumi			Serum vaspin levels: A possible correlation with digital ulcers in patients with systemic sclerosis	JOURNAL OF DERMATOLOGY			English	Article						digital ulcers; endothelial cells; systemic sclerosis; vascular smooth muscle cells; vaspin	RHEUMATOID-ARTHRITIS; INSULIN-RESISTANCE; ACTIVATION; INFLAMMATION; ASSOCIATION; SCLERODERMA; ADIPOKINES; SERPINA12; CELLS	Vaspin is an adipokine implicated in vascular inflammation and remodeling. We herein evaluated the clinical correlation of serum vaspin levels in systemic sclerosis (SSc). Consistent with previous reports, 12% of subjects exhibited serum vaspin levels over 10ng/mL, likely due to genetic effects. Excluding these subjects, despite no difference between SSc and control subjects, serum vaspin levels were significantly decreased in SSc patients with digital ulcers compared with those without, suggesting the potential contribution of vaspin to digital ulcers of this disease.	[Miura, Shunsuke; Asano, Yoshihide; Saigusa, Ryosuke; Yamashita, Takashi; Taniguchi, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Tamaki, Zenshiro; Tada, Yayoi; Sugaya, Makoto; Sato, Shinichi; Kadono, Takafumi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp; kadono-der@h.u-tokyo.ac.jp			Ministry of Health, Labor and Welfare of Japan	This work was supported by a grant for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan.	Wolf SI, 2013, VASC PHARMACOL, V59, P19, DOI 10.1016/j.vph.2013.05.002; Noda S, 2013, ARCH DERMATOL RES, V305, P325, DOI 10.1007/s00403-012-1307-4; Toyama T, 2013, J EUR ACAD DERMATOL, V27, P337, DOI 10.1111/j.1468-3083.2011.04413.x; Ozgen M, 2010, ARCH MED RES, V41, P457, DOI 10.1016/j.arcmed.2010.08.012; Aozasa N, 2013, J EUR ACAD DERMATOL, V27, P37, DOI 10.1111/j.1468-3083.2011.04354.x; Heiker JT, 2014, J PEPT SCI, V20, P299, DOI 10.1002/psc.2621; Pehlivan Y, 2012, INT J RHEUM DIS, V15, P374, DOI 10.1111/j.1756-185X.2012.01755.x; Phalitakul S, 2011, PHARMACOL RES, V64, P493, DOI 10.1016/j.phrs.2011.06.001; Verma S, 2003, CIRCULATION, V108, P736, DOI 10.1161/01.CIR.0000084503.91330.49; Masui Y, 2014, RHEUMATOL INT, V34, P1165, DOI 10.1007/s00296-013-2880-3; Kukla M, 2011, POL J PATHOL, V62, P218; Senolt L, 2010, ANN RHEUM DIS, V69, P1410, DOI 10.1136/ard.2009.119735; Nakatsuka A, 2013, CIRC RES, V112, P771, DOI 10.1161/CIRCRESAHA.111.300049; Teshigawara S, 2012, J CLIN ENDOCR METAB, V97, pE1202, DOI 10.1210/jc.2011-3297; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					528	531		10.1111/1346-8138.12810		4	Dermatology	Dermatology	CH3VW	WOS:000353959700016		
J	Takahashi, H; Takahashi, I; Iinuma, S; Honma, M; Iizuka, H				Takahashi, Hidetoshi; Takahashi, Ichiro; Iinuma, Shin; Honma, Masaru; Iizuka, Hajime			Disseminated superficial actinic porokeratosis in a psoriasis patient with a long-term sun-bathing habit	JOURNAL OF DERMATOLOGY			English	Letter									[Takahashi, Hidetoshi; Takahashi, Ichiro; Iinuma, Shin; Honma, Masaru; Iizuka, Hajime] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan	Takahashi, H (reprint author), Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	htakahashi@cpost.plala.or.jp					Bauer JA, 2010, DERMATOL ONLINE J, V16, P20; HAZEN PG, 1985, J AM ACAD DERMATOL, V12, P1077, DOI 10.1016/S0190-9622(85)70136-3; Jung JY, 2009, J DERMATOL, V36, P446; Kawara S, 2011, J DERMATOL, V38, P585, DOI 10.1111/j.1346-8138.2010.01099.x; Stewart L, 2010, ARCH DERMATOL, V146, P1193, DOI 10.1001/archdermatol.2010.298	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					532	533		10.1111/1346-8138.12832		2	Dermatology	Dermatology	CH3VW	WOS:000353959700017		
J	Kato, M; Shimizu, A; Ishikawa, O				Kato, Madoka; Shimizu, Akira; Ishikawa, Osamu			Case of familial Michelin tire baby syndrome	JOURNAL OF DERMATOLOGY			English	Letter							UNDERLYING LIPOMATOUS NEVUS; GENERALIZED FOLDED SKIN		[Kato, Madoka; Shimizu, Akira; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gumma 3718511, Japan	Kato, M (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	mado95@gunma-u.ac.jp					ROSS CM, 1969, ARCH DERMATOL, V100, P320, DOI 10.1001/archderm.100.3.320; Nomura Y, 2010, J AM ACAD DERMATOL, V63, P1110, DOI 10.1016/j.jaad.2009.03.025; ROSS CM, 1972, ARCH DERMATOL, V106, P766; Sardana K, 2003, PEDIATR DERMATOL, V20, P150, DOI 10.1046/j.1525-1470.2003.20212.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					534	536		10.1111/1346-8138.12826		3	Dermatology	Dermatology	CH3VW	WOS:000353959700019		
J	Hirose-Matsuda, H; Okamoto, O; Sakai, T; Ito, A; Kai, Y; Hatano, Y; Hanada, K; Yamaoka, Y; Fujiwara, S				Hirose-Matsuda, Haruna; Okamoto, Osamu; Sakai, Takashi; Ito, Akiko; Kai, Yoshitaka; Hatano, Yutaka; Hanada, Katsuhiro; Yamaoka, Yoshio; Fujiwara, Sakuhei			Multiple malignant changes and recurrent infections in the skin associated with long-term exposure to ultraviolet light and topical psoralen plus ultraviolet A therapy	JOURNAL OF DERMATOLOGY			English	Letter							CARCINOGENESIS		[Hirose-Matsuda, Haruna; Okamoto, Osamu; Sakai, Takashi; Ito, Akiko; Kai, Yoshitaka; Hatano, Yutaka; Fujiwara, Sakuhei] Oita Univ, Dept Dermatol, Fac Med, Yufu City, Oita 8795593, Japan; [Hanada, Katsuhiro; Yamaoka, Yoshio] Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu City, Oita 8795593, Japan	Fujiwara, S (reprint author), Oita Univ, Dept Dermatol, Fac Med, 1-1 Idaigaoka,Hasama Machi, Yufu City, Oita 8795593, Japan.	fujiwara@oita-u.ac.jp					Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Halliday GM, 2011, SEMIN CUTAN MED SURG, V30, P214, DOI 10.1016/j.sder.2011.08.002; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kawasumi M, 2011, P NATL ACAD SCI USA, V108, P13716, DOI 10.1073/pnas.1111378108; Goto T, 2003, NISHINIHON J DERMATO, V65, P25, DOI 10.2336/nishinihonhifu.65.25; Kobayashi K, 2002, JPN J DERMATOL, V112, P1247; Zhang YG, 2002, J BIOL CHEM, V277, P3124, DOI 10.1074/jbc.M110245200	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					536	537		10.1111/1346-8138.12835		2	Dermatology	Dermatology	CH3VW	WOS:000353959700020		
J	Fujii, M; Takahashi, I; Kishiyama, K; Honma, M; Ishida-Yamamoto, A				Fujii, Mizue; Takahashi, Ichiro; Kishiyama, Kazunori; Honma, Masaru; Ishida-Yamamoto, Akemi			Erythema multiforme-type drug eruption with prominent keratinocyte necrosis induced by long-term administration of telmisartan	JOURNAL OF DERMATOLOGY			English	Letter									[Fujii, Mizue; Takahashi, Ichiro] Kitami Red Cross Hosp, Dept Dermatol, Kitami, Hokkaido 0908666, Japan; [Fujii, Mizue; Honma, Masaru; Ishida-Yamamoto, Akemi] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan	Fujii, M (reprint author), Kitami Red Cross Hosp, Dept Dermatol, Kita 6 Jo Higashi 2 Chome, Kitami, Hokkaido 0908666, Japan.	ma0dj@asahikawa-med.ac.jp					Marquart-Elbaz C, 2002, BRIT J DERMATOL, V147, P617, DOI 10.1046/j.1365-2133.2002.48848.x; Constable S, 2006, BRIT J DERMATOL, V155, P491, DOI 10.1111/j.1365-2133.2006.07338.x; Ejaz A Ahsan, 2004, South Med J, V97, P614, DOI 10.1097/00007611-200406000-00023; Ma FF, 2014, J IMMUNOL, V192, P3365, DOI 10.4049/jimmunol.1301522; Vena GA, 2013, IMMUNOPHARM IMMUNOT, V35, P447, DOI 10.3109/08923973.2013.797992	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					537	539		10.1111/1346-8138.12828		3	Dermatology	Dermatology	CH3VW	WOS:000353959700021		
J	Aoshima, M; Ito, T; Tokura, Y				Aoshima, Masahiro; Ito, Taisuke; Tokura, Yoshiki			Erosive pustular dermatosis of the scalp arising concomitantly with elevation of serum matrix metalloproteinase-3 in a patient with rheumatoid arthritis	JOURNAL OF DERMATOLOGY			English	Letter									[Aoshima, Masahiro; Ito, Taisuke; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Aoshima, M (reprint author), Hamamatsu Univ Sch Med, Dept Dermatol, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	maoshima@hama-med.ac.jp					Louis E, 2000, CLIN EXP IMMUNOL, V120, P241, DOI 10.1046/j.1365-2249.2000.01227.x; PYE RJ, 1979, BRIT J DERMATOL, V100, P559, DOI 10.1111/j.1365-2133.1979.tb05581.x; Sawada Y, 2010, ACTA DERM-VENEREOL, V90, P652, DOI 10.2340/00015555-0971; Patton D, 2007, J AM ACAD DERMATOL, V57, P421, DOI 10.1016/j.jaad.2007.04.026; YAMAMOTO T, 1995, INT J DERMATOL, V34, P148, DOI 10.1111/j.1365-4362.1995.tb03605.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					540	541		10.1111/1346-8138.12815		2	Dermatology	Dermatology	CH3VW	WOS:000353959700023		
J	Kikuchi, N; Hanami, Y; Ohtsuka, M; Yamamoto, T				Kikuchi, Nobuyuki; Hanami, Yuka; Ohtsuka, Mikio; Yamamoto, Toshiyuki			Pustular pyoderma gangrenosum: Report of two cases	JOURNAL OF DERMATOLOGY			English	Letter									[Kikuchi, Nobuyuki; Hanami, Yuka; Ohtsuka, Mikio; Yamamoto, Toshiyuki] Fukushima Med Univ, Dept Dermatol, Fukushima 9601295, Japan	Kikuchi, N (reprint author), Fukushima Med Univ, Dept Dermatol, 1 Hikarigaoka, Fukushima 9601295, Japan.	nobuyuk@fmu.ac.jp					BARNES L, 1986, J AM ACAD DERMATOL, V15, P608, DOI 10.1016/S0190-9622(86)70212-0; Brouard MC, 2004, J EUR ACAD DERMATOL, V18, P89, DOI 10.1111/j.1468-3083.2004.00712.x; Larsen CG, 2012, ACTA DERM-VENEREOL, V92, P104, DOI 10.2340/00015555-1167; Nakano S, 2012, EUR J DERMATOL, V22, P153, DOI 10.1684/ejd.2011.1594; Omiya W, 2012, EUR J DERMATOL, V22, P711, DOI 10.1684/ejd.2012.1813	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					542	543		10.1111/1346-8138.12817		2	Dermatology	Dermatology	CH3VW	WOS:000353959700024		
J	Kawaguchi, A; Yamamoto, T; Okubo, Y; Mitsuhashi, Y; Tsuboi, R				Kawaguchi, Atsuko; Yamamoto, Toshiyuki; Okubo, Yukari; Mitsuhashi, Yoshihiko; Tsuboi, Ryoji			Multiple halo nevi subsequent to a short period of sunbathing	JOURNAL OF DERMATOLOGY			English	Letter									[Kawaguchi, Atsuko; Okubo, Yukari; Mitsuhashi, Yoshihiko; Tsuboi, Ryoji] Tokyo Med Univ, Dept Dermatol, Tokyo 1600023, Japan; [Yamamoto, Toshiyuki] Fukushima Med Univ, Dept Dermatol, Fukushima, Japan	Kawaguchi, A (reprint author), Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	atsuko-r@tokyo-med.ac.jp					AKASU R, 1994, J CUTAN PATHOL, V21, P302, DOI 10.1111/j.1600-0560.1994.tb00704.x; TRONNIER M, 1995, J INVEST DERMATOL, V104, P475, DOI 10.1111/1523-1747.ep12605910; Kadekaro AL, 2003, PIGM CELL RES, V16, P434, DOI 10.1034/j.1600-0749.2003.00088.x; Dereure O, 2004, ACTA DERM-VENEREOL, V84, P495; Kuet K, 2014, CLIN EXP DERMATOL, V39, P717, DOI 10.1111/ced.12385	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					543	544		10.1111/1346-8138.12814		2	Dermatology	Dermatology	CH3VW	WOS:000353959700025		
J	Nishibayashi, A; Kubo, T; Matsuda, K; Ikeda, J; Hosokawa, K				Nishibayashi, Akimitsu; Kubo, Tateki; Matsuda, Ken; Ikeda, Jun-ichiro; Hosokawa, Ko			Bronchogenic cyst in the chin region	JOURNAL OF DERMATOLOGY			English	Letter							NECK		[Nishibayashi, Akimitsu; Kubo, Tateki; Hosokawa, Ko] Osaka Univ, Grad Sch Med, Dept Plast Surg, Suita, Osaka 5650871, Japan; [Matsuda, Ken] Niigata Univ, Grad Sch Med, Div Plast & Reconstruct Surg, Niigata, Japan; [Ikeda, Jun-ichiro] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan	Kubo, T (reprint author), Osaka Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, 2-2 C11 Yamadaoka, Suita, Osaka 5650871, Japan.	tateki@psurg.med.osaka-u.ac.jp					Koeller KK, 1999, RADIOGRAPHICS, V19, P52; Koeller KK, 1999, RADIOGRAPHICS, V19, P121; Kotsuji-Maruyama T, 2001, DERMATOLOGY, V203, P192, DOI 10.1159/000051743; Magliocca KR, 2011, J ORAL MAXIL SURG, V69, P2604, DOI 10.1016/j.joms.2011.01.015; Shahin A, 2005, DIAGN CYTOPATHOL, V33, P365, DOI 10.1002/dc.20346; Ustundag E, 2005, J LARYNGOL OTOL, V119, P419	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					544	545		10.1111/1346-8138.12816		2	Dermatology	Dermatology	CH3VW	WOS:000353959700026		
J	Honda, S; Fujimoto, N; Tanaka, T				Honda, Shinichiro; Fujimoto, Noriki; Tanaka, Toshihiro			Basal cell carcinoma with an epidermal collarette: A case report and review of published work	JOURNAL OF DERMATOLOGY			English	Letter									[Honda, Shinichiro; Fujimoto, Noriki; Tanaka, Toshihiro] Shiga Univ Med Sci, Dept Dermatol, Otsu, Shiga 5202192, Japan	Fujimoto, N (reprint author), Shiga Univ Med Sci, Dept Dermatol, Setatsukinowacho, Otsu, Shiga 5202192, Japan.	noriki@belle.shiga-med.ac.jp					Adachi K, 2007, J DERMATOL, V34, P844, DOI 10.1111/j.1346-8138.2007.00398.x; JACOBY RA, 1982, AM J DERMATOPATH, V4, P117, DOI 10.1097/00000372-198204000-00003; Kiyohara T, 2012, J DERMATOL, V39, P1031, DOI 10.1111/j.1346-8138.2012.01528.x; Kramer E, 2014, ISR MED ASSOC J, V16, P229; Lin RL, 2004, CUTIS, V74, P229	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					546	547		10.1111/1346-8138.12823		2	Dermatology	Dermatology	CH3VW	WOS:000353959700027		
J	Kaneko, Y; Asai, J; Wada, M; Kanehisa, F; Yasumi, M; Ikeda, Y; Takenaka, H; Katoh, N				Kaneko, Yuka; Asai, Jun; Wada, Makoto; Kanehisa, Fuminao; Yasumi, Maki; Ikeda, Yoshihiro; Takenaka, Hideya; Katoh, Norito			The triangular intermuscular space: An uncommon sentinel node location in melanoma of the upper arm	JOURNAL OF DERMATOLOGY			English	Letter							DRAINAGE		[Kaneko, Yuka; Asai, Jun; Wada, Makoto; Kanehisa, Fuminao; Yasumi, Maki; Takenaka, Hideya; Katoh, Norito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kyoto 6028566, Japan; [Ikeda, Yoshihiro] Japanese Red Cross Kyoto Daini Hosp, Dept Dermatol, Kyoto, Japan	Asai, J (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	jasai@koto.kpu-m.ac.jp					Coit DG, 2014, J NATL COMPR CANC NE, V12, P621; Caraco C, 2014, ANN SURG ONCOL, V21, P300, DOI 10.1245/s10434-013-3285-y; Gordon D, 2014, ANN SURG ONCOL, V21, P3386, DOI 10.1245/s10434-014-3744-0; Hennessy SA, 2010, ANN SURG ONCOL, V17, P2465, DOI 10.1245/s10434-010-1018-z; Herbert GS, 2010, ANN PLAS SURG, V64, P52, DOI 10.1097/SAP.0b013e31819b6c87	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	MAY	2015	42	5					548	550		10.1111/1346-8138.12831		3	Dermatology	Dermatology	CH3VW	WOS:000353959700029		
J	Tsutsumi, E; Murata, Y; Sakamoto, M; Horikawa, E				Tsutsumi, Eriko; Murata, Yuzo; Sakamoto, Maiko; Horikawa, Etsuo			Effects of exercise on the nephron of Goto-Kakizaki rats: morphological, and advanced glycation end-products and inducible nitric oxide synthase immunohistochemical analyses	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						GK rat; Exercise; Kidney; AGEs; iNOS	INDUCED DIABETIC-RATS; SKELETAL-MUSCLE; OXIDATIVE STRESS; MODEL; EXPRESSION; GLOMERULI; APOPTOSIS; DISEASE; KIDNEY	The current study aimed to examine how exercise affects morphology of the nephron, and localization of advanced glycation end-products (AGEs) and inducible nitric oxide synthase (iNOS) immunoreactivity in diabetic Goto-Kakizaki rats. Four groups of male rats were studied. WE SED (Wistar rats; sedentary) group served as a control. Other groups were WIS EX (Wistar rats; exercise), GK SED (Goto-Kakizaki diabetic rats; sedentary) and GK EX (Goto-Kakizaki diabetic rats; exercise) groups. The rats in EX groups were subjected to 15 weeks of treadmill running at a speed of 15 m/min for a total of 30 minutes, three times a week. Changes in the structure of renal corpuscles and in the distribution of AGEs- and iNOS-immunoreactive cells of the uriniferous tubules were evaluated. Every parameter of GK EX was significantly different from that of GK SED (area of Bowman's capsules: p < 0.001, area of glomeruli: p < 0.05 and the occupancy of a glomerulus: p < 0.05). These findings suggest that exercise may ameliorate glomerular filtration rate (GFR). The localizations of AGEs and iNOS immunostaining in the uriniferous tubules were similar in each group. Immunohistochemical assays revealed that the number of the AGEs and iNOS immunopositive cells of the proximal tubule of cortico-deep layer in EX groups were markedly greater than those in SED groups and that iNOS expression in GK EX was significantly higher than GK SED (p < 0.05). Exercise seems to normalize the GFR and glomerular filtrate absorption from the uriniferous tubules in Goto-Kakizaki diabetic rats with the recovered shape of renal corpuscles and may be involved in the absorption and catabolization of AGEs with iNOS-related reactions for reabsorption. (C) 2015 Elsevier Inc. All rights reserved.	[Tsutsumi, Eriko] Nishikyushu Univ, Fac Rehabil Sci, Kanzaki, Saga 8428585, Japan; [Tsutsumi, Eriko; Sakamoto, Maiko; Horikawa, Etsuo] Saga Univ, Sch Med, Ctr Comprehens & Community Med, Saga 8498501, Japan; [Murata, Yuzo] Saga Univ, Fac Med, Dept Anat & Physiol, Saga 8498501, Japan	Tsutsumi, E (reprint author), Nishikyushu Univ, Fac Rehabil Sci, 4490-9 Ozaki, Kanzaki, Saga 8428585, Japan.	tutumie@nisikyu-u.ac.jp; murata@cc.saga-u.ac.jp; masaka@cc.saga-u.ac.jp; ethori@cc.saga-u.ac.jp					ALBRIGHT AL, 1995, MED SCI SPORT EXER, V27, P1270; Song W, 2009, J GERONTOL A-BIOL, V64, P540, DOI 10.1093/gerona/glp021; Saito A, 2005, ANN NY ACAD SCI, V1043, P637, DOI 10.1196/annals.1333.072; WARD KM, 1994, ANN CLIN LAB SCI, V24, P266; Boor P, 2009, METABOLISM, V58, P1669, DOI 10.1016/j.metabol.2009.05.025; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Luippold G, 2004, NEPHROL DIAL TRANSPL, V19, P342, DOI 10.1093/ndt/gfg584; Maric C, 2008, GENDER MED, V5, P147, DOI 10.1016/j.genm.2008.05.002; Sugimoto H, 1999, DIABETOLOGIA, V42, P878, DOI 10.1007/s001250051241; Kim J, 2010, GRAEF ARCH CLIN EXP, V248, P811, DOI 10.1007/s00417-010-1313-1; Sena CM, 2012, PHARMACOL RES, V65, P497, DOI 10.1016/j.phrs.2012.03.004; Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518; Sellam J, 2013, JOINT BONE SPINE, V80, P568, DOI 10.1016/j.jbspin.2013.09.007; Miyata T, 1998, KIDNEY INT, V53, P416, DOI 10.1046/j.1523-1755.1998.00756.x; Appelhoff RJ, 2010, LAB INVEST, V90, P1225, DOI 10.1038/labinvest.2010.96; Chiasera JM, 2000, ANN CLIN LAB SCI, V30, P346; Choi JY, 2012, J HISTOCHEM CYTOCHEM, V60, P301, DOI 10.1369/0022155411436131; Delbin MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053318; Han XY, 1999, PFLUG ARCH EUR J PHY, V437, P857, DOI 10.1007/s004240050855; HORSTER M, 1968, PFLUG ARCH EUR J PHY, V301, P162, DOI 10.1007/BF00362733; Inagi R., 2012, J ANTI-AGING MED, V8, P29; Kurdak H, 2010, J SPORT SCI MED, V9, P294; Lima-Cabello E, 2010, J APPL PHYSIOL, V108, P575, DOI 10.1152/japplphysiol.00816.2009; Saito A, 2003, J AM SOC NEPHROL, V14, P1123, DOI 10.1097/01.ASN.0000062962.51879.F8; Soya H, 2007, NEUROSCI RES, V58, P341, DOI 10.1016/j.neures.2007.04.004; Tugcu V, 2006, BJU INT, V98, P680, DOI 10.1111/j.1464-410X.2006.06321.x; Vinas JL, 2006, FREE RADICAL BIO MED, V40, P992, DOI 10.1016/j.freeradbiomed.2005.10.046; Yin DK, 2014, J ETHNOPHARMACOL, V151, P667, DOI 10.1016/j.jep.2013.11.025	28	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	MAY-JUN	2015	29	4					472	478		10.1016/j.jdiacomp.2015.03.002		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CH6PE	WOS:000354157700003		
J	Shim, E; Zaima, E				Shim, Eungbo; Zaima, Eiichi			Introduction of Insulation Coordination for UHV AC Systems	JOURNAL OF ELECTRICAL ENGINEERING & TECHNOLOGY			English	Article						Insulation coordination; UHV; Overvoltage; Surge arrester; TOV; VFTO		This paper introduces the insulation coordination study results for UHV AC systems which was performed by CIGRE working group. The study results will be discussed within IEC technical committee in order to amend the IEC Insulation Coordination 60071-1 Ed. 8 2010 and 60071-2 Ed. 3, 1996. This paper includes the insulation coordination of transformer, gas insulated switchgear, metal oxide arresters and clearances of transmission towers. This article also illustrates the overvoltage specific to UHV systems such as TOV(temporary overvoltage), switching overvoltage, lightning overvoltage and VFTO(very fast transient overvoltage).	[Shim, Eungbo] Korea Elect Power Corp, KEPCO Res Inst, Naju, South Korea; [Zaima, Eiichi] Cent Res Inst Elect Power Ind, Tokyo, Japan	Shim, E (reprint author), Korea Elect Power Corp, KEPCO Res Inst, Naju, South Korea.	ebshim@kepco.co.kr; eiichi.zaima@mbr.nifty.com					[Anonymous], 2010, TECHN REQ SUBST EXC; [Anonymous], 2013, INS COORD UHV TRANSM; [Anonymous], 2011, 600711 IEC; Guagfan Li, INT C DEV 1200KV NAT; Zaima Eiichi, IEC CIGRE 2 INT S ST	5	0	0	KOREAN INST ELECTR ENG	SEOUL	901 KSTC, 635-4 YEOKSAM-DONG, GANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1975-0102	2093-7423		J ELECTR ENG TECHNOL	J. Electr. Eng. Technol.	MAY	2015	10	3					1293	1297		10.5370/JEET.2015.10.3.1293		5	Engineering, Electrical & Electronic	Engineering	CH3NM	WOS:000353937400067		
J	Sakamoto, O				Sakamoto, Orie			A Diesel Generator Model with Fluctuating Engine Torque Including Magnetic Saturation for Transient Analysis using XTAP	JOURNAL OF ELECTRICAL ENGINEERING & TECHNOLOGY			English	Article						Diesel engine generator; Electromagnetic transient analysis; Power systems; Synchronous generator; XTAP		Diesel engine generators are widely used in the world, especially in remote site power systems as distributed generators. A weak distribution feeder with a small diesel engine may suffer from voltage and power fluctuations due to misfiring of the engine cylinder. In this study, new generator model with example engine torque was developed for the electromagnetic transient analysis program for power systems named XTAP. The configuration and verification results of the developed model are presented in the paper. The model is considered to be useful for analyses of small power systems with those diesel engines.	Sophia Univ, Dept Engn & Appl Sci, Tokyo, Japan	Sakamoto, O (reprint author), Sophia Univ, Dept Engn & Appl Sci, Tokyo, Japan.	orie-sakamoto@sophia.ac.jp			Japan Power Academy	This work was partly supported by research grant from Japan Power Academy.	ANDERSON PM, 1995, IEEE T ENERGY CONVER, V10, P37, DOI 10.1109/60.372566; Boldea I., 2005, SYNCHRONOUS GENERATO; Noda T., 2011, P INT C POW SYST TRA; Noda T, 2009, IEEE T POWER DELIVER, V24, P390, DOI 10.1109/TPWRD.2008.923397; Noda T, 2011, IEEE T POWER DELIVER, V26, P1030, DOI 10.1109/TPWRD.2010.2091288	5	0	0	KOREAN INST ELECTR ENG	SEOUL	901 KSTC, 635-4 YEOKSAM-DONG, GANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1975-0102	2093-7423		J ELECTR ENG TECHNOL	J. Electr. Eng. Technol.	MAY	2015	10	3					1298	1303		10.5370/JEET.2015.10.3.1298		6	Engineering, Electrical & Electronic	Engineering	CH3NM	WOS:000353937400068		
J	Imanaka, M; Sasamoto, H; Baba, J; Higa, N; Shimabuku, M; Kamizato, R				Imanaka, Masaki; Sasamoto, Hideki; Baba, Jumpei; Higa, Naoto; Shimabuku, Masanori; Kamizato, Ryota			Compensation for Photovoltaic Generation Fluctuation by Use of Pump System with Consideration for Water Demand	JOURNAL OF ELECTRICAL ENGINEERING & TECHNOLOGY			English	Article						Solar powered pumping; Island power system; Demand response; Controllable load	ELECTRICITY; DESIGN	In remote islands, due to expense of existing generation systems, installation of photovoltaic cells (PVs) and wind turbines has a chance of reducing generation costs. However, in island power systems, even short-term power fluctuations change the frequency of grids because of their small inertia constant. In order to compensate power fluctuations, the authors proposed the power consumption control of pumps which send water to tanks. The power control doesn't affect water users' convenience as long as tanks hold water. Based on experimental characteristics of a pump system, this paper shows methods to determine reference power consumption of the system with compensation for short-term PV fluctuations while satisfying water demand. One method uses a PI controller and the other method calculates reference power consumption from water flow reference. Simulations with a PV and a pump system are carried out to find optimum parameters and to compare the methods. Results show that both PI control method and water flow calculation method are useful for satisfying the water demand constraint. The water demand constraint has a little impact to suppression of the short-term power fluctuation in this condition.	[Imanaka, Masaki; Sasamoto, Hideki; Baba, Jumpei] Univ Tokyo, Dept Adv Energy, Tokyo 1138654, Japan; [Higa, Naoto; Shimabuku, Masanori; Kamizato, Ryota] Okinawa Enetech Co Inc, Energy Dev Dept, Urasoe, Okinawa, Japan	Imanaka, M (reprint author), Univ Tokyo, Dept Adv Energy, Tokyo 1138654, Japan.	imanaka@asc.t.u-tokyo.ac.jp; baba@asc.t.u-tokyo.ac.jp; m-shimabuku@o-enetech.co.jp			Okinawa Prefecture	This research is carried out as a project of "Okinawa Smart Energy Island Project" funded by Okinawa Prefecture.	Acakpovi A, 2012, IEEE 4 INT C AD SCI, P65; Ackermann T., 2012, WIND POWER POWER SYS; [Anonymous], 2014, RENEWABLE ENERGY NET; Burt Charles, 2011, R11003 IRR TRAIN RES; Glacia Alvalo, 2008, RENEWABLE ENERGY POT; Hwang WH, 2014, J ELECTR ENG TECHNOL, V9, P1112, DOI 10.5370/JEET.2014.9.3.1112; Imanaka Masaki, 2013, IEEJ ANN C TOK JAP M, V6; Imanaka Masaki, 2011, JICEE, V1, P345; IRENA, 2012, ELECT STORAGE RENEWA; Katan Ramzy E., 1996, POW EL DRIV EN SYST, P81; Kawachi Shunsuke, 2013, JICEE, V3, P25; Masuta Taisuke, 2014, JICEE, V4, P42; Orvis Sierra A., 2011, P11010 IRR TRAIB RES; Park MG, 2014, J ELECTR ENG TECHNOL, V9, P1851, DOI 10.5370/JEET.2014.9.6.1851; Patel D, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P688; Sasamoto Hideki, 2013, IEEE PES INN SMART G; Sasamoto Hideki, 2012, IEEJ ANN C TOK JAP M, V6; Sasamoto Hideki, 2013, IEEJ ANN C TOK JAP M, V6; Tokudome Motoki, 2009, TRANSM DISTR C EXP A	19	0	0	KOREAN INST ELECTR ENG	SEOUL	901 KSTC, 635-4 YEOKSAM-DONG, GANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1975-0102	2093-7423		J ELECTR ENG TECHNOL	J. Electr. Eng. Technol.	MAY	2015	10	3					1304	1310		10.5370/JEET.2015.10.3.1304		7	Engineering, Electrical & Electronic	Engineering	CH3NM	WOS:000353937400069		
J	Fonseca, JGD; Oozeki, T; Ohtake, H; Takashima, T; Kazuhiko, O				Fonseca, Joao Gari da Silva, Jr.; Oozeki, Takashi; Ohtake, Hideaki; Takashima, Takumi; Kazuhiko, Ogimoto			On the Use of Maximum Likelihood and Input Data Similarity to Obtain Prediction Intervals for Forecasts of Photovoltaic Power Generation	JOURNAL OF ELECTRICAL ENGINEERING & TECHNOLOGY			English	Article						Photovoltaic power generation; One-day-ahead forecasts; Prediction intervals; Maximum likelihood estimation; Support vector regression		The objective of this study is to propose a method to calculate prediction intervals for oneday-ahead hourly forecasts of photovoltaic power generation and to evaluate its performance. One year of data of two systems, representing contrasting examples of forecast' accuracy, were used. The method is based on the maximum likelihood estimation, the similarity between the input data of future and past forecasts of photovoltaic power, and on an assumption about the distribution of the error of the forecasts. Two assumptions for the forecast error distribution were evaluated, a Laplacian and a Gaussian distribution assumption. The results show that the proposed method models well the photovoltaic power forecast error when the Laplacian distribution is used. For both systems and intervals calculated with 4 confidence levels, the intervals contained the true photovoltaic power generation in the amount near to the expected one.	[Fonseca, Joao Gari da Silva, Jr.; Kazuhiko, Ogimoto] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Oozeki, Takashi; Ohtake, Hideaki; Takashima, Takumi] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Syst & Applicat Team, Tsukuba, Ibaraki, Japan	Fonseca, JGD (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	jfonseca@iis.u-tokyo.ac.jp			NEDO in the project Research and Development of PV Performance and Reliability Characterization Technologies; JST Agency (CREST)	This work was funded by NEDO in the project Research and Development of PV Performance and Reliability Characterization Technologies, and by the JST Agency (CREST).	Mellit A, 2010, SOL ENERGY, V84, P807, DOI 10.1016/j.solener.2010.02.006; Espinar B., 2010, P 5 EUR PV HYBR MIN, P250; Fonseca J. G. da S., 2012, PROG PHOTOVOLTAICS, V20, P874; Fonseca Jr J. G. da S., 2014, P INT C EL ENG 2014, P1181; Fonseca Jr J. G. da S., 2013, P 281 1 EUR PHOT SOL, P3601; Fonseca Jr J.G.S., 2013, P 17 INT C INT SYST; Geisser Seymour, 1993, PREDICTIVE INFERENCE; Lin C., 2004, SIMPLE PROBABILISTIC; Lorenz E., 2007, P 20 EUR PV C IT; Paulescu M, 2012, WEATHER MODELING FOR; Platt J., 1999, ADV LARGE MARGIN CLA, V1, P61; Yona A., 2008, P IEEE POW EN SOC GE, P1	12	0	0	KOREAN INST ELECTR ENG	SEOUL	901 KSTC, 635-4 YEOKSAM-DONG, GANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1975-0102	2093-7423		J ELECTR ENG TECHNOL	J. Electr. Eng. Technol.	MAY	2015	10	3					1342	1348		10.5370/JEET.2015.10.3.1342		7	Engineering, Electrical & Electronic	Engineering	CH3NM	WOS:000353937400074		
J	Akuzawa, N; Seki, H; Oku, Y; Totsuka, M; Hatori, T; Imai, K; Kitahara, Y; Aoki, J; Tashiro, M; Kurabayashi, M				Akuzawa, Nobuhiro; Seki, Hidenori; Oku, Yuko; Totsuka, Masayuki; Hatori, Takashi; Imai, Kunihiko; Kitahara, Yonosuke; Aoki, Jun; Tashiro, Masahiko; Kurabayashi, Masahiko			THREE CASES OF SPONTANEOUS ISOLATED DISSECTION OF THE SUPERIOR MESENTERIC ARTERY	JOURNAL OF EMERGENCY MEDICINE			English	Article						anticoagulation; conservative therapy; computed tomography; dissection; superior mesenteric artery	MANAGEMENT	Background: Spontaneous isolated superior mesenteric artery dissection is a rare disease that may cause bowel ischemia or aneurysm rupture and subsequent death. Thus, the establishment of a correct diagnosis in the early stage is quite important. Objective: To describe the presentation of 3 patients diagnosed with spontaneous isolated supramesenteric artery dissection and briefly summarize the diagnostic procedure, treatment, and clinical course. Case Reports: We experienced three cases of isolated mesenteric artery dissection in the past 5 years. A definitive diagnosis was obtained by abdominal spiral computed tomography in two cases and angiography in one case. All patients were provided anticoagulation therapy. Conclusion: One patient died of bowel ischemia, 2 were discharged within 21 days without complications, and one was able to discontinue anticoagulation therapy 12 months after discharge. The remaining patient has continued warfarin, making it difficult to determine the end point of anticoagulation. (C) 2015 Elsevier Inc.	[Akuzawa, Nobuhiro; Seki, Hidenori; Oku, Yuko; Totsuka, Masayuki; Hatori, Takashi; Imai, Kunihiko; Kitahara, Yonosuke; Aoki, Jun; Tashiro, Masahiko] Social Insurance Gunma Chuo Gen Hosp, Dept Internal Med, Maebashi, Gumma 3710025, Japan; [Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Gunma, Japan	Akuzawa, N (reprint author), Social Insurance Gunma Chuo Gen Hosp, 1-7-13 Koun Cho, Maebashi, Gumma 3710025, Japan.						Yun WS, 2009, EUR J VASC ENDOVASC, V37, P572, DOI 10.1016/j.ejvs.2008.12.010; Picquet J, 2005, J VASC SURG, V42, P788, DOI 10.1016/j.jvs.2005.05.048; Yasuhara H, 1998, J VASC SURG, V27, P776, DOI 10.1016/S0741-5214(98)70250-2; Morris JT, 2008, J VASC SURG, V47, P649, DOI 10.1016/j.jvs.2007.08.052; Subhas G, 2009, ANN VASC SURG, V23, P788, DOI 10.1016/j.avsg.2008.12.006; Sakamoto I, 2007, EUR J RADIOL, V64, P103, DOI 10.1016/j.ejrad.2007.05.027; Leung DA, 2000, EUR RADIOL, V10, P1916, DOI 10.1007/s003300000520; Javerliat I, 2003, EUR J VASC ENDOVASC, V25, P180, DOI 10.1053/ejvs.2002.1785; Nagai T, 2004, INTERNAL MED, V43, P473, DOI 10.2169/internalmedicine.43.473; Nozu Tsukasa, 2004, Gastroenterology, V127, P1282, DOI 10.1053/j.gastro.2004.01.069; Solis M M, 1993, Ann Vasc Surg, V7, P457, DOI 10.1007/BF02002130; Sparks SR, 2000, ANN VASC SURG, V14, P105, DOI 10.1007/s100169910019; Suzuki S, 2004, ABDOM IMAGING, V29, P153, DOI 10.1007/s00261-003-0110-2; Wain RA, 1999, VASCULAR SURG, V33, P641, DOI 10.1177/153857449903300609; Watring NJ, 2010, J EMERG MED, V39, P576, DOI 10.1016/j.jemermed.2007.05.054; Zimmermam-Lima PM, 2000, ANN VASC SURG, V14, P410, DOI 10.1007/s100169910074	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAY	2015	48	5					E111	E116		10.1016/j.jemermed.2014.12.017		6	Emergency Medicine	Emergency Medicine	CH4VB	WOS:000354030200001		
J	Matsuda, T				Matsuda, Tadashi			Crowd-Sourced Assessment of Technical Skills: An Adjunct to Urology Resident Surgical Simulation Training Editorial Comment	JOURNAL OF ENDOUROLOGY			English	Editorial Material							QUALIFICATION SYSTEM; JAPAN		Kansai Med Univ, Dept Urol & Androl, Hirakata, Osaka 5731010, Japan	Matsuda, T (reprint author), Kansai Med Univ, Dept Urol & Androl, Shinmachi 2-5-1, Hirakata, Osaka 5731010, Japan.	matsudat@takii.kmu.ac.jp					Habuchi T, 2012, SURG ENDOSC, V26, P1656, DOI 10.1007/s00464-011-2088-0; Iwanaka T, 2011, PEDIATR SURG INT, V27, P727, DOI 10.1007/s00383-011-2871-y; Kimura T, 2010, ASIAN J ENDOSC SURG, V3, P66; Matsuda T, 2006, J UROLOGY, V176, P2168, DOI 10.1016/j.juro.2006.07.034; Matsuda T, 2014, J ENDOUROL, V28, P1374, DOI 10.1089/end.2014.0092	5	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0892-7790	1557-900X		J ENDOUROL	J. Endourol.	MAY 1	2015	29	5					609	610		10.1089/end.2015.0033		2	Urology & Nephrology	Urology & Nephrology	CH4XN	WOS:000354037000021		
J	Fukamichi, T; Nishimoto, E				Fukamichi, Tomoe; Nishimoto, Etsuko			Conformational Change Near the Redox Center of Dihydrolipoamide Dehydrogenase Induced by NAD(+) to Regulate the Enzyme Activity	JOURNAL OF FLUORESCENCE			English	Article						Dihydrolipoamide dehydrogenase; FAD; NAD(+); PDC; Time-resolved fluorescence	FLUORESCENCE SPECTROSCOPY; GLUTATHIONE-REDUCTASE; PROTEIN INTERACTIONS; ELECTRON-TRANSFER; DEFICIENCY; DYNAMICS; FLAVOPROTEIN; RESOLUTION; PYRUVATE; ACID	Dihydrolipoamide dehydrogenase (LipDH) transfers two electrons from dihydrolipoamide (DHL) to NAD(+) mediated by FAD. Since this reaction is the final step of a series of catalytic reaction of pyruvate dehydrogenase multi-enzyme complex (PDC), LipDH is a key enzyme to maintain the fluent metabolic flow. We reported here the conformational change near the redox center of LipDH induced by NAD(+) promoting the access of the DHL to FAD. The increase in the affinity of DHL to redox center was evidenced by the decrease in K (M) responding to the increase in the concentration of NAD(+) in Lineweaver-Burk plots. The fluorescence intensity of FAD transiently reduced by the addition of DHL was not recovered but rather reduced by the binding of NAD(+) with LipDH. The fluorescence decay lifetimes of FAD and Trp were prolonged in the presence of NAD(+) to show that FAD would be free from the electron transfer from the neighboring Tyrs and the resonance energy transfer efficiency between Trp and FAD lowered. These results consistently reveal that the conformation near the FAD and the surroundings would be so rearranged by NAD(+) to allow the easier access of DHL to the redox center of LipDH.	[Fukamichi, Tomoe; Nishimoto, Etsuko] Kyushu Univ, Grad Sch, Fac Agr, Biophys Chem Lab, Fukuoka 8128581, Japan	Nishimoto, E (reprint author), Kyushu Univ, Grad Sch, Fac Agr, Biophys Chem Lab, Fukuoka 8128581, Japan.	enish@brs.kyushu-u.ac.jp					ZUKER M, 1985, REV SCI INSTRUM, V56, P14, DOI 10.1063/1.1138457; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; van den Berg PAW, 2002, J PHYS CHEM B, V106, P8858, DOI 10.1021/jp020356s; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Berger I, 1996, CLIN CHIM ACTA, V256, P197, DOI 10.1016/S0009-8981(96)06420-0; DANNA JA, 1971, BIOCHEMISTRY-US, V10, P57; Elpeleg ON, 1997, MUSCLE NERVE, V20, P238; Hong YS, 1997, BBA-MOL BASIS DIS, V1362, P160, DOI 10.1016/S0925-4439(97)00073-2; Liu TC, 1999, PROTEIN EXPRES PURIF, V16, P27, DOI 10.1006/prep.1999.1047; MATTEVI A, 1992, PROTEINS, V13, P336, DOI 10.1002/prot.340130406; Nakashima H, 2014, J FLUORESC, V24, P951, DOI 10.1007/s10895-014-1378-z; Nishimoto E, 2006, J BIOCHEM, V140, P349, DOI 10.1093/jb/mvj156; REED LJ, 1958, J BIOL CHEM, V232, P143; ROBINSON BH, 1977, PEDIATR RES, V11, P1198, DOI 10.1203/00006450-197712000-00006; SAKAGUCHI Y, 1986, EUR J PEDIATR, V145, P271, DOI 10.1007/BF00439399; van den Berg PAW, 2004, BIOPHYS J, V87, P2577, DOI 10.1529/biophysj.104.040030; van den Berg PAW, 1998, BIOPHYS J, V74, P2046; Williams Jr CH, 1992, CHEM BIOCH FLAVOENZY, VIII, P121; WILLIS KJ, 1989, BIOCHEMISTRY-US, V28, P4902, DOI 10.1021/bi00437a056	21	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0509	1573-4994		J FLUORESC	J. Fluoresc.	MAY	2015	25	3					577	583		10.1007/s10895-015-1537-x		7	Biochemical Research Methods; Chemistry, Analytical; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	CH7FS	WOS:000354201800012		
J	Terada, T; Hira, D				Terada, Tomohiro; Hira, Daiki			Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles	JOURNAL OF GASTROENTEROLOGY			English	Review						Drug transporters; Pharmacokinetics; Polymorphisms; Drug-drug interaction	INFLAMMATORY-BOWEL-DISEASE; MULTIDRUG-RESISTANCE PROTEINS; POLYMORPHISM MARKEDLY AFFECTS; ORGANIC ANION TRANSPORTER; RENAL-CELL CARCINOMA; P-GLYCOPROTEIN MDR1; SALT EXPORT PUMP; GENETIC POLYMORPHISMS; PEPTIDE TRANSPORTERS; 421C-GREATER-THAN-A POLYMORPHISM	The efficacy and safety of pharmacotherapies are determined by the complex processes involved in the interactions between drugs with the human body, including pharmacokinetic aspects. Among pharmacokinetic factors, it has been recognized that drug transporters play critical roles for absorption, distribution and excretion of drugs, regulating the membrane transport of drugs. The vast amounts of information on drug transporters collected in the past 20 years have been organized according to biochemical, molecular, genetic, and clinical analyses. Novel technologies, public databases, and regulatory guidelines have advanced the use of such information in drug development and clinical practice. In this review, we selected some clinically important drug transporters expressed in the intestine and liver, and introduced the research history and current knowledge of their pharmacokinetic, pathophysiological, and pharmacogenetic implications.	[Terada, Tomohiro; Hira, Daiki] Shiga Univ Med Sci Hosp, Dept Pharm, Otsu, Shiga 5202192, Japan	Terada, T (reprint author), Shiga Univ Med Sci Hosp, Dept Pharm, Otsu, Shiga 5202192, Japan.	teradat@belle.shiga-med.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology	Work in the authors' laboratory is supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Sugawara M, 2000, J PHARM SCI, V89, P781, DOI 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7; Ieiri I, 2012, DRUG METAB PHARMACOK, V27, P85, DOI 10.2133/dmpk.DMPK-11-RV-098; Sawada K, 1999, J PHARMACOL EXP THER, V291, P705; Kubitz R, 2012, CLIN RES HEPATOL GAS, V36, P536, DOI 10.1016/j.clinre.2012.06.006; Scheffer GL, 2002, LAB INVEST, V82, P193; Ichimaru N, 2001, ATHEROSCLEROSIS, V158, P417, DOI 10.1016/S0021-9150(01)00438-5; Giacomini KM, 2013, CLIN PHARMACOL THER, V94, P3, DOI 10.1038/clpt.2013.86; Dalmasso G, 2011, GASTROENTEROLOGY, V141, P1334, DOI 10.1053/j.gastro.2011.06.080; Link E, 2008, NEW ENGL J MED, V359, P789; Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y; Thomas F, 2009, EUR J CANCER, V45, P2316, DOI 10.1016/j.ejca.2009.05.007; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Hillgren KM, 2013, CLIN PHARMACOL THER, V94, P52, DOI 10.1038/clpt.2013.74; Ingersoll SA, 2012, AM J PHYSIOL-GASTR L, V302, pG484, DOI 10.1152/ajpgi.00477.2011; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Terada T, 2004, CURR DRUG METAB, V5, P85, DOI 10.2174/1389200043489153; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gast.2004.07.024; Pasanen MK, 2006, PHARMACOGENET GENOM, V16, P873, DOI 10.1097/01.fpc.0000230416.82349.90; Hirohashi T, 2000, J BIOL CHEM, V275, P2905, DOI 10.1074/jbc.275.4.2905; Cusatis G, 2006, J NATL CANCER I, V98, P1739, DOI 10.1093/jnci/djj469; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Fukudo M, 2013, CLIN PHARMACOKINET, V52, P593, DOI 10.1007/s40262-013-0058-5; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Giacomini KM, 2013, CLIN PHARMACOL THER, V94, P23, DOI 10.1038/clpt.2013.12; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Urquhart BL, 2008, PHARMACOGENET GENOM, V18, P439, DOI 10.1097/FPC.0b013e3282f974dc; Ritter CA, 2005, DRUG METAB REV, V37, P253, DOI 10.1081/DMR-200047984; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; Zelcer N, 2006, J HEPATOL, V44, P768, DOI 10.1016/j.jhep.2005.07.022; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Bailey KM, 2010, CIRC-CARDIOVASC GENE, V3, P276, DOI 10.1161/CIRCGENETICS.109.898502; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Elsby R, 2012, CLIN PHARMACOL THER, V92, P584, DOI 10.1038/clpt.2012.163; Suzuki H, 1998, SEMIN LIVER DIS, V18, P359, DOI 10.1055/s-2007-1007170; Niemi M, 2011, PHARMACOL REV, V63, P157, DOI 10.1124/pr.110.002857; Donner MG, 2001, HEPATOLOGY, V34, P351, DOI 10.1053/jhep.2001.26213; Yamasaki Y, 2008, CLIN PHARMACOL THER, V84, P95, DOI 10.1038/sj.clpt.6100459; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI [10.1161/CIRCGENETICS.109.934455, 10.1161/CIRCGENETICS.110.934455]; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; Polgar O, 2008, EXPERT OPIN DRUG MET, V4, P1, DOI 10.1517/17425255.4.1.1 ; Tirona RG, 2001, J BIOL CHEM, V276, P35669, DOI 10.1074/jbc.M103792200; Hirohashi T, 1999, J BIOL CHEM, V274, P15181, DOI 10.1074/jbc.274.21.15181; Yoshida K, 2013, ANNU REV PHARMACOL, V53, P581, DOI 10.1146/annurev-pharmtox-011112-140309; Zintzaras E, 2012, INFLAMM BOWEL DIS, V18, P562, DOI 10.1002/ibd.21728; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Van Limbergen J, 2007, INFLAMM BOWEL DIS, V13, P338, DOI 10.1002/ibd.20096; Tomlinson B, 2010, CLIN PHARMACOL THER, V87, P558, DOI 10.1038/clpt.2009.232; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Kajosaari LI, 2005, CLIN PHARMACOL THER, V78, P388, DOI 10.1016/j.clpt.2005.07.005; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Chowbay B, 2005, BRIT J CLIN PHARMACO, V60, P159, DOI 10.1111/j.1365-2125.2005.02392.x; Zhang W, 2006, CLIN CHIM ACTA, V373, P99, DOI 10.1016/j.cca.2006.05.010; Lown KS, 1997, CLIN PHARMACOL THER, V62, P248, DOI 10.1016/S0009-9236(97)90027-8; Furukawa T, 2009, PHARM RES-DORD, V26, P469, DOI 10.1007/s11095-008-9752-7; Mizuno T, 2010, ANN ONCOL, V21, P1382, DOI 10.1093/annonc/mdq150; Keskitalo JE, 2009, PHARMACOGENOMICS, V10, P1617, DOI [10.2217/pgs.09.85, 10.2217/PGS.09.85]; Takada T, 2014, NUCLEOS NUCLEOT NUCL, V33, P275, DOI 10.1080/15257770.2013.854902; Keskitalo JE, 2009, CLIN PHARMACOL THER, V86, P197, DOI 10.1038/clpt.2009.79; Wojtal KA, 2009, DRUG METAB DISPOS, V37, P1871, DOI 10.1124/dmd.109.027367; van Herwaarden AE, 2007, MOL CELL BIOL, V27, P1247, DOI 10.1128/MCB.01621-06; Kohlrausch FB, 2010, BRIT J CLIN PHARMACO, V69, P95, DOI 10.1111/j.1365-2125.2009.03551.x; Adkison KK, 2010, J PHARM SCI-US, V99, P1046, DOI 10.1002/jps.21860; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Ban H, 2010, J GASTROENTEROL, V45, P1014, DOI 10.1007/s00535-010-0248-y; D'Avolio A, 2014, J ANTIMICROB CHEMOTH, V69, P3061, DOI 10.1093/jac/dku234; European Medicines Agency, GUID INV DRUG INT; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Giacomini KM, 2010, MEMBRANE TRANSPORTER; Gradhand U, 2008, PHARMACOGENOMICS J, V8, P42, DOI 10.1038/sj.tpj.6500451; Hashida T, 2001, CLIN PHARMACOL THER, V69, P308, DOI 10.1067/mcp.2001.115142; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; Kartenbeck J, 1996, HEPATOLOGY, V23, P1061; Keppler D, 2014, DRUG METAB DISPOS, V42, P561, DOI 10.1124/dmd.113.055772; Merlin D, 1998, J CLIN INVEST, V102, P2011, DOI 10.1172/JCI4179; Mizuno T, 2012, DRUG METAB PHARMACOK, V27, P631, DOI 10.2133/dmpk.DMPK-12-RG-026; Mizuno T, 2014, THER DRUG MONIT, V36, P310, DOI 10.1097/FTD.0000000000000025; Takahashi N, 2011, PHARMACOLOGY, V87, P241, DOI 10.1159/000324900; Tanaka Y, 2014, PHARMACOGENOMICS J; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; US Department of Health and Human Services Food and Drug Administration, 2012, GUID IND DRUG INT ST; US Department of Health and Human Services Food and Drug Administration, 2009, GUID IND DRUG IND LI	85	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	MAY	2015	50	5					508	519		10.1007/s00535-015-1061-4		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH6EN	WOS:000354129200002		
J	Niikura, R; Yasunaga, H; Yamaji, Y; Horiguchi, H; Fushimi, K; Yamada, A; Hirata, Y; Koike, K				Niikura, Ryota; Yasunaga, Hideo; Yamaji, Yutaka; Horiguchi, Hiromasa; Fushimi, Kiyohide; Yamada, Atsuo; Hirata, Yoshihiro; Koike, Kazuhiko			Factors affecting in-hospital mortality in patients with lower gastrointestinal tract bleeding: a retrospective study using a national database in Japan	JOURNAL OF GASTROENTEROLOGY			English	Article						Lower gastrointestinal tract bleeding; In-hospital mortality; Nonsteroidal anti-inflammatory drugs	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ONTARIO GI BLEED; RESOURCE UTILIZATION; RISK-FACTORS; HEMORRHAGE; OUTCOMES; GENDER; COLONOSCOPY; MANAGEMENT; IMPACT	Bleeding of the lower gastrointestinal tract requires hospitalization and can cause in-hospital death in the most serious cases; however, only a few studies have evaluated in-hospital death from bleeding of the lower gastrointestinal tract. The aim of this study was to investigate the in-hospital mortality of patients with bleeding of the lower gastrointestinal tract and elucidate the factors associated with it using a large-scale database. We analyzed a nationwide database in Japan retrospectively. From the Diagnosis Procedure Combination database, we extracted data on patients who were admitted with visible blood in stool between July 1, 2010 and March 31, 2012. We assessed age, sex, comorbidity, cause of bleeding, type of hospital, medications, body mass index (BMI), and need for blood transfusion and treatments. A multivariable logistic regression model was used to examine factors associated with blood transfusion and in-hospital death. A total of 30,846 patients were identified. The median age was 74 years, and 52.0 % of patients were male. A total of 782 patients died in hospital (2.5 %), and 8,060 patients (26.1 %) needed blood transfusion. In a multivariate analysis, in-hospital death was significantly associated with being older or male; comorbidities, including congestive heart failure, renal disease, and mild to severe liver disease; the cause of bleeding; a nonacademic hospital; nonsteroidal anti-inflammatory drug use; lower BMI; and requirements for blood transfusion, interventional radiology, and surgery. Most factors were similarly associated with blood transfusion. In-hospital mortality was 2.5 % and was associated with age, sex, comorbidities, cause of bleeding, type of hospital, nonsteroidal anti-inflammatory drug use, BMI, blood transfusion, and requirements for treatments.	[Niikura, Ryota; Yamaji, Yutaka; Yamada, Atsuo; Hirata, Yoshihiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan; [Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Hlth Econ & Epidemiol Res, Tokyo 1138655, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Grad Sch Med, Tokyo, Japan	Yamaji, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yamaji-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H22-Policy-031]; Council for Science and Technology Policy, Japan [Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)] [0301002001001]	This study was funded by grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant number H22-Policy-031), and the Council for Science and Technology Policy, Japan [Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) grant number 0301002001001]. The funders played no role in the design of the study, data collection, data analysis, decision to publish the findings, or preparation of the manuscript.	Angtuaco TL, 2001, AM J GASTROENTEROL, V96, P1782, DOI 10.1016/S0002-9270(01)02434-0; Singh S, 2009, AM J GASTROENTEROL, V104, P1298, DOI 10.1038/ajg.2009.15; Yasunaga H, 2013, BRIT J SURG, V100, P1335, DOI 10.1002/bjs.9221; Lanas A, 2005, AM J GASTROENTEROL, V100, P1685, DOI 10.1111/j.1572-0241.2005.41833.x; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1053/S1542-3565(04)00603-2; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; [Anonymous], 2000, WHO TECH REP SER, V894, P1; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832; Arroja B, 2011, EUR J GASTROEN HEPAT, V23, P317, DOI 10.1097/MEG.0b013e328344ccb5; Laine L, 2006, ALIMENT PHARM THERAP, V24, P751, DOI 10.1111/j.1365-2036.2006.03043.x; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Mostafa G, 2002, J TRAUMA, V53, P430, DOI 10.1097/01.TA.0000022347.85881.A8; Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; Yamada A, 2008, DIS COLON RECTUM, V51, P116, DOI 10.1007/s10350-007-9137-8; Yasunaga H, 2013, ANN SURG, V257, P640, DOI 10.1097/SLA.0b013e31826fd541; Chaudhry V, 1998, AM SURGEON, V64, P723; Berrington de GA, 2010, NEW ENGL J MED, V363, P2211, DOI DOI 10.1056/NEJMO0A1000367; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; BROWDER W, 1986, ANN SURG, V204, P530, DOI 10.1097/00000658-198611000-00004; Comay D, 2002, CAN J GASTROENTEROL, V16, P677; Isomura Y, 2014, GASTROINTEST ENDOSC, V80, P118, DOI 10.1016/j.gie.2013.12.030; LEITMAN IM, 1989, ANN SURG, V209, P175, DOI 10.1097/00000658-198902000-00007; Marshall JK, 1999, J CLIN GASTROENTEROL, V29, P165, DOI 10.1097/00004836-199909000-00013; RICHTER JM, 1995, GASTROINTEST ENDOSC, V41, P93, DOI 10.1016/S0016-5107(05)80588-7; Wilcox CM, 1997, DIGEST DIS SCI, V42, P985, DOI 10.1023/A:1018880818217	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	MAY	2015	50	5					533	540		10.1007/s00535-014-0994-3		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH6EN	WOS:000354129200004		
J	Narabayashi, K; Ito, Y; Eid, N; Maemura, K; Inoue, T; Takeuchi, T; Otsuki, Y; Higuchi, K				Narabayashi, Ken; Ito, Yuko; Eid, Nabil; Maemura, Kentaro; Inoue, Takuya; Takeuchi, Toshihisa; Otsuki, Yoshinori; Higuchi, Kazuhide			Indomethacin suppresses LAMP-2 expression and induces lipophagy and lipoapoptosis in rat enterocytes via the ER stress pathway	JOURNAL OF GASTROENTEROLOGY			English	Article						Enterocytes; Indomethacin; LAMP-2; Lipid droplet; Lipophagy; Lipoapoptosis; Endoplasmic reticulum stress; 4-Phenylbutyrate; LC3 puncta	ENDOPLASMIC-RETICULUM STRESS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; UNFOLDED PROTEIN RESPONSE; COLORECTAL-CANCER CELLS; SMALL-INTESTINAL INJURY; INDUCED APOPTOSIS; INDUCED AUTOPHAGY; ARACHIDONIC-ACID; LIPID-METABOLISM; DEATH	Indomethacin enhances small intestinal epithelial cell apoptosis, which may account for mucosal ulceration. However, the involvement of autophagy in indomethacin-induced enterocyte damage is unreported. Using light microscopy and electron microscopy techniques, Western blot analysis, and pharmacological inhibition of autophagy, we investigated the autophagic response of cultured rat enterocytes to indomethacin treatment (200 A mu M) at various time points. Furthermore, autophagy was examined in enterocytes of rats given indomethacin by gavage (10 mg/kg). Our data indicate that indomethacin induced accumulation of cytoplasmic lipid droplets (LDs) in cultured enterocytes, which was associated with time-dependent autophagic responses. Initially (0-6 h), mediated by endoplasmic reticulum stress and suppression of mammalian target of rapamycin, a predominant cytoprotective lipophagy was activated in indomethacin-treated enterocytes, as evidenced by induction and colocalization of LC3-II with LDs, excessive formation of autophagosomes sequestering LDs (autolipophagosomes; ALPs), and decreased viability of enterocytes on blocking autophagy with 3-methyladenine. On prolonged exposure to indomethacin (6-24 h), there was a decrease of LAMP-2 expression in enterocytes coupled with accumulation of ALPs and LDs with fewer autolysosomes in addition to an elevation of lipoapoptosis. These time-dependent autophagic and apoptotic responses to indomethacin treatment were detected in enterocytes of indomethacin-treated rats, confirming in vitro results. The findings of this study describe a novel mechanism of enterocyte damage by indomethacin mediated by endoplasmic reticulum stress, accumulation of LDs, and subsequent activation of the early phase of cytoprotective lipophagy. This is followed by a late phase characterized by reduced expression of lysosomal autophagic proteins, accumulation of ALPs, and enhanced lipoapoptosis.	[Narabayashi, Ken; Inoue, Takuya; Takeuchi, Toshihisa; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 5698686, Japan; [Ito, Yuko; Eid, Nabil; Maemura, Kentaro; Otsuki, Yoshinori] Osaka Med Coll, Div Life Sci, Dept Anat & Cell Biol, Takatsuki, Osaka 5698686, Japan	Otsuki, Y (reprint author), Osaka Med Coll, Div Life Sci, Dept Anat & Cell Biol, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	an1001@art.osaka-med.ac.jp					Benbrook D. M., 2012, Experimental Oncology, V34, P286; Styner M, 2010, J CELL BIOCHEM, V111, P1042, DOI 10.1002/jcb.22793; Yin JJ, 2012, AUTOPHAGY, V8, P158, DOI 10.4161/auto.8.2.18807; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Huang SB, 2010, AUTOPHAGY, V6, P256; Tanaka A, 2002, J PHARMACOL EXP THER, V303, P1248, DOI 10.1124/jpet.102.041715; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P131, DOI 10.1097/MPG.0b013e31822578db; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Ishihara T, 2010, BIOCHEM PHARMACOL, V79, P1622, DOI 10.1016/j.bcp.2010.01.030; Fukumoto K, 2011, INT J MOL MED, V27, P353, DOI 10.3892/ijmm.2011.602; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Eid N, 2013, J MOL HISTOL, V44, P311, DOI 10.1007/s10735-013-9483-x; Lin CW, 2013, J HEPATOL, V58, P993, DOI 10.1016/j.jhep.2013.01.011; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; NAVAROVA J, 1994, METHOD FIND EXP CLIN, V16, P119; Igusa Y, 2012, J GASTROENTEROL, V47, P433, DOI 10.1007/s00535-011-0500-0; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kanamori H, 2009, AM J PATHOL, V174, P1705, DOI 10.2353/ajpath.2009.080875; Fortunato F, 2009, GASTROENTEROLOGY, V137, P350, DOI 10.1053/j.gastro.2009.04.003; Deegan S, 2013, CELL MOL LIFE SCI, V70, P2425, DOI 10.1007/s00018-012-1173-4; Eid N, 2012, J MOL HISTOL, V43, P71, DOI 10.1007/s10735-011-9372-0; Pohle T, 2004, CANCER RES, V64, P3900, DOI 10.1158/0008-5472.CAN-03-3149; Higuchi K, 2009, J GASTROENTEROL, V44, P879, DOI 10.1007/s00535-009-0102-2; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Tatti M, 2012, HUM MOL GENET, V21, P5159, DOI 10.1093/hmg/dds367; Saftig P, 2008, AUTOPHAGY, V4, P510; Gniuli D, 2008, INT J OBESITY, V32, P871, DOI 10.1038/ijo.2008.9; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Fujimori S, 2011, J GASTROENTEROL, V46, P57, DOI 10.1007/s00535-010-0332-3; Eid N, 2013, J HEPATOL, V59, P398, DOI 10.1016/j.jhep.2013.03.038; OTSUKI Y, 1994, LANCET, V344, P28; Basivireddy J, 2003, BIOCHEM PHARMACOL, V65, P683, DOI 10.1016/S0006-2952(02)01616-7; Basseri S, 2012, BIOCH RES INT, V2012, DOI DOI 10.1155/2012/841362; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009; DHAUNSI GS, 1988, BIOCHEM INT, V16, P511; Garris DR, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-15; Guimaraes ELM, 2007, LIVER INT, V27, P1255, DOI 10.1111/j.1478-3231.2007.01578.x; Handa O, 2014, J CLIN BIOCHEM NUTR, V54, P2, DOI 10.3164/jcbn.13-84; Huang KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082034; Inami Y, 2011, BIOCHEM BIOPH RES CO, V412, P618, DOI 10.1016/j.bbrc.2011.08.012; Ito Y, 2011, INT J BREAST CANC, DOI [10.4061/2011/867152, DOI 10.4061/2011/867152]; Kanthasamy A, 2006, ANN NY ACAD SCI, V1074, P234, DOI 10.1196/annals.1369.022; Kim DS, 2012, ARCH PHARM RES, V35, P1269, DOI 10.1007/s12272-012-0718-2; Koga H, 2010, AUTOPHAGY, V6, P825, DOI 10.1096/fj.09-144519; Laha D, 2014, BBA-GEN SUBJECTS, V1840, P1, DOI 10.1016/j.bbagen.2013.08.011; Levine L, 2003, FASEB J, V17, P800, DOI 10.1096/fj.02-0906hyp; Levine Lawrence, 2006, BMC Pharmacology, V6, P7, DOI 10.1186/1471-2210-6-7; Lin CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038706; Naito Y, 2005, DIGEST DIS SCI, V50, pS104, DOI 10.1007/s10620-005-2814-3; Omatsu T, 2010, J GASTROENTEROL, V45, P692, DOI 10.1007/s00535-010-0213-9; Orido T, 2010, ARCH BIOCHEM BIOPHYS, V494, P78, DOI 10.1016/j.abb.2009.11.025; Otsuki Yoshinori, 2004, Medical Electron Microscopy, V37, P163; Quan W, 2012, EXP MOL MED, V44, P81, DOI 10.3858/emm.2012.44.2.030; Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109; Rodriguez-Navarro JA, 2010, SEMIN IMMUNOPATHOL, V32, P343, DOI 10.1007/s00281-010-0219-7; SAITOH O, 1994, J GASTROENTEROL, V29, P703, DOI 10.1007/BF02349274; Takeuchi K, 2010, ADV CLIN CHEM, V51, P121, DOI 10.1016/S0065-2423(10)51005-9; Tanigawa T, 2010, GASTROENTEROLOGY, V138, pS; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Unuma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056526; Zhang YJ, 2011, ANN SURG ONCOL, V18, P580, DOI 10.1245/s10434-010-1268-9	68	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	MAY	2015	50	5					541	554		10.1007/s00535-014-0995-2		14	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH6EN	WOS:000354129200005		
J	Uraoka, T; Higashi, R; Horii, J; Harada, K; Hori, K; Okada, H; Mizuno, M; Tomoda, J; Ohara, N; Tanaka, T; Chiu, HM; Yahagi, N; Yamamoto, K				Uraoka, Toshio; Higashi, Reiji; Horii, Joichiro; Harada, Keita; Hori, Keisuke; Okada, Hiroyuki; Mizuno, Motowo; Tomoda, Jun; Ohara, Nobuya; Tanaka, Takehiro; Chiu, Han-Mo; Yahagi, Naohisa; Yamamoto, Kazuhide			Prospective evaluation of endoscopic criteria characteristic of sessile serrated adenomas/polyps	JOURNAL OF GASTROENTEROLOGY			English	Article						Sessile serrated adenoma/polyp; Colonoscopy; Magnification endoscopy; Pit pattern; Narrowband imaging; Varicose microvascular vessel	PATHOLOGICAL CHARACTERISTICS; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; POLYPS; COLONOSCOPY; LESIONS; COLON; DIAGNOSIS; FEATURES; ADENOMA	Differentiating sessile serrated adenoma/polyp (SSA/P) from hyperplastic polyp (HP) is clinically important in determining the necessity of endoscopic resection or recommending appropriate surveillance. There are few reports of characterization of SSA/P using narrowband imaging and chromoendoscopy with and without magnification. We aimed to establish imaging criteria to aid real-time diagnosis of SSA/P. Patients with pale sessile or flat lesions of 6 mm or greater were prospectively enrolled in this multicenter trial. Nine endoscopic criteria, determined in real time, were investigated for possible association with SSA/P. Endoscopic mucosal resection was performed; specimens were retrieved and analyzed by histopathological examination. In 63 patients, 89 lesions were detected, including 41 HP, 38 SSA/P, five mixed polyps, and five other lesions. Right-side colon location, lesion size of 10 mm or greater, excessive mucus, the presence of a varicose microvascular vessel (VMV) noted with high-magnification narrowband imaging, and type IIIH pit pattern were each commonly associated with SSA/P compared with HP. Multivariate analysis substantiated three independent endoscopic criteria for SSA/P: the presence of VMV (p = 0.001), lesion size of 10 mm or greater (p = 0.0017), and right-side location (p = 0.0041), with odds ratios of 8.2, 7.2, and 6.1, respectively. The presence of VMV had a significantly higher specificity (87.8 %) than the other two independent endoscopic criteria (p = 0.0007 and p = 0.0008, respectively), but a lower sensitivity (57.9 %), whereas a combination of the three criteria (two or more positive) increased the sensitivity significantly (89.5 % and p = 0.0033) and had a higher degree of accuracy (82.3 %). Three endoscopic criteria individually and in combination were effective in predicting a diagnosis of SSA/P without the need for chromoendoscopy.	[Uraoka, Toshio; Yahagi, Naohisa] Keio Univ, Sch Med, Ctr Canc, Div Res & Dev Minor Invas Treatment, Tokyo, Japan; [Uraoka, Toshio; Harada, Keita; Hori, Keisuke; Okada, Hiroyuki] Okayama Univ Hosp, Dept Endoscopy, Okayama, Japan; [Uraoka, Toshio] Natl Hosp Org, Tokyo Med Ctr, Dept Gastroenterol, Meguro Ku, Tokyo 1528902, Japan; [Higashi, Reiji; Yamamoto, Kazuhide] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Higashi, Reiji; Mizuno, Motowo] Hiroshima City Hosp, Dept Internal Med, Hiroshima, Japan; [Horii, Joichiro; Tomoda, Jun] Fukuyama Med Ctr, Dept Internal Med, Fukuyama, Hiroshima, Japan; [Ohara, Nobuya] Japanese Red Cross Okayama Hosp, Dept Pathol, Okayama, Japan; [Tanaka, Takehiro] Okayama Univ Hosp, Dept Pathol, Okayama, Japan; [Chiu, Han-Mo] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Uraoka, T (reprint author), Natl Hosp Org, Tokyo Med Ctr, Dept Gastroenterol, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528902, Japan.	turaoka@a3.keio.jp					Hawkins NJ, 2001, J NATL CANCER I, V93, P1307, DOI 10.1093/jnci/93.17.1307; Tadepalli US, 2011, GASTROINTEST ENDOSC, V74, P1360, DOI 10.1016/j.gie.2011.08.008; Ignjatovic A, 2009, LANCET ONCOL, V10, P1171, DOI 10.1016/S1470-2045(09)70329-8; Hazewinkel Y, 2013, GASTROINTEST ENDOSC, V77, P916, DOI 10.1016/j.gie.2012.12.018; Tajiri H, 2008, ENDOSCOPY, V40, P775, DOI 10.1055/s-2008-1077507; Kudo SE, 1996, GASTROINTEST ENDOSC, V44, P8, DOI 10.1016/S0016-5107(96)70222-5; Chiu HM, 2007, GUT, V56, P373, DOI 10.1136/gut.2006.099614; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Snover DC, 2005, AM J CLIN PATHOL, V124, P380, DOI 10.1309/V2EPTPLJRB3FGHJL; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Boparai KS, 2009, GASTROINTEST ENDOSC, V70, P947, DOI 10.1016/j.gie.2009.03.1172; Kimura T, 2012, AM J GASTROENTEROL, V107, P460, DOI 10.1038/ajg.2011.457; Nakao Y, 2013, EUR J GASTROEN HEPAT, V25, P981, DOI 10.1097/MEG.0b013e3283614b2b; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; SKINNER SA, 1995, DIGEST DIS SCI, V40, P373, DOI 10.1007/BF02065424; Dell'Abate P, 2000, Surg Endosc, V14, P865; Fujii Takahiro, 1999, Stomach and Intestine (Tokyo), V34, P1653; Gurudu SR, 2010, WORLD J GASTROENTERO, V16, P3402, DOI 10.3748/wjg.v16.i27.3402; Higuchi T, 2005, HISTOPATHOLOGY, V47, P32, DOI 10.1111/j.1365-2259.2005.02180.x; MORSON BC, 1962, JAMA-J AM MED ASSOC, V179, P316; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rex DK, 2002, AM J GASTROENTEROL, V97, P1530, DOI 10.1016/S0002-9270(02)04158-8; Sano Y, 2006, DIGEST ENDOSC, V18, pS44, DOI DOI 10.1111/J.1443-1661.2006.00621.X; Snover DC, 2010, WHO CLASSIFICATION T, P160; Uraoka T, 2011, STOMACH INTESTINE, V46, P406; Uraoka T, 2009, GUT, V58, P604, DOI 10.1136/gut.2008.157164; Workshop. PitP, 2003, GASTROINTEST ENDOS S, V58, pS3	27	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	MAY	2015	50	5					555	563		10.1007/s00535-014-0999-y		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH6EN	WOS:000354129200006		
J	Hijioka, S; Hosoda, W; Mizuno, N; Hara, K; Imaoka, H; Bhatia, V; Mekky, MA; Tajika, M; Tanaka, T; Ishihara, M; Yogi, T; Tsutumi, H; Fujiyoshi, T; Sato, T; Hieda, N; Yoshida, T; Okuno, N; Shimizu, Y; Yatabe, Y; Niwa, Y; Yamao, K				Hijioka, Susumu; Hosoda, Waki; Mizuno, Nobumasa; Hara, Kazuo; Imaoka, Hiroshi; Bhatia, Vikram; Mekky, Mohamed A.; Tajika, Masahiro; Tanaka, Tsutomu; Ishihara, Makoto; Yogi, Tatsuji; Tsutumi, Hideharu; Fujiyoshi, Toshihisa; Sato, Takamitsu; Hieda, Nobuhiro; Yoshida, Tsukasa; Okuno, Nozomi; Shimizu, Yasuhiro; Yatabe, Yasushi; Niwa, Yasumasa; Yamao, Kenji			Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?	JOURNAL OF GASTROENTEROLOGY			English	Article						Neuroendocrine carcinoma; Ki67 labeling index; KRAS mutation; WHO classification	FINE-NEEDLE-ASPIRATION; ENDOSCOPIC ULTRASOUND; PROGNOSTIC-FACTORS; CENTER EXPERIENCE; ENDOCRINE TUMORS; FNA SPECIMENS; SMALL-CELL; ENETS; KI-67; GUIDELINES	The WHO classified pancreatic neuroendocrine neoplasms in 2010 as G1, G2, and neuroendocrine carcinoma (NEC), according to the Ki67 labeling index (LI). However, the clinical behavior of NEC is still not fully studied. We aimed to clarify the clinicopathological and molecular characteristics of NECs. We retrospectively evaluated the clinicopathological characteristics, KRAS mutation status, treatment response, and the overall survival of eleven pNEC patients diagnosed between 2001 and 2014 according to the WHO 2010. We subclassified WHO-NECs into well-differentiated NEC (WDNEC) and poorly differentiated NEC (PDNEC). The latter was further subdivided into large-cell and small-cell subtypes. The median Ki67 LI was 69.1 % (range 40-95 %). Eleven WHO-NECs were subclassified into 4 WDNECs and 7 PDNECs. The latter was further separated into 3 large-cell and 4 small-cell subtypes. Comparisons of WDNEC vs. PDNEC revealed the following traits: hypervascularity on CT, 50 % (2/4) vs. 0 % (0/7) (P = 0.109); median Ki67 LI, 46.3 % (40-53 %) vs. 85 % (54-95 %) (P = 0.001); Rb immunopositivity, 100 % (4/4) vs. 14 % (1/7) (P = 0.015); KRAS mutations, 0 % (0/4) vs. 86 % (6/7) (P = 0.015); response rates to platinum-based chemotherapy, 0 % (0/2) vs. 100 % (4/4) (P = 0.067), and median survival, 227 vs. 186 days (P = 0.227). The WHO-NEC category may be composed of heterogeneous disease entities, namely WDNEC and PDNEC. These subgroups tended to exhibit differing profiles of Ki67 LI, Rb immunopositivity and KRAS mutation, and distinct response to chemotherapy. Further studies for the reevaluation of the current WHO 2010 classification are warranted.	[Hijioka, Susumu; Mizuno, Nobumasa; Hara, Kazuo; Imaoka, Hiroshi; Yogi, Tatsuji; Tsutumi, Hideharu; Fujiyoshi, Toshihisa; Sato, Takamitsu; Hieda, Nobuhiro; Yoshida, Tsukasa; Okuno, Nozomi; Yamao, Kenji] Aichi Canc Ctr Hosp, Dept Gastroenterol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Hosoda, Waki; Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 4648681, Japan; [Bhatia, Vikram] Inst Liver & Biliary Sci, Dept Med Hepatol, Delhi, India; [Mekky, Mohamed A.] Assiut Univ Hosp, Dept Trop Med & Gastroenterol, Assiut, Egypt; [Tajika, Masahiro; Tanaka, Tsutomu; Ishihara, Makoto; Niwa, Yasumasa] Aichi Canc Ctr Hosp, Dept Endoscopy, Nagoya, Aichi 4648681, Japan; [Shimizu, Yasuhiro] Aichi Canc Ctr Hosp, Dept Surg, Nagoya, Aichi 4648681, Japan	Hijioka, S (reprint author), Aichi Canc Ctr Hosp, Dept Gastroenterol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	rizasusu@aichi-cc.jp			Pancreas Research Foundation of Japan; JSPS KAKENHI [26461041]	This study was supported by a grant from the Pancreas Research Foundation of Japan and JSPS KAKENHI Grant Number 26461041.	Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Pape UF, 2008, CANCER-AM CANCER SOC, V113, P256, DOI 10.1002/cncr.23549; Haba S, 2013, J GASTROENTEROL, V48, P973, DOI 10.1007/s00535-012-0695-8; Rodallec M, 2006, PANCREATOLOGY, V6, P77, DOI 10.1159/000090026; Mitry E, 1999, BRIT J CANCER, V81, P1351, DOI 10.1038/sj.bjc.6690325; Larghi A, 2012, GASTROINTEST ENDOSC, V76, P570, DOI 10.1016/j.gie.2012.04.477; Piani C, 2008, ENDOCR-RELAT CANCER, V15, P175, DOI 10.1677/ERC-07-0126; Hosoda W, 2010, PATHOL INT, V60, P358, DOI 10.1111/j.1440-1827.2010.02527.x; MOERTEL CG, 1991, CANCER, V68, P227, DOI 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I; Nassar H, 2005, AM J SURG PATHOL, V29, P588, DOI 10.1097/01.pas.0000157974.05397.4f; Plockinger U, 2004, NEUROENDOCRINOLOGY, V80, P394, DOI 10.1159/000085237; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Ito T, 2015, J GASTROENTEROL, V50, P58, DOI 10.1007/s00535-014-0934-2; Ogura T, 2012, GASTROINTEST ENDOSC, V75, P769, DOI 10.1016/j.gie.2011.11.012; Sorbye H, 2013, ANN ONCOL, V24, P152, DOI 10.1093/annonc/mds276; Pavel M, 2012, NEUROENDOCRINOLOGY, V95, P157, DOI 10.1159/000335597; Rindi G, 2006, VIRCHOWS ARCH, V449, P395, DOI 10.1007/s00428-006-0250-1; Gerdes B, 2002, ANN SURG, V235, P51, DOI 10.1097/00000658-200201000-00007; Chatzipantelis P, 2009, CANCER CYTOPATHOL, V117, P211, DOI 10.1002/cncy.20025; Yachida S, 2012, AM J SURG PATHOL, V36, P173, DOI 10.1097/PAS.0b013e3182417d36; d'Assignies G, 2009, RADIOLOGY, V250, P407, DOI 10.1148/radiol.2501080291; BARTON CM, 1995, MOL CARCINOGEN, V13, P61, DOI 10.1002/mc.2940130202; Basturk O, 2014, AM J SURG PATHOL, V38, P437, DOI 10.1097/PAS.0000000000000169; Bosman FT, 2010, WHO CLASSIFICATION T; Fonseca Paula J, 2013, Case Rep Oncol, V6, P441, DOI 10.1159/000354754; Hasegawa T, 2014, ENDOSCOPY, V46, P32, DOI 10.1055/s-0033-1344958; Hijioka S, 2011, PANCREATOLOGY, V11, P390, DOI 10.1159/000330536; Parwani AV, 2003, MODERN PATHOL, V16, P299, DOI 10.1097/01.MP.0000062656.60581.AA; Velayoudom-Cephise FL, 2013, ENDOCR-RELAT CANCER, V20, P649, DOI 10.1530/ERC-13-0027; Weynand B, 2014, CYTOPATHOLOGY, V25, P389, DOI 10.1111/cyt.12111	30	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	MAY	2015	50	5					564	572		10.1007/s00535-014-0987-2		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH6EN	WOS:000354129200007		
J	Yoshiya, S; Shirabe, K; Imai, D; Toshima, T; Yamashita, Y; Ikegami, T; Okano, S; Yoshizumi, T; Kawanaka, H; Maehara, Y				Yoshiya, Shohei; Shirabe, Ken; Imai, Daisuke; Toshima, Takeo; Yamashita, Yo-ichi; Ikegami, Toru; Okano, Shinji; Yoshizumi, Tomoharu; Kawanaka, Hirofumi; Maehara, Yoshihiko			Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy	JOURNAL OF GASTROENTEROLOGY			English	Article						F13A; Apelin-APJ signaling; Hepatocyte proliferation; TNF-alpha; IL-6	HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR; MICE; RAT; NECROSIS; RECEPTOR; INJURY; TRANSPLANTATION; EXPRESSION; RESECTION	Liver regeneration after massive hepatectomy or living donor liver transplantation is critical. The apelin-APJ system is involved in the regulation of cardiovascular function, inflammation, fluid homeostasis, the adipo-insular axis, and angiogenesis, but its function in liver regeneration remains unclear. We investigated the impact of pharmacologic blockade of the apelin-APJ system, using the specific APJ antagonist F13A on liver regeneration after hepatectomy in mice. F13A-treated mice had significantly higher serum concentrations of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 than control mice, due to F13A-promoted activation of Kupffer cells. Compared with untreated mice, F13A enhanced the signal transducer and activator of transcription 3 and mitogen-activated protein kinase pathways, stimulated cell-cycle progression, and promoted hepatocyte proliferation and liver regeneration without inducing apoptosis or inflammation in regenerating livers. In vitro, Kupffer cells expressed APJ and were activated directly by F13A treatment, releasing TNF-alpha and IL-6. Moreover, F13A-treated mice had a higher survival rate than untreated mice in the extended hepatectomy model. F13A treatment promotes early phase liver regeneration after hepatectomy by promoting the activation of Kupffer cells and increasing serum levels of TNF-alpha and IL-6. F13A treatment may become a therapeutic option to facilitate efficient liver regeneration after liver surgery.	[Yoshiya, Shohei; Shirabe, Ken; Imai, Daisuke; Toshima, Takeo; Yamashita, Yo-ichi; Ikegami, Toru; Okano, Shinji; Yoshizumi, Tomoharu; Kawanaka, Hirofumi; Maehara, Yoshihiko] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan	Yoshiya, S (reprint author), Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yoshiya@surg2.med.kyushu-u.ac.jp; kshirabe@surg2.med.kyushu-u.ac.jp			JSPS KAKENHI [26861081]	This work was supported in part by JSPS KAKENHI Grant Number 26861081.	Tian YH, 2006, P NATL ACAD SCI USA, V103, P4598, DOI 10.1073/pnas.0600499103; Webber EM, 1998, HEPATOLOGY, V28, P1226, DOI 10.1002/hep.510280509; Meijer C, 2000, LIVER, V20, P66, DOI 10.1034/j.1600-0676.2000.020001066.x; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Ijichi H, 2006, J HEPATOL, V45, P28, DOI 10.1016/j.jhep.2005.12.021; Takeishi T, 1999, ARCH HISTOL CYTOL, V62, P413, DOI 10.1679/aohc.62.413; Higgins GM, 1931, ARCH PATHOL, V12, P186; Shirabe K, 1999, J AM COLL SURGEONS, V188, P304, DOI 10.1016/S1072-7515(98)00301-9; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Ninomiya M, 2010, AM J TRANSPLANT, V10, P1580, DOI 10.1111/j.1600-6143.2010.03150.x; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Abshagen K, 2007, AM J PHYSIOL-GASTR L, V292, pG1570, DOI 10.1152/ajpgi.00399.2006; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Kidoya H, 2012, J BIOCHEM, V152, P125, DOI 10.1093/jb/mvs071; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Leeper NJ, 2009, AM J PHYSIOL-HEART C, V296, pH1329, DOI 10.1152/ajpheart.01341.2008; Ikegami T, 2012, AM J TRANSPLANT, V12, P1886, DOI 10.1111/j.1600-6143.2012.04052.x; Reichenbach V, 2012, J PHARMACOL EXP THER, V340, P629, DOI 10.1124/jpet.111.188078; Yasuzaki H, 2013, LIVER INT, V33, P118, DOI 10.1111/liv.12006; da Silva CG, 2013, HEPATOLOGY, V57, P2014, DOI 10.1002/hep.26197; Brenndorfer ED, 2010, HEPATOLOGY, V52, P1553, DOI 10.1002/hep.23870; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Han S, 2013, AM J PHYSIOL-GASTR L, V305, pG139, DOI 10.1152/ajpgi.00370.2012; Chu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057231; GAVIOLI R, 1992, CELL IMMUNOL, V142, P186, DOI 10.1016/0008-8749(92)90279-X; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Lam SP, 2010, LIVER TRANSPLANT, V16, P1195, DOI 10.1002/lt.22136; Liu K, 2003, WORLD J GASTROENTERO, V9, P1946; Melgar-Lesmes P, 2010, ENDOCRINOLOGY, V151, P5306, DOI 10.1210/en.2010-0754; Ringelhan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046469; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Tiani Carolina, 2009, J Hepatol, V50, P296, DOI 10.1016/j.jhep.2008.09.019; Yang K, 2013, J SURG RES, V183, P922, DOI 10.1016/j.jss.2013.02.033; Zimmers TA, 2003, HEPATOLOGY, V38, P326, DOI 10.1053/jhep.2003.50318	38	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	MAY	2015	50	5					573	582		10.1007/s00535-014-0992-5		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH6EN	WOS:000354129200008		
J	Miyake, T; Kumagi, T; Furukawa, S; Hirooka, M; Kawasaki, K; Koizumi, M; Todo, Y; Yamamoto, S; Tokumoto, Y; Ikeda, Y; Abe, M; Kitai, K; Matsuura, B; Hiasa, Y				Miyake, Teruki; Kumagi, Teru; Furukawa, Shinya; Hirooka, Masashi; Kawasaki, Keitarou; Koizumi, Mitsuhito; Todo, Yasuhiko; Yamamoto, Shin; Tokumoto, Yoshio; Ikeda, Yoshio; Abe, Masanori; Kitai, Kohichiro; Matsuura, Bunzo; Hiasa, Yoichi			Short sleep duration reduces the risk of nonalcoholic fatty liver disease onset in men: a community-based longitudinal cohort study	JOURNAL OF GASTROENTEROLOGY			English	Article						Sleep; Short sleep duration; Nonalcoholic fatty liver disease onset; Risk factor	HEPATIC STEATOSIS; PREVALENCE; OBESITY; STEATOHEPATITIS; ASSOCIATION; POPULATION; WEIGHT; IMPACT; LEVEL	Epidemiologic studies show an association between short sleep duration and the presence of nonalcoholic fatty liver disease (NAFLD). This study examined the association between short sleep duration and the onset of NAFLD. This community-based, retrospective, longitudinal cohort study included 6,370 Japanese subjects who had undergone annual health check-ups more than twice at a single center between April 2003 and March 2010. After excluding 3,941 subjects, the records of 2,429 Japanese subjects were reviewed. Two groups comprised the study cohort: those with short (a parts per thousand currency sign6 h) sleep durations (n = 1,543) and those with moderate (7-8 h) sleep durations (n = 886). During the observation period, 296 subjects developed NAFLD. Multivariate analysis identified an association between short sleep duration and the reduced onset of NAFLD in men (odds ratio: 0.551, 95 % confidence interval 0.365-0.832, p = 0.005). There was no association between short sleep duration and NAFLD onset in women. The prevalence of NAFLD onset in men increased significantly as sleep duration increased, as follows: 12.5, 18.4, and 27.4 % among subjects who had sleep durations of a parts per thousand currency sign4, 5-6, and 7-8 h, respectively (p = 0.02). This study demonstrates an association between sleep duration and NAFLD onset. Short sleep duration reduced the risk of NAFLD onset in men. Correct recognition is important to prevent disease progression and further complications.	[Miyake, Teruki; Kumagi, Teru; Hirooka, Masashi; Kawasaki, Keitarou; Koizumi, Mitsuhito; Todo, Yasuhiko; Yamamoto, Shin; Tokumoto, Yoshio; Ikeda, Yoshio; Abe, Masanori; Matsuura, Bunzo; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan; [Kumagi, Teru; Kitai, Kohichiro] Ehime Univ, Grad Sch Med, Dept Community Med, Toon City, Ehime 7910295, Japan; [Furukawa, Shinya] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Toon City, Ehime 7910295, Japan; [Kawasaki, Keitarou; Koizumi, Mitsuhito] Ehime Gen Hlth Care Assoc, Matsuyama, Ehime 7900814, Japan	Hiasa, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan.	hiasa@m.ehime-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [25750045]; Ehime University	This work was supported in part by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI No. 25750045), and a research grant from Ehime University.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Miyake T, 2013, J GASTROENTEROL, V48, P413, DOI 10.1007/s00535-012-0650-8; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Bellentani S, 2000, ANN INTERN MED, V132, P112; Ohkuma T, 2013, DIABETES CARE, V36, P611, DOI 10.2337/dc12-0904; Stranges S, 2008, AM J EPIDEMIOL, V167, P321, DOI 10.1093/aje/kwm302; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Gangwisch JE, 2005, SLEEP, V28, P1289; Lucassen EA, 2012, ANN NY ACAD SCI, V1264, P110, DOI 10.1111/j.1749-6632.2012.06655.x; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Miyake T, 2012, J GASTROENTEROL, V47, P696, DOI 10.1007/s00535-012-0534-y; Watanabe M, 2010, SLEEP, V33, P161; BONNET MH, 1991, J APPL PHYSIOL, V71, P1112; Hayashino Y., 2007, PUBLIC HLTH, V7, P129, DOI DOI 10.1186/1471-2458-7-129; Miyake T, 2013, J GASTROENTEROL, V48, P550, DOI 10.1007/s00535-012-0735-4; Miyake T, 2013, J GASTROEN HEPATOL, V28, P71, DOI 10.1111/jgh.12251; Miyake T, 2015, J GASTROENTEROL, V50, P230, DOI 10.1007/s00535-014-0959-6; [OECD OECD], 2009, OECD SOC GLANC 2009; Shimada M, 2002, J HEPATOL, V37, P154, DOI 10.1016/S0168-8278(02)00099-5	24	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	MAY	2015	50	5					583	589		10.1007/s00535-014-0989-0		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH6EN	WOS:000354129200009		
J	Oya, H; Kanda, M; Sugimoto, H; Shimizu, D; Takami, H; Hibino, S; Hashimoto, R; Okamura, Y; Yamada, S; Fujii, T; Nakayama, G; Koike, M; Nomoto, S; Fujiwara, M; Kodera, Y				Oya, Hisaharu; Kanda, Mitsuro; Sugimoto, Hiroyuki; Shimizu, Dai; Takami, Hideki; Hibino, Soki; Hashimoto, Ryoji; Okamura, Yukiyasu; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Koike, Masahiko; Nomoto, Shuji; Fujiwara, Michitaka; Kodera, Yasuhiro			Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor	JOURNAL OF GASTROENTEROLOGY			English	Article						Hepatocellular carcinoma; DPYSL3; Methylation; Tumor suppressor	EPITHELIAL-MESENCHYMAL TRANSITION; PROMOTER HYPERMETHYLATION; CANCER; GENE; EXPRESSION; FAMILY; MECHANISMS; TUSC1	Patients with hepatocellular carcinoma (HCC) may relapse after curative resection. Sensitive biomarkers for HCC are required to enhance disease management. Dihydropyrimidinase-like 3 (DPYSL3) suppresses cell proliferation and tumorigenicity of certain malignancies; however, its role in HCC is unknown. The expression levels of DPYSL3 and genes encoding potential interacting proteins vascular endothelial growth factor (VEGF), focal adhesion kinase (FAK), ezrin, and cellular src were determined using RT-PCR. Further, we determined the methylation status of the DPYSL3 promoter in HCC cells lines and the effect of inhibiting DPYSL3 expression on their phenotype. DPYSL3 expression was determined in 151 pairs of resected liver tissues. DPYSL3 mRNA levels were down-regulated in most HCC cell lines with DPYSL3 promoter hypermethylation, and expression was restored after demethylation. DPYSL3 expression levels inversely correlated with those of VEGF and FAK. Knockdown of DPYSL3 significantly increased migration and the invasive properties of HCC cells. The mean level of DPYSL3 mRNA was significantly lower in HCC tissues compared with corresponding noncancerous tissues. The expression patterns of DPYSL3 mRNA and protein were consistent. DPYSL3 mRNA expression in HCC tissues inversely correlated with preoperative serum tumor markers and was significantly lower in patients with extrahepatic recurrences. Disease-specific and recurrence-free survival was significantly shorter in patients with down-regulated DPYSL3 expression. Our results indicate that DPYSL3 is a putative HCC tumor suppressor, and promoter hypermethylation potently regulates DPYSL3 transcription. Down-regulation of DPYSL3 expression in HCC tissues may serve as a predictive biomarker for HCC after curative resection.	[Oya, Hisaharu; Kanda, Mitsuro; Sugimoto, Hiroyuki; Shimizu, Dai; Takami, Hideki; Hibino, Soki; Hashimoto, Ryoji; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Koike, Masahiko; Nomoto, Shuji; Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, Nagoya, Aichi 4668550, Japan; [Okamura, Yukiyasu] Shizuoka Canc Ctr, Dept Hepatobiliary Pancreat Surg, Shunto, Shizuoka 4118777, Japan	Kanda, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	m-kanda@med.nagoya-u.ac.jp					Coulon S, 2011, LIVER INT, V31, P146, DOI 10.1111/j.1478-3231.2010.02369.x; Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Seitz HK, 2006, BIOL CHEM, V387, P349, DOI 10.1515/BC.2006.047; Sawan C, 2008, MUTAT RES-FUND MOL M, V642, P1, DOI 10.1016/j.mrfmmm.2008.03.002; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Vincent P, 2005, J IMMUNOL, V175, P7650; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Kanda M, 2014, INT J ONCOL, V44, P44, DOI 10.3892/ijo.2013.2165; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Blasco H, 2013, HUM MUTAT, V34, P953, DOI 10.1002/humu.22329; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Gao X, 2010, ONCOGENE, V29, P4555, DOI 10.1038/onc.2010.213; Kanda M, 2008, J SURG ONCOL, V98, P190, DOI 10.1002/jso.21095; Kanda M, 2014, J SURG ONCOL, V110, P136, DOI 10.1002/jso.23614; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Khare S, 2013, WORLD J GASTROENTERO, V19, P5439, DOI 10.3748/wjg.v19.i33.5439; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; Hiroshima Y, 2013, ANN SURG ONCOL, V20, pS369, DOI 10.1245/s10434-012-2491-3; Kawahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079654; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Matsuo T, 2000, J BIOL CHEM, V275, P16560, DOI 10.1074/jbc.M001312200; Ning Z, 2014, ONCOL REP, V32, P1451, DOI 10.3892/or.2014.3354; Shimizu D, 2014, ONCOL REP, V31, P1305, DOI 10.3892/or.2013.2939; Sobin LH, 2009, TNM CLASSIFICATION M; Wang LH, 1997, J NEUROCHEM, V69, P2261	35	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	MAY	2015	50	5					590	600		10.1007/s00535-014-0993-4		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH6EN	WOS:000354129200010		
J	Uematsu, H; Inoue, Y; Ohto, Y				Uematsu, Hiroshi; Inoue, Yasuhiro; Ohto, Yasuo			Detection of Pantoea stewartii from sweet corn leaves by loop-mediated isothermal amplification (LAMP)	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Pantoea stewartii; Loop-mediated isothermal amplification (LAMP); Diagnostics	ERWINIA-STEWARTII; SUBSP INDOLOGENES; RAPID DETECTION; IDENTIFICATION; PCR; ASSAY; DIFFERENTIATION; MAIZE; SEEDS; GENE	To improve the diagnosis of Stewart's wilt, we developed a loop-mediated isothermal amplification (LAMP) assay, based on two conserved sequences of the cpsD and pstS-glmS gene regions. The detection limit of the LAMP assay was 10(4) colony-forming units/mL. No cross reaction was observed with other Pantoea spp., other genera associated with sweet corn diseases, or strains isolated from the surface of maize leaves in Japan. The LAMP reaction was not inhibited by leaf contents. The simplicity of sample preparation and short processing time make this LAMP assay useful for field surveillance of Stewart's wilt.	[Uematsu, Hiroshi; Inoue, Yasuhiro; Ohto, Yasuo] Agr Res Ctr, Natl Agr & Food Res Org, Tsukuba, Ibaraki 3058666, Japan	Uematsu, H (reprint author), Agr Res Ctr, Natl Agr & Food Res Org, Tsukuba, Ibaraki 3058666, Japan.	uematsuh@affrc.go.jp					Wensing A, 2010, APPL ENVIRON MICROB, V76, P6248, DOI 10.1128/AEM.01032-10; MERGAERT J, 1993, INT J SYST BACTERIOL, V43, P162; Tambong JT, 2008, J APPL MICROBIOL, V104, P1525, DOI 10.1111/j.1365-2672.2007.03674.x; Xu R, 2010, LETT APPL MICROBIOL, V50, P216, DOI 10.1111/j.1472-765X.2009.02780.x; Kubota R, 2008, PHYTOPATHOLOGY, V98, P1045, DOI 10.1094/PHYTO-98-9-1045; Coplin DL, 2002, PLANT DIS, V86, P304, DOI 10.1094/PDIS.2002.86.3.304; Harper SJ, 2010, PHYTOPATHOLOGY, V100, P1282, DOI [10.1094/PHYTO-06-10-0168, 10.1094/PHYTO.06.10.0168]; LAMKA GL, 1991, PHYTOPATHOLOGY, V81, P839, DOI 10.1094/Phyto-81-839; Gehring I, 2014, J APPL MICROBIOL, V116, P1553, DOI 10.1111/jam.12467; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; COPLIN DL, 1990, MOL PLANT MICROBE IN, V3, P286, DOI 10.1094/MPMI-3-286; IPPC (International Plant Protection Convention), 2002, IPPC PUB, V27; MAFF Plant Protection Station, 2014, PLANTS PLANT PROD SU; Notomi T., 2000, NUCLEIC ACIDS RES, V28, pe63; Okuda M, 2005, PLANT DIS, V89, P705, DOI 10.1094/PD-89-0705; Okuda M., 2008, Japanese Journal of Phytopathology, V74, P316, DOI 10.3186/jjphytopath.74.316; Oya H., 2008, Japanese Journal of Phytopathology, V74, P304, DOI 10.3186/jjphytopath.74.304; Pataky J, 2003, PEST RISK ANAL RISK	18	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	MAY	2015	81	3					173	179		10.1007/s10327-015-0580-4		7	Plant Sciences	Plant Sciences	CH6ER	WOS:000354129600001		
J	Liu, JY; Kim, BM; Kaneko, YH; Inukai, T; Masuta, C				Liu, Jinyan; Kim, Bo Min; Kaneko, Yo-hei; Inukai, Tsuyoshi; Masuta, Chikara			Identification of the TuNI gene causing systemic necrosis in Arabidopsis ecotype Ler infected with Turnip mosaic virus and characterization of its expression	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Arabidopsis; Turnip mosaic virus; Systemic necrosis; R gene	PROGRAMMED CELL-DEATH; NBS-LRR PROTEIN; HYPERSENSITIVE RESPONSE; RESISTANCE GENE; SILENCING SUPPRESSOR; DEFENSE RESPONSES; VENOUS NECROSIS; SALICYLIC-ACID; CRINKLE-VIRUS; TOBACCO	We previously observed that Turnip mosaic virus (TuMV) induces systemic necrosis in Arabidopsis ecotype Ler but not in Col-0. Sharing most of the common features of the hypersensitive reaction, this systemic necrosis has been found to be a result of a gene-for-gene interaction between the host TuNI gene and viral P3 gene. We here analyzed the TuNI locus in detail and identified three very similar candidates for TuNI gene(s). Our functional and expression analyses using transgenic plants expressing each of the candidates and a protoplast transient expression assay suggested that the expression of the best candidate, named RGX, is responsible for the systemic necrosis although concomitant expression with the other two candidates may be necessary. To understand the expression profile of RGX, we analyzed promoter activity by producing transgenic Col-0 plants that express the reporter GFP gene under the control of the 500-1400-bp upstream regions of RGX. The transgenic plants reproduced the expression patterns of RGX; GFP expression increased after TuMV infection but decreased in the shade treatment. The expression of two other candidates was also upregulated by TuMV infection, suggesting that transcriptional activation of the TuNI candidate genes has a role in controlling TuMV-mediated systemic necrosis.	[Liu, Jinyan; Kim, Bo Min; Kaneko, Yo-hei; Inukai, Tsuyoshi; Masuta, Chikara] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Inukai, T (reprint author), Hokkaido Univ, Grad Sch Agr, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	yoshi@abs.agr.hokudai.ac.jp; masuta@res.agr.hokudai.ac.jp	Masuta, Chikara/A-6689-2012		Japan Society for the Promotion of Science [1758001, 24380025]	We thank Dr. Atsushi Kato for providing information on the TuNI locus in Ler. This work was partly supported by Grants in Aid for Scientific Research (C) 1758001 and (B) 24380025 from the Japan Society for the Promotion of Science.	Kim BM, 2010, MOL PLANT MICROBE IN, V23, P144, DOI 10.1094/MPMI-23-2-0144; Bendahmane A, 1999, PLANT CELL, V11, P781; Mastrangelo AM, 2012, PLANT SCI, V185, P40, DOI 10.1016/j.plantsci.2011.09.006; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Goto K, 2007, PLANT CELL PHYSIOL, V48, P1050, DOI 10.1093/pcp/pcm074; Chandra-Shekara AC, 2006, PLANT J, V45, P320, DOI 10.1111/j.1365-313X.2005.02618.x; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842; Pacheco R, 2012, MOL PLANT MICROBE IN, V25, P709, DOI 10.1094/MPMI-11-11-0305; Kiraly L, 2008, J GEN VIROL, V89, P799, DOI 10.1099/vir.0.83328-0; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Erickson FL, 1999, PLANT J, V18, P67, DOI 10.1046/j.1365-313X.1999.00426.x; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49; Kobayashi M, 2010, J PHYTOPATHOL, V158, P826, DOI 10.1111/j.1439-0434.2010.01686.x; Walsh JA, 2002, MOL PLANT PATHOL, V3, P289, DOI 10.1046/j.1364-3703.2002.00132.x; Zeier J, 2004, PLANTA, V219, P673, DOI 10.1007/s00425-004-1272-z; Kim M, 2003, J BIOL CHEM, V278, P19406, DOI 10.1074/jbc.M210539200; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Jeong RD, 2008, MOL PLANT MICROBE IN, V21, P1316, DOI 10.1094/MPMI-21-10-1316; Komatsu K, 2010, MOL PLANT MICROBE IN, V23, P283, DOI 10.1094/MPMI-23-3-0283; Zhang Y, 2004, PLANT J, V40, P213, DOI 10.1111/j.1365-313X.2004.02201.x; Kim SH, 2009, PLANT PHYSIOL, V150, P1723, DOI 10.1104/pp.109.139238; Atsumi G, 2009, MOL PLANT MICROBE IN, V22, P166, DOI 10.1094/MPMI-22-2-0166; Duque Paula, 2011, Plant Signal Behav, V6, P49; Gu Lianfeng, 2007, Journal of Genetics and Genomics, V34, P247, DOI 10.1016/S1673-8527(07)60026-5; Haque A., 2008, PMPP Physiological and Molecular Plant Pathology, V73, P101, DOI 10.1016/j.pmpp.2009.03.001; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Inaba J, 2011, PLANT PHYSIOL, V156, P2026, DOI 10.1104/pp.111.180042; Kaneko Y, 2004, THEOR APPL GENET, V110, P33, DOI 10.1007/s00122-004-1824-4; Kato A, 2009, J PLANT BIOL, V52, P616, DOI 10.1007/s12374-009-9080-4; Kim B, 2008, MOL PLANT MICROBE IN, V21, P260, DOI 10.1094/MPMI-21-2-0260; Lee Min Woo, 2006, V323, P225; Takabatake R, 2006, PLANT CELL PHYSIOL, V47, P254, DOI 10.1093/pcp/pci243; Takahashi H, 2012, MOL PLANT MICROBE IN, V25, P1171, DOI 10.1094/MPMI-04-12-0076-R; Zheng HQ, 2009, MOL GENET GENOMICS, V282, P381, DOI 10.1007/s00438-009-0471-5	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	MAY	2015	81	3					180	191		10.1007/s10327-015-0583-1		12	Plant Sciences	Plant Sciences	CH6ER	WOS:000354129600002		
J	Miyake, N; Nagai, H; Kato, S; Matsusaki, M; Ishikawa, H; Kageyama, K				Miyake, Noriyuki; Nagai, Hirofumi; Kato, Shinro; Matsusaki, Masashi; Ishikawa, Hiroshi; Kageyama, Koji			Detection of damping-off of Cape gooseberry caused by Pythium aphanidermatum and its suppression with phosphonate	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Pythium aphanidermatum; Cape gooseberry; Damping-off; High temperature; Phosphonate; Disease control	FOSETYL-AL; ANTIFUNGAL ACTIVITY; 3 PHYTOPHTHORA; IN-VITRO; PHOSPHITE; MODE; SPP.; AZOXYSTROBIN; INHIBITION; FUNGICIDES	Cape gooseberry cultivated in commercial greenhouses developed wilt and root rot during the summer growing season of 2013 in Aichi Prefecture, Japan. A Pythium species was isolated from affected roots and identified as P. aphanidermatum on the basis of morphological characteristics and sequence homologies in the rDNA internal transcribed spacer regions. In pathogenicity tests, this isolate caused severe wilt and root rot. P. aphanidermatum, which previously was not known to cause damping-off in Cape gooseberry, was isolated by a bait method from soil samples collected from within and outside of the greenhouses. Pre- and post-inoculation activity of phosphonate and two fungicides, cyazofamid and metalaxyl, was evaluated with in vivo experiments. The three compounds were applied 3 days before inoculation, and phosphonate and cyazofamid also were applied at 24 h after inoculation. All three substances provided similar protectant activity. Phosphonate and cyazofamid also exhibited curative activity. In vitro activity of phosphonate on mycelial growth, sporulation, and zoospore cyst germination was evaluated; the EC50 concentration for the inhibition of mycelial growth was low. Zoospore formation was sensitive to phosphonate, while the germination of encysted zoospores was not.	[Miyake, Noriyuki] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Miyake, Noriyuki; Nagai, Hirofumi; Kato, Shinro; Matsusaki, Masashi; Ishikawa, Hiroshi] Aichi Agr Res Ctr, Nagakute, Aichi 4801193, Japan; [Kageyama, Koji] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan	Miyake, N (reprint author), Gifu Univ, United Grad Sch Agr Sci, 1-1 Yanagido, Gifu 5011193, Japan.	noriyuki_miyake@pref.aichi.lg.jp			Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industries from the Ministry of Agriculture, Forestry and Fisheries, Japan	This work was supported by Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industries from the Ministry of Agriculture, Forestry and Fisheries, Japan.	AFEK U, 1989, PHYTOPATHOLOGY, V79, P736, DOI 10.1094/Phyto-79-736; Al-Sa'di AM, 2008, J PHYTOPATHOL, V156, P502, DOI 10.1111/j.1439-0434.2008.01396.x; Anderson MG, 1997, PLANT DIS, V81, P227, DOI 10.1094/PDIS.1997.81.2.227D; HENDRIX FF, 1973, ANNU REV PHYTOPATHOL, V11, P77, DOI 10.1146/annurev.py.11.090173.000453; Morita Y, 2007, PLANT DIS, V91, P1591, DOI 10.1094/PDIS-91-12-1591; Chellemi DO, 2000, PLANT DIS, V84, P1271, DOI 10.1094/PDIS.2000.84.12.1271; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Mitani S, 2001, PESTIC BIOCHEM PHYS, V70, P92, DOI 10.1006/pest.2001.2541; Mitani S, 2001, PESTIC BIOCHEM PHYS, V71, P107, DOI 10.1006/pest.2001.2569; SMILLIE R, 1989, PHYTOPATHOLOGY, V79, P921, DOI 10.1094/Phyto-79-921; Kromann P, 2012, PLANT DIS, V96, P1008, DOI 10.1094/PDIS-12-11-1029-RE; Rebollar-Alviter A, 2007, PLANT DIS, V91, P559, DOI 10.1094/PDIS-91-5-0559; Jackson TJ, 2000, PLANT PATHOL, V49, P147, DOI 10.1046/j.1365-3059.2000.00422.x; Cook PJ, 2009, PLANT DIS, V93, P809, DOI 10.1094/PDIS-93-8-0809; Erwin DC, 1996, PHYTOPHTHORA DIS WOR, P211; FENN ME, 1984, PHYTOPATHOLOGY, V74, P606, DOI 10.1094/Phyto-74-606; FISHER DJ, 1982, PESTIC SCI, V13, P330, DOI 10.1002/ps.2780130316; GUEST D I, 1990, Australasian Plant Pathology, V19, P113, DOI 10.1071/APP9900113; Kageyama Koji, 2002, Journal of General Plant Pathology, V68, P15, DOI 10.1007/PL00013047; KO WH, 1973, PHYTOPATHOLOGY, V63, P1206; Matheron ME, 2000, PLANT DIS, V84, P454, DOI 10.1094/PDIS.2000.84.4.454; Miyake N, 2014, J GEN PLANT PATHOL, V80, P479, DOI 10.1007/s10327-014-0542-2; Tojo M, 1993, P KANSAI PLANT PROT, V35, P1; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; Watanabe H, 2008, J GEN PLANT PATHOL, V74, P417, DOI 10.1007/s10327-008-0116-2; Watanabe Hideki, 2007, Journal of General Plant Pathology, V73, P81, DOI 10.1007/s10327-006-0338-0; Waterhouse GM, 1967, MYCOL PAP, V109, P1; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	MAY	2015	81	3					192	200		10.1007/s10327-015-0582-2		9	Plant Sciences	Plant Sciences	CH6ER	WOS:000354129600003		
J	Galarza, L; Akagi, Y; Takao, K; Kim, CS; Maekawa, N; Itai, A; Peralta, E; Santos, E; Kodama, M				Galarza, Luis; Akagi, Yasunori; Takao, Kazumi; Kim, Chang Sun; Maekawa, Nitaro; Itai, Akihiro; Peralta, Esther; Santos, Efren; Kodama, Motoichiro			Characterization of Trichoderma species isolated in Ecuador and their antagonistic activities against phytopathogenic fungi from Ecuador and Japan	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Trichoderma spp.; Biocontrol; Fusarium oxysporum f. sp cubense; Mycosphaerella fijiensis; Moniliophthora roreri; Moniliophthora perniciosa	MOLECULAR CHARACTERIZATION; RHIZOCTONIA-SOLANI; BIOLOGICAL-CONTROL; BIOCONTROL AGENTS; HARZIANUM; IDENTIFICATION; ASPERELLUM; PLANT; MYCOPARASITISM; PHYLOGENY	Native Trichoderma spp. were isolated from agricultural fields in several regions of Ecuador. These isolates were characterized via morphological observation as well as molecular phylogenetic analysis based on DNA sequences of the rDNA internal transcribed spacer region, elongation factor-1 alpha gene and RNA polymerase subunit II gene. Fifteen native Trichoderma spp. were identified as T. harzianum, T. asperellum, T. virens and T. reesei. Some of these strains showed strong antagonistic activities against several important pathogens in Ecuador, such as Fusarium oxysporum f. sp. cubense (Panama disease) and Mycosphaerella fijiensis (black Sigatoka) on banana, as well as Moniliophthora roreri (frosty pod rot) and Moniliophthora perniciosa (witches' broom disease) on cacao. The isolates also showed inhibitory effects on in vitro colony growth tests against Japanese isolates of Fusarium oxysporum f. sp. lycopersici, Alternaria alternata and Rosellinia necatrix. The native Trichoderma strains characterized here are potential biocontrol agents against important pathogens of banana and cacao in Ecuador.	[Galarza, Luis; Takao, Kazumi; Kodama, Motoichiro] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Akagi, Yasunori; Itai, Akihiro] Tottori Univ, Fac Agr, Tottori 6808553, Japan; [Kim, Chang Sun; Maekawa, Nitaro] Tottori Univ, Fungus Mushroom Resource & Res Ctr, Fac Agr, Tottori 6808553, Japan; [Peralta, Esther; Santos, Efren] Higher Polytech Coll Littoral CIBE ESPOL, Biotechnol Res Ctr Ecuador, Guayaquil, Ecuador	Kodama, M (reprint author), Tottori Univ, United Grad Sch Agr Sci, 4-101 Koyama Minami, Tottori 6808553, Japan.	mk@muses.tottori-u.ac.jp			MEXT, Japan; National Secretary of Higher Education, Science, Technology and Education of Ecuador; Biotechnology Research Center of Ecuador, Higher Polytechnic College of the Littoral CIBE-ESPOL	We thank T. Arie, T. Yasuda and D. G. Gilchrist for providing the fungal strains. This work was supported by the Global COE Program "Advanced Utilization of Fungus/Mushroom Resources for Sustainable Society in Harmony with Nature," MEXT, Japan. We thank the National Secretary of Higher Education, Science, Technology and Education of Ecuador and the Biotechnology Research Center of Ecuador, Higher Polytechnic College of the Littoral CIBE-ESPOL for supporting this research.	Abdullah F, 2007, EXPLORING LIFE CATAL, P107; Adebesin Abolade Ayodeji, 2009, Journal of Plant Protection Research, V49, P302, DOI 10.2478/v10045-009-0049-6; Hjeljord LG, 2003, PHYTOPATHOLOGY, V93, P1593, DOI 10.1094/PHYTO.2003.93.12.1593; Zhang CL, 2005, FEMS MICROBIOL LETT, V251, P251, DOI 10.1016/j.femsle.2005.08.034; Samuels GJ, 2006, PHYTOPATHOLOGY, V96, P195, DOI 10.1094/PHYTO-96-0195; Chaverri P, 2003, MOL PHYLOGENET EVOL, V27, P302, DOI 10.1016/S1055-7903(02)00400-1; Hermosa MR, 2000, APPL ENVIRON MICROB, V66, P1890, DOI 10.1128/AEM.66.5.1890-1898.2000; ELAD Y, 1981, PLANT SOIL, V60, P245, DOI 10.1007/BF02374109; Sharma K, 2009, J PHYTOPATHOL, V157, P51, DOI 10.1111/j.1439-0434.2008.01451.x; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; Karthikeyan M., 2006, Brazilian Journal of Plant Physiology, V18, P367, DOI 10.1590/S1677-04202006000300003; Jeger MJ, 2009, J THEOR BIOL, V256, P201, DOI 10.1016/j.jtbi.2008.09.036; Druzhinina IS, 2005, FUNGAL GENET BIOL, V42, P813, DOI 10.1016/j.fgb.2005.06.007; GARBER RC, 1983, ANAL BIOCHEM, V135, P416, DOI 10.1016/0003-2697(83)90704-2; Samuels GJ, 2010, MYCOLOGIA, V102, P944, DOI 10.3852/09-243; Rosado IV, 2007, FUNGAL GENET BIOL, V44, P950, DOI 10.1016/j.fgb.2007.01.001; Qualhato TF, 2013, BIOTECHNOL LETT, V35, P1461, DOI 10.1007/s10529-013-1225-3; CARSOLIO C, 1994, P NATL ACAD SCI USA, V91, P10903, DOI 10.1073/pnas.91.23.10903; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bowers JH, 2001, PLANT HLTH PROG, DOI [10.1094/PHP-2001-0709-01-RV, DOI 10.1094/PHP-2001-0709-01-RV]; Druzhinina IS, 2010, BMC EVOL BIOL, V1, P94; Ezziyyani M, 2004, ANALES BIOL, V26, P35; Garcia Simoes ML, 2012, J BIOL LIFE SCI, V3, P18; Hanada RE, 2009, BIOL CONTROL, V50, P143, DOI 10.1016/j.biocontrol.2009.04.005; Harjono K, 2001, INDON J PLANT PROTEC, V7, P55; HARMAN GE, 1981, PHYTOPATHOLOGY, V71, P569, DOI 10.1094/Phyto-71-569; Hjeljord LG, 1998, TRICHODERMA GLIOCLAD, V2, P129; Hoyos-Carvajal L, 2008, REV COLOMBIANA CIENC, V2, P76; Kim CS, 2012, PLANT PATHOLOGY J, V28, P137, DOI 10.5423/PPJ.OA.02.2011.0030; Kopchinskiy Alexey, 2005, Mycol Res, V109, P658, DOI 10.1017/S0953756205233397; Krauss U, 2010, BIOL CONTROL, V54, P230, DOI 10.1016/j.biocontrol.2010.05.011; Kullnig-Gradinger CM, 2002, MYCOL RES, V106, P757, DOI 10.1017/S0953756202006172; Kullnig CM, 2001, MYCOL RES, V105, P769; Lieckfeldt E, 1999, APPL ENVIRON MICROB, V65, P2418; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; Lo ChaurTsuen, 1998, Plant Pathology Bulletin, V7, P155; Matheny PB, 2005, MOL PHYLOGENET EVOL, V35, P1, DOI 10.1016/j.ympev.2004.11.014; Mukherjee M, 2006, CURR GENET, V50, P193, DOI 10.1007/s00294-006-0075-0; Nelson EB, 1991, CURRENT LIMITS BIOL, V1, P800; Perez L, 2009, FITOSANIDAD, V4, P259; Rubio MB, 2008, FUNGAL GENET BIOL, V46, P17; Samuels GJ, 1999, SYDOWIA, V51, P71; Samuels GJ, 2014, TRICHODERMA ONLINE S; Scherm B, 2009, CURR GENET, V55, P81, DOI 10.1007/s00294-008-0226-6; Seidl V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-327; Stover R. H., 1962, FUSARIAL WILT PANAMA; Watanabe Satoshi, 2005, Journal of General Plant Pathology, V71, P351, DOI 10.1007/s10327-005-0217-0; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Woo Sheridan L., 2007, P107, DOI 10.1007/978-1-4020-5799-1_6; Wood G. A. R., 2001, TROPICAL AGR SERIES, V4th	52	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	MAY	2015	81	3					201	210		10.1007/s10327-015-0587-x		10	Plant Sciences	Plant Sciences	CH6ER	WOS:000354129600004		
J	Galarza, L; Akagi, Y; Takao, K; Peralta, E; Santos, E; Kodama, M				Galarza, Luis; Akagi, Yasunori; Takao, Kazumi; Peralta, Esther; Santos, Efren; Kodama, Motoichiro			Involvement of ThSNF1 in the development and virulence of biocontrol agent Trichoderma harzianum	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Trichoderma harzianum; ThSNF1; Mycoparasitism; Biocontrol; Cell-wall-degrading enzymes	CELL-WALL; SACCHAROMYCES-CEREVISIAE; GENE; FUNGI; SNF1; EXPRESSION; REPRESSION; DEFICIENT; PATHOGENS; STRAINS	Trichoderma harzianum, a biocontrol agent for various plant pathogens, is known to degrade fungal cell walls; this mycoparasitism is believed to require secretion of cell-wall-degrading enzymes against host pathogens. In this study, we identified a homologue of yeast SNF1 (sucrose nonfermenting 1) encoding protein kinase in T. harzianum (ThSNF1) by draft genome sequencing of strain T36. Targeted gene disruption of ThSNF1 was performed using the PEG method with fusion PCR products. Growth of mutant Delta ThSNF1 was markedly less than for the wild-type strain on minimal medium with chitin as a carbon source. The mutant exhibited reduced expression of the genes encoding chitinase and polygalacturonase and markedly reduced spore production. Mycoparasitism against plant pathogens such as Fusarium oxysporum f. sp. cubense (Panama disease) and Fusarium graminearum (Fusarium head blight) was clearly impaired in the mutant. The results suggest that ThSNF1 is critical for asexual development, utilization of certain carbon sources and virulence on fungi, and is therefore important for the biocontrol ability of T. harzianum.	[Galarza, Luis; Takao, Kazumi; Kodama, Motoichiro] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Akagi, Yasunori] Tottori Univ, Fac Agr, Tottori 6808553, Japan; [Peralta, Esther; Santos, Efren] Higher Polytech Coll Littoral CIBE ESPOL, Biotechnol Res Ctr Ecuador, Guayaquil, Ecuador	Kodama, M (reprint author), Tottori Univ, United Grad Sch Agr Sci, 4-101 Koyama Minami, Tottori 6808553, Japan.	mk@muses.tottori-u.ac.jp			MEXT, Japan; National Secretary of Higher Education, Science, Technology and Education of Ecuador; Biotechnology Research Center of Ecuador, Higher Polytechnic College of the Littoral CIBE-ESPOL	We thank H. Suga for providing the fungal strains and R. P. Oliver for providing the transformation vector. This work was supported by the Global COE Program "Advanced Utilization of Fungus/Mushroom Resources for Sustainable Society in Harmony with Nature," MEXT, Japan. We thank the National Secretary of Higher Education, Science, Technology and Education of Ecuador and the Biotechnology Research Center of Ecuador, Higher Polytechnic College of the Littoral CIBE-ESPOL for supporting this research.	Abdullah F, 2007, EXPLORING LIFE CATAL, P107; Lorito M, 1998, P NATL ACAD SCI USA, V95, P7860, DOI 10.1073/pnas.95.14.7860; Treitel MA, 1998, MOL CELL BIOL, V18, P6273; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Dickman MB, 1999, FUNGAL GENET BIOL, V26, P99, DOI 10.1006/fgbi.1999.1118; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; Akamatsu H, 1997, PHYTOPATHOLOGY, V87, P967, DOI 10.1094/PHYTO.1997.87.9.967; Ospina-Giraldo MD, 2003, CURR GENET, V44, P49, DOI 10.1007/s00294-003-0419-y; Seidl V, 2005, FEBS J, V272, P5923, DOI 10.1111/j.1742-4658.2005.04994.x; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Viterbo A, 2001, FEMS MICROBIOL LETT, V200, P169, DOI 10.1016/S0378-1097(01)00217-8; Benitez T, 2004, INT MICROBIOL, V7, P249; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113; CELENZA JL, 1984, MOL CELL BIOL, V4, P49; Chet I, 1987, INNOVATIVE APPROACHE, P137; Cziferszky A, 2003, FUNGAL GENET BIOL, V40, P166, DOI 10.1016/S1087-1845(03)00082-3; Ezziyyani M, 2004, ANALES BIOL, V26, P35; Hjeljord L, 1998, TRICHODERMA GLIOCLAD, V2, P129; Hoyos-Carvajal L, 2008, REV COLOMBIANA CIENC, V2, P76; Lopez-Mondejar R, 2009, FEBS J, V276, P5137, DOI 10.1111/j.1742-4658.2009.07211.x; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Vieira PM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-177; Woo Sheridan L., 2007, P107, DOI 10.1007/978-1-4020-5799-1_6	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	MAY	2015	81	3					211	217		10.1007/s10327-015-0590-2		7	Plant Sciences	Plant Sciences	CH6ER	WOS:000354129600005		
J	Misawa, T; Takeuchi, M				Misawa, Tomoo; Takeuchi, Masanobu			Species composition of Botrytis leaf blight pathogens of Chinese chives and their seasonal and annual changes in Hokkaido, Japan	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Botrytis cinerea; Botrytis squamosa; Chinese chives; Species composition; Seasonal change		Botrytis leaf blight is the most important disease of Chinese chives. We examined a total of 345 isolates from symptomatic plants sampled from 14 fields in Hokkaido once in 2010 (summer) and twice in 2011 and 2012 (summer and autumn). They were identified as Botrytis squamosa (BS: 285 isolates) and B. cinerea (BC: 60 isolates) based on conidial morphology. Morphological identification of 65 BS isolates and 23 BC isolates supported by PCR-RFLP analysis and specific PCR. BS isolates were much more frequently obtained than BC isolates in autumn, but in summer, both species were almost equally recovered. BS predominated in all the fields in the autumn of the 3 years although the ratio of BS to BC in summer varied, depending on the field and year. These results indicate that both species infect leaves in summer, then BS becomes dominant in autumn. Inoculation tests revealed that BS was more virulent than BC at 15 and 20 A degrees C and that the level of virulence of both species was greatly reduced at 20 A degrees C. These results may account for fluctuations in the occurrence of the pathogens.	[Misawa, Tomoo] Hokkaido Res Org, Donan Agr Expt Stn, Hokuto, Hokkaido 0411201, Japan; [Takeuchi, Masanobu] Hokkaido Prefectural Oshima Agr Extens Ctr, Shiriuchi, Hokkaido 0491102, Japan	Misawa, T (reprint author), Hokkaido Res Org, Donan Agr Expt Stn, Hokuto, Hokkaido 0411201, Japan.	misawa-tomoo@hro.or.jp					Agrios GN, 2005, PLANT PATHOL, P510; Zhang J, 2010, MYCOSCIENCE, V51, P421, DOI 10.1007/s10267-010-0057-4; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; Beever R. E., 2007, BOTRYTIS BIOL PATHOL, P29, DOI 10.1007/978-1-4020-2626-3_3; Carisse O, 2011, PLANT DIS, V95, P504, DOI 10.1094/PDIS-11-10-0797; Crowe F, 1995, COMPENDIUM ONION GAR, P19; Ellis MB, 1971, DEMATIACEOUS HYPHOMY, P178; Hennebert GL, 1963, MEDED LANDBHOOGESCH, V28, P851; Jarvis WR, 1980, BIOL BOTRYTIS, P1; Kannno H, 2000, ANN REPT PLANT PROT, V51, P295; Kawagishi K, 2009, SCI HORTIC-AMSTERDAM, V119, P197, DOI 10.1016/j.scienta.2008.07.018; Lacy ML, 1995, COMPENDIUM ONION GAR, P16; Lorbeer J. W., 2007, BOTRYTIS BIOL PATHOL, P273, DOI 10.1007/978-1-4020-2626-3_15; Misawa T, 2014, JPN J PHYTOPATHOL, V80, P58; Misawa T, 2010, ANN REPT PLANT PROT, V61, P85; Nieda H, 1971, ANN REPT KANTOTOSAN, V18, P49; Nielsen K, 2002, PLANT DIS, V86, P682, DOI 10.1094/PDIS.2002.86.6.682; Nielsen K, 2001, PHYTOPATHOLOGY, V91, P527, DOI 10.1094/PHYTO.2001.91.6.527; Rigotti S, 2006, PHYTOPATHOL MEDITERR, V45, P253; SHOEMAKER PB, 1977, PHYTOPATHOLOGY, V67, P409; Takakuwa M, 1974, B HOKKAIDO PREF AGR, V29, P1	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	MAY	2015	81	3					218	225		10.1007/s10327-015-0588-9		8	Plant Sciences	Plant Sciences	CH6ER	WOS:000354129600006		
J	Shimomoto, Y; Kiba, A; Hikichi, Y				Shimomoto, Yoshifumi; Kiba, Akinori; Hikichi, Yasufumi			Multiplex polymerase chain reaction discriminates which eggplant isolates of Corynespora cassiicola are virulent to sweet pepper	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Corynespora cassiicola; Solanum melongena; Capsicum annuum; Multiplex polymerase chain reaction	LEAF-SPOT; GENETIC-VARIATION; 1ST REPORT; FUNGUS; BLIGHT	Some isolates of Corynespora cassiicola from eggplant leaves with black blight can also cause Corynespora blight on sweet pepper. To differentiate eggplant isolates differing in virulence to sweet pepper, we first created two sets of primers based on nucleotide sequences of DNA fragments specific to virulent and to avirulent isolates, respectively, in a random amplified polymorphic DNA analysis using two random primers. A multiplex polymerase chain reaction using the two primer sets allowed us to discriminate isolates virulent to sweet pepper from among eggplant isolates.	[Shimomoto, Yoshifumi] Kochi Agr Res Ctr, Nankoku, Kochi 7830023, Japan; [Kiba, Akinori; Hikichi, Yasufumi] Kochi Univ, Lab Plant Pathol & Biotechnol, Nankoku, Kochi 7838502, Japan	Shimomoto, Y (reprint author), Kochi Agr Res Ctr, 1100 Hataeda, Nankoku, Kochi 7830023, Japan.	yoshifumi_shimomoto@ken2.pref.kochi.lg.jp					Jimenez-Gasco MM, 2002, PLANT PATHOL, V51, P72, DOI 10.1046/j.0032-0862.2001.x; Dixon LJ, 2009, PHYTOPATHOLOGY, V99, P1015, DOI 10.1094/PHYTO-99-9-1015; Shimomoto Y, 2011, PLANT PATHOL, V60, P253, DOI 10.1111/j.1365-3059.2010.02374.x; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Penner G A, 1993, PCR Methods Appl, V2, P341; Conner KN, 2013, PLANT DIS, V97, P1379, DOI 10.1094/PDIS-02-13-0133-PDN; Luo CX, 2005, PHYTOPATHOLOGY, V95, P640, DOI 10.1094/PHYTO-95-0640; Park JH, 2013, PLANT DIS, V97, P1512, DOI 10.1094/PDIS-05-13-0480-PDN; Qi YX, 2011, EUR J PLANT PATHOL, V130, P83, DOI 10.1007/s10658-010-9734-6; Shimomoto Y, 2008, J GEN PLANT PATHOL, V74, P335, DOI 10.1007/s10327-008-0100-x; Shimomoto Y., 2011, Japanese Journal of Phytopathology, V77, P105; Silva WPK, 2003, MYCOL RES, V107, P567, DOI 10.1017/S0953756203007755; Silva WPK, 1998, PLANT PATHOL, V47, P267, DOI 10.1046/j.1365-3059.1998.00245.x; Silva WPK, 1995, AUST J BOT, V43, P609, DOI 10.1071/BT9950609; Ye YF, 2013, PLANT DIS, V97, P1659, DOI 10.1094/PDIS-04-13-0454-PDN	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	MAY	2015	81	3					226	231		10.1007/s10327-015-0584-0		6	Plant Sciences	Plant Sciences	CH6ER	WOS:000354129600007		
J	Sasaki, K; Nakahara, K; Shigyo, M; Tanaka, S; Ito, S				Sasaki, Kazunori; Nakahara, Katsuya; Shigyo, Masayoshi; Tanaka, Shuhei; Ito, Shin-ichi			Detection and quantification of onion isolates of Fusarium oxysporum f. sp cepae in onion plant	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Fusarium basal rot; SIX3; Allium cepa	TIME PCR ASSAY; RESISTANCE; TOMATO; SOIL; WILT	Fusarium oxysporum f. sp. cepae (FOC) isolated from onion basal rot possessed a SIX3 homolog (FocSIX3) with 91.4 % identity to the SIX3 gene (FolSIX3) of F. oxysporum f. sp. lycopersici (FOL). A primer pair (P1) was designed to detect onion FOC based on differences in nucleotide sequences between FocSIX3 and FolSIX3. P1 amplified a 106-bp-long DNA segment only from FOC isolates pathogenic to onions, but not from FOC isolated from either Welsh onion or F. oxysporum strains belonging to formae speciales other than cepae. Real-time quantitative PCR with P1 was developed to quantify onion root- and basal-plate-colonizing FOC.	[Sasaki, Kazunori] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Nakahara, Katsuya; Shigyo, Masayoshi; Tanaka, Shuhei; Ito, Shin-ichi] Yamaguchi Univ, Fac Agr, Dept Biol & Environm Sci, Yamaguchi 7538515, Japan	Ito, S (reprint author), Yamaguchi Univ, Fac Agr, Dept Biol & Environm Sci, Yamaguchi 7538515, Japan.	shinsan@yamaguchi-u.ac.jp			Japanese Society for Promotion of Sciences (JSPS) [23580063]	This work was supported by a Grant-in-Aid for Scientific Research (C) (23580063) from the Japanese Society for Promotion of Sciences (JSPS). We thank Mr. Hidetsugu Nishihata (Toyama Prefectural Agricultural, Forestry and Fisheries Research Center) and Mr. Atsuoki Sue (Takii & Company Ltd.) for kindly providing onion samples. We thank Dr. F. Namiki for providing F. oxysporum f. sp. lycopersici strain CK3-1.	Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Cramer CS, 2000, EUPHYTICA, V115, P159, DOI 10.1023/A:1004071907642; van der Does HC, 2008, ENVIRON MICROBIOL, V10, P1475, DOI 10.1111/j.1462-2920.2007.01561.x; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Abd-Elsalam KA, 2006, J PLANT DIS PROTECT, V113, P14; Zhang ZG, 2005, FEMS MICROBIOL LETT, V249, P39, DOI 10.1016/j.femsle.2005.05.057; Haegi A, 2013, PHYTOPATHOLOGY, V103, P802, DOI 10.1094/PHYTO-11-12-0293-R; Lievens B, 2009, FEMS MICROBIOL LETT, V300, P201, DOI 10.1111/j.1574-6968.2009.01783.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Alves-Santos FM, 2002, PHYTOPATHOLOGY, V92, P237, DOI 10.1094/PHYTO.2002.92.3.237; Armstrong GM, 1981, FUSARIUM DIS BIOL TA, P391; Dan H, 2001, PLANT DIS, V85, P700, DOI 10.1094/PDIS.2001.85.7.700; de Sousa MV, 2015, PLANT PATHOL, V64, P478, DOI 10.1111/ppa.12257; Dissanayake MLMC, 2009, J GEN PLANT PATHOL, V75, P125, DOI 10.1007/s10327-009-0152-6; Hirano Yasushi, 2006, Journal of General Plant Pathology, V72, P273, DOI 10.1007/s10327-006-0287-7; Inami K, 2010, J GEN PLANT PATHOL, V76, P116, DOI 10.1007/s10327-010-0224-7; Jimenez-Fernandez D, 2011, PHYTOPATHOLOGY, V101, P250, DOI 10.1094/PHYTO-07-10-0190; Kodama F., 1983, REP HOKKAIDO AGR EXP, V39, P1; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Pasquali M, 2007, PHYTOPATHOLOGY, V97, P987, DOI 10.1094/PHYTO-97-8-0987; Sasaki K, 2014, PHYTOPATHOLOGY, DOI [10.1094/PHYTO-06-14-0164-R, DOI 10.1094/PHYTO-06-14-0164-R]; Scarlett K, 2013, EUR J PLANT PATHOL, V137, P315, DOI 10.1007/s10658-013-0244-1; Suga H, 2013, PLANT DIS, V97, P619, DOI 10.1094/PDIS-07-12-0663-RE	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	MAY	2015	81	3					232	236		10.1007/s10327-015-0589-8		5	Plant Sciences	Plant Sciences	CH6ER	WOS:000354129600008		
J	Komatsu, T; Kondo, N				Komatsu, Tsutomu; Kondo, Norio			Winter habitat of Xylophilus ampelinus, the cause of bacterial blight of grapevine, in Japan	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Xylophilus ampelinus; Bacterial blight; Grapevine; Overwintering; Bud	NECROSIS; TISSUE; AGENT	Xylophilus ampelinus, the cause of bacterial blight of grapevine, was first identified in 2009 in Hokkaido, Japan. We investigated the distribution of X. ampelinus in grapevines and its winter habitat in Hokkaido. After defoliation of artificially infected potted plants, new branches were cut and stored in plastic bags at 5 A degrees C in the dark for 60 days. PCR analysis of samples from the stored branches using a pathogen-specific primer set detected X. ampelinus in the axillary buds but not in the epidermis and vascular bundle. In the naturally infected vineyards, we confirmed the presence of X. ampelinus in the axillary buds and in the vascular bundles at defoliation. However, the pathogen DNA was not detected in the vascular bundles or sap after overwintering. In contrast, the detection frequency in whole axillary buds decreased only slightly, even after overwintering. Additionally, the bacteria were detected in cold-stored bracts and wool at a higher frequency than in the interior axillary bud tissues. Our findings indicate that X. ampelinus likely is not maintained inside tissues or sap and that it might not survive on plant surfaces; rather, bacteria can be found on the underside surface of the bract and bud wool during winter in Hokkaido.	[Komatsu, Tsutomu; Kondo, Norio] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Komatsu, Tsutomu] Hokkaido Res Org, Cent Agr Expt Stn, Naganuma, Hokkaido 0691395, Japan	Komatsu, T (reprint author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	komatsu-tsutomu@hro.or.jp	Kondo, Norio/A-4358-2012				MINSAVAGE GV, 1994, PHYTOPATHOLOGY, V84, P456, DOI 10.1094/Phyto-84-456; Bradbury JF, 1991, MYCOPATHOLOGIA, V115, P63; Grall S, 2005, APPL ENVIRON MICROB, V71, P8292, DOI 10.1128/AEM.71.12.8292-8300.2005; Grall S, 2003, APPL ENVIRON MICROB, V69, P1904, DOI 10.1128/AEM.69.4.1904-1912.2003; Kageyama Koji, 2003, Journal of General Plant Pathology, V69, P153; Lopez M. M., 1981, Proceedings of the Fifth Congress of the Mediterranean Phytopathological Union, Patras, Greece, 21-27 September 1980., P56; Manceau C., 2005, Bulletin OEPP, V35, P55, DOI 10.1111/j.1365-2338.2005.00813.x; Nakaune R, 2006, J VIROL METHODS, V134, P244, DOI 10.1016/j.jviromet.2006.01.016; PANAGOPOULOS C G, 1987, Bulletin OEPP, V17, P225; PANAGOPOULOS C G, 1969, Annales de l'Institut Phytopathologique Benaki, V9, P59; Ride M, 2000, MALADIES VIRUS BACTE, P77; Ride M, 1977, ANN PHYTOPATHOL, V9, P87; Ridee M, 1983, B TECH PYRENEES ORIE, V106, P5; ROWHANI A, 1993, PHYTOPATHOLOGY, V83, P749, DOI 10.1094/Phyto-83-749; Shinmura A, 2012, JPN J PHYTOPATHOL, V78, P60; WILLEMS A, 1987, Bulletin OEPP, V17, P237	16	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	MAY	2015	81	3					237	242		10.1007/s10327-015-0581-3		6	Plant Sciences	Plant Sciences	CH6ER	WOS:000354129600009		
J	Nomiyama, K; Sasaya, T; Sekiguchi, H; Tomioka, K; Osaki, H; Takeshita, M; Takehara, T; Furuya, N; Tsuchiya, K				Nomiyama, Koji; Sasaya, Takahide; Sekiguchi, Hiroyuki; Tomioka, Keisuke; Osaki, Hideki; Takeshita, Minoru; Takehara, Toshiaki; Furuya, Naruto; Tsuchiya, Kenichi			DAS-ELISA quantification of resting spores of Olpidium virulentus in roots and correlation between resting spore density in soil and severity of lettuce big-vein disease	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						DAS-ELISA; Lettuce big-vein disease; Olpidium virulentus; Resting spore density	PLASMODIOPHORA-BRASSICAE; SEROLOGICAL DETECTION; CLUBROOT DISEASE; VIRUS; TRANSMISSION	A method to quantify resting spores of Olpidium virulentus, fungal vector of Mirafiori lettuce big-vein virus, which causes lettuce big-vein disease, in lettuce roots was developed using a DAS-ELISA with a polyclonal antibody against the resting spores and used to evaluate the relationship between the resting spore density in soil and disease severity. When lettuce seedlings were grown on soils containing a powder made from diseased roots with a known number of resting spores, symptoms developed from ca. 10(2) spores/g of soil or more. This simple method can be used in soil diagnosis and risk assessment of the disease.	[Nomiyama, Koji; Sekiguchi, Hiroyuki; Tomioka, Keisuke; Osaki, Hideki; Takehara, Toshiaki] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan; [Nomiyama, Koji; Takeshita, Minoru; Furuya, Naruto; Tsuchiya, Kenichi] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan; [Sasaya, Takahide] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Koshi, Kumamoto 8611192, Japan	Nomiyama, K (reprint author), Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan.	nomiyama@affrc.go.jp					CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; CAMPBELL RN, 1985, CAN J BOT, V63, P2288; Lot H, 2002, PHYTOPATHOLOGY, V92, P288, DOI 10.1094/PHYTO.2002.92.3.288; Ratti C, 2004, J VIROL METHODS, V122, P95, DOI 10.1016/j.jviromet.2004.08.013; Murakami H, 2000, SOIL BIOL BIOCHEM, V32, P1637, DOI 10.1016/S0038-0717(00)00079-1; CAMPBELL RN, 1963, PHYTOPATHOLOGY, V53, P252; CAMPBELL RN, 1964, PHYTOPATHOLOGY, V54, P681; IWAKI M, 1978, Annals of the Phytopathological Society of Japan, V44, P578; Kawazu Y, 2010, SHOKUBUTSU BOEKI, V64, P584; Maeda T, 1993, LAB GUIDE PLANT PATH, P287; Murakami H, 2002, SOIL SCI PLANT NUTR, V48, P421; Nomiyama K, 2013, J GEN PLANT PATHOL, V79, P64, DOI 10.1007/s10327-012-0424-4; Nomiyama K, 2004, JPN J PHYTOPATHOL, V70, P239; Orihara Shoko, 1998, Annals of the Phytopathological Society of Japan, V64, P569; Roggero P, 2000, ARCH VIROL, V145, P2629, DOI 10.1007/s007050070012; Sasaya T, 2008, PHYTOPATHOLOGY, V98, P464, DOI 10.1094/PHYTO-98-4-0464; Sasaya Takahide, 2006, Journal of General Plant Pathology, V72, P20, DOI 10.1007/s10327-005-0239-7; TOMLINSON JA, 1962, NATURE, V194, P249, DOI 10.1038/194249a0; van der Wilk F, 2002, J GEN VIROL, V83, P2869; Wakeham AJ, 1996, PHYSIOL MOL PLANT P, V48, P289, DOI 10.1006/pmpp.1996.0024; Walsh JA, 1996, PLANT PATHOL, V45, P884, DOI 10.1111/j.1365-3059.1996.tb02899.x	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	MAY	2015	81	3					243	248		10.1007/s10327-015-0586-y		6	Plant Sciences	Plant Sciences	CH6ER	WOS:000354129600010		
J	Gratchev, IB; Sassa, K				Gratchev, Ivan B.; Sassa, Kyoji			Shear Strength of Clay at Different Shear Rates	JOURNAL OF GEOTECHNICAL AND GEOENVIRONMENTAL ENGINEERING			English	Article						Shear strength; Ring-shear tests; Strength recovery	LANDSLIDES; BEHAVIOR; SOILS	A test procedure that involved shearing soil specimens at different shear rates was proposed to study the effect of shear rate on the strength recovery of three natural clays. The obtained results indicated that an increase in shear strength occurred when the shear rate decreased. This strength regain was more pronounced for higher plasticity clays, which were sheared at a relatively lower confining pressure of 100 kPa. (C) 2015 American Society of Civil Engineers.	[Gratchev, Ivan B.] Griffith Univ, Griffith Sch Engn, Southport, Qld 4222, Australia; [Sassa, Kyoji] Kyoto Univ, Uji, Kyoto 6110011, Japan	Gratchev, IB (reprint author), Griffith Univ, Griffith Sch Engn, Southport, Qld 4222, Australia.	ivangratchev@gmail.com; kyoji.sassa@gmail.com					Gibo S, 2002, GEOTECHNIQUE, V52, P683, DOI 10.1680/geot.52.9.683.38837; Tatsuoka F, 2008, SOILS FOUND, V48, P41, DOI 10.3208/sandf.48.41; Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9; Carrubba P, 2008, J GEOTECH GEOENVIRON, V134, P302, DOI 10.1061/(ASCE)1090-0241(2008)134:3(302); Gratchev IB, 2009, J GEOTECH GEOENVIRON, V135, P271, DOI 10.1061/(ASCE)1090-0241(2009)135:2(271); OSIPOV VI, 1984, GEOTECHNIQUE, V34, P293; Perret D, 1996, ENG GEOL, V43, P31, DOI 10.1016/0013-7952(96)00031-2; Stark TD, 2005, J GEOTECH GEOENVIRON, V131, P575, DOI 10.1061/(ASCE)1090-0241(2005)131:5(575); Stark TD, 2010, J GEOTECH GEOENVIRON, V136, P957, DOI 10.1061/(ASCE)GT.1943-5606.0000308; Tika TE, 1996, GEOTECHNIQUE, V46, P197	10	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1090-0241	1943-5606		J GEOTECH GEOENVIRON	J. Geotech. Geoenviron. Eng.	MAY	2015	141	5							06015002	10.1061/(ASCE)GT.1943-5606.0001297		3	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CH4HA	WOS:000353993400013		
J	Okuda, K; Takarada, S; Hirota, T; Sasaki, K				Okuda, Kensuke; Takarada, Shigeki; Hirota, Takashi; Sasaki, Kenji			Polycyclic N-Heterocyclic Compounds. Part 86: Synthesis and Evaluation of Antiplatelet Aggregation Activity of 2,4-Disubstituted 9-Chloro-5,6-dihydropyrimido[5,4-d]benzazepine and Related Compounds	JOURNAL OF HETEROCYCLIC CHEMISTRY			English	Article							VIVO ANTITHROMBOTIC EVALUATION; RESERPINE-INDUCED HYPOTHERMIA; 3D QSAR ANALYSIS; PLATELET-AGGREGATION; INHIBITORY-ACTIVITY; DESIGN; DERIVATIVES; DISCOVERY; SERIES; AGENTS	Libraries of tricyclic 2-substituted 4-alkylamino-9-chloro-5,6-dihydropyrimido[5,4-d]benzazepines and tetracyclic 12-substituted 8-chloro-1,2,5,6-tetrahydro-4H-imidazo[1,2:1,6]pyrimido[5,4-d]benzazepines were synthesized as part of our research to develop new effective antiplatelet drugs. Several alkyl and aryl groups were used as substituents at the 2-position. Evaluation of the effects of the newly synthesized compounds on collagen-induced platelet aggregation revealed several promising antiplatelet candidates with potencies superior to aspirin.	[Okuda, Kensuke] Gifu Pharmaceut Univ, Lab Med & Pharmaceut Chem, Gifu 5011196, Japan; [Takarada, Shigeki; Hirota, Takashi; Sasaki, Kenji] Okayama Univ, Fac Pharmaceut Sci, Lab Pharmaceut Chem, Kita Ku, Okayama 7008530, Japan	Okuda, K (reprint author), Gifu Pharmaceut Univ, Lab Med & Pharmaceut Chem, Gifu 5011196, Japan.	okuda@gifu-pu.ac.jp					Chen HF, 2011, EUR J MED CHEM, V46, P5609, DOI 10.1016/j.ejmech.2011.09.030; Buswell M, 2004, ORG BIOMOL CHEM, V2, P3006, DOI 10.1039/b412768d; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178; Hsieh PW, 2010, BIOORGAN MED CHEM, V18, P7621, DOI 10.1016/j.bmc.2010.08.039; Sunada Y, 2009, ANGEW CHEM INT EDIT, V48, P9511, DOI 10.1002/anie.200905025; Liu GC, 2011, TETRAHEDRON, V67, P5156, DOI 10.1016/j.tet.2011.05.056; Ihmaid S, 2010, EUR J MED CHEM, V45, P4934, DOI 10.1016/j.ejmech.2010.07.066; Hernandes MZ, 2010, CURR DRUG TARGETS, V11, P303; Cheng SL, 2009, EUR J MED CHEM, V44, P4904, DOI 10.1016/j.ejmech.2009.08.002; Gui L, 2012, MEDCHEMCOMM, V3, P102, DOI 10.1039/c1md00222h; HIROTA T, 1986, HETEROCYCLES, V24, P143; HIROTA T, 1990, HETEROCYCLES, V31, P153; Li CY, 2011, EUR J MED CHEM, V46, P5598, DOI 10.1016/j.ejmech.2011.09.027; NAGAMATSU T, 1993, J HETEROCYCLIC CHEM, V30, P193; NAGAMATSU T, 1991, J HETEROCYCLIC CHEM, V28, P513; NAGAMATSU T, 1993, J HETEROCYCLIC CHEM, V30, P233; Okuda K, 2011, J HETEROCYCLIC CHEM, V48, P715, DOI 10.1002/jhet.564; Okuda K, 2015, J HETEROCYCLIC CHEM, V52, P888, DOI 10.1002/jhet.2040; Okuda K, 2010, CHEM PHARM BULL, V58, P369; Okuda K, 2013, SYNTHETIC COMMUN, V43, P1619, DOI 10.1080/00397911.2012.656295; Rafferty M, 2010, CURR MED CHEM, V17, P4578, DOI 10.2174/092986710794182962; SASAKI K, 1990, J HETEROCYCLIC CHEM, V27, P1771; SASAKI K, 1995, HETEROCYCLES, V41, P2251; Sasaki K, 1996, J HETEROCYCLIC CHEM, V33, P1663; SASAKI K, 1993, J HETEROCYCLIC CHEM, V30, P989; SASAKI K, 1993, J HETEROCYCLIC CHEM, V30, P993; SASAKI K, 1991, J HETEROCYCLIC CHEM, V28, P503; SLEBOCKATILK H, 1988, J ORG CHEM, V53, P1153, DOI 10.1021/jo00241a006; Wang H, 2011, BIOORGAN MED CHEM, V19, P871, DOI 10.1016/j.bmc.2010.12.005; Yao K, 2011, EUR J MED CHEM, V46, P3237, DOI 10.1016/j.ejmech.2011.04.037; Zhang XY, 2010, BIOORGAN MED CHEM, V18, P1536, DOI 10.1016/j.bmc.2010.01.009	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-152X	1943-5193		J HETEROCYCLIC CHEM	J. Heterocycl. Chem.	MAY	2015	52	3					780	792		10.1002/jhet.2190		13	Chemistry, Organic	Chemistry	CH4QV	WOS:000354018900021		
J	Okuda, K; Ide, R; Uramaru, N; Hirota, T				Okuda, Kensuke; Ide, Ryota; Uramaru, Naoto; Hirota, Takashi			Polycyclic N-Heterocyclic Compounds. Part 84: Reaction of N-(pyrido[3 ',2 ':4,5]thieno[3,2-d]pyrimidin-4-yl)amidines or N-(pyrido[2 ',3 ':4,5]furo[3,2-d]pyrimidin-4-yl)amidines with Hydroxylamine Hydrochloride	JOURNAL OF HETEROCYCLIC CHEMISTRY			English	Article							N-(QUINAZOLIN-4-YL)AMIDINE DERIVATIVES	The reactions of nine N-(pyrido[3,2:4,5]thieno[3,2-d]pyrimidin-4-yl)amidines (3) with hydroxylamine hydrochloride produced new cyclization products. These were formed via ring cleavage of the pyrimidine component followed by a 1,2,4-oxadiazole-forming ring closure to give N-[2-([1,2,4]oxadiazol-5-yl)thieno[2,3-b]pyridin-3-yl]formamide oximes (11). Reaction of six N-(pyrido[2,3:4,5]furo[3,2-d]pyrimidin-4-yl)amidines (12) with hydroxylamine hydrochloride gave similar results. Effects of the newly synthesized compounds on pentosidine formation were also evaluated.	[Okuda, Kensuke] Gifu Pharmaceut Univ, Lab Med & Pharmaceut Chem, Gifu 5011196, Japan; [Ide, Ryota; Uramaru, Naoto; Hirota, Takashi] Okayama Univ, Fac Pharmaceut Sci, Lab Pharmaceut Chem, Kita Ku, Okayama 7008530, Japan	Okuda, K (reprint author), Gifu Pharmaceut Univ, Lab Med & Pharmaceut Chem, Gifu 5011196, Japan.	okuda@gifu-pu.ac.jp					Piccionello AP, 2009, TETRAHEDRON LETT, V50, P1472, DOI 10.1016/j.tetlet.2009.01.071; Adamo MFA, 2008, TETRAHEDRON LETT, V49, P941, DOI 10.1016/j.tetlet.2007.12.019; Sunada Y, 2009, ANGEW CHEM INT EDIT, V48, P9511, DOI 10.1002/anie.200905025; Odani H, 1998, FEBS LETT, V427, P381, DOI 10.1016/S0014-5793(98)00416-5; Buscemi S, 2004, EUR J ORG CHEM, P974, DOI 10.1002/ejoc.200300737; Guerrera F., 1976, ED SCI, V31, P21; Loidreau Y, 2012, TETRAHEDRON LETT, V53, P944, DOI 10.1016/j.tetlet.2011.12.042; Naumov Y. A., 1975, ENV QUAL SAF S, P722; Okuda K, 2012, J HETEROCYCLIC CHEM, V49, P755, DOI 10.1002/jhet.850; Okuda K, 2010, CHEM PHARM BULL, V58, P369; Okuda K, 2011, J HETEROCYCLIC CHEM, V48, P1407, DOI 10.1002/jhet.695; Patel B, 2012, ORG PROCESS RES DEV, V16, P447, DOI 10.1021/op2003419; Sasaki K, 1999, J CHEM RES-S, P92, DOI 10.1039/a809077g; SLEBOCKATILK H, 1988, J ORG CHEM, V53, P1153, DOI 10.1021/jo00241a006; van der Plas HC, 1999, ADV HETEROCYCL CHEM, V74, P1; Zhao CL, 2009, BIOORG MED CHEM LETT, V19, P319, DOI 10.1016/j.bmcl.2008.11.093	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-152X	1943-5193		J HETEROCYCLIC CHEM	J. Heterocycl. Chem.	MAY	2015	52	3					880	887		10.1002/jhet.2033		8	Chemistry, Organic	Chemistry	CH4QV	WOS:000354018900032		
J	Okuda, K; Zhang, YX; Hirota, T; Sasaki, K				Okuda, Kensuke; Zhang, Ying-Xue; Hirota, Takashi; Sasaki, Kenji			Polycyclic N-Heterocyclic Compounds. Part 85: Synthesis and Evaluation of Antiplatelet Aggregation Activity of 2,4-Disubstituted 5,6-Dihydro[1]benzazepino[5,4-d]pyrimidine and Related Compounds	JOURNAL OF HETEROCYCLIC CHEMISTRY			English	Article							VIVO ANTITHROMBOTIC EVALUATION; 3D QSAR ANALYSIS; PLATELET-AGGREGATION; DISCOVERY; DESIGN; AGENTS	We have synthesized a large number of tricyclic 2-substituted 4-alkylamino-5,6-dihydro[1]benzazepino[5,4-d]pyrimidines as part of our research to develop new effective antiplatelet drugs. A variety of alkyl and aryl groups were used as substituents at the 2-position. Evaluation of the effects of the newly synthesized compounds on collagen-induced platelet aggregation revealed several promising antiplatelet candidates with potencies superior to aspirin.	[Okuda, Kensuke] Gifu Pharmaceut Univ, Lab Med & Pharmaceut Chem, Gifu 5011196, Japan; [Zhang, Ying-Xue; Hirota, Takashi; Sasaki, Kenji] Okayama Univ, Fac Pharmaceut Sci, Lab Pharmaceut Chem, Kita Ku, Okayama 7008530, Japan	Okuda, K (reprint author), Gifu Pharmaceut Univ, Lab Med & Pharmaceut Chem, Gifu 5011196, Japan.	okuda@gifu-pu.ac.jp					Chen HF, 2011, EUR J MED CHEM, V46, P5609, DOI 10.1016/j.ejmech.2011.09.030; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178; Hsieh PW, 2010, BIOORGAN MED CHEM, V18, P7621, DOI 10.1016/j.bmc.2010.08.039; Sunada Y, 2009, ANGEW CHEM INT EDIT, V48, P9511, DOI 10.1002/anie.200905025; Liu GC, 2011, TETRAHEDRON, V67, P5156, DOI 10.1016/j.tet.2011.05.056; Ihmaid S, 2010, EUR J MED CHEM, V45, P4934, DOI 10.1016/j.ejmech.2010.07.066; Cheng SL, 2009, EUR J MED CHEM, V44, P4904, DOI 10.1016/j.ejmech.2009.08.002; Gui L, 2012, MEDCHEMCOMM, V3, P102, DOI 10.1039/c1md00222h; HIROTA T, 1986, HETEROCYCLES, V24, P143; HIROTA T, 1990, HETEROCYCLES, V31, P153; Li CY, 2011, EUR J MED CHEM, V46, P5598, DOI 10.1016/j.ejmech.2011.09.027; NAGAMATSU T, 1993, J HETEROCYCLIC CHEM, V30, P193; Okuda K, 2014, J HETEROCYCLIC CHEM, V51, P1607, DOI 10.1002/jhet.1714; Rafferty M, 2010, CURR MED CHEM, V17, P4578, DOI 10.2174/092986710794182962; Sasaki K, 1996, J HETEROCYCLIC CHEM, V33, P1663; Wang H, 2011, BIOORGAN MED CHEM, V19, P871, DOI 10.1016/j.bmc.2010.12.005; Yao K, 2011, EUR J MED CHEM, V46, P3237, DOI 10.1016/j.ejmech.2011.04.037; Zhang XY, 2010, BIOORGAN MED CHEM, V18, P1536, DOI 10.1016/j.bmc.2010.01.009	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-152X	1943-5193		J HETEROCYCLIC CHEM	J. Heterocycl. Chem.	MAY	2015	52	3					888	895		10.1002/jhet.2040		8	Chemistry, Organic	Chemistry	CH4QV	WOS:000354018900033		
J	Kubagawa, H; Carroll, MC; Jacob, CO; Lang, KS; Lee, KH; Mak, T; McAndrews, M; Morse, HC; Nolan, GP; Ohno, H; Richter, GH; Seal, R; Wang, JY; Wiestner, A; Coligan, JE				Kubagawa, Hiromi; Carroll, Michael C.; Jacob, Chaim O.; Lang, Karl S.; Lee, Kyeong-Hee; Mak, Tak; McAndrews, Monica; Morse, Herbert C., III; Nolan, Garry P.; Ohno, Hiroshi; Richter, Guenther H.; Seal, Ruth; Wang, Ji-Yang; Wiestner, Adrian; Coligan, John E.			Nomenclature of Toso, Fas Apoptosis Inhibitory Molecule 3, and IgM FcR	JOURNAL OF IMMUNOLOGY			English	Article							MU-R; IMMUNE-RESPONSES; T-CELLS; DENDRITIC CELLS; B-CELLS; RECEPTOR; ACTIVATION; BINDING; DEATH; GRANULOCYTES	Hiromi Kubagawa and John E. Coligan coordinated an online meeting to define an appropriate nomenclature for the cell surface glycoprotein presently designated by different names: Toso, Fas apoptosis inhibitory molecule 3 (FAIM3), and IgM FcR (Fc mu R). FAIM3 and Faim3 are the currently approved symbols for the human and mouse genes, respectively, in the National Center for Biotechnology Information, Ensembl, and other databases. However, recent functional results reported by several groups of investigators strongly support a recommendation for renaming FAIM3/Faim3 as FCMR/Fcmr, a name better reflecting its physiological function as the FcR for IgM. Participants included 12 investigators involved in studying Toso/FAIM3(Faim3)/F mu R, representatives from the Human Genome Nomenclature Committee (Ruth Seal) and the Mouse Genome Nomenclature Committee (Monica McAndrews), and an observer from the IgM research field (Michael Carroll). In this article, we provide a brief background of the key research on the Toso/FAIM3(Faim3)/Fc mu R proteins, focusing on the ligand specificity and functional activity, followed by a brief summary of discussion about adopting a single name for this molecule and its gene and a resulting recommendation for genome nomenclature committees.	[Kubagawa, Hiromi] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Carroll, Michael C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Jacob, Chaim O.] Univ So Calif, Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Lang, Karl S.] Univ Duisburg Essen, Inst Immunol, D-45147 Essen, Germany; [Lee, Kyeong-Hee] Hannover Med Sch, Inst Clin Chem, D-30625 Hannover, Germany; [Mak, Tak] Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON M5T 2M9, Canada; [McAndrews, Monica] Jackson Lab, Mouse Genome Informat, Bar Harbor, ME 04609 USA; [Morse, Herbert C., III; Coligan, John E.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Ohno, Hiroshi] RIKEN, Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan; [Richter, Guenther H.] Tech Univ Munich, Klinikum Rechts Isar, Kinderklin, D-81664 Munich, Germany; [Seal, Ruth] European Bioinformat Inst, Human Genome Org Gene Nomenclature Comm, Hinxton CB10 1SD, Cambs, England; [Wang, Ji-Yang] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China; [Wiestner, Adrian] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	Kubagawa, H (reprint author), Deutsch Rheuma Forschungszentrum Berlin, Charitepl, D-10117 Berlin, Germany.	hiromi.kubagawa@drfz.de; JCOLIGAN@niaid.nih.gov	Ohno, Hiroshi/L-7899-2014	Ohno, Hiroshi/0000-0001-8776-9661	National Institutes of Health/National Institute of Allergy and Infectious Diseases [R21AI094625]; National Human Genome Research Institute [U41HG003345]; Wellcome Trust [099129/Z/12/Z]	This work was supported in part by National Institutes of Health/National Institute of Allergy and Infectious Diseases Grant R21AI094625 (to H.K.), the National Institutes of Health/National Institute of Allergy and Infectious Diseases Intramural Research Programs (to H.C.M. and J.E.C.), and National Human Genome Research Institute Grant U41HG003345 and Wellcome Trust Grant 099129/Z/12/Z (to R.S.).	Murakami Y, 2012, J IMMUNOL, V189, P587, DOI 10.4049/jimmunol.1200840; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Vire B, 2011, J IMMUNOL, V187, P4040, DOI 10.4049/jimmunol.1100532; Honjo K, 2012, P NATL ACAD SCI USA, V109, P15882, DOI 10.1073/pnas.1206567109; Kubagawa H, 2009, J EXP MED, V206, P2779, DOI 10.1084/jem.20091107; Richter GHS, 2009, SCAND J IMMUNOL, V70, P206, DOI 10.1111/j.1365-3083.2009.02281.x; Ouchida R, 2013, BLOOD, V121, P2368, DOI 10.1182/blood-2012-12-470906; Nguyen XH, 2011, BLOOD, V118, P598, DOI 10.1182/blood-2010-10-313643; Ouchida R, 2012, P NATL ACAD SCI USA, V109, pE2699, DOI 10.1073/pnas.1210706109; Shima H, 2010, INT IMMUNOL, V22, P149, DOI 10.1093/intimm/dxp121; Honjo K, 2012, BLOOD, V119, P1789, DOI 10.1182/blood-2011-09-380782; Choi SC, 2013, J IMMUNOL, V190, P987, DOI 10.4049/jimmunol.1202227; Lang KS, 2013, P NATL ACAD SCI USA, V110, P2593, DOI 10.1073/pnas.1222264110; Brenner D, 2014, P NATL ACAD SCI USA, V111, P1060, DOI 10.1073/pnas.1323166111; Ding Z., 2013, PLOS ONE, V8; Honjo K, 2014, INT IMMUNOL, V26, P659, DOI 10.1093/intimm/dxu070; Honjo K, 2015, J IMMUNOL, V194, P1975, DOI 10.4049/jimmunol.1401866; Honjo K, 2013, P NATL ACAD SCI USA, V110, pE2540, DOI 10.1073/pnas.1304904110; Kubagawa H, 2014, CURR TOP MICROBIOL, V382, P3, DOI 10.1007/978-3-319-07911-0_1; Kubagawa Yoshiki, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P393, DOI 10.1089/mab.2014.0053; Lang KS, 2013, P NATL ACAD SCI USA, V110, pE2542, DOI 10.1073/pnas.1306422110; Lang PA, 2015, CELL DEATH DIFFER, V22, P164, DOI 10.1038/cdd.2014.138; Nguyen Xuan-Hung, 2012, Blood, V119, P1790; Song YH, 2005, J BIOL CHEM, V280, P9618, DOI 10.1074/jbc.M413609200	24	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	MAY 1	2015	194	9					4055	4057		10.4049/jimmunol.1500222		3	Immunology	Immunology	CH0QN	WOS:000353727400001		
J	Akieda, Y; Wakamatsu, E; Nakamura, T; Ishida, Y; Ogawa, S; Abe, R				Akieda, Yuki; Wakamatsu, Ei; Nakamura, Tomoe; Ishida, Yasuo; Ogawa, Shuhei; Abe, Ryo			Defects in Regulatory T Cells Due to CD28 Deficiency Induce a Qualitative Change of Allogeneic Immune Response in Chronic Graft-versus-Host Disease	JOURNAL OF IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; PHOSPHATIDYLINOSITOL 3-KINASE; CD28-MEDIATED COSTIMULATION; CYTOPLASMIC DOMAIN; NEPHROTIC SYNDROME; CLINICAL-TRIALS; RECEPTOR CD28; B-CELLS	In patients receiving allogeneic hematopoietic cell transplantation, chronic graft-versus-host disease (cGVHD) remains a frequent complication and resembles autoimmune diseases such as systemic lupus erythematosus and systemic sclerosis. Our previous work demonstrated the critical role of CD28 costimulation of donor T cells for GVHD induction. In this study, we investigate the role of CD28 costimulation of host T cells in cGVHD. CD28-intact mice as hosts showed systemic lupus erythematosus-type cGVHD, whereas CD28-deficient mice developed a distinct phenotype of cGVHD, with fibrotic damage in skin and internal organs, resembling systemic sclerosis. This phenotype was due to a lack of signaling through the C-terminal proline-rich motif within host CD28's cytoplasmic tail, a motif previously shown to be required for development of regulatory T cells (Tregs) and function of conventional T cells. Adoptive transfer experiments demonstrated that a defect in host CD4(+)CD25(+)Tregs, but not in conventional T cells, was responsible for disease phenotype. Host Treg deficiency altered the cytokine pattern of donor CD4(+) T cells and the Ag specificity of autoantibodies, and these might lead to phenotypic change. Thus, host CD28 signaling controlled the pathogenesis of cGVHD through effects on host Tregs, whose status impacts qualitatively on the allogeneic immune responses.	[Akieda, Yuki; Wakamatsu, Ei; Nakamura, Tomoe; Ogawa, Shuhei; Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Noda, Chiba 2780022, Japan; [Ishida, Yasuo] Teikyo Univ, Chiba Med Ctr, Dept Pathol, Chiba 2990111, Japan	Abe, R (reprint author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, 2669 Yamazaki, Noda, Chiba 2780022, Japan.	rabe@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24700438, S0901020]; Research Associate grant at Tokyo University of Science	This work was supported by Grant-in-Aid for Scientific Research 24700438 (to S.O.), Strategic Research Foundation Grant-aided Project for Private Universities Grant S0901020 (to R.A.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and a Research Associate grant at Tokyo University of Science (to Y.A.).	al-Jurf M, 2005, J CLIN ONCOL, V23, P5074, DOI 10.1200/JCO.2005.09.020; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; JAFFEE BD, 1983, CELL IMMUNOL, V77, P1, DOI 10.1016/0008-8749(83)90001-1; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Riella LV, 2012, AM J TRANSPLANT, V12, P846, DOI 10.1111/j.1600-6143.2011.03929.x; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Li HW, 2012, NAT REV IMMUNOL, V12, P403, DOI 10.1038/nri3226; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Harada Y, 2001, J BIOL CHEM, V276, P9003, DOI 10.1074/jbc.M005051200; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Takeda K, 2008, INT IMMUNOL, V20, P1507, DOI 10.1093/intimm/dxn108; Kaplan DH, 2004, J IMMUNOL, V173, P5467; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; HUTCHCROFT JE, 1994, P NATL ACAD SCI USA, V91, P3260, DOI 10.1073/pnas.91.8.3260; King PD, 1997, J IMMUNOL, V158, P580; Zhang CY, 2006, BLOOD, V107, P2993, DOI 10.1182/blood-2005-09-3623; Yamazaki T, 2008, J IMMUNOL, V181, P8391; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P215, DOI 10.1053/bbmt.2003.50026; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Watanabe R, 2006, J IMMUNOL, V177, P1085; Sakkas LI, 2004, ARTHRITIS RHEUM, V50, P1721, DOI 10.1002/art.20315; Jain N, 2013, NAT MED, V19, P1632, DOI 10.1038/nm.3393; Marengere LEM, 1997, J IMMUNOL, V159, P3220; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Petersdorf EW, 2013, BLOOD, V122, P1863, DOI 10.1182/blood-2013-05-355982; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013; Via CS, 2010, TRENDS IMMUNOL, V31, P236, DOI 10.1016/j.it.2010.02.001; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; Tang QZ, 2003, J IMMUNOL, V171, P3348; Ong C, 1998, EUR J IMMUNOL, V28, P2619, DOI 10.1002/(SICI)1521-4141(199809)28:09<2619::AID-IMMU2619>3.0.CO;2-M; Andres PG, 2004, NAT IMMUNOL, V5, P435, DOI 10.1038/ni1044; Dodson LF, 2009, MOL CELL BIOL, V29, P3710, DOI 10.1128/MCB.01869-08; Via CS, 1996, J IMMUNOL, V157, P4258; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Brukamp K, 2006, CLIN J AM SOC NEPHRO, V1, P685, DOI 10.2215/CJN.00380705; Chen FQ, 1998, J IMMUNOL, V161, P5880; Giorgini A, 2007, J LEUKOCYTE BIOL, V82, P1053, DOI 10.1189/jlb.0407227; Harada Y, 2001, J IMMUNOL, V166, P3797; Jedlickova Z, 2011, BIOL BLOOD MARROW TR, V17, P657, DOI 10.1016/j.bbmt.2010.07.025; Lee SJ, 2005, BLOOD, V105, P4200, DOI 10.1182/blood-2004-10-4023; Leon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4495; Mavalia C, 1997, Am J Pathol, V151, P1751; MCINTYRE KR, 1984, NATURE, V308, P551, DOI 10.1038/308551a0; Meagher C, 2008, J IMMUNOL, V180, P7793; Miura K, 2012, CLIN EXP NEPHROL, V16, P180, DOI 10.1007/s10157-011-0538-6; MORRIS SC, 1990, J IMMUNOL, V144, P916; Murphy WJ, 2000, J CLIN INVEST, V106, P745, DOI 10.1172/JCI11088; Nergizoglu G, 1999, NEPHROL DIAL TRANSPL, V14, P2461, DOI 10.1093/ndt/14.10.2461; Ogawa S, 2013, INT IMMUNOL, V25, P671, DOI 10.1093/intimm/dxt028; Ogawa S, 2001, J IMMUNOL, V167, P5741; Ogawa S, 2000, KIDNEY INT, V58, P2215, DOI 10.1111/j.1523-1755.2000.00396.x; Srinivasan R, 2005, BRIT J HAEMATOL, V131, P74, DOI 10.1111/j.1365-2141.2005.05728.x; Teshima T, 2008, BIOL BLOOD MARROW TR, V14, P142, DOI 10.1016/j.bbmt.2007.10.023; Tian L, 2011, BLOOD, V118, P1845, DOI 10.1182/blood-2011-04-346056; VANELVEN EH, 1981, J IMMUNOL, V126, P1684	64	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	MAY 1	2015	194	9					4162	4174		10.4049/jimmunol.1402591		13	Immunology	Immunology	CH0QN	WOS:000353727400015		
J	Schlie, K; Westerback, A; DeVorkin, L; Hughson, LR; Brandon, JM; MacPherson, S; Gadawski, I; Townsend, KN; Poon, VI; Elrick, MA; Cote, HCF; Abraham, N; Wherry, EJ; Mizushima, N; Lum, JJ				Schlie, Katrin; Westerback, Ashley; DeVorkin, Lindsay; Hughson, Luke R.; Brandon, Jillian M.; MacPherson, Sarah; Gadawski, Izabelle; Townsend, Katelin N.; Poon, Vincent I.; Elrick, Mary A.; Cote, Helene C. F.; Abraham, Ninan; Wherry, E. John; Mizushima, Noboru; Lum, Julian J.			Survival of Effector CD8(+) T Cells during Influenza Infection Is Dependent on Autophagy	JOURNAL OF IMMUNOLOGY			English	Article							METABOLIC-REGULATION; MEMORY; LYMPHOCYTES; DIFFERENTIATION; ACTIVATION; APOPTOSIS; VIRUS; P53; STIMULATION; MAINTENANCE	The activation and expansion of effector CD8(+) T cells are essential for controlling viral infections and tumor surveillance. During an immune response, T cells encounter extrinsic and intrinsic factors, including oxidative stress, nutrient availability, and inflammation, that can modulate their capacity to activate, proliferate, and survive. The dependency of T cells on autophagy for in vitro and in vivo activation, expansion, and memory remains unclear. Moreover, the specific signals and mechanisms that activate autophagy in T effector cells and their survival are not known. In this study, we generated a novel inducible autophagy knockout mouse to study T cell effector responses during the course of a virus infection. In response to influenza infection, Atg5(-/-) CD8(+) T cells had a decreased capacity to reach the peak effector response and were unable to maintain cell viability during the effector phase. As a consequence of Atg5 deletion and the impairment in effector-to-memory cell survival, mice fail to mount a memory response following a secondary challenge. We found that Atg5(-/-) effector CD8(+) T cells upregulated p53, a transcriptional state that was concomitant with widespread hypoxia in lymphoid tissues of infected mice. The onset of p53 activation was concurrent with higher levels of reactive oxygen species (ROS) that resulted in ROS-dependent apoptotic cell death, a fate that could be rescued by treating with the ROS scavenger N-acetylcysteine. Collectively, these results demonstrate that effector CD8(+) T cells require autophagy to suppress cell death and maintain survival in response to a viral infection.	[Schlie, Katrin; Westerback, Ashley; DeVorkin, Lindsay; Hughson, Luke R.; Brandon, Jillian M.; MacPherson, Sarah; Townsend, Katelin N.; Poon, Vincent I.; Elrick, Mary A.; Lum, Julian J.] British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC V8R 6V5, Canada; [DeVorkin, Lindsay; Hughson, Luke R.; MacPherson, Sarah; Townsend, Katelin N.; Poon, Vincent I.; Elrick, Mary A.; Lum, Julian J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Gadawski, Izabelle; Cote, Helene C. F.] Univ British Columbia, Ctr Blood Res, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada; [Abraham, Ninan] Univ British Columbia, Inst Life Sci, Dept Zool, Vancouver, BC V6T 1Z3, Canada; [Abraham, Ninan] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Mizushima, Noboru] Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 1130033, Japan	Lum, JJ (reprint author), British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, 2410 Lee Ave, Victoria, BC V8R 6V5, Canada.	jjlum@bccancer.bc.ca	Mizushima, Noboru/C-3635-2009		Canadian Institutes for Health Research; Cancer Research Society Operating Grant; Canadian Institutes for Health Research New Investigator Award; British Columbia Cancer Foundation [MOP97909]; Deutsche Forschungsgemeinschaft [SCHL 1938/1-1]	This work was supported by grants from the Canadian Institutes for Health Research and a Cancer Research Society Operating Grant, as well as by a Canadian Institutes for Health Research New Investigator Award, British Columbia Cancer Foundation Grant MOP97909 (to J.J.L.), and Deutsche Forschungsgemeinschaft Grant SCHL 1938/1-1 (to K.S.).	Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; O'Brien TF, 2011, EUR J IMMUNOL, V41, P3361, DOI 10.1002/eji.201141411; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Yatmaz S, 2013, AM J RESP CELL MOL, V48, P17, DOI 10.1165/rcmb.2011-0345OC; Yoshida T, 2010, FASEB J, V24, P1759, DOI 10.1096/fj.09-145664; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Kovacs JR, 2012, CELL DEATH DIFFER, V19, P144, DOI 10.1038/cdd.2011.78; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Tzelepis F, 2013, J IMMUNOL, V190, P1066, DOI 10.4049/jimmunol.1200639; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Jenkins MR, 2006, J IMMUNOL, V177, P2917; Zhirnov OP, 2013, J VIROL, V87, P13107, DOI 10.1128/JVI.02148-13; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Wiesel M, 2012, EUR J IMMUNOL, V42, P1080, DOI 10.1002/eji.201142205; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Chandel NS, 2000, ONCOGENE, V19, P3840, DOI 10.1038/sj.onc.1203727; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005; Altman BJ, 2011, ONCOGENE, V30, P1855, DOI 10.1038/onc.2010.561; Hildeman DA, 2004, FREE RADICAL BIO MED, V36, P1496, DOI 10.1016/j.freeradbiomed.2004.03.023; Stephenson LM, 2009, AUTOPHAGY, V5, P625; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; BUDD RC, 1987, J IMMUNOL, V138, P3120; Chen M, 2014, NAT MED, V20, P507, DOI 10.1038/nm.3521; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Goldberg EL, 2014, J IMMUNOL, V193, P757, DOI 10.4049/jimmunol.1400188; He MX, 2012, FRONT IMMUNOL, V21, P3, DOI DOI 10.3389/FIMMU.2012.00022; He S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020107; Huang W, 2009, NUCLEIC ACIDS RES, V37, P1, DOI DOI 10.1093/NAR/GKN923; Huang W., 2009, NAT PROTOC, V4, P44, DOI DOI 10.1038/NPR0T.2008.211; Jia W, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00179; Lang PA, 2013, CELL DEATH DIFFER, V20, P649, DOI 10.1038/cdd.2012.167; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036; Puelston D., 2014, ELIFE, V3, DOI [10.7554/eLife03706, DOI 10.7554/ELIFE03706]; Puleston D. J., 2014, ELIFE, V3, P11; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025	57	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	MAY 1	2015	194	9					4277	4286		10.4049/jimmunol.1402571		10	Immunology	Immunology	CH0QN	WOS:000353727400026		
J	Buddhisa, S; Rinchai, D; Ato, M; Bancroft, GJ; Lertmemongkolchai, G				Buddhisa, Surachat; Rinchai, Darawan; Ato, Manabu; Bancroft, Gregory J.; Lertmemongkolchai, Ganjana			Programmed Death Ligand 1 on Burkholderia pseudomallei-Infected Human Polymorphonuclear Neutrophils Impairs T Cell Functions	JOURNAL OF IMMUNOLOGY			English	Article							BACTERIAL-INFECTION; IMPROVES SURVIVAL; OXIDATIVE STRESS; MURINE MODEL; MELIOIDOSIS; RESPONSES; SEPSIS; IMMUNITY; PD-1; INTERLEUKIN-27	Polymorphonuclear neutrophils (PMNs) are terminally differentiated cells that are involved in innate immune responses and form an early line of defense against pathogens. More recently, it has been shown that PMNs have immunosuppressive abilities on other immune cells. However, the effect of PMNs on T cell responses during bacterial infection remains to be determined. In this report, we examined the interaction of PMNs and T cells in response to infection with Burkholderia pseudomallei, the causative agent of human melioidosis. We observed that CD4(+) T cell proliferation and IFN-gamma production in response to polyclonal activators is significantly inhibited by uninfected PMNs, and to a greater extent B. pseudomallei-infected PMNs. Programmed death ligand 1 (PD-L1), a known regulator of T cell activation, is increased in mRNA expression in the blood of patients and upon infection of PMNs in vitro. The increased expression of PD-L1 was correlated with the degree of T cell inhibition in individuals with type 2 diabetes, a major risk factor of melioidosis. In vitro, addition of anti-PD-L1 Abs blocked this inhibitory activity and restored proliferation of CD4(+) T cells and IFN-gamma production, suggesting that PD-L1 on B. pseudomallei-infected PMNs is a regulatory molecule for the functions of T cells and may be involved in pathogenesis versus control of melioidosis.	[Buddhisa, Surachat; Rinchai, Darawan; Lertmemongkolchai, Ganjana] Khon Kaen Univ, Fac Associated Med Sci, Ctr Res & Dev Med Diagnost Labs, Khon Kaen 40002, Thailand; [Ato, Manabu] Natl Inst Infect Dis, Dept Immunol, Tokyo 1628640, Japan; [Bancroft, Gregory J.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1E 7HT, England	Lertmemongkolchai, G (reprint author), Khon Kaen Univ, Fac Associated Med Sci, Cellular & Mol Immunol Unit, Ctr Res & Dev Med Diagnost Labs, Khon Kaen 40002, Thailand.	ganja_le@kku.ac.th		Rinchai, Darawan/0000-0001-8851-7730			Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Brown KE, 2010, CURR OPIN IMMUNOL, V22, P397, DOI 10.1016/j.coi.2010.03.007; Haque A, 2006, J INFECT DIS, V194, P1241, DOI 10.1086/508217; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Jurado JO, 2008, J IMMUNOL, V181, P116; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Tan KS, 2012, J CLIN INVEST, V122, P2289, DOI 10.1172/JCI57817; Youn JI, 2008, J IMMUNOL, V181, P5791; Schmielau J, 2001, CANCER RES, V61, P4756; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Santanirand P, 1999, INFECT IMMUN, V67, P3593; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Hock BD, 2012, IMMUNOLOGY, V137, P249, DOI 10.1111/imm.12004; Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739; McNab FW, 2011, EUR J IMMUNOL, V41, P1941, DOI 10.1002/eji.201141421; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Koh GCKW, 2011, CLIN INFECT DIS, V52, P717, DOI 10.1093/cid/ciq192; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Bowers NL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003993; de Kleijn S., 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0072249#; Kewcharoenwong C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03363; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Limmathurotsakul D, 2006, CLIN INFECT DIS, V43, P979, DOI 10.1086/507632; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Rinchai D, 2012, EUR J IMMUNOL, V42, P3280, DOI 10.1002/eji.201242526; Sarkar-Tyson M, 2007, J MED MICROBIOL, V56, P1005, DOI 10.1099/jmm.0.47043-0; Tateda K, 2001, J IMMUNOL, V166, P3355; Thewissen M, 2011, MOL IMMUNOL, V48, P2094, DOI 10.1016/j.molimm.2011.07.006; Tippayawat P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000407; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354	42	2	2	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	MAY 1	2015	194	9					4413	4421		10.4049/jimmunol.1402417		9	Immunology	Immunology	CH0QN	WOS:000353727400039		
J	Nakano, N; Nishiyama, C; Yagita, H; Hara, M; Motomura, Y; Kubo, M; Okumura, K; Ogawa, H				Nakano, Nobuhiro; Nishiyama, Chiharu; Yagita, Hideo; Hara, Mutsuko; Motomura, Yasutaka; Kubo, Masato; Okumura, Ko; Ogawa, Hideoki			Notch Signaling Enhances Fc epsilon RI-Mediated Cytokine Production by Mast Cells through Direct and Indirect Mechanisms	JOURNAL OF IMMUNOLOGY			English	Article							T(H)2 CELLS; T-CELLS; IN-VIVO; IMMUNITY; TRANSCRIPTION; EXPRESSION; MUCOSAL; IGE; ACTIVATION; MICE	Th2-type cytokines and TNF-alpha secreted by activated mast cells upon cross-linking of Fc epsilon RI contribute to the development and maintenance of Th2 immunity to parasites and allergens. We have previously shown that cytokine secretion by mouse mast cells is enhanced by signaling through Notch receptors. In this study, we investigated the molecular mechanisms by which Notch signaling enhances mast cell cytokine production induced by Fc epsilon RI cross-linking. Fc epsilon RI-mediated production of cytokines, particularly IL-4, was significantly enhanced in mouse bone marrow-derived mast cells by priming with Notch ligands. Western blot analysis showed that Notch signaling augmented and prolonged Fc epsilon RI-mediated phosphorylation of MAPKs, mainly JNK and p38 MAPK, through suppression of the expression of SHIP-1, a master negative regulator of Fc epsilon RI signaling, resulting in the enhanced production of multiple cytokines. The enhancing effect of Notch ligand priming on multiple cytokine production was abolished by knockdown of Notch2, but not Notch1, and Fc epsilon RI-mediated production of multiple cytokines was enhanced by retroviral transduction with the intracellular domain of Notch2. However, only IL-4 production was enhanced by both Notch1 and Notch2. The enhancing effect of Notch signaling on IL-4 production was lost in bone marrow-derived mast cells from mice lacking conserved noncoding sequence 2, which is located at the distal 39 element of the Il4 gene locus and contains Notch effector RBP-J binding sites. These results indicate that Notch2 signaling indirectly enhances the Fc epsilon RI-mediated production of multiple cytokines, and both Notch1 and Notch2 signaling directly enhances IL-4 production through the noncoding sequence 2 enhancer of the Il4 gene.	[Nakano, Nobuhiro; Nishiyama, Chiharu; Hara, Mutsuko; Okumura, Ko; Ogawa, Hideoki] Juntendo Univ, Atopy Allergy Res Ctr, Sch Med, Tokyo 1138421, Japan; [Nishiyama, Chiharu] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 1258585, Japan; [Yagita, Hideo; Okumura, Ko] Juntendo Univ, Dept Immunol, Sch Med, Tokyo 1138421, Japan; [Motomura, Yasutaka; Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Chiba 2788510, Japan; [Motomura, Yasutaka; Kubo, Masato] RIKEN Yokohama Inst, Res Ctr Integrat Med Sci, Lab Cytokine Regulat, RIKEN Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan	Nakano, N (reprint author), Juntendo Univ, Atopy Allergy Res Ctr, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nbnakano@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported in part by Grants-in-Aid for Scientific Research (to N.N.) and the Ministry of Education, Culture, Sports, Science, and Technology, Japan-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015.	Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; Ruschmann J, 2012, J IMMUNOL, V188, P3839, DOI 10.4049/jimmunol.1003875; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017; Haddon DJ, 2009, J IMMUNOL, V183, P228, DOI 10.4049/jimmunol.0900427; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Ma PL, 2011, BLOOD, V118, P3459, DOI 10.1182/blood-2011-04-351809; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; RAZIN E, 1984, J IMMUNOL, V132, P1479; Hepworth MR, 2012, P NATL ACAD SCI USA, V109, P6644, DOI 10.1073/pnas.1112268109; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Boyce JA, 2003, J ALLERGY CLIN IMMUN, V111, P24, DOI 10.1067/mai.2003.60; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; Nakano N, 2009, J ALLERGY CLIN IMMUN, V123, P74, DOI 10.1016/j.jaci.2008.10.040; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Furumoto Y, 2004, J BIOL CHEM, V279, P49177, DOI 10.1074/jbc.M404730200; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nishimoto H, 2005, BLOOD, V106, P4241, DOI 10.1182/blood-2005-04-1358; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Taube C, 2004, J IMMUNOL, V172, P6398; Macey MR, 2010, J IMMUNOL, V184, P4688, DOI 10.4049/jimmunol.0903477; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; BEFUS AD, 1982, J IMMUNOL, V128, P2475; Da'as SI, 2012, BLOOD, V119, P3585, DOI 10.1182/blood-2011-10-385989; Hofmann AM, 2009, CURR OPIN IMMUNOL, V21, P679, DOI 10.1016/j.coi.2009.09.007; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kambayashi T, 2007, J ALLERGY CLIN IMMUN, V119, P544, DOI 10.1016/j.jaci.2007.01.017; Monticelli S, 2005, INT IMMUNOL, V17, P1513, DOI 10.1093/intimm/dxh329; Nakano N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.138966; Sakata-Yanagimoto M, 2008, P NATL ACAD SCI USA, V105, P7839, DOI 10.1073/pnas.0801074105; Sakata-Yanagimoto M, 2011, BLOOD, V117, P128, DOI 10.1182/blood-2010-07-289611; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509; Sibilano R, 2012, J ALLERGY CLIN IMMUN, V130, P751, DOI 10.1016/j.jaci.2012.03.032; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07	44	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	MAY 1	2015	194	9					4535	4544		10.4049/jimmunol.1301850		10	Immunology	Immunology	CH0QN	WOS:000353727400052		
J	Arimoto, K; Hishiki, T; Kiyonari, H; Abe, T; Cheng, CY; Yan, M; Fan, JB; Futakuchi, M; Tsuda, H; Murakami, Y; Suzuki, H; Zhang, DE; Shimotohno, K				Arimoto, Kei-ichiro; Hishiki, Takayuki; Kiyonari, Hiroshi; Abe, Takaya; Cheng, Chuyi; Yan, Ming; Fan, Jun-Bao; Futakuchi, Mitsuru; Tsuda, Hiroyuki; Murakami, Yoshiki; Suzuki, Hideyuki; Zhang, Dong-Er; Shimotohno, Kunitada			Murine Herc6 Plays a Critical Role in Protein ISGylation In Vivo and Has an ISGylation-Independent Function in Seminal Vesicles	JOURNAL OF INTERFERON AND CYTOKINE RESEARCH			English	Article							UBIQUITIN-LIKE PROTEIN; INNATE ANTIVIRAL RESPONSE; STIMULATED GENE-15; HUMAN-CELLS; ISG15; CONJUGATION; VIRUS; TARGETS; EXPRESSION; INFLUENZA	ISG15 conjugation (ISGylation) to proteins is a multistep process involving interferon (IFN)-inducible UBE1L (E1), UbcH8 (E2), and ISG15 E3 ligases (E3s). Studies performed over the past several years have shown that ISGylation plays a pivotal role in the host antiviral response against certain viruses. Recent in vitro studies revealed that human Herc5 and mouse Herc6 are major ISG15 E3 ligases, respectively. However, the global function of Herc5/6 proteins in vivo still remains unclear. Here, we report generation and initial characterization of Herc6 knockout mice. Substantial reductions of ISGylation were observed in Herc6-deficient cells after polyinosinic-polycytidylic acid double-stranded RNA injection of mice or IFN treatment of cells. On the other hand, Herc6-deficient cells and wild-type (WT) cells had similar responses to IFN stimulation, Sendai virus (Z strain) infection, and vesicular stomatitis virus infection. These results indicate that Herc6 does not play a critical role in antiviral defense of these viral infections in mice. Interestingly, male Herc6-deficient mice showed seminal vesicle hypertrophy. No such problem was detected in WT and ISG15 activating enzyme Ube1L-deficient mice. These results suggest that in addition to promoting protein ISGylation, Herc6 has a novel and protein ISGylation-independent function in the male reproductive system.	[Arimoto, Kei-ichiro; Yan, Ming; Fan, Jun-Bao; Zhang, Dong-Er] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Hishiki, Takayuki] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Lab Primate Model,Sakyo Ku, Kyoto, Japan; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan; [Cheng, Chuyi] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Futakuchi, Mitsuru] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Toxicol, Nagoya, Aichi, Japan; [Tsuda, Hiroyuki] Nagoya City Univ, Lab Nanotoxicol Project, Nagoya, Aichi, Japan; [Murakami, Yoshiki] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Osaka 558, Japan; [Suzuki, Hideyuki] Oriental Bio Serv Inc, Kobe BM Lab, Kobe, Hyogo, Japan; [Zhang, Dong-Er] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Shimotohno, Kunitada] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan	Arimoto, K (reprint author), Univ Calif San Diego, Moores UCSD Canc Ctr, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	karimoto@ucsd.edu	Fan, Jun-bao/E-7155-2012		Ministry of Education, Culture, Sports, Science, and Technology from National Institutes of Health USA [22114004, 22249012, R01CA177305, R01HL091549]; JSPS KAKENHI Grant [10J00577]	The authors thank all lab members for helpful discussion. They especially thank Dr. Kentson Lam (School of Medicine, University of California San Diego) and Samuel Stoner (Moores Cancer Center, University of California San Diego) for discussion and a critical reading of this article. They also thank Shuichiro Ogawa (Kyoto University) for several experiments and discussion. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (22114004 & 22249012), funding from National Institutes of Health USA (R01CA177305 and R01HL091549), and JSPS KAKENHI Grant (No. 10J00577); Kei-ichiro Arimoto is a JSPS Postdoctoral Fellow for Research Abroad.	Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Lenschow DJ, 2010, VIRUSES-BASEL, V2, P2154, DOI 10.3390/v2102154; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Park JM, 2014, MOL CELL, V54, P626, DOI 10.1016/j.molcel.2014.03.031; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Hochrainer K, 2005, GENOMICS, V85, P153, DOI 10.1016/j.ygeno.2004.10.006; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Burkart Christoph, 2013, EMBO Mol Med, V5, P967, DOI 10.1002/emmm.201201864; Guerra S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000096; Hsiang TY, 2009, J VIROL, V83, P5971, DOI 10.1128/JVI.01667-08; Hsiao NW, 2010, ANTIVIR RES, V85, P504, DOI 10.1016/j.antiviral.2009.12.007; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Oudshoorn D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029870; Philip J, 2007, FERTIL STERIL, V88; PRYOR JP, 1991, FERTIL STERIL, V56, P725	29	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1079-9907	1557-7465		J INTERF CYTOK RES	J. Interferon Cytokine Res.	MAY 1	2015	35	5					351	358		10.1089/jir.2014.0113		8	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CH3XQ	WOS:000353964800004		
J	Iguchi, S; Niwayama, M; Takahashi, HE				Iguchi, Seitaro; Niwayama, Masaaki; Takahashi, Hideaki E.			A conference report of the interprofessional satellite symposium in Uonuma, Japan: an international exchange on the future of community care	JOURNAL OF INTERPROFESSIONAL CARE			English	Editorial Material									[Iguchi, Seitaro] Niigata Univ, Grad Sch Med & Dent Sci, Dept Community Med, Niigata, Japan; [Niwayama, Masaaki] Ojiya & Uonuma Med Assoc, Ojiya, Niigata, Japan; [Takahashi, Hideaki E.] Niigata Rehabil Hosp, Niigata 9503304, Japan	Takahashi, HE (reprint author), Niigata Rehabil Hosp, Kita Ku, 761 Kizaki, Niigata 9503304, Japan.	hideaki.takahashi@aiko.or.jp						0	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	1356-1820	1469-9567		J INTERPROF CARE	J. Interprofessional Care	MAY	2015	29	3					284	287		10.3109/13561820.2014.966541		4	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	CH3GH	WOS:000353916600024		
J	Okuyama, H; Koga, H; Ishimaru, T; Kawashima, H; Yamataka, A; Urushihara, N; Segawa, O; Uchida, H; Iwanaka, T				Okuyama, Hiroomi; Koga, Hiroyuki; Ishimaru, Tetsuya; Kawashima, Hiroshi; Yamataka, Atsuyuki; Urushihara, Naoto; Segawa, Osamu; Uchida, Hiroo; Iwanaka, Tadashi			Current Practice and Outcomes of Thoracoscopic Esophageal Atresia and Tracheoesophageal Fistula Repair: A Multi-institutional Analysis in Japan	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							THORACOTOMY	Background: In order to better understand the current practice and outcomes of thoracoscopic repair of esophageal atresia (EA)/tracheoesophageal fistula (TEF), a multi-institutional analysis was conducted among seven Japanese institutes. Materials and Methods: A survey was sent to the seven institutes regarding the surgical technique, postoperative management, and outcomes of thoracoscopic repair of EA/TEF. Results: The operation was uniformly performed via an intrapleural approach in the 0-45 degrees prone position. The TEF was occluded with suture ligature in four (57.1%) institutes and clips in the remaining three (42.9%) institutes. Anastomosis was performed using the extracorporeal knot-tying technique in four institutes and the intracorporeal technique in three institutes. Patients were routinely left intubated and paralyzed for 3-7 days postoperatively in four institutes. In total, 58 patients underwent thoracoscopic repair of EA/TEF. Fifty-two (89.7%) of the patients underwent successful thoracoscopic repair. Six (10.3%) operations were converted to open thoracotomy because of a long gap (n=4), right aortic arch (n=1), and intraoperative instability (n=1). The body weight at operation ranged from 1.2 to 4.6 kg, and the operative time ranged from 115 to 428 minutes. There were no major intraoperative complications. Eleven patients (19.0%) suffered from anastomotic leakage. Twenty-eight patients (48.3%) developed anastomotic stricture. One patient died during the postoperative period because of an unrelated disease. Recurrent TEF developed in three patients (5.2%). Thirteen patients (22.4%) later required fundoplication. Conclusions: The outcome of thoracoscopic repair of EA/TEF was comparable to that of the open procedure. As considerable variability was observed among the seven institutes with respect to the surgical technique and management, standardizing the surgical management may improve the outcome.	[Okuyama, Hiroomi] Osaka Univ, Dept Pediat Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Koga, Hiroyuki; Yamataka, Atsuyuki] Juntendo Univ, Sch Med, Dept Pediat Surg, Tokyo 113, Japan; [Ishimaru, Tetsuya; Iwanaka, Tadashi] Tokyo Univ Hosp, Dept Pediat Surg, Tokyo 113, Japan; [Kawashima, Hiroshi] Saitama Childrens Hosp, Dept Pediat Surg, Saitama, Japan; [Urushihara, Naoto] Shizuoka Childrens Hosp, Dept Pediat Surg, Shizuoka, Japan; [Segawa, Osamu] Tokyo Womens Med Univ, Dept Pediat Surg, Tokyo, Japan; [Uchida, Hiroo] Nagoya Univ, Dept Pediat Surg, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Okuyama, H (reprint author), Osaka Univ, Dept Pediat Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	okuyama@pedsurg.med.osaka-u.ac.jp	UCHIDA, Hiroo/E-4437-2015	UCHIDA, Hiroo/0000-0002-1818-6697			Lal D, 2013, J LAPAROENDOSC ADV S, V23, P635, DOI 10.1089/lap.2013.0210; Holcomb GW, 2005, ANN SURG, V242, P422, DOI 10.1097/01.sla.0000179649.15576.db; JAUREGUIZAR E, 1985, J PEDIATR SURG, V20, P511, DOI 10.1016/S0022-3468(85)80477-2; GILSANZ V, 1983, AM J ROENTGENOL, V141, P457; Borruto FA, 2012, EUR J PEDIATR SURG, V22, P415, DOI 10.1055/s-0032-1329711; CHETCUTI P, 1989, J PEDIATR SURG, V24, P244, DOI 10.1016/S0022-3468(89)80003-X; ENGUM SA, 1995, ARCH SURG-CHICAGO, V130, P502; Huang JS, 2012, J PEDIATR SURG, V47, P2224, DOI 10.1016/j.jpedsurg.2012.09.011; Lobe TE, 1999, PEDIAT ENDOSURG INNO, V3, P141, DOI 10.1089/pei.1999.3.141; Patkowski D, 2009, J LAPAROENDOSC ADV S, V19, pS19, DOI 10.1089/lap.2008.0139; Rothenberg SS, 2000, PEDIAT ENDOSURG INNO, V4, P289, DOI 10.1089/pei.2000.4.289; Rothenberg SS, 2012, J LAPAROENDOSC ADV S, V22, P195, DOI 10.1089/lap.2011.0063; Tanaka Y, 2013, SURG TODAY, V43, P906, DOI 10.1007/s00595-012-0426-z; Yanchar NL, 2001, J PEDIATR SURG, V36, P815, DOI 10.1053/jpsu.2001.22969	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	MAY 1	2015	25	5					441	444		10.1089/lap.2014.0250		4	Surgery	Surgery	CI0YE	WOS:000354465100016		
J	Takazawa, S; Ishimaru, T; Harada, K; Tsukuda, Y; Sugita, N; Mitsuishi, M; Iwanaka, T				Takazawa, Shinya; Ishimaru, Tetsuya; Harada, Kanako; Tsukuda, Yusuke; Sugita, Naohiko; Mitsuishi, Mamoru; Iwanaka, Tadashi			Video-Based Skill Assessment of Endoscopic Suturing in a Pediatric Chest Model and a Box Trainer	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							LAPAROSCOPIC SURGERY; CONSTRUCT; SIMULATOR; VALIDITY	Purpose: Pediatric endoscopic surgery requires special surgical skills because of the small working space and tissue fragility. This article presents a video-based skill assessment method for endoscopic suturing using a pediatric chest model. Materials and Methods: A commercial suture pad was placed in a rapid-prototyped pediatric chest model of a 1-year-old patient to simulate the thoracoscopic repair of esophageal atresia type C. Twenty-eight pediatric surgeons (9 experts, 9 intermediates, and 10 trainees) performed an endoscopic intracorporeal suturing and knot-tying task both in the pediatric chest model and in a box trainer. The tasks were video-recorded and rated by two blinded observers using the 29-point checklist method and a suturing errors score sheet method. The task completion time and the number of needle manipulations were measured. Results: The expert group showed better performance than the intermediate and trainee groups in the pediatric chest model, and the differences were larger than those in the box trainer. Significant differences between the expert and the trainee groups were observed in the items related to safety such as the skills for keeping the needle in view at all times. Significant differences between the expert and intermediate groups were observed in the items related to task quality and efficiency such as the smoothness of knot tying and the number of needle manipulations. Conclusions: Video-based skill assessment of endoscopic suturing using the pediatric chest model and a box trainer distinguished pediatric endoscopic surgeons according to their clinical experience, and pediatric-specific skills were identified.	[Takazawa, Shinya; Ishimaru, Tetsuya; Iwanaka, Tadashi] Tokyo Univ Hosp, Dept Pediat Surg, Tokyo 1138655, Japan; [Harada, Kanako; Tsukuda, Yusuke; Sugita, Naohiko; Mitsuishi, Mamoru] Univ Tokyo, Dept Mech Engn, Tokyo 113, Japan	Ishimaru, T (reprint author), Tokyo Univ Hosp, Dept Pediat Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	i-tetsuya@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26293378, 23226006]; Accelerating Regulatory Science Initiative, Ministry of Health, Labour and Welfare, Japan	The authors thank Prof. Yuji Nirasawa of Kyorin University for kindly providing the opportunity for conducting the experiments. This study was partially supported by a Grant-in-Aid for Scientific Research (B) (number 26293378), Grant-in-Aid for Scientific Research (S) (number 23226006) from the Ministry of Education, Culture, Sports, Science and Technology, and the project "Assessment methodology for innovative minimally invasive therapeutic devices, materials, and nano-bio diagnostic devices" from the Accelerating Regulatory Science Initiative, Ministry of Health, Labour and Welfare, Japan.	Aggarwal R, 2006, SURGERY, V139, P729, DOI 10.1016/j.surg.2005.12.010; Moorthy K, 2004, SURG ENDOSC, V18, P1608, DOI 10.1007/s00464-003-9312-5; Azzie G, 2011, J PEDIATR SURG, V46, P897, DOI 10.1016/j.jpedsurg.2011.02.026; Kroeze SGC, 2009, EUR UROL, V56, P865, DOI 10.1016/j.eururo.2008.09.045; Mason JD, 2013, SURG ENDOSC, V27, P1468, DOI 10.1007/s00464-012-2631-7; Barsness KA, 2013, J LAPAROENDOSC ADV S, V23, P714, DOI 10.1089/lap.2013.0196; Narayanan SK, 2014, PEDIATR SURG INT, V30, P655, DOI 10.1007/s00383-014-3502-1; Davis Lauren M, 2013, Stud Health Technol Inform, V184, P114; Hamilton JM, 2011, J PEDIATR SURG, V46, P138, DOI 10.1016/j.jpedsurg.2010.09.078; Harada K, 2014, INT J CARS S1, V9, pS139; Ieiri S, 2010, PEDIATR SURG INT, V26, P947, DOI 10.1007/s00383-010-2665-7; Ieiri S, 2013, PEDIATR SURG INT, V29, P501, DOI 10.1007/s00383-013-3276-x; Iwanaka T, 2011, PEDIATR SURG INT, V27, P727, DOI 10.1007/s00383-011-2871-y; Iwanaka T, 2004, J PEDIATR SURG, V39, P1838, DOI 10.1016/j.jpedsurg.2004.08.011; Van Sickle KR, 2008, AM J SURG, V196, P74, DOI 10.1016/j.amjsurg.2007.08.058	15	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	MAY 1	2015	25	5					445	453		10.1089/lap.2014.0269		9	Surgery	Surgery	CI0YE	WOS:000354465100017		
J	Joshi, A; Pooley, C; Freeman, TC; Lennartsson, A; Babina, M; Schmidl, C; Geijtenbeek, T; Michoel, T; Severin, J; Itoh, M; Lassmann, T; Kawaji, H; Hayashizaki, Y; Carninci, P; Forrest, ARR; Rehli, M; Hume, DA				Joshi, Anagha; Pooley, Christopher; Freeman, Tom C.; Lennartsson, Andreas; Babina, Magda; Schmidl, Christian; Geijtenbeek, Teunis; Michoel, Tom; Severin, Jessica; Itoh, Masayoshi; Lassmann, Timo; Kawaji, Hideya; Hayashizaki, Yoshihide; Carninci, Piero; Forrest, Alistair R. R.; Rehli, Michael; Hume, David A.		FANTOM Consortium	Technical Advance: Transcription factor, promoter, and enhancer utilization in human myeloid cells	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						transcriptome; CAGE; hematopoiesis	GENE-EXPRESSION; MESSENGER-RNA; IN-VITRO; DIFFERENTIATION; LEUKEMIA; RECEPTOR; MACROPHAGE; PROGENITOR; CHROMATIN; LINEAGE	The generation of myeloid cells from their progenitors is regulated at the level of transcription by combinatorial control of key transcription factors influencing cell-fate choice. To unravel the global dynamics of this process at the transcript level, we generated transcription profiles for 91 human cell types of myeloid origin by use of CAGE profiling. The CAGE sequencing of these samples has allowed us to investigate diverse aspects of transcription control during myelopoiesis, such as identification of novel transcription factors, miRNAs, and noncoding RNAs specific to the myeloid lineage. We further reconstructed a transcription regulatory network by clustering coexpressed transcripts and associating them with enriched cis-regulatory motifs. With the use of the bidirectional expression as a proxy for enhancers, we predicted over 2000 novel enhancers, including an enhancer 38 kb downstream of IRF8 and an intronic enhancer in the KIT gene locus. Finally, we highlighted relevance of these data to dissect transcription dynamics during progressive maturation of granulocyte precursors. A multifaceted analysis of the myeloid transcriptome ismade available (www.myeloidome.roslin.ed.ac.uk). This high-quality dataset provides a powerful resource to study transcriptional regulation during myelopoiesis and to infer the likely functions of unannotated genes in human innate immunity.	[Joshi, Anagha; Pooley, Christopher; Freeman, Tom C.; Michoel, Tom; Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Joshi, Anagha; Pooley, Christopher; Freeman, Tom C.; Michoel, Tom; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland; [Itoh, Masayoshi; Kawaji, Hideya; Hayashizaki, Yoshihide; FANTOM Consortium] RIKEN Prevent Med & Diag Innovat Program, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Severin, Jessica; Itoh, Masayoshi; Lassmann, Timo; Kawaji, Hideya; Carninci, Piero; Forrest, Alistair R. R.] RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Lennartsson, Andreas] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Babina, Magda] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Schmidl, Christian; Rehli, Michael] Univ Regensburg, Univ Hosp, Dept Internal Med 3, D-93053 Regensburg, Germany; [Geijtenbeek, Teunis] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Severin, Jessica; Itoh, Masayoshi; Lassmann, Timo; Kawaji, Hideya; Hayashizaki, Yoshihide; Carninci, Piero; Forrest, Alistair R. R.] RIKEN Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan	Joshi, A (reprint author), Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland.	anagha.joshi@roslin.ed.ac.uk; david.hume@roslin.ed.ac.uk	Rehli, Michael/E-9093-2011; 	Rehli, Michael/0000-0003-3992-932X; Forrest, Alistair/0000-0003-4543-1675	University of Edinburgh; Scottish government through the Strategic Partnership for Animal Science Excellence (SPASE); Biotechnology and Biological Sciences Research Council [BB/JO1446X/1]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT	A.J. is supported by a chancellor's fellowship from the University of Edinburgh. C.P. is funded by the Scottish government through the Strategic Partnership for Animal Science Excellence (SPASE). T.C.F. and D.A.H. are funded by an Institute Strategic Grant from the Biotechnology and Biological Sciences Research Council (Grant Number BB/JO1446X/1) and are part of the FANTOM5 project. FANTOM5 is supported through a research grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to Y.H.), and a grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from MEXT (to Y.H.). This work was supported by a research grant from the MEXT to the RIKEN Center for Life Science Technologies, and RIKEN Preventive Medicine and Diagnosis Innovation Program (to Y.H.). The authors thank all members of the FANTOM5 consortium for contributing to generation of samples and analysis of the dataset and thank GeNAS for data production. RIKEN Omics Science Center ceased to exist as of April 1, 2013, due to RIKEN reorganization.	Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb1206713; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; de Jong MAWP, 2010, METHODS MOL BIOL, V595, P55, DOI 10.1007/978-1-60761-421-0_4; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Gordon S, 2011, EUR J IMMUNOL, V41, P2472, DOI 10.1002/eji.201141715; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Platt AM, 2013, ADV IMMUNOL, V120, P51, DOI 10.1016/B978-0-12-417028-5.00002-8; Li ZJ, 2013, J CLIN ONCOL, V31, P1172, DOI 10.1200/JCO.2012.44.3184; Yang ZF, 2011, BLOOD, V118, P2243, DOI 10.1182/blood-2010-07-298802; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Crosslin DR, 2013, HUM MOL GENET, V22, P2119, DOI 10.1093/hmg/ddt010; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Krause DS, 2002, ONCOGENE, V21, P3262, DOI 10.1038/sj/onc/1205316; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Severin J, 2014, NAT BIOTECHNOL, V32, P217, DOI 10.1038/nbt.2840; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Legrand F, 2014, J ALLERGY CLIN IMMUN, V133, P1439, DOI 10.1016/j.jaci.2013.11.041; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; MacDonald KPA, 2005, J IMMUNOL, V175, P1399; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Coppe A, 2009, NUCLEIC ACIDS RES, V37, P533, DOI 10.1093/nar/gkn948; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Fiedler Katja, 2012, Am J Blood Res, V2, P57; Joshi A, 2008, BIOINFORMATICS, V24, P176, DOI 10.1093/bioinformatics/btm562; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Khanna-Gupta A, 2007, BLOOD, V109, P4181, DOI 10.1182/blood-2005-05-022004; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; O'Sullivan BJ, 2000, P NATL ACAD SCI USA, V97, P11421, DOI 10.1073/pnas.97.21.11421; Rohan PJ, 1997, P SOC EXP BIOL MED, V215, P269; Schaff UY, 2008, EUR J IMMUNOL, V38, P550, DOI 10.1002/eji.200737777; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; TAKATSUKI H, 1995, LEUKEMIA, V9, P889; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Van Limbergen J, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.27; VISVADER J, 1989, MOL CELL BIOL, V9, P1336; Wang Q, 2007, LEUKEMIA, V21, P1015, DOI 10.1038/sj.leu.2404644; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; Zeisig Bernd B, 2012, Cancer Cell, V22, P698, DOI 10.1016/j.ccr.2012.10.017; Zhang Y, 1998, BLOOD, V92, P118	56	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	MAY	2015	97	5					985	995		10.1189/jlb.6TA1014-477RR		11	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	CH3BK	WOS:000353900500016		
J	Lang, FQ; Yamaguchi, H; Nakagawa, H; Sato, H				Lang, F. Q.; Yamaguchi, H.; Nakagawa, H.; Sato, H.			Solid-State Interfacial Reaction between Eutectic Au-Ge Solder and Cu/Ni(P)/Au Metalized Ceramic Substrate and Its Suppression	JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY			English	Article						High-temperature solder; Interfacial reaction; Activation energy; Kinetics; Diffusion barrier; Reliability	DIFFUSION-BARRIERS; METALLIZATION; RELIABILITY; TEMPERATURE; STABILITY; FILMS	Eutectic Au-12Ge solder was employed to bond the SiC power devices to a Si3N4/Cu/Ni(P)/Au multilayered substrate. The high-temperature reliability of the bond was investigated in detail at 200, 250, 300 and 330 degrees C, respectively. NiGe and Ni5Ge3 intermetallic compounds (IMCs) were identified at the Au-12Ge/Ni(P) interface by micro X-ray diffraction (mu XRD) and scanning electron microscopy (SEM) equipped with energy dispersive X-ray analysis (EDX). The growth of the Ni-Ge IMCs was dominated by Ni5Ge3 layer, which formed at the Ni5Ge3/NiGe interface by outward diffusion of Ni from the Ni(P) layer. The activation energy of the total Ni-Ge IMCs growth was 66 kJ/mol. The shear strength of the bond was tested at both 25 degrees C and the aging temperatures, respectively. The shear strength decreased slightly after aging at 200 and 250 degrees C. The shear strength tested at 250 degrees C was 46 MPa after aging at 250 degrees C for 3000 h. The shear strength aged at 300 and 330 degrees C rapidly decreased with aging time due to the rapid growth of the Ni5Ge3 IMC. To slow down the interfacial reaction between the high temperature solder and the Ni(P) layer, an approximately 200 nm-thick Ta/TaN/Ta new diffusion barrier (DB) was deposited on the substrate. Analysis by transmission electron microscopy (TEM) equipped with EDX, reveals that the Ta/TaN/Ta DB was bonded well to the Ni(P) layer and the solder. High temperature storage test at 330 degrees C for 1500 h reveals that the bond of the SiC devices maintained its high shear strength of approximately 56 MPa without decrease. The new DB effectively suppressed the interfacial reaction between the Au-12Ge solder and the Ni(P) layer of the substrate. Copyright (C) 2015, The editorial office of Journal of Materials Science & Technology. Published by Elsevier Limited. All rights reserved.	[Lang, F. Q.; Yamaguchi, H.; Nakagawa, H.; Sato, H.] Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr ADPERC, Tsukuba, Ibaraki 3058568, Japan	Lang, FQ (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr ADPERC, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	fqlang03325@yahoo.co.jp			NEDO (New Energy and Industrial Technology Development Organization, Japan) [P09004]	This work was supported by the NEDO (New Energy and Industrial Technology Development Organization, Japan, P09004) projects, Development of Next-Generation Power Electronics Technology.	KANAMORI S, 1986, THIN SOLID FILMS, V136, P195, DOI 10.1016/0040-6090(86)90280-4; He M, 2004, THIN SOLID FILMS, V462, P387, DOI 10.1016/j.tsf.2004.05.062; Kisiel R, 2009, MICROELECTRON RELIAB, V49, P627, DOI 10.1016/j.microrel.2009.03.009; Nemouchi F, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358189; Jiang HC, 2010, J MATER SCI TECHNOL, V26, P597; Dimoulas A, 2009, MRS BULL, V34, P522, DOI 10.1557/mrs2009.140; Liang ZX, 2014, IEEE T POWER ELECTR, V29, P2289, DOI 10.1109/TPEL.2013.2289395; He M, 2004, ACTA MATER, V52, P2047, DOI 10.1016/j.actamat.2003.12.042; Buttay C, 2011, MATER SCI ENG B-ADV, V176, P283, DOI 10.1016/j.mseb.2010.10.003; Biela J., 2012, IEEE T IND ELECTRON, V58, P2872; Chidambaram V, 2012, J ELECTRON MATER, V41, P2107, DOI 10.1007/s11664-012-2114-6; Chuang CM, 2003, J ELECTRON MATER, V32, P1426, DOI 10.1007/s11664-003-0111-5; Drevin-Bazin A, 2013, MATER SCI FORUM, V740-742, P1032, DOI 10.4028/www.scientific.net/MSF.740-742.1032; Goto H., 2005, IEEE MTT S INT MICR, V2, P831; Habanyama A., 2011, AFRI PHYS, V6, P87; Hsu HH, 2014, J ALLOY COMPD, V588, P633, DOI 10.1016/j.jallcom.2013.11.138; Johnson W. R., 2005, MATER SCI FORUM, V483-485, P785; Jonathan H., 2008, ADV MICROELECTRO JUL, P20; Lang F. Q., 2012, J JPN I ELECT PACKAG, V15, P271; Leinenbach C, 2011, J ELECTRON MATER, V40, P1533, DOI 10.1007/s11664-011-1639-4; Matsui K, 2012, MATER SCI FORUM, V717-720, P1233, DOI 10.4028/www.scientific.net/MSF.717-720.1233; McCluskey FP, 2006, MICROELECTRON RELIAB, V46, P1910, DOI 10.1016/j.microrel.2006.07.090; Msolli S., 2010, P IEEE INT POW EL SY, P1; Robkowski J., 2012, IEEE IND ELECTRON M, V6, P17; Shiue RK, 2003, MICROELECTRON RELIAB, V43, P453, DOI 10.1016/S0026-2714(02)00259-7; Sousa M. F., 2011, P INT C TABL EXH HIG, P68; Wang H, 2003, J ELECTRON MATER, V32, P994, DOI 10.1007/s11664-003-0081-7; Xie Q, 2006, APPL SURF SCI, V253, P1666, DOI 10.1016/j.apsusc.2006.03.002; Zhang H, 2014, J MATER SCI TECHNOL, V30, P928, DOI 10.1016/j.jmst.2014.06.009; Zhong XQ, 2014, IEEE T POWER ELECTR, V29, P5091, DOI 10.1109/TPEL.2014.2311800	30	0	0	JOURNAL MATER SCI TECHNOL	SHENYANG	72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA	1005-0302			J MATER SCI TECHNOL	J. Mater. Sci. Technol.	MAY	2015	31	5					445	452		10.1016/j.jmst.2014.10.010		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH6WN	WOS:000354177200003		
J	Narumi, T; Shishido, T; Otaki, Y; Kadowaki, S; Honda, Y; Funayama, A; Honda, S; Hasegawa, H; Kinoshita, D; Yokoyama, M; Nishiyama, S; Takahashi, H; Arimoto, T; Miyamoto, T; Watanabe, T; Tanaka, A; Woo, CH; Abe, J; Takeishi, Y; Kubota, I				Narumi, Taro; Shishido, Tetsuro; Otaki, Yoichiro; Kadowaki, Shinpei; Honda, Yuki; Funayama, Akira; Honda, Shintaro; Hasegawa, Hiromasa; Kinoshita, Daisuke; Yokoyama, Miyuki; Nishiyama, Satoshi; Takahashi, Hiroki; Arimoto, Takanori; Miyamoto, Takuya; Watanabe, Tetsu; Tanaka, Atsushi; Woo, Chang-Hoon; Abe, Jun-ichi; Takeishi, Yasuchika; Kubota, Isao			High-mobility group box 1-mediated heat shock protein beta 1 expression attenuates mitochondrial dysfunction and apoptosis	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Apoptosis; Cardiomyopathy; Heart failure; Molecular biology; Mitochondria	CAMP EARLY REPRESSOR; CARDIAC APOPTOSIS; DOXORUBICIN CARDIOTOXICITY; MYOCARDIAL-INFARCTION; HMGB1 RELEASE; INHIBITION; AUTOPHAGY; CHROMATIN; CELLS; HSP27	Aims: Apoptosis of cardiomyocytes is thought to account for doxorubicin cardiotoxicity as it contributes to loss of myocardial tissue and contractile dysfunction. Given that high-mobility group box 1 (HMGB1) is a nuclear DNA-binding protein capable of inhibiting apoptosis, we aimed to clarify the role of HMGB1 in heat shock protein beta 1 (HSPB1) expression during doxorubicin-induced cardiomyopathy. Methods and results: Mitochondrial damage, cardiomyocyte apoptosis, and cardiac dysfunction after doxorubicin administration were significantly attenuated in mice with cardiac-specific overexpression of HMGB1 (HMGB1-Tg) compared with wild type (WT) -mice. HSPB1 levels after doxorubicin administration were significantly higher in HMGB1-Tg mice than in WT mice. Transfection with HMGB1 increased the expression of HSPB1 at both the protein and mRNA levels, and HMGB1 inhibited mitochondrial dysfunction and apoptosis after exposure of cardiomyocytes to doxorubicin. HSPB1 silencing abrogated the inhibitory effect of HMGB1 on cardiomyocyte apoptosis. Doxorubicin increased the binding of HMGB1 to heat shock factor 2 and enhanced heat shock element promoter activity. Moreover, HMGB1 overexpression greatly enhanced heat shock element promoter activity. Silencing of heat shock factor 2 attenuated HMGB1-dependent HSPB1 expression and abrogated the ability of HMGB1 to suppress cleaved caspase-3 accumulation after doxorubicin stimulation. Conclusions: We report the first in vivo and in vitro evidence that cardiac HMGB1 increases HSPB1 expression and attenuates cardiomyocyte apoptosis associated with doxorubicin-induced cardiomyopathy. Cardiac HMGB1 increases HSPB1 expression in cardiomyocytes in a heat shock factor 2-dependent manner. (C) 2015 The Authors. Published by Elsevier Ltd.	[Narumi, Taro; Shishido, Tetsuro; Otaki, Yoichiro; Kadowaki, Shinpei; Honda, Yuki; Funayama, Akira; Honda, Shintaro; Hasegawa, Hiromasa; Kinoshita, Daisuke; Yokoyama, Miyuki; Nishiyama, Satoshi; Takahashi, Hiroki; Arimoto, Takanori; Miyamoto, Takuya; Watanabe, Tetsu; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 9909585, Japan; [Tanaka, Atsushi] Yamagata Univ, Sch Med, Res Inst Med Sci, Yamagata 9909585, Japan; [Woo, Chang-Hoon] Yeungnam Univ, Coll Med, Dept Pharmacol, Daegu, South Korea; [Abe, Jun-ichi] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Div Internal Med, Houston, TX 77030 USA; [Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan	Shishido, T (reprint author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, 2-2-2 Lida Nishi, Yamagata 9909585, Japan.	tshishid@med.id.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24659380, 26461121, 25860580, 26461122]; 21st Global Century Center of Excellence (COE) program of the Japan Society for the Promotion of Science; Japan Heart Foundation Research Grant	This work was supported in part by a grant-in-aid for Scientific Research (Nos. 24659380 and 26461121 to I.K., 25860580 to A.F., and 26461122 to T.S.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan and a grant-in-aid from the 21st Global Century Center of Excellence (COE) program of the Japan Society for the Promotion of Science to I.K. T.S. was supported by a Japan Heart Foundation Research Grant. The funders had no role in the design of the study, the collection and analysis of the data, the decision to publish, or the preparation of the manuscript	Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Kang R, 2011, AUTOPHAGY, V7, P1256, DOI 10.4161/auto.7.10.16753; Carvalho C, 2009, CURR MED CHEM, V16, P3267; Arola OJ, 2000, CANCER RES, V60, P1789; Shishido T, 2008, CIRC RES, V102, P1416, DOI 10.1161/CIRCRESAHA.107.168138; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Green PS, 2002, BBA-MOL BASIS DIS, V1588, P94, DOI 10.1016/S0925-4439(02)00144-8; LEFRAK EA, 1973, CANCER, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Funayama A, 2013, CARDIOVASC RES, V99, P657, DOI 10.1093/cvr/cvt128; Yan C, 2007, CIRC RES, V100, P510, DOI 10.1161/01.RES.0000259045.49371.9c; Volp K, 2006, GUT, V55, P234, DOI 10.1136/gut.2004.062729; Wang XW, 2013, BIOCHEM BIOPH RES CO, V440, P696, DOI 10.1016/j.bbrc.2013.09.131; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; YOUNG RC, 1981, NEW ENGL J MED, V305, P139, DOI 10.1056/NEJM198107163050305; Yu Y, 2012, MOL CELL BIOCHEM, V364, P263, DOI 10.1007/s11010-012-1226-x; Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163; DILISA F, 1995, J PHYSIOL-LONDON, V486, P1; Bianchi Marco E., 2000, EMBO Reports, V1, P109, DOI 10.1093/embo-reports/kvd030; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Chauhan D, 2003, BLOOD, V102, P3379, DOI 10.1182/blood-2003-05-1417; Le NT, 2012, CIRC RES, V110, P536, DOI 10.1161/CIRCRESAHA.111.254730; Loukili N, 2011, CARDIOVASC RES, V89, P586, DOI 10.1093/cvr/cvq373; Netsu S, 2014, BIOCHEM BIOPH RES CO, V443, P205, DOI 10.1016/j.bbrc.2013.11.083; Nightingale K, 1996, EMBO J, V15, P548; Sato-Nishiwaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073963; Suzuki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053133; Wilkerson DC, 2007, CELL STRESS CHAPERON, V12, P283, DOI 10.1379/CSC-250.1; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636	33	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	MAY	2015	82						1	12		10.1016/j.yjmcc.2015.02.018		12	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CH6KO	WOS:000354145700001		
J	Matsuhashi, T; Hishiki, T; Zhou, HP; Ono, T; Kaneda, R; Iso, T; Yamaguchi, A; Endo, J; Katsumata, Y; Atsushi, A; Yamamoto, T; Shirakawa, K; Yan, XX; Shinmura, K; Suematsu, M; Fukuda, K; Sano, M				Matsuhashi, Tomohiro; Hishiki, Takako; Zhou, Heping; Ono, Tomohiko; Kaneda, Ruri; Iso, Tatsuya; Yamaguchi, Aiko; Endo, Jin; Katsumata, Yoshinori; Atsushi, Anzai; Yamamoto, Tsunehisa; Shirakawa, Kohsuke; Yan, Xiaoxiang; Shinmura, Ken; Suematsu, Makoto; Fukuda, Keiichi; Sano, Motoaki			Activation of pyruvate dehydrogenase by dichloroacetate has the potential to induce epigenetic remodeling in the heart	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Metabolomics; Metabolic modulation therapy; Acetylation; Ketone	ISCHEMIA-REPERFUSION INJURY; HYPERTROPHIED RAT HEARTS; CARDIAC-HYPERTROPHY; CARDIOMYOCYTE HYPERTROPHY; HISTONE ACETYLATION; CELLULAR-METABOLISM; EXPRESSION; PROTECTS; FAILURE; DISEASE	Dichloroacetate (DCA) promotes pyruvate entry into the Krebs cycle by inhibiting pyruvate dehydrogenase (PDH) kinase and thereby maintaining PDH in the active dephosphorylated state. DCA has recently gained attention as a potential metabolic-targeting therapy for heart failure but the molecular basis of the therapeutic effect of DCA in the heart remains a mystery. Once-daily oral administration of DCA alleviates pressure overload-induced left ventricular remodeling. We examined changes in the metabolic fate of pyruvate carbon (derived from glucose) entering the Krebs cycle by metabolic interventions of DCA. C-13(6)-glucose pathway tracing analysis revealed that instead of being completely oxidized in the mitochondria for ATP production, DCA-mediated PDH dephosphorylation results in an increased acetyl-CoA pool both in control and pressure-overloaded hearts. DCA induces hyperacetylation of histone H3K9 and H4 in a dose-dependent manner in parallel to the dephosphorylation of PDH in cultured cardiomyocytes. DCA administration increases histone H3K9 acetylation in in vivo mouse heart. Interestingly, DCA-dependent histone acetylation was associated with an up-regulation of 23% of genes (545 out of 23,474 examined). Gene ontology analysis revealed that these genes are highly enriched in transcription-related categories. This evidence suggests that sustained activation of PDH by DCA results in an overproduction of acetyl-CoA, which exceeds oxidation in the Krebs cycle and results in histone acetylation. We propose that DCA-mediated PDH activation has the potential to induce epigenetic remodeling in the heart, which, at least in part, forms the molecular basis for the therapeutic effect of DCA in the heart. (C) 2015 Elsevier Ltd. All rights reserved.	[Matsuhashi, Tomohiro; Ono, Tomohiko; Kaneda, Ruri; Endo, Jin; Katsumata, Yoshinori; Atsushi, Anzai; Yamamoto, Tsunehisa; Shirakawa, Kohsuke; Yan, Xiaoxiang; Shinmura, Ken; Fukuda, Keiichi; Sano, Motoaki] Keio Univ, Dept Cardiol, Sch Med, Tokyo 1608582, Japan; [Hishiki, Takako; Suematsu, Makoto] Keio Univ, Dept Biochem, Sch Med, Tokyo 1608582, Japan; [Kaneda, Ruri; Sano, Motoaki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Hishiki, Takako; Suematsu, Makoto] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Suematsu Gas Biol Project, Tokyo, Japan; [Zhou, Heping] Fourth Mil Med Univ, Dept Cardiovasc Surg, Affiliated Hosp 1, Xian 710032, Peoples R China; [Iso, Tatsuya] Gunma Univ, Dept Med & Biol Sci, Grad Sch Med, Gunma, Japan; [Iso, Tatsuya] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Gunma, Japan; [Yamaguchi, Aiko] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Gunma, Japan	Sano, M (reprint author), Keio Univ, Dept Cardiol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	msano@a8.keio.jp	Suematsu, Makoto/I-8135-2013	Suematsu, Makoto/0000-0002-7165-6336	KAKENHI; Ministry of Education, Culture, Sports, Science and Technology Japan	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) (to M.S.) and by a grant from the Ministry of Education, Culture, Sports, Science and Technology Japan (to M.S. and K.S. and T.I.).	Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Lydell CP, 2002, CARDIOVASC RES, V53, P841, DOI 10.1016/S0008-6363(01)00560-0; Bai SM, 2011, MOL CELL BIOL, V31, P3068, DOI 10.1128/MCB.00925-10; Piao L, 2010, J MOL MED-JMM, V88, P47, DOI 10.1007/s00109-009-0524-6; Yoshioka J, 2012, J CLIN INVEST, V122, P267, DOI 10.1172/JCI44927; Myers SA, 2009, MOL CELL ENDOCRINOL, V309, P101, DOI 10.1016/j.mce.2009.05.006; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; VanLint C, 1996, GENE EXPRESSION, V5, P245; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Xie M, 2013, TRENDS CARDIOVAS MED, V23, P229, DOI 10.1016/j.tcm.2012.12.006; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCUALTIONAHA.105.559724; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Wambolt RB, 2000, J AM COLL CARDIOL, V36, P1378, DOI 10.1016/S0735-1097(00)00856-1; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; Kee HJ, 2009, J MOL CELL CARDIOL, V47, P770, DOI 10.1016/j.yjmcc.2009.08.022; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Bersin RM, 1997, AM HEART J, V134, P841, DOI 10.1016/S0002-8703(97)80007-5; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Lewis JF, 1998, CLIN CARDIOL, V21, P888; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Calvert LD, 2008, AM J RESP CRIT CARE, V177, P1090, DOI 10.1164/rccm.200707-1032OC; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Dromparis P, 2009, AM J PHYSIOL-CELL PH, V297; Franklin S, 2012, MOL CELL PROTEOMICS, V11; Katsumata Y, 2014, HYPERTENSION, V63, P80, DOI 10.1161/HYPERTENSIONAHA.113.01639; Rathmell JC, 2009, SCIENCE, V324, P1021, DOI 10.1126/science.1174665; WARGOVICH TJ, 1988, AM J CARDIOL, V61, P65, DOI 10.1016/0002-9149(88)91306-9; WISNESKI JA, 1985, J CLIN INVEST, V76, P1819, DOI 10.1172/JCI112174	39	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	MAY	2015	82						116	124		10.1016/j.yjmcc.2015.02.021		9	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CH6KO	WOS:000354145700014		
J	Zheng, B; Bernier, M; Zhang, XH; Suzuki, T; Nie, CQ; Li, YH; Zhang, Y; Song, LL; Shi, HJ; Liu, Y; Zheng, CY; Wen, JK				Zheng, Bin; Bernier, Michel; Zhang, Xin-hua; Suzuki, Toru; Nie, Chan-quan; Li, Yong Hui; Zhang, Yong; Song, Li-li; Shi, Hui-jing; Liu, Yan; Zheng, Cui-ying; Wen, Jin-kun			miR-200c-SUMOylated KLF4 feedback loop acts as a switch in transcriptional programs that control VSMC proliferation	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Letter						miR-200c; Ubc9; SUMOylation; KLF4; VSMC; Proliferation	SMOOTH-MUSCLE-CELLS; MEDIATES NUCLEAR-LOCALIZATION; GENE-EXPRESSION; DOWN-REGULATION; CANCER-CELLS; PROMOTER ACTIVITY; IN-VIVO; SUMOYLATION; GROWTH; ALPHA	The regulation of vascular smooth muscle cell (VSMC) proliferation is an important issue because it has major implications for the prevention of pathological vascular conditions. Using microRNA array screen, we found the expression levels of 200 unique miRNAs in hyperplasic tissues. Among them, miR-200c expression substantially was down-regulated. The objective of this work was to assess the function of miR-200c and SUMOylated Kruppel-like transcription factor 4 (KLF4) in the regulation of VSMC proliferation in both cultured cells and animal models of balloon injury. Under basal conditions, we found that miR-200c inhibited the expression of KLF4 and the SUMO-conjugating enzyme Ubc9. Upon PDGF-BB treatment, Ubc9 interacted with and promoted the SUMOylation of KLF4, which allowed the recruitment of transcriptional corepressors (e.g., nuclear receptor corepressor (NCoR) and HDAC2) to the miR-200c promoter. The reduction in miR-200c levels led to increased target gene expression (e.g., Ubc9 and KLF4), which further repressed miR-200c levels and accelerated VSMC proliferation. These results demonstrate that induction of a miR-200c-SUMOylated KLF4 feedback loop is a significant aspect of the PDGF-BB proliferative response in VSMCs and that targeting Ubc9 represents a novel approach for the prevention of restenosis. (C) 2015 Elsevier Ltd. All rights reserved.	[Zheng, Bin; Zhang, Xin-hua; Nie, Chan-quan; Li, Yong Hui; Song, Li-li; Shi, Hui-jing; Liu, Yan; Zheng, Cui-ying; Wen, Jin-kun] Hebei Med Univ, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [Bernier, Michel] NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA; [Suzuki, Toru] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Zhang, Yong] Hebei Med Univ, Dept Urinary Surg, Hosp 2, Shijiazhuang 050000, Peoples R China	Zheng, B (reprint author), Hebei Med Univ, Dept Biochem & Mol Biol, 361 Zhongshan East Rd, Shijiazhuang 050017, Peoples R China.	doublezb@sina.com; wjk@hebmu.edu.cn					Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Liu SJ, 2012, AM J PATHOL, V181, P1823, DOI 10.1016/j.ajpath.2012.07.009; Shi JH, 2012, J BIOL CHEM, V287, P10799, DOI 10.1074/jbc.M111.321836; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Kurtzman AL, 2001, P NATL ACAD SCI USA, V98, P5602, DOI 10.1073/pnas.101129698; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Wassmann S, 2007, J MOL CELL CARDIOL, V43, P301, DOI 10.1016/j.yjmcc.2007.06.001; Qin YL, 2011, J CELL PHYSIOL, V226, P3355, DOI 10.1002/jcp.22695; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Chen ZY, 2002, J BIOL CHEM, V277, P46831, DOI 10.1074/jbc.M204816200; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Sun SG, 2011, EMBO REP, V12, P56, DOI 10.1038/embor.2010.172; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Kiyan Y, 2012, ARTERIOSCL THROM VAS, V32, P110, DOI 10.1161/ATVBAHA.111.234369; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Zhang Y, 2011, J HYPERTENS, V29, P1560, DOI 10.1097/HJH.0b013e328348ef8e; Coinu R, 2006, FEBS LETT, V580, P2465, DOI 10.1016/j.femslet.2006.03.078; Gamper AM, 2012, MOL CELL, V45, P233, DOI 10.1016/j.molcel.2011.11.031; Guo YG, 2008, BIOCHEM BIOPH RES CO, V374, P570, DOI 10.1016/j.bbrc.2008.07.064; Kampmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027854; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; Khanna-Gupta A, 2008, BLOOD CELL MOL DIS, V41, P77, DOI 10.1016/j.bcmd.2008.02.011; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Rebustiniv IT, 2012, DEVELOPMENT, V139, P20; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Sun YG, 2008, MOL CELL ENDOCRINOL, V295, P59, DOI 10.1016/j.mce.2008.05.008; Tetreault MP, 2010, GASTROENTEROLOGY, V139, P2124, DOI 10.1053/j.gastro.2010.08.048; Wang CY, 2007, EXP MOL PATHOL, V83, P453, DOI 10.1016/j.yexmp.2007.08.002; Yu K, 2011, CARDIOVASC RES, V90, P464, DOI 10.1093/cvr/cvr017; Zhang XH, 2012, ARTERIOSCL THROM VAS, V32, P1015, DOI 10.1161/ATVBAHA.111.244962; Zheng B, 2009, J BIOL CHEM, V284, P22773, DOI 10.1074/jbc.M109.026989	45	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	MAY	2015	82						201	212		10.1016/j.yjmcc.2015.03.011		12	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CH6KO	WOS:000354145700023		
J	Ueta, K; Okada, Y; Nakano, H; Osumi, M; Morioka, S				Ueta, Kozo; Okada, Yohei; Nakano, Hideki; Osumi, Michihiro; Morioka, Shu			Effects of Voluntary and Automatic Control of Center of Pressure Sway During Quiet Standing	JOURNAL OF MOTOR BEHAVIOR			English	Article						quiet standing; voluntary control; automatic control; center of pressure; postural control strategy	POSTURAL CONTROL; TASK; BALANCE; STANCE	The authors investigated the effects of voluntary and automatic control on the spatial variables (envelope area, maximal amplitude, and root mean square [RMS]) of center of pressure (COP) displacement during quiet standing and identified differences in their postural control strategies (mean velocity [MV], mean power frequency [MPF], and power density). COP data were recorded under relaxed (experimental control), still (voluntary control), and dual (automatic control) conditions. RMS was significantly lower in the still and dual conditions than in the relaxed condition. MV, MPF, and power density were significantly higher in the still condition than in the dual condition. These results indicate that both voluntary and automatic control decrease the spatial variables of COP displacement; however, their postural control strategies are different.	[Ueta, Kozo; Okada, Yohei; Osumi, Michihiro; Morioka, Shu] Kio Univ, Grad Sch Hlth Sci, Dept Neurorehabil, Koryo, Nara 6350832, Japan; [Ueta, Kozo] Hoshigaoka Med Ctr, Dept Rehabil, Osaka, Japan; [Okada, Yohei; Nakano, Hideki; Morioka, Shu] Kio Univ, Neurorehabil Res Ctr, Koryo, Nara 6350832, Japan	Ueta, K (reprint author), Kio Univ, Grad Sch Hlth Sci, Dept Neurorehabil, 4-2-2 Umaminaka, Koryo, Nara 6350832, Japan.	p0511105@univ.kio.ac.jp					Chan AOO, 2007, JAMA-J AM MED ASSOC, V298, P1412, DOI 10.1001/jama.298.12.1412; Era P, 2006, GERONTOLOGY, V52, P204, DOI 10.1159/000093652; Dault MC, 2003, COGNITIVE BRAIN RES, V16, P434, DOI 10.1016/S0926-6410(03)00058-2; Yardley L, 1999, NEUROREPORT, V10, P215, DOI 10.1097/00001756-199902050-00003; Dault MC, 2001, GAIT POSTURE, V14, P110, DOI 10.1016/S0966-6362(01)00113-8; Perennou D, 2005, J NEUROL NEUROSUR PS, V76, P621, DOI 10.1136/jnnp.2004.050468; Mansfield A, 2011, CLIN BIOMECH, V26, P312, DOI 10.1016/j.clinbiomech.2010.10.001; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Mitra S, 2013, J EXP PSYCHOL HUMAN, V39, P323, DOI 10.1037/a0030588; HOLM S, 1979, SCAND J STAT, V6, P65; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Fraizer EV, 2008, GAIT POSTURE, V27, P271, DOI 10.1016/j.gaitpost.2007.04.002; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Quant S, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-18; Zok M, 2008, MED ENG PHYS, V30, P913, DOI 10.1016/j.medengphy.2007.12.002; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Niam S, 1999, ARCH PHYS MED REHAB, V80, P1227, DOI 10.1016/S0003-9993(99)90020-5; MAURITZ KH, 1979, BRAIN, V102, P461, DOI 10.1093/brain/102.3.461; Bie E., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094247, DOI 10.1371/JOURNAL.PONE.0094247]; Cohen J., 1998, STAT POWER ANAL BEHA; Kanekar N, 2014, J NEUROSCI METH, V222, P91, DOI 10.1016/j.jneumeth.2013.10.020; LeClair K, 1996, CLIN BIOMECH, V11, P176, DOI 10.1016/0268-0033(95)00027-5; Loram ID, 2001, J PHYSIOL-LONDON, V532, P879, DOI 10.1111/j.1469-7793.2001.0879e.x; Masani K, 2014, GAIT POSTURE, V39, P946, DOI 10.1016/j.gaitpost.2013.12.008; Nafati G, 2011, RES Q EXERCISE SPORT, V82, P634; PANZER VP, 1995, ARCH PHYS MED REHAB, V76, P151, DOI 10.1016/S0003-9993(95)80024-7; R Development Core Team, 2008, R LANG ENV STAT COMP; Remaud A, 2012, J MOTOR BEHAV, V44, P329, DOI 10.1080/00222895.2012.708680; Reynolds RF, 2010, GAIT POSTURE, V31, P78, DOI 10.1016/j.gaitpost.2009.09.001; Teranishi T, 2011, GAIT POSTURE, V34, P295, DOI 10.1016/j.gaitpost.2011.05.007; Turner M., 2004, DIGIT MEMORY TEST; Weaver TB, 2012, J MOTOR BEHAV, V44, P289, DOI 10.1080/00222895.2012.702142	32	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0022-2895	1940-1027		J MOTOR BEHAV	J. Mot. Behav.	MAY-JUN	2015	47	3					256	264		10.1080/00222895.2014.974496		9	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	CH5XW	WOS:000354110300009		
J	Adachi, Y; Sato, N; Saito, Y; Kimura, Y; Nakata, Y; Ito, K; Kamiya, K; Matsuda, H; Tsukamoto, T; Ogawa, M				Adachi, Yuko; Sato, Noriko; Saito, Yuko; Kimura, Yukio; Nakata, Yasuhiro; Ito, Kimiteru; Kamiya, Kouhei; Matsuda, Hiroshi; Tsukamoto, Tadashi; Ogawa, Masahumi			Usefulness of SWI for the Detection of Iron in the Motor Cortex in Amyotrophic Lateral Sclerosis	JOURNAL OF NEUROIMAGING			English	Article						validation; erectile dysfunction; prostate cancer; alprostadil	MATTER TRACT DAMAGE; DEEP GRAY-MATTER; WHITE-MATTER; CEREBRAL MICROBLEEDS; MULTIPLE-SCLEROSIS; GRADIENT-ECHO; SPIN-ECHO; BRAIN; DISEASE; MRI	PURPOSEThe purpose of the present retrospective study was to evaluate the sensitivity of susceptibility-weighted imaging (SWI) compared to conventional spin-echo T2-weighted and T2*-weighted images in detecting iron deposition in the motor cortex of amyotrophic lateral sclerosis (ALS) patients in comparison with age-matched normal controls. We also investigated the etiology of the low signal referring to the pathology of one autopsy case. METHODSThis retrospective magnetic resonance (MR) study included 23 ALS patients and 28 age-matched normal controls. The signal intensity of the motor cortex was scored by SWI, conventional T2-weighted images and T2*-weighted images. A postmortem study of one patient was also performed. RESULTSOn SWI, there was a significant difference between the precentral cortical signal intensity scores in the ALS patients and the controls (P < .0001). The total scores of signal intensities of the precentral cortex were positively correlated with age in the normal controls (r = .494), but no correlation was observed in the ALS patients. The postmortem study showed intensely stained microglias and macrophages after antiferritin antibody staining in the precentral cortices. CONCLUSIONSDecreased signal intensity of the motor cortex on SWI may serve a useful role in ALS diagnoses, particularly in young patients. MR images were also helpful for speculating on the etiology of ALS.	[Adachi, Yuko; Sato, Noriko; Saito, Yuko; Kimura, Yukio; Nakata, Yasuhiro; Ito, Kimiteru; Kamiya, Kouhei; Matsuda, Hiroshi; Tsukamoto, Tadashi; Ogawa, Masahumi] Natl Ctr Hosp Neurol & Psychiat Radiol, Kodaira, Tokyo 1878551, Japan	Sato, N (reprint author), Natl Ctr Hosp Neurol & Psychiat Radiol, 4-1-1 Ogawahigashi Chyo, Kodaira, Tokyo 1878551, Japan.	snoriko@ncnp.go.jp					Adachi T, 2010, J NEUROPATH EXP NEUR, V69, P737, DOI 10.1097/NEN.0b013e3181e5ae5c; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Qian ZM, 1998, BRAIN RES REV, V27, P257, DOI 10.1016/S0165-0173(98)00012-5; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Chan S, 1999, RADIOLOGY, V212, P763; Jellinger KA, 1999, DRUG AGING, V14, P115, DOI 10.2165/00002512-199914020-00004; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Agosta F, 2010, EUR J NEUROSCI, V32, P1490, DOI 10.1111/j.1460-9568.2010.07445.x; Chamberlain R, 2009, MAGN RESON MED, V61, P1158, DOI 10.1002/mrm.21951; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Agosta F, 2010, AM J NEURORADIOL, V31, P1457, DOI 10.3174/ajnr.A2105; Haacke EM, 2004, MAGNET RESON MED, V52, P612, DOI 10.1002/mrm.20198; Cirillo M, 2012, AM J NEURORADIOL, V33, P1102, DOI 10.3174/ajnr.A2918; Canu E, 2011, AM J NEURORADIOL, V32, P1307, DOI 10.3174/ajnr.A2469; Vymazal J, 1999, RADIOLOGY, V211, P489; Sarro L, 2011, AM J NEURORADIOL, V32, P1866, DOI 10.3174/ajnr.A2658; ATLAS SW, 1988, RADIOLOGY, V168, P803; Bakshi R, 2000, NEUROREPORT, V11, P15, DOI 10.1097/00001756-200001170-00004; Benatar M, 2006, NEUROMUSCULAR DIS EV, P43; Carrara G, 2011, AM J NEURORADIOL, V33, P733; desRochefort L, 2008, MAGN RESON MED, V60, P1003; desRochefort L, 2010, MAGN RESON MED, V63, P194; desSouza JM, 2008, AM J NEURORADIOL, V29, P154; Govind V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035607; Haque TL, 2003, EUR J RADIOL, V48, P230, DOI 10.1016/s0720-048X(03)00054-8; Harder SL, 2008, AM J NEURORADIOL, V29, P176, DOI 10.3174/ajnr.A0770; IWASAKI S, 1991, RADIOLOGY, V179, P207; KIM JK, 1993, RADIOLOGY, V187, P735; Kwan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035241; Lerner AJ, 2006, DIAGNOSTIC CRITERIA, P183; OBA H, 1993, RADIOLOGY, V189, P843; Sharma KR, 2013, J NEUROIMAGING, V23, P368, DOI 10.1111/j.1552-6569.2011.00679.x; SWAIMAN KF, 1991, ARCH NEUROL-CHICAGO, V48, P1285; Tao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045477; Turner MR, 2010, EXPERT OPIN MED DIAG, V4, P438; Wang S, 2006, AM J NEURORADIOL, V27, P1234; Welsh Robert C, 2013, Front Hum Neurosci, V7, P251, DOI 10.3389/fnhum.2013.00251; Wu EX, 2010, ANN NY ACAD SCI, V1202, P115, DOI 10.1111/j.1749-6632.2010.05587.x	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	MAY-JUN	2015	25	3					443	451		10.1111/jon.12127		9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CH6EL	WOS:000354129000016		
J	Takahashi, W; Netsu, S; Kijima, C; Moriya, Y; Shirasugi, Y; Takizawa, S				Takahashi, Wakoh; Netsu, Shizuka; Kijima, Chikage; Moriya, Yusuke; Shirasugi, Yukari; Takizawa, Shunya			Streptococcus agalactiae Infective Endocarditis with Multiple Cerebral Hemorrhages: A Case Report	JOURNAL OF NEUROIMAGING			English	Article						Infective endocarditis; microbleeds; cerebral hemorrhage; Streptococcus agalactiae	COMPLICATIONS; BRAIN		[Takahashi, Wakoh; Kijima, Chikage; Moriya, Yusuke; Takizawa, Shunya] Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa 2591143, Japan; [Netsu, Shizuka] Tokai Univ Hosp, Dept Clin Practice, Tokyo, Japan; [Shirasugi, Yukari] Tokai Univ, Sch Med, Dept Hematol, Isehara, Kanagawa 2591143, Japan	Takahashi, W (reprint author), Tokai Univ, Sch Med, Dept Neurol, Shimokasuya143, Isehara, Kanagawa 2591143, Japan.	kawasi29@is.icc.u-tokai.ac.jp					Heiro M, 2000, ARCH INTERN MED, V160, P2781, DOI 10.1001/archinte.160.18.2781; Okazaki S, 2011, CEREBROVASC DIS, V32, P483, DOI 10.1159/000331475; Iung B, 2013, STROKE, V44, P3056, DOI 10.1161/STROKEAHA.113.001470; Rollan MJ, 2003, AM HEART J, V146, P1095, DOI 10.1016/S0002-8703(03)00444-7; Klein I, 2009, STROKE, V40, P3461, DOI 10.1161/STROKEAHA.109.562546; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Sambola A, 2002, CLIN INFECT DIS, V34, P1576, DOI 10.1086/340538; Garcia-Cabrera E, 2013, CIRCULATION, V127, P2272, DOI 10.1161/CIRCULATIONAHA.112.000813; Duval X, 2010, ANN INTERN MED, V152, P497, DOI 10.7326/0003-4819-152-8-201004200-00006; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Snygg-Martin U, 2008, CLIN INFECT DIS, V47, P23, DOI 10.1086/588663; BERTORINI TE, 1989, ARCH INTERN MED, V149, P815, DOI 10.1001/archinte.149.4.815; Jeon AB, 2010, CEREBROVASC DIS, V30, P194; Matsuda T, 2002, NEUROL SURG TOKYO, V30, P73	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	MAY-JUN	2015	25	3					507	509		10.1111/jon.12157		3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CH6EL	WOS:000354129000027		
J	Togawa, J; Ohi, T				Togawa, Jumpei; Ohi, Takekazu			Bilateral Optic Neuropathy with Bilateral Putaminal Lesions: A Case Report	JOURNAL OF NEUROIMAGING			English	Article						Bilateral putaminal lesions; optic neuropathy; Leber hereditary optic neuropathy; Leigh syndrome; neuromyelitis optica		Bilateral optic neuropathy with bilateral putaminal lesions may be caused by methanol or cyanide poisoning or mitochondrial disorders including Leber hereditary optic neuropathy and Leigh syndrome. We report the case of a 34-year-old Japanese man who developed bilateral visual loss 5 days after the development of gastrointestinal symptoms. Magnetic resonance imaging of the brain on admission revealed high-intensity signal areas in the bilateral putamina on diffusion-weighted and T2-weighted images as well as a high-intensity signal area in the left middle cerebellar peduncle that had been identified 3 years previously. We diagnosed bilateral optic neuropathy with bilateral putaminal lesions caused by preceding infection-triggered demyelination. We administered methylprednisolone, but his vision did not recover.	[Togawa, Jumpei] Otsu Red Cross Hosp, Dept Neurol, Otsu, Shiga 5208511, Japan; [Ohi, Takekazu] Kyoto Hakuaikai Hosp, Dept Neurol, Kyoto, Japan	Togawa, J (reprint author), Otsu Red Cross Hosp, Dept Neurol, 1-1-35 Nagara, Otsu, Shiga 5208511, Japan.	togawa-kyt@umin.org					Sefidbakht S, 2007, NEURORADIOLOGY, V49, P427, DOI 10.1007/s00234-007-0210-8; Sellner J, 2010, J AUTOIMMUN, V34, P371, DOI 10.1016/j.jaut.2009.09.013; Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Chen F, 2011, CLIN TOXICOL, V49, P121, DOI 10.3109/15563650.2011.556643; Jurkiewicz E, 2011, Neuroradiol J, V24, P424; Kaida K, 2001, J NEUROIMMUNOL, V113, P260, DOI 10.1016/S0165-5728(00)00451-3; Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	MAY-JUN	2015	25	3					514	516		10.1111/jon.12153		3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CH6EL	WOS:000354129000030		
J	Inoue, Y; Nagahara, K; Tanaka, Y; Miyatake, H; Hata, H; Hara, T				Inoue, Yusuke; Nagahara, Kazunori; Tanaka, Yoshihito; Miyatake, Hiroki; Hata, Hirofumi; Hara, Toshimasa			Methods of CT Dose Estimation in Whole-Body F-18-FDG PET/CT	JOURNAL OF NUCLEAR MEDICINE			English	Article						PET/CT; CT; radiation exposure; effective dose; dose-length product	STATISTICAL ITERATIVE RECONSTRUCTION; LENGTH PRODUCT; RADIATION-EXPOSURE; MULTISECTION CT; PROTOCOLS; OPTIMIZATION; TOMOGRAPHY; RISK	We evaluated the effective dose (ED) of the CT component of wholebody PET/CT using software dedicated to CT dose estimation and from dose-length product (DLP) values to establish practical methods of ED estimation. Methods: Eighty adult patients who underwent F-18-FDG whole-body PET/CT were divided into groups A and B, each consisting of 20 men and 20 women. In group A, ED of the CT component was calculated using CT-Expo for 6 anatomic regions separately, and whole-body ED was obtained by summing the regional EDs (CT-Expo method). DLP was calculated for each of the 6 regions and multiplied by a corresponding conversion factor described in International Commission on Radiological Protection publication 102 to obtain the ED for each region (regional DLP method). Whole-body ED was also calculated as the product of a whole-body DLP value provided by the scanner automatically and a conversion factor (simple DLP method). Moreover, the ED/DLP values were calculated using whole-body ED estimated by the CT-Expo method and the scannerderived DLP, to optimize the conversion factor. In group B, the optimized conversion factor was applied for the estimation of ED by the simple DLP method. Results: In group A, the regional DLP method allowed an accurate estimation of mean whole-body ED as a result of counterbalance of mild overestimation in men and mild underestimation in women, regarding the CT-Expo method as a standard. The simple DLP method using a conversion factor for the trunk (0.015 mSv/mGy/cm) caused overestimation. On the basis of the ED/DLP values in group A, a modified conversion factor of 0.013 mSv/mGy/cm and sex-specific conversion factors of 0.012 and 0.014 mSv/mGy/cm for men and women, respectively, were determined. In group B, the use of the modified conversion factor improved accuracy, and the use of sex-specific conversion factors eliminated sex-dependent residual errors. Conclusion: ED of the CT component of whole-body PET/CT can be assessed by multiplying the scannerderived DLP by a conversion factor optimized for whole-body PET/CT.	[Inoue, Yusuke; Hara, Toshimasa] Kitasato Univ, Sch Med, Dept Diagnost Radiol, Sagamihara, Kanagawa 2520374, Japan; [Nagahara, Kazunori; Tanaka, Yoshihito; Miyatake, Hiroki; Hata, Hirofumi] Kitasato Univ Hosp, Dept Radiol, Sagamihara, Kanagawa, Japan	Inoue, Y (reprint author), Kitasato Univ, Sch Med, Dept Diagnost Radiol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	inoueys34@gmail.com					Abdullah A, 2012, RADIAT PROT DOSIM, V151, P153, DOI 10.1093/rpd/ncr451; Huda W, 2011, RADIOLOGY, V258, P236, DOI 10.1148/radiol.10100297; Goo HW, 2012, KOREAN J RADIOL, V13, P1, DOI 10.3348/kjr.2012.13.1.1; Huda W, 2008, RADIOLOGY, V248, P995, DOI 10.1148/radiol.2483071964; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Brix G, 2005, J NUCL MED, V46, P608; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI [10.1097/RLI.ob013e3181dzfeec, 10.1097/RLI.0b013e3181dzfeec]; Townsend DW, 2008, SEMIN NUCL MED, V38, P152, DOI 10.1053/j.semnuclmed.2008.01.003; Schilham A, 2010, RADIOGRAPHICS, V30, P1057, DOI 10.1148/rg.304095167; [Anonymous], 2007, ANN ICRP, V37, P1, DOI 10.1016/j.icrp.2007.09.001; Etard C, 2012, RADIAT PROT DOSIM, V152, P334, DOI 10.1093/rpd/ncs066; Lee TY, 2010, EUR J RADIOL, V76, P28, DOI 10.1016/j.ejrad.2010.06.036; Huang BS, 2009, RADIOLOGY, V251, P166, DOI 10.1148/radiol.2511081300; Huda W, 2011, MED PHYS, V38, P1261, DOI 10.1118/1.3544350; Khamwan K, 2010, RADIAT PROT DOSIM, V141, P50, DOI 10.1093/rpd/ncq140; Tonkopi E, 2013, AM J ROENTGENOL, V201, P257, DOI 10.2214/AJR.12.10495; van der Molen AJ, 2007, RADIOLOGY, V242, P208, DOI 10.1148/radiol.2421051350; Willowson KP, 2012, AUSTRALAS PHYS ENG S, V35, P49, DOI 10.1007/s13246-011-0119-8; Wu TH, 2004, EUR J NUCL MED MOL I, V31, P38, DOI 10.1007/s00259-003-1327-6; Zhang YK, 2012, MED PHYS, V39, P3404, DOI 10.1118/1.4718710	21	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	MAY 1	2015	56	5					695	700		10.2967/jnumed.114.153718		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH2CB	WOS:000353831000014		
J	Hanaoka, H; Ohshima, Y; Suzuki, Y; Yamaguchi, A; Watanabe, S; Uehara, T; Nagamori, S; Kanai, Y; Ishioka, NS; Tsushima, Y; Endo, K; Arano, Y				Hanaoka, Hirofumi; Ohshima, Yasuhiro; Suzuki, Yurika; Yamaguchi, Aiko; Watanabe, Shigeki; Uehara, Tomoya; Nagamori, Shushi; Kanai, Yoshikatsu; Ishioka, Noriko S.; Tsushima, Yoshito; Endo, Keigo; Arano, Yasushi			Development of a Widely Usable Amino Acid Tracer: Br-76-alpha-Methyl-Phenylalanine for Tumor PET Imaging	JOURNAL OF NUCLEAR MEDICINE			English	Article						Br-76; alpha n-methyl-L-phenylalanine; tumor imaging; PET	POSITRON-EMISSION-TOMOGRAPHY; ALPHA-METHYL TYROSINE; BRAIN-TUMORS; TRANSPORTER 1; EXPRESSION; LAT1; BIODISTRIBUTION; PROTEIN; CANCER; ANALOG	Radiolabeled amino acids are superior PET tracers for the imaging of malignant tumors, and amino acids labeled with Br-76, an attractive positron emitter because of its relatively long half-life (16.2 h), could potentially be a widely usable tumor imaging tracer. In this study, in consideration of its stability and tumor specificity, we designed two Br-76-labeled amino acid derivatives, 2-Br-76-bromo-alpha- methyl-L-phenylalanine (2-Br-76-BAMP) and 4-Br-76-bromo-alpha-methylL-phenylalanine (4-Br-76-BAMP), and investigated their potential as tumor imaging agents. Methods: Both Br-76-and Br-77-labeled amino acid derivatives were prepared. We performed in vitro and in vivo stability studies and cellular uptake studies using the LS180 colon adenocarcinoma cell line. Biodistribution studies in normal mice and in LS180 tumor-bearing mice were performed, and the tumors were imaged with a small-animal PET scanner. Results: Both Br-77-BAMPs were stable in the plasma and in the murine body. Although both Br-77-BAMPs were taken up by LS180 cells and the uptake was inhibited by L-type amino acid transporter 1 inhibitors, 2-Br-77-BAMP exhibited higher uptake than 4-Br-77-BAMP. In the biodistribution studies, 2-Br-77-BAMP showed more rapid blood clearance and lower renal accumulation than 4-Br-77-BAMP. More than 90% of the injected radioactivity was excreted in the urine by 6 h after the injection of 2-Br-77-BAMP. High tumor accumulation of 2-Br-77-BAMP was observed in tumor-bearing mice, and PET imaging with 2-Br-76-BAMP enabled clear visualization of the tumors. Conclusion: 2-Br-77-BAMP exhibited preferred pharmacokinetics and high LS180 tumor accumulation, and 2-Br-76-BAMP enabled clear visualization of the tumors by PET imaging. These findings suggest that 2-Br-76-BAMP could constitute a potential new PET tracer for tumor imaging and may eventually enable the wider use of amino acid tracers.	[Hanaoka, Hirofumi; Yamaguchi, Aiko] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Maebashi, Gumma 3718511, Japan; [Hanaoka, Hirofumi; Suzuki, Yurika; Uehara, Tomoya; Arano, Yasushi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Imaging & Radiotherapy, Chiba, Japan; [Ohshima, Yasuhiro; Watanabe, Shigeki; Ishioka, Noriko S.] Japan Atom Energy Agcy, Med Radioisotope Applicat Grp, Life Sci & Biotechnol Div, Quantum Beam Sci Ctr,Res Dept Nucl Sci, Takasaki, Gumma, Japan; [Nagamori, Shushi; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Biosyst Pharmacol, Suita, Osaka, Japan; [Tsushima, Yoshito; Endo, Keigo] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gumma 3718511, Japan	Hanaoka, H (reprint author), Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	hanaokah@gunma-u.ac.jp			Ministry of Health, Labor and Welfare [22689035]	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This work was supported by a grant-in-aid for young scientists (A) (22689035) to from the Ministry of Health, Labor and Welfare. No other potential conflict of interest relevant to this article was reported.	Wiriyasermkul P, 2012, J NUCL MED, V53, P1253, DOI 10.2967/jnumed.112.103069; Bruehlmeier M, 2003, J NUCL MED, V44, P1210; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Inoue T, 2001, RADIOLOGY, V220, P54; Tomiyoshi K, 1997, NUCL MED COMMUN, V18, P169, DOI 10.1097/00006231-199702000-00013; Tolmachev V, 1998, APPL RADIAT ISOTOPES, V49, P1537, DOI 10.1016/S0969-8043(97)10129-4; McConathy J, 2008, CANCER METAST REV, V27, P555, DOI 10.1007/s10555-008-9154-7; Inoue T, 1999, J NUCL MED, V40, P399; Huang CF, 2013, J NUCL MED, V54, P1007, DOI 10.2967/jnumed.112.113100; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; WIELAND DM, 1980, J NUCL MED, V21, P349; Fletcher JW, 2008, J NUCL MED, V49, P480, DOI 10.2967/jnumed.107.047787; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; ESSIG A, 1960, AM J PHYSIOL, V199, P509; Gudjonsson O, 2001, NUCL MED BIOL, V28, P59, DOI 10.1016/S0969-8051(00)00193-1; Inoue T, 1998, J NUCL MED, V39, P663; Kaira K, 2010, NUCL MED BIOL, V37, P911, DOI 10.1016/j.nucmedbio.2010.06.004; Khunweeraphong N, 2012, J PHARMACOL SCI, V119, P368, DOI 10.1254/jphs.12124FP; Kuga N, 2009, J NUCL MED, V50, P1378, DOI 10.2967/jnumed.108.060095; Lahoutte T, 2003, J NUCL MED, V44, P1489; Lovqvist A, 1997, J NUCL MED, V38, P395; Lovqvist A, 1997, J NUCL MED, V38, P1029; Miyakubo M, 2007, ANN NUCL MED, V21, P129; Ohshima Y, 2011, NUCL MED BIOL, V38, P857, DOI 10.1016/j.nucmedbio.2011.02.001; Plathow C, 2008, J NUCL MED, V49, P43, DOI DOI 10.2967/JNUMED.107.045930; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Watanabe S, 2010, J NUCL MED, V51, P1472, DOI 10.2967/jnumed.110.075465	27	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	MAY 1	2015	56	5					791	797		10.2967/jnumed.114.152215		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH2CB	WOS:000353831000028		
J	Ozawa, Y; Kawashima, M; Inoue, S; Inagaki, E; Suzuki, A; Ooe, E; Kobayashi, S; Tsubota, K				Ozawa, Y.; Kawashima, M.; Inoue, S.; Inagaki, E.; Suzuki, A.; Ooe, E.; Kobayashi, S.; Tsubota, K.			Bilberry extract supplementation for preventing eye fatigue in video display terminal workers	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						Eye fatigue; video display terminal; bilberry extract; anthocyanins	BLACK-CURRANT CONCENTRATE; VISUAL FATIGUE; VDT WORK; SUBJECTIVE SYMPTOMS; RISK-FACTORS; VISION; USERS; PREVALENCE; DISEASE; QUALITY	To examine the effect of a dietary supplement containing bilberry extract (BE) on eye fatigue induced by acute video display terminal (VDT) loads. A prospective, randomized, double-blind, placebo-controlled study was performed from August 2012 to February 2013 in the Medical Corporation Jico-kai Yagi Hospital, and the Shinyokohama Shinoharaguchi Orthopedic Surgery and Dermatology Clinic, in Japan. Two hundred eighty-one office workers aged 20-40 years that used VDTs were screened by critical flicker fusion (CFF) and near point accommodation (NPA). The participants were randomized to either a BE (480 mg/day) or placebo (vehicle) group, and took allocated capsule, daily, for 8 weeks. The CFF, NPA, contrast visual acuity, functional visual acuity, keratoconjunctival epithelial damage, and fluorescein tear film break-up time were examined, and 18 subjective symptoms of eye fatigue were evaluated by questionnaire. Adverse events were reported via medical interviews. Data were collected both before and after VDT load at baseline, and 4, and 8 weeks after daily supplementation with either BE or placebo. Of 281 participants screened, 88 having relatively lower levels of CFF and NPA were enrolled in the study. Of these, 37 control and 43 BE group subjects completed the study. The VDT load-induced reduction in CFF was alleviated after 8 weeks of BE supplementation (95% confidence interval, 0.10-1.60; p=0.023), in contrast to placebo supplementation, while NPA variation was not. Of the subjective symptoms of eye fatigue, VDT load-induced ocular fatigue sensation, ocular pain, eye heaviness, uncomfortable sensation, and foreign body sensation were mitigated more in the BE group than in the control group, at week 8 (p < 0.05). There were no severe adverse events in either group. BE supplementation improved some of the objective and subjective parameters of eye fatigue induced by VDT loads.	[Ozawa, Y.; Kawashima, M.; Inoue, S.; Inagaki, E.; Suzuki, A.; Tsubota, K.] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan; [Ooe, E.; Kobayashi, S.] Wakasa Seikatsu Co Ltd, Kyoto, Japan	Tsubota, K (reprint author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tsubota@z3.keio.jp					Ghosh D, 2007, ASIA PAC J CLIN NUTR, V16, P200; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Murata K, 1996, IND HEALTH, V34, P61, DOI 10.2486/indhealth.34.61; Nakamura Y, 2002, JPN J PHARMACOL, V89, P29, DOI 10.1254/jjp.89.29; Lee J, 2005, BRIT J NUTR, V93, P895, DOI 10.1079/BJN20051438; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Kojima T, 2011, AM J OPHTHALMOL, V152, P933, DOI 10.1016/j.ajo.2011.05.025; Friedman NJ, 2010, CURR OPIN OPHTHALMOL, V21, P310, DOI 10.1097/ICU.0b013e32833a8c15; Thomson WD, 1998, OPHTHAL PHYSL OPT, V18, P111, DOI 10.1046/j.1475-1313.1998.00323.x; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; MURATA K, 1991, INT ARCH OCC ENV HEA, V63, P109, DOI 10.1007/BF00379073; BERGQVIST U, 1989, BRIT J IND MED, V46, P217; Gopinath B, 2014, J NUTR HEALTH AGING, V18, P251, DOI 10.1007/s12603-013-0408-x; Iwasaki-Kurashige K, 2006, VASC PHARMACOL, V44, P215, DOI 10.1016/j.vph.2005.12.001; Kawabata F, 2011, BIOMED RES-TOKYO, V32, P387, DOI 10.2220/biomedres.32.387; Kawashima M, 2013, J MED INTERNET RES, V15, P102, DOI 10.2196/jmir.2198; KNAVE BG, 1985, SCAND J WORK ENV HEA, V11, P457; KURIMOTO S, 1983, Journal of UOEH, V5, P101; Matsumoto H, 2005, EXP EYE RES, V80, P313, DOI 10.1016/j.exer.2004.10.002; Matsunaga N, 2009, MOL NUTR FOOD RES, V53, P869, DOI 10.1002/mnfr.200800394; Miyake S, 2012, LAB INVEST, V92, P102, DOI 10.1038/labinvest.2011.132; Nakaishi H, 2000, Altern Med Rev, V5, P553; Neuringer M, 2000, AM J CLIN NUTR, V71, p256S; Russell J, 2014, J NUTR HEALTH AGING, V18, P3, DOI 10.1007/s12603-013-0339-6; SAITO S, 1994, IND HEALTH, V32, P57; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; Uchino Y, 2012, J NUTR HEALTH AGING, V16, P478, DOI 10.1007/s12603-012-0059-3; Uchino Y, 2012, JPN J OPHTHALMOL, V56, P8, DOI 10.1007/s10384-011-0099-y; Wolkoff P, 2004, OCCUPAT ENV MED, V62, P4; Ye Zhaojia, 2007, Journal of Physiological Anthropology, V26, P69, DOI 10.2114/jpa2.26.69; Yoshihara A, 2009, INT J OCCUP SAF ERGO, V15, P339; Zhang M, 2004, AMINO ACIDS, V26, P59, DOI 10.1007/s00726-003-0032-x	35	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	MAY	2015	19	5					548	554		10.1007/s12603-014-0573-6		7	Geriatrics & Gerontology; Nutrition & Dietetics	Geriatrics & Gerontology; Nutrition & Dietetics	CH7EU	WOS:000354199200010		
J	Leung, KY; Poon, CF; Teotico, AR; Hata, T; Won, HS; Chen, M; Chittacharoen, A; Malhotra, J; Shah, PK; Salim, A				Leung, Kwok Yin; Poon, Chung Fan; Teotico, Angelita R.; Hata, Toshiyuki; Won, H. S.; Chen, Ming; Chittacharoen, Apichart; Malhotra, Jaideep; Shah, P. K.; Salim, Azen		Asia Oceania Federation Obstet	Recommendations on routine mid-trimester anomaly scan	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						congenital anomalies; fetal structures; fetal ultrasonography; prenatal diagnosis; ultrasound	RANDOMIZED CONTROLLED-TRIAL; 3-DIMENSIONAL SONOGRAPHIC ASSESSMENT; PLACENTA-PREVIA; ULTRASOUND EXAMINATION; PRACTICE GUIDELINES; PRENATAL DETECTION; GESTATIONAL WEEKS; FETAL BIOMETRY; DIAGNOSIS; PREGNANCY	The purpose of this paper is to discuss the minimal requirements of the routine mid-trimester anomaly scan in Asian countries after taking into account various factors, including local circumstances, medical practice, guidelines, and availability of experienced sonographers and high-resolution ultrasound machines, which affect the prenatal detection rate of fetal anomalies. In general, a routine mid-trimester anomaly scan includes the assessment of the number of fetuses, fetal cardiac activity, size, anatomy, liquor and placental location. The most controversial issue is which fetal structures should at least be examined. We discussed the requirements of a basic routine scan, as well as the optional views, which can be obtained if feasible to improve the detection of fetal, placental or maternal abnormalities. Routine anomaly scan remains a clinical challenge.	[Leung, Kwok Yin; Poon, Chung Fan] Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Teotico, Angelita R.] Manila Cent Univ Hosp, Dept Obstet & Gynecol, Manila, Philippines; [Hata, Toshiyuki] Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, Kagawa, Japan; [Won, H. S.] Univ Ulsan, Dept Obstet & Gynecol, Asan Med Ctr, Seoul, South Korea; [Chen, Ming] Changhua Christian Hosp Med Ctr, Dept Genom Med, Changhua, Taiwan; [Chittacharoen, Apichart] Mahidol Univ, Ramathibodi Hosp, Dept Obstet & Gynecol, Bangkok 10700, Thailand; [Malhotra, Jaideep] Ctr Women Care & Res, Malhotra Nursing & Matern Home, Agra, Uttar Pradesh, India; [Shah, P. K.] King Edward Mem Hosp, Dept Obstet & Gynaecol, Bombay, Maharashtra, India; [Salim, Azen] Univ Indonesia, Fetomaternal Div, Dept Obstet & Gynecol, Jakarta, Indonesia	Leung, KY (reprint author), Queen Elizabeth Hosp, Dept Obstet & Gynaecol, O&G Off, 10-F,Block H,Gascoigne Rd, Hong Kong, Hong Kong, Peoples R China.	Leungky1@ha.org.hk		Chen, Ming/0000-0001-5076-2917			Alfirevic Z, 2010, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD007529.PUB2; Altman DG, 1997, ULTRASOUND OBST GYN, V10, P174, DOI 10.1046/j.1469-0705.1997.10030174.x; FINBERG HJ, 1992, J ULTRAS MED, V11, P333; Sepulveda W, 2003, ULTRASOUND OBST GYN, V21, P564, DOI 10.1002/uog.132; Romosan G, 2009, ULTRASOUND OBST GYN, V34, P526, DOI 10.1002/uog.6446; Holder-Espinasse M, 2004, AM J MED GENET A, V124A, P417, DOI 10.1002/ajmg.a.20359; COMSTOCK CH, 1987, OBSTET GYNECOL, V70, P255; Ruano R, 2004, PRENATAL DIAG, V24, P26, DOI 10.1002/pd.772; Schwarzler P, 1999, ULTRASOUND OBST GYN, V14, P92, DOI 10.1046/j.1469-0705.1999.14020092.x; Reddy UM, 2014, AM J OBSTET GYNECOL, V210, P387, DOI 10.1016/j.ajog.2014.02.028; Gardiner H, 2013, SEMIN FETAL NEONAT M, V18, P261, DOI 10.1016/j.siny.2013.01.007; Bhide A, 2004, CURR OPIN OBSTET GYN, V16, P447, DOI 10.1097/00001703-200412000-00002; Rotten D, 2004, ULTRASOUND OBST GYN, V24, P402, DOI 10.1002/uog.1718; Comstock CH, 2004, AM J OBSTET GYNECOL, V190, P1135, DOI 10.1016/j.ajog.2003.11.024; Dudley NJ, 2005, ULTRASOUND OBST GYN, V25, P80, DOI 10.1002/uog.1751; Grandjean H, 1999, AM J OBSTET GYNECOL, V181, P446, DOI 10.1016/S0002-9378(99)70577-6; Salomon LJ, 2011, ULTRASOUND OBST GYN, V37, P116, DOI 10.1002/uog.8831; Vinals F, 2007, ULTRASOUND OBST GYN, V30, P162, DOI 10.1002/uog.4073; Qidwai GI, 2006, OBSTET GYNECOL, V107, P376, DOI 10.1097/01.AOG.0000196806.25897.7c; Abramowicz JS, 2003, ULTRASOUND OBST GYN, V21, P100, DOI 10.1002/uog.36; Carvalho JS, 2013, ULTRASOUND OBST GYN, V41, P348, DOI 10.1002/uog.12403; Hunter S, 2000, HEART, V84, P294, DOI 10.1136/heart.84.3.294; Yagel S, 2002, ULTRASOUND OBST GYN, V20, P340, DOI 10.1046/j.1469-0705.2002.00801.x; JAGO JR, 1994, ULTRASOUND MED BIOL, V20, P699, DOI 10.1016/0301-5629(94)90027-2; Azouz EM, 1998, CAN ASSOC RADIOL J, V49, P105; Becker RH, 2001, ULTRASOUND OBST GYN, V17, P496, DOI 10.1046/j.1469-0705.2001.00423.x; Berghella V, 2009, COCHRANE DB SYST REV, V3; Blaas HGK, 2008, PRENATAL DIAG, V28, P568, DOI 10.1002/pd.1963; Bonilla-Musoles F, 2002, J PERINAT MED, V30, P99, DOI 10.1515/JPM.2002.012; Bromley B, 2014, J ULTRAS MED, V33, P1737, DOI [10.7863/ultra.33.10.1737, 10.7863/tiltra.33.10.1737]; Bronshtein M, 2002, OBSTET GYNECOL, V99, P1129, DOI 10.1016/S0029-7844(02)02017-3; BROWN BS, 1984, J CAN ASSOC RADIOL, V35, P63; Butt Kimberly, 2014, J Obstet Gynaecol Can, V36, P171; Chervenak FA, 1998, AM J OBSTET GYNECOL, V178, P678, DOI 10.1016/S0002-9378(98)70477-6; Dar P, 2000, CLIN PERINATOL, V27, P813; Degani S, 2001, OBSTET GYNECOL SURV, V56, P159, DOI 10.1097/00006254-200103000-00023; Doubilet PM, 2013, SEMIN PERINATOL, V37, P307, DOI 10.1053/j.semperi.2013.06.006; Gindes L, 2013, PRENATAL DIAG, V33, P436, DOI 10.1002/pd.4083; HADLOCK FP, 1981, AM J ROENTGENOL, V137, P83; Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909; LESSOWAY VA, 1990, J CLIN ULTRASOUND, V18, P471, DOI 10.1002/jcu.1870180604; Li TK, 2010, PRENAT DIAGN, V30, P1126; MAHONY BS, 1984, RADIOLOGY, V153, P773; Miller C, 2002, CLEFT PALATE-CRAN J, V39, P73, DOI 10.1597/1545-1569(2002)039<0073:UDOC>2.0.CO;2; National Institute of Health and Clinical Excellence (NICE), 2010, ANT CAR; Neilson JP, 2000, COCHRANE DB SYST REV; Rotten D, 2004, ULTRASOUND OBST GYN, V23, P224, DOI 10.1002/uog.984; Royal College of Obstetricians and Gynaecologists, 2005, PLAC PRAEV PLAC PRAE; Saltvedt S, 2006, BJOG-INT J OBSTET GY, V113, P664, DOI 10.1111/j.1471-0528.2006.00953.x; Schoonen HMHJD, 2011, ULTRASOUND OBST GYN, V37, P649, DOI 10.1002/uog.8906; Signorelli M, 2004, ULTRASOUND OBST GYN, V23, P14, DOI 10.1002/uog.941; Taipale P, 2001, OBSTET GYNECOL, V97, P189, DOI 10.1016/S0029-7844(00)01131-5; WALDENSTROM U, 1988, LANCET, V2, P585; Westin M, 2006, BJOG-INT J OBSTET GY, V113, P675, DOI 10.1111/j.1471-0528.2006.00951.x; World Health Organization, 1998, WHO TECHN REP SER, V875	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					653	661		10.1111/jog.12700		9	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100001		
J	Sumi, G; Yasuda, K; Tsuji, S; Kanamori, C; Tsuzuki, T; Cho, H; Nishigaki, A; Okada, H; Kanzaki, H				Sumi, Genichiro; Yasuda, Katsuhiko; Tsuji, Shoko; Kanamori, Chiharu; Tsuzuki, Tomoko; Cho, Hisayuu; Nishigaki, Akemi; Okada, Hidetaka; Kanzaki, Hideharu			Lipid-soluble fraction of Shakuyaku-kanzo-to inhibits myometrial contraction in pregnant women	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						Kampo; lipid-soluble fraction; myometrial contractions; pregnancy; shakuyaku-kanzo-to	JAPANESE HERBAL MEDICINE; MAINTENANCE HEMODIALYSIS; RHYTHMIC CONTRACTIONS; GLYCYRRHETIC ACID; RAT; CRAMPS	AimShakuyaku-kanzo-to, a Kampo medicine composed equally of shakuyaku and kanzo, is an antispasmodic drug that can inhibit contraction of uterine smooth muscles in pregnant women and rats. We aimed to test the inhibitory effects of water- and lipid-soluble extracts of shakuyaku-kanzo-to, shakuyaku, and kanzo in order to identify the fraction responsible for inhibiting uterine smooth muscle contraction in pregnancy. Material and MethodsMyometrial tissues were obtained from pregnant women and rats. The water- and lipid-soluble fractions of shakuyaku-kanzo-to, shakuyaku, and kanzo were obtained using the method of Bligh and Dyer. Lipid-soluble fractions were also partially purified using thin-layer chromatography (TLC) with a chloroform:methanol:water (65:25:4 by volume) solvent system to yield four TLC fractions. The effect of each fraction on oxytocin-induced myometrial contraction was examined in vitro. ResultsLipid-soluble fractions obtained from shakuyaku-kanzo-to and kanzo inhibited myometrial contraction; water-soluble fractions had no effect. Of the four TLC fractions, the inhibitory effect was greatest with TLC fraction 1 (0.75<Rf value1.0). Neither the water-soluble nor the lipid-soluble fraction from shakuyaku inhibited myometrial contraction. ConclusionsThese results suggest that lipid-soluble substances with low polarity derived from kanzo are responsible for the inhibitory effect of shakuyaku-kanzo-to on myometrial contraction.	[Sumi, Genichiro; Yasuda, Katsuhiko; Tsuji, Shoko; Kanamori, Chiharu; Tsuzuki, Tomoko; Cho, Hisayuu; Nishigaki, Akemi; Okada, Hidetaka; Kanzaki, Hideharu] Kansai Med Univ, Dept Obstet & Gynecol, Moriguchi, Osaka 5700074, Japan	Yasuda, K (reprint author), Kansai Med Univ, Dept Obstet & Gynecol, 10-15 Fumizono Cho, Moriguchi, Osaka 5700074, Japan.	yasuda@takii.kmu.ac.jp			Japan Smoking Research Foundation	We thank Ms Khono for her secretarial assistance. This work was supported by a grant from the Japan Smoking Research Foundation.	Hyodo T, 2002, NEPHRON, V90, P240, DOI 10.1159/000049057; Hyodo T, 2006, NEPHRON CLIN PRACT, V104, pC28, DOI 10.1159/000093256; Yasuda K, 2007, REPRODUCTION, V133, P797, DOI 10.1530/REP-06-0041; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Ai M, 2006, WORLD J GASTROENTERO, V12, P760; Tsuji S, 2012, J OBSTET GYNAECOL RE, V38, P1004, DOI 10.1111/j.1447-0756.2011.01827.x; Hinoshita F, 2003, AM J CHINESE MED, V31, P445, DOI 10.1142/S0192415X03001144; HATTORI M, 1983, PLANTA MED, V48, P38, DOI 10.1055/s-2007-969875; HEBER M, 1984, BRIT MED J, V289, P1269; Hisha H, 1997, BLOOD, V90, P1022; IMAI A, 1995, J MED, V26, P163; Meselhy MR, 2000, J TRADIT MED, V17, P26; Nakamoto T, 2006, REPRODUCTION, V132, P343, DOI 10.1530/rep.1.00908; NYBERG G, 1988, EUR J CLIN PHARMACOL, V34, P561, DOI 10.1007/BF00615218; Okamura N, 2001, BIOL PHARM BULL, V24, P1161, DOI 10.1248/bpb.24.1161; Ozaki Hiroshi, 2003, British Journal of Pharmacology, V140, P1303, DOI 10.1038/sj.bjp.0705552; Sakai Y, 2009, J NAT MED, V63, P200, DOI 10.1007/s11418-008-0304-6; Sato Y, 2006, J ETHNOPHARMACOL, V105, P409, DOI 10.1016/j.jep.2005.11.017; SEITCHIK J, 1985, AM J OBSTET GYNECOL, V151, P757; Tahara M, 2002, ENDOCRINOLOGY, V143, P920, DOI 10.1210/en.143.3.920; Tanaka T, 2003, Clin Exp Obstet Gynecol, V30, P95; TERASAWA K, 1986, J PHARMACOBIO-DYNAM, V9, P95	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					670	679		10.1111/jog.12618		10	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100003		
J	Watanabe, M; Shinohara, H; Kodama, H				Watanabe, Minako; Shinohara, Hitomi; Kodama, Hideya			Impact of overnight oximetry findings on cardiac autonomic modulation in women during second trimester of uncomplicated pregnancy	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						autonomic nervous system; complication related to pregnancy; heart rate variability; home pulse oximetry; sleep-disordered breathing	OBSTRUCTIVE SLEEP-APNEA; HEART-RATE-VARIABILITY; SYMPATHETIC ACTIVITY; DAYTIME SLEEPINESS; VAGAL TONE; POLYSOMNOGRAPHY; PREVALENCE; DISORDERS; FREQUENCY; STRESS	AimAlthough sleep-disordered breathing (SDB) might impose an underlying health threat upon some pregnant women, the influence of SDB on the health status of most pregnant women is not discernible. In order to find out which pregnant women should be evaluated for clinically meaningful SDB during the second trimester, the present study aimed to determine which overnight oximetry findings significantly affect maternal resting cardiac autonomic modulations. Material and MethodsOvernight arterial oxygen saturation (SaO(2)) was monitored at home using pulse oximetry by 64 women with uncomplicated pregnancy between 24 and 28 weeks of gestation. We then determined the impact of the findings on maternal resting heart rate variability (HRV) using 5-min photoplethysmography. ResultsA relatively increased oxygen desaturation index (number of oxygen desaturation events where SaO(2) fell >3% below the baseline saturation/h) of 3.0 in five women did not significantly impact HRV. On the other hand, events associated with profound oxygen desaturation (minimum SaO(2)90%) in three women were associated with decreased HRV, including high- and low-frequency powers. ConclusionParasympathetic activities of cardiac autonomic modulations might be attenuated in women who experience profound night-time oxygen desaturation, even if the incidence of significant events is quite low. The oximetry finding of minimum SaO(2)90% might be a valuable criterion for clinically meaningful sleep-disordered breathing among women with early uncomplicated pregnancy.	[Watanabe, Minako] Japanese Red Cross Akita Coll Nursing, Akita, Japan; [Shinohara, Hitomi; Kodama, Hideya] Akita Grad Sch Med, Dept Matern Child Nursing, Akita, Japan; [Shinohara, Hitomi; Kodama, Hideya] Sch Hlth Sci, Fac Med, Akita, Japan	Kodama, H (reprint author), 1-1-1 Hondo, Akita 0108543, Japan.	kodamah@hs.akita-u.ac.jp			Japan Society for the Promotion of Science [23593281]	The present study was supported by a Grant-in-Aid for Scientific Research (No. 23593281) from the Japan Society for the Promotion of Science.	McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1193/annals.1314.001; Venkata C, 2009, J AM BOARD FAM MED, V22, P158, DOI 10.3122/jabfm.2009.02.080057; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Morong S, 2014, SLEEP BREATH, V18, P31, DOI 10.1007/s11325-013-0849-9; CARLSON JT, 1993, CHEST, V103, P1763, DOI 10.1378/chest.103.6.1763; DAVIES RJO, 1990, EUR RESPIR J, V3, P509; Haba-Rubio J, 2005, CHEST, V128, P3350, DOI 10.1378/chest.128.5.3350; O'Brien LM, 2012, J CLIN SLEEP MED, V8, P287, DOI 10.5664/jcsm.1916; Pien GW, 2004, SLEEP, V27, P1405; Grassi G, 1999, J HYPERTENS, V17, P719, DOI 10.1097/00004872-199917060-00001; Netzer N, 2001, CHEST, V120, P625, DOI 10.1378/chest.120.2.625; Mador MJ, 2005, CHEST, V128, P2130, DOI 10.1378/chest.128.4.2130; Narkiewicz K, 1998, CIRCULATION, V98, P1071; Louis J, 2012, OBSTET GYNECOL, V120, P1085, DOI [http://10.1097/AOG.0b013e31826eb9d8, 10.1097/AOG.0b013e31826eb9d8]; Facco FL, 2011, SEMIN PERINATOL, V35, P335, DOI 10.1053/j.semperi.2011.05.018; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Donadio V, 2007, J SLEEP RES, V16, P327, DOI 10.1111/j.1365-2869.2007.00602.x; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Brain KA, 2001, BRIT J OBSTET GYNAEC, V108, P543, DOI 10.1111/j.1471-0528.2001.00106.x; Chens YH, 2012, AM J OBSTET GYNECOL, V206, p136e1; COOPER BG, 1991, THORAX, V46, P586, DOI 10.1136/thx.46.8.586; Facco FL, 2013, PREGNANCY HYPERTENS, V3, P133, DOI 10.1016/j.preghy.2013.01.005; Faccos FL, 2014, AM J OBSTET GYNECOL, V210; Fischer T, 2004, EUR J CLIN INVEST, V34, P443, DOI 10.1111/j.1365-2362.2004.01350.x; Fung AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068057; Hilton MF, 2001, EUR RESPIR J, V17, P1258, DOI 10.1183/09031936.01.00009301; JOHNS MW, 1991, SLEEP, V14, P540; Koos BB, 2008, SLEEP BREATH, V12, P259; Kuos CD, 2000, BRIT J ANAESTH, V84, P323; Matsuo H, 2007, CLIN EXP OBSTET GYN, V34, P73; Millman Alexandra L, 2011, J Obstet Gynaecol Can, V33, P705; Pals GK, 2011, INT J HYPERTENS, V2011; Pamidis S, 2014, AM J OBSTET GYNECOL, V210; Reid J, 2011, SLEEP, V34, P1033, DOI 10.5665/SLEEP.1156; Shiga K, 2012, INT J GYNECOL OBSTET, V119, P149, DOI 10.1016/j.ijgo.2012.05.034; Task Force, 1996, EUR HEART J, V17, P354, DOI DOI 10.1093/0XF0RDJ0URNALS.EURHEARTJ.A014868; Yins TT, 2008, EUR J OBSTET GYN R B, V141, P35	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					689	696		10.1111/jog.12634		8	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100005		
J	Nagasaka, K; Kawana, K; Tomio, K; Tsuruga, T; Mori-Uchino, M; Miura, S; Tanikawa, M; Miyamoto, Y; Ikeda, Y; Sone, K; Adachi, K; Matsumoto, Y; Arimoto, T; Oda, K; Osuga, Y; Fujii, T				Nagasaka, Kazunori; Kawana, Kei; Tomio, Kensuke; Tsuruga, Tetsushi; Mori-Uchino, Mayuyo; Miura, Shiho; Tanikawa, Michihiro; Miyamoto, Yuichiro; Ikeda, Yuji; Sone, Kenbun; Adachi, Katsuyuki; Matsumoto, Yoko; Arimoto, Takahide; Oda, Katsutoshi; Osuga, Yutaka; Fujii, Tomoyuki			Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						interval surgery; ovarian cancer; peritoneal cytology; prognostic factor	DEBULKING SURGERY; NEOADJUVANT CHEMOTHERAPY; SURGICAL CYTOREDUCTION; RESIDUAL DISEASE; ONCOLOGY-GROUP; CANCER; SURVIVAL; MANAGEMENT; IMPACT	AimThe purpose of our study is to investigate clinically significant prognostic factors at the time of interval surgery (IS), comprising interval look surgery and interval debulking surgery, for T3c (International Federation of Gynecology and Obstetrics stage IIIc to IV) advanced ovarian cancer (AOC) patients during primary treatment. MethodsWe reviewed records of patients with T3c AOC who underwent IS following neoadjuvant chemotherapy or up-front primary debulking surgery with adjuvant chemotherapy at our institution between January 1996 and December 2010. For analysis of prognostic factors, cytology of peritoneal exfoliative cells at IS was added to clinicopathological variables. ResultsA retrospective analysis was performed on 50 cases. The median age was 61.1 years (range, 38-78), with median follow-up of 45.9 months (range, 12-122). Macroscopic tumors were completely resected in 32 cases (64%) at IS. Univariate analyses of clinicopathological factors for IS identified preoperative serum cancer antigen-125 levels (20IU/mL; P=0.0539), number of residual lesions at IS (20; P=0.0554), incomplete surgery at IS (P=0.0171) and positive peritoneal cytology at IS (P=0.0015) as significant factors for prognosis regarding progression-free survival (PFS). Multivariate analysis identified positive peritoneal cytology (P=0.0303) as a unique independent predictor of poor prognosis in PFS. ConclusionPositive peritoneal cytology at IS appears to be a significant factor for poor prognosis in PFS, which may provide useful information for post-IS chemotherapy planning. IS in the treatment of AOC may be useful for not only complete resection, but also for identification of patients with poor prognosis.	[Nagasaka, Kazunori; Kawana, Kei; Tomio, Kensuke; Tsuruga, Tetsushi; Mori-Uchino, Mayuyo; Miura, Shiho; Tanikawa, Michihiro; Miyamoto, Yuichiro; Ikeda, Yuji; Sone, Kenbun; Adachi, Katsuyuki; Matsumoto, Yoko; Arimoto, Takahide; Oda, Katsutoshi; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Dept Obstet & Gynecol, Fac Med, Tokyo 1138655, Japan	Kawana, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kkawana-tky@umin.org			Ministry of Education, Science and Culture, Japan	The authors are grateful to Dr Gautam A. Deshpande (St Luke's International Hospital, John A. Burns School of Medicine) for the critical reading of our manuscript. This work was supported by a Grant-in-Aid for Scientific Research (K. K.) from the Ministry of Education, Science and Culture, Japan.	Weinberg LE, 2010, J SURG ONCOL, V101, P334, DOI 10.1002/jso.21482; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Rose PG, 2004, NEW ENGL J MED, V351, P2489, DOI 10.1056/NEJMoa041125; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; BEREK JS, 1983, OBSTET GYNECOL, V61, P189; Chang SJ, 2012, ANN SURG ONCOL, V19, P4059, DOI 10.1245/s10434-012-2446-8; Sehouli J, 2010, INT J GYNECOL CANCER, V20, P1331, DOI 10.1111/IGC.0b013e3181f15714; Karoo ROS, 2003, POSTGRAD MED J, V79, P292, DOI 10.1136/pmj.79.931.292; Vergote I, 2011, EUR J CANCER, V47, pS88, DOI 10.1016/S0959-8049(11)70152-6; Rauh-Hain JA, 2012, GYNECOL ONCOL, V125, P376, DOI 10.1016/j.ygyno.2012.02.016; Fanfani F, 2003, ONCOLOGY-BASEL, V65, P316, DOI 10.1159/000074644; Bonnefoi H, 1999, J CLIN ONCOL, V17, P767; Onda T, 2011, EXPERT REV ANTICANC, V11, P1053, DOI [10.1586/era.11.24, 10.1586/ERA.11.24]; VANDERBURG MEL, 1995, NEW ENGL J MED, V332, P629, DOI 10.1056/NEJM199503093321002; Ushijima K, 2009, J GYNECOL ONCOL, V20, P67, DOI 10.3802/jgo.2009.20.2.67; Chi DS, 2010, INT J GYNECOL CANCER, V20, P353, DOI 10.1111/IGC.0b013e3181d09fd6; Dewdney SB, 2010, GYNECOL ONCOL, V119, P18, DOI 10.1016/j.ygyno.2010.06.021; du Bois A, 2012, INT J GYNECOL CANCER, V22, P182; Le T, 2006, ANN SURG ONCOL, V13, P1711, DOI 10.1245/s10434-006-9125-6; Morice P, 2003, ANN ONCOL, V14, P74, DOI 10.1093/annonc/mdg003; Onda T, 2010, JPN J CLIN ONCOL, V40, P36, DOI 10.1093/jjco/hyp127; REDMAN CWE, 1994, BRIT J OBSTET GYNAEC, V101, P142, DOI 10.1111/j.1471-0528.1994.tb13080.x; Rose PG, 2011, GYNECOL ONCOL, V120, P300, DOI 10.1016/j.ygyno.2010.10.021; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Tangjitgamol S, 2009, GYNECOL ONCOL, V112, P257, DOI 10.1016/j.ygyno.2008.09.041; Tsubamoto H, 2013, GYNECOL ONCOL, V128, P22, DOI 10.1016/j.ygyno.2012.10.001; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					755	762		10.1111/jog.12616		8	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100015		
J	Yamagami, W; Susumu, N; Ninomiya, T; Nakadaira, N; Iwasa, N; Kuwahata, M; Nomura, H; Kataoka, F; Banno, K; Aoki, D				Yamagami, Wataru; Susumu, Nobuyuki; Ninomiya, Tomomi; Nakadaira, Naoki; Iwasa, Naomi; Kuwahata, Michiko; Nomura, Hiroyuki; Kataoka, Fumio; Banno, Kouji; Aoki, Daisuke			Hysteroscopic transcervical resection is useful to diagnose myometrial invasion in atypical polypoid adenomyoma coexisting with atypical endometrial hyperplasia or endometrial cancer with suspicious myometrial invasion	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						atypical polypoid adenomyoma; endometrial cancer; hysteroscopic transcervical resection; medroxyprogesterone acetate; myometrial invasion	CARCINOMA; ABSENCE	AimManagement of atypical polypoid adenomyoma (APAM) is complicated because it can sometimes coexist with atypical endometrial hyperplasia (AEH) or endometrioid adenocarcinoma. It is often difficult to assess myometrial invasion in APAM complicated with endometrial cancer. We encountered three patients who, contrary to magnetic resonance imaging, did not have myometrial invasion on hysteroscopic transcervical resection (TCR) and therefore could have fertility preserved, and consequently could become pregnant. MethodsWe removed the polypoid lesion and a 3-5mm-thick layer of the normal inner membrane at the root of the polypoid lesion, and then performed total curettage. Several pathological diagnostic procedures were then carried out on each of these resected specimens. Thereafter, high-dose medroxyprogesterone acetate (MPA) was initiated. ResultsAll three patients underwent hysteroscopic transcervical tumor resection. The pathological diagnoses were as follows: patient 1, G1 endometrioid adenocarcinoma (EMG1)+APAM; patients 2,3, AEH+APAM. No findings of myometrial invasion in the resected root specimen were observed in any patient. In all cases, high-dose MPA was initiated. After the disappearance of tumors, each patient achieved pregnancy. Complications such as placenta accreta were not observed at the time of delivery. ConclusionIn patients with APAM and AEH or EMG1, TCR may aid accurate diagnosis when myometrial invasion is unclear on diagnostic imaging.	[Yamagami, Wataru; Susumu, Nobuyuki; Ninomiya, Tomomi; Nakadaira, Naoki; Iwasa, Naomi; Kuwahata, Michiko; Nomura, Hiroyuki; Kataoka, Fumio; Banno, Kouji; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1608582, Japan	Yamagami, W (reprint author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	gami@z8.keio.jp					Suh DS, 2009, ACTA OBSTET GYN SCAN, V88, P990, DOI 10.1080/00016340903141135; KURMAN RJ, 1982, CANCER, V49, P2547, DOI 10.1002/1097-0142(19820615)49:12<2547::AID-CNCR2820491224>3.0.CO;2-0; Gunderson CC, 2012, GYNECOL ONCOL, V125, P477, DOI 10.1016/j.ygyno.2012.01.003; MAZUR MT, 1981, AM J SURG PATHOL, V5, P473, DOI 10.1097/00000478-198107000-00006; Munro MG, 2010, OBSTET GYN CLIN N AM, V37, P399, DOI 10.1016/j.ogc.2010.05.006; Chang YN, 2011, FERTIL STERIL, V96, P957, DOI 10.1016/j.fertnstert.2011.07.1146; Mazzon I, 2005, INT J GYNECOL CANCER, V15, P974, DOI 10.1111/j.1525-1438.2005.00162.x; Beuker JM, 2005, J CLIN PATHOL, V58, P273, DOI 10.1136/jcp.2004.020602; Ushijima K, 2009, J GYNECOL ONCOL, V20, P67, DOI 10.3802/jgo.2009.20.2.67; Nakao Y, 2006, GYNECOL ONCOL, V102, P343, DOI 10.1016/j.ygyno.2005.12.028; Di Spiezio Sardos A, 2008, FERTIL STERIL, V89; Dunton CJ, 1996, AM J OBSTET GYNECOL, V174, P1518, DOI 10.1016/S0002-9378(96)70599-9; Ewies A. A. A., 1999, Journal of Obstetrics and Gynaecology (Abingdon), V19, P192; Guida Maurizio, 2008, Fertil Steril, V89, P1283, DOI 10.1016/j.fertnstert.2008.01.093; Kisu I, 2013, ACTA OBSTET GYN SCAN, V92, P525, DOI 10.1111/aogs.12048; Kisus I, 2011, J CANC THER, V2, P458; Longacre TA, 1996, AM J SURG PATHOL, V20, P1, DOI 10.1097/00000478-199601000-00001; Matsumoto T, 2013, GYNECOL ONCOL, V129, P54, DOI 10.1016/j.ygyno.2012.12.040; Tanakas K, 2012, KANTO J OBSTET GYNEC, V49, P633; Yahatas T, 2011, FERTIL STERIL, V95	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					768	775		10.1111/jog.12645		8	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100017		
J	Ichizuka, K; Mishina, M; Hasegawa, J; Matsuoka, R; Sekizawa, A; Pooh, RK				Ichizuka, Kiyotake; Mishina, Miyuki; Hasegawa, Junichi; Matsuoka, Ryu; Sekizawa, Akihiko; Pooh, Ritsuko K.			Diagnosis of a case of Dandy-Walker malformation aided by measurement of the brainstem-vermis angle at 14 weeks gestation	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						brainstem-vermis angle; Dandy-Walker malformation; fetus; prenatal diagnosis	ABNORMALITIES	Reported is a fetal Dandy-Walker malformation that was strongly suspected in the first trimester through measurement of the brainstem-vermis (B-V) angle, which was found to be 119 degrees on transvaginal ultrasound examination at 14 weeks and 2 days gestation. Definitive diagnosis of the Dandy-Walker malformation was made by magnetic resonance imaging following stillbirth. Ultrasound measurement of the B-V angle may be a useful index for prenatal diagnosis of Dandy-Walker anomalies during early pregnancy.	[Ichizuka, Kiyotake; Mishina, Miyuki] Showa Univ, Northern Yokohama Hosp, Dept Obstet & Gynecol, Yokohama, Kanagawa 2248503, Japan; [Hasegawa, Junichi; Matsuoka, Ryu; Sekizawa, Akihiko] Showa Univ, Dept Obstet & Gynecol, Tokyo, Japan; [Pooh, Ritsuko K.] Clin Res Inst Fetal Med, Osaka, Japan	Ichizuka, K (reprint author), Showa Univ, Northern Yokohama Hosp, Dept Obstet & Gynecol, Tsuzuki Ku, 35-1 Chigasakicyuuou, Yokohama, Kanagawa 2248503, Japan.	ichizuka@med.showa-u.ac.jp					Carroll SGM, 2000, ULTRASOUND OBST GYN, V16, P149, DOI 10.1046/j.1469-0705.2000.00199.x; Contro E, 2014, ULTRASOUND OBST GYN, V43, P154, DOI 10.1002/uog.13227; GANDOLFI C, 2012, ULTRASOUND OBST GYN, V39, P625, DOI DOI 10.1002/U0G.11071.EPUB; Ghis T, 2012, PRENAT DIAGN, V32, P440; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Imataka George, 2007, Congenital Anomalies, V47, P113, DOI 10.1111/j.1741-4520.2007.00158.x; KOLLIAS SS, 1993, RADIOGRAPHICS, V13, P1211; Tohyamas J, 2011, AM J MED GENET A, V155A, P130; Volpe P, 2012, ULTRASOUND OBST GYN, V39, P632, DOI 10.1002/uog.11101	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					790	793		10.1111/jog.12623		4	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100020		
J	Himoto, Y; Kido, A; Minamiguchi, S; Mogami, H; Konishi, I; Togashi, K				Himoto, Yuki; Kido, Aki; Minamiguchi, Sachiko; Mogami, Haruta; Konishi, Ikuo; Togashi, Kaori			Visualization of placental hypocirculation with typical patterns using conventional magnetic resonance imaging: Two case reports	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						fetal growth restriction; half-Fourier acquisition single-shot turbo spin-echo; magnetic resonance imaging; placental hypocirculation; pregnancy-induced hypertension	MRI	We report two cases of clinically suspected placental hypocirculation, as per evidenced by specific half-Fourier acquisition single-shot turbo spin-echo (HASTE) magnetic resonance findings of the whole placenta. Patient 1 was a case of fetal growth restriction caused by pregnancy-induced hypertension, while patient 2 experienced a discordant dichorionic diamniotic twin pregnancy with fetal growth restriction complication with a velamentous insertion of the umbilical cord in the smaller twin. In both cases, HASTE images showed noticeably decreased signal intensity with high-intensity signal spots present in the central region of the placenta. In the twin pregnancy case, the low-intensity signal area in the placenta of the smaller twin was much lower compared to that of the larger twin. Pathological findings failed to support or explain these observations. HASTE images might reflect compensatory alternation of the distribution of maternal blood and villus caused by hypocirculation. In conclusion, our results suggest that HASTE imaging might be a useful approach for the visualization of placental hypocirculation.	[Himoto, Yuki; Kido, Aki; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan; [Minamiguchi, Sachiko] Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Kyoto 6068507, Japan; [Mogami, Haruta; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto 6068507, Japan	Kido, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	akikido@kuhp.kyoto-u.ac.jp					PROUD J, 1987, BRIT MED J, V294, P1641; GRANNUM PAT, 1979, AM J OBSTET GYNECOL, V133, P915; Damodaram M, 2010, PLACENTA, V31, P491, DOI 10.1016/j.placenta.2010.03.001; Elsayes KM, 2009, RADIOGRAPHICS, V29, P1371, DOI 10.1148/rg.295085242; Derwig I, 2013, PLACENTA, V34, P474, DOI 10.1016/j.placenta.2013.03.005; Bonel HM, 2010, RADIOLOGY, V257, P810, DOI 10.1148/radiol.10092283; Gowland PA, 1998, MAGNET RESON MED, V40, P467, DOI 10.1002/mrm.1910400318; Levine D, 2006, J MAGN RESON IMAGING, V24, P1, DOI 10.1002/jmri.20608; Gowland P, 2005, SEMIN FETAL NEONAT M, V10, P485, DOI 10.1016/j.siny.2005.05.001; Fox H, 2007, PATHOLOGY PLACENTA, P17; Takagi K, 2009, J INT MED RES, V37, P227	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					794	798		10.1111/jog.12632		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100021		
J	Kobayashi, T; Minami, S; Mitani, A; Tanizaki, Y; Booka, M; Okutani, T; Yamaguchi, S; Ino, K				Kobayashi, Tomoko; Minami, Sawako; Mitani, Ayuki; Tanizaki, Yuko; Booka, Mina; Okutani, Takahiro; Yamaguchi, Seiji; Ino, Kazuhiko			Acute fatty liver of pregnancy associated with fetal mitochondrial trifunctional protein deficiency	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						acute fatty liver of pregnancy; coagulopathy; fatty acid oxidation disorder; gene analysis; mitochondrial trifunctional protein deficiency	MOLECULAR CHARACTERIZATION; DYSFUNCTION	Acute fatty liver of pregnancy (AFLP) is a devastating disorder of the maternal liver in the third trimester. Recent studies have demonstrated an association between AFLP and fetal fatty acid oxidation disorders. Here, we report a case of AFLP caused by fetal mitochondrial trifunctional protein (TFP) deficiency. A 21-year-old parous woman presented with nausea, genital bleeding and abdominal pain at 33weeks of gestation. Laboratory data revealed hepatic failure and disseminated intravascular coagulopathy. The patient underwent emergency cesarean section and was diagnosed with AFLP from the clinical characteristics. She was successfully treated with frequent plasma exchange. The newborn presented severe heart failure and died on the 39th day after birth. Tandem mass spectrometry indicated long-chain fatty acid oxidation disorder. Gene analysis demonstrated homozygous mutation in exon 13 of HADHB, the gene responsible for mitochondrial TFP deficiency. The parents carried a heterozygous mutation at the same location in HADHB.	[Kobayashi, Tomoko; Minami, Sawako; Mitani, Ayuki; Tanizaki, Yuko; Ino, Kazuhiko] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama 6410012, Japan; [Booka, Mina; Okutani, Takahiro] Wakayama Med Univ, Div Neonatol, Maternal & Perinatal Care Ctr, Wakayama 6410012, Japan; [Yamaguchi, Seiji] Shimane Univ, Fac Med, Dept Pediat, Izumo, Shimane, Japan	Minami, S (reprint author), Wakayama Med Univ, Dept Obstet & Gynecol, 811-1 Kimiidera, Wakayama 6410012, Japan.	sawako@wakayama-med.ac.jp					Ch'ng CL, 2002, GUT, V51, P876, DOI 10.1136/gut.51.6.876; Browning MF, 2006, OBSTET GYNECOL, V107, P115, DOI 10.1097/01.AOG.0000191297.47183.bd; Chakrapani A, 2000, J INHERIT METAB DIS, V23, P826, DOI 10.1023/A:1026712719416; Ibdah Jamal-A, 2006, World J Gastroenterol, V12, P7397; Jamerson PA, 2005, JOGNN-J OBST GYN NEO, V34, P87, DOI 10.1177/0884217504272800; Isaacs JD, 1996, PEDIATR RES, V40, P393, DOI 10.1203/00006450-199609000-00005; Kos H, 2006, CAN J GASTROENTEROL, V20, P25; Purevsuren J, 2009, MOL GENET METAB, V98, P372, DOI 10.1016/j.ymgme.2009.07.011; SCHOEMAN MN, 1991, GASTROENTEROLOGY, V100, P544; Spiekerkoetter U, 2008, MOL GENET METAB, V94, P428, DOI 10.1016/j.ymgme.2008.04.002; TREEM WR, 1994, HEPATOLOGY, V19, P339; Ushikubo S, 1996, AM J HUM GENET, V58, P979	12	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					799	802		10.1111/jog.12609		4	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100022		
J	Nakamura, Y; Kamei, T; Shinagawa, M; Sakamoto, Y; Miwa, I				Nakamura, Yasuhiko; Kamei, Toshiaki; Shinagawa, Masahiro; Sakamoto, Yuka; Miwa, Ichiro			Case of pure ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin but responsive to monotherapy with weekly irinotecan	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						carboplatin; irinotecan; ovarian cancer; paclitaxel; squamous cell carcinoma	PHASE-II; CANCER; TRIAL	Primary ovarian squamous cell carcinoma is uncommon, and the optimal treatment strategy for this disease has not yet been established. A 71-year-old woman diagnosed with FIGO stage IIb pure ovarian squamous cell carcinoma underwent cytoreductive surgery followed by combination chemotherapy with paclitaxel and carboplatin. After the second treatment course, a recurrent mass grew rapidly, and serum tumor maker levels increased. Monotherapy with weekly irinotecan was then instituted. This second-line chemotherapy was remarkably effective, and the patient subsequently underwent complete interval debulking surgery with a pathological complete response after the third treatment course. Weekly irinotecan is an effective choice for primary ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin.	[Nakamura, Yasuhiko; Shinagawa, Masahiro; Sakamoto, Yuka; Miwa, Ichiro] Yamaguchi Grand Med Ctr, Dept Gynecol, Yamaguchi 7478511, Japan; [Kamei, Toshiaki] Yamaguchi Grand Med Ctr, Dept Pathol, Yamaguchi 7478511, Japan	Nakamura, Y (reprint author), Yamaguchi Grand Med Ctr, Dept Gynecol, 77 Ohsaki, Yamaguchi 7478511, Japan.	yasu-ygc@umin.net					Pins MR, 1996, AM J SURG PATHOL, V20, P823, DOI 10.1097/00000478-199607000-00005; Kikkawa F, 1997, OBSTET GYNECOL, V89, P1017, DOI 10.1016/S0029-7844(97)00117-8; Bodurka DC, 2003, J CLIN ONCOL, V21, P291, DOI 10.1200/JCO.2003.02.091; Eltabbakh GH, 1998, OBSTET GYNECOL, V91, P844, DOI 10.1016/S0029-7844(97)00665-0; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Ohtani K, 2000, GYNECOL ONCOL, V79, P515, DOI 10.1006/gyno.2000.5985; Yamaguchi S, 2012, ONCOL REP, V28, P487, DOI 10.3892/or.2012.1814; Yamakawa Y, 2011, INT J CLIN ONCOL, V16, P709, DOI 10.1007/s10147-011-0189-3; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Matasumotos K, 2006, GYNECOL ONCOL, V100, P412; Todo Y, 2005, GYNECOL ONCOL, V97, P223, DOI 10.1016/j.ygyno.2004.11.055	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					809	812		10.1111/jog.12631		4	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100024		
J	Yanazume, S; Arimura, T; Kobayashi, H; Douchi, T				Yanazume, Shintaro; Arimura, Takeshi; Kobayashi, Hiroaki; Douchi, Tsutomu			Potential proton beam therapy for recurrent endometrial cancer in the vagina	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						particle; proton beam; radiotherapy; recurrent endometrial cancer; vagina	CARCINOMA; RADIOTHERAPY	Proton beam radiotherapy mainly has been used in the gynecological field in patients with cervical cancer. The efficacy of proton beam therapy in patients with recurrent endometrial cancer has not yet been determined. A 77-year-old endometrial cancer patient presented with recurrence in the vagina without distant metastasis following hysterectomy. A hard mass measuring 6cm originated from the apex of the vagina, surrounded the vaginal cavity, and infiltrated the proximal and distal vagina. The patient received proton beam radiotherapy using a less invasive particle treatment system while minimizing the dose to the surrounding normal tissues. The dose to the planning target volume was 74Gy (relative biological effectiveness) with 37 fractions. The patient was treated with 150-210-MeV proton beams for 53days. Proton beam therapy led to the disappearance of tumors without any complications except for grade 1 cystitis although evidence of further complications is not available past our 6-month follow-up period. Proton beam therapy may become a useful treatment modality for recurrent endometrial cancer as well as cervical uterine cancer.	[Yanazume, Shintaro; Kobayashi, Hiroaki; Douchi, Tsutomu] Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, Kagoshima 8908520, Japan; [Arimura, Takeshi] Medipolis Proton Therapy & Res Ctr, Ibusuki, Japan	Yanazume, S (reprint author), Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	s-yana@m3.kufm.kagoshima-u.ac.jp					CURRAN WJ, 1988, INT J RADIAT ONCOL, V15, P803; KUTEN A, 1989, INT J RADIAT ONCOL, V17, P29; Jhingran A, 2003, INT J RADIAT ONCOL, V56, P1366, DOI 10.1016/S0360-3016(03)00414-0; Wylie J, 2000, GYNECOL ONCOL, V77, P66, DOI 10.1006/gyno.2000.5727; van de Water TA, 2011, ONCOLOGIST, V16, P366, DOI 10.1634/theoncologist.2010-0171; ARIMOTO T, 1991, CANCER, V68, P79, DOI 10.1002/1097-0142(19910701)68:1<79::AID-CNCR2820680116>3.0.CO;2-9; GREVEN K, 1987, CANCER, V60, P419, DOI 10.1002/1097-0142(19870801)60:3<419::AID-CNCR2820600323>3.0.CO;2-A; SMIT BM, 1992, INT J RADIAT ONCOL, V22, P349	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					813	816		10.1111/jog.12611		4	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100025		
J	Matsubara, S; Lefor, AK; Ohkuchi, A				Matsubara, Shigeki; Lefor, Alan K.; Ohkuchi, Akihide			Purse-string double-layer closure for cesarean incision (Turan technique): Some concerns	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Letter							DEFECTS		[Matsubara, Shigeki; Ohkuchi, Akihide] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan; [Lefor, Alan K.] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.			Lefor, Alan/0000-0001-6673-5630			Osser OV, 2009, ULTRASOUND OBST GYN, V34, P90, DOI 10.1002/uog.6395; Rozenberg P, 1996, LANCET, V347, P281, DOI 10.1016/S0140-6736(96)90464-X; Turan C, 2015, J OBSTET GYNAECOL RE, V41, P565, DOI 10.1111/jog.12593	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	MAY	2015	41	5					828	829		10.1111/jog.12679		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CH4FP	WOS:000353989100028		
J	Imamura, K; Kawakami, N; Furukawa, TA; Matsuyama, Y; Shimazu, A; Umanodan, R; Kawakami, S; Kasai, K				Imamura, Kotaro; Kawakami, Norito; Furukawa, Toshi A.; Matsuyama, Yutaka; Shimazu, Akihito; Umanodan, Rino; Kawakami, Sonoko; Kasai, Kiyoto			Effects of an Internet-Based Cognitive Behavioral Therapy Intervention on Improving Work Engagement and Other Work-Related Outcomes An Analysis of Secondary Outcomes of a Randomized Controlled Trial	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							DEPRESSIVE-DISORDERS; OCCUPATIONAL STRESS; MENTAL-HEALTH; MANAGEMENT; PRODUCTIVITY; METAANALYSIS; PERFORMANCE; ANXIETY; FUTURE; JAPAN	Objective: This study reported a randomized controlled trial of the effectiveness of an Internet-based cognitive behavioral therapy (iCBT) program on work engagement and secondary work-related outcomes. Methods: Participants who fulfilled the inclusion criteria were randomly allocated to an intervention or a control group (N = 381 for each). A 6-week, 6-lesson iCBT program using a Manga (Japanese comic) story was provided only to the intervention group. Work engagement was assessed at baseline and at 3- and 6-month follow-ups for both groups. Results: The iCBT program showed a significant intervention effect on work engagement (P = 0.04) with small effect sizes (Cohen's d = 0.16 at 6-month follow-up). Conclusions: The study showed computerized cognitive behavior therapy delivered via the Internet to be effective (with a small effect size) in increasing work engagement in the general working population.	[Imamura, Kotaro; Kawakami, Norito; Shimazu, Akihito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan; [Matsuyama, Yutaka] Univ Tokyo, Dept Biostat, Grad Sch Med, Tokyo, Japan; [Kasai, Kiyoto] Univ Tokyo, Dept Neuropsychiat, Grad Sch Med, Tokyo, Japan; [Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav, Tokyo, Japan; [Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol, Tokyo, Japan; [Umanodan, Rino] Hlth Wave Co Ltd, Kyoto Off, Tokyo, Japan; [Kawakami, Sonoko] Nippon Univ, Coll Arts, Tokyo, Japan	Kawakami, N (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	nkawakami@m.u-tokyo.ac.jp			Japan Society for the Promotion of Science [20240062, 26860433]; GlaxoSmithKline; Eizai; Pfizer; Fujitsu Software Technologies, Ltd; Softbank, Co, Ltd; Japan Management Association; Eli Lilly; Meiji; Mochida; MSD; Tanabe-Mitsubishi; Sekisui; Takeda Science Foundation; Japanese Ministry of Education, Science, and Technology; Japanese Ministry of Health, Labor and Welfare; Japan Foundation for Neuroscience and Mental Health; Union of Japanese Scientists and Engineers; EPS Co, Ltd; Statcom Co, Ltd; Zeria Pharmaceutical Co, Ltd; Ono Pharmaceutical Co, Ltd; Mebix Co, Ltd; Astellas; Novartis; Otsuka; Dainippon-Sumitomo; Yoshitomi Pharmaceutical Companies; Hitachi Co; Hitachi Medical; Yoshitomi; GSK	This study was supported by the Grant-in-Aid for Scientific Research (A) 2009 and 2010 (No. 20240062) and the Grant-in-Aid for Young Scientists (B) 2014 (No. 26860433) from the Japan Society for the Promotion of Science.; Dr Kawakami has received honoraria for speaking at CME meetings sponsored by GlaxoSmithKline, Eizai, and Pfizer. He is on the advisory board for Sekisui Chemicals and Junpukai Health Care Center. He has received royalties from Chuo-Hoki-Shuppan, Igaku-Shoin, Kyobun-do, Life Science, Maruzen, Nanko-do, Nanzan-do, and Fujitsu Software Technologies, Ltd, and research grants from Fujitsu Software Technologies, Ltd, Softbank, Co, Ltd, and Japan Management Association.; Dr Furukawa has received lecture fees from Eli Lilly, Meiji, Mochida, MSD, Pfizer, and Tanabe-Mitsubishi, and consultancy fees from Sekisui and Takeda Science Foundation. He is diplomate of the Academy of Cognitive Therapy. He has received royalties from Igaku-Shoin, Seiwa-Shoten, and Nihon Bunka Kagaku-sha. The Japanese Ministry of Education, Science, and Technology, the Japanese Ministry of Health, Labor and Welfare, and the Japan Foundation for Neuroscience and Mental Health have funded his research projects.; Dr Matsuyama has received lecture fees from the Union of Japanese Scientists and Engineers, EPS Co, Ltd, and Statcom Co, Ltd, and consultancy fees from Zeria Pharmaceutical Co, Ltd, Ono Pharmaceutical Co, Ltd, and Mebix Co, Ltd. He has received royalties from Igaku-Shoin and Ewanami-Shoten.; Dr Kasai has received lecture fees from Astellas, Novartis, Eli Lilly, Otsuka, Dainippon-Sumitomo, and Yoshitomi Pharmaceutical Companies. He has received collaborative research grants from Astellas, Hitachi Co, and Hitachi Medical, and research grants from Yoshitomi, Dainippon-Sumitomo, Astellas, and GSK.	Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Kawakami N, 1999, IND HEALTH, V37, P174, DOI 10.2486/indhealth.37.174; Strijk JE, 2013, SCAND J WORK ENV HEA, V39, P66, DOI 10.5271/sjweh.3311; Mackenzie CS, 2006, APPL NURS RES, V19, P105, DOI 10.1016/j.apnr.2005.08.002; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; Kaltenthaler E, 2008, PSYCHOL MED, V38, P1521, DOI 10.1017/S0033291707002607; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P156, DOI 10.1097/01.jom.0000052967.43131.51; Kessler RC, 2006, AM J PSYCHIAT, V163, P1561, DOI 10.1176/appi.ajp.163.9.1561; Aikens KA, 2014, J OCCUP ENVIRON MED, V56, P721, DOI 10.1097/JOM.0000000000000209; Richardson KM, 2008, J OCCUP HEALTH PSYCH, V13, P69, DOI 10.1037/1076-8998.13.1.69; Schaufeli WB, 2009, CROSS-CULT RES, V43, P320, DOI 10.1177/1069397109337239; van der Klink JJL, 2001, AM J PUBLIC HEALTH, V91, P270, DOI 10.2105/AJPH.91.2.270; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Hiroe T, 2005, PSYCHIAT RES, V135, P229, DOI 10.1016/j.psychres.2004.03.014; Atlantis E, 2004, PREV MED, V39, P424, DOI 10.1016/j.ypmed.2004.02.007; Beck A. T., 1967, DEPRESSION CLIN EXPT; Beck A. T., 1979, COGNITIVE THERAPY DE; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Bee PE, 2010, GEN HOSP PSYCHIAT, V32, P337, DOI 10.1016/j.genhosppsych.2010.01.006; Bond F W, 2000, J Occup Health Psychol, V5, P156, DOI 10.1037//1076-8998.5.1.156; Coffeng JK, 2014, J OCCUP ENVIRON MED, V56, P258, DOI 10.1097/JOM.0000000000000116; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Furukawa TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035330; Gega L, 2004, J CLIN PSYCHOL, V60, P147, DOI 10.1002/jclp.10241; Hengel KMO, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1008; HIGGINS NC, 1986, J VOCAT BEHAV, V29, P66, DOI 10.1016/0001-8791(86)90030-8; Imamura K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097167; Koyuncu M., 2006, EQUAL OPPORTUNITIES, V25, P299, DOI DOI 10.1108/02610150610706276; Peters L, 1998, PSYCHOL MED, V28, P893, DOI 10.1017/S0033291798006655; Schaufeli W., 2003, UWES UTRECHT WORK EN; Schaufeli WB, 2004, APPL PSYCHOL-INT REV, V53, P502, DOI 10.1111/j.1464-0597.2004.00184.x; Schaufeli WB, 2002, J HAPPINESS STUD, V3, P71, DOI DOI 10.1023/A:1015630930326; Shimazu A, 2008, APPL PSYCHOL-INT REV, V57, P510, DOI 10.1111/j.1464-0597.2008.00333.x; Titov N, 2010, F1000 MED REPORTS, V2, P49, DOI DOI 10.3410/M2; Umanodan R, 2009, J OCCUP HEALTH, V51, P294; van Ballegooijen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100674; van Berkel J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084118; Vuori J, 2012, J APPL PSYCHOL, V97, P273, DOI 10.1037/a0025584; Wantland Dean J, 2004, J Med Internet Res, V6, pe40, DOI 10.2196/jmir.6.4.e40	42	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-2752	1536-5948		J OCCUP ENVIRON MED	J. Occup. Environ. Med.	MAY	2015	57	5					578	584		10.1097/JOM.0000000000000411		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CH7NY	WOS:000354225000015		
J	Satoh, M; Aso, K; Ogikubo, S; Yoshizawa-Ogasawara, A; Saji, T				Satoh, Mari; Aso, Keiko; Ogikubo, Sayaka; Yoshizawa-Ogasawara, Atsuko; Saji, Tsutomu			Hypothyroidism caused by the combination of two heterozygous mutations: one in the TSH receptor gene the other in the DUOX2 gene	JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM			English	Article						dual oxidase 2 (DUOX2); hypotyroidism; oligogenicity; TSH receptor	CONGENITAL HYPOTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; COMPENSATED HYPOTHYROIDISM; INACTIVATING MUTATIONS; THYROTROPIN; RESISTANCE; CHILDREN; IDENTIFICATION; CARRIERS; JAPANESE	Subjects who are heterozygous for thyroid stimulating hormone receptor (TSHR) gene mutations present various phenotypes that range from euthyroid to hyperthyrotropinemia. Similarly, heterozygous dual oxidase 2 (DUOX2) gene mutations result in variable phenotypes, such as transient congenital hypothyroidism, subclinical hyperthyrotropinemia, and euthyroid in children. Here, we describe an 8-year-old boy who had normal newborn screening results, but who developed nonautoimmune hypothyroidism at the age of 1 year and 8 months of age. He was heterozygous for previously reported R450H-TSHR mutation and heterozygous for a novel double mutant allele A1323T-DUOX2 and L1343F-DUOX2. He needed levothyroxine (l-T4) replacement therapy to keep serum TSH levels within normal limits; l-T4 dose of 2.01-2.65 mu g/kg/day corresponded to the dose taken by children homozygous for R450H-TSHR and by children with permanent congenital hypothyroidism. Therefore, the coexistence of a heterozygous TSHR mutation and a heterozygous DUOX2 mutation may have affected the severity of his hypothyroid condition.	[Satoh, Mari] Toho Univ, Omori Med Ctr, Dept Pediat, Ota Ku, Tokyo 1438541, Japan; [Aso, Keiko; Saji, Tsutomu] Toho Univ, Omori Med Ctr, Dept Pediat, Tokyo 1438541, Japan; [Ogikubo, Sayaka] Okinaka Mem Inst Med Res, Tokyo, Japan; [Yoshizawa-Ogasawara, Atsuko] Ibaraki Childrens Hosp, Dept Pediat, Mito, Ibaraki, Japan	Satoh, M (reprint author), Toho Univ, Omori Med Ctr, Dept Pediat, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	satomari@med.toho-u.ac.jp					Alberti L, 2002, J CLIN ENDOCR METAB, V87, P2549, DOI 10.1210/jc.87.6.2549; Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107; Rigutto S, 2009, J BIOL CHEM, V284, P6725, DOI 10.1074/jbc.M806893200; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Avbelj M, 2007, EUR J ENDOCRINOL, V156, P511, DOI 10.1530/EJE-07-0037; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Rabbiosi S, 2013, J CLIN ENDOCR METAB, V98, P1395, DOI 10.1210/jc.2012-3174; Calebiro D, 2012, J CLIN ENDOCR METAB, V97, pE156, DOI 10.1210/jc.2011-1938; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Camilot M, 2005, CLIN ENDOCRINOL, V63, P146, DOI 10.1111/j.1365-2265.2005.02314.x; De Marco G, 2011, J CLIN ENDOCR METAB, V96, pE1335, DOI 10.1210/jc.2010-2467; deRoux N, 1996, MOL CELL ENDOCRINOL, V117, P253, DOI 10.1016/0303-7207(95)03753-5; Kanda K, 2006, ENDOCRINE, V30, P383, DOI 10.1007/s12020-006-0018-z; Kotani T, 2001, MOL CELL ENDOCRINOL, V182, P61, DOI 10.1016/S0303-7207(01)00547-0; Nagashima T, 2001, THYROID, V11, P551, DOI 10.1089/105072501750302859; Narumi S, 2009, J CLIN ENDOCR METAB, V94, P1317, DOI 10.1210/jc.2008-1767; Narumi S, 2011, J CLIN ENDOCR METAB, V96, pE1340, DOI 10.1210/jc.2011-0070; Niu DM, 2005, ARCH DIS CHILD, V90, pF69, DOI 10.1136/adc.2003.039065; Ohye H, 2008, THYROID, V18, P561, DOI 10.1089/thy.2007.0258; Park SM, 2004, CLIN ENDOCRINOL, V60, P220, DOI 10.1046/j.1365-2265.2003.01967.x; Sriphrapradang C, 2011, J CLIN ENDOCR METAB, V96, pE1001, DOI 10.1210/jc.2011-0127; Tonacchera M, 2007, CLIN ENDOCRINOL, V67, P712, DOI 10.1111/j.1365-2265.2007.02950.x; Tonacchera M, 2009, J CLIN ENDOCR METAB, V94, P4309, DOI 10.1210/jc.2009-0426; Yoshizawa-Ogasawara A, 2013, J PEDIATR ENDOCR MET, V26, P45, DOI 10.1515/jpem-2012-0082	24	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-018X	2191-0251		J PEDIATR ENDOCR MET	J. Pediatr. Endocrinol. Metab.	MAY	2015	28	5-6					657	661		10.1515/jpem-2014-0078		5	Endocrinology & Metabolism; Pediatrics	Endocrinology & Metabolism; Pediatrics	CH1PE	WOS:000353793000025		
J	Yamamichi, T; Oue, T; Yonekura, T; Owari, M; Nakahata, K; Umeda, S; Nara, K; Ueno, T; Uehara, S; Usui, N				Yamamichi, Taku; Oue, Takaharu; Yonekura, Takeo; Owari, Mitsugu; Nakahata, Kengo; Umeda, Satoshi; Nara, Keigo; Ueno, Takehisa; Uehara, Shuichiro; Usui, Noriaki			Clinical application of indocyanine green (ICG) fluorescent imaging of hepatoblastoma	JOURNAL OF PEDIATRIC SURGERY			English	Article						Indocyanine green; Fluorescence; Hepatoblastoma; Metastasis; Navigation surgery	LIVER	Background/purpose: Although the usefulness of intraoperative indocyanine green (ICG) fluorescent imaging for the resection of hepatocellular carcinoma has been reported, its usefulness for the resection of hepatoblastoma remains unclear. This study clarifies the feasibility of intraoperative ICG fluorescent imaging for the resection of hepatoblastoma. Methods: In three hepatoblastoma patients, a primary tumor, recurrent tumor, and lung metastatic lesions were intraoperatively examined using a near-infrared fluorescence imaging systemafter the preoperative administration of ICG. Results: ICG fluorescent imaging was useful for the surgical navigation in hepatoblastoma patients. In the first case, the primary hepatoblastoma exhibited intense fluorescence during right hepatectomy, but no fluorescence was detected in the residual liver. In the second case, a recurrent tumor exhibited fluorescence between the residual liver and diaphragm. A complete resection of the residual liver, with a partial resection of the diaphragm, followed by liver transplantation was performed. In the third case withmultiple lungmetastases, eachmetastatic lesion showed positive fluorescence, and all were completely resected. These fluorescence-positive lesions were pathologically proven to be viable hepatoblastoma cells. Conclusion: Intraoperative ICG fluorescence imaging for patientswith hepatoblastoma was feasible and useful for identifying small viable lesions and confirming that no remnant tumor remained after resection. (C) 2015 Elsevier Inc. All rights reserved.	[Yamamichi, Taku; Oue, Takaharu; Owari, Mitsugu; Nakahata, Kengo; Umeda, Satoshi; Nara, Keigo; Ueno, Takehisa; Uehara, Shuichiro; Usui, Noriaki] Osaka Univ, Div Pediat Surg, Dept Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yonekura, Takeo] Kinki Univ, Fac Med, Dept Pediat Surg, Higashiosaka, Osaka 577, Japan	Oue, T (reprint author), Osaka Univ, Div Pediat Surg, Dept Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ooue@pedsurg.med.osaka-u.ac.jp					van der Vorst JR, 2013, CANCER-AM CANCER SOC, V119, P3411, DOI 10.1002/cncr.28203; Gotoh K, 2009, J SURG ONCOL, V100, P75, DOI 10.1002/jso.21272; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Ishizawa T, 2009, CANCER, V115, P2491, DOI 10.1002/cncr.24291; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575; Kitai T, 1999, PHYS MED BIOL, V44, P2049, DOI 10.1088/0031-9155/44/8/314; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Kokudo Norihiro, 2012, Liver Cancer, V1, P15, DOI 10.1159/000339017	8	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAY	2015	50	5					833	836		10.1016/j.jpedsurg.2015.01.014		4	Pediatrics; Surgery	Pediatrics; Surgery	CH1WQ	WOS:000353813300030		
J	Yoshida, K; de Jong, KJ; Kruschke, JK; Paivio, PM				Yoshida, Kenji; de Jong, Kenneth J.; Kruschke, John K.; Paivio, Pia-Maria			Cross-language similarity and difference in quantity categorization of Finnish and Japanese	JOURNAL OF PHONETICS			English	Article						Quantity categorization; Cue co-variation; Language-specific cues; Word-level prosody; Finnish; Japanese	GEMINATE STOPS; SPEAKING RATE; PERCEPTION; CONTRAST; VOWELS; ACCENT	The present study investigates how listeners of Finnish and Japanese, languages with very similar contrasts in plosive quantity (short vs. long), use language-specific phonetic knowledge of acoustic attributes which covary with closure duration. A fully-crossed perceptual experiment on consonant quantity categorization was conducted with 22 Finnish and 20 Japanese listeners, using natural speech stimuli with systematically manipulated closure durations. Stimuli were created from Finnish and Japanese productions of both long and short plosives. In the naturally produced stimuli, the duration of the vowel preceding the target consonant was affected by language-specific word prosody patterns. The results showed an across-the-board effect of the original quantity of the produced stimulus, with the stimuli created from words with a geminate consonant tending to be perceived as geminate, irrespective of the language of the listeners or talkers, suggesting a strong influence of cues besides closure duration that are shared by the two languages. However, Japanese listeners were more heavily affected by the acoustic cues concomitant to the quantity contrast in their native language, likely due to robust language-specific vowel duration effects in the Japanese productions. Word prosody, besides creating subtle shifts in category boundary for both language groups, created confusions in the listener responses, especially when the language-specific word-level prosodic effect is localized in the vowel preceding the target word, and when the listener is confronted with stimuli from the other language. Thus, some aspects of the quantity contrast are remarkably similar between the two languages, and listeners from one language group are attuned to attributes found in the other language. However, other attributes appear to be language specific, and such durational differences may interfere with categorization in an unfamiliar language. (C) 2015 Published by Elsevier Ltd.	[Yoshida, Kenji] Waseda Univ, Sch Culture Media & Soc, Shinjuku Ku, Tokyo 1628644, Japan; [de Jong, Kenneth J.] Indiana Univ, Dept Linguist, Bloomington, IN 47405 USA; [de Jong, Kenneth J.; Kruschke, John K.] Indiana Univ, Cognit Sci Program, Bloomington, IN 47406 USA; [Kruschke, John K.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Paivio, Pia-Maria] Univ Copenhagen, Dept Scandinavian Studies & Linguist, DK-2300 Copenhagen, Denmark	Yoshida, K (reprint author), 7-16-7 Asahigaoka, Tajimi City, Gifu 5070071, Japan.	kenjiyo.work@gmail.com; kdejong@indiana.edu; kruschke@indiana.edu; hng786@hum.ku.dk			Finlandia Foundation Fellowship Award	We thank Reijo Aulanko, Marjut Maenpaa and Seppo Kittila at University of Helsinki for providing support for running subjects in Finland, Donna Erickson, Takuya Oomae and Yosuke Igarashi for providing support in Japan, and Jussi Ylikoski and Keiko Kuriyama for references. We also acknowledge the audience at 2010 Meeting of LSA, members at Riken Brain and Language Lab and three anonymous reviewers for helpful comments on this research, and Isabelle Darcy's help with using DMDX was invaluable. We also thank the Finlandia Foundation Fellowship Award 2009 for financial support for experiments in Finland. Finally, we thank three anonymous reviewers, Holger Mitterer, and Taehong Cho for many helpful comments on previous versions of this work.	Akpanglo-Narty J., 1982, UCLA WORKING PAPERS, V55, P1; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Kruschke JK, 2010, TRENDS COGN SCI, V14, P293, DOI 10.1016/j.tics.2010.05.001; KINGSTON J, 1994, LANGUAGE, V70, P419, DOI 10.2307/416481; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; PORT RF, 1987, J ACOUST SOC AM, V81, P1574, DOI 10.1121/1.394510; Cho TH, 2001, J PHONETICS, V29, P155, DOI 10.1006/jpho.2001.0131; Hirata Y, 2005, J ACOUST SOC AM, V118, P1647, DOI 10.1121/1.2000807; Kruschke JK, 2011, PERSPECT PSYCHOL SCI, V6, P299, DOI 10.1177/1745691611406925; Cho T, 2009, J PHONETICS, V37, P466, DOI 10.1016/j.wocn.2009.08.001; Kingston J, 2009, J PHONETICS, V37, P297, DOI 10.1016/j.wocn.2009.03.007; Idemaru K, 2010, PHONETICA, V67, P25, DOI 10.1159/000319377; Idemaru K, 2008, J INT PHON ASSOC, V38, P167, DOI 10.1017/S0025100308003459; Kruschke JK, 2010, WIRES COGN SCI, V1, P658, DOI 10.1002/wcs.72; Pickett ER, 1999, PHONETICA, V56, P135, DOI 10.1159/000028448; Amano S, 2010, J ACOUST SOC AM, V128, P2049, DOI 10.1121/1.3458847; Escudero P, 2012, J PHONETICS, V40, P280, DOI 10.1016/j.wocn.2011.11.004; Suomi K, 2007, J PHONETICS, V35, P40, DOI 10.1016/j.wocn.2005.12.001; Krakow RA, 1999, J PHONETICS, V27, P23, DOI 10.1006/jpho.1999.0089; Aoyama Katsura, 2001, PSYCHOLINGUISTIC PER; Beckman ME, 1986, STRESS NONSTRESS ACC; Boersma P, 2009, PRAAT DOING PHONETIC; Campbell Nick, 1999, J PHONETIC SOC JAPAN, V3, P29; CARAMAZZ.A, 1973, J ACOUST SOC AM, V54, P421, DOI 10.1121/1.1913594; Disner S., 1983, UCLA WORKING PAPER P, V58, P1; Doty S. C., 2007, P 8 ANN C INT SPEECH, P2737; Ferrari Disner S., 1977, UCLA WORKING PAPERS, V40, P1; Ham William, 2001, PHONETIC PHONOLOGICA; Jarvikivi J., 2007, P 16 INT C PHON SCI, P693; Jarvikivi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012603; Jo'o H., 1977, IWANAMI KOOZA NIHONG, P107; Kato Hiroaki, 2003, P 15 INT C PHON SCI, P2043; KEATING PA, 1981, J ACOUST SOC AM, V70, P1261, DOI 10.1121/1.387139; Krakow R. A., 1995, PRODUCING SPEECH CON; Kruschke J, 2015, DOING BAYESIAN DATA; Lehtonen J., 1970, ASPECTS QUANTITY STA; Local J., 1999, P 14 INT C PHON SCI, P595; lsei-Jaakkola T., 2010, COMMUNICATION; Maddieson I., 1980, UCLA WORKING PAPERS, V51, P120; Maddieson I., 1985, UCLA WORKING PAPERS, V59, P85; Moreton E., 1999, EUR 99; Myers S., 2005, PHONOLOGY, V22, P317; Nagano-Madsen Y., 1992, MORA PROSODIC COORDI; O'Dell M., 2003, THESIS U TAMPERE TAM; Ofuka Etsuko, 2005, J PHONETIC SOC JAPAN, V9, P59; Plummer M, 2003, P 3 INT WORKSH DISTR; POLS LCW, 1969, J ACOUST SOC AM, V46, P458, DOI 10.1121/1.1911711; R Development Core Team, 2009, R LANG ENV STAT COMP; Research Institute for the Languages of Finland, 2007, DIAL DISTR MAP; Richardson U, 2003, DEV NEUROPSYCHOL, V23, P385, DOI 10.1207/S15326942DN2303_5; Strange W, 2004, J ACOUST SOC AM, V115, P1791, DOI 10.1121/1.1687832; Suomi K, 2005, J PHONETICS, V33, P291, DOI 10.1016/j.wocn.2005.01.002; Suomi K, 2003, J PHONETICS, V31, P113, DOI 10.1016/S0095-4470(02)00074-8; Terbeek D., 1971, UCLA WORKING PAPERS, V19, P26; Terbeek D., 1977, UCLA WORKING PAPERS, V37, P1; Vainio M, 2010, J ACOUST SOC AM, V128, P1313, DOI 10.1121/1.3467767; Vayra M., 1987, PHONETICA, V49, P48; Ylitalo R., 2009, THESIS U OULU OULU	58	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0095-4470			J PHONETICS	J. Phon.	MAY	2015	50						81	98		10.1016/j.wocn.2014.12.006		18	Linguistics; Language & Linguistics	Linguistics	CH2HQ	WOS:000353846700006		
J	Noma, S; Uwatoko, T; Ono, M; Miyagi, T; Murai, T				Noma, Shun'ichi; Uwatoko, Teruhisa; Ono, Miki; Miyagi, Takashi; Murai, Toshiya			Differences Between Nonsuicidal Self-Injury and Suicidal Behavior in Patients With Eating Disorders	JOURNAL OF PSYCHIATRIC PRACTICE			English	Article						eating disorders; self-harming behaviors; nonsuicidal self-injury; suicidal behavior; dissociation; sense of ineffectiveness	HIGH-SCHOOL-STUDENTS; ATTACHMENT STYLES; BULIMIA-NERVOSA; UNIVERSITY-STUDENTS; ANOREXIA-NERVOSA; IMPULSIVITY; DISSOCIATION; ASSOCIATION; ADOLESCENTS; PREVALENCE	Although it has been reported that 25% to 50% of patients with eating disorders engage in self-harming behaviors (SHBs), including non-suicidal self-injury (NSSI) and suicidal behavior (SB), no study has investigated the psychological mechanisms underlying these SHBs or any differences that may exist between NSSI and SB. This study involved 76 female patients with eating disorders who were treated at the Kyoto University Hospital between July and August, 2010, who answered questionnaires about SHBs, eating attitudes, tendency to dissociate, and attachment style. Some of the participants (22.4%) had other psychiatric disorders in addition to eating disorders, including borderline personality disorder, dissociative disorder, and posttraumatic stress disorder. Of the participants without comorbidity, 23.7% had engaged in SHBs in the past 3 months. Participants with comorbidity tended to dissociate significantly more than participants without comorbidity. Logistic regression indicated that, in all participants, NSSI in the past 3 months was related to the tendency to dissociate and having a higher body mass index, whereas preoccupied attachment style was potentially related to recent SB. Specifically, among the participants without comorbidity, a sense of ineffectiveness and poor interoceptive awareness were related to recent NSSI, and severity of binge-eating was related to SB. In contrast, a history of NSSI in the patients with eating disorders without comorbidity was related to a sense of ineffectiveness. The results of our study suggest that it may be important to help patients with eating disorders recover their own sense of effectiveness as a possible way to reduce SHBs.	[Noma, Shun'ichi; Ono, Miki; Murai, Toshiya] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto 6068507, Japan; [Uwatoko, Teruhisa] Kyoto Univ Hlth Serv, Kyoto, Japan; [Miyagi, Takashi] Toyooka Hosp, Dept Psychiat, Kobe, Hyogo, Japan	Noma, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Psychiat, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	noma@kuhp.kyoto-u.ac.jp					American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anestis MD, 2011, INT J EAT DISORDER, V45, P808; Nagata T, 2000, PSYCHIAT RES, V94, P239, DOI 10.1016/S0165-1781(00)00157-8; HENDERSON M, 1987, BRIT J PSYCHIAT, V150, P18, DOI 10.1192/bjp.150.1.18; Joubert D, 2012, CHILD PSYCHIAT HUM D, V43, P471, DOI 10.1007/s10578-011-0276-8; Selby EA, 2012, PERSONAL DISORD, V3, P167, DOI 10.1037/a0024405; FAHY T, 1993, BRIT J PSYCHIAT, V162, P193, DOI 10.1192/bjp.162.2.193; Vansteelandt K, 2013, EUR EAT DISORD REV, V21, P143, DOI 10.1002/erv.2220; Levesque C, 2010, J YOUTH ADOLESCENCE, V39, P474, DOI 10.1007/s10964-009-9471-3; Ross S, 2009, AM J ORTHOPSYCHIAT, V79, P83, DOI 10.1037/a0014826; Gollust SE, 2008, J AM COLL HEALTH, V56, P491, DOI 10.3200/JACH.56.5.491-498; Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002; Stein D, 2004, COMPR PSYCHIAT, V45, P447, DOI 10.1016/j.comppsych.2004.07.011; Ebrinc S, 2008, ISR J PSYCHIATR REL, V45, P39; Vansteenkiste M, 2013, EUR EAT DISORD REV, V21, P209, DOI 10.1002/erv.2215; Smith NB, 2014, TRAUMA VIOLENCE ABUS, V15, P41, DOI 10.1177/1524838013496332; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037//0022-3514.61.2.226; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Waller NG, 1996, PSYCHOL METHODS, V1, P300, DOI 10.1037/1082-989X.1.3.300; Stepp SD, 2008, SUICIDE LIFE-THREAT, V38, P592, DOI 10.1521/suli.2008.38.5.592; RUSSELL G, 1979, PSYCHOL MED, V9, P429; Chen EY, 2009, PSYCHIAT RES, V170, P86, DOI 10.1016/j.psychres.2009.03.006; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Claes L, 2012, EUR EAT DISORD REV, V20, P196, DOI 10.1002/erv.1158; Hamza CA, 2013, PSYCHIAT RES, V205, P172, DOI 10.1016/j.psychres.2012.08.036; Hertz P, 2012, HEALTH SOC WORK, V37, P110, DOI 10.1093/hsw/hls019; Kato K, 1998, J COGN P EXPER, V7, P41; LACEY JH, 1993, BRIT J PSYCHIAT, V163, P190, DOI 10.1192/bjp.163.2.190; Matsumoto T, 2008, PSYCHIAT CLIN NEUROS, V62, P123, DOI 10.1111/j.1440-1819.2007.01783.x; MITCHELL JE, 1986, COMPR PSYCHIAT, V27, P165, DOI 10.1016/0010-440X(86)90025-8; Muehlenkamp JJ, 2010, PSYCHIAT RES, V188, P102; Muehlenkamp JJ, 2012, SUICIDE LIFE-THREAT, V42, P416, DOI 10.1111/j.1943-278X.2012.00100.x; NEWTON JR, 1993, ACTA PSYCHIAT SCAND, V87, P389, DOI 10.1111/j.1600-0447.1993.tb03393.x; Nilsson D, 2011, ATTACH HUM DEV, V13, P579, DOI 10.1080/14616734.2011.609004; Palitsky D, 2013, J NERV MENT DIS, V201, P579, DOI 10.1097/NMD.0b013e31829829ab; Peebles R, 2011, J ADOLESCENT HEALTH, V48, P310, DOI 10.1016/j.jadohealth.2010.06.017; Putnam F., 1997, DISSOCIATION CHILDRE; Sansone Randy A, 2002, Eat Disord, V10, P205, DOI 10.1080/10640260290081786; Saxf GN, 2002, SUICIDE LIFE-THREAT, V32, P313; Simeon D, 2001, CLIN PRAC, P1; Walsh B. W., 1988, SELF MUTILATION THEO; Wildman P, 2004, INT J EAT DISORDER, V35, P190, DOI 10.1002/eat.10213; Wilkinson P, 2013, EUR CHILD ADOLES PSY, V22, pS75, DOI 10.1007/s00787-012-0365-7; Wonderlich Stephen, 2002, Eat Disord, V10, P257, DOI 10.1080/10640260290081849	45	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1527-4160	1538-1145		J PSYCHIATR PRACT	J. Psychiatr. Pract.	MAY	2015	21	3					198	207		10.1097/PRA.0000000000000067		10	Psychiatry	Psychiatry	CH8PA	WOS:000354297100004		
J	Hatada, S				Hatada, S.			Impaired musical ability in people with schizophrenia (vol 39, pg 118, 2014)	JOURNAL OF PSYCHIATRY & NEUROSCIENCE			English	Correction									Tosa Rehabil Coll, Dept Occupat Therapy, Kochi, Japan	Hatada, S (reprint author), Tosa Rehabil Coll, Dept Occupat Therapy, Kochi, Japan.						Hatada S, 2014, J PSYCHIATR NEUROSCI, V39, P118, DOI 10.1503/jpn.120207	1	0	0	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	1180-4882	1488-2434		J PSYCHIATR NEUROSCI	J. Psychiatry Neurosci.	MAY	2015	40	3					161	161				1	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CH3BN	WOS:000353901000004		
J	Takahashi, N; Kojima, T; Kaneko, A; Kida, D; Hirano, Y; Fujibayashi, T; Yabe, Y; Takagi, H; Oguchi, T; Miyake, H; Kato, T; Watanabe, T; Hayashi, M; Kanayama, Y; Funahashi, K; Asai, S; Yoshioka, Y; Takemoto, T; Terabe, K; Asai, N; Ishiguro, N				Takahashi, Nobunori; Kojima, Toshihisa; Kaneko, Atsushi; Kida, Daihei; Hirano, Yuji; Fujibayashi, Takayoshi; Yabe, Yuichiro; Takagi, Hideki; Oguchi, Takeshi; Miyake, Hiroyuki; Kato, Takefumi; Watanabe, Tsuyoshi; Hayashi, Masatoshi; Kanayama, Yasuhide; Funahashi, Koji; Asai, Shuji; Yoshioka, Yutaka; Takemoto, Toki; Terabe, Kenya; Asai, Nobuyuki; Ishiguro, Naoki			Longterm Efficacy and Safety of Abatacept in Patients with Rheumatoid Arthritis Treated in Routine Clinical Practice: Effect of Concomitant Methotrexate after 24 Weeks	JOURNAL OF RHEUMATOLOGY			English	Article						RHEUMATOID ARTHRITIS; LONGTERM EFFECT; ABATACEPT; METHOTREXATE; MULTICENTER STUDIES	INADEQUATE RESPONSE; DOUBLE-BLIND; DISEASE-ACTIVITY; SEDIMENTATION-RATE; PLUS METHOTREXATE; MULTICENTER; TOCILIZUMAB; TRIAL; REGISTRY; THERAPY	Objective. Our study aimed to evaluate the longterm efficacy and safety of abatacept (ABA), and to explore factors that increase its longterm efficacy in patients with rheumatoid arthritis (RA) treated in routine clinical practice. Methods. There were 231 participants with RA treated with ABA who were prospectively registered in a Japanese multicenter registry. They were followed up for at least 52 weeks. Results. Mean age of the patients was 64.3 years, mean disease duration was 12.1 years, mean 28-joint Disease Activity Score (DAS28)-C-reactive protein was 4.49, and 48.5% of patients were concomitantly treated with methotrexate (MTX). Overall retention rate of ABA was 77.1% at 52 weeks; 14.8% of patients discontinued because of inadequate response and 3.5% because of adverse events. The proportion of patients achieving DAS28-defined low disease activity (LDA) significantly increased from baseline to 52 weeks (7.3% to 43.8%, p < 0.01); 40.9% of patients who did not achieve LDA at 24 weeks had more than 1 categorical improvement in DAS28-defined disease activity at 52 weeks. Multivariate logistic regression revealed concomitant MTX use to be an independent predictor of the categorical improvement in DAS28-defined disease activity from 24 to 52 weeks (adjusted OR 3.124, p = 0.010). Conclusion. In routine clinical practice, ABA demonstrated satisfactory clinical efficacy and safety in patients with established RA for 52 weeks. The clinical efficacy of ABA increased with time even after 24 weeks, and this was strongly influenced by concomitant MTX use. Our study provides valuable real-world findings on the longterm management of RA with ABA.	[Takahashi, Nobunori; Kojima, Toshihisa; Funahashi, Koji; Asai, Shuji; Yoshioka, Yutaka; Takemoto, Toki; Terabe, Kenya; Asai, Nobuyuki; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg & Rheumatol, Nagoya, Aichi 4668550, Japan; [Kaneko, Atsushi; Kida, Daihei] Nagoya Med Ctr, Dept Orthoped Surg & Rheumatol, Nagoya, Aichi, Japan; [Takagi, Hideki] Nagoya Cent Hosp, Dept Orthoped Surg, Nagoya, Aichi, Japan; [Hirano, Yuji] Toyohashi Municipal Hosp, Dept Rheumatol, Toyohashi, Aichi, Japan; [Fujibayashi, Takayoshi] Konan Kosei Hosp, Dept Orthoped Surg, Konan, Japan; [Yabe, Yuichiro] Tokyo Koseinenkin Hosp, Dept Rheumatol, Tokyo, Japan; [Oguchi, Takeshi] Anjo Kosei Hosp, Dept Orthoped Surg, Anjo, Japan; [Miyake, Hiroyuki] Ichinomiya Municipal Hosp, Dept Orthoped Surg, Ichinomiya, Japan; [Kato, Takefumi] Kato Orthoped Clin, Okazaki, Aichi, Japan; [Watanabe, Tsuyoshi] Kariya Toyota Gen Hosp, Dept Orthoped Surg, Kariya, Aichi, Japan; [Hayashi, Masatoshi] Nagano Red Cross Hosp, Dept Rheumatol, Nagano, Japan; [Kanayama, Yasuhide] Toyota Kosei Hosp, Dept Orthoped Surg, Toyota, Japan	Takahashi, N (reprint author), Nagoya Univ, Grad Sch Med, Dept Orthoped Surg & Rheumatol, Nagoya Univ Hosp,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nobunori@med.nagoya-u.ac.jp					Kremer JM, 2006, ANN INTERN MED, V144, P865; Genovese MC, 2008, ANN RHEUM DIS, V67, P547, DOI 10.1136/ard.2007.074773; Gottenberg JE, 2012, ANN RHEUM DIS, V71, P1815, DOI 10.1136/annrheumdis-2011-201109; Leffers HC, 2011, ANN RHEUM DIS, V70, P1216, DOI 10.1136/ard.2010.140129; Kremer JM, 2011, ANN RHEUM DIS, V70, P1826, DOI 10.1136/ard.2010.139345; Breedveld FC, 2006, ARTHRITIS RHEUM, V54, P26, DOI 10.1002/art.21519; Schiff M, 2009, ANN RHEUM DIS, V68, P1708, DOI 10.1136/ard.2008.099218; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kojima T, 2012, MOD RHEUMATOL, V22, P339, DOI 10.1007/s10165-011-0518-4; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Dougados M, 2014, ANN RHEUM DIS, V73, P803, DOI 10.1136/annrheumdis-2013-204761; Takahashi N, 2013, MOD RHEUMATOL, V23, P904, DOI 10.1007/s10165-012-0760-4; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; Emery P, 2015, ANN RHEUM DIS, V74, P19, DOI 10.1136/annrheumdis-2014-206106; GOLDEN MR, 1995, J RHEUMATOL, V22, P1043; Hirabara S, 2014, CLIN RHEUMATOL, V33, P1247, DOI 10.1007/s10067-014-2711-2; Takahashi N, 2014, RHEUMATOLOGY; Takahashi N, 2014, CLIN RHEUMATOL, V33, P39, DOI 10.1007/s10067-013-2392-2; Wells AF, 2011, J RHEUMATOL, V38, P2362, DOI 10.3899/jrheum.110054; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121	24	1	1	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	MAY	2015	42	5					786	793		10.3899/jrheum.141288		8	Rheumatology	Rheumatology	CH1KD	WOS:000353779400009		
J	Ogata, A; Amano, K; Dobashi, H; Inoo, M; Ishii, T; Kasama, T; Kawai, S; Kawakami, A; Koike, T; Miyahara, H; Miyamoto, T; Munakata, Y; Murasawa, A; Nishimoto, N; Ogawa, N; Ojima, T; Sano, H; Shi, K; Shono, E; Suematsu, E; Takahashi, H; Tanaka, Y; Tsukamoto, H; Nomura, A				Ogata, Atsushi; Amano, Koichi; Dobashi, Hiroaki; Inoo, Masayuki; Ishii, Tomonori; Kasama, Tsuyoshi; Kawai, Shinichi; Kawakami, Atsushi; Koike, Tatsuya; Miyahara, Hisaaki; Miyamoto, Toshiaki; Munakata, Yasuhiko; Murasawa, Akira; Nishimoto, Norihiro; Ogawa, Noriyoshi; Ojima, Tomohiro; Sano, Hajime; Shi, Kenrin; Shono, Eisuke; Suematsu, Eiichi; Takahashi, Hiroki; Tanaka, Yoshiya; Tsukamoto, Hiroshi; Nomura, Akira		MUSASHI Study Investigators	Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study	JOURNAL OF RHEUMATOLOGY			English	Article						RHEUMATOID ARTHRITIS; HUMANIZED MONOCLONAL ANTIBODIES; SUBCUTANEOUS INJECTIONS; ADVERSE EVENTS	MODIFYING ANTIRHEUMATIC DRUGS; INTERLEUKIN-6 RECEPTOR INHIBITION; RHEUMATOID-ARTHRITIS PATIENTS; ANTITUMOR NECROSIS FACTOR; INADEQUATE RESPONSE; IL-6 RECEPTOR; PATIENT PREFERENCES; DISEASE-ACTIVITY; CONTROLLED-TRIAL; THERAPY	Objective. To evaluate the longterm safety and efficacy of subcutaneous tocilizumab (TCZ-SC) as monotherapy in patients with rheumatoid arthritis (RA). Methods. Of 346 patients who received 24 weeks of double-blind treatment with either TCZ-SC monotherapy, 162 mg every 2 weeks (q2w); or intravenous TCZ (TCZ-IV) monotherapy, 8 mg/kg every 4 weeks; 319 patients continued to receive TCZ-SC q2w in the 84-week open-label extension (OLE) of the MUSASHI study (JAPICCTI-101117). Efficacy, safety, and immunogenicity were evaluated for all patients treated with TCZ during 108 weeks. Results. The proportions of patients who achieved American College of Rheumatology 20/50/70 responses, low disease activity [28-joint Disease Activity Score (DAS28) <= 3.2], or remission (DAS28 < 2.6) at Week 24 were maintained until Week 108. The incidences of adverse events and serious adverse events were 498.3 and 16.9 per 100 patient-years (PY), respectively. The overall safety of TCZ-SC monotherapy was similar to that of TCZ-IV monotherapy. Rates of injection site reactions (ISR) through 108 weeks remained similar to rates through 24 weeks. ISR were mild and did not cause any patient withdrawals. No serious hypersensitivity events (including anaphylactic reactions) occurred. Anti-TCZ antibodies were present in 2.1% of patients treated with TCZ-SC monotherapy. Conclusion. TCZ-SC monotherapy maintained a favorable safety profile and consistent efficacy throughout the 108-week study. Like TCZ-IV, TCZ-SC could provide an additional treatment option for patients with RA.	[Ogata, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Immunopathol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; Saitama Med Univ, Saitama Med Ctr, Dept Rheumatol & Clin Immunol, Saitama, Japan; Kagawa Univ, Dept Internal Med, Div Endocrinol & Metab Hematol Rheumatol & Resp M, Fac Med, Takamatsu, Kagawa 760, Japan; Utazu Hama Clin, Dept Rheumatol, Utazu, Kagawa, Japan; Tohoku Univ Hosp, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan; Showa Univ, Sch Med, Dept Med, Div Rheumatol, Tokyo 142, Japan; Toho Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, Nagasaki 852, Japan; Osaka City Univ, Grad Sch Med, Dept Rheumatosurg, Osaka 558, Japan; Kyushu Med Ctr, Natl Hosp Org, Dept Internal Med & Rheumatol, Fukuoka, Japan; Seirei Hamamatsu Gen Hosp, Dept Rheumatol, Shizuoka, Japan; [Munakata, Yasuhiko] Munakata Yasuhiko Clin, Sendai, Miyagi, Japan; Niigata Rheumat Ctr, Dept Rheumatol, Niigata, Japan; [Nishimoto, Norihiro] Osaka Rheumatol Clin, Osaka, Japan; Hamamatsu Univ Sch Med, Dept Internal Med 3, Shizuoka, Japan; Fukui Gen Hosp, Dept Orthoped Surg, Fukui, Japan; Hyogo Coll Med, Div Rheumatol, Dept Internal Med, Nishinomiya, Hyogo, Japan; Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Suita, Osaka 5650871, Japan; [Shono, Eisuke] Shono Rheumatol Clin, Fukuoka, Japan; Sapporo Med Univ, Sch Med, Dept Internal Med 1, Sapporo, Hokkaido, Japan; Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Fukuoka, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Nomura, Akira] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Ogata, Atsushi; Shi, Kenrin] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Ogata, Atsushi] Osaka Univ, Suita, Osaka 5650871, Japan; [Amano, Koichi] Saitama Med Univ, Saitama Med Ctr, Saitama, Japan; [Dobashi, Hiroaki] Kagawa Univ, Takamatsu, Kagawa 760, Japan; [Inoo, Masayuki] Utazu Hama Clin, Utazu, Kagawa, Japan; [Ishii, Tomonori] Tohoku Univ Hosp, Sendai, Miyagi, Japan; [Kasama, Tsuyoshi] Showa Univ, Sch Med, Tokyo 142, Japan; [Kawai, Shinichi] Toho Univ, Sch Med, Tokyo, Japan; [Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Koike, Tatsuya] Osaka City Univ, Sch Med, Osaka 545, Japan; [Miyahara, Hisaaki; Suematsu, Eiichi] Kyushu Med Ctr, Natl Hosp Org, Fukuoka, Japan; [Miyamoto, Toshiaki] Seirei Hamamatsu Gen Hosp, Shizuoka, Japan; [Murasawa, Akira] Niigata Rheumat Ctr, Niigata, Japan; [Ogawa, Noriyoshi] Hamamatsu Univ Sch Med, Shizuoka, Japan; [Ojima, Tomohiro] Fukui Gen Hosp, Fukui, Japan; [Sano, Hajime] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan; [Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Fukuoka, Japan; [Tsukamoto, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan	Ogata, A (reprint author), Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ogata@imed3.med.osaka-u.ac.jp			Chugai Pharmaceutical Co. Ltd.; Genentech Inc.; Chugai Pharmaceutical	Funded by Chugai Pharmaceutical Co. Ltd. Support for third-party writing assistance for this manuscript, provided by Denise Kenski, PhD, of Health Interactions, was supported by Genentech Inc. A. Ogata has received consulting fees, speaking fees, and/or honoraria from Chugai Pharmaceutical. N. Nishimoto has received consulting fees, speaking fees, and patent or license-related income from Chugai Pharmaceutical. Y. Tanaka has received speaking fees from Chugai Pharmaceutical. A. Nomura is employed by Chugai Pharmaceutical.	Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Gremese E, 2013, ARTHRIT CARE RES, V65, P94, DOI 10.1002/acr.21768; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; Nishimoto N, 2009, ANN RHEUM DIS, V68, P1580, DOI 10.1136/ard.2008.092866; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Heimans L, 2013, ARTHRIT CARE RES, V65, P1235, DOI 10.1002/acr.21978; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Barton JL, 2009, PATIENT PREFER ADHER, V3, P335; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Stubenrauch K, 2010, CLIN THER, V32, P1597, DOI 10.1016/j.clinthera.2010.07.021; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Klaasen R, 2011, ARTHRITIS RHEUM-US, V63, P359, DOI 10.1002/art.30136; Genovese MC, 2008, ARTHRITIS RHEUM, V58, P2968, DOI 10.1002/art.23940; Ogata A, 2014, ARTHRIT CARE RES, V66, P344, DOI 10.1002/acr.22110; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Scott DL, 2012, CLIN PHARMACOL THER, V91, P30, DOI 10.1038/clpt.2011.278; Chilton Frances, 2008, Musculoskeletal Care, V6, P1, DOI 10.1002/msc.110; Genovese MC, 2013, J RHEUMATOL, V40, P768, DOI 10.3899/jrheum.120687; Kivitz A, 2014, ARTHRIT CARE RES, V66, P1653, DOI 10.1002/acr.22384; Ogata Atsushi, 2012, Clin Med Insights Arthritis Musculoskelet Disord, V5, P27, DOI 10.4137/CMAMD.S7371; Ohta S, 2014, J CLIN PHARMACOL, V54, P109, DOI 10.1002/jcph.185; Williams EL, 2006, RHEUMATOLOGY, V45, P1575, DOI 10.1093/rheumatology/kel369	24	1	1	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	MAY	2015	42	5					799	809		10.3899/jrheum.140665		11	Rheumatology	Rheumatology	CH1KD	WOS:000353779400011		
J	Doe, K; Nozawa, K; Hirai, T; Tsushima, H; Hayashi, E; Hiruma, K; Ando, S; Nakano, S; Kon, T; Amano, H; Yamaji, K; Tamura, N; Takasaki, Y				Doe, Kentaro; Nozawa, Kazuhisa; Hirai, Takuya; Tsushima, Hiroshi; Hayashi, Eri; Hiruma, Kaori; Ando, Seiichiro; Nakano, Soichiro; Kon, Takayuki; Amano, Hirofumi; Yamaji, Ken; Tamura, Naoto; Takasaki, Yoshinari			Second-to-fourth Digit Ratio in Systemic Lupus Erythematosus	JOURNAL OF RHEUMATOLOGY			English	Article						SYSTEMIC LUPUS ERYTHEMATOSUS; SEX HORMONE; DIGIT RATIO; 2D4D	BLOOD MONONUCLEAR-CELLS; DNA ANTIBODY; CANCER; 2ND; ESTROGEN; LENGTH; 2D4D; TESTOSTERONE; PREDICTOR; HORMONE	Objective. Systemic lupus erythematosus (SLE) occurs predominantly in women, and sex hormones play an important role in SLE. Variation in the second-to-fourth digit ratio (2D4D ratio) is attributed to sex hormone exposure. Therefore, we evaluated the relationship between sex hormones and SLE by measuring 2D4D ratios. Methods. We measured 2D4D ratios in 100 patients with SLE and 200 normal healthy controls (NHC). Results. Patients with SLE had a lower 2D4D ratio than NHC. Conclusion. Our study suggests that patients with SLE have experienced high prenatal testosterone and low prenatal estrogen. To our knowledge, this is the first study evaluating the association between 2D4D ratio and SLE.	[Doe, Kentaro; Nozawa, Kazuhisa; Hirai, Takuya; Tsushima, Hiroshi; Hayashi, Eri; Hiruma, Kaori; Ando, Seiichiro; Nakano, Soichiro; Kon, Takayuki; Amano, Hirofumi; Yamaji, Ken; Tamura, Naoto; Takasaki, Yoshinari] Juntendo Univ, Fac Med, Dept Internal Med & Rheumatol, Tokyo 1138421, Japan	Doe, K (reprint author), Juntendo Univ, Fac Med, Dept Internal Med & Rheumatol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	kdoe@juntendo.ac.jp					Trivers R, 2006, HORM BEHAV, V49, P150, DOI 10.1016/j.yhbeh.2005.05.023; Vivekananda U, 2011, J NEUROL NEUROSUR PS, V82, P635, DOI 10.1136/jnnp.2010.237412; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Kanda N, 1999, ARTHRITIS RHEUM, V42, P328, DOI 10.1002/1529-0131(199902)42:2<328::AID-ANR16>3.0.CO;2-#; Jung H, 2011, BJU INT, V107, P591, DOI 10.1111/j.1464-410X.2010.09490.x; FOLOMEEV M, 1992, LUPUS, V1, P191, DOI 10.1177/096120339200100312; Butovskaya ML, 2012, BEHAV GENET, V42, P647, DOI 10.1007/s10519-012-9533-2; Baker F, 1888, AM ANTHROPOL, V1, P51, DOI 10.1525/aa.1888.1.1.02a00040; Divakaran Anjith, 2012, Indian J Psychol Med, V34, P355, DOI 10.4103/0253-7176.108220; GREENSTEIN BD, 1993, LUPUS, V2, P221, DOI 10.1177/096120339300200403; Hopp RN, 2011, AM J HUM BIOL, V23, P423, DOI 10.1002/ajhb.21144; Hopp RN, 2013, EARLY HUM DEV, V89, P327, DOI 10.1016/j.earlhumdev.2012.11.002; Kanda N, 1997, ARTHRITIS RHEUM, V40, P1703, DOI 10.1002/art.1780400921; Manning JT, 2013, ANDROLOGY-US, V1, P94, DOI 10.1111/j.2047-2927.2012.00013.x; Muller DC, 2012, BRIT J CANCER, V107, P1631, DOI 10.1038/bjc.2012.418; ROUBINIAN J, 1979, ARTHRITIS RHEUM, V22, P1162; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wu XL, 2013, INT J MED SCI, V10, P1584, DOI 10.7150/ijms.6360	19	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	MAY	2015	42	5					826	828		10.3899/jrheum.140974		3	Rheumatology	Rheumatology	CH1KD	WOS:000353779400014		
J	Schlichting, I; White, WE; Yabashi, M				Schlichting, Ilme; White, William E.; Yabashi, Makina			An introduction to the special issue on X-ray free-electron lasers	JOURNAL OF SYNCHROTRON RADIATION			English	Editorial Material									[Schlichting, Ilme] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; [White, William E.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Yabashi, Makina] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Schlichting, I (reprint author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	jsr@mpimf-heidelberg.mpg.de; wewhite@slac.stanford.edu; yabashi@spring8.or.jp	Yabashi, Makina/A-2832-2015	Yabashi, Makina/0000-0002-2472-1684				0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	MAY	2015	22		3		SI		471	471		10.1107/S1600577515008176		1	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	CH3HL	WOS:000353920300001		
J	Yabashi, M; Tanaka, H; Ishikawa, T				Yabashi, Makina; Tanaka, Hitoshi; Ishikawa, Tetsuya			Overview of the SACLA facility	JOURNAL OF SYNCHROTRON RADIATION			English	Article						X-ray free-electron laser; beamline instrumentation; X-ray optics; ultrafast X-ray science; quantum X-ray optics	FREE-ELECTRON LASER; SINGLE; PULSES; DIFFRACTION; ABSORPTION; REGION; BEAM; SCATTERING; SPRING-8; INTENSE	In March 2012, SACLA started user operations of the first compact X-ray free-electron laser (XFEL) facility. SACLA has been routinely providing users with stable XFEL light over a wide photon energy range from 4 to 15 keV and an ultrafast pulse duration below 10 fs. The facility supports experimental activities in broad fields by offering high-quality X-ray optics and diagnostics, as well as reliable multiport charge-coupled-device detectors, with flexible experimental configurations. A two-stage X-ray focusing system was developed that enables the highest intensity of 10(20) W cm(-2). Key scientific results published in 2013 and 2014 in diverse fields are reviewed. The main experimental systems developed for these applications are summarized. A perspective on the facility upgrade is presented.	[Yabashi, Makina; Tanaka, Hitoshi; Ishikawa, Tetsuya] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Yabashi, M (reprint author), RIKEN SPring 8 Ctr, Kouto 1-1-1, Sayo, Hyogo 6795148, Japan.	yabashi@spring8.or.jp	Ishikawa, Tetsuya/I-4775-2012; Yabashi, Makina/A-2832-2015	Ishikawa, Tetsuya/0000-0002-6906-9909; Yabashi, Makina/0000-0002-2472-1684			Nakasako M, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4822123; Fukuzawa H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.173005; Harmand M, 2013, NAT PHOTONICS, V7, P215, DOI [10.1038/nphoton.2013.11, 10.1038/NPHOTON.2013.11]; Kato M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733354; Kameshima T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867668; Geloni G, 2011, J MOD OPTIC, V58, P1391, DOI 10.1080/09500340.2011.586473; Ishikawa T, 2001, P SOC PHOTO-OPT INS, V4145, P1, DOI 10.1117/12.424242; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/nmeth.2962, 10.1038/NMETH.2962]; Yabashi M, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/16/164001; Barends TRM, 2013, ACTA CRYSTALLOGR D, V69, P838, DOI 10.1107/S0907444913002448; Yamauchi K, 2002, REV SCI INSTRUM, V73, P4028, DOI 10.1063/1.1510573; Song C, 2014, J APPL CRYSTALLOGR, V47, P188, DOI 10.1107/S1600576713029944; Yabashi M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.084802; Amann J, 2012, NAT PHOTONICS, V6, P693, DOI [10.1038/nphoton.2012.180, 10.1038/NPHOTON.2012.180]; Sugahara M, 2015, NAT METHODS, V12, P61, DOI [10.1038/nmeth.3172, 10.1038/NMETH.3172]; Togashi T, 2011, OPT EXPRESS, V19, P317, DOI 10.1364/OE.19.000317; Obara Y, 2014, OPT EXPRESS, V22, P1105, DOI 10.1364/OE.22.001105; Lambert G, 2008, NAT PHYS, V4, P296, DOI 10.1038/nphys889; Takahashi Y, 2013, NANO LETT, V13, P6028, DOI 10.1021/nl403247x; Tamasaku K, 2014, NAT PHOTONICS, V8, P313, DOI [10.1038/nphoton.2014.10, 10.1038/NPHOTON.2014.10]; Katayama T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821108; Shintake T, 2008, NAT PHOTONICS, V2, P555, DOI 10.1038/nphoton.2008.134; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Tono K, 2015, J SYNCHROTRON RADIAT, V22, P532, DOI 10.1107/S1600577515004464; Shwartz S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.163901; Struder L, 2010, NUCL INSTRUM METH A, V614, P483, DOI 10.1016/j.nima.2009.12.053; Hara T, 2013, PHYS REV SPEC TOP-AC, V16, DOI 10.1103/PhysRevSTAB.16.080701; Kayser Y, 2014, OPT EXPRESS, V22, P9004, DOI 10.1364/OE.22.009004; Koyama T, 2013, OPT EXPRESS, V21, P15382, DOI 10.1364/OE.21.015382; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Tono K, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3549133; Tono K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083035; Joti Y, 2015, J SYNCHROTRON RADIAT, V22, P571, DOI 10.1107/S1600577515004506; Yamauchi K, 2015, J SYNCHROTRON RADIAT, V22, P592, DOI 10.1107/S1600577515005093; Inubushi Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.144801; Yabashi M, 2014, J SYNCHROTRON RADIAT, V21, P976, DOI 10.1107/S1600577514016415; Aquila A, 2013, PROC SPIE, V8777, DOI 10.1117/12.2017725; Feng Y., 2012, J PHYS C SER, V425, P298; Gallagher-Jones M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4798; Goto S, 2007, P SOC PHOTO-OPT INS, V6705, pH7050, DOI 10.1117/12.735356; Hara T, 2002, REV SCI INSTRUM, V73, P1125, DOI 10.1063/1.1445866; Hara T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3919; Inada T, 2014, PHYS LETT B, V732, P356, DOI [10.1016/j.physletb.2014.03.054, 10.1016/j.physletb.2014..03.054]; Juranic PN, 2014, OPT EXPRESS, V22, P30004, DOI 10.1364/OE.22.030004; Kim KH, 2015, NATURE, V518, DOI 10.1038/nature14163; Kimura T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4052; Kodama R, 2015, UNPUB; Lehmkuhler F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05234; Mimura H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4539; Mimura H, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2964928; Newton M. C., 2014, NANO LETT, V5, P2413; Ohashi H, 2013, NUCL INSTRUM METH A, V710, P139, DOI 10.1016/j.nima.2012.10.094; Osaka T, 2013, OPT EXPRESS, V21, P2823, DOI 10.1364/OE.21.002823; Sato T, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.012702; Schmuser P., 2014, FREE ELECTRON LASERS, V2nd, P165; Suzuki M, 2014, J SYNCHROTRON RADIAT, V21, P466, DOI 10.1107/S1600577514004780; Tamasaku K, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.043001; Tanaka Hitoshi, 2014, Synchrotron Radiation News, V27, DOI 10.1080/08940886.2014.970935; Tanaka H., 2015, WORLD SCI R IN PRESS; Tanaka T, 2012, PHYS REV SPEC TOP-AC, V15, DOI 10.1103/PhysRevSTAB.15.110701; Tanaka T, 2004, P FEL 2004, P435; Xu R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5061; Yoneda H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6080; Yumoto H, 2013, NAT PHOTONICS, V7, P43, DOI [10.1038/nphoton.2012.306, 10.1038/NPHOTON.2012.306]	66	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	MAY	2015	22		3		SI		477	484		10.1107/S1600577515004658		8	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	CH3HL	WOS:000353920300003		
J	Tono, K; Nango, E; Sugahara, M; Song, CY; Park, J; Tanaka, T; Tanaka, R; Joti, Y; Kameshima, T; Ono, S; Hatsui, T; Mizohata, E; Suzuki, M; Shimamura, T; Tanaka, Y; Iwata, S; Yabashi, M				Tono, Kensuke; Nango, Eriko; Sugahara, Michihiro; Song, Changyong; Park, Jaehyun; Tanaka, Tomoyuki; Tanaka, Rie; Joti, Yasumasa; Kameshima, Takashi; Ono, Shun; Hatsui, Takaki; Mizohata, Eiichi; Suzuki, Mamoru; Shimamura, Tatsuro; Tanaka, Yoshiki; Iwata, So; Yabashi, Makina			Diverse application platform for hard X-ray diffraction in SACLA (DAPHNIS): application to serial protein crystallography using an X-ray free-electron laser	JOURNAL OF SYNCHROTRON RADIATION			English	Article						serial femtosecond crystallography; XFEL	LIPIDIC CUBIC PHASE; FEMTOSECOND CRYSTALLOGRAPHY; ROOM-TEMPERATURE; PHOTOSYSTEM-II; MICROCRYSTALS	An experimental system for serial femtosecond crystallography using an X-ray free-electron laser (XFEL) has been developed. It basically consists of a sample chamber, fluid injectors and a two-dimensional detector. The chamber and the injectors are operated under helium atmosphere at 1 atm. The ambient pressure operation facilitates applications to fluid samples. Three kinds of injectors are employed to feed randomly oriented crystals in aqueous solution or highly viscous fluid. Experiments on lysozyme crystals were performed by using the 10 keV XFEL of the SPring-8 Angstrom Compact free-electron LAser (SACLA). The structure of model protein lysozyme from 1 mm crystals at a resolution of 2.4 angstrom was obtained.	[Tono, Kensuke; Joti, Yasumasa; Kameshima, Takashi] Japan Synchrotron Radiat Res Inst, Sayo 6795198, Japan; [Nango, Eriko; Sugahara, Michihiro; Song, Changyong; Park, Jaehyun; Tanaka, Tomoyuki; Tanaka, Rie; Ono, Shun; Hatsui, Takaki; Suzuki, Mamoru; Iwata, So; Yabashi, Makina] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Mizohata, Eiichi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Suzuki, Mamoru] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Shimamura, Tatsuro; Tanaka, Yoshiki; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan	Tono, K (reprint author), Japan Synchrotron Radiat Res Inst, 1-1-1 Kouto, Sayo 6795198, Japan.	tono@spring8.or.jp	Yabashi, Makina/A-2832-2015	Yabashi, Makina/0000-0002-2472-1684	X-ray Free-Electron Laser Priority Strategy Program (MEXT)	The XFEL experiments were carried out at BL3 of SACLA with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal Numbers 2012B8036, 2013A8039, 2013A8040, 2013B8045 and 2014A8032). This work was supported by the X-ray Free-Electron Laser Priority Strategy Program (MEXT). The authors thank members of the Engineering Team of RIKEN SPring-8 Center, especially Mr Shimazu, Mr Hata, Mr Suzuki and Mr Kin, for their technical support.	Kameshima T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867668; Kern J, 2012, P NATL ACAD SCI USA, V109, P9721, DOI 10.1073/pnas.1204598109; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Song C, 2014, J APPL CRYSTALLOGR, V47, P188, DOI 10.1107/S1600576713029944; Sierra RG, 2012, ACTA CRYSTALLOGR D, V68, P1584, DOI 10.1107/S0907444912038152; Sugahara M, 2015, NAT METHODS, V12, P61, DOI [10.1038/nmeth.3172, 10.1038/NMETH.3172]; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Tono K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083035; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; Barends TRM, 2014, NATURE, V505, P244, DOI 10.1038/nature12773; Demirci H, 2013, ACTA CRYSTALLOGR F, V69, P1066, DOI 10.1107/S174430911302099X; Deponte DP, 2011, ULTRAMICROSCOPY, V111, P824, DOI 10.1016/j.ultramic.2010.11.036; DUISENBERG AJM, 1992, J APPL CRYSTALLOGR, V25, P92, DOI 10.1107/S0021889891010634; Goto S, 2007, P SOC PHOTO-OPT INS, V6705, pH7050, DOI 10.1117/12.735356; Liu W, 2014, NAT PROTOC, V9, P2123, DOI 10.1038/nprot.2014.141; Kirian RA, 2011, ACTA CRYSTALLOGR A, V67, P131, DOI 10.1107/S0108767310050981; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; Yumoto H, 2013, NAT PHOTONICS, V7, P43, DOI [10.1038/nphoton.2012.306, 10.1038/NPHOTON.2012.306]	29	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	MAY	2015	22		3		SI		532	537		10.1107/S1600577515004464		6	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	CH3HL	WOS:000353920300012		
J	Joti, Y; Kameshima, T; Yamaga, M; Sugimoto, T; Okada, K; Abe, T; Furukawa, Y; Ohata, T; Tanaka, R; Hatsui, T; Yabashi, M				Joti, Yasumasa; Kameshima, Takashi; Yamaga, Mitsuhiro; Sugimoto, Takashi; Okada, Kensuke; Abe, Toshinori; Furukawa, Yukito; Ohata, Toru; Tanaka, Ryotaro; Hatsui, Takaki; Yabashi, Makina			Data acquisition system for X-ray free-electron laser experiments at SACLA	JOURNAL OF SYNCHROTRON RADIATION			English	Article						X-ray free-electron laser; shot-to-shot data acquisition; massive data analysis	CRYSTALLOGRAPHY; SOFTWARE; PULSES	A data acquisition system for X-ray free-electron laser experiments at SACLA has been developed. The system has been designed for reliable shot-to-shot data storage with a high data stream greater than 4 Gbps and massive data analysis. Configuration of the system and examples of prompt data analysis during experiments are presented. Upgrade plans for the system to extend flexibility are described.	[Joti, Yasumasa; Kameshima, Takashi; Yamaga, Mitsuhiro; Sugimoto, Takashi; Okada, Kensuke; Abe, Toshinori; Furukawa, Yukito; Ohata, Toru; Tanaka, Ryotaro] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Hatsui, Takaki; Yabashi, Makina] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Joti, Y (reprint author), Japan Synchrotron Radiat Res Inst, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan.	joti@spring8.or.jp	Yabashi, Makina/A-2832-2015	Yabashi, Makina/0000-0002-2472-1684	JSPS KAKENHI [25400438]	This research was partially supported by JSPS KAKENHI Grant Number 25400438. A part of the software development described here was performed using the XFEL experiments carried out at BL3 of SACLA with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal Numbers 2012B8053, 2013A8062, 2013B8069, 2014A8052 and 2014B8072). The authors thank all experimental users at SACLA who provided valuable input to improvements of the DAQ system, and thank in particular Professor Fumitaka Mafune and Professor Yoshinori Nishino for providing us with their data (portrayed in Figs. 2 and 3). The authors also gratefully acknowledge the help of several members of the engineering and technical staff at SACLA. The authors are developing the parallel computing framework in collaboration with researches in RIKEN AICS.	Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Kameshima T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867668; Yoon CH, 2011, OPT EXPRESS, V19, P16542, DOI 10.1364/OE.19.016542; Song C, 2014, J APPL CRYSTALLOGR, V47, P188, DOI 10.1107/S1600576713029944; Sugahara M, 2015, NAT METHODS, V12, P61, DOI [10.1038/nmeth.3172, 10.1038/NMETH.3172]; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Foucar L, 2012, COMPUT PHYS COMMUN, V183, P2207, DOI 10.1016/j.cpc.2012.04.023; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; Tono K, 2015, J SYNCHROTRON RADIAT, V22, P532, DOI 10.1107/S1600577515004464; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Tono K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083035; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Luke DR, 2005, INVERSE PROBL, V21, P37, DOI 10.1088/0266-5611/21/1/004; MacQueen J., 1967, P 5 BERK S MATH STAT, P281, DOI DOI 10.1234/12345678; McLachlan G. J., 1988, MIXTURE MODELS INFER; Yamaga M., 2011, P ICALEPCS	20	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	MAY	2015	22		3		SI		571	576		10.1107/S1600577515004506		6	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	CH3HL	WOS:000353920300017		
J	Yamauchi, K; Yabashi, M; Ohashi, H; Koyama, T; Ishikawa, T				Yamauchi, Kazuto; Yabashi, Makina; Ohashi, Haruhiko; Koyama, Takahisa; Ishikawa, Tetsuya			Nanofocusing of X-ray free-electron lasers by grazing-incidence reflective optics	JOURNAL OF SYNCHROTRON RADIATION			English	Article						nanofocusing; X-ray free-electron laser; KB mirror; phase diagnosis	WAVE-FRONT CHARACTERIZATION; 2-DIMENSIONAL GRATING INTERFEROMETER; AT-WAVELENGTH METROLOGY; SHEARING INTERFEROMETER; MIRROR; BEAM; PULSES; PHASE; SITU	Total-reflection mirror devices for X-ray free-electron laser focusing are discussed in terms of optical design, mirror-fabrication technology, a wavefront diagnosis method and radiation-damage testing, as a review of the present status of the focusing optics at the SPring-8 angstrom compact free-electron laser (SACLA). Designed beam sizes of 1 mm and 50 nm, and spot sizes almost matching prediction have been achieved and used to explore topics at the forefront of natural science. The feasibility of these devices is determined to be sufficient for long-term and stable operation at SACLA by investigating the radiation-damage threshold and achievable accuracies in the mirror figure and alignment.	[Yamauchi, Kazuto] Osaka Univ, Suita, Osaka 5650871, Japan; [Yabashi, Makina; Ishikawa, Tetsuya] RIKEN SPring 8, Sayo, Hyogo 6785198, Japan; [Ohashi, Haruhiko; Koyama, Takahisa] JASRI SPring 8, Sayo, Hyogo 6785198, Japan	Yamauchi, K (reprint author), Osaka Univ, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	yamauchi@prec.eng.osaka-u.ac.jp	Ishikawa, Tetsuya/I-4775-2012; Yabashi, Makina/A-2832-2015	Ishikawa, Tetsuya/0000-0002-6906-9909; Yabashi, Makina/0000-0002-2472-1684	CREST (JST); KAKENHI (JSPS) [23226004]; X-ray Free-Electron Laser Priority Strategy Program (MEXT)	This research was supported by CREST (JST), KAKENHI (JSPS), grant number 23226004, and the X-ray Free-Electron Laser Priority Strategy Program (MEXT). The XFEL experiments were performed at BL3 of SACLA partially with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2012B8052 and 2013A8063). The authors are grateful to all SACLA staff who participated in operation of the SACLA facility. They also thank Mr Jangwoo Kim, Miss Ayaka Nagahira, Mr Akihiko Nishihara, Mr Ryousuke Fukui, Dr Satoshi Matsuyama and Professor Yasuhisa Sano of Osaka University, Professor Hidekazu Mimura of the University of Tokyo, and Dr Hirokatsu Yumoto, Dr Kensuke Tono, Dr Yuichi Inubushi and Dr Shunji Goto of RIKEN/JASRI for their significant contributions.	Mimura H, 2010, NAT PHYS, V6, P122, DOI 10.1038/NPHYS1457; MORI Y, 1987, PRECIS ENG, V9, P123, DOI 10.1016/0141-6359(87)90029-8; Yamauchi K, 2002, REV SCI INSTRUM, V73, P4028, DOI 10.1063/1.1510573; Yumoto H, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2216870; Matsuyama S, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2349594; Matsuyama S, 2012, OPT EXPRESS, V20, P24977, DOI 10.1364/OE.20.024977; KIRKPATRICK P, 1948, J OPT SOC AM, V38, P766, DOI 10.1364/JOSA.38.000766; Mimura H, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1868472; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Yamauchi K, 2005, APPL OPTICS, V44, P6927, DOI 10.1364/AO.44.006927; Yamauchi K, 2003, REV SCI INSTRUM, V74, P2894, DOI 10.1063/1.1569405; Koyama T, 2013, OPT EXPRESS, V21, P15382, DOI 10.1364/OE.21.015382; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Weitkamp T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1857066; Ando M, 1995, NANOTECHNOLOGY, V6, P111, DOI 10.1088/0957-4484/6/4/002; Inubushi Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.144801; Wang HC, 2011, OPT EXPRESS, V19, P16550, DOI 10.1364/OE.19.016550; Aspden R., 1972, APPL OPTICS, V16, P218; Berujon S, 2012, OPT LETT, V37, P4464, DOI 10.1364/OL.37.004464; Born M., 1999, PRINCIPLES OPTICS, V7th, P421; Diaz A, 2010, J SYNCHROTRON RADIAT, V17, P299, DOI 10.1107/S0909049510004644; Fukui Ryosuke, 2013, Synchrotron Radiation News, V26, DOI 10.1080/08940886.2013.832585; Kim J., 2015, UNPUB; Koyama T, 2013, PROC SPIE, V8848, DOI 10.1117/12.2025377; Merthe DJ, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.3.033603; Merthe DJ, 2013, NUCL INSTRUM METH A, V710, P82, DOI 10.1016/j.nima.2012.10.105; Mimura H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4539; Mimura H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2436469; Mimura H, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.015812; Mori Y, 2001, P SOC PHOTO-OPT INS, V4501, P30, DOI 10.1117/12.448496; Preda I, 2013, NUCL INSTRUM METH A, V710, P98, DOI 10.1016/j.nima.2012.10.136; Rutishauser S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3665063; Rutishauser S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1950; Schindler A., 2002, OSA, P64; Takeda Y, 2007, JPN J APPL PHYS 2, V46, pL89, DOI 10.1143/JJAP.46.L89; Talbot H. F., 1836, PHILOS MAG, V9, P401, DOI DOI 10.1080/14786443; Wang HC, 2013, NUCL INSTRUM METH A, V710, P78, DOI 10.1016/j.nima.2012.10.096; Wang HC, 2013, OPT LETT, V38, P827, DOI 10.1364/OL.38.000827; Yamauchi K, 2002, J SYNCHROTRON RADIAT, V9, P313, DOI [10.1107/S0909049502012578, 10.1107/S090949502012578]; Yuan S, 2011, NUCL INSTRUM METH A, V635, pS58, DOI 10.1016/j.nima.2010.09.120; Yumoto H, 2013, NAT PHOTONICS, V7, P43, DOI [10.1038/nphoton.2012.306, 10.1038/NPHOTON.2012.306]	41	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	MAY	2015	22		3		SI		592	598		10.1107/S1600577515005093		7	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	CH3HL	WOS:000353920300020		
J	Fujiwara, H; Kiss, T; Wakabayashi, YK; Nishitani, Y; Mori, T; Nakata, Y; Kitayama, S; Fukushima, K; Ikeda, S; Fuchimoto, H; Minowa, Y; Mo, SK; Denlinger, JD; Allen, JW; Metcalf, P; Imai, M; Yoshimura, K; Suga, S; Muro, T; Sekiyama, A				Fujiwara, Hidenori; Kiss, Takayuki; Wakabayashi, Yuki K.; Nishitani, Yoshito; Mori, Takeo; Nakata, Yuki; Kitayama, Satoshi; Fukushima, Kazuaki; Ikeda, Shinji; Fuchimoto, Hiroto; Minowa, Yosuke; Mo, Sung-Kwan; Denlinger, Jonathan D.; Allen, James W.; Metcalf, Patricia; Imai, Masaki; Yoshimura, Kazuyoshi; Suga, Shigemasa; Muro, Takayuki; Sekiyama, Akira			Soft X-ray angle-resolved photoemission with micro-positioning techniques for metallic V2O3	JOURNAL OF SYNCHROTRON RADIATION			English	Article						angle-resolved photoemission spectroscopy (ARPES); soft X-ray; micro-positioning; strongly correlated oxide	TWIN-HELICAL UNDULATOR; TRANSITIONS; BEAMLINE; SPRING-8	Soft X-ray angle-resolved photoemission has been performed for metallic V2O3. By combining a microfocus beam (40 mu m x 65 mu m) and micro-positioning techniques with a long-working-distance microscope, it has been possible to observe band dispersions from tiny cleavage surfaces with a typical size of several tens of mu m. The photoemission spectra show a clear position dependence, reflecting the morphology of the cleaved sample surface. By selecting high-quality flat regions on the sample surface, it has been possible to perform band mapping using both photon-energy and polar-angle dependences, opening the door to three-dimensional angle-resolved photoemission spectroscopy for typical three-dimensional correlated materials where large cleavage planes are rarely obtained.	[Fujiwara, Hidenori; Kiss, Takayuki; Wakabayashi, Yuki K.; Mori, Takeo; Nakata, Yuki; Kitayama, Satoshi; Fukushima, Kazuaki; Ikeda, Shinji; Fuchimoto, Hiroto; Minowa, Yosuke; Sekiyama, Akira] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Nishitani, Yoshito] Konan Univ, Fac Sci & Engn, Kobe, Hyogo 6588501, Japan; [Mo, Sung-Kwan; Allen, James W.] Univ Michigan, Randall Lab Phys, Ann Arbor, MI 48109 USA; [Mo, Sung-Kwan; Denlinger, Jonathan D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Metcalf, Patricia] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Imai, Masaki; Yoshimura, Kazuyoshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo, Tokyo 6068502, Japan; [Suga, Shigemasa] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Muro, Takayuki] Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795198, Japan	Fujiwara, H (reprint author), Osaka Univ, Grad Sch Engn Sci, Machikaneyama 1-3, Toyonaka, Osaka 5608531, Japan.	fujiwara@mp.es.osaka-u.ac.jp	Mo, Sung-Kwan/F-3489-2013	Mo, Sung-Kwan/0000-0003-0711-8514	MEXT/JSPS KAKENHI [23740240]; MEXT Japan [20102003]; Toray Science Foundation	The ARPES measurements were supported by K. Yamagami, S. Naimen and T. Matsushita. This work was supported by MEXT/JSPS KAKENHI grant No. 23740240 and the Grant-in-Aid for Innovative Areas (20102003) 'Heavy Electrons' from MEXT Japan, as well as by the Toray Science Foundation. The measurements were under the approval of the Japan Synchrotron Radiation Research Institute (2011B1348, 2012 A1486 and 2013 A1089).	Park JH, 2000, PHYS REV B, V61, P11506, DOI 10.1103/PhysRevB.61.11506; Mo SK, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165101; Laad MS, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045109; Muro T, 2011, J SYNCHROTRON RADIAT, V18, P879, DOI 10.1107/S0909049511034418; Saitoh Y, 2000, REV SCI INSTRUM, V71, P3254, DOI 10.1063/1.1287626; Hansmann P, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.115136; Fujiwara H, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075117; Sekiyama A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156402; Poteryaev AI, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085127; Mo SK, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.186403; Yokoya T, 2005, NATURE, V438, P647, DOI 10.1038/nature04278; Rodolakis F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.066805; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Cancellieri C, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.121412; Berner G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.247601; Braun J, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.205409; SMITH KE, 1988, PHYS REV B, V38, P5965, DOI 10.1103/PhysRevB.38.5965; Held K, 2010, NAT COMMUN, V1, P1, DOI DOI 10.1038/NSCOMMS1109; Kamakura N, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045127; Kobayashi M, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205204; Muro T, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3124145; Saitoh Y, 1998, J SYNCHROTRON RADIAT, V5, P542, DOI 10.1107/S090904959701902X; Sekiyama A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.060506; Strocov Vladimir N., 2014, Synchrotron Radiation News, V27, DOI 10.1080/08940886.2014.889550; Tanuma A., 1987, SURF SCI, V192, pL849; Yano M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.036405	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	MAY	2015	22		3		SI		776	780		10.1107/S1600577515003707		5	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	CH3HL	WOS:000353920300043		
J	Lu, B; Li, JG; Suzuki, TS; Estili, M; Liu, WG; Sun, XD; Sakka, Y				Lu, Bin; Li, Ji-Guang; Suzuki, Tohru S.; Estili, Mehdi; Liu, Weigang; Sun, Xudong; Sakka, Yoshio			Controlled Synthesis of Layered Rare-Earth Hydroxide Nanosheets Leading to Highly Transparent (Y0.95Eu0.05)(2)O-3 Ceramics	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							SINTERED SC2O3 CERAMICS; LUMINESCENCE PROPERTIES; PHOSPHOR PARTICLES; COLLOIDAL SPHERES; CUBIC Y2O3; FABRICATION; PHOTOLUMINESCENCE; YTTRIA; LN; SCINTILLATORS	Chemical precipitation at the freezing temperature of similar to 4 degrees C has directly yielded layered rare-earth hydroxide [LRH, Ln(2)(OH)(5)-NO3 center dot nH(2)O, Ln = Y0.95Eu0.05] nanosheets (up to 7 nm thick) for the Y/Eu binary system, with the interlayer NO3- exchangeable with SO42-. Calcining the sulfate derivative at 1100 degrees C for 4 h produces well-dispersed and readily sinterable Ln(2)O(3) red phosphor powders (similar to 14.8 m(2)/g) that can be densified into highly transparent ceramics via optimized vacuum sintering at the relatively low temperature of 1700 degrees C for 4 h (average grain size similar to 14 mu m; in-line transmittance similar to 80% at the 613 nm Eu3+ emission or similar to 99% of the theoretical transmittance of Y2O3 single crystal). Our systematic studies also found that (1) the extent of SO42 - exchange and the interlayer distance of LRH are both affected by the SO42-/Ln(3)(+) molar ratio (R), and an almost complete exchange is achievable at R = 0.25 as expected from the chemical formula (one SO42- replaces two NO3- for charge balance). The optimal R value for sintering, however, was found to be 0.03; (2) The Ln(3+) concentration for LRH synthesis substantially affects properties of the resultant oxides, and hard agglomeration has been significantly reduced at the optimized Ln(3+) concentration of 0.05-0.075 mol/L; (3) Sulfate exchange significantly alters the thermal decomposition pathway of LRH, and was found essential to produce well-dispersed and highly sinterable oxide powders; (4) Both the oxide powders and transparent ceramics exhibit the typical red emission of Eu3+ at similar to 613 nm (the D-5(0) -> F-7(2) transition) under charge-transfer (CT) excitation. Red-shifted CT band center, stronger excitation/emission, and shorter fluorescence lifetime were, however, observed for the transparent ceramics.	[Lu, Bin; Li, Ji-Guang; Suzuki, Tohru S.; Sakka, Yoshio] Natl Inst Mat Sci, Mat Proc Unit, Tsukuba, Ibaraki 3050047, Japan; [Lu, Bin; Sakka, Yoshio] Univ Tsukuba, Grad Sch Pure & Appl Sci, Dept Mat Sci & Engn, Tsukuba, Ibaraki 3058571, Japan; [Li, Ji-Guang; Liu, Weigang; Sun, Xudong] Northeastern Univ, Key Lab Anisotropy & Texture Mat, Shenyang 110819, Liaoning, Peoples R China; [Li, Ji-Guang; Liu, Weigang; Sun, Xudong] Northeastern Univ, Sch Met & Mat, Shenyang 110819, Liaoning, Peoples R China; [Estili, Mehdi] Natl Inst Mat Sci, Int Ctr Young Scientists, Tsukuba, Ibaraki 3050047, Japan	Li, JG (reprint author), Natl Inst Mat Sci, Mat Proc Unit, Tsukuba, Ibaraki 3050047, Japan.	LI.Jiguang@nims.go.jp; SAKKA.Yoshio@nims.go.jp			China Scholar Council (CSC); National Natural Science Foundation of China [51172038]; Special Fund for Fundamental Research in Central Universities [N110802001]; KAKENHI [26420686]	Thanks are due to the Materials Analysis Station and World Premier International Center for Materials Nanoarchitectonics (WPI-MANA) of the National Institute for Materials Science (NIMS) for performing elemental analysis and allowing to access research facilities. Bin Lu acknowledges the China Scholar Council (CSC) for financial support. Sincere thanks are due to Dr. Hidehiko Tanaka and Ms. Keiko Suzuta of MANA for making dilatometry analysis. The work is supported in part by the National Natural Science Foundation of China (Grant no. 51172038), the Special Fund for Fundamental Research in Central Universities (Grant no. N110802001), and Grants-in-Aid for Scientific Research (KAKENHI, No. 26420686).	ACHUTARA.G, 1973, J AM CERAM SOC, V56, P230, DOI 10.1111/j.1151-2916.1973.tb12472.x; Byeon SH, 2002, CHEM MATER, V14, P603, DOI 10.1021/cm010533m; Chen QW, 2006, J AM CERAM SOC, V89, P2038, DOI 10.1111/j.1551-2916.2006.01016.x; Geng FX, 2008, J AM CHEM SOC, V130, P16344, DOI 10.1021/ja807050e; Wang XJ, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/1/014204; RHODES WH, 1981, J AM CERAM SOC, V64, P19, DOI 10.1111/j.1151-2916.1981.tb09552.x; Konrad A, 1999, J APPL PHYS, V86, P3129, DOI 10.1063/1.371177; Wu XL, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/015006; Geng FX, 2010, ACCOUNTS CHEM RES, V43, P1177, DOI 10.1021/ar900289v; Wakefield G, 2001, ADV MATER, V13, P1557, DOI 10.1002/1521-4095(200110)13:20<1557::AID-ADMA1557>3.0.CO;2-W; Messing GL, 2008, SCIENCE, V322, P383, DOI 10.1126/science.1160903; Lee KH, 2009, EUR J INORG CHEM, P929, DOI 10.1002/ejic.200801052; Hu LF, 2009, ANGEW CHEM INT EDIT, V48, P3846, DOI 10.1002/anie.200806206; Zeng SY, 2007, J COLLOID INTERF SCI, V316, P921, DOI 10.1016/j.jcis.2007.08.034; Lu SZ, 2013, OPT MATER, V35, P718, DOI 10.1016/j.optmat.2012.09.014; Huang YH, 2009, J AM CERAM SOC, V92, P2883, DOI 10.1111/j.1551-2916.2009.03312.x; Geng FX, 2009, INORG CHEM, V48, P6724, DOI 10.1021/ic900669p; Bagayev SN, 2012, J EUR CERAM SOC, V32, P4257, DOI 10.1016/j.jeurceramsoc.2012.07.006; Wu XL, 2012, DALTON T, V41, P1854, DOI 10.1039/c1dt11332a; Li JG, 2008, J PHYS CHEM C, V112, P11707, DOI 10.1021/jp802383a; Shea LE, 1996, J AM CERAM SOC, V79, P3257, DOI 10.1111/j.1151-2916.1996.tb08103.x; McIntyre LJ, 2008, CHEM MATER, V20, P335, DOI 10.1021/cm7019284; Li JG, 2008, CHEM MATER, V20, P2274, DOI 10.1021/cm7033257; Gandara F, 2006, ANGEW CHEM INT EDIT, V45, P7998, DOI 10.1002/anie.200602502; Poudret L, 2008, CHEM MATER, V20, P7447, DOI 10.1021/cm802301a; LANGE FF, 1984, J AM CERAM SOC, V67, P83, DOI 10.1111/j.1151-2916.1984.tb09620.x; Packiyaraj P, 2014, J LUMIN, V145, P997, DOI 10.1016/j.jlumin.2013.07.074; Cheng JP, 2000, AM CERAM SOC BULL, V79, P71; GRESKOVICH CD, 1992, AM CERAM SOC BULL, V71, P1120; Grasso S, 2011, J AM CERAM SOC, V94, P1405, DOI 10.1111/j.1551-2916.2010.04274.x; Greskovich C, 1997, ANNU REV MATER SCI, V27, P69, DOI 10.1146/annurev.matsci.27.1.69; Li JG, 2005, J AM CERAM SOC, V88, P817, DOI 10.1111/j.1551-2916.2005.00162.x; Egorov SV, 2014, RADIOPHYS QUANT EL+, V56, P574, DOI 10.1007/s11141-014-9461-5; Ganjkhanlou Y, 2010, NANO, V5, P111, DOI 10.1142/S1793292010001998; Huang H, 2002, NANOTECHNOLOGY, V13, P318, DOI 10.1088/0957-4484/13/3/316; IKEGAMI T, 1987, J AM CERAM SOC, V70, P885, DOI 10.1111/j.1151-2916.1987.tb04911.x; Ji LF, 2006, MATER LETT, V60, P1502, DOI 10.1016/j.matlet.2005.11.060; Jia ML, 2004, CHEM PHYS LETT, V384, P193, DOI 10.1016/j.cplett.2003.11.103; Kang YC, 2000, ADV MATER, V12, P451, DOI 10.1002/(SICI)1521-4095(200003)12:6<451::AID-ADMA451>3.0.CO;2-S; Lee KH, 2009, EUR J INORG CHEM, P4727, DOI 10.1002/ejic.200900635; Li JK, 2012, J AM CERAM SOC, V95, P931, DOI 10.1111/j.1551-2916.2011.04991.x; Li XD, 2010, INT J APPL CERAM TEC, V7, pE1, DOI 10.1111/j.1744-7402.2008.02351.x; Lu B, 2012, ADV APPL CERAM, V111, P389, DOI 10.1179/1743676112Y.0000000010; Lu B, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/6/064202; MURRAY MGS, 1995, J MATER SCI, V30, P3061, DOI 10.1007/BF01209218; NIGARA Y, 1968, JPN J APPL PHYS, V7, P404, DOI 10.1143/JJAP.7.404; Wang Y, 2011, ADV APPL CERAM, V110, P95, DOI 10.1179/1743676110Y.0000000006; Wu X. L., J MAT CHE C IN PRESS; Wu X. L., 2013, THESIS NE U; Zhang HB, 2011, J AM CERAM SOC, V94, P3206, DOI 10.1111/j.1551-2916.2011.04789.x; Zhao YS, 2013, J MATER CHEM C, V1, P3584, DOI 10.1039/c3tc30205a; Zhu Q., 2010, CHEM MATER, V22, P4202	52	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	MAY	2015	98	5					1413	1422		10.1111/jace.13488		10	Materials Science, Ceramics	Materials Science	CH2TK	WOS:000353877300006		
J	Nagasawa, Y; Uematsu, M; Takahashi, Y; Kato, Z; Uematsu, K; Tanaka, S				Nagasawa, Yoshihiro; Uematsu, Masako; Takahashi, Yuuki; Kato, Zenji; Uematsu, Keizo; Tanaka, Satoshi			Observation of Particle Motion in High-Concentration Ceramic Slurries Under Low Shear Rate	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							POLYMER DISPERSANT; SIZE DISTRIBUTION; ALUMINA GRANULES; COLLOIDAL GELS; SUSPENSIONS; VISCOSITY; RHEOLOGY; BEHAVIOR; MICROSTRUCTURE; MICROSCOPY	The dispersed state of particles in high-concentration slurries has a significant effect on the development of the particle packing structure of the powder compact. We observed individual particle motion directly in highly concentrated ceramic slurries under slow flow through confocal laser scanning fluorescent microscopy using transparent slurries. In particular, we focused on particle motion soon after the application of a constant low shear rate. Measurements of the shear stresses indicated that the stress of a 30 vol% slurry gradually increased from 0.018 Pa over time, whereas the stress of a 40 vol% slurry soon reached 0.03 Pa and remained constant. For direct observation, shear stress was applied to the slurry, which was set between two glass plates, by moving one unilateral glass plate at 0.8 mu m/s, to create a shear rate of 0.01 s(-1). The motion of the particles could be observed continuously. In the early stage, particles in the 30 vol% slurry near the moving plate were united as one body and did not alternate positions. Then, a speed incline developed gradually over time. For the 40 vol% case, the particles moved at the same time and together. Increases in the shear stress were caused by increased interaction when the particles were close together.	[Nagasawa, Yoshihiro; Uematsu, Masako; Takahashi, Yuuki; Kato, Zenji; Uematsu, Keizo; Tanaka, Satoshi] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan	Tanaka, S (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	stanaka@vos.nagaokaut.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) of Japan	We would like to thank Dr. Koji Watari, Dr. Yuji Hotta, Dr. Kimiyasu Sato for discussion of concentrated slurry observations. This work was partially supported by Leading Industrial Technology Development Project Grant Funds of the New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Kakui T, 2005, J EUR CERAM SOC, V25, P655, DOI 10.1016/j.jeurceramsoc.2004.03.014; Lerche D, 2014, COLLOID SURFACE A, V440, P122, DOI 10.1016/j.colsurfa.2012.10.015; Lewis JA, 2000, J AM CERAM SOC, V83, P2341; Hotta Y, 2008, J AM CERAM SOC, V91, P1095, DOI 10.1111/j.1551-2916.2008.02310.x; Rensing PJ, 2011, J NON-NEWTON FLUID, V166, P859, DOI 10.1016/j.jnnfm.2011.05.003; Rhodes SK, 2009, LANGMUIR, V25, P6787, DOI 10.1021/la9003092; VANBLAADEREN A, 1992, LANGMUIR, V8, P1514, DOI 10.1021/la00042a005; Singh BP, 2005, J COLLOID INTERF SCI, V291, P181, DOI 10.1016/j.jcis.2005.04.091; Sigmund WM, 2000, J AM CERAM SOC, V83, P1557; Tari G, 1998, J EUR CERAM SOC, V18, P249, DOI 10.1016/S0955-2219(97)00113-1; Barns H. A., 1989, INTRO RHEOLOGY; Chun J, 2011, COLLOID SURFACE A, V384, P304, DOI 10.1016/j.colsurfa.2011.04.003; Conrad JC, 2008, LANGMUIR, V24, P7628, DOI 10.1021/la800919k; Ducker WA, 1997, J AM CERAM SOC, V80, P575; Eral HB, 2011, LANGMUIR, V27, P12297, DOI 10.1021/la2024764; Ewais E, 2002, J EUR CERAM SOC, V22, P2805, DOI 10.1016/S0955-2219(02)00060-2; Frank G. V., 2000, J RHEOL, V44, P459; Furushima R, 2011, J CERAM SOC JPN, V119, P198, DOI 10.2109/jcersj2.119.198; Horri BA, 2012, POWDER TECHNOL, V223, P116, DOI 10.1016/j.powtec.2011.06.015; Hunter R. J., 2008, INTRO PARTICLE TECHN, V2nd, P117; Reis N, 2005, J AM CERAM SOC, V88, P802, DOI 10.1111/j.1551-2916.2005.00138.x; Saito Y, 2002, AM CERAM SOC BULL, V81, P35; Takahashi M, 2004, ADV POWDER TECHNOL, V15, P97, DOI 10.1163/15685520460740098; Takai C, 2006, ADV MAT RES, V11-12, P681; Tallon C, 2010, J EUR CERAM SOC, V30, P2819, DOI 10.1016/j.jeurceramsoc.2010.03.019; Tanaka S, 2003, POWDER TECHNOL, V129, P153, DOI 10.1016/S0032-5910(02)00226-7; Tanaka S, 2007, J EUR CERAM SOC, V27, P873, DOI 10.1016/j.jeurceramsoc.2006.04.038; Tsubaki J, 2001, CHEM ENG SCI, V56, P3021, DOI 10.1016/S0009-2509(00)00485-1; Uematsu K, 1996, POWDER TECHNOL, V88, P291, DOI 10.1016/S0032-5910(96)03133-6; UEMATSU K, 1990, J AM CERAM SOC, V73, P2555, DOI 10.1111/j.1151-2916.1990.tb07635.x; Uematu K., 1990, J CERAM SOC JPN, V98, P515; van Schooneveld MM, 2009, J PHYS CHEM B, V113, P4560, DOI 10.1021/jp809659g; Zainuddin MI, 2011, J EUR CERAM SOC, V31, P3, DOI 10.1016/j.jeurceramsoc.2010.09.011	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	MAY	2015	98	5					1429	1436		10.1111/jace.13498		8	Materials Science, Ceramics	Materials Science	CH2TK	WOS:000353877300008		
J	Sekine, T; Suzuki, T; Yamamoto, K				Sekine, Tomomi; Suzuki, Toshio; Yamamoto, Kiyoshi			Inward Migration of Glass-Modifier Cations During Heat Treatment Under an N-2 Atmosphere	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							SODA-LIME GLASS; SILICA GLASS; FLOAT GLASS; DIFFUSION; TEMPERATURE; CORROSION; SURFACE; WATER; HYDRATION; CERAMICS	An Na+/Ca2+ -deficient layer is observed to form on the glass surface region up to a depth of hundreds of nanometers when a soda-lime-silicate glass is heat treated under an N-2 atmosphere near its glass-transition temperature. The measurements were performed using X-ray photoelectron spectroscopy with C-60-ion sputtering (C-60-XPS) and dynamic secondary-ion mass spectrometry (D-SIMS) with consideration of the mass and charge balances. The increase in the amount of hydrogen is substantially less than the decrease in the total charge due to the loss of modifier cations in the Na+/Ca2+-deficient layer; furthermore, the oxygen concentration in this layer is lower than the bulk value, suggesting that the silanol groups in the surface layer of the glass are dehydrated. A high-concentration layer of Ca2+ is also confirmed in the dehydration layer of the glass heat treated under an N-2 atmosphere, suggesting that Na+ and Ca2+ ions migrate inward into the glass via an ion-exchange reaction with protons, which migrate toward the surface from the bulk. We also confirmed that a thicker Na+/Ca2+-deficient layer is formed on glass surfaces with higher water content. Our results suggest that the dehydration of the silanol groups is the driving force of the inward migration of Na+ and Ca2+ ions.	[Sekine, Tomomi; Suzuki, Toshio; Yamamoto, Kiyoshi] Res Ctr ASAHI Glass Co LTD, Kanagawa Ku, Yokohama, Kanagawa 2218755, Japan	Sekine, T (reprint author), Res Ctr ASAHI Glass Co LTD, Kanagawa Ku, 1150 Hazawa Cho, Yokohama, Kanagawa 2218755, Japan.	tomomi-sekine@agc.com					Jansen KW, 2003, THIN SOLID FILMS, V423, P153, DOI 10.1016/S0040-6090(02)01020-9; Davis KM, 1996, J NON-CRYST SOLIDS, V203, P27, DOI 10.1016/0022-3093(96)00330-4; Yamamoto Y, 2010, J NON-CRYST SOLIDS, V356, P14, DOI 10.1016/j.jnoncrysol.2009.09.027; SHELBY JE, 1982, J AM CERAM SOC, V65, pC59, DOI 10.1111/j.1151-2916.1982.tb10420.x; KRIEGER UK, 1988, J NON-CRYST SOLIDS, V102, P50, DOI 10.1016/0022-3093(88)90112-3; WAKABAYASHI H, 1989, J AM CERAM SOC, V72, P1850, DOI 10.1111/j.1151-2916.1989.tb05990.x; LANFORD WA, 1979, J NON-CRYST SOLIDS, V33, P249, DOI 10.1016/0022-3093(79)90053-X; Rudmann D, 2005, THIN SOLID FILMS, V480, P55, DOI 10.1016/j.tsf.2004.11.071; Bacon F. R., 1967, CERAM B, V46, P850; Bange K, 2002, GLASS SCI TECHNOLOG, V75, P20; Douglas R. W., 1949, J SOC GLASS TECHNOL, V33, P289; Dremus R. H., 1975, J NONCRYST SOLIDS, V19, P137; Frischat GH, 2010, PHYS CHEM GLASSES-B, V51, P107; Harder U, 1998, GLASTECH BER-GLASS, V71, P12; HOMMA Y, 1985, ANAL CHEM, V57, P2928, DOI 10.1021/ac00291a041; Ikeda H, 2013, J APPL PHYS, V114, DOI 10.1063/1.4817760; LAUBE M, 1995, NUCL INSTRUM METH B, V99, P436, DOI 10.1016/0168-583X(94)00590-7; Nicollian E. H., 1982, MOS METAL OXIDE SEMI, P754; PANTANO CG, 1981, AM CERAM SOC BULL, V60, P1154; RICHTER T, 1990, GLASTECH BER-GLASS, V63, P300; Senturk U, 1997, J NON-CRYST SOLIDS, V222, P160, DOI 10.1016/S0022-3093(97)00358-X; Sharagov V., 2007, NONCONVENTIONAL TECH, V3, P97; Smedskjaer MM, 2010, J AM CERAM SOC, V93, P2161, DOI 10.1111/j.1551-2916.2010.03701.x; Smedskjaer MM, 2010, J NON-CRYST SOLIDS, V356, P290, DOI 10.1016/j.jnoncrysol.2009.12.004; Smedskjaer MM, 2009, SOLID STATE IONICS, V180, P1121, DOI 10.1016/j.ssi.2009.05.009; Smedskjaer MM, 2009, CHEM MATER, V21, P1242, DOI 10.1021/cm802513r; Smedskjaer MM, 2009, J NON-CRYST SOLIDS, V355, P908, DOI 10.1016/j.jnoncrysol.2009.04.008; Suzuki T., 2013, J NONCRYST SOLIDS, V382, P6; Takeda S, 1999, J NON-CRYST SOLIDS, V249, P41, DOI 10.1016/S0022-3093(99)00297-5; Yamamoto Y, 2011, OPT MATER, V33, P1927, DOI 10.1016/j.optmat.2011.03.026; YAMANAKA H, 1990, J NON-CRYST SOLIDS, V116, P286, DOI 10.1016/0022-3093(90)90704-P	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	MAY	2015	98	5					1464	1470		10.1111/jace.13469		7	Materials Science, Ceramics	Materials Science	CH2TK	WOS:000353877300013		
J	Asai, T; Shimotsuma, Y; Kurita, T; Murata, A; Kubota, S; Sakakura, M; Miura, K; Brisset, F; Poumellec, B; Lancry, M				Asai, Taiga; Shimotsuma, Yasuhiko; Kurita, Torataro; Murata, Atsushi; Kubota, Sho; Sakakura, Masaaki; Miura, Kiyotaka; Brisset, Francois; Poumellec, Bertrand; Lancry, Matthieu			Systematic Control of Structural Changes in GeO2 Glass Induced by Femtosecond Laser Direct Writing	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							TRANSPARENT MATERIALS; FUSED-SILICA; INDUCED NANOGRATINGS; FORM BIREFRINGENCE; WAVE-GUIDES; IRRADIATION; PULSE; MANIPULATION; DENSITY; DRIVEN	We report the structural changes inside germania glass induced by femtosecond laser pulses. Inspection by polarization microscopy and secondary electron microscopy indicate that the periodic nanostructures consist of oxygen defects such as ODCs (oxygen deficient centers) and NBOHCs (nonbridging oxygen hole centers) for laser pulse energy less than 0.2 mu J. However, the glass network was dissociated and O-2 molecules were generated for laser pulse energy greater than 0.4 lJ. Two different structural changes, form-birefringence and dissociation, were induced in GeO2 glass, depending on the laser pulse energy. The form-birefringence exhibited by the nanogratings in GeO2 glass is larger than that in SiO2 glass for pulse energy less than 0.2 mu J, as the density of nanovoids enclosed by ODCs in GeO2 glass is higher than that in SiO2 glass. Arrhenius plots of the phase retardation caused by the nanogratings in GeO2 and SiO2 indicate that the oxygen defects are relaxed at a temperature 100 degrees C above the glass-transition temperature.	[Asai, Taiga; Shimotsuma, Yasuhiko; Kurita, Torataro; Murata, Atsushi; Kubota, Sho; Sakakura, Masaaki; Miura, Kiyotaka] Kyoto Univ, Dept Chem Mat, Kyoto 6158510, Japan; [Brisset, Francois; Poumellec, Bertrand; Lancry, Matthieu] Univ Paris 11, ICMMO, UMR CNRS PSUD 8182, F-91405 Orsay, France	Shimotsuma, Y (reprint author), Kyoto Univ, Dept Chem Mat, Kyoto 6158510, Japan.	ayshimo@func.mc.kyoto-u.ac.jp			JSPS KAKENHI [26630129]; Agence Nationale pour la Recherche [ANR-09-BLAN-0172-01]; FP7-PEOPLE-IRSES e-FLAG [247635]	This work was financially supported by JSPS KAKENHI grant number 26630129. We thank Prof. Kazuyuki Hirao from Kyoto University, Prof. Peter G. Kazansky from University of Southampton and Prof. Jianrong Qiu from South China University of Technology for their kind suggestions and discussions. This work has been performed in the frame of FLAG (Femtosecond Laser Application in Glasses) consortium project with the support of the Agence Nationale pour la Recherche (ANR-09-BLAN-0172-01) and FP7-PEOPLE-IRSES e-FLAG 247635.	SIPE JE, 1983, PHYS REV B, V27, P1141, DOI 10.1103/PhysRevB.27.1141; Poumellec B, 2008, OPT EXPRESS, V16, P18354, DOI 10.1364/OE.16.018354; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Bricchi E, 2004, OPT LETT, V29, P119, DOI 10.1364/OL.29.000119; Bressel L, 2011, OPT MATER EXPRESS, V1, P1150; Qiu JR, 2004, ANGEW CHEM INT EDIT, V43, P2230, DOI 10.1002/anie.200352380; BIRNBAUM M, 1965, J APPL PHYS, V36, P3688, DOI 10.1063/1.1703071; Sun Q, 2005, J OPT A-PURE APPL OP, V7, P655, DOI 10.1088/1464-4258/7/11/006; Hnatovsky C, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1991991; Kazansky PG, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2722240; Eaton SM, 2005, OPT EXPRESS, V13, P4708, DOI 10.1364/OPEX.13.004708; Davis KM, 1996, OPT LETT, V21, P1729, DOI 10.1364/OL.21.001729; Bonse J, 2012, J LASER APPL, V24, DOI 10.2351/1.4712658; Corbari C, 2013, OPT EXPRESS, V21, P3946, DOI 10.1364/OE.21.003946; Shimizu M, 2011, OPT LETT, V36, P2161, DOI 10.1364/OL.36.002161; Bressel L, 2011, OPT MATER EXPRESS, V1, P605; Glezer EN, 1997, APPL PHYS LETT, V71, P882, DOI 10.1063/1.119677; Shimotsuma Y, 2010, ADV MATER, V22, P4039, DOI 10.1002/adma.201000921; Shimotsuma Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247405; Lancry M, 2013, LASER PHOTONICS REV, V7, P953, DOI 10.1002/lpor.201300043; ROTHSCHILD M, 1989, APPL PHYS LETT, V55, P1276, DOI 10.1063/1.102471; Zachariasen WH, 1932, J AM CHEM SOC, V54, P3841, DOI 10.1021/ja01349a006; Richter S, 2012, LASER PHOTONICS REV, V6, P787, DOI 10.1002/lpor.201200048; Sakakura M, 2013, OPT LETT, V38, P4939, DOI 10.1364/OL.38.004939; Mauclair C, 2012, OPT EXPRESS, V20, P12997, DOI 10.1364/OE.20.012997; Braun MM, 2006, THIN SOLID FILMS, V496, P505, DOI 10.1016/j.tsf.2005.08.173; Henderson GS, 2009, J NON-CRYST SOLIDS, V355, P468, DOI 10.1016/j.jnoncrysol.2009.01.024; Farsari M, 2009, NAT PHOTONICS, V3, P450; Bhardwaj VR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.057404; Born M., 1999, PRINCIPLES OPTICS; Bressel L, 2011, J NON-CRYST SOLIDS, V357, P2637, DOI 10.1016/j.jnoncrysol.2011.03.014; Canning J, 2011, OPT MATER EXPRESS, V1, P998; Hashida M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803940; Richter S, 2013, OPT MATER EXPRESS, V3, P1161, DOI 10.1364/OME.3.001161; Sakakura M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3046101; Schurman MK, 1996, J NON-CRYST SOLIDS, V202, P93, DOI 10.1016/0022-3093(96)00169-X; Sharma SP, 2014, J APPL PHYS, V116, DOI 10.1063/1.4892562; Shimizu M, 2010, J APPL PHYS, V108, DOI 10.1063/1.3483238; Shimotsuma Y, 2006, J NON-CRYST SOLIDS, V352, P646, DOI [10.1016/j.jnoncrysol.2005.11.060, 10.1016/j.noncrysol.2005.11.060]; Shimotsuma Y, 2014, J LASER MICRO NANOEN, V9, DOI 10.2961/jlmn.2014.01.0007; Shimotsuma Y, 2005, MOD PHYS LETT B, V19, P225, DOI 10.1142/S0217984905008281; STUART BC, 1995, PHYS REV LETT, V74, P2248, DOI 10.1103/PhysRevLett.74.2248; Zhang FT, 2014, J OPT SOC AM B, V31, P860, DOI 10.1364/JOSAB.31.000860; Zhang JY, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.033901	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	MAY	2015	98	5					1471	1477		10.1111/jace.13482		7	Materials Science, Ceramics	Materials Science	CH2TK	WOS:000353877300014		
J	Kim, Y; Morita, K				Kim, Youngjae; Morita, Kazuki			Thermal Conductivity of Molten B2O3, B2O3-SiO2, Na2O-B2O3, and Na2O-SiO2 Systems	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							ALKALI SILICATE-GLASSES; SODIUM-BORATE GLASSES; BOROSILICATE GLASSES; RAMAN-SPECTROSCOPY; BORON-OXIDE; DIFFUSIVITY MEASUREMENTS; MELTS; NMR; SLAGS; TEMPERATURES	With the aid of the transient hot-wire method, the thermal conductivity of molten B2O3, B2O3-SiO2, Na-2 O-SiO2, and Na2O-B2O3 systems was measured along with their temperature and composition. It was observed that the thermal conductivity of pure B2O3 increased with temperature, until about 1400 K, and then decreased subsequently. Using the MAS-NMR, 3Q-MAS, and Raman spectroscopy, the structure of B2O3 and SiO2 in the B2O3-SiO2 system was confirmed. Findings show that an addition of B2O3 into the pure SiO2 system causes a significant decrease in thermal conductivity, due to the formation of boroxol rings. The thermal conductivity of the Na2O-SiO2 system was measured and its phonon mean free path was calculated. In addition, a positive linear relation between viscosity and thermal conductivity was observed. In the Na2O-B2O3 system, it was found that a change in the relative fraction of 4-coordinated boron has an influence on the thermal conductivity when the concentration of Na2O is between 10 and 30 mol%, in which case the tetraborate unit is dominant.	[Kim, Youngjae; Morita, Kazuki] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan	Kim, Y (reprint author), Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	youngjae@iis.u-tokyo.ac.jp	Morita, Kazuki/N-6397-2015				Ammar M. M., 1983, J AM CERAM SOC, V66; Ammar M. M., 1982, J AM CERAM SOC, V65, pc174, DOI 10.1111/j.1151-2916.1982.tb10356.x; Hasegawa H, 2012, HIGH TEMP MAT PR-ISR, V31, P491, DOI 10.1515/htmp-2012-0085; Ozawa S, 2007, TETSU TO HAGANE, V93, P416; Lee SK, 2001, J PHYS CHEM B, V105, P12583, DOI 10.1021/jp012119f; MISAWA M, 1990, J NON-CRYST SOLIDS, V122, P33, DOI 10.1016/0022-3093(90)90221-7; WALRAFEN GE, 1983, J CHEM PHYS, V79, P3609, DOI 10.1063/1.446297; GRIMSDITCH M, 1989, PHYS REV LETT, V62, P2616, DOI 10.1103/PhysRevLett.62.2616; Lee SK, 2002, GEOCHIM COSMOCHIM AC, V66, P303, DOI 10.1016/S0016-7037(01)00775-X; Du LS, 2003, J PHYS CHEM B, V107, P10063, DOI 10.1021/jp0340481; Kim Y, 2014, ISIJ INT, V54, P2077, DOI 10.2355/isijinternational.54.2077; GHONEIM NA, 1985, THERMOCHIM ACTA, V83, P341, DOI 10.1016/0040-6031(85)87017-9; Sakamoto M, 2013, ISIJ INT, V53, P1143, DOI 10.2355/isijinternational.53.1143; Susa M, 2007, IRONMAK STEELMAK, V34, P124, DOI 10.1179/174328107X165672; [Anonymous], 1967, INTRO CERAMICS; NILSSON O, 1985, INT J THERMOPHYS, V6, P267, DOI 10.1007/BF00522148; Kang Y, 2012, METALL MATER TRANS B, V43, P1420, DOI 10.1007/s11663-012-9706-7; FURUKAWA T, 1981, J AM CERAM SOC, V64, P443, DOI 10.1111/j.1151-2916.1981.tb09893.x; Eriksson R, 2003, INT J THERMOPHYS, V24, P785, DOI 10.1023/A:1024048518617; Yano T, 2003, J NON-CRYST SOLIDS, V321, P137, DOI 10.1016/S0022-3093(03)00158-3; SALMAN SM, 1984, THERMOCHIM ACTA, V77, P227, DOI 10.1016/0040-6031(84)87062-8; Ferlat G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.065504; AMMAR MM, 1982, J NON-CRYST SOLIDS, V53, P165, DOI 10.1016/0022-3093(82)90026-6; SALAMA SN, 1987, J NON-CRYST SOLIDS, V93, P203, DOI 10.1016/S0022-3093(87)80039-X; KITTEL C, 1949, PHYS REV, V75, P972, DOI 10.1103/PhysRev.75.972; Mysen B, 1998, PHYS EARTH PLANET IN, V107, P23, DOI 10.1016/S0031-9201(97)00121-0; Nelson AT, 2014, J AM CERAM SOC, V97, P1177, DOI 10.1111/jace.12792; MILLS KC, 1993, ISIJ INT, V33, P148, DOI 10.2355/isijinternational.33.148; WALRAFEN GE, 1980, J CHEM PHYS, V72, P113, DOI 10.1063/1.438894; Hayashi M, 2001, PHYS CHEM GLASSES, V42, P6; MAEKAWA H, 1991, J NON-CRYST SOLIDS, V127, P53, DOI 10.1016/0022-3093(91)90400-Z; Angeli F, 2010, J AM CERAM SOC, V93, P2693, DOI 10.1111/j.1551-2916.2010.03771.x; TILTON LW, 1958, J RES NAT BUR STAND, V61, P463, DOI 10.6028/jres.061.039; van der Tempel L, 2000, GLASS PHYS CHEM+, V26, P606, DOI 10.1023/A:1007164501169; LI PC, 1962, J AM CERAM SOC, V45, P83, DOI 10.1111/j.1151-2916.1962.tb11085.x; Nanba T, 2004, GEOCHIM COSMOCHIM AC, V68, P5103, DOI 10.1016/j.gca.2004.05.042; OGURA G, 1990, NIPPON SERAM KYO GAK, V98, P305; BELL RJ, 1980, J NON-CRYST SOLIDS, V35-6, P1185, DOI 10.1016/0022-3093(80)90358-0; Southard JC, 1941, J AM CHEM SOC, V63, P3147, DOI 10.1021/ja01856a073; Yano T, 2003, J NON-CRYST SOLIDS, V321, P147, DOI 10.1016/S0022-3093(03)00159-5; Hasegawa H, 2012, METALL MATER TRANS B, V43, P1413, DOI 10.1007/s11663-012-9745-0; Amoureux JP, 1996, J MAGN RESON SER A, V123, P116, DOI 10.1006/jmra.1996.0221; HASSAN AK, 1992, PHYS REV B, V45, P12797, DOI 10.1103/PhysRevB.45.12797; Kang Y, 2006, ISIJ INT, V46, P420, DOI 10.2355/isijinternational.46.420; KINGERY WD, 1955, J AM CERAM SOC, V38, P251, DOI 10.1111/j.1151-2916.1955.tb14940.x; Kishimoto M., 1984, 2ND P INT S MET SLAG, P891; Krogh-Moe J., 1969, Journal of Non-Crystalline Solids, V1, DOI 10.1016/0022-3093(69)90025-8; Mills K., 1995, SLAG ATLAS; Nagata K., 1984, 2ND P INT S MET SLAG, P875; NAPOLITA.A, 1965, J AM CERAM SOC, V48, P613, DOI 10.1111/j.1151-2916.1965.tb14690.x; Ohta H., 2013, J MANUF SCI PROD, V13, P115; Ozawa S, 2005, IRONMAK STEELMAK, V32, P487, DOI 10.1179/174328105X48179; Park JH, 2012, J NON-CRYST SOLIDS, V358, P3096, DOI 10.1016/j.jnoncrysol.2012.08.014; Richardson F. D., 1974, PHYS CHEM MELTS META; Scholze H., 1991, GLASS; Sharp D. E., 1951, J AM CERAM SOC, V34, P260, DOI 10.1111/j.1151-2916.1951.tb09128.x; Soleilhavoup A, 2010, MAGN RESON CHEM, V48, pS159, DOI 10.1002/mrc.2673; Uhlmann D. R., 1969, Journal of Non-Crystalline Solids, V1, DOI 10.1016/0022-3093(69)90018-0; Weyl W. A., 1962, CONSTITUTION CLASSES; WRAY KL, 1959, J APPL PHYS, V30, P1702, DOI 10.1063/1.1735040; Yano T, 2006, J AM CERAM SOC, V89, P89, DOI 10.1111/j.1551-2916.2005.00815.x; Ziman J M, 1960, ELECT PHONONS THEORY	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	MAY	2015	98	5					1588	1595		10.1111/jace.13490		8	Materials Science, Ceramics	Materials Science	CH2TK	WOS:000353877300031		
J	Lu, Y; Karaki, T; Fujii, T				Lu, Yao; Karaki, Tomoaki; Fujii, Tadashi			Preparation of Morphology-Controlled Plate-Like Sodium Niobate Particles by Hydrothermal Synthesis	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							LEAD-FREE; NANBO3 POWDERS; CERAMICS; TEMPLATE; PHASE	Sodium niobate (NaNbO3) particles with plate-like morphology and hexagonal unit cells were prepared by the hydrothermal method. The result of SEM showed that the hexagonal NaNbO3 were characterized by plate-like morphology with a diameter of 5-15 mu m and a thickness of 1-2 mu m. The crucial influences on the morphology and crystal phase of the NaNbO3, such as concentration of [OH-], surfactant, and K+:Na+ ratio, were established. By further calcination treatment, the plate-like hexagonal NaNbO3 particles could be completely transformed into perovskite structure without morphology change. The XRD and EBSD results indicate that the major face of the calcined particles is parallel to the crystallographic (001)(pc) (pseudo cubic index) plane. Compared with the traditional high-temperature molten salt method, this work provides a simpler way to prepare the template for fabricating textured ceramics.	[Lu, Yao; Karaki, Tomoaki; Fujii, Tadashi] Toyama Prefectural Univ, Dept Intelligent Syst Design Engn, Fac Engn, Imizu, Toyama 9390398, Japan	Karaki, T (reprint author), Toyama Prefectural Univ, Dept Intelligent Syst Design Engn, Fac Engn, Imizu, Toyama 9390398, Japan.	chen@pu-toyama.ac.jp			CAS/SAFEA International Partnership Program for Creative Research Teams	This work was partly supported by the CAS/SAFEA International Partnership Program for Creative Research Teams.	Guo YP, 2005, MATER LETT, V59, P241, DOI 10.1016/j.matlet.2004.07.057; Zhang F, 2008, JPN J APPL PHYS, V47, P7685, DOI 10.1143/JJAP.47.7685; Zhu KJ, 2012, CRYSTENGCOMM, V14, P411, DOI 10.1039/c1ce06100c; Zhen YH, 2006, J AM CERAM SOC, V89, P3669, DOI 10.1111/j.1551-2916.2006.01313.x; Cross E, 2004, NATURE, V432, P24, DOI 10.1038/nature03142; Zhu HY, 2006, J AM CHEM SOC, V128, P2373, DOI 10.1021/ja056301w; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Wu JS, 2011, CRYSTENGCOMM, V13, P3773, DOI 10.1039/c1ce05042g; Goh GKL, 2003, J MATER RES, V18, P338, DOI 10.1557/JMR.2003.0044; Tellier J, 2009, SOLID STATE SCI, V11, P320, DOI 10.1016/j.solidstatesciences.2008.07.011; Poterala SF, 2010, CHEM MATER, V22, P2061, DOI 10.1021/cm903315u; Lu CH, 1998, MATER LETT, V34, P172, DOI 10.1016/S0167-577X(97)00170-5; Wu SY, 2010, J MATER SCI-MATER EL, V21, P450, DOI 10.1007/s10854-009-9937-9; Kroupa J, 2005, J PHYS D APPL PHYS, V38, P679, DOI 10.1088/0022-3727/38/5/003; Bai S, 2013, J AM CERAM SOC, V96, P2515, DOI 10.1111/jace.12345; Cao MH, 2010, FERROELECTRICS, V404, P39, DOI 10.1080/00150193.2010.482005; Chu SY, 2003, FERROELECTRICS, V287, P23, DOI 10.1080/00150190390200767; Dias A, 2003, CHEM MATER, V15, P1344, DOI 10.1021/cm0210187; European Union, 2003, OFF J EUR UNION, V46, P19; Karaki T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD11; KINOMURA N, 1984, MATER RES BULL, V19, P299, DOI 10.1016/0025-5408(84)90170-3; Saito Y, 2010, J ELECTROCERAM, V24, P39, DOI 10.1007/s10832-008-9557-4	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	MAY	2015	98	5					1668	1672		10.1111/jace.13512		5	Materials Science, Ceramics	Materials Science	CH2TK	WOS:000353877300042		
J	Kawakami, T; Gomez, IG; Ren, SY; Hudkins, K; Roach, A; Alpers, CE; Shankland, SJ; D'Agati, VD; Duffield, JS				Kawakami, Takahisa; Gomez, Ivan G.; Ren, Shuyu; Hudkins, Kelly; Roach, Allie; Alpers, Charles E.; Shankland, Stuart J.; D'Agati, Vivette D.; Duffield, Jeremy S.			Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; KIDNEY-DISEASE; NEPHROTIC SYNDROME; OXIDATIVE STRESS; REPAIR; MICE; ROS	FSGS is a heterogeneous fibrosing disease of the kidney, the cause of which remains poorly understood. In most cases, there is no effective treatment to halt or retard progression to renal failure. Increasing evidence points to mitochondrial dysfunction and the generation of reactive oxygen species in the pathogenesis of CKD. Autophagy, a major intracellular lysosomal degradation system, performs homeostatic functions linked to metabolism and organelle turnover. We prevented normal autophagic pathways in nephrons of mice by mutating critical autophagy genes ATG5 or ATG7 during nephrogenesis. Mutant mice developed mild podocyte and tubular dysfunction within 2 months, profound glomerular and tubular changes bearing close similarity to human disease by 4 months, and organ failure by 6 months. Ultrastructurally, podocytes and tubular cells showed vacuolization, abnormal mitochondria, and evidence of endoplasmic reticulum stress, features that precede the appearance of histologic or clinical disease. Similar changes were observed in human idiopathic FSGS kidney biopsy specimens. Biochemical analysis of podocytes and tubules of 2-month-old mutant mice revealed elevated production of reactive oxygen species, activation of endoplasmic reticulum stress pathways, phosphorylation of p38, and mitochondrial dysfunction. Furthermore, cultured proximal tubule cells isolated from mutant mice showed marked mitochondrial dysfunction and elevated mitochondrial reactive oxygen species generation that was suppressed by a mitochondrial superoxide scavenger. We conclude that mitochondrial dysfunction and endoplasmic reticulum stress due to impaired autophagic organelle turnover in podocytes and tubular epithelium are sufficient to cause many of the manifestations of FSGS in mice.	[Kawakami, Takahisa; Gomez, Ivan G.; Ren, Shuyu; Hudkins, Kelly; Roach, Allie; Alpers, Charles E.; Shankland, Stuart J.; Duffield, Jeremy S.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Kawakami, Takahisa; Gomez, Ivan G.; Ren, Shuyu; Hudkins, Kelly; Roach, Allie; Alpers, Charles E.; Shankland, Stuart J.; Duffield, Jeremy S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kawakami, Takahisa; Gomez, Ivan G.; Ren, Shuyu; Roach, Allie; Duffield, Jeremy S.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Kawakami, Takahisa; Gomez, Ivan G.] Univ Tokyo, Div Nephrol & Endocrinol, Tokyo, Japan; [Ren, Shuyu; Roach, Allie; Duffield, Jeremy S.] Biogen Idec Inc, Cambridge, MA 02142 USA; [D'Agati, Vivette D.] Columbia Univ, Dept Pathol, New York, NY USA	Duffield, JS (reprint author), Biogen Idec Inc, Cambridge Ctr 14, Cambridge, MA 02142 USA.	jeremy.duffield@biogenidec.com			Institute for Stem Cell and Regenerative Medicine at University of Washington; Nephcure Foundation career development grant; National Institutes of Health [DK94768, DK93493, DK84077, TR000504]; American Heart Association [12040023]; Overseas Research Grant from Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported in part by the Institute for Stem Cell and Regenerative Medicine at University of Washington; a Nephcure Foundation career development grant; National Institutes of Health grants DK94768, DK93493, DK84077, and TR000504; and American Heart Association grant 12040023 (J.S.D.), as well as an Overseas Research Grant from Mochida Memorial Foundation for Medical and Pharmaceutical Research (T.K.).	Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; ELNAHAS AM, 1991, KIDNEY INT, V40, P29, DOI 10.1038/ki.1991.175; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Lowik MM, 2009, EUR J PEDIATR, V168, P1291, DOI 10.1007/s00431-009-1017-x; Bock F, 2013, P NATL ACAD SCI USA, V110, P648, DOI 10.1073/pnas.1218667110; Eid N, 2013, J MOL HISTOL, V44, P311, DOI 10.1007/s10735-013-9483-x; ZWACKA RM, 1994, EMBO J, V13, P5129; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Nijmeh J, 2010, AM J PHYSIOL-LUNG C, V299, pL535, DOI 10.1152/ajplung.00002.2010; Lieberthal W, 2008, KIDNEY INT, V74, P555, DOI 10.1038/ki.2008.325; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Kim HR, 2009, J CELL SCI, V122, P1126, DOI 10.1242/jcs.038430; Pollak MR, 2003, SEMIN NEPHROL, V23, P141, DOI 10.1053/snep.2003.50014; MCVICAR M, 1980, J PEDIATR-US, V97, P918, DOI 10.1016/S0022-3476(80)80420-3; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Mizushima N, 1998, NATURE, V395, P395; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Campanholle G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068640; Cardaioli E, 2012, J NEUROL SCI, V321, P92, DOI 10.1016/j.jns.2012.07.027; Chau BN, 2012, SCI TRANSL MED, V4; Cho MH, 2007, NEPHROLOGY, V12, pS11, DOI 10.1111/j.1440-1797-2007.00875.x; Emma F, 2011, INT J NEPHROL, V609213; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gomez IG, 2014, J CLIN INVE IN PRESS; Kuroki T, 2003, J AM SOC NEPHROL, V14, pS216, DOI 10.1097/01.ASN.0000077405.07888.07; WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3	36	4	4	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	MAY	2015	26	5					1040	1052		10.1681/ASN.2013111202		13	Urology & Nephrology	Urology & Nephrology	CH2PX	WOS:000353868200009		
J	Recuenco, MC; Ohmori, T; Tanigawa, S; Taguchi, A; Fujimura, S; Conti, MA; Wei, QZ; Kiyonari, H; Abe, T; Adelstein, RS; Nishinakamura, R				Recuenco, Mariam C.; Ohmori, Tomoko; Tanigawa, Shunsuke; Taguchi, Atsuhiro; Fujimura, Sayoko; Conti, Mary Anne; Wei, Qize; Kiyonari, Hiroshi; Abe, Takaya; Adelstein, Robert S.; Nishinakamura, Ryuichi			Nonmuscle Myosin II Regulates the Morphogenesis of Metanephric Mesenchyme-Derived Immature Nephrons	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							KIDNEY DEVELOPMENT; AFRICAN-AMERICANS; HEAVY-CHAIN; MURINE HOMOLOG; RENAL-DISEASE; MYH9; GENE; CELLS; PROLIFERATION; EXPRESSION	The kidney develops from reciprocal interactions between the metanephric mesenchyme and ureteric bud. The mesenchyme transforms into epithelia and forms complicated nephron structures, whereas the ureteric bud extends its pre-existing epithelial ducts. Although the roles are well established for extracellular stimuli, such as Wnt and Notch, it is unclear how the intracellular cytoskeleton regulates these morphogenetic processes. Myh9 and Myh10 encode nonmuscle myosin II heavy chains, and Myh9 mutations in humans are implicated in congenital kidney diseases and focal segmental glomerulosclerosis in adults. Here, we analyzed the roles of Myh9 and Myh10 in the developing kidney. Ureteric bud-specific depletion of Myh9 resulted in no apparent phenotypes, whereas mesenchyme-specific Myh9 deletion caused proximal tubule dilations and renal failure. Mesenchyme-specific Myh9/Myh10 mutant mice died shortly after birth and showed a severe defect in nephron formation. The nascent mutant nephrons failed to form a continuous lumen, which likely resulted from impaired apical constriction of the elongating tubules. In addition, nephron progenitors lacking Myh9/Myh10 or the possible interactor Kif26b were less condensed at midgestation and reduced at birth. Taken together, nonmuscle myosin II regulates the morphogenesis of immature nephrons derived from the metanephric mesenchyme and the maintenance of nephron progenitors. Our data also suggest that Myh9 deletion in mice results in failure to maintain renal tubules but not in glomerulosclerosis.	[Recuenco, Mariam C.; Ohmori, Tomoko; Tanigawa, Shunsuke; Taguchi, Atsuhiro; Nishinakamura, Ryuichi] Kumamoto Univ, Dept Kidney Dev, Kumamoto 8600811, Japan; [Fujimura, Sayoko] Kumamoto Univ, Inst Mol Embryol & Genet, Liaison Lab Res Promot Ctr, Kumamoto 8600811, Japan; [Conti, Mary Anne; Wei, Qize; Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan	Nishinakamura, R (reprint author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ryuichi@kumamoto-u.ac.jp			KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology, Japan [24112518, 24790851]	This study was supported by KAKENHI Grants 24112518 and 24790851 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Yu J, 2002, DEVELOPMENT, V129, P5301; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Fujimura S, 2010, J AM SOC NEPHROL, V21, P803, DOI 10.1681/ASN.2009040353; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Yang ZF, 2013, DEVELOPMENT, V140, P1774, DOI 10.1242/dev.087957; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Bedzhov I, 2014, CELL, V156, P1032, DOI 10.1016/j.cell.2014.01.023; Johnstone DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067839; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Kanda S, 2014, J AM SOC NEPHROL; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Ma XF, 2009, CIRC RES, V105, P1102, DOI 10.1161/CIRCRESAHA.109.200303; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; Matsumoto S, 2014, EMBO J, V33, P702, DOI 10.1002/embj.201386942; Seri M, 2000, NAT GENET, V26, P103; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Zhang Y, 2012, BLOOD, V119, P238	33	1	1	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	MAY	2015	26	5					1081	1091		10.1681/ASN.2014030281		11	Urology & Nephrology	Urology & Nephrology	CH2PX	WOS:000353868200012		
J	Xie, J; Yoon, J; An, SW; Kuro-o, M; Huang, CL				Xie, Jian; Yoon, Joonho; An, Sung-Wan; Kuro-o, Makoto; Huang, Chou-Long			Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; DOWN-REGULATION; MORTALITY RISK; TRPV5 CHANNEL; EMERGING ROLE; ALPHA-KLOTHO; MUTANT MICE; FGF23; MOUSE	Cardiac hypertrophy occurs in up to 95% of patients with CKD and increases their risk for cardiovascular death. In the kidney, full-length membranous Klotho forms the coreceptor for fibroblast growth factor 23 (FGF23) to regulate phosphate metabolism. The prevailing view is that the decreased level of Klotho in CKD causes cardiomyopathy through increases in serum FGF23 and/or phosphate levels. However, we reported recently that soluble Klotho protects against cardiac hypertrophy by inhibiting abnormal calcium signaling in the heart. Here, we tested whether this protective effect requires changes in FGF23 and/or phosphate levels. Heterozygous Klotho-deficient CKD mice exhibited aggravated cardiac hypertrophy compared with wildtype CKD mice. Cardiac magnetic resonance imaging studies revealed that Klotho-deficient CKD hearts had worse functional impairment than wild-type CKD hearts. Normalization of serum phosphate and FGF23 levels by dietary phosphate restriction did not abrogate the aggravated cardiac hypertrophy observed in Klotho-deficient CKD mice. Circulating levels of the cleaved soluble ectodomain of Klotho were lower in wild-type CKD mice than in control mice and even lower in Klotho-deficient CKD mice. Intravenous delivery of a transgene encoding soluble Klotho ameliorated cardiac hypertrophy in Klotho-deficient CKD mice. These results suggest that the decreased level of circulating soluble Klotho in CKD is an important cause of uremic cardiomyopathy independent of FGF23 and phosphate, opening new avenues for treatment of this disease.	[Xie, Jian; Yoon, Joonho; An, Sung-Wan; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, Dallas, TX 75230 USA; [Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75230 USA; [Kuro-o, Makoto; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75230 USA; [Kuro-o, Makoto] Jichi Med Univ, Ctr Mol Med, Shimotsuke, Tochigi, Japan	Huang, CL (reprint author), Univ Texas SW Med Ctr Dallas, Dept Med, 5323 Harry Hines Blvd, Dallas, TX 75230 USA.	Chou-long.huang@utsouthwestern.edu			National Institutes of Health [R01-DK85726, R01-DK100605, P30-DK79328]	This work was supported by National Institutes of Health Grants R01-DK85726, R01-DK100605, and P30-DK79328. C.-L.H. holds the Jacob Lemann Professorship in Calcium Transport at the University of Texas Southwestern Medical Center.	ADHR Consortium, 2000, Nature Genetics, V26, P345; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.11114245; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Wolf M, 2012, KIDNEY INT, V82, P737, DOI 10.1038/ki.2012.176; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Lekawanvijit S, 2012, CIRC RES, V111, P1470, DOI 10.1161/CIRCRESAHA.112.278457; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Agarwal I, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000584; Hamada K, 2013, CLIN EXP NEPHROL, V17, P848, DOI 10.1007/s10157-013-0803-y; Hu MC, 2012, NEPHROL DIAL TRANSPL, V27, P2650, DOI 10.1093/ndt/gfs160; Rowell J, 2010, J CARDIOVASC TRANSL, V3, P516, DOI 10.1007/s12265-010-9208-4; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Liu Z, 2011, HUM MOL GENET, V20, P855, DOI 10.1093/hmg/ddq525; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Heijboer AC, 2013, NEPHROL DIAL TRANSPL, V28, P2283, DOI 10.1093/ndt/gft236; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Kalra SS, 2012, ANN MED, V44, pS85, DOI 10.3109/07853890.2012.660498; Taddei S, 2011, HEART FAIL REV, V16, P615, DOI 10.1007/s10741-010-9197-z; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683; Morishita K, 2001, J NUTR, V131, P3182; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Moe OW, 2012, J CLIN INVEST, V122, P2354, DOI 10.1172/JCI64184; Semple D, 2011, J AM SOC NEPHROL, V22, P207, DOI 10.1681/ASN.2009090900; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240	46	8	8	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	MAY	2015	26	5					1150	1160		10.1681/ASN.2014040325		11	Urology & Nephrology	Urology & Nephrology	CH2PX	WOS:000353868200018		
J	Kanehara, K; Hoshina, T; Takeda, H; Tsurumi, T				Kanehara, Kazuki; Hoshina, Takuya; Takeda, Hiroaki; Tsurumi, Takaaki			Terahertz permittivity of rutile TiO2 single crystal measured by anisotropic far-infrared ellipsometry	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						THz; Ellipsometry; Rutile; Dielectric property; Ionic polarization; Phonon	ROTATING-ANALYZER ELLIPSOMETRY; LATTICE-DYNAMICS; SPECTROSCOPIC ELLIPSOMETRY; GENERALIZED ELLIPSOMETRY; DIELECTRIC-PROPERTIES; VARISTORS; CONSTANT; FILMS	Rutile structured TiO2 has very high dielectric permittivities in non-ferroelectric materials. To understand the reason why rutile TiO2 has high ionic polarizabilities, it is essential to analyze accurate dielectric spectra of rutile TiO2 in the THz region. In this study, the complex permittivity of rutile TiO2 single crystal in the range 30-700 cm(-1) (0.90-21 THz) was directly measured using the anisotropic far-infrared spectroscopic ellipsometer. The three E-u modes and one A(2u) mode, which are all infrared-active phonon modes in rutile TiO2, were observed. Moreover, the resonance frequencies of the phonon modes approximately were coincident with a calculation result of first-principles and the analysis data by a harmonic oscillator model. From the examination of the dielectric response, it was found that Eu(1) mode, which indicates the oscillation of Ti ions against O ions in the same phase, was dominant contributor to the static permittivity for a-axis. On the other hand, the high permittivity for c-axis was due to "soft" A(2u) mode. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Kanehara, Kazuki; Hoshina, Takuya; Takeda, Hiroaki; Tsurumi, Takaaki] Tokyo Inst Technol, Grad Sch Sci & Engn, Nanophonon Lab, Meguro Ku, Tokyo 1528552, Japan	Hoshina, T (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Nanophonon Lab, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	thoshina@ceram.titech.ac.jp			Japan Society for the Promotion of Science (JSPS); Murata Science Foundation	This work was supported by the Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), and the Murata Science Foundation.	LEE C, 1994, PHYS REV B, V50, P13379, DOI 10.1103/PhysRevB.50.13379; WASER R, 1990, J AM CERAM SOC, V73, P1654, DOI 10.1111/j.1151-2916.1990.tb09810.x; YAN MF, 1982, APPL PHYS LETT, V40, P536, DOI 10.1063/1.93134; COLLINS RW, 1990, REV SCI INSTRUM, V61, P2029, DOI 10.1063/1.1141417; Navale SC, 2007, CERAM INT, V33, P301, DOI 10.1016/j.ceramint.2005.07.026; GRANT FA, 1959, REV MOD PHYS, V31, P646, DOI 10.1103/RevModPhys.31.646; Kim SK, 2004, APPL PHYS LETT, V85, P4112, DOI 10.1063/1.1812832; Kanehara K, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4891767; Thompson DW, 1998, THIN SOLID FILMS, V313, P341, DOI 10.1016/S0040-6090(97)00843-2; Azzam R. M., 1977, ELLIPSOMETRY POLARIZ; Chao S, 2011, INT J APPL CERAM TEC, V8, P1363, DOI 10.1111/j.1744-7402.2010.02592.x; CHINDAUDOM P, 1993, APPL OPTICS, V32, P6391, DOI 10.1364/AO.32.006391; DENENGEL.D, 1971, J OPT SOC AM, V61, P1460; DENIJS JMM, 1988, J OPT SOC AM A, V5, P773, DOI 10.1364/JOSAA.5.000773; EAGLES DM, 1964, J PHYS CHEM SOLIDS, V25, P1243, DOI 10.1016/0022-3697(64)90022-8; Fujiwara H, 2007, SPECTROSCOPIC ELLIPS; Hoshina T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PD03; Mitev PD, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.134303; Montanari B, 2002, CHEM PHYS LETT, V364, P528, DOI 10.1016/S0009-2614(02)01401-X; Montanari B, 2004, J PHYS-CONDENS MAT, V16, P273, DOI 10.1088/0953-8984/16/3/008; Naciri A. E., 1999, APPL OPTICS, V38, P647; Pang LX, 2010, J MATER SCI-MATER EL, V21, P1285, DOI 10.1007/s10854-010-0064-4; PARKER RA, 1961, PHYS REV, V124, P1719, DOI 10.1103/PhysRev.124.1719; ROSELER A, 1993, THIN SOLID FILMS, V234, P307, DOI 10.1016/0040-6090(93)90275-T; Schubert M, 1996, J OPT SOC AM A, V13, P875, DOI 10.1364/JOSAA.13.000875; Shojaee E, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/1/015401; Sikora R, 2005, J PHYS CHEM SOLIDS, V66, P1069, DOI 10.1016/j.jpcs.2005.01.007; Tobar ME, 1998, IEEE T ULTRASON FERR, V45, P830, DOI 10.1109/58.677747; TRAYLER JG, 1971, PHYS REV B, V3, P3457, DOI 10.1103/PhysRevB.3.3457; von Hippel A. R., 1954, DIELECTRIC MAT APPL	30	1	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					303	306		10.2109/jcersj2.123.303		4	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500001		
J	Katase, T; Endo, K; Ohta, H				Katase, Takayoshi; Endo, Kenji; Ohta, Hiromichi			Characterization of electronic structure around metal-insulator transition in V1-x WxO2 thin films by thermopower measurement	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Vanadium dioxide; Thermopower; Metal-insulator transition; Electronic structure	VO2; PHASE; STABILIZATION; TEMPERATURE	Electronic structure across the metal-insulator (MI) transition of electron-doped V1-x WxO2 epitaxial films (x = 0-0.06) grown on alpha-Al2O3 substrates was studied by means of thermopower (S) measurements. Significant increase of vertical bar S vertical bar-values accompanied by MI transition was observed, and the transition temperatures of S (T-S) decreased with x in good linear relation with MI transition temperatures. vertical bar S vertical bar values of V1-x WxO2 films at T > T-S were constant at low values of 23 mu VK-1 independently of x, which reflects a metallic electronic structure, whereas, those at T < T-S almost linearly decreased with logarithmic W-concentrations. The gradient of -213 mu VK-1 agrees well with -k(B)/e.ln10 (-198 mu VK-1), suggesting that V1-x WxO2 films have insulating electronic structures with a parabolic density of state around the conduction band bottom. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Katase, Takayoshi; Endo, Kenji; Ohta, Hiromichi] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0010020, Japan	Ohta, H (reprint author), Hokkaido Univ, Res Inst Elect Sci, N20W10, Sapporo, Hokkaido 0010020, Japan.	hiromichi.ohta@es.hokudai.ac.jp	Katase, Takayoshi/H-5956-2012; Ohta, Hiromichi/H-4468-2012	Katase, Takayoshi/0000-0002-2593-7487; 	Japan Society for the Promotion of Science (JSPS) [25246023, 25106007]; Asahi Glass and Murata Science Foundation	This work was supported by Grant-in-Aid for Scientific Research A (No. 25246023), Grant-in-Aid for Scientific Research on Innovative Areas (No. 25106007) from the Japan Society for the Promotion of Science (JSPS), and partly supported by the Asahi Glass and Murata Science Foundation.	ABBATE M, 1991, PHYS REV B, V43, P7263, DOI 10.1103/PhysRevB.43.7263; Kim H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866806; Wu CZ, 2011, J AM CHEM SOC, V133, P13798, DOI 10.1021/ja203186f; BERGLUND CN, 1969, PHYS REV, V185, P1022, DOI 10.1103/PhysRev.185.1022; Shibuya K, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291053; Ruzmetov D, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.153107; Ohta H, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3231873; Muraoka Y, 2002, APPL PHYS LETT, V80, P583, DOI 10.1063/1.1446215; JONSON M, 1980, PHYS REV B, V21, P4223, DOI 10.1103/PhysRevB.21.4223; Nakano M, 2012, NATURE, V487, P459, DOI 10.1038/nature11296; Fu DY, 2013, J APPL PHYS, V113, DOI 10.1063/1.4788804; JONKER GH, 1968, PHILIPS RES REP, V23, P131; Cao J, 2009, NANO LETT, V9, P4001, DOI 10.1021/nl902167b; MORIN FJ, 1959, PHYS REV LETT, V3, P34, DOI 10.1103/PhysRevLett.3.34; WENTZCOVITCH RM, 1994, PHYS REV LETT, V72, P3389, DOI 10.1103/PhysRevLett.72.3389; Wei J, 2012, NAT NANOTECHNOL, V7, P357, DOI 10.1038/NNANO.2012.70; CARUTHER.E, 1973, PHYS REV B, V7, P3760, DOI 10.1103/PhysRevB.7.3760; GOODENOU.JB, 1971, J SOLID STATE CHEM, V3, P26, DOI 10.1016/0022-4596(71)90004-1; Nagao Y, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507898; Saeki K, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.125406; Sakai E, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195132	21	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					307	311		10.2109/jcersj2.123.307		5	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500002		
J	Kato, M; Kakimoto, K				Kato, Minato; Kakimoto, Ken-ichi			Electrospinning of ferroelectric (Na,K)NbO3 fiber through citrate precursor route	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Lead-free piezoelectric material; Citrate precursor; Electrospinning; Ceramic fiber; Non-woven fabric	POLYSTYRENE FIBERS; DIELECTRIC-PROPERTIES; MOLECULAR-WEIGHT; PZT FIBERS; SOL-GEL; NANOFIBERS; CERAMICS; SOLVENTS; FABRICATION; COMPOSITES	Ferroelectric ceramic fiber is expected to demonstrate a wide variety of practical applications in industrial fields due to the flexibility and shape anisotropy. Lead-free ferroelectric (Na,K) NbO3 (NKN) fiber was synthesized through electrospinning method using aqueous-based citrate precursor (CP). The morphology of electrospun fibers was observed and the properties of the precursor solution, such as viscosity, electrical conductivity and evaporation rate, were investigated. Addition of ethanol and acetic acid to the solvent of the PVA solution worked well for the electrospinning since both additives could control the electrical conductivity as well as evaporation rate of the CP/PVA prepared solution. The properties of the precursor, especially electrical conductivity and evaporation rate have significant influence on the morphology and homogeneity of the developed fibers. The homogeneous NKN fibers with a single perovskite structure of orthorhombic phase at room temperature and controllable diameter ranging approximately 100 to 1100nm were obtained, indicating that the electrospinning of ferroelectric NKN fiber through CP route was successfully conducted. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Kato, Minato; Kakimoto, Ken-ichi] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Kakimoto, K (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	kakimoto.kenichi@nitech.ac.jp			JSPS Challenging Exploratory Research [26630313]	The present work is supported by Grant-in-Aids for JSPS Challenging Exploratory Research (no. 26630313).	Guo YP, 2004, APPL PHYS LETT, V85, P4121, DOI 10.1063/1.1813636; Maensiri S, 2006, J COLLOID INTERF SCI, V297, P578, DOI 10.1016/j.jcis.2005.11.005; Alkoy EM, 2009, J AM CERAM SOC, V92, P2566, DOI 10.1111/j.1551-2916.2009.03261.x; Son WK, 2005, MATER LETT, V59, P1571, DOI 10.1016/j.matlet.2005.01.025; Guo YP, 2004, JPN J APPL PHYS 1, V43, P6662, DOI 10.1143/JJAP.43.6662; Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Ellison CJ, 2007, POLYMER, V48, P3306, DOI 10.1016/j.polymer.2007.04.005; McEachin Z, 2012, J APPL POLYM SCI, V126, P473, DOI 10.1002/app.36843; Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3; Tripatanasuwan S, 2007, POLYMER, V48, P5742, DOI 10.1016/j.polymer.2007.07.045; Kobayashi K, 2012, J AM CERAM SOC, V95, P2928, DOI 10.1111/j.1551-2916.2012.05266.x; TENNERY VJ, 1968, J APPL PHYS, V39, P4749, DOI 10.1063/1.1655833; Uyar T, 2008, POLYMER, V49, P5336, DOI 10.1016/j.polymer.2008.09.025; Chen X, 2010, NANO LETT, V10, P2133, DOI 10.1021/nl100812k; Handoko AD, 2011, THIN SOLID FILMS, V519, P5156, DOI 10.1016/j.tsf.2011.01.078; EGERTON L, 1959, J AM CERAM SOC, V42, P438, DOI 10.1111/j.1151-2916.1959.tb12971.x; SHIRANE G, 1954, PHYS REV, V96, P581, DOI 10.1103/PhysRev.96.581; JAEGER RE, 1962, J AM CERAM SOC, V45, P209, DOI 10.1111/j.1151-2916.1962.tb11127.x; Jarusuwannapoom T, 2005, EUR POLYM J, V41, P409, DOI 10.1016/j.eurpolymj.2004.10.010; Wannatong L, 2004, POLYM INT, V53, P1851, DOI 10.1002/pi.1599; Wang LJ, 2011, SENSOR ACTUAT B-CHEM, V153, P460, DOI 10.1016/j.snb.2010.11.016; Binkle O, 1998, J SOL-GEL SCI TECHN, V13, P1023, DOI 10.1023/A:1008616516686; Casper CL, 2004, MACROMOLECULES, V37, P573, DOI 10.1021/ma0351975; Chen CF, 2012, NANOSCI NANOTECH LET, V4, P95, DOI 10.1166/nnl.2012.1290; Choy SH, 2005, APPL PHYS A-MATER, V81, P817, DOI 10.1007/s00339-004-2874-9; Chuangchote S, 2009, J APPL POLYM SCI, V114, P2777, DOI 10.1002/app.30637; Kakimoto K, 2010, J AM CERAM SOC, V93, P2423, DOI 10.1111/j.1551-2916.2010.03748.x; Nakane K, 1999, J APPL POLYM SCI, V74, P133, DOI 10.1002/(SICI)1097-4628(19991003)74:1<133::AID-APP16>3.0.CO;2-N; Li N, 2008, MATER LETT, V62, P1345, DOI 10.1016/j.matlet.2007.08.048; Shigemi A, 2005, JPN J APPL PHYS 1, V44, P8048, DOI 10.1143/JJAP.44.8048; Tanaka K., 2007, FERROELECTRICS, V358, P175, DOI 10.1080/00150190701537216; Wang HQ, 2011, J MATER SCI-MATER EL, V22, P458, DOI 10.1007/s10854-010-0159-y; Yu N, 2005, J COLLOID INTERF SCI, V285, P163, DOI 10.1016/j.jcis.2004.11.014	34	1	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					312	316		10.2109/jcersj2.123.312		5	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500003		
J	Hotate, M; Yoshidome, D; Kojima, T; Hoshina, T; Takeda, H; Tsurumi, T				Hotate, Mei; Yoshidome, Daichi; Kojima, Takahiro; Hoshina, Takuya; Takeda, Hiroaki; Tsurumi, Takaaki			Design and fabrication of acoustic matching layer for lead-free ultrasonic flowmeter	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Ultrasonic flow meter; Piezoelectric ceramics; Lead-free; Acoustic matching layer; Composite	FREE PIEZOELECTRIC CERAMICS; TRANSDUCERS; IMPEDANCE; SYSTEM; GROWTH; ACTUATORS	We designed and fabricated acoustic matching layers made of a BaTiO3/epoxy 0-3 composite material for a lead-free ultrasonic flowmeter. Specific acoustic impedance of fabricated 0-3 composite was controlled by changing volume fraction of BaTiO3 fine particles. When the volume fraction of BaTiO3 fine particles was 40 vol % or less, sufficiently uniform 0-3 composite materials and various specific acoustic impedances of 2.6-6.9 x 10(6) kg/m(2)s were obtained. For improving an accuracy of a lead-free ultrasonic transducer with (K,Na) NbO3-based ceramics, a pair of acoustic matching layers with a specific acoustic impedance of 6.35 x 10(6) kg/m(2)s and a thickness of 0.260 mm were fabricated. By using the fabricated acoustic matching layers in a lead-free ultrasonic flowmeter, the amplitude of output voltage was improved by 35% compared to that using commercialized matching layers. Even in comparison with the commercialized ultrasonic flowmeter with PZT-based materials, the amplitude of output voltage with the fabricated composite matching layers was 83.1%. The lead-free ultrasonic flowmeter with the fabricated composite matching layer had high accuracy of a flow rate error of 3.5% or less. From above results, the effectiveness of the optimized composite matching layers was verified. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Hotate, Mei; Yoshidome, Daichi; Kojima, Takahiro; Hoshina, Takuya; Takeda, Hiroaki; Tsurumi, Takaaki] Tokyo Inst Technol, Grad Sch Sci & Engn, Nanophonon Lab, Meguro Ku, Tokyo 1528552, Japan	Tsurumi, T (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Nanophonon Lab, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	ttsurumi@ceram.titech.ac.jp					Karaki T, 2007, JPN J APPL PHYS 2, V46, pL97, DOI 10.1143/JJAP.46.L97; Noguchi Y, 2001, APPL PHYS LETT, V78, P1903, DOI 10.1063/1.1357215; Iooss B, 2002, ULTRASONICS, V40, P1009, DOI 10.1016/S0041-624X(02)00387-6; Leontsev SO, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/4/044302; Hiruma Y, 2008, J APPL PHYS, V104, DOI 10.1063/1.3043588; Randall CA, 2005, J ELECTROCERAM, V14, P177, DOI 10.1007/s10832-005-0956-5; Tashiro S, 2002, JPN J APPL PHYS 1, V41, P7113, DOI 10.1143/JJAP.41.7113; TAKENAKA T, 1991, JPN J APPL PHYS 1, V30, P2236, DOI 10.1143/JJAP.30.2236; Takeda H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4811163; Zhang SJ, 2007, J ELECTROCERAM, V19, P251, DOI 10.1007/s10832-007-9056-z; Rodel J, 2009, J AM CERAM SOC, V92, P1153, DOI 10.1111/j.1551-2916.2009.03061.x; Alvarez-Arenas TEG, 2004, IEEE T ULTRASON FERR, V51, P624, DOI 10.1109/TUFFC.2004.1320834; GERLACH R, 1992, J NON-CRYST SOLIDS, V145, P227, DOI 10.1016/S0022-3093(05)80461-2; Maeder MD, 2004, J ELECTROCERAM, V13, P385, DOI 10.1007/s10832-004-5130-y; Damjanovic D, 2010, FUNCT MATER LETT, V3, P5, DOI 10.1142/S1793604710000919; Tressler JF, 1999, COMPOS PART A-APPL S, V30, P477, DOI 10.1016/S1359-835X(98)00137-7; Sugawara K, 2005, JPN J APPL PHYS 1, V44, P4347, DOI 10.1143/JJAP.44.4347; PEDERSEN PC, 1982, J ACOUST SOC AM, V72, P327, DOI 10.1121/1.388085; Hadimioglu B., 1990, ULTR S 1990 P IEEE 1, V3, P1337; INOUE T, 1987, IEEE T ULTRASON FERR, V34, P8, DOI 10.1109/T-UFFC.1987.26905; Jaffe B, 1971, PIEZOELECTRIC CERAMI; Kakimoto K, 2002, JPN J APPL PHYS 1, V41, P6908, DOI 10.1143/JJAP.41.6908; Li EZ, 2008, JPN J APPL PHYS, V47, P7702, DOI 10.1143/JJAP.47.7702; Nagata H, 1997, JPN J APPL PHYS 1, V36, P6055, DOI 10.1143/JJAP.36.6055; Nagata H, 1998, JPN J APPL PHYS 1, V37, P5311, DOI 10.1143/JJAP.37.5311; Nagata H., 2000, T MAT RES SOC JAPAN, V25, P273; Shimamura K, 1996, J CRYST GROWTH, V163, P388, DOI 10.1016/0022-0248(95)01002-5; Takenaka T., 1999, Ferroelectrics, V230, DOI 10.1080/00150199908214902; Tohmyoh H, 2006, J ACOUST SOC AM, V120, P31, DOI 10.1121/1.2205127; Uchino K., 2000, FERROELECTRIC DEVICE; Waanders J. W., 1991, PIEZOELECTRIC CERAMI; Wada S, 2007, JPN J APPL PHYS 1, V46, P7039, DOI 10.1143/JJAP.46.7039	32	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					317	321		10.2109/jcersj2.123.317		5	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500004		
J	Nagasaka, K; Oshima, N; Kim, JW; Shima, H; Akama, A; Kiguchi, T; Nishida, K; Konno, TJ; Funakubo, H; Uchida, H				Nagasaka, Kohei; Oshima, Naoya; Kim, Jin Woong; Shima, Hiromi; Akama, Akihiro; Kiguchi, Takanori; Nishida, Ken; Konno, Toyohiko J.; Funakubo, Hiroshi; Uchida, Hiroshi			Fabrication of (100)(c)-oriented Mn-doped bismuth ferrite films on silicon and stainless steel substrates using calcium niobate nanosheets	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Ferroelectrics; Thin film; Bismuth ferrite; Calcium niobate; Chemical solution deposition (CSD); Nanosheets; Crystal orientation; Thermal stress	THIN-FILMS; DEPOSITION; BIFEO3; PB(ZR0.53TI0.47)O-3; ELECTRODE; GROWTH	One-axis-oriented BiFeO3 (BFO)-based films were fabricated on platinized silicon and SUS 316L substrates using nanosheets of calcium niobate (ns-CN) with pseudo-perovskite crystal structure. Ca2Nb3O10 nanosheets (ns-CNs) were supported on the substrates by dip coating, followed by chemical solution deposition (CSD) of Mn-doped BFO (Mn-BFO) films. Preferential crystal growth of (100)-oriented BFO films was achieved on both ns-CN/(111)Pt/TiO2/(100)Si and ns-CN/(111)Pt/SUS316L substrates. The out-of-plane lattice parameters of the BFO films on ns-CN/(111)Pt/SUS316L were larger than the parameter reported for BFO bulk because of elastic deformation caused by thermal stress between the BFO films and SUS316L substrate, whereas those of the films on ns-CN/(111) Pt/TiO2/(100) Si were smaller than the reported value. The remanent polarization of the Mn-BFO films was enhanced to approximately 60 mu C/cm(2) on ns-CN/(111)Pt/SUS316L because of the compressive thermal stress that causes elastic elongation of Mn-BFO crystals to align or change the tilt angle of their polar axes for the substrate surface. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Nagasaka, Kohei; Konno, Toyohiko J.; Uchida, Hiroshi] Sophia Univ, Dept Mat & Life Sci, Tokyo 1028554, Japan; [Oshima, Naoya; Funakubo, Hiroshi] Tokyo Inst Technol, Dept Innovat & Engn Mat, Yokohama, Kanagawa 2268503, Japan; [Kim, Jin Woong; Shima, Hiromi; Nishida, Ken] Natl Def Acad Japan, Dept Commun Engn, Yokosuka, Kanagawa 2398686, Japan; [Akama, Akihiro; Kiguchi, Takanori] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Uchida, H (reprint author), Sophia Univ, Dept Mat & Life Sci, Tokyo 1028554, Japan.	uchidah@sophia.ac.jp	Kiguchi, Takanori/D-5334-2015		Center for Integrated Nanotechnology Center at Tohoku University; Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japanese Government	This research was supported by the Center for Integrated Nanotechnology Center at Tohoku University and also by Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japanese Government.	ACHENBAC.GD, 1967, J AM CERAM SOC, V50, P437, DOI 10.1111/j.1151-2916.1967.tb15153.x; Osada M, 2012, ADV MATER, V24, P210, DOI 10.1002/adma.201103241; Lee YH, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2112181; Miyazaki H, 2004, J EUR CERAM SOC, V24, P1005, DOI 10.1016/S0955-2219(03)00382-0; Ederer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257601; Wei M, 2001, J SOL-GEL SCI TECHN, V21, P39, DOI 10.1023/A:1011201414651; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Jang HW, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107602; Osada M, 2010, ACS NANO, V4, P5225, DOI 10.1021/nn101453v; Eom CB, 2012, MRS BULL, V37, P1007, DOI 10.1557/mrs.2012.273; MERZ WJ, 1949, PHYS REV, V76, P1221, DOI 10.1103/PhysRev.76.1221; Amirov AA, 2009, PHYS SOLID STATE+, V51, P1189, DOI 10.1134/S1063783409060183; Ebina Y, 2002, SOLID STATE IONICS, V151, P177, DOI 10.1016/S0167-2738(02)00707-5; YANG CC, 1995, APPL PHYS LETT, V66, P2643, DOI 10.1063/1.113111; Chen MS, 1996, APPL PHYS LETT, V68, P1430, DOI 10.1063/1.116103; Ehara Y, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.091A14, 10.1143/JJAP.51.09LA14]; Hayashi M, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/9/092033; Kariya K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA14; Kikuta K, 2007, J SOL-GEL SCI TECHN, V42, P381, DOI 10.1007/s10971-006-0200-z; Kondoh Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NA04; Li Z, 1996, J PHYS CHEM SOLIDS, V57, P1433, DOI 10.1016/0022-3697(96)00009-1; Minemura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KA04; Osada M., 2009, J MATER CHEM, V19, P2503; Pintilie L, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3152784; Shibata T, 2014, J MATER CHEM C, V2, P441, DOI 10.1039/c3tc31787k; Sone K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MB03; Waser R., 2012, NANOELECTRONICS INFO; Yasui S, 2008, JPN J APPL PHYS, V47, P7582, DOI 10.1143/JJAP.47.7582	28	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					322	328		10.2109/jcersj2.123.322		7	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500005		
J	Morita, T; Ueno, S; Hosono, E; Zhou, HS; Hagiwara, M; Fujihara, S				Morita, Takahiro; Ueno, Shintaro; Hosono, Eiji; Zhou, Haoshen; Hagiwara, Manabu; Fujihara, Shinobu			Fabrication of transparent conductive zinc oxide films by chemical bath deposition using solutions containing Zn2+ and Al3+ ions	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						ZnO; Oriented film; Chemical bath deposition; UV irradiation; Transparent conductive oxide	ZNO THIN-FILMS; PULSED-LASER DEPOSITION; DOPED ZNO; VAPOR-DEPOSITION; SUBSTRATE-TEMPERATURE; AQUEOUS-SOLUTIONS; SOLAR-CELLS; GROWTH; NANORODS; SURFACE	Transparent ZnO films were fabricated on glass substrates by a chemical bath deposition method using zinc acetate solutions also containing AlCl3. A predominant effect of the Al3+ addition seemed to be suppression of the growth of ZnO crystals and change of the crystallographic orientation of ZnO films. The c-axis and the a-axis of the ZnO films came to stand parallel and vertical to the substrate, respectively, by increasing the Al3+ concentration. A post ultraviolet irradiation to the films led to a decrease in the sheet resistance from the order of 106 to 10(4) Omega.sq.(-1) without changing the morphology or the crystallinity. This might be related to the photocatalytic effect of ZnO to decompose residual organics in the films and increase the number of carriers. The ZnO film obtained from the solution with 1.0 mol% AlCl3 showed the lowest sheet resistance of 2.5 x 10(4) Omega.sq.(-1). (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Morita, Takahiro; Hagiwara, Manabu; Fujihara, Shinobu] Keio Univ, Dept Appl Chem, Yokohama, Kanagawa 2238522, Japan; [Ueno, Shintaro] Univ Yamanashi, Grad Sch, Dept Interdisciplinary Res, Kofu, Yamanashi 4008510, Japan; [Hosono, Eiji; Zhou, Haoshen] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Hosono, E (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	e-hosono@aist.go.jp; shinobu@applc.keio.ac.jp	Hosono, Eiji/M-8402-2013				Al Dahoudi N, 2014, B MATER SCI, V37, P1243, DOI 10.1007/s12034-014-0068-4; SERNELIUS BE, 1988, PHYS REV B, V37, P10244, DOI 10.1103/PhysRevB.37.10244; Sugahara T, 2014, J AM CERAM SOC, V97, P3238, DOI 10.1111/jace.13116; Kahraman S, 2013, J CRYST GROWTH, V363, P86, DOI 10.1016/j.jcrysgro.2012.10.018; Feng XJ, 2004, J AM CHEM SOC, V126, P62, DOI 10.1021/ja038636o; Wagata H, 2012, J MATER CHEM, V22, P20706, DOI 10.1039/c2jm33584k; Vayssieres L, 2003, ADV MATER, V15, P464, DOI 10.1002/adma.200390108; Muller J, 2004, SOL ENERGY, V77, P917, DOI 10.1016/j.solener.2004.03.015; Gondoni P, 2012, THIN SOLID FILMS, V520, P4707, DOI 10.1016/j.tsf.2011.10.072; Xu F, 2011, ENERG ENVIRON SCI, V4, P818, DOI 10.1039/c0ee00448k; Houng B, 2012, CERAM INT, V38, P801, DOI 10.1016/j.ceramint.2011.08.007; Yen WT, 2010, THIN SOLID FILMS, V518, P3882, DOI 10.1016/j.tsf.2009.10.149; Liu X, 2004, J APPL PHYS, V95, P3141, DOI 10.1063/1.1646440; Yamabi S, 2002, J MATER CHEM, V12, P3773, DOI 10.1039/B205384E; Grundmann M, 2010, PHYS STATUS SOLIDI A, V207, P1437, DOI 10.1002/pssa.200983771; Damm H, 2014, CHEM MATER, V26, P5839, DOI 10.1021/cm501820a; Lin SS, 2005, SURF COAT TECH, V190, P39, DOI 10.1016/j.surfcoat.2004.03.022; Park SM, 2006, THIN SOLID FILMS, V513, P90, DOI 10.1016/j.tsf.2006.01.051; Gorla CR, 1999, J APPL PHYS, V85, P2595, DOI 10.1063/1.369577; Gong L, 2010, SOL ENERG MAT SOL C, V94, P937, DOI 10.1016/j.solmat.2010.02.026; Daneshvar N, 2004, J PHOTOCH PHOTOBIO A, V162, P317, DOI 10.1016/s1010-6030(03)00378-2; Hosono E, 2012, CRYST GROWTH DES, V12, P2923, DOI 10.1021/cg300116h; Asakuma N, 2003, THIN SOLID FILMS, V445, P284, DOI 10.1016/S0040-6090(03)01162-3; Chae GS, 2001, JPN J APPL PHYS 1, V40, P1282, DOI 10.1143/JJAP.40.1282; Chen WJ, 2012, PROCEDIA ENGINEER, V36, P54, DOI 10.1016/j.proeng.2012.03.010; Varol SF, 2014, RSC ADV, V4, P56645, DOI 10.1039/c4ra11324a; HU JH, 1992, J APPL PHYS, V71, P880, DOI 10.1063/1.351309; Lee S, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/11/115007; Minami T, 2005, SEMICOND SCI TECH, V20, pS35, DOI 10.1088/0268-1242/20/4/004; MINAMI T, 1985, JPN J APPL PHYS 2, V24, pL605, DOI 10.1143/JJAP.24.L605; Shukla RK, 2006, J CRYST GROWTH, V294, P427, DOI 10.1016/j.jcrysgro.2006.06.035; Tseng YH, 2013, THIN SOLID FILMS, V534, P186, DOI 10.1016/j.tsf.2013.02.134; Ueno S, 2011, J ELECTROCHEM SOC, V158, pK1, DOI 10.1149/1.3509161; Vunnam S, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/19/195301; Wang B., 2007, J CRYST GROWTH, V304, P730; Wang T, 2011, CRYSTENGCOMM, V13, P2661, DOI 10.1039/c0ce00890g	36	1	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					329	334		10.2109/jcersj2.123.329		6	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500006		
J	Kim, YH; Osada, M; Dong, L; Kim, HJ; Sasaki, T				Kim, Yoon-Hyun; Osada, Minoru; Dong, Lei; Kim, Hyung-Jun; Sasaki, Takayoshi			High-temperature dielectric responses of molecularly-thin titania nanosheet	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Titania nanosheet; Nanodielectric; Thermal stability; In-situ characterization	PEROVSKITE NANOSHEETS; SINGLE-CRYSTALS; FILMS; TIO2; THICKNESS; ANATASE; CAPACITORS; DEPOSITION; CONSTANT; LAYER	We have investigated high-temperature dielectric properties of titania nanosheet (Ti0.87O2), a new class of high-kappa nanomaterials derived from the exfoliation of layered compounds. In-situ characterizations using atomic force microscopy indicate a robust insulating property in a monolayer form of Ti0.87O2 nanosheets even at 200 degrees C. Furthermore, layer-by-layer assembled nanocapacitors exhibit both size-free high-epsilon(r) characteristic (similar to 120) and high insulation resistance (similar to 10(-7) A/cm(2)) at high temperatures up to 250 degrees C. The simultaneous improvement of epsilon(r) and thermal stability in high-kappa nanodielectrics is of critical importance for applications of high-temperature capacitors. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Kim, Yoon-Hyun; Osada, Minoru; Dong, Lei; Kim, Hyung-Jun; Sasaki, Takayoshi] NIMS, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Kim, Yoon-Hyun; Osada, Minoru; Dong, Lei] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjyu Ku, Tokyo 1698555, Japan	Osada, M (reprint author), NIMS, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan.	osada.minoru@nims.go.jp			World Premier International Research Center Initiative on Materials Nanoarchitectonics (WPI-MANA; MEXT; CREST; JST; JSPS, Japan	This work was partly supported by World Premier International Research Center Initiative on Materials Nanoarchitectonics (WPI-MANA), MEXT, CREST, JST, and the Grant-in-Aid for Scientific Research, JSPS, Japan.	SHIRANE G, 1952, J PHYS SOC JPN, V7, P5, DOI 10.1143/JPSJ.7.5; Osada M, 2012, ADV MATER, V24, P210, DOI 10.1002/adma.201103241; Osada M, 2006, ADV MATER, V18, P1023, DOI 10.1002/adma.200501224; Kadoshima M, 2003, THIN SOLID FILMS, V424, P224, DOI 10.1016/S0040-6090(02)01105-7; Takahashi K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2336626; Kim SK, 2010, ADV FUNCT MATER, V20, P2989, DOI 10.1002/adfm.201000599; BETHE K, 1971, MATER RES BULL, V6, P209, DOI 10.1016/0025-5408(71)90032-8; Wilk GD, 2001, J APPL PHYS, V89, P5243, DOI 10.1063/1.1361065; Fukuda K, 2007, J AM CHEM SOC, V129, P202, DOI 10.1021/ja0668116; Parker CB, 2002, APPL PHYS LETT, V81, P340, DOI 10.1063/1.1490148; Chang LW, 2009, ADV MATER, V21, P4911, DOI 10.1002/adma.200901756; Tanaka T, 2003, CHEM MATER, V15, P3564, DOI 10.1021/cm034307j; Johnson RW, 2004, IEEE T ELECTRON PACK, V27, P164, DOI 10.1109/TEPM.2004.843109; Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l; Akatsuka K, 2009, ACS NANO, V3, P1097, DOI 10.1021/nn900104u; Kim SK, 2004, APPL PHYS LETT, V85, P4112, DOI 10.1063/1.1812832; Kim YH, 2014, ACS APPL MATER INTER, V6, P19510, DOI 10.1021/am506629g; Sakai N, 2004, J AM CHEM SOC, V126, P5851, DOI 10.1021/ja0394582; Hammoud A. N., 1989, ANN REP C EL INS DIE, P459; Hwang CS, 2002, J APPL PHYS, V92, P432, DOI 10.1063/1.1483105; Kimura J, 2013, J APPL PHYS, V114, DOI 10.1063/1.4811816; Li BW, 2014, ACS NANO, V8, P5449, DOI 10.1021/nn502014c; Osada M, 2008, JPN J APPL PHYS, V47, P7556, DOI 10.1143/JJAP.47.7556; PARKER RA, 1961, PHYS REV, V124, P1719, DOI 10.1103/PhysRev.124.1719; Randall C. A., 2009, IEEE INT PULS POW C, P346; TANG H, 1994, J APPL PHYS, V75, P2042, DOI 10.1063/1.356306	26	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					335	339		10.2109/jcersj2.123.335		5	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500007		
J	Tanaka, S; Sano, K; Imai, M; Uematsu, K; Harada, T; Doshida, Y				Tanaka, Satoshi; Sano, Keisuke; Imai, Mitsuru; Uematsu, Keizo; Harada, Tomohiro; Doshida, Yutaka			Crystal-oriented (Bi-0.5, Na-0.5)(0.85)-Ba0.15TiO3 ceramics prepared by colloidal processing in rotating high magnetic field	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Piezoelectric material; Orientation	FREE PIEZOELECTRIC CERAMICS; BISMUTH TITANATE CERAMICS; BARIUM NIOBATE CERAMICS; LEAD-FREE PIEZOCERAMICS; ELECTRICAL-PROPERTIES; FABRICATION; ORIENTATION; TEMPERATURE; SYSTEM; SLURRY	Crystal-oriented (Bi-0.5, Na-0.5)(0.85)-Ba0.15TiO3 (BNBT15) ceramics with a perovskite crystal structure were prepared by colloidal processing in a rotating high magnetic field to improve their piezoelectric properties. The presence of BaTiO3 leads to anisotropic crystal lattices, allowing crystal-oriented BNBT15 ceramics to be successfully fabricated, using a rotating magnetic field to orient the c- and a-axes of the crystal in the powder compact. The phase transformation that occurred during sintering redistributed the c-axis oriented structure along both the a- and c-axes. Again, the c-axis was enhanced by electrical field polarization. A piezoelectric constant of 122 pC/N was obtained, which is larger than the 88 pC/N of BNBT ceramics. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Tanaka, Satoshi; Sano, Keisuke; Imai, Mitsuru; Uematsu, Keizo] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan; [Harada, Tomohiro; Doshida, Yutaka] Taiyo Yuden Co Ltd, R&D Ctr, Takasaki, Gunma 3703347, Japan	Tanaka, S (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka Machi, Nagaoka, Niigata 9402188, Japan.	stanaka@vos.nagaokaut.ac.jp			Leading Industrial Technology Development Project Grant Funds of the New Energy and Industrial Technology Development Organization (NEDO) of Japan	This work was partially supported by Leading Industrial Technology Development Project Grant Funds of the New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Tanaka S, 2010, J CERAM SOC JPN, V118, P722, DOI 10.2109/jcersj2.118.722; Hiruma Y, 2008, J APPL PHYS, V103, DOI 10.1063/1.2903498; Zhang SJ, 2007, IEEE T ULTRASON FERR, V54, P910, DOI 10.1109/TUFFC.2007.336; TAKENAKA T, 1991, JPN J APPL PHYS 1, V30, P2236, DOI 10.1143/JJAP.30.2236; Qu YF, 2005, MAT SCI ENG B-SOLID, V121, P148, DOI 10.1016/j.mseb.2005.03.023; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Nagata H, 2003, JPN J APPL PHYS 1, V42, P7401, DOI 10.1143/JJAP.42.7401; Rodel J, 2009, J AM CERAM SOC, V92, P1153, DOI 10.1111/j.1551-2916.2009.03061.x; Tanaka S, 2007, J AM CERAM SOC, V90, P3503, DOI 10.1111/j.1551-2916.2007.01978.x; Xu CG, 2008, SOLID STATE SCI, V10, P934, DOI 10.1016/j.solidstatesciences.2007.11.003; LOTGERING FK, 1959, J INORG NUCL CHEM, V9, P113, DOI 10.1016/0022-1902(59)80070-1; Picht G, 2010, J EUR CERAM SOC, V30, P3445, DOI 10.1016/j.jeurceramsoc.2010.07.042; Hiruma Y, 2008, JPN J APPL PHYS, V47, P7659, DOI [10.1143/JJAP.47.7659, 10.1143/JJAP.47.7059]; TAKENAKA T, 1990, FERROELECTRICS, V106, P375, DOI 10.1080/00150199008214612; Takenaka T, 2005, J EUR CERAM SOC, V25, P2693, DOI 10.1016/j.jeurceramsoc.2005.03.125; Shrout TR, 2007, J ELECTROCERAM, V19, P113, DOI 10.1007/s10832-007-9047-0; Chu BJ, 2002, J EUR CERAM SOC, V22, P2115, DOI 10.1016/S0955-2219(02)00027-4; Barns H. A., 1989, INTRO RHEOLOGY; Doshida Y., 2005, 12 US JAP SEM DIEL P, P123; Doshida Y, 2004, JPN J APPL PHYS 1, V43, P6645, DOI 10.1143/JJAP.43.6645; Doshida Y, 2006, JPN J APPL PHYS 1, V45, P7460, DOI 10.1143/JJAP.45.7460; Frank G. V., 2000, J RHEOL, V44, P459; Furushima R, 2011, J CERAM SOC JPN, V119, P198, DOI 10.2109/jcersj2.119.198; Hiruma Y, 2009, J APPL PHYS, V105, DOI 10.1063/1.3115409; Hu DW, 2014, J EUR CERAM SOC, V34, P1169, DOI 10.1016/j.jeurceramsoc.2013.11.031; Hunter R. J., 2008, INTRO PARTICLE TECHN, V2nd; Li HD, 2003, JPN J APPL PHYS 1, V42, P7387, DOI 10.1143/JJAP.42.7387; Makiya A, 2002, KEY ENG MAT, V206-2, P445; Makiya A, 2003, J CERAM SOC JPN, V111, P702, DOI 10.2109/jcersj.111.702; Messing G. L., 2004, CRIT REV SOLID STATE, V29, P46; Nagata H, 2010, J CERAM SOC JPN, V118, P726, DOI 10.2109/jcersj2.118.726; Pettry J. R. G., 2004, J EUR CERAM SOC, V24, P1165; Shimizu H, 2008, JPN J APPL PHYS, V47, P7693, DOI 10.1143/JJAP.47.7693; Shimizu H, 2010, KEY ENG MAT, V421-422, P21, DOI 10.4028/www.scientific.net/KEM.421-422.21; Shimizu H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD02; Tabara K, 2007, J CERAM SOC JPN, V115, P237, DOI 10.2109/jcersj.115.237; Takahashi T, 2013, J CERAM SOC JPN, V121, P411, DOI 10.2109/jcersj2.121.411; Takenaka T., 1999, Ferroelectrics, V230, DOI 10.1080/00150199908214902; Takenaka T., 1997, Ferroelectrics, V196, DOI 10.1080/00150199708224156; TAKENAKA T, 1989, FERROELECTRICS, V95, P153, DOI 10.1080/00150198908245194; Tanaka S, 2009, J EUR CERAM SOC, V29, P955, DOI 10.1016/j.jeurceramsoc.2008.07.025; Tanaka S, 2006, J MATER RES, V21, P703, DOI 10.1557/JMR.2006.0098; Tanaka S., 2011, CERAM T, V226, P91; Tanaka S, 2014, J EUR CERAM SOC, V34, P3723, DOI 10.1016/j.jeurceramsoc.2014.05.006; Tanaka S, 2007, CERAM TRANS, V198, P243; Tanaka S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/1/014602; Tanaka S, 2011, IOP Conference Series: Materials Science and Engineering, V20, DOI 10.1088/1757-899X/20/1/012002; Tanaka S, 2009, CERAM TRANS, V204, P39, DOI 10.1002/9780470528990.ch6	48	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					340	344		10.2109/jcersj2.123.340		5	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500008		
J	Watanabe, S; Kodera, T; Ogihara, T				Watanabe, Shizuharu; Kodera, Takayuki; Ogihara, Takashi			Preparation and sintering of tellurium-doped silver powder for electrodes in silicon solar cells	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Silicon solar cell; Silver pastes; Ag thick film; Eutectic alloy; Contact resistance	GLASS FRIT; CONTACTS	Silver electrodes were prepared on the silicon wafer surface using the wetness of an alloy liquid phase produced in the sintering process of the silver powder. Tellurium, which forms a low-melting-point alloy with silver, was doped to the silver powder, and the physical and chemical properties of the synthesized tellurium-doped silver powder were investigated. When silver and tellurium powders were mixed to produce a low-melting-point eutectic crystalline mixture with a silver-to-tellurium ratio of 33.0:67.0 (mol%), a rapid mutual diffusion occurred by heating, following which fusion occurred at the eutectic temperature. When tellurium-doped silver paste prepared with a silver-to-tellurium ratio of 98.5:1.5 (mol%) was printed onto a silicon wafer with texture formed on the surface and then sintered, wetting due to a phase which have been a liquid phase during the sintering process was confirmed at the interface between the silver electrodes and wafer. Silicon was dispersed in silver and tellurium in this phase, and physical contacts of a phase composed of silver, tellurium, and silicon were confirmed between the silver electrodes and wafer. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Watanabe, Shizuharu] Univ Fukui, Grad Sch Engn Adv Interdisciplinary Sci & Technol, Fukui 9108507, Japan; [Kodera, Takayuki; Ogihara, Takashi] Univ Fukui, Grad Sch Engn Mat Sci & Engn, Fukui 9108507, Japan	Ogihara, T (reprint author), Univ Fukui, Grad Sch Engn Mat Sci & Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	ogihara@matse.u-fukui.ac.jp					Hong KK, 2009, MET MATER INT, V15, P307, DOI 10.1007/s12540-009-0307-1; Ionkin AS, 2011, ACS APPL MATER INTER, V3, P606, DOI 10.1021/am1011996; Butler KT, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.235307; Hilali MM, 2006, J ELECTRON MATER, V35, P2041, DOI 10.1007/s11664-006-0311-x; Park H, 2010, CURR APPL PHYS, V10, P113, DOI 10.1016/j.cap.2009.05.005; Hong KK, 2009, SOL ENERG MAT SOL C, V93, P898, DOI 10.1016/j.solmat.2008.10.021; Dobrzanski L.A., 2010, J ACHIEVEMENTS MAT M, V41, P57; Ennart L., 1989, CERAM ENG SCI P, V10, P1655; Iida T., 1994, J JPN WELD SOC, V63, P140; Karakaya I., 1991, J PHASE EQUILIB, V12, P56, DOI 10.1007/BF02663676; Li ZG, 2011, J APPL PHYS, V110, DOI 10.1063/1.3642956; Schroder D. K., 2006, SEMICONDUCTOR MAT DE, V3rd, P138; Vinod PN, 2011, J MATER SCI-MATER EL, V22, P1248, DOI 10.1007/s10854-011-0295-z; Xu YB, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.11RH02	14	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					345	350		10.2109/jcersj2.123.345		6	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500009		
J	Ueno, S; Sakamoto, Y; Taguchi, H; Nakashima, K; Wada, S				Ueno, Shintaro; Sakamoto, Yasunao; Taguchi, Hiroya; Nakashima, Kouichi; Wada, Satoshi			Microstructures of lanthanum nickel oxide particles with crystal facets synthesized in molten chlorides	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Lanthanum nickel oxide; Sol-gel method; Molten salts; Morphological control; Facet control; Crystal growth	LANIO3 THIN-FILMS; CHEMICAL SOLUTION DEPOSITION; SOL-GEL METHOD; COMBINED COPRECIPITATION; ELECTRICAL-PROPERTIES; SALT REACTIONS; ELECTRODE; POWDERS; CRYSTALLIZATION; SUBSTRATE	LaNiO3 cuboid particles were successfully synthesized by the sol-gel method in the presence of molten chlorides. The precursor gels derived from the La(NO3)(3) and Ni(CH3COO)(2) solution were heated with molten chloride, NaCl or KCl, above the melting point of respective molten salts. The formation reaction of LaNiO3 was completed below the melting point of these chlorides, and then crystal growth process might be facilitated in liquid phase provided by the molten chlorides due to an increase in the mass-transportation rate. The formation of the submicron to micron-sized LaNiO3 cuboid particles, which are enclosed by {100} facets of pseudocubic perovskite, is confirmed by the electron microscope observations and the electron diffraction analysis. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Ueno, Shintaro; Sakamoto, Yasunao; Taguchi, Hiroya; Nakashima, Kouichi; Wada, Satoshi] Univ Yamanashi, Grad Sch, Dept Interdisciplinary Res, Kofu, Yamanashi 4008510, Japan	Ueno, S (reprint author), Univ Yamanashi, Grad Sch, Dept Interdisciplinary Res, 4-4-37 Takeda, Kofu, Yamanashi 4008510, Japan.	sueno@yamanashi.ac.jp	Wada, Satoshi/G-1235-2015	Wada, Satoshi/0000-0003-1276-6620			Xiang PH, 2005, MATER LETT, V59, P1876, DOI 10.1016/j.matlet.2005.02.003; Miyazaki H, 2004, J EUR CERAM SOC, V24, P1005, DOI 10.1016/S0955-2219(03)00382-0; Meng XJ, 2000, J CRYST GROWTH, V220, P100, DOI 10.1016/S0022-0248(00)00742-9; Zinkevich M, 2004, J ALLOY COMPD, V375, P147, DOI 10.1016/j.jallcom.2003.11.138; Vradman L, 2013, PHYS CHEM CHEM PHYS, V15, P10914, DOI 10.1039/c3cp50713k; Dominguez-Crespo MA, 2011, INT J HYDROGEN ENERG, V36, P135, DOI 10.1016/j.ijhydene.2010.09.064; Li AD, 1997, APPL PHYS LETT, V70, P1616, DOI 10.1063/1.118633; RAJEEV KP, 1991, SOLID STATE COMMUN, V79, P591, DOI 10.1016/0038-1098(91)90915-I; SATYALAKSHMI KM, 1993, APPL PHYS LETT, V62, P1233, DOI 10.1063/1.109612; ARENDT RH, 1979, MATER RES BULL, V14, P703, DOI 10.1016/0025-5408(79)90055-2; Chen MS, 1996, APPL PHYS LETT, V68, P1430, DOI 10.1063/1.116103; CHEN MS, 1995, JPN J APPL PHYS 1, V34, P4870, DOI 10.1143/JJAP.34.4870; HOFER HE, 1993, J ELECTROCHEM SOC, V140, P2889; Kao CF, 1999, CERAM INT, V25, P375, DOI 10.1016/S0272-8842(98)00047-9; Kao CF, 2000, CERAM INT, V26, P237, DOI 10.1016/S0272-8842(99)00048-6; Lee HY, 2005, MATER CHEM PHYS, V92, P585, DOI 10.1016/j.matchemphys.2005.02.008; Mao CL, 2007, MATER CHEM PHYS, V106, P164, DOI 10.1016/j.matchemphys.2007.06.052; Matei C, 2007, PROG SOLID STATE CH, V35, P203, DOI 10.1016/j.progsolidstchem.2007.01.002; Miyake S, 2001, J EUR CERAM SOC, V21, P1525, DOI 10.1016/S0955-2219(01)00056-5; OBAYASHI H, 1975, JPN J APPL PHYS, V14, P330, DOI 10.1143/JJAP.14.330; Predoana L, 2007, J EUR CERAM SOC, V27, P4407, DOI [10.1016/j.jeurceramsoc.2007.02.161, 10.1016/j.jeurceramsoc.2006.02.161]; Sun L, 1997, J MATER RES, V12, P931, DOI 10.1557/JMR.1997.0133; Suzuki H, 2006, J EUR CERAM SOC, V26, P1953, DOI 10.1016/j.jeurceramsoc.2005.09.037; Suzuki H, 2007, J EUR CERAM SOC, V27, P3769, DOI 10.1016/j.jeurceramsoc.2007.02.026; Tseng TF, 1996, JPN J APPL PHYS 1, V35, P4743, DOI 10.1143/JJAP.35.4743; Ueno K, 2001, JPN J APPL PHYS 1, V40, P6049, DOI 10.1143/JJAP.40.6049; Wang YP, 2006, MATER RES BULL, V41, P1565, DOI 10.1016/j.materresbull.2005.11.017; WOLD A, 1957, J AM CHEM SOC, V79, P4911, DOI 10.1021/ja01575a022; Yang Z, 2005, J SOLID STATE CHEM, V178, P1157, DOI 10.1016/j.jssc.2005.01.022	29	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					351	354		10.2109/jcersj2.123.351		4	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500010		
J	Kim, SW; Uematsu, K; Toda, K; Sato, M				Kim, Sun Woog; Uematsu, Kazuyoshi; Toda, Kenji; Sato, Mineo			Viscosity analysis of alkali metal carbonate molten salts at high temperature	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Viscosity analysis; Alkali metal carbonate molten salts; Rotation method	THERMAL-ENERGY STORAGE; SOLAR POWER-PLANTS; ENHANCEMENT	The viscosities of unary, binary, and ternary eutectic alkali metal carbonate molten salts were measured for the first time by a rotation method using a high-temperature rheometer system and the reliability of the viscosity values was evaluated. The viscosity values obtained in this study are similar to that reported by Sato's research group, which is considered to have the highest reliability among the studies reported till date. The standard errors in the viscosity values at each temperature are less than +/- 5%. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Kim, Sun Woog; Toda, Kenji] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Uematsu, Kazuyoshi; Sato, Mineo] Niigata Univ, Dept Chem & Chem Engn, Niigata 9502181, Japan	Toda, K (reprint author), Niigata Univ, Grad Sch Sci & Technol, 8050 Ikarashi 2 Nocho, Niigata 9502181, Japan.	ktoda@eng.niigata-u.ac.jp	KIM, Sun Woog/O-5366-2015		Council for Science, Technology and Innovation(CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP); JST	This work was supported by Council for Science, Technology and Innovation(CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), "energy carrier" (Funding agency: JST).	Abalin SS, 2000, NUCL ENG DES, V200, P107, DOI 10.1016/S0029-5493(00)00238-7; Olivares RI, 2012, SOL ENERGY, V86, P2576, DOI 10.1016/j.solener.2012.05.025; Cavallaro F, 2010, APPL ENERG, V87, P496, DOI 10.1016/j.apenergy.2009.07.009; Fernandez AG, 2014, APPL ENERG, V119, P131, DOI 10.1016/j.apenergy.2013.12.061; Ge ZW, 2014, PARTICUOLOGY, V15, P77, DOI 10.1016/j.partic.2013.09.002; Zhao Y, 2006, PHYSICA A, V367, P42, DOI 10.1016/j.physa.2005.11.020; Peng Q, 2013, APPL ENERG, V112, P682, DOI 10.1016/j.apenergy.2012.10.048; Acem Z, 2010, APPL THERM ENG, V30, P1580, DOI 10.1016/j.applthermaleng.2010.03.013; Kuravi S, 2013, PROG ENERG COMBUST, V39, P285, DOI 10.1016/j.pecs.2013.02.001; Guillot S, 2012, APPL ENERG, V94, P174, DOI 10.1016/j.apenergy.2011.12.057; Cardenas B, 2013, RENEW SUST ENERG REV, V27, P724, DOI 10.1016/j.rser.2013.07.028; Wang T, 2013, APPL ENERG, V102, P1422, DOI 10.1016/j.apenergy.2012.09.001; Flueckiger SM, 2012, SOL ENERGY, V86, P1621, DOI 10.1016/j.solener.2012.02.028; Serrano-Lopez R, 2013, CHEM ENG PROCESS, V73, P87, DOI 10.1016/j.cep.2013.07.008; JANZ GJ, 1963, J ELECTROCHEM SOC, V110, P452, DOI 10.1149/1.2425785; Khare S, 2012, SOL ENERG MAT SOL C, V107, P20, DOI 10.1016/j.solmat.2012.07.020; Luzzi A, 1999, SOL ENERGY, V66, P91, DOI 10.1016/S0038-092X(98)00108-X; Merzlyakov AV, 2011, J NUCL MATER, V419, P361, DOI 10.1016/j.jnucmat.2011.06.030; Sato Y., 1999, NETSU BUSSEI, V13, P156; Sato Y., 1999, NETSU BUSSEI, V13, P162; Steinmann Wolf-Dieter, 2008, Journal of Solar Energy Engineering, V130, DOI 10.1115/1.2804624; Zhang P, 2015, APPL ENERG, V137, P758, DOI 10.1016/j.apenergy.2014.10.004	22	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					355	358		10.2109/jcersj2.123.355		4	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500011		
J	Mitsumori, T; Yano, K; Fujihara, R; Sasaki, K; Yoshinaga, M				Mitsumori, Taku; Yano, Kazuki; Fujihara, Ryunosuke; Sasaki, Kazuya; Yoshinaga, Masashi			Effects of microwave irradiation heating in the homogeneous precipitation method using the reductant generated by hydrolysis of urea in an autoclave under high pressure	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Microwave heating; Urea precipitation; Hydrothermal synthesis; Yttria-stabilized zirconia	PARTICLES	In order to synthesize the fine composite oxide powder with uniform composition and good sinterability, reduce the alkaline effluent, and increase the process flexibility by shorten the precipitation time, improvement of the homogeneous precipitation method using the reductant generated by hydrolysis of urea is investigated. Yttria-stabilized zirconia (YSZ) fine powder, which is representative of complex oxide consisting of multiple metal ion, is synthesized by the homogenous precipitation method under high pressure in an autoclave with the microwave irradiation heating. Effects of microwave irradiation heating on microstructure, size, composition uniformity, and sinterability of the powder particles are elucidated. By using the improved method, the hydroxide powder, which is a precursor of the YSZ powder, is generated quickly even when the amount of urea used is not large excess. The YSZ powder particle synthesized by this method is fine and has the uniform composition and good sinterability. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Mitsumori, Taku; Sasaki, Kazuya] Tokai Univ, Grad Sch Engn, Course Mech Engn, Hiratsuka, Kanagawa 2591292, Japan; [Yano, Kazuki; Fujihara, Ryunosuke; Sasaki, Kazuya; Yoshinaga, Masashi] Tokai Univ, Sch Engn, Dept Prime Mover Engn, Hiratsuka, Kanagawa 2591292, Japan	Yoshinaga, M (reprint author), Tokai Univ, Sch Engn, Dept Prime Mover Engn, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	yoshinaga@tokai-u.jp					Wang ZZ, 2014, CERAM INT, V40, P15801, DOI 10.1016/j.ceramint.2014.07.106; Wang LF, 1999, J COLLOID INTERF SCI, V218, P545, DOI 10.1006/jcis.1999.6463; Xin XS, 2006, J ALLOY COMPD, V425, P69, DOI 10.1016/j.jallcom.2006.01.047; Sohn S, 2004, POWDER TECHNOL, V142, P136, DOI 10.1016/j.powtec.2004.03.013; Guo XF, 2009, SOLID STATE IONICS, V180, P386, DOI 10.1016/j.ssi.2008.11.021; Zhao Y. L., 2014, HYDROGEN ENERGY, V29, P889	6	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					359	362		10.2109/jcersj2.123.359		4	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500012		
J	Nakashima, K; Ueno, S; Wada, S				Nakashima, Kouichi; Ueno, Shintaro; Wada, Satoshi			Microwave synthesis of KNbO3 nanocubes	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						KNbO3; Nanocube; Microwave synthesis; Perovskite oxide	HYDROXIDE-MEDIATED APPROACH; LOW-TEMPERATURE; SOLVOTHERMAL METHOD; HYDROTHERMAL METHOD; NANOCRYSTALS; TITANATE	Potassium niobate (KNbO3) nanocubes were obtained by microwave synthesis. The synthesis was performed using niobium oxide (Nb2O5) and potassium hydroxide (KOH) as starting materials. Water was used as the reaction medium. KNbO3 particles with perovskite structure were confirmed from X-ray diffraction (XRD). The morphology of the KNbO3 was investigated using transmission electron microscopy (TEM). KNbO3 nanocubes were synthesized by microwave synthesis at low temperature. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Nakashima, Kouichi; Ueno, Shintaro; Wada, Satoshi] Univ Yamanashi, Dept Interdisciplinary Res, Grad Sch, Kofu, Yamanashi 4008510, Japan	Nakashima, K (reprint author), Univ Yamanashi, Dept Interdisciplinary Res, Grad Sch, 4-4-37 Takeda, Kofu, Yamanashi 4008510, Japan.	knakashima@yamanashi.ac.jp	Wada, Satoshi/G-1235-2015	Wada, Satoshi/0000-0003-1276-6620			Adireddy S, 2010, CHEM MATER, V22, P1946, DOI 10.1021/cm9038768; da Silva LF, 2012, CRYSTENGCOMM, V14, P4068, DOI 10.1039/c2ce25229e; Liu H, 2006, NANO LETT, V6, P1535, DOI 10.1021/nl061253e; Moreira ML, 2012, J PHYS CHEM C, V116, P24792, DOI 10.1021/jp306638r; Dang F, 2011, CRYSTENGCOMM, V13, P3878, DOI 10.1039/c1ce05296a; Tao AR, 2008, SMALL, V4, P310, DOI 10.1002/smll.200701295; Nakashima K, 2013, CERAM INT, V39, P3231, DOI 10.1016/j.ceramint.2012.10.009; Nakashima K, 2013, J CRYST GROWTH, V376, P35, DOI 10.1016/j.jcrysgro.2013.04.022; da Silva LF, 2013, PHYS CHEM CHEM PHYS, V15, P12386, DOI 10.1039/c3cp50643f; Murphy CJ, 2002, SCIENCE, V298, P2139, DOI 10.1126/science.1080007; Nakashima K, 2014, J CERAM SOC JPN, V122, P547, DOI 10.2109/jcersj2.122.547; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Nakashima K, 2011, J CERAM SOC JPN, V119, P532, DOI 10.2109/jcersj2.119.532; Wang X, 2005, NATURE, V437, P121, DOI 10.1038/nature03968; Fujinami K., 2010, NANOSCALE, V2, P2080; Hou B, 2006, POWDER TECHNOL, V170, P26, DOI 10.1016/j.powtec.2006.08.010; Lopez-Juarez R, 2014, CERAM INT, V40, P14757, DOI 10.1016/j.ceramint.2014.06.065; Nakashima K, 2013, J CERAM SOC JPN, V121, P693, DOI 10.2109/jcersj2.121.693; Nakashima K., 2012, J SOC INORG MAT JAPA, V19, P97; Nozawa A, 2010, KEY ENG MAT, V421-422, P514, DOI 10.4028/www.scientific.net/KEM.421-422.514; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Swaminathan V, 2010, ACS APPL MATER INTER, V2, P3037, DOI 10.1021/am1004865	22	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					363	366		10.2109/jcersj2.123.363		4	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500013		
J	Haneda, M; Taguchi, R; Hattori, M				Haneda, Masaaki; Taguchi, Rikiya; Hattori, Masatomo			Influence of particle morphology on catalytic performance of CeO2/ZrO2 for soot oxidation	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Soot oxidation; CeO2/ZrO2; Catalyst; Morphology; Active oxygen species	OXYGEN STORAGE; CERIA-ZIRCONIA; CAPACITY	The effect of size and morphology of CeO2/ZrO2 catalysts, prepared by impregnation [CZ(IMP)], coprecipitation [CZ(CP)] and deposition-precipitation [CZ(DP)] methods, on the soot oxidation performance was investigated. TEM observation revealed that CeO2 particles are well dispersed with the size of 10nm on ZrO2 support for CZ(IMP). In case of CZ(CP), the agglomeration of CeO2-ZrO2 solid solution particles was recognized. On the other hand, large CeO2 particles (50 nm) were independently present in CZ(DP). Soot oxidation activity of CeO2/ZrO2 was strongly dependent on the morphology of CeO2 particles and decreased in the order of CZ(IMP) > CZ(CP) > CZ(DP). From isotopic transient kinetics analysis using O-18(2), the lattice oxygen in the surface region of CeO2 particles in CZ(IMP) was highly reactive compared with those in the surface and bulk of CeZrOx solid solution in CZ(CP), resulting in high soot oxidation activity. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Haneda, Masaaki; Taguchi, Rikiya; Hattori, Masatomo] Nagoya Inst Technol, Adv Ceram Res Ctr, Tajimi, Gifu 5070071, Japan	Haneda, M (reprint author), Nagoya Inst Technol, Adv Ceram Res Ctr, 10-6-29 Asahigaoka, Tajimi, Gifu 5070071, Japan.	haneda.masaaki@nitech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan;  [26550061]	This study was partly supported by a Grant-in-Aid for Scientific Research (No. 26550061) and by a project of the Gifu Technical Innovation Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors thank Mr. Hisashi Hibino of Advanced Ceramics Research Center for taking the TEM micrograph of the sample.	Sugiura M, 2005, B CHEM SOC JPN, V78, P752, DOI 10.1246/bcsj.78.752; Neeft JPA, 1996, APPL CATAL B-ENVIRON, V8, P57, DOI 10.1016/0926-3373(95)00057-7; Reddy BA, 2002, J PHYS CHEM B, V106, P10964, DOI 10.1021/jp021195v; Machida M, 2008, CHEM MATER, V20, P4489, DOI 10.1021/cm800832w; Trovarelli A, 1997, J CATAL, V169, P490, DOI 10.1006/jcat.1997.1705; Piumetti M, 2015, APPL CATAL B-ENVIRON, V165, P742, DOI 10.1016/j.apcatb.2014.10.062; van Setten BAAL, 2001, CATAL REV, V43, P489, DOI 10.1081/CR-120001810; Dong F, 2004, CATAL TODAY, V90, P223, DOI 10.1016/j.cattod.2004.04.030; Krishna K, 2007, APPL CATAL B-ENVIRON, V75, P201, DOI 10.1016/j.apcatb.2007.04.007; Yamazaki K, 2011, J CATAL, V282, P289, DOI 10.1016/j.jcat.2011.07.001; YAO HC, 1984, J CATAL, V86, P254, DOI 10.1016/0021-9517(84)90371-3; Daturi M, 2000, J PHYS CHEM B, V104, P9186, DOI 10.1021/jp000670r; Harada K, 2011, B CHEM SOC JPN, V84, P1374, DOI 10.1246/bcsj.20110250; Kamiuchi N, 2014, CATAL TODAY, V232, P179, DOI 10.1016/j.cattod.2013.10.044; Setiabudi A, 2004, APPL CATAL B-ENVIRON, V51, P9, DOI 10.1016/j.apcath.2004.01.005; Trovarelli A, 1996, CATAL REV, V38, P439, DOI 10.1080/01614949608006464	16	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					414	418		10.2109/jcersj2.123.414		5	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500022		
J	Zhang, JF; Zhang, X; Li, GY; Wu, YP; Goto, T				Zhang, Jianfeng; Zhang, Xin; Li, Gaiye; Wu, Yuping; Goto, Takashi			Densification of hBN with the as-coated SiO2 nanolayer by rotary chemical vapor deposition	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						SiO2 nanolayer; Hexagonal boron nitride (hBN); Rotary chemical vapor deposition; Spark plasma sintering	HEXAGONAL BORON-NITRIDE; MECHANICAL-PROPERTIES; COMPOSITE CERAMICS; NI NANOPARTICLE; CBN POWDER; MULLITE; BN	SiO2 nanolayer, less than 50nm in thickness, was coated on hexagonal boron nitride (hBN) plate powders by rotary chemical vapor deposition (RCVD) to assist densification of sinter-hard hBN. In RCVD process, tetraethylorthosilicate (TEOS) precursor heated at 110 degrees C was carried into a reactor by argon, and then reacted with oxygen to form SiO2 at 700 degrees C, with by-products of CO2 or H2O gases vacuumed out the reactor. Full expose of the surface of hBN powders to TEOS, argon and oxygen gases by RCVD technique and stable proceeding of decomposition reaction of TEOS contributed to the uniform distribution of SiO2 nanolayer. Viscous or liquid flow of uniform SiO2 nanolayer sintering aids assisted densification process of hBN and elevated its relative density to a maximum value of 96.2% at 1900 degrees C. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Zhang, Jianfeng; Zhang, Xin; Li, Gaiye; Wu, Yuping] Hohai Univ, Coll Mech & Mat, Nanjing 210098, Jiangsu, Peoples R China; [Goto, Takashi] Tohoku Univ, Inst Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Zhang, JF (reprint author), Hohai Univ, Coll Mech & Mat, Xikang Rd 1, Nanjing 210098, Jiangsu, Peoples R China.	jfzhang_sic@163.com			Fundamental Research Funds for the Central Universities [2013B34414]; National Natural Science Foundation of China [50979028]; National 973 Plan Project [2015CB057803]; Natural Key Foundation of Jiangsu Provience [BK2011025]	The authors would like to acknowledge the financial supports from Fundamental Research Funds for the Central Universities (2013B34414), National Natural Science Foundation of China (50979028), National 973 Plan Project (2015CB057803) and Natural Key Foundation of Jiangsu Provience (BK2011025).	Duan XM, 2013, J CENT SOUTH UNIV, V20, P1462, DOI 10.1007/s11771-013-1635-3; Zhang JF, 2012, J AM CERAM SOC, V95, P2827, DOI 10.1111/j.1551-2916.2012.05269.x; Vahlas C, 2006, MAT SCI ENG R, V53, P1, DOI 10.1016/j.mser.2006.05.001; Bartsch M, 1999, J AM CERAM SOC, V82, P1388; Duan XM, 2014, MAT SCI ENG A-STRUCT, V607, P38, DOI 10.1016/j.msea.2014.03.132; Viana CE, 2001, BRAZ J PHYS, V31, P299, DOI 10.1590/S0103-97332001000200023; Zhang JF, 2011, J EUR CERAM SOC, V31, P2083, DOI 10.1016/j.jeurceramsoc.2011.05.019; Boies AM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/31/315603; Boies AM, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/29/295604; CHEN CC, 1994, J MATER SCI, V29, P3215, DOI 10.1007/BF00356665; Chen GQ, 2000, J MATER SCI LETT, V19, P81, DOI 10.1023/A:1006772320587; Eichler J, 2008, J EUR CERAM SOC, V28, P1105, DOI 10.1016/j.jeurceramsoc.2007.09.005; HAGIO T, 1994, J MATER SCI LETT, V13, P653, DOI 10.1007/BF00271224; HAGIO T, 1989, J AM CERAM SOC, V72, P1482, DOI 10.1111/j.1151-2916.1989.tb07682.x; He ZH, 2014, J AM CERAM SOC, V97, P681, DOI 10.1111/jace.12813; Lipp A., 1989, Journal of the European Ceramic Society, V5, DOI 10.1016/0955-2219(89)90003-4; Pierson H. O., 1996, HDB REFRACTORY CARBI; SACKS MD, 1991, J AM CERAM SOC, V74, P2428, DOI 10.1111/j.1151-2916.1991.tb06780.x; Zhang J., 2010, MATER LETT, V65, P367; Zhang JF, 2012, CERAM INT, V38, P4961, DOI 10.1016/j.ceramint.2012.02.090; Zhang JF, 2010, J ALLOY COMPD, V502, P371, DOI 10.1016/j.jallcom.2010.04.170	21	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					423	427		10.2109/jcersj2.123.423		5	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500024		
J	Nukunudompanich, M; Chuangchote, S; Okamoto, Y; Shinoda, Y; Suzuki, Y				Nukunudompanich, Methawee; Chuangchote, Surawut; Okamoto, Yuji; Shinoda, Yutaka; Suzuki, Yoshikazu			TiO2 nanorods and semi-nanotubes prepared from anodic aluminum oxide template and their applications as photoelectrodes in dye-sensitized solar cells	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Anodic aluminum oxide (AAO); Dye-sensitized solar cell (DSSC); TiO2; Nanorod; Nanotube	NANOMATERIALS; FABRICATION; EFFICIENCY	Anodic aluminum oxide (AAO) was used as a template coupled with liquid process for synthesis of TiO2 nanorods and semi-nanotubes. Immersion setting (IS) and vacuum drop setting (VDS) were carried out to insert a TiO2 precursor solution into AAO pores. With the calcination and NaOH aq. treatment to remove AAO, scanning electron microscopy (SEM) revealed that TiO2 nanorods with diameter around 100-200nm were successfully fabricated from IS, whereas TiO2 semi-nanotubes were given from VDS. The synthesized nanorods or semi-nanotubes were mixed with commercial TiO2 nanoparticles (P-25) with mixing ratios of 5:95, 10:90 and 15:85 (by mass). The optimum mixing ratios for nanorods and semi-nanotubes are 5:95 and 10: 90, respectively. The photoelectrodes made with nanorods or semi-nanotubes showed better performances than the cells used of only P-25, because of the effects of one-dimensional (1-D) nanostructure. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Nukunudompanich, Methawee; Chuangchote, Surawut] King Mongkuts Univ Technol Thonburi, Joint Grad Sch Energy & Environm, Bangkok 10140, Thailand; [Okamoto, Yuji; Suzuki, Yoshikazu] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Shinoda, Yutaka] Tokyo Inst Technol, Secure Mat Ctr, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan; [Nukunudompanich, Methawee; Suzuki, Yoshikazu] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Suzuki, Y (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	suzuki@ims.tsukuba.ac.jp	Suzuki, Yoshikazu/N-3525-2015; Shinoda, Yutaka/F-7502-2014		Joint Graduate School of Energy and Environment (JGSEE); University of Tsukuba	We acknowledge to The Joint Graduate School of Energy and Environment (JGSEE) and University of Tsukuba for their financial supports.	Aisu K, 2013, J CERAM SOC JPN, V121, P915, DOI 10.2109/jcersj2.121.915; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Tsai CC, 2006, CHEM MATER, V18, P367, DOI 10.1021/cm0518527; Ding Y, 2014, J POWER SOURCES, V272, P1046, DOI 10.1016/j.jpowsour.2014.09.007; Okamoto Y, 2014, J CERAM SOC JPN, V122, P728, DOI 10.2109/jcersj2.122.728; Shingubara S, 2003, J NANOPART RES, V5, P17, DOI 10.1023/A:1024479827507; Asagoe K, 2007, CENT EUR J CHEM, V5, P605, DOI 10.2478/s11532-007-0001-4; Oekermann T, 2004, J PHYS CHEM B, V108, P2227, DOI 10.1021/jp034918z; Ito S, 2008, THIN SOLID FILMS, V516, P4613, DOI 10.1016/j.tsf.2007.05.090; Chuangchote S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2958347; Lee S, 2004, CHEM MATER, V16, P4292, DOI 10.1021/cm049466x; Nukunudompanich M., 2015, INT LETT CHEM PHYS A, V7, P30; Sulka G. D., 2009, ENCY NANOSCIENCE NAN, V10, P1; Suzuki Y, 2006, CENT EUR J CHEM, V4, P476, DOI 10.2478/s11532-006-0015-3	15	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					428	432		10.2109/jcersj2.123.428		5	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500025		
J	Seya, K; Jang, BK; Ueno, S				Seya, Kyosuke; Jang, Byung-Koog; Ueno, Shunkichi			Microstructure formation of Al2O3-HfO2 eutectic	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Al2O3-HfO2 eutectic; Unidirectional solidification; Rapid solidification	RECESSION BEHAVIOR; HIGH-TEMPERATURE; SILICON-NITRIDE; CORROSION; MECHANISM; GROWTH; EBC	The microstructure formation of Al2O3-HfO2 eutectic prepared by unidirectional solidification and rapid solidification was examined. The microstructure of the Al2O3-HfO2 eutectic samples showed lamellar structure and the relationship between the inter-lamellar spacing - and solidification rate R can be expressed by lambda R-2=constant. A small amount of tetragonal HfO2 phase exists in the sample prepared by rapid solidification. Only monoclinic HfO2 phase can be found in the eutectic samples prepared by unidirectional solidification. A tensile stress was induced in Al2O3 phase during the cooling step due to the transformation of HfO2 from tetragonal to monoclinic phase. The tensile stress of the Al2O3 phase in the eutectic structure was estimated to 420 MPa. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Seya, Kyosuke; Ueno, Shunkichi] Nihon Univ, Coll Engn, Koriyama, Fukushima 9638642, Japan; [Jang, Byung-Koog] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Ueno, S (reprint author), Nihon Univ, Coll Engn, Koriyama, Fukushima 9638642, Japan.	ueno@chem.ce.nihon-u.ac.jp					Ueno S, 2004, INT J APPL CERAM TEC, V1, P362; JACKSON KA, 1966, T METALL SOC AIME, V236, P1129; Bourban S, 1997, ACTA MATER, V45, P5069, DOI 10.1016/S1359-6454(97)00198-5; Harlan NR, 2002, J AM CERAM SOC, V85, P2025; HE J, 1995, J AM CERAM SOC, V78, P1347, DOI 10.1111/j.1151-2916.1995.tb08493.x; Lopato L. M., 1976, NEORGANICHESKI MAT, V12, P1623; Moon TH, 2005, APPL SURF SCI, V240, P105, DOI 10.1016/j.apsusc.2004.06.017; SCHMID F, 1970, J MATER SCI, V5, P470, DOI 10.1007/BF00556032; Seya K., 2015, J MAT SCI SOC JPN, V51, P33; Ueno S, 2005, J MATER SCI, V40, P2643, DOI 10.1007/s10853-005-2095-4; Ueno S, 2008, J EUR CERAM SOC, V28, P2359, DOI 10.1016/j.jeurceramsoc.2008.01.008; Ueno S, 2007, CORROS SCI, V49, P1162, DOI 10.1016/j.corsci.2006.08.013; Ueno S, 2004, J CERAM PROCESS RES, V5, P355; Waku Y, 1998, J MATER SCI, V33, P4943, DOI 10.1023/A:1004486303958; Yuri I., 2004, GT200454277 ASME; Zheng YT, 2013, J ALLOY COMPD, V551, P475, DOI 10.1016/j.jallcom.2012.11.064; Zheng YT, 2011, APPL SURF SCI, V258, P1531, DOI 10.1016/j.apsusc.2011.09.125	17	1	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					433	436		10.2109/jcersj2.123.433		4	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500026		
J	Kato, S; Nishide, T; Nara, M; Nagai, N; Hakuta, Y; Mizukami, F				Kato, Sadaaki; Nishide, Toshikazu; Nara, Masahiro; Nagai, Naofumi; Hakuta, Yukiya; Mizukami, Fujio			Preparation of superhydrophilic alumina films by hydrothermal processes using an organophosphorous compound	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Superhydrophilicity; Alumina; Phosphorylation; Hydrothermal treatment	SURFACE; AL2O3; MOLECULES; WATER	Superhydrophilic alumina films were successfully fabricated by a hydrothermal reaction of nanofibrous alumina films in a nitrilotris(methylenephosphonic acid) (NMP) aqueous solution at 180 degrees C for 6 h. The films showed superhydrophilicity not only as prepared but also after a boiling water resistance test, indicating that they had good durability. The alumina films were phosphorylated wholly in a hydrothermal condition only at 180 degrees C for 6 h. Phosphate moieties were present both at the surface and inside the films and a micro-structure with a serrated morphology was observed over the entire film surface. Whole phosphorylation of the alumina films resulted in good durability in the boiling water resistance test. Other films were phosphorylated partially at 160 degrees C for 6 h and at 180 degrees C for 4 h. The micro-structure with a serrated morphology was observed partially at the film surface. This morphology corresponded to the degree of phosphorylation. These results indicate that the phosphate moieties present on and in the films and the micro-structure of the films produced superhydrophilicity. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Kato, Sadaaki; Nishide, Toshikazu; Nara, Masahiro] Nihon Univ, Coll Engn, Fukushima 9638642, Japan; [Nagai, Naofumi] Kawaken Fine Chem Co Ltd, Tokyo 1030012, Japan; [Hakuta, Yukiya; Mizukami, Fujio] Natl Inst Adv Ind Sci & Technol, Tsukuba 3058565, Japan	Nishide, T (reprint author), Nihon Univ, Coll Engn, Fukushima 9638642, Japan.	nishide@ce.nihon-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) of Japan	This research was financially supported by the New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Boonchom B, 2008, J THERM ANAL CALORIM, V91, P511, DOI 10.1007/s10973-007-8420-1; Kim Y, 2012, ACS APPL MATER INTER, V4, P5074, DOI 10.1021/am301411z; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Roodenko K, 2011, J PHYS CHEM C, V115, P21351, DOI 10.1021/jp207839w; Tadanaga K, 2000, J SOL-GEL SCI TECHN, V19, P211, DOI 10.1023/A:1008732204421; Appapillai AT, 2007, CHEM MATER, V19, P5748, DOI 10.1021/cm0715390; Zhao ZG, 2012, J MATER CHEM, V22, P9738, DOI 10.1039/c2jm15798e; Nagai N, 2012, J MATER CHEM, V22, P3234, DOI 10.1039/c2jm15704g; Zhang LW, 2012, ENERG ENVIRON SCI, V5, P7491, DOI 10.1039/c2ee03390a; Tadanaga K, 1997, J AM CERAM SOC, V80, P1040; Nagai N, 2011, J MATER CHEM, V21, P14884, DOI 10.1039/c1jm11571e; Park JW, 2010, ACTA BIOMATER, V6, P1661, DOI 10.1016/j.actbio.2009.10.011; Nishide T, 2000, THIN SOLID FILMS, V371, P61, DOI 10.1016/S0040-6090(00)01010-5; Zhao ZG, 2011, J MATER CHEM, V21, P14984, DOI 10.1039/c1jm12241j; Liu YH, 2012, COLLOID SURFACE A, V404, P52, DOI 10.1016/j.colsurfa.2012.04.008; Bolis V, 2012, PHILOS T R SOC A, V370, P1313, DOI 10.1098/rsta.2011.0273; Chen M., 2010, NANO BIOMED ENG, V2, P121; Cui XJ, 2013, CORROS SCI, V76, P474, DOI 10.1016/j.corsci.2013.07.024; DAVIS GD, 1985, J MATER SCI, V20, P975, DOI 10.1007/BF00585742; Jiang FY, 2005, J CRYST GROWTH, V283, P108, DOI 10.1016/j.jcrysgro.2005.05.069; Joud JC, 2013, APPL SURF SCI, V287, P37, DOI 10.1016/j.apsusc.2013.09.054; Li MY, 2014, APPL SURF SCI, V297, P147, DOI 10.1016/j.apsusc.2014.01.105; Matsuda Y, 2013, J MATER CHEM A, V1, P15544, DOI 10.1039/c3ta13004e; Moulder J. F., 1992, HDB XRAY PHOTOELECTR, P54; Moulder J. F., 1992, HDB XRAY PHOTOELECTR, P59; Nakajima A, 2011, J CERAM SOC JPN, V119, P711, DOI 10.2109/jcersj2.119.711; Nishide T, 2005, J CERAM SOC JPN, V113, P77, DOI 10.2109/jcersj.113.77; Pazik R, 2011, J PHYS CHEM C, V115, P9850, DOI 10.1021/jp2000656; Qiu YF, 2015, J MATER SCI, V50, P1586, DOI 10.1007/s10853-014-8719-9; Tapia H. S. M.-, 2000, J SOLID STATE CHEM, V151, P122; Yao CW, 2014, APPL SURF SCI, V290, P59, DOI 10.1016/j.apsusc.2013.10.188; Ye JM, 2009, THIN SOLID FILMS, V517, P6012, DOI 10.1016/j.tsf.2009.04.042	32	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					437	442		10.2109/jcersj2.123.437		6	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500027		
J	Nasu, H; Hasegawa, M; Hashimoto, T; Ishihara, A; Fujita, K; Tanaka, K				Nasu, Hiroyuki; Hasegawa, Masayuki; Hashimoto, Tadanori; Ishihara, Atsushi; Fujita, Koji; Tanaka, Katsuhisa			Preparation and properties of Sol-Gel derived CuFeO2 thin films by dip-coating technique	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Transparent conducting oxide; Sol-gel method; Dipping method; Delafossite structure; Transmittance; Electrical conductivity; Hall effect; P-type; Glass substrate	CUALO2; CU	CuFeO2 crystal thin films were successfully prepared by dip-coating technique through sol-gel route on silica glass substrates. Heat treatment under nitrogen atmosphere was necessary to obtain monovalent Cu and 800-900 degrees C firing was indispensable to prepare CuFeO2 stable phase, and 2-9 h heat-treatment was appropriate to lower the electrical resistivity. For the dip-coated films, CuO impurity phase was observed in Cu:Fe = 1:1 solution from X-ray diffraction pattern (XRD), and thus the Cu containing solution of Cu:Fe = 0.99:1, 0.97:1, 0.95:1, 0.9:1 and 0.8:1 were prepared to eliminate excess CuO phase. Too lower content of Cu such as 0.9:1 and 0.8:1 provided Fe oxides as impurity phase, but slight decrease of Cu iecreased the electric resistivity although CuO was still slightly observed by XRD. The visible transparency of the films was nearly 10%, and some films of conduction type was confirmed as p-type by measuring Hall effect. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Nasu, Hiroyuki; Hasegawa, Masayuki; Hashimoto, Tadanori; Ishihara, Atsushi] Mie Univ, Graduat Sch, Div Mat Sci, Tsu, Mie 5148507, Japan; [Fujita, Koji; Tanaka, Katsuhisa] Kyoto Univ, Graduat Sch, Div Mat Chem, Nishikyo Ku, Kyoto 6158510, Japan	Nasu, H (reprint author), Mie Univ, Graduat Sch, Div Mat Sci, 1577 Kurima Machiyamachi, Tsu, Mie 5148507, Japan.	nasu@chem.mie-u.ac.jp	Fujita, Koji/C-7662-2012; Ishihara, Atsushi/N-9481-2015; HASHIMOTO, Tadanori/J-3909-2013	Fujita, Koji/0000-0002-1700-0889; Ishihara, Atsushi/0000-0002-6390-8898; HASHIMOTO, Tadanori/0000-0003-2887-7536			Marquardt MA, 2006, THIN SOLID FILMS, V496, P146, DOI 10.1016/j.tsf.2005.08.316; Li G, 2010, J SOL-GEL SCI TECHN, V53, P641, DOI 10.1007/s10971-009-2143-7; Tonooka K, 2002, THIN SOLID FILMS, V411, P129, DOI 10.1016/S0040-6090(02)00201-8; Kawazoe H, 1997, NATURE, V389, P939, DOI 10.1038/40087; Banarjee A. N., 2003, J APPL PHYS, V97; Bouzidi C, 2005, MAT SCI ENG B-SOLID, V118, P259, DOI 10.1016/j.mseb.2004.12.039; Cai JL, 2005, J APPL PHYS, V98, DOI 10.1063/1.1997293; Chen HY, 2012, THIN SOLID FILMS, V520, P5029, DOI 10.1016/j.tsf.2012.03.032; Lan W, 2007, MAT SCI ENG B-SOLID, V139, P155, DOI 10.1016/j.mseb.2007.01.045; Lockman Z, 2009, SOL ENERG MAT SOL C, V93, P1383, DOI 10.1016/j.solmat.2009.02.027; Spallart M. N., 2007, THIN SOLID FILMS, V515, P8641	11	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					448	451		10.2109/jcersj2.123.448		4	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500029		
J	Segawa, H; Hirosaki, N				Segawa, Hiroyo; Hirosaki, Naoto			Fabrication of sodium borosilicate glass and Eu-doped SiAlON composites for white LED	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Glass composite; Phosphors; Photoluminescence; Light-emitting diodes; Glass structures; Quantum efficiency	LIGHT-EMITTING-DIODES; PHOSPHATE-GLASSES; NA2O-B2O3-SIO2; OXIDE	The oxynitride phosphor Ca-alpha-SiAlON:Eu2+ has a high thermal tolerance. A series of sodium borosilicate glasses [xNa(2)O-(60 - x)B2O3-40SiO(2), mol%, x = 2-40] was prepared to investigate their ability to host the Ca-alpha-SiAlON:Eu2+ phosphor powder. The glass-SiAlON phosphor composites, which can emit yellow light when irradiated with blue light (wavelength = 450 nm), were successfully fabricated when the re-melting temperature was 1000 or 1100 degrees C. The chromaticity of the composites, which was estimated from photoluminescence spectra, changed from blue to yellow with increasing SiAlON concentration and sample thickness. This indicates that white light could be generated by controlling the SiAlON concentration and sample thickness. In particular, the 3-mm-thick 10Na(2)O-50B(2)O(3)-40SiO(2) glass with a 2 mass% of phosphor generated near-white light. The quantum efficiency of the composites increased with increasing SiAlON concentration and reached a similar value to that of the phosphor powder, and increased as the Na2O concentration of the glass decreased. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Segawa, Hiroyo; Hirosaki, Naoto] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Segawa, H (reprint author), Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	SEGAWA.Hiroyo@nims.go.jp					Lin SE, 2011, J EUR CERAM SOC, V31, P1975, DOI 10.1016/j.jeurceramsoc.2011.04.017; Hirosaki N, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1935027; Uheda K, 2000, J LUMIN, V87-9, P967, DOI 10.1016/S0022-2313(99)00494-9; Segawa H, 2013, OPT MATER, V35, P2677, DOI 10.1016/j.optmat.2013.08.006; YUN YH, 1978, J NON-CRYST SOLIDS, V27, P363, DOI 10.1016/0022-3093(78)90020-0; Morena R, 2000, J NON-CRYST SOLIDS, V263, P382, DOI 10.1016/S0022-3093(99)00678-X; Sasmal N, 2014, J NON-CRYST SOLIDS, V387, P62, DOI 10.1016/j.jnoncrysol.2013.12.030; McKeown DA, 2003, J NON-CRYST SOLIDS, V317, P290, DOI 10.1016/S0022-3093(02)01816-1; Xie RJ, 2004, APPL PHYS LETT, V84, P5404, DOI 10.1063/1.1767596; Marzouk SY, 2013, OPT MATER, V35, P2077, DOI 10.1016/j.optmat.2013.05.023; Segawa H, 2010, OPT MATER, V33, P170, DOI 10.1016/j.optmat.2010.10.004; Sakuma K, 2004, OPT LETT, V29, P2001, DOI 10.1364/OL.29.002001; Mahmoud KH, 2013, J NON-CRYST SOLIDS, V363, P116, DOI 10.1016/j.jnoncrysol.2012.12.004; Liu Q, 2013, OPT MATER EXPRESS, V3, P2096, DOI 10.1364/OME.3.002096; Segawa H, 2015, OPT MATER, V42, P399, DOI 10.1016/j.optmat.2015.01.036; Zhang R, 2014, LASER PHOTONICS REV, V8, P158, DOI 10.1002/lpor.201300140; DELL WJ, 1983, J NON-CRYST SOLIDS, V58, P1, DOI 10.1016/0022-3093(83)90097-2; Yano T, 2003, J NON-CRYST SOLIDS, V321, P147, DOI 10.1016/S0022-3093(03)00159-5; Chen P., 2001, GLASS PHYS CHEM+, V37, P29; Veasey DL, 1999, APPL PHYS LETT, V74, P789, DOI 10.1063/1.123368	20	1	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	MAY	2015	123	1437					452	455		10.2109/jcersj2.123.452		4	Materials Science, Ceramics	Materials Science	CH3FF	WOS:000353912500030		
J	Sugisaka, J; Yasui, T; Hirayama, K				Sugisaka, Jun-ichiro; Yasui, Takashi; Hirayama, Koichi			Expansion of the difference-field boundary element method for numerical analyses of various local defects in periodic surface-relief structures	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION			English	Article							SOURCE-MODEL TECHNIQUE; ELECTROMAGNETIC SCATTERING; INTEGRAL-EQUATIONS; WAVE-GUIDE; DIFFRACTION; PERFORMANCE; ALGORITHM; GRATINGS; CAVITIES; LIGHT	We expand the difference-field boundary element method (DFBEM) to calculate wave scattering from a variety of local periodic structure defects. The DFBEM is a numerical method for simulating the diffraction caused by a periodic surface-relief structure with a defect. Although it is more efficient than conventional techniques such as the finite-difference time-domain (FDTD) method, the original DFBEM is limited to projection defects. Here, we derive the integral equations and expressions for crack and buried-pillar defects, and also demonstrate some numerical analyses, validating the results by comparison with results from the FDTD method and the dielectric interface boundary conditions. (C) 2015 Optical Society of America	[Sugisaka, Jun-ichiro; Yasui, Takashi; Hirayama, Koichi] Kitami Inst Technol, Kitami, Hokkaido 0908507, Japan	Sugisaka, J (reprint author), Kitami Inst Technol, Koen Cho 165, Kitami, Hokkaido 0908507, Japan.	sugisaka@mail.kitami-it.ac.jp					Alavikia B, 2009, J OPT SOC AM A, V26, P1915, DOI 10.1364/JOSAA.26.001915; LU CC, 1994, MICROW OPT TECHN LET, V7, P466, DOI 10.1002/mop.4650071013; Xie Y, 2004, OPT EXPRESS, V12, P6106, DOI 10.1364/OPEX.12.006106; Gross H, 2012, APPL OPTICS, V51, P7384, DOI 10.1364/AO.51.007384; Silberstein E, 2001, J OPT SOC AM A, V18, P2865, DOI 10.1364/JOSAA.18.002865; Lalanne P, 2000, OPT LETT, V25, P1092, DOI 10.1364/OL.25.001092; Blattner P, 1998, J MOD OPTIC, V45, P1395, DOI 10.1080/09500349808230636; Chien DN, 2002, J OPT SOC AM A, V19, P1649, DOI 10.1364/JOSAA.19.001649; Dossou K, 2006, J COMPUT PHYS, V219, P120, DOI 10.1016/j.jcp.2006.03.029; Erdmann A, 2000, P SOC PHOTO-OPT INS, V4000, P684, DOI 10.1117/12.389060; Glytsis EN, 1998, APPL OPTICS, V37, P6591, DOI 10.1364/AO.37.006591; Hakko M, 2013, OPT LETT, V38, P3862, DOI 10.1364/OL.38.003862; JIN JM, 1995, IEEE T ANTENN PROPAG, V43, P1130; Joannopoulos J D, 2011, PHOTONIC CRYSTALS MO; Karamehmedovic M, 2010, J EUR OPT SOC-RAPID, V5, DOI 10.2971/jeos.2010.10021; Liu Y., 2014, FAST MULTIPOLE BOUND; Lu T, 2003, J LIGHTWAVE TECHNOL, V21, P1793, DOI 10.1109/JLT.2003.815494; Ludwig A, 2004, J OPT SOC AM A, V21, P1334, DOI 10.1364/JOSAA.21.001334; MORITA N, 1978, IEEE T ANTENN PROPAG, V26, P261, DOI 10.1109/TAP.1978.1141820; NAKATA Y, 1990, J OPT SOC AM A, V7, P1494, DOI 10.1364/JOSAA.7.001494; Nguyen-Huu N, 2014, OPT EXPRESS, V22, pA282, DOI 10.1364/OE.22.00A282; PRATHER DW, 1995, P SOC PHOTO-OPT INS, V2404, P28, DOI 10.1117/12.207492; ROKHLIN V, 1985, J COMPUT PHYS, V60, P187, DOI 10.1016/0021-9991(85)90002-6; Song J, 2005, J OPT SOC AM A, V22, P1620, DOI 10.1364/JOSAA.22.001620; Sugisaka J, 2012, OPT LETT, V37, P2079, DOI 10.1364/OL.37.002079; Sun JG, 2009, J OPT SOC AM A, V26, P156; Trotskovsky K, 2011, J OPT SOC AM A, V28, P502, DOI 10.1364/JOSAA.28.000502; Vial A, 2002, P SOC PHOTO-OPT INS, V4754, P890, DOI 10.1117/12.476992; Walker S., 1978, BOUNDARY ELEMENT MET; Watanabe K, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.009978; Watanabe K, 2011, OPT EXPRESS, V19, P25799, DOI 10.1364/OE.19.025799	31	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1084-7529	1520-8532		J OPT SOC AM A	J. Opt. Soc. Am. A-Opt. Image Sci. Vis.	MAY	2015	32	5					751	763		10.1364/JOSAA.32.000751		13	Optics	Optics	CH3IT	WOS:000353924900006		
J	Seto, K; Tsukada, T; Okuda, Y; Tokunaga, E; Kobayashi, T				Seto, Keisuke; Tsukada, Toshiaki; Okuda, Yoshinao; Tokunaga, Eiji; Kobayashi, Takayoshi			Noise cancellation with phase-detection technique for pump-probe measurement and application to stimulated Raman imaging	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION			English	Article							SCATTERING MICROSCOPY; PHOTOTHERMAL MICROSCOPY; SUPERCONTINUUM GENERATION; HIGH-SENSITIVITY; MICROSTRUCTURED FIBER; LIGHT-SOURCE; IN-VIVO; LASER; POWER; SPECTROSCOPY	Intensity noise on a probe beam is a serious obstacle to highly sensitive and high-speed pump-probe microscopy. In this report, a reference beam of the probe is prepared and delayed. The intensity modulation by the sample is measured as the phase modulation of the superposition of detected electrical signals of the probe and reference beams, and the intensity noise is canceled. We evaluate performance of the noise cancellation using the supercontinuum light from a piece of photonic crystal fiber, and find that the noise is canceled by similar to 26 dB. We then apply the method to a stimulated Raman microscope. This method contributes to highly sensitive and high-speed pump-probe imaging with various light sources. (C) 2015 Optical Society of America	[Seto, Keisuke; Kobayashi, Takayoshi] Univ Electrocommun, Adv Ultrafast Laser Res Ctr, Chofu, Tokyo 1828585, Japan; [Seto, Keisuke; Kobayashi, Takayoshi] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Seto, Keisuke; Kobayashi, Takayoshi] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Tsukada, Toshiaki] Keisoku Solut Co Ltd, Koganei, Tokyo 1840015, Japan; [Okuda, Yoshinao; Tokunaga, Eiji] Tokyo Univ Sci, Fac Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan; [Kobayashi, Takayoshi] Natl Chiao Tung Univ, Dept Elect, Hsinchu 300, Taiwan; [Kobayashi, Takayoshi] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650971, Japan	Seto, K (reprint author), Univ Electrocommun, Adv Ultrafast Laser Res Ctr, Chofu, Tokyo 1828585, Japan.	seto@ils.uec.ac.jp			JSPS KAKENHI [26620117]; Institute of Laser Engineering, Osaka University [B1-27, 2014B2-19]; Japan Society for the Promotion of Science [24740261]; National Science Council of the Republic of China, Taiwan [NSC 98-2112-M-009-001-MY3]; Ministry of Education, Aiming for Top University (MOE ATU) Program at National Chiao-Tung University (NCTU)	This work was partially supported by JSPS KAKENHI, Grant Number 26620117. This study was partially supported by a joint research project at the Institute of Laser Engineering, Osaka University, under contract number B1-27. This work was partially financially supported by a Grant-in-Aid for Scientific Research (No. 24740261) received from the Japan Society for the Promotion of Science and a joint research project at the Institute of Laser Engineering, Osaka University, Project number 2014B2-19. This work was partially supported by the National Science Council of the Republic of China, Taiwan (NSC 98-2112-M-009-001-MY3), and a grant from the Ministry of Education, Aiming for Top University (MOE ATU) Program at National Chiao-Tung University (NCTU).	Lu FK, 2012, MOL PHYS, V110, P1927, DOI 10.1080/00268976.2012.695028; Gaiduk A, 2010, CHEM SCI, V1, P343, DOI 10.1039/c0sc00210k; Miyazaki J, 2014, OPT EXPRESS, V22, P9024, DOI 10.1364/OE.22.009024; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Rock W, 2013, OPT EXPRESS, V21, P15113, DOI 10.1364/OE.21.015113; Freudiger CW, 2014, NAT PHOTONICS, V8, P153, DOI [10.1038/nphoton.2013.360, 10.1038/NPHOTON.2013.360]; Slipchenko MN, 2012, J BIOPHOTONICS, V5, P801, DOI 10.1002/jbio.201200005; Dudley JM, 2006, REV MOD PHYS, V78, P1135, DOI 10.1103/RevModPhys.78.1135; Nedosekin DA, 2014, SMALL, V10, P135, DOI 10.1002/smll.201300024; Nandakumar P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033026; Tamaki E, 2002, ANAL CHEM, V74, P1560, DOI 10.1021/ac011092t; Newbury NR, 2003, OPT LETT, V28, P944, DOI 10.1364/OL.28.000944; Nose K, 2012, OPT EXPRESS, V20, P13958, DOI 10.1364/OE.20.013958; Ploetz E, 2007, APPL PHYS B-LASERS O, V87, P389, DOI 10.1007/s00340-007-2630-x; Seto K, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4818670; Saar BG, 2010, SCIENCE, V330, P1368, DOI 10.1126/science.1197236; Hobbs PCD, 1997, APPL OPTICS, V36, P903, DOI 10.1364/AO.36.000903; Corwin KL, 2003, APPL PHYS B-LASERS O, V77, P269, DOI 10.1007/s00340-003-1175-x; Beier HT, 2011, OPT EXPRESS, V19, P18885, DOI 10.1364/OE.19.018885; Fu D, 2012, J AM CHEM SOC, V134, P3623, DOI 10.1021/ja210081h; Ames JN, 2003, APPL PHYS B-LASERS O, V77, P279, DOI 10.1007/s00340-003-1177-8; Ploetz E, 2009, OPT EXPRESS, V17, P18612, DOI 10.1364/OE.17.018612; Min W, 2009, NATURE, V461, P1105, DOI 10.1038/nature08438; Gambetta A, 2010, OPT LETT, V35, P226, DOI 10.1364/OL.35.000226; Moller U, 2012, OPT EXPRESS, V20, P2851, DOI 10.1364/OE.20.002851; Arunkarthick S, 2014, J MICROSC-OXFORD, V256, P111, DOI 10.1111/jmi.12164; Corwin KL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.113904; Kawakami R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01014; Leukos, INN OPT SYST; Min W, 2011, CURR OPIN CHEM BIOL, V15, P831, DOI 10.1016/j.cbpa.2011.10.005; Miyazaki J, 2014, OPT LETT, V39, P4219, DOI 10.1364/OL.39.004219; Miyazaki J, 2014, OPT EXPRESS, V22, DOI 10.1364/OE.22.018833; NKT Photonics, SUPERK EXTREME SUP W; Owyoung A, 1977, Opt Lett, V1, P152, DOI 10.1364/OL.1.000152; OWYOUNG A, 1977, OPT COMMUN, V22, P323, DOI 10.1016/S0030-4018(97)90020-1; Ozeki Y, 2010, LASER PHYS, V20, P1114, DOI 10.1134/S1054660X10090318; Ozeki Y, 2010, OPT EXPRESS, V18, P13708, DOI 10.1364/OE.18.013708; Ozeki Y, 2012, NAT PHOTONICS, V6, P844, DOI [10.1038/nphoton.2012.263, 10.1038/NPHOTON.2012.263]; Schreiber T, 2003, OPT COMMUN, V228, P71, DOI 10.1016/j.optcom.2003.09.091; Seefeldt M, 2003, OPT COMMUN, V216, P199, DOI 10.1016/S0030-4018(02)02329-5; Seto K, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4863879; Seto K, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/34/345401	42	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1084-7529	1520-8532		J OPT SOC AM A	J. Opt. Soc. Am. A-Opt. Image Sci. Vis.	MAY	2015	32	5					809	821		10.1364/JOSAA.32.000809		13	Optics	Optics	CH3IT	WOS:000353924900014		
J	Lu, HM; Li, YJ; Zhang, LF; Serikawa, S				Lu, Huimin; Li, Yujie; Zhang, Lifeng; Serikawa, Seiichi			Contrast enhancement for images in turbid water	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION			English	Article							SCATTERING; VISIBILITY; FUSION; MEDIA	Absorption, scattering, and color distortion are three major degradation factors in underwater optical imaging. Light rays are absorbed while passing through water, and absorption rates depend on the wavelength of the light. Scattering is caused by large suspended particles, which are always observed in an underwater environment. Color distortion occurs because the attenuation ratio is inversely proportional to the wavelength of light when light passes through a unit length in water. Consequently, underwater images are dark, low contrast, and dominated by a bluish tone. In this paper, we propose a novel underwater imaging model that compensates for the attenuation discrepancy along the propagation path. In addition, we develop a robust color lines-based ambient light estimator and a locally adaptive filtering algorithm for enhancing underwater images in shallow oceans. Furthermore, we propose a spectral characteristic-based color correction algorithm to recover the distorted color. The enhanced images have a reasonable noise level after the illumination compensation in the dark regions, and demonstrate an improved global contrast by which the finest details and edges are enhanced significantly. (C) 2015 Optical Society of America	[Lu, Huimin; Li, Yujie; Zhang, Lifeng; Serikawa, Seiichi] Kyushu Inst Technol, Dept Elect & Elect Engn, Kitakyushu, Fukuoka 8048550, Japan; [Lu, Huimin] Shanghai Jiao Tong Univ, State Key Lab Ocean Engn, Shanghai 200240, Peoples R China; [Lu, Huimin] Tongji Univ, State Key Lab Marine Geol, Shanghai 200092, Peoples R China	Lu, HM (reprint author), Kyushu Inst Technol, Dept Elect & Elect Engn, Kitakyushu, Fukuoka 8048550, Japan.	luhuimin@ieee.org			Open Research Fund of State Key Laboratory of Marine Geology in Tongji University [MGK1407]; Open Research Fund of State Key Laboratory of Ocean Engineering in Shanghai Jiaotong University [OEK1315];  [13J10713];  [P15077]	Grant in Aid for Research Fellows of Japan Society for the Promotion of Science (13J10713); Grant in Aid for Foreigner Research Fellows of Japan Society for the Promotion of Science (P15077); Open Research Fund of State Key Laboratory of Marine Geology in Tongji University (MGK1407); Open Research Fund of State Key Laboratory of Ocean Engineering in Shanghai Jiaotong University (OEK1315).	Ahlen J., 2007, Pattern Recognition and Image Analysis, V17, DOI 10.1134/S105466180701021X; Schechner YY, 2005, IEEE J OCEANIC ENG, V30, P570, DOI 10.1109/JOE.2005.850871; Treibitz T, 2012, IEEE T IMAGE PROCESS, V21, P4662, DOI 10.1109/TIP.2012.2208978; [Anonymous], 2009, P IEEE INT C COMP VI; He KM, 2011, IEEE T PATTERN ANAL, V33, P2341, DOI 10.1109/TPAMI.2010.168; Yang QX, 2013, IEEE T IMAGE PROCESS, V22, P4841, DOI 10.1109/TIP.2013.2278917; Kim JH, 2013, J VIS COMMUN IMAGE R, V24, P410, DOI 10.1016/j.jvcir.2013.02.004; Ancuti C, 2012, PROC CVPR IEEE, P81, DOI 10.1109/CVPR.2012.6247661; Gibson KB, 2012, IEEE T IMAGE PROCESS, V21, P662, DOI 10.1109/TIP.2011.2166968; Narasimhan SG, 2003, IEEE T PATTERN ANAL, V25, P713, DOI 10.1109/TPAMI.2003.1201821; He KM, 2013, IEEE T PATTERN ANAL, V35, P1397, DOI 10.1109/TPAMI.2012.213; Cozman F, 1997, PROC CVPR IEEE, P801, DOI 10.1109/CVPR.1997.609419; Kocak DM, 2008, MAR TECHNOL SOC J, V42, P52; Schettini R, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/746052; Chiang JY, 2012, IEEE T IMAGE PROCESS, V21, P1756, DOI 10.1109/TIP.2011.2179666; Arnold-Bos A., 2005, P IEEE EUR OC C BRES, V1, P527; Bongiorno DL, 2013, PROC SPIE, V8660, DOI 10.1117/12.2001460; Drews P., 2013, P IEEE INT C COMP VI, P825; Fattal R, 2008, ACM T GRAPHIC, V27, P1, DOI DOI 10.1145/1360612.1360671; Fattal R, 2014, ACM T GRAPHIC, V34, DOI 10.1145/2651362; Garcia R., 2002, P MTS IEEE OCEANS C, V2, P1018; Gastal ESL, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964964; Grabtchak S, 2012, BIOMED OPT EXPRESS, V3, P3001, DOI 10.1364/BOE.3.003001; Hautiere N., 2008, P IEEE INT WORKSH VS, P1; Kopf J, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1409060.1409069; Liang J., 2014, J APPL PHYS, V116; LU H, 2013, P 20 IEEE INT C IM P, P3412; Narasimhan SG, 2005, IEEE I CONF COMP VIS, P420; Tomasi C., 1998, P INT C COMPUTER VIS, V1, P839, DOI DOI 10.1109/ICCV.1998.710815; Tsiotsios C., 2014, P IEEE C COMP VIS PA, P4321; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; YANG QX, 2010, P EUR C COMP VIS, V6314, P87; Yao S., 2005, P IEEE ICIP, P397; Yin L, 1996, IEEE T CIRCUITS-II, V43, P157	34	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1084-7529	1520-8532		J OPT SOC AM A	J. Opt. Soc. Am. A-Opt. Image Sci. Vis.	MAY	2015	32	5					886	893		10.1364/JOSAA.32.000886		8	Optics	Optics	CH3IT	WOS:000353924900022		
J	Souri, M; Osaki, T; Ichinose, A				Souri, M.; Osaki, T.; Ichinose, A.			Anti-factorXIII A subunit (FXIII-A) autoantibodies block FXIII-A(2)B(2) assembly and steal FXIII-A from native FXIII-A(2)B(2)	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						antibody diversity; autoimmune diseases; chronic disease; hemorrhagic disorders; immunosuppressive agents	FACTOR-XIII DEFICIENCY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COAGULATION-FACTOR-XIII; PLASMA FACTOR-XIII; B-SUBUNIT; HEMORRHAGIC DISORDER; CROSS-LINKING; AUTOIMMUNE ANTIBODY; HUMAN-MONOCYTES; IGG INHIBITOR	BackgroundAutoimmune hemophilia-like disease (hemorrha-philia or hemorrhagic disorder) caused by anti-factorXIII antibodies (termed AH13) or autoimmune FXIII deficiency' is a life-threatening bleeding disorder. AH13 was thought to be rare worldwide. ObjectivesBecause the number of diagnosed AH13 cases has recently been increasing, at least in Japan, we conducted a nationwide survey supported by the Japanese Ministry of Health, Labor, and Welfare, and explored the pathologic mechanism(s) of AH13. MethodsWe diagnosed AH13 cases during the last 11years according to the presence of anti-FXIII autoantibodies confirmed by a dot blot assay and ELISA, and characterized 33 of these both immunologically and biochemically. ResultsThe AH13 cases were immunologically classified into three types, Aa, Ab, and B. TypeAa autoantibodies, observed in 27 cases, were directed against the native FXIII A subunit (FXIII-A), and blocked FXIII activation. The autoantibodies not only prevented assembly of new FXIII-A(2)B(2) heterotetramers, but also removed FXIII-A from native FXIII-A(2)B(2) heterotetramers by forming an FXIII-A-IgG complex. TypeAb autoantibodies, detected in three cases, preferentially bound to activated FXIII-A and inhibited its activity. TypeAa and Ab autoantibodies were neutralizing' FXIII antibodies (or FXIII inhibitors), and thus could be screened with functional assays. TypeB antibodies, detected in two cases, were non-neutralizing anti-FXIII B subunit (FXIII-B) autoantibodies that possibly accelerated the clearance of FXIII, and thus could be diagnosed exclusively with immunologic methods. ConclusionThere are three major types of anti-FXIII autoantibody, with distinct targets and mechanisms that cause AH13.	[Souri, M.; Osaki, T.; Ichinose, A.] Yamagata Univ, Sch Med, Dept Mol Pathobiochem & Pathobiol, Yamagata 9909585, Japan; [Souri, M.; Osaki, T.; Ichinose, A.] Japanese Collaborat Res Grp JCRG Acquired Hemorrh, Yamagata, Japan	Ichinose, A (reprint author), Yamagata Univ, Sch Med, Dept Mol Pathobiochem & Pathobiol, Yamagata 9909585, Japan.	aichinos@med.id.yamagata-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labor, and Welfare	We would like to thank all members of the Japanese Collaborative Study Group on AH13 for their cooperation in conducting a nationwide survey on AH13 from the Japanese business year 2009 through 2013. The authors also thank N. Mutch for useful discussions, and Y. Shibue for her help in preparation of the manuscript. This study was supported by research grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and the Japanese Ministry of Health, Labor, and Welfare. This study was presented in part at the 23rd Congress of the International Society on Thrombosis and Haemostasis in Kyoto in July 2011, and at the 85th Annual Meeting of the Japanese Biochemical Society in Fukuoka in December 2012.	ADANY R, 1987, BRIT J HAEMATOL, V67, P167, DOI 10.1111/j.1365-2141.1987.tb02321.x; Ahmad F, 1996, BRIT J HAEMATOL, V93, P700, DOI 10.1046/j.1365-2141.1996.d01-1678.x; Ichinose A, 2001, THROMB HAEMOSTASIS, V86, P57; MUSZBEK L, 1985, THROMB RES, V37, P401, DOI 10.1016/0049-3848(85)90069-6; WOLPL A, 1987, TRANSPLANTATION, V43, P151; Ichinose A, 2012, INT J HEMATOL, V95, P362, DOI 10.1007/s12185-012-1064-3; Souri M, 2008, INT J HEMATOL, V87, P60, DOI 10.1007/s12185-007-0005-z; Nugent DJ, 2006, THROMB RES, V118, pS23, DOI 10.1016/j.thromres.2006.02.009; Ichinose A, 2011, THROMB HAEMOSTASIS, V105, P925, DOI 10.1160/TH10-11-0724; Mutch NJ, 2010, J THROMB HAEMOST, V8, P2017, DOI 10.1111/j.1538-7836.2010.03963.x; Wada H, 2013, THROMB HAEMOSTASIS, V109, P661, DOI 10.1160/TH12-12-0936; Ajzner E, 2009, BLOOD, V113, P723, DOI 10.1182/blood-2008-09-179333; NAKAMURA S, 1988, BRIT J HAEMATOL, V68, P313, DOI 10.1111/j.1365-2141.1988.tb04208.x; Ichinose A, 2012, INT J HEMATOL, V95, P47, DOI 10.1007/s12185-011-0992-7; Kohler HP, 2011, J THROMB HAEMOST, V9, P1404, DOI 10.1111/j.1538-7836.2011.04315.x; Ichinose A, 2011, SEMIN THROMB HEMOST, V37, P382, DOI 10.1055/s-0031-1276587; Biswas A, 2014, HAMOSTASEOLOGIE, V34, P160, DOI 10.5482/HAMO-13-08-0046; DALY HM, 1991, BLOOD COAGUL FIBRIN, V2, P507, DOI 10.1097/00001721-199108000-00003; Fraser SR, 2011, BLOOD, V117, P6371, DOI [10.1182/blood-2011-02-333203, 10.1182/2011-02-333203]; FUKUE H, 1992, BLOOD, V79, P65; Green D, 1994, ANTICOAGULANTS PHYSL, P169; HENRIKSSON P, 1985, J CLIN INVEST, V76, P528, DOI 10.1172/JCI112002; Ichinose Akitada, 1996, Seminars in Thrombosis and Hemostasis, V22, P385, DOI 10.1055/s-2007-999036; KIESSELB.TH, 1972, ANN NY ACAD SCI, V202, P318, DOI 10.1111/j.1749-6632.1972.tb16344.x; KRUMDIECK R, 1991, AM J MED, V90, P639; LOPACIUK S, 1978, J CLIN INVEST, V61, P1196, DOI 10.1172/JCI109035; Lorand L, 1980, Prog Hemost Thromb, V5, P245; LORAND L, 1972, BRIT J HAEMATOL, V23, P17, DOI 10.1111/j.1365-2141.1972.tb03455.x; Lorand L, 2002, THROMB HAEMOSTASIS, V88, P919; Lorand L., 1977, HAEMOSTASIS BIOCH PH, P405; LORAND L, 1988, P NATL ACAD SCI USA, V85, P232, DOI 10.1073/pnas.85.1.232; Lorand L, 1999, BLOOD, V93, P909; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; MILNER GR, 1977, J CLIN PATHOL, V30, P770, DOI 10.1136/jcp.30.8.770; Muszbek L, 2007, J THROMB HAEMOST, V5, P181, DOI 10.1111/j.1538-7836.2006.02182.x; NAGY JA, 1986, BLOOD, V68, P1272; Shinkai K, 1996, INT J HEMATOL S1, V63, P291; Souri M, 2008, BIOCHEMISTRY-US, V47, P8656, DOI 10.1021/bi8006143; Teruya J, 1986, Rinsho Ketsueki, V27, P1680; TOSETTO A, 1995, AM J HEMATOL, V48, P34, DOI 10.1002/ajh.2830480107	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	MAY	2015	13	5					802	814		10.1111/jth.12877		13	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CH8AU	WOS:000354259000016		
J	Saito, N; Matsumoto, H; Yagi, T; Hara, Y; Hayashida, K; Motomura, T; Mashiko, K; Iida, H; Yokota, H; Wagatsuma, Y				Saito, Nobuyuki; Matsumoto, Hisashi; Yagi, Takanori; Hara, Yoshiaki; Hayashida, Kazuyuki; Motomura, Tomokazu; Mashiko, Kazuki; Iida, Hiroaki; Yokota, Hiroyuki; Wagatsuma, Yukiko			Evaluation of the safety and feasibility of resuscitative endovascular balloon occlusion of the aorta	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Resuscitative endovascular balloon occlusion of the aorta; hemorrhagic shock; endovascular	EMERGENCY-DEPARTMENT THORACOTOMY; CRITICALLY-ILL PATIENTS; HEMORRHAGIC-SHOCK; ABDOMINAL-TRAUMA; MODEL; SCORE; SURVIVAL; CATHETER; ANEURYSM; CARE	BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is one of the ultimately invasive procedures for managing a noncompressive torso injury. Since it is less invasive than resuscitative open aortic cross-clamping, its clinical application is expected. METHODS: We retrospectively evaluated the safety and clinical feasibility of REBOA (intra-aortic occlusion balloon, MERA, Tokyo, Japan) using the Seldinger technique to control severe hemorrhage. Of 5,230 patients admitted to our trauma center in Japan from 2007 to 2013, we included 24 who underwent REBOA primarily. The indications for REBOA were a pelvic ring fracture or hemoperitoneum with hemodynamically instability and impending cardiac arrest. Emergency hemostasis was performed during REBOA in all patients. RESULTS: All 24 patients had a blunt injury, the median age was 59 (interquartile range, 41-71 years), the median Injury Severity Score (ISS) was 47 (interquartile range, 37-52), the 30-day survival rate was 29.2% (n = 7), and the median probability survival rate was 12.5%. Indications for REBOA were hemoperitoneum and pelvic ring fracture in 15 cases and overlap in 8 cases. In 10 cases of death, the balloon could not be deflated in 5 cases. In 19 cases in which the balloon was deflated, the median duration of aortic occlusion was shorter in survivors than in deaths (21 minutes vs. 35 minutes, p = 0.05). The mean systolic blood pressure was significantly increased by REBOA (from 53.1 [21] mm Hg to 98.0 [26.6] mm Hg, p < 0.01). There were three cases with complications (12.5%), one external iliac artery injury and two lower limb ischemias in which lower limb amputation was necessary in all cases. Acute kidney injury developed in all three cases, but failure was not persistent. CONCLUSION: REBOA seems to be feasible for trauma resuscitation and may improve survivorship. However, the serious complication of lower limb ischemia warrants more research on its safety. (J Trauma Acute Care Surg. 2015; 78: 897-904. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.)	[Saito, Nobuyuki; Matsumoto, Hisashi; Yagi, Takanori; Hara, Yoshiaki; Hayashida, Kazuyuki; Motomura, Tomokazu; Mashiko, Kazuki; Iida, Hiroaki] Nippon Med Sch Chiba Hokusoh Hosp, Shock & Trauma Ctr, Inzai 2701694, Japan; [Yokota, Hiroyuki] Nippon Med Sch, Emergency & Crit Care Med, Tokyo 113, Japan; [Wagatsuma, Yukiko] Univ Tsukuba, Fac Med, Dept Clin Trial & Clin Epidemiol, Tsukuba, Ibaraki, Japan	Saito, N (reprint author), Nippon Med Sch Chiba Hokusoh Hosp, Shock & Trauma Ctr, 1715 Kamagari, Inzai 2701694, Japan.	nobu99@nms.ac.jp					Zipfel B, 2014, ANN THORAC SURG, V97, P774, DOI 10.1016/j.athoracsur.2013.09.034; Khorsandi M, 2013, INTERACT CARDIOV TH, V16, P509, DOI 10.1093/icvts/ivs540; Vincent JL, 1998, CRIT CARE MED, V26, P1793; Morrison JJ, 2014, J SURG RES, V191, P423, DOI 10.1016/j.jss.2014.04.012; Panici PB, 2012, J MATERN-FETAL NEO M, V25, P2512, DOI 10.3109/14767058.2012.712566; Nayeemuddin M, 2013, CLIN RADIOL, V68, P529, DOI 10.1016/j.crad.2012.10.013; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; White JM, 2011, SURGERY, V150, P400, DOI 10.1016/j.surg.2011.06.010; Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664; BOYD CR, 1987, J TRAUMA, V27, P370; Martinelli T, 2010, J TRAUMA, V68, P942, DOI 10.1097/TA.0b013e3181c40579; Villamaria CY, 2014, J TRAUMA ACUTE CARE, V76, P929, DOI 10.1097/TA.0000000000000164; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; Matsumoto H, 2009, RESUSCITATION, V80, P1270, DOI 10.1016/j.resuscitation.2009.08.010; Avaro JP, 2011, J TRAUMA, V71, P720, DOI 10.1097/TA.0b013e318221a94a; Moore EE, 2011, J TRAUMA, V70, P334, DOI 10.1097/TA.0b013e3182077c35; Ogura T, 2014, J TRAUMA ACUTE CARE, V76, P1243, DOI 10.1097/TA.0000000000000200; HUGHES CW, 1954, SURGERY, V36, P65; Morrison JJ, 2012, J SURG RES, V177, P341, DOI 10.1016/j.jss.2012.04.035; Stannard A, 2011, J TRAUMA, V71, P1869, DOI 10.1097/TA.0b013e31823fe90c; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; GUPTA BK, 1989, J TRAUMA, V29, P861, DOI 10.1097/00005373-198906000-00026; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Morrison JJ, 2014, SHOCK, V41, P130, DOI 10.1097/SHK.0000000000000085; Malina M, 2005, J ENDOVASC THER, V12, P556, DOI 10.1583/05-1587.1; Holcomb JB, 2007, J TRAUMA, V62, pS36, DOI 10.1097/TA.0b013e3180654134; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; LOW RB, 1986, ANN EMERG MED, V15, P1466, DOI 10.1016/S0196-0644(86)80945-3; Matsuda H, 2003, J VASC SURG, V38, P1293, DOI 10.1016/S0741-5214(03)00774-2	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2015	78	5					897	903		10.1097/TA.0000000000000614		7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	CH3KR	WOS:000353930100001		
J	Barnett, CA; Suzuki, TN; Sakaluk, SK; Thompson, CF				Barnett, C. A.; Suzuki, T. N.; Sakaluk, S. K.; Thompson, C. F.			Mass-based condition measures and their relationship with fitness: in what condition is condition?	JOURNAL OF ZOOLOGY			English	Review						birds; condition; fat reserves; fitness; individual phenotypic quality; insects; mammals; mass reserves	BODY CONDITION; TERMINAL INVESTMENT; INDIVIDUAL QUALITY; CONDITION INDEXES; IMMUNE CHALLENGE; PREDATION RISK; FAT; REPEATABILITY; DETERMINANTS; VERTEBRATES	Mass- or body-size measures of condition' are of central importance to the study of ecology and evolution, and it is often assumed that differences in condition measures are positively and linearly related to fitness. Using examples drawn from ecological studies, we show that indices of condition frequently are unlikely to be related to fitness in a linear fashion. Researchers need to be more explicit in acknowledging the limitations of mass-based condition measures and accept that, under some circumstances, they may not relate to fitness as traditionally assumed. Any relationship between a particular condition measure and fitness should first be empirically validated before condition is used as a proxy for fitness. In the absence of such evidence, researchers should explicitly acknowledge that assuming such a relationship may be unrealistic.	[Barnett, C. A.; Suzuki, T. N.] Rikkyo Univ, Dept Life Sci, Tokyo 171, Japan; [Suzuki, T. N.] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Miura, Kanagawa, Japan; [Sakaluk, S. K.; Thompson, C. F.] Illinois State Univ, Sch Biol Sci, Behav Ecol Evolut & Systemat Sect, Normal, IL 61761 USA	Barnett, CA (reprint author), Rikkyo Univ, Dept Life Sci, Tokyo 171, Japan.	optimalforager@hotmail.com			National Science Foundation [IBN-0316580, IOS-1118160]; National Institutes of Health [R15HD076308-01]	Our work is supported by Grants-in-Aid for JSPS fellows (C. A. B. and T. N. S.) and from the National Science Foundation (IBN-0316580, IOS-1118160) and National Institutes of Health (R15HD076308-01) (S. K. S. and C. F. T.).	Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.1890/0012-9658(2001)082[1473:MLRMOB]2.0.CO;2; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Bowers EK, 2012, P ROY SOC B-BIOL SCI, V279, P2891, DOI 10.1098/rspb.2012.0443; ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.2307/2408465; Wilson AJ, 2010, TRENDS ECOL EVOL, V25, P207, DOI 10.1016/j.tree.2009.10.002; GOSLER AG, 1995, NATURE, V377, P621, DOI 10.1038/377621a0; Lailvaux SP, 2011, P ROY SOC B-BIOL SCI, V278, P321, DOI 10.1098/rspb.2010.1591; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; Milot E, 2014, METHODS ECOL EVOL, V5, P146; Adamo SA, 2008, J EXP BIOL, V211, P531, DOI 10.1242/jeb.013136; Horak P, 2002, CAN J ZOOL, V80, P636, DOI 10.1139/Z02-038; Bergeron P, 2011, J ANIM ECOL, V80, P361, DOI 10.1111/j.1365-2656.2010.01770.x; Roff DA, 1996, EVOLUTION, V50, P1392, DOI 10.2307/2410877; Velando A, 2006, P R SOC B, V273, P1443, DOI 10.1098/rspb.2006.3480; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Blem C.R., 1990, Current Ornithology, V7, P59; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; LLOYD DG, 1977, J THEOR BIOL, V69, P543, DOI 10.1016/0022-5193(77)90155-2; CHEVERUD JM, 1988, EVOLUTION, V42, P958, DOI 10.2307/2408911; Weil ZM, 2006, BIOL LETT-UK, V2, P393, DOI 10.1098/rsbl.2006.0475; Schamber JL, 2009, J AVIAN BIOL, V40, P49, DOI 10.1111/j.1600-048X.2008.04462.x; Ratikainen II, 2013, ANIM BEHAV, V85, P427, DOI 10.1016/j.anbehav.2012.12.002; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; BARCLAY RMR, 1994, AM NAT, V144, P1021, DOI 10.1086/285723; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; EVANS PR, 1969, J ANIM ECOL, V38, P415, DOI 10.2307/2781; Forsman AM, 2008, J EVOLUTION BIOL, V21, P873, DOI 10.1111/j.1420-9101.2008.01503.x; Gonzalez-Braojos S, 2013, ANN ZOOL FENN, V50, P279; Grafen A., 1984, BEHAV ECOLOGY EVOLUT, P62; Grubb Jr T. C., 2006, PTILOCHRONOLOGY FEAT; Hatch MI, 2010, J FIELD ORNITHOL, V81, P64, DOI 10.1111/j.1557-9263.2009.00261.x; Krams I, 2010, FUNCT ECOL, V24, P172, DOI 10.1111/j.1365-2435.2009.01628.x; Maynard Smith J., 1978, ANNU REV ECOL SYST, V9, P31, DOI DOI 10.1146/ANNUREV.ES.09.110178.000335; Pabian SE, 2011, AUK, V128, P441, DOI 10.1525/auk.2011.10283; Salewski V, 2009, IBIS, V151, P640; Hayes Jack P., 2001, P8, DOI 10.1017/CBO9780511551741.003; Williams G, 1966, ADAPTATION NATURAL S; Willie J, 2010, PHYSIOL BIOCHEM ZOOL, V83, P119, DOI 10.1086/605478; WINGFIELD JC, 1976, CONDOR, V78, P570, DOI 10.2307/1367117	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-8369	1469-7998		J ZOOL	J. Zool.	MAY	2015	296	1					1	5		10.1111/jzo.12213		5	Zoology	Zoology	CH4WV	WOS:000354034900001		
J	Taguchi, A; Nishinakamura, R				Taguchi, Atsuhiro; Nishinakamura, Ryuichi			Nephron reconstitution from pluripotent stem cells	KIDNEY INTERNATIONAL			English	Review						development; intermediate mesoderm; kidney; origin; regenerative medicine; stem cell	MAMMALIAN KIDNEY; DIRECTED DIFFERENTIATION; METANEPHRIC MESENCHYME; INTERMEDIATE MESODERM; STROMAL CELLS; ADULT; PROGENITORS; REGENERATION; IDENTIFICATION; SPECIFICATION	It has been a challenge in developmental biology and regenerative medicine to generate nephron progenitors that reconstitute the three-dimensional (3D) nephron structure in vitro. Many studies have tried to induce nephron progenitors from pluripotent stem cells by mimicking the developmental processes in vivo. However, the current developmental model does not precisely address the spatiotemporal origin of nephron progenitors, hampering our understanding of cell fate decisions in the kidney. Here, we present a revised model of early-stage kidney specification, suggesting distinct origins of the two major kidney components: the ureteric bud and metanephric mesenchyme. This model enables the induction of metanephric nephron progenitors from both mouse and human pluripotent stem cells. The induced cells self-organize in the presence of Wnt signaling and reconstitute 3D nephron structures including both nephric tubules with a clear lumina and glomeruli with podocytes. The engrafted kidney tissue develops vascularized glomeruli and nephric tubules, but it does not produce urine, suggesting the requirement for further maturation. Nevertheless, the generation of nephron components from human-induced pluripotent stem cells will be useful for future application in regenerative therapy and modeling of congenital kidney diseases in vitro. This review discusses the possibility of de novo organogenesis of a functional kidney from pluripotent stem cells and the future direction toward clinical applications.	[Taguchi, Atsuhiro; Nishinakamura, Ryuichi] Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan	Nishinakamura, R (reprint author), Kumamoto Univ, Dept Kidney Dev, Inst Mol Embryol & Genet, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ryuichi@kumamoto-u.ac.jp					Lasagni L, 2010, J AM SOC NEPHROL, V21, P1612, DOI 10.1681/ASN.2010010048; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Hendry CE, 2013, J AM SOC NEPHROL, V24, P1424, DOI 10.1681/ASN.2012121143; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Das A, 2013, NAT CELL BIOL, V15, P1035, DOI 10.1038/ncb2828; Shkreli M, 2012, NAT MED, V18, P111, DOI 10.1038/nm.2550; Costantini F, 2010, DEV CELL, V18, P698, DOI [10.1016/j.devcel.2010.04.008, 10.1016/j.devce1.2010.04.008]; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Kispert A, 1998, DEVELOPMENT, V125, P4225; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Cirio MC, 2014, PEDIATR NEPHROL, V29, P553, DOI 10.1007/s00467-013-2597-2; Drawbridge J, 2003, DEV DYNAM, V226, P1, DOI 10.1002/dvdy.10205; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; Lam AQ, 2013, J AM SOC NEPHROL, V25, P1211; Li W, 2014, DEV DYNAM, V243, P853, DOI [10.1002/dvdy.24134, 10.1002/DVDY.24134]; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Moriya N, 1993, DEV GROWTH DIFFER, V35, P6; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; TAGUCHI A, 2013, CELL STEM CELL, V14, P53; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Williams LA, 2012, CELL, V149, P1174, DOI 10.1016/j.cell.2012.05.015; Williams LA, 2012, CELL, V149, pe1171	45	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	MAY	2015	87	5					894	900		10.1038/ki.2014.358		7	Urology & Nephrology	Urology & Nephrology	CH5HS	WOS:000354066900007		
J	Yokoyama, K; Maruyama, Y; Ohkido, I; Yokoo, T				Yokoyama, Keitaro; Maruyama, Yukio; Ohkido, Ichiro; Yokoo, Takashi			The value of ferric citrate, an iron-containing phosphate binder, might be different between Japan and the United States	KIDNEY INTERNATIONAL			English	Letter							HEMODIALYSIS		[Yokoyama, Keitaro; Maruyama, Yukio; Ohkido, Ichiro; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Tokyo 1058471, Japan	Yokoyama, K (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo, Tokyo 1058471, Japan.	keitaro@jikei.ac.jp					Yokoyama K, 2014, J RENAL NUTR, V24, P261, DOI 10.1053/j.jrn.2014.03.006; Kuragano T, 2014, KIDNEY INT, V86, P845, DOI 10.1038/ki.2014.114; Lewis JB, 2014, J AM SOC NEPHROL, V26, P493	3	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	MAY	2015	87	5					1074	1075		10.1038/ki.2015.45		4	Urology & Nephrology	Urology & Nephrology	CH5HS	WOS:000354066900027		
J	Kuragano, T; Matsumura, O; Matsuda, A; Hara, T; Kiyomoto, H; Murata, T; Kitamura, K; Fujimoto, S; Hase, H; Joki, N; Fukatsu, A; Inoue, T; Itakura, Y; Nakanishi, T				Kuragano, Takahiro; Matsumura, Osamu; Matsuda, Akihiko; Hara, Taiga; Kiyomoto, Hideyasu; Murata, Toshiaki; Kitamura, Kenichiro; Fujimoto, Shouichi; Hase, Hiroki; Joki, Nobuhiko; Fukatsu, Atushi; Inoue, Toru; Itakura, Yukihiro; Nakanishi, Takeshi			The value of ferric citrate, an iron-containing phosphate binder, might be different between Japan and the United States Reply	KIDNEY INTERNATIONAL			English	Letter							HEMODIALYSIS		[Kuragano, Takahiro] Hyogo Coll Med, Dept Internal Med, Div Nephrol & Dialysis, Nishinomiya, Hyogo 6638510, Japan; [Matsumura, Osamu] Musashi Ranzan Hosp, Dept Internal Med, Musashi, Japan; [Matsuda, Akihiko] Saitama Med Univ, Saitama Med Ctr, Dept Nephrol & Blood Purificat, Saitama, Japan; [Hara, Taiga] Kagawa Univ, Fac Med, Dept Cardiorenal & Cerebrovasc Med, Div Nephrol & Dialysis, Kagawa, Japan; [Kiyomoto, Hideyasu] Tohoku Univ, Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Biol, Sendai, Miyagi 980, Japan; [Murata, Toshiaki] Fukuoka Univ, Fac Med, Dept Internal Med, Div Nephrol & Rheumatol, Fukuoka 81401, Japan; [Kitamura, Kenichiro] Univ Yamanashi, Fac Med, Dept Internal Med 3, Chuo Ku, Kofu, Yamanashi, Japan; [Fujimoto, Shouichi] Univ Miyazaki Hosp, Dialysis Div, Miyazaki, Japan; [Hase, Hiroki; Joki, Nobuhiko] Toho Univ, Ohashi Med Ctr, Dept Nephrol, Tokyo, Japan; [Fukatsu, Atushi] Yachiyo Hosp, Dept Internal Med, Anjyou, Japan; [Inoue, Toru] Higashikouri Hosp, Dept Internal Med, Hirakata, Osaka, Japan; [Itakura, Yukihiro] Itakura Clin, Dept Internal Med, Saitama, Japan; [Nakanishi, Takeshi] Hyougo Coll Med, Dept Internal Med, Div Artificial Kidney, Nishinomiya, Hyogo, Japan	Kuragano, T (reprint author), Hyogo Coll Med, Dept Internal Med, Div Nephrol & Dialysis, Mukogawa Cho, Nishinomiya, Hyogo 6638510, Japan.	kuragano@hyo-med.ac.jp					Yokoyama K, 2014, J RENAL NUTR, V24, P261, DOI 10.1053/j.jrn.2014.03.006; Kuragano T, 2014, KIDNEY INT, V86, P845, DOI 10.1038/ki.2014.114; Yahiro M, 2012, CLIN EXP NEPHROL, V16, P448, DOI 10.1007/s10157-011-0584-0; Yokoyama K, 2015, KIDNEY INT, V87, P1074, DOI 10.1038/ki.2015.45	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	MAY	2015	87	5					1075	1076		10.1038/ki.2015.47		3	Urology & Nephrology	Urology & Nephrology	CH5HS	WOS:000354066900028		
J	Uzu, T; Araki, SI; Araki, H; Kume, S; Maegawa, H				Uzu, Takashi; Araki, Shin-Ichi; Araki, Hisazumi; Kume, Shinji; Maegawa, Hiroshi			Multiple osteoporotic fractures in a patient with CKD stage G3b	KIDNEY INTERNATIONAL			English	Editorial Material									[Uzu, Takashi; Araki, Shin-Ichi; Araki, Hisazumi; Kume, Shinji; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Internal Med, Otsu, Shiga 5202192, Japan	Uzu, T (reprint author), Shiga Univ Med Sci, Dept Internal Med, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	takuzu@belle.shiga-med.ac.jp						0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	MAY	2015	87	5					1077	1077		10.1038/ki.2013.232		1	Urology & Nephrology	Urology & Nephrology	CH5HS	WOS:000354066900029		
J	Mineo, N; Ryochi, Y; Mari, T; Yuuji, H; Kiyotaka, U; Yuka, K; Rie, F; Yoshitaka, I				Mineo, Nakatsuka; Ryochi, Yoshida; Mari, Tone; Yuuji, Hakozaki; Kiyotaka, Uchiyama; Yuka, Kamijo; Rie, Furutera; Yoshitaka, Ishibashi			Amputation of the peritoneal dialysis catheter in the abdominal cavity	KIDNEY INTERNATIONAL			English	Editorial Material									[Mineo, Nakatsuka; Ryochi, Yoshida; Mari, Tone; Yuuji, Hakozaki; Kiyotaka, Uchiyama; Yuka, Kamijo; Rie, Furutera; Yoshitaka, Ishibashi] Japanese Red Cross Med Ctr, Div Nephrol, Shibuya Ku, Tokyo 1508935, Japan	Mineo, N (reprint author), Japanese Red Cross Med Ctr, Div Nephrol, Shibuya Ku, 4-1-22 Hiroo, Tokyo 1508935, Japan.	hiromaekikaku@gmail.com						0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	MAY	2015	87	5					1078	1078		10.1038/ki.2014.267		1	Urology & Nephrology	Urology & Nephrology	CH5HS	WOS:000354066900030		
J	Naganuma, M; Hosoe, N; Kanai, T; Ogata, H				Naganuma, Makoto; Hosoe, Naoki; Kanai, Takanori; Ogata, Haruhiko			Recent trends in diagnostic techniques for inflammatory bowel disease	KOREAN JOURNAL OF INTERNAL MEDICINE			English	Review							COLON CAPSULE ENDOSCOPY; ACTIVE ULCERATIVE-COLITIS; CROHNS-DISEASE; MR ENTEROGRAPHY; CT ENTEROGRAPHY; PILLCAM COLON; BALLOON ENTEROSCOPY; CLINICAL-OUTCOMES; MEDICAL THERAPY; VALIDATION	Although ileocolonoscopy is the gold standard for diagnosis of inflammatory bowel disease and is useful for assessing the disease severity in the colon and terminal ileum, several alternative diagnostic technique's have been developed recently. For ulcerative colitis (UC), magnification colonoscopy, endocytoscopy, and confocal laser endomicroscopy enable assessment of histological inflammation without the need for biopsy. Capsule endoscopy is useful for detection of small intestinal and colonic lesions in both female and male patients. For UC, capsule endoscopy may be useful for evaluating colonic inflammation in patients with a previous poor colonoscopy experience, while it should be used only in Crohn's disease (CD) patients with unexplained symptoms when other examinations are negative. Magnetic resonance enterography (MRE) is particularly useful for detecting transmural inflammation, stenosis, and extraintestinal lesions, including abscesses and fistulas. MRE is also useful when evaluating small and large intestinal lesions, even in cases with severe strictures in which full evaluation of the small bowel would be virtually impossible using other devices. Therefore, the appropriate diagnostic devices for detecting CD lesions in the small and large intestine should be used.	[Naganuma, Makoto; Hosoe, Naoki; Ogata, Haruhiko] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Tokyo 1608582, Japan; [Kanai, Takanori] Keio Univ, Sch Med, Dept Gastroenterol & Hepatol, Tokyo 1608582, Japan	Ogata, H (reprint author), Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hogata@z8.keio.jp					Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Kopylov U, 2015, INFLAMM BOWEL DIS, V21, P93, DOI 10.1097/MIB.0000000000000255; Lee SS, 2009, RADIOLOGY, V251, P751, DOI 10.1148/radiol.2513081184; Kunihiro M, 2004, INFLAMM BOWEL DIS, V10, P737, DOI 10.1097/00054725-200411000-00007; Bessissow T, 2012, AM J GASTROENTEROL, V107, P1684, DOI 10.1038/ajg.2012.301; MARY JY, 1989, GUT, V30, P983, DOI 10.1136/gut.30.7.983; Colombel JF, 2011, GASTROENTEROLOGY, V141, P1194, DOI 10.1053/j.gastro.2011.06.054; Travis SPL, 2012, GUT, V61, P535, DOI 10.1136/gutjnl-2011-300486; Travis SPL, 2013, GASTROENTEROLOGY, V145, P987, DOI 10.1053/j.gastro.2013.07.024; Oshitani N, 2006, AM J GASTROENTEROL, V101, P1484, DOI 10.1111/j.1572-0241.2006.00648.x; Hanauer SB, 2005, AM J GASTROENTEROL, V100, P2478, DOI 10.1111/j.1572-0241.2005.00248.x; Siddiki HA, 2009, AM J ROENTGENOL, V193, P113, DOI 10.2214/AJR.08.2027; Kruis W, 2009, GUT, V58, P233, DOI 10.1136/gut.2008.154302; Yamamoto H, 2001, GASTROINTEST ENDOSC, V53, P216, DOI 10.1067/mge.2001.112181; de Melo SW, 2012, GASTROENTEROL CLIN N, V41, P315, DOI 10.1016/j.gtc.2012.01.005; Fiorino G, 2011, INFLAMM BOWEL DIS, V17, P1073, DOI 10.1002/ibd.21533; Neumann H, 2011, WORLD J GASTROENTERO, V17, P63, DOI 10.3748/wjg.v17.i1.63; Tsujikawa T, 2008, ENDOSCOPY, V40, P11, DOI 10.1055/s-2007-966976; Niv E, 2014, J CROHNS COLITIS, V8, P1616, DOI 10.1016/j.crohns.2014.03.003; Spada C, 2012, ENDOSCOPY, V44, P527, DOI 10.1055/s-0031-1291717; Bourreille A, 2009, ENDOSCOPY, V41, P618, DOI 10.1055/s-0029-1214790; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; Neurath MF, 2012, GUT, V61, P1619, DOI 10.1136/gutjnl-2012-302830; Meister T, 2013, TECH COLOPROCTOL, V17, P641, DOI 10.1007/s10151-012-0965-8; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Bessho R, 2011, J GASTROENTEROL, V46, P1197, DOI 10.1007/s00535-011-0439-1; Sung J, 2012, ENDOSCOPY, V44, P754, DOI 10.1055/s-0032-1309819; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; Yamamoto H, 2004, CLIN GASTROENTEROL H, V2, P1010, DOI 10.1053/S1542-3565(04)00453-7; Herrerias JM, 2008, GASTROINTEST ENDOSC, V67, P902, DOI 10.1016/j.gie.2007.10.063; Van Assche G, 2013, J CROHNS COLITIS, V7, P950, DOI 10.1016/j.crohns.2013.01.011; Panes J, 2011, ALIMENT PHARM THER, V34, P125, DOI 10.1111/j.1365-2036.2011.04710.x; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Tielbeek JAW, 2013, INFLAMM BOWEL DIS, V19, P1943, DOI 10.1097/MIB.0b013e3182905536; Kiesslich R, 2007, GASTROENTEROLOGY, V132, P874, DOI 10.1053/j.gastro.2007.01.048; Cotter J, 2015, ENDOSCOPY, V47, P330, DOI 10.1055/s-0034-1390894; Jensen MD, 2011, SCAND J GASTROENTERO, V46, P1449, DOI 10.3109/00365521.2011.613947; Li CQ, 2010, AM J GASTROENTEROL, V105, P1391, DOI 10.1038/ajg.2009.664; Hurlstone DP, 2006, ENDOSCOPY, V38, P1213, DOI 10.1055/s-2006-944732; Ardizzone S, 2011, CLIN GASTROENTEROL H, V9; Eliakim R, 2006, ENDOSCOPY, V38, P963, DOI 10.1055/s-2006-944832; Florholmen J, 2015, SCAND J GASTROENTERO, V50, P43, DOI 10.3109/00365521.2014.977943; Gal E, 2008, DIGEST DIS SCI, V53, P1933, DOI 10.1007/s10620-007-0084-y; Gralnev IM, 2008, ALIMENT PHARM THERAP, V27, P146, DOI 10.1111/j.1365-2036.2007.03556.x; Herfarth HH, 2010, DIGEST DIS, V28, P439, DOI 10.1159/000320400; Hosoe N, 2013, J GASTROEN HEPATOL, V28, P1174, DOI 10.1111/jgh.12203; Naganuma M, 2015, EXPERT REV GASTROENT, V9, P37, DOI 10.1586/17474124.2014.939631; Naganuma M, 2014, DIGEST ENDOSC, V26, P20, DOI 10.1111/den.12161; Ordas I, 2014, GASTROENTEROLOGY, V146; Spada C, 2011, GASTROINTEST ENDOSC, V74; Spada C, 2010, CLIN GASTROENTEROL H, V8, P516, DOI 10.1016/j.cgh.2010.02.018; Takenaka K, 2014, GASTROENTEROLOGY, V147; Usui S, 2014, DIGEST ENDOSC, V26, P665, DOI 10.1111/den.12269; Ye CA, 2013, J DIGEST DIS, V14, P117, DOI 10.1111/1751-2980.12005	54	1	1	KOREAN ASSOC INTERNAL MEDICINE	SEOUL	101-2501 LOTTE CASTLE PRESIDENT, 109 MAPO-DAERO, MAPO-GU, SEOUL, 121-916, SOUTH KOREA	1226-3303			KOREAN J INTERN MED	Korean J. Intern. Med.	MAY	2015	30	3					271	278		10.3904/kjim.2015.30.3.271		8	Medicine, General & Internal	General & Internal Medicine	CH3MB	WOS:000353933700001		
J	Kenzaka, T				Kenzaka, Tsuneaki			Purple urine bag syndrome in a patient with a urethral balloon catheter and a history of ileal conduit urinary diversion	KOREAN JOURNAL OF INTERNAL MEDICINE			English	Editorial Material									Jichi Med Univ Hosp, Div Gen Internal Med, Shimotsuke, Japan	Kenzaka, T (reprint author), Jichi Med Univ Hosp, Div Gen Internal Med, Shimotsuke, Japan.	smile.kenzaka@jichi.ac.jp						0	0	0	KOREAN ASSOC INTERNAL MEDICINE	SEOUL	101-2501 LOTTE CASTLE PRESIDENT, 109 MAPO-DAERO, MAPO-GU, SEOUL, 121-916, SOUTH KOREA	1226-3303			KOREAN J INTERN MED	Korean J. Intern. Med.	MAY	2015	30	3					420	420		10.3904/kjim.2015.30.3.420		1	Medicine, General & Internal	General & Internal Medicine	CH3MB	WOS:000353933700021		
J	Tabernero, J; Yoshino, T; Cohn, AL; Obermannova, R; Bodoky, G; Garcia-Carbonero, R; Ciuleanu, TE; Portnoy, DC; Van Cutsem, E; Grothey, A; Prausova, J; Garcia-Alfonso, P; Yamazaki, K; Clingan, PR; Lonardi, S; Kim, TW; Simms, L; Chang, SC; Nasroulah, F				Tabernero, Josep; Yoshino, Takayuki; Cohn, Allen Lee; Obermannova, Radka; Bodoky, Gyorgy; Garcia-Carbonero, Rocio; Ciuleanu, Tudor-Eliade; Portnoy, David C.; Van Cutsem, Eric; Grothey, Axel; Prausova, Jana; Garcia-Alfonso, Pilar; Yamazaki, Kentaro; Clingan, Philip R.; Lonardi, Sara; Kim, Tae Won; Simms, Lorinda; Chang, Shao-Chun; Nasroulah, Federico		RAISE Study Investigators	Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study	LANCET ONCOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER; TRIAL; FLUOROURACIL; LEUCOVORIN; AFLIBERCEPT; IRINOTECAN; ONCOLOGY; SURVIVAL	Background Angiogenesis is an important therapeutic target in colorectal carcinoma. Ramucirumab is a human IgG-1 monoclonal antibody that targets the extracellular domain of VEGF receptor 2. We assessed the efficacy and safety of ramucirumab versus placebo in combination with second-line FOLFIRI (leucovorin, fluorouracil, and irinotecan) for metastatic colorectal cancer in patients with disease progression during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine. Methods Between Dec 14, 2010, and Aug 23, 2013, we enrolled patients into the multicentre, randomised, double-blind, phase 3 RAISE trial. Eligible patients had disease progression during or within 6 months of the last dose of first-line therapy. Patients were randomised (1: 1) via a centralised, interactive voice-response system to receive 8 mg/kg intravenous ramucirumab plus FOLFIRI or matching placebo plus FOLFIRI every 2 weeks until disease progression, unacceptable toxic effects, or death. Randomisation was stratified by region, KRAS mutation status, and time to disease progression after starting first-line treatment. The primary endpoint was overall survival in the intention-to-treat population. This study is registered with ClinicalTrials.gov, number NCT01183780.ld Findings We enrolled 1072 patients (536 in each group). Median overall survival was 13.3 months (95% CI 12.4-14.5) for patients in the ramucirumab group versus 11.7 months (10.8-12.7) for the placebo group (hazard ratio 0.844 95% CI 0.730-0.976; log-rank p=0.0219). Survival benefit was consistent across subgroups of patients who received ramucirumab plus FOLFIRI. Grade 3 or worse adverse events seen in more than 5% of patients were neutropenia (203 [38%] of 529 patients in the ramucirumab group vs 123 [23%] of 528 in the placebo group, with febrile neutropenia incidence of 18 [3%] vs 13 [2%]), hypertension (59 [11%] vs 15 [3%]), diarrhoea (57 [11%] vs 51 [10%]), and fatigue (61 [12%] vs 41 [8%]). Interpretation Ramucirumab plus FOLFIRI significantly improved overall survival compared with placebo plus FOLFIRI as second-line treatment for patients with metastatic colorectal carcinoma. No unexpected adverse events were identified and toxic effects were manageable.	[Tabernero, Josep] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona 08035, Spain; [Tabernero, Josep] Univ Autonoma Barcelona, Inst Oncol, E-08193 Barcelona, Spain; [Yoshino, Takayuki] Natl Canc Ctr Hosp East, Dept Gastroenterol, Chiba, Japan; [Cohn, Allen Lee] US Oncol, Rocky Mt Canc Ctr, Denver, CO USA; [Obermannova, Radka] Masaryk Mem Canc Inst, Dept Comprehens Canc Care, Brno, Czech Republic; [Bodoky, Gyorgy] Szent Laszlo Hosp, Dept Oncol, Budapest, Hungary; [Garcia-Carbonero, Rocio] Hosp Univ Virgen Rocio, Spanish Minist Sci & Innovat, Inst Biomed Sevilla, RTICC,Inst Carlos III, Seville, Spain; [Ciuleanu, Tudor-Eliade] Prof Dr Ion Chiricuta Inst Oncol, Cluj Napoca, Romania; [Ciuleanu, Tudor-Eliade] UMF Iuliu Hatieganu, Cluj Napoca, Romania; [Portnoy, David C.] West Clin, Memphis, TN USA; [Van Cutsem, Eric] Univ Hosp Gasthuisberg, Leuven, Belgium; [Grothey, Axel] Mayo Clin, Dept Oncol, Rochester, MN USA; [Prausova, Jana] Univ Hosp Motol, Prague, Czech Republic; [Garcia-Alfonso, Pilar] Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Yamazaki, Kentaro] Shizuoka Canc Ctr, Shizuoka, Japan; [Clingan, Philip R.] Southern Med Day Care Ctr, Wollongong, NSW, Australia; [Lonardi, Sara] IRCCS, Ist Oncol Veneto, Med Oncol 1, Padua, Italy; [Kim, Tae Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Simms, Lorinda] Eli Lilly Canada, Toronto, ON, Canada; [Chang, Shao-Chun] Eli Lilly, Indianapolis, IN USA; [Nasroulah, Federico] Eli Lilly & Co, Bridgewater, NJ USA	Tabernero, J (reprint author), Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Dept Med Oncol, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.	jtabernero@vhio.net	zagonel, vittorina/F-4226-2014; Lonardi, Sara/F-4228-2014	zagonel, vittorina/0000-0002-0829-2525; Lonardi, Sara/0000-0002-7593-8138	Eli Lilly	The study was funded by Eli Lilly. We thank the patients, investigators, and institutions involved in this study and the members of the data monitoring committee. Additionally, we thank Mark Rutstein for assistance with development of the protocol, Astra Liepa for help with the quality-of-life analysis, Yawei Zhang for study support, Christopher Asakiewicz for clinical trial management, Anastasia Perkowski for editorial support, and Mary Dugan Wood for writing assistance; all were Eli Lilly employees or collaborators at the time of their involvement with the study and were compensated as such.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Amini A, 2012, CURR CANCER DRUG TAR, V12, P23; Tabernero J, 2014, EUR J CANCER, V50, P320, DOI 10.1016/j.ejca.2013.09.013; Maitland ML, 2010, JNCI-J NATL CANCER I, V102, P596, DOI 10.1093/jnci/djq091; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Tugues S, 2011, MOL ASPECTS MED, V32, P88, DOI 10.1016/j.mam.2011.04.004; Hochster HS, 2008, J CLIN ONCOL, V26, P3523, DOI 10.1200/JCO.2007.15.4138; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Sullivan LA, 2010, MABS-AUSTIN, V2, P165; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Brown L F, 1997, EXS, V79, P233; Bruns CJ, 2000, CANCER, V89, P488, DOI 10.1002/1097-0142(20000801)89:3<488::AID-CNCR3>3.0.CO;2-X; EuroQol Group, 1990, Health Policy, V16, P199; Ferlay J, GLOBOCAN 2012 V1 0 C; FERRARA N, 1993, TRENDS CARDIOVAS MED, V3, P244, DOI 10.1016/1050-1738(93)90046-9; National Comprehensive Care Network, CLIN PRACT GUID ONC; Surveillance Epidemiology and End Results Program, SEER STAT FACT SHEET; Tonra JR, 2006, CLIN CANCER RES, V12, P2197, DOI 10.1158/1078-0432.CCR-05-1682; US Department of Health and Human Services, 2009, COMM TERM CRIT ADV E; Van Cutsem E, 2014, ANN ONCOL, V25, piii19; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6	26	17	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	MAY	2015	16	5					499	508		10.1016/S1470-2045(15)70127-0		10	Oncology	Oncology	CH3DW	WOS:000353908200044		
J	Torchia, J; Picard, D; Lafay-Cousin, L; Hawkins, CE; Kim, SK; Letourneau, L; Ra, YS; Ho, KC; Chan, TSY; Sin-Chan, P; Dunham, CP; Yip, S; Ng, HK; Lu, JQ; Albrecht, S; Pimentel, J; Chan, JA; Somers, GR; Zielenska, M; Faria, CC; Roque, L; Baskin, B; Birks, D; Foreman, N; Strother, D; Klekner, A; Garami, M; Hauser, P; Hortobagyi, T; Bognar, L; Wilson, B; Hukin, J; Carret, AS; Van Meter, TE; Nakamura, H; Toledano, H; Fried, I; Fults, D; Wataya, T; Fryer, C; Eisenstat, DD; Scheineman, K; Johnston, D; Michaud, J; Zelcer, S; Hammond, R; Ramsay, DA; Fleming, AJ; Lulla, RR; Fangusaro, JR; Sirachainan, N; Larbcharoensub, N; Hongeng, S; Barakzai, MA; Montpetit, A; Stephens, D; Grundy, RG; Schuller, U; Nicolaides, T; Tihan, T; Phillips, J; Taylor, MD; Rutka, JT; Dirks, P; Bader, GD; Warmuth-Metz, M; Rutkowski, S; Pietsch, T; Judkins, AR; Jabado, N; Bouffet, E; Huang, A				Torchia, Jonathon; Picard, Daniel; Lafay-Cousin, Lucie; Hawkins, Cynthia E.; Kim, Seung-Ki; Letourneau, Louis; Ra, Young-Shin; Ho, King Ching; Chan, Tiffany Sin Yu; Sin-Chan, Patrick; Dunham, Christopher P.; Yip, Stephen; Ng, Ho-Keung; Lu, Jian-Qiang; Albrecht, Steffen; Pimentel, Jose; Chan, Jennifer A.; Somers, Gino R.; Zielenska, Maria; Faria, Claudia C.; Roque, Lucia; Baskin, Berivan; Birks, Diane; Foreman, Nick; Strother, Douglas; Klekner, Almos; Garami, Miklos; Hauser, Peter; Hortobagyi, Tibor; Bognar, Laszlo; Wilson, Beverly; Hukin, Juliette; Carret, Anne-Sophie; Van Meter, Timothy E.; Nakamura, Hideo; Toledano, Helen; Fried, Iris; Fults, Daniel; Wataya, Takafumi; Fryer, Chris; Eisenstat, David D.; Scheineman, Katrin; Johnston, Donna; Michaud, Jean; Zelcer, Shayna; Hammond, Robert; Ramsay, David A.; Fleming, Adam J.; Lulla, Rishi R.; Fangusaro, Jason R.; Sirachainan, Nongnuch; Larbcharoensub, Noppadol; Hongeng, Suradej; Barakzai, Muhammad Abrar; Montpetit, Alexandre; Stephens, Derek; Grundy, Richard G.; Schueller, Ulrich; Nicolaides, Theodore; Tihan, Tarik; Phillips, Joanna; Taylor, Michael D.; Rutka, James T.; Dirks, Peter; Bader, Gary D.; Warmuth-Metz, Monika; Rutkowski, Stefan; Pietsch, Torsten; Judkins, Alexander R.; Jabado, Nada; Bouffet, Eric; Huang, Annie			Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis	LANCET ONCOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; TERATOID/RHABDOID TUMORS; PROGNOSTIC-FACTORS; RADIATION-THERAPY; GENE-EXPRESSION; MUTATIONS; SURVIVAL; CELLS; EXPERIENCE; HSNF5/INI1	Background Rhabdoid brain tumours, also called atypical teratoid rhabdoid tumours, are lethal childhood cancers with characteristic genetic alterations of SMARCB1/hSNF5. Lack of biological understanding of the substantial clinical heterogeneity of these tumours restricts therapeutic advances. We integrated genomic and clinicopathological analyses of a cohort of patients with atypical teratoid rhabdoid tumours to find out the molecular basis for clinical heterogeneity in these tumours. Methods We obtained 259 rhabdoid tumours from 37 international institutions and assessed transcriptional profiles in 43 primary tumours and copy number profiles in 38 primary tumours to discover molecular subgroups of atypical teratoid rhabdoid tumours. We used gene and pathway enrichment analyses to discover group-specific molecular markers and did immunohistochemical analyses on 125 primary tumours to evaluate clinicopathological significance of molecular subgroup and ASCL1-NOTCH signalling. Findings Transcriptional analyses identified two atypical teratoid rhabdoid tumour subgroups with differential enrichment of genetic pathways, and distinct clinicopathological and survival features. Expression of ASCL1, a regulator of NOTCH signalling, correlated with supratentorial location (p=0.004) and superior 5-year overall survival (35%, 95% CI 13-57, and 20%, 6-34, for ASCL1-positive and ASCL1-negative tumours, respectively; p=0.033) in 70 patients who received multimodal treatment. ASCL1 expression also correlated with superior 5-year overall survival (34%, 7-61, and 9%, 0-21, for ASCL1-positive and ASCL1-negative tumours, respectively; p=0.001) in 39 patients who received only chemotherapy without radiation. Cox hazard ratios for overall survival in patients with differential ASCL1 enrichment treated with chemotherapy with or without radiation were 2.02 (95% CI 1.04-3.85; p=0.038) and 3.98 (1.71-9.26; p=0.001). Integrated analyses of molecular subgroupings with clinical prognostic factors showed three distinct clinical risk groups of tumours with different therapeutic outcomes. Interpretation An integration of clinical risk factors and tumour molecular groups can be used to identify patients who are likely to have improved long-term radiation-free survival and might help therapeutic stratification of patients with atypical teratoid rhabdoid tumours.	[Torchia, Jonathon; Picard, Daniel; Chan, Tiffany Sin Yu; Sin-Chan, Patrick; Bouffet, Eric] Univ Calgary, Div Hematol Oncol, Calgary, AB, Canada; [Torchia, Jonathon; Picard, Daniel; Hawkins, Cynthia E.; Ho, King Ching; Chan, Tiffany Sin Yu; Sin-Chan, Patrick; Taylor, Michael D.; Huang, Annie] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Torchia, Jonathon; Picard, Daniel; Hawkins, Cynthia E.; Chan, Tiffany Sin Yu; Sin-Chan, Patrick; Somers, Gino R.; Zielenska, Maria; Taylor, Michael D.; Rutka, James T.; Dirks, Peter; Huang, Annie] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Torchia, Jonathon; Picard, Daniel; Chan, Tiffany Sin Yu; Sin-Chan, Patrick; Bouffet, Eric; Huang, Annie] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Lafay-Cousin, Lucie; Strother, Douglas] Univ Calgary, Alberta Childrens Hosp, Calgary, AB, Canada; [Lafay-Cousin, Lucie; Strother, Douglas] Univ Calgary, Cumming Sch Med, Dept Oncol & Pediat, Calgary, AB, Canada; [Hawkins, Cynthia E.] Hosp Sick Children, Dept Pathol, Toronto, ON M5G 1X8, Canada; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Letourneau, Louis; Montpetit, Alexandre] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Kim, Seung-Ki] Seoul Natl Univ, Childrens Hosp, Dept Neurosurg, Seoul, South Korea; [Taylor, Michael D.; Rutka, James T.; Dirks, Peter] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Bader, Gary D.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Comp Sci, Toronto, ON M5S 1A1, Canada; [Ra, Young-Shin] Asan Med Ctr, Dept Neurosurg, Seoul, South Korea; [Dunham, Christopher P.] Childrens & Womens Hlth Ctr British Columbia, Div Anat Pathol, Vancouver, BC, Canada; [Yip, Stephen] Vancouver Gen Hosp, Dept Neuropathol, Vancouver, BC, Canada; [Ng, Ho-Keung] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Lu, Jian-Qiang] Univ Alberta Hosp, Dept Lab Med & Pathol, Edmonton, AB T6G 2R7, Canada; [Albrecht, Steffen] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Res Inst,Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Pimentel, Jose] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Dept Neurol, Lisbon, Portugal; [Faria, Claudia C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Chan, Jennifer A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Somers, Gino R.; Zielenska, Maria] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada; [Roque, Lucia] Portuguese Canc Inst, Ctr Invest & Patobiol Mol, Cytogenet Lab, Lisbon, Portugal; [Baskin, Berivan] Univ Uppsala Hosp, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Birks, Diane; Foreman, Nick] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Klekner, Almos; Bognar, Laszlo] Univ Debrecen, Dept Neurosurg, Debrecen, Hungary; [Garami, Miklos; Hauser, Peter] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Hortobagyi, Tibor] Univ Szeged, Fac Med, Dept Histopathol, Szeged, Hungary; [Wilson, Beverly] Univ Alberta, Dept Pediat, Div Pediat Hematol Oncol, Edmonton, AB, Canada; [Hukin, Juliette] Univ British Columbia, Dept Pediat, Div Neurol & Oncol, Vancouver, BC V5Z 1M9, Canada; [Carret, Anne-Sophie] Univ Montreal, Ctr Hosp Univ Sainte Justine, Div Hematol Oncol, Montreal, PQ, Canada; [Van Meter, Timothy E.] Virginia Commonwealth Univ, Sch Med, Dept Pediat, Pediat Hematol Oncol, Richmond, VA USA; [Nakamura, Hideo] Kumamoto Univ, Dept Neurosurg, Kumamoto, Japan; [Toledano, Helen] Schneider Hosp, Dept Oncol, Petah Tiqwa, Israel; [Fried, Iris] Hadassah Hebrew Univ Hosp, Pediat Hematol Oncol Dept, Jerusalem, Israel; [Fults, Daniel] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT USA; [Wataya, Takafumi] Shizuoka Childrens Hosp, Dept Neurosurg, Shizuoka, Japan; [Fryer, Chris] Univ British Columbia, Dept Pediat, Div Hematol & Oncol, Vancouver, BC V5Z 1M9, Canada; [Eisenstat, David D.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Eisenstat, David D.] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Scheineman, Katrin] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Johnston, Donna] Univ Ottawa, Fac Med, Dept Pediat, Ottawa, ON, Canada; [Michaud, Jean] Ottawa Hosp, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Michaud, Jean] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Zelcer, Shayna] Childrens Hlth Res Inst, Div Childrens Hlth & Therapeut, London, ON, Canada; [Hammond, Robert] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Ramsay, David A.] London Hlth Sci Ctr, Dept Pathol, London, ON, Canada; [Fleming, Adam J.] McMaster Univ, Div Pediat Hematol Oncol, Hamilton, ON, Canada; [Lulla, Rishi R.; Fangusaro, Jason R.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60611 USA; [Sirachainan, Nongnuch] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat,Div Hematol & Oncol, Bangkok 10400, Thailand; [Larbcharoensub, Noppadol] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10400, Thailand; [Barakzai, Muhammad Abrar] Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan; [Stephens, Derek] Hosp Sick Children, Dept Clin Res Serv, Toronto, ON M5G 1X8, Canada; [Grundy, Richard G.] Univ Nottingham, Queens Med Ctr, Childrens Brain Tumour Res Ctr, Sch Clin Sci, Nottingham NG7 2RD, England; [Schueller, Ulrich] Univ Munich, Ctr Neuropathol, Munich, Germany; [Nicolaides, Theodore] Univ Calif San Francisco, Dept Pediat Hematol Oncol, San Francisco, CA 94143 USA; [Tihan, Tarik] Univ Calif San Francisco, Dept Pathol & Lab Med, San Francisco, CA 94143 USA; [Phillips, Joanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Warmuth-Metz, Monika] Univ Wurzburg, Dept Neuroradiol, Wurzburg, Germany; [Rutkowski, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Paediat Haematol & Oncol, Hamburg, Germany; [Pietsch, Torsten] Univ Bonn, Ctr Med, Dept Neuropathol, Bonn, Germany; [Judkins, Alexander R.] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90027 USA	Huang, A (reprint author), Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Dept Pediat,Div Hematol Oncol, 100 Coll St, Toronto, ON M5G 1X8, Canada.	annie.huang@sickkids.ca	Ng, Ho Keung/I-3952-2015		b.r.a.i.n. child foundation (Toronto, ON, Canada); Mitchell Duckman foundation (Toronto, ON, Canada); Tal Doron foundation (Toronto, ON, Canada); Suri Boon foundation (Toronto, ON, Canada); C17 Research Network grant; Genome Canada Grant Advancing Technology Innovation through Discovery competition (the Canadian Pediatric Cancer Genome Consortium); Ontario Graduate Scholarship; SickKids; Ontario Student Opportunity Trust Funds Frank Fletcher Memorial Fund; Hayden Hantho Award; Ontario Student Opportunity Trust Funds Hilda; William Courtney Clayton Paediatric Research Fund	This work was supported by endowed funds from b.r.a.i.n. child, Mitchell Duckman, Tal Doron, and Suri Boon foundations (Toronto, ON, Canada) to AH, a C17 Research Network grant to LL-C, EB, and AH, and a Genome Canada Grant Advancing Technology Innovation through Discovery competition (the Canadian Pediatric Cancer Genome Consortium: translating next-generation sequencing technologies into improved therapies for high risk childhood cancer) to AH and NJ. JT and PS-C are the recipients of an Ontario Graduate Scholarship. JT and TSYC are the recipients of a Research and Training fellowship from SickKids. TSYC and PS-C are the recipients of the Ontario Student Opportunity Trust Funds Frank Fletcher Memorial Fund. PS-C is the recipient of the Hayden Hantho Award. TSYC is the recipient of the Ontario Student Opportunity Trust Funds Hilda and the William Courtney Clayton Paediatric Research Fund. We thank colleagues Sergio Pereira and Jo-Anne Herbrick (both at the Centre for Applied Genomics at SickKids, Toronto, ON, Canada) for facilitating our work, and to Veronique Voisin (University of Toronto) for technical advice.	Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lafay-Cousin L, 2012, EUR J CANCER, V48, P353, DOI 10.1016/j.ejca.2011.09.005; Nicolaides T, 2010, J NEURO-ONCOL, V98, P117, DOI 10.1007/s11060-009-0071-6; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Hilden JM, 2004, J CLIN ONCOL, V22, P2877, DOI 10.1200/jco.2004.07.073; Venneti S, 2011, J NEUROPATH EXP NEUR, V70, P596, DOI 10.1097/NEN.0b013e31822146ca; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; D'cunja J, 2007, EUR J CANCER, V43, P1581, DOI 10.1016/j.ejca.2007.03.003; Tekautz TM, 2005, J CLIN ONCOL, V23, P1491, DOI 10.1200/JCO.2005.05.187; Panandiker ASP, 2012, INT J RADIAT ONCOL, V82, P1756, DOI 10.1016/j.ijrobp.2011.02.059; Sultan I, 2010, PEDIATR BLOOD CANCER, V54, P35, DOI 10.1002/pbc.22285; Dufour C, 2012, CANCER-AM CANCER SOC, V118, P3812, DOI 10.1002/cncr.26684; Zaky W, 2014, PEDIATR BLOOD CANCER, V61, P95, DOI 10.1002/pbc.24648; Squire SE, 2007, J NEURO-ONCOL, V81, P97, DOI 10.1007/s11060-006-9196-z; Biegel JA, 2002, CLIN CANCER RES, V8, P3461; Eaton KW, 2011, PEDIATR BLOOD CANCER, V56, P7, DOI 10.1002/pbc.22831; Sharifi K, 2011, HISTOCHEM CELL BIOL, V136, P501, DOI 10.1007/s00418-011-0865-4; Chi SN, 2009, J CLIN ONCOL, V27, P385, DOI 10.1200/JCO.2008.18.7724; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Reinhard H, 2008, ONCOL REP, V19, P819; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; von Hoff K, 2011, PEDIATR BLOOD CANCER, V57, P978, DOI 10.1002/pbc.23236; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Cecconi F, 1997, DEV DYNAM, V210, P184, DOI 10.1002/(SICI)1097-0177(199710)210:2<184::AID-AJA10>3.0.CO;2-E; Kim HJ, 2009, STEM CELLS, V27, P390, DOI 10.1634/stemcells.2007-1047; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Bourdeaut F, 2011, CLIN CANCER RES, V17, P31, DOI 10.1158/1078-0432.CCR-10-1795; Birks DK, 2011, NEURO-ONCOLOGY, V13, P1296, DOI 10.1093/neuonc/nor140; Bruggers CS, 2011, PEDIATR BLOOD CANCER, V56, P1026, DOI 10.1002/pbc.22757; Chau JFL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1832; Cimica V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-634; Elms P, 2003, DEV BIOL, V264, P391, DOI 10.1016/j.ydbio.2003.09.005; Finkelstein-Shechter T, 2010, J PEDIAT HEMATOL ONC, V32, pE182, DOI 10.1097/MPH.0b013e3181dce1a2; Gadd S, 2010, LAB INVEST, V90, P724, DOI 10.1038/labinvest.2010.66; Hasan A, 2011, PEDIATR NEUROSURG, V47, P7, DOI 10.1159/000323412; Kieran MW, 2012, PEDIATR BLOOD CANCER, V59, P1155, DOI 10.1002/pbc.24315; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500; Lunenburger H, 2010, ANTI-CANCER DRUG, V21, P514, DOI 10.1097/CAD.0b013e3283375d5c; Roy A., 2013, CEREB CORTEX, V24, P1361; Slavc I, 2014, CANCER MED-US, V3, P91, DOI 10.1002/cam4.161; Smith ME, 2011, P NATL ACAD SCI USA, V108, P319, DOI 10.1073/pnas.0913297108; Venkataraman S, 2012, J NEURO-ONCOL, V107, P517, DOI 10.1007/s11060-011-0795-y; Wortham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036211	47	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	MAY	2015	16	5					569	582		10.1016/S1470-2045(15)70114-2		14	Oncology	Oncology	CH3DW	WOS:000353908200051		
J	Machiels, JPH; Haddad, RI; Fayette, J; Licitra, LF; Tahara, M; Vermorken, JB; Clement, PM; Gauler, T; Cupissol, D; Grau, JJ; Guigay, J; Caponigro, F; de Castro, G; Viana, LD; Keilholz, U; del Campo, JM; Cong, XYJL; Ehrnrooth, E; Cohen, EEW				Machiels, Jean-Pascal H.; Haddad, Robert I.; Fayette, Jerome; Licitra, Lisa F.; Tahara, Makoto; Vermorken, Jan B.; Clement, Paul M.; Gauler, Thomas; Cupissol, Didier; Jose Grau, Juan; Guigay, Joel; Caponigro, Francesco; de Castro, Gilberto, Jr.; Viana, Luciano de Souza; Keilholz, Ulrich; del Campo, Joseph M.; Cong, Xiuyu Julie; Ehrnrooth, Eva; Cohen, Ezra E. W.		LUX-H N 1 Investigators	Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial	LANCET ONCOLOGY			English	Article							ERBB FAMILY BLOCKER; CHEMOTHERAPY PLUS CETUXIMAB; HUMAN-PAPILLOMAVIRUS; RETROSPECTIVE ANALYSIS; CLINICAL-PRACTICE; SOLID TUMORS; EFFICACY; CANCER; P16(INK4A); BIOMARKER	Background Patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (HNSCC) progressing after first-line platinum regimens have a poor prognosis and few treatment options. Afatinib, an irreversible ERBB family blocker, has shown efficacy in a phase 2 study in this setting. We aimed to assess the efficacy and safety of afatinib compared with methotrexate as second-line treatment in patients with recurrent or metastatic HNSCC progressing on or after platinum-based therapy. Methods In this open-label, phase 3, randomised controlled trial conducted in 101 centres in 19 countries, we enrolled patients aged 18 years or older with histologically or cytologically confirmed HNSCC that was recurrent, metastatic, or both who had progressed on or after first-line platinum-based therapy, were not amenable for salvage surgery or radiotherapy, and who had an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. Previous treatment with more than one systemic regimen in this setting was not allowed; previous treatment with EGFR-targeted antibody therapy (but not EGFR-targeted tyrosine-kinase inhibitors) was allowed. We randomly assigned eligible patients in a 2: 1 ratio to receive oral afatinib (40 mg/day) or intravenous methotrexate (40 mg/m(2) per week), stratified by ECOG performance status and previous EGFR-targeted antibody therapy for recurrent or metastatic disease. Randomisation was done centrally with an interactive voice or web-based response system. Clinicians and patients were not masked to treatment allocation; independent review of tumour response was done in a blinded manner. The primary endpoint was progression-free survival as assessed by an independent, central imaging review committee. Efficacy analyses were done in the intention-to-treat population and safety analyses were done in patients who received at least one dose of study drug. This ongoing study is registered with ClinicalTrials.gov, number NCT01345682. Findings Between Jan 10, 2012, and Dec 12, 2013, we enrolled 483 patients and randomly assigned 322 to afatinib and 161 to methotrexate. After a median follow-up of 6.7 months (IQR 3.1-9.0), progression-free survival was longer in the afatinib group than in the methotrexate group (median 2.6 months [95% CI 2.0-2.7] for the afatinib group vs 1.7 months [1.5-2.4] for the methotrexate group; hazard ratio [HR] 0.80 [95% CI 0.65-0.98], p=0.030). The most frequent grade 3 or 4 drug-related adverse events were rash or acne (31 [10%] of 320 patients in the afatinib group vs none of 160 patients in the methotrexate group), diarrhoea (30 [9%] vs three [2%]), stomatitis (20 [6%] vs 13 [8%]), fatigue (18 [6%] vs five [3%]), and neutropenia (1 [<1%] vs 11 [7%]); serious adverse events occurred in 44 (14%) of afatinib-treated patients and 18 (11%) of methotrexate-treated patients. Interpretation Afatinib was associated with significant improvements in progression-free survival and had a manageable safety profile. These findings provide important new insights into the treatment of this patient population and support further investigations with irreversible ERBB family blockers in HNSCC.	[Machiels, Jean-Pascal H.] Clin Univ St Luc, Inst Roi Albert II, Med Oncol Serv, B-1200 Brussels, Belgium; [Machiels, Jean-Pascal H.] Catholic Univ Louvain, Inst Rech Clin & Expt, Pole MIRO, B-1200 Brussels, Belgium; [Haddad, Robert I.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Haddad, Robert I.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Fayette, Jerome] Univ Lyon, Ctr Leon Berard, Lyon, France; [Fayette, Jerome] Univ Lyon, Hosp Civils Lyon, Lyon, France; [Licitra, Lisa F.] Ist Nazl Tumori, Fdn IRCCS, I-20133 Milan, Italy; [Tahara, Makoto] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; [Vermorken, Jan B.] Univ Antwerp Hosp, Edegem, Belgium; [Clement, Paul M.] Katholieke Univ Leuven, Dept Oncol, Leuven, Belgium; [Gauler, Thomas] Univ Hosp Essen, West German Canc Ctr, Essen, Germany; [Cupissol, Didier] Inst Canc Montpellier Val dAurelle, Montpellier, France; [Jose Grau, Juan] Univ Barcelona, Hosp Clin, E-08007 Barcelona, Spain; [Guigay, Joel] Gustave Roussy, Villejuif, France; [Guigay, Joel] Ctr Antoine Lacassagne, F-06054 Nice, France; [Caponigro, Francesco] IRCCS, Fdn G Pascale, Ist Nazl Tumori, Div Head & Neck Med Oncol, Naples, Italy; [de Castro, Gilberto, Jr.] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil; [Viana, Luciano de Souza] Hosp Canc Barretos, Sao Paulo, Brazil; [Keilholz, Ulrich] Charite, Ctr Comprehens Canc, Berlin, Germany; [del Campo, Joseph M.] Hosp Univ Vall DHebron, Dept Med Oncol, Barcelona, Spain; [Cong, Xiuyu Julie] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Ehrnrooth, Eva] Danmark AS, Boehringer Ingelheim, Copenhagen, Denmark; [Cohen, Ezra E. W.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Machiels, JPH (reprint author), Clin Univ St Luc, Inst Roi Albert II, Med Oncol Serv, B-1200 Brussels, Belgium.	jean-pascal.machiels@uclouvain.be			Boehringer Ingelheim	We thank the patients, their families, and all of the investigators who participated in this study. We would also like to thank Liz Svensson (Boehringer Ingelheim, Copenhagen, Denmark), for her contributions to the study. Medical writing assistance was provided by Katie McClendon (GeoMed, Macclesfield, UK [an Ashfield business, part of UDG Healthcare plc]) and was supported financially by Boehringer Ingelheim during the preparation of this report.	Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Gregoire V, 2010, ANN ONCOL, V21, pv184, DOI 10.1093/annonc/mdq185; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Machiels JP, 2011, LANCET ONCOL, V12, P333, DOI 10.1016/S1470-2045(11)70034-1; Vermorken JB, 2014, ANN ONCOL, V25, P801, DOI 10.1093/annonc/mdt574; Chung CH, 2014, J CLIN ONCOL, V32, P3930, DOI 10.1200/JCO.2013.54.5228; Deng ZY, 2014, INT J ONCOL, V45, P67, DOI 10.3892/ijo.2014.2440; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Shepard HM, 2008, J CLIN INVEST, V118, P3574, DOI 10.1172/JCI36049; Gillison ML, 2000, J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Colevas AD, 2006, J CLIN ONCOL, V24, P2644, DOI 10.1200/JCO.2005.05.3348; Mesia R, 2010, ANN ONCOL, V21, P1967, DOI 10.1093/annonc/mdq077; Stewart JSW, 2009, J CLIN ONCOL, V27, P1864, DOI 10.1200/JCO.2008.17.0530; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Wang HZ, 2013, CANCER SCI, V104, P1553, DOI 10.1111/cas.12287; Leon X, 2005, CLIN ONCOL-UK, V17, P418, DOI 10.1016/j.clon.2005.02.014; Vermorken JB, 2008, CANCER-AM CANCER SOC, V112, P2710, DOI 10.1002/cncr.23442; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Denaro N, 2014, ONCOLOGY, V86, P212; EORTC, EORTC QLQ H N35; EORTC, EORTC QLQ C30 SCORIN; Gy C, 2013, ENCY BIOPHARMACEUTIC, V2nd, P494; Lacouture ME, 2013, EXPERT REV ANTICANC, V13, P721, DOI [10.1586/era.13.30, 10.1586/ERA.13.30]; Murphy Barbara A, 2013, J Support Oncol, V11, P149; National Comprehensive Cancer Network Inc, 2014, NCCN CLIN PRACT GUID; Robinson AG, 2014, EUR J CANCER, V50, P2303, DOI 10.1016/j.ejca.2014.05.024; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Seiwert TY, 2014, ANN ONCOL, V25, P1813, DOI 10.1093/annonc/mdu216; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Weingart Saul N, 2008, J Natl Compr Canc Netw, V6 Suppl 3, pS1; Yang JCH, 2013, EXPERT REV ANTICANC, V13, P729, DOI [10.1586/era.13.31, 10.1586/ERA.13.31]	34	9	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	MAY	2015	16	5					583	594		10.1016/S1470-2045(15)70124-5		12	Oncology	Oncology	CH3DW	WOS:000353908200052		
J	Reed, GM; Rebello, TJ; Pike, KM; Medina-Mora, ME; Gureje, O; Zhao, M; Dai, YF; Roberts, MC; Maruta, T; Matsumoto, C; Krasnov, VN; Kulygina, M; Lovell, AM; Stona, AC; Sharan, P; Robles, R; Gaebel, W; Zielasek, J; Khoury, B; Mari, JD; Ayuso-Mateos, JL; Evans, SC; Kogan, CS; Saxena, S				Reed, Geoffrey M.; Rebello, Tahilia J.; Pike, Kathleen M.; Medina-Mora, Maria Elena; Gureje, Oye; Zhao, Min; Dai, Yunfei; Roberts, Michael C.; Maruta, Toshimasa; Matsumoto, Chihiro; Krasnov, Valery N.; Kulygina, Maya; Lovell, Anne M.; Stona, Anne-Claire; Sharan, Pratap; Robles, Rebeca; Gaebel, Wolfgang; Zielasek, Juergen; Khoury, Brigitte; Mari, Jair de Jesus; Luis Ayuso-Mateos, Jose; Evans, Spencer C.; Kogan, Cary S.; Saxena, Shekhar			WHO's Global Clinical Practice Network for mental health	LANCET PSYCHIATRY			English	Letter							DISORDERS; CLASSIFICATION		[Reed, Geoffrey M.; Saxena, Shekhar] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland; [Rebello, Tahilia J.; Pike, Kathleen M.] Columbia Univ, Dept Psychiat, New York State Psychiat Inst, Global Mental Hlth Program,Med Ctr, New York, NY USA; [Medina-Mora, Maria Elena; Robles, Rebeca] World Hlth Org Collaborating Ctr Addict & Mental, Inst Nacl Psiquiatria, Mexico City, DF, Mexico; [Gureje, Oye] Univ Ibadan, World Hlth Org Collaborating Ctr Res & Training M, Dept Psychiat, Univ Coll Hosp, Ibadan, Nigeria; [Zhao, Min; Dai, Yunfei] Shanghai Jiao Tong Univ, World Hlth Org Collaborating Ctr Res & Training M, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Roberts, Michael C.; Evans, Spencer C.] Univ Kansas, Clin Child Psychol Program, Lawrence, KS 66045 USA; [Maruta, Toshimasa] Seitoku Univ, Hlth Management Ctr, Matsudo, Chiba, Japan; [Matsumoto, Chihiro] Tokyo Med Univ, Dept Psychiat, Shinjuku Ku, Tokyo 1608402, Japan; [Krasnov, Valery N.; Kulygina, Maya] Moscow Res Inst Psychiat, Moscow, Russia; [Lovell, Anne M.] Ctr Rech, INSERM, U988, Med,Sci,Sante,Sante Mentale,Soc, Paris, France; [Stona, Anne-Claire] Ctr Collaborateur Org Mondiale Sante Rech & Forma, Hellemmes, France; [Sharan, Pratap] All India Inst Med Sci, Dept Psychiat, New Delhi, India; [Gaebel, Wolfgang; Zielasek, Juergen] Univ Dusseldorf, Dept Psychiat & Psychotherapy, World Hlth Org Collaborating Ctr Qual Assurance &, Med Fac,LVR Klinikum Dusseldorf, Dusseldorf, Germany; [Khoury, Brigitte] Amer Univ Beirut, Dept Psychiat, Med Ctr, Beirut, Lebanon; [Mari, Jair de Jesus] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, Dept Psychiat, WHO Collaborating Ctr Mental Hlth Serv Res & Trai, Madrid, Spain; [Kogan, Cary S.] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada	Reed, GM (reprint author), WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland.	reedg@who.int	Mari, Jair/A-7309-2008	Mari, Jair/0000-0002-5403-0112			Evans SC, 2015, INT J CLIN HLTH PSYC, V15, P160, DOI 10.1016/j.ijchp.2014.12.001; Saxena S, 2013, LANCET, V381, P1970, DOI 10.1016/S0140-6736(13)61139-3; Reed GM, 2011, WORLD PSYCHIATRY, V10, P118; Evans SC, 2013, INT J PSYCHOL, V48, P177, DOI 10.1080/00207594.2013.804189; Roberts MC, 2012, INT REV PSYCHIATR, V24, P578, DOI 10.3109/09540261.2012.736368	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2215-0374			LANCET PSYCHIAT	Lancet Psychiatry	MAY	2015	2	5					379	380				2	Psychiatry	Psychiatry	CH3DG	WOS:000353906200015		
J	Ono, K; Mano, M; Han, GH; Nagai, H; Yamada, T; Kobayashi, Y; Miyata, A; Inoue, Y; Lal, R				Ono, K.; Mano, M.; Han, G. H.; Nagai, H.; Yamada, T.; Kobayashi, Y.; Miyata, A.; Inoue, Y.; Lal, R.			ENVIRONMENTAL CONTROLS ON FALLOW CARBON DIOXIDE FLUX IN A SINGLE-CROP RICE PADDY, JAPAN	LAND DEGRADATION & DEVELOPMENT			English	Article						soil organic carbon; rice paddy; decomposition; fallow season; eddy covariance; flux measurement	BARE SOIL; SEASONAL-VARIATION; SONIC ANEMOMETER; QUALITY-CONTROL; WATER-CONTENT; CO2 FLUX; FIELD; TEMPERATURE; SEQUESTRATION; DECOMPOSITION	Soil organic carbon (SOC) is one of the important measures of soil fertility and sustainability in arable lands. With continuous CO2 flux measurements, this study assessed the SOC decomposition and its environmental controls at both half-hourly and season-long scales in a single-crop rice (Oryza sativa L.) paddy during three fallow periods between 2004 and 2007. Measurements were made on a gray lowland soil sited in eastern Japan using the eddy covariance method. Ecosystem respiration was strongly affected by soil water content measured at 0-01m depth. At 05m(3)m(-3) or more of soil water content, the baseline of ecosystem respiration decreased by 50% compared with that at 02m(3)m(-3) . The effect was quantified at half-hourly scale using an empirical multiple regression model, together with the soil surface temperature and the time after residue incorporation. At season-long scale, net biome production, which is equivalent to the change in the SOC pool during the fallow period, was estimated from the flux and ancillary data at 150gCm(-2) in 2004-2005, 70gm(-2) in 2005-2006, and 270gCm(-2) in 2006-2007. Apparently, as much as 46 to 79% of the soil organic matter incorporated (crop residues, ratoon, and stable manure) was decomposed during the fallow period. Precipitation, or associated soil water content, was important for the carbon balance of the field at season-long scale because of its large interannual variability and relatively low permeability of the paddy soil. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Ono, K.; Mano, M.; Nagai, H.; Yamada, T.; Kobayashi, Y.; Miyata, A.; Inoue, Y.] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Han, G. H.] Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju 361763, Chungbuk, South Korea; [Lal, R.] Ohio State Univ, Carbon Management & Sequestrat Ctr, Columbus, OH 43210 USA	Ono, K (reprint author), Natl Inst Agroenvironm Sci, Agrometeorol, Tsukuba, Ibaraki 3058604, Japan.	onok@affrc.go.jp		Ono, Keisuke/0000-0002-0653-6346	Ministry of Agriculture, Forestry and Fisheries of Japan; Global Environmental Research Fund [S-1]; CWCP-TIE project of The Ohio State University	This study was supported by Ministry of Agriculture, Forestry and Fisheries of Japan through "Evaluation, Adaptation and Mitigation of Global Warming in Agriculture, Forestry and Fisheries: Research and Development", the Global Environmental Research Fund (S-1), and Grant-in-Aid for JSPS Fellows (K. Ono). The authors are grateful to Dr. Ryuichi Hirata, Ms. Yoshiko Higashikozono and Ms. Mariko Marushima for improving the manuscript and Mr. Fumio Sasaki for giving permission to use his field. The senior author was visiting scholar at Carbon Management and Sequestration Center (C-MASC) in January-March 2009. The visiting scholar position at C-MASC was sponsored by CWCP-TIE project of The Ohio State University.	Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Vickers D, 1997, J ATMOS OCEAN TECH, V14, P512, DOI 10.1175/1520-0426(1997)014<0512:QCAFSP>2.0.CO;2; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Mano Masayoshi, 2007, Journal of Agricultural Meteorology, V63, P125, DOI 10.2480/agrmet.63.125; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267; Saito M, 2005, AGR FOREST METEOROL, V135, P93, DOI 10.1016/j.agrformet.2005.10.007; Mahrt L, 1998, J ATMOS OCEAN TECH, V15, P416, DOI 10.1175/1520-0426(1998)015<0416:FSEFAA>2.0.CO;2; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Aubinet M, 2009, AGR FOREST METEOROL, V149, P407, DOI 10.1016/j.agrformet.2008.09.003; Schlesinger WH, 2000, AGR ECOSYST ENVIRON, V82, P121, DOI 10.1016/S0167-8809(00)00221-8; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; FRANZLUEBBERS AJ, 1995, APPL SOIL ECOL, V2, P95, DOI 10.1016/0929-1393(94)00044-8; Miyata A, 2005, PHYTON-ANN REI BOT A, V45, P89; DUGAS WA, 1993, AGR FOREST METEOROL, V67, P115, DOI 10.1016/0168-1923(93)90053-K; Nakadai T, 2002, APPL SOIL ECOL, V19, P161, DOI 10.1016/S0929-1393(01)00180-9; Cultivated Soil Classification Committee, 1995, MISC PUBL NAT I AGR, V17; Inoue Y, 2004, INT J REMOTE SENS, V25, P1881, DOI 10.1080/0143116031000102449; Kimura M, 2004, SOIL BIOL BIOCHEM, V36, P1399, DOI 10.1016/j.soilbio.2004.03.006; Lals R., 2006, LAND DEGRAD DEV, V17, P197; Lus Y, 2003, SOIL BIOL BIOCHEM, V35, P1223; Moncrieff J. B., 1997, Journal of Hydrology (Amsterdam), V188-189, P589, DOI 10.1016/S0022-1694(96)03194-0; Nishimura S, 2008, AGR ECOSYST ENVIRON, V125, P9, DOI 10.1016/j.agee.2007.11.003; Onos K, 2008, THEORETICAL APPL CLI, V92, P195; Onos K, 2007, J AGROMETEOROL, V63, P139; Reths S, 2006, THEORETICAL APPL CLI, V80, P105; ROCHETTE P, 1992, CAN J SOIL SCI, V72, P591; Ruimy A., 1995, Advances in Ecological Research, V26, P1, DOI 10.1016/S0065-2504(08)60063-X; SCHOTANUS P, 1983, BOUND-LAY METEOROL, V26, P81, DOI 10.1007/BF00164332; Shirato Y, 2005, SOIL SCI PLANT NUTR, V51, P405, DOI 10.1111/j.1747-0765.2005.tb00046.x; Soil Survey Staff, 2006, KEYS SOIL TAX; Takimoto Takahiro, 2010, Journal of Agricultural Meteorology, V66, P181, DOI 10.2480/agrmet.66.3.5; Watanabe T, 2000, BOUND-LAY METEOROL, V96, P473, DOI 10.1023/A:1002642028984	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1085-3278	1099-145X		LAND DEGRAD DEV	Land Degrad. Dev.	MAY	2015	26	4					331	339		10.1002/ldr.2211		9	Environmental Sciences; Soil Science	Environmental Sciences & Ecology; Agriculture	CH4HY	WOS:000353995800003		
J	Tateya, I; Morita, S; Muto, M; Miyamoto, S; Hayashi, T; Funakoshi, M; Aoyama, I; Hirano, S; Kitamura, M; Ishikawa, S; Kishimoto, Y; Morita, M; Mahattanasakul, P; Morita, S; Ito, J				Tateya, Ichiro; Morita, Shuko; Muto, Manabu; Miyamoto, Shin'ichi; Hayashi, Tomomasa; Funakoshi, Makiko; Aoyama, Ikuo; Hirano, Shigeru; Kitamura, Morimasa; Ishikawa, Seiji; Kishimoto, Yo; Morita, Mami; Mahattanasakul, Patnarin; Morita, Satoshi; Ito, Juichi			Magnifying Endoscope With NBI to Predict the Depth of Invasion in Laryngo-Pharyngeal Cancer	LARYNGOSCOPE			English	Article						Magnifying endoscopy; narrow band imaging; endoscopic laryngo-pharyngeal surgery; transoral robotic surgery; TNM classification	TRANSORAL ROBOTIC SURGERY; SQUAMOUS-CELL CARCINOMA; HYPOPHARYNGEAL; OROPHARYNGEAL; ESOPHAGUS; RESECTION	Objectives/HypothesisTo examine if macroscopic classification with a magnifying gastrointestinal endoscope with narrow band imaging (ME-NBI) is useful in predicting pathological depth of tumor invasion in laryngo-pharyngeal cancer. Study DesignRetrospective study. MethodsPreoperative endoscopy reports and postoperative pathological reports on 139 laryngo-pharyngeal cancer lesions were retrospectively reviewed, and the association between macroscopic findings in the lesions and the depth of tumor invasion was analyzed statistically. ResultsThe ratios of lesions macroscopically classified as 0-I (superficial and protruding), 0-IIa (slightly elevated), 0-IIb (true flat), 0-IIc (slightly depressed), and 0-III (superficial and excavated) in the preoperative endoscopy reports were 3%, 25%, 71%, 1%, and 0%, respectively. Regarding the depth of tumor invasion in the postoperative pathological reports, the ratios of lesions classified as EP (carcinoma in situ), SEP (tumor invades subepithelial layer), and MP (tumor invades muscularis propria) were 73%, 26%, and 1%, respectively. The ratios of subepithelial invasion or muscular invasion in 0-I, 0-IIa, and 0-IIb were 100%, 54%, and 14%, respectively, and showed significant difference (P<0.0001). Only one of 139 lesions invaded the muscular propria. ConclusionsThis study is the first one to show that macroscopic findings by ME-NBI predict the depth of tumor invasion in superficial laryngo-pharyngeal cancer. It was indicated that there is a little chance of muscular invasion if the lesion is endoscopically diagnosed as 0-I or 0-II. A new T stage classification based on the depth of tumor invasion may be needed in order to adapt the classification to include transoral surgery. Level of Evidence4 Laryngoscope, 125:1124-1129, 2015	[Tateya, Ichiro; Hirano, Shigeru; Kitamura, Morimasa; Ishikawa, Seiji; Kishimoto, Yo; Ito, Juichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068507, Japan; [Morita, Shuko; Miyamoto, Shin'ichi] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan; [Muto, Manabu; Hayashi, Tomomasa] Kyoto Univ, Grad Sch Med, Dept Clin Oncol, Kyoto 6068507, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto 6068507, Japan; [Mahattanasakul, Patnarin] King ChulalongKorn Mem Hosp, Bangkok, Thailand	Tateya, I (reprint author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kyoto 6068507, Japan.	tateya@ent.kuhp.kyoto-u.ac.jp					Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Kodama M, 1998, SURGERY, V123, P432, DOI 10.1016/S0039-6060(98)70165-5; [Anonymous], 2003, GASTROINTEST ENDO S6, V58, pS3; Muto M, 2009, J GASTROEN HEPATOL, V24, P1333, DOI 10.1111/j.1440-1746.2009.05925.x; Muto M, 2011, GASTROINTEST ENDOSC, V74, P477, DOI 10.1016/j.gie.2011.04.027; Weinstein GS, 2007, ANN OTO RHINOL LARYN, V116, P19; Park YM, 2013, ACTA OTO-LARYNGOL, V133, P641, DOI 10.3109/00016489.2012.761350; O'Malley BW, 2006, LARYNGOSCOPE, V116, P1465, DOI 10.1097/01.mlg.0000227184.90514.1a; Jang Jae Young, 2012, Clin Endosc, V45, P379, DOI 10.5946/ce.2012.45.4.379; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P1; Japan Society for Head and Neck Cancer, 2012, GEN RUL CLIN STUD HE, P58; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016]; Kikuchi D, 2014, HEAD NECK-J SCI SPEC, DOI [10.1002/hed.23683, DOI 10.1002/HED.23683]; Kumagai Y, 2002, ENDOSCOPY, V34, P369, DOI 10.1055/s-2002-25285; Muto Manabu, 2005, Clin Gastroenterol Hepatol, V3, pS16, DOI 10.1016/S1542-3565(05)00262-4; Muto M, 2004, CANCER, V101, P1375, DOI 10.1002/cncr.20482; Okami K, 2013, HEAD NECK-J SCI SPEC, V35, P1162, DOI 10.1002/hed.23094; Satou Yasuo, 2006, Nihon Jibiinkoka Gakkai Kaiho, V109, P581; Sobin LH, 2009, TNM CLASSIFICATION M; Tomifuji M, 2014, EUR ARCH OTO-RHINO-L, V271, P589, DOI 10.1007/s00405-013-2575-0	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	MAY	2015	125	5					1124	1129		10.1002/lary.25035		6	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CH4IJ	WOS:000353996900026		
J	Sato, K; Chitose, S; Umeno, H				Sato, Kiminori; Chitose, Shun-ichi; Umeno, Hirohito			Dimensions and Morphological Characteristics of Human Newborn Glottis	LARYNGOSCOPE			English	Article						Posterior glottis; human vocal fold; newborn; larynx	HUMAN VOCAL FOLD; MUCOSA; INTUBATION; CELLS	ObjectivesThe anterior glottis has the most important role in phonation. However, the posterior glottis appears to have an equally important role in respiration. Dimensions and morphological characteristics of the newborn glottis were investigated. Study DesignHistologic analysis of the human newborn glottis. MethodsA total of 16 larynges were used. The whole organ section technique was employed. ResultsThere was no statistically significant difference between the genders. The average length of the glottis was 5.40.6 mm in males and 5.70.4 mm in females. The average length of the posterior glottis was 3.10.5 mm in males and 3.20.4 mm in females. It accounted for 57.5 +/- 3.2% of the entire glottic length in males and 55.5 +/- 5.3% in females and also accounted for 56.3 +/- 4.6% of the entire glottic area in both sexes. The average area of the glottis was 7.5 +/- 2.5 mm(2) in males and 8.2 +/- 1.7 mm(2) in females. The average area of the posterior glottis was 5.3 +/- 2.0 mm(2) in males and 5.5 +/- 1.4 mm(2) in females. It accounted for 69.2%+/- 4.6% of the entire glottic area in males and 67.3%+/- 5.8% in females. It also accounted for 68.0%+/- 5.3% of the entire glottic area in both sexes. The epithelium in the newborn posterior glottis was a ciliated epithelium, whereas it was stratified squamous epithelium in the anterior glottis. ConclusionsThe newborn posterior glottis occupied approximately 70% of the entire glottic area and was covered with respiratory epithelium. Due to size and configuration, the newborn glottis appears to be favored for respiration over phonation. Level of EvidenceNA. Laryngoscope, 125:E186-E189, 2015	[Sato, Kiminori; Chitose, Shun-ichi; Umeno, Hirohito] Kurume Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kurume, Fukuoka 8300011, Japan	Sato, K (reprint author), Kurume Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	kimisato@oct-net.ne.jp					Benjamin B, 1993, Ann Otol Rhinol Laryngol Suppl, V160, P1; HAWKINS DB, 1978, LARYNGOSCOPE, V88, P201, DOI 10.1288/00005537-197802000-00001; Hirano M., 1983, VOCAL FOLD PHYSL CON, P22; HIRANO M, 1986, ANN OTO RHINOL LARYN, V95, P576; Hirano M, 1975, OTOLOGIA FUKUOKA  S1, V21, P239; Hirano MS, 1993, HISTOLOGICAL COLOR A; Kurpinski K, 2010, CELLULAR MECHANOTRAN, P403; Sato K, 2008, ACTA OTO-LARYNGOL, V128, P694, DOI 10.1080/00016480701675643; Sato K, 2015, ANN OTO RHINOL LARYN, V124, P49, DOI 10.1177/0003489414542091; Sato K, 2006, ANN OTO RHINOL LARYN, V115, P816; Sato K, 2012, J VOICE, V26, P37, DOI 10.1016/j.jvoice.2010.10.006; Sato K, 1990, JPN ANAESTH J, V4, P103; SATO K, 1995, ANN OTO RHINOL LARYN, V104, P556; Sato K, 2001, ANN OTO RHINOL LARYN, V110, P417; Sato K, 2012, ANN OTO RHINOL LARYN, V121, P798; Sato K, 2009, ANN OTO RHINOL LARYN, V118, P773	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	MAY	2015	125	5					E186	E189		10.1002/lary.25142		4	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CH4IJ	WOS:000353996900005		
J	Jo, A; Mitani, S; Shiba, N; Hayashi, Y; Hara, Y; Takahashi, H; Tsukimoto, I; Tawa, A; Horibe, K; Tomizawa, D; Taga, T; Adachi, S; Yoshida, T; Ichikawa, H				Jo, A.; Mitani, S.; Shiba, N.; Hayashi, Y.; Hara, Y.; Takahashi, H.; Tsukimoto, I.; Tawa, A.; Horibe, K.; Tomizawa, D.; Taga, T.; Adachi, S.; Yoshida, T.; Ichikawa, H.			High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML	LEUKEMIA			English	Article							ACUTE MYELOID-LEUKEMIA; POLYMERASE-CHAIN-REACTION; COOPERATIVE-STUDY GROUP; GENE-EXPRESSION; TRANSLOCATIONS; CYTARABINE; SIGNATURE; PREDICTION; CHILDREN; SUBTYPES	EVI1 and MEL1 are homolog genes whose transcriptional activations by chromosomal translocations are known in small subsets of leukemia. From gene expression profiling data of 130 Japanese pediatric acute myeloid leukemia (AML) patients, we found that EVI1 and MEL1 were overexpressed in similar to 30% of patients without obvious translocations of these gene loci, and that their high expression was significantly associated with inferior survival. High EVI1 expression was detected mainly in myelomonocytic-lineage (designated as e-M4/M5 subtype) leukemia with MLL rearrangements and in megakaryocytic-lineage (designated as e-M7 subtype) leukemia, and its prognostic association was observed in the e-M4/M5 subtype but not in the e-M7 subtype. On the other hand, high MEL1 expression was detected in myelocytic-lineage (designated as e-M0/M1/M2 subtype) and e-M4/M5 subtype leukemia without MLL rearrangements, and its prognostic association was independent from the subtypes. Because of their subtype-dependent and mutually exclusive expression, a combined evaluation of their high expression enabled a clear distinction of patients with inferior survival (P < 0.00001 in event-free survival (EFS) and overall survival (OS)). This association was confirmed by quantitative reverse transcription PCR analysis of an independent cohort of 81 patients (P = 0.00017 in EFS, P = 0.00028 in OS). We propose that the combined estimation of EVI1 and MEL1 expression will be an effective method to predict the prognosis of pediatric AML.	[Jo, A.; Mitani, S.; Yoshida, T.; Ichikawa, H.] Natl Canc Ctr, Div Genet, Tokyo 1040045, Japan; [Shiba, N.; Hayashi, Y.; Hara, Y.] Gunma Childrens Med Ctr, Dept Hematol Oncol, Shibukawa, Japan; [Shiba, N.; Hara, Y.] Gunma Univ, Grad Sch Med, Dept Pediat, Maebashi, Gumma 371, Japan; [Takahashi, H.] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Tsukimoto, I.] Toho Univ, Sch Med, Dept Pediat 1, Tokyo, Japan; [Tawa, A.] Osaka Natl Hosp, Natl Hosp Org, Dept Pediat, Osaka, Japan; [Horibe, K.] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Tomizawa, D.] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Taga, T.] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan; [Adachi, S.] Kyoto Univ, Human Hlth Sci, Kyoto, Japan; [Ichikawa, H.] Natl Canc Ctr, Res Inst, Dept Clin Genom, Tokyo 104, Japan; [Ichikawa, H.] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Tokyo 104, Japan	Ichikawa, H (reprint author), Natl Canc Ctr, Div Genet, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	hichikaw@ncc.go.jp	Takahashi, Hiro/E-6746-2013; 	Takahashi, Hiro/0000-0002-8230-9524; Tomizawa, Daisuke/0000-0003-1520-7007	Ministry of Health, Labour and Welfare of Japan; programme for promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank the following institutions and investigators that participated in the AML99 and AML-05 studies conducted by Japanese Childhood AML Cooperative Study Group and Japanese Pediatric Leukemia/Lymphoma Study Group, respectively: Kazuko Hamamoto, Department of Pediatrics, Hiroshima Red Cross Hospital; Ryoji Hanada, Department of Hematology/Oncology, Saitama Children's Medical Center; Masue Imaizumi, Department of Hematology/Oncology, Miyagi Prefectural Children's Hospital; Shotaro Iwamoto, Department of Pediatrics, Mie University School of Medicine; Hisato Kigasawa, Department of Hematology, Kanagawa Children's Medical Center; Akitoshi Kinoshita, Department of Pediatrics, St Marianna University School of Medicine; Ryoji Kobayashi, Department of Pediatrics, Hokkaido University School of Medicine; Katsuyoshi Koh, Department of Hematology/Oncology, Saitama Children's Medical Center; Yoshiyuki Kosaka, Department of Hematology and Oncology, Hyogo Children's Hospital; Kazuko Kudo, Department of Pediatrics, Nagoya University Graduate School of Medicine; Akira Morimoto, Department of Pediatrics, Kyoto Prefectural University of Medicine; Hiroshi Moritake, Division of Pediatrics, Department of Reproductive and Developmental Medicine, Faculty of Medicine, University of Miyazaki; Hideki Nakayama, Department of Pediatrics, Hamanomachi Hospital; Akira Ohara, Department of First Pediatrics, Toho University School of Medicine; Akira Shimada, Department of Pediatrics, Okayama University; Hiroyuki Takahashi, Department of Pediatrics, Saiseikai Yokohama City Southern Hospital; Kiminori Terui, Department of Pediatrics, Hirosaki University Graduate School of Medicine; Masahiro Tsuchida, Department of Pediatrics, Ibaraki Children's Hospital; Shigeru Tsuchiya, Department of Pediatric Oncology, Institute of Development, Aging and Cancer, Tohoku University; and Hiromasa Yabe, Department of Pediatrics, Tokai University School of Medicine. This work was supported by a Grant-in-Aid for the Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labour and Welfare of Japan; the programme for promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan; and Grants-in-Aid for Scientific Research (B, C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Tomizawa D, 2013, INT J HEMATOL, V98, P578, DOI 10.1007/s12185-013-1429-2; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; Mochizuki N, 2000, BLOOD, V96, P3209; Balgobind BV, 2010, LEUKEMIA, V24, P942, DOI 10.1038/leu.2010.47; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Groschel S, 2010, J CLIN ONCOL, V28, P2101, DOI 10.1200/JCO.2009.26.0646; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Metzeler KH, 2009, J CLIN ONCOL, V27, P5031, DOI 10.1200/JCO.2008.20.5328; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Kudo K, 2007, J CLIN ONCOL, V25, P5442, DOI 10.1200/JCO.2007.12.3687; Staffas A, 2011, BLOOD, V118, P5905, DOI 10.1182/blood-2011-05-353185; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Tsukimoto I, 2009, J CLIN ONCOL, V27, P4007, DOI 10.1200/JCO.2008.18.7948; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Aguilo F, 2011, BLOOD, V117, P5057, DOI 10.1182/blood-2010-08-300145; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Imaizumi M, 2011, BRIT J HAEMATOL, V152, P89, DOI 10.1111/j.1365-2141.2010.08332.x; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; Pallisgaard N, 1998, BLOOD, V92, P574; Salto-Tellez M, 2003, J MOL DIAGN, V5, P231, DOI 10.1016/S1525-1578(10)60479-5; Shiba N, 2013, GENE CHROMOSOME CANC, V52, P683, DOI 10.1002/gcc.22064; Theilgaard-Monch K, 2011, LEUKEMIA, V25, P909, DOI 10.1038/leu.2011.48	30	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	MAY	2015	29	5					1076	1083		10.1038/leu.2015.5		8	Oncology; Hematology	Oncology; Hematology	CH5JA	WOS:000354070600009		
J	Dolatshad, H; Pellagatti, A; Fernandez-Mercado, M; Yip, BH; Malcovati, L; Attwood, M; Przychodzen, B; Sahgal, N; Kanapin, AA; Lockstone, H; Scifo, L; Vandenberghe, P; Papaemmanuil, E; Smith, CWJ; Campbell, PJ; Ogawa, S; Maciejewski, JP; Cazzola, M; Savage, KI; Boultwood, J				Dolatshad, H.; Pellagatti, A.; Fernandez-Mercado, M.; Yip, B. H.; Malcovati, L.; Attwood, M.; Przychodzen, B.; Sahgal, N.; Kanapin, A. A.; Lockstone, H.; Scifo, L.; Vandenberghe, P.; Papaemmanuil, E.; Smith, C. W. J.; Campbell, P. J.; Ogawa, S.; Maciejewski, J. P.; Cazzola, M.; Savage, K. I.; Boultwood, J.			Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells	LEUKEMIA			English	Article							RING SIDEROBLASTS; MUTATIONS; MACHINERY; U2AF1; HAPLOINSUFFICIENCY; DIFFERENTIATION; FREQUENCY; NEOPLASMS; PROFILES; ANEMIA	The splicing factor SF3B1 is the most commonly mutated gene in the myelodysplastic syndrome (MDS), particularly in patients with refractory anemia with ring sideroblasts (RARS). We investigated the functional effects of SF3B1 disruption in myeloid cell lines: SF3B1 knockdown resulted in growth inhibition, cell cycle arrest and impaired erythroid differentiation and deregulation of many genes and pathways, including cell cycle regulation and RNA processing. MDS is a disorder of the hematopoietic stem cell and we thus studied the transcriptome of CD34(+) cells from MDS patients with SF3B1 mutations using RNA sequencing. Genes significantly differentially expressed at the transcript and/or exon level in SF3B1 mutant compared with wild-type cases include genes that are involved in MDS pathogenesis (ASXL1 and CBL), iron homeostasis and mitochondrial metabolism (ALAS2, ABCB7 and SLC25A37) and RNA splicing/processing (PRPF8 and HNRNPD). Many genes regulated by a DNA damage-induced BRCA1-BCLAF1-SF3B1 protein complex showed differential expression/splicing in SF3B1 mutant cases. This is the first study to determine the target genes of SF3B1 mutation in MDS CD34(+) cells. Our data indicate that SF3B1 has a critical role in MDS by affecting the expression and splicing of genes involved in specific cellular processes/pathways, many of which are relevant to the known RARS pathophysiology, suggesting a causal link.	[Dolatshad, H.; Pellagatti, A.; Fernandez-Mercado, M.; Yip, B. H.; Attwood, M.; Scifo, L.; Boultwood, J.] Univ Oxford, LLR Mol Haematol Unit, NDCLS, RDM, Oxford, England; [Malcovati, L.; Cazzola, M.] Policlin San Matteo, IRCCS, Dept Hematol Oncol, I-27100 Pavia, Italy; [Malcovati, L.; Cazzola, M.] Univ Pavia, Dept Mol Med & Med Therapy, I-27100 Pavia, Italy; [Przychodzen, B.; Maciejewski, J. P.] Taussig Canc Inst, Dept Translat Haematol & Oncol Res, Cleveland, OH USA; [Sahgal, N.; Lockstone, H.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Kanapin, A. A.] Univ Oxford, Dept Oncol, Oxford, England; [Vandenberghe, P.] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Papaemmanuil, E.; Campbell, P. J.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Smith, C. W. J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ogawa, S.] Grad Sch Med, Canc Genom Projects, Tokyo, Japan; [Savage, K. I.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Boultwood, J (reprint author), John Radcliffe Hosp, LLR Mol Haematol Unit, NDCLS, RDM, Oxford OX3 9DU, England.	jacqueline.boultwood@ndcls.ox.ac.uk		Vandenberghe, Peter/0000-0003-4719-1935; Boultwood, Jacqueline/0000-0002-4330-2928; Pellagatti, Andrea/0000-0002-6122-0221	Leukaemia and Lymphoma Research of the United Kingdom; High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (Wellcome Trust Grant) [090532/Z/09/Z]; High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (MRC Hub Grant) [G0900747 91070]	This work was supported by Leukaemia and Lymphoma Research of the United Kingdom. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust Grant reference 090532/Z/09/Z and MRC Hub Grant G0900747 91070) for the generation of the RNA-Seq data. PV is a senior clinical investigator of Research Foundation-Flanders. We are also grateful to the patients who participated in this study and to all physicians for providing samples and clinical data.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Thol F, 2012, BLOOD, V119, P3578, DOI 10.1182/blood-2011-12-399337; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Inoue D, 2013, J CLIN INVEST, V123, P4627, DOI 10.1172/JCI70739; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Boultwood Jacqueline, 2014, Advances in Biological Regulation, V54, P153, DOI 10.1016/j.jbior.2013.09.005; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Nikpour M, 2013, LEUKEMIA, V27, P889, DOI 10.1038/leu.2012.298; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Visconte V, 2012, LEUKEMIA, V26, P542, DOI 10.1038/leu.2011.232; Damm F, 2012, LEUKEMIA, V26, P1137, DOI 10.1038/leu.2011.321; Savage KI, 2014, MOL CELL, V54, P445, DOI 10.1016/j.molcel.2014.03.021; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Gandoura S, 2013, J HEPATOL, V58, P936, DOI 10.1016/j.jhep.2012.12.025; Cazzola M, 2011, HAEMATOL-HEMATOL J, V96, P789, DOI 10.3324/haematol.2011.044628; Przychodzen B, 2013, BLOOD, V122, P999, DOI 10.1182/blood-2013-01-480970; Bargou RC, 1996, J EXP MED, V183, P1205, DOI 10.1084/jem.183.3.1205; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Visconte V, 2012, BLOOD, V120, P3173, DOI 10.1182/blood-2012-05-430876; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Cazzola M, 2003, BLOOD, V101, P1996, DOI 10.1182/blood-2002-07-2006; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Furney SJ, 2013, CANCER DISCOV, V3, P1122, DOI 10.1158/2159-8290.CD-13-0330; Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970; Je EM, 2013, INT J CANCER, V133, P260, DOI 10.1002/ijc.28011; Keightley MC, 2013, FEBS LETT, V587, P2150, DOI 10.1016/j.febslet.2013.05.030; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kurtovic-Kozaric A, 2015, LEUKEMIA, V29, P126, DOI 10.1038/leu.2014.144; Matsunawa M, 2014, LEUKEMIA, V28, P1844, DOI 10.1038/leu.2014.73; Moriguchi T, 2014, INT J HEMATOL, V100, P417, DOI 10.1007/s12185-014-1568-0; Tan JS, 2006, BLOOD, V107, P2557, DOI 10.1182/blood-2005-07-2957; Tucker EJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004034; Visconte V, 2015, LEUKEMIA, V29, P188, DOI 10.1038/leu.2014.170; Wang CS, 2014, BLOOD, V123, P3336, DOI 10.1182/blood-2013-12-544544; Wang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051266; Yip BH, 2012, LEUKEMIA, V26, P2154, DOI 10.1038/leu.2012.82; Zhang R, 2014, CELL CYCLE, V13, P279, DOI 10.4161/cc.27053	47	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	MAY	2015	29	5					1092	1103		10.1038/leu.2014.331		12	Oncology; Hematology	Oncology; Hematology	CH5JA	WOS:000354070600011		
J	Yamaguchi, O; Marui, E; Igawa, Y; Takeda, M; Nishizawa, O; Ikeda, Y; Ohkawa, S				Yamaguchi, Osamu; Marui, Eiji; Igawa, Yasuhiko; Takeda, Masayuki; Nishizawa, Osamu; Ikeda, Yasushi; Ohkawa, Sumito			Efficacy and Safety of the Selective beta(3)-Adrenoceptor Agonist Mirabegron in Japanese Patients with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study	LUTS-LOWER URINARY TRACT SYMPTOMS			English	Article						dose-response; efficacy; mirabegron; overactive bladder; safety	URINARY-TRACT SYMPTOMS; HUMAN DETRUSOR MUSCLE; BETA-3-ADRENOCEPTOR	ObjectivesTo evaluate the efficacy and safety of the (3)-adrenoceptor agonist, mirabegron, compared with placebo in Japanese patients with overactive bladder (OAB). MethodsPatients with OAB symptoms for24weeks, 8 micturitions/24h on average, and1 episode of urgency and/or urgency incontinence/24h were randomized to mirabegron (25, 50 or 100mg) or placebo for 12weeks. The primary endpoint was change from baseline to end of study in the mean number of micturitions/24h. Secondary endpoints included micturition variables related to urgency, incontinence, volume voided, and quality of life based on the King's Health Questionnaire (KHQ). Safety was evaluated based on adverse events (AEs), laboratory findings, vital signs, electrocardiogram, and post-void residual volume. ResultsIn total, 842 patients were randomized to placebo (n=214), mirabegron 25mg (n=211), 50mg (n=208), or 100mg (n=209). The primary endpoint was significantly improved in each mirabegron group compared with placebo (P<0.001; Williams' multiple comparison test). The maximal efficacy in the primary endpoint was observed at the 50mg dose. Significant improvements were also observed in incontinence, urgency incontinence, mean volume voided, and 3 of the 9 domains from the KHQ (incontinence impact, physical limitations, and severity measures) at each mirabegron dose. Urgency episodes decreased, and mean volume voided increased, dose-dependently. The incidence of AEs in each mirabegron dose was comparable with placebo. ConclusionsMirabegron demonstrated significant improvements in OAB symptoms compared with placebo and was well tolerated.	[Yamaguchi, Osamu] Nihon Univ, Sch Engn, Div Bioengn & LUTD Res, Koriyama, Fukushima 9638642, Japan; [Marui, Eiji] Saitama Univ, Dept Human Arts Sci, Saitama 3388570, Japan; [Marui, Eiji] Grad Sch Human Arts Sci, Saitama, Japan; [Igawa, Yasuhiko] Univ Tokyo, Dept Continence Med, Grad Sch Med, Tokyo, Japan; [Takeda, Masayuki] Univ Yamanashi, Dept Urol, Kofu, Yamanashi, Japan; [Nishizawa, Osamu] Shinshu Univ, Dept Urol, Matsumoto, Nagano 390, Japan; [Ikeda, Yasushi; Ohkawa, Sumito] Astellas Pharma Inc, Tokyo, Japan	Yamaguchi, O (reprint author), Nihon Univ, Sch Engn, Div Bioengn & Lower Urinary Tract Dysfunct Res, 1 Nakagawara, Koriyama, Fukushima 9638642, Japan.	yamaosa@ee.ce.nihon-u.ac.jp			Astellas Pharma Inc; Astellas Pharma Inc.	The study was designed by the study sponsor (Astellas Pharma Inc) in collaboration with the authors. Data were collected by the investigators at the study center and were monitored and analyzed by personnel at Astellas Pharma Inc. The study and editorial support were funded by Astellas Pharma Inc. Editorial support in the form of assistance with the first draft, collating author comments, and editorial suggestions to draft versions of this manuscript was provided by Emad Siddiqui BSc, MBBS, MRCS, MD (Astellas Pharma Europe Ltd, Surrey, UK) and Stuart Murray MSc from Envision Scientific Solutions Ltd. All authors reviewed the initial manuscript draft and contributed to revision of the manuscript.	Yamaguchi O, 2002, UROLOGY, V59, P25, DOI 10.1016/S0090-4295(01)01635-1; Gopal M, 2008, OBSTET GYNECOL, V112, P1311, DOI 10.1097/AOG.0b013e31818e8aa4; Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Basra RK, 2008, BJU INT, V102, P774, DOI 10.1111/j.1464-410X.2008.07769.x; Hampel C, 2007, EUR UROL SUPPL, V6, P432, DOI 10.1016/j.eursup.2007.01.002; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; Igawa Y, 1999, BRIT J PHARMACOL, V126, P819, DOI 10.1038/sj.bjp.0702358; Fujimura T, 1999, J UROLOGY, V161, P680, DOI 10.1016/S0022-5347(01)61994-3; Chapple CR, 2008, EUR UROL, V54, P543, DOI 10.1016/j.eururo.2008.06.047; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Takeda M, 1999, J PHARMACOL EXP THER, V288, P1367; NERGARDH A, 1977, ACTA PHARMACOL TOX, V40, P14; Brubaker L, 2006, UROLOGY, V68, P3, DOI 10.1016/j.urology.2006.05.045; Chapple C., 2010, EUR UROL SUPPL, V9, P249; Homma Y, 2003, J NEUROGENIC BLADDER, V14, P266; Lucas MG, 2012, GUIDELINES URINARY I	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-5664	1757-5672		LUTS	LUTS	MAY	2015	7	2					84	92		10.1111/luts.12053		9	Urology & Nephrology	Urology & Nephrology	CH3AH	WOS:000353897300004		
J	Yono, M; Otani, M; Ito, K; Inoue, Y; Furukawa, K; Hori, M; Tsuji, S; Tanaka, T; Sakata, Y; Irie, S				Yono, Makoto; Otani, Masayuki; Ito, Kazuya; Inoue, Yumi; Furukawa, Kohichiro; Hori, Masaharu; Tsuji, Shigeki; Tanaka, Takanori; Sakata, Yukikuni; Irie, Shin			Effect of Duloxetine on Urethral Resting Pressure and on Sphincter Contractility in Response to Coughing and Magnetic Stimulation in Healthy Women	LUTS-LOWER URINARY TRACT SYMPTOMS			English	Article						duloxetine; healthy women; proof-of-mechanism; stress urinary incontinence; urethra	STRESS URINARY-INCONTINENCE; PLACEBO-CONTROLLED TRIAL; NEURAL-CONTROL; SACRAL ROOTS; CONTINENCE; TRACT	ObjectivesAs a proof-of-mechanism (POM) study of drugs developed to treat stress urinary incontinence (SUI) has not been conducted, this urodynamic study in healthy women was performed to determine an appropriate method to confirm POM, and to evaluate the effect of duloxetine, a serotonin and noradrenaline reuptake inhibitor, on urethral resting pressure and on sphincter contractility in response to coughing and magnetic stimulation. MethodsThe urethral pressure profiles at rest, during coughing and during sacral root magnetic stimulation (SMS), and the motor threshold (MT) for urethral sphincter contraction in response to transcranial magnetic stimulation (TMS) were measured before and 6h after the administration of 40mg duloxetine in 10 healthy female subjects. ResultsOral administration of duloxetine significantly increased the mean and maximal urethral closure pressures at rest over the proximal and middle third of the urethra. During coughing, duloxetine marginally significantly increased the mean distal urethral pressure and significantly reduced the mean delay in the distal urethral pressure peak relative to the vesical peak. Although duloxetine did not change amplitudes of pressure spikes in response to SMS, this drug significantly lowered the MT in response to TMS. ConclusionThe proposed method for measuring the urethral resistance in healthy women can be used in POM studies of new drugs developed to treat SUI. Clinical trial registration number: UMIN000009096	[Yono, Makoto; Inoue, Yumi; Furukawa, Kohichiro; Hori, Masaharu; Tsuji, Shigeki; Tanaka, Takanori; Sakata, Yukikuni; Irie, Shin] Med Co LTA, Nishi Kumamoto Hosp, Dept Clin Pharmacol, Kumamoto 8614157, Japan; [Yono, Makoto; Otani, Masayuki] Med Co LTA, Nishi Kumamoto Hosp, Dept Urol, Kumamoto 8614157, Japan; [Ito, Kazuya] Med Co LTA, Sumida Hosp, Dept Clin Pharmacol, Tokyo, Japan	Yono, M (reprint author), Med Co LTA, Nishi Kumamoto Hosp, Dept Clin Pharmacol, Minami Ku, 1012 Koga,Tomiai Machi, Kumamoto 8614157, Japan.	yonomakoto@hotmail.com					Fujishiro T, 2002, J UROLOGY, V168, P1036, DOI 10.1097/01.ju.0000025868.08859.9e; Craggs M, 1999, EXP PHYSIOL, V84, P149; Karam I, 2005, EUR UROL, V47, P627, DOI 10.1016/j.eururo.2005.01.001; Lose G, 2002, NEUROUROL URODYNAM, V21, P258, DOI 10.1002/nau.10051; Fujishiro T, 2000, J UROLOGY, V164, P1277, DOI 10.1016/S0022-5347(05)67155-8; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; HEIDLER H, 1987, UROL INT, V42, P195; Athanasiou S, 2007, INT UROGYNECOL J, V18, P763, DOI 10.1007/s00192-006-0230-7; Boy S, 2006, EUR UROL, V50, P119, DOI 10.1016/j.eururo.2005.12.020; Chan C, 2007, BRIT J CLIN PHARMACO, V63, P310, DOI 10.1111/j.1365-2125.2006.02770.x; Sweeney Danielle D, 2005, Rev Urol, V7, P81; Fraser MO, 2003, BJU INT, V91, P743, DOI 10.1046/j.1464-410X.2003.04161.x; Jost Wolfgang H, 2005, Ther Clin Risk Manag, V1, P259; Millard RJ, 2004, BJU INT, V93, P311, DOI 10.1111/j.1464-410X.2004.04607.x; Schmid DM, 2005, NEUROUROL URODYNAM, V24, P117, DOI 10.1002/nau.20066; THOR KB, 1995, J PHARMACOL EXP THER, V274, P1014; THUROFF JW, 1982, J UROLOGY, V127, P1202; THUROFF JW, 1987, UROL INT, V42, P185; Verghese T, 2014, INT J UROL, V21, P25, DOI 10.1111/iju.12238; Wefer B, 2005, NEUROUROL URODYNAM, V24, P311, DOI 10.1002/nau.20125	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-5664	1757-5672		LUTS	LUTS	MAY	2015	7	2					93	98		10.1111/luts.12057		6	Urology & Nephrology	Urology & Nephrology	CH3AH	WOS:000353897300005		
J	Ichihara, K; Masumori, N; Takahashi, S; Miyao, N; Kato, R				Ichihara, Koji; Masumori, Naoya; Takahashi, Satoshi; Miyao, Noriomi; Kato, Ryuichi			Bladder Neck Rupture and Vesicovaginal Fistula Associated with Pelvic Fracture in Female	LUTS-LOWER URINARY TRACT SYMPTOMS			English	Article						pelvic fracture; urethra; vesicovaginal fistula; wound and injuries	URETHRAL INJURIES; GIRLS	CaseFemale urethral injury or bladder neck rupture associated with pelvic fracture is rare. The experience of this injury is limited and the management is still challenging. Here we describe a young female patient with urethral injury and vesicovaginal fistula associated with pelvic fracture due to traffic accident. We discuss the recommendation and management about this problem. OutcomeWe selected staged surgical management for this case, and fortunately succeeded in the repair of the urethral and vaginal injury and acquired favorable continence. ConclusionAppropriate management should be selected according to the condition in each patient. But it should be taken into consideration that a patient with pelvic fracture is critically ill, and an experienced urologist of this field is not always available at that time.	[Ichihara, Koji; Masumori, Naoya; Takahashi, Satoshi] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido 0608543, Japan; [Miyao, Noriomi; Kato, Ryuichi] Muroran Gen City Hosp, Dept Urol, Muroran, Hokkaido, Japan	Ichihara, K (reprint author), Sapporo Med Univ, Sch Med, Dept Urol, S1,W16 Chuo Ku, Sapporo, Hokkaido 0608543, Japan.	kichi@sapmed.ac.jp					Ahmed S, 1996, BRIT J UROL, V78, P450, DOI 10.1046/j.1464-410X.1996.00096.x; Black PC, 2006, J UROLOGY, V175, P2140, DOI 10.1016/S0022-5347(06)00309-0; BREDAEL JJ, 1979, J UROLOGY, V122, P560; Dorairajan LN, 2004, BJU INT, V94, P134, DOI 10.1111/j.1464-410X.2004.04874.x; Hemal AK, 2000, J UROLOGY, V163, P282, DOI 10.1016/S0022-5347(05)68037-8; PERRY MO, 1992, J UROLOGY, V147, P139; Podesta ML, 2001, J UROLOGY, V165, P1660, DOI 10.1016/S0022-5347(05)66386-0; WILLIAMS D I, 1975, European Urology, V1, P129	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-5664	1757-5672		LUTS	LUTS	MAY	2015	7	2					115	117		10.1111/luts.12056		3	Urology & Nephrology	Urology & Nephrology	CH3AH	WOS:000353897300009		
J	Matsumura, A; Kawabata, K; Goto, H				Matsumura, Atsushi; Kawabata, Kohsuke; Goto, Hiromasa			Synthesis, Properties, and Doping Behavior of Optically Active Polythiophenes Bearing a Bornyl Group	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article						chiroptical activity; L-borneol; polythiophenes; vapor-phase iodine doping	CONJUGATED POLYMERS; POLYMERIZATION; COPOLYMERS	Polythiophenes bearing a bornyl group as a side chain are synthesized. The polymers, which consist of multiple thiophenes and a substituted aromatic ring in the repeat unit, demonstrate right-handed helicity in the film state. Results of energy level measurements show good agreement with the density functional theory calculation results for the model compounds. In situ electron spin resonance (ESR) studies indicate that increasing the number of unsubstituted thiophene units in the repeat unit increases susceptibility for the dopants. The chiral charge carriers are confirmed with ESR and circular dichroism spectroscopy measurements.	[Matsumura, Atsushi; Kawabata, Kohsuke; Goto, Hiromasa] Univ Tsukuba, Div Mat Sci, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Goto, H (reprint author), Univ Tsukuba, Div Mat Sci, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	gotoh@ims.tsukuba.ac.jp					Al-Farhan K., 2010, CENT EUR J CHEM, V8, P1127, DOI 10.2478/s11532-010-1093-0; Song JK, 2013, INT J PHARMACEUT, V445, P163, DOI 10.1016/j.ijpharm.2013.01.047; MOHAMMAD F, 1995, B MATER SCI, V18, P255, DOI 10.1007/BF02749663; Langeveld-Voss BMW, 2000, J MOL STRUCT, V521, P285, DOI 10.1016/S0022-2860(99)00444-5; CHEN TA, 1992, J AM CHEM SOC, V114, P10087, DOI 10.1021/ja00051a066; JENEKHE SA, 1994, SCIENCE, V265, P765, DOI 10.1126/science.265.5173.765; Oda M, 2000, ADV MATER, V12, P362, DOI 10.1002/(SICI)1521-4095(200003)12:5<362::AID-ADMA362>3.0.CO;2-P; Seri M, 2013, MACROMOLECULES, V46, P6419, DOI 10.1021/ma4011186; Berson S, 2010, SOL ENERG MAT SOL C, V94, P699, DOI 10.1016/j.solmat.2009.12.028; Brito A. N., 2005, SYNTHETIC MET, V153, P493; De Crerner L, 2008, MACROMOLECULES, V41, P568, DOI 10.1021/ma7024946; Deng J, 2009, MACROMOLECULES, V42, P6865, DOI 10.1021/ma901326h; ELSENBAUMER RL, 1987, SYNTHETIC MET, V18, P277, DOI 10.1016/0379-6779(87)90892-7; Goto H, 2009, J MATER CHEM, V19, P4914, DOI 10.1039/b818993e; Harada N., 1982, ENNISHOKUSEISPUPEKUT, P5; Harada N., 1971, ACCOUNTS CHEM RES, V8, P257; Kawabata K, 2012, J MATER CHEM, V22, P23514, DOI 10.1039/c2jm35594a; Kawashima H, 2011, MATERIALS, V4, P1013, DOI 10.3390/ma4061013; KRIEGER PE, 1978, J ORG CHEM, V43, P4447, DOI 10.1021/jo00417a011; Loewe RS, 2000, CHEM MATER, V12, P3214, DOI 10.1021/cm000421f; MARQUE P, 1990, J PHYS CHEM-US, V94, P8614, DOI 10.1021/j100386a024; McDowell JJ, 2013, MACROMOLECULES, V46, P6794, DOI 10.1021/ma401346y; Onitsuka K, 2006, MACROMOLECULES, V39, P7224, DOI 10.1021/ma061758r; Pu L, 1997, ACTA POLYM, V48, P116, DOI 10.1002/actp.1997.010480402	24	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1352	1521-3935		MACROMOL CHEM PHYS	Macromol. Chem. Phys.	MAY	2015	216	9					931	938		10.1002/macp.201400594		8	Polymer Science	Polymer Science	CH7NE	WOS:000354222700001		
J	Kim, YH; Kim, JH; Hwang, TH; Lee, JY; Kang, CY				Kim, Y. H.; Kim, J. H.; Hwang, T. H.; Lee, J. Y.; Kang, C. Y.			Effect of Austenite on Mechanical Properties in High Manganese Austenitic Stainless Steel with Two Phase of Martensite and Austenite	METALS AND MATERIALS INTERNATIONAL			English	Article						deformation; retained austenite; mechanical property; transmission electron microscopy (TEM)	REVERSE TRANSFORMATION	The effect of the austenite phase on mechanical properties of austenitic stainless steels was investigated using specimens with different volume fractions of retained and reversed austenite. Stainless steels with dual-phase coexisting martensite and austenite were successfully synthesized by deformation and reverse transformation treatment in the cold-rolled high manganese austenitic stainless steel and the ultrafine reverse austenite with less than 0.5 mu m in size was formed by reverse transformation treatment in the temperature range of 500-750 degrees C for various times. With the increase of deformation degree, the volume fraction of retained austenite decreased, while that of the reversed austenite increased as the annealing time increased. From the results of the mechanical properties, it was obvious that as the volume fraction of retained and reversed austenite increased, hardness and strength rapidly decreased, while elongation increased. With regard to each austenite, reversed austenite indicated higher value of hardness and strength, while elongation suggested a lower value because of strengthening owing to grain refinement.	[Kim, Y. H.; Lee, J. Y.; Kang, C. Y.] Pukyong Natl Univ, Dept Met Engn, Busan 608739, South Korea; [Kim, J. H.] Japan Atom Energy Agcy, Fus Res & Dev Directorate, Aomori 0393212, Japan; [Hwang, T. H.] Tohoku Univ, Dept Quantum Sci & Engn, Sendai, Miyagi 9808579, Japan	Kang, CY (reprint author), Pukyong Natl Univ, Dept Met Engn, Busan 608739, South Korea.	metkcy@pknu.ac.kr			Pukyong National University [C-D-2014-0509]	This work was supported by a Research Grant of Pukyong National University (C-D-2014-0509).	BOGERS AJ, 1964, ACTA METALL MATER, V12, P255, DOI 10.1016/0001-6160(64)90194-4; CHANANI GR, 1971, METALL TRANS, V2, P133, DOI 10.1007/BF02662648; Hwang TH, 2013, KOREAN J MET MATER, V51, P645, DOI 10.3365/KJMM.2013.51.9.645; Irvine K. J., 1959, J IRON STEEL I, V192, P218; Jung Y. S., 2001, MET MATER INT, V17, P553; Kang CY, 2012, KOREAN J MET MATER, V50, P413, DOI 10.3365/KJMM.2012.50.6.413; Kim Y. H., 1995, Journal of the Korean Institute of Metals and Materials, V33; Lee Y. K., 1993, J KOREAN INST MET MA, V10, P208; Lee YS, 2001, MET MATER-KOREA, V7, P107; Miller R. L., 1964, T ASM, V57, P892; Tanaka H., 1990, IRON STEEL, V69, P1456; Yang ST, 2013, MET MATER INT, V19, P1181, DOI 10.1007/s12540-013-6003-1; Zacky V. F., 1967, T AM SOC MET, V60, P252	13	1	1	KOREAN INST METALS MATERIALS	SEOUL	KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881, SOUTH KOREA	1598-9623	2005-4149		MET MATER INT	Met. Mater.-Int.	MAY	2015	21	3					485	489		10.1007/s12540-015-4480-0		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH6IT	WOS:000354141000008		
J	Chun, EJ; Baba, H; Nishimoto, K; Saida, K				Chun, Eun-Joon; Baba, Hayato; Nishimoto, Kazutoshi; Saida, Kazuyoshi			Development of Laser Beam Welding Transverse-Varestraint Test for Assessment of Solidification Cracking Susceptibility in Laser Welds	METALS AND MATERIALS INTERNATIONAL			English	Article						metals; welding; defect; solidification; segregation	AUSTENITIC STAINLESS-STEELS; RAPID SOLIDIFICATION; ALLOYS; WELDABILITY; BEHAVIOR; METAL	In order to quantitatively evaluate the solidification cracking susceptibility in laser welds of type 310S stainless steel, a transverse-Varestraint testing system using a laser beam welding apparatus was newly constructed. The timing-synchronization between the laser oscillator, welding robot and hydraulic pressure devices was established by employing high-speed camera observations together with electrical signal control among the three components. Moreover, the yoke-drop time measured by the camera was used to prevent underestimation of the crack length. The laser beam melt-run welding used a variable welding speed from 10.0 to 400 mm/s, while the gas tungsten arc welding varied the welding speed from 1.67 to 5.00 mm/s As the welding speed increased from 1.67 to 40.0 mm/s, the solidification brittle temperature range of type 310S stainless steel welds was reduced from 146 to 120 K. It follows that employing the laser beam welding process mitigates the solidification cracking susceptibility for type 310S stainless steel welds.	[Chun, Eun-Joon; Baba, Hayato; Saida, Kazuyoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Nishimoto, Kazutoshi] Fukui Univ Technol, Dept Applicat Nucl Technol, Fukui, Fukui 9108505, Japan	Chun, EJ (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ejchun@mapse.eng.osaka-u.ac.jp					VITEK JM, 1983, METALL TRANS A, V14, P1833, DOI 10.1007/BF02645553; Arata Y., 1974, T JWRI, V3, P79; Biffi CA, 2014, MET MATER INT, V20, P83, DOI 10.1007/s12540-013-6011-1; Bollinghaus T, 2011, HOT CRACKING PHENOMENA IN WELDS III, P103, DOI 10.1007/978-3-642-16864-2_7; Cross CE, 2005, Hot Cracking Phenomena in Welds, P3, DOI 10.1007/3-540-27460-X_1; Cross CE, 2008, HOT CRACKING PHENOMENA IN WELDS II, P39; Cross C. E., 2011, HOT CRACKING PHENOME, P103; DAVIS SA, 1987, WELD J, V66, pS289; ELMER JW, 1989, METALL TRANS A, V20, P2117, DOI 10.1007/BF02650298; Farrar JCM, 2005, Hot Cracking Phenomena in Welds, P291, DOI 10.1007/3-540-27460-X_15; Fukumoto S, 1997, ISIJ INT, V37, P677, DOI 10.2355/isijinternational.37.677; Gittos MF, 2011, HOT CRACKING PHENOMENA IN WELDS III, P225, DOI 10.1007/978-3-642-16864-2_13; Herold H, 2005, Hot Cracking Phenomena in Welds, P328, DOI 10.1007/3-540-27460-X_17; Jang JH, 2013, MET MATER INT, V19, P497, DOI 10.1007/s12540-013-3018-6; Kadoi K, 2013, WELD WORLD, V57, P383, DOI 10.1007/s40194-013-0023-9; Katayama S., 2001, WELDING INT, V15, P627; Kim IH, 2013, KOREAN J MET MATER, V51, P437, DOI 10.3365/KJMM.2013.51.6.437; Kou S, 2003, WELDING METALLURGY, P170; Kromm K., 2008, HOT CRACKING PHENOME, P127; LINGENFE.AC, 1972, WELD J, V51, pS430; LIPPOLD JC, 1982, WELD J, V61, pS388; Lippold J. C., 2005, WELDING METALLURGY W, P141; LIPPOLD JC, 1994, WELD J, V73, pS129; Lippold JC, 2005, Hot Cracking Phenomena in Welds, P271, DOI 10.1007/3-540-27460-X_14; Matsuda F., 1979, T JWRI, V8, P85; Matsuda F., 1983, T JWRI, V12, P65; Matsuda F., 1987, T JWRI, V16, P103; Matsuda F., 1978, T JWRI, V7, P59; Nishimoto K, 2004, SCI TECHNOL ADV MAT, V5, P231, DOI 10.1016/j.stam.2003.10.006; Nishimoto K, 2011, HOT CRACKING PHENOMENA IN WELDS III, P183, DOI 10.1007/978-3-642-16864-2_11; OGAWA T, 1982, WELD J, V61, pS82; Quiroz V, 2012, J STRAIN ANAL ENG, V47, P587, DOI [10.1177/03093247124621201, 10.1177/0309324712462120]; SAIDA K, 2013, WELD J, V92, P322; Saida K, 2013, SCI TECHNOL WELD JOI, V18, P616, DOI 10.1179/1362171813Y.0000000149; Saida K., 2013, Q J JAPAN WELDING SO, V31, P157; SAVAGE WF, 1966, WELD J, V45, pS497; SAVAGE WF, 1965, WELD J, V44, pS433; Senda T., 1973, Q J JAPAN WELDING SO, V42, P48; Senda T., 1972, Q J JAPAN WELDING SO, V41, P709; Shinozaki K., 2010, T JWRI, V39, P136; Weeter L. A., 1986, WELD J, V63, p51s; Wen P., 2009, Q J JAPAN WELDING SO, V27, P134; Wolf M, 2005, Hot Cracking Phenomena in Welds, P245, DOI 10.1007/3-540-27460-X_13	43	0	0	KOREAN INST METALS MATERIALS	SEOUL	KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881, SOUTH KOREA	1598-9623	2005-4149		MET MATER INT	Met. Mater.-Int.	MAY	2015	21	3					543	553		10.1007/s12540-015-4394-x		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH6IT	WOS:000354141000017		
J	Pittarello, L; Ji, G; Yamaguchi, A; Schryvers, D; Debaille, V; Claeys, P				Pittarello, Lidia; Ji, Gang; Yamaguchi, Akira; Schryvers, Dominique; Debaille, Vinciane; Claeys, Philippe			From olivine to ringwoodite: a TEM study of a complex process	METEORITICS & PLANETARY SCIENCE			English	Article							SHOCK METAMORPHISM; MARTIAN METEORITES; WADSLEYITE; TRANSFORMATIONS; CRYSTALLIZATION; CHONDRITES; MECHANISMS; PRESSURE; MINERALS; MELTS	The study of shock metamorphism of olivine might help to constrain impact events in the history of meteorites. Although shock features in olivine are well known, so far, there are processes that are not yet completely understood. In shock veins, olivine clasts with a complex structure, with a ringwoodite rim and a dense network of lamellae of unidentified nature in the core, have been reported in the literature. A highly shocked (S5-6), L6 meteorite, Asuka 09584, which was recently collected in Antarctica by a Belgian-Japanese joint expedition, contains this type of shocked olivine clasts and has been, therefore, selected for detailed investigations of these features by transmission electron microscopy (TEM). Petrographic, geochemical, and crystallographic studies showed that the rim of these shocked clasts consists of an aggregate of nanocrystals of ringwoodite, with lower Mg/Fe ratio than the unshocked olivine. The clast's core consists of an aggregate of iso-oriented grains of olivine and wadsleyite, with higher Mg/Fe ratio than the unshocked olivine. This aggregate is crosscut by veinlets of nanocrystals of olivine, with extremely low Mg/Fe ratio. The formation of the ringwoodite rim is likely due to solid-state, diffusion-controlled, transformation from olivine under high-temperature conditions. The aggregate of iso-oriented olivine and wadsleyite crystals is interpreted to have formed also by a solid-state process, likely by coherent intracrystalline nucleation. Following the compression, shock release is believed to have caused opening of cracks and fractures in olivine and formation of olivine melt, which has lately crystallized under postshock equilibrium pressure conditions as olivine.	[Pittarello, Lidia; Claeys, Philippe] Vrije Univ Brussel, Earth Syst Sci, Analyt Environm & Geochem AMGC, B-1050 Brussels, Belgium; [Ji, Gang; Schryvers, Dominique] Univ Antwerp, Electron Microscopy Mat Sci EMAT, B-2020 Antwerp, Belgium; [Yamaguchi, Akira] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Debaille, Vinciane] Univ Libre Bruxelles, Lab G Time Geochim Tracage Isotop Mineral & Eleme, B-1050 Brussels, Belgium	Pittarello, L (reprint author), Vrije Univ Brussel, Earth Syst Sci, Analyt Environm & Geochem AMGC, Pl Laan 2, B-1050 Brussels, Belgium.	lidia.pittarello@vub.ac.be	Claeys, Philippe/B-4895-2008; 	Claeys, Philippe/0000-0002-4585-7687; Pittarello, Lidia/0000-0002-1080-0226	Belgian Science Policy Office (BELSPO); FWO [G.0603.10N]; BELAM project - BELSPO; Interuniversity Attraction Poles Programme Planet Topers - BELSPO	The authors thank S. Ozawa for assistance with Raman spectroscopy at the National Institute of Polar Research, Tachikawa, Japan; S. Van Den Broeck for the FIB cut at EMAT, Antwerp, Belgium; and S. McKibbin (VUB) for the insightful discussions on phase diagrams and interpretation. LP was funded by the Belgian Science Policy Office (BELSPO). G. Ji was supported by the FWO project G.0603.10N. The sample, a polished thin section, was kindly provided by the NIPR. This research is supported by the BELAM project and the Interuniversity Attraction Poles Programme Planet Topers both financed by the BELSPO. R. Wirth and C. Koeberl are thanked for helpful comments in reviewing the paper. A. Greshake and J. Fritz are thanked for insightful discussions on the interpretation of the observed features in the framework of impact events. C. Koeberl is also thanked for editorial handling of the manuscript.	Agee CB, 1998, REV MINERAL, V37, P165; Kerschhofer L, 1998, MINERAL MAG, V62, P617, DOI 10.1180/002646198548016; Kenkmann T, 2000, METEORIT PLANET SCI, V35, P1275; Xie ZD, 2006, GEOCHIM COSMOCHIM AC, V70, P504, DOI 10.1016/j.gca.2005.09.003; Whitney DL, 2010, AM MINERAL, V95, P185, DOI 10.2138/am.2010.3371; Sharp TG, 1997, SCIENCE, V277, P352, DOI 10.1126/science.277.5324.352; STOFFLER D, 1994, METEORITICS, V29, P155; MADON M, 1983, PHYS EARTH PLANET IN, V33, P31, DOI 10.1016/0031-9201(83)90005-5; Gillet P, 2000, SCIENCE, V287, P1633, DOI 10.1126/science.287.5458.1633; Miyahara M, 2010, EARTH PLANET SC LETT, V295, P321, DOI 10.1016/j.epsl.2010.04.023; STOFFLER D, 1991, GEOCHIM COSMOCHIM AC, V55, P3845, DOI 10.1016/0016-7037(91)90078-J; Feng L, 2011, AM MINERAL, V96, P1480, DOI 10.2138/am.2011.3679; Miyahara M, 2008, P NATL ACAD SCI USA, V105, P8542, DOI 10.1073/pnas.0801518105; Chen M, 2004, P NATL ACAD SCI USA, V101, P15033, DOI 10.1073/pnas.0405048101; French B. M., 1998, LPI CONTRIBUTION; Fritz J., 2011, 42 LUN PLAN SCI C; Greshake A., 2011, 42 LUN PLAN SCI C; Langenhorst F., 2002, B CZECH GEOLOGICAL S, V77, P265; Mitra S., 2004, HIGH PRESSURE GEOCHE; PRICE GD, 1983, PHYS EARTH PLANET IN, V33, P137, DOI 10.1016/0031-9201(83)90146-2; Sharp T.G., 2006, METEORITES EARLY SOL, VII, P653; Shaw CSJ, 2013, METEORIT PLANET SCI, V48, P758, DOI 10.1111/maps.12100; Smyth J.R., 1988, CRYSTAL STRUCTURES C; Stadelmann P. A., 2004, JEMS JAVA VERSION EL; Walton EL, 2013, GEOCHIM COSMOCHIM AC, V107, P299, DOI 10.1016/j.gca.2012.12.021; Xie Z., 2012, 43 LUN PLAN SCI C; Xie Z., 2006, 37 LUN PLAN SCI C; Yamaguchi A., 2014, METEORITE NEWSLETTER, V23	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	MAY	2015	50	5					944	957		10.1111/maps.12441		14	Geochemistry & Geophysics	Geochemistry & Geophysics	CH8AP	WOS:000354258400008		
J	Ishii, Y; Imamura, K; Kikuchi, Y; Miyagawa, S; Hamada, R; Sekino, J; Sugito, H; Ishihara, K; Saito, A				Ishii, Yoshihito; Imamura, Kentaro; Kikuchi, Yuichiro; Miyagawa, Satoshi; Hamada, Ryo; Sekino, Jin; Sugito, Hiroki; Ishihara, Kazuyuki; Saito, Atsushi			Point-of-care detection of Tannerella forsythia using an antigen-antibody assisted dielectrophoretic impedance measurement method	MICROBIAL PATHOGENESIS			English	Article						Periodontopathic bacteria; Tannerella forsythia; Antigen; Antibody; Microbiological testing	BACTERIA DETECTION APPARATUS; SUBGINGIVAL PLAQUE SAMPLES; REAL-TIME PCR; PORPHYROMONAS-GINGIVALIS; PERIODONTOPATHIC BACTERIA; TREPONEMA-DENTICOLA; SELECTIVE DETECTION; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS	The importance of periodontal treatment planning based on diagnosis with clinical detection of periodontal pathogens has been well recognized. However, reliable detection and quantification methods that can be conveniently used at chair-side have yet to be developed. This study aimed to evaluate the clinical use of a novel apparatus which uses an antigen antibody reaction assisted dielectrophoretic impedance measurement (AA-DEPIM) for the detection of a prominent periodontal pathogen, Tannerella forsythia. A total of 15 patients with a clinical diagnosis of chronic periodontitis, three periodontally healthy volunteers and two with gingivitis were subjected to clinical and microbiological examinations. Saliva samples were analyzed for the presence of T. forsythia using AA-DEPIM, PCR-Invader and real-time PCR methods. The measurement values for total bacteria and T forsythia using the prototype AA-DEPIM apparatus were significantly greater in periodontitis group than those in healthy/gingivitis group. Using the AA-DEPIM apparatus with tentative cut-off values, T forsythia was detected for 14 (12 with periodontitis and 2 either healthy or with gingivitis) out of 20 individuals. The measurement for the detection of T forsythia by the AA-DEPIM method showed a significant positive correlation with the detection by PCR-Invader (r = 0.541, p = 0.01) and the real-time PCR method (r = 0.834, p = 0.01). When the PCR-Invader method was used as a reference, the sensitivity and specificity of the AA-DEPIM method were 76.5% and 100%, respectively. The results suggested that the AA-DEPIM method has potential to be used for clinically evaluating salivary presence of T forsythia at chair-side. Trial registration: UMIN Clinical Trials Registry (UMIN-CTR) UMIN000012181. (C) 2015 Elsevier Ltd. All rights reserved.	[Ishii, Yoshihito; Imamura, Kentaro; Sekino, Jin; Saito, Atsushi] Tokyo Dent Coll, Dept Periodontol, Chiyoda Ku, Tokyo 1010061, Japan; [Kikuchi, Yuichiro; Ishihara, Kazuyuki] Tokyo Dent Coll, Dept Microbiol, Chiyoda Ku, Tokyo 1010061, Japan; [Miyagawa, Satoshi; Hamada, Ryo] Panason Healthcare, Minato Ku, Tokyo 1058433, Japan; [Sugito, Hiroki] Tokyo Dent Coll, Dept Clin Oral Hlth Sci, Chiyoda Ku, Tokyo 1010061, Japan; [Ishihara, Kazuyuki; Saito, Atsushi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiyoda Ku, Tokyo 1010061, Japan	Saito, A (reprint author), Tokyo Dent Coll, Dept Periodontol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo 1010061, Japan.	atsaito@tdc.ac.jp		Ishihara, Kazuyuki/0000-0002-6567-807X	Tokyo Dental College; Ministry of Economy, Trade and Industry of Japan [H23-086]	This study was supported in part by a department grant from Tokyo Dental College and by a grant for "Program to develop medical equipment and devices to solve unmet medical needs" (H23-086) from the Ministry of Economy, Trade and Industry of Japan. The authors report no competing interests.	Abiko Y, 2010, J PERIODONTAL RES, V45, P389, DOI 10.1111/j.1600-0765.2009.01250.x; Eick S, 2002, J CLIN PERIODONTOL, V29, P638, DOI 10.1034/j.1600-051X.2002.290708.x; Hamada R, 2011, IET NANOBIOTECHNOL, V5, P25, DOI 10.1049/iet-nbt.2010.0011; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Suehiro J, 2003, J ELECTROSTAT, V57, P157, DOI 10.1016/S0304-3886(02)00124-9; Tomita S, 2013, MICROB PATHOGENESIS, V61-62, P11, DOI 10.1016/j.micpath.2013.04.006; Tanner ACR, 2006, PERIODONTOL 2000, V42, P88, DOI 10.1111/j.1600-0757.2006.00184.x; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Yang HW, 2004, J PERIODONTOL, V75, P1077, DOI 10.1902/jop.2004.75.8.1077; Komiya A, 2000, J PERIODONTOL, V71, P760, DOI 10.1902/jop.2000.71.5.760; Umeda M, 1998, J PERIODONTOL, V69, P828; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Ammann TW, 2013, J PERIODONTAL RES, V48, P517, DOI 10.1111/jre.12034; Sanz M, 2004, J CLIN PERIODONTOL, V31, P1034, DOI 10.1111/j.1600-051X.2004.00609.x; Mineoka T, 2008, J PERIODONTOL, V79, P670, DOI 10.1902/jop.2008.070398 ; Tada A, 2012, JPN J INFECT DIS, V65, P415; Suehiro J, 2006, SENSOR ACTUAT B-CHEM, V119, P319, DOI 10.1016/j.snb.2005.12.027; Machtei EE, 1997, J CLIN PERIODONTOL, V24, P102, DOI 10.1111/j.1600-051X.1997.tb00474.x; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Haffajee AD, 2006, ORAL MICROBIOL IMMUN, V21, P269, DOI 10.1111/j.1399-302X.2006.00287.x; Haffajee AD, 2000, PERIODONTOL, V5, P78; Haririan H, 2014, J PERIODONTOL, V85, P819, DOI 10.1902/jop.2013.130306; Hirota K, 2014, BIOCONTROL SCI, V19, P45; Japanese Society of Periodontology, 2011, GUID ANT TREATM PAT; Kikutani T, 2012, GERODONTOLOGY, V29, pE560, DOI 10.1111/j.1741-2358.2011.00517.x; Ready D, 2008, J CLIN MICROBIOL, V46, P3380, DOI 10.1128/JCM.01007-08; Suehiro J, 2003, J ELECTROSTAT, V58, P229, DOI 10.1016/S0304-3886(03)00062-7; Takeuchi Y, 2003, J PERIODONTOL, V74, P1460, DOI 10.1902/jop.2003.74.10.1460; Tanner ACR, 1998, J PERIODONTAL RES, V33, P105; Tran SD, 2001, J PERIODONTOL, V72, P1, DOI 10.1902/jop.2001.72.1.1	32	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0882-4010			MICROB PATHOGENESIS	Microb. Pathog.	MAY	2015	82						37	42		10.1016/j.micpath.2015.03.017		6	Immunology; Microbiology	Immunology; Microbiology	CH6KK	WOS:000354145300006		
J	Noguchi, E; Saito, N; Kobayashi, M; Kameoka, S				Noguchi, Eiichiro; Saito, Noboru; Kobayashi, Maki; Kameoka, Shingo			Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression	MOLECULAR MEDICINE REPORTS			English	Article						hepatocyte growth factor; c-Met; gastric cancer prognosis; risk factor	C-MET; COLORECTAL-CANCER; SOMATIC MUTATIONS; FACTOR-RECEPTOR; KINASE DOMAIN; RAT PLATELETS; E-CADHERIN; CARCINOMA; SERUM; OVEREXPRESSION	Among the mechanisms that control cancer progression, cell mobility is a significant factor required for cellular liberation from the primary focus and infiltration. Hepatocyte growth factor (HGF) has been shown to facilitate cell mobility. In the present study, the clinical significance of the HGF/c-Met pathway in the assessment of gastric cancer progression was evaluated. From a cohort of patients with gastric cancer who underwent surgical resection between April 1999 and March 2003, 110 subjects were randomly selected. Preoperative serum HGF levels were measured and various pathological factors were analyzed. Furthermore, 50 subjects were randomly selected from within this group and immunohistochemical staining of tissue preparations for HGF and its receptor c-Met were performed. In the infiltrative growth pattern [(KINF)alpha,beta vs. INF gamma] advanced progression was associated with elevated preoperative serum HGF levels (P<0.001). No correlation was identified between serum HGF levels and immunostaining for HGF or c-Met in the tissue preparations. Immunostaining revealed a significant correlation between c-Met expression and lymphatic vessel invasion (ly0.1 vs. 2.3; P=0.0416), lymph node metastasis (n0.1 vs. 2; P=0.0184) and maximum tumor diameter (<= 50 mm vs. >50 mm; P=0.0469). Furthermore, c-Met-positivity was associated with a significant difference in overall survival (P=0.0342), despite stage land II cases accounting for 82% of the total cohort (41 of 50 cases). These results suggested that the expression of the HGF/c-Met pathway in gastric cancer may be a potential predictive factor for disease progression.	[Noguchi, Eiichiro; Saito, Noboru; Kameoka, Shingo] Tokyo Womens Med Univ, Dept Surg 2, Tokyo 1628666, Japan; [Kobayashi, Maki] Tokyo Womens Med Univ, Dept Pathol 1, Tokyo 1628666, Japan	Saito, N (reprint author), Tokyo Womens Med Univ, Dept Surg 2, 8-1 Kawada Cho, Tokyo 1628666, Japan.	nobosaito@surg2.twmu.ac.jp					Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; NALDINI L, 1991, EMBO J, V10, P2867; Jiang WG, 2005, CRIT REV ONCOL HEMAT, V53, P35, DOI 10.1016/j.critrevonc.2004.09.004; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; Maeda K, 1996, CANCER, V77, P858, DOI 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Nakajima M, 1999, CANCER, V85, P1894; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; Iveson T, 2014, LANCET ONCOL, V15, P1007, DOI 10.1016/S1470-2045(14)70023-3; HIGASHIO K, 1990, BIOCHEM BIOPH RES CO, V170, P397, DOI 10.1016/0006-291X(90)91287-3; Saito N, 2008, MOL MED REP, V1, P77; Li Y, 2012, J SURG ONCOL, V106, P304, DOI 10.1002/jso.23008; Taniguchi K, 1998, CANCER, V82, P2112, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2112::AID-CNCR5>3.0.CO;2-X; Drebber U, 2008, ONCOL REP, V19, P1477; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Kubicka S, 2002, DIGEST DIS SCI, V47, P114, DOI 10.1023/A:1013275706401; Tani H, 2013, MOL MED REP, V7, P1381, DOI 10.3892/mmr.2013.1397; Schmidt L, 1998, CANCER RES, V58, P1719; Huang TJ, 2001, ACTA ONCOL, V40, P638; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; STOKER M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P81, DOI 10.1016/0304-419X(91)90008-9; Botraro DP, 1991, SCIENCE, V251, P802; Daiko W, 2005, NIPPON DAICHO KOMONB, V58, P377; Davidenko I, 2012, EUR SOC MED ONC C VI, p687P; Han SU, 2005, ANN SURG, V242, P676, DOI 10.1097/01.sla.0000786171.85804; Han SU, 1999, WORLD J SURG, V23, P1176; Hashimoto T, 2004, ACTA HISTOCHEM CYTOC, V37, P139, DOI 10.1267/ahc.37.139; Hirosawa T, 2002, NIPPON DAICHO KOMONB, V55, P402; Ide T, 2006, INT J CANCER, V119, P2750, DOI 10.1002/ijc.22178; Japanese Gastric Cancer Association, 1998, JAP CLASS GASTR CARC, P10; Ma PC, 2003, CANCER RES, V63, P6272; Ma PC, 2004, P AM ASSOC CANC RES, V45, P1875; NAKAMURA T, 1991, Progress in Growth Factor Research, V3, P67, DOI 10.1016/0955-2235(91)90014-U; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; Niki M, 1995, JPN J GASTROENTEROL, V28, P2139; Nishimoto N, 2001, HIROSHIMA J MED SCI, V49, P171; Park WS, 1999, CANCER RES, V59, P307; Soyama K, 1999, NIPPON DAICHO KOMONB, V52, P119; Suda A, 2009, INT SURG, V94, P182; Taniguchi T, 1997, BRIT J CANCER, V75, P673, DOI 10.1038/bjc.1997.120; Wu CW, 1998, ANTICANCER RES, V18, P3657; Yamada A, 2007, HEPATO-GASTROENTEROL, V54, P1049; Yamada Yasuhide, 2013, Chin Clin Oncol, V2, P5, DOI 10.3978/j.issn.2304-3865.2012.11.03; Yi S, 2000, NEOPLASIA, V2, P226	49	4	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAY	2015	11	5					3423	3431		10.3892/mmr.2015.3205		9	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CH2IS	WOS:000353849500030		
J	Kamada, Y; Sato, M; Kida, S; Akita, M; Mizutani, K; Fujii, H; Sobajima, T; Yoshida, Y; Shinzaki, S; Takamatsu, S; Takehara, T; Miyoshi, E				Kamada, Yoshihiro; Sato, Motoya; Kida, Sachiho; Akita, Maaya; Mizutani, Kayo; Fujii, Hironobu; Sobajima, Tomoaki; Yoshida, Yuichi; Shinzaki, Shinichiro; Takamatsu, Shinji; Takehara, Tetsuo; Miyoshi, Eiji			N-Acetylglucosaminyltransferase V exacerbates concanavalin A-induced hepatitis in mice	MOLECULAR MEDICINE REPORTS			English	Article						glycosylation; N-glycan; macrophage; galectin-3; T cell receptor	T-CELL; ENDOTHELIAL-CELLS; STELLATE CELLS; LIVER-INJURY; NKT CELLS; CANCER; MACROPHAGES; CYTOKINE; HEPATOCARCINOGENESIS; GLYCOSYLATION	N-Acetylglucosaminyltransferase V (GnT-V) catalyzes beta 1-6 branching in asparagine-linked oligosaccharides and is one of the most important glycosyltransferases involved in carcinogenesis, cancer metastasis and immunity. To investigate the biological functions of GnT-V, the present study developed GnT-V transgenic (Tg) mice and the role of GnT-V in experimental immune-mediated hepatitis, induced by concanavalin A (ConA), were investigated. It was found that the aberrant expression of GnT-V exacerbated ConA-induced hepatitis in the Tg mice compared with the wild-type (WT) mice. The survival rate of the ConA-induced hepatitis at a high-dose of ConA was significantly lower in the Tg mice. Intravenously injected ConA is known to initially bind predominantly to the mannose gland of the liver sinusoidal endothelial cell (LSEC) surface and to leads to the activation of various immune cells. In the present study, the binding affinity of ConA to the LSECs did not differ between the WT and Tg mice. In addition, T cell receptor stimulation by anti-cluster of differentiation (CD)3/CD28 antibodies produced lower levels of T helper (Th)1 cytokine (interferon-gamma) and higher levels of Th2 cytokine (interleukin-10) in the Tg mouse splenic lymphocytes compared with WT mice. The composition of the hepatic mononuclear cells revealed that CD11b-positive cells were significantly increased in the GnT-V Tg mice. In addition, F4/80-positive cells were significantly increased in the Tg mouse liver and the depletion of macrophages reduced the difference in the severity of ConA-induced hepatitis between the WT and Tg mice. In conclusion, the present findings indicated that the aberrant expression of GnT-V led to an increase in hepatic macrophage infiltration and enhanced ConA-induced hepatitis. Modulation of glycosylation may be a novel therapeutic target for immunity-associated acute hepatitis.	[Kamada, Yoshihiro; Sato, Motoya; Kida, Sachiho; Akita, Maaya; Mizutani, Kayo; Fujii, Hironobu; Sobajima, Tomoaki; Shinzaki, Shinichiro; Takamatsu, Shinji; Miyoshi, Eiji] Osaka Univ, Dept Mol Biochem & Clin Invest, Grad Sch Med, Suita, Osaka 5650871, Japan; [Kamada, Yoshihiro; Yoshida, Yuichi; Shinzaki, Shinichiro; Takehara, Tetsuo] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Suita, Osaka 5650871, Japan	Miyoshi, E (reprint author), Osaka Univ, Dept Mol Biochem & Clin Invest, Grad Sch Med, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [24590972];  [21249038]	The present study was supported by Grants-in-Aid for Scientific Research (no. 21249038) and the Japan Society for the Promotion of Science (no. 24590972),.	AICHER WK, 1992, INT IMMUNOL, V4, P959, DOI 10.1093/intimm/4.9.959; Sano H, 2000, J IMMUNOL, V165, P2156; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Miller ML, 2009, J IMMUNOL, V183, P32, DOI 10.4049/jimmunol.0900690; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Takahashi K, 2011, LIFE SCI, V88, P480, DOI 10.1016/j.lfs.2011.01.004; Miyoshi E, 1995, HEPATOLOGY, V22, P1847, DOI 10.1016/0270-9139(95)90214-7; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Li DQ, 2008, J IMMUNOL, V180, P3158; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Kamada Y, 2012, GLYCOBIOLOGY, V22, P778, DOI 10.1093/glycob/cws012; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Knolle PA, 1996, HEPATOLOGY, V24, P824; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1016/0270-9139(95)90428-X; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Bacigalupo ML, 2013, WORLD J GASTROENTERO, V19, P8831, DOI 10.3748/wjg.v19.i47.8831; Di Marco R, 1999, AUTOIMMUNITY, V31, P75; Gove ME, 2009, J LEUKOCYTE BIOL, V85, P491, DOI 10.1189/jlb.0808508; Kato M, 2001, HEPATOL RES, V20, P232, DOI 10.1016/S1386-6346(00)00137-6; Kristensen DB, 2000, HEPATOLOGY, V32, P268; Margalit M, 2005, AM J PHYSIOL-GASTR L, V289, pG917, DOI 10.1152/ajpgi.00105.2005; MIYOSHI E, 1993, CANCER RES, V53, P3899; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; Schrage A, 2008, HEPATOLOGY, V48, P1262, DOI 10.1002/hep.22443; Shinzaki S, 2012, GASTROENTEROLOGY, V142, P1172, DOI 10.1053/j.gastro.2012.02.008; Taniguchi N, 2001, GLYCOCONJUGATE J, V18, P859, DOI 10.1023/A:1022292223878; Taniguchi N, 1999, BBA-MOL BASIS DIS, V1455, P287, DOI 10.1016/S0925-4439(99)00066-6; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Trobonjaca Z, 2001, J IMMUNOL, V167, P1413; Tsui TY, 2007, SHOCK, V27, P165, DOI 10.1097/01.shk.0000239781.71516.61; Volarevic V, 2012, HEPATOLOGY, V55, P1954, DOI 10.1002/hep.25542; Yang MC, 2010, INT IMMUNOL, V22, P661, DOI 10.1093/intimm/dxq050	38	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAY	2015	11	5					3573	3584		10.3892/mmr.2015.3168		12	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CH2IS	WOS:000353849500052		
J	Tahara, T; Shibata, T; Okubo, M; Ishizuka, T; Kawamura, T; Yamashita, H; Nakamura, M; Nakagawa, Y; Nagasaka, M; Arisawa, T; Ohmiya, N; Hirata, I				Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Ishizuka, Takamitsu; Kawamura, Tomohiko; Yamashita, Hiromi; Nakamura, Masakatsu; Nakagawa, Yoshihito; Nagasaka, Mitsuo; Arisawa, Tomiyasu; Ohmiya, Naoki; Hirata, Ichiro			Association between interleukin-1 beta and tumor necrosis factor-alpha polymorphisms and symptoms of dyspepsia	MOLECULAR MEDICINE REPORTS			English	Article						interleukin-1 beta; tumor necrosis factor-alpha; polymorphism; dyspepsia; functional dyspepsia	HELICOBACTER-PYLORI INFECTION; IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL DYSPEPSIA; PSYCHOSOCIAL FACTORS; GASTRIC-CANCER; PEPTIC-ULCER; JAPANESE; GENE; RISK; HYPERSENSITIVITY	Interleukin (IL)-1 beta, and tumor necrosis factor (TNF)-alpha have significant roles in the mediation of inflammatory immune responses and are also potent inhibitors of gastric acid secretion in the stomach. The present study aimed to investigate the associations between polymorphisms at position -31 (T>C) of the IL-1 beta gene and -857 (C>T) of the TNF-alpha gene with dyspeptic symptoms. Polymorphisms at position -31 (T>C) of the IL-1 beta gene and -857 (C>T) of the TNF-alpha gene were genotyped in 261 subjects, including 126 subjects without symptoms and 135 subjects exhibiting symptoms of dyspepsia. The IL-1 beta -31 CC genotype was inversely associated with dyspeptic symptoms in all subjects, as determined by the Fisher's exact test [odds ratio (OR), 0.57; 95% confidence interval (CI), 0.34-0.96; P=0.046]; however, this association was not detected following logistic regression analysis. Within the subgroups of symptoms, the CC genotype was also inversely associated with upper abdominal pain (OR, 0.28; 95% CI, 0.12-0.67; P=0.003) and epigastric pain syndrome (EPS)-like symptoms (OR, 0.14; 95% CI, 0.07-0.28; P=0.003), according to the Rome III classifications. These associations were also found following logistic regression analysis (upper abdominal pain: OR, 0.34; 95% CI, 0.14-0.80; P=0.014; and EPS-like symptoms: OR, 0.41; 95% CI, 0.20-0.84; P=0.015). No significant associations were identified between the TNF-alpha -857 polymorphism and dyspeptic symptoms, including amongst the various subtypes analyzed. In conclusion, the IL-1 beta -31 CC genotype was inversely associated with susceptibility to dyspeptic symptoms, in particular, upper abdominal pain and EPS-like symptoms.	[Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Ishizuka, Takamitsu; Kawamura, Tomohiko; Yamashita, Hiromi; Nakagawa, Yoshihito; Nagasaka, Mitsuo; Ohmiya, Naoki; Hirata, Ichiro] Fujita Hlth Univ, Dept Gastroenterol, Sch Med, Toyoake, Aichi 4701192, Japan; [Nakamura, Masakatsu; Arisawa, Tomiyasu] Kanazawa Med Univ, Dept Gastroenterol, Uchinadamachi, Ishikawa 9208641, Japan	Tahara, T (reprint author), Fujita Hlth Univ, Dept Gastroenterol, Sch Med, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	tomomiccyu@yahoo.co.jp					Mahadeva S, 2006, WORLD J GASTROENTERO, V12, P2661; Tack J, 1998, GASTROENTEROLOGY, V115, P1346, DOI 10.1016/S0016-5085(98)70012-5; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Stanghellini V, 1996, GASTROENTEROLOGY, V110, P1036, DOI 10.1053/gast.1996.v110.pm8612991; TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P1259; Yamaoka Y, 1997, GUT, V41, P442; Furuta T, 2002, GASTROENTEROLOGY, V123, P92, DOI 10.1053/gast.2002.34156; Holtmann G, 2004, GASTROENTEROLOGY, V126, P971, DOI 10.1053/j.gastro.2004.01.006; Locke GR, 2004, AM J GASTROENTEROL, V99, P350, DOI 10.1111/j.1572-0241.2004.04043.x; Holtmann G, 1998, GUT, V42, P501; Higuchi T, 1998, TISSUE ANTIGENS, V51, P605, DOI 10.1111/j.1399-0039.1998.tb03002.x; Mearin F, 2005, GASTROENTEROLOGY, V129, P98, DOI 10.1016/j.gast.2005.04.012; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P51, DOI 10.1111/j.1440-1746.2006.04442.x; Hwang IR, 2002, GASTROENTEROLOGY, V123, P1793, DOI 10.1053/gast.2002.37043; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; DROSSMAN DA, 1988, GASTROENTEROLOGY, V95, P701; Miwa H, 2007, ALIMENT PHARM THERAP, V26, P257, DOI 10.1111/j.1365-2036.2007.03367.x; Camilleri CE, 2006, AM J GASTROENTEROL, V101, P581, DOI 10.1111/j.1572-0241.2006.00481.x; COFFIN B, 1994, GASTROENTEROLOGY, V107, P1345; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; DROSSMAN DA, 1990, GASTROEN CLIN BIOL, V14, pC49; Hamajima N, 2001, JPN J CANCER RES, V92, P383; KONDO S, 1994, AM J PHYSIOL-GASTR L, V267, pG966; Lee KJ, 2004, AM J PHYSIOL-GASTR L, V286, pG278, DOI 10.1152/ajpgi.00086.2003; Locke GR, 1998, BAILLIERE CLIN GASTR, V12, P435; Manabe N, 2010, SCAND J GASTROENTERO, V45, P567, DOI 10.3109/00365521003592663; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65; Soga Y, 2003, J CLIN PERIODONTOL, V30, P524, DOI 10.1034/j.1600-051X.2003.00287.x; Tahara T, 2008, DIGEST DIS SCI, V53, P642, DOI 10.1007/s10620-007-9923-0; WALLACE JL, 1991, AM J PHYSIOL, V261, pG559; Wang MC, 1999, J GASTROENTEROL, V34, P10; Wolfe M M, 1992, Gastroenterology, V102, P2177; Zeng ZR, 2003, GUT, V52, P1684, DOI 10.1136/gut.52.12.1684	34	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAY	2015	11	5					3888	3893		10.3892/mmr.2015.3163		6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CH2IS	WOS:000353849500098		
J	Chi, HT; Ly, BTK; Vu, HA; Sato, Y; Dung, PC; Xinh, PT				Hoang Thanh Chi; Bui Thi Kim Ly; Hoang Anh Vu; Sato, Yuko; Phu Chi Dung; Phan Thi Xinh			Synergistic effect of all-trans retinoic acid in combination with protein kinase C 412 in FMS-like tyrosine kinase 3-mutated acute myeloid leukemia cells	MOLECULAR MEDICINE REPORTS			English	Article						acute myeloid leukemia; FMS-like tyrosine kinase 3; all-trans retinoic acid; protein kinase C 412; apoptosis; synergistic	ACUTE PROMYELOCYTIC LEUKEMIA; LUNG-CANCER; PHASE-I; CLINICAL-TRIAL; GROWTH-FACTOR; LINES; FLT3; DIFFERENTIATION; PKC412; INHIBITOR	Acute myeloid leukemia (AML) is a heterogeneous disease. Numerous molecular abnormalities have been identified in AML and, amongst these, FMS-like tyrosine kinase 3 (FLT3) mutations are one of the most common somatic alterations detected. In the present study, an in vitro investigation was performed to evaluate the effects of all-trans retinoic acid (ATRA) and PKC412, alone and in combination, in FLT3-mutated AML cell lines. Trypan blue exclusion test, as well as morphological, western blot and isobologram analyses were conducted. The results indicated that the combined ATRA and PKC412 treatment exhibited additive or synergistic effects in FLT3-mutated AML cell lines. These results provided in vitro evidence for the future clinical trials evaluating the effects of a combination treatment using PKC412 and ATRA on AML patients with FLT3-mutations.	[Hoang Thanh Chi; Phan Thi Xinh] Hosp Ho Chi Minh City, Dept Mol Cytogenet Blood Transfus & Hematol, Ho Chi Minh City 711512, Vietnam; [Bui Thi Kim Ly] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 1088639, Japan; [Hoang Anh Vu] Univ Med & Pharm Ho Chi Minh City, Ctr Mol Biomed, Ho Chi Minh City 748908, Vietnam; [Sato, Yuko] Japanese Red Cross Coll Nursing, Tokyo 1500012, Japan; [Phu Chi Dung] Blood Transfus & Hematol Hosp Ho Chi Minh City, Dept Pediat Hematol 1, Ho Chi Minh City 711512, Vietnam; [Phan Thi Xinh] Univ Med & Pharm Ho Chi Minh City, Dept Hematol, Ho Chi Minh City 748908, Vietnam	Chi, HT (reprint author), Hosp Ho Chi Minh City, Dept Mol Cytogenet Blood Transfus & Hematol, 118 Hong Bang St,Dist 5, Ho Chi Minh City 711512, Vietnam.	hoangchidc1985@yahoo.com					AMOS B, 1990, METHOD ENZYMOL, V190, P217; STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; Kuchenbauer F, 2005, HAEMATOL-HEMATOL J, V90, P1617; Foran JM, 2010, HEMATOL-AM SOC HEMAT, P47, DOI 10.1182/asheducation-2010.1.47; Sofou S, 2008, INT J NANOMED, V3, P181; Arrieta O, 2010, J CLIN ONCOL, V28, P3463, DOI 10.1200/JCO.2009.26.6452; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307; LANGE B, 1987, BLOOD, V70, P192; Chu SH, 2009, DRUG RESIST UPDATE, V12, P8, DOI 10.1016/j.drup.2008.12.001; Sarkar K, 2008, DRUG DELIV, V15, P343, DOI 10.1080/10717540802035343 ; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; BREITMAN TR, 1981, BLOOD, V57, P1000; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Levis M, 2011, BLOOD, V117, P3294, DOI 10.1182/blood-2010-08-301796; Karmakar S, 2008, CANCER, V112, P596, DOI 10.1002/cncr.23223; MUINDI J, 1992, BLOOD, V79, P299; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Bryan M, 2011, INVEST NEW DRUG, V29, P1482, DOI 10.1007/s10637-010-9478-3; DEGOS L, 1995, BLOOD, V85, P2643; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Torchilin V, 2008, EXPERT OPIN DRUG DEL, V5, P1003, DOI [10.1517/17425247.5.9.1003 , 10.1517/17425240802370001]; Ravandi F, 2010, LEUKEMIA RES, V34, P752, DOI 10.1016/j.leukres.2009.10.001; Boorjian SA, 2007, J IMMUNOTHER, V30, P655, DOI 10.1097/CJI.0b013e31805449a8; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Ridwelski K, 2001, ANN ONCOL, V12, P47, DOI 10.1023/A:1008328501128; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; FRANKEL SR, 1992, ANN INTERN MED, V117, P292; Breitenbuecher F, 2009, BLOOD, V113, P4074, DOI 10.1182/blood-2007-11-125476; Burnett Alan K, 2002, Rev Clin Exp Hematol, V6, P26, DOI 10.1046/j.1468-0734.2002.00058.x; CALIARO MJ, 1994, INT J CANCER, V56, P743, DOI 10.1002/ijc.2910560522; Conley BA, 1997, CANCER CHEMOTH PHARM, V39, P291, DOI 10.1007/s002800050575; Das A, 2008, J NEUROONCOL, V87, P9; Furukawa Y, 2007, LEUKEMIA, V21, P1005, DOI 10.1038/sj.leu.2404593; HOFMANN SL, 1992, AM J MED SCI, V304, P202, DOI 10.1097/00000441-199209000-00010; IIDA S, 1992, LEUKEMIA RES, V16, P1155, DOI 10.1016/0145-2126(92)90113-L; Kang HJ, 2005, J KOREAN MED SCI, V25, P841; Kano Y, 1998, CANCER CHEMOTH PHARM, V42, P91, DOI 10.1007/s002800050790; Kini AR, 2001, BLOOD, V97, P3919, DOI 10.1182/blood.V97.12.3919; LOTAN R, 1994, CANCER RES, V54, pS1987; Lotan R, 1991, Semin Cancer Biol, V2, P197; Ly BTK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066378; Monnerat C, 2004, ANN ONCOL, V15, P316, DOI 10.1093/annonc/mdh052; Naga S, 2008, CHEMOTHERAPY, V54, P166, DOI 10.1159/000140360; O'Donnell Margaret R, 2008, J Natl Compr Canc Netw, V6, P962; Ortiz MA, 2002, DRUG RESIST UPDATE, V5, P162, DOI 10.1016/S1368-7646(02)00050-X; Propper DJ, 2001, J CLIN ONCOL, V19, P1485; Taketani T, 2004, BLOOD, V103, P1085, DOI 10.1182/blood-2003-02-0418; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002	50	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAY	2015	11	5					3969	3975		10.3892/mmr.2015.3203		7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CH2IS	WOS:000353849500110		
J	Sekiguchi, A; Kotozaki, Y; Sugiura, M; Nouchi, R; Takeuchi, H; Hanawa, S; Nakagawa, S; Miyauchi, CM; Araki, T; Sakuma, A; Taki, Y; Kawashima, R				Sekiguchi, A.; Kotozaki, Y.; Sugiura, M.; Nouchi, R.; Takeuchi, H.; Hanawa, S.; Nakagawa, S.; Miyauchi, C. M.; Araki, T.; Sakuma, A.; Taki, Y.; Kawashima, R.			Resilience after 3/11: structural brain changes 1 year after the Japanese earthquake	MOLECULAR PSYCHIATRY			English	Letter							COMBAT STRESS; DISORDER		[Sekiguchi, A.; Taki, Y.] Tohoku Univ, Div Med Neuroimage Anal, Dept Commun Med Supports, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Sekiguchi, A.; Nouchi, R.; Hanawa, S.; Nakagawa, S.; Miyauchi, C. M.; Sakuma, A.; Kawashima, R.] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kotozaki, Y.; Nouchi, R.; Araki, T.; Kawashima, R.] Tohoku Univ, Dept Adv Brain Sci, Smart Ageing Int Res Ctr, IDAC, Sendai, Miyagi 980, Japan; [Sugiura, M.; Nouchi, R.] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Takeuchi, H.; Taki, Y.; Kawashima, R.] Tohoku Univ, Div Dev Cognit Neurosci, IDAC, Sendai, Miyagi 980, Japan; [Miyauchi, C. M.] Univ Tokyo, Grad Sch Law & Polit, Tokyo, Japan; [Sakuma, A.] Tohoku Univ, Grad Sch Med, Dept Psychiat, Sendai, Miyagi 980, Japan; [Taki, Y.] Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Sekiguchi, A (reprint author), Tohoku Univ, Div Med Neuroimage Anal, Dept Commun Med Supports, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan.	asekiguchi@idac.tohoku.ac.jp					Chen L, 2013, HUM BRAIN MAPP, V34, P367, DOI 10.1002/hbm.21438; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; van Wingen GA, 2011, MOL PSYCHIATR, V16, P664, DOI 10.1038/mp.2010.132; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Lui S., 2013, J PSYCHIATR NEUROSCI, V38; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; van Wingen GA, 2012, MOL PSYCHIATR, V17, P116, DOI 10.1038/mp.2011.110	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	MAY	2015	20	5					552	554		10.1038/mp.2014.28		4	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	CH0JS	WOS:000353706400004		
J	Ruiz, J; Pulido, M				Ruiz, Juan; Pulido, Manuel			Parameter Estimation Using Ensemble-Based Data Assimilation in the Presence of Model Error	MONTHLY WEATHER REVIEW			English	Article							TRANSFORM KALMAN FILTER; PART II; MICROPHYSICAL PARAMETERS; CLIMATE ESTIMATION; ATMOSPHERIC STATE; COUPLED MODEL; RADAR DATA; PREDICTION; COVARIANCE; SYSTEM	This work explores the potential of online parameter estimation as a technique for model error treatment under an imperfect model scenario, in an ensemble-based data assimilation system, using a simple atmospheric general circulation model, and an observing system simulation experiment (OSSE) approach. Model error is introduced in the imperfect model scenario by changing the value of the parameters associated with different schemes. The parameters of the moist convection scheme are the only ones to be estimated in the data assimilation system. In this work, parameter estimation is compared and combined with techniques that account for the lack of ensemble spread and for the systematic model error. The OSSEs show that when parameter estimation is combined with model error treatment techniques, multiplicative and additive inflation or a bias correction technique, parameter estimation produces a further improvement of analysis quality and medium-range forecast skill with respect to the OSSEs with model error treatment techniques without parameter estimation. The improvement produced by parameter estimation is mainly a consequence of the optimization of the parameter values. The estimated parameters do not converge to the value used to generate the observations in the imperfect model scenario; however, the analysis error is reduced and the forecast skill is improved.	[Ruiz, Juan] Univ Buenos Aires, CIMA, CONICET, DCAO,FCEyN,UMI,IFAECI,CNRS, Buenos Aires, DF, Argentina; [Ruiz, Juan] RIKEN, AICS, Kobe, Hyogo, Japan; [Pulido, Manuel] Univ Nacl Nordeste, Dept Phys, IMIT, UNNE,CONICET, Corrientes, Argentina; [Pulido, Manuel] CNRS, UMI, IFAECI, Buenos Aires, DF, Argentina	Ruiz, J (reprint author), Univ Buenos Aires, CIMA, CONICET, Ciudad Univ,CABA C1428EGA, Buenos Aires, DF, Argentina.	jruiz@cima.fcen.uba.ar			University of Buenos Aires [UBACYT-20020100300089]; ANPCyT [PICT 2010N1986, PICT 2011N2452, PIP 112-20120100414CO]	This work was partially supported by University of Buenos Aires Grant UBACYT-20020100300089; and ANPCyT Grants PICT 2010N1986, PICT 2011N2452, and PIP 112-20120100414CO. The authors thank Takemasa Miyoshi and Eugenia Kalnay for helpful discussions and also for providing the SPEEDY-LETKF code used in the experiments.	Aksoy A., 2015, ENCY ATMOSPHERIC SCI, V4, P181; Aksoy A, 2006, MON WEATHER REV, V134, P2951, DOI 10.1175/MWR3224.1; Annan JD, 2005, TELLUS A, V57, P709, DOI 10.1111/j.1600-0870.2005.00143.x; Jakob C, 2010, B AM METEOROL SOC, V91, P869, DOI 10.1175/2009BAMS2898.1; Ruiz JJ, 2013, J METEOROL SOC JPN, V91, P79, DOI 10.2151/jmsj.2013-201; Ruiz JJ, 2013, J METEOROL SOC JPN, V91, P453, DOI 10.2151/jmsj.2013-403; Baek SJ, 2006, TELLUS A, V58, P293, DOI 10.1111/j.1600-0870.2006.00178.x; Shutts G, 2005, Q J ROY METEOR SOC, V131, P3079, DOI 10.1256/qj.04.106; Fertig EJ, 2007, TELLUS A, V59, P719, DOI 10.1111/J.1600-0870.2007.00260.x; Annan JD, 2005, OCEAN MODEL, V8, P135, DOI 10.1016/j.ocemod.2003.12.004; Li H, 2009, MON WEATHER REV, V137, P3407, DOI 10.1175/2009MWR2766.1; Buizza R, 1999, Q J ROY METEOR SOC, V125, P2887, DOI 10.1256/smsqj.56005; Meng ZY, 2007, MON WEATHER REV, V135, P1403, DOI 10.1175/MWR3352.1; Miyoshi T, 2007, SOLA, V3, P89, DOI 10.2151/sola.2007-023; Hamill TM, 2001, MON WEATHER REV, V129, P2776, DOI 10.1175/1520-0493(2001)129<2776:DDFOBE>2.0.CO;2; Miyoshi T, 2007, MON WEATHER REV, V135, P3841, DOI 10.1175/2007MWR1873.1; Dee DP, 1998, Q J ROY METEOR SOC, V124, P269, DOI 10.1002/qj.49712454512; Danforth CM, 2007, MON WEATHER REV, V135, P281, DOI 10.1175/MWR3289.1; Molteni F, 2003, CLIM DYNAM, V20, P175, DOI 10.1007/s00382-002-0268-2; Stainforth DA, 2005, NATURE, V433, P403, DOI 10.1038/nature03301; Tong MJ, 2008, MON WEATHER REV, V136, P1649, DOI 10.1175/2007MWR2071.1; Aksoy A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026186; Wu XR, 2012, MON WEATHER REV, V140, P3956, DOI 10.1175/MWR-D-11-00298.1; Miyoshi T, 2011, MON WEATHER REV, V139, P1519, DOI 10.1175/2010MWR3570.1; Houtekamer PL, 2009, MON WEATHER REV, V137, P2126, DOI 10.1175/2008MWR2737.1; Kang JS, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014673; Whitaker JS, 2012, MON WEATHER REV, V140, P3078, DOI 10.1175/MWR-D-11-00276.1; Greybush SJ, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004097; Anderson JL, 2009, TELLUS A, V61, P72, DOI 10.1111/j.1600-0870.2008.00361.x; Whitaker JS, 2008, MON WEATHER REV, V136, P463, DOI 10.1175/2007MWR2018.1; Greybush SJ, 2011, MON WEATHER REV, V139, P511, DOI 10.1175/2010MWR3328.1; Anderson JL, 2001, MON WEATHER REV, V129, P2884, DOI 10.1175/1520-0493(2001)129<2884:AEAKFF>2.0.CO;2; Hunt BR, 2007, PHYSICA D, V230, P112, DOI 10.1016/j.physd.2006.11.008; Bellsky T, 2014, MON WEATHER REV, V142, P2150, DOI 10.1175/MWR-D-13-00200.1; Cornick M, 2009, CHAOS, V19, DOI 10.1063/1.3072780; Jazwinski A. H., 1970, MATH SCI ENG SERIES, V64; Jung YS, 2010, MON WEATHER REV, V138, P539, DOI 10.1175/2009MWR2748.1; Kondrashov D, 2008, MON WEATHER REV, V136, P5062, DOI 10.1175/2008MWR2544.1; Koyama H, 2010, MON WEATHER REV, V138, P3316, DOI 10.1175/2010MWR3067.1; Miyoshi T., 2005, THESIS U MARYLAND CO; Pulido M, 2006, Q J ROY METEOR SOC, V132, P1527, DOI 10.1256/qj.05.43; Schirber S, 2013, J ADV MODEL EARTH SY, V5, P58, DOI 10.1029/2012MS000167; Yang SC, 2012, WEATHER FORECAST, V27, P878, DOI 10.1175/WAF-D-11-00153.1; Zhang S, 2012, TELLUS A, V64, DOI 10.3402/tellusa.v64i0.10963	44	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	MAY	2015	143	5					1568	1582		10.1175/MWR-D-14-00017.1		15	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CH5RW	WOS:000354094000006		
J	Tomikawa, Y; Nomoto, M; Miura, H; Tsutsumi, M; Nishimura, K; Nakamura, T; Yamagishi, H; Yamanouchi, T; Sato, T; Sato, K				Tomikawa, Yoshihiro; Nomoto, Masahiro; Miura, Hiroaki; Tsutsumi, Masaki; Nishimura, Koji; Nakamura, Takuji; Yamagishi, Hisao; Yamanouchi, Takashi; Sato, Toru; Sato, Kaoru			Vertical Wind Disturbances during a Strong Wind Event Observed by the PANSY Radar at Syowa Station, Antarctica	MONTHLY WEATHER REVIEW			English	Article							MODEL; TROPOSPHERE; ICE	Characteristically strong vertical wind disturbances (VWDs) with magnitudes larger than 1 m s(-1) were observed in the Antarctic troposphere using a new mesosphere-stratosphere-troposphere (MST) radar called the Program of the Antarctic Syowa MST/incoherent scatter (IS) Radar (PANSY) during 15-19 June 2012 at Syowa Station (69.0 degrees S, 39.6 degrees E). In the same period, two synoptic-scale cyclones approached Syowa Station and caused a strong wind event (SWE) at the surface. The VWDs observed during the SWE at Syowa Station had a nearly standing (i.e., no phase tilt with height) phase structure up to the tropopause and a power spectrum proportional to the -5/3 power of frequency. On the other hand, the observed VWDs were not associated with systematic horizontal momentum fluxes. Meteorological fields around Syowa Station during the SWE were successfully simulated using the Nonhydrostatic Icosahedral Atmospheric Model (NICAM). A strong VWD was also simulated at the model grid of 70.0 degrees S, 40.0 degrees E in NICAM, which had a standing phase structure similar to the observed ones. An analysis based on the Froude number showed that the simulated VWD was likely due to a hydraulic jump leeward of the coastal mountain ridge. The Scorer parameter analysis indicated that the observed VWDs at Syowa Station during 16-17 June 2012 were likely due to the hydraulic jump similar to that in NICAM. On the other hand, a possibility of lee waves was also suggested for the VWD observed on 18 June 2012.	[Tomikawa, Yoshihiro; Tsutsumi, Masaki; Nishimura, Koji; Nakamura, Takuji; Yamagishi, Hisao; Yamanouchi, Takashi] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Tomikawa, Yoshihiro; Tsutsumi, Masaki; Nishimura, Koji; Nakamura, Takuji; Yamagishi, Hisao; Yamanouchi, Takashi] Grad Univ Adv Studies SOKENDAI, Tokyo, Japan; [Nomoto, Masahiro; Miura, Hiroaki; Sato, Kaoru] Univ Tokyo, Tokyo, Japan; [Sato, Toru] Kyoto Univ, Kyoto, Japan	Tomikawa, Y (reprint author), Natl Inst Polar Res, 10-3 Midori Cho, Tachikawa, Tokyo 1908518, Japan.	tomikawa@nipr.ac.jp	Tomikawa, Yoshihiro/D-5304-2012; Satoh, Kaoru/P-2047-2015	Tomikawa, Yoshihiro/0000-0002-5652-3017; 	Ministry of Education, Culture, Sports and Technology, Japan [25247075]; NIPR	The operational observations of surface meteorology and the PANSY radar at Syowa Station were conducted by the Japanese Antarctic Research Expedition (JARE). The surface meteorological data at Syowa Station were provided by the Japan Meteorological Agency. The authors appreciate constructive and useful comments from Prof. M. Satoh at the Atmosphere and Ocean Research Institute (AORI) about NICAM. The authors are deeply grateful to Prof. Niino at AORI for his insightful comments and suggestions. We are also indebted to Assist. Prof. N. Hirasawa at the National Institute of Polar Research (NIPR) for his kindly providing AVHRR data. This study is supported by Grant-in-Aid for Scientific Research (A) 25247075 of the Ministry of Education, Culture, Sports and Technology, Japan. Numerical simulations were run on the supercomputer at NIPR. The MERRA data were provided by the NASA GSFC Global Modeling and Assimilation Office (GMAO) at http://disc.sci.gsfc.nasa.gov/daac-bin/DataHoldings.pl. Figures were drawn using Dennou Club Library (DCL). The production of this paper was supported by an NIPR publication subsidy.	Adams N, 2004, WEATHER FORECAST, V19, P653, DOI 10.1175/1520-0434(2004)019<0653:ANMSOT>2.0.CO;2; Steinhoff DF, 2008, MON WEATHER REV, V136, P7, DOI 10.1175/2007MWR1999.1; Tomita H, 2008, J METEOROL SOC JPN, V86A, P121; Nakanishi M, 2004, BOUND-LAY METEOROL, V112, P1, DOI 10.1023/B:BOUN.0000020164.04146.98; Tomita H, 2008, J METEOROL SOC JPN, V86A, P107; Miura H, 2007, SCIENCE, V318, P1763, DOI 10.1126/science.1148443; Fudeyasu H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036003; PARISH TR, 1987, NATURE, V328, P51, DOI 10.1038/328051a0; SCORER RS, 1949, Q J ROY METEOR SOC, V75, P41, DOI 10.1002/qj.49707532308; Satoh M, 2008, J COMPUT PHYS, V227, P3486, DOI 10.1016/j.jcp.2007.02.006; Valkonen T, 2010, TELLUS A, V62, P319, DOI 10.1111/j.1600-0870.2010.00443.x; [Anonymous], 2014, TOTENTANZ ERSTE WELT, V64, DOI DOI 10.1016/J.JASTP.2013.08.022; VINCENT RA, 1983, J ATMOS SCI, V40, P1321, DOI 10.1175/1520-0469(1983)040<1321:HDMOMG>2.0.CO;2; TRENBERTH KE, 1991, J ATMOS SCI, V48, P2159, DOI 10.1175/1520-0469(1991)048<2159:STITSH>2.0.CO;2; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Arnault J, 2012, TELLUS A, V64, DOI 10.3402/tellusa.v64i0.17261; Blackman R.B., 1958, MEASUREMENT POWER SP; ECKLUND WL, 1986, J CLIM APPL METEOROL, V25, P885, DOI 10.1175/1520-0450(1986)025<0885:APCOTS>2.0.CO;2; ECKLUND WL, 1985, RADIO SCI, V20, P1196, DOI 10.1029/RS020i006p01196; King J. C., 1997, ANTARCTIC METEOROLOG; LIN YL, 1983, J CLIM APPL METEOROL, V22, P1065, DOI 10.1175/1520-0450(1983)022<1065:BPOTSF>2.0.CO;2; Nigro MA, 2012, MON WEATHER REV, V140, P2044, DOI 10.1175/MWR-D-11-00261.1; Sato K, 2014, J ATMOS SOL-TERR PHY, V118, P2, DOI 10.1016/j.jastp.2013.08.022; Sato K., 2007, POLAR SCI, V1, P1, DOI [10.1016/j.polar.2007.05.001, DOI 10.1016/J.POLAR.2007.05.001]; SATO K, 1990, J ATMOS SCI, V47, P2803, DOI 10.1175/1520-0469(1990)047<2803:VWDITT>2.0.CO;2; Turner J, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011642; Turner J, 2001, J GEOPHYS RES-ATMOS, V106, P7291, DOI 10.1029/2000JD900544; WMO, 1957, WMO B, V6, P134	28	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	MAY	2015	143	5					1804	1821		10.1175/MWR-D-14-00289.1		18	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CH5RW	WOS:000354094000018		
J	Chen, GX; Zhu, XY; Sha, WM; Iwasaki, T; Seko, H; Saito, K; Iwai, H; Ishii, S				Chen, Guixing; Zhu, Xinyue; Sha, Weiming; Iwasaki, Toshiki; Seko, Hiromu; Saito, Kazuo; Iwai, Hironori; Ishii, Shoken			Toward Improved Forecasts of Sea-Breeze Horizontal Convective Rolls at Super High Resolutions. Part I: Configuration and Verification of a Down-Scaling Simulation System (DS3)	MONTHLY WEATHER REVIEW			English	Article							LARGE-EDDY SIMULATION; PLANETARY BOUNDARY-LAYER; WEATHER PREDICTION MODELS; COLD-AIR OUTBREAK; SECONDARY CIRCULATIONS; NUMERICAL-SIMULATION; COHERENT STRUCTURES; MESOSCALE MODEL; DOPPLER LIDAR; TURBULENCE	Horizontal convective rolls (HCRs) that develop in sea breezes greatly influence local weather in coastal areas. In this study, the authors present a realistic simulation of sea-breeze HCRs over an urban-scale area at a resolution of a few meters. An advanced Down-Scaling Simulation System (DS3) is built to derive the analyzed data using a nonhydrostatic model and data assimilation scheme that drive a building-resolving computational fluid dynamics (CFD) model. The mesoscale-analyzed data well capture the inland penetration of the sea breeze in northeastern Japan. The CFD model reproduces the HCRs over Sendai Airport in terms of their coastal initiation, inland growth, streamwise orientation, specific locations, roll wavelength, secondary flows, and regional differences due to complex surfaces. The simulated HCRs agree fairly well with those observed by dual-Doppler lidar and heliborne sensors. Both the simulation and observation analyses suggest that roll updrafts typically originate in the narrow bands of low-speed streaks and warm air near the ground. The HCRs are primarily driven and sustained by a combination of wind shear and buoyancy forces within the slightly unstable sea-breeze layer. In contrast, the experiment without data assimilation exhibits a higher deficiency in the reproduction of roll characteristics. The findings highlight that CFD modeling, given reliable mesoscale weather and surface conditions, aids in high-precision forecasting of HCRs at unprecedented high resolutions, which may help determine the roll structure, dynamics, and impacts on local weather.	[Chen, Guixing; Zhu, Xinyue; Sha, Weiming; Iwasaki, Toshiki] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi 980, Japan; [Seko, Hiromu; Saito, Kazuo] Meteorol Res Inst, Tsukuba, Ibaraki 305, Japan; [Seko, Hiromu; Saito, Kazuo] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan; [Iwai, Hironori; Ishii, Shoken] Natl Inst Informat & Commun Technol, Tokyo, Japan	Chen, GX (reprint author), Sun Yat Sen Univ, Dept Atmospher Sci, 135 Xingangxi Rd, Guangzhou 510275, Guangdong, Peoples R China.	guixing_chen@yahoo.com	Chen, Guixing/B-6270-2013		Strategic Programs for Innovative Research (SPIRE) - Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT through NICT [19204046]; MEXT through ENRI [19204046]; MEXT through JAXA [19204046]; MEXT through Tohoku University [19204046]	The authors thank the three anonymous reviewers for their helpful comments and constructive suggestions. This study was supported by the Strategic Programs for Innovative Research (SPIRE) funded by the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT). The numerical calculations were performed using the K computer at RIKEN Advanced Institute for Computational Science (Proposals hp120282, hp130012, and hp140220) and the supercomputing resource SX-9 at the Cyberscience Center, Tohoku University. The observational data were collected in a field experiment funded by the MEXT (PI: Prof. T. Iwasaki, 19204046) through the collaboration of NICT, ENRI, JAXA, and Tohoku University.	PENNELL WT, 1974, J ATMOS SCI, V31, P1308, DOI 10.1175/1520-0469(1974)031<1308:AESOTS>2.0.CO;2; Ashie Y, 2011, INT J CLIMATOL, V31, P174, DOI 10.1002/joc.2226; LEMONE MA, 1976, J ATMOS SCI, V33, P1308, DOI 10.1175/1520-0469(1976)033<1308:MOTEBL>2.0.CO;2; MOENG CH, 1994, J ATMOS SCI, V51, P999, DOI 10.1175/1520-0469(1994)051<0999:ACOSAB>2.0.CO;2; ORLANSKI I, 1976, J COMPUT PHYS, V21, P251, DOI 10.1016/0021-9991(76)90023-1; Weckwerth TM, 1997, MON WEATHER REV, V125, P505, DOI 10.1175/1520-0493(1997)125<0505:HCRDTE>2.0.CO;2; KUETTNER JP, 1987, Q J ROY METEOR SOC, V113, P445, DOI 10.1256/smsqj.47602; Miao SG, 2008, ATMOS RES, V89, P298, DOI 10.1016/j.atmosres.2008.02.013; Foster RC, 2006, BOUND-LAY METEOROL, V120, P229, DOI 10.1007/s10546-005-9054-0; Kanda M, 2004, BOUND-LAY METEOROL, V112, P343, DOI 10.1023/B:BOUN.0000027909.40439.7c; Beare RJ, 2014, BOUND-LAY METEOROL, V151, P39, DOI 10.1007/s10546-013-9881-3; Raasch S, 2001, BOUND-LAY METEOROL, V101, P31, DOI 10.1023/A:1019297504109; Miller STK, 2003, REV GEOPHYS, V41, DOI 10.1029/2003RG000124; Castillo MC, 2011, BOUND-LAY METEOROL, V140, P453, DOI 10.1007/s10546-011-9614-4; Weckwerth TM, 1996, MON WEATHER REV, V124, P769, DOI 10.1175/1520-0493(1996)124<0769:TVWTCB>2.0.CO;2; Maronga B, 2013, BOUND-LAY METEOROL, V146, P17, DOI 10.1007/s10546-012-9748-z; Shin HH, 2013, J ATMOS SCI, V70, P3248, DOI 10.1175/JAS-D-12-0290.1; Atkinson BW, 1996, REV GEOPHYS, V34, P403, DOI 10.1029/96RG02623; LILLY DK, 1962, TELLUS, V14, P148; LEONARD BP, 1979, COMPUT METHOD APPL M, V19, P59, DOI 10.1016/0045-7825(79)90034-3; KUO HL, 1963, PHYS FLUIDS, V6, P195, DOI 10.1063/1.1706719; Saito K, 2007, J METEOROL SOC JPN, V85B, P271, DOI 10.2151/jmsj.85B.271; Seko H, 2011, TELLUS A, V63, P402, DOI 10.1111/j.1600-0870.2010.00508.x; Dorrestijn J, 2013, THEOR COMP FLUID DYN, V27, P133, DOI 10.1007/s00162-012-0281-y; Mirocha J, 2014, MON WEATHER REV, V142, P806, DOI 10.1175/MWR-D-13-00064.1; Baik JJ, 2009, J APPL METEOROL CLIM, V48, P1667, DOI 10.1175/2009JAMC2066.1; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; Ching J, 2014, MON WEATHER REV, V142, P3284, DOI 10.1175/MWR-D-13-00318.1; Newsom R, 2008, BOUND-LAY METEOROL, V127, P111, DOI 10.1007/s10546-007-9243-0; Wyngaard JC, 2004, J ATMOS SCI, V61, P1816, DOI 10.1175/1520-0469(2004)061<1816:TNMITT>2.0.CO;2; HAYASE T, 1992, J COMPUT PHYS, V98, P108, DOI 10.1016/0021-9991(92)90177-Z; Liu AQ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018530; ETLING D, 1993, BOUND-LAY METEOROL, V65, P215, DOI 10.1007/BF00705527; ASAI T, 1964, J METEOR SOC JAPAN, V42, P245; Asai T., 1970, J METEOR SOC JAPAN, V48, P129; Chen GX, 2015, MON WEATHER REV, V143, P1849, DOI [10.1175/MWR-D-14-00230.1, 10.1175/MWR-D-14-00212.1]; DEARDORF.JW, 1969, J FLUID MECH, V35, P7, DOI 10.1017/S0022112069000942; DEARDORF.JW, 1972, J ATMOS SCI, V29, P91, DOI 10.1175/1520-0469(1972)029<0091:NIONAU>2.0.CO;2; Eito H, 2010, J METEOROL SOC JPN, V88, P625, DOI 10.2151/jmsj.2010-402; Gryschka M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022872; Inagaki A, 2012, BOUND-LAY METEOROL, V142, P207, DOI 10.1007/s10546-011-9671-8; Inagaki A, 2010, BOUND-LAY METEOROL, V135, P209, DOI 10.1007/s10546-010-9477-0; Ishii S, 2007, J METEOROL SOC JPN, V85, P797, DOI 10.2151/jmsj.85.797; Iwai H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034571; Kang SL, 2011, MON WEATHER REV, V139, P2901, DOI 10.1175/MWR-D-10-05037.1; KELLY RD, 1984, J ATMOS SCI, V41, P1816, DOI 10.1175/1520-0469(1984)041<1816:HRABLI>2.0.CO;2; Khanna S, 1998, J ATMOS SCI, V55, P710, DOI 10.1175/1520-0469(1998)055<0710:TDBASI>2.0.CO;2; Komatsubara T., 2005, P 13 COH LAS RAD C, P140; KRISTOVICH DAR, 1993, BOUND-LAY METEOROL, V63, P293, DOI 10.1007/BF00710463; KROPFLI RA, 1978, J APPL METEOROL, V17, P669, DOI 10.1175/1520-0450(1978)017<0669:PHRITU>2.0.CO;2; LEMONE MA, 1973, J ATMOS SCI, V30, P1077, DOI 10.1175/1520-0469(1973)030<1077:TSADOH>2.0.CO;2; Lin CL, 1997, PHYS FLUIDS, V9, P3235, DOI 10.1063/1.869439; Liu HZ, 2011, ADV ATMOS SCI, V28, P477, DOI 10.1007/s00376-010-9229-6; Matayoshi N., 2005, AIAA ATM FLIGHT MECH, P2005; Miyoshi T, 2006, SOLA, V2, P128, DOI 10.2151/sola.2006-033; MOENG CH, 1986, J ATMOS SCI, V43, P2886, DOI 10.1175/1520-0469(1986)043<2886:LESOAS>2.0.CO;2; Munoz-Esparza D, 2014, BOUND-LAY METEOROL, V153, P409, DOI 10.1007/s10546-014-9956-9; Oda R., 2010, 9 S URB ENV, V10.1; Oda R., 2012, P 8 INT C URB CLIM, P295; Park SB, 2013, J APPL METEOROL CLIM, V52, P1348, DOI 10.1175/JAMC-D-12-0162.1; Patankar S. V., 1980, NUMERICAL HEAT TRANS; Prabha TV, 2007, BOUND-LAY METEOROL, V123, P239, DOI 10.1007/s10546-006-9137-6; Rao PA, 1999, MON WEATHER REV, V127, P1808, DOI 10.1175/1520-0493(1999)127<1808:HRMOTC>2.0.CO;2; Saito K, 2013, J PHYS CONF SER, V454, DOI 10.1088/1742-6596/454/1/012073; Saito K., 2012, ATMOSPHERIC MODEL AP, P85, DOI [DOI 10.5772/35368, dx.doi.org/10.5772/35368]; Seko H., 2013, DATA ASSIMILATION AT, P197; Sha W., 2008, METEOROLOGICAL RES N, V219, P21; Sha W., 2002, KAIYO MON, V2, P107; SHA WM, 1991, J ATMOS SCI, V48, P1649, DOI 10.1175/1520-0469(1991)048<1649:ANSOSB>2.0.CO;2; SIMPSON JE, 1969, Q J ROY METEOR SOC, V95, P758, DOI 10.1002/qj.49709540609; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Stull R. B., 1988, INTRO BOUNDARY LAYER; WYNGAARD JC, 1992, BOUND-LAY METEOROL, V60, P1, DOI 10.1007/BF00122059; Young GS, 2002, B AM METEOROL SOC, V83, P997, DOI 10.1175/1520-0477(2002)083<0997:RSWAMA>2.3.CO;2	74	2	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	MAY	2015	143	5					1849	1872		10.1175/MWR-D-14-00212.1		24	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CH5RW	WOS:000354094000021		
J	Chen, GX; Zhu, XY; Sha, WM; Iwasaki, T; Seko, H; Saito, K; Iwai, H; Ishii, S				Chen, Guixing; Zhu, Xinyue; Sha, Weiming; Iwasaki, Toshiki; Seko, Hiromu; Saito, Kazuo; Iwai, Hironori; Ishii, Shoken			Toward Improved Forecasts of Sea-Breeze Horizontal Convective Rolls at Super High Resolutions. Part II: The Impacts of Land Use and Buildings	MONTHLY WEATHER REVIEW			English	Article							LARGE-EDDY SIMULATIONS; ATMOSPHERIC BOUNDARY-LAYER; TURBULENT ORGANIZED STRUCTURES; WEATHER PREDICTION MODELS; SURFACE INHOMOGENEITIES; SECONDARY CIRCULATIONS; COHERENT STRUCTURES; MESOSCALE MODEL; URBAN AREAS; SCALE	Horizontal convective rolls form in coastal areas around Sendai Airport during sea-breeze events. Using a building-resolving computational fluid dynamics model nested in an advanced forecast system with a data assimilation scheme, the authors perform a series of sensitivity experiments to investigate the impacts of land use and buildings on these rolls. The results show that the roll positions, intensities, and structures are significantly affected by variations in land use and the presence of buildings. Land-use heterogeneity is responsible for generating rolls with evident regional features. Major rolls tend to develop downwind of warm surfaces, and they dominate over neighboring rolls; thus, a heterogeneity-scale mode is imposed on the inherent roll wavelength. The roll's rapid growth is attributable to warm surfaces that initiate a strong coupling among turbulent thermals, convective updrafts, pressure perturbations, and secondary flows in sea breezes. The heterogeneity-induced features differ considerably from the nearly homogeneous features that form over uniform surfaces. Additionally, the wake flow behind buildings helps organize near-surface warm air into streamwise bands that drive streaky ejections. The building-induced turbulence acts to modify secondary flows and displace roll updrafts toward building wakes. Such effects are most effective over villages with scattered houses that are aligned with the ambient wind. Building signatures are elongated in downwind open areas due to sustained secondary circulations. An analysis of turbulent kinetic energy shows that both land use and buildings regulate energy generation and transport, resulting in a clear response in roll growth. Thus, including complex surfaces in forecast models helps determine detailed characteristics and structures of roll convection over coastal regions.	[Chen, Guixing; Zhu, Xinyue; Sha, Weiming; Iwasaki, Toshiki] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi 980, Japan; [Seko, Hiromu; Saito, Kazuo] Meteorol Res Inst, Tsukuba, Ibaraki 305, Japan; [Seko, Hiromu; Saito, Kazuo] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan; [Iwai, Hironori; Ishii, Shoken] Natl Inst Informat & Commun Technol, Tokyo, Japan	Chen, GX (reprint author), Sun Yat Sen Univ, Dept Atmospher Sci, 135 Xingangxi Rd, Guangzhou 510275, Guangdong, Peoples R China.	guixing_chen@yahoo.com	Chen, Guixing/B-6270-2013		Strategic Programs for Innovative Research (SPIRE) - Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT through the NICT [19204046]; MEXT through the ENRI [19204046]; MEXT through the JAXA [19204046]; MEXT through the Tohoku University [19204046]	The authors thank the three anonymous reviewers for their helpful comments and constructive suggestions. This study was supported by the Strategic Programs for Innovative Research (SPIRE) funded by the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT). The numerical calculations were performed using the K computer at RIKEN Advanced Institute for Computational Science (Proposals hp120282, hp130012, and hp140220) and the supercomputing resource SX-9 at the Cyberscience Center, Tohoku University. The observational data were collected in a field experiment funded by the MEXT (PI: Prof. T. Iwasaki, 19204046) through the collaboration of NICT, ENRI, JAXA, and Tohoku University.	Ashie Y, 2011, INT J CLIMATOL, V31, P174, DOI 10.1002/joc.2226; LEMONE MA, 1976, J ATMOS SCI, V33, P1308, DOI 10.1175/1520-0469(1976)033<1308:MOTEBL>2.0.CO;2; MOENG CH, 1994, J ATMOS SCI, V51, P999, DOI 10.1175/1520-0469(1994)051<0999:ACOSAB>2.0.CO;2; Weckwerth TM, 1997, MON WEATHER REV, V125, P505, DOI 10.1175/1520-0493(1997)125<0505:HCRDTE>2.0.CO;2; Munoz-Esparza D, 2014, BOUND-LAY METEOROL, V151, P453, DOI 10.1007/s10546-014-9911-9; Avissar R, 1998, J ATMOS SCI, V55, P2666, DOI 10.1175/1520-0469(1998)055<2666:AEOTSA>2.0.CO;2; Miao SG, 2008, ATMOS RES, V89, P298, DOI 10.1016/j.atmosres.2008.02.013; Foster RC, 2006, BOUND-LAY METEOROL, V120, P229, DOI 10.1007/s10546-005-9054-0; Kanda M, 2004, BOUND-LAY METEOROL, V112, P343, DOI 10.1023/B:BOUN.0000027909.40439.7c; Beare RJ, 2014, BOUND-LAY METEOROL, V151, P39, DOI 10.1007/s10546-013-9881-3; Raasch S, 2001, BOUND-LAY METEOROL, V101, P31, DOI 10.1023/A:1019297504109; Castillo MC, 2011, BOUND-LAY METEOROL, V140, P453, DOI 10.1007/s10546-011-9614-4; Maronga B, 2013, BOUND-LAY METEOROL, V146, P17, DOI 10.1007/s10546-012-9748-z; Smith WS, 2001, ATMOS ENVIRON, V35, P3811, DOI 10.1016/S1352-2310(01)00177-7; Shin HH, 2013, J ATMOS SCI, V70, P3248, DOI 10.1175/JAS-D-12-0290.1; Atkinson BW, 1996, REV GEOPHYS, V34, P403, DOI 10.1029/96RG02623; HADFIELD MG, 1992, BOUND-LAY METEOROL, V58, P307, DOI 10.1007/BF00120235; Courault D, 2007, BOUND-LAY METEOROL, V124, P383, DOI 10.1007/s10546-007-9172-y; Collier CG, 2006, Q J ROY METEOR SOC, V132, P1, DOI 10.1256/qj.05.199; LENSCHOW DH, 1980, J ATMOS SCI, V37, P1313, DOI 10.1175/1520-0469(1980)037<1313:MFASMB>2.0.CO;2; Saito K, 2007, J METEOROL SOC JPN, V85B, P271, DOI 10.2151/jmsj.85B.271; Seko H, 2011, TELLUS A, V63, P402, DOI 10.1111/j.1600-0870.2010.00508.x; Dorrestijn J, 2013, THEOR COMP FLUID DYN, V27, P133, DOI 10.1007/s00162-012-0281-y; Roth M, 2000, Q J ROY METEOR SOC, V126, P941, DOI 10.1256/smsqj.56408; Mirocha J, 2014, MON WEATHER REV, V142, P806, DOI 10.1175/MWR-D-13-00064.1; Baik JJ, 2009, J APPL METEOROL CLIM, V48, P1667, DOI 10.1175/2009JAMC2066.1; Letzel MO, 2003, J ATMOS SCI, V60, P2328, DOI 10.1175/1520-0469(2003)060<2328:LESOTI>2.0.CO;2; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; Ching J, 2014, MON WEATHER REV, V142, P3284, DOI 10.1175/MWR-D-13-00318.1; Newsom R, 2008, BOUND-LAY METEOROL, V127, P111, DOI 10.1007/s10546-007-9243-0; Huang HY, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007175; ASAI T, 1964, J METEOR SOC JAPAN, V42, P245; Asai T., 1970, J METEOR SOC JAPAN, V48, P129; Chen GX, 2015, MON WEATHER REV, V143, P1849, DOI [10.1175/MWR-D-14-00230.1, 10.1175/MWR-D-14-00212.1]; Inagaki A, 2012, BOUND-LAY METEOROL, V142, P207, DOI 10.1007/s10546-011-9671-8; Inagaki A, 2010, BOUND-LAY METEOROL, V135, P209, DOI 10.1007/s10546-010-9477-0; Iwai H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034571; Kanda M, 2006, BOUND-LAY METEOROL, V118, P151, DOI 10.1007/s10546-005-5294-2; Kang SL, 2011, MON WEATHER REV, V139, P2901, DOI 10.1175/MWR-D-10-05037.1; Khanna S, 1998, J ATMOS SCI, V55, P710, DOI 10.1175/1520-0469(1998)055<0710:TDBASI>2.0.CO;2; KROPFLI RA, 1978, J APPL METEOROL, V17, P669, DOI 10.1175/1520-0450(1978)017<0669:PHRITU>2.0.CO;2; LEMONE MA, 1973, J ATMOS SCI, V30, P1077, DOI 10.1175/1520-0469(1973)030<1077:TSADOH>2.0.CO;2; Lin CL, 2000, PHYS FLUIDS, V12, P1112, DOI 10.1063/1.870365; Munoz-Esparza D, 2014, BOUND-LAY METEOROL, V153, P409, DOI 10.1007/s10546-014-9956-9; Oda R., 2010, 9 S URB ENV, V10.1; Park SB, 2013, J APPL METEOROL CLIM, V52, P1348, DOI 10.1175/JAMC-D-12-0162.1; Park SB, 2014, J ATMOS SCI, V71, P1880, DOI 10.1175/JAS-D-13-0191.1; Prabha TV, 2007, BOUND-LAY METEOROL, V123, P239, DOI 10.1007/s10546-006-9137-6; Seko H., 2013, DATA ASSIMILATION AT, P197; Sha W., 2008, METEOROLOGICAL RES N, V219, P21; Sha W., 2002, KAIYO MON, V2, P107; SHA WM, 1991, J ATMOS SCI, V48, P1649, DOI 10.1175/1520-0469(1991)048<1649:ANSOSB>2.0.CO;2; SHEN SH, 1995, Q J ROY METEOR SOC, V121, P1209, DOI 10.1002/qj.49712152603; Young GS, 2002, B AM METEOROL SOC, V83, P997, DOI 10.1175/1520-0477(2002)083<0997:RSWAMA>2.3.CO;2	54	2	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	MAY	2015	143	5					1873	1894		10.1175/MWR-D-14-00230.1		22	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CH5RW	WOS:000354094000022		
J	de Jong, PR; Takahashi, N; Peiris, M; Bertin, S; Lee, J; Gareau, MG; Paniagua, A; Harris, AR; Herdman, DS; Corr, M; Blackshaw, LA; Raz, E				de Jong, P. R.; Takahashi, N.; Peiris, M.; Bertin, S.; Lee, J.; Gareau, M. G.; Paniagua, A.; Harris, A. R.; Herdman, D. S.; Corr, M.; Blackshaw, L. A.; Raz, E.			TRPM8 on mucosal sensory nerves regulates colitogenic responses by innate immune cells via CGRP	MUCOSAL IMMUNOLOGY			English	Article							GENE-RELATED PEPTIDE; POTENTIAL VANILLOID 1; SUBSTANCE-P; DENDRITIC CELLS; EXPERIMENTAL COLITIS; INTESTINAL TUMORIGENESIS; VISCERAL HYPERALGESIA; KNOCKOUT MICE; MOUSE MODELS; ION-CHANNEL	TRPM8 is the molecular sensor for cold; however, the physiological role of TRPM8+ neurons at mucosal surfaces is unclear. Here we evaluated the distribution and peptidergic properties of TRPM8+ fibers in naive and inflamed colons, as well as their role in mucosal inflammation. We found that Trpm8(-/-) mice were hypersusceptible to dextran sodium sulfate (DSS)-induced colitis, and that Trpm8(-/-) CD11c+ DCs (dendritic cells) showed hyperinflammatory responses to toll-like receptor (TLR) stimulation. This was phenocopied in calcitonin gene-related peptide (CGRP) receptor-deficient mice, but not in substance P receptor-deficient mice, suggesting a functional link between TRPM8 and CGRP. The DSS phenotype of CGRP receptor-deficient mice could be adoptively transferred to wild-type (WT) mice, suggesting that CGRP suppresses the colitogenic activity of bone marrow-derived cells. TRPM8+ mucosal fibers expressed CGRP in human and mouse colon. Furthermore, neuronal CGRP contents were increased in colons from naive and DSS-treated Trpm8(-/-) mice, suggesting deficient CGRP release in the absence of TRPM8 triggering. Finally, treatment of Trpm8(-/-) mice with CGRP reversed their hyperinflammatory phenotype. These results suggest that TRPM8 signaling in mucosal sensory neurons is indispensable for the regulation of innate inflammatory responses via the neuropeptide CGRP.	[de Jong, P. R.; Takahashi, N.; Bertin, S.; Lee, J.; Gareau, M. G.; Paniagua, A.; Harris, A. R.; Herdman, D. S.; Corr, M.; Raz, E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [de Jong, P. R.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Takahashi, N.] Niiaata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Niiaata, Japan; [Peiris, M.; Blackshaw, L. A.] Univ London, Blizard Inst, Bans & London Sch Med & Dent, Wingate Inst Neurogastroenterol, London, England	Raz, E (reprint author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	eraz@ucsd.edu		de Jong, Petrus/0000-0003-2321-1153	NIH through the NINDS [P30 NS047101]; Wellcome Trust; Crohn's and Colitis Foundation of America (CCFA) [2927, 3574, 3038]; Japan Society for the Promotion of Science (JSPS); NIH [AI095623, DK35108, AI077989-05]	We thank Melissa Scholl for animal breeding. Liwen Deng and Steve Shenouda performed the tissue processing and Professor Nissi Varki from the Department of Pathology (UCSD) assisted with histological evaluations. Richard Blackshaw and James Blackshaw assisted with image analysis. We thank Jennifer Santini for assistance in confocal imaging at the University of California at San Diego Neuroscience Microscopy Shared Facility, funded by NIH Grant P30 NS047101 through the NINDS. LAB was the principal investigator on the immunohistochemical studies, funded by the Wellcome Trust. This study was supported by grants from the Crohn's and Colitis Foundation of America (CCFA) to PRJ (Research Fellowship Award no. 2927), SB (RFA no. 3574), and ER (Senior Research Award no. 3038); the Japan Society for the Promotion of Science (JSPS) to NT; and the NIH (AI095623, DK35108, and AI077989-05).	Abe K, 2007, P NATL ACAD SCI USA, V104, P17022, DOI 10.1073/pnas.0708469104; Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Altmayr F, 2010, J BIOL CHEM, V285, P3525, DOI 10.1074/jbc.M109.066787; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Tan LL, 2008, NEUROSCIENCE, V156, P334, DOI 10.1016/j.neuroscience.2008.06.071; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Phillis BD, 2009, NEUROSCI LETT, V459, P57, DOI 10.1016/j.neulet.2009.04.051; Weinstock JV, 2003, J IMMUNOL, V171, P3762; Li MC, 2011, J ALLERGY CLIN IMMUN, V128, P626, DOI 10.1016/j.jaci.2011.04.032; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Holzer P, 2011, CURR PHARM BIOTECHNO, V12, P24, DOI 10.2174/138920111793937862; Li XL, 2012, J CLIN INVEST, V122, P963, DOI 10.1172/JCI59097; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Gareau MG, 2007, GUT, V56, P1522, DOI 10.1136/gut.2006.117176; Fichna J, 2012, NEUROGASTROENT MOTIL, V24, pe557, DOI 10.1111/j.1365-2982.2012.01999.x; De Petrocellis L, 2007, EXP CELL RES, V313, P1911, DOI 10.1016/j.yexcr.2007.01.008; Blackshaw LA, 2010, GUT, V59, P126, DOI 10.1136/gut.2009.179523; Perraud AL, 2004, MOL IMMUNOL, V41, P657, DOI 10.1016/j.molimm.2004.04.013; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Engel MA, 2012, DIGEST LIVER DIS, V44, P24, DOI 10.1016/j.dld.2011.08.030; Thompson BJ, 2008, DIGEST DIS SCI, V53, P229, DOI 10.1007/s10620-007-9848-7; Milling S, 2010, IMMUNOL REV, V234, P259, DOI 10.1111/j.0105-2896.2009.00866.x; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Abe J, 2005, MOL BRAIN RES, V136, P91, DOI 10.1016/j.molbrainres.2005.01.013; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; Harzenetter MD, 2007, J IMMUNOL, V179, P607; Christianson JA, 2006, NEUROSCIENCE, V140, P247, DOI 10.1016/j.neuroscience.2006.02.015; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Ramachandran R, 2013, P NATL ACAD SCI USA, V110, P7476, DOI 10.1073/pnas.1217431110; Kimball ES, 2004, NEUROGASTROENT MOTIL, V16, P811, DOI 10.1111/j.1365-2982.2004.00549.x; Almeida MC, 2012, J NEUROSCI, V32, P2086, DOI 10.1523/JNEUROSCI.5606-11.2012; de Jong PR, 2014, J CLIN INVEST, V124, P3793, DOI 10.1172/JCI72340; Szitter I, 2010, J MOL NEUROSCI, V42, P80, DOI 10.1007/s12031-010-9366-5; Zhang L, 2004, AM J PHYSIOL-GASTR L, V286, pG983, DOI 10.1152/ajpgi.00441.2003; Miranda A, 2007, NEUROSCIENCE, V148, P1021, DOI 10.1016/j.neuroscience.2007.05.034; Reinshagen M, 1998, J PHARMACOL EXP THER, V286, P657; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Engel MA, 2012, J GASTROENTEROL, V47, P256, DOI 10.1007/s00535-011-0495-6; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Matsumoto K, 2011, NEUROSCIENCE, V172, P518, DOI 10.1016/j.neuroscience.2010.10.024; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Axelsson HE, 2009, NEUROSCIENCE, V162, P1322, DOI 10.1016/j.neuroscience.2009.05.052; Denda M, 2010, EXP DERMATOL, V19, P791, DOI 10.1111/j.1600-0625.2010.01154.x; Eijkelkamp N, 2007, AM J PHYSIOL-GASTR L, V293, pG749, DOI 10.1152/ajpgi.00114.2007; Engel M. A., 2010, INFLAMM BOWEL DIS, V17, P1030, DOI [10.1002/ibd.21422, DOI 10.1002/IBD.21422]; Fisher JT, 2011, CURR OPIN PHARMACOL, V11, P218, DOI 10.1016/j.coph.2011.06.004; Garza A, 2008, J PARASITOL, V94, P1253, DOI 10.1645/GE-1481.1; Gonzalez-Navajas JM, 2010, J EXP MED, V207, P2799, DOI 10.1084/jem.20101326; Harrington AM, 2011, PAIN, V152, P1459, DOI 10.1016/j.pain.2011.01.027; Hayashi T, 2009, NEUROSCI RES, V65, P245, DOI 10.1016/j.neures.2009.07.005; Holzer P, 2004, NEUROGASTROENT MOTIL, V16, P697, DOI 10.1111/j.1365-2982.2004.00598.x; Hosoya T, 2014, NEUROGASTROENT MOTIL, V26, P1112, DOI 10.1111/nmo.12368; Kimball ES, 2007, NEUROGASTROENT MOTIL, V19, P390, DOI 10.1111/j.1365-2982.2007.00939.x; Marchelletta RR, 2013, GASTROENTEROLOGY, V145, P1358, DOI 10.1053/j.gastro.2013.08.054; Meyer MC, 2005, AM J PHYSIOL-CELL PH, V289, pC1485, DOI 10.1152/ajpcell.00215.2005; Rochlitzer S, 2011, CLIN EXP ALLERGY, V41, P1609, DOI 10.1111/j.1365-2222.2011.03822.x; Wright BD, 2014, NEURON, V82, P836, DOI 10.1016/j.neuron.2014.04.006; Wu SN, 2011, J MEMBRANE BIOL, V241, P11, DOI 10.1007/s00232-011-9358-6; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529	65	2	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1933-0219	1935-3456		MUCOSAL IMMUNOL	Mucosal Immunol.	MAY	2015	8	3					491	504		10.1038/mi.2014.82		14	Immunology	Immunology	CH5OR	WOS:000354085700006		
J	Kimura, S; Yamakami-Kimura, M; Obata, Y; Hase, K; Kitamura, H; Ohno, H; Iwanaga, T				Kimura, S.; Yamakami-Kimura, M.; Obata, Y.; Hase, K.; Kitamura, H.; Ohno, H.; Iwanaga, T.			Visualization of the entire differentiation process of murine M cells: suppression of their maturation in cecal patches	MUCOSAL IMMUNOLOGY			English	Article							FOLLICLE-ASSOCIATED EPITHELIUM; FACTOR SPI-B; PEYERS-PATCHES; LYMPHOID FOLLICLES; EXPRESSION; MICE; SPECIALIZATION; MUTATION; RELB	The microfold (M) cell residing in the follicle-associated epithelium is a specialized epithelial cell that initiates mucosal immune responses by sampling lumina! antigens. The differentiation process of M cells remains unclear due to limitations of analytical methods. Here we found that M cells were classified into two functionally different subtypes based on the expression of Glycoprotein 2 (GP2) by newly developed image cytometric analysis. GP2-high M cells actively took up luminal microbeads, whereas GP2-negative or low cells scarcely ingested them, even though both subsets equally expressed the other M-cell signature genes, suggesting that GP2-high M cells represent functionally mature M cells. Further, the GP2-high mature M cells were abundant in Peyer's patch but sparse in the cecal patch: this was most likely due to a decrease in the nuclear translocation of RelB, a downstream transcription factor for the receptor activator of nuclear factor-kappa B signaling. Given that murine cecum contains a protrusion of beneficial commensals, the restriction of M-cell activity might contribute to preventing the onset of any excessive immune response to the commensals through decelerating the M-cell-dependent uptake of microorganisms.	[Kimura, S.; Yamakami-Kimura, M.; Iwanaga, T.] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido, Japan; [Kimura, S.; Hase, K.; Ohno, H.] RIKEN, Ctr Integrat Med Sci IMS, Lab Intestinal Ecosyst, Yokohama, Kanagawa, Japan; [Obata, Y.] Chiba Univ, Grad Sch Med, Lab Immune Regulat, Chiba, Japan; [Obata, Y.; Hase, K.] Univ Tokyo, Inst Med Sci, Div Mucosal Barriol, Tokyo, Japan; [Hase, K.] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan; [Hase, K.] Keio Univ, Fac Pharm, Dept Biochem, Tokyo, Japan; [Kitamura, H.] Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Physiol, Ebetsu, Hokkaido, Japan; [Ohno, H.] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Div Immunobiol, Yokohama, Kanagawa 232, Japan	Kimura, S (reprint author), Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido, Japan.	skimu@med.hokudai.ac.jp	Ohno, Hiroshi/L-7899-2014; Kimura, Shunsuke/D-7093-2012	Ohno, Hiroshi/0000-0001-8776-9661; Kimura, Shunsuke/0000-0001-9408-2884	JSPS [23790521, 25460261, 24790186]; Research Foundation for Opto-Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research	We are grateful to Professor Masahiko Watanabe and Dr Kohtaro Konno, Laboratory of Anatomy and Embryology, Graduate School of Medicine, Hokkaido University, for their assistance in the production of the polyclonal antibody against Tnfaip2 and the start-up of the FISH analysis. This work was supported by JSPS KAKENHI grant numbers 23790521, 25460261, and 24790186. This work was also supported by grants from the Research Foundation for Opto-Science and Technology, and the Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Sato S, 2013, MUCOSAL IMMUNOL, V6, P838, DOI 10.1038/mi.2012.122; OWEN RL, 1974, GASTROENTEROLOGY, V66, P189; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; BOCKMAN DE, 1973, AM J ANAT, V136, P455, DOI 10.1002/aja.1001360406; Kobayashi A, 2013, MUCOSAL IMMUNOL, V6, P1027, DOI 10.1038/mi.2012.141; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Terahara K, 2008, J IMMUNOL, V180, P7840; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Gebert A, 1999, AM J PATHOL, V154, P1573, DOI 10.1016/S0002-9440(10)65410-7; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Lugering A, 2005, AM J PATHOL, V166, P1647, DOI 10.1016/S0002-9440(10)62475-3; CLARK MA, 1993, J HISTOCHEM CYTOCHEM, V41, P1679; Tahoun A, 2012, CELL HOST MICROBE, V12, P645, DOI 10.1016/j.chom.2012.10.009; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; BYE WA, 1984, GASTROENTEROLOGY, V86, P789; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; Lelouard H, 2001, J CELL SCI, V114, P2077; Lo D, 2003, CELL IMMUNOL, V224, P8, DOI 10.1016/S0008-8749(03)00155-2; Masahata K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4704; Verbrugghe P, 2006, J PATHOL, V209, P240, DOI 10.1002/path.1970	29	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1933-0219	1935-3456		MUCOSAL IMMUNOL	Mucosal Immunol.	MAY	2015	8	3					650	660				11	Immunology	Immunology	CH5OR	WOS:000354085700019		
J	Kikitsu, H; Sarkar, PP				Kikitsu, Hitomitsu; Sarkar, Partha P.			Building Damage, Wind Speed Estimation, and Post Disaster Recovery in an EF5 Tornado	NATURAL HAZARDS REVIEW			English	Article						Tornado damage; Tornado wind estimation; Disaster recovery; Enhanced Fujita scale; Damage investigation; Rankine vortex model		This paper presents an overview of the investigation of the damage to buildings caused by an EF5 tornado that hit Parkersburg in Iowa, United States, in May 2008. The tornado wind speed in Parkersburg is estimated on the basis of the degree of damage (DOD), which is defined in the Enhanced Fujita (EF) Scale on the basis of damaged buildings, and it is compared with wind speed estimated using an engineering model. The characteristics of the estimated wind speed distribution are consistent between the two methods. With respect to postdisaster activity, the authors carried out field investigations in Parkersburg for four months to ascertain the progress in the recovery process of buildings that sustained damage. It became clear through the investigation that the recovery of damaged buildings depended on the degree of structural damage. Finally, the recovery process of damaged buildings is summarized along with the processes related to response and recovery taken by federal and state governments. (C) 2014 American Society of Civil Engineers.	[Kikitsu, Hitomitsu] Bldg Res Inst, Dept Struct Engn, Tsukuba, Ibaraki 3050802, Japan; [Sarkar, Partha P.] Iowa State Univ, Dept Aerosp Engn, Ames, IA 50011 USA	Sarkar, PP (reprint author), Iowa State Univ, Dept Aerosp Engn, Ames, IA 50011 USA.	ppsarkar@iastate.edu					American Nuclear Society, 1983, ANSIANS231983; [Anonymous], 2008, CLAR DAM ASS; Des Moines Register, 2008, IOW DEADL TORN; Des Moines Resister, 2008, PARK TORN REB TOWN; National Oceanic and Atmospheric Administration (NOAA), 2008, EF5 TORN PARK NEW HA; Okuda Y., 2008, FINAL RES REP MECH P, P371; Phillips B., 2009, DISASTER RECOVERY; Prevatt D., 2012, ASCE LEADERSH MANAG, V12, P254, DOI DOI 10.1061/(ASCE)LM.1943-5630.0000192; Prevatt D. O., 2013, JOPLIN MISSOURI TORN; Rebuild Iowa Advisory Commission, 2008, 45 DAY REP GOV CHET; Roueche D. B., 2013, J DISASTER RES, V8, P1061; van de Lindt JW, 2013, J STRUCT ENG-ASCE, V139, P251, DOI 10.1061/(ASCE)ST.1943-541X.0000622; Wind Science and Engineering Center (WiSE), 2006, REC EF SCAL; Zhang W., 2011, EXP FLUIDS, V52, P479, DOI [10.1007/s00348-011-1229-5EXFLDU0723-4864, DOI 10.1007/S00348-011-1229-5EXFLDU0723-4864]	14	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1527-6988	1527-6996		NAT HAZARDS REV	Nat. Hazards Rev.	MAY	2015	16	2							04014019	10.1061/(ASCE)NH.1527-6996.0000156		10	Engineering, Civil; Environmental Studies; Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Geology; Meteorology & Atmospheric Sciences; Water Resources	CH5RL	WOS:000354092900004		
J	Takagi, H; Tamiru, M; Abe, A; Yoshida, K; Uemura, A; Yaegashi, H; Obara, T; Oikawa, K; Utsushi, H; Kanzaki, E; Mitsuoka, C; Natsume, S; Kosugi, S; Kanzaki, H; Matsumura, H; Urasaki, N; Kamoun, S; Terauchi, R				Takagi, Hiroki; Tamiru, Muluneh; Abe, Akira; Yoshida, Kentaro; Uemura, Aiko; Yaegashi, Hiroki; Obara, Tsutomu; Oikawa, Kaori; Utsushi, Hiroe; Kanzaki, Eiko; Mitsuoka, Chikako; Natsume, Satoshi; Kosugi, Shunichi; Kanzaki, Hiroyuki; Matsumura, Hideo; Urasaki, Naoya; Kamoun, Sophien; Terauchi, Ryohei			MutMap accelerates breeding of a salt-tolerant rice cultivar	NATURE BIOTECHNOLOGY			English	Letter							GENOME; SELECTION; TSUNAMI; GENES; LOCI; SEQ		[Takagi, Hiroki; Tamiru, Muluneh; Abe, Akira; Uemura, Aiko; Yaegashi, Hiroki; Obara, Tsutomu; Oikawa, Kaori; Utsushi, Hiroe; Kanzaki, Eiko; Mitsuoka, Chikako; Natsume, Satoshi; Kanzaki, Hiroyuki; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Yoshida, Kentaro; Kamoun, Sophien] Norwich Res Pk, Sainsbury Lab, Norwich, Norfolk, England; [Kosugi, Shunichi] Kazusa DNA Res Inst, Kisarazu, Chiba, Japan; [Matsumura, Hideo] Shinshu Univ, Gene Res Ctr, Ueda, Nagano, Japan; [Urasaki, Naoya] Okinawa Prefectural Agr Res Ctr, Itoman, Okinawa, Japan	Takagi, H (reprint author), Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan.	h-takagi@ibrc.or.jp; terauchi@ibrc.or.jp	Kamoun, Sophien/B-3529-2009	Kamoun, Sophien/0000-0002-0290-0315			Allen R. G., 1998, IRRIG DRAIN; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Takai T, 2007, BREEDING SCI, V57, P257, DOI 10.1270/jsbbs.57.257; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Chague-Goff C, 2012, SEDIMENT GEOL, V282, P175, DOI 10.1016/j.sedgeo.2012.06.002; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Szczucinski W, 2005, ENVIRON GEOL, V49, P321, DOI 10.1007/s00254-005-0094-z; Tsai YC, 2012, PLANT PHYSIOL, V158, P1666, DOI 10.1104/pp.111.192765; Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; Kosugi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075402; Mom N., 2011, GEOPHYS RES LETT, V38, DOI DOI 10.1029/2011GL049210; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Rakshit S., 2010, HDB PLANT MUTATION S, P185, DOI 10.1002/9783527629398.ch11; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267	23	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					445	449		10.1038/nbt.3188		5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CH8VP	WOS:000354314500015		
J	Suzuki, H; Aoki, K; Chiba, K; Sato, Y; Shiozawa, Y; Shiraishi, Y; Shimamura, T; Niida, A; Motomura, K; Ohka, F; Yamamoto, T; Tanahashi, K; Ranjit, M; Wakabayashi, T; Yoshizato, T; Kataoka, K; Yoshida, K; Nagata, Y; Sato-Otsubo, A; Tanaka, H; Sanada, M; Kondo, Y; Nakamura, H; Mizoguchi, M; Abe, T; Muragaki, Y; Watanabe, R; Ito, I; Miyano, S; Natsume, A; Ogawa, S				Suzuki, Hiromichi; Aoki, Kosuke; Chiba, Kenichi; Sato, Yusuke; Shiozawa, Yusuke; Shiraishi, Yuichi; Shimamura, Teppei; Niida, Atsushi; Motomura, Kazuya; Ohka, Fumiharu; Yamamoto, Takashi; Tanahashi, Kuniaki; Ranjit, Melissa; Wakabayashi, Toshihiko; Yoshizato, Tetsuichi; Kataoka, Keisuke; Yoshida, Kenichi; Nagata, Yasunobu; Sato-Otsubo, Aiko; Tanaka, Hiroko; Sanada, Masashi; Kondo, Yutaka; Nakamura, Hideo; Mizoguchi, Masahiro; Abe, Tatsuya; Muragaki, Yoshihiro; Watanabe, Reiko; Ito, Ichiro; Miyano, Satoru; Natsume, Atsushi; Ogawa, Seishi			Mutational landscape and clonal architecture in grade II and III gliomas	NATURE GENETICS			English	Article							COMPREHENSIVE GENOMIC CHARACTERIZATION; CENTRAL-NERVOUS-SYSTEM; MALIGNANT GLIOMAS; IDH2 MUTATIONS; MYELODYSPLASTIC SYNDROMES; INTRATUMOR HETEROGENEITY; ADJUVANT TEMOZOLOMIDE; GENETIC ALTERATIONS; ASTROCYTIC TUMORS; SURVIVAL RATES	Grade II and III gliomas are generally slowly progressing brain cancers, many of which eventually transform into more aggressive tumors. Despite recent findings of frequent mutations in IDH1 and other genes, knowledge about their pathogenesis is still incomplete. Here, combining two large sets of high-throughput sequencing data, we delineate the entire picture of genetic alterations and affected pathways in these glioma types, with sensitive detection of driver genes. Grade II and III gliomas comprise three distinct subtypes characterized by discrete sets of mutations and distinct clinical behaviors. Mutations showed significant positive and negative correlations and a chronological hierarchy, as inferred from different allelic burdens among coexisting mutations, suggesting that there is functional interplay between the mutations that drive clonal selection. Extensive serial and multi-regional sampling analyses further supported this finding and also identified a high degree of temporal and spatial heterogeneity generated during tumor expansion and relapse, which is likely shaped by the complex but ordered processes of multiple clonal selection and evolutionary events.	[Suzuki, Hiromichi; Aoki, Kosuke; Motomura, Kazuya; Ohka, Fumiharu; Yamamoto, Takashi; Tanahashi, Kuniaki; Ranjit, Melissa; Wakabayashi, Toshihiko; Natsume, Atsushi] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan; [Suzuki, Hiromichi; Aoki, Kosuke; Sato, Yusuke; Shiozawa, Yusuke; Yoshizato, Tetsuichi; Kataoka, Keisuke; Yoshida, Kenichi; Nagata, Yasunobu; Sato-Otsubo, Aiko; Sanada, Masashi; Ogawa, Seishi] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan; [Chiba, Kenichi; Shiraishi, Yuichi; Niida, Atsushi; Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Tokyo, Japan; [Shimamura, Teppei] Nagoya Univ, Sch Med, Div Syst Biol, Nagoya, Aichi 466, Japan; [Ohka, Fumiharu; Kondo, Yutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Epigen, Nagoya, Aichi, Japan; [Nakamura, Hideo] Kumamoto Univ, Dept Neurosurg, Kumamoto, Japan; [Mizoguchi, Masahiro] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 812, Japan; [Abe, Tatsuya] Oita Univ, Dept Neurosurg, Oita 87011, Japan; [Muragaki, Yoshihiro] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan; [Watanabe, Reiko; Ito, Ichiro] Shizuoka Canc Ctr, Div Clin Pathol, Shizuoka, Japan	Ogawa, S (reprint author), Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan.	anatsume@med.nagoya-u.ac.jp; sogawa-tky@umin.ac.jp			Funding Program for World-Leading Innovative Research and Development on Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [23107010]; Japan Neurosurgical Society [FY2012-2014];  [22134006]	We thank Y. Mori, M. Nakamura and H. Higashi for their technical assistance. We gratefully acknowledge the TCGA Consortium and all its members for making their invaluable data publically available. We are grateful to all patients who generously agreed to participate in this study. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (S.O.; 22134006) and the Funding Program for World-Leading Innovative Research and Development on Science and Technology (S.O.) and by a Grant-in Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (A. Natsume; 23107010) and funding from the Japan Neurosurgical Society (A. Natsume; Basic Project Plan FY2012-2014).	Jiao YC, 2012, ONCOTARGET, V3, P709; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Santos-Rosa H, 2005, EUR J CANCER, V41, P2381, DOI 10.1016/j.ejca.2005.08.010; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Wiestler B, 2013, ACTA NEUROPATHOL, V126, P443, DOI 10.1007/s00401-013-1156-z; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Bauman G, 2009, INT J RADIAT ONCOL, V75, P1401, DOI 10.1016/j.ijrobp.2009.01.010; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wiestler B, 2014, ACTA NEUROPATHOL, V128, P561, DOI 10.1007/s00401-014-1315-x; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Okamoto Y, 2004, ACTA NEUROPATHOL, V108, P49, DOI 10.1007/s00401-004-0861-z; Kannan K, 2012, ONCOTARGET, V3, P1194; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Claus EB, 2006, CANCER, V106, P1358, DOI 10.1002/cncr.21733; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Yachida S, 2013, ONCOGENE, V32, P5253, DOI 10.1038/onc.2013.29; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Vogazianou AP, 2010, NEURO-ONCOLOGY, V12, P664, DOI 10.1093/neuonc/nop075; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Bao ZS, 2014, GENOME RES, V24, P1765, DOI 10.1101/gr.165126.113; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Di Stefano A. L., 2015, CLIN CANCER RES, DOI [10.1158/1078-0432.CCR-14-2199, DOI 10.1158/1078-0432.CCR-14-2199]; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Katagiri T, 2011, BLOOD, V118, P6601, DOI 10.1182/blood-2011-07-365189; LANCASTER JF, 1983, BIOMETRICS, V39, P245, DOI 10.2307/2530824; Mantha S, 2007, LEUKEMIA RES, V31, P321, DOI 10.1016/j.leukres.2006.06.009; Niida A., 2012, BIOINFORMATICS, V28, pi115; Purdom PW, 2000, BIOINFORMATICS, V16, P140, DOI 10.1093/bioinformatics/16.2.140; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	65	8	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					458	U52		10.1038/ng.3273		14	Genetics & Heredity	Genetics & Heredity	CG9LE	WOS:000353635800008		
J	Lee, WC; Kim, K; Park, J; Koo, J; Jeong, HY; Lee, H; Weitz, DA; Zettl, A; Takeuchi, S				Lee, Won Chul; Kim, Kwanpyo; Park, Jungwon; Koo, Jahyun; Jeong, Hu Young; Lee, Hoonkyung; Weitz, David A.; Zettl, Alex; Takeuchi, Shoji			Graphene-templated directional growth of an inorganic nanowire	NATURE NANOTECHNOLOGY			English	Article							ATOMIC LAYER DEPOSITION; CARBON NANOTUBES; NANOSTRUCTURES; NANOPARTICLES; FUNCTIONALIZATION; NANOGENERATORS; NANORIBBONS; COVALENT; SURFACES; CATALYST	Assembling inorganic nanomaterials on graphene(1-3) is of interest in the development of nanodevices and nanocomposite materials, and the ability to align such inorganic nanomaterials on the graphene surface is expected to lead to improved functionalities(4), as has previously been demonstrated with organic nanomaterials epitaxially aligned on graphitic surfaces(5-10). However, because graphene is chemically inert, it is difficult to precisely assemble inorganic nanomaterials on pristine graphene(2,11-16). Previous techniques(2,3) based on dangling bonds of damaged graphene(11,17-20), intermediate seed materials(11,15,16,21,22) and vapour-phase deposition at high temperature(12-14,23-25) have only formed randomly oriented or poorly aligned inorganic nanostructures. Here, we show that inorganic nanowires of gold(I) cyanide can grow directly on pristine graphene, aligning themselves with the zigzag lattice directions of the graphene. The nanowires are synthesized through a self-organized growth process in aqueous solution at room temperature, which indicates that the inorganic material spontaneously binds to the pristine graphene surface. First-principles calculations suggest that this assembly originates from lattice matching and pi interaction to gold atoms. Using the synthesized nanowires as templates, we also fabricate nanostructures with controlled crystal orientations such as graphene nanoribbons with zigzag-edged directions.	[Lee, Won Chul; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Lee, Won Chul; Takeuchi, Shoji] Japan Sci & Technol Agcy, ERATO Takeuchi Biohybrid Innovat Project, Tokyo 1538904, Japan; [Kim, Kwanpyo; Zettl, Alex] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Kim, Kwanpyo] Ulsan Natl Inst Sci & Technol, Dept Phys, Ulsan 689798, South Korea; [Park, Jungwon; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Park, Jungwon; Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Koo, Jahyun; Lee, Hoonkyung] Konkuk Univ, Dept Phys, Seoul 143701, South Korea; [Jeong, Hu Young] Ulsan Natl Inst Sci & Technol, UNIST Cent Res Facil UCRF, Ulsan 689798, South Korea; [Zettl, Alex] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	Zettl, A (reprint author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	azettl@berkeley.edu; takeuchi@iis.u-tokyo.ac.jp	Kim, Kwanpyo/D-9121-2011		Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO); Japan Science and Technology (JST); Office of Energy Research, Materials Sciences and Engineering Division, of the US Department of Energy [DE-AC02-05CH11231]; Office of Naval Research (MURI grant) [N00014-09-1066]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2058178]; Harvard MRSEC [DMR-0820484]; Amore-Pacific; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2015R1A1A1001583]; KISTI under the Supercomputing Applications Support Program [KSC-2013-C3-034]; UNIST [1.120032.01]	The authors thank A.P. Alivisatos, H. Fujita, Y. Arakawa, B.J. Kim, L. Yang, J. Moon, Y. Ota, H. Suh, J. Kwon and J. Min for helpful discussions. The authors also thank J. Kim and Y. Mizutani for the AFM analysis, S. Mori and M. Onuki for technical support and A. Sato for help with graphic illustrations. This work was mainly supported by the Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology (JST). A.Z. and K.K. acknowledge support from the Director, Office of Energy Research, Materials Sciences and Engineering Division, of the US Department of Energy (DE-AC02-05CH11231) and from the Office of Naval Research (MURI grant N00014-09-1066). K.K. also acknowledges support from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A1A2058178). D.A.W. and J.P. acknowledge support from the Harvard MRSEC (DMR-0820484) and Amore-Pacific. H.L. and J.K. acknowledge support from the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, ICT & Future Planning (NRF-2015R1A1A1001583) and also acknowledge support from KISTI under the Supercomputing Applications Support Program (KSC-2013-C3-034). H.Y.J. acknowledges support from the 2012 Research Fund (1.120032.01) of UNIST.	Shi ZW, 2011, ADV MATER, V23, P3061, DOI 10.1002/adma.201100633; Kim DW, 2012, NAT NANOTECHNOL, V7, P29, DOI [10.1038/nnano.2011.198, 10.1038/NNANO.2011.198]; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Choi D, 2010, ADV MATER, V22, P2187, DOI 10.1002/adma.200903815; Barth JV, 2005, NATURE, V437, P671, DOI 10.1038/nature04166; Kim K, 2011, ACS NANO, V5, P2142, DOI 10.1021/nn1033423; Garnica M, 2013, NAT PHYS, V9, P368, DOI [10.1038/nphys2610, 10.1038/NPHYS2610]; Liang YY, 2011, NAT MATER, V10, P780, DOI [10.1038/nmat3087, 10.1038/NMAT3087]; Chung K, 2010, SCIENCE, V330, P655, DOI 10.1126/science.1195403; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Huang X, 2010, SMALL, V6, P513, DOI 10.1002/smll.200902001; Si YC, 2008, CHEM MATER, V20, P6792, DOI 10.1021/cm801356a; Wang XR, 2008, J AM CHEM SOC, V130, P8152, DOI 10.1021/ja8023059; Lightcap IV, 2010, NANO LETT, V10, P577, DOI 10.1021/nl9035109; Halas NJ, 2011, CHEM REV, V111, P3913, DOI 10.1021/cr200061k; Fukushima T, 2003, SCIENCE, V300, P2072, DOI 10.1126/science.1082289; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Zhang F, 2006, ANGEW CHEM INT EDIT, V45, P3611, DOI 10.1002/anie.200503636; Dang WH, 2010, NANO LETT, V10, P2870, DOI 10.1021/nl100938e; Colson JW, 2011, SCIENCE, V332, P228, DOI 10.1126/science.1202747; Sarkar S, 2013, ADV MATER, V25, P1131, DOI 10.1002/adma.201203161; Addou R, 2013, NAT NANOTECHNOL, V8, P41, DOI [10.1038/nnano.2012.217, 10.1038/NNANO.2012.217]; Georgakilas V, 2012, CHEM REV, V112, P6156, DOI 10.1021/cr3000412; Zhou HQ, 2013, CARBON, V52, P379, DOI 10.1016/j.carbon.2012.09.048; Jiao LY, 2009, NATURE, V458, P877, DOI 10.1038/nature07919; Shi YM, 2012, NANO LETT, V12, P2784, DOI [10.1021/nl204562j, 10.1021/nl204562J]; Hong YJ, 2013, ADV MATER, V25, P6847, DOI 10.1002/adma.201302312; Alaboson JMP, 2013, NANO LETT, V13, P5763, DOI 10.1021/nl4000932; Kumar B, 2011, ACS NANO, V5, P4197, DOI 10.1021/nn200942s; Hong G, 2013, NANO TODAY, V8, P388, DOI 10.1016/j.nantod.2013.07.003; Giovannetti G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026803; Hibble SJ, 2003, INORG CHEM, V42, P4724, DOI 10.1021/ic0342043; Kim K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5781	33	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-3387	1748-3395		NAT NANOTECHNOL	Nat. Nanotechnol.	MAY	2015	10	5					423	428		10.1038/NNANO.2015.36		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CH5SF	WOS:000354094900011		
J	Horiuchi, N				Horiuchi, Noriaki			SYNCHROTRONS Taiwan unveils new synchrotron	NATURE PHOTONICS			English	News Item									Nat Photon, Shinjuku Ku, Tokyo 1620843, Japan	Horiuchi, N (reprint author), Nat Photon, Shinjuku Ku, 2-37 Ichigayatamachi, Tokyo 1620843, Japan.	n.horiuchi@nature.com						0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	MAY	2015	9	5					292	293				2	Optics; Physics, Applied	Optics; Physics	CG9OU	WOS:000353646800005		
J	Masada, G; Miyata, K; Politi, A; Hashimoto, T; O'Brien, JL; Furusawa, A				Masada, Genta; Miyata, Kazunori; Politi, Alberto; Hashimoto, Toshikazu; O'Brien, Jeremy L.; Furusawa, Akira			Continuous-variable entanglement on a chip	NATURE PHOTONICS			English	Article							GUIDE QUANTUM CIRCUITS; HYBRID ENTANGLEMENT; TELEPORTATION; LIGHT; GENERATION; CRITERION; SYSTEMS	Encoding quantum information in continuous variables, as the quadrature of electromagnetic fields, is a powerful approach to quantum information science and technology(1). Continuousvariable entanglement (light beams in Einstein-PodolskyRosen, or EPR2, states) is a key resource for quantum information protocols(3) and enables hybridization between continuous-variable and single-photon discrete-variable qubit systems(4). However, continuous-variable systems are currently limited by their implementation in free-space optical networks, and the demand for increased complexity, low loss, high-precision alignment and stability, as well as hybridization, require an alternative approach. Here we present an integrated photonic implementation of the key capabilities for continuousvariable quantum technologies-the generation and characterization of EPR beams in a photonic chip. When combined with integrated squeezing and non-Gaussian operations, these results will open the way to universal quantum information processing with light.	[Masada, Genta; Miyata, Kazunori; Furusawa, Akira] Univ Tokyo, Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Masada, Genta] Tamagawa Univ, Quantum ICT Res Inst, Machida, Tokyo 1948610, Japan; [Politi, Alberto] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Hashimoto, Toshikazu] NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan; [O'Brien, Jeremy L.] Univ Bristol, Ctr Quantum Photon, HH Wills Phys Lab, Bristol BS8 1UB, Avon, England; [O'Brien, Jeremy L.] Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1UB, Avon, England	Furusawa, A (reprint author), Univ Tokyo, Sch Engn, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	akiraf@ap.t.u-tokyo.ac.jp	Politi, Alberto/D-7134-2011	Politi, Alberto/0000-0002-3668-9474	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Nippon Telegraph and Telephone Corporation (NTT); Engineering and Physical Sciences Research Council (EPSRC); European Research Council (ERC); Photonic Integrated Compound Quantum Encoding (PICQUE); Breaking the Barriers of Optical Integration (BBOI); US Army Research Office (ARO) [W911NF-14-1-0133]; US Air Force Office of Scientific Research (AFOSR); Royal Society Wolfson Merit Award; Royal Academy of Engineering Chair in Emerging Technologies	The authors thank H. Bachor for advice. This work was partly supported by the Project for Developing Innovation Systems (PDIS), Grants-in-Aid for Scientific Research (GIA) and the Advanced Photon Science Alliance (APSA) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the Nippon Telegraph and Telephone Corporation (NTT), the Engineering and Physical Sciences Research Council (EPSRC), the European Research Council (ERC), Photonic Integrated Compound Quantum Encoding (PICQUE), Breaking the Barriers of Optical Integration (BBOI), the US Army Research Office (ARO; grant no. W911NF-14-1-0133) and the US Air Force Office of Scientific Research (AFOSR). J.L.O. acknowledges a Royal Society Wolfson Merit Award and a Royal Academy of Engineering Chair in Emerging Technologies.	Dakna M, 1997, PHYS REV A, V55, P3184, DOI 10.1103/PhysRevA.55.3184; Jeong H, 2014, NAT PHOTONICS, V8, P564, DOI 10.1038/NPHOTON.2014.136; Matthews JCF, 2009, NAT PHOTONICS, V3, P346, DOI 10.1038/NPHOTON.2009.93; O'Brien JL, 2009, NAT PHOTONICS, V3, P687, DOI 10.1038/nphoton.2009.229; Campbell JC, 2007, J LIGHTWAVE TECHNOL, V25, P109, DOI 10.1109/JLT.2006.888481; Laing A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3497087; Takeno Y, 2007, OPT EXPRESS, V15, P4321, DOI 10.1364/OE.15.004321; Zhang TC, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.033802; Morin O, 2014, NAT PHOTONICS, V8, P570, DOI [10.1038/nphoton.2014.137, 10.1038/NPHOTON.2014.137]; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Politi A, 2008, SCIENCE, V320, P646, DOI 10.1126/science.1155441; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; O'Brien JL, 2007, SCIENCE, V318, P1567, DOI 10.1126/science.1142892; Masada G, 2010, OPT EXPRESS, V18, P13114, DOI 10.1364/OE.18.013114; Dowling JP, 2003, PHILOS T R SOC A, V361, P1655, DOI 10.1098/rsta.2003.1227; Duan LM, 2000, PHYS REV LETT, V84, P2722, DOI 10.1103/PhysRevLett.84.2722; Sprengers JP, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3657518; Simon R, 2000, PHYS REV LETT, V84, P2726, DOI 10.1103/PhysRevLett.84.2726; Weedbrook C, 2012, REV MOD PHYS, V84, P621, DOI 10.1103/RevModPhys.84.621; Takeda S, 2013, NATURE, V500, P315, DOI 10.1038/nature12366; Braunstein L., 2005, REV MOD PHYS, V77, P513; Furusawa A., 2011, QUANTUM TELEPORTATIO; Pernice WHP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2307; Shadbolt PJ, 2012, NAT PHOTONICS, V6, P45, DOI [10.1038/nphoton.2011.283, 10.1038/NPHOTON.2011.283]; Suzuki S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335806; Takeda S, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.053824	27	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	MAY	2015	9	5					316	319		10.1038/NPHOTON.2015.42		4	Optics; Physics, Applied	Optics; Physics	CG9OU	WOS:000353646800009		
J	Colvin, H; Mori, M				Colvin, Hugh; Mori, Masaki			Back to the stroma-the real villain in colorectal cancer?	NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY			English	Editorial Material							BREAST-CANCER; TUMOR STROMA; STEM-CELLS; METASTASIS; EXPRESSION	The cells responsible for particular gene signatures in large-scale microarray studies of colorectal cancer have now been revealed. In doing so, the gene signature associated with poor prognosis is shown to be predominantly of stromal origin.	[Colvin, Hugh; Mori, Masaki] Osaka Univ, Dept Surg, Grad Sch Med, Suita, Osaka 5650871, Japan	Mori, M (reprint author), Osaka Univ, Dept Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mmori@gesurg.med.osaka-u.ac.jp					Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Ngan CY, 2007, BRIT J CANCER, V96, P986, DOI 10.1038/sj.bjc.6603651; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Isella C., 2015, NAT GENET, V14, P312; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-5045	1759-5053		NAT REV GASTRO HEPAT	Nat. Rev. Gastroenterol. Hepatol.	MAY	2015	12	5					256	257		10.1038/nrgastro.2015.57		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH5JB	WOS:000354070800003		
J	Hosomi, K; Seymour, B; Saitoh, Y				Hosomi, Koichi; Seymour, Ben; Saitoh, Youichi			Modulating the pain network-neurostimulation for central poststroke pain	NATURE REVIEWS NEUROLOGY			English	Review							MOTOR-CORTEX-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; CHRONIC NEUROPATHIC PAIN; DEEP BRAIN-STIMULATION; POST-STROKE PAIN; INTRACTABLE DEAFFERENTATION PAIN; PLACEBO-CONTROLLED TRIAL; SPINAL-CORD STIMULATION; DOUBLE-BLIND TRIAL; LONG-TERM	Central poststroke pain (CPSP) is one of the most under-recognized consequences of stroke, occurring in up to 10% of patients, and is also one of the most difficult to treat. The condition characteristically develops after selective lesions to the spinothalamic system, most often to the ventral posterior thalamus. Here, we suggest that CPSP is best characterized as a disorder of brain network reorganization, and that this characterization offers insight into the inadequacy of most current pharmacological treatments. Accordingly, we review the progress in identification of nonpharmacological treatments, which could ultimately lead to mechanism-based therapeutics. Of the invasive neurostimulation treatments available, electrical motor cortex stimulation seems to be superior to deep brain stimulation of the thalamus or brainstem, but enthusiasm for clinical use of the procedure is limited by its invasiveness. The current preference is for noninvasive transcranial magnetic stimulation, which, though effective, requires repeated application, causing logistical difficulties. Although CPSP is often severe and remains difficult to treat, future characterization of the precise underlying neurophysiological mechanisms, together with technological innovation, should allow new treatments to evolve.	[Hosomi, Koichi; Saitoh, Youichi] Osaka Univ, Grad Sch Med, Dept Neuromodulat & Neurosurg, Suita, Osaka 5650871, Japan; [Seymour, Ben] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England	Saitoh, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Neuromodulat & Neurosurg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	neurosaitoh@mbk.nifty.com			Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Wellcome Trust (UK); National Institute of Information and Communications Technology (Japan); Japanese Ministry of Health, Labour and Welfare	The authors would like to thank Ms Keiko Sano for her assistance in preparing artwork. K.H., B.S. and Y.S. are supported by the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan. B.S. is also funded by the Wellcome Trust (UK) and the National Institute of Information and Communications Technology (Japan). Y.S. is also supported by the Japanese Ministry of Health, Labour and Welfare.	Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Aly M. M., 2010, NEUROSURGERY, V67; Andre-Obadia N, 2014, PAIN PHYSICIAN, V17, P53; CRAIG AD, 1994, NATURE, V372, P770, DOI 10.1038/372770a0; Rasche D, 2006, PAIN, V121, P43, DOI 10.1016/j.pain.2005.12.006; Hosomi K, 2013, PAIN, V154, P1065, DOI 10.1016/j.pain.2013.03.016; Kim JS, 2003, NEUROLOGY, V61, P679; Levy R, 2010, PAIN PHYSICIAN, V13, P157; Krause T, 2012, J NEUROL NEUROSUR PS, V83, P776, DOI 10.1136/jnnp-2011-301936; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Klit H, 2011, PAIN, V152, P818, DOI 10.1016/j.pain.2010.12.030; Farmer MA, 2012, NEUROSCI LETT, V520, P197, DOI 10.1016/j.neulet.2012.05.001; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; ANDERSEN G, 1995, PAIN, V61, P187, DOI 10.1016/0304-3959(94)00144-4; Bittar RG, 2005, J CLIN NEUROSCI, V12, P515, DOI 10.1016/j.jocn.2004.10.005; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Andre-Obadia N, 2011, PAIN, V152, P1233, DOI 10.1016/j.pain.2010.12.027; Bowsher D, 1996, J NEUROL NEUROSUR PS, V61, P62, DOI 10.1136/jnnp.61.1.62; Hirayama A, 2006, PAIN, V122, P22, DOI 10.1016/j.pain.2005.12.001; Ducreux D, 2006, BRAIN, V129, P963, DOI 10.1093/brain/awl016; Radhakrishnan V, 1999, PAIN, V80, P567, DOI 10.1016/S0304-3959(98)00248-6; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Velasco F, 2008, J NEUROSURG, V108, P698, DOI 10.3171/JNS/2008/108/4/0698; Jonsson AC, 2006, J NEUROL NEUROSUR PS, V77, P590, DOI 10.1136/jnnp.2005.079145; Nguyen JP, 2011, NAT REV NEUROL, V7, P699, DOI 10.1038/nrneurol.2011.138; Leung A, 2009, J PAIN, V10, P1205, DOI 10.1016/j.jpain.2009.03.010; Sprenger T, 2012, BRAIN, V135, P2536, DOI 10.1093/brain/aws153; Willoch F, 2004, PAIN, V108, P213, DOI 10.1016/j.pain.2003.08.014; Nandi D, 2002, J CLIN NEUROSCI, V9, P557, DOI 10.1054/jocn.2001.1042; Harno H, 2014, NEUROLOGY, V83, P1147, DOI 10.1212/WNL.0000000000000818; Bowsher D, 1998, NEUROLOGY, V51, P1352; Goto T, 2008, PAIN, V140, P509, DOI 10.1016/j.pain.2008.10.009; Garcia-Larrea L, 2010, BRAIN, V133, P2528, DOI 10.1093/brain/awq220; O'Donnell MJ, 2013, STROKE, V44, P1238, DOI 10.1161/STROKEAHA.111.671008; Attal N, 2000, NEUROLOGY, V54, P564; LENZ FA, 1993, J NEUROPHYSIOL, V70, P200; Andre-Obadia N, 2008, NEUROLOGY, V71, P833, DOI 10.1212/01.wnl.0000325481.61471.f0; Lundstrom E, 2009, EUR J NEUROL, V16, P188, DOI 10.1111/j.1468-1331.2008.02378.x; Hosomi K, 2008, CLIN NEUROPHYSIOL, V119, P993, DOI 10.1016/j.clinph.2007.12.022; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Andre-Obadia N, 2006, CLIN NEUROPHYSIOL, V117, P1536, DOI 10.1016/j.clinph.2006.03.025; Attal N, 2002, NEUROLOGY, V58, P554; Boccard SGJ, 2014, NEUROSURGERY, V74, P628, DOI 10.1227/NEU.0000000000000321; TURNBULL IM, 1980, J NEUROSURG, V52, P486, DOI 10.3171/jns.1980.52.4.0486; Lefaucheur JP, 2001, NEUROPHYSIOL CLIN, V31, P247, DOI 10.1016/S0987-7053(01)00260-X; LEIJON G, 1989, PAIN, V36, P13, DOI 10.1016/0304-3959(89)90107-3; Vranken JH, 2008, PAIN, V136, P150, DOI 10.1016/j.pain.2007.06.033; Kim JS, 2009, EXPERT REV NEUROTHER, V9, P711, DOI [10.1586/ern.09.19, 10.1586/ERN.09.19]; Flaster M, 2013, TOP STROKE REHABIL, V20, P116, DOI 10.1310/tsr2002-116; Kern D, 2008, PAIN, V135, P291, DOI 10.1016/j.pain.2007.12.001; Lefaucheur JP, 2001, NEUROREPORT, V12, P2963, DOI 10.1097/00001756-200109170-00041; Garcia-Larrea L, 2002, BRAIN, V125, P2766, DOI 10.1093/brain/awf275; Vestergaard K, 2001, NEUROLOGY, V56, P184; Lefaucheur JP, 2008, CLIN NEUROPHYSIOL, V119, P2179, DOI 10.1016/j.clinph.2008.07.007; Saitoh Y, 2007, J NEUROSURG, V107, P555, DOI 10.3171/JNS-07/09/0555; Owen SLF, 2006, PAIN, V120, P202, DOI 10.1016/j.pain.2005.09.035; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Jungehulsing GJ, 2013, EUR J NEUROL, V20, P331, DOI 10.1111/j.1468-1331.2012.03857.x; LEVY RM, 1987, NEUROSURGERY, V21, P885; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; VESTERGAARD K, 1995, PAIN, V61, P177, DOI 10.1016/0304-3959(94)00140-A; Lima MC, 2008, NEUROLOGY, V70, P2329, DOI 10.1212/01.wnl.0000314649.38527.93; Kim JH, 2007, J NEUROSCI, V27, P4995, DOI 10.1523/JNEUROSCI.0716-07.2007; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Kong KH, 2004, ARCH PHYS MED REHAB, V85, P35, DOI 10.1016/S0003-9993(03)00369-1; Kumar G, 2009, J NEUROL SCI, V284, P10, DOI 10.1016/j.jns.2009.04.030; Widar M, 2002, J REHABIL MED, V34, P165, DOI 10.1080/16501970213237; Lefaucheur JP, 2011, J PAIN, V12, P1102, DOI 10.1016/j.jpain.2011.05.004; Bowsher D, 2001, J PAIN, V2, P258, DOI 10.1054/jpai.2001.24549; SIMPSON BA, 1991, J NEUROL NEUROSUR PS, V54, P196, DOI 10.1136/jnnp.54.3.196; BAINTON T, 1992, PAIN, V48, P159, DOI 10.1016/0304-3959(92)90052-D; ADAMS JE, 1974, J NEUROSURG, V41, P740, DOI 10.3171/jns.1974.41.6.0740; Lefaucheur JP, 2008, J NEUROL NEUROSUR PS, V79, P1044, DOI 10.1136/jnnp.2007.135327; Yakhnitsa V, 1999, PAIN, V79, P223, DOI 10.1016/S0304-3959(98)00169-9; Kim JS, 2011, PAIN, V152, P1018, DOI 10.1016/j.pain.2010.12.023; Sachs AJ, 2014, NEUROMODULATION, V17, P303, DOI 10.1111/ner.12181; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; Frese A, 2006, CLIN J PAIN, V22, P252, DOI 10.1097/01.ajp.0000173020.10483.13; Dworkin RH, 2013, PAIN, V154, P2249, DOI 10.1016/j.pain.2013.06.004; MacGowan DJL, 1997, NEUROLOGY, V49, P120; Tanei T, 2011, NEUROL MED-CHIR, V51, P8, DOI 10.2176/nmc.51.8; TSUBOKAWA T, 1991, PACE, V14, P131, DOI 10.1111/j.1540-8159.1991.tb04058.x; HOLMGREN H, 1990, PAIN, V40, P43, DOI 10.1016/0304-3959(90)91049-O; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; HOSOBUCHI Y, 1986, J NEUROSURG, V64, P543, DOI 10.3171/jns.1986.64.4.0543; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Kumar K, 1997, NEUROSURGERY, V40, P736, DOI 10.1097/00006123-199704000-00015; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; Hamani C, 2006, PAIN, V125, P188, DOI 10.1016/j.pain.2006.05.019; Greenspan JD, 2004, PAIN, V109, P357, DOI 10.1016/j.pain.2004.02.002; Lampl C, 2002, STROKE, V33, P3030, DOI 10.1161/01.STR.0000037674.95228.86; Hosomi K, 2013, PAIN, V154, P1352, DOI 10.1016/j.pain.2013.04.017; Nguyen JP, 1999, PAIN, V82, P245, DOI 10.1016/S0304-3959(99)00062-7; Weimar C, 2002, CEREBROVASC DIS, V14, P261, DOI 10.1159/000065663; MIGITA K, 1995, NEUROSURGERY, V36, P1037; LEIJON G, 1989, PAIN, V36, P27, DOI 10.1016/0304-3959(89)90108-5; Canavero S, 2004, CLIN NEUROPHARMACOL, V27, P182, DOI 10.1097/01.wnf.0000138635.42121.9e; Wang GX, 2008, J NEUROSCI, V28, P11959, DOI 10.1523/JNEUROSCI.3296-08.2008; Kumar B, 2009, ANESTH ANALG, V108, P1645, DOI 10.1213/ane.0b013e31819d644c; Bae SH, 2014, TOHOKU J EXP MED, V234, P189, DOI 10.1620/tjem.234.189; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Brown JA, 2005, NEUROSURGERY, V56, P290, DOI 10.1227/01.neu.0000148905.75845.98; Casey KL, 2012, PAIN, V153, P331, DOI 10.1016/j.pain.2011.10.029; Craig AD, 2008, PAIN, V135, P215, DOI 10.1016/j.pain.2008.01.022; Craig AD, 2007, CENTRAL NEUROPATHIC, P81; de Oliveira RAA, 2014, J PAIN, V15, P1271, DOI 10.1016/j.jpain.2014.09.009; Dejerine J, 1906, REV NEUROL-FRANCE, V14, P521; Fontaine D, 2009, J NEUROSURG, V110, P251, DOI 10.3171/2008.6.17602; Gharabaghi A, 2005, NEUROSURGERY, V57, P114, DOI 10.1227/01.NEU.0000164385.42652.9E; Hayashi M, 2007, INT J RADIAT ONCOL, V69, P852, DOI 10.1016/j.ijrobp.2007.04.043; Helmchen C, 2002, PAIN, V98, P325, DOI 10.1016/S0304-3959(02)00139-2; HOSOBUCH.Y, 1973, ARCH NEUROL-CHICAGO, V29, P158; IASP Taxonomy, 2014, IASP TAX; Katayama Y, 1998, J NEUROSURG, V89, P585, DOI 10.3171/jns.1998.89.4.0585; Katayama Y, 2001, STEREOT FUNCT NEUROS, V77, P183, DOI 10.1159/000064618; Kim JS, 2014, CNS DRUGS, V28, P787, DOI 10.1007/s40263-014-0194-y; Kim JS, 2007, NEUROLOGY, V68, P174, DOI 10.1212/01.wnl.0000251298.12763.9b; Kishima H, 2010, NEUROIMAGE, V49, P2564, DOI 10.1016/j.neuroimage.2009.10.054; Krause T., CORTEX; Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P117, DOI 10.1016/j.neurcli.2006.08.002; Lefaucheur JP, 2004, J NEUROL NEUROSUR PS, V75, P612, DOI 10.1136/jnnp.2003.022236; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lefaucheur JP, 2011, NEUROSURGERY, V68, P180, DOI 10.1227/NEU.0b013e318207f896; LENZ FA, 1989, BRAIN RES, V496, P357, DOI 10.1016/0006-8993(89)91088-3; Linderoth B, 2009, EUR J PAIN SUPP, P89, DOI 10.1016/j.eujps.2009.07.003; Mano H, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002037; Mazars G J, 1975, Surg Neurol, V4, P93; Nuti C, 2005, PAIN, V118, P43, DOI 10.1016/j.pain.2005.07.020; O'Connell N. E., COCHRANE DATABASE SY; Ohn SH, 2012, NEUROREHAB NEURAL RE, V26, P344, DOI 10.1177/1545968311423110; Pirotte Benoit, 2005, Neurosurgery, V56, P344, DOI 10.1227/01.NEU.0000144837.31665.29; Raffaeli W, 2013, J PAIN RES, V6, P705, DOI 10.2147/JPR.S46553; Rasche Dirk, 2006, Neurosurg Focus, V21, pE8; Richardson D E, 1977, Neurosurgery, V1, P199; Saitoh Y, 2007, ACTA NEUROCHIR SUPPL, V97, P51; SORIA ED, 1991, PAIN, V44, P285, DOI 10.1016/0304-3959(91)90098-I; Tsubokawa T, 1991, Acta Neurochir Suppl (Wien), V52, P137; TSUBOKAWA T, 1993, J NEUROSURG, V78, P393, DOI 10.3171/jns.1993.78.3.0393; Vranken JH, 2005, PAIN, V118, P224, DOI 10.1016/j.pain.2005.08.020	139	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4758	1759-4766		NAT REV NEUROL	Nat. Rev. Neurol.	MAY	2015	11	5					290	299		10.1038/nrneurol.2015.58		10	Clinical Neurology	Neurosciences & Neurology	CH5IU	WOS:000354069700008		
J	Yamamoto, Y; Terayama, R; Kishimoto, N; Maruhama, K; Mizutani, M; Iida, S; Sugimoto, T				Yamamoto, Yuya; Terayama, Ryuji; Kishimoto, Noriko; Maruhama, Kotaro; Mizutani, Masahide; Iida, Seiji; Sugimoto, Tomosada			Activated Microglia Contribute to Convergent Nociceptive Inputs to Spinal Dorsal Horn Neurons and the Development of Neuropathic Pain	NEUROCHEMICAL RESEARCH			English	Article						Microglia; Minocycline; Nerve injury; c-Fos; ERK; Spinal dorsal horn	PERIPHERAL-NERVE INJURY; C-FOS EXPRESSION; PROTEIN-KINASE; SCIATIC-NERVE; TACTILE ALLODYNIA; GRACILE NUCLEUS; SOMATOTOPIC ORGANIZATION; ANION GRADIENT; ADULT-RAT; CORD	The activation of microglia in the spinal dorsal horn following peripheral nerve injury has been reported previously, and this change has been proposed to contribute to the development of a neuropathic pain state. We recently demonstrated that peripheral nerve injury activated convergent nociceptive inputs to spinal dorsal horn neurons. The present study was designed to further examine the role of microglia in the activation of convergent nociceptive inputs as well as development of a neuropathic pain state after peripheral nerve injury. Tibial nerve injury initially induced hyposensitivity at 3 days post-injury, and this was followed by hypersensitivity to tactile and thermal stimuli at 14 days. The intraperitoneal administration of minocycline (30 mg/kg), an inhibitor of microglial activation, for 8 days starting on the day of surgery prevented increases in OX-42 immunofluorescence labeling in the spinal dorsal horn and the development of tactile and thermal hypersensitivity at 14 days post-injury. The same minocycline treatment (day 0-7) also reduced the nerve injury-induced convergence of nociceptive inputs to spinal dorsal horn neurons, as revealed by double immunofluorescence labeling for c-Fos induced by noxious heat stimulation of the hindpaw and phosphorylated extracellular signal-regulated kinase induced by electrical stimulation of the injured tibial nerve. However, the administration of minocycline for 8 days starting 7 days after surgery did not prevent nerve injury-induced microglial activation, convergent nociceptive inputs, or tactile and thermal hypersensitivity. These results suggest that microglial activation in the early stage following peripheral nerve injury plays an important role in the anomalous convergence of nociceptive signals to spinal dorsal horn neurons and the development of neuropathic pain.	[Yamamoto, Yuya; Terayama, Ryuji; Kishimoto, Noriko; Maruhama, Kotaro; Sugimoto, Tomosada] Okayama Univ, Dept Oral Funct & Anat, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008525, Japan; [Yamamoto, Yuya; Kishimoto, Noriko; Mizutani, Masahide; Iida, Seiji] Okayama Univ, Dept Oral & Maxillofacial Reconstruct Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan; [Terayama, Ryuji; Maruhama, Kotaro; Mizutani, Masahide; Iida, Seiji; Sugimoto, Tomosada] Okayama Univ, Sch Dent, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008525, Japan	Terayama, R (reprint author), Okayama Univ, Dept Oral Funct & Anat, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 5-1 Shikata Cho, Okayama 7008525, Japan.	ryujit@md.okayama-u.ac.jp			Japan Society for the Promotion of Science [24592764]	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24592764).	Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; GARRISON CJ, 1991, BRAIN RES, V565, P1, DOI 10.1016/0006-8993(91)91729-K; Tikka T, 2001, J NEUROSCI, V21, P2580; Tikka TM, 2001, J IMMUNOL, V166, P7527; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Piao ZG, 2006, PAIN, V121, P219, DOI 10.1016/j.pain.2005.12.023; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Padi SSV, 2008, EUR J PHARMACOL, V601, P79, DOI 10.1016/j.ejphar.2008.10.018; Owolabi SA, 2006, FEBS LETT, V580, P4306, DOI 10.1016/j.febslet.2006.06.087; Terayama R, 2008, NEUROSCIENCE, V153, P1245, DOI 10.1016/j.neuroscience.2008.03.041; Zhou LJ, 2011, BRAIN BEHAV IMMUN, V25, P322, DOI 10.1016/j.bbi.2010.09.025; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Watkins LR, 2001, PAIN, V93, P201, DOI 10.1016/S0304-3959(01)00359-1; Wen YR, 2007, ANESTHESIOLOGY, V107, P312, DOI 10.1097/01.anes.0000270759.11086.e7; Inoue K, 2006, PHARMACOL THERAPEUT, V109, P210, DOI 10.1016/j.pharmthera.2005.07.001; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Jin SX, 2003, J NEUROSCI, V23, P4017; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; DEVOR M, 1983, PAIN, V16, P73, DOI 10.1016/0304-3959(83)90087-8; Nomura H, 2002, PAIN, V95, P225, DOI 10.1016/S0304-3959(01)00403-1; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; DEVOR M, 1978, NATURE, V276, P75, DOI 10.1038/276075a0; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; Wieseler-Frank J, 2005, NEUROSIGNALS, V14, P166, DOI 10.1159/000087655; Biggs JE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-44; Cho IH, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-13; Eriksson NP, 1997, EXP BRAIN RES, V114, P393, DOI 10.1007/PL00005649; Fujisawa N, 2012, EXP BRAIN RES, V219, P191, DOI 10.1007/s00221-012-3078-8; Hughes AS, 2008, NEUROSCIENCE, V153, P507, DOI 10.1016/j.neuroscience.2008.01.082; Kalla R, 2001, J COMP NEUROL, V436, P182; LISNEY SJW, 1987, BRAIN RES, V415, P122, DOI 10.1016/0006-8993(87)90275-7; LISNEY SJW, 1983, BRAIN RES, V259, P31, DOI 10.1016/0006-8993(83)91064-8; MARKUS H, 1984, BRAIN RES, V296, P27, DOI 10.1016/0006-8993(84)90508-0; Mei XP, 2011, NEUROSCI RES, V70, P305, DOI 10.1016/j.neures.2011.03.012; MOLANDER C, 1992, NEUROSCIENCE, V50, P223, DOI 10.1016/0306-4522(92)90394-H; SELTZER Z, 1979, NEUROLOGY, V29, P1061; Shortland P, 1998, BRAIN RES, V810, P288, DOI 10.1016/S0006-8993(98)00940-8; SUGIMOTO T, 1993, BRAIN RES, V621, P161, DOI 10.1016/0006-8993(93)90314-D; SWETT JE, 1985, J COMP NEUROL, V231, P66, DOI 10.1002/cne.902310106; Terayama R, 2015, NEUROCHEM RES, V40, P438, DOI 10.1007/s11064-014-1484-y; Terayama R, 2011, NEUROSCI RES, V69, P100, DOI 10.1016/j.neures.2010.11.004; Terayama R, 2015, CELL MOL NEUROBIOL, V35, P417, DOI 10.1007/s10571-014-0137-7; Tokunaga A, 1999, BRAIN RES, V847, P321, DOI 10.1016/S0006-8993(99)02074-0	54	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAY	2015	40	5					1000	1012		10.1007/s11064-015-1555-8		13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CH5SH	WOS:000354095100014		
J	Tamai, M; Hashimoto, T; Isobe, T; Sato, H; Doden, T; Nakano, T				Tamai, Michihiro; Hashimoto, Takao; Isobe, Takashi; Sato, Hiromasa; Doden, Tadashi; Nakano, Takeshi			Treatment of myasthenia gravis with dropped head: A report of 2 cases and review of the literature	NEUROMUSCULAR DISORDERS			English	Review						Myasthenia gravis; Dropped head; Steroid; Immunoadsorption plasmapheresis	SIGN	We report two patients with myasthenia gravis (MG) who showed dropped head as an early myasthenic manifestation. They had elevated anti-acetylcholine receptor antibody and showed improvement of the symptoms after intravenous injection of edorophonium chloride. One patient had thymoma and developed myasthenic crisis two weeks after thymectomy. The patient recovered from the crisis after a combination of immunoadsorption plasmapheresis (IAPP) and initiation of steroid and tacrolimus. The other patient without thymoma initiated treatment with steroid, tacrolimus and IAPP and showed complete recovery one month later. Dropped head in MG can recover well with immunosuppression therapy using steroid, and IAPP is helpful in getting a rapid improvement of dropped head as well as recovery from myasthenic crisis. When we consider treatment for MG with dropped head, we should take into account that MG of this type can develop myasthenic crisis and use the same treatment strategy as that for generalized MG. (C) 2015 Elsevier B.V. All rights reserved.	[Tamai, Michihiro; Hashimoto, Takao; Isobe, Takashi; Sato, Hiromasa; Doden, Tadashi] Aizawa Hosp, Dept Neurol, Matsumoto, Nagano 3908510, Japan; [Nakano, Takeshi] Azumino Red Cross Hosp, Dept Neurol, Azumino, Nagano, Japan	Hashimoto, T (reprint author), Aizawa Hosp, Ctr Neurol Dis, 2-5-1 Honjo, Matsumoto, Nagano 3908510, Japan.	sinke-dr@ai-hosp.or.jp					Matsuda M, 2005, INTERNAL MED, V44, P572, DOI 10.2169/internalmedicine.44.572; Casasnovas C, 2007, NEUROMUSCULAR DISORD, V17, P544, DOI 10.1016/j.nmd.2007.03.007; D'Amelio M, 2007, NEUROL SCI, V28, P104, DOI 10.1007/s10072-007-0796-y; Fesano A, 2008, PARKINSONISM RELAT D, V14, P164; GROB D, 1981, ANN NY ACAD SCI, V377, P652, DOI 10.1111/j.1749-6632.1981.tb33764.x; Nagane Y, 2011, EUR NEUROL, V65, P16, DOI 10.1159/000322497; PERLO VP, 1966, NEUROLOGY, V16, P431; Puruckherr M, 2004, NEUROMUSCULAR DISORD, V14, P378, DOI 10.1016/j.nmd.2004.01.009; Sawa N, 2013, BMJ CASE REP, DOI [10.113/bcr-2012007616, DOI 10.1136/BCR-2012007616]; Spengos K, 2008, NEUROMUSCULAR DISORD, V18, P175, DOI 10.1016/j.nmd.2007.09.007; Uludag IF, 2011, NEUROLOGIST, V17, P144, DOI 10.1097/NRL.0b013e3182173356; Yaguchi H, 2007, INTERNAL MED, V46, P743, DOI 10.2169/internalmedicine.46.6167	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	MAY	2015	25	5					429	431		10.1016/j.nmd.2015.01.014		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH6JX	WOS:000354144000014		
J	Meng, PF; Yoshida, H; Tanji, K; Matsumiya, T; Xing, F; Hayakari, R; Wang, L; Tsuruga, K; Tanaka, H; Mimura, J; Kosaka, K; Itoh, K; Takahashi, I; Kawaguchi, S; Imaizumi, T				Meng, Pengfei; Yoshida, Hidemi; Tanji, Kunikazu; Matsumiya, Tomoh; Xing, Fei; Hayakari, Ryo; Wang, Liang; Tsuruga, Kazushi; Tanaka, Hiroshi; Mimura, Junsei; Kosaka, Kunio; Itoh, Ken; Takahashi, Ippei; Kawaguchi, Shogo; Imaizumi, Tadaatsu			Carnosic acid attenuates apoptosis induced by amyloid-beta 1-42 or 1-43 in SH-SY5Y human neuroblastoma cells	NEUROSCIENCE RESEARCH			English	Article						Carnosic acid; A beta 342; A beta 343; Caspases; Alzheimer's disease; SH-SY5Y	STRESS-INDUCED APOPTOSIS; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; NERVOUS-SYSTEM; DEATH; INVOLVEMENT; A-BETA-42; CASPASES; NEURODEGENERATION	Amyloid-beta (A beta) peptides, A beta 1-42 (A beta 42) and A beta 43 in particular, cause neurotoxicity and cell death in the brain of Alzheimer's disease (AD) at higher concentrations. Carnosic acid (CA), a phenolic diterpene compound in the labiate herbs rosemary and sage, serves as an activator for neuroprotective and neurotrophic functions in brain cells. We investigated the effect of CA on apoptosis induced by A beta 42 or A beta 43 in cultured SH-SY5Y human neuroblastoma cells. Treatment of the cells with A beta 42 or A beta 43 (monomer, 10 mu M each) induced apoptosis, which was confirmed by the cleavage of poly-(ADP-ribose) polymerase (PARP) and apoptosis-inducing factor (AIF). Concurrently, the AP treatment induced the activation of caspase (Casp) cascades including an effector Casp (Casp3) and initiator Casps (Casp4, Casp8 and Casp9). Pretreatment of the cells with CA (10 mu M) partially attenuated the apoptosis induced by A beta 42 or A beta 43. CA pretreatment also reduced the cellular oligomers of A beta 42 and A beta 43. These results suggest that CA suppressed the activation of Casp cascades by reducing the intracellular oligomerization of exogenous A beta 42/43 monomer. The ingestion of an adequate amount of CA may have a potential in the prevention of A beta-mediated diseases, particularly AD. (C) 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Meng, Pengfei; Yoshida, Hidemi; Matsumiya, Tomoh; Xing, Fei; Hayakari, Ryo; Wang, Liang; Imaizumi, Tadaatsu] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan; [Tanji, Kunikazu] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neuropathol, Hirosaki, Aomori 0368562, Japan; [Tsuruga, Kazushi; Tanaka, Hiroshi] Hirosaki Univ, Sch Med & Hosp, Dept Pediat, Hirosaki, Aomori 0368563, Japan; [Tanaka, Hiroshi] Hirosaki Univ, Fac Educ, Dept Sch Hlth Sci, Hirosaki, Aomori 0368560, Japan; [Mimura, Junsei; Itoh, Ken] Hirosaki Univ, Grad Sch Med, Dept Stress Response Sci, Hirosaki, Aomori 0368562, Japan; [Kosaka, Kunio] Nagase & Co Ltd, Ctr Res & Dev, Kobe, Hyogo 6512241, Japan; [Takahashi, Ippei] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori 0368562, Japan; [Kawaguchi, Shogo] Hirosaki Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Hirosaki, Aomori 0368562, Japan	Yoshida, H (reprint author), Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Vasc Biol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	hidemi_yoshida@gakushikai.jp			JSPS KAKENHI (from Japan Society of the Promotion of Science) [23592081]; Grant for Hirosaki University Institutional Research (Japan)	The authors would like to thank Drs. Kei Satoh, Koichi Wakabayashi and Shigeyuki Nakaji for their help, as well as Mses. Kumiko Munakata, Michiko Nakata and Ayano Ono for technical assistance. This study was supported in part by JSPS KAKENHI Grant Number 23592081 (from Japan Society of the Promotion of Science to H.Y.) and by a Grant for Hirosaki University Institutional Research (Japan).	Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Park JA, 2008, NEUROREPORT, V19, P1301, DOI 10.1097/WNR.0b013e32830abc1f; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Rohn TT, 2010, APOPTOSIS, V15, P1403, DOI 10.1007/s10495-010-0463-2; Resende R, 2008, NEUROSCIENCE, V155, P725, DOI 10.1016/j.neuroscience.2008.06.036; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Butterfield DA, 2002, FREE RADICAL RES, V36, P1307, DOI 10.1080/1071576021000049890; Kanninen K, 2008, MOL CELL NEUROSCI, V39, P302, DOI 10.1016/j.mcn.2008.07.010; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Dickson DW, 2004, J CLIN INVEST, V114, P23, DOI 10.1172/JC1200422317; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Shiraishi H, 2006, J CELL SCI, V119, P3958, DOI 10.1242/jcs.03160; D'Amelio M, 2012, TRENDS NEUROSCI, V35, P700, DOI 10.1016/j.tins.2012.06.004; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Meng PF, 2013, NEUROSCI RES, V75, P94, DOI 10.1016/j.neures.2012.11.007; Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792; Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schengrund CL, 2010, BRAIN RES BULL, V82, P7, DOI 10.1016/j.brainresbull.2010.02.013; Bhullar KS, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/891748; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Kosaka K, 2010, J BIOCHEM, V147, P73, DOI 10.1093/jb/mvp149; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Favaloro B, 2012, AGING-US, V4, P330; Ito S, 2007, J NEUROCHEM, V103, P2482, DOI 10.1111/j.1471-4159.2007.04938.x; Ivins KJ, 1999, NEUROBIOL DIS, V6, P440, DOI 10.1006/nbdi.1999.0268; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Yoshida H, 2014, NEUROSCI RES, V79, P83, DOI 10.1016/j.neures.2013.11.004; Bao F, 2012, NEUROBIOL AGING, V33, P825; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Dumanchin-Njock C, 2001, J NEUROCHEM, V78, P1153, DOI 10.1046/j.1471-4159.2001.00513.x; Jana K., 2013, J TRANSL MED S, VS2; Kirkitadze MD, 2005, ACTA BIOCHIM POL, V52, P417; Lai A.Y., 2011, INT J ALZHEIMERS DIS; Li Z, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-15; Mimura J, 2011, J BIOCHEM, V150, P209, DOI 10.1093/jb/mvr065; Omtri R.S., 2012, MOL PHARM; Ooi HK, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-65; Ovsepian SV, 2013, NEUROBIOL AGING, V34, P2517, DOI 10.1016/j.neurobiolaging.2013.05.005; Pan WH, 2004, J CELL SCI, V117, P5071, DOI 10.1242/jcs.01381; Sandebring A., 2013, PLOS ONE, V8; Sandebring A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055847; Tamayev R., 2013, MOL NEURODEGENER, V7, P60; Tanji K, 2012, J NEUROSCI RES, V90, P2034, DOI 10.1002/jnr.23081; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Yoshida H, 2011, NEUROSCI RES, V69, P291, DOI 10.1016/j.neures.2010.12.016; Yoshihara T, 2008, J BIOCHEM, V143, P475, DOI 10.1093/jb/mvm239	63	4	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	MAY	2015	94						1	9		10.1016/j.neures.2014.12.003		9	Neurosciences	Neurosciences & Neurology	CH9FM	WOS:000354341400001		
J	Imaizumi, T; Sakashita, N; Mushiga, Y; Yoshida, H; Hayakari, R; Xing, F; Wang, L; Matsumiya, T; Tanji, K; Chiba, Y; Furudate, K; Kawaguchi, S; Murakami, M; Tanaka, H				Imaizumi, Tadaatsu; Sakashita, Nina; Mushiga, Yasuaki; Yoshida, Hidemi; Hayakari, Ryo; Xing, Fei; Wang, Liang; Matsumiya, Tomoh; Tanji, Kunikazu; Chiba, Yuki; Furudate, Ken; Kawaguchi, Shogo; Murakami, Manabu; Tanaka, Hiroshi			Desferrioxamine, an iron chelator, inhibits CXCL10 expression induced by polyinosinic-polycytidylic acid in U373MG human astrocytoma cells	NEUROSCIENCE RESEARCH			English	Article						DFX; FeSO4; TLR3; STAT1; CXCL10; U373MG cells	DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; ALZHEIMERS-DISEASE; INNATE IMMUNITY; ACTIVATION; HELICASES; FAMILY; ISG56; MDA5	Although iron is essential in physiological processes, accumulation of iron in central nervous system is associated with various neurological diseases including Alzheimer's disease and Parkinson's disease. Innate immune reactions are involved in the pathogenesis of those diseases, but roles of iron in innate immunity are not known well. In the present study, pretreatment of U373MG human astrocytoma cells with an iron chelator desferrioxamine (DFX) inhibited the expression of CXCL10 induced by a Toll-like receptor 3 (TLR3) agonist polyinosinic polycytidylic acid (poly IC). Induction of interferon-beta (IFN-beta) was not affected, but phosphorylation of signal transducer and transcription 1 (STAT1) was decreased by DFX. We have previously reported that various IFN-stimulated genes (ISGs) are involved in CXCL10 induction by poly IC. Pretreatment with DFX also decreased the expression of these ISGs. Pretreatment of cells with FeSO4 counteracted inhibitory effects of DFX on ISG56, retinoic acid-inducible gene-I (RIG-I), CXCL10 and phosphorylation of STAT1. These results suggest that iron may positively regulate STAT1 phosphorylation and following signaling to express ISG56, RIG-I and CXCL10 in U373MG cells treated with poly IC. Iron may contribute to innate immune and inflammatory reactions elicited by the TLR3 signaling in astrocytes, and may play an important role in neuroinflammatory diseases. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Imaizumi, Tadaatsu; Sakashita, Nina; Mushiga, Yasuaki; Yoshida, Hidemi; Hayakari, Ryo; Xing, Fei; Wang, Liang; Matsumiya, Tomoh] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan; [Tanji, Kunikazu] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neuropathol, Hirosaki, Aomori 0368562, Japan; [Chiba, Yuki; Tanaka, Hiroshi] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori 0368562, Japan; [Furudate, Ken] Hirosaki Univ, Grad Sch Med, Dept Dent & Oral Surg, Hirosaki, Aomori 0368562, Japan; [Kawaguchi, Shogo] Hirosaki Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Hirosaki, Aomori 0368562, Japan; [Murakami, Manabu] Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Hirosaki, Aomori 0368562, Japan; [Tanaka, Hiroshi] Hirosaki Univ, Fac Educ, Dept Sch Hlth Sci, Hirosaki, Aomori 0368560, Japan	Imaizumi, T (reprint author), Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Vasc Biol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	timaizum@cc.hirosaki-u.ac.jp			Hirosaki University	The work was supported by a Hirosaki University Institutional Research Grant, and a Priority Research Grant for Young Scientists Designated by the President of Hirosaki University. The authors thank Yoshiya Asano, Kumiko Munakata, Michiko Nakata and Ayano Ono for their help.	Schwer B, 2001, NAT STRUCT BIOL, V8, P113, DOI 10.1038/84091; Andersen HH, 2014, CELL MOL LIFE SCI, V71, P1607, DOI 10.1007/s00018-013-1509-8; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Imaizumi T, 2002, BIOCHEM BIOPH RES CO, V292, P274, DOI 10.1006/bbrc.2002.6650; Percy ME, 2011, J INORG BIOCHEM, V105, P1505, DOI 10.1016/j.jinorgbio.2011.08.001; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Imaizumi T, 2013, NEUROSCI RES, V76, P195, DOI 10.1016/j.neures.2013.05.002; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Zhang Z, 2012, MOL MED REP, V5, P562, DOI 10.3892/mmr.2011.671; Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; Yoshida H, 2007, NEUROSCI RES, V58, P199, DOI 10.1016/j.neures.2007.02.017; Yoneyama M, 2005, J IMMUNOL, V175, P2851; Zhang WJ, 2010, EXP BIOL MED, V235, P633, DOI 10.1258/ebm.2009.009229; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Choi EY, 2007, J CELL BIOCHEM, V102, P1442, DOI 10.1002/jcb.21367; Chu PWY, 2010, EUR J PHARMACOL, V633, P24, DOI 10.1016/j.ejphar.2010.02.008; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Gira AK, 2009, J INVEST DERMATOL, V129, P723, DOI 10.1038/jid.2008.269; Imaizumi T, 2014, NEUROSCI RES, V84, P34, DOI 10.1016/j.neures.2014.03.001; Kigerl KA, 2009, CURR TOP MICROBIOL, V336, P121, DOI 10.1007/978-3-642-00549-7_7; Koo S.W., 2003, J INVEST DERMATOL, V120, P871; Mehla R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-239; Rappert A., 2004, J NEUROSCI, V25, P312; Stankiewicz JM, 2014, NEUROBIOL AGING, V35, pS51, DOI 10.1016/j.neurobiolaging.2014.03.039; Tanji K, 2001, BBA-MOL CELL BIOL L, V1530, P227, DOI 10.1016/S1388-1981(01)00089-0; Varesio L, 2010, MOL IMMUNOL, V47, P685, DOI [10.1016/j.molimm.2009.10.031, 10.1016/j.molimin.2009.10.031]; Yoshida H, 2002, BRAIN RES, V944, P65, DOI 10.1016/S0006-8993(02)02708-7; Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613	34	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	MAY	2015	94						10	16		10.1016/j.neures.2015.01.001		7	Neurosciences	Neurosciences & Neurology	CH9FM	WOS:000354341400002		
J	Itoh, M; Hata, K				Itoh, Mariko; Hata, Kohei			Munch's SCREAM: A spontaneous movement by zebrafish larvae featuring strong abduction of both pectoral fins often associated with a sudden bend	NEUROSCIENCE RESEARCH			English	Article						Escape; Swimming; Locomotion; Limb; Struggling; Tactile stimulation	DANIO-RERIO; NEURONS	Stereotyped movement of paired pectoral fins in zebrafish larvae could be considered a simple model with which to investigate the neural basis of behavior. Using a high-speed camera, we explored the repertoire of pectoral fin movements by naturally behaving larvae at 5-6 days post-fertilization. Previously, two types of fin movements were characterized in association with locomotion: 'CRAWLing,' an alternating fin movement associated with slow swimming, and 'TUCKing,' the adduction of both fins associated with fast swimming. We here describe a third mode of fin movement, which we call 'Munch's SCREAM', in which both pectoral fins were flipped anteriorly so that they reached the skin on the sides of the head, thus covering the otic vesicles. This behavior occurred spontaneously and was often associated with a slight regression or a sudden bending and change in body orientation. It could be also induced effectively in the agarose-embedded larvae by tactile stimulation on the skin around the eye and nose, some of which are associated with struggling, in which waves of bending propagate from the tail to the head. Larvae can still CRAWL and perform the SCREAM even when their forebrain and midbrain have been removed, suggesting that the neural circuits involved in the SCREAM are present in the hindbrain and/or spinal cord. (C) 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Itoh, Mariko; Hata, Kohei] Univ Hyogo, Grad Sch Life Sci, Kobe, Hyogo 6781297, Japan	Itoh, M (reprint author), Univ Hyogo, Grad Sch Life Sci, Kamigyo Ku, 3-2-1 Kouto, Kobe, Hyogo 6781297, Japan.	mitoko.no.mori@gmail.com; khatta@sci.u-hyogo.ac.jp			GCOE program of the Graduate School of Life Science, University of Hyogo; Japanese Association of University Women Kobe Chapter	We thank Drs. Yukinori Nishigami and Atsushi Taniguchi, and Mr. Kengo Arima, for their help in data analysis, and Drs. Kenji Watanabe and Masataka Nikaido for their critical comments on the manuscript. This work was partially supported by the GCOE program of the Graduate School of Life Science, University of Hyogo, and by the Japanese Association of University Women Kobe Chapter.	Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Green MH, 2011, J EXP BIOL, V214, P3111, DOI 10.1242/jeb.057497; Azizi E, 2004, ZOOLOGY, V107, P111, DOI 10.1016/j.zool.2004.03.002; Green MH, 2012, J NEUROPHYSIOL, V108, P3393, DOI 10.1152/jn.00623.2012; Hatta K, 1999, P NATL ACAD SCI USA, V96, P12090, DOI 10.1073/pnas.96.21.12090; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; Hatta K, 1998, J COMP NEUROL, V395, P493; Ijspeert J.A., 2007, SCIENCE, V315, P1416; Itoh M, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.065; Kahn A.J., 1982, J EXP BIOL, V99, P197; KIMMEL CB, 1995, DEV DYNAM, V203, P253; Liao C.J., 2008, J NEUROSCI, V28, P12982; McClenahan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032295; Moly PK, 2011, NEUROSCI RES, V70, P251, DOI 10.1016/j.neures.2011.03.003; Okamoto S, 2013, ZOOL SCI, V30, P716, DOI 10.2108/zsj.30.716; Sankrithi S.N., 2010, NEUROSCIENCE, V166, P970; Thorsen DH, 2007, J COMP NEUROL, V504, P168, DOI 10.1002/cne.21425; Thorsen D.H., 2004, J EXP BIOL, V207, P853	18	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	MAY	2015	94						17	27		10.1016/j.neures.2014.12.004		11	Neurosciences	Neurosciences & Neurology	CH9FM	WOS:000354341400003		
J	Lin, ST; Onimaru, H				Lin, Shih Tien; Onimaru, Hiroshi			Effects of riluzole on respiratory rhythm generation in the brainstem-spinal cord preparation from newborn rat	NEUROSCIENCE RESEARCH			English	Article						Riluzole; Respiratory rhythm; In vitro; Persistent sodium channels; Burst generation	PERSISTENT SODIUM CURRENT; AMYOTROPHIC-LATERAL-SCLEROSIS; MAMMALIAN CNS NEURONS; IN-VITRO; NEONATAL-RAT; PACEMAKER NEURONS; HYPOGLOSSAL MOTONEURONS; PREINSPIRATORY NEURONS; PREBOTZINGER COMPLEX; NA+ CURRENT	The persistent sodium channel is an important pacemaker component in rhythm generation. In the present study, we examined the effects of a persistent sodium channel blocker, riluzole on pre-inspiratory (Pre-I) and inspiratory neurons in the rostral medulla as well as on 4th cervical ventral root (C4)inspiratory activity in brainstem-spinal cord preparations. Preparations were isolated from postnatal day 0-3 Wistar rats and were superfused with artificial cerebrospinal fluid, equilibrated with 95% O-2 and 5% CO2, pH 7.4, at 25-26 degrees C. The C4 inspiratory burst rate decreased in a dose-dependent manner (50-200 mu M) after 15 min application of riluzole. Riluzole caused a strong reduction in the drive potential of Pre-I neurons but not of inspiratory neurons. After washout, C4 inspiratory burst gradually changed into an episodic pattern, in which one burst consisted of 3-9 short separate bursts. Riluzole also depressed the induction of repetitive firing induced by depolarizing stimulation. Under voltage clamp conditions, riluzole suppressed the negative-slope component of Pre-I neurons. Riluzole also depressed the intrinsic burst generation of Pre-I neurons in low calcium and high magnesium solution. Our findings indicate that the burst generation of Pre-I neurons is more sensitive than inspiratory burst generation to riluzole and thus suggested that persistent sodium channels have an important role in the burst generation of Pre-I neurons and are involved in the primary respiratory rhythm generation. (C) 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Lin, Shih Tien] Showa Univ, Dept Pharmacotherapeut, Div Clin Pharm, Shinagawa Ku, Tokyo 1428555, Japan; [Onimaru, Hiroshi] Showa Univ, Sch Med, Dept Physiol, Shinagawa Ku, Tokyo 1428555, Japan	Onimaru, H (reprint author), Showa Univ, Sch Med, Dept Physiol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	mikiii0322@pharm.showa-u.ac.jp; oni@med.showa-u.ac.jp			KAKENHI [22500296, 25430012]	This study was supported by Grants-in Aid for Scientific Research (KAKENHI: 22500296, 25430012).	Bellingham MC, 2011, CNS NEUROSCI THER, V17, P4, DOI 10.1111/j.1755-5949.2009.00116.x; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Onimaru H, 2003, J NEUROSCI, V23, P1478; Moraes DJA, 2013, J NEUROSCI, V33, P19223, DOI 10.1523/JNEUROSCI.3041-13.2013; Del Negro CA, 2002, J NEUROPHYSIOL, V88, P2242, DOI 10.1152/jn.00081.2002; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; Li J, 2011, J NEUROSCI, V31, P9010, DOI 10.1523/JNEUROSCI.6555-10.2011; Gordon PH, 2013, AGING DIS, V4, P295, DOI 10.14336/AD.2013.0400295; Kuo JJ, 2006, J PHYSIOL-LONDON, V574, P819, DOI 10.1113/jphysiol.2006.107094; Lamanauskas N, 2008, EUR J NEUROSCI, V27, P2501, DOI 10.1111/j.1460-9568.2008.06211.x; Brocard F, 2006, J NEUROPHYSIOL, V96, P2410, DOI 10.1152/jn.00352.2006; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; Paton JFR, 2006, NAT NEUROSCI, V9, P311, DOI 10.1038/nn1650; Pena F, 2004, NEURON, V43, P105, DOI 10.1016/j.neuron.2004.06.023; van Drongelen W, 2006, J NEUROPHYSIOL, V96, P2564, DOI 10.1152/jn.00446.2006; Ballanyi K, 1999, PROG NEUROBIOL, V59, P583, DOI 10.1016/S0301-0082(99)00009-X; Ballanyi K, 2009, PFLUG ARCH EUR J PHY, V458, P571, DOI 10.1007/s00424-009-0645-3; Beltran-Parrazal L, 2003, BRIT J PHARMACOL, V140, P881, DOI 10.1038/sj.bjp.0705491; CHAO TI, 1995, NEUROREPORT, V6, P1778, DOI 10.1097/00001756-199509000-00017; Darbon P, 2004, EUR J NEUROSCI, V20, P976, DOI 10.1111/j.1460-9568.2004.03565.x; Fong AY, 2009, RESP PHYSIOL NEUROBI, V166, P175, DOI 10.1016/j.resp.2009.03.004; Gajda BM, 2010, AM J PHYSIOL-REG I, V298, pR887, DOI 10.1152/ajpregu.00339.2009; St John Jeremy, 2008, Monash Bioeth Rev, V27, P12; Kawai A, 2006, J PHYSIOL-LONDON, V572, P525, DOI 10.1113/jphysiol.2005.102533; Koizumi H, 2008, J NEUROSCI, V28, P1773, DOI 10.1523/JNEUROSCI.3916-07.2008; Koizumi H, 2013, J NEUROSCI, V33, P2994, DOI 10.1523/JNEUROSCI.4427-12.2013; Lacomblez L, 2002, AMYOTROPH LATERAL SC, V3, P23, DOI 10.1080/146608202317576507; Lal A, 2011, J COMPUT NEUROSCI, V30, P225, DOI 10.1007/s10827-010-0249-0; Lampl I, 1998, J PHARMACOL EXP THER, V284, P228; Onimaru H, 2007, J PHYSIOL-LONDON, V584, P271, DOI 10.1113/jphysiol.2007.136572; ONIMARU H, 1988, BRAIN RES, V445, P314, DOI 10.1016/0006-8993(88)91194-8; Onimaru H, 1996, NEUROSCI RES, V25, P183; ONIMARU H, 1995, EXP BRAIN RES, V106, P57; Onimaru H, 2003, J PHYSIOL-LONDON, V552, P727, DOI 10.1113/jphysiol.2003.049312; ONIMARU H, 1992, PFLUG ARCH EUR J PHY, V420, P399, DOI 10.1007/BF00374476; ONIMARU H, 1989, EXP BRAIN RES, V76, P530, DOI 10.1007/BF00248909; Onimaru H, 2006, J NEUROPHYSIOL, V96, P55, DOI 10.1152/jn.01175.2005; Osaka Y, 2014, ANAESTHESIA, V69, P468, DOI 10.1111/anae.12590; Pace RW, 2007, J PHYSIOL-LONDON, V580, P485, DOI 10.1113/jphysiol.2006.124602; Pena F, 2007, NEUROSCI LETT, V415, P288, DOI 10.1016/j.neulet.2007.01.032; Ptak K, 2005, J NEUROSCI, V25, P5159, DOI 10.1523/JNEUROSCI.4238-04.2005; Radulovacki M, 2001, J PHARM PHARMACOL, V53, P1555, DOI 10.1211/0022357011777936; Ramirez JM, 2011, J BIOL PHYS, V37, P241, DOI 10.1007/s10867-011-9214-z; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; Rybak IA, 2007, PROG BRAIN RES, V165, P201, DOI 10.1016/S0079-6123(06)65013-9; St John WA, 2007, RESP PHYSIOL NEUROBI, V155, P97, DOI 10.1016/j.resp.2006.04.018; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173; Taccola G, 2007, NEUROSCIENCE, V146, P1906, DOI 10.1016/j.neuroscience.2007.03.033; Theiss RD, 2007, J PHYSIOL-LONDON, V580, P507, DOI 10.1113/jphysiol.2006.124123; Wu SN, 1999, J INVEST MED, V47, P484; Yvon C, 2007, J NEUROPHYSIOL, V97, P3607, DOI 10.1152/jn.00924.2006; Zeng JS, 2005, J NEUROPHYSIOL, V93, P1035, DOI 10.1152/jn.00831.2004	55	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	MAY	2015	94						28	36		10.1016/j.neures.2014.12.001		9	Neurosciences	Neurosciences & Neurology	CH9FM	WOS:000354341400004		
J	Miyamoto, Y; Fukuda, T				Miyamoto, Yuta; Fukuda, Takaichi			Immunohistochemical study on the neuronal diversity and three-dimensional organization of the mouse entopeduncular nucleus	NEUROSCIENCE RESEARCH			English	Article						Basal ganglia; Substance P; Parvalbumin; Somatostatin; Glutamic acid decarboxylase; Immunohistochemistry	GLUTAMIC-ACID DECARBOXYLASE; LATERAL HABENULA; GABAERGIC NEURONS; BASAL GANGLIA; SUBSTANCE-P; COMPARATIVE LOCALIZATION; QUANTITATIVE-ANALYSIS; CALBINDIN D-28K; MESSENGER-RNAS; 2 FORMS	The entopeduncular nucleus (EPN) is one of the major output nuclei of the basal ganglia in rodents. Previous studies have divided it into rostral and caudal halves, with the former containing somatostatin (SUM)-immunoreactive neurons and the latter dominated by parvalbumin (PV)-containing neurons, respectively. However, it is unclear whether this simple rostrocaudal segmentation is appropriate, and the possibility of the existence of other neuronal populations remains to be investigated. In this study the cytoarchitecture of the mouse EPN was analyzed immunohistochemically. Substance P (SP)immunoreactivity determined the extent of the EPN, which was 800 pm-long along the rostrocaudal axis. PV-positive neurons were concentrated in the caudal two-thirds of this range. PV-negative neurons were abundant in the rostral half but were further located caudally around the PV neuron-rich core. PV(+)/SOM(-) and PV(-)/SOM(+) neurons constituted 28.6% and 45.7% of EPN neurons, respectively, whereas the remaining population (25.7%) exhibited neither immunoreactivity. Eleven percent of EPN neurons lacked immunoreactivity for glutamic acid decarboxylase, indicating their non-GABAergic nature. Three-dimensional reconstruction revealed that PV-rich/SP-poor core was surrounded by PV-poor/SP-rich shell region. Therefore, presumptive thalamus-targeting PV neurons are outnumbered by other populations, and the regional heterogeneity shown here might be related to functionally distinct pathways through the basal ganglia. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Miyamoto, Yuta; Fukuda, Takaichi] Kumamoto Univ, Grad Sch Med Sci, Dept Anat & Neurobiol, Kumamoto 8608556, Japan	Fukuda, T (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Anat & Neurobiol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	tfukuda@kumamoto-u.ac.jp			JSPS KAKENHI [24300127, 24390345]	This work was supported by JSPS KAKENHI Grant Numbers 24300127, 24390345. We thank Naoki Shigematsu for his helpful discussion.	Shigematsu N, 2008, BRAIN RES, V1198, P55, DOI 10.1016/j.brainres.2007.12.064; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; KOSAKA T, 1985, J COMP NEUROL, V239, P420, DOI 10.1002/cne.902390408; Fukuda T, 1998, J COMP NEUROL, V395, P177, DOI 10.1002/(SICI)1096-9861(19980601)395:2<177::AID-CNE3>3.0.CO;2-#; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229; VANDERKOOY D, 1981, BRAIN RES, V211, P15, DOI 10.1016/0006-8993(81)90064-0; RAJAKUMAR N, 1994, J COMP NEUROL, V350, P324, DOI 10.1002/cne.903500214; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Fukuda T, 2000, J NEUROSCI, V20, P1519; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Shabel SJ, 2014, SCIENCE, V345, P1494, DOI 10.1126/science.1250469; Fukuda T, 1996, NEUROSCI RES, V26, P181, DOI 10.1016/S0168-0102(96)01102-9; Crittenden Jill R, 2011, Front Neuroanat, V5, P59, DOI 10.3389/fnana.2011.00059; Fukuda T, 1997, BRAIN RES, V764, P237, DOI 10.1016/S0006-8993(97)00683-5; Hontanilla B, 1998, BRAIN RES BULL, V47, P107, DOI 10.1016/S0361-9230(98)00035-5; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834; Antal M, 2014, J NEUROSCI, V34, P8032, DOI 10.1523/JNEUROSCI.0236-14.2014; VINCENT SR, 1986, NEUROSCI LETT, V68, P160, DOI 10.1016/0304-3940(86)90134-5; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; ESCLAPEZ M, 1993, J COMP NEUROL, V331, P339, DOI 10.1002/cne.903310305; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; CUELLO AC, 1978, J COMP NEUROL, V178, P129, DOI 10.1002/cne.901780108; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Pennartz CMA, 2009, J NEUROSCI, V29, P12831, DOI 10.1523/JNEUROSCI.3177-09.2009; Franklin K.B.J., 2008, MOUSE BRAIN ATLAS ST; GERFEN CR, 1988, BRAIN RES, V460, P161, DOI 10.1016/0006-8993(88)91217-6; GRAYBIEL AM, 1981, NEUROSCIENCE, V6, P377, DOI 10.1016/0306-4522(81)90131-7; Hong S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00778; Hontanilla B, 1997, SYNAPSE, V25, P359, DOI 10.1002/(SICI)1098-2396(199704)25:4<359::AID-SYN7>3.0.CO;2-9; JESSELL TM, 1978, BRAIN RES, V152, P487, DOI 10.1016/0006-8993(78)91104-6; MARTIN LJ, 1991, NEUROSCIENCE, V43, P397, DOI 10.1016/0306-4522(91)90303-6; MUGNAINI E, 1983, J HISTOCHEM CYTOCHEM, V31, P1435; Prensa L, 1999, J COMP NEUROL, V413, P603; RAJAKUMAR N, 1993, J COMP NEUROL, V331, P286, DOI 10.1002/cne.903310210; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127; Tajima K, 2013, NEUROSCIENCE, V241, P215, DOI 10.1016/j.neuroscience.2013.03.012	38	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	MAY	2015	94						37	49		10.1016/j.neures.2015.02.006		13	Neurosciences	Neurosciences & Neurology	CH9FM	WOS:000354341400005		
J	Kasuga, S; Kurata, M; Liu, MG; Ushiba, J				Kasuga, Shoko; Kurata, Makiko; Liu, Meigen; Ushiba, Junichi			Alteration of a motor learning rule under mirror-reversal transformation does not depend on the amplitude of visual error	NEUROSCIENCE RESEARCH			English	Article						Visuomotor learning; Arm-reaching; Mirror-reversal transformation; Visual gain; Error sensitivity; Error history	INTERNAL-MODELS; VISUOMOTOR TRANSFORMATION; ADAPTATION; SENSITIVITY; VISION; NOISE	Human's sophisticated motor learning system paradoxically interferes with motor performance when visual information is mirror-reversed (MR), because normal movement error correction further aggravates the error. This error-increasing mechanism makes performing even a simple reaching task difficult, but is overcome by alterations in the error correction rule during the trials. To isolate factors that trigger learners to change the error correction rule, we manipulated the gain of visual angular errors when participants made arm-reaching movements with mirror-reversed visual feedback, and compared the rule alteration timing between groups with normal or reduced gain. Trial-by-trial changes in the visual angular error was tracked to explain the timing of the change in the error correction rule. Under both gain conditions, visual angular errors increased under the MR transformation, and suddenly decreased after 3-5 trials with increase. The increase became degressive at different amplitude between the two groups, nearly proportional to the visual gain. The findings suggest that the alteration of the error-correction rule is not dependent on the amplitude of visual angular errors, and possibly determined by the number of trials over which the errors increased or statistical property of the environment. The current results encourage future intensive studies focusing on the exact rule-change mechanism. (C) 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Kasuga, Shoko; Kurata, Makiko; Ushiba, Junichi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Liu, Meigen; Ushiba, Junichi] Keio Univ, Sch Med, Dept Rehabil Med, Shinjuku Ku, Tokyo 1608582, Japan	Ushiba, J (reprint author), Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	kasuga@brain.bio.keio.ac.jp; kurata@brain.bio.keio.ac.jp; meigenliukeio@mac.com; ushiba@brain.bio.keio.ac.jp			MEXT [25750267]	The authors thank Daichi Nozaki for helpful discussions. The authors thank all members of the Ushiba laboratory, especially Sayoko Ishii and Sawako Ohtaki for their assistance during the experiments. This study resulted from "Brain-Machine Interface Development" under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of japan. This work was also supported by Grant-in-Aid for Young Scientists (B) (#25750267), MEXT to SK.	Abdelghani MN, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-150; Abdelghani MN, 2008, NEURAL COMPUT, V20, P2085, DOI 10.1162/neco.2008.04-07-507; Hatada Y, 2006, EXP BRAIN RES, V169, P417, DOI 10.1007/s00221-005-0159-y; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616; HARRIS CS, 1965, PSYCHOL REV, V72, P419, DOI 10.1037/h0022616; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Lillicrap TP, 2013, EXP BRAIN RES, V228, P327, DOI 10.1007/s00221-013-3565-6; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Krakauer JW, 2000, J NEUROSCI, V20, P8916; Gritsenko V, 2010, J NEUROPHYSIOL, V104, P3084, DOI 10.1152/jn.00909.2009; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026; Sekiyama K, 2000, NATURE, V407, P374, DOI 10.1038/35030096; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Marko MK, 2012, J NEUROPHYSIOL, V108, P1752, DOI 10.1152/jn.00177.2012; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Day BL, 2000, EXP BRAIN RES, V130, P159, DOI 10.1007/s002219900218; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Kasuga S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072741; Kasuga S, 2011, J NEUROPHYSIOL, V106, P1218, DOI 10.1152/jn.00278.2011; Kohler I., 1964, PSYCHOL ISSUES, V3, P1; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; Thoroughman KA, 2000, NATURE, V407, P742	28	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	MAY	2015	94						62	69		10.1016/j.neures.2014.12.010		8	Neurosciences	Neurosciences & Neurology	CH9FM	WOS:000354341400007		
J	Johzaki, T; Taguchi, T; Sentoku, Y; Sunahara, A; Nagatomo, H; Sakagami, H; Mima, K; Fujioka, S; Shiraga, H				Johzaki, T.; Taguchi, T.; Sentoku, Y.; Sunahara, A.; Nagatomo, H.; Sakagami, H.; Mima, K.; Fujioka, S.; Shiraga, H.			Control of an electron beam using strong magnetic field for efficient core heating in fast ignition	NUCLEAR FUSION			English	Article						fast ignition; electron beam guiding; magnetic field; PIC simulation	TRANSPORT; LASER; TARGET	To enhance the core heating efficiency in electron-driven fast ignition, we propose fast-electron beam guiding using externally applied longitudinal magnetic fields. Based on particle-in-cell simulations for FIREX-class experiments, we demonstrate sufficient beam guiding performance in collisional dense plasma by kilotesla-class external magnetic fields for the case with moderate mirror ratio (<= 10). Boring of the mirror field was found through the formation of magnetic pipe structure due to the resistive effects, which indicates a possibility of beam guiding in high mirror field for higher laser intensity and/or longer pulse duration.	[Johzaki, T.] Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398527, Japan; [Taguchi, T.] Setsunan Univ, Dept Elect & Elect Engn, Neyagawa, Osaka 5728508, Japan; [Sentoku, Y.] Univ Nevada, Dept Phys, Reno, NV 89557 USA; [Sunahara, A.] Inst Laser Technol, Suita, Osaka 5650871, Japan; [Nagatomo, H.; Fujioka, S.; Shiraga, H.] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Sakagami, H.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Mima, K.] Grad Sch Creat New Photon Ind, Nishi Ku, Hamamatsu, Shizuoka 4312102, Japan	Johzaki, T (reprint author), Hiroshima Univ, Grad Sch Engn, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	tjohzaki@hiroshima-u.ac.jp	Shiraga, Hiroyuki/I-9565-2015; Fujioka, Shinsuke/J-5530-2015; 	Fujioka, Shinsuke/0000-0001-8406-1772; SUNAHARA, ATSUSHI/0000-0001-7543-5226	NIFS Collaboration Research program [NIFS12KUGK057, NIFS14KNSS054]; JSPS KAKENHI [25400534]	This work is partially conducted under the joint research projects of the Institute of Laser Engineering, Osaka University (FIREX project), and with the support of the NIFS Collaboration Research program (NIFS12KUGK057 and NIFS14KNSS054) and JSPS KAKENHI grant number 25400534.	Strozzi DJ, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4739294; Robinson APL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.025002; Sentoku Y, 2008, J COMPUT PHYS, V227, P6846, DOI 10.1016/j.jcp.2008.03.043; Cai HB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.245001; Robinson APL, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/5/054003; Gremillet L, 2002, PHYS PLASMAS, V9, P941, DOI 10.1063/1.1432994; Solodov AA, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3000674; GLINSKY ME, 1995, PHYS PLASMAS, V2, P2796, DOI 10.1063/1.871472; Robinson APL, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2768317; Bell AR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.035003; Nakamura T, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2789561; Robinson APL, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4812193; Arikawa T., 2013, P IFSA NAR JAP 2013; Azechi H, 2006, PLASMA PHYS CONTR F, V48, pB267, DOI 10.1088/0741-3335/48/12B/S26; Davies JR, 1997, PHYS REV E, V56, P7193, DOI 10.1103/PhysRevE.56.7193; Fujioka S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01170; Fujioka S., 2014, J PLASMA FUSION RES, V90, P679; Johzaki T., 2013, P IFSA NAR JAP 2013; Johzaki T, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3157249; Johzaki T, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073022; Johzaki T., 2013, J PLASMA FUSION RES, V89, P456; Johzaki T, 2013, EPJ WEB CONF, V59, DOI 10.1051/epjconf/20135903010; Johzaki T., 2008, J PHYS C SER, V112; Nagatomo H., 2015, NUCL FUSION UNPUB; ROBINSON APL, 2012, PHYS REV SPEC TOP-AC, V15; Strozzi D. J., 2010, B AM PHYS SOC, V55, P68	26	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	MAY	2015	55	5							053022	10.1088/0029-5515/55/5/053022		7	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CG8HA	WOS:000353546700023		
J	Kurskiev, GS; Sdvizhenskii, PA; Bassan, M; Andrew, P; Bazhenov, AN; Bukreev, IM; Chernakov, PV; Kochergin, MM; Kukushkin, AB; Kukushkin, AS; Mukhin, EE; Razdobarin, AG; Samsonov, DS; Semenov, VV; Tolstyakov, SY; Kajita, S; Masyukevich, SV				Kurskiev, G. S.; Sdvizhenskii, P. A.; Bassan, M.; Andrew, P.; Bazhenov, A. N.; Bukreev, I. M.; Chernakov, P. V.; Kochergin, M. M.; Kukushkin, A. B.; Kukushkin, A. S.; Mukhin, E. E.; Razdobarin, A. G.; Samsonov, D. S.; Semenov, V. V.; Tolstyakov, S. Yu.; Kajita, S.; Masyukevich, S. V.			A study of core Thomson scattering measurements in ITER using a multi-laser approach	NUCLEAR FUSION			English	Article						ITER; Thomson scattering; laser diagnostic		The electron component is the main channel for anomalous power loss and the main indicator of transient processes in the tokamak plasma. The electron temperature and density profiles mainly determine the operational mode of the machine. This imposes demanding requirements on the precision and on the spatial and temporal resolution of the Thomson scattering (TS) measurements. Measurements of such high electron temperature with good accuracy in a large fusion device such as ITER using TS encounter a number of physical problems. The 40 keV TS spectrum has a significant blue shift. Due to the transmission functions of the fibres and to their darkening that can occur under a strong neutron irradiation, the operational wavelength range is bounded on the blue side. For example, high temperature measurements become impossible with the 1064 nm probing wavelength since the TS signal within the boundaries of the operational window weakly depends on T-e. The second problem is connected with the TS calibration. The TS system for a large fusion machine like ITER will have a set of optical components inaccessible for maintenance, and their spectral characteristics may change with time. Since the present concept of the TS system for ITER relies on the classical approach to measuring the shape of the scattered spectra using wide spectral channels, the diagnostic will be very sensitive to the changes in the optical transmission. The third complication is connected with the deviation of the electron velocity distribution function from a Maxwellian that can happen under a strong ECRH/ECCD, and it may additionally hamper the measurements. This paper analyses the advantages of a 'multi-laser approach' implementation for the current design of the core TS system. Such an approach assumes simultaneous plasma probing with different wavelengths that allows the measurement accuracy to be improved significantly and to perform the spectral calibration of the TS system. Comparative analysis of the conservative and advanced approaches is given.	[Kurskiev, G. S.; Bazhenov, A. N.; Bukreev, I. M.; Chernakov, P. V.; Kochergin, M. M.; Mukhin, E. E.; Razdobarin, A. G.; Samsonov, D. S.; Semenov, V. V.; Tolstyakov, S. Yu.; Masyukevich, S. V.] Ioffe Phys Tech Inst, St Petersburg 194021, Russia; [Sdvizhenskii, P. A.; Kukushkin, A. B.; Kukushkin, A. S.] NRC Kurchatov Inst, Moscow 123182, Russia; [Bassan, M.; Andrew, P.; Kukushkin, A. S.] ITER Org, F-13067 St Paul Les Durance, France; [Chernakov, P. V.] ZAO Spectral Tech, St Petersburg 194021, Russia; [Kukushkin, A. B.; Kukushkin, A. S.] Natl Res Nucl Univ MEPhI, Moscow 115409, Russia; [Kajita, S.] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan	Kurskiev, GS (reprint author), Ioffe Phys Tech Inst, St Petersburg 194021, Russia.	gleb.kurskiev@gmail.com	Kajita, Shin/Q-1020-2015		Federal Agency for Scientific Organizations	The views and opinions expressed here do not necessarily reflect those of the ITER Organization. Many thanks to Dr A.F. Kornev for a fruitful discussion of modern laser technology. This work was supported by Federal Agency for Scientific Organizations.	FAN TY, 1987, IEEE J QUANTUM ELECT, V23, P605; Zhuang G, 2005, PLASMA PHYS CONTR F, V47, P1539, DOI 10.1088/0741-3335/47/9/011; Bevington P. R., 1969, DATA REDUCTION ERROR; Cooke DW, 1996, J NUCL MATER, V232, P214, DOI 10.1016/S0022-3115(96)00405-9; Harvey R. W., 1992, P IAEA TECHN COMM M, P498; Koechner W., 1999, SOLID STATE LASER EN; Kukushkin A. B., 1981, SOV J PLASMA PHYS, V7, P63; Kukushkin A. B., 1981, SOV J PLASMA PHYS, V7, P669; Kurskiev G. S., 2014, P 41 EPS C PLASM PHY, P5009; Mukhin EE, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/4/043007; Pacher HD, 2015, J NUCL MATER, V463, P591, DOI 10.1016/j.jnucmat.2014.11.104; Sdvizhenskii P. A., 2014, SERIES THERMONUCLEAR, V37, P38; Smith O. R. P., 1997, REV SCI INSTRUM, V7, P68725; Tojo H, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3685612; Turner A, 2014, FUSION ENG DES, V89, P1949, DOI 10.1016/j.fusengdes.2014.01.066	15	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	MAY	2015	55	5							053024	10.1088/0029-5515/55/5/053024		11	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CG8HA	WOS:000353546700025		
J	Nishiura, M; Yoshida, Z; Saitoh, H; Yano, Y; Kawazura, Y; Nogami, T; Yamasaki, M; Mushiake, T; Kashyap, A				Nishiura, M.; Yoshida, Z.; Saitoh, H.; Yano, Y.; Kawazura, Y.; Nogami, T.; Yamasaki, M.; Mushiake, T.; Kashyap, A.			Improved beta (local beta > 1) and density in electron cyclotron resonance heating on the RT-1 magnetosphere plasma	NUCLEAR FUSION			English	Article						high beta; magnetosphere plasmas; inward diffusion; dipole field; metric distortion		This study reports the recent progress in improved plasma parameters of the RT-1 device. Increased input power and the optimized polarization of electron cyclotron resonance heating (ECRH) with an 8.2 GHz klystron produce a significant increase in electron beta, which is evaluated by an equilibrium analysis of the Grad-Shafranov equation. The peak value of the local electron beta beta(e) is found to exceed 1. In the high-beta and high-density regime, the density limit is observed for H, D and He plasmas. The line-averaged density is close to the cutoff density for 8.2 GHz ECRH. When the filling gas pressure is increased, the density limit still exists even in the low-beta region. This result indicates that the density limit is caused by the cutoff density rather than the beta limit. From the analysis of interferometer data, we found that inward diffusion causes a peaked density profile beyond the cutoff density.	[Nishiura, M.; Yoshida, Z.; Saitoh, H.; Yano, Y.; Kawazura, Y.; Nogami, T.; Yamasaki, M.; Mushiake, T.; Kashyap, A.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan	Nishiura, M (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan.	nishiura@ppl.k.u-tokyo.ac.jp			JSPS KAKENHI Grant [23224014, 24360384]	Authors would like to thank Dr Furukawa of Tottori University for discussion. This work was supported by JSPS KAKENHI Grant Nos 23224014 and 24360384.	Yoshida Z, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3505821; Yoshida Z, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.235004; Saitoh H, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063034; HASEGAWA A, 1990, NUCL FUSION, V30, P2405, DOI 10.1088/0029-5515/30/11/018; Boxer AC, 2010, NAT PHYS, V6, P207, DOI 10.1038/NPHYS1510; ENGLAND AC, 1989, NUCL FUSION, V29, P1527, DOI 10.1088/0029-5515/29/9/011; Furukawa M, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4862037; Garnier DT, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/5/055023; RICE JE, 1988, PHYS REV A, V38, P1461, DOI 10.1103/PhysRevA.38.1461; Saitoh H, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4893137; Schulz M., 1974, PARTICLE DIFFUSION R; Yoshida Z, 2014, PROG THEOR EXP PHYS, DOI 10.1093/ptep/ptu104	12	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	MAY	2015	55	5							UNSP 053019	10.1088/0029-5515/55/5/053019		5	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CG8HA	WOS:000353546700020		
J	Shoji, M; Kasahara, H; Tokitani, M; Seki, T; Saito, K; Kamio, S; Seki, R; Tanaka, Y; Pigarov, A; Smirnov, R; Kawamura, G; Tanaka, H; Masuzaki, S; Uesugi, Y; Mutoh, T				Shoji, M.; Kasahara, H.; Tokitani, M.; Seki, T.; Saito, K.; Kamio, S.; Seki, R.; Tanaka, Y.; Pigarov, A.; Smirnov, R.; Kawamura, G.; Tanaka, H.; Masuzaki, S.; Uesugi, Y.; Mutoh, T.		LHD Expt Grp	Studies of dust transport in long pulse plasma discharges in the large helical device	NUCLEAR FUSION			English	Article						LHD; dust; long pulse discharge; DUSTT; EMC3-EIRENE; fast framing camera; stereoscopic observation	LHD; PARTICLES; PHYSICS	Three-dimensional trajectories of incandescent dust particles in plasmas were observed with stereoscopic fast framing cameras in a large helical device. It proved that the dust is located in the peripheral plasma and most of the dust moves along the magnetic field lines with acceleration in the direction that corresponds to the plasma flow. ICRF heated long pulse plasma discharges were terminated with the release of large amounts of dust from a closed divertor region. After the experimental campaign, the traces of exfoliation of carbon rich mixed-material deposition layers were found in the divertor region. Transport of carbon dust is investigated using a modified dust transport simulation code, which can explain the observed dust trajectories. It also shows that controlling the radius of the dust particles to less than 1mm is necessary to prevent the plasma termination by penetration of dust for the long pulse discharges. Dust transport simulation including heavy metal dust particles demonstrates that high heating power operation is effective for shielding the main plasma from dust penetration by an enhanced plasma flow effect and a high heat load onto the dust particles in the peripheral plasma. It shows a more powerful penetration characteristic of tungsten dust particles compared to that of carbon and iron dust particles.	[Shoji, M.; Kasahara, H.; Tokitani, M.; Seki, T.; Saito, K.; Kamio, S.; Seki, R.; Kawamura, G.; Tanaka, H.; Masuzaki, S.; Mutoh, T.; LHD Expt Grp] Natl Inst Fus Sci, Dept Helical Plasma Res, Toki, Gifu 5095292, Japan; [Tanaka, Y.; Uesugi, Y.] Kanazawa Univ, Div Elect Engn & Comp Sci, Kanazawa, Ishikawa 9201192, Japan; [Pigarov, A.; Smirnov, R.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA	Shoji, M (reprint author), Natl Inst Fus Sci, Dept Helical Plasma Res, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	shohji.mamoru@nifs.ac.jp	Smirnov, Roman/B-9916-2011; Tanaka, Yasunori/E-6609-2015; Uesugi, Yoshihiko/C-3311-2015	Smirnov, Roman/0000-0002-9114-5330; Tanaka, Yasunori/0000-0002-0796-2507; Uesugi, Yoshihiko/0000-0001-6039-6842	NIFSULPP015; NIFS Collaboration Research program [NIFS12KNXN236]	This work is financially supported by NIFSULPP015 and is performed with the support and under the auspices of the NIFS Collaboration Research program (NIFS12KNXN236). It is performed by NIFS/NINS under the project of the Formation of an International Scientific Base and Network with an international collaboration research framework between NIFS and CIEMAT in Spain.	Pigarov AY, 2007, J NUCL MATER, V363, P216, DOI 10.1016/j.jnucmat.2007.01.053; Kobayashi M, 2010, FUSION SCI TECHNOL, V58, P220; Feng Y, 2002, PLASMA PHYS CONTR F, V44, P611, DOI 10.1088/0741-3335/44/5/308; Saito K, 2007, J NUCL MATER, V363, P1323, DOI 10.1016/j.jnucmat.2007.01.269; Pigarov AY, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2145157; Smirnov RD, 2007, PLASMA PHYS CONTR F, V49, P347, DOI 10.1088/0741-3335/49/4/001; Krasheninnikov SI, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124054; Reiter D, 2005, FUSION SCI TECHNOL, V47, P172; Federici G., 2001, NUCL FUSION, V41, p12R; Hong SH, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/3/035002; Kasahara H., 2014, 25 IAEA INT C FUS EN; Kawamura G, 2014, CONTRIB PLASM PHYS, V54, P437, DOI 10.1002/ctpp.201410027; Koga K., 2009, PLASMA FUSION RES, V4, P34; Komori A, 2010, FUSION SCI TECHNOL, V58, P1; Morisaki T., 2012, P 24 INT C FUS EN SA; Mutoh T., 2003, J NUCL MATER, V313-316, P1131; Rosanvallon S, 2009, J NUCL MATER, V390-91, P57, DOI 10.1016/j.jnucmat.2009.01.048; Seki T., 2014, 25 IAEA INT C FUS EN; Shoji M., 2014, 21 INT C PLASM SURF; Shoji M., 2014, PLASMA FUSION RES, V9; Shoji M., 2014, 24 INT TOK C TOK GIF, P4; Sudo S, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/9/095014; Tanaka Y, 2011, J NUCL MATER, V415, pS1106, DOI 10.1016/j.jnucmat.2010.12.237; Tokitani M., 2014, 21 INT C PLASM SURF; Tokitani M, 2013, J NUCL MATER, V438, pS818, DOI 10.1016/j.jnucmat.2013.01.177	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	MAY	2015	55	5							053014	10.1088/0029-5515/55/5/053014		13	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CG8HA	WOS:000353546700015		
J	Tani, K; Honda, M; Oikawa, T; Shinohara, K; Kusama, Y; Sugie, T				Tani, K.; Honda, M.; Oikawa, T.; Shinohara, K.; Kusama, Y.; Sugie, T.			Effects of the radial electric field on the confinement of fast ions in ITER	NUCLEAR FUSION			English	Article						radial electric field; fast ion confinement; error field; ITER	TRANSPORT SIMULATION; ALPHA-PARTICLES; TOKAMAK REACTOR; RIPPLE; EDGE; PLASMAS; ORBITS	The effects of a radial electric field (EF) on the losses of alpha particles and neutral beam injection (NBI) fast ions in typical ITER operation scenarios for both error fields due to test blanket modules (TBMs) and toroidal field (TF) ripple were evaluated using an iterative method to execute an orbit-following Monte-Carlo code and a one-dimensional transport code. The EF effect on the loss of fast ions strongly depends on the operation scenario as well as on the error field. The electric field is very significant in the loss of fast ions in a 9MA ITER operation scenario with a higher safety factor and in the error field associated with TBMs. The EF effect in the error field of TF ripple is very small in any operation scenario. The electric field is much more significant for the loss of NBI fast ions than for that of alpha particles. The radial electric field changes the toroidal precession of fast ions and consequently alters their condition of resonance with the error field, which may account for the EF effect on the loss of fast ions in ITER with TBMs.	[Tani, K.] Nippon Adv Technol Co LTD, Naka, Ibaraki 3110102, Japan; [Honda, M.; Shinohara, K.; Kusama, Y.; Sugie, T.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Oikawa, T.] ITER Org, F-13067 St Paul Les Durance, France	Tani, K (reprint author), Nippon Adv Technol Co LTD, Naka, Ibaraki 3110102, Japan.	tani_keiji@yahoo.co.jp					Andreev VV, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4836578; Yoshida M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/12/123005; CHANKIN AV, 1993, NUCL FUSION, V33, P1459, DOI 10.1088/0029-5515/33/10/I05; Honda M, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073018; TANI K, 1981, J PHYS SOC JPN, V50, P1726, DOI 10.1143/JPSJ.50.1726; Miyamoto K, 1996, NUCL FUSION, V36, P927, DOI 10.1088/0029-5515/36/7/I09; Honda M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073050; FUKUYAMA A, 1995, PLASMA PHYS CONTR F, V37, P611, DOI 10.1088/0741-3335/37/6/002; DAVYDENKO VI, 1994, PLASMA PHYS CONTR F, V36, P1805, DOI 10.1088/0741-3335/36/11/008; GOLDSTON RJ, 1981, J PLASMA PHYS, V26, P283; Gribov Y, 2009, MAGNETIC FIELD PRODU; Honda M, 2008, J COMPUT PHYS, V227, P2808, DOI 10.1016/j.jcp.2007.11.017; Honda M, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/9/095012; Honda M., 2011, PLASMA FUSION RES, V6; Hynonen V, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/3/035014; ITOH K, 1991, NUCL FUSION, V31, P1405, DOI 10.1088/0029-5515/31/7/018; KRASHENINNIKOV SI, 1994, PHYS PLASMAS, V1, P1186, DOI 10.1063/1.870715; Mimata H., 2009, PLASMA FUSION RES, V4, P008; OHNISHI M, 1976, NUCL FUSION, V16, P690, DOI 10.1088/0029-5515/16/4/017; Oikawa T., 2012, P 24 FUS EN C SAN DI; Polevoi 8 A. R., 2002, J PLASMA FUSION RES, V5, P82; Polevoi A. R., 2010, P 37 EPS DUBL IR 201; Tani K, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/8/085001; TANI K, 1983, NUCL FUSION, V23, P657, DOI 10.1088/0029-5515/23/5/007; Tani K, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/1/013012; Trubnikov B.A., 1965, Reviews of Plasma Physics	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	MAY	2015	55	5							053010	10.1088/0029-5515/55/5/053010		15	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CG8HA	WOS:000353546700011		
J	Yanagi, N; Ito, S; Terazaki, Y; Seino, Y; Hamaguchi, S; Tamura, H; Miyazawa, J; Mito, T; Hashizume, H; Sagara, A				Yanagi, N.; Ito, S.; Terazaki, Y.; Seino, Y.; Hamaguchi, S.; Tamura, H.; Miyazawa, J.; Mito, T.; Hashizume, H.; Sagara, A.			Design and development of high-temperature superconducting magnet system with joint-winding for the helical fusion reactor	NUCLEAR FUSION			English	Article						helical fusion reactor design; high-temperature superconductor; joint-winding	CONDUCTOR; FFHR	An innovative winding method is developed by connecting high-temperature superconducting (HTS) conductors to enable efficient construction of a magnet system for the helical fusion reactor FFHR-d1. A large-current capacity HTS conductor, referred to as STARS, is being developed by the incorporation of several innovative ideas, such as the simple stacking of state-of-the-art yttrium barium copper oxide tapes embedded in a copper jacket, surrounded by electrical insulation inside a conductor, and an outer stainless-steel jacket cooled by helium gas. A prototype conductor sample was fabricated and reached a current of 100 kA at a bias magnetic field of 5.3 T with the temperature at 20 K. At 4.2 K, the maximum current reached was 120 kA, and a current of 100 kA was successfully sustained for 1 h. A low-resistance bridge-type mechanical lap joint was developed and a joint resistance of 2 n Omega was experimentally confirmed for the conductor sample.	[Yanagi, N.; Hamaguchi, S.; Tamura, H.; Miyazawa, J.; Mito, T.; Sagara, A.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ito, S.; Seino, Y.; Hashizume, H.] Tohoku Univ, Dept Quantum Sci & Energy Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Terazaki, Y.] Grad Univ Adv Studies, Toki, Gifu 5095292, Japan	Yanagi, N (reprint author), Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	yanagi@LHD.nifs.ac.jp					Sagara A, 2012, FUSION ENG DES, V87, P594, DOI 10.1016/j.fusengdes.2012.01.030; Shiohara Y, 2008, PHYSICA C, V468, P1498, DOI 10.1016/j.physc.2008.05.232; Celentano G, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2287910; Bansal G, 2008, IEEE T APPL SUPERCON, V18, P1151, DOI 10.1109/TASC.2008.922522; BANSAL G., 2008, PLASMA FUSION RES, V3, pS1049, DOI [http://dx.doi.org/10.1585/pfr.3.51049, DOI 10.1585/PFR.3.51049]; Goldacker W, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/3/034003; Hashizume H, 2002, FUSION ENG DES, V63-64, P449, DOI 10.1016/S0920-3796(02)00271-5; Horiuchi T, 1985, P 6 M TECH FUS EN SA; Isono T, 2003, IEEE T APPL SUPERCON, V13, P1512, DOI 10.1109/TASC.2003.812763; Ito S, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2176290; ITO S., 2014, PLASMA FUSION RES, V9; Ito S, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2291157; Kawai K, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2239335; Sagara A, 2008, FUSION ENG DES, V83, P1690, DOI 10.1016/j.fusengdes.2008.07.029; Terazaki Y, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2287715; Uo K, 1986, P 14 S AV FRANC 8 12; Yanagi N, 2011, FUSION SCI TECHNOL, V60, P648; Yanagi N, 2014, APPL SUPERCOND, V24; Yanagi Nagato, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S1026; Yanagi N, 2014, PLASMA FUSION RES, V9	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	MAY	2015	55	5							053021	10.1088/0029-5515/55/5/053021		7	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CG8HA	WOS:000353546700022		
J	Taguchi, T; Yamaguchi, K				Taguchi, Tomitsugu; Yamaguchi, Kenji			Tailoring crystallinity and configuration of silica nanotubes by electron irradiation	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Silica; Nanotubes; Oxidation; Transmission electron microscopy; Microstructure observation	CARBON NANOTUBES; POLYMORPHS; CARBIDE; PHOTOLUMINESCENCE; NANOSTRUCTURES; TEMPERATURE; NANOWIRES; MECHANISM; OXIDATION; DAMAGE	SiO2 nanotubes show potential in applications such as nanoscale electronic and optical devices, bioseparation, biocatalysis, and nanomedicine. As-grown SiO2 nanotubes in the previous studies always have an amorphous wall, and here we demonstrate the successful synthesis of single-crystal nanotubes for the first time by the heat treatment of SiC nanotubes at 1300 degrees C for 10 h under low-vacuum conditions. According to TEM observations, the single-crystal SiO2 was alpha-cristobalite. We also demonstrate that single-crystal SiO2 nanotubes can be transformed into amorphous SiO2 nanotubes by electron beam irradiation. Moreover, we synthesized a crystalline/amorphous SiO2 composite nanotube, in which crystalline and amorphous SiO2 coexisted in different localized regions. In addition, for biomedical applications such as drug delivery systems, controlling the configuration of the open end, the diameter, and capsulation of SiO2 nanotubes is crucial. We can also obturate, capsulate, and cut a SiO2 nanotube, as well as modify the inner diameter of the nanotube at a specific, nanometer-sized region using the focused electron beam irradiation technique. (C) 2015 Elsevier B.V. All rights reserved.	[Taguchi, Tomitsugu; Yamaguchi, Kenji] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki 3191195, Japan	Taguchi, T (reprint author), Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki 3191195, Japan.	taguchi.tomitsugu@jaea.go.jp			Ministry of Education, Science, Sports and Culture of Japan [23760646]	This work was partly supported by a Grant-in-Aid for Young Scientist (B) (No. 23760646) from the Ministry of Education, Science, Sports and Culture of Japan.	Adachi M, 1999, LANGMUIR, V15, P7097, DOI 10.1021/la9904859; Krasheninnikov AV, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125428; Wang LZ, 2001, J MATER CHEM, V11, P1465, DOI 10.1039/b010189n; DAI HJ, 1995, NATURE, V375, P769, DOI 10.1038/375769a0; Hillebrenner H, 2006, NANOMEDICINE-UK, V1, P39, DOI 10.2217/17435889.1.1.39; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Dai HJ, 2002, SURF SCI, V500, P218, DOI 10.1016/S0039-6028(01)01558-8; Presser V, 2009, J AM CERAM SOC, V92, P724, DOI 10.1111/j.1551-2916.2009.02930.x; Yu J, 2009, J AM CHEM SOC, V131, P15574, DOI 10.1021/ja905485s; Yin LW, 2004, ADV MATER, V16, P929, DOI 10.1002/adma.200306571; Banhart F, 1999, REP PROG PHYS, V62, P1181, DOI 10.1088/0034-4885/62/8/201; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Mitchell DT, 2002, J AM CHEM SOC, V124, P11864, DOI 10.1021/ja027247b; Taguchi T, 2005, PHYSICA E, V28, P431, DOI 10.1016/j.physe.2005.05.048; Taguchi T, 2007, J PHYS CHEM C, V111, P18888, DOI 10.1021/jp0756909; Yang XF, 2011, J MATER CHEM, V21, P6122, DOI 10.1039/c0jm04516k; Lakshtanov DL, 2007, PHYS CHEM MINER, V34, P11, DOI 10.1007/s00269-006-0113-y; Fan R, 2003, J AM CHEM SOC, V125, P5254, DOI 10.1021/ja034163; Sun L, 2006, SCIENCE, V312, P1199, DOI 10.1126/science.1124594; Banhart F, 1997, CHEM PHYS LETT, V269, P349, DOI 10.1016/S0009-2614(97)00269-8; Bjorkman T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03482; Chang HJ, 2001, APPL PHYS LETT, V78, P3791, DOI 10.1063/1.1370991; Chen YQ, 2006, NANOTECHNOLOGY, V17, P1022, DOI 10.1088/0957-4484/17/4/029; Crespi VH, 1996, PHYS REV B, V54, P5927, DOI 10.1103/PhysRevB.54.5927; Egerton R.F., 1971, ELECT ENERGY LOSS SP; Guinel MJF, 2006, J MATER RES, V21, P2550, DOI 10.1557/JMR.2006.0317; He B, 2006, LANGMUIR, V22, P8263, DOI 10.1021/la060187t; Hillebrenner H, 2006, J AM CHEM SOC, V128, P4236, DOI 10.1021/ja058455h; KUNUGI M, 1972, J AM CERAM SOC, V55, P580, DOI 10.1111/j.1151-2916.1972.tb13442.x; LIU LG, 1993, MECH MATER, V14, P283, DOI 10.1016/0167-6636(93)90083-4; Loffler D., 2010, J SAUER PHYS REV LET, V105; PFEFFER RL, 1985, J APPL PHYS, V57, P5176, DOI 10.1063/1.335252; SCHNEIDER R, 1995, FRESEN J ANAL CHEM, V353, P263, DOI 10.1007/BF00322049; Taguchi T, 2005, J AM CERAM SOC, V88, P459, DOI 10.1111/j.1551-2916.2005.00066.x; Taguchi T, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/48/485601; Uchino T, 2004, APPL PHYS LETT, V85, P1164, DOI 10.1063/1.1782263; XU YN, 1991, PHYS REV B, V44, P11048, DOI 10.1103/PhysRevB.44.11048; Zhang MC, 2010, J PHYS CHEM C, V114, P15640, DOI 10.1021/jp106690q; Zhao M., 2006, PHYS REV B, V73	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	MAY 1	2015	350						1	5		10.1016/j.nimb.2015.03.040		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH9FU	WOS:000354342200001		
J	Yoshii, Y; Sasaki, K; Matsuya, Y; Date, H				Yoshii, Y.; Sasaki, K.; Matsuya, Y.; Date, H.			Cluster analysis for the probability of DSB site induced by electron tracks	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Electron tracks; Cluster analysis; Monte Carlo simulation; Aggregation index	MONTE-CARLO-SIMULATION; LIQUID WATER; DNA-DAMAGE; MONOENERGETIC ELECTRONS; IONIZING-RADIATIONS; ENERGY DEPOSITION; STRAND BREAKS; IONIZATION; MODEL; DISTRIBUTIONS	To clarify the influence of bio-cells exposed to ionizing radiations, the densely populated pattern of the ionization in the cell nucleus is of importance because it governs the extent of DNA damage which may lead to cell lethality. In this study, we have conducted a cluster analysis of ionization and excitation events to estimate the number of double-strand breaks (DSBs) induced by electron tracks. A Monte Carlo simulation for electrons in liquid water was performed to determine the spatial location of the ionization and excitation events. The events were divided into clusters by using the density-based spatial clustering of applications with noise (DBSCAN) algorithm. The algorithm enables us to sort out the events into the groups (clusters) in which a minimum number of neighboring events are contained within a given radius. For evaluating the dumber of DSBs in the extracted clusters, we have introduced an aggregation index (AI). The computational results show that a sub-key electron produces DSBs in a dense formation more effectively than higher energy electrons. The root-mean square radius (RMSR) of the cluster size is below 5 nm, which is smaller than the chromatin fiber thickness. It was found that this size of clustering events has a high possibility to cause lesions in DNA within the chromatin fiber site. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshii, Y.] Sapporo Med Univ, Biol Res Educ & Instrumentat Ctr, Sapporo, Hokkaido 0608556, Japan; [Sasaki, K.] Hokkaido Univ Sci, Fac Hlth Sci, Sapporo, Hokkaido 0068585, Japan; [Yoshii, Y.; Matsuya, Y.] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido 0600812, Japan; [Date, H.] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido 0600812, Japan	Date, H (reprint author), Kita 12,Nishi 5,Kita Ku, Sapporo, Hokkaido 0600812, Japan.	date@hs.hokudai.ac.jp					Friedland W, 1998, RADIAT RES, V150, P170, DOI 10.2307/3579852; Nikjoo H, 2002, RADIAT PROT DOSIM, V99, P77; Emfietzoglou D, 2003, RADIAT PHYS CHEM, V66, P373, DOI 10.1016/S0969-806X(02)00504-2; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; MOZUMDER A, 1966, RADIAT RES, V28, P203, DOI 10.2307/3572190; Friedland W, 1999, RADIAT ENVIRON BIOPH, V38, P39, DOI 10.1007/s004110050136; Nikjoo H, 2006, RADIAT MEAS, V41, P1052, DOI 10.1016/j.radmeas.2006.02.001; [Anonymous], 1984, 37 ICRU, V37; Wilson WE, 2004, RADIAT RES, V161, P591, DOI 10.1667/RR3179; ROOTS R, 1975, RADIAT RES, V64, P306, DOI 10.2307/3574267; Pater P, 2014, MED PHYS, V41, DOI 10.1118/1.4901555; Bug MU, 2010, EUR PHYS J D, V60, P85, DOI 10.1140/epjd/e2010-00145-1; Hsiao Y, 2008, PHYS MED BIOL, V53, P233, DOI 10.1088/0031-9155/53/1/016; Francis Z, 2012, PHYS MED BIOL, V57, P209, DOI 10.1088/0031-9155/57/1/209; Nikjoo H, 1999, RADIAT ENVIRON BIOPH, V38, P31, DOI 10.1007/s004110050135; Nikjoo H, 1997, INT J RADIAT BIOL, V71, P467; Garty G, 2002, NUCL INSTRUM METH A, V492, P212, DOI 10.1016/S0168-9002(02)01278-0; Semenenko VA, 2003, RADIAT ENVIRON BIOPH, V42, P213, DOI 10.1007/s00411-003-0201-z; Grosswendt B, 2002, RADIAT ENVIRON BIOPH, V41, P103, DOI 10.1007/s00411-002-0155-6; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Garty G, 2010, PHYS MED BIOL, V55, P761, DOI 10.1088/0031-9155/55/3/015; Francis Z, 2011, COMPUT METH PROG BIO, V101, P265, DOI 10.1016/j.cmpb.2010.12.012; Bernal MA, 2011, PHYS MED BIOL, V56, P7393, DOI 10.1088/0031-9155/56/23/004; Date H, 2009, NUCL INSTRUM METH B, V267, P1135, DOI 10.1016/j.nimb.2009.02.048; Date H, 2007, NUCL INSTRUM METH B, V265, P515, DOI 10.1016/j.nimb.2007.09.039; Ester M., 1997, KDD, V97, P10; GOODHEAD DT, 1983, PHYS MED BIOL, V28, P485, DOI 10.1088/0031-9155/28/5/003; Hanai M., 1998, INT J RADIAT BIOL, V73, P475; MICHALIK V, 1994, INT J RADIAT BIOL, V66, P467, DOI 10.1080/09553009414551471; MICHALIK V, 1993, RADIAT ENVIRON BIOPH, V32, P251, DOI 10.1007/BF01209774; NIKJOO H, 1991, INT J RADIAT BIOL, V60, P739, DOI 10.1080/09553009114552561; PINAK M, 1993, J RADIAT RES, V34, P221, DOI 10.1269/jrr.34.221; Verhaegen F, 2004, RADIAT RES, V162, P592, DOI 10.1667/RR3246; Yoshii Y, 2011, NUCL INSTRUM METH B, V269, P1887, DOI 10.1016/j.nimb.2011.05.028; Zhang LM, 2010, RADIAT ENVIRON BIOPH, V49, P15, DOI 10.1007/s00411-009-0262-8	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	MAY 1	2015	350						55	59		10.1016/j.nimb.2015.03.025		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH9FU	WOS:000354342200010		
J	Ueki, T				Ueki, Taro			Robust Statistical Error Estimation of Local Power Tallies in Monte Carlo Calculation of Light Water Reactor	NUCLEAR SCIENCE AND ENGINEERING			English	Article							TIME-SERIES ANALYSIS; EIGENVALUE CALCULATIONS; CRITICALITY CALCULATION; DIGITAL-SIMULATION; DOMINANCE RATIO; FISSION SOURCES; VARIANCE; COMPUTATION; OUTPUT; CORE	The overlapping batch means method (OBM) has been investigated for robust statistical error estimation of local power tallies in Monte Carlo ( MC) reactor core calculation. Originally, a nonoverlapping version was introduced in MC criticality calculation by Gelbard and Prael. However, the issue of batch size optimization was thought of as a lack of robustness. In this work, OBM with asymptotic bias correction was implemented with the batch size of the square root of the number of generations and compared with the orthonormally weighted standardized time series method (OWSTS). Numerical tests were conducted for various positions of the core of a pressurized water reactor. Results obtained indicate that neither OBM nor OWSTS consistently outperforms the other in terms of an overall performance measure incorporating bias and stability. Therefore, OBM with asymptotic bias correction can be an option to statistical error estimation in production MC criticality codes since OWSTS lacks an automated process to determine the number of weighting functions and can output the estimate only at the final generation. It is also shown that OBM with asymptotic bias correction performs equally regardless of the batch size.	Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Ueki, T (reprint author), Japan Atom Energy Agcy, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	tueki09@gmail.com					CONWAY RW, 1963, MANAGE SCI, V10, P47, DOI 10.1287/mnsc.10.1.47; Ueki T, 2003, NUCL SCI ENG, V145, P279; DAMERDJI H, 1995, OPER RES, V43, P282, DOI 10.1287/opre.43.2.282; DEMARET L., 1999, P 6 INT C NUCL CRIT, V1, P66; FISHMAN GS, 1978, MANAGE SCI, V24, P510, DOI 10.1287/mnsc.24.5.510; FOLEY R. D., 1999, ACM T MODEL COMPUT S, V9, P297, DOI 10.1145/352222.352223; GELBARD EM, 1990, PROG NUCL ENERG, V24, P237, DOI 10.1016/0149-1970(90)90041-3; NAKAGAWA M, 1993, J NUCL SCI TECHNOL, V30, P692, DOI 10.3327/jnst.30.692; SCHMEISER B, 1982, OPER RES, V30, P556, DOI 10.1287/opre.30.3.556; Shim HJ, 2014, NUCL SCI ENG, V176, P58; SONG WMT, 1993, OPER RES, V41, P501, DOI 10.1287/opre.41.3.501; Ueki T, 2013, J NUCL SCI TECHNOL, V50, P762, DOI 10.1080/00223131.2013.808003; Ueki T, 2011, ANN NUCL ENERGY, V38, P2462, DOI 10.1016/j.anucene.2011.07.015; Ueki T, 2012, NUCL SCI ENG, V171, P220; Ueki T, 2011, J NUCL SCI TECHNOL, V48, P292, DOI 10.3327/jnst.48.292; Ueki T, 1997, NUCL SCI ENG, V125, P1; Ueki T, 2012, J NUCL SCI TECHNOL, V49, P1134, DOI 10.1080/00223131.2012.740356; Ueki T, 2010, J NUCL SCI TECHNOL, V47, P739, DOI 10.3327/jnst.47.739; Ueki T, 2006, NUCL SCI ENG, V153, P184; Ueki T, 2004, NUCL SCI ENG, V148, P374; X-5 Monte Carlo Team, 2003, LAUR031987 LOS AL NA	21	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	MAY	2015	180	1					58	68				11	Nuclear Science & Technology	Nuclear Science & Technology	CH3LI	WOS:000353931800004		
J	Sakamura, Y; Iizuka, M; Koyama, T; Kitawaki, S; Nakayoshi, A				Sakamura, Yoshiharu; Iizuka, Masatoshi; Koyama, Tadafumi; Kitawaki, Shinichi; Nakayoshi, Akira			NOVEL APPROACH TO EXTRACTING TRANSURANIC ELEMENTS IN MOLTEN SALT ELECTROREFINING	NUCLEAR TECHNOLOGY			English	Article						molten salt; electrorefining; transuranic element; liquid cadmium	LIQUID CADMIUM CATHODE; FISSION-PRODUCT ELEMENTS; NUCLEAR-FUEL; PHASE DIAGRAM; URANIUM; PLUTONIUM; AMERICIUM; DISTILLATION; PERFORMANCE; ACTINIDES	A novel approach to extracting transuranic elements (TRUs) from molten salt into liquid Cd using U metal as a reductant was investigated for the molten salt electrorefining process. We considered two methods of adding U metal: direct extraction (DE) and electrochemical extraction (EE). In the DE method, U metal added to Cd is dissolved and exchanged for TRU ions in the salt. The EE method is based on the principle of a concentration cell. When U metal and Cd separately placed in the salt are electrically connected, the U metal is anodically dissolved in the salt, and U and TRU ions are reduced at the Cd. The advantages of these methods over the conventional electrolytic method are as follows: The container for Cd can be made of steel, dendritic U metal does not form on the surface of the Cd or the crucible, and the operation is simple and stable. It was experimentally demonstrated that Pu and Am could be extracted from LiCl-KCl melt into liquid Cd by both the DE and EE methods when U metal collected at the solid cathode was used as a reductant. Crucibles made of steel could be used as containers for Cd, and a total of similar to 3 wt% of U, Pu, and Am in the Cd was collected in 10 h. In the EE tests, the separation factors among U, Pu, and Am were always equal to the values at equilibrium. The rate-determining step for the extraction was not the mass transfer in the Cd or salt phase but the electron transfer at the Cd-salt interface. Then, a concept high-performance electrorefiner equipped with two anode solid cathode modules and an EE or DE module was preliminarily designed.	[Sakamura, Yoshiharu; Iizuka, Masatoshi; Koyama, Tadafumi] Cent Res Inst Elect Power Ind, Komae, Tokyo 2018511, Japan; [Kitawaki, Shinichi; Nakayoshi, Akira] Japan Atom Energy Agcy, Naka, Ibaraki 3191194, Japan	Sakamura, Y (reprint author), Cent Res Inst Elect Power Ind, 2-11-1 Iwadokita, Komae, Tokyo 2018511, Japan.	sakamura@criepi.denken.or.jp					ACKERMAN JP, 1993, J ALLOY COMPD, V199, P77, DOI 10.1016/0925-8388(93)90430-U; Sakamura Y, 2001, J ALLOY COMPD, V321, P76, DOI 10.1016/S0925-8388(01)00973-2; TOMCZUK Z, 1992, J ELECTROCHEM SOC, V139, P3523, DOI 10.1149/1.2069109; Murakami T, 2011, J NUCL MATER, V414, P194, DOI 10.1016/j.jnucmat.2011.03.009; Kinoshita K, 2005, J PHYS CHEM SOLIDS, V66, P619, DOI 10.1016/j.jpcs.2004.06.069; Iizuka M, 2013, NUCL TECHNOL, V181, P507; Uozumi K, 2004, J NUCL MATER, V325, P34, DOI 10.1016/j.jnucmat.2003.10.010; KOYAMA T, 1992, J ALLOY COMPD, V189, P37, DOI 10.1016/0925-8388(92)90043-9; Koyama T, 2007, J NUCL SCI TECHNOL, V44, P382, DOI 10.3327/jnst.44.382; [Anonymous], 1995, ANL9524 CHEM TECHN D, P86; JOHNSON I, 1965, T METALL SOC AIME, V233, P1408; Hijikata T, 2009, J ENG GAS TURB POWER, V131, DOI 10.1115/1.3079608; Iizuka M, 2009, J NUCL SCI TECHNOL, V46, P699, DOI 10.3327/jnst.46.699; Iizuka M, 2013, NUCL TECHNOL, V184, P107; Iizuka M, 2014, J NUCL MATER, V448, P259, DOI 10.1016/j.jnucmat.2014.02.015; KATO T., 2003, P GLOBAL 2003 NEW OR, P1591; Kinoshita K, 2010, J NUCL SCI TECHNOL, V47, P211, DOI 10.3327/jnst.47.211; KOYAMA T., 2011, NUCL ENG PYROCHEMICA; Koyama T, 1997, J NUCL SCI TECHNOL, V34, P384, DOI 10.3327/jnst.34.384; Kurata M, 2009, J NUCL SCI TECHNOL, V46, P175, DOI 10.3327/jnst.46.175; Lee JH, 2009, NUCL TECHNOL, V165, P370; Lee JH, 2008, NUCL TECHNOL, V162, P135; Li S. X., 2005, P INT C GLOBAL 2005; Li SX, 2009, NUCL TECHNOL, V165, P190; Iizuka M, 2001, J NUCL MATER, V299, P32, DOI 10.1016/S0022-3115(01)00667-5; MARTIN AE, 1961, T METALL SOC AIME, V221, P789; Paek S, 2010, RADIOCHIM ACTA, V98, P779, DOI 10.1524/ract.2010.1778; Priebe S, 2008, NUCL TECHNOL, V162, P199; SATO K., 2005, P INT C GLOBAL 2005; SATO K., 2003, P GLOB 2003 NEW ORL, P744; Tsukada T, 2008, NUCL TECHNOL, V162, P229; VADEN D., 2002, P 5 TOPL M DOE SPENT; Vaden D, 2008, NUCL TECHNOL, V162, P124; Westphav BR, 2008, NUCL ENG TECHNOL, V40, P163	34	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5450	1943-7471		NUCL TECHNOL	Nucl. Technol.	MAY	2015	190	2					193	206		10.13182/NT14-64		14	Nuclear Science & Technology	Nuclear Science & Technology	CH0ZX	WOS:000353752000006		
J	Tashiro, S; Uchiyama, G; Amano, Y; Abe, H; Yamane, Y; Yoshida, K				Tashiro, S.; Uchiyama, G.; Amano, Y.; Abe, H.; Yamane, Y.; Yoshida, K.			RELEASE OF RADIOACTIVE MATERIALS FROM SIMULATED HIGH-LEVEL LIQUID WASTE AT BOILING ACCIDENT IN REPROCESSING PLANT	NUCLEAR TECHNOLOGY			English	Article						fission product release behavior; boiling accident; high active liquid waste		The release behavior of radioactive materials from high active liquid waste (HALW) has been investigated under boiling accident conditions. Results of the experiment using a nonradioactive simulated HALW found Ru to be a volatile element under the accident conditions and to be released into the gas phase in the form of both mist and gas. The Ru release rate and the apparent Ru volatilization rate constant were obtained under the boiling conditions of simulated HALW. The other fission product elements such as Cs were found to be nonvolatile and to be released into the gas phase in the form of mist. The mist size distribution near the surface of the simulated HALW in the reactor vessel was found to range from 0.05 to 20 mu m with a peak diameter of similar to 2 mu m.	[Tashiro, S.; Uchiyama, G.; Amano, Y.; Abe, H.; Yamane, Y.; Yoshida, K.] Japan Atom Energy Agcy, Naka, Ibaraki 3191195, Japan	Tashiro, S (reprint author), Japan Atom Energy Agcy, 2-4 Shirane, Naka, Ibaraki 3191195, Japan.	tashiro.shinsuke@jaea.go.jp					AMANO Y., 2011, P 2011 FALL M AT EN, pC10; Kodama T, 2010, NUCL TECHNOL, V172, P77; [Anonymous], 2008, JAEA REV; MERCIER J. P., 1991, EXAMPLE R D SAFETY A; Miyata Takashi, 2008, Transactions of the Atomic Energy Society of Japan, V7; Mun C, 2007, RADIOCHIM ACTA, V95, P643, DOI 10.1524/ract.2007.95.11.643; PHILIPPE M., 1991, P 21 DOE NRC NUCL AI, V2, P831; Sasahira A, 1996, J NUCL SCI TECHNOL, V33, P753, DOI 10.3327/jnst.33.753; TASHIRO S., 2012, P 2012 FALL M AT EN, pp; UCHIYAMA G., 2012, P 2012 FALL M AT EN, pE33	10	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5450	1943-7471		NUCL TECHNOL	Nucl. Technol.	MAY	2015	190	2					207	213		10.13182/NT14-57		7	Nuclear Science & Technology	Nuclear Science & Technology	CH0ZX	WOS:000353752000007		
J	Nirengi, S; Yoneshiro, T; Sugie, H; Saito, M; Hamaoka, T				Nirengi, Shinsuke; Yoneshiro, Takeshi; Sugie, Hiroki; Saito, Masayuki; Hamaoka, Takafumi			Human Brown Adipose Tissue Assessed by Simple, Noninvasive Near-Infrared Time-Resolved Spectroscopy	OBESITY			English	Article							ADULT HUMANS; QUANTITATIVE MEASUREMENT; INSULIN SENSITIVITY; FAT DEVELOPMENT; HEALTHY HUMANS; COLD-EXPOSURE; BLOOD-FLOW; MUSCLE; EXERCISE; IDENTIFICATION	ObjectiveHuman brown adipose tissue (BAT) activity has been typically evaluated by F-18-fluorodeoxyglucose (FDG)-positron emission tomography (PET) combined with computed tomography (CT). However, FDG-PET/CT has serious limitations (e.g., radiation and cold exposure). This study evaluated BAT density using near-infrared time-resolved spectroscopy (NIRTRS), a simple and noninvasive method of measuring the indices of tissue hemoglobin concentration [total-Hb] and mitochondrial density (mu(s)). MethodsThe NIRTRS parameters at 760, 800, and 830 nm in the supraclavicular region potentially containing BAT were evaluated. First, the NIRTRS parameters were compared at 27 degrees C and during a 2-h cold exposure (19 degrees C) in 18 men. Then, NIRTRS parameters at 27 degrees C were compared with mean standardized uptake values (SUVmean) assessed by FDG-PET/CT after the 2-h cold exposure (19 degrees C) in 29 men. ResultsThere was no significant difference between the NIRTRS parameters at 27 degrees C and 19 degrees C. The [total-Hb] and mu(s) were significantly correlated to SUVmean (r=0.73 and r=0.64, respectively). A receiver operating characteristic analysis revealed that the sensitivity (75.0-82.4%), specificity (91.7-100%), and accuracy (82.8-86.2%) of the NIRTRS parameters were all good to determine the NIRTRS reliability. ConclusionsOur novel NIRTRS method is noninvasive and simple and can reliably assess human BAT density in the supraclavicular region.	[Nirengi, Shinsuke; Hamaoka, Takafumi] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Yoneshiro, Takeshi] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido, Japan; [Sugie, Hiroki] LSI Sapporo Clin, Sapporo, Hokkaido, Japan; [Saito, Masayuki] Hokkaido Univ, Sapporo, Hokkaido, Japan	Hamaoka, T (reprint author), Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga, Japan.	kyp02504@nifty.com					Cypess AM, 2014, CELL METAB, V20, P408, DOI 10.1016/j.cmet.2014.07.025; CHANCE B, 1988, ANAL BIOCHEM, V174, P698, DOI 10.1016/0003-2697(88)90076-0; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; CHANCE B, 1992, AM J PHYSIOL, V262, pC766; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Lee P, 2010, AM J PHYSIOL-ENDOC M, V299, pE601, DOI 10.1152/ajpendo.00298.2010; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Hu HCH, 2012, J MAGN RESON IMAGING, V35, P938, DOI 10.1002/jmri.23531; Chen YCI, 2013, J NUCL MED, V54, P1584, DOI 10.2967/jnumed.112.117275; Boushel R, 2013, INT J BIOCHEM CELL B, V45, P68, DOI 10.1016/j.biocel.2012.09.024; Muzik O, 2013, J NUCL MED, V54, P523, DOI 10.2967/jnumed.112.111336; Stebbings GK, 2013, J ATHL TRAINING, V48, P209, DOI 10.4085/1062-6050-48.1.17; Beauvoit B, 1998, MOL CELL BIOCHEM, V184, P445, DOI 10.1023/A:1006855716742; Borga M, 2014, METHOD ENZYMOL, V537, P142; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Ferreira LF, 2007, J APPL PHYSIOL, V102, P358, DOI 10.1152/japplphysiol.00920.2005; Hamaoka T, 2011, PHILOS T R SOC A, V369, P4591, DOI 10.1098/rsta.2011.0298; Hamaoka T, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2805437; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; McCully K K, 2000, Exerc Sport Sci Rev, V28, P123; Niwayama M, 2000, REV SCI INSTRUM, V71, P4571, DOI 10.1063/1.1322578; SUZUKI K, 1994, INVEST RADIOL, V29, P410, DOI 10.1097/00004424-199404000-00003; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500; vansder Lans AA, 2013, J CLIN INVEST, V123, P3395; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	MAY	2015	23	5					973	980		10.1002/oby.21012		8	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CH3XL	WOS:000353964200011		
J	Fitriadhy, A; Yasukawa, H; Maimun, A				Fitriadhy, A.; Yasukawa, H.; Maimun, A.			Theoretical and experimental analysis of a slack towline motion on tug-towed ship during turning	OCEAN ENGINEERING			English	Article						Tug-towed ship; Turning; Towline length; Deflection-rudder angle; Towing angle; Slack towline	STABILITY	Concerning the safety of towing, a slack towline condition on tug-towed ship motions interaction during turning is necessary to be studied. This paper presents a fundamental investigation aimed at gaining a more comprehensive insight into the basic mechanism of the slack towline condition identified via several towing parameters affecting its occurrence. Through applying steady turning theory of the tug-towed ship presented by Fitriadhy and Yasukawa (2011a), a slack towline formula is derived, which is capable of defining a boundary limit of their turning ability before the towline falls into the slack condition. Several criteria of the slack towline are described and the reason behind its proposed formula explained. A comprehensive theoretical clarification is presented here using nonlinear analysis for a better prediction of their turning ability including capturing the slack towline condition, where effects of towline length and deflection-rudder angle are discussed. The results revealed that the tug was vulnerable to lose handling of towing with respect to the towed ship that led to the towline falling into the slack condition. For validation, a series of turning tests for the towed ship model were carried out at Towing-Tank in which the theoretical approaches agreed qualitatively with the experimental results. (C) 2015 Elsevier Ltd. All rights reserved.	[Fitriadhy, A.] Univ Malaysia, Sch Ocean Engn, Program Maritime Technol, Terengganu, Malaysia; [Yasukawa, H.] Hiroshima Univ, Fac Engn, Dept Transportat & Environm Syst, Hiroshima 730, Japan; [Maimun, A.] Univ Teknol Malaysia, Fac Mech Engn, Marine Technol Ctr, Skudai, Malaysia	Fitriadhy, A (reprint author), Univ Malaysia, Sch Ocean Engn, Program Maritime Technol, Terengganu, Malaysia.	naoe.afit@gmail.com					Abkowitz M.A, 1972, STABILITY MOTION CON; BERNITSAS MM, 1990, APPL OCEAN RES, V12, P77, DOI 10.1016/S0141-1187(05)80032-X; Eda H, 1972, T SNAME, V80, P299; Fitriadhy A., 2011, SHIP TECHNOL RES SCH, V58, P4; Fitriadhy A, 2013, OCEAN ENG, V64, P135, DOI 10.1016/j.oceaneng.2013.02.001; Fitriadhy A., 2011, SHIP TECHNOL RES SCH, V58, P112; Hirano M, 1980, J SOC NAVAL ARCHITEC, V147, P144; Inoue S., 1977, T W JAPAN SOC NAVAL, V54, P193; Shigehiro R., 1998, KANSAI SOC NAVAL ARC, V230, P165; Strandhagen AG, 1950, T SNAME, V58, P32; Varyani K.S., 2007, INT C TOW SALV DIS T, P117; Yasukawa H., 2006, J JPN SOC NAVAL ARCH, V4, P137; Yoshimura Y., 1978, J SOC NAVAL ARCHITEC, V144, P57	13	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0029-8018			OCEAN ENG	Ocean Eng.	MAY 1	2015	99						95	106		10.1016/j.oceaneng.2015.03.008		12	Engineering, Marine; Engineering, Civil; Engineering, Ocean; Oceanography	Engineering; Oceanography	CH6KN	WOS:000354145600011		
J	Palma, E; Deatrick, JA; Hobbie, WL; Ogle, SK; Kobayashi, K; Maldonado, L				Palma, Erica; Deatrick, Janet A.; Hobbie, Wendy L.; Ogle, Sue K.; Kobayashi, Kyoko; Maldonado, Linda			Maternal Caregiving Demands for Adolescent and Young Adult Survivors of Pediatric Brain Tumors	ONCOLOGY NURSING FORUM			English	Article						caregiver tasks; pediatric brain tumors; caregiving demands; caregiving burden; parents; qualitative research	QUALITY-OF-LIFE; HEALTH-RELATED QUALITY; CHILDHOOD-CANCER; CEREBRAL-PALSY; FAMILY CAREGIVERS; CHILDREN; PARENTS; BURDEN; IMPACT; MOTHERS	Purpose/Objectives: To examine the daily maternal caregiving demands for adolescent and young adult survivors of pediatric brain tumors who live with their families. Design: A secondary analysis was conducted on interview data gathered during a large mixed-methods study that focused on perceived maternal caregiver competency and survivor health-related quality of life. Setting: Home interviews. Sample: A purposive sample of 46 maternal caregivers was selected from participants in the larger study. Methods: Semistructured interviews were conducted with mothers. A directed content analysis was informed by Sullivan-Bolyai's framework describing the components of primary caregiving. Main Research Variables: Caregiving demands. Findings: Data regarding four main categories of maternal daily caregiving demands were identified from 25 of the 46 interviews: managing the illness; identifying, accessing, and coordinating resources; assisting with everyday responsibilities; and fostering psychosocial health. Conclusions: Potential day-to-day management tasks or demands of mothers of adolescent and young adult survivors of pediatric brain tumors were identified. Implications for Nursing: The major demands of caregiving are similar to those for children with other chronic conditions, with the addition of assisting with everyday responsibilities and fostering psychosocial health.	[Palma, Erica; Hobbie, Wendy L.; Maldonado, Linda] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Palma, Erica] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Deatrick, Janet A.] Univ Penn, Sch Nursing, Ctr Hlth Equ Res, Philadelphia, PA 19104 USA; [Hobbie, Wendy L.] Childrens Hosp Philadelphia, Canc Survivorship Program, Philadelphia, PA USA; [Ogle, Sue K.] Childrens Hosp Philadelphia, Med & Med Subspecialty Nursing, Philadelphia, PA USA; [Ogle, Sue K.] Childrens Hosp Philadelphia, Philadelphia, PA USA; [Kobayashi, Kyoko] St Lukes Int Univ, Sch Nursing, Dept Child & Family Nursing, Tokyo, Japan; [Maldonado, Linda] Univ Penn, Ctr Global Womens Hlth, Philadelphia, PA 19104 USA; [Maldonado, Linda] Univ Penn, Ctr Hlth Equ Res, Philadelphia, PA 19104 USA	Palma, E (reprint author), Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA.	deatrick@nursing.upenn.edu			National Institutes of Nursing Research [R01 NR009651, 3-T32-NR007100]; National Institutes of Health; ONS Foundation through American Brain Tumor Association	Erica Palma, BSN, RN, OCN (R), is a graduate student in the School of Nursing at the University of Pennsylvania in Philadelphia and a clinical nurse at Memorial Sloan-Kettering Cancer Center in New York, NY; Janet A. Deatrick, PhD, RN, FAAN, is a professor, a Shearer Endowed Term Chair in Healthy Community Practices, and a director of the Center for Health Equity Research, all in the School of Nursing at the University of Pennsylvania; Wendy L. Hobbie, MSN, CRNP, FAAN, is the associate director for the Cancer Survivorship Program at the Children's Hospital of Philadelphia and the director of the Pediatric Oncology Nurse Practitioner Concentration in the School of Nursing at the University of Pennsylvania; Sue K. Ogle, MSN, CRNP, is an advanced practice nurse manager for Medical and Medical Subspecialty Nursing and a cancer survivorship nurse practitioner at the Children's Hospital of Philadelphia; Kyoko Kobayashi, PhD, RN, PHN, is an associate professor in the Department of Child and Family Nursing at St. Luke's International University School of Nursing in Tokyo, Japan; and Linda Maldonado, PhD, RN, is a Ruth L. Kirschstein National Research Service Award Postdoctoral Fellow in the School of Nursing and the Centers for Global Women's Health and Health Equity Research, both at the University of Pennsylvania. This study was supported, in part, by grants (R01 NR009651 and 3-T32-NR007100) from the National Institutes of Nursing Research and National Institutes of Health, and funding from the ONS Foundation through a grant from the American Brain Tumor Association. Deatrick can be reached at deatrick@nursing.upenn.edu, with copy to editor at ONFEditor@ons.org. (Submitted August 2014. Accepted for publication November 13, 2014.)	Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Carlson CA, 2008, J PEDIATR ONCOL NURS, V25, P7, DOI 10.1177/1043454207311741; Hatzmann J, 2008, PEDIATRICS, V122, pE1030, DOI 10.1542/peds.2008-0582; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Brehaut JC, 2004, PEDIATRICS, V114, P182; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Murphy NA, 2007, CHILD CARE HLTH DEV, V33, P180, DOI 10.1111/j.1365-2214.2006.00644.x; Klassen AF, 2008, J CLIN ONCOL, V26, P5884, DOI 10.1200/JCO.2007.15.2835; Armstrong GT, 2014, J CLIN ONCOL, V32, P1218, DOI 10.1200/JCO.2013.51.1055; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Northouse LL, 2010, CA-CANCER J CLIN, V60, P317, DOI 10.3322/caac.20081; Forinder U, 2010, SUPPORT CARE CANCER, V18, P543, DOI 10.1007/s00520-009-0678-3; Svavarsdottir EK, 2005, J ADV NURS, V50, P153, DOI 10.1111/j.1365-2648.2005.03374.x; Meltzer LJ, 2006, ARCH INTERN MED, V166, P1749, DOI 10.1001/archinte.166.16.1749; Yamazaki S, 2005, QUAL LIFE RES, V14, P1079, DOI 10.1007/s11136-004-3288-z; Davis E, 2010, CHILD CARE HLTH DEV, V36, P63, DOI 10.1111/j.1365-2214.2009.00989.x; Barakat L. P., 2014, PSYCHO-ONCOLOGY, DOI [10.1002/pon.3649, DOI 10.1002/PON.3649]; Cadell Susan, 2012, J Soc Work End Life Palliat Care, V8, P356, DOI 10.1080/15524256.2012.732021; Chien LY, 2003, CANCER NURS, V26, P305, DOI 10.1097/00002820-200308000-00009; Cooper C, 2003, J AM ACAD CHILD PSY, V42, P1370, DOI 10.1097/01.CHI.0000085751.71002.48; Deatrick JA, 2009, J PEDIATR ONCOL NURS, V26, P303, DOI 10.1177/1043454209343210; Deatrick JA, 2014, HEALTH PSYCHOL, V33, P1103, DOI 10.1037/a0033756; Driscoll KA, 2009, PEDIATR PULM, V44, P784, DOI 10.1002/ppul.21057; Fletcher Paula C, 2010, Issues Compr Pediatr Nurs, V33, P164, DOI 10.3109/01460862.2010.498698; Grady PA, 2014, NURS OUTLOOK, V62, P362, DOI 10.1016/j.outlook.2014.05.007; Hobbie W., CANC NURSIN IN PRESS; Hricik Allison, 2011, Oncol Nurs Forum, V38, P149, DOI 10.1188/11.ONF.149-155; Iwamoto V, 2008, J PEDIAT, V84, P91, DOI [10.2223/JPED.1738, 10.1590/S0021-75572008000100015]; James Kelly, 2002, J Pediatr Oncol Nurs, V19, P218, DOI 10.1053/jpon.2002.128777; Kelly P, 2013, INT J NURS STUD, V50, P933, DOI 10.1016/j.ijnurstu.2012.11.004; Klassen AF, 2011, INT J CANCER, V129, P1190, DOI 10.1002/ijc.25737; National Cancer Institute, 2013, SEER CANC STAT REV 1; Reiter-Purtill J, 2008, J PEDIATR PSYCHOL, V33, P422, DOI 10.1093/jpepsy/jsm077; Shepherd EJW, 2011, J PEDIATR ONCOL NURS, V28, P231, DOI 10.1177/1043454211409583; Skalla KA, 2013, CLIN J ONCOL NURS, V17, P500, DOI 10.1188/13.CJON.17-05AP; Stewart M J, 1994, Can J Nurs Res, V26, P61; Sullivan-Bolyai Susan, 2004, Pediatr Nurs, V30, P52; Sullivan-Bolyai Susan, 2003, Pediatr Nurs, V29, P457; Wells Diane Keegan, 2002, J Pediatr Nurs, V17, P201, DOI 10.1053/jpdn.2002.124113; Xu JY, 2012, PROG TRANSPLANT, V22, P41, DOI 10.7182/pit2012815	42	0	0	ONCOLOGY NURSING SOC	PITTSBURGH	125 ENTERPRISE DR, PITTSBURGH, PA 15275 USA	0190-535X	1538-0688		ONCOL NURS FORUM	Oncol. Nurs. Forum	MAY	2015	42	3					222	229		10.1188/15.ONF.222-229		8	Oncology; Nursing	Oncology; Nursing	CH7QZ	WOS:000354233000005		
J	Takahashi, Y; Kakizaki, H				Takahashi, Yasuhiro; Kakizaki, Hirohiko			Meibomian Gland Dysfunction in Cranial Nerve VII Palsy	OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							DRY EYE; MARGIN	Purpose: To examine clinical findings on meibomian gland dysfunction (MGD) in patients with unilateral cranial nerve VII (CN VII) palsy. Methods: This prospective observational study included 35 patients with unilateral CN VII palsy. The following features were compared between the affected and the unaffected sides: incidence of eyelid abnormalities (irregular eyelid margin, vascular engorgement, and plugged meibomian gland orifices), Marx line score, meibom expression score, area and density scores for corneal fluorescein staining, Schirmer test I (without topical anesthesia), and tear break-up time. Results: The affected side demonstrated significantly higher incidences of vascular engorgement (p = 0.004) and plugged meibomian gland orifices (p < 0.001) than the unaffected side. The incidence of an irregular eyelid margin was similar for both sides (p = 0.168). The scores for the Marx line (p < 0.001), meibom expression (p < 0.001), area (p = 0.034), and density (p = 0.026) were significantly higher for the affected side than for the unaffected side. The affected side showed a significantly higher Schirmer value than the unaffected side (p = 0.030). Tear break-up time was significantly shorter on the affected side than on the unaffected side (p = 0.023). Conclusions: MGD was more markedly demonstrated on the affected side in patients with unilateral CN VII palsy.	[Takahashi, Yasuhiro; Kakizaki, Hirohiko] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 4801195, Japan	Takahashi, Y (reprint author), Aichi Med Univ, Dept Ophthalmol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	yasuhiro_tak_oprs@yahoo.co.jp					Al-Faky YH, 2013, BRIT J OPHTHALMOL, V97, P1325, DOI 10.1136/bjophthalmol-2013-303662; Amano S, 2010, J EYE, V27, P627; Kakizaki H, 2008, OPHTHAL PLAST RECONS, V24, P126, DOI 10.1097/IOP.0b013e3181647cb2; Arita R, 2013, BRIT J OPHTHALMOL, V97, P725, DOI 10.1136/bjophthalmol-2012-302668; Arita R, 2009, OPHTHALMOLOGY, V116, P2058, DOI 10.1016/j.ophtha.2009.04.037; Lee V, 2004, EYE, V18, P1225, DOI 10.1038/sj.eye.6701383; Shimazaki J, 1998, OPHTHALMOLOGY, V105, P1485, DOI 10.1016/S0161-6420(98)98033-2; Yokoi N, 1999, ARCH OPHTHALMOL-CHIC, V117, P723; MATHERS WD, 1991, CORNEA, V10, P277, DOI 10.1097/00003226-199107000-00001; Yamaguchi M, 2006, AM J OPHTHALMOL, V141, P669, DOI 10.1016/j.ajo.2005.11.004; Miyata K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1537, DOI 10.1001/archopht.121.11.1537; Bron AJ, 2011, OCUL SURF, V9, P92; Call CB, 2012, OPHTHAL PLAST RECONS, V28, P396, DOI 10.1097/IOP.0b013e3182611641; Goto E, 2006, AM J OPHTHALMOL, V142, P264, DOI 10.1016/j.ajo.2006.03.022; Ho MC, 2014, JAMA OPHTHALMOL, V132, P332, DOI 10.1001/jamaophthalmol.2013.6243; Kang Hyera, 2012, Orbit, V31, P279, DOI 10.3109/01676830.2012.694957; Lipham WJ, 2002, OPHTHALMIC PLAST REC, V18, P93, DOI 10.1097/00002341-200203000-00002; Mavrikakis Ioannis, 2008, Orbit, V27, P466, DOI 10.1080/01676830802352543; Qiao Jing, 2013, Clin Ophthalmol, V7, P1797, DOI 10.2147/OPTH.S33182; Shah CT, 2012, OPHTHAL PLAST RECONS, V28, P166, DOI 10.1097/IOP.0b013e31823f2f82	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0740-9303	1537-2677		OPHTHAL PLAST RECONS	Ophthalmic Plast. Reconstr. Surg.	MAY-JUN	2015	31	3					179	181		10.1097/IOP.0000000000000235		3	Ophthalmology; Surgery	Ophthalmology; Surgery	CH7MZ	WOS:000354222200015		
J	Tronciu, VZ; Rusu, S; Yamada, M				Tronciu, V. Z.; Rusu, S.; Yamada, Minoru			InGaN tandem blue-violet quantum well lasers with high frequency self-pulsations	OPTICAL AND QUANTUM ELECTRONICS			English	Article						InGaN multi-quantum well structure; Self-pulsations; Tandem blue lasers	SEMICONDUCTOR-LASERS; SPONTANEOUS EMISSION; THEORETICAL-ANALYSIS; ROOM-TEMPERATURE; DIODES; NOISE	Theoretical investigations have been carried out to study the dynamics of tandem blue-violet lasers. The theoretical results show that self-pulsating operations are possible when one of the regions is adjusted with an external electric circuit. Self-pulsation with high frequencies has been observed in the numerical calculations. We found that features of the external circuit strongly affect the self-pulsation. Influence of device and material parameters on the laser dynamics was also investigated.	[Tronciu, V. Z.; Rusu, S.] Tech Univ Moldova, Dept Phys, Kishinev 2004, Moldova; [Yamada, Minoru] Kanazawa Univ, Inst Sci & Engn, Fac Elect & Comp Engn, Kanazawa, Ishikawa 9201192, Japan	Tronciu, VZ (reprint author), Tech Univ Moldova, Dept Phys, Kishinev 2004, Moldova.	tronciu@mail.utm.md; myamada@t.kanazawa-u.ac.jp			CIM - Returning Experts Programme;  [106 b/s - 11.817.05.17F];  [STCU 5937/14.820.18.02.012]	VZT and SSR acknowledge the support of projects 106 b/s - 11.817.05.17F and STCU 5937/14.820.18.02.012. VZT acknowledges the support from the CIM - Returning Experts Programme.	YAMADA M, 1994, IEEE J QUANTUM ELECT, V30, P1511, DOI 10.1109/3.299482; Kneissl M, 1999, APPL PHYS LETT, V75, P581, DOI 10.1063/1.124448; YAMADA M, 1993, IEEE J QUANTUM ELECT, V29, P1330, DOI 10.1109/3.236146; Jho YD, 2001, APPL PHYS LETT, V79, P1130, DOI 10.1063/1.1396315; AVRUTIN EA, 1993, IEE PROC-J, V140, P16; Avrutin E. A., 2005, OPTOELECTRONIC DEVIC, P151; Carr TW, 2001, IEEE J QUANTUM ELECT, V37, P1171, DOI 10.1109/3.945322; DIXON RW, 1979, IEEE J QUANTUM ELECT, V15, P470, DOI 10.1109/JQE.1979.1070024; Fairgrieve TF, 1997, AUTO97 CONTINUATION; Egan A, 1996, IEE P-OPTOELECTRON, V143, P31, DOI 10.1049/ip-opt:19960132; HENRY CH, 1980, J APPL PHYS, V51, P3051, DOI 10.1063/1.328092; Ito S, 2003, PHYS STATUS SOLIDI A, V200, P131, DOI 10.1002/pssa.200303345; KUZNETSOV M, 1985, IEEE J QUANTUM ELECT, V21, P587, DOI 10.1109/JQE.1985.1072706; MATSUI S, 1983, APPL PHYS LETT, V43, P219, DOI 10.1063/1.94306; Nagahama S, 2001, JPN J APPL PHYS 2, V40, pL788, DOI 10.1143/JJAP.40.L788; Nakamura S, 2000, BLUE LASER DIODE; Ohno T, 2003, APPL PHYS LETT, V83, P1098, DOI 10.1063/1.1599622; Sun CK, 1997, APPL PHYS LETT, V71, P425, DOI 10.1063/1.119568; Tronciu V. Z., 2005, J SCI ENG, V4, P7; Tronciu VZ, 2004, OPT COMMUN, V235, P409, DOI 10.1016/j.optcom.2004.02.070; Tronciu VZ, 2003, PHYS STATUS SOLIDI C, V0, P2296, DOI 10.1002/pssc.200303377; Tronciu VZ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.026604; Tronciu VZ, 2003, IEEE J QUANTUM ELECT, V39, P1509, DOI 10.1109/JQE.2003.819541; Yamada M, 1996, J APPL PHYS, V79, P61, DOI 10.1063/1.360791	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0306-8919	1572-817X		OPT QUANT ELECTRON	Opt. Quantum Electron.	MAY	2015	47	5					1047	1054		10.1007/s11082-014-9960-9		8	Engineering, Electrical & Electronic; Optics	Engineering; Optics	CH7JU	WOS:000354213100006		
J	Xu, J; Ueda, J; Tanabe, S				Xu, Jian; Ueda, Jumpei; Tanabe, Setsuhisa			Design of deep-red persistent phosphors of Gd3Al5-xGaxO12:Cr3+ transparent ceramics sensitized by Eu3+ as an electron trap using conduction band engineering	OPTICAL MATERIALS EXPRESS			English	Article							HIGH-BRIGHTNESS; LUMINESCENCE; MECHANISM; GARNET; DY3+; EU&3	We developed bright deep-red persistent phosphors of Cr3+-Eu3+ co-doped Gd3Al5-xGaxO12 garnet (GAGG:Cr3+-Eu3+), in which only Cr3+ ion shows emission bands centered at 730 nm after ceasing UV illumination and Eu3+ ion acts as an excellent electron trap capturing one electron to be Eu2+ with tunable trap depth by varying conduction band with Ga3+ content, x. The persistent radiance of the GGG:Cr3+-Eu3+ (x = 5) sample at 1 h after ceasing UV light is approximately 25 times higher than that of the Cr3+ singly doped GGG sample, and is over 6 times higher than that of the widely used ZnGa2O4:Cr3+ red persistent phosphor. (C)2015 Optical Society of America	[Xu, Jian; Ueda, Jumpei; Tanabe, Setsuhisa] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan	Xu, J (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan.	tanabe.setsuhisa.4v@kyoto-u.ac.jp			JSPS KAKENHI [25620184]	We would like to acknowledge Prof. Bruno Viana from Chimie Paris-tech and Dr. Yixi Zhuang from Xiamen University for fruitful discussions on persistent phosphors. This work was supported by JSPS KAKENHI Grant Number 25620184.	Ueda J, 2010, J AM CERAM SOC, V93, P3084, DOI 10.1111/j.1551-2916.2010.04065.x; Dorenbos P, 2003, J PHYS-CONDENS MAT, V15, P8417, DOI 10.1088/0953-8984/15/49/018; Van den Eeckhout K, 2010, MATERIALS, V3, P2536, DOI 10.3390/ma3042536; Zhuang YX, 2014, J MATER CHEM C, V2, P5502, DOI 10.1039/c4tc00369a; Ueda J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868138; Maldiney T, 2014, NAT MATER, V13, P418, DOI 10.1038/NMAT3908; BLASSE G, 1993, J ALLOY COMPD, V200, P17, DOI 10.1016/0925-8388(93)90464-X; BLASSE G, 1967, J INORG NUCL CHEM, V29, P2231, DOI 10.1016/0022-1902(67)80277-X; Matsuzawa T, 1996, J ELECTROCHEM SOC, V143, P2670, DOI 10.1149/1.1837067; Wang XX, 2003, MATER CHEM PHYS, V80, P1, DOI 10.1016/S0254-0584(02)00097-4; Ueda J, 2013, OPT MATER, V35, P1952, DOI 10.1016/j.optmat.2012.11.016; FONGER WH, 1970, J CHEM PHYS, V52, P6364, DOI 10.1063/1.1672952; Dorenbos P, 2005, J ELECTROCHEM SOC, V152, pH107, DOI 10.1149/1.1926652; Singh SK, 2014, RSC ADV, V4, P58674, DOI 10.1039/c4ra08847f; Van den Eeckhout K, 2013, MATERIALS, V6, P2789, DOI 10.3390/ma6072789; Ueda J, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.062201; Dorenbos P, 2013, J LUMIN, V134, P310, DOI 10.1016/j.jlumin.2012.08.028; Pan ZW, 2012, NAT MATER, V11, P58, DOI [10.1038/nmat3173, 10.1038/NMAT3173]; Bessiere A, 2011, OPT EXPRESS, V19, P10131, DOI 10.1364/OE.19.010131; FOREST H, 1968, J ELECTROCHEM SOC, V115, pC64; Ueda J, 2011, J APPL PHYS, V110, DOI 10.1063/1.3632069; Ueda J, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.042602; Xu J., SCR MAT IN PRESS; Xu J, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.042602; Yamamoto H, 1997, J LUMIN, V72-4, P287, DOI 10.1016/S0022-2313(97)00012-4; You FT, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.115101; Zhuang YX, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.052602; Zhuang YX, 2013, J MATER CHEM C, V1, P7849, DOI 10.1039/c3tc31462f; Zhuang YX, 2014, OPT MATER, V36, P1907, DOI 10.1016/j.optmat.2014.05.035	29	2	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2159-3930			OPT MATER EXPRESS	Opt. Mater. Express	MAY 1	2015	5	5					963	968		10.1364/OME.5.000963		6	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CH3IB	WOS:000353922700005		
J	Hidai, H; Matsushita, M; Matsusaka, S; Akira, C; Morita, N				Hidai, Hirofumi; Matsushita, Makoto; Matsusaka, Souta; Akira, Chiba; Morita, Noboru			Laser-induced nickel sphere migration and nanoparticle precipitation in silica glass	OPTICAL MATERIALS EXPRESS			English	Article							BACKSIDE IRRADIATION; BOROSILICATE GLASS; ION IMPLANTATION; SIO2; DIFFUSION; DIOXIDE	Techniques to control the colors and properties of glasses based on doping of the glasses with various metals and nanoparticles are widely used. In this paper, we demonstrate the migration of a nickel sphere in silica glass caused by laser illumination accompanied by nickel nanoparticle precipitation in the sphere migration trajectory. During migration, the diameter of the nickel sphere decreased. Precipitated nanoparticles with diameters of several hundred nanometers were observed in areas of up to 50 mu m in radius and these nanoparticles formed four cylindrical coaxial layers with stripes at 10-20 mu m intervals in the migration direction. (C)2015 Optical Society of America	[Hidai, Hirofumi; Matsushita, Makoto; Matsusaka, Souta; Akira, Chiba; Morita, Noboru] Chiba Univ, Dept Mech Engn, Inage Ku, Chiba 2638522, Japan	Hidai, H (reprint author), Chiba Univ, Dept Mech Engn, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	hidai@faculty.chiba-u.jp			Japan Society for the Promotion of Science [24656096]	The authors gratefully acknowledge T. Kishi and S. Itoh for their helpful comments. The support of the Japan Society for the Promotion of Science through a Grant-in-Aid for Scientific Research (no. 24656096) is also gratefully acknowledged.	Amekura H, 2004, NUCL INSTRUM METH B, V219, P825, DOI 10.1016/j.nimb.2004.01.171; Amekura H, 2005, NUCL INSTRUM METH B, V230, P193, DOI 10.1016/j.nimb.2004.12.039; Amekura H, 2004, NUCL INSTRUM METH B, V222, P114, DOI 10.1016/j.nimb.2004.01.214; Qiu JR, 2004, OPT LETT, V29, P370, DOI 10.1364/OL.29.000370; RAMASWAMY RV, 1988, J LIGHTWAVE TECHNOL, V6, P984, DOI 10.1109/50.4090; Qiu JR, 1999, OPT LETT, V24, P786, DOI 10.1364/OL.24.000786; Hidai H, 2013, OPT EXPRESS, V21, P18955, DOI 10.1364/OE.21.018955; Borisov AA, 2006, PETROLOGY+, V14, P530, DOI 10.1134/S0869591106060026; GHOSHTAG.RN, 1969, J APPL PHYS, V40, P4374, DOI 10.1063/1.1657201; HARANOH T, 1982, J MATER SCI, V17, P1493, DOI 10.1007/BF00752265; Hidai H, 2010, OPT EXPRESS, V18, P20313, DOI 10.1364/OE.18.020313; Hidai H, 2009, APPL PHYS A-MATER, V96, P869, DOI 10.1007/s00339-009-5324-x; Hidai H, 2010, J AM CERAM SOC, V93, P1597, DOI 10.1111/j.1551-2916.2010.03615.x; Jiang XW, 2004, CHEM PHYS LETT, V391, P91, DOI 10.1016/j.cplett.2004.04.061; Louis C, 2012, GOLD NANOPARTICLES FOR PHYSICS, CHEMISTRY AND BIOLOGY, P1, DOI 10.1142/p815; Matsusaka S, 2012, J PHYS CONF SER, V379, DOI 10.1088/1742-6596/379/1/012035; Matsusaka S, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895521; MAYER JT, 1992, SURF SCI, V265, P102, DOI 10.1016/0039-6028(92)90491-N; RODNEY WS, 1954, J OPT SOC AM, V44, P677, DOI 10.1364/JOSA.44.000677	19	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2159-3930			OPT MATER EXPRESS	Opt. Mater. Express	MAY 1	2015	5	5					1006	1015		10.1364/OME.5.001006		10	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CH3IB	WOS:000353922700010		
J	Cai, B; Kaino, T; Sugihara, O				Cai, Bin; Kaino, Toshikuni; Sugihara, Okihiro			Sulfonyl-containing polymer and its alumina nanocomposite with high Abbe number and high refractive index	OPTICAL MATERIALS EXPRESS			English	Article							OPTICAL-PROPERTIES; FILMS; STABILITY; HYBRIDS	In this study, we focus on refractive-index and Abbe-number improvements to optical polyesters. First, we modify polymers by introducing sulfonyl groups and removing phenyl groups in the monomer structure. In this manner, new polymers with Abbe numbers higher than 40 are synthesized. To further increase the refractive index and Abbe number, the polymers are hybridized with well-dispersed alumina nanoparticles (NPs). The prepared polymer/alumina nanocomposites have a high refractive index and Abbe number; (n(D) = 1.580 and V-D = 55) and (n(D) = 1.631 and V-D = 53), which easily exceeds the empirical "limiting line" of conventional optical polymers. (C) 2015 Optical Society of America	[Cai, Bin] Univ Shanghai Sci & Technol, Engn Res Ctr Opt Instrument & Syst, Minist Educ, Shanghai 200093, Peoples R China; [Cai, Bin] Univ Shanghai Sci & Technol, Shanghai Key Lab Modern Opt Syst, Shanghai 200093, Peoples R China; [Kaino, Toshikuni] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Sugihara, Okihiro] Utsunomiya Univ, Ctr Opt Res & Educ, Utsunomiya, Tochigi 3218585, Japan	Cai, B (reprint author), Univ Shanghai Sci & Technol, Engn Res Ctr Opt Instrument & Syst, Minist Educ, Shanghai 200093, Peoples R China.	bullcai@gmail.com			Major National Development Project of Scientific Instrument and Equipment [2012YQ14000504, 2011YQ150021]; National Natural Science Foundation of China [61377111, 61138001, 61205094, 61307126]; Ability Enhancement Project of Shanghai Science and Technology Committee [12510502300]	This work is partly supported by the Major National Development Project of Scientific Instrument and Equipment (2012YQ14000504, 2011YQ150021), National Natural Science Foundation of China (61377111, 61138001, 61205094, 61307126), and the Ability Enhancement Project of Shanghai Science and Technology Committee (12510502300).	YANG CJ, 1995, MACROMOLECULES, V28, P1180, DOI 10.1021/ma00108a054; Caseri WR, 2006, MATER SCI TECH-LOND, V22, P807, DOI 10.1179/174328406X101256; Abe K, 2013, POLYM INT, V62, P141, DOI 10.1002/pi.4285; Liu JG, 2009, J MATER CHEM, V19, P8907, DOI 10.1039/b909690f; Zhang QY, 2013, J APPL POLYM SCI, V129, P1793, DOI 10.1002/app.38883; Okutsu R, 2008, MACROMOLECULES, V41, P6165, DOI 10.1021/ma800797p; Braun MM, 2006, THIN SOLID FILMS, V496, P505, DOI 10.1016/j.tsf.2005.08.173; Cai B, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.092601; DISLICH H, 1973, ANGEW CHEM INT EDIT, V12, P439, DOI 10.1002/anie.197304391; DISLICH H, 1979, ANGEW CHEM INT EDIT, V18, P49, DOI 10.1002/anie.197900491; Jha G. S., 2008, E POLY, V8, P376; Liou GS, 2010, J POLYM SCI POL CHEM, V48, P1433, DOI 10.1002/pola.23914; Lv C. L., 2009, J MATER CHEM, V19, P2884; Matsuda T, 2000, J APPL POLYM SCI, V76, P45, DOI 10.1002/(SICI)1097-4628(20000404)76:1<45::AID-APP6>3.0.CO;2-M; Okubo T, 1998, J APPL POLYM SCI, V68, P1791, DOI 10.1002/(SICI)1097-4628(19980613)68:11<1791::AID-APP10>3.0.CO;2-Y; Potzsch R., POLYM CHEM, V5, P2911; Russo M, 2012, J POLYM SCI POL PHYS, V50, P65, DOI 10.1002/polb.22373; Speight J. G., 2005, LANGES HDB CHEM, V16th, P508; Suri G., 2010, J NANOTECHNOLOGY; Yu YY, 2013, THIN SOLID FILMS, V546, P236, DOI 10.1016/j.tsf.2013.05.038	20	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2159-3930			OPT MATER EXPRESS	Opt. Mater. Express	MAY 1	2015	5	5					1210	1216		10.1364/OME.5.001210		7	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CH3IB	WOS:000353922700028		
J	Cheng, TL; Sakai, Y; Suzuki, T; Ohishi, Y				Cheng, Tonglei; Sakai, Yukiko; Suzuki, Takenobu; Ohishi, Yasutake			Fabrication and characterization of an all-solid tellurite - phosphate photonic bandgap fiber	OPTICS LETTERS			English	Article							MICROSTRUCTURED OPTICAL-FIBERS; CRYSTAL FIBERS; GENERATION; DISPERSION; GUIDANCE	We present an all-solid tellurite-phosphate photonic bandgap fiber (PBGF) with two layers of high-index rods (TeO2-Li2O-WO3-MoO3-Nb2O5, TLWMN) in the cladding (TeO2-ZnO-Li2O-K2O-Al2O3-P2O5, TZLKAP). TLWMN and TZLKAP glasses have good compatibility for fabricating the all-solid PBGF. Photonic bandgap (PBG) properties are calculated by the plane wave expansion method (PWM), and the results agree well with the measured transmission spectrum. Furthermore, the modal field patterns are measured at similar to 1300 and 1520 nm, respectively. The light is confined to the core at similar to 1300 nm and lost in the cladding at similar to 1520 nm, which match well with the calculated modal field intensities. (C) 2015 Optical Society of America	[Cheng, Tonglei; Sakai, Yukiko; Suzuki, Takenobu; Ohishi, Yasutake] Toyota Technol Inst, Res Ctr Adv Photon Technol, Tempaku Ku, Nagoya, Aichi 4688511, Japan	Cheng, TL (reprint author), Toyota Technol Inst, Res Ctr Adv Photon Technol, Tempaku Ku, 2-12-1 Hisakata, Nagoya, Aichi 4688511, Japan.	chengtonglei@gmail.com			JSPS; MEXT; Support Program for Forming Strategic Research Infrastructure; Daiko Foundation	Tonglei Cheng acknowledges the support of the JSPS Postdoctoral Fellowship. This work is supported by MEXT, the Support Program for Forming Strategic Research Infrastructure (2011-2015) and Daiko Foundation.	Luan F, 2004, OPT LETT, V29, P2369, DOI 10.1364/OL.29.002369; Granzow N, 2011, OPT LETT, V36, P2432, DOI 10.1364/OL.36.002432; Dudley JM, 2009, NAT PHOTONICS, V3, P85, DOI 10.1038/NPHOTON.2008.285; Lousteau J, 2012, OPT LETT, V37, P4922, DOI 10.1364/OL.37.004922; Litchinitser NM, 2002, OPT LETT, V27, P1592, DOI 10.1364/OL.27.001592; Smith CM, 2003, NATURE, V424, P657, DOI 10.1038/nature01849; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; Kuhlmey BT, 2009, J LIGHTWAVE TECHNOL, V27, P1617, DOI 10.1109/JLT.2009.2021142; Guo SP, 2003, OPT EXPRESS, V11, P167, DOI 10.1364/OE.11.000167; White TP, 2002, OPT LETT, V27, P1977, DOI 10.1364/OL.27.001977; Klimczak M, 2014, OPT EXPRESS, V22, P18824, DOI 10.1364/OE.22.018824; Knight JC, 2006, JPN J APPL PHYS 1, V45, P6059, DOI 10.1143/JJAP.45.6059; Saitoh K, 2010, OPT FIBER TECHNOL, V16, P409, DOI 10.1016/j.yofte.2010.08.007; Caillaud C, 2014, MATERIALS, V7, P6120, DOI 10.3390/ma7096120; Cheng TL, 2014, OPT LETT, V39, P1005, DOI 10.1364/OL.39.001005; Geng YF, 2011, OPT EXPRESS, V19, P8167, DOI 10.1364/OE.19.008167; Gu GC, 2014, OPT EXPRESS, V22, P13962, DOI 10.1364/OE.22.013962; Liu BW, 2008, IEEE PHOTONIC TECH L, V20, P581, DOI 10.1109/LPT.2008.918816; Martynkien T, 2014, OPT LETT, V39, P2342, DOI 10.1364/OL.39.002342; Schmidt MA, 2009, OPT LETT, V34, P1946, DOI 10.1364/OL.34.001946; St P., 2006, J LIGHTWAVE TECHNOL, V24, P4729; Tong H. T., 2009, OPT MATER, V31, P1795; Tong H. T., 2012, PHYS STATUS SOLIDI C, V9, P2598; Wang LF, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4870630	24	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	MAY 1	2015	40	9					2088	2090		10.1364/OL.40.002088		3	Optics	Optics	CH3IQ	WOS:000353924600053		
J	Kurokawa, K; Makita, S; Hong, YJ; Yasuno, Y				Kurokawa, Kazuhiro; Makita, Shuichi; Hong, Young-Joo; Yasuno, Yoshiaki			In-plane and out-of-plane tissue micro-displacement measurement by correlation coefficients of optical coherence tomography	OPTICS LETTERS			English	Article							ELASTOGRAPHY; OCT; STRAIN	We propose a method to measure the in-plane and out-of-plane displacements of tissue using the correlation coefficients of optical coherence tomography (OCT) signals. The displacements are determined by the local correlation coefficients between digitally shifted reference OCT images and a target image. The method achieves sub-micron displacement measurement with an accuracy better than 0.32 mu m and repeatability better than 0.36 mu m. The feasibility of the method was examined by measuring the displacement field of a laser irradiated porcine retina. This method successfully visualized the dynamic change of the displacement field during laser irradiation. (C) 2015 Optical Society of America	[Kurokawa, Kazuhiro; Makita, Shuichi; Hong, Young-Joo; Yasuno, Yoshiaki] Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki 3058573, Japan; [Kurokawa, Kazuhiro; Makita, Shuichi; Hong, Young-Joo; Yasuno, Yoshiaki] Computat Opt & Ophthalmol Grp, Tsukuba, Ibaraki 3058573, Japan	Yasuno, Y (reprint author), Univ Tsukuba, Computat Opt Grp, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	yasuno@optlab2.bk.tsukuba.ac.jp	Makita, Shuichi/G-3806-2011; Yasuno, Yoshiaki/F-2586-2011	Makita, Shuichi/0000-0002-6614-3640; Yasuno, Yoshiaki/0000-0003-1645-7948	Nidek Co. Ltd.	This research was supported in part by Nidek Co. Ltd.	Kennedy BF, 2011, OPT EXPRESS, V19, P6623, DOI 10.1364/OE.19.006623; Kurokawa K, 2015, BIOMED OPT EXPRESS, V6, P170, DOI 10.1364/BOE.6.000170; Schmitt JM, 1998, OPT EXPRESS, V3, P199; Liu X, 2012, OPT EXPRESS, V20, P16567, DOI 10.1364/OE.20.016567; Wang RKK, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2357854; Makita S, 2014, OPT EXPRESS, V22, P4830, DOI 10.1364/OE.22.004830; Muller HH, 2012, BIOMED OPT EXPRESS, V3, P1025, DOI 10.1364/BOE.3.001025	7	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	MAY 1	2015	40	9					2153	2156		10.1364/OL.40.002153		4	Optics	Optics	CH3IQ	WOS:000353924600071		
J	Furumatsu, T; Fujii, M; Tanaka, T; Miyazawa, S; Ozaki, T				Furumatsu, T.; Fujii, M.; Tanaka, T.; Miyazawa, S.; Ozaki, T.			The figure-of-nine leg position for anatomic anterior cruciate ligament reconstruction	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Anterior cruciate ligament reconstruction; Double-bundle reconstruction; Femoral tunnel; Figure-of-nine position	ATTACHMENTS; INJURY; TENDON	Anatomic double-bundle anterior cruciate ligament (ACL) reconstruction can restore the function and kinematics of the knee in ACL-deficient patients. Several outside-in drilling systems for accurate femoral tunnel creations have been developed. However, the femoral tunnel creation at the lower position of the intercondylar notch can be difficult in a usual leg position with the knee flexed at 90 degrees without varus stress. This technical note describes that the figure-of-nine leg position provides a better arthroscopic view to safely clean up the ACL femoral footprint located at the lower area of the lateral intercondylar wall. This position is useful to create the optimal femoral tunnels using the outside-in drilling technique, without damaging the lateral meniscus posterior root, lateral tibial eminence, and supplemental fibers that bridge the gap between the lateral meniscus and the ACL tibial insertion. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Furumatsu, T.; Fujii, M.; Tanaka, T.; Miyazawa, S.; Ozaki, T.] Okayama Univ, Dept Orthopaed Surg, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan	Furumatsu, T (reprint author), Okayama Univ, Dept Orthopaed Surg, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	matino@md.okayama-u.ac.jp	FURUMATSU, Takayuki/B-2233-2011				Ferretti M, 2007, ARTHROSCOPY, V23, P1218, DOI 10.1016/j.arthro.2007.09.008; Woo SLY, 2002, J BONE JOINT SURG AM, V84A, P907; Hara K, 2009, AM J SPORT MED, V37, P2386, DOI 10.1177/0363546509340404; Johannsen AM, 2012, AM J SPORT MED, V40, P2342, DOI 10.1177/0363546512457642; Furumatsu T, 2014, INT ORTHOP, V38, P1393, DOI 10.1007/s00264-013-2238-1; Yasuda K, 2006, ARTHROSCOPY, V22, P240, DOI 10.1016/j.arthro.2005.12.017; Ellman MB, 2014, AM J SPORT MED, V42, P1881, DOI 10.1177/0363546514531730; Fujii M, 2014, KNEE SURG SPORTS TRA; Kamei G, 2014, ORTHOP TRAUMATOL-SUR, V100, P827, DOI 10.1016/j.otsr.2014.06.016; Okazaki K, 2014, ARTHROSCOPY, V30, P841, DOI 10.1016/j.arthro.2014.03.004; Sonnery-Cottet B, 2007, ARTHROSCOPY, V23, P1128; Sonnery-Cottet B, 2007, ARTHROSCOPY, V23, DOI 10.1016/j.arthro.2006.11.028; Tejwani SG, 2000, ORTHOPEDICS, V23, P1153	13	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	MAY	2015	101	3					391	393		10.1016/j.otsr.2014.12.015		3	Orthopedics; Surgery	Orthopedics; Surgery	CH4CA	WOS:000353977600021		
J	Nakanishi, T; Fukuzawa, K; Yoshida, A; Itoh, M; Imamura, K; Fujiwara, R; Suzuki, A; Yamashita, S; Matsumoto, A; Konishi, H; Ichibori, H; Hirata, KI				Nakanishi, Tomoyuki; Fukuzawa, Koji; Yoshida, Akihiro; Itoh, Mitsuaki; Imamura, Kimitake; Fujiwara, Ryudo; Suzuki, Atsushi; Yamashita, Soichiro; Matsumoto, Akinori; Konishi, Hiroki; Ichibori, Hirotoshi; Hirata, Ken-Ichi			Crista Terminalis as the Anterior Pathway of Typical Atrial Flutter: Insights from Entrainment Map with 3D Intracardiac Ultrasound	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						crista terminalis; atrial flutter; electrophysiology - clinical; mapping; intracardiac echo	NONCONTACT MAPPING SYSTEM; CATHETER ABLATION; TRICUSPID ANNULUS; FUNCTIONAL BLOCK; REENTRY CIRCUIT; SINUS VENOSA; ECHOCARDIOGRAPHY; ACTIVATION; CONDUCTION; POSTERIOR	BackgroundThe precise location of truly active reentry circuits of typical atrial flutter (AFL) has not been well identified. The purpose of this study was to verify our hypothesis that the posterior block line is located along the posteromedial right atrium (PMRA) and the crista terminalis (CT) is the anterior pathway of AFL, with real-time intracardiac echo (ICE). MethodsThe entire right atrium (RA) three-dimensional activation and entrainment mapping were evaluated during AFL in 18 patients using CARTO sound. ResultsThe CT was clearly visualized by ICE and the local electrograms along the CT were single potentials in all the patients. The CT was recognized as the truly active anterior pathway based on entrainment mapping in all patients. Double potentials were recorded along the PMRA. Entire RA entrainment mapping could be performed in 16 patients. The reentry circuits were separated into three passages. The first was around the tricuspid annulus (TA), the second the anterior superior vena cava (SVC; AFL waves passed between the anterior SVC and RA appendage), and the last the posterior SVC (between the posterior SVC and upper limit of the PMRA). All three of these passages were active in four, around the TA and anterior SVC in eight, around the TA and posterior SVC in three, and around only the anterior SVC in one patient. ConclusionsThe CT functions as the anterior pathway of typical AFL, and the posterior block line was located along the PMRA. Dual or triple circuits were recognized in the majority of AFL patients.	[Nakanishi, Tomoyuki; Fukuzawa, Koji; Yoshida, Akihiro; Itoh, Mitsuaki; Imamura, Kimitake; Fujiwara, Ryudo; Suzuki, Atsushi; Yamashita, Soichiro; Matsumoto, Akinori; Konishi, Hiroki; Ichibori, Hirotoshi; Hirata, Ken-Ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan; [Fukuzawa, Koji; Yoshida, Akihiro] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Sect Arrhythmia, Kobe, Hyogo 6500017, Japan	Fukuzawa, K (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Sect Arrhythmia,Chuoh Ku, Kusunoki Cho 7-5-2, Kobe, Hyogo 6500017, Japan.	kfuku@med.kobe-u.ac.jp			Medtronic JAPAN; St. Jude Medical JAPAN	This work was not supported by any grants. The Section of Arrhythmia is financially supported by Medtronic JAPAN and St. Jude Medical JAPAN.	Sanchez-Quintana D, 2013, J CARDIOVASC TRANSL, V6, P124, DOI 10.1007/s12265-013-9447-2; Zhang SL, 2004, CIRCULATION, V109, P1630, DOI 10.1161/01.CIR.0000124221.84399.48; Nakagawa H, 1996, CIRCULATION, V94, P407; OLGIN JE, 1995, CIRCULATION, V92, P1839; Friedman PA, 2000, CIRCULATION, V101, P1568; Okumura Y, 2008, CIRC-ARRHYTHMIA ELEC, V1, P110, DOI 10.1161/CIRCEP.108.769935; Kalman JM, 1996, CIRCULATION, V94, P398; POTY H, 1995, CIRCULATION, V92, P1389; Becker R, 2001, CIRCULATION, V103, P2521; Chen JA, 2003, J CARDIOVASC ELECTR, V14, P1041, DOI 10.1046/j.1540-8167.2003.03068.x; Cosio FG, 1996, PACE, V19, P841, DOI 10.1111/j.1540-8159.1996.tb03368.x; Fujiki A, 2004, J CARDIOVASC ELECTR, V15, P679, DOI 10.1046/j.1540-8167.2004.03579.x; Fukuzawa K, 2008, PACE, V31, P1160, DOI 10.1111/j.1540-8159.2008.01157.x; Gonzalez MD, 2005, J CARDIOVASC ELECTR, V16, P193, DOI 10.1046/j.1540-8167.2005.40483.x; Ishida A, 2003, CIRC J, V67, P940, DOI 10.1253/circj.67.940; Li-jun Jin, 2012, Cell Biochem Biophys, V62, P267, DOI 10.1007/s12013-011-9290-5; Maury P, 2008, EUROPACE, V10, P190, DOI 10.1093/europace/eum296; Okumura Y, 2007, CIRC J, V71, P636, DOI 10.1253/circj.71.636; Okumura Y, 2010, J INTERV CARD ELECTR, V29, P147, DOI 10.1007/s10840-010-9526-0; Otomo K, 2006, PACE, V29, P589, DOI 10.1111/j.1540-8159.2006.00383.x; Rodriguez LM, 2001, CIRCULATION, V104, P2545, DOI 10.1161/hc4601.097996; Santucci PA, 2009, HEART RHYTHM, V6, P1586, DOI 10.1016/j.hrthm.2009.08.010; Schumacher B, 1999, J AM COLL CARDIOL, V34, P363, DOI 10.1016/S0735-1097(99)00211-9; Shah DC, 1997, CIRCULATION, V96, P3904; Tai CT, 2004, J CARDIOVASC ELECTR, V15, P406, DOI 10.1046/j.1540-8167.2004.03535.x; Takami M, 2012, J CARDIOVASC ELECTR, V23, P827, DOI 10.1111/j.1540-8167.2012.02313.x; WALDO AL, 1977, CIRCULATION, V56, P737	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	MAY	2015	38	5					608	616		10.1111/pace.12597		9	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	CH4EY	WOS:000353987200010		
J	Makimoto, H; Nakajima, I; Miyamoto, K; Yamada, Y; Okamura, H; Noda, T; Aiba, T; Kamakura, S; Kusano, K; Shimizu, W; Satomi, K				Makimoto, Hisaki; Nakajima, Ikutaro; Miyamoto, Koji; Yamada, Yuko; Okamura, Hideo; Noda, Takashi; Aiba, Takeshi; Kamakura, Shiro; Kusano, Kengo; Shimizu, Wataru; Satomi, Kazuhiro			Clinical Impact of Mapping Strategies for Treatment of Ventricular Tachycardias in Patients with Structural Heart Disease	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						ventricular tachycardia; catheter ablation; mapping strategy; inducibility	SINUS RHYTHM; CATHETER ABLATION; DEFIBRILLATOR IMPLANTATION; MYOCARDIAL-INFARCTION; TRIAL; CARDIOMYOPATHY; ORIGIN; DEATH; SITE; SCAR	BackgroundSubstrate-based catheter ablation (CA) can be applied to more complicated cases such as hemodynamically unstable ventricular tachycardia (VT). We aimed to compare the efficacy between substrate-based and activation/entrainment-based ablation. MethodsWe investigated 85 consecutive patients (62 male, 53 16 years) who underwent CA of VT to analyze the relationship between the ablation strategy and clinical outcome. The patients included 34 individuals with arrhythmogenic right ventricular cardiomyopathy, 16 with ischemic heart disease, 14 with dilated cardiomyopathy, 11 with sarcoidosis, and 10 with other heart diseases. The primary strategy was activation/entrainment mapping (Group-AE, N = 35); otherwise, substrate-based strategy was adopted (Group-S, N = 50) because of non-inducibility of VT or hemodynamic instability. Successful CA was defined as the non-inducibility of any VT at the end of the procedure in those with inducible clinical VT before ablation, and substrate elimination in those without. ResultsThere were no significant differences in the left ventricular function, percentage of implantable cardioverter-defibrillator implantations, results of CA, and number of radiofrequency applications between Group-S and Group-AE. During 5 years of follow-up, there were no significant differences in sustained VT recurrences (15/50 vs. 15/35, P = 0.22), and cardiac death (2/50 vs. 3/35, P = 0.38). In patients with inducible VT before ablation, the elimination of the VT inducibility was associated with a lower recurrence rate (12/47 vs. 16/26, P = 0.003). ConclusionsThe substrate-based strategy adopted as an alternative option when the activation/entrainment-based strategy was unable to be performed resulted in a comparable VT recurrence rate. The extinction of VT inducibility achieved a favorable prognosis in structural heart disease patients.	[Makimoto, Hisaki; Nakajima, Ikutaro; Miyamoto, Koji; Yamada, Yuko; Okamura, Hideo; Noda, Takashi; Aiba, Takeshi; Kamakura, Shiro; Kusano, Kengo; Shimizu, Wataru; Satomi, Kazuhiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Div Arrhythmia & Electrophysiol, Suita, Osaka, Japan	Satomi, K (reprint author), Tokyo Med Univ, Hachioji Med Ctr, Div Cardiol, 1163 Tatemachi, Hachioji, Tokyo 1930944, Japan.	VYW02402@nifty.com					STEVENSON WG, 1993, CIRCULATION, V88, P1647; Kuck KH, 2010, LANCET, V375, P31, DOI 10.1016/S0140-6736(09)61755-4; KIENZLE MG, 1984, CIRCULATION, V70, P957; Di Biase L, 2012, J AM COLL CARDIOL, V60, P132, DOI 10.1016/j.jacc.2012.03.044; STEVENSON WG, 1995, J CARDIOVASC ELECTR, V6, P201, DOI 10.1111/j.1540-8167.1995.tb00771.x; CASSIDY DM, 1984, CIRCULATION, V69, P1103; Jais P, 2012, CIRCULATION, V125, P2184, DOI 10.1161/CIRCULATIONAHA.111.043216; Marchlinski FE, 2000, CIRCULATION, V101, P1288; Soejima K, 2001, CIRCULATION, V104, P664, DOI 10.1161/hc3101.093764; Zipes DP, 2006, EUROPACE, V8, P746, DOI 10.1093/europace/eul108; Arenal A, 2003, J AM COLL CARDIOL, V41, P81, DOI 10.1016/S0735-1097(02)02623-2; Bogun F, 2006, J AM COLL CARDIOL, V47, P2013, DOI 10.1016/j.jacc.2005.12.062; Daubert JP, 2006, J AM COLL CARDIOL, V47, P98, DOI 10.1016/j.jacc.2005.08.049; Buxton AE, 2002, CIRCULATION, V106, P2466, DOI 10.1161/01.CIR.0000037224.15873.83; JOSEPHSON ME, 1980, CIRCULATION, V61, P395; ROSENBAUM MS, 1991, J AM COLL CARDIOL, V17, P133; Satomi K, 2006, J CARDIOVASC ELECTR, V17, P469, DOI 10.1111/j.1540-8167.2006.00434.x	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	MAY	2015	38	5					630	640		10.1111/pace.12601		11	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	CH4EY	WOS:000353987200013		
J	Kaneko, K; Kimata, T; Tsuji, S				Kaneko, Kazunari; Kimata, Takahisa; Tsuji, Shoji			Genetic predisposition to hyperuricaemia in rotavirus gastro-enteritis	PAEDIATRICS AND INTERNATIONAL CHILD HEALTH			English	Letter							RENAL-FAILURE; EXCRETION		[Kaneko, Kazunari; Kimata, Takahisa; Tsuji, Shoji] Kansai Med Univ, Dept Pediat, Hirakata, Osaka 5371191, Japan	Kaneko, K (reprint author), Kansai Med Univ, Dept Pediat, 2-5-1 Shin Machi, Hirakata, Osaka 5371191, Japan.	kanekok@hirakata.kmu.ac.jp					Al-Shibli A, 2014, PAEDIATR INT CHILD H, V34, P19, DOI 10.1179/2046905513Y.0000000077; Fujinaga S, 2005, PEDIATR NEPHROL, V20, P239, DOI 10.1007/s00467-004-1675-x; Kaneko K, 2010, PEDIATR NEPHROL, V25, P2187, DOI 10.1007/s00467-010-1490-5; Morita T, 2010, CLIN NEPHROL, V73, P398; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Kaneko K, 2011, PEDIATR NEPHROL, V26, P2261, DOI 10.1007/s00467-011-2005-8; Matsuo H, 2011, NUCLEOS NUCLEOT NUCL, V30, P1098, DOI 10.1080/15257770.2011.627902; Morita T, 2011, PEDIATR NEPHROL, V26, P2259, DOI 10.1007/s00467-011-2003-x	8	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	2046-9047	2046-9055		PAEDIATR INT CHILD H	Paediatr. Int. Child Health	MAY	2015	35	2					165	165		10.1179/2046905515Y.0000000003		1	Pediatrics	Pediatrics	CI1UB	WOS:000354529300013		
J	Andersen, HH; Poulsen, JN; Uchida, Y; Nikbakht, A; Arendt-Nielsen, L; Gazerani, P				Andersen, Hjalte H.; Poulsen, Jeppe N.; Uchida, Yugo; Nikbakht, Anahita; Arendt-Nielsen, Lars; Gazerani, Parisa			Cold and L-menthol-induced sensitization in healthy volunteers-a cold hypersensitivity analogue to the heat/capsaicin model	PAIN			English	Article						L-menthol; Cold; Allodynia; Hyperalgesia; Rekindling; TRPA1; TRPM8	SURROGATE PAIN MODEL; HUMAN SKIN; TOPICAL APPLICATION; NEUROPATHIC PAIN; SEX-DIFFERENCES; TRPM8; CAPSAICIN; CINNAMALDEHYDE; HYPERALGESIA; RECEPTORS	Topical high-concentration L-menthol is the only established human experimental pain model to study mechanisms underlying cold hyperalgesia. We aimed at investigating the combinatorial effect of cold stimuli and topical L-menthol on cold pain and secondary mechanical hyperalgesia. Analogue to the heat-capsaicin model on skin sensitization, we proposed that cold/menthol enhances or prolong L-menthol-evoked sensitization. Topical 40% L-menthol or vehicle was applied (20 minutes) on the volar forearms of 20 healthy females and males (age, 28.7 +/- 0.6 years). Cold stimulation of 5 degrees C for 5 minutes was then applied to the treated area 3 times with 40-minute intervals. Cold detection threshold and pain, mechanical hyperalgesia (pinprick), static and dynamic mechanical allodynia (von Frey and brush), skin blood flow (laser speckle), and temperature (thermocamera) were assessed. Cold detection threshold and cold pain threshold (CPT) increased after L-menthol and remained high after the cold rekindling cycles (P < 0.001). L-menthol evoked secondary hyperalgesia to pinprick (P < 0.001) particularly in females (P < 0.05) and also induced secondary allodynia to von Frey and brush (P < 0.001). Application of cold stimuli kept these areas enlarged with a higher response in females to brush after the third cold cycle (P < 0.05). Skin blood flow increased after L-menthol (P < 0.001) and stayed stable after cold cycles. Repeated application of cold on skin treated by L-menthol facilitated and prolonged L-menthol-induced cold pain and hyperalgesia. This model may prove beneficial for testing analgesic compounds when a sufficient duration of time is needed to see drug effects on CPT or mechanical hypersensitivity.	[Andersen, Hjalte H.; Poulsen, Jeppe N.; Uchida, Yugo; Nikbakht, Anahita; Arendt-Nielsen, Lars; Gazerani, Parisa] Aalborg Univ, Fac Med, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, DK-9220 Aalborg, Denmark; [Uchida, Yugo] Asahi Kasel Pharma Corp, Clin Dev Ctr, Dept Clin Dev, Kanda Jinbocho, Tokyo, Japan	Gazerani, P (reprint author), Aalborg Univ, Fac Med, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact, Fredrik Bajers Vej 7D3, DK-9220 Aalborg, Denmark.	gazerani@hst.aau.dk					Altis K, 2009, PAIN, V147, P116, DOI 10.1016/j.pain.2009.08.018; Andersen HH, 2013, EUR J PAIN, V18, P315; Modir JG, 2010, METHODS MOL BIOL, V617, P169, DOI 10.1007/978-1-60327-323-7_14; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; ECCLES R, 1994, J PHARM PHARMACOL, V46, P618; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Walk D, 2009, CLIN J PAIN, V25, P632, DOI 10.1097/AJP.0b013e3181a68c64; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Campero M, 2009, J PHYSIOL-LONDON, V587, P5633, DOI 10.1113/jphysiol.2009.176040; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Zimmermann K, 2011, P NATL ACAD SCI USA, V108, P18114, DOI 10.1073/pnas.1115387108; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Petersen KL, 2001, ANESTHESIOLOGY, V94, P15, DOI 10.1097/00000542-200101000-00008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dirks J, 2003, J PAIN, V4, P122, DOI 10.1054/jpai.2003.10; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Sherkheli MA, 2010, J PHARM PHARM SCI, V13, P242; Binder A, 2011, J PAIN, V12, P764, DOI 10.1016/j.jpain.2010.12.013; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Namer B, 2005, NEUROREPORT, V16, P955, DOI 10.1097/00001756-200506210-00015; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Petersen KL, 1999, NEUROREPORT, V10, P1511, DOI 10.1097/00001756-199905140-00022; Anand P, 2003, GUT, V52, P1233, DOI 10.1136/gut.52.9.1233; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; McKemy DD, 2013, ACS CHEM NEUROSCI, V4, P238, DOI 10.1021/cn300193h; Baron R, 2009, PAIN, V146, P34, DOI 10.1016/j.pain.2009.06.001; Sherkheli MA, 2012, SCI WORLD J, DOI 10.1100/2012/982725; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Arendt-Nielsen L, 2014, EXPERT REV NEUROTHER, V14, P241, DOI 10.1586/14737175.2014.884925; Averbeck B, 2013, EUR J PAIN, V17, P724, DOI 10.1002/j.1532-2149.2012.00239.x; Campero M, 2010, NEUROSCI LETT, V470, P188, DOI 10.1016/j.neulet.2009.06.089; Caspani O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007383; Cavallone LF, 2013, J PAIN RES, V6, P771, DOI 10.2147/JPR.S53437; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Eccles R, 2000, APPETITE, V34, P29, DOI 10.1006/appe.1999.0291; GREEN BG, 1992, SOMATOSENS MOT RES, V9, P235; Hatem S, 2006, PAIN, V122, P190, DOI 10.1016/j.pain.2006.01.026; Mahn F, 2014, EUR J PAIN, V18, P1248, DOI 10.1002/j.1532-2149.2014.484.x; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Okazawa M, 2004, NEUROSCI LETT, V359, P33, DOI 10.1016/j.neulet.2004.01.074; Olsen RV, 2014, EUR J PAIN, V18, P1333, DOI 10.1002/j.1532-2149.2014.494.x; Perkins FM, 2004, ACTA ANAESTH SCAND, V48, P486, DOI 10.1111/j.1399-6576.2004.00344.x; Petersen LJ, 2010, INFLAMM RES, V59, P775, DOI 10.1007/s00011-010-0189-1; Petersen-Felix Steen, 2002, Best Pract Res Clin Anaesthesiol, V16, P667, DOI 10.1053/bean.2002.0258; SIMONE DA, 1989, PAIN, V38, P99, DOI 10.1016/0304-3959(89)90079-1	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959	1872-6623		PAIN	Pain	MAY	2015	156	5					880	889		10.1097/j.pain.0000000000000123		10	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	CH4MO	WOS:000354007800015		
J	Yonemura, H; Forbes, MDE				Yonemura, Hiroaki; Forbes, Malcolm D. E.			Electron Spin Exchange in Linked Phenothiazine-Viologen Charge Transfer Complexes Incorporated in "Through-Ring" (Rotaxane) alpha-Cyclodextrins	PHOTOCHEMISTRY AND PHOTOBIOLOGY			English	Article							CORRELATED RADICAL PAIRS; TIME-RESOLVED EPR; PARAMAGNETIC-RESONANCE SPECTROSCOPY; EXTERNAL MAGNETIC-FIELD; BAND MICROWAVE REGION; FLEXIBLE BIRADICALS; MOLECULAR-MOTION; CHAIN DYNAMICS; TREPR SPECTRA; SPACER CHAIN	A series of covalently bound phenothiazine (PHZ) donor and methylviologen (V) acceptor compounds with polymethylene chain spacers (C-8, C-10, C-12) were incorporated in a through-ring (rotaxane) fashion to -cyclodextrin (-CD) hosts such that the alkyl chains were fully extended, with the donor and acceptor on opposite sides of the -CD cylinder. Photoexcitation of the PHZ unit induces electron transfer from the PHZ first excited triplet state to the V moiety, forming a biradicaloid charge-separated state. Time-resolved electron paramagnetic resonance (TREPR) spectroscopy at the X-band and Q-band microwave frequencies was used to investigate the spin exchange interaction, J, in these biradicaloids. Simulation of the spectra using a static model for spin-correlated radical pairs allows extraction of the J values, which are negative in sign and have absolute values range from 2 to 1000 Gauss. Comparison of the PHZ(n)V (n=8, 10, 12) spectra to those obtained using phenyl ether spacers indicates that -bonds may assist the electronic coupling. The results are discussed in terms of through-bond vs through-space electronic coupling mechanisms.	[Yonemura, Hiroaki] Kyushu Univ, Dept Appl Chem, Fac Engn, Higashi Ku, Fukuoka 812, Japan; [Forbes, Malcolm D. E.] Univ N Carolina, Dept Chem, Caudill Labs, Chapel Hill, NC 27514 USA	Forbes, MDE (reprint author), Univ N Carolina, Dept Chem, Caudill Labs, Chapel Hill, NC 27514 USA.	mdef@unc.edu			National Science Foundation [CHE-1111873]	We thank the National Science Foundation for their generous support of our program through grant CHE-1111873.	Zachariasse KA, 1999, J PHYS CHEM B, V103, P9356, DOI 10.1021/jp991611k; Yonemura H, 1998, TETRAHEDRON LETT, V39, P6915, DOI 10.1016/S0040-4039(98)01451-8; Colvin MT, 2013, J PHYS CHEM A, V117, P5314, DOI 10.1021/jp4045012; Scott AM, 2009, J AM CHEM SOC, V131, P17655, DOI 10.1021/ja907625k; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; CLOSS GL, 1988, SCIENCE, V240, P440, DOI 10.1126/science.240.4851.440; Forbes MDE, 2013, ADV PHYS ORG CHEM, V47, P1, DOI 10.1016/B978-0-12-407754-6.00001-6; Avdievich NI, 1997, J PHYS CHEM A, V101, P617, DOI 10.1021/jp961947j; Burns CS, 2001, ORG LETT, V3, P2197, DOI 10.1021/ol0160452; Closs G. L., 1990, KINETICS SPECTROSCOP, P51; CLOSS GL, 1991, J PHYS CHEM-US, V95, P1924, DOI 10.1021/j100158a009; CLOSS GL, 1987, J PHYS CHEM-US, V91, P3592, DOI 10.1021/j100297a026; FORBES MDE, 1993, J PHYS CHEM-US, V97, P3396, DOI 10.1021/j100115a052; FORBES MDE, 1992, J PHYS CHEM-US, V96, P7836, DOI 10.1021/j100199a002; Forbes M. D. E., 2012, RSC SPEC PERIODICAL, V23, P58; FORBES MDE, 1993, J PHYS CHEM-US, V97, P13223, DOI 10.1021/j100152a029; Forbes MDE, 1996, J AM CHEM SOC, V118, P4707, DOI 10.1021/ja960101q; FORBES MDE, 1993, J AM CHEM SOC, V115, P3382, DOI 10.1021/ja00061a068; FORBES MDE, 1993, Z PHYS CHEM, V182, P63; Forbes MDE, 1996, J PHYS CHEM-US, V100, P13887, DOI 10.1021/jp960245r; Forbes MDE, 2006, J PHYS CHEM A, V110, P1767, DOI 10.1021/jp053183q; FORBES MDE, 1993, J AM CHEM SOC, V115, P1613, DOI 10.1021/ja00057a077; Forbes MDE, 1997, PHOTOCHEM PHOTOBIOL, V65, P73, DOI 10.1111/j.1751-1097.1997.tb01879.x; FORBES MDE, 1993, REV SCI INSTRUM, V64, P397, DOI 10.1063/1.1144208; HUDSON A, 1969, CHEM REV, V69, P191, DOI 10.1021/cr60258a003; Kang Y. S., 1991, J PHYS CHEM-US, V95, P7941; Lersch W., 1989, ADV EPR APPL BIOL BI, P689; NISHIMOTO S, 1988, RADIAT PHYS CHEM, V32, P727; Tarasov VF, 2014, PHOTOCH PHOTOBIO SCI, V13, P454, DOI 10.1039/c3pp50329a; Tarasov VF, 2014, PHOTOCH PHOTOBIO SCI, V13, P439, DOI 10.1039/c3pp50328c; Tarasov VF, 2000, SPECTROCHIM ACTA A, V56, P245, DOI 10.1016/S1386-1425(99)00236-X; WASIELEWSKI MR, 1992, CHEM REV, V92, P435, DOI 10.1021/cr00011a005; YONEMURA H, 1989, CHEM PHYS LETT, V155, P157, DOI 10.1016/0009-2614(89)85341-2; YONEMURA H, 1992, J PHYS CHEM-US, V96, P5765, DOI 10.1021/j100193a021; YONEMURA H, 1992, CHEM PHYS, V162, P69, DOI 10.1016/0301-0104(92)80221-G; YONEMURA H, 1989, TETRAHEDRON LETT, V30, P3143, DOI 10.1016/S0040-4039(00)99186-X	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-8655	1751-1097		PHOTOCHEM PHOTOBIOL	Photochem. Photobiol.	MAY-JUN	2015	91	3					672	677		10.1111/php.12436		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH4DK	WOS:000353981900020		
J	Fuji, Y; Pollmann, F; Oshikawa, M				Fuji, Yohei; Pollmann, Frank; Oshikawa, Masaki			Distinct Trivial Phases Protected by a Point-Group Symmetry in Quantum Spin Chains	PHYSICAL REVIEW LETTERS			English	Article							STAGGERED MAGNETIC-FIELD; XXZ CHAINS; INSULATORS; STATE	The ground state of the S = 1 antiferromagnetic Heisenberg chain belongs to the Haldane phase-a well-known example of the symmetry-protected topological phase. A staggered field applied to the S = 1 antiferromagnetic chain breaks all the symmetries that protect the Haldane phase as a topological phase, reducing it to a trivial phase. That is, the Haldane phase is then connected adiabatically to an antiferromagnetic product state. Nevertheless, as long as the symmetry under site-centered inversion combined with a spin rotation is preserved, the phase is still distinct from another trivial phase. We demonstrate the existence of such distinct symmetry-protected trivial phases using a field-theoretical approach and numerical calculations. Furthermore, a general proof and a nonlocal order parameter are given in terms of a matrix-product state formulation.	[Fuji, Yohei; Oshikawa, Masaki] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Pollmann, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Fuji, Y (reprint author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.		Pollmann, Frank/L-5378-2013; Oshikawa, Masaki/F-4992-2011	Oshikawa, Masaki/0000-0002-7637-7432	Program for Leading Graduate Schools, MEXT, Japan; JSPS [25400392]; JSPS Strategic International Networks Program [R2604]	Y. F. thanks P. Lecheminant, S. Nishimoto, and K. Totsuka for fruitful discussions. Y. F. was supported in part by the Program for Leading Graduate Schools, MEXT, Japan. This work was supported in part by JSPS Grant-in-Aid for Scientific Research (KAKENHI) No. 25400392 and JSPS Strategic International Networks Program No. R2604 "TopoNet." Numerical calculations were performed on supercomputers at the Institute for Solid State Physics, University of Tokyo.	Berg E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110405; Endres M, 2011, SCIENCE, V334, P200, DOI 10.1126/science.1209284; AFFLECK I, 1988, COMMUN MATH PHYS, V115, P477, DOI 10.1007/BF01218021; Chen X, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035107; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863; Vidal G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.147902; Berg E, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245119; Kitaev A, 2009, AIP CONF PROC, V1134, P22, DOI 10.1063/1.3149495; HALDANE FDM, 1983, PHYS REV LETT, V50, P1153, DOI 10.1103/PhysRevLett.50.1153; Perez-Garcia D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.167202; Liu ZX, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195122; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Chen X, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235128; Chen X, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155138; Pollmann F, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.075125; TASAKI H, 1991, PHYS REV LETT, V66, P798, DOI 10.1103/PhysRevLett.66.798; Pollmann F, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.125441; Perez-Garcia D, 2007, QUANTUM INF COMPUT, V7, P401; Tsukano M, 1998, PHYS REV B, V57, pR8087, DOI 10.1103/PhysRevB.57.R8087; Verstraete F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.140601; Chen W, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.104401; Gu ZC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155131; Chen X, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155114; Schuch N, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165139; SCHULZ HJ, 1986, PHYS REV B, V34, P6372, DOI 10.1103/PhysRevB.34.6372; Calabrese P, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/06/P06002; DENNIJS M, 1989, PHYS REV B, V40, P4709, DOI 10.1103/PhysRevB.40.4709; Deng XL, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195101; Fuji Y., ARXIV14104211; Kjall JA, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235106; McCulloch I. P., ARXIV08042509; Orus R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.155117; Tsukano M, 1998, J PHYS SOC JPN, V67, P302, DOI 10.1143/JPSJ.67.302; Wen XG, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.085103; Yao H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166402; Yao H, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.161104	36	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007	1079-7114		PHYS REV LETT	Phys. Rev. Lett.	MAY 1	2015	114	17							177204	10.1103/PhysRevLett.114.177204		5	Physics, Multidisciplinary	Physics	CH1NA	WOS:000353787200010		
J	Igarashi, T; Kawai, H; Yanagi, K; Cuong, NT; Okada, S; Pichler, T				Igarashi, Toru; Kawai, Hideki; Yanagi, Kazuhiro; Nguyen Thanh Cuong; Okada, Susumu; Pichler, Thomas			Tuning Localized Transverse Surface Plasmon Resonance in Electricity-Selected Single-Wall Carbon Nanotubes by Electrochemical Doping	PHYSICAL REVIEW LETTERS			English	Article							ELECTRONIC-STRUCTURE; TERAHERTZ CONDUCTIVITY; FILMS	Localized surface-plasmon resonance affects the optical absorption and scattering of nanosized materials. The intensities and peak energies of the surface plasmons strongly depend on the carrier density; thus, the optical absorption peaks originating from the surface-plasmon resonance can be manipulated by the density of injected carriers. In single-wall carbon nanotubes (SWCNTs), the correct identification of surface-plasmon resonance modes is of great interest due to their emerging plasmonic and optoelectronic applications. Here, we demonstrate that high-carrier injection by electric double layers can induce a transverse surface-plasmon peak in aggregated, electricity-selected SWCNTs. In contrast to the well-discussed surface-plasmon resonance mode, whose polarization is parallel to the axis and whose resonance frequency is located in the THz region, our identified mode, which was normal to the axis, was located in the near-infrared range. In addition, our mode's peak position and intensities were tunable by carrier injections, indicating a route to control plasmonic optical processes by electric double-layer carrier injections using ionic liquid.	[Igarashi, Toru; Kawai, Hideki; Yanagi, Kazuhiro] Tokyo Metropolitan Univ, Dept Phys, Tokyo 1920397, Japan; [Nguyen Thanh Cuong] Natl Inst Adv Ind Sci & Technol, NRI, Tsukuba, Ibaraki 3058568, Japan; [Okada, Susumu] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Pichler, Thomas] Univ Vienna, Fac Phys, A-1090 Vienna, Austria	Igarashi, T (reprint author), Tokyo Metropolitan Univ, Dept Phys, Tokyo 1920397, Japan.	yanagi-kazuhiro@tmu.ac.jp	Okada, Susumu/D-7461-2012; Pichler, Thomas/E-4351-2013	Pichler, Thomas/0000-0001-5377-9896	MEXT/JSPS KAKENHI [13370772, 13393646]; CREST-JST, Japan	This study was partially supported by grant in aids from MEXT/JSPS KAKENHI (13370772, 13393646), and by CREST-JST, Japan.	Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/nnano.2011.146, 10.1038/NNANO.2011.146]; Kavan L, 2001, J PHYS CHEM B, V105, P10764, DOI 10.1021/jp011709a; Yanagi K, 2014, NANO LETT, V14, P6437, DOI 10.1021/nl502982f; Jeon TI, 2002, APPL PHYS LETT, V80, P3403, DOI 10.1063/1.1476713; Yanagi K, 2011, ADV MATER, V23, P2811, DOI 10.1002/adma.201100549; Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243; Kazaoui S, 2001, APPL PHYS LETT, V78, P3433, DOI 10.1063/1.1372208; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Yanagi K, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.034003; Liu HP, 2011, PHYS STATUS SOLIDI B, V248, P2524, DOI 10.1002/pssb.201100230; Zhang Q, 2013, NANO LETT, V13, P5991, DOI 10.1021/nl403175g; Akima N, 2006, ADV MATER, V18, P1166, DOI 10.1002/adma.200502505; Yanagi K, 2010, ACS NANO, V4, P4027, DOI 10.1021/nn101177n; Ilani S, 2006, NAT PHYS, V2, P687, DOI 10.1038/nphys412; Yan HG, 2013, NAT PHOTONICS, V7, P394, DOI 10.1038/NPHOTON.2013.57; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Link S, 1999, J PHYS CHEM B, V103, P8410, DOI 10.1021/jp9917648; Kawai H, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.065103; Bohren C. F., 1983, ABSORPTION SCATTERIN; Kawai M, 2012, J AM CHEM SOC, V134, P9545, DOI 10.1021/ja3013853; Latessa L., 2005, J COMPUT ELECTRON, V4, P51, DOI 10.1007/s10825-005-7106-9; Pichler T, 1999, SOLID STATE COMMUN, V109, P721, DOI 10.1016/S0038-1098(98)00614-0; Saito R, 1998, PHYS PROPERTIES CARB; Sarid D., 2010, MODERN INTRO SURFACE; Shuba MV, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.165435; Wang FH, 2013, NAT PHOTONICS, V7, P460, DOI 10.1038/NPHOTON.2013.66; Yanagi K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.086801	27	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007	1079-7114		PHYS REV LETT	Phys. Rev. Lett.	MAY 1	2015	114	17							176807	10.1103/PhysRevLett.114.176807		5	Physics, Multidisciplinary	Physics	CH1NA	WOS:000353787200007		
J	Ham, CJ; Chapman, IT; Simpson, J; Suzuki, Y				Ham, C. J.; Chapman, I. T.; Simpson, J.; Suzuki, Y.			Tokamak equilibria and edge stability when non-axisymmetric fields are applied	PLASMA PHYSICS AND CONTROLLED FUSION			English	Article						tokamak; equilibria; stability; edge localized modes	PLASMAS	Tokamaks are traditionally viewed as axisymmetric devices. However this is not always true, for example in the presence of saturated instabilities, error fields, or resonant magnetic perturbations (RMPs) applied for edge localized mode (ELM) control. We use the VMEC code (Hirshman and Whitson 1983 Phys. Fluids 26 3553) to calculate three dimensional equilibria by energy minimization for tokamak plasmas. MAST free boundary equilibria have been calculated with profiles for plasma pressure and current derived from two dimensional reconstruction. It is well known that ELMs will need to be controlled in ITER to prevent damage that may limit the lifetime of the machine (Loarte et al 2003 Plasma Phys. Control. Fusion 45 1549). ELM control has been demonstrated on several tokamaks including MAST (Kirk et al 2013 Nucl. Fusion 53 043007). However the application of RMPs causes the plasma to gain a displacement or corrugation (Liu et al 2011 Nucl. Fusion 51 083002). Previous work has shown that the phase and size of these corrugations is in agreement with experiment (Chapman et al 2012 Plasma Phys. Control. Fusion 54 105013). The interaction of these corrugations with the plasma control system (PCS) may cause high heat loads at certain toroidal locations if care is not taken (Chapman et al 2014 Plasma Phys. Control. Fusion 56 075004). VMEC assumes nested flux surfaces but this assumption has been relaxed in other stellarator codes. These codes allow equilibria where magnetic islands and stochastic regions can form. We show some initial results using the HINT2 code (Suzuki et al 2006 Nucl. Fusion 46 L19). The Mercier stability of VMEC equilibria with RMPs applied is calculated. The geodesic curvature contribution can be strongly influenced by helical Pfirsch-Schlter currents driven by the applied RMPs. ELM mitigation is not fully understood but one of the factors that influences peeling-ballooning stability, which is linked to ELMs, is a three dimensional corrugation of the plasma edge (Chapman et al 2013 Phys. Plasmas 20 056101). The infinite n ideal ballooning stability of the equilibria with and without the RMPs applied has been calculated using the COBRA code (Sanchez et al 2000 J. Comput. Phys. 161 576-88). When RMPs are applied, the most unstable ballooning mode growth rate is increased.	[Ham, C. J.; Chapman, I. T.; Simpson, J.] CCFE, Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England; [Suzuki, Y.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Ham, CJ (reprint author), CCFE, Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England.	christopher.ham@ccfe.ac.uk			European Union's Horizon research and innovation programme [633053]; RCUK Energy Programme [EP/I501045]	This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement number 633053 and from the RCUK Energy Programme (grant number EP/I501045). The views and opinions expressed herein do not necessarily reflect those of the European Commission. A part of this work was carried out using the HELIOS supercomputer system at Computational Simulation Centre of International Fusion Energy Research Centre (IFERC-CSC), Aomori, Japan, under the Broader Approach collaboration between Euratom and Japan, implemented by Fusion for Energy and JAEA. To obtain further information on the data and models underlying this paper please contact PublicationsManager@ccfe.ac.uk.	DOMINGUEZ N, 1989, NUCL FUSION, V29, P2079, DOI 10.1088/0029-5515/29/12/002; HIRSHMAN SP, 1983, PHYS FLUIDS, V26, P3553, DOI 10.1063/1.864116; Fitzpatrick R, 1998, PHYS PLASMAS, V5, P3325, DOI 10.1063/1.873000; BOOZER AH, 1981, PHYS FLUIDS, V24, P1999, DOI 10.1063/1.863297; HIRSHMAN SP, 1986, COMPUT PHYS COMMUN, V43, P143, DOI 10.1016/0010-4655(86)90058-5; Woodruff S, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2188086; Saarelma S, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/8/085009; Suzuki Y, 2006, NUCL FUSION, V46, pL19, DOI 10.1088/0029-5515/46/11/L01; Chapman IT, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083006; Becoulet M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.115001; Turnbull AD, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4805087; Loarte A, 2003, PLASMA PHYS CONTR F, V45, P1549, DOI 10.1088/0741-3335/45/9/302; Chapman IT, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801743; Kirk A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043007; Liu YQ, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083002; Chapman IT, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/7/075004; DEWAR RL, 1983, PHYS FLUIDS, V26, P3038, DOI 10.1063/1.864028; Connor JW, 1998, PHYS PLASMAS, V5, P2687, DOI 10.1063/1.872956; Sanchez R, 2001, COMPUT PHYS COMMUN, V135, P82, DOI 10.1016/S0010-4655(00)00225-3; Hanson JD, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075031; Helander P, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/8/087001; Orain F, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4824820; Bird TM, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/1/013004; Ham CJ, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/2/025009; Hegna CC, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4887008; Lazarus EA, 2006, PLASMA PHYS CONTR F, V48, pL65, DOI 10.1088/0741-3335/48/8/L01; Suzuki Y, 2014, EUR C 41 EPS C PLA F, V38F; Waelbroeck F L, 2002, NUCL FUSION, V52; Wesson J., 2004, TOKAMAKS	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0741-3335	1361-6587		PLASMA PHYS CONTR F	Plasma Phys. Control. Fusion	MAY	2015	57	5							054006	10.1088/0741-3335/57/5/054006		7	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CH8CP	WOS:000354263900007		
J	Murakami, S; Yamaguchi, H; Sakai, A; Wakasa, A; Fukuyama, A; Nagaoka, K; Takahashi, H; Nakano, H; Osakabe, M; Ida, K; Yoshinuma, M; Yokoyama, M				Murakami, S.; Yamaguchi, H.; Sakai, A.; Wakasa, A.; Fukuyama, A.; Nagaoka, K.; Takahashi, H.; Nakano, H.; Osakabe, M.; Ida, K.; Yoshinuma, M.; Yokoyama, M.		LHD Expt Grp	Integrated transport simulations of high ion temperature plasmas of LHD	PLASMA PHYSICS AND CONTROLLED FUSION			English	Article						integrated modeling; transport simulation; TASK3D; LHD; neoclassical transport; turbulent transport		An integrated transport simulation code, TASK3D, is developed and applied to the high ion temperature plasma of LHD. The particle and heat transport equations are solved and compared with LHD experimental results. The heat and particle transports are assumed to be the sum of the neoclassical transport and the turbulent transport. The neoclassical transport is evaluated by the LHD/DGN neoclassical transport database, and the gyro-Bohm and the gyro-Bohm + gradT turbulent transport models are applied to the heat transport analysis. On the other hand we assume a constant turbulent transport model for particle transport. Relatively good agreements are obtained between the simulated and experimental profiles of the density and temperature in the steady state plasma of LHD. Next the high ion temperature plasma with the carbon pellet injection is simulated. It is found that the reduction of turbulence transport is the most significant contribution to achieving the high ion temperature and that the reduction of the turbulent transport compared to the L-mode plasma (normal hydrogen plasma) is evaluated to be a factor of about five.	[Murakami, S.; Yamaguchi, H.; Sakai, A.; Wakasa, A.; Fukuyama, A.] Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, Kyoto 6158540, Japan; [Nagaoka, K.; Takahashi, H.; Nakano, H.; Osakabe, M.; Ida, K.; Yoshinuma, M.; Yokoyama, M.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Murakami, S (reprint author), Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, Kyoto 6158540, Japan.	murakami@nucleng.kyoto-u.ac.jp					Houlberg WA, 2005, NUCL FUSION, V45, P1309, DOI 10.1088/0029-5515/45/11/012; Nagaoka K, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083022; Hayashi N, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3327917; HUGHES MH, 1978, J COMPUT PHYS, V28, P43, DOI 10.1016/0021-9991(78)90045-1; Osakabe M, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/9/095011; Honda M, 2006, NUCL FUSION, V46, P580, DOI 10.1088/0029-5515/46/5/009; Wakasa A, 2007, JPN J APPL PHYS 1, V46, P1157, DOI 10.1143/JJAP.46.1157; Takahashi H, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073034; Nunami M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4822337; Artaud JF, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/4/043001; Fukuyama A, 2004, P 20 INT AT EN AG FU; Garcia J, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124032; Kritz AH, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/12/123009; Murakami S, 2006, NUCL FUSION, V46, pS425, DOI 10.1088/0029-5515/46/7/S05; Murakami S, 1995, T FUSION TECHNOL, V27, P256; Sakai A, 2014, PLASMA FUSION RES, V9; Sato M, 2014, PLASMA FUSION RES, V3, pS1063; Toda S, 2014, J PHYS CONF SER, V561, DOI 10.1088/1742-6596/561/1/012020; Wakasa A, 2008, PLASMA FUSION RES, V3, pS1030; Wakasa A, 2012, P 39 EPS C 16 INT C; Yamaguchi H, 2014, JPS C P, V1; Yamaguchi H, 2013, PLASMA FUSION RES, V8	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0741-3335	1361-6587		PLASMA PHYS CONTR F	Plasma Phys. Control. Fusion	MAY	2015	57	5							054009	10.1088/0741-3335/57/5/054009		7	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CH8CP	WOS:000354263900010		
J	Tsuchiya, K; Ishida, Y; Higashihara, T; Kameyama, A; Ueda, M				Tsuchiya, Kousuke; Ishida, Yoshihito; Higashihara, Tomoya; Kameyama, Atsushi; Ueda, Mitsuru			Synthesis of poly(arylene ether sulfone): 18-Crown-6 catalyzed phase-transfer polycondensation of bisphenol A with 4,4 '-dichlorodiphenyl sulfone	POLYMER JOURNAL			English	Editorial Material							POTASSIUM CARBONATE; CROWN-ETHER		[Tsuchiya, Kousuke; Ishida, Yoshihito; Kameyama, Atsushi; Ueda, Mitsuru] Kanagawa Univ, Dept Chem, Yokohama, Kanagawa, Japan; [Higashihara, Tomoya] Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Yonezawa, Yamagata, Japan	Tsuchiya, K (reprint author), Kanagawa Univ, Dept Chem, Yokohama, Kanagawa, Japan.	ueda.m.ad@m.titech.ac.jp		Tsuchiya, Kousuke/0000-0003-2364-8275			Guo R, 2012, POLYMER SCIENCE A CO, V5, P377; IMAI Y, 1984, J SYN ORG CHEM JPN, V42, P1095; Lellman R., 1987, ACS SYM SER, V326, P128; LIOTTA CL, 1975, TETRAHEDRON LETT, P4205; Lue LC, 2002, J CHIN CHEM SOC-TAIP, V49, P69; Starks C.M., 1978, PHASE TRANSFER CATAL; UEDA M, 1983, MAKROMOL CHEM-RAPID, V4, P613; VISWANATHAN R, 1984, POLYMER, V25, P1827, DOI 10.1016/0032-3861(84)90258-1; Wang S, 2003, SYNTHETIC METHODS ST, P327, DOI 10.1002/0471220523.ch6	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAY	2015	47	5					353	354		10.1038/pj.2015.9		2	Polymer Science	Polymer Science	CH5IT	WOS:000354069600001		
J	Nakazono, K; Yamashita, C; Ogawa, T; Iguchi, H; Takata, T				Nakazono, Kazuko; Yamashita, Chika; Ogawa, Takahiro; Iguchi, Hiroyuki; Takata, Toshikazu			Synthesis and properties of pendant fluorene moiety-tethered aliphatic polycarbonates	POLYMER JOURNAL			English	Article							RING-OPENING POLYMERIZATION; EXCELLENT OPTICAL-PROPERTIES; HIGH REFRACTIVE-INDEX; CYCLIC CARBONATES; TRIMETHYLENE CARBONATE; MAIN-CHAIN; 2,2-DIMETHYLTRIMETHYLENE CARBONATE; 9,9-DIARYLFLUORENE MOIETY; POLY(ARYLENE THIOETHER)S; HYDROCARBON SOLVENTS	A series of novel fluorene moiety-containing polycarbonates was synthesized by the anionic ring-opening polymerization of six-membered spirocyclic carbonates possessing 9,9-fluorene groups at the 5,5-position. The polymers could be considered cardo-type polymers because they had 9,9-fluorene groups as a loop-shaped side chain. Interestingly, the fluorene pendant polycarbonates were obtained in sufficiently high molecular weights and in good yields, although the monomers were structurally closely related to the 5,5-diphenyl-substituted cyclic carbonate that exhibited very low polymerizability. Furthermore, the polymerizations of substituted fluorene-based six-membered spirocyclic carbonates were investigated. All of the obtained polymers showed favorable properties, including good solubility, amorphous natures, favorable thermal stabilities, remarkably low birefringence values and high refractive indices despite consisting only of C, H and O atoms. The good potentiality in the application to optical materials was shown here.	[Nakazono, Kazuko; Yamashita, Chika; Ogawa, Takahiro; Iguchi, Hiroyuki; Takata, Toshikazu] Tokyo Inst Technol, Dept Organ & Polymer Mat, Tokyo 1528552, Japan	Takata, T (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	ttakata@polymer.titech.ac.jp			Tokuyama Science Foundation; Global COE Program (Education and Research Center for Material Innovation), MEXT, Japan	This work was financially supported in part by the Tokuyama Science Foundation and the Global COE Program (Education and Research Center for Material Innovation), MEXT, Japan. We give special thanks to Dr Takahiro Kojima and Mr Katsumoto Hosokawa from the Production Engineering Research Laboratory, Canon Inc., for their help in the measurement of the optical properties.	ALBERTSSON AC, 1992, J MACROMOL SCI PURE, V29, P43, DOI 10.1080/10101329208054106; Alder RW, 1998, CHEM COMMUN, P309, DOI 10.1039/a707389e; Rokicki G, 2000, PROG POLYM SCI, V25, P259, DOI 10.1016/S0079-6700(00)00006-X; TAKATA T, 1993, PROG POLYM SCI, V18, P839, DOI 10.1016/0079-6700(93)90019-9; Venkataraman S, 2014, POLYM CHEM-UK, V5, P2035, DOI 10.1039/c3py01207g; Nakano T, 2010, POLYM J, V42, P103, DOI 10.1038/pj.2009.332; Kamber NE, 2007, CHEM REV, V107, P5813, DOI 10.1021/cr068415b; Watanabe K, 2011, CHEM COMMUN, V47, P10996, DOI 10.1039/c1cc13711e; KORSHAK VV, 1974, J MACROMOL SCI R M C, VC 11, P45; Hasegawa T, 2010, MACROMOLECULES, V43, P131, DOI 10.1021/ma901841y; Varma IK, 2005, PROG POLYM SCI, V30, P949, DOI 10.1016/j.progpolymsci.2005.06.010; Matsuo J, 1998, MACROMOL CHEM PHYSIC, V199, P2489; Wang Y, 2012, CHEM COMMUN, V48, P1871, DOI 10.1039/c2cc17027b; Ariga T, 1997, MACROMOLECULES, V30, P737, DOI 10.1021/ma9607325; Bisht KS, 1997, MACROMOLECULES, V30, P7735, DOI 10.1021/ma9708858; BRAUN AM, 1971, MAKROMOLEKUL CHEM, V146, P195; BROWN TL, 1965, J ORGANOMET CHEM, V3, P1, DOI 10.1016/S0022-328X(00)82729-1; BYWATER S, 1967, J ORGANOMET CHEM, V10, P1, DOI 10.1016/S0022-328X(00)81711-8; Carter KR, 1997, MACROMOLECULES, V30, P6074, DOI 10.1021/ma961275v; Dobrzynski P, 2006, J POLYM SCI POL CHEM, V44, P3184, DOI 10.1002/pola.21428; Endo T, 2002, J POLYM SCI POL CHEM, V40, P2190, DOI 10.1002/pola.10289; Eugene G, 1960, J AM CHEM SOC, V82, P4945; Hayashi H, 2009, POLYM J, V41, P609, DOI 10.1295/polymj.PJ2009046; Hayashi H, 2009, POLYM J, V41, P272, DOI 10.1295/polymj.PJ2008241; HSIEH HL, 1965, J POLYM SCI PART A, V3, P163, DOI 10.1002/pol.1965.100030118; HSIEH HL, 1965, J POLYM SCI PART A, V3, P153, DOI 10.1002/pol.1965.100030117; Ishiwari F., 2008, CHEM LETT, V37, P853; Kakimoto K, 2002, CHEM LETT, P156, DOI 10.1246/cl.2002.156; Kawasaki S, 2010, J APPL POLYM SCI, V118, P2690, DOI 10.1002/app.32624; Kawasaki S, 2009, POLYM ENG SCI, V49, P2374, DOI 10.1002/pen.21485; Kawasaki S, 2008, POLYM COMPOSITE, V29, P1044, DOI 10.1002/pc.20482; Kawasaki S, 2009, J APPL POLYM SCI, V111, P461, DOI 10.1002/app.28961; Kawasaki S, 2007, POLYM J, V39, P115, DOI 10.1295/polymj.PJ2006120; Kawasaki S, 2007, MACROMOLECULES, V40, P5284, DOI 10.1021/ma070589n; KEUL H, 1986, MAKROMOL CHEM, V187, P2579; Koyama Y, 2010, CHEM LETT, V39, P2, DOI 10.1246/cl.2010.2; KRICHELDORF HR, 1991, MAKROMOL CHEM, V192, P2391; KRICHELDORF HR, 1987, MAKROMOL CHEM, V188, P2453; Kricheldorf HR, 1996, MACROMOL CHEM PHYSIC, V197, P1043, DOI 10.1002/macp.1996.021970323; Matsuo J, 1998, MACROMOLECULES, V31, P4432, DOI 10.1021/ma971227q; Mei JG, 2010, MACROMOLECULES, V43, P5909, DOI 10.1021/ma100863h; Okuda H, 2013, J POLYM SCI POL CHEM, V51, P4541, DOI 10.1002/pola.26870; Okuda H, 2010, J POLYM SCI POL CHEM, V48, P4192, DOI 10.1002/pola.24202; Okuda H, 2010, POLYM J, V42, P795, DOI 10.1038/pj.2010.77; Seesukphronrarak S, 2007, J POLYM SCI POL CHEM, V45, P3073, DOI 10.1002/pola.22063; Seesukphronrarak S, 2007, POLYM J, V39, P731, DOI 10.1295/polymj.PJ20062; Seesukphronrarak S, 2008, J POLYM SCI POL CHEM, V46, P2549, DOI 10.1002/pola.22586; Seesukphronrarak S, 2007, CHEM LETT, V36, P1138, DOI 10.1246/cl.2007.1138; Sekiguchi H, 1984, RING OPENING POLYM, V2; Seto R, 2010, J POLYM SCI POL CHEM, V48, P3658, DOI 10.1002/pola.24150; Seto R, 2010, POLYMER, V51, P4744, DOI 10.1016/j.polymer.2010.08.032; Takata T, 1997, MACROMOL RAPID COMM, V18, P461, DOI 10.1002/marc.1997.030180602; Takata T., 1992, EXPANDING MONOMERS S, P63; Yamashita C., 2011, POLYM PREPR JPN, V60, P512; Young R. N., 1984, ANIONIC POLYMERIZATI, P3	55	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAY	2015	47	5					355	361		10.1038/pj.2015.7		7	Polymer Science	Polymer Science	CH5IT	WOS:000354069600002		
J	Sakaguchi, T; Nakano, T; Tominaga, S; Hashimoto, T				Sakaguchi, Toshikazu; Nakano, Takuya; Tominaga, Shinichi; Hashimoto, Tamotsu			Polycondensation of di- and tetrasubstituted dibromobenzenes for synthesis of poly(p-phenylene)s having alkoxy groups and gas permeability of membranes	POLYMER JOURNAL			English	Article							OXIDATIVE COUPLING POLYMERIZATION; CONTROLLED MOLECULAR-WEIGHT; PI-CONJUGATED POLYMERS; INTRINSIC MICROPOROSITY; LOW POLYDISPERSITY; SEPARATION; DERIVATIVES	Polymerizations of di-substituted p-dibromobenzenes [with the following substituents: linear alkoxy groups (1a-d), branched alkoxy groups (1e and 1f), and methoxyethoxy (1g)] and tetrasubstituted p-dibromobenzenes [ with the following substituents: butoxy (1h) as well as butoxy and methyl (1i)] were investigated with a Ni catalyst. Monomers having linear alkoxy groups polymerized to give relatively high molecular weight polymers (M-n = 40 300-49 600) in good yields. However, the molecular weights and yields of the polymers having branched alkoxy groups were relatively low because of the steric effect of branched alkoxy chains. The methoxyethoxy group-containing monomer afforded an oligomer with an M-n of 666. The coupling reaction of tetrasubstituted p-dibromobenzenes occurred at a very-low level because of the steric hindrance of the tetra substituents. Polymers 2a-f exhibited high thermal stability, and the decomposition temperatures were higher than 350 degrees C. From the differential scanning calorimetry thermograms, 2b-d and 2f showed melting of crystallites (T-m: 120 degrees C for 2b, 95 degrees C for 2c, 100 degrees C for 2d and 16 degrees C for 2f), and 2a and 2e showed glass transitions (T-g: 155 degrees C for 2a, 65 degrees C for 2e). The freestanding membranes could be prepared by the hot-press method from the crystalline polymers (2b-d). These membranes exhibited relatively high gas permeability, and the oxygen permeability coefficients were 14.8-27.8 barrer, higher than those previously reported for poly(p-phenylene)s having ester substituents.	[Sakaguchi, Toshikazu; Nakano, Takuya; Tominaga, Shinichi; Hashimoto, Tamotsu] Univ Fukui, Grad Sch Engn, Dept Mat Sci & Engn, Fukui 9108507, Japan	Sakaguchi, T (reprint author), Univ Fukui, Grad Sch Engn, Dept Mat Sci & Engn, Bunkyo 3-9-1, Fukui 9108507, Japan.	sakaguchi@matse.u-fukui.ac.jp			Ministry of Education, Science, Culture and Sports, Japan [25810071]	This research was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Culture and Sports, Japan (No. 25810071).	Pandey P, 2001, PROG POLYM SCI, V26, P853, DOI 10.1016/S0079-6700(01)00009-0; Lanni EL, 2009, J AM CHEM SOC, V131, P16573, DOI 10.1021/ja904197q; Tsujita Y, 2003, PROG POLYM SCI, V28, P1377, DOI 10.1016/S0079-6700(03)00048-0; Kuster S, 2012, DYES PIGMENTS, V95, P657, DOI 10.1016/j.dyepig.2012.06.017; Yokozawa T, 2009, CHEM REV, V109, P5595, DOI 10.1021/cr900041c; Ismail AF, 2001, J MEMBRANE SCI, V193, P1, DOI 10.1016/S0376-7388(01)00510-5; Miyakoshi R, 2008, J POLYM SCI POL CHEM, V46, P753, DOI 10.1002/pola.22389; Miyakoshi R, 2006, J AM CHEM SOC, V128, P16012, DOI 10.1021/ja067107s; Yamamoto T, 2010, B CHEM SOC JPN, V83, P431, DOI 10.1246/bcsj.20090338; KOVACIC P, 1987, CHEM REV, V87, P357, DOI 10.1021/cr00078a005; Budd PM, 2005, J MEMBRANE SCI, V251, P263, DOI 10.1016/j.memsci.2005.01.009; Kim YK, 2005, J MEMBRANE SCI, V255, P265, DOI 10.1016/j.memsci.2005.02.002; Nagai K, 2001, PROG POLYM SCI, V26, P721, DOI 10.1016/S0079-6700(01)00008-9; Baker RW, 2014, MACROMOLECULES, V47, P6999, DOI 10.1021/ma501488s; Umezawa K, 2012, ACS MACRO LETT, V1, P969, DOI 10.1021/mz300290x; Aoki T, 1999, PROG POLYM SCI, V24, P951, DOI 10.1016/S0079-6700(99)00020-9; Bai WB, 2005, CHEM LETT, V34, P924, DOI 10.1246/cl.2005.924; Budd PM, 2004, CHEM COMMUN, P230, DOI 10.1039/b311764b; Huang SP, 2007, SYNTHETIC MET, V157, P863, DOI 10.1016/j.synthmet.2007.08.013; Kaeriyama K, 1998, PLAST ENGN, V49, P33; Keegstra EMD, 1996, J CHEM SOC PERK T 2, P229, DOI 10.1039/p29960000229; Kwak G, 2007, CHEM MATER, V19, P3654, DOI 10.1021/cm070303t; Moy CL, 2011, J ORG CHEM, V76, P8501, DOI 10.1021/jo201353j; Nemoto N, 2006, POLYM BULL, V57, P661, DOI 10.1007/s00289-006-0644-x; Nunes S. P., 2001, MEMBRANE TECHNOLOGY; Okada T, 1996, MACROMOLECULES, V29, P7645, DOI 10.1021/ma9604101; Pauly S., 1998, POLYM HDB; Pinnau I., 2004, ACS S SERIES, V876; Sakaguchi T, 2006, J POLYM SCI POL CHEM, V44, P5028, DOI 10.1002/pola.21622; Sakaguchi T, 2009, J APPL POLYM SCI, V114, P2339, DOI 10.1002/app.30834; Sakaguchi T, 2011, POLYMER, V52, P2163, DOI 10.1016/j.polymer.2011.03.036; Sakaguchi T, 2013, POLYMER, V54, P2272, DOI 10.1016/j.polymer.2013.03.007; TSUCHIHARA K, 1992, MACROMOLECULES, V25, P5816, DOI 10.1021/ma00047a038; UEDA M, 1992, MACROMOLECULES, V25, P5125, DOI 10.1021/ma00046a002; YAMAMOTO T, 1985, MAKROMOL CHEM-RAPID, V6, P671	35	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAY	2015	47	5					362	368		10.1038/pj.2015.11		7	Polymer Science	Polymer Science	CH5IT	WOS:000354069600003		
J	Kobayashi, M; Sim, JH; Sato, H				Kobayashi, Minoru; Sim, Jae Ho; Sato, Hisaya			Conformational analyses of an alanine oligomer during chain propagation using quantum chemical calculations	POLYMER JOURNAL			English	Article							VIBRATIONAL SPECTROSCOPY; PEPTIDES; DYNAMICS; HELIX	Conformational convergent calculations of alanine oligomer models (from 2- to 7-mer, x=2-7) were performed using QCC starting from the 2-mer (4 x 164 types). The energies and dihedral angle distributions (phi/psi) of the conformers were examined, and the results were compared with the experimental and calculated data previously reported by other authors. The two end group types (that is, 'amide type' and 'methyl type') and the left- and right-handed rotational directions were determined. The number of conformers decreased as x increased, and those of the 'methyl type' were larger than those of the 'amide type'. The phi/psi of the 4- to 7-mers converged to three types (that is, alpha-helix (g+/g+ or g-/g-), PPII-like (g+/g- or g-/g+) and beta-extended (t+/t- or t-/t+) in decreasing energy order). The stabilities of the alpha-helix increased as x increased because of the intramolecular hydrogen bonds between amino acids located two or three units apart. The PPII-like type was different from the reported PPII (g-/t+) type and considered to be a 2.2(7) ribbon (g-/g+). No energy differences were observed between the left- and right-handed 'amide type'. However, energy differences were observed for the 'methyl type'. The unique energies and conformations of the 'methyl type' are mainly because of intramolecular hydrogen bonding.	[Kobayashi, Minoru] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Sim, Jae Ho] Halla Univ, Dept Adv Mat & Chem Engn, Wonju, South Korea; [Sato, Hisaya] Tokyo Univ Agr & Technol, Grad Sch Tech Management, Koganei, Tokyo 1848588, Japan	Kobayashi, M (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Naka Cho, Koganei, Tokyo 1848588, Japan.	mikoba3@gmail.com					Woutersen S, 2000, J PHYS CHEM B, V104, P11316, DOI 10.1021/jp001546a; Shi ZS, 2002, P NATL ACAD SCI USA, V99, P9190, DOI 10.1073/pnas.112193999; [Anonymous], 2003, GAUSS 03 US REF; Kentsis A, 2004, PROTEINS, V55, P493, DOI 10.1002/prot.20051; Graf J, 2007, J AM CHEM SOC, V129, P1179, DOI 10.1021/ja0660406; Pace CN, 1998, BIOPHYS J, V75, P422; Berg J.M., 2002, BIOCHEMISTRY; Kobayashi M., 2010, PHARM PHARM, V1, P60; Kobayashi M, 2009, POLYM J, V41, P880, DOI 10.1295/polymj.PJ2009115; Kobayashi M, 2007, KOBUNSHI RONBUNSHU, V64, P119, DOI 10.1295/koron.64.119; Kobayashi M, 2008, POLYM J, V40, P343, DOI 10.1295/polymj.PJ2007140; Makowska J., 2011, BIOPOLYMERS, V97, P240; Mirkin NG, 2007, J PHYS CHEM A, V111, P5300, DOI 10.1021/jp070852m; Parchansky V, 2013, J PHYS CHEM LETT, V4, P2763, DOI 10.1021/jz401366j; Rigaudy J., 1979, NOMENCLATURE ORGAN E; Schweitzer-Stenner R, 2009, J PHYS CHEM B, V113, P2922, DOI 10.1021/jp8087644; Woutersen S, 2002, J CHEM PHYS, V117, P6833, DOI 10.1063/1.1506151	17	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAY	2015	47	5					369	378		10.1038/pj.2015.8		10	Polymer Science	Polymer Science	CH5IT	WOS:000354069600004		
J	Ikehara, T; Ito, D; Kataoka, T				Ikehara, Takayuki; Ito, Daiki; Kataoka, Toshiyuki			Analysis of the degree of crystallinity in interpenetrating spherulites of poly(ethylene succinate) and poly(ethylene oxide) blends using pulsed NMR	POLYMER JOURNAL			English	Article							NUCLEAR MAGNETIC-RESONANCE; ATOMIC-FORCE MICROSCOPY; POLY(BUTYLENE SUCCINATE)/POLY(ETHYLENE OXIDE); CRYSTALLINE/CRYSTALLINE POLYMER BLENDS; CO-BUTYLENE ADIPATE); POLY(VINYLIDENE FLUORIDE); CRYSTALLIZATION KINETICS; MISCIBLE BLENDS; CARBONATE)/POLY(L-LACTIC ACID); MORPHOLOGY	The degree of crystallinity (phi) in interpenetrating spherulites, whereby spherulites of one component continue to grow inside those of the other component, was examined for the blends of poly(ethylene succinate) (PES) and poly(ethylene oxide) (PEO) using pulsed nuclear magnetic resonance. The value of phi or PES increased with PEO blending and was slightly dependent on the blend composition when crystallized below similar to 65 degrees C. However, phi or PEO monotonically decreased with the PES content in the blends and was dependent on the blend composition. The composition dependence of. is discussed based on the change in temperature at which the molecular transport is frozen with the blend composition. The effect of secondary crystallization, which is only relevant for PEO, was taken into account when determining phi. The amount of crystals of both constituents in the blends primarily depended on the blend composition.	[Ikehara, Takayuki; Ito, Daiki; Kataoka, Toshiyuki] Kanagawa Univ, Fac Engn, Dept Mat & Life Chem, Yokohama, Kanagawa 2218686, Japan	Ikehara, T (reprint author), Kanagawa Univ, Fac Engn, Dept Mat & Life Chem, Kanagawa Ku, 3-27-1 Rokkakubashi, Yokohama, Kanagawa 2218686, Japan.	ikehara@kanagawa-u.ac.jp			Japan Society for the Promotion of Science [22550201]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	We thank Ms Miharu Tomita for her help in performing the experiments. This work was partially supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (22550201) and by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 'Creation of new fusion materials by integration of highly-ordered nano inorganic materials and ultra-precisely controlled organic polymers'.	Chen HL, 2000, POLYMER, V41, P5157, DOI 10.1016/S0032-3861(99)00745-4; Wang HJ, 2007, POLYMER, V48, P3530, DOI 10.1016/j.polymer.2007.03.079; Qiu ZB, 2007, J PHYS CHEM B, V111, P2783, DOI 10.1021/jp067606f; Ikehara T, 2005, MACROMOLECULES, V38, P5104, DOI 10.1021/ma0502809; Lee JC, 1998, POLYM J, V30, P780, DOI 10.1295/polymj.30.780; Hirano S, 2002, POLYM J, V34, P85, DOI 10.1295/polymj.34.85; Ikehara T, 2000, POLYM J, V32, P683, DOI 10.1295/polymj.32.683; Qiu ZB, 2002, MACROMOLECULES, V35, P8251, DOI 10.1021/ma025599x; TANAKA H, 1986, J CHEM PHYS, V85, P6197, DOI 10.1063/1.451850; Wang TC, 2011, J PHYS CHEM B, V115, P7814, DOI 10.1021/jp203680e; Ikehara T, 2009, J POLYM SCI POL PHYS, V47, P539, DOI 10.1002/polb.21661; BLUMM E, 1995, POLYMER, V36, P4077, DOI 10.1016/0032-3861(95)90987-D; Lu JM, 2008, MACROMOLECULES, V41, P141, DOI 10.1021/ma7020997; Ikehara T, 2003, POLYMER, V44, P6657, DOI 10.1016/S0032-3861(03)00685-2; Qiu ZB, 2007, MACROMOLECULES, V40, P5047, DOI 10.1021/ma070255y; He SA, 2007, POLYM J, V39, P537, DOI 10.1295/polymj.PJ2006139; Ikehara T, 2007, MACROMOLECULES, V40, P8726, DOI 10.1021/ma070973k; Qiu ZB, 2003, POLYMER, V44, P2799, DOI 10.1016/S0032-3861(03)00149-6; Li QH, 2013, COLLOID POLYM SCI, V291, P2007, DOI 10.1007/s00396-013-2929-6; DOUGLASS DC, 1976, J CHEM PHYS, V64, P1533, DOI 10.1063/1.432373; FUJIMOTO K, 1972, POLYM J, V3, P448; GORNICK F, 1962, J APPL PHYS, V33, P907, DOI 10.1063/1.1777189; Ikehara T, 2012, J POLYM SCI POL PHYS, V50, P563, DOI 10.1002/polb.23036; Ikehara T, 2000, POLYMER, V41, P7855, DOI 10.1016/S0032-3861(00)00134-8; Ikehara T, 2010, J POLYM SCI POL PHYS, V48, P706, DOI 10.1002/polb.21940; KITAMARU R, 1977, J POLYM SCI POL PHYS, V15, P821, DOI 10.1002/pol.1977.180150506; Mandelkern L., 2004, CRYSTALLIZATION POLY, V2; McBrierty V. J., 1981, J POLYM SCI MACROMOL, V16, P295, DOI DOI 10.1002/POL.1981.230160105; MCBRIERTY VJ, 1980, PHYS REP, V63, P63; Paul D. R., 1980, Polymer Alloys II. Blends, Blocks, Grafts and Interpenetrating Networks; POWLES JG, 1963, P PHYS SOC LOND, V82, P6, DOI 10.1088/0370-1328/82/1/303; Qiu ZB, 2004, POLYMER, V45, P4355, DOI 10.1016/j.polymer.2004.04.054; Runt J. P., 2000, POLYM BLENDS, V1, P167; Terada Y, 2000, POLYM J, V32, P900, DOI 10.1295/polymj.32.900; Wang HJ, 2012, POLYM BULL, V69, P955, DOI 10.1007/s00289-012-0806-y	35	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAY	2015	47	5					379	384		10.1038/pj.2015.1		6	Polymer Science	Polymer Science	CH5IT	WOS:000354069600005		
J	Matsushita, A; Okamoto, S				Matsushita, Akifumi; Okamoto, Shigeru			Strong temperature dependencies of diblock copolymer domain spacing in a solvent mixture comprising ternary components with varied selectivity	POLYMER JOURNAL			English	Article							BLOCK-COPOLYMER; MOLECULAR-WEIGHT	The lamella formed in polystyrene-block-polyisoprene (PS-b-PI) swollen with solvent mixtures shows temperature-dependent domain spacing. Solvent mixtures consisting of a polystyrene (PS)-selective solvent, dimethylphthalate, and a polyisoprene (PI)-selective solvent, n-tetradecane, which are immiscible at temperatures below 124 degrees C, as well as a neutral solvent, di-n-octylphthalate, were studied. Two molecular weights of PS-b-PI were used. Solutions of the lower-molecular-weight PS-b-PI were characterized by using small-angle X-ray scattering, whereas higher molecular weight PS-b-PI solutions were characterized with UV-vis spectroscopy. The domain spacings of the lamella formed in these solutions showed stronger temperature dependencies than the neat diblock copolymer or the diblock copolymer/neutral solvent system. The dependencies varied with the polymer concentration and solvent composition. The reflection peaks for a solution of the higher molecular weight PS-b-PI were astonishingly tunable over wavelengths between 836 and 377 nm in the temperature range of 20-80 degrees C.	[Matsushita, Akifumi; Okamoto, Shigeru] Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan	Okamoto, S (reprint author), Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	okamoto.shigeru@nitech.ac.jp			JSPS KAKENHI Grant [21550208, 24550250]	The synchrotron radiation experiments were performed at BL40B2 and BL08B2 of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal Numbers 2011B1502, 2012B1476, 2013B1689 and 2014A1423), and at BL8S3 of Aichi Synchrotron Radiation Center, Aichi Science & Technology Foundation, Aichi, Japan (Proposal Numbers 201402054 and 201405071). This work was supported by JSPS KAKENHI Grant Numbers 21550208 and 24550250.	Ando K, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012040; Valkama S, 2004, NAT MATER, V3, P872, DOI 10.1038/nmat1254; Botiz I, 2009, MACROMOLECULES, V42, P8211, DOI 10.1021/ma901420h; Paquet C, 2008, MATER TODAY, V11, P48, DOI 10.1016/S1369-7021(08)70056-7; Cheng JY, 2008, ADV MATER, V20, P3155, DOI 10.1002/adma.200800826; Sundrani D, 2004, LANGMUIR, V20, P5091, DOI 10.1021/la036123p; LODGE TP, 1995, J POLYM SCI POL PHYS, V33, P2289, DOI 10.1002/polb.1995.090331614; Hanley KJ, 2000, MACROMOLECULES, V33, P5918, DOI 10.1021/ma000318b; HASHIMOTO T, 1983, MACROMOLECULES, V16, P1093, DOI 10.1021/ma00241a010; Alexandridis P, 1998, LANGMUIR, V14, P2627, DOI 10.1021/la971117c; Watanabe H, 2001, MACROMOLECULES, V34, P662, DOI 10.1021/ma000897k; Brandrup J., 1999, POLYM HDB; Chastek TQ, 2003, MACROMOLECULES, V36, P7672, DOI 10.1021/ma034833w; Jang Y, 2013, POLYM BULL, V70, P593, DOI 10.1007/s00289-012-0877-9; Lai CJ, 2002, MACROMOLECULES, V35, P4044, DOI 10.1021/ma0122223; Matsushita A, 2014, MACROMOLECULES, V47, P7169, DOI 10.1021/ma501560n; Ogawa T, 1996, MACROMOLECULES, V29, P2113, DOI 10.1021/ma951066v; Sun SS, 2003, SOL ENERG MAT SOL C, V79, P257, DOI 10.1016/S0927-0248(03)00104-1; Suo TC, 2009, MACROMOLECULES, V42, P6791, DOI 10.1021/ma900939u; Yoon J, 2008, MACROMOLECULES, V41, P4582, DOI 10.1021/ma8009504	20	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAY	2015	47	5					385	390		10.1038/pj.2015.4		6	Polymer Science	Polymer Science	CH5IT	WOS:000354069600006		
J	Liu, CY; Matsusaki, M; Akashi, M				Liu, Chun-Yen; Matsusaki, Michiya; Akashi, Mitsuru			Cell effects on the formation of collagen triple helix fibers inside collagen gels or on cell surfaces	POLYMER JOURNAL			English	Article							SKELETAL-MUSCLE; I COLLAGEN; TISSUE; CULTURE; MATRICES; BIOMATERIALS; SPECTROSCOPY; SCAFFOLDS; PH	Collagen molecules are widely used in the field of tissue engineering, especially as cell culture hydrogels. However, the cellular effects on collagen fiber formation inside collagen gels have not been reported. Here, we evaluated the effect of cells on collagen triple helix fiber formation at a molecular level in collagen hydrogels or on cell surfaces. Swelling ratios of collagen gels decreased with increasing cell numbers, most likely because of interactions between cell surface integrin molecules and collagen fibers. Circular dichroism and ultraviolet-visible spectroscopic analyses revealed aggregations of cells and collagen molecules because of their strong interaction. X-ray diffraction analyses suggested that cells did not affect the weak molecular orientation of collagen fibers inside collagen gels because the collagen gels usually do not have as dense molecular packing as natural collagen fibers in tendons. Scanning electron microscopy showed aggregations of submicrometer-sized spherical collagen structures mainly around cells inside collagen gels. The results suggest that interactions between cell surfaces and collagen molecules induce the formation of spherical constructs rather than microfiber formation, which in turn indicates that interactions between cells and collagen molecules induce the adsorption of collagen molecules onto cell surfaces and lead to the formation of spherical constructs in hydrogels.	[Liu, Chun-Yen; Matsusaki, Michiya; Akashi, Mitsuru] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Osaka, Japan	Akashi, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	akashi@chem.eng.osaka-u.ac.jp			NEXT Program [LR026]; SENTAN-JST Program	This work was supported by the NEXT Program (LR026), a Grant-in-Aid for Scientific Research (S) and the SENTAN-JST Program. We also thank Mrs Kimura for her technical assistance.	Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Ko YG, 2010, J BIOACT COMPAT POL, V25, P360, DOI 10.1177/0883911510370002; Lu JQ, 2002, APPL CATAL A-GEN, V237, P11, DOI 10.1016/S0926-860X(02)00062-5; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Xia Z, 2014, J MATER CHEM B, V2, P1998, DOI 10.1039/c3tb21595d; Sung KE, 2009, BIOMATERIALS, V30, P4833, DOI 10.1016/j.biomaterials.2009.05.043; Janin-Manificat H, 2012, MOL VIS, V18, P2896; Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Fernandes LL, 2011, POLIMEROS, V21, P1, DOI 10.1590/S0104-14282011005000008; Cheng PN, 2012, NAT CHEM, V4, P927, DOI [10.1038/nchem.1433, 10.1038/NCHEM.1433]; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Sugino A, 2008, J MATER SCI-MATER M, V19, P2269, DOI 10.1007/s10856-007-3327-8; Lai JY, 2013, J BIOMED NANOTECHNOL, V9, P2048, DOI 10.1166/jbn.2013.1734; Saska S, 2012, J MATER CHEM, V22, P22102, DOI 10.1039/c2jm33762b; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067; Petibois C, 2006, ANAL BIOANAL CHEM, V386, P1961, DOI 10.1007/s00216-006-0828-0; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Liu CY, 2014, RSC ADV, V4, P46141, DOI 10.1039/c4ra09085c; Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; Jiang FZ, 2004, J STRUCT BIOL, V148, P268, DOI 10.1016/j.jsb.2004.07.001; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; Chaubaroux C, 2012, BIOMACROMOLECULES, V13, P2128, DOI 10.1021/bm300529a; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Viney ME, 2009, REGEN MED, V4, P397, DOI [10.2217/rme.09.4, 10.2217/RME.09.4]; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1; Belbachir K, 2009, ANAL BIOANAL CHEM, V395, P829, DOI 10.1007/s00216-009-3019-y; Baia L, 2008, J OPTOELECTRON ADV M, V10, P933; Beier JP, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-34; Bonda M, 2011, ANAL CHEM, V83, P7712, DOI 10.1021/ac201102p; Brown EM, 2000, J PROTEIN CHEM, V19, P85, DOI 10.1023/A:1007074314686; Hongo C, 2008, CHEM LETT, V37, P1254, DOI 10.1246/cl.2008.1254; Kim HS, 2003, INT J HEMATOL, V78, P126, DOI 10.1007/BF02983380; Kim TG, 2010, J MATER CHEM, V20, P8927, DOI 10.1039/c0jm01062f; KIRCHHOFER D, 1990, J BIOL CHEM, V265, P615; Nasir N.F.M., 2006, AM J BIOCH BIOTECHNO, V2, P175; Harris JR, 2007, MICRON, V38, P513, DOI 10.1016/j.micron.2006.07.026; Shan A., 2008, PEDIATR RES, V63, P535; Thanikaivelan P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00230; Thermistocleous G. S., 2004, IN VIVO, V18, P687; Vileno B, 2010, BIOPHYS CHEM, V152, P164, DOI 10.1016/j.bpc.2010.09.004	44	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAY	2015	47	5					391	399		10.1038/pj.2015.2		9	Polymer Science	Polymer Science	CH5IT	WOS:000354069600007		
J	Moriga, T; Aoyama, N; Tanaka, K				Moriga, Toshinori; Aoyama, Naoki; Tanaka, Keiji			Development of a polyurethane sealing gasket with excellent sealing and opening properties	POLYMER JOURNAL			English	Article							EPOXIDIZED SOYBEAN OIL; PLASTICIZED PVC GASKETS; BOTTLED FOODS; BABY FOOD; MIGRATION	Alternative materials to replace the currently used poly(vinyl chloride) (PVC) plastisols as sealing gaskets for use in wide-mouth glass jars have been desired. In this study, we propose a novel urethane-based polymer as a better replacement for PVC plastisols. This polymer was prepared by reacting a diol with a molecular weight (MW) of 1000 g mol(-1), a triol with an MW of 500 g mol(-1) and an aliphatic diisocyanate adduct with MW of 430 g mol(-1). When additives, such as hollow particles as a blowing agent and lubricants, were incorporated into this urethane polymer, the resulting material exhibited a rubbery plateau with a low modulus over a wide temperature range, from a temperature <0 degrees C to a temperature >100 degrees C. These properties favorably support this material for use as a sealing gasket owing to its remarkable sealing and opening characteristics.	[Moriga, Toshinori; Tanaka, Keiji] Kyushu Univ, Dept Appl Chem, Fukuoka 8190395, Japan; [Moriga, Toshinori] Toyo Kohan Co Ltd, R&D Ctr, Kudamatsu, Japan; [Aoyama, Naoki] Toyo Seikan Grp Holdings Ltd, Tokyo, Japan	Moriga, T (reprint author), Kyushu Univ, Dept Appl Chem, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	moriga.toshinori@toyokohan.co.jp; k-tanaka@cstf.kyushu-u.ac.jp					[Anonymous], 2004, EFSA J, V64, P1, Patent No. 2674947; [Anonymous], 1989, Toluene Diisocyanate (TDI) and Toluenediamine(TDA): Evidence of Carcinogenicity, Patent No. 2674947; Fantoni L, 2003, FOOD ADDIT CONTAM, V20, P1087, DOI 10.1080/02652030310001615186; CHEN WP, 1992, J MACROMOL SCI PURE, V29, P567, DOI 10.1080/10101329208052183; Frankhauser-Noti A., 2005, EUR FOOD RES TECHNOL, V221, P416; Frankhauser-Noti A, 2006, EUR FOOD RES TECHNOL, V223, P447; Frankhauser-Noti A., 2006, TRENDS FOOD SCI TECH, V17, P105; Furukawa M., 2011, NIPPON GOMU KYOKAISH, V84, P124; Hammarling L, 1998, FOOD ADDIT CONTAM A, V15, P203; Iwata K, 1987, POLYURETHANE HDB; Japan Crown Cork Co. Ltd, 2004, INV EFF FOOD CONT SU; Kanno S, 2006, J FOOD HYG SOC JPN, V47, P196, DOI 10.3358/shokueishi.47.196; Kawamura Y, 2006, J FOOD HYG SOC JPN, V47, P243, DOI 10.3358/shokueishi.47.243; Krevelen D.W., 2008, MECH PROPERTIES SOLI, P383; Moriga T., 1995, US Patent, Patent No. [5441994, 6872796]; Moriga T., 2005, TOLUENE DIISOCYANATE, Patent No. 6872796; Moriga T., 2008, Japanese Patent, Patent No. [4068831, 5677053]; Moriga T., 1997, Japanese Patent, Patent No. [2674947, 2739805]; Moriga T., 1997, US Patent, Patent No. [5677053, 6878449]; Moriga T., 2007, Japanese Patent, Patent No. [2674947, 3810346]; Moriga T., 1998, Japanese Patent, Patent No. [2739805, 3860509]; Moriga T., 2005, EFSA J, Patent No. 6878449; Moriga T., 2006, Japanese Patent, Patent No. [3810346, 4068831]; Moriga T., 2006, Japanese Patent, Patent No. [3860509, 5441994]; Murayama S, 2011, J ADHESION SOC JAPAN, V31, P12; Nakazawa H., 1999, STUDY ENDOCRINE DISR, P93; Okuri Y., 2002, J ADHESION SOC JAPAN, V22, P62; Prisacariu C., 2011, P WORLD C ENG 2011 L, VIII, P2178; Shirasaka H., 1999, NIPPON GOMU KYOKAISH, V72, P123; Takemura Y, 1998, ENG MAT, V46, P28; Treloar L. R. G., 2005, PHYS RUBBER ELASTICI; Tsumura Y, 2002, J FOOD HYG SOC JPN, V43, P377; Yokoyama T., 1993, NIPPON GOMU KYOKAISH, V66, P98	33	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAY	2015	47	5					400	407		10.1038/pj.2015.6		8	Polymer Science	Polymer Science	CH5IT	WOS:000354069600008		
J	Baba, E; Yatsunami, T; Yamamoto, T; Tezuka, Y				Baba, Eisuke; Yatsunami, Toshiaki; Yamamoto, Takuya; Tezuka, Yasuyuki			A study on emulsion stabilization induced with linear and cyclized polystyrene-poly(ethylene oxide) block copolymer surfactants	POLYMER JOURNAL			English	Article							OXIDE)-B-POLYSTYRENE TRIBLOCK COPOLYMERS; THERMAL-STABILITY; MICELLES; POLYMERIZATION		[Baba, Eisuke; Yatsunami, Toshiaki; Yamamoto, Takuya; Tezuka, Yasuyuki] Tokyo Inst Technol, Dept Organ & Polymer Mat, Tokyo 1528552, Japan	Tezuka, Y (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan.	ytezuka@o.cc.titech.ac.jp			Integrated Doctoral Education Program at Tokyo Tech; KAKENHI [26288099, 26310206]	EB acknowledges support from Integrated Doctoral Education Program at Tokyo Tech. This work was partially supported by KAKENHI (26288099 to TY and 26310206 to YT).	Hong LZ, 2012, LANGMUIR, V28, P2332, DOI 10.1021/la205108w; Bhargava P, 2007, J AM CHEM SOC, V129, P1113, DOI 10.1021/ja0653019; Baba E, 2012, POLYM CHEM-UK, V3, P1903, DOI 10.1039/c1py00475a; Lee CU, 2011, MACROMOLECULES, V44, P9574, DOI 10.1021/ma2020936; Lonsdale DE, 2011, J POLYM SCI POL CHEM, V49, P4603, DOI 10.1002/pola.24935; Zhang BY, 2013, ACS MACRO LETT, V2, P845, DOI 10.1021/mz4003936; Wang X, 2014, MACROMOLECULES, V47, P2487, DOI 10.1021/ma5000255; Mai YY, 2012, CHEM SOC REV, V41, P5969, DOI 10.1039/c2cs35115c; Isono T, 2014, MACROMOLECULES, V47, P2853, DOI 10.1021/ma500494e; Honda S, 2010, J AM CHEM SOC, V132, P10251, DOI 10.1021/ja104691j; Heo K, 2014, ACS MACRO LETT, V3, P233, DOI 10.1021/mz5000224; Yuan JJ, 2003, EUR POLYM J, V39, P767, DOI 10.1016/S0014-3057(02)00276-8; Binks BP, 2000, LANGMUIR, V16, P1025, DOI 10.1021/la990952m; Honda S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2585; Tadros T., 2013, EMULSION FORMATION S; Tezuka Y, 2013, TOPOLOGICAL POLYMER CHEMISTRY: PROGRESS OF CYCLIC POLYMERS IN SYNTHESES, PROPERTIES AND FUNCTIONS, P1, DOI 10.1142/8443; Xu DM, 2006, J APPL POLYM SCI, V101, P727, DOI 10.1002/app.23971	17	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAY	2015	47	5					408	412		10.1038/pj.2015.5		5	Polymer Science	Polymer Science	CH5IT	WOS:000354069600009		
J	Miura, K; Higashijima, A; Hasegawa, Y; Abe, S; Miura, S; Kaneuchi, M; Yoshiura, K; Masuzaki, H				Miura, Kiyonori; Higashijima, Ai; Hasegawa, Yuri; Abe, Shuhei; Miura, Shoko; Kaneuchi, Masanori; Yoshiura, Koh-ichiro; Masuzaki, Hideaki			Circulating levels of maternal plasma cell-free miR-21 are associated with maternal body mass index and neonatal birth weight	PRENATAL DIAGNOSIS			English	Article							PLACENTA-SPECIFIC MICRORNAS; FREE DNA; PREGNANCY		[Miura, Kiyonori; Higashijima, Ai; Hasegawa, Yuri; Abe, Shuhei; Miura, Shoko; Kaneuchi, Masanori; Masuzaki, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 852, Japan; [Yoshiura, Koh-ichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan	Miura, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 852, Japan.	kiyonori@nagasaki-u.ac.jp			JSPS KAKENHI [26462495, 24791712, 25462563]	K.M., S.M., and H.M. were supported by JSPS KAKENHI (grant numbers 26462495, 24791712, and 25462563, respectively).	Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Higashijima A, 2013, PRENATAL DIAG, V33, P214, DOI 10.1002/pd.4045; Jiang H, 2014, J PERINATOL, V34, P658, DOI 10.1038/jp.2014.58; Haghiac M, 2012, OBESITY, V20, P2213, DOI 10.1038/oby.2012.138; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Maccani MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021210; Miura K, 2014, PLACENTA, V35, P848, DOI 10.1016/j.placenta.2014.06.002; Vora NL, 2012, PRENATAL DIAG, V32, P912, DOI 10.1002/pd.3919; Whitehead CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078487	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-3851	1097-0223		PRENATAL DIAG	Prenat. Diagn.	MAY	2015	35	5					509	511		10.1002/pd.4509		3	Genetics & Heredity; Obstetrics & Gynecology	Genetics & Heredity; Obstetrics & Gynecology	CH4EX	WOS:000353987100017		
J	Lim, OT; Iida, N				Lim, Ock Taeck; Iida, Norimasa			A study on the spray and engine combustion characteristics of diesel-dimethyl ether fuel blends	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART D-JOURNAL OF AUTOMOBILE ENGINEERING			English	Article						Diesel-dimethyl ether fuel blends; emission characteristics; spray characteristics; reactivity		The purpose of this study was to compare the spray characteristics, the combustion characteristics and the emissions (nitrogen oxides, carbon monoxide, hydrocarbon and smoke) of typical fuels (100% diesel and 100% dimethyl ether) and diesel-dimethyl ether fuel blends in a constant-volume chamber and a single-cylinder direct-injection diesel engine. The spray characteristics were investigated by varying the ambient pressure and the fuel injection pressure using a common-rail fuel injection system with various fuel mixture ratios. The spray characteristic research parameters were the spray shape, the penetration length and the spray angle at the seven-hole injector. Common types of injector were used (Bosch). Two types of fuel blended by mass fraction were employed. Typical fuels (100% diesel and 100% dimethyl ether) and fuel blends with diesel:dimethyl ether mixture ratios of 95:5 and 90:10 were used. The injection pressure was fixed at 70 MPa while the ambient pressure was varied (0 MPa, 2.5 MPa and 5 MPa). The combustion experiments were conducted in a single-cylinder engine equipped with a common rail. The injection pressure was 700 bar at 1200 r/min. The amount of injected fuel was adjusted to obtain a fixed input calorific value of 972.2 J/cycle in order to make a comparison between the fuel types. The results showed that the injection quantity was greater with diesel fuel but not for dimethyl ether fuel and for the fuel blend with the higher mixing ratio. The spray penetration length increased with increasing ambient pressure for diesel but decreased for dimethyl ether with a larger spray angle. The ignition delay and the heat release rate decreased with increasing dimethyl ether which led to a higher indicated mean effective pressure and higher thermal efficiency because there was less negative work in the expansion. The total hydrocarbon emissions and the carbon monoxide emissions decreased with increasing dimethyl ether, but the nitrogen oxide emissions generated were greater owing to the increased combustion temperature.	[Lim, Ock Taeck] Univ Ulsan, Dept Mech Engn, Ulsan 680749, South Korea; [Lim, Ock Taeck; Iida, Norimasa] Keio Univ, Dept Syst Design, Yokohama, Kanagawa 223, Japan	Lim, OT (reprint author), Univ Ulsan, Dept Mech Engn, San 29,Mugeo2 Dong, Ulsan 680749, South Korea.	otlim@ulsan.ac.kr			University of Ulsan [2014-0032]	This work was supported by the 2014 Research Fund of University of Ulsan (grant number 2014-0032).	Bielaczyc P, 2012, 2012011052 SAE; Dan T, 2012, 8 KSME JSME THERM FL, P1; Delgado R, 2012, 2012011273 SAE; Ikeda M., 2000, 2000012006 SAE; Kajitani S, 2002, 14 INT S ALC FUELS P; Komatsu K, 2011, 2011320522 SAE; Oh YI, 2011, 7 AS DME C NIIG JAP, P361; Sato Y., 2004, 2004011862 SAE; Seto T, 2005, JSAE ANN C YOK JAP 1; Sivalakshmi S, 2012, 2012010870 SAE; Sivebaek IM, 2001, 2001012013 SAE; Wang Y, 2006, ATMOS ENVIRON, V40, P2313, DOI 10.1016/j.atmosenv.2005.12.016; Yu J, 2010, 2010010879 SAE; Yu J-Z, 2010, 2010011485 SAE; Zhao X., 2005, FUEL, V28, P2380	15	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4070	2041-2991		P I MECH ENG D-J AUT	Proc. Inst. Mech. Eng. Part D-J. Automob. Eng.	MAY	2015	229	6			SI		782	792		10.1177/0954407014539673		11	Engineering, Mechanical; Transportation Science & Technology	Engineering; Transportation	CH4EN	WOS:000353985700011		
J	Kuno, Y				Kuno, Y.			Rare lepton decays	PROGRESS IN PARTICLE AND NUCLEAR PHYSICS			English	Review						Lepton; Rare decay; Charged lepton flavor violation; Muon; Tau; New physics	MU-E CONVERSION; NUCLEAR MU(-)-E(-) CONVERSION; R-PARITY VIOLATION; FLAVOR VIOLATION; POSITRON CONVERSION; BRANCHING RATIO; STANDARD MODEL; IMPROVED LIMIT; SEARCH; ELECTRON	This article describes rare lepton decays, in particular, the rare processes in which lepton flavor of charged leptons is not conserved. Physics motivation, phenomenology, current experimental status and their future prospects for rare lepton decays are presented. (C) 2015 Elsevier B.V. All rights reserved.	Osaka Univ, Suita, Osaka 565, Japan	Kuno, Y (reprint author), Osaka Univ, Suita, Osaka 565, Japan.	kuno@phys.sci.osaka-u.ac.jp			 [25000004]	The author would like to thank Profs. G. Isidori, Y. Okada, K. Tobe for many discussions on CLFV. This work is supported by Grant-in-Aid, Specially-Promoted Research 25000004.	AHMAD S, 1988, PHYS REV D, V38, P2102, DOI 10.1103/PhysRevD.38.2102; Ahmed M, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.112002; Miyazaki Y, 2007, PHYS LETT B, V648, P341, DOI 10.1016/j.physletb.2007.03.027; Honecker W, 1996, PHYS REV LETT, V76, P200, DOI 10.1103/PhysRevLett.76.200; DOHMEN C, 1993, PHYS LETT B, V317, P631, DOI 10.1016/0370-2693(93)91383-X; Kosmas TS, 2001, PHYS LETT B, V519, P78, DOI 10.1016/S0370-2693(01)01096-6; MAKI Z, 1962, PROG THEOR PHYS, V28, P870, DOI 10.1143/PTP.28.870; Isidori G, 2010, ANNU REV NUCL PART S, V60, P355, DOI 10.1146/annurev.nucl.012809.104534; HALL LJ, 1986, NUCL PHYS B, V267, P415, DOI 10.1016/0550-3213(86)90397-4; Bertl W, 2006, EUR PHYS J C, V47, P337, DOI 10.1140/epjc/s2006-02582-x; BORZUMATI F, 1986, PHYS REV LETT, V57, P961, DOI 10.1103/PhysRevLett.57.961; WEINBERG S, 1959, PHYS REV LETT, V3, P111, DOI 10.1103/PhysRevLett.3.111; Miyazaki Y, 2008, PHYS LETT B, V660, P154, DOI 10.1016/j.physletb.2007.12.046; SHANKER O, 1979, PHYS REV D, V20, P1608, DOI 10.1103/PhysRevD.20.1608; Domin P, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.065501; Adam J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.201801; Hisano J, 1996, PHYS REV D, V53, P2442, DOI 10.1103/PhysRevD.53.2442; Calibbi L, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.116002; Hisano J, 1998, PHYS LETT B, V437, P351, DOI 10.1016/S0370-2693(98)00929-0; Czarnecki A, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.013006; Arbuzov AB, 1998, PHYS LETT B, V432, P421, DOI 10.1016/S0370-2693(98)00652-2; Aubert B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.251803; Aubert B, 2005, PHYS REV LETT, V95, DOI [10.1103/PhysRevLett.95.221801, 10.1103/PhysRevLett.95.011801, 10.1103/PhysRevLett.95.191801, 10.1103/PhysRevLett.95.111801]; Aubert B., 2006, PHYS REV LETT, V96; Aubert B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.061803; BABU KS, 1995, PHYS REV LETT, V75, P2276, DOI 10.1103/PhysRevLett.75.2276; Bachman M., 1997, MECO BNL PROPOSAL E9, VE940; BADERTSCHER A, 1982, NUCL PHYS A, V377, P406, DOI 10.1016/0375-9474(82)90049-5; BARANOV VA, 1991, SOV J NUCL PHYS+, V53, P802; BARBIERI R, 1995, NUCL PHYS B, V449, P437, DOI 10.1016/0550-3213(95)00311-F; Bellgardt U., 1988, NUCL PHYS B, V229, P1; BERTL W, 1984, PHYS LETT B, V140, P299, DOI 10.1016/0370-2693(84)90757-3; BERTL W, 1985, NUCL PHYS B, V260, P1, DOI 10.1016/0550-3213(85)90308-6; BOLTON RD, 1984, PHYS REV LETT, V53, P1415, DOI 10.1103/PhysRevLett.53.1415; BOLTON RD, 1988, PHYS REV D, V38, P2077, DOI 10.1103/PhysRevD.38.2077; Brooks M.L., 1999, PHYS REV LETT, V83, P1521; BRYMAN DA, 1972, PHYS REV LETT, V28, P1469, DOI 10.1103/PhysRevLett.28.1469; BRYMAN DA, 1985, PHYS REV LETT, V55, P465, DOI 10.1103/PhysRevLett.55.465; Carry R.M., 2008, PROPOSAL SEARCH MU N; Cirigliano V, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.013002; Czarnecki A, 1998, AIP CONF PROC, V435, P409, DOI 10.1063/1.56214; Czarnecki A, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.093002; de Gouvea A, 2010, ANNU REV NUCL PART S, V60, P513, DOI 10.1146/annurev-nucl-100809-131949; DEPOMMIER P, 1995, REP PROG PHYS, V58, P61, DOI 10.1088/0034-4885/58/1/002; DZHILKIBAEV RM, 1989, SOV J NUCL PHYS+, V49, P384; ECKSTEIN SG, 1959, ANN PHYS-NEW YORK, V8, P297, DOI 10.1016/0003-4916(59)90024-7; Faessler A, 2000, NUCL PHYS B, V587, P25, DOI 10.1016/S0550-3213(00)00446-6; Faessler A, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.075006; Faessler A, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.055008; Faessler A, 2004, PHYS LETT B, V590, P57, DOI 10.1016/j.physletb.2004.03.068; Fronsdal C., 1959, PHYS REV, V118, P654; Gonzalez M, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.096020; Hayasaka K, 2008, PHYS LETT B, V666, P16, DOI 10.1016/j.physletb.2008.06.056; Hisano J, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.116005; Kanemura S, 2005, PHYS LETT B, V607, P165, DOI 10.1016/j.physletb.2004.12.038; Kaulard J, 1998, PHYS LETT B, V422, P334, DOI 10.1016/S0370-2693(97)01423-8; KERSCH A, 1988, NUCL PHYS A, V485, P606, DOI 10.1016/0375-9474(88)90556-8; KINNISON WW, 1982, PHYS REV D, V25, P2846, DOI 10.1103/PhysRevD.25.2846; Kitano R, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.059902; Kitano R, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.096002; Korenchenko S.M., 1976, SOV PHYS JETP, V43, P1; Kosmas TS, 2000, PHYS ATOM NUCL+, V63, P1158, DOI 10.1134/1.855761; Kosmas TS, 2001, PHYS LETT B, V511, P203, DOI 10.1016/S0370-2693(01)00657-8; Kuno Y, 1996, PHYS REV LETT, V77, P434, DOI 10.1103/PhysRevLett.77.434; Kuno Y., 2007, J PARC 50 GEV PROTON; Kuno Y., 2006, J PARC 50 GEV PROTON; Kuno Y, 1997, PHYS REV D, V55, pR2517; Okada Y., 1988, PHYS REV D, V58; Okada Y, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.094001; Simkovic F, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.033005; Simkovic F, 2002, PHYS LETT B, V544, P121, DOI 10.1016/S0370-2693(02)02466-8; VANDERSCHAAF A, 1980, NUCL PHYS A, V340, P249, DOI 10.1016/0375-9474(80)90274-2; WEINBERG S, 1959, PHYS REV LETT, V3, P244, DOI 10.1103/PhysRevLett.3.244.2; Wintz P., 1998, P 1 INT S LEPT BAR N, P534; Yusa Y, 2006, PHYS LETT B, V640, P138, DOI 10.1016/j.physletb.2006.07.025	75	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0146-6410	1873-2224		PROG PART NUCL PHYS	Prog. Part. Nucl. Phys.	MAY	2015	82						1	20		10.1016/j.ppnp.2015.01.003		20	Physics, Nuclear; Physics, Particles & Fields	Physics	CH7PN	WOS:000354229200001		
J	Funaki, Y; Horiuchi, H; Tohsaki, A				Funaki, Y.; Horiuchi, H.; Tohsaki, A.			Cluster models from RGM to alpha condensation and beyond	PROGRESS IN PARTICLE AND NUCLEAR PHYSICS			English	Review						Nuclear cluster models; Hoyle state; Alpha condensation; THSR wave function	ANTISYMMETRIZED MOLECULAR-DYNAMICS; ORTHOGONALITY CONDITION MODEL; C-12+C-12 INELASTIC-SCATTERING; R-MATRIX THEORY; EXCITED-STATES; PARTICLE MODEL; LIGHT-NUCLEI; 2-NUCLEON COLLISIONS; ATOMIC NUCLEI; SHELL-MODEL	The purpose of this article is firstly to review the study of the duster-gas-like structure, especially the a-cluster-condensate-like structure, which is a novel type of nuclear structure. The second purpose is to explain the recent proposal of the container model of general cluster dynamics which is a novel powerful cluster model that may be adopted in place of the traditional cluster models of resonating group method (RGM) and generator coordinate method (GCM) of Brink wave functions. The container model has been proposed based on the Tohsaki-Horiuchi-Schuck-Ropke (THSR) wave function which was introduced to investigate the a-cluster-condensate-like states. The main reason for the introduction of the container model was the striking fact that the RGM/GCM wave functions of various cluster states which include both gas-like and non-gas-like states are almost 100% equivalent to single THSR wave functions. For the sake of historical evolution, we give a concise review of various cluster models before the introduction of the THSR wave function. In particular, because the idea of the cluster-gas-like structure was proposed in the 1970s for explaining the properties of the Hoyle state, this review of traditional cluster models is indispensable. In view of the importance of the THSR wave function, various characteristic properties of the THSR wave function are explained. Since, at least until now, most calculations of matrix elements with the THSR wave functions have been done only analytically in order to get sufficient numerical accuracy, some analytical manipulations of the THSR wave function will be explained. (C) 2015 Elsevier B.V. All rights reserved.	[Funaki, Y.] RIKEN, Nishina Ctr Accelerator Based Sci, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; [Horiuchi, H.; Tohsaki, A.] Osaka Univ, Nucl Phys Res Ctr, Ibaraki 5670047, Japan; [Horiuchi, H.] Int Inst Adv Studies, Kizugawa 6190225, Japan	Funaki, Y (reprint author), RIKEN, Nishina Ctr Accelerator Based Sci, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan.	funaki@riken.jp	Funaki, Yasuro/F-5951-2015	Funaki, Yasuro/0000-0002-0801-8315			AGUILAR J, 1971, COMMUN MATH PHYS, V22, P269, DOI 10.1007/BF01877510; MORINAGA H, 1966, PHYS LETT, V21, P78, DOI 10.1016/0031-9163(66)91349-7; Ohkubo S, 2010, PHYS LETT B, V684, P127, DOI 10.1016/j.physletb.2009.12.066; KOHN W, 1948, PHYS REV, V74, P1763, DOI 10.1103/PhysRev.74.1763; Kanada-En'yo Y, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.024302; Chernykh M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.032501; Yamada T, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.024309; DESCOUVEMONT P, 1987, PHYS REV C, V36, P54, DOI 10.1103/PhysRevC.36.54; Zimmerman WR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.152502; Kurokawa C, 2007, NUCL PHYS A, V792, P87, DOI 10.1016/j.nuclphysa.2007.05.007; Funaki Y, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.064326; HORIUCHI H, 1977, PROG THEOR PHYS, V58, P204, DOI 10.1143/PTP.58.204; AJZENBERGSELOVE F, 1986, NUCL PHYS A, V460, P1, DOI 10.1016/0375-9474(86)90038-2; Tohsaki A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.192501; Kawabata T, 2007, PHYS LETT B, V646, P6, DOI 10.1016/j.physletb.2006.11.079; KUKULIN VI, 1986, NUCL PHYS A, V453, P365, DOI 10.1016/0375-9474(86)90443-4; KUKULIN VI, 1979, SOV J NUCL PHYS+, V29, P421; Navratil P, 2000, PHYS REV C, V62, DOI 10.1103/PhysRevC.62.054311; BALSLEV E, 1971, COMMUN MATH PHYS, V22, P280, DOI 10.1007/BF01877511; HORIUCHI H, 1975, PROG THEOR PHYS, V53, P447, DOI 10.1143/PTP.53.447; Itagaki N, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.037303; Itoh M, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.054308; Yamada T, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.035603; BLOCH C, 1957, NUCL PHYS, V4, P503, DOI 10.1016/0029-5582(87)90058-7; Kanada-En'yo Y, 1998, PHYS REV LETT, V81, P5291, DOI 10.1103/PhysRevLett.81.5291; Matsumura H, 2004, NUCL PHYS A, V739, P238, DOI 10.1016/j.nuclphysa.2004.04.104; Yamada T, 2005, EUR PHYS J A, V26, P185, DOI 10.1140/epja/i2005-10168-1; COOK CW, 1957, PHYS REV, V107, P508, DOI 10.1103/PhysRev.107.508; Gamow G, 1930, P R SOC LOND A-CONTA, V126, P632, DOI 10.1098/rspa.1930.0032; KAMIMURA M, 1981, NUCL PHYS A, V351, P456, DOI 10.1016/0375-9474(81)90182-2; AFZAL SA, 1969, REV MOD PHYS, V41, P247, DOI 10.1103/RevModPhys.41.247; WUOSMAA AH, 1992, PHYS REV LETT, V68, P1295, DOI 10.1103/PhysRevLett.68.1295; Itoh M, 2004, NUCL PHYS A, V738, P268, DOI 10.1016/j.nuclphysa.2004.04.044; SCHMID EW, 1961, NUCL PHYS, V26, P463, DOI 10.1016/0029-5582(61)90105-5; Ohkubo S, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.044609; Zimmerman WR, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.027304; KRUPPA AT, 1990, PROG THEOR PHYS, V84, P1145; UEGAKI E, 1979, PROG THEOR PHYS, V62, P1621, DOI 10.1143/PTP.62.1621; Hiyama E, 2003, PROG PART NUCL PHYS, V51, P223, DOI 10.1016/S0146-6410(03)00082-6; KAMIMURA M, 1988, PHYS REV A, V38, P621, DOI 10.1103/PhysRevA.38.621; Kanada-En'yo Y, 2007, PROG THEOR PHYS, V117, P655, DOI 10.1143/PTP.117.655; Margenau H, 1941, PHYS REV, V59, P37, DOI 10.1103/PhysRev.59.37; LANE AM, 1958, REV MOD PHYS, V30, P257, DOI 10.1103/RevModPhys.30.257; ALI S, 1966, NUCL PHYS, V80, P99, DOI 10.1016/0029-5582(66)90829-7; Danilov AN, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.054603; Hafstad LR, 1938, PHYS REV, V54, P681, DOI 10.1103/PhysRev.54.681; Yamada T, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.064315; Funaki Y, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.024312; Funaki Y, 2005, EUR PHYS J A, V24, P321, DOI 10.1140/epja/i2004-10238-x; SKYRME THR, 1959, NUCL PHYS, V9, P615, DOI 10.1016/0029-5582(58)90345-6; Freer M, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.034314; Ropke G, 1998, PHYS REV LETT, V80, P3177, DOI 10.1103/PhysRevLett.80.3177; Yamada T, 2008, INT J MOD PHYS E, V17, P2101; Aoyama S, 2006, PROG THEOR PHYS, V116, P1, DOI 10.1143/PTP.116.1; Yamada T, 2008, PROG THEOR PHYS, V120, P1139, DOI 10.1143/PTP.120.1139; LOWDIN PO, 1955, PHYS REV, V97, P1490, DOI 10.1103/PhysRev.97.1490; Suhara T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.062501; AOKI K, 1982, PROG THEOR PHYS, V68, P1658, DOI 10.1143/PTP.68.1658; BAYE D, 1974, NUCL PHYS A, VA233, P304, DOI 10.1016/0375-9474(74)90458-8; Bayman B. F., 1958, NUCL PHYS, V9, P596; Brink D., 1966, COURSE, V36, P247; Brink D M, 2008, Journal of Physics: Conference Series, DOI 10.1088/1742-6596/111/1/012001; BUCK B, 1977, NUCL PHYS A, V275, P246, DOI 10.1016/0375-9474(77)90287-1; Cherubini S, 1997, Z PHYS A-HADRON NUCL, V357, P291, DOI 10.1007/s002180050245; DENNISON DM, 1954, PHYS REV, V96, P378, DOI 10.1103/PhysRev.96.378; Descouvemont P, 2012, LECT NOTES PHYS, V848, P1, DOI 10.1007/978-3-642-24707-1_1; Dote A, 1997, PHYS REV C, V56, P1844, DOI 10.1103/PhysRevC.56.1844; Freer M, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.041303; Fujimura H, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.064327; Fujita Y, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.011306; Fujiwara Y., 1980, PROG THEOR PHYS SUPP, V68, P29, DOI 10.1143/PTPS.68.29; Fujiwara Y, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.037002; Fujiwara Y, 2004, FEW-BODY SYST, V34, P237, DOI 10.1007/s00601-004-0021-y; Fukushima Y., 1978, J PHYSICAL SOC JAP S, V44, P225; FULTON BR, 1980, PHYS REV C, V21, P198, DOI 10.1103/PhysRevC.21.198; Funaki Y, 2006, PROG THEOR PHYS, V115, P115, DOI 10.1143/PTP.115.115; Funaki Y, 2002, PROG THEOR PHYS, V108, P297, DOI 10.1143/PTP.108.297; Funaki Y, 2014, PROG THEOR EXP PHYS, DOI 10.1093/ptep/ptu143; Funaki Y., 2012, PROGR THEORET PHYS S, V196, P439; Funaki Y, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.051306; Funaki Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.082502; Funaki Y, ARXIV14085855; Funaki Y, 2006, EUR PHYS J A, V28, P259, DOI 10.1140/epja/i2006-10061-5; Fynbo H. O. U., 2011, PHYSICS, V4, P94; Gamow G, 1931, CONSTITUTION ATOMIC; GLASSGOLD AE, 1956, PHYS REV, V103, P701, DOI 10.1103/PhysRev.103.701; HASEGAWA A, 1971, PROG THEOR PHYS, V45, P1786, DOI 10.1143/PTP.45.1786; Hill D.L., 1953, PHYS REV, V89, P1120; Horiuchi H., 2012, PROGR THEORET PHYS S, V192, P1; Horiuchi H, 1977, PROG THEOR PHYS SUPP, V62, P90, DOI 10.1143/PTPS.62.90; HORIUCHI H, 1968, PROG THEOR PHYS, V40, P277, DOI 10.1143/PTP.40.277; Horiuchi H, 2009, INT J MOD PHYS A, V24, P2205; Horiuchi H., 1986, INT REV NUCL PHYS, V4, P1; Horiuchi H, 2011, J PHYS CONF SER, V321, DOI 10.1088/1742-6596/321/1/012042; HORIUCHI H, 1991, NUCL PHYS A, V522, pC257; HORIUCHI H, 1974, PROG THEOR PHYS, V51, P1266, DOI 10.1143/PTP.51.1266; Horiuchi H, 2012, ROM J PHYS, V57, P227; HORIUCHI H, 1970, PROG THEOR PHYS, V43, P375, DOI 10.1143/PTP.43.375; Hoyle F., 1954, ASTROPHYS J S, V1, P121, DOI DOI 10.1086/190005; Hulthen L., 1948, ARKIV MAT ASTRON F A, V35A, P25; HUTZELME.H, 1970, Z PHYS, V232, P356, DOI 10.1007/BF01395387; Ichikawa T, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.061301; Ito M, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.034307; Ito M, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.064303; Itoh M, 2013, J PHYS CONF SER, V436, DOI 10.1088/1742-6596/436/1/012006; KAMENY SL, 1956, PHYS REV, V103, P358, DOI 10.1103/PhysRev.103.358; KAMIMURA M, 1972, PROG THEOR PHYS, V47, P1537, DOI 10.1143/PTP.47.1537; Kamimura M, 1977, PROG THEOR PHYS SUPP, V62, P236, DOI 10.1143/PTPS.62.236; Kanada-En'yo Y, 2012, PROG THEOR EXP PHYS, DOI 10.1093/ptep/pts001; Kanada-En'yo Y, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.034306; KANADA-EN'YO Y, 1995, PHYS REV C, V52, P628, DOI 10.1103/PhysRevC.52.628; Kanada-En'yo Y, 2003, CR PHYS, V4, P497, DOI 10.1016/S1631-0705(03)00062-8; KANADA-EN'YO Y, 1995, PHYS REV C, V52, P647, DOI 10.1103/PhysRevC.52.647; KATO T, 1951, PROG THEOR PHYS, V6, P394; Kawabata T, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.034318; Khoa DT, 2008, PHYS LETT B, V660, P331, DOI 10.1016/j.physletb.2007.12.059; Kokalova T, 2005, EUR PHYS J A, V23, P19, DOI 10.1140/epja/i2004-10071-3; KRUPPA AT, 1988, PHYS REV C, V37, P383, DOI 10.1103/PhysRevC.37.383; Kukulin V.I., 1977, J PHYS A, V10, P33; Mirgule ET, 1997, PHYS REV C, V56, P1943, DOI 10.1103/PhysRevC.56.1943; Navratil P, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.034305; Neff T., 2008, PROGRAM; Ohkubo S, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.041602; Ohtsubo SI, 2013, PROG THEOR EXP PHYS, DOI 10.1093/ptep/ptt048; ONO A, 1992, PROG THEOR PHYS, V87, P1185, DOI 10.1143/PTP.87.1185; Ono A., 2004, PROG PART NUCL PHYS, V53, P497; ONO A, 1992, PHYS REV LETT, V68, P2898, DOI 10.1103/PhysRevLett.68.2898; PATE SF, 1988, PHYS REV C, V37, P1953, DOI 10.1103/PhysRevC.37.1953; PERRING JK, 1956, P PHYS SOC LOND A, V69, P600, DOI 10.1088/0370-1298/69/8/304; Sasamoto Y, 2006, MOD PHYS LETT A, V21, P2393, DOI 10.1142/S0217732306022031; SHELINE RK, 1960, NUCL PHYS, V21, P196, DOI 10.1016/0029-5582(60)90046-8; SMIRNOV YF, 1974, NUCL PHYS A, VA235, P289, DOI 10.1016/0375-9474(74)90193-6; SUZUKI Y, 1972, PROG THEOR PHYS, V47, P1517, DOI 10.1143/PTP.47.1517; SUZUKI Y, 1976, PROG THEOR PHYS, V55, P1751, DOI 10.1143/PTP.55.1751; Szilner S, 1997, PHYS REV C, V55, P1312, DOI 10.1103/PhysRevC.55.1312; Takashina M, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.054606; Takashina M, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.014602; TAMAGAKI R, 1965, PROG THEOR PHYS, V34, P191, DOI 10.1143/PTP.34.191; TANABE F, 1975, PROG THEOR PHYS, V53, P677, DOI 10.1143/PTP.53.677; TOHSAKI A, 1994, PHYS REV C, V49, P1814, DOI 10.1103/PhysRevC.49.1814; Tohsaki A, 2008, INT J MOD PHYS E, V17, P2106; Tohsaki A, 2011, FRONT PHYS-BEIJING, V6, P320, DOI 10.1007/s11467-011-0184-1; Tomita M, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.034619; UEGAKI E, 1977, PROG THEOR PHYS, V57, P1262, DOI 10.1143/PTP.57.1262; VISSCHER.JL, 1971, PHYS LETT B, VB 34, P455, DOI 10.1016/0370-2693(71)90652-6; VOLKOV AB, 1970, NUCL PHYS A, VA141, P337, DOI 10.1016/0375-9474(70)90850-X; von Oertzen W, 2006, EUR PHYS J A, V29, P133, DOI 10.1140/epja/i2006-10076-x; Wakasa T, 2007, PHYS LETT B, V653, P173, DOI 10.1016/j.physletb.2007.08.016; Wefelmeier W., 1937, NATURWISSENSCHAFTEN, V25, P525; Wheeler JA, 1937, PHYS REV, V52, P1083, DOI 10.1103/PhysRev.52.1083; Wildermuth K., 1977, UNIFIED THEORY NUCL; WILDERMUTH K, 1958, NUCL PHYS, V7, P150, DOI 10.1016/0029-5582(58)90245-1; Wildermuth K., 1958, NUCL PHYS, V9, P449; Wildermuth K., 1959, CERN REP UNPUB, P59; Wildermuth K., 1966, SPRINGER TRACTS MODE, V41; Wiringa R.B., WILHELM ELSE HERAEUS; Wuosmaa AH, 2003, PHYS LETT B, V571, P155, DOI 10.1016/j.physletb.2003.07.074; WUOSMAA AH, 1994, PHYS REV C, V50, P2909, DOI 10.1103/PhysRevC.50.2909; Yamada T, 2012, LECT NOTES PHYS, V848, P229, DOI 10.1007/978-3-642-24707-1_5; Yamada T, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.054314; Yamada T, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.034315; Zhou B, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.014301; Zhou B, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.262501; Zhou B, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.034319; Zhou B, 2014, PROG THEOR EXP PHYS, DOI 10.1093/ptep/ptu127	165	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0146-6410	1873-2224		PROG PART NUCL PHYS	Prog. Part. Nucl. Phys.	MAY	2015	82						78	132		10.1016/j.ppnp.2015.01.001		55	Physics, Nuclear; Physics, Particles & Fields	Physics	CH7PN	WOS:000354229200004		
J	Luthje, S; Renaut, J; Job, D; Hajduch, M; Carpentier, S; Sarkar, A; Agrawal, R; Dunn, MJ; Rakwal, R; Agrawal, GK				Luethje, Sabine; Renaut, Jenny; Job, Dominique; Hajduch, Martin; Carpentier, Sebastien; Sarkar, Abhijit; Agrawal, Raj; Dunn, Michael J.; Rakwal, Randeep; Agrawal, Ganesh Kumar			INPPO2014, First INPPO World Congress on "Plant Proteomics: Methodology to Biology"-A global platform for involving, gathering and disseminating knowledge	PROTEOMICS			English	Article						Collaboration; INPPO; Plant biology; Plant proteomics; World congress		The International Plant Proteomics Organization (INPPO) is a global platform of the plant proteomics community or, more generally, the scientific community that uses proteomics to address plant biology. Organizing an international conference is one of its initiatives to promote plant proteomics by involving and gathering scientists/researchers/students and by disseminating the acquired knowledge. In this fourth INPPO Highlights, the first INPPO World Congress 2014 (INPPO2014) is described and discussed. The INPPO2014 was held at the University of Hamburg (Germany) with the title "Plant Proteomics: Methodology to Biology" under the leadership of Sabine Luthje (Germany). Participants (around 150) from 38 nations attended this congress covering all continents. The four-day scientific program comprised 52 lectures and 61 poster presentations in a highly professional and friendly atmosphere on mass spectrometry and gel-based proteomics. Two round-table open discussions deliberated on plant proteomics, its associated international organizations/initiatives and future INPPO perspectives. The Second INPPO World Congress 2016 (INPPO2016) "The Quest for Tolerant Varieties-Phenotyping at Plant and Cellular Level" is planned to be organized in Bratislava (Slovakia) under the leadership of Martin Hajduch (Slovak Republic) and Sebastien Carpentier (Belgium) and cosponsored by the COST action FA1306.	[Luethje, Sabine] Univ Hamburg, Bioctr Klein Flottbek, Oxidat Stress & Plant Prote Grp, Hamburg, Germany; [Renaut, Jenny] Luxembourg Inst Sci & Technol, Belvaux, GD, Luxembourg; [Job, Dominique] UCB, INSA, CNRS, Prote Platform,Bayer CropSci Joint Lab,UMR5240, Lyon, France; [Hajduch, Martin] Slovak Acad Sci, Inst Plant Genet & Biotechnol, Bratislava, Slovakia; [Carpentier, Sebastien] Univ Leuven, Dept Biosyst, Leuven, Belgium; [Sarkar, Abhijit; Rakwal, Randeep; Agrawal, Ganesh Kumar] Res Lab Biotechnol & Biochem RLABB, Kathmandu, Nepal; [Sarkar, Abhijit; Rakwal, Randeep; Agrawal, Ganesh Kumar] GRADE Global Res Arch Developing Educ Acad Privat, Birgunj, Nepal; [Sarkar, Abhijit] Raiganj Surendranath Mahavidyalaya, Dept Bot, Sudarshanpur, Raiganj, India; [Sarkar, Abhijit; Agrawal, Raj] Int Plant Prote Org INPPO, Hamburg, Germany; [Dunn, Michael J.] Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki, Japan; [Rakwal, Randeep] Showa Univ, Sch Med, Dept Anat 1, Shinagawa, Tokyo, Japan	Luthje, S (reprint author), Univ Hamburg, Bioctr Klein Flottbek, Oxidat Stress & Plant Prote Grp, Hamburg, Germany.				Deutsche Forschungsgemeinschaft [DFG Lu-668/16-1]; Biocenter Klein Flottbek; JPT; Agrisera; Thermo Scientific; Serva; ABSciex; Conviron; Brucker; Decodon; Totallab; Eurisotop; Beckman Coulter	Authors gratefully acknowledge great support of University of Hamburg for providing space, technical support, web-space, and equipment for organizing INPPO2014, and the Deutsche Forschungsgemeinschaft for financial support (DFG Lu-668/16-1). Funding is appreciated from Biocenter Klein Flottbek, JPT, Agrisera, Thermo Scientific, Serva, ABSciex, Conviron, Brucker, Decodon, Totallab, Eurisotop, and Beckman Coulter. INPPO is highly grateful to PROTEOMICS and, in particular, Hans-Joachim Kraus, Senior Publishing Editor, for constant support.	Agrawal GK, 2011, PROTEOMICS, V11, P1559, DOI 10.1002/pmic.201000608	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	MAY	2015	15	10			SI		1631	1637		10.1002/pmic.201570084		7	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH8GG	WOS:000354273800001		
J	Sharma, TK; Ramanathan, R; Rakwal, R; Agrawal, GK; Bansal, V				Sharma, Tarun K.; Ramanathan, Rajesh; Rakwal, Randeep; Agrawal, Ganesh K.; Bansal, Vipul			Moving forward in plant food safety and security through NanoBioSensors: Adopt or adapt biomedical technologies?	PROTEOMICS			English	Review						Agriculture; Diagnostics; Food; Nanobiosensors; Nanoproteomics; Nanotechnology	UNMODIFIED GOLD NANOPARTICLES; UP-CONVERSION NANOPARTICLES; SILVER NANOPARTICLES; ELECTROCHEMICAL IMMUNOSENSOR; SALMONELLA-TYPHIMURIUM; NANOZYME ACTIVITY; CARBON NANOTUBES; APTAMER; OCHRATOXIN; BIOSENSORS	Plant-based foods are integral part of our day-to-day diet. Increasing world population has put forth an ever increasing demand for plant-based foods, and food security remains a major concern. Similarly, biological, chemical, and physical threats to our food and increasing regulatory demands to control the presence of foreign species in food products have made food safety a growing issue. Nanotechnology has already established its roots in diverse disciplines. However, the food industry is yet to harness the full potential of the unique capabilities offered by this next-generation technology. While there might be safety concerns in regards to integration of nanoproducts with our food products, an aspect of nanotechnology that can make remarkable contribution to different elements of the food chain is the use of nanobiosensors and diagnostic platforms for monitoring food traceability, quality, safety, and nutritional value. This brings us to an important question that whether existing diagnostic platforms that have already been well developed for biomedical and clinical application are suitable for food industry or whether the demands of the food industry are altogether different that may not allow adoption/adaptation of the existing technology. This review is an effort to raise this important "uncomfortable" yet "timely" question.	[Sharma, Tarun K.] Translat Hlth Sci & Technol Inst, Ctr Biodesign & Diagnost, Gurgaon, Haryana, India; [Ramanathan, Rajesh; Bansal, Vipul] RMIT Univ, Sch Appl Sci, Ian Potter NanoBioSensing Facil, NanoBiotechnol Res Lab NBRL, Melbourne, Vic 3001, Australia; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki, Japan; [Rakwal, Randeep] Showa Univ, Sch Med, Dept Anat 1, Shinagawa, Tokyo, Japan; [Rakwal, Randeep; Agrawal, Ganesh K.] Res Lab Biotechnol & Biochem RLABB, Kathmandu, Nepal; [Rakwal, Randeep; Agrawal, Ganesh K.] GRADE Acad Private Ltd, Birgunj, Nepal	Bansal, V (reprint author), RMIT Univ, Sch Appl Sci, Ian Potter NanoBioSensing Facil, NanoBiotechnol Res Lab NBRL, GPO Box 2476V, Melbourne, Vic 3001, Australia.	vipul.bansal@rmit.edu.au			Australian Research Council [FT140101285, DP110105125, LP130100437]; Department of Biotechnology, Government of India through the Innovation Award scheme	V. Bansal thanks the Ian Potter Foundation for their valuable support in establishing a state-of-the-art Ian Potter NanoBioSensing Facility at RMIT University, Australia. V. Bansal would like to dedicate this article to Late Sir Ian Potter for his visionary philanthropic support that has made a major impact in improving the lives of Australian and global populations. V. Bansal further acknowledges the Australian Research Council for a Future Fellowship (FT140101285) and research support through the Discovery (DP110105125) and Linkage (LP130100437) grant schemes. T. K. Sharma acknowledges the Department of Biotechnology, Government of India for funding through the Innovation Award scheme. Authors appreciate the INPPO platform (www.inppo.com) for connecting plant proteomics researchers with the nanotechnologists.	Ali M. A., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P697; Zheng ZZ, 2011, BIOSENS BIOELECTRON, V26, P3081, DOI 10.1016/j.bios.2010.12.021; Fulponi L, 2006, FOOD POLICY, V31, P1, DOI 10.1016/j.foodpol.2005.06.006; Rhouati A, 2013, TOXINS, V5, P1988, DOI 10.3390/toxins5111988; Daniel O, 1999, ENVIRON HEALTH PERSP, V107, P109, DOI 10.2307/3434477; Goldman ER, 2004, ANAL CHEM, V76, P684, DOI 10.1021/ac035083r; Tuttle J, 1999, EPIDEMIOL INFECT, V122, P185, DOI 10.1017/S0950268898001976; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Fu ZY, 2013, METHODS, V64, P260, DOI 10.1016/j.ymeth.2013.08.003; Baeumner A, 2004, FOOD TECHNOL-CHICAGO, V58, P51; Nap JP, 2003, PLANT J, V33, P1, DOI 10.1046/j.0960-7412.2003.01602.x; Song S, 2006, INT J NANOMED, V1, P433, DOI 10.2147/nano.2006.1.4.433; Arora P, 2011, BIOSENS BIOELECTRON, V28, P1, DOI 10.1016/j.bios.2011.06.002; Leistner L, 2000, INT J FOOD MICROBIOL, V55, P181, DOI 10.1016/S0168-1605(00)00161-6; Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178; Davoudi ZM, 2014, ADV FUNCT MATER, V24, P1047, DOI 10.1002/adfm.201302368; Agrawal GK, 2013, J PROTEOMICS, V93, P74, DOI 10.1016/j.jprot.2013.04.014; Barthelmebs L, 2011, FOOD CONTROL, V22, P737, DOI 10.1016/j.foodcont.2010.11.005; Wang SG, 2010, CHEM-EUR J, V16, P5600, DOI 10.1002/chem.201000176; Soni SK, 2010, LANGMUIR, V26, P16020, DOI 10.1021/la101965j; Li SC, 2011, FOOD CONTROL, V22, P43, DOI 10.1016/j.foodcont.2010.05.005; Ma XY, 2014, EUR FOOD RES TECHNOL, V238, P919, DOI 10.1007/s00217-014-2176-1; Selvakannan PR, 2013, PHYS CHEM CHEM PHYS, V15, P12920, DOI 10.1039/c3cp51646f; Kalidasan K, 2013, MOL BIOSYST, V9, P618, DOI 10.1039/c3mb25527a; Malhotra S, 2014, J MOL RECOGNIT, V27, P493, DOI 10.1002/jmr.2370; Yang C, 2011, BIOSENS BIOELECTRON, V26, P2724, DOI 10.1016/j.bios.2010.09.032; Chrimes AF, 2012, ANAL CHEM, V84, P4029, DOI 10.1021/ac203381n; Moon J, 2012, MATERIALS, V5, P634, DOI 10.3390/ma5040634; Vikesland PJ, 2010, ENVIRON SCI TECHNOL, V44, P3656, DOI 10.1021/es903704z; Garcia-Canas V, 2012, ANAL CHEM, V84, P10150, DOI 10.1021/ac301680q; Weerathunge P, 2014, ANAL CHEM, V86, P11937, DOI 10.1021/ac5028726; Wu WH, 2014, ACS APPL MATER INTER, V6, P16974, DOI 10.1021/am5045828; Hansen JA, 2006, J AM CHEM SOC, V128, P3860, DOI 10.1021/ja0574116; Cruz-Aguado JA, 2008, J AGR FOOD CHEM, V56, P10456, DOI 10.1021/jf801957h; Wu SJ, 2011, ANALYST, V136, P2306, DOI 10.1039/c0an00735h; Valdes MG, 2009, MICROCHIM ACTA, V166, P1, DOI 10.1007/s00604-009-0165-z; Shi HJ, 2013, J HAZARD MATER, V260, P754, DOI 10.1016/j.jhazmat.2013.06.031; Cheng YX, 2008, TALANTA, V75, P167, DOI 10.1016/j.talanta.2007.10.047; Sheng LF, 2011, BIOSENS BIOELECTRON, V26, P3494, DOI 10.1016/j.bios.2011.01.032; Kandjani AE, 2014, J COLLOID INTERF SCI, V436, P251, DOI 10.1016/j.jcis.2014.09.017; Wu XM, 2011, J CHROMATOGR A, V1218, P7341, DOI 10.1016/j.chroma.2011.08.045; Hussein HS, 2001, TOXICOLOGY, V167, P101, DOI 10.1016/S0300-483X(01)00471-1; Singh C, 2013, SENSOR ACTUAT B-CHEM, V185, P258, DOI 10.1016/j.snb.2013.04.040; Sivakumar S, 2009, ADV MATER, V21, P1820, DOI 10.1002/adma.200802475; Moon J, 2014, ANAL METHODS-UK, V6, P7442, DOI 10.1039/c4ay01035c; Wu SJ, 2014, ANAL CHEM, V86, P3100, DOI 10.1021/ac404205c; Vasimalai N, 2013, TALANTA, V115, P24, DOI 10.1016/j.talanta.2013.04.033; Yang C, 2012, BIOSENS BIOELECTRON, V32, P208, DOI 10.1016/j.bios.2011.12.011; Ang LY, 2011, NANOMEDICINE-UK, V6, P1273, DOI [10.2217/nnm.11.108, 10.2217/NNM.11.108]; Cho EJ, 2009, ANNU REV ANAL CHEM, V2, P241, DOI 10.1146/annurev.anchem.1.031207.112851; Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571; Campbell JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021857; Cho EC, 2008, COLLOID SURFACE A, V313, P95, DOI 10.1016/j.colsurfa.2007.04.154; Davis D., 2013, Industrial Biotechnology, V9, P31; Labbe R. G., 2001, GUIDE FOODBORNE PATH, V2nd; Liu X, 2014, SENSOR ACTUAT B-CHEM, V191, P408, DOI 10.1016/j.snb.2013.10.033; Malhotra BD, 2014, APPL BIOCHEM BIOTECH, V174, P880, DOI 10.1007/s12010-014-0993-0; Adams MR, 2007, FOOD MICROBIOLOGY, THIRD EDITION, P1; Nugen SR, 2008, ANAL BIOANAL CHEM, V391, P451, DOI 10.1007/s00216-008-1886-2; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Pearson A, 2014, ADV FUNCT MATER, V24, P7570, DOI 10.1002/adfm.201402320; Ramanathan R., 2014, LANGMUIR, V31, P1581; Scallan E, 2011, EMERG INFECT DIS, V17, P1; Sharma TK, 2014, CHEM COMMUN, V50, P15856, DOI 10.1039/c4cc07275h; Tothill IE, 2001, COMPUT ELECTRON AGR, V30, P205, DOI 10.1016/S0168-1699(00)00165-4; Trojanowicz M, 2006, TRAC-TREND ANAL CHEM, V25, P480, DOI 10.1016/j.trac.2005.11.008	66	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	MAY	2015	15	10			SI		1680	1692		10.1002/pmic.201400503		13	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH8GG	WOS:000354273800007		
J	Gupta, R; Min, CW; Kim, SW; Wang, YM; Agrawal, GK; Rakwal, R; Kim, SG; Lee, BW; Ko, JM; Baek, IY; Bae, DW; Kim, ST				Gupta, Ravi; Min, Chul Woo; Kim, So Wun; Wang, Yiming; Agrawal, Ganesh Kumar; Rakwal, Randeep; Kim, Sang Gon; Lee, Byong Won; Ko, Jong Min; Baek, In Yeol; Bae, Dong Won; Kim, Sun Tae			Comparative investigation of seed coats of brown-versus yellow-colored soybean seeds using an integrated proteomics and metabolomics approach	PROTEOMICS			English	Article						Isoflavone; Mallikong mutant; Phenylpropanoid pathway; Plant proteomics; Seed storage proteins; Soybean seed coat	MAX L. MERR; GENE; EXPRESSION; FLAVONOIDS; GENOTYPES; PLANTS; ROOTS; BLACK	Seed coat color is an important attribute determining consumption of soybean seeds. Soybean cultivar Mallikong (M) has yellow seed coat while its naturally mutated cultivar Mallikong mutant (MM), has brown colored seed coat. We used integrated proteomics and metabolomics approach to investigate the differences between seed coats of M and MM during different stages of seed development (4, 5, and 6 weeks after flowering). 2DE profiling of total seed coat proteins from three stages showed 178 differentially expressed spots between M and MM of which 172 were identified by MALDI-TOF/TOF. Of these, 62 were upregulated and 105 were downregulated in MM compared with M, while five spots were detected only in MM. Proteins involved in primary metabolism showed downregulation in MM suggesting energy in MM might be utilized for proanthocyanidin biosynthesis via secondary metabolic pathways that leads to the development of brown seed coat color. Besides, downregulation of two isoforms of isoflavone reductase indicated reduced isoflavones in seed coat of MM that was confirmed by quantitative estimation of total and individual isoflavones using HPLC. We propose that low isoflavones level in MM may offer a high substrate for proanthocyanidin production that results in the development of brown seed coat in MM.	[Gupta, Ravi; Min, Chul Woo; Kim, So Wun; Kim, Sun Tae] Pusan Natl Univ, Dept Plant Biosci, Coll Nat Resources & Life Sci, Miryang 627706, South Korea; [Wang, Yiming] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Agrawal, Ganesh Kumar; Rakwal, Randeep] Res Lab Biotechnol & Biochem RLABB, Kathmandu, Nepal; [Agrawal, Ganesh Kumar; Rakwal, Randeep] GRADE Acad Private Ltd, Birgunj, Nepal; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki, Japan; [Rakwal, Randeep] Showa Univ, Sch Med, Dept Anat 1, Shinagawa, Tokyo, Japan; [Kim, Sang Gon] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju, South Korea; [Lee, Byong Won; Ko, Jong Min; Baek, In Yeol] RDA, NICS, Dept Funct Crops, Miryang, South Korea; [Bae, Dong Won] Gyeongsang Natl Univ, Cent Lab, Jinju, South Korea	Kim, ST (reprint author), Pusan Natl Univ, Dept Plant Biosci, Miryang 627706, South Korea.	stkim71@pusan.ac.kr			Next-Generation BioGreen 21 Program (SSAC) [PJ009571]; Cooperative Research Program for Agriculture Science & Technology Development of Department of Functional Crop [PJ007155]; National Institute of Crop Science; National Agenda Programs for Agricultural R&D, Rural Development Administration (RDA), Republic of Korea [PJ01004602201401]; RDA	This work was supported by grants from the Next-Generation BioGreen 21 Program (SSAC, grant#: PJ009571), Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ007155) of Department of Functional Crop, National Institute of Crop Science and National Agenda Programs for Agricultural R&D (PJ01004602201401), Rural Development Administration (RDA), Republic of Korea. RG acknowledge financial support from RDA.	Batchelor AK, 2002, PLANTA, V215, P523, DOI 10.1007/s00425-002-0798-1; TODD JJ, 1993, PLANT PHYSIOL, V102, P663; Gijzen M, 2001, J EXP BOT, V52, P2283, DOI 10.1093/jexbot/52.365.2283; Moise JA, 2005, IN VITRO CELL DEV-PL, V41, P620, DOI 10.1079/IVP2005686; Lee Jin Hwan, 2006, Agricultural Chemistry and Biotechnology, V49, P57; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Weber H, 2005, ANNU REV PLANT BIOL, V56, P253, DOI 10.1146/annurev.arplant.56.032604.144201; RAO AV, 1995, J NUTR, V125, pS717; Agrawal GK, 2008, PLANT PHYSIOL, V148, P504, DOI 10.1104/pp.108.119222; Kwon YS, 2010, PLANTA, V232, P1355, DOI 10.1007/s00425-010-1259-x; Pawlak-Sprada S, 2011, ACTA BIOCHIM POL, V58, P211; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Mullin WJ, 2001, J AGR FOOD CHEM, V49, P5331, DOI 10.1021/jf010303s; He XZ, 2000, PLANT CELL, V12, P1689, DOI 10.1105/tpc.12.9.1689; Di Carli M, 2011, J PROTEOME RES, V10, P429, DOI 10.1021/pr1005313; Kim ST, 2008, J PROTEOME RES, V7, P1750, DOI 10.1021/pr700878t; Kleczkowski LA, 2010, CRIT REV PLANT SCI, V29, P191, DOI 10.1080/07352689.2010.483578; McClean PE, 2002, J HERED, V93, P148, DOI 10.1093/jhered/93.2.148; Kim SG, 2010, PHYSIOL PLANTARUM, V138, P1, DOI 10.1111/j.1399-3054.2009.01290.x; Xu CP, 2007, J SCI FOOD AGR, V87, P2511, DOI 10.1002/jsfa.3017; Batchelor AK, 2000, PLANTA, V211, P484, DOI 10.1007/s004250000320; Battaglia M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00190; Bellaloui N., 2012, Food and Nutrition Sciences, V3, P447; Christie W.W., 1993, ADV LIPID METHODOLOG, P69; GIJZEN M, 1993, PLANT PHYSIOL, V103, P1061; Kim YJ, 2013, PROTEOMICS, V13, P2176, DOI 10.1002/pmic.201200555; Kim YJ, 2013, PLANT OMICS, V6, P456; Koshiyama I., 1983, STORAGE PROTEINS SOY; Kovinich N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-381; Lee Jin Hwan, 2006, Agricultural Chemistry and Biotechnology, V49, P51; Messina M, 2000, EUR J CANCER, V36, pS71; Miernyk JA, 2011, SEX PLANT REPROD, V24, P9, DOI 10.1007/s00497-010-0149-5; Miernyk JA, 2013, J PROTEOMICS, V89, P265, DOI 10.1016/j.jprot.2013.05.013; Natarajan S. S., 2014, J DATA MINING GENOMI, V5, P1; Ramalingam Radhakrishnan, 2014, Journal of Crop Science and Biotechnology, V17, P35, DOI 10.1007/s12892-013-0111-9; SCHULER MA, 1982, NUCLEIC ACIDS RES, V10, P8225, DOI 10.1093/nar/10.24.8225; Sessa DJ, 2001, IND CROP PROD, V14, P73, DOI 10.1016/S0926-6690(00)00090-X; Winkel-Shirley B, 1998, SEED SCI RES, V8, P415	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	MAY	2015	15	10			SI		1706	1716		10.1002/pmic.201400453		11	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH8GG	WOS:000354273800009		
J	Moro, CF; Fukao, Y; Shibato, J; Rakwal, R; Timperio, AM; Zolla, L; Agrawal, GK; Shioda, S; Kouzuma, Y; Yonekura, M				Moro, Carlo F.; Fukao, Yoichiro; Shibato, Junko; Rakwal, Randeep; Timperio, Anna Maria; Zolla, Lello; Agrawal, Ganesh Kumar; Shioda, Seiji; Kouzuma, Yoshiaki; Yonekura, Masami			Unraveling the seed endosperm proteome of the lotus (Nelumbo nucifera Gaertn.) utilizing 1DE and 2DE separation in conjunction with tandem mass spectrometry	PROTEOMICS			English	Article						1/2DE; LC-MS/MS; Lotus; Proteome analysis; Plant proteomics; Seed	ARABIDOPSIS-THALIANA; JATROPHA-CURCAS; RICE PROTEOMICS; PATHWAYS; PROTEINS	Nelumbo nucifera (Gaertn.) or lotus, is an aquatic plant native to India, and presently consumed as food mainly in China and Japan. Lotus is also widely used in Indian and Chinese traditional medicine. Extracts from different parts of the lotus plant have been reported to show diverse biological activities-antioxidant, free radical scavenging, anti-inflammatory, and immunomodulatory. Despite this, little work has been done in isolating and identifying proteins responsible for these activities, or yet importantly to establish a lotus proteome. The aim of our group is to develop a proteome catalog of the lotus plant, starting with its seed, the nutrient rich food source. In this present study, the seed endosperm-most abundant in proteins, and main nutrient storage tissue-was targeted for protein extraction by testing five different extraction protocols, followed by their proteomic analyses using complementary 1DE and 2DE approaches in conjunction with MS/MS. The inventory of 66 nonredundant proteins obtained by 1DE-MS and the 30 obtained by 2DE-MS provides the first catalog of the lotus seed endosperm, where the most abundant protein functions were in categories of metabolic activities related to carbohydrate metabolism and nutrient storage.	[Moro, Carlo F.; Kouzuma, Yoshiaki; Yonekura, Masami] Coll Agr, Lab Mol Food Funct, Ami, Ibaraki, Japan; [Fukao, Yoichiro] Nara Inst Sci & Technol, Plant Global Educ Project, Ikoma, Japan; [Shibato, Junko; Rakwal, Randeep; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat 1, Shinagawa, Tokyo, Japan; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki 3058577, Japan; [Rakwal, Randeep; Agrawal, Ganesh Kumar] Res Lab Biotechnol & Biochem RLABB, Kathmandu, Nepal; [Rakwal, Randeep; Agrawal, Ganesh Kumar] GRADE Acad Private Ltd, Adarsh Nagar, Birgunj, Nepal; [Timperio, Anna Maria; Zolla, Lello] Univ Tuscia, Dept Ecol & Biol, Viterbo, Italy	Rakwal, R (reprint author), Univ Tsukuba, Org Educ Initiat, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	plantproteomics@gmail.com		Timperio, Anna Maria/0000-0001-8457-042X	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	C.F.M. greatly appreciates and acknowledges the financial support of the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in the conducting this research.	Agrawal GK, 2006, MASS SPECTROM REV, V25, P1, DOI 10.1002/mas.20056; Agrawal Ganesh Kumar, 2013, Methods Mol Biol, V956, P151, DOI 10.1007/978-1-62703-194-3_12; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; [Anonymous], 1992, WEALTH INDIA, V3; Lorenz C, 2014, J PROTEOMICS, V108, P382, DOI 10.1016/j.jprot.2014.05.024; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Liu ZL, 2012, APPL BIOCHEM BIOTECH, V166, P722, DOI 10.1007/s12010-011-9461-2; Celis JE, 1999, CURR OPIN BIOTECH, V10, P16, DOI 10.1016/S0958-1669(99)80004-4; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Agrawal GK, 2006, PROTEOMICS, V6, P5549, DOI 10.1002/pmic.200600233; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Amalraj RS, 2010, ELECTROPHORESIS, V31, P1959, DOI 10.1002/elps.200900779; Horie K, 2008, J PROTEOME RES, V7, P1819, DOI 10.1021/pr070369o; [Anonymous], 1966, WEALTH INDIA DICT IN, V7; Guo HB, 2009, GENET RESOUR CROP EV, V56, P323, DOI 10.1007/s10722-008-9366-2; Chu P, 2012, PLANTA, V235, P1271, DOI 10.1007/s00425-011-1573-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Dong C., 2010, APPL BIOCHEM BIOTECH, V163, P679; Dupont FM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-39; Gorecka KM, 2007, PLANT CELL PHYSIOL, V48, P792, DOI 10.1093/pcp/pcm046; Komatsu E., 1975, CULTIVATION MANAGEME, P9; Ling ZQ, 2005, J AGR FOOD CHEM, V53, P2441, DOI 10.1021/jf040325p; Liu H, 2011, PLANT SCI, V181, P660, DOI 10.1016/j.plantsci.2011.03.012; Moro C. F., 2013, International Journal of Life Sciences, V7, P1; Ni X. M., 1987, LOTUS IN CHINA; Ou M., 1989, CHINESE ENGLISH MANU; Pinheiro CB, 2013, J PROTEOME RES, V12, P5137, DOI 10.1021/pr400515b; Sridhar K.R., 2007, J AGR TECHNOL, V3, P143; Wang Q. C., 2005, LOTUS FLOWER CULTIVA; Wang XC, 2007, BIOTECHNOL LETT, V29, P1599, DOI 10.1007/s10529-007-9425-3; Wu YR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00240; Zhou YL, 2012, PLANT CELL REP, V31, P379, DOI 10.1007/s00299-011-1173-0	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	MAY	2015	15	10			SI		1717	1735		10.1002/pmic.201400406		19	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH8GG	WOS:000354273800010		
J	Kim, YJ; Wang, YM; Gupta, R; Kim, SW; Min, CW; Kim, YC; Park, KH; Agrawal, GK; Rakwal, R; Choung, MG; Kang, KY; Kim, ST				Kim, Yu Ji; Wang, Yiming; Gupta, Ravi; Kim, So Wun; Min, Chul Woo; Kim, Yong Chul; Park, Ki Hun; Agrawal, Ganesh Kumar; Rakwal, Randeep; Choung, Myoung-Gun; Kang, Kyu Young; Kim, Sun Tae			Protamine sulfate precipitation method depletes abundant plant seed-storage proteins: A case study on legume plants	PROTEOMICS			English	Article						Legume seeds; Plant proteomics; Protamine sulfate precipitation method; Seed proteome; Seed storage proteins		Depletion of abundant proteins is one of the effective ways to improve detection and identification of low-abundance proteins. Our previous study showed that protamine sulfate precipitation (PSP) method can deplete abundant ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) from leaf proteins and is suitable for their in-depth proteome investigation. In this study, we provide evidence that the PSP method can also be effectively used for depletion of abundant seed-storage proteins (SSPs) from the total seed proteins of diverse legume plants including soybean, broad bean, pea, wild soybean, and peanut. The 0.05% protamine sulfate (PS) was sufficient to deplete major SSPs from all legumes tested except for peanut where 0.1% PS was required. SDS-PAGE, Western blotting and 2DE analyses of PS-treated soybean and peanut seed proteins showed enriched spots in PS-supernatant than total proteins. Coefficient of variation percentage (%CV) and principal component analysis of 2DE spots support the reproducibility, suitability, and efficacy of the PSP method for quantitative and comparative seed proteome analysis. MALDI-TOF-TOF successfully identified some protein spots from soybean and peanut. Hence, this simple, reproducible, economical PSP method has a broader application in depleting plant abundant proteins including SSPs in addition to RuBisCO, allowing discussion for comprehensive proteome establishment and parallel comparative studies in plants.	[Kim, Yu Ji; Gupta, Ravi; Kim, So Wun; Min, Chul Woo; Kim, Yong Chul; Kim, Sun Tae] Pusan Natl Univ, Dept Plant Biosci, Life & Ind Convergence Res Inst, Miryang 627706, South Korea; [Wang, Yiming] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Park, Ki Hun; Kang, Kyu Young] Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Jinju, South Korea; [Agrawal, Ganesh Kumar; Rakwal, Randeep] Res Lab Biotechnol & Biochem RLABB, Kathmandu, Nepal; [Agrawal, Ganesh Kumar; Rakwal, Randeep] GRADE Acad Private Ltd, Birgunj, Nepal; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki, Japan; [Rakwal, Randeep] Showa Univ, Sch Med, Dept Anat 1, Tokyo 142, Japan; [Choung, Myoung-Gun] Kangwon Natl Univ, Dept Herbal Med Resource, Samcheok, South Korea	Kim, ST (reprint author), Pusan Natl Univ, Dept Plant Biosci, Miryang 627706, South Korea.	stkim71@pusan.ac.kr			Next-Generation BioGreen 21 Program (SSAC) [PJ011070032015]; National Agenda Programs for Agricultural R&D, Rural Development Administration (RDA), Republic of Korea [PJ01004602201501]	This work was supported by a grant from the Next-Generation BioGreen 21 Program (SSAC, grant#: PJ011070032015) and the National Agenda Programs for Agricultural R&D (PJ01004602201501), Rural Development Administration (RDA), Republic of Korea.	Agrawal G. K., 2013, SEED DEV OMICS TECHN; Agrawal G. K., 2008, PLANT PROTEOMICS TEC; Miernyk JA, 2011, J PROTEOMICS, V74, P389, DOI 10.1016/j.jprot.2010.12.004; Kim ST, 2003, PROTEOMICS, V3, P2368, DOI 10.1002/pmic.200300577; Kim ST, 2001, ELECTROPHORESIS, V22, P2103, DOI 10.1002/1522-2683(200106)22:10<2103::AID-ELPS2103>3.0.CO;2-W; Kim YJ, 2013, PROTEOMICS, V13, P2176, DOI 10.1002/pmic.201200555; Kottapalli K. R., 2013, SEED DEV OMICS TECHN, P143; Krishnan HB, 2009, PROTEOMICS, V9, P3174, DOI 10.1002/pmic.200800875; Lee SJ, 2013, J HORTIC SCI BIOTECH, V88, P509; Nambara E, 2012, PLANT CELL PHYSIOL, V53, P1, DOI 10.1093/pcp/pcr184; Natrajan S. S., 2009, ANAL BIOCHEM, V394, P259	11	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	MAY	2015	15	10			SI		1760	1764		10.1002/pmic.201400488		5	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH8GG	WOS:000354273800013		
J	Lee, HM; Gupta, R; Kim, SH; Wang, YM; Rakwal, R; Agrawal, GK; Kim, ST				Lee, Hye Min; Gupta, Ravi; Kim, Sun Hyung; Wang, Yiming; Rakwal, Randeep; Agrawal, Ganesh Kumar; Kim, Sun Tae			Abundant storage protein depletion from tuber proteins using ethanol precipitation method: Suitability to proteomics study	PROTEOMICS			English	Article						Ethanol precipitation method; Plant proteomics; Sporamin; Storage proteins; Sweet potato tuber; Trypsin inhibitor	SEEDS; INHIBITOR	High-abundance proteins (HAPs) hamper in-depth proteome study necessitating development of a HAPs depletion method. Here, we report a novel ethanol precipitation method (EPM) for HAPs depletion from total tuber proteins. Ethanol showed a dose-dependent effect on depletion of sporamin from sweet potato and patatin from potato tubers, respectively. The 50% ethanol was an optimal concentration. 2DE analysis of EPM-prepared sweet potato proteins also revealed enrichment of storage proteins (SPs) in ethanol supernatant (ES) resulting in detection of new low-abundance proteins in ethanol pellet (EP), compared to total fraction. The ES fraction showed even higher trypsin inhibitor activity than total proteins, further showing the efficacy of EPM in enrichment of sporamin in ES fraction. Application of this method was demonstrated for comparative proteomics of two sweet potato cultivars (Hwang-geum and Ho-bac) and purification of SP (sporamin) in its native form, as examples. Comparative proteomics identified many cultivar specific protein spots and selected spots were confidently assigned for their protein identity using MALDI-TOF-TOF analysis. Overall, the EPM is simple, reproducible, and economical for depletion of SPs and is suitable for downstream proteomics study. This study opens a door for its potential application to other tuber crops or fruits rich in carbohydrates.	[Lee, Hye Min; Gupta, Ravi; Kim, Sun Tae] Pusan Natl Univ, Dept Plant Biosci, Life & Ind Convergence Res Inst, Miryang 627706, South Korea; [Kim, Sun Hyung] Univ Seoul, Dept Environm Hort, Seoul, South Korea; [Wang, Yiming] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki, Japan; [Rakwal, Randeep] Showa Univ, Sch Med, Dept Anat 1, Shinagawa, Tokyo, Japan; [Rakwal, Randeep; Agrawal, Ganesh Kumar] Res Lab Biotechnol & Biochem RLABB, Kathmandu, Nepal; [Rakwal, Randeep; Agrawal, Ganesh Kumar] GRADE Acad Private Ltd, Birgunj, Nepal	Kim, ST (reprint author), Pusan Natl Univ, Dept Plant Biosci, Miryang 627706, South Korea.	stkim71@pusan.ac.kr			Korea Institute of Planning and Evaluation for Technology (IPET) - Ministry for Food, Agriculture, Forestry and Fisheries [110034055HD120]; Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration (RDA), Republic of Korea [PJ009571, PJ011070032015]	This work was supported by Korea Institute of Planning and Evaluation for Technology (IPET) funded by Ministry for Food, Agriculture, Forestry and Fisheries (110034055HD120) and grants from the Next-Generation BioGreen 21 Program (SSAC, grant#: PJ009571 and grant#: PJ011070032015), Rural Development Administration (RDA), Republic of Korea.	Agrawal G. K., 2013, SEED DEV OMICS TECHN; Agrawal G. K., 2008, PLANT PROTEOMICS TEC; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084; Yeh KW, 1997, PLANT MOL BIOL, V33, P565, DOI 10.1023/A:1005764702510; Kim U. G., 2012, J PLANT BIOTECHNOL, V39, P81; Natarajan SS, 2009, ANAL BIOCHEM, V394, P259, DOI 10.1016/j.ab.2009.07.048; Palavalli MH, 2012, J AGR FOOD CHEM, V60, P3135, DOI 10.1021/jf205308w; Wati RK, 2010, J FOOD SCI, V75, pC223, DOI 10.1111/j.1750-3841.2010.01515.x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	MAY	2015	15	10			SI		1765	1769		10.1002/pmic.201400526		5	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH8GG	WOS:000354273800014		
J	Shigematsu, Y; Hatano, Y; Kimura, H				Shigematsu, Yukako; Hatano, Yoko; Kimura, Hitoe			A Partnership Development Process Assessment Scale for Public Health Nurses in Japan	PUBLIC HEALTH NURSING			English	Article						assessment scale; community-based; instrument validation; organizations; partnership; public health nurse		ObjectiveThe objective of this study was to develop and test a Partnership Development Process Assessment (PDPA) scale for content and construct validity and internal consistency reliability. This is needed to document and evaluate community health partnership development processes between public health nurses and community-based organizations in Japan. DesignThe study was conducted in three phases. Ten semi-structured interviews were conducted to generate items for a new scale. Thirty items were generated and reviewed by anexpert panel for content validity and item refinement. A national postal survey of public health nurses was conducted to determine the scale's internal structure, evaluate its reliability, and explore its construct and criterion validity. MeasuresValidity and reliability testing of thePDPA scale using a content validity index and analysis of correlations with an existing scalewere performed. ResultsTwenty-six items were selected and grouped into four factors: activities to share roles to manage community health issues, platform activities to support partnerships, activities to evaluate partnership practices, and activities to share information regarding community health issues. After factor analysis, 23 items were retained. ConclusionThe PDPA scale is a valid and reliable instrument for public health nurses to assess partnership development activities.	[Shigematsu, Yukako] Shokei Univ, Jr Coll, Childhood Educ, Kumamoto 8618538, Japan; [Hatano, Yoko; Kimura, Hitoe] Kyushu Univ, Dept Hlth Sci, Fac Med Sci, Fukuoka 812, Japan	Shigematsu, Y (reprint author), Shokei Univ, Jr Coll, Childhood Educ, Kita Ku, Kumamoto 8618538, Japan.	yushige@shokei-gakuen.ac.jp			JSPS KAKENHI [23593377]	The authors thank all the public health nurses who participated in this study. The study was supported by a grant, the JSPS KAKENHI (Grant No. 23593377). Its contents are solely the responsibility of the authors.	American Public Health Association Public Health Nursing Section, 1996, DEF ROL PUBL HLTH NU; Dowling B, 2004, HEALTH SOC CARE COMM, V12, P309, DOI 10.1111/j.1365-2524.2004.00500.x; Yamashita J, 2013, SOC SCI JPN J, V16, P45, DOI 10.1093/ssjj/jys028; Courtney R, 1996, PUBLIC HEALTH NURS, V13, P177, DOI 10.1111/j.1525-1446.1996.tb00238.x; Baker G. A., 2008, HIGH PERFORMING HLTH, P279; Buckett K., 2011, WORLD C SOC DET HLTH; Chrisman NJ, 2002, HEALTH EDUC BEHAV, V29, P232, DOI 10.1177/109019810202900208; El Ansari W, 2004, PUBLIC HEALTH NURS, V21, P277; Funashima N, 2009, KANGOZISEN KYOUIKU N; Institute of Medicine (IOM), 2002, FUT PUBL HLTH 21 CEN, P96; Kegler Michelle C, 2008, Health Promot Pract, V9, P170, DOI 10.1177/1524839906292180; Keller LO, 2004, PUBLIC HEALTH NURS, V21, P469, DOI 10.1111/j.0737-1209.2004.21510.x; Koshida M., 2012, NURSING HLTH SCI, V15, P22; Lincoln Y. S., 1985, NATURALISTIC INQUIRY; Ministry of Health Labour and Welfare, 2012, NAT DAT PUBL HLTH NU; Ministry of Health Labour and Welfare, 2012, BAS DIR COMPR IMPL N; Ministry of Internal Affairs and Communications Statistics Bureau, 2010, POP SIZ MUN; Navruzov Y., 2000, 8 ANN C NETW I SCH P; O'Mara-Eves A., 2013, COMMUNITY ENGAGEMENT; Perkins N, 2010, POLICY POLIT, V38, P101, DOI 10.1332/030557309X458425; Polit D. F., 2012, NURSING RES GENERATI; Public Health Agency of Canada, 2008, COR COMP PUBL HLTH C; Suzuki Y., 2008, J JAPAN ACAD COMMUNI, V12, P44; VicHealth, 2011, PARTN AN TOOL; Yoshioka-Maeda Kyoko, 2006, J Nurs Manag, V14, P483, DOI 10.1111/j.1365-2934.2006.00688.x	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0737-1209	1525-1446		PUBLIC HEALTH NURS	Public Health Nurs.	MAY-JUN	2015	32	3					266	276		10.1111/phn.12178		11	Public, Environmental & Occupational Health; Nursing	Public, Environmental & Occupational Health; Nursing	CH8BG	WOS:000354260300010		
J	Machida, T; Segawa, E				Machida, Takuya; Segawa, Etsuo			Trapping and spreading properties of quantum walk in homological structure	QUANTUM INFORMATION PROCESSING			English	Article						Quantum walk; Homological structure; Spectral mapping; Localization; Linear spreading	GRAPHS	We attempt to extract a homological structure of two kinds of graphs by the Grover walk. The first one consists of a cycle and two semi-infinite lines, and the second one is assembled by a periodic embedding of the cycles in . We show that both of them have essentially the same eigenvalues induced by the existence of cycles in the infinite graphs. The eigenspace of the homological structure appears as so called localization in the Grover walks, in which the walk is partially trapped by the homological structure. On the other hand, the difference of the absolutely continuous part of spectrum between them provides different behaviors. We characterize the behaviors by the density functions in the weak convergence theorem: The first one is the delta measure at the bottom, while the second one is expressed by two kinds of continuous functions, which have different finite supports (-1/root 10, 1/root 10) and (-2/7, 2/7), respectively.	[Machida, Takuya] Japan Soc Promot Sci, Bunkyo Ku, Tokyo 1138654, Japan; [Machida, Takuya] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Segawa, Etsuo] Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan	Segawa, E (reprint author), Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan.	machida@stat.t.u-tokyo.ac.jp; e-segawa@m.tohoku.ac.jp			Japan Society for the Promotion of Science [25800088]	TM is grateful to the Japan Society for the Promotion of Science for the support and to the Math. Dept. UC Berkeley for hospitality. ES thanks to the financial support of the Grant-in-Aid for Young Scientists (B) of Japan Society for the Promotion of Science (Grant No. 25800088).	Ambainis A, 2004, ANN IEEE SYMP FOUND, P22, DOI 10.1109/FOCS.2004.54; Ambainis A., 2005, P 33 ACM S THEOR COM, P37; Szegedy M, 2004, ANN IEEE SYMP FOUND, P32, DOI 10.1109/FOCS.2004.53; Grimmett G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026119; Venegas-Andraca SE, 2010, QUANTUM INF PROCESS, V9, P1, DOI 10.1007/s11128-009-0123-z; Feldman E, 2005, CONTEMP MATH, V381, P71; Gnutzmann S, 2006, ADV PHYS, V55, P527, DOI 10.1080/00018730600908042; Konno N, 2005, J MATH SOC JPN, V57, P1179, DOI 10.2969/jmsj/1150287309; Konno N, 2002, QUANTUM INF PROCESS, V1, P345, DOI 10.1023/A:1023413713008; Exner P., 1989, Reports on Mathematical Physics, V28, DOI 10.1016/0034-4877(89)90023-2; Grover L.K., 1996, P 28 ACM S THEOR COM, V212, P212, DOI DOI 10.1145/237814.237866; Higuchi Yu., 2013, YOKOHAMA MATH J, V59, P34; Higuchi Yu., ARXIV14010154; Schanz H, 2000, PHYS REV LETT, V84, P1427, DOI 10.1103/PhysRevLett.84.1427; Shenvi N, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.052307; Sunada T., 2013, SURVEYS TUTORIALS AP, V6; Tanner GK, 2006, NATO SCI SER II MATH, V213, P69, DOI 10.1007/1-4020-3949-2_6; Venegas-Andraca SE, 2003, P SOC PHOTO-OPT INS, V5105, P137, DOI 10.1117/12.485960; Watrous J, 2001, J COMPUT SYST SCI, V62, P376, DOI [10.1006/jcss.2000.1732, 10.1006/jcss.2000]	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1570-0755	1573-1332		QUANTUM INF PROCESS	Quantum Inf. Process.	MAY	2015	14	5			SI		1539	1558		10.1007/s11128-014-0819-6		20	Physics, Multidisciplinary; Physics, Mathematical	Physics	CH7WF	WOS:000354246600002		
J	Yan, F; Iliyasu, AM; Sun, B; Venegas-Andraca, SE; Dong, FY; Hirota, K				Yan, Fei; Iliyasu, Abdullah M.; Sun, Bo; Venegas-Andraca, Salvador E.; Dong, Fangyan; Hirota, Kaoru			A duple watermarking strategy for multi-channel quantum images	QUANTUM INFORMATION PROCESSING			English	Article						Quantum computation; Quantum image processing; Quantum information; Quantum watermarking; Quantum measurement	VIDEO PROCESSING APPLICATIONS; FOURIER-TRANSFORM; EFFICIENT IMAGE; REPRESENTATION; OPERATIONS; COMPUTERS; PROTOCOL	Utilizing a stockpile of efficient transformations consisting of channel of interest, channel swapping, and quantum Fourier transforms, a duple watermarking strategy on multi-channel quantum images is proposed. It embeds the watermark image both into the spatial domain and the frequency domain of the multi-channel quantum carrier image, while also providing a quantum measurement-based algorithm to generate an unknown key that is used to protect the color information, which accompanies another key that is mainly used to scramble the spatial content of the watermark image in order to further safeguard the copyright of the carrier image. Simulation-based experiments using a watermark logo and nine building images as watermark image and carrier images, respectively, offer a duple protection for the copyright of carrier images in terms of the visible quality of the watermarked images. The proposed stratagem advances available literature in the quantum watermarking research field and sets the stage for the applications aimed at quantum data protection.	[Yan, Fei] Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun 130022, Peoples R China; [Yan, Fei; Iliyasu, Abdullah M.; Sun, Bo; Dong, Fangyan; Hirota, Kaoru] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268502, Japan; [Iliyasu, Abdullah M.] Salman Bin Abdulaziz Univ, Coll Engn, Al Kharj 11942, Saudi Arabia; [Venegas-Andraca, Salvador E.] Escuela Ciencias & Ingn, Tecnol Monterrey, Atizapan De Zaragoza 52926, Estado De Mexic, Mexico	Yan, F (reprint author), Changchun Univ Sci & Technol, Sch Comp Sci & Technol, 7089 Weixing Rd, Changchun 130022, Peoples R China.	yanfei@cust.edu.cn			Salman Bin Abdulaziz University Saudi Arabia [2014/01/2079]; Tecnologico de Monterrey-Escuela de Ciencias e Ingenieria; CONACyT [41594]	The study was sponsored in full by the Salman Bin Abdulaziz University Saudi Arabia via the Deanship for Scientific Research Project Number 2014/01/2079. SEVA gratefully acknowledges the financial support of Tecnologico de Monterrey-Escuela de Ciencias e Ingenieria and CONACyT (SNI member Number 41594). FY would like to acknowledge the suggestions and support of Dr. Jiajun Lu towards the successful completion of the work presented.	Al-Nu'aimi A., 2007, J DIGIT INF MANAG, V5, P211; Iliyasu AM, 2012, INFORM SCIENCES, V186, P126, DOI 10.1016/j.ins.2011.09.028; Song XH, 2014, MULTIMEDIA SYST, V20, P379, DOI 10.1007/s00530-014-0355-3; Zhang WW, 2013, INT J THEOR PHYS, V52, P504, DOI 10.1007/s10773-012-1354-9; Iliyasu AM, 2011, INT J QUANTUM INF, V9, P1459, DOI 10.1142/S0219749911008015; Song XH, 2013, QUANTUM INF PROCESS, V12, P3689, DOI 10.1007/s11128-013-0629-2; Yang YG, 2013, QUANTUM INF PROCESS, V12, P2765, DOI 10.1007/s11128-013-0561-5; Zhang WW, 2013, QUANTUM INF PROCESS, V12, P793, DOI 10.1007/s11128-012-0423-6; Le PQ, 2011, QUANTUM INF PROCESS, V10, P63, DOI 10.1007/s11128-010-0177-y; Iliyasu Abdullah M., 2013, International Innovative Computing and Applications, V5; Iliyasu AM, 2013, ENTROPY-SWITZ, V15, P2874, DOI 10.3390/e15082874; Iliyasu AM, 2014, ENTROPY-SWITZ, V16, P3537, DOI 10.3390/e16063537; Iliyasu AM, 2013, INT J UNCONV COMPUT, V9, P125; Jiang Y., 2011, J SHENYANG LIGONG U, V30, P63; Latorre J.I., 2005, ARXIVQUANTPH0510031; Le P.Q., 2011, J ADV COMPUT INTELL, V15, P698; Le Phuc Q, 2010, IAENG International Journal of Applied Mathematics, V40; Luthon F., 2010, INT C AUT QUAL TEST, V3, P1; Machnes S, 2007, ARXIV07080478; Nielsen M, 2000, QUANTUM COMPUTATION; Sun B., 2014, J ADV COMPUT INTELL, V18, P140; Sun B., 2013, J ADV COMPUT INTELL, V17, P404; Sun B., 2011, IEEE 7 INT S INT SIG, P1; Venegas-Andraca S., 2003, P SPIE C QUANTUM INF, V5105, P134; Yan F, 2014, ENTROPY-SWITZ, V16, P5290, DOI 10.3390/e16105290; Yan F., 2012, IEEE WORLD C COMP IN, P1; Yan F., 2012, J QUANTUM INFORM SCI, V2, P55; Yan F., 2013, INT J INNOV COMPUT A, V5, P199	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1570-0755	1573-1332		QUANTUM INF PROCESS	Quantum Inf. Process.	MAY	2015	14	5			SI		1675	1692		10.1007/s11128-014-0912-x		18	Physics, Multidisciplinary; Physics, Mathematical	Physics	CH7WF	WOS:000354246600009		
J	Ohno, T; Lee, SY; Yang, Y				Ohno, Teruhisa; Lee, Szu Ying; Yang, Yin			Fabrication of morphology-controlled TiO2 photocatalyst nanoparticles and improvement of photocatalytic activities by modification of Fe compounds	RARE METALS			English	Article						Morphology-controlled TiO2; Separation of reaction sites; Visible-light responsive TiO2 loaded with Fe3+	TITANIUM-DIOXIDE NANOMATERIALS; SITE-SELECTIVE MODIFICATION; VISIBLE-LIGHT; DOPED TIO2; ANATASE TIO2; PHOTOELECTROCHEMICAL PROPERTIES; ENVIRONMENTAL APPLICATIONS; HYDROTHERMAL CONDITIONS; PLATINUM(IV) CHLORIDE; CRYSTAL FACES	Our previous studies suggested that redox reaction proceeded separately on specific exposed crystal faces of TiO2 nanoparticles. Site-selective deposition of metal or metal oxide on TiO2 specific exposed crystal faces successfully proceeded using the unique reactivity properties on the surface of TiO2 nanoparticles under photoexcitation. A remarkable improvement of photocatalytic activity of shape-controlled brookite and rutile TiO2 nanorods with modification of Fe3+ compounds was observed under visible light. Crystal face-selective metal compound modification on exposed crystal faces of TiO2 nanorods with brookite and rutile phases was successfully prepared. Brookite and rutile TiO2 nanorods prepared by site-selective modification with metal compounds should be ideal visible-light responsive TiO2 photocatalysts because of the remarkable suppression of back electron transfer from TiO2 to oxidized metal compounds on the surface of the TiO2 nanorod with a brookite or rutile phase. In this paper, the development of exposed crystal face-controlled TiO2 nanorods with rutile and brookite phases was described. The obtained rutile and brookite TiO2 nanorod, showing remarkably high activity for degradation of organic compounds compared with the photocatalytic activities of anatase fine particles (ST-01), is one of the most active commercially available photocatalysts for environmental cleanup in Japan. The technology of visible-light responsive treatment for morphology-controlled rutile and brookite TiO2 nanorods by crystal face-selective modification of Fe3+ compounds was also discussed in this paper. The Fe3+ compound-modified rutile and brookite TiO2 nanorods show much higher activity than conventional visible-light responsive N-doped TiO2, which is commercially available in Japan.	[Ohno, Teruhisa; Lee, Szu Ying; Yang, Yin] Kyushu Inst Technol, Grad Sch Engn, Dept Mat Sci, Fukuoka 8048550, Japan	Ohno, T (reprint author), Kyushu Inst Technol, Grad Sch Engn, Dept Mat Sci, Fukuoka 8048550, Japan.	tohno@che.kyutech.ac.jp			Advanced Catalytic Transformation Program for Carbon Utilization (ACT-C), Japan Science and Technology Agency (JST)	This work was financially supported by the Advanced Catalytic Transformation Program for Carbon Utilization (ACT-C), Japan Science and Technology Agency (JST).	Testino A, 2007, J AM CHEM SOC, V129, P3564, DOI 10.1021/ja067050+; Kandiel TA, 2010, CHEM MATER, V22, P2050, DOI 10.1021/cm903472p; Lv KL, 2012, PHYS CHEM CHEM PHYS, V14, P5349, DOI 10.1039/c2cp23461k; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; SERPONE N, 1994, LANGMUIR, V10, P643, DOI 10.1021/la00015a010; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Hosono E, 2004, J AM CHEM SOC, V126, P7790, DOI 10.1021/ja048820p; Murakami N, 2010, APPL CATAL B-ENVIRON, V97, P115, DOI 10.1016/j.apcatb.2010.03.030; Kisch H, 1998, ANGEW CHEM INT EDIT, V37, P3034; Yu JG, 2014, J AM CHEM SOC, V136, P8839, DOI 10.1021/ja5044787; Ohno T, 2002, NEW J CHEM, V26, P1167, DOI 10.1039/b202140d; Choi W, 2006, CATAL SURV ASIA, V10, P16, DOI 10.1007/s10563-006-9000-2; Macyk W, 2001, CHEM-EUR J, V7, P1862, DOI 10.1002/1521-3765(20010504)7:9<1862::AID-CHEM1862>3.3.CO;2-7; Umebayashi T, 2002, APPL PHYS LETT, V81, P454, DOI 10.1063/1.1493647; Ohno T, 1997, J PHYS CHEM B, V101, P6415, DOI 10.1021/jp971093i; Zhang HZ, 2000, J PHYS CHEM B, V104, P3481, DOI 10.1021/jp000499j; Bae E, 2009, J MOL CATAL A-CHEM, V300, P72, DOI 10.1016/j.molcata.2008.10.048; Oliver PM, 1997, J MATER CHEM, V7, P563, DOI 10.1039/a606353e; Bae E, 2009, APPL CATAL B-ENVIRON, V91, P634, DOI 10.1016/j.apcatb.2009.06.034; Wang C, 2014, APPL SURF SCI, V292, P161, DOI 10.1016/j.apsusc.2013.11.105; Ohno T, 2004, APPL CATAL A-GEN, V265, P115, DOI 10.1016/j.apcata.2004.01.007; Ikeda S, 2001, PHYS CHEM CHEM PHYS, V3, P267, DOI 10.1039/b008028o; Irie H, 2003, CHEM LETT, V32, P772, DOI 10.1246/cl.2003.772; SATO S, 1986, CHEM PHYS LETT, V123, P126, DOI 10.1016/0009-2614(86)87026-9; Zang L, 1998, J PHYS CHEM B, V102, P10765, DOI 10.1021/jp981755j; Murakami N, 2008, APPL CATAL A-GEN, V348, P148, DOI 10.1016/j.apcata.2008.06.040; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Sakthivel S, 2004, J PHYS CHEM B, V108, P19384, DOI 10.1021/jp046857q; Murakami N, 2009, J PHYS CHEM C, V113, P3062, DOI 10.1021/jp809104t; Zhou P, 2014, APPL SURF SCI, V319, P167, DOI 10.1016/j.apsusc.2014.05.045; Bae E, 2010, APPL CATAL A-GEN, V380, P48, DOI 10.1016/j.apcata.2010.03.029; Ren CJ, 2014, RARE METALS, V33, P714, DOI 10.1007/s12598-014-0326-z; Huang XP, 2007, J CRYST GROWTH, V306, P117, DOI 10.1016/j.jcrysgro.2007.04.018; Huang ZA, 2015, APPL CATAL B-ENVIRON, V164, P420, DOI 10.1016/j.apcatb.2014.09.043; Kobayashi M, 2009, J AM CERAM SOC, V92, pS21, DOI 10.1111/j.1551-2916.2008.02641.x; Kobayashi M, 2007, SOL ST PHEN, V124-126, P723; Ma ZX, 2015, RARE METALS, V34, P590, DOI 10.1007/s12598-014-0263-x; Murakami N, 2009, CATAL COMMUN, V10, P963, DOI 10.1016/j.catcom.2008.12.038; Murakami N, 2007, J PHYS CHEM C, V111, P11927, DOI 10.1021/jp071362x; Neale NR, 2007, J MATER CHEM, V17, P3216, DOI 10.1039/b700885f; Ohno T, 2004, CHEM LETT, V33, P750, DOI 10.1246/cl.2004.750; Ohno T, 2015, J MOL CATAL A-CHEM, V396, P261, DOI 10.1016/j.molcata.2014.09.036	42	0	0	NONFERROUS METALS SOC CHINA	BEIJING	12B FUXIN RD, BEIJING 100814, PEOPLES R CHINA	1001-0521	1867-7185		RARE METALS	Rare Metals	MAY	2015	34	5					291	300		10.1007/s12598-015-0483-8		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH9ZL	WOS:000354395200001		
J	Iwase, A; Nakamura, T; Nakahara, T; Goto, M; Kikkawa, F				Iwase, Akira; Nakamura, Tomoko; Nakahara, Tatsuo; Goto, Maki; Kikkawa, Fumitaka			Anti-Mullerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment: A Systematic Narrative Review	REPRODUCTIVE SCIENCES			English	Review						anti-Mullerian hormone; chemotherapy; oncofertility; ovarian reserve	NON-HODGKIN-LYMPHOMA; STAGE BREAST-CANCER; ANTIMULLERIAN HORMONE; YOUNG-WOMEN; FERTILITY PRESERVATION; INHIBIN-B; RHEUMATOID-ARTHRITIS; PREMENOPAUSAL WOMEN; LUPUS-ERYTHEMATOSUS; CHILDHOOD-CANCER	Since serum anti-Mullerian hormone (AMH) levels enable quantitative evaluation of ovarian damage, we conducted a computer-based search, using key words, of all articles published in English through the PubMed database from inception until September 2013 to summarize available studies evaluating ovarian reserve after ovarian toxic interventions to discuss the usefulness of serum AMH levels. We found that most of the studies demonstrated a decline in serum AMH levels when compared to control or pretreatment levels, with levels dependent on the type of treatment modality. Measurement of serum AMH levels enables quantitative evaluation of ovarian damage caused by ovarian toxic interventions, such as chemotherapy and radiotherapy, instead of qualitative evaluation using menstrual condition or basal follicle-stimulating hormone levels. Serum AMH levels are becoming indispensable to assess the ovarian reserve of patients who desire preservation of ovarian function for fertility and endogenous sex steroid hormones.	[Iwase, Akira; Nakamura, Tomoko; Nakahara, Tatsuo; Goto, Maki; Kikkawa, Fumitaka] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Iwase, Akira] Nagoya Univ Hosp, Dept Maternal & Perinatal Med, Showa Ku, Nagoya, Aichi, Japan	Iwase, A (reprint author), Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	akiwase@med.nagoya-u.ac.jp					Anderson RA, 2006, HUM REPROD, V21, P2583, DOI 10.1093/humrep/del201; Li HWR, 2012, J ASSIST REPROD GEN, V29, P1443, DOI 10.1007/s10815-012-9880-1; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Partridge AH, 2010, FERTIL STERIL, V94, P638, DOI 10.1016/j.fertnstert.2009.03.045; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Rosendahl M, 2008, HUM REPROD, V23, P2475, DOI 10.1093/humrep/den248; Franco JG, 2012, MED HYPOTHESES, V78, P442, DOI 10.1016/j.mehy.2011.12.015; Morse H, 2013, PEDIATR BLOOD CANCER, V60, P676, DOI 10.1002/pbc.24327; Brougham MFH, 2012, J CLIN ENDOCR METAB, V97, P2059, DOI 10.1210/jc.2011-3180; Lee S, 2011, J ASSIST REPROD GEN, V28, P651, DOI 10.1007/s10815-011-9567-z; Bancsi LFJMM, 2003, FERTIL STERIL, V79, P1091, DOI 10.1016/S0015-0282(03)00078-5; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Welsh P, 2014, HUM REPROD, V29, P1035, DOI 10.1093/humrep/deu036; Loh JS, 2011, HUM REPROD, V26, P2925, DOI 10.1093/humrep/der271; Dillon KE, 2013, FERTIL STERIL, V99, P477, DOI 10.1016/j.fertnstert.2012.09.039; Decanter C, 2010, REPROD BIOMED ONLINE, V20, P280, DOI 10.1016/j.rbmo.2009.11.010; Bath LE, 2003, HUM REPROD, V18, P2368, DOI 10.1093/humrep/deg473; Anderson RA, 2011, J CLIN ENDOCR METAB, V96, P1336, DOI 10.1210/jc.2010-2582; Mok CC, 2013, ARTHRITIS RHEUM-US, V65, P206, DOI 10.1002/art.37719; Lee S, 2010, J CLIN ONCOL, V28, P4683, DOI 10.1200/JCO.2010.30.5748; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Nelson SM, 2013, FERTIL STERIL, V99, P963, DOI 10.1016/j.fertnstert.2012.11.051; van Rooij IAJ, 2005, FERTIL STERIL, V83, P979, DOI 10.1016/j.fertnstert.2004.11.029; Hamre H, 2012, PEDIATR BLOOD CANCER, V59, P271, DOI 10.1002/pbc.23363; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; van Disseldorp J, 2010, HUM REPROD, V25, P221, DOI 10.1093/humrep/dep366; Brouwer J, 2013, ARTHRIT CARE RES, V65, P1534, DOI 10.1002/acr.22013; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015; Dieudonne AS, 2011, MENOPAUSE, V18, P821, DOI 10.1097/gme.0b013e318204af88; Anderson RA, 2012, MATURITAS, V71, P28, DOI 10.1016/j.maturitas.2011.11.008; Fong SL, 2009, HUM REPROD, V24, P982, DOI 10.1093/humrep/den487; Su HI, 2013, BREAST CANCER RES TR, V137, P571, DOI 10.1007/s10549-012-2361-5; Rustamov O, 2014, J CLIN ENDOCR METAB, V99, P723, DOI 10.1210/jc.2013-3476; Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042; Smith GD, 2010, FERTIL STERIL, V94, P2088, DOI 10.1016/j.fertnstert.2009.12.065; Anders C, 2008, CANCER INVEST, V26, P286, DOI 10.1080/07357900701829777; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; van Beek RD, 2007, J CLIN ENDOCR METAB, V92, P3869, DOI 10.1210/jc.2006-2374; Decanter C, 2014, FERTIL STERIL, V102, P483, DOI 10.1016/j.fertnstert.2014.05.014; Lambalk CB, 2009, MATURITAS, V63, P280, DOI 10.1016/j.maturitas.2009.06.007; Cuny A, 2011, J PEDIAT, V158; Domingues TS, 2010, CURR OPIN OBSTET GYN, V22, P271, DOI 10.1097/GCO.0b013e32833b4f5c; Donnez J, 2009, SEMIN REPROD MED, V27, P472, DOI 10.1055/s-0029-1241057; Fong SL, 2008, HUM REPROD, V23, P674, DOI 10.1093/humrep/dem392; Giuseppe Loverro, 2007, Hematology, V12, P141, DOI 10.1080/10245330600954072; Gracia CR, 2012, FERTIL STERIL, V97; Iwase A, 2013, GYNECOL ENDOCRINOL, V29, P357, DOI 10.3109/09513590.2012.743008; Iwase A, 2013, EUR J OBSTET GYN R B, V167, P194, DOI 10.1016/j.ejogrb.2012.11.021; Jantke A, 2012, J OBSTET GYNAECOL RE, V38, P1254, DOI 10.1111/j.1447-0756.2012.01861.x; Lawrenz B, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.021; Singh KL, 2007, BRIT J CANCER, V96, P1808, DOI 10.1038/sj.bjc.6603814; McLaren JF, 2012, AM J OBSTET GYNECOL, V207, P455, DOI 10.1016/j.ajog.2012.08.013; Morel N, 2013, J CLIN ENDOCR METAB, V98, P3785, DOI 10.1210/jc.2013-1235; Su HI, 2010, CANCER-AM CANCER SOC, V116, P592, DOI 10.1002/cncr.24746; Su HI, 2014, FERTIL STERIL, V101; van Waas M, 2012, ANN ONCOL, V23, P1626, DOI 10.1093/annonc/mdr511	57	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAY	2015	22	5					519	526		10.1177/1933719114549856		8	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CH4IF	WOS:000353996500002		
J	Khan, KN; Kitajima, M; Inoue, T; Fujishita, A; Nakashima, M; Masuzaki, H				Khan, Khaleque Newaz; Kitajima, Michio; Inoue, Tsuneo; Fujishita, Akira; Nakashima, Masahiro; Masuzaki, Hideaki			17 beta-Estradiol and Lipopolysaccharide Additively Promote Pelvic Inflammation and Growth of Endometriosis	REPRODUCTIVE SCIENCES			English	Article						endometriosis; macrophages; stromal cells; estradiol; LPS	PERITONEAL-FLUID MACROPHAGES; RECEPTOR 4-MEDIATED GROWTH; OVARIAN-STEROIDS; IN-VIVO; ESTROGEN-RECEPTORS; EPITHELIAL-CELLS; EXPRESSION; WOMEN; ESTRADIOL; RELEASE	Endometriosis is a multifactorial disease mostly affecting women of reproductive age. An additive effect between inflammation and stress reaction on the growth of endometriosis has been demonstrated. Here we investigated the combined effect between 17-estradiol (E-2) and lipopolysaccharide (LPS) on pelvic inflammation and growth of endometriotic cells. Peritoneal fluid was collected from 46 women with endometriosis and 30 control women during laparoscopy. Peritoneal macrophages (M phi) and stromal cells from eutopic/ectopic endometrial stromal cells (ESCs) were isolated from 10 women each with and without endometriosis in primary culture. Changes in cytokine secretion (interleukin 6 [IL-6] and tumor necrosis factor [TNF-]) by M phi and proliferation of ESCs in response to single and combined treatment with E-2 and LPS were measured by enzyme-linked immunosorbent assay and by bromodeoxyuridine incorporation assay, respectively. A significantly increased secretion of IL-6 and TNF- in M phi culture media was found in response to E-2 (10(-8) mol/L) compared to nontreated M phi. This effect of E-2 was abrogated after pretreatment of cells with ICI 182720 (10(-6) mol/L; an estrogen receptor [ER] antagonist). Combined treatment with E-2 and LPS (10 ng/mL) additively promoted IL-6 and TNF- secretion by peritoneal M phi and growth of eutopic/ectopic ESCs. The additive effects of E-2 + LPS on cytokine secretion and growth of ESCs were effectively suppressed after combined blocking of ER and Toll-like receptor 4. An additive effect was observed between E-2 and LPS on promoting proinflammatory response in pelvis and growth of endometriosis.	[Khan, Khaleque Newaz; Kitajima, Michio; Inoue, Tsuneo; Masuzaki, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 8528501, Japan; [Fujishita, Akira] Saiseikai Nagasaki Hosp, Dept Gynecol, Nagasaki, Japan; [Nakashima, Masahiro] Atom Bomb Dis Inst, Dept Tumor & Diagnost Pathol, Nagasaki, Japan	Khan, KN (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	nemokhan@nagasaki-u.ac.jp			Japan Society for the Promotion of Science [21592101, 24592474]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Grants-in-Aid for Scientific Research (Grant Nos. 21592101 and 24592474) from the Japan Society for the Promotion of Science (to K. N. Khan).	Canis M, 1997, FERTIL STERIL, V67, P817; Mor G, 2003, J IMMUNOL, V170, P114; Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029; Khan KN, 2005, HUM REPROD, V20, P2004, DOI 10.1093/humrep/deh897; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Rettew JA, 2009, ENDOCRINOLOGY, V150, P3877, DOI 10.1210/en.2009-0098; HALME J, 1988, J CLIN ENDOCR METAB, V66, P1044; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; Khan KN, 2008, HUM REPROD, V23, P2210, DOI 10.1093/humrep/den195; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Montagna P, 2008, FERTIL STERIL, V90, P156, DOI 10.1016/j.fertnstert.2006.11.200; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; Nirgianakis K, 2013, EUR J OBSTET GYN R B, V170, P550, DOI 10.1016/j.ejogrb.2013.08.010; King AE, 2010, HUM REPROD, V25, P510, DOI 10.1093/humrep/dep421; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Attar E, 2006, HUM REPROD UPDATE, V12, P49, DOI 10.1093/humupd/dmi034; Khan KN, 2008, AM J REPROD IMMUNOL, V60, P383, DOI 10.1111/j.1600-0897.2008.00643.x; Calippe B, 2008, J IMMUNOL, V180, P7980; BABSON AL, 1991, CLIN CHEM, V37, P1521; Cakmak Hakan, 2009, Front Biosci (Elite Ed), V1, P429; EISCHEN A, 1994, BRIT J HAEMATOL, V88, P712, DOI 10.1111/j.1365-2141.1994.tb05109.x; HALME J, 1989, AM J OBSTET GYNECOL, V161, P1718; Kamiyama S, 2004, FERTIL STERIL, V82, P788, DOI 10.1016/j.fertnstert.2004.01.054; Kaponis A, 2012, FRONT BIOSCI S, VS4, P1568; Khan KN, 2002, ACTA OBSTET GYN SCAN, V81, P764, DOI 10.1034/j.1600-0412.2002.810814.x; Khan KN, 2013, HUM REPROD, V28, P2794, DOI 10.1093/humrep/det280; Khan KN, 2010, FERTIL STERIL, V94, P2860, DOI 10.1016/j.fertnstert.2010.04.053; Kwon JH, 2003, J BIOL CHEM, V278, P875, DOI 10.1074/jbc.M208241200; TAKAGI S, 1993, CYTOMETRY, V14, P640, DOI 10.1002/cyto.990140608	29	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	MAY	2015	22	5					585	594		10.1177/1933719114556487		10	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CH4IF	WOS:000353996500010		
J	Carleton, T; Cockayne, W; Sawatani, Y				Carleton, Tamara; Cockayne, William; Sawatani, Yuriko			Changing the Culture of R&D	RESEARCH-TECHNOLOGY MANAGEMENT			English	Editorial Material									[Carleton, Tamara] Stanford Univ, Sch Engn, Execut Educ program, Stanford, CA 94305 USA; [Cockayne, William] Stanford Univ, Stanford, CA 94305 USA; [Sawatani, Yuriko] Waseda Univ, Tokyo, Tokyo, Japan	Carleton, T (reprint author), Stanford Univ, Sch Engn, Execut Educ program, Stanford, CA 94305 USA.	carleton@innovation.io; cockayne@stanford.edu; yurikosw@gmail.com					House C., 2009, HP PHENOMENON INNOVA; Katzenbach J., 2011, STRATEGY BUSINES SPR, V62	2	0	0	INDUSTRIAL RESEARCH INST, INC	ARLINGTON	2300 CLARENDON BLVD, STE 400, ARLINGTON, VA 22201 USA	0895-6308	1930-0166		RES TECHNOL MANAGE	Res.-Technol. Manage.	MAY-JUN	2015	58	3					9	10		10.5437/08956308X5803002		2	Business; Engineering, Industrial; Management	Business & Economics; Engineering	CH3ML	WOS:000353934700005		
J	Yamaguchi, Y; Hibi, S; Ishii, M; Hanaoka, Y; Yamamoto, H; Ouchi, Y; Akishita, M				Yamaguchi, Yasuhiro; Hibi, Shinichiro; Ishii, Masaki; Hanaoka, Yoko; Yamamoto, Hiroshi; Ouchi, Yasuyoshi; Akishita, Masahiro			Removal of the CPAP Therapy Device During Sleep and Its Association With Body Position Changes and Oxygen Desaturations	RESPIRATORY CARE			English	Article						obstructive sleep apnea syndrome; positive airway pressure; adherence; body position changes; supine; non-supine	AIRWAY PRESSURE THERAPY; ADHERENCE; APNEA; MORTALITY; IMPACT; TRIAL	BACKGROUND: Some patients with obstructive sleep apnea syndrome remove the CPAP device during sleep, although they start CPAP at bedtime. We hypothesized that body position changes and oxygen desaturations may be associated with patient removal of the CPAP device. METHODS: We consecutively enrolled 36 poor CPAP adherers and 25 good CPAP adherers. Body positions and oxygen desaturations were evaluated when these subjects used CPAP during sleep for 2 nights, permitting the removal of the CPAP device during the recording. RESULTS: Twelve poor CPAP adherers exhibited subject removal of the CPAP device within 4 h from the start of body position recording. The frequency of body position changes was significantly higher within 15 min before the CPAP removal than during other periods when CPAP was used. At the same time, oxygen desaturations were significantly more frequent within 15 min before CPAP removal than during other periods when CPAP was used. In addition, the majority (66.7%) of the CPAP removal events were followed by a change from a supine position to a non-supine position within 5 min. The number of body position changes during the first 4-h recording was significantly higher in the poor CPAP adherers who had removed their CPAP device compared with the poor CPAP adherers who had not removed their device. However, the number of body position changes or oxygen desaturation index under CPAP during the first 4-h recording was not significantly different between the poor CPAP adherers and good CPAP adherers. CONCLUSIONS: Our findings are the first to indicate associations among CPAP removal, body position changes, and oxygen desaturations during sleep in poor CPAP adherers. However, our findings also indicated that most good CPAP adherers make frequent body position changes without removal of CPAP device, suggesting that patients can adapt to the discomfort of CPAP therapy at the time of body position changes. (C) 2015 Daedalus Enterprises	[Yamaguchi, Yasuhiro; Hibi, Shinichiro; Ishii, Masaki; Hanaoka, Yoko; Yamamoto, Hiroshi; Ouchi, Yasuyoshi; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriat Med, Bunkyo Ku, Tokyo 1138655, Japan	Yamaguchi, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Geriat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yamayasu-tky@umin.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Mitsui Sumitomo Insurance Welfare Foundation	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan and by research grants from the Mitsui Sumitomo Insurance Welfare Foundation. The authors have disclosed no other conflicts of interest.	Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Shapiro GK, 2010, SLEEP BREATH, V14, P323, DOI 10.1007/s11325-010-0391-y; Fox N, 2012, SLEEP, V35, P477, DOI 10.5665/sleep.1728; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Campos-Rodriguez F, 2005, CHEST, V128, P624, DOI 10.1378/chest.128.2.624; Jenkinson C, 1999, LANCET, V353, P2100, DOI 10.1016/S0140-6736(98)10532-9; Sawyer AM, 2011, SLEEP MED REV, V15, P343, DOI 10.1016/j.smrv.2011.01.003; Falcone VA, 2014, RESP CARE, V59, P193, DOI 10.4187/respcare.02491; Nannapaneni Srikant, 2013, World J Diabetes, V4, P238, DOI 10.4239/wjd.v4.i6.238; Trupp RJ, 2011, BEHAV SLEEP MED, V9, P38, DOI 10.1080/15402002.2011.533993	11	0	0	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	MAY	2015	60	5					658	665		10.4187/respcare.03520		8	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CH7CB	WOS:000354192100012		
J	Shingai, K; Kanezaki, M; Senjyu, H				Shingai, Kazuya; Kanezaki, Masashi; Senjyu, Hideaki			Distractive Auditory Stimuli Alleviate the Perception of Dyspnea Induced by Low-Intensity Exercise in Elderly Subjects With COPD	RESPIRATORY CARE			English	Article						distractive auditory stimuli; exercise-induced dyspnea; COPD; elderly; low-intensity exercise; cycle ergometer	UNPLEASANTNESS	BACKGROUND: Although recent studies have shown that distractive auditory stimuli (DAS) in the form of music increase adherence to exercise in subjects with COPD, the effect of DAS on dyspnea induced by low-intensity, constant-load exercise in elderly patients with COPD has not been elucidated. Therefore, the purpose of this study was to investigate the effect of DAS on the perception of dyspnea induced by low-intensity, constant-load exercise in elderly subjects with COPD. METHODS: We enrolled 16 male out-patients with COPD. Subjects completed cycling exercises with and without DAS at 40% maximum oxygen consumption. They were asked to rate their perception of dyspnea using the modified Borg scale every 3 min during exercise and every 1 min during the recovery period. RESULTS: Dyspnea perception during low-intensity exercise showed a significant correlation between the exercise condition (DAS and control) and exercise duration (P = .04). Exercise-induced dyspnea perception under the DAS condition was significantly lower than that under the control condition from 18 min after the start of exercise to 3 min after the end of exercise (18, 20, 21, 22, and 23 min, P = .01, P < .001, P = .009, P = .006, and P = .006, respectively). However, oxygen consumption and ventilation in response to low-intensity exercise did not significantly differ in the DAS and control conditions (P = .39 and .14, respectively) CONCLUSIONS: Our results suggest that DAS is a non-pharmacologic therapy that can be used to reduce the dyspneic sensation in elderly patients with COPD. (C) 2015 Daedalus Enterprises	[Shingai, Kazuya] Tosei Gen Hosp, Dept Rehabil Med, Seto, Aichi, Japan; [Kanezaki, Masashi] Himeji Dokkyo Univ, Fac Hlth Care Sci, Dept Phys Therapy, Himeji, Hyogo 6708524, Japan; [Senjyu, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiopulm Rehabil Sci, Nagasaki 852, Japan	Kanezaki, M (reprint author), Himeji Dokkyo Univ, Fac Hlth Care Sci, Dept Phys Therapy, 7-2-1 Kamiohno, Himeji, Hyogo 6708524, Japan.	kmasashi@gm.himeji-du.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [24500589, 26870760]; Kirigaoka-Tsuda Hospital; Nagasaki Pulmonary Rehabilitation Clinic; Tagami Hospital	This study was supported by Grants-in-Aid for Scientific Research 24500589 and 26870760 from the Ministry of Education, Culture, Sports, Science, and Technology and by Kirigaoka-Tsuda Hospital, the Nagasaki Pulmonary Rehabilitation Clinic, and Tagami Hospital. The authors have disclosed no conflicts of interest.	American Thoracic Society American College of Chest Physicians, 2003, AM J RESP CRIT CARE, V167, P211, DOI DOI 10.1164/RCCM.167.2.211; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI [10.1164/rccm.200712-1821OC, 10.1164/rccm.200712-18210C]; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; von Leupoldt A, 2005, CHEST, V128, P345, DOI 10.1378/chest.128.1.345; Bauldoff GS, 2002, CHEST, V122, P948, DOI 10.1378/chest.122.3.948; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; Luxton N, 2008, RESPIROLOGY, V13, P856, DOI 10.1111/j.1440-1843.2008.01355.x; von Leupoldt A, 2007, CHEST, V132, P1506, DOI 10.1378/chest.07-1245; Barbaro MPF, 2011, RESP MED, V105, P195, DOI 10.1016/j.rmed.2010.09.013; Castro AAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079727; ELDRIDGE FL, 1982, J PHYSIOL-LONDON, V324, P285; Kanezaki M, 2010, COUGH, V6; Murray JA, 2009, CHEST, V135, P384, DOI 10.1378/chest.08-1258; Pfister T, 1998, J Cardiopulm Rehabil, V18, P228, DOI 10.1097/00008483-199805000-00007; Shingai K, 2014, J PHYS THER SCI, V26, P255, DOI 10.1589/jpts.26.255; THORNBY MA, 1995, CHEST, V107, P1213, DOI 10.1378/chest.107.5.1213; Tun PA, 2012, AM J AUDIOL, V21, P344, DOI 10.1044/1059-0889(2012/12-0030); Yamashita S, 2006, J SPORT MED PHYS FIT, V46, P425	18	0	0	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	MAY	2015	60	5					689	694		10.4187/respcare.03533		6	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CH7CB	WOS:000354192100016		
J	Takaki, S; Mihara, T; Mizutani, K; Yamaguchi, O; Goto, T				Takaki, Shunsuke; Mihara, Takahiro; Mizutani, Kenji; Yamaguchi, Osamu; Goto, Takahisa			Evaluation of an Oxygen Mask-Based Capnometry Device in Subjects Extubated After Abdominal Surgery	RESPIRATORY CARE			English	Article						capnometry; end-tidal carbon dioxide; postoperative monitoring; ventilation/perfusion mismatch	MONITORED ANESTHESIA CARE; CARBON-DIOXIDE; CAPNOGRAPHY; VENTILATION; DIFFERENCE; TRANSPORT; ACCURACY; ARTERIAL	BACKGROUND: For early detection of respiratory and hemodynamic changes during anesthesia, continuous end-tidal carbon dioxide concentration (P-ETCO2) is monitored by capnometry. However, the accuracy of CO2 monitoring during spontaneous breathing in extubated patients remains undetermined. Therefore, we aimed to compare P-ETCO2 measured by capnometry using an oxygen mask with a carbon dioxide sampling port (capnometry-type oxygen mask) and P-CO2 in extubated subjects who had undergone abdominal surgery. Furthermore, we investigated whether spontaneous deep breathing affected dissociation between P-aCO2 and P-ETCO2. METHODS: Adult post-abdominal surgery subjects admitted to the ICU were enrolled in this study. After extubation, oxygen was supplied at 6 L/min using the capnometry-type oxygen mask. After 30 min of oxygen supply, P-aCO2 blood gas analysis was performed, and P-ETCO2 was measured under resting and deep-breathing conditions. For both resting and deep-breathing conditions, the correlation between P-aCO2 and P-ETCO2 was analyzed. Furthermore, bias, precision, and limits of agreement were calculated using the Bland-Altman method. RESULTS: Twenty-five subjects (15 men, 10 women) with a mean age of 62 y (interquartile range of 57-76 y) and body mass index of 20-24 kg/m(2) were studied. The correlation (r) between P-aCO2 and P-ETCO2 under resting and deep-breathing conditions was 0.50 and 0.56, respectively. Compared with P-aCO2, the bias and limits of agreement were -12.6 (-20.6 to -4.6) for resting P-ETCO2 and -9.1 (-16.0 to -2.1) for deep-breathing P-ETCO2. The association between P-aCO2 and deep-breathing P-ETCO2 was significantly smaller compared with resting P-ETCO2 (P = .002). CONCLUSIONS: It is possible to measure the P-ETCO2 under varying breathing conditions with the capnometry-type oxygen mask in subjects receiving oxygen supplementation after extubation following upper abdominal surgery to determine whether they are properly ventilating. (ClinicalTrials.gov registration UMIN000011925.) (C) 2015 Daedalus Enterprises	[Takaki, Shunsuke; Mizutani, Kenji; Yamaguchi, Osamu; Goto, Takahisa] Yokohama City Univ Med, Dept Anesthesiol, Yokohama, Kanagawa 2360004, Japan; [Takaki, Shunsuke; Mizutani, Kenji; Yamaguchi, Osamu; Goto, Takahisa] Yokohama City Univ Med, Intens Care Unit, Yokohama, Kanagawa 2360004, Japan; [Mihara, Takahiro] Kanagawa Childrens Med Ctr, Dept Anesthesiol, Yokohama, Kanagawa, Japan	Takaki, S (reprint author), Yokohama City Univ Med, Dept Anesthesiol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	shunty5323@gmail.com			Yokohama City University Hospital	The study was supported by the Yokohama City University Hospital. The authors have disclosed no conflicts of interest.	Ahrens Tom, 2003, AACN Clin Issues, V14, P123, DOI 10.1097/00044067-200305000-00002; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Warner DO, 2000, ANESTHESIOLOGY, V92, P1467, DOI 10.1097/00000542-200005000-00037; LIU S, 1995, ANESTHESIOLOGY, V82, P1474, DOI 10.1097/00000542-199506000-00019; Soto RG, 2004, ANESTH ANALG, V99, P379; Griffin J, 2003, BRIT J ANAESTH, V91, P498, DOI 10.1093/bja/aeg217; YAMANAKA MK, 1987, CHEST, V92, P832, DOI 10.1378/chest.92.5.832; Sesay M, 2008, EUR J ANAESTH, V25, P769, DOI 10.1017/S0265021508004134; Anderson CT, 2000, CRIT CARE, V4, P207, DOI 10.1186/cc696; Beecher HK, 1933, J CLIN INVEST, V12, P651, DOI 10.1172/JCI100526; Bongard F, 1994, J Invest Surg, V7, P259, DOI 10.3109/08941939409018291; BREEN PH, 1994, ANESTH ANALG, V78, P584; Cook D, 2001, CHEST, V120, p438S, DOI 10.1378/chest.120.6_suppl.438S; DOYLE DJ, 1991, J BIOMED ENG, V13, P500, DOI 10.1016/0141-5425(91)90098-R; Gaucher A, 2012, BRIT J ANAESTH, V108, P316, DOI 10.1093/bja/aer383; Haldane J S, 1919, J Physiol, V52, P433; Lumb AB, 2005, NUNNS APPL RESP PHYS; McKeague H, 1997, BRIT J ANAESTH, V79, P415; Palmon SC, 1996, CRIT CARE MED, V24, P608, DOI 10.1097/00003246-199604000-00010; Paul J, 2003, CAN J ANAESTH, V50, P137; PLEWA MC, 1995, ACAD EMERG MED, V2, P901, DOI 10.1111/j.1553-2712.1995.tb03106.x; SHARMA SK, 1995, CAN J ANAESTH, V42, P498; Yanagidate F, 2006, Eur J Anaesthesiol, V23, P257, DOI 10.1017/S0265021505002279; Yazigi Alexandre, 2007, Middle East Journal of Anesthesiology, V19, P483	24	0	0	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	MAY	2015	60	5					705	710		10.4187/respcare.03557		6	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CH7CB	WOS:000354192100018		
J	Seki, K; Watanabe, H; Morita, R; Sato, K; Asano, M; Iino, T; Iino, K; Ito, H				Seki, Katsuhito; Watanabe, Hiroyuki; Morita, Ryo; Sato, Kazuhiro; Asano, Mariko; Iino, Takako; Iino, Kenji; Ito, Hiroshi			Serial Changes in Hamman's Sign Secondary to the Evolution of a Shallow Left-Sided Spontaneous Pneumothorax	RESPIRATORY CARE			English	Article							PNEUMOMEDIASTINUM; CLICKS		[Seki, Katsuhito; Watanabe, Hiroyuki; Morita, Ryo; Sato, Kazuhiro; Asano, Mariko; Iino, Takako; Iino, Kenji; Ito, Hiroshi] Akita Univ, Sch Med, Dept Cardiovasc & Resp Med, Akita 0108543, Japan	Watanabe, H (reprint author), Akita Univ, Sch Med, Dept Cardiovasc & Resp Med, 1-1-1 Hondoh, Akita 0108543, Japan.	hirow@doc.med.akita-u.ac.jp					BAUMANN MH, 1992, CHEST, V102, P1281, DOI 10.1378/chest.102.4.1281; CHAPMAN JS, 1955, AM J MED, V18, P547, DOI 10.1016/0002-9343(55)90454-X; Drury NE, 2006, INT J CARDIOL, V113, P104, DOI 10.1016/j.ijcard.2005.08.013; Hamman L., 1937, T A AM PHYSICIANS, V52, P311; Remmelts HHF, 2010, NETH J MED, V68, P187; ROELANDT J, 1969, DIS CHEST, V56, P31; Scadding JG, 1939, LANCET, V2, P1208	7	0	0	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	MAY	2015	60	5					E110	E112		10.4187/respcare.03562		3	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CH7CB	WOS:000354192100005		
J	Izumi, T; Sawano, Y; Tanaka, H				Izumi, Takashi; Sawano, Yoshihiro; Tanaka, Hitoshi			Littlewood-Paley theory for Morrey spaces and their preduals	REVISTA MATEMATICA COMPLUTENSE			English	Article						Block spaces; Morrey spaces; Littlewood-Paley spaces; Fatou property	FOURIER-SERIES	Zorko proved that Morrey spaces are known to have preduals. In the present paper such predual spaces are shown to be characterized by means of the Littlewood-Paley operators. Recently, many function spaces are shown to admit the Littlewood-Paley characterization. As for the predual spaces of Morrey spaces, it had not been clear that a pointwise increasing norm-bounded sequence has a least bound. However, the author proved in the earlier paper that it actually has a least bound. In the present paper, by taking advantage of this property, a characterization by means of Littlewood-Paley operators is proposed.	[Izumi, Takashi] Yamagata Univ, Dept Math Sci, Yamagata 9908560, Japan; [Sawano, Yoshihiro] Tokyo Metropolitan Univ, Dept Math & Informat Sci, Hachioji, Tokyo 1920397, Japan; [Tanaka, Hitoshi] Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan	Sawano, Y (reprint author), Tokyo Metropolitan Univ, Dept Math & Informat Sci, 1-1 Minami Ohsawa, Hachioji, Tokyo 1920397, Japan.	Takashi.Izumi2@mc4.seikyou.ne.jp; yoshihiro-sawano@celery.ocn.ne.jp; htanaka@ms.u-tokyo.ac.jp			Japan Society for the Promotion of Science [24740085, 23540187]; FMSP program at Graduate School of Mathematical Sciences, the University of Tokyo	The second author was supported financially by Grant-in-Aid for Young Scientists (B) No. 24740085, Japan Society for the Promotion of Science. Tanaka was supported by the FMSP program at Graduate School of Mathematical Sciences, the University of Tokyo, and Grant-in-Aid for Scientific Research (C) (No. 23540187), the Japan Society for the Promotion of Science. The authors are grateful to the anonymous referee for his kind suggestion, which made us aware of the difference between two different Littlewood-Paley characterizations.	Tang L, 2005, MATH NACHR, V278, P904, DOI 10.1002/mana.200310281; Morrey CB, 1938, T AM MATH SOC, V43, P126, DOI 10.2307/1989904; Adams DR, 2004, INDIANA U MATH J, V53, P1629; Sawano Y, 2007, MATH Z, V257, P871, DOI 10.1007/s00209-007-0150-3; Kalita EA, 1998, DOKL AKAD NAUK+, V361, P447; Mazzucato AL, 2003, CONTEMP MATH, V320, P279; Gogatishvili A, 2013, J MATH ANAL APPL, V397, P678, DOI 10.1016/j.jmaa.2012.08.025; ZORKO CT, 1986, P AM MATH SOC, V98, P586, DOI 10.2307/2045731; Sawano Y, 2005, ACTA MATH SIN, V21, P1535, DOI 10.1007/s10114-005-0660-z; Chiarenza F., 1987, REND MAT, V7, P273; Duoandikoetxea J., 2001, GRADUATE STUDIES MAT, V29; FEFFERMA.C, 1971, AM J MATH, V93, P107, DOI 10.2307/2373450; Grafakos L., 2004, CLASSICAL MODERN FOU; Izumi T, 2014, TOKYO J MATH, V37, P185; Komori- Furuya Y., J FUNCT SPACES APPL; Komori Y, 2003, ACTA MATH SIN, V19, P297, DOI 10.1007/s10114-002-0226-2; Liang YY, 2013, DISS MATH, P1, DOI 10.4064/dm489-0-1; Littlewood J. E., 1931, J LOND MATH SOC, V6, P230; LITTLEWOOD JE, 1936, P LOND MATH SOC, V42, P52, DOI DOI 10.1112/PLMS/S2-42.1.52; Littlewood JE, 1937, P LOND MATH SOC, V43, P105; Mizuta Y, 2013, J MATH SOC JPN, V65, P633, DOI 10.2969/jmsj/06520633; Rosenthal M., REV MAT COMPLUT, V27, P1; Sawano Y., 2009, TOKYO J MATH, V32, P471; Sawano Y., ARXIV14042688; Triebel H, 1992, THEORY FUNCTION SPAC; Triebel H, 2013, EMS TRACTS MATH, V20, P1, DOI 10.4171/123	26	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1139-1138	1988-2807		REV MAT COMPLUT	Rev. Mat. Complut.	MAY	2015	28	2					411	447		10.1007/s13163-014-0158-2		37	Mathematics, Applied; Mathematics	Mathematics	CH7NH	WOS:000354223100006		
J	Mironov, VP; Rakevich, AL; Stepanov, FA; Emel'yanova, AS; Zedgenizov, DA; Shatsky, VS; Kagi, H; Martynovich, EF				Mironov, V. P.; Rakevich, A. L.; Stepanov, F. A.; Emel'yanova, A. S.; Zedgenizov, D. A.; Shatsky, V. S.; Kagi, H.; Martynovich, E. F.			Luminescence in diamonds of the Sao Luiz placer (Brazil)	RUSSIAN GEOLOGY AND GEOPHYSICS			English	Article						diamond; defect; luminescence; laser; spectrum; microscopy	ABSORPTION; DEFECTS; AREA	Plates made of diamonds from the Sao Luiz province (Brazil) were investigated by confocal scanning luminescence microscopy. The samples have many macroinhomogeneities (cracks and inclusions), but there is a quasi-uniform distribution of luminescence centers in the bulk. At all investigated points of the crystals, the same group of centers was observed: N3, H4, 575, and a red band with a maximum at 690-700 nm. The visible nonuniformities in the distribution of luminescence over the area of the plates are determined by relatively small fluctuations in the ratio of the intensities of individual bands in the spectra. Nitrogen centers of different degrees of aggregation (H4, N3, and 575 nm, with four, three, and one nitrogen atom, respectively) coexist in these crystals. In the same zones of the samples, the distribution of blue luminescence (N3 centers) is diffuse (uniform), but the distribution of yellow-green luminescence is characterized by layering on (111). This might be a consequence of the tangential growth of octahedron faces or a result of plastic deformation of the crystals and dislocations along (111). (C) 2015, V.S. Sobolev IGM, Siberian Branch of the RAS. Published by Elsevier B.V. All rights reserved.	[Mironov, V. P.; Rakevich, A. L.; Stepanov, F. A.; Emel'yanova, A. S.; Martynovich, E. F.] Russian Acad Sci, Inst Laser Phys, Irkutsk Div, Siberian Branch, Irkutsk 664033, Russia; [Zedgenizov, D. A.; Shatsky, V. S.] Russian Acad Sci, VS Sobolev Inst Geol & Mineral, Siberian Branch, Novosibirsk 630090, Russia; [Shatsky, V. S.] Russian Acad Sci, AP Vinogradov Inst Geochem, Siberian Branch, Irkutsk 664033, Russia; [Kagi, H.] Univ Tokyo, GRC, Grad Sch Sci, Tokyo 1130033, Japan; [Shatsky, V. S.; Martynovich, E. F.] Irkutsk State Univ, Irkutsk 664003, Russia; [Zedgenizov, D. A.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Mironov, VP (reprint author), Russian Acad Sci, Inst Laser Phys, Irkutsk Div, Siberian Branch, Ul Lermontova 130a, Irkutsk 664033, Russia.	mironov2011@gmail.com	Zedgenizov, Dmitry/A-3282-2014				Shirey SB, 2013, REV MINERAL GEOCHEM, V75, P355, DOI 10.2138/rmg.2013.75.12; Kaminsky FV, 2001, CONTRIB MINERAL PETR, V140, P734; Beskrovanov V.V, 1992, ONTOGENY DIAMOND; Garanin V.K, 1990, MINERAL ZH, V12, P28; Harte B, 1999, GEOCHEM SOC SPEC PUB, V6, P125; Kesson SE, 1991, EARTH PLANET SC LETT, V111, P229; LANG AR, 1974, P ROY SOC LOND A MAT, V340, P233, DOI 10.1098/rspa.1974.0150; Lang AR, 2007, J CRYST GROWTH, V309, P170, DOI 10.1016/j.jcrysgro.2007.09.022; Martynovich E.F., 2013, IZV VUZ FIZ, V56, P227; Mironov V., 1994, ARCH MINERAL, V50, P3; Mironov V.P., 1993, FIZIKOTEKHNICHESKIE, V3, P110; Mironov VP, 2001, GEOL GEOFIZ, V42, P831; Varshavskii A.V., 1968, ABNORMAL BIREFRINGEN; Yakubova S.A., 1973, ALMAZY, P2	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1068-7971	1878-030X		RUSS GEOL GEOPHYS+	Russ. Geol. Geophys.	MAY	2015	56	5					729	736		10.1016/j.rgg.2015.04.004		8	Geosciences, Multidisciplinary	Geology	CH4JC	WOS:000353998800004		
J	Okada, S; Hasegawa, S; Suzuki, Y; Matsubara, T; Shimomura, M; Okuda, M; Ichiyama, T; Ohga, S				Okada, S.; Hasegawa, S.; Suzuki, Y.; Matsubara, T.; Shimomura, M.; Okuda, M.; Ichiyama, T.; Ohga, S.			Acute pericardial effusion representing the TNF-alpha-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease	SCANDINAVIAN JOURNAL OF RHEUMATOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; INTRAVENOUS IMMUNOGLOBULIN TREATMENT; ANIMAL-MODEL; LESIONS; INFLIXIMAB; PREDICTION; RESISTANCE; PROTEINS; ANEURYSM	Objectives: To establish the optimal inflammation control of Kawasaki disease (KD), we investigated the clinical and pathophysiological basis of pericardial effusion (PE) during the acute phase of KD. Method: Clinical and laboratory features of Japanese KD children with PE (PE group: n = 9) and without PE (non-PE group: n = 89) were studied retrospectively by using the medical records. Serum levels of soluble tumour necrosis factor receptor 1 (sTNFR1), interleukin 6 (IL-6), and vascular endothelial growth factor (VEGF) were assessed by enzyme-linked immunosorbent assays (ELISAs). Results: PE group patients had coronary artery lesions (CALs) more frequently than non-PE group patients during the acute phase of KD (33% vs. 5.6%, p = 0.024). PE patients also showed lower levels of haemoglobin (p < 0.01) and serum albumin (p < 0.01) and higher platelet counts (p = 0.013) than non-PE patients. The proportion of neurological symptoms, but not other manifestations, in the PE group was higher than in the non-PE group (p = 0.022). All patients survived free from coronary artery aneurisms. Serum levels of sTNFR1, but not the other cytokines, in the PE group were higher than those in the non-PE group (p < 0.001). The sTNFR1 levels correlated positively with C-reactive protein (CRP) (r = 0.30, p = 0.019) or total bilirubin (r = 0.40, p < 0.01) levels. Conclusions: Acute PE in KD patients indicated the severity of TNF-mediated vascular inflammation and concurrent CALs. According to the progression, these patients might need more targeted therapy of anti-inflammation for a better coronary outcome.	[Okada, S.; Hasegawa, S.; Suzuki, Y.; Shimomura, M.; Ichiyama, T.; Ohga, S.] Yamaguchi Univ, Grad Sch Med, Dept Paediat, Ube, Yamaguchi 7558505, Japan; [Matsubara, T.] Dokkyo Med Univ, Koshigaya Hosp, Dept Paediat, Koshigaya, Saitama, Japan; [Okuda, M.] Yamaguchi Univ, Grad Sch Sci & Technol, Dept Environm Safety, Ube, Yamaguchi 7558505, Japan	Okada, S (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Paediat, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	p002um@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	We thank Midori Wakabayashi (Department of Paediatrics, Yamaguchi University Graduate School of Medicine, Ube, Japan) for assistance in quality control in the cytokine assays. This work was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Ministry of Health, Labour and Welfare of Japan.	Gruys E, 2006, ACTA HISTOCHEM, V108, P229, DOI 10.1016/j.acthis.2006.03.009; Takanashi J, 2012, J NEUROL SCI, V315, P167, DOI 10.1016/j.jns.2011.11.022; Hui-Yuen JS, 2006, J IMMUNOL, V176, P6294; Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z; KAWASAKI T, 1974, PEDIATRICS, V54, P271; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; Lau AC, 2008, ARTHRITIS RHEUM, V58, P854, DOI 10.1002/art.23225; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Morceau F, 2009, MEDIAT INFLAMM, DOI 10.1155/2009/405016; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; BETTE M, 1993, J EXP MED, V178, P1531, DOI 10.1084/jem.178.5.1531; Chantepie A, 2001, ARCH PEDIATRIE, V8, P713, DOI 10.1016/S0929-693X(00)00303-1; Davies S, 2013, PEDIATR CARDIOL, V34, P1756, DOI 10.1007/s00246-013-0731-3; DUNCOMBE AS, 1988, NEW ENGL J MED, V319, P1227; GIDDING SS, 1987, AM J CARDIOL, V60, P76, DOI 10.1016/0002-9149(87)90988-X; Hamada H, 2005, PEDIATR INT, V47, P112, DOI 10.1111/j.1442-200x.2005.02015.x; Ogawa S, 2010, CIRC J, V74, P1989, DOI 10.1253/circj.CJ-10-74-0903; Johnson JN, 2013, MOSS ADAMS HEART DIS, VII, P1350; Karatolios K, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/382082; Lega JC, 2013, ARCH DIS CHILD, V98, P97, DOI 10.1136/archdischild-2011-301256; Muneuchi J, 2006, BRAIN DEV-JPN, V28, P30, DOI 10.1016/j.braindev.2005.04.003; Nishio H, 2011, ARTERIOSCL THROM VAS, V31, P1093, DOI 10.1161/ATVBAHA.110.216325; Ohno T, 2000, EUR J PEDIATR, V159, P424, DOI 10.1007/s004310051300; Oishi T, 2008, CIRC J, V72, P850, DOI 10.1253/circj.72.850; Salice P, 1998, Cardiologia, V43, P1367; Shikama N, 2000, HEART, V83, P711, DOI 10.1136/heart.83.6.711; Tremoulet AH, 2014, LANCET, V6736; Ulger Zülal, 2005, Anadolu Kardiyol Derg, V5, P234; Yasukawa K, 2002, CIRCULATION, V105, P766, DOI 10.1161/hc0602.103396	30	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0300-9742	1502-7732		SCAND J RHEUMATOL	Scand. J. Rheumatol.	MAY	2015	44	3					247	252		10.3109/03009742.2014.956140		6	Rheumatology	Rheumatology	CH9YO	WOS:000354392800012		
J	Matsuda, Z				Matsuda, Zene			Recent advance in the structural analysis of HIV-1 envelope protein	SCIENCE CHINA-LIFE SCIENCES			English	Review						HIV-1; envelope glycoprotein; CryoEM; structure; membrane fusion; vaccine	DEPENDENT EPITOPE; MEMBRANE-FUSION; GLYCOPROTEIN; TRIMERS; GP41; ANTIBODIES; INFECTION; GENE; ENV	Human immunodeficiency virus type I (HIV-1), a causative agent of AIDS, is affecting today more than 35 millions of people worldwide. The advance of anti-HIV chemotherapy has made AIDS a chronic non-fatal disease in resourceful countries. Long-awaited anti-HIV-1 vaccine is still not with us yet; however, great progress in structural analyses of the envelope protein of HIV-1 in recent years starts to shed light on rational intervention targeted at the envelope protein, as will be reviewed in this article.	[Matsuda, Zene] Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo 1088639, Japan; [Matsuda, Zene] Chinese Acad Sci, Inst Biophys, Lab Struct Virol & Immunol, Beijing 100101, Peoples R China	Matsuda, Z (reprint author), Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo 1088639, Japan.	zmatsuda@ibp.ac.cn					Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI 10.1080/10409230802058320 ; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Strebel K, 2013, CURR OPIN VIROL, V3, P692, DOI 10.1016/j.coviro.2013.08.004; Nekhai S, 2006, FUTURE MICROBIOL, V1, P417, DOI 10.2217/17460913.1.4.417; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Smyth RP, 2012, VIRUS RES, V169, P415, DOI 10.1016/j.virusres.2012.06.015; Ensoli B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00417; Kim JH, 2015, ANNU REV MED, V66, P423, DOI 10.1146/annurev-med-052912-123749; Loftin LM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S3; Mouquet H, 2014, TRENDS IMMUNOL, V35, P549, DOI 10.1016/j.it.2014.08.007; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808	26	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	MAY	2015	58	5					420	424		10.1007/s11427-015-4852-1		5	Biology	Life Sciences & Biomedicine - Other Topics	CH7WY	WOS:000354248500002		
J	Iwamoto, A; Liu, HL; Li, H				Iwamoto, Aikichi; Liu HuanLiang; Li Hong			AIDS is not over	SCIENCE CHINA-LIFE SCIENCES			English	News Item							CHINA		[Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Liu HuanLiang] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510655, Guangdong, Peoples R China; [Liu HuanLiang] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510655, Guangdong, Peoples R China; [Liu HuanLiang] Sun Yat Sen Univ, Guangdong Inst Gastroenterol, Guangzhou 510655, Guangdong, Peoples R China; [Liu HuanLiang] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510655, Guangdong, Peoples R China; [Li Hong] Yunnan Ctr Dis Control & Prevent, Kunming 650022, Peoples R China	Iwamoto, A (reprint author), Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan.	aikichi@ra3.so-net.ne.jp					Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Zhang FJ, 2009, ANN INTERN MED, V151, P241; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401	6	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	MAY	2015	58	5					517	518		10.1007/s11427-015-4840-5		2	Biology	Life Sciences & Biomedicine - Other Topics	CH7WY	WOS:000354248500017		
J	Obayashi, K; Saeki, K; Kurumatani, N				Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio			Quantitative association between nocturnal voiding frequency and objective sleep quality in the general elderly population: the HEIJO-KYO cohort	SLEEP MEDICINE			English	Article						Nocturia; Nocturnal voiding frequency; Sleep quality; Actigraphy; Melatonin	OLDER-ADULTS; FOLLOW-UP; INSOMNIA; WOMEN; PREVALENCE; DISORDERS; HEALTH; INDIVIDUALS; MORBIDITY; EXPOSURE	Objective: A significant association between nocturia and subjective sleep quality has previously been reported; however, the association between nocturia and objective sleep quality remains unclear. The purpose of this study was to evaluate the quantitative association between nocturnal voiding (NV) frequency and objective sleep quality in a large, general, elderly population. Methods: Nocturnal voiding frequency, objective sleep quality, and subjective sleep quality were measured among 1086 community-based elderly individuals using actigraphy and the Pittsburgh Sleep Quality Index (PSQI) questionnaire. Results: In multivariate analyses adjusted for potential confounding factors (such as age, gender, body mass index, medication use, renal function, bedtime, rising time, daytime physical activity, endogenous melatonin levels, and bedroom light levels), increased NV frequency, ranging from zero, one, two, three or more voids, was significantly associated with poorer objective sleep quality, including lower sleep efficiency (SE) and longer wake after sleep onset (WASO) (mean SE, 86.3, 84.8, 83.6, and 81.2%, respectively; p for trend <0.001; meanWASO: 42.6, 49.0, 53.6, and 66.1 min, respectively; p for trend <0.001), but shorter sleep onset latency (SOL) (mean SOL, 3.0, 3.0, 2.8, and 2.8 log min, respectively; p for trend = 0.018). In addition, an increased NV frequency was significantly associated with poorer subjective sleep quality in a multivariate model (mean PSQI global score, 4.60, 4.86, 5.22, and 5.48, respectively; p for trend 0.012). Conclusion: The present study revealed a quantitative association between NV frequency and objective sleep quality in the general elderly population. (C) 2015 Elsevier B.V. All rights reserved.	[Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio] Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, Nara 6348521, Japan	Obayashi, K (reprint author), Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, 840 Shijocho, Nara 6348521, Japan.	obayashi@naramed-u.ac.jp			Department of Indoor Environmental Medicine, Nara Medical University; Ministry of Education, Culture, Sports, Science, and Technology [24790774, 22790567, 25860447, 25461393]; Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Daiwa Securities Health Foundation; Japan Science and Technology Agency [AS242Z03522P]; YKK AP Inc.; Nara Prefecture Health Promotion Foundation; Special Collaboration Study from Nara Medical University	We would like to thank Sachiko Uemura, Naomi Takenaka, Keiko Nakajima and Nobuhiro Tone for their valuable support during the data collection. This work was supported by grants from the Department of Indoor Environmental Medicine, Nara Medical University; Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (24790774; 22790567; 25860447; 25461393); Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Daiwa Securities Health Foundation; the Japan Science and Technology Agency (AS242Z03522P); YKK AP Inc.; Nara Prefecture Health Promotion Foundation; and the Special Collaboration Study from Nara Medical University.	Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; Nakagawa H, 2010, J UROLOGY, V184, P1413, DOI 10.1016/j.juro.2010.05.093; Feldstein CA, 2013, J AM SOC HYPERTENS, V7, P75, DOI 10.1016/j.jash.2012.12.004; EAKER ED, 1992, AM J EPIDEMIOL, V135, P854; van den Berg JF, 2009, SLEEP, V32, P1367; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Rembratt A, 2003, BJU INT, V92, P726, DOI 10.1046/j.1464-410X.2003.04467.x; Calem M, 2012, SLEEP, V35, P377, DOI 10.5665/sleep.1700; Kamperis K, 2010, AM J PHYSIOL-RENAL, V299, pF404, DOI 10.1152/ajprenal.00126.2010; Yoshimura K, 2004, INT J UROL, V11, P282, DOI 10.1111/j.1442-2042.2004.00791.x; Dew MA, 2003, PSYCHOSOM MED, V65, P63, DOI 10.1097/01.PSY.0000039756.23250.7C; Obayashi K, 2012, J CLIN ENDOCR METAB, V97, P4166, DOI 10.1210/jc.2012-1873; Yokoyama E, 2010, SLEEP, V33, P1693; Walsh JK, 2011, SLEEP, V34, P997, DOI 10.5665/SLEEP.1150; van Kerrebroeck P, 2002, NEUROUROL URODYNAM, V21, P179, DOI 10.1002/nau.10053; Bing MH, 2006, BJU INT, V98, P599, DOI 10.1111/j.1464-410X.2006.06390.x; Asplund R, 2002, BJU INT, V90, P533, DOI 10.1046/j.1464-410X.2002.02975.x; Coyne KS, 2003, BJU INT, V92, P948, DOI 10.1046/j.1464-410X.2003.04527.x; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Gopal M, 2008, J UROLOGY, V180, P2063, DOI 10.1016/j.juro.2008.07.050; Mehra R, 2008, SLEEP, V31, P1569; Obayashi K, 2014, J UROLOGY, V191, P1816, DOI 10.1016/j.juro.2013.12.043; Obayashi K, 2014, CHRONOBIOL INT, V31, P976, DOI 10.3109/07420528.2014.937491; Parthasarathy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030969; PRINZ PN, 1990, NEW ENGL J MED, V323, P520; Sacomori C, 2014, SLEEP MED, V15, P677, DOI 10.1016/j.sleep.2014.01.017; Spira AP, 2012, J AM GERIATR SOC, V60, P1237, DOI 10.1111/j.1532-5415.2012.04044.x; Zeitzer JM, 2013, J CLIN SLEEP MED, V9, P259, DOI 10.5664/jcsm.2492	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAY	2015	16	5					577	582		10.1016/j.sleep.2015.01.021		6	Clinical Neurology	Neurosciences & Neurology	CH2YV	WOS:000353892800007		
J	Futenma, K; Asaoka, S; Takaesu, Y; Komada, Y; Ishikawa, J; Murakoshi, A; Nishida, S; Inoue, Y				Futenma, Kunihiro; Asaoka, Shoichi; Takaesu, Yoshikazu; Komada, Yoko; Ishikawa, Jun; Murakoshi, Akiko; Nishida, Shingo; Inoue, Yuichi			Impact of hypnotics use on daytime function and factors associated with usage by female shift work nurses	SLEEP MEDICINE			English	Article						Shift work; Nurse; Sleep; Hypnotic medication use; Prevalence; Japan	SLEEP; INSOMNIA; PREVALENCE; DISORDER; POPULATION; ABUSE; MEDICATION; DEPENDENCE; TOLERANCE; SCALE	Objective: We investigated quality of life (QOL) and work performance of hypnotics users, and explored the factors associated with multiple hypnotics usage in shift work nurses. Methods: We conducted a questionnaire-based, cross-sectional survey on nurses in university hospitals. We analyzed responses from 1202 nurses; 997 were female shift work nurses (82.9%), including 696 and 281 two-and three-shift workers, respectively. Results: The rate of hypnotics use was 10% (6.9% were single hypnotic users and 3.1% were multiple hypnotics users). The rate of insomnia did not differ between the single and multiple hypnotics users. However, multiple hypnotics users showed lower QOL, more severe depressive symptoms, and greater frequencies of work-related errors than those using a single hypnotic. A multiple logistic regression analysis revealed that age >= 27 years, presence of depression, eveningness chronotype, and presence of insomnia symptoms were significantly associated with hypnotics use. On the other hand, only the existence of shift work disorder (SWD) was significantly associated with usage of multiple hypnotics. Conclusions: The present study suggested that usage of multiple hypnotics is not beneficial for relieving insomnia or for keeping better QOL in shift work nurses. It would be desirable to explore the causal relationship between SWD and multiple hypnotics use in a future longitudinal study. (C) 2014 Elsevier B.V. All rights reserved.	[Futenma, Kunihiro; Takaesu, Yoshikazu; Ishikawa, Jun; Murakoshi, Akiko; Inoue, Yuichi] Tokyo Med Univ Hosp, Dept Psychiat, Shinjuku Ku, Tokyo 1600023, Japan; [Asaoka, Shoichi; Komada, Yoko; Nishida, Shingo; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Shinjuku Ku, Tokyo 1608402, Japan; [Asaoka, Shoichi] Edogawa Univ, Sleep Res Inst, Chiba 2700132, Japan; [Komada, Yoko; Nishida, Shingo; Inoue, Yuichi] Japan Somnol Ctr, Neuropsychiat Res Inst, Shinjuku Ku, Tokyo 1620851, Japan	Inoue, Y (reprint author), Tokyo Med Univ Hosp, Dept Psychiat, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	inoue@somnology.com			Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare [H25-Seishin-Ippan-010]	This study was supported by Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare (H25-Seishin-Ippan-010).	Akerstedt T, 1995, J SLEEP RES, V4, P15; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Asaoka S, 2013, CHRONOBIOL INT, V30, P628, DOI 10.3109/07420528.2012.762010; Epstein PM, 2010, AAOHN J, V58, P513, DOI 10.3928/08910162-20101116-03; Drake CL, 2004, SLEEP, V27, P1453; Schweitzer PK, 2006, SLEEP, V29, P39; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Chan JWY, 2014, SLEEP, V37, P911, DOI 10.5665/sleep.3658; HARMA M, 1993, ERGONOMICS, V36, P101, DOI 10.1080/00140139308967860; Harrington JM, 2001, OCCUP ENVIRON MED, V58, P68, DOI 10.1136/oem.58.1.68; Morgenthaler TI, 2007, SLEEP, V30, P1445; Pallesen S, 2001, SLEEP, V24, P771; Kaneita Y, 2007, SLEEP MED, V8, P723, DOI 10.1016/j.sleep.2006.10.009; Waage S, 2009, SLEEP, V32, P558; Licata SC, 2008, PHARMACOL BIOCHEM BE, V90, P74, DOI 10.1016/j.pbb.2008.01.001; Lader M, 2014, BRIT J CLIN PHARMACO, V77, P295, DOI 10.1111/j.1365-2125.2012.04418.x; Merikanto I, 2012, CHRONOBIOL INT, V29, P311, DOI 10.3109/07420528.2012.655870; GORDON NP, 1986, AM J PUBLIC HEALTH, V76, P1225, DOI 10.2105/AJPH.76.10.1225; Flo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033981; Fukuhara S, 2004, MANUAL SF 8 JAPANESE; GOLD DR, 1992, AM J PUBLIC HEALTH, V82, P1011, DOI 10.2105/AJPH.82.7.1011; Kageyama T, 2001, J Hum Ergol (Tokyo), V30, P149; Kageyama T, 1998, PSYCHIAT CLIN NEUROS, V52, P69, DOI 10.1111/j.1440-1819.1998.tb00975.x; Khan AK, 2011, GOMAL J MED SCI, V9, P28; Komada Y, 2011, PSYCHIAT CLIN NEUROS, V65, P20, DOI 10.1111/j.1440-1819.2010.02154.x; Lemmer B, 2007, PHYSIOL BEHAV, V90, P285, DOI 10.1016/j.physbeh.2006.09.006; Lugoboni F, 2014, BRIT J CLIN PHARMACO, V77, P239, DOI 10.1111/bcp.12148; Ong Jason C, 2007, J Clin Sleep Med, V3, P289; Ministry of Health Labour and Welfare, 2007, BAS SURV IND HLTH SA; Oda E, 2006, CIRC J, V70, P150, DOI 10.1253/circj.70.150; OHAYON MM, 1995, PROG NEURO-PSYCHOPH, V19, P421, DOI 10.1016/0278-5846(94)00023-B; OSTBERG O, 1973, BRIT J IND MED, V30, P341; Roehrs T, 2002, J PSYCHOSOM RES, V53, P571, DOI 10.1016/S0022-3999(02)00448-8; Schuckit MA, 2002, AM J DRUG ALCOHOL AB, V28, P73, DOI 10.1081/ADA-120001282; Takahashi T, 2003, PSYCHIAT CLIN NEUROS, V57, P303, DOI 10.1046/j.1440-1819.2003.01121.x; TORSVALL L, 1980, SCAND J WORK ENV HEA, V6, P283	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAY	2015	16	5					604	611		10.1016/j.sleep.2014.11.018		8	Clinical Neurology	Neurosciences & Neurology	CH2YV	WOS:000353892800012		
J	Kawada, T				Kawada, Tomoyuki			Sleep-onset tome by actigraphy in patients with Parkinson's disease	SLEEP MEDICINE			English	Letter							POLYSOMNOGRAPHY; PARAMETERS		[Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Blackwell T, 2008, SLEEP, V31, P283; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; Lichstein KL, 2006, SLEEP, V29, P232; Bolitho SJ, 2014, SLEEP MED, V15, P342, DOI 10.1016/j.sleep.2013.10.016; Kawada T, 2012, APPL ERGON, V43, P266, DOI 10.1016/j.apergo.2011.03.009	6	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAY	2015	16	5					668	668		10.1016/j.sleep.2015.03.001		1	Clinical Neurology	Neurosciences & Neurology	CH2YV	WOS:000353892800022		
J	Hu, ZJ; Lara, J				Hu, Zhenjiang; lara, Juan de			Guest editorial to the special section on model transformation	SOFTWARE AND SYSTEMS MODELING			English	Editorial Material									[Hu, Zhenjiang] Natl Inst Informat, Tokyo, Japan; [lara, Juan de] Univ Autonoma Madrid, Dept Comp Sci, Madrid, Spain; [lara, Juan de] Univ Autonoma Madrid, Modeling & Software Engn Res Grp, Madrid, Spain	Hu, ZJ (reprint author), Natl Inst Informat, Tokyo, Japan.	hu@nii.ac.jp; Juan.deLara@uam.es						0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1619-1366	1619-1374		SOFTW SYST MODEL	Softw. Syst. Model.	MAY	2015	14	2					533	535		10.1007/s10270-013-0388-7		3	Computer Science, Software Engineering	Computer Science	CH5SA	WOS:000354094400002		
J	Perry, NH; Pergolesi, D; Bishop, SR; Tuller, HL				Perry, Nicola H.; Pergolesi, Daniele; Bishop, Sean R.; Tuller, Harry L.			Defect chemistry and surface oxygen exchange kinetics of La-doped Sr(Ti,Fe)O3-alpha in oxygen-rich atmospheres	SOLID STATE IONICS			English	Article						Defect chemistry; Electrical conductivity; Optical absorption; Oxygen surface exchange; SrTiO3; Thin films	MIXED CONDUCTING OXIDES; STRONTIUM-TITANATE; HIGH-TEMPERATURE; SRTIO3; ABSORPTION	The mixed-ionic and electronic conductor Sr(Ti,Fe)O3-alpha, (STF) exhibits fast oxygen surface exchange kinetics, with electron concentration potentially playing a key role. The effect of La donor doping on electron concentration, Fermi level, and overall defect chemistry of STF is investigated on Sr1-yLayTi0.65Fe0.35O3-alpha (LSTF, 0 <= y <= 0.5) thin films. Defect chemical modeling, optical absorption, and electrical conductivity measurements in oxidizing conditions indicate compensation of donors by an increase in oxygen and electron concentrations, increase in Fermi level, decrease in oxygen vacancy and hole concentrations, and formation of cation vacancies (for [La] > [Fe]). The surface exchange coefficient, Measured by impedance spectroscopy, decreased with increasing donor concentration, suggesting that oxygen exchange kinetics in LSTF are limited by low oxygen vacancy and/or hole concentrations, rather than electron transfer. (C) 2014 Elsevier B.V. All rights reserved.	[Perry, Nicola H.; Bishop, Sean R.; Tuller, Harry L.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan; [Perry, Nicola H.; Bishop, Sean R.; Tuller, Harry L.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Pergolesi, Daniele] Paul Scherrer Inst, Dept Gen Energy Res, CH-5225 Villigen, Switzerland	Perry, NH (reprint author), Kyushu Univ, Int Inst Carbon Neutral Energy Res, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	perry@i2cner.kyushu-u.ac.jp	Pergolesi, Daniele/P-8813-2015	Pergolesi, Daniele/0000-0002-6231-0237	JSPS KAKENHI [25820334]; I2CNER; World Premier International Research Center Initiative (WPI), MEXT, Japan; Basic Energy Sciences, U.S. Department of Energy [DE-SC0002633]	NHP gratefully acknowledges support from JSPS KAKENHI grant number 25820334. NHP and SRB recognize partial support from I2CNER, supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan. HLT thanks the Basic Energy Sciences, U.S. Department of Energy under award DE-SC0002633 for research support. The authors would like to thank Mr. Takeshi Daio for TEM-EDS measurements of thin film composition.	GRENIER JC, 1985, J SOLID STATE CHEM, V58, P243, DOI 10.1016/0022-4596(85)90241-5; Moos R, 1997, J MATER SCI, V32, P4247, DOI 10.1023/A:1018647117607; Moos R, 1997, J AM CERAM SOC, V80, P2549; Keeble DJ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195409; Adler SB, 2004, CHEM REV, V104, P4791, DOI 10.1021/cr020724o; WASER R, 1990, SOLID STATE COMMUN, V76, P1077, DOI 10.1016/0038-1098(90)90087-R; Jung W, 2011, ADV ENERGY MATER, V1, P1184, DOI 10.1002/aenm.201100164; Kuhn M, 2013, CHEM MATER, V25, P2970, DOI 10.1021/cm400546z; Rothschild A, 2006, CHEM MATER, V18, P3651, DOI 10.1021/cm052803x; Merkle R, 2002, PHYS CHEM CHEM PHYS, V4, P4140, DOI 10.1039/b204032h; Merkle R, 2006, TOP CATAL, V38, P141, DOI 10.1007/s11244-006-0079-5; MCLACHLAN DS, 1990, J AM CERAM SOC, V73, P2187, DOI 10.1111/j.1151-2916.1990.tb07576.x; Menesklou W, 1999, SENSOR ACTUAT B-CHEM, V59, P184, DOI 10.1016/S0925-4005(99)00218-X; Bamberger CE, 1997, J AM CERAM SOC, V80, P1024; BIEGER T, 1992, SENSOR ACTUAT B-CHEM, V7, P763, DOI 10.1016/0925-4005(92)80400-R; BLAZEY KW, 1975, SOLID STATE COMMUN, V16, P589, DOI 10.1016/0038-1098(75)90431-7; Boukamp B.A., 1985, EQUIVALENT CIRCUIT W; Hagemann H.-J., 1980, THESIS AACHEN; Heilig C., 1996, THESIS U KARLSRUHE T; Jung W, 2008, J ELECTROCHEM SOC, V155, pB1194, DOI 10.1149/1.2976212; Jung W.C., 2010, THESIS MIT; Jurado JR, 1999, SOLID STATE IONICS, V118, P89, DOI 10.1016/S0167-2738(98)00471-8; Kim JJ, 2014, CHEM MATER, V26, P1374, DOI 10.1021/cm403066p; Kim JJ, 2013, SOLID STATE IONICS, V230, P2, DOI 10.1016/j.ssi.2012.06.023; Merkle R, 2001, ANGEW CHEM INT EDIT, V40, P2126, DOI 10.1002/1521-3773(20010601)40:11<2126::AID-ANIE2126>3.0.CO;2-K; Perry NH, 2013, ECS TRANSACTIONS, V57, P1719, DOI 10.1149/05701.1719ecst; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Toby B. H., 2005, Journal of Applied Crystallography, V38, DOI 10.1107/S0021889805030232; Yeoh YY, 2012, PHYS CHEM CHEM PHYS, V14, P1642, DOI 10.1039/c2cp22711h	29	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738	1872-7689		SOLID STATE IONICS	Solid State Ion.	MAY	2015	273				SI		18	24		10.1016/j.ssi.2014.09.013		7	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CH3KG	WOS:000353929000005		
J	Abuova, AU; Mastrikov, YA; Kotomin, EA; Kawazoe, Y; Inerbaev, TM; Akilbekov, AT				Abuova, A. U.; Mastrikov, Yu. A.; Kotomin, E. A.; Kawazoe, Y.; Inerbaev, T. M.; Akilbekov, A. T.			First principles modeling of Ag adsorption on the LaMnO3 (001) surfaces	SOLID STATE IONICS			English	Article						LaMnO3; Surface; Ag adsorption; Solid oxide fuel cells; Ab initio calculations	OXIDE FUEL-CELLS; ELECTROCHEMICAL PERFORMANCE; INTERMEDIATE TEMPERATURE; ELECTRONIC-STRUCTURE; OXYGEN-ADSORPTION; CATHODES; 1ST-PRINCIPLES; APPROXIMATION; CATALYSTS	Doping of oxide surfaces with Ag atoms could improve their catalytic properties, e.g. for solid oxide fuel cell and oxygen permeation membrane applications. We present results of the ab initio calculations of Ag adsorption on the LaMnO3 (LMO) (001) surfaces. The energetically most favorable adsorption sites for low coverage of Ag atoms and monolayer on both MnO2- and LaO-terminations have been determined. The electron charge transfer between Ag and substrate and interatomic distances have been analyzed. The Ag atom migration along the MnO2 surface is similar to 0.5 eV which could lead to a fast clustering of adsorbates at moderate temperatures whereas the adhesion energy of silver monolayer is relatively low which could indicate its mechanical instability. (C) 2014 Elsevier B.V. All rights reserved.	[Abuova, A. U.; Inerbaev, T. M.; Akilbekov, A. T.] LN Gumilyov Eurasian Natl Univ, Astana, Kazakhstan; [Mastrikov, Yu. A.; Kotomin, E. A.] Univ Latvia, Inst Solid State Phys, Riga, Latvia; [Kawazoe, Y.] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 980, Japan; [Kawazoe, Y.] Russian Acad Sci, Inst Thermophys, Siberian Branch, Novosibirsk 630090, Russia	Abuova, AU (reprint author), LN Gumilyov Eurasian Natl Univ, Mirzoyan Str 2, Astana, Kazakhstan.		Kotomin, Eugene/B-8070-2013	Kotomin, Eugene/0000-0002-8122-6276	EC [608524]; ESF [2013/0015/1DP/1.1.1.2.0/13/APIA/VIAA/010]; Russian Mega Grant project "New energy technologies and energy carriers" [14.B25.31.0030];  [237/2012];  [137/2013]	This study was partly supported by the EC GREEN-CC project (grant agreement 608524), the Latvian Research grant 237/2012 and the grant of Kazakhstan 137/2013. Y. M. thanks ESF project nr. 2013/0015/1DP/1.1.1.2.0/13/APIA/VIAA/010. Authors are indebted to J. Serra and R. Merkle for stimulating discussions. One of the authors (Y. K.) thanks the Russian Mega Grant project no. 14.B25.31.0030 "New energy technologies and energy carriers" for supporting the present research.	Mastrikov YA, 2010, J PHYS CHEM C, V114, P3017, DOI 10.1021/jp909401g; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Huang SG, 2011, INT J HYDROGEN ENERG, V36, P10968, DOI 10.1016/j.ijhydene.2011.05.135; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Zhou YJ, 2012, APPL SURF SCI, V258, P2602, DOI 10.1016/j.apsusc.2011.10.102; Singhal SC, 2000, SOLID STATE IONICS, V135, P305, DOI 10.1016/S0167-2738(00)00452-5; Fleig J, 2003, ANNU REV MATER RES, V33, P361, DOI 10.1146/annurev.matsci.33.022802.093258; Kuklja MM, 2013, PHYS CHEM CHEM PHYS, V15, P5443, DOI 10.1039/c3cp44363a; Kotomin EA, 2008, PHYS CHEM CHEM PHYS, V10, P4644, DOI 10.1039/b804378g; Jacobson AJ, 2010, CHEM MATER, V22, P660, DOI 10.1021/cm902640j; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Munoz D, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.085115; Henkelman G, 2006, COMP MATER SCI, V36, P354, DOI 10.1016/j.commatsci.2005.04.010; Carvajal J.R., 1998, PHYS REV B, V57, P3190; Evarestov RA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214411; Haanappel VAC, 2004, J POWER SOURCES, V130, P119, DOI 10.1016/j.jpowsour.2003.11.046; Heifets Eugene, 2011, Thermodynamics - Interaction Studies - Solids, Liquids and Gases; Huang Q., 1997, PHYS REV B, V55, P987; Kotomin EA, 2005, PHYS CHEM CHEM PHYS, V7, P2346, DOI 10.1039/b503272e; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Nicastro M., 2002, PHYS REV B, V665; Piskunov S., 2005, SURF SCI, V75, P575; Su YS, 2000, PHYS REV B, V61, P1324, DOI 10.1103/PhysRevB.61.1324; Uhlenbruck S, 2004, J SOLID STATE ELECTR, V8, P923, DOI 10.1007/s10008-004-0510-4; Wang W, 2000, APPL CATAL B-ENVIRON, V24, P219, DOI 10.1016/S0926-3373(99)00106-X; Zhou W., 2012, J MATER CHEM, V21, P15343; Zhou YJ, 2012, J POWER SOURCES, V209, P158, DOI 10.1016/j.jpowsour.2012.02.097	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738	1872-7689		SOLID STATE IONICS	Solid State Ion.	MAY	2015	273				SI		46	50		10.1016/j.ssi.2014.09.039		5	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CH3KG	WOS:000353929000010		
J	Kanazawa, Y; Xia, K; Tan, HY; Suzuki, K				Kanazawa, Yumiko; Xia, Ke; Tan, Hong-yu; Suzuki, Kojiro			Seed storage longevity of Hosta sieboldiana (Asparagaceae)	SOUTH AFRICAN JOURNAL OF BOTANY			English	Article						Hosta; Desiccation-tolerant; Seed longevity; Short-lived seeds; Sub-orthodox	BEHAVIOR	Seed storage longevity of Hosta sieboldiana (Lodd.) Engler was studied. Mature and immature seeds of H. sieboldiana were stored immediately after collection at -20 degrees C and 5 degrees C with a moisture content of about 65%. In addition, the seeds were dried to either about 10% or 5% moisture content (MC) and then stored at either -20 degrees C or 5 degrees C. Seeds of H. sieboldiana were desiccation-tolerant but short-lived, with the P50 (the time required to reduce germination to half of the maximum germination) under storage conditions ranging from 0.5 to 221.9 months and 2.3 to 56.7 months for mature and immature seeds, respectively. Seed longevity of H. sieboldiana was increased by decreasing moisture content, but the responses of the seeds to temperatures were different from typical orthodox seeds. The dry seeds of H. sieboldiana (-5% to 10% MC) lost viability more quickly at -20 degrees C than at 5 degrees C. Storage allowed immature seeds to continue some maturation, but the longevity of these seeds was generally shorter than that of the mature seeds stored under the same conditions. (C) 2015 SAAB. Published by Elsevier B.V. All rights reserved.	[Kanazawa, Yumiko; Suzuki, Kojiro] Tokyo Univ Agr, Fac Reg Environm Sci, Setagaya Ku, Tokyo 1568502, Japan; [Xia, Ke] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming 650201, Peoples R China; [Tan, Hong-yu] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA	Xia, K (reprint author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming 650201, Peoples R China.	xiakk@mail.kib.ac.cn			Ministry of Education, Culture, Sports, Science, and Technology of Japan; West Light Foundation of the Chinese Academy of Sciences; Independent Research Program of the Chinese Academy of Sciences [KSCX2-EW-J-24]	We gratefully acknowledge the anonymous reviewer whose comments significantly improved this manuscript. Financial support was provided by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, 2013-2015, to Kojiro Suzuki; the West Light Foundation of the Chinese Academy of Sciences to Ke Xia; and the Independent Research Program of the Chinese Academy of Sciences, Grant No. KSCX2-EW-J-24.	Probert RJ, 2009, ANN BOT-LONDON, V104, P57, DOI 10.1093/aob/mcp082; Maroder HL, 2000, ANN BOT-LONDON, V86, P1017, DOI 10.1006/anbo.2000.1265; SCOTT SJ, 1984, CROP SCI, V24, P1192; BONNER FT, 1990, FOREST ECOL MANAG, V35, P35, DOI 10.1016/0378-1127(90)90230-9; ELLIS RH, 1990, J EXP BOT, V41, P1167, DOI 10.1093/jxb/41.9.1167; FAO/IPGRI, 1994, GEN STAND; FUJITA N, 1976, Japanese Journal of Ecology, V26, P71; Hosmer DW, 2000, APPL LOGISTIC REGRES; R Development Core Team, 2013, R LANG ENV STAT COMP; ROBERTS EH, 1989, ANN BOT-LONDON, V63, P39; Stanwood P.C., 1984, 2 M INT BOARD PLANT; Suzuki K, 2007, SEED SCI TECHNOL, V35, P129; Walters C, 2005, SEED SCI RES, V15, P1, DOI 10.1079/SSR2004195; ZASADA JC, 1977, SEED SCI TECHNOL, V5, P509	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0254-6299	1727-9321		S AFR J BOT	S. Afr. J. Bot.	MAY	2015	98						6	9		10.1016/j.sajb.2015.01.009		4	Plant Sciences	Plant Sciences	CG9CP	WOS:000353612300002		
J	Husltu; Bao, YH; Xu, J; Qing, S; Bao, G				Husltu; Bao Yu-hai; Xu Jian; Qing Song; Bao Gang			Radiative Properties of Cirrus Clouds Based on Hexagonal and Spherical Ice Crystals Models	SPECTROSCOPY AND SPECTRAL ANALYSIS			Chinese	Article						Cirrus cloud ice crystal; Radiative transfer model; Phase function; Radiation flux	SCATTERING	Single scattering properties for spherical and hexagonal ice crystal models with different size parameters and wavelengths were employed to calculate satellite observed radiation and downward flux in ground surface using RSTAR radiative transfer model. Results indicated that simulated satellite observed radiation and ground surface downward radiant flux from different shapes of ice crystal models were different. The difference in the spectral radiation fluxes between 0. 4 and 1. 0 mu m was largest, and particle shapes affected the downward radiant flux significantly. It was verified that the proper selection of the effective ice crystal model is not only important for retrieval of the microphysical and optical parameters of the cirrus cloud, but also important for obtaining the radiant flux on the earth's surface correctly. These results are important for retrieving cloud micro-physical parameters and simulation of the ground surface downward radiant flux.	[Husltu; Bao Yu-hai; Qing Song; Bao Gang] Inner Mongolia Normal Univ, Hohhot 010022, Peoples R China; [Xu Jian] German Aerosp Ctr, D-82234 Oberpfaffenhofen, Germany; [Husltu] Tokai Univ, Tokyo 1510063, Japan	Bao, YH (reprint author), Inner Mongolia Normal Univ, Hohhot 010022, Peoples R China.	husiletuw@hotmail.com; baoyuhai@imnu.edu.cn					Yang P, 2005, APPL OPTICS, V44, P5512, DOI 10.1364/AO.44.005512; Yang P, 2013, J ATMOS SCI, V70, P330, DOI 10.1175/JAS-D-12-039.1; Sekiguchi M, 2008, J QUANT SPECTROSC RA, V109, P2779, DOI 10.1016/j.jqsrt.2008.07.013; NAKAJIMA T, 1986, J QUANT SPECTROSC RA, V35, P13, DOI 10.1016/0022-4073(86)90088-9; Li Juan, 2005, CHINESE SCI BULL, V50, P24131; LIOU KN, 1972, APPL OPTICS, V11, P667, DOI 10.1364/AO.11.000667; MACKE A, 1993, APPL OPTICS, V32, P2780, DOI 10.1364/AO.32.002780; Solomon S., 2007, PHYS SCI BASIS CONTR, P235; Yang P, 2000, J GEOPHYS RES-ATMOS, V105, P4699, DOI 10.1029/1999JD900755	9	0	0	OFFICE SPECTROSCOPY & SPECTRAL ANALYSIS	BEIJING	NO 76 COLLAGE SOUTH RD BEIJING, BEIJING 100081, PEOPLES R CHINA	1000-0593			SPECTROSC SPECT ANAL	Spectrosc. Spectr. Anal.	MAY	2015	35	5					1165	1168		10.3964/j.issn.1000-0593(2015)05-1165-04		4	Spectroscopy	Spectroscopy	CH6JM	WOS:000354142900003		
J	Morishita, Y; Matsushita, A; Maeda, T; Ueta, T; Naito, M; Shiba, K				Morishita, Y.; Matsushita, A.; Maeda, T.; Ueta, T.; Naito, M.; Shiba, K.			Rapid progressive clinical deterioration of cervical spondylotic myelopathy	SPINAL CORD			English	Article							INCREASED SIGNAL INTENSITY; STENOTIC MYELOPATHY; SPINE; LAMINOPLASTY; COMPRESSION; DIAGNOSIS; IMAGES; LEVEL	Study Design: Retrospective clinical study. Objective: To elucidate the pathophysiology of rapid progressive clinical deterioration following the onset of cervical myelopathy. Setting: Spinal Injuries Center, Fukuoka, Japan. Methods: A total of 43 cervical spondylotic myelopathy (CSM) patients were treated surgically by a senior surgeon. All patients showed intramedullary intensity changes on magnetic resonance (MR) imaging. Overall, eight patients suffered rapid progressive clinical deterioration; four of them had obvious anamnesis of minor trauma. We assessed the responsible injured segment by MR T2-weighted images. Clinical instabilities at the focal segment were evaluated using functional sagittal plain radiographs. Neurological evaluations were performed preoperatively and at 12 months postoperatively using American Spinal Injury Association (ASIA) motor scores and Japanese Orthopaedic Association (JOA) scores for cervical myelopathy. Intraoperatively, we evaluated the presence of adhesive scar tissue on the dura mater at the focal segment. Results: The responsible injured segment was C3-4 in 75% of the rapid progressive (rp)-CSM and in 28.57% of the conventional CSM subjects. One with rp-CSM showed sagittal translational segmental instability. Preoperative ASIA motor scores and JOA scores in the rp-CSM were significantly lower than those in the conventional CSM subjects. Postoperative ASIA motor scores between the subjects showed no significant differences; however, postoperative JOA scores in the rp-CSM subjects were significantly lower. Moreover, an epidural membrane was observed in 62.5% of rp-CSM and 11.4% of conventional CSM subjects. Conclusions: We hypothesized that the pathophysiology of rp-CSM might be additional cervical cord disorder following the onset of cervical myelopathy. Early decompression surgery is recommended in such patients.	[Morishita, Y.; Matsushita, A.; Maeda, T.; Ueta, T.; Shiba, K.] Spinal Injuries Ctr, Dept Orthoped Surg, Iizuka, Fukuoka 8200053, Japan; [Naito, M.] Fukuoka Univ, Dept Orthoped Surg, Fukuoka 81401, Japan	Morishita, Y (reprint author), Spinal Injuries Ctr, Dept Orthoped Surg, 550-4 Igisu, Iizuka, Fukuoka 8200053, Japan.	uchiro1968@mac.com					American College of Surgeons, 2004, ADV TRAUM LIF SUPP A, V7; ALMEFTY O, 1988, J NEUROSURG, V68, P217, DOI 10.3171/jns.1988.68.2.0217; Yukawa Y, 2008, J NEUROSURG-SPINE, V8, P524, DOI 10.3171/SPI/2008/8/6/524; Bednarik J, 2008, EUR SPINE J, V17, P421, DOI 10.1007/s00586-008-0585-1; Oshima Y, 2012, SPINE, V37, P1909, DOI 10.1097/BRS.0b013e318259a65b; Mastronardi L, 2007, J NEUROSURG-SPINE, V7, P615, DOI 10.3171/SPI-07/12/615; Tomita K, 1998, SPINE, V23, P32, DOI 10.1097/00007632-199801010-00007; Schmitt-Sody M, 2008, INT ORTHOP, V32, P511, DOI 10.1007/s00264-007-0349-2; TAKAHASHI M, 1989, RADIOLOGY, V173, P219; HIRABAYASHI K, 1983, SPINE, V8, P693, DOI 10.1097/00007632-198310000-00003; Clarke E, 1956, BRAIN, V95, P87; Kalantar SB, 2012, ORTHOPAEDIC KNOWLEDG, V4, P51; Kurokawa T, 1982, BESSATSU SEIKEI GEKA, V2, P234; Matsumoto M, 2005, J NEUROSURG-SPINE, V2, P535, DOI 10.3171/spi.2005.2.5.0535; Miyauchi A, 2012, SPINE, V37, pE1182, DOI 10.1097/BRS.0b013e31825fcfb5; Rhee JM, 2009, SPINE, V34, P890, DOI 10.1097/BRS.0b013e31819c944b; Seichi A, 2006, SPINE, V31, P1338, DOI 10.1097/01.brs.0000219475.21126.6b; WHITE AA, 1975, CLIN ORTHOP RELAT R, P85	18	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAY	2015	53	5					408	412		10.1038/sc.2014.137		5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CH6HU	WOS:000354138000015		
J	Reyes, RB; Nagai, M; Kamiya, Y; Tipdecho, T; Ninsawat, S				Reyes, R. B.; Nagai, M.; Kamiya, Y.; Tipdecho, T.; Ninsawat, S.			Effect of sea level rise in the validation of geopotential/geoid models in Metro Manila, Philippines	SURVEY REVIEW			English	Article						Geoid; Global geopotential model; Sea level rise; GOCE; LSMSA	GRAVITY-FIELD MODEL; BAY	The release of new global geopotential models (GGMs) has raised the question of whether these GGMs could now supplant the development of regional/local geoid models. For geodetic surveying purposes the importance of a geoid model fitted to the local condition will greatly help in the resolution of many vertical datum issues especially for an archipelagic country such as the Philippines. Since the geoid as a vertical reference surface is used to convert ellipsoidal heights acquired through GNSS survey to orthometric heights, it is vital that this should at least match the heights derived through geodetic levelling within the allowed accuracy. However, the issue of mean sea level (MSL) as vertical reference for geodetic levelling has introduced another issue of concern especially when it is exhibiting accelerated sea level rise (ASLR). The results of the validation and comparison of recent GGMs showed that EGM 2008 and the 2012 released EIGEN-6C2 both classified as combined type model have RMS around 14 and 13 cm respectively in the study area. These results were achieved when ASLR was considered in the validation. The local geoid model (LGM) developed using least squares modification of Stokes formula with additive corrections (LSMSA) approach has RMS around 11 cm using an integration cap of 3 degrees from the limit of study area. The LGM validated the level of the combined type GGMs in reference to the local vertical datum in Manila Bay. Based on the result of this study, the ASLR contributed much to the departure of the latest MSL from the geoid.	[Reyes, R. B.; Nagai, M.; Tipdecho, T.; Ninsawat, S.] Asian Inst Technol, Bangkok, Thailand; [Reyes, R. B.] Natl Mapping & Resource Informat Author NAMRIA, Manila, Philippines; [Kamiya, Y.] Japan Aerosp Explorat Agcy JAXA, Tokyo, Japan	Reyes, RB (reprint author), Asian Inst Technol, Bangkok, Thailand.	rbr_lally@yahoo.com			Department of Science and Technology (DOST); National Mapping and Resource Information Authority (NAMRIA) of the Philippines	The research was sponsored by the Department of Science and Technology (DOST) and National Mapping and Resource Information Authority (NAMRIA) of the Philippines. Thank you to Professor Sjoberg and Dr R. Kiahmer for sharing the theory and application of the LSMSA method and to Prof. C. C. Tscherning and R. Forsberg for the GRAVSOFT software.	Agren J., 2008, INTEGRATING GENERATI; Sjoberg LE, 2003, J GEODESY, V77, P459, DOI 10.1007/s00190-003-0346-1; Sjoberg LE, 2000, J GEODESY, V74, P255, DOI 10.1007/s001900050284; Bruinsma SL, 2013, GEOPHYS RES LETT, V40, P3607, DOI 10.1002/grl.50716; Rodolfo KS, 2006, DISASTERS, V30, P118, DOI 10.1111/j.1467-9523.2006.00310.x; Berry PAM, 2010, IAG SYMP, V135, P231, DOI 10.1007/978-3-642-10634-7_30; Bruinsma S. L., 2010, ESA LIV PLAN S 2010; Deguchi T., 2011, FIG WORK WEEK 2011 B; Farahani HH, 2013, J GEODESY, V87, P843, DOI 10.1007/s00190-013-0650-3; Farr T. G., 2007, REV GEOPHYS, V45, DOI http://dx.doi.org/10.1029/2005RG000183; Forsberg R., 2008, OVERVIEW MANUAL GRAV; Forste C., 2012, AGU FALL M 3 7 DEC 2; Hofmann-Wellenhof B., 2006, PHYS GEODESY; Johnston K, 2003, USING ARCGIS GEOSTAT; Kearsley A. W. H, 1991, EVALUATION GEOID PHI; KEARSLEY AHW, 1988, J GEOPHYS RES-SOLID, V93, P6559, DOI 10.1029/JB093iB06p06559; Kiahmer R, 2006, PRECISE GRAVIMETRIC; Kiamehr R, 2006, J GEODESY, V79, P602, DOI 10.1007/s00190-005-0009-5; Mayer-Gurr T., 2012, GRAV GEOID HEI UNPUB; Meneses S. F., 2009, P 30 AS C REM SENS A; NASA, 2011, ADV SPAC THERM EM RE; Paul M, 1973, B GEOD, V110, P413, DOI 10.1007/BF02521951; Pavlis N. K., 2008, GEN ASSEMBLY EUROPEA; Perez RT, 1996, WATER AIR SOIL POLL, V92, P137; Rummel R., 2012, GOCE HIGH LEVEL PROC; Schall J, 2014, J GEODESY, V88, P403, DOI 10.1007/s00190-014-0691-2; Sjoberg L. E., 1984, MANUSCRIPTA GEODAETI, V9, P209; Sjoberg L. E., 1991, Manuscripta Geodaetica, V16; Sjoberg LE, 2005, J GEODESY, V78, P645, DOI 10.1007/s00190-004-0430-1; Vanicek P., 1994, GEOID ITS GEOPHYS IN	30	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0039-6265	1752-2706		SURV REV	Surv. Rev.	MAY	2015	47	342					211	219		10.1179/1752270614Y.0000000102		9	Engineering, Civil; Geosciences, Multidisciplinary; Remote Sensing	Engineering; Geology; Remote Sensing	CH8PB	WOS:000354297200008		
J	Yanagisawa, A; Sawae, T; Yamafuji, S; Heima, T; Yoshida, K				Yanagisawa, Akira; Sawae, Toshiki; Yamafuji, Seiya; Heima, Toshihiko; Yoshida, Kazuhiro			Reactive Barium-Promoted Benzylation of Diaryl Azo Compounds	SYNLETT			English	Article						azo compounds; barium; benzylation; benzylic amines; hydrazines	BARBIER-TYPE ALKYLATION; CARBONYL-COMPOUNDS; BUTENAFINE HYDROCHLORIDE; METALLIC STRONTIUM; ALZHEIMERS-DISEASE; REAGENTS; HALIDES; ALLYLBARIUM; ALLYLATION; DONEPEZIL	The Barbier-type benzylation of azo compounds with benzylic chlorides was achieved by using reactive barium as the promoter. Various benzylic hydrazines were synthesized from the corresponding benzylic chlorides. The thus-obtained benzylic hydrazines were further efficiently converted into benzylic amines by reductive N-N bond cleavage.	[Yanagisawa, Akira; Sawae, Toshiki; Yamafuji, Seiya; Heima, Toshihiko; Yoshida, Kazuhiro] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan	Yanagisawa, A (reprint author), Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan.	ayanagi@faculty.chiba-u.jp	Yoshida, Kazuhiro/B-7272-2011		Iodine Research Project in Chiba University	We gratefully acknowledge the financial support from the Iodine Research Project in Chiba University headed by Professor Hideo Togo.	ARIKA T, 1990, ANTIMICROB AGENTS CH, V34, P2250; Zhang Y, 2011, ORG BIOMOL CHEM, V9, P4977, DOI 10.1039/c1ob05328k; Shintani EY, 1997, AM J HEALTH-SYST PH, V54, P2805; Sapountzis I, 2004, ANGEW CHEM INT EDIT, V43, P897, DOI 10.1002/anie.200353241; Yanagisawa A, 2013, SYNLETT, V24, P635, DOI 10.1055/s-0032-1318306; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Ding H, 2004, ORG LETT, V6, P637, DOI 10.1021/ol036480r; Friestad GK, 2001, ANGEW CHEM INT EDIT, V40, P4491, DOI 10.1002/1521-3773(20011203)40:23<4491::AID-ANIE4491>3.0.CO;2-8; Gilchrist T. L., 1991, COMPREHENSIVE ORGANI, V8, P388; Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601; Miyoshi N, 2004, B CHEM SOC JPN, V77, P341, DOI 10.1246/bcsj.77.341; Miyoshi N, 2012, CHEM LETT, V41, P35, DOI 10.1246/cl.2012.35; Miyoshi N, 2005, CHEM LETT, V34, P760, DOI 10.1246/cl.2005.760; Miyoshi N, 2006, J SYN ORG CHEM JPN, V64, P845; Miyoshi N., 2004, SCI SYNTHESIS, V7, P685; Nemeth EF, 1996, PEDIATR NEPHROL, V10, P275; Rieke R. D., 1996, ACTIVE METALS PREPAR, P1; Rieke RD, 1997, TETRAHEDRON, V53, P1925, DOI 10.1016/S0040-4020(96)01097-6; SELL MS, 1995, SYNTHETIC COMMUN, V25, P4107, DOI 10.1080/00397919508011489; MAEDA T, 1991, YAKUGAKU ZASSHI, V111, P126; Yanagisawa A., 2004, MAIN GROUP METALS OR, V1, P175; Yanagisawa A, 2010, SYNLETT, P1515, DOI 10.1055/s-0029-1219944; Yanagisawa A., 2004, SCI SYNTHESIS, V7, P695; YANAGISAWA A, 1991, J AM CHEM SOC, V113, P8955, DOI 10.1021/ja00023a058; YANAGISAWA A, 1994, J AM CHEM SOC, V116, P6130, DOI 10.1021/ja00093a010; Yanagisawa A., 1996, ACTIVE METALS PREPAR, P61	26	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	MAY	2015	26	8					1073	1076		10.1055/s-0034-1380380		4	Chemistry, Organic	Chemistry	CH3GX	WOS:000353918600013		
J	Ozaki, T; Kobayashi, Y				Ozaki, Takuri; Kobayashi, Yuichi			Concise Synthesis of (-)-Axenol by Using Stereocontrolled Allylic Substitution	SYNLETT			English	Article						drug discovery; allylic substitution; quaternary carbon; copper reagent; ring-closing metathesis	ALPHA,BETA-UNSATURATED CARBOXYLIC ESTERS; CLAISEN REARRANGEMENT; ANTIMALARIAL ACTIVITY; SPIROCYCLIC COMPOUNDS; METATHESIS CATALYSTS; SESQUITERPENES; (-)-GLEENOL; SPONGE; DERIVATIVES; EFFICIENT	Synthesis of (-)-axenol was achieved stereoselectively through allylic substitution to form the quaternary carbon followed by ring-closing metathesis. The key allylic picolinate was synthesized from natural menthol.	[Ozaki, Takuri; Kobayashi, Yuichi] Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Kobayashi, Y (reprint author), Tokyo Inst Technol, Dept Bioengn, Midori Ku, Box B-52,Nagatsuta Cho 4259, Yokohama, Kanagawa 2268501, Japan.	ykobayas@bio.titech.ac.jp			Ministry of Education, Science, Sports, and Culture, Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture, Japan.	Wright AD, 2001, J MED CHEM, V44, P873, DOI 10.1021/jm0010724; Scholl M, 1999, ORG LETT, V1, P953, DOI 10.1021/ol990909q; BARROW CJ, 1988, AUST J CHEM, V41, P1755; Kawashima H, 2014, CHEM-EUR J, V20, P272, DOI 10.1002/chem.201303538; Weyerstahl P, 1998, FLAVOUR FRAG J, V13, P295, DOI 10.1002/(SICI)1099-1026(1998090)13:5<295::AID-FFJ751>3.0.CO;2-I; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Oesterreich K, 2002, TETRAHEDRON, V58, P4331, DOI 10.1016/S0040-4020(02)00336-8; Karimi B, 2000, J ORG CHEM, V65, P7228, DOI 10.1021/jo005519s; Nakazaki A, 2007, CHEM PHARM BULL, V55, P1606, DOI 10.1248/cpb.55.1606; Hirota H, 1996, TETRAHEDRON, V52, P2359, DOI 10.1016/0040-4020(95)01079-3; Kiguchi T, 2000, CHEM PHARM BULL, V48, P1536; BLANCHETTE MA, 1984, TETRAHEDRON LETT, V25, P2183, DOI 10.1016/S0040-4039(01)80205-7; BARRERO AF, 1991, PHYTOCHEMISTRY, V30, P1551, DOI 10.1016/0031-9422(91)84207-9; Blay G, 2005, TETRAHEDRON, V61, P10853, DOI 10.1016/j.tet.2005.09.025; Bozan B, 1999, PLANTA MED, V65, P781, DOI 10.1055/s-2006-960872; CAINE D, 1978, J AM CHEM SOC, V100, P8030, DOI 10.1021/ja00493a054; Fujioka H, 2003, J SYN ORG CHEM JPN, V61, P133; Kaneko Y, 2010, CHEM COMMUN, V46, P5482, DOI 10.1039/c0cc00653j; Nakazaki A, 2012, SYNLETT, P1427, DOI 10.1055/s-0031-1290982; KURVYAKOV P I, 1979, Chemistry of Natural Compounds (English Translation of Khimiya Prirodnykh Soedinenii), V15, P138, DOI 10.1007/BF00570782; Nakazaki A, 2008, CHEM LETT, V37, P770, DOI 10.1246/cl.2008.770; Oesterreich K, 2002, SYNLETT, P1712; Ohira S, 1998, CHEM LETT, P739, DOI 10.1246/cl.1998.739; ANGERHOFER CK, 1992, J NAT PROD, V55, P1787, DOI 10.1021/np50090a014; Rosa S. D., 1994, PHYTOCHEMISTRY, V37, P1327; SHIMOJI K, 1974, J AM CHEM SOC, V96, P1620, DOI 10.1021/ja00812a071; TAGUCHI H, 1974, B CHEM SOC JPN, V47, P2529, DOI 10.1246/bcsj.47.2529; Tamura K, 2009, SYNLETT, P2449, DOI 10.1055/s-0029-1217826; UNDERINER TL, 1989, J ORG CHEM, V54, P2369, DOI 10.1021/jo00271a024	29	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	MAY	2015	26	8					1085	1088		10.1055/s-0034-1380273		4	Chemistry, Organic	Chemistry	CH3GX	WOS:000353918600016		
J	Fujita, K; Sato, J; Yasuda, H				Fujita, Ken-ichi; Sato, Junichi; Yasuda, Hiroyuki			Tautomerization of 5-Alkylidene-2-Oxazolidinone to 2-Oxazolone by Use of an N-Heterocyclic Carbene Catalyst	SYNLETT			English	Article						carbenes; catalysis; 5-alkylidene-2-oxazolidinone; tautomerization; 2-oxazolone	CARBON-DIOXIDE; CARBOXYLATIVE CYCLIZATION; PROPARGYLIC AMINES; OXAZOLIDINONES; OXAZOLONES; COMPLEXES; EFFICIENT; ORGANOCATALYSTS; DERIVATIVES; CO2	By employing an N-heterocyclic carbene as a catalyst, the tautomerization of 5-alkylidene-2-oxazolidinone proceeded to afford the corresponding 2-oxazolone. Among N-heterocyclic carbenes, 1,3-di-tert-butylimidazol-2-ylidene was the most effective catalyst for the tautomerization of 5-alkylidene-2-oxazolidinone.	[Fujita, Ken-ichi; Sato, Junichi; Yasuda, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Tsukuba Cent 5, Tsukuba, Ibaraki 3058565, Japan	Fujita, K (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba Cent 5, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	k.fujita@aist.go.jp					Enders D, 2007, CHEM REV, V107, P5606, DOI 10.1021/cr068372z; Yoshida S, 2009, CHEM LETT, V38, P786, DOI 10.1246/cl.2009.786; Istrate FM, 2008, ORG LETT, V10, P925, DOI 10.1021/ol703077g; Fujita K, 2014, TETRAHEDRON LETT, V55, P3013, DOI 10.1016/j.tetlet.2014.03.074; Nelson DJ, 2013, CHEM SOC REV, V42, P6723, DOI 10.1039/c3cs60146c; Kikuchi S, 2011, B CHEM SOC JPN, V84, P698, DOI 10.1246/bcsj.20110078; Yoshida M, 2012, CHEM-EUR J, V18, P15578, DOI 10.1002/chem.201203366; Kuhl O, 2007, CHEM SOC REV, V36, P592, DOI 10.1039/b603765h; de Fremont P, 2009, COORDIN CHEM REV, V253, P862, DOI 10.1016/j.ccr.2008.05.018; Seebach D, 1997, TETRAHEDRON, V53, P7539, DOI 10.1016/S0040-4020(97)00456-0; Hase S, 2013, ORGANOMETALLICS, V32, P5285, DOI 10.1021/om400949m; Chai DI, 2011, ORG LETT, V13, P106, DOI 10.1021/ol102634c; Bugaut X, 2012, CHEM SOC REV, V41, P3511, DOI 10.1039/c2cs15333e; Crudden CM, 2004, COORDIN CHEM REV, V248, P2247, DOI 10.1016/j.ccr.2004.05.013; Fevre M, 2013, CHEM SOC REV, V42, P2142, DOI 10.1039/c2cs35383k; Ranganath KVS, 2013, CATAL SCI TECHNOL, V3, P2161, DOI 10.1039/c3cy00118k; Marion N, 2007, ANGEW CHEM INT EDIT, V46, P2988, DOI 10.1002/anie.200603380; Bala S., 2011, INT J CHEMTECH RES, V3, P1102; Hashmi ASK, 2007, SYNLETT, P1763, DOI 10.1055/s-2007-982562; Jiang HF, 2008, SYNTHESIS-STUTTGART, P763, DOI 10.1055/s-2008-1032166; KUNIEDA T, 1982, J ORG CHEM, V47, P4291, DOI 10.1021/jo00143a024; LENZ GR, 1988, J ORG CHEM, V53, P1176, DOI 10.1021/jo00241a011; Makino K, 2001, TETRAHEDRON-ASYMMETR, V12, P1757, DOI 10.1016/S0957-4166(01)00306-8; Matsunaga H, 2005, TETRAHEDRON, V61, P8073, DOI 10.1016/j.tet.2005.05.076; Kayaki Y, 2006, GREEN CHEM, V8, P1019, DOI 10.1039/b603700c; Yamashita M, 2005, TETRAHEDRON LETT, V46, P5495, DOI 10.1016/j.tetlet.2005.06.061	26	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	MAY	2015	26	8					1106	1110		10.1055/s-0034-1380274		5	Chemistry, Organic	Chemistry	CH3GX	WOS:000353918600021		
J	Tsubo, T; Yamada, T				Tsubo, Tatsuyuki; Yamada, Tohru			Enantioselective Michael Addition Catalyzed by an Optically Active 1-Chlorovinyl Cobalt(III) Complex	SYNLETT			English	Article						cobalt catalysis; enantioselective reaction; enone; malonate; Michael addition	ORGANOCATALYTIC CONJUGATE ADDITION; TRANSITION-METAL-COMPLEXES; LINKED-BINOL COMPLEX; BOROHYDRIDE REDUCTION; ALPHA,BETA-UNSATURATED ENONES; ASYMMETRIC CATALYST; HETEROBIMETALLIC CATALYSTS; KETONES; LIGANDS; INTERMEDIATE	The optically active 1-chlorovinyl cobalt(III) complex was prepared from the ketoiminatocobalt(II) complex upon treatment with sodium borohydride in the presence of 1,1,1-trichloroethane. The obtained complex was found to catalyze the enantioselective Michael addition of various malonates on cyclic or acyclic enones to afford the corresponding adduct. In this reaction, the use of sodium alkoxide as a base with 1-chlorovinyl cobalt(III) complex catalyst was crucial to improving both the reactivity and enantioselectivity.	[Tsubo, Tatsuyuki; Yamada, Tohru] Keio Univ, Dept Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Yamada, T (reprint author), Keio Univ, Dept Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.	yamada@chem.keio.ac.jp					Adachi S, 2009, ORG LETT, V11, P5206, DOI 10.1021/ol9021436; Watanabe M, 2003, J AM CHEM SOC, V125, P7508, DOI 10.1021/ja035435b; SASAI H, 1995, J AM CHEM SOC, V117, P6194, DOI 10.1021/ja00128a005; Belokon' YN, 2009, TETRAHEDRON-ASYMMETR, V20, P1746, DOI 10.1016/j.tetasy.2009.06.006; Guo RW, 2005, ORG LETT, V7, P1757, DOI 10.1021/ol050336j; Annamalai V, 2003, J ORG CHEM, V68, P1973, DOI 10.1021/jo025993t; Luo CH, 2012, ORG BIOMOL CHEM, V10, P4116, DOI 10.1039/c2ob07191f; End N, 1998, CHEM-EUR J, V4, P818, DOI 10.1002/(SICI)1521-3765(19980515)4:5<818::AID-CHEM818>3.0.CO;2-#; Mao ZF, 2010, J ORG CHEM, V75, P7428, DOI 10.1021/jo101188m; DiMauro EF, 2001, ORG LETT, V3, P1641, DOI 10.1021/ol0158213; SASAI H, 1994, J AM CHEM SOC, V116, P1571, DOI 10.1021/ja00083a053; Wang J, 2006, J AM CHEM SOC, V128, P12652, DOI 10.1021/ja065187u; Arai T, 1996, CHEM-EUR J, V2, P1368, DOI 10.1002/chem.19960021107; Halland N, 2003, ANGEW CHEM INT EDIT, V42, P661, DOI 10.1002/anie.200390182; Arai T, 1996, ANGEW CHEM INT EDIT, V35, P104, DOI 10.1002/anie.199601041; Li PF, 2009, ORG LETT, V11, P753, DOI 10.1021/ol802892h; Chen C, 2006, TETRAHEDRON-ASYMMETR, V17, P2761, DOI 10.1016/j.tetasy.2006.10.006; Clapham SE, 2006, ORGANOMETALLICS, V25, P5477, DOI 10.1021/om060661q; DiMauro EF, 2002, ORGANOMETALLICS, V21, P1454, DOI 10.1021/om010571f; Dub PA, 2012, TETRAHEDRON LETT, V53, P3452, DOI 10.1016/j.tetlet.2012.04.100; Iwakura I, 2006, CHEM-ASIAN J, V1, P656, DOI 10.1002/asia.200600150; Jha SC, 2001, TETRAHEDRON-ASYMMETR, V12, P2463, DOI 10.1016/S0957-4166(01)00433-5; Jia Y.-X., 2013, SYNLETT, V25, P457; KAWARA A, 1994, TETRAHEDRON LETT, V35, P8805, DOI 10.1016/S0040-4039(00)78503-0; Kim YS, 2000, J AM CHEM SOC, V122, P6506, DOI 10.1021/ja001036u; Knudsen KR, 2006, CHEM COMMUN, P66, DOI 10.1039/b514636d; Kobayashi T, 2014, TETRAHEDRON LETT, V55, P2818, DOI 10.1016/j.tetlet.2014.03.062; Kokura A, 2007, CHEM LETT, V36, P26, DOI 10.1246/cl.2007.26; Kumaraswamy G, 2001, TETRAHEDRON LETT, V42, P8515, DOI 10.1016/S0040-4039(01)01736-1; Mahoney SJ, 2009, ORG LETT, V11, P5346, DOI 10.1021/ol902216y; Majima K, 2003, J AM CHEM SOC, V125, P15837, DOI 10.1021/ja037635t; Mase N, 2010, SYNLETT, P2340, DOI 10.1055/s-0030-1258533; Matsunaga S, 2000, TETRAHEDRON LETT, V41, P8473, DOI 10.1016/S0040-4039(00)01486-6; NAGATA T, 1995, ANGEW CHEM INT EDIT, V34, P2145, DOI 10.1002/anie.199521451; Narasimhan S, 2001, TETRAHEDRON LETT, V42, P719, DOI 10.1016/S0040-4039(00)01986-9; Procopio A, 2010, SYNLETT, P1849, DOI 10.1055/s-0030-1258126; Takita R, 2002, TETRAHEDRON LETT, V43, P4661, DOI 10.1016/S0040-4039(02)00882-1; Tsubo T, 2012, CHEM LETT, V41, P780, DOI 10.1246/cl.2012.780; Tsubo T, 2012, CHEM LETT, V41, P783, DOI 10.1246/cl.2012.783; Tsubo T, 2013, B CHEM SOC JPN, V86, P983, DOI 10.1246/bcsj.20130085; Velmathi S, 2003, TETRAHEDRON-ASYMMETR, V14, P113, DOI 10.1016/S0957-4166(02)00737-1; Wascholowski V, 2008, CHEM-EUR J, V14, P6155, DOI 10.1002/chem.200800673; Yamada T, 2003, CHEM-EUR J, V9, P4485, DOI 10.1002/chem.200304794; Yang YQ, 2008, CHEM-EUR J, V14, P10888, DOI 10.1002/chem.200801749; Zhang ZL, 2014, TETRAHEDRON LETT, V55, P3797, DOI 10.1016/j.tetlet.2014.05.067	45	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	MAY	2015	26	8					1111	1115		10.1055/s-0034-1380265		5	Chemistry, Organic	Chemistry	CH3GX	WOS:000353918600022		
J	Nakazaki, A; Miyagawa, K; Nishikawa, T				Nakazaki, Atsuo; Miyagawa, Keitaro; Nishikawa, Toshio			Diastereoselective Synthesis of 3,3-Disubstituted Oxindoles from N-Aryl-3-Chlorooxindoles Bearing C-N Axial Chirality via Nucleophilic Substitution	SYNLETT			English	Article						3; 3-disubstituted oxindole; C-N axial chirality; ortho-azaxylylene	CATALYTIC ASYMMETRIC-SYNTHESIS; CONCISE TOTAL-SYNTHESIS; CLAISEN REARRANGEMENT; ENANTIOSELECTIVE SYNTHESIS; NATURAL-PRODUCTS; STEREOSELECTIVE-SYNTHESIS; EFFICIENT SYNTHESIS; ALKALOIDS; SPIROOXINDOLES; CONSTRUCTION	Diastereoselective synthesis of 3,3-disubstituted oxindoles was examined using racemic N-aryl-3-chlorooxindoles bearing C-N axial chirality. The reaction involved the nucleophilic substitution of 3-chlorooxindoles via an ortho-azaxylylene intermediate in the presence of AgBF4 and MS 4 angstrom. High diastereoselectivities (up to >95:<5) were achieved in the formation of 3-alkyl-3-aryloxindole derivatives when electron-rich arenes were used.	[Nakazaki, Atsuo; Miyagawa, Keitaro; Nishikawa, Toshio] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nakazaki, A (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	nakazaki@agr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23780115, 25450151]	Financial support for this research by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, No. 23780115 and 25450151) is gratefully acknowledged.	Lesma G, 2009, J ORG CHEM, V74, P4537, DOI 10.1021/jo900623c; KISHIKAWA K, 1994, CHEM LETT, P1605, DOI 10.1246/cl.1994.1605; Sacchetti A, 2011, ORG BIOMOL CHEM, V9, P5515, DOI 10.1039/c1ob05532a; MARSDEN SP, 1994, J AM CHEM SOC, V116, P11143, DOI 10.1021/ja00103a034; Miyamoto H, 2007, TETRAHEDRON LETT, V48, P1805, DOI 10.1016/j.tetlet.2007.01.002; Shirakawa S, 2012, J AM CHEM SOC, V134, P916, DOI 10.1021/ja211069f; Piemontesi C, 2013, ORG BIOMOL CHEM, V11, P1533, DOI 10.1039/c2ob27196f; Galliford CV, 2007, ANGEW CHEM INT EDIT, V46, P8748, DOI 10.1002/anie.200701342; Miyamoto H, 2013, TETRAHEDRON, V69, P9481, DOI 10.1016/j.tet.2013.08.057; Kitagawa O, 2005, J AM CHEM SOC, V127, P3676, DOI 10.1021/ja042216x; Bennett DJ, 2004, TETRAHEDRON, V60, P4491, DOI 10.1016/j.tet.2004.01.100; Dalpozzo R, 2012, CHEM SOC REV, V41, P7247, DOI 10.1039/c2cs35100e; Palmisano G, 1996, TETRAHEDRON-ASYMMETR, V7, P1, DOI 10.1016/0957-4166(95)00406-8; Zhou F, 2010, ADV SYNTH CATAL, V352, P1381, DOI 10.1002/adsc.201000161; Hughes AD, 1996, TETRAHEDRON LETT, V37, P7607, DOI 10.1016/0040-4039(96)01673-5; CURRAN DP, 1994, J AM CHEM SOC, V116, P3131, DOI 10.1021/ja00086a056; Xie WQ, 2013, ANGEW CHEM INT EDIT, V52, P12924, DOI 10.1002/anie.201306774; Kim J, 2011, J AM CHEM SOC, V133, P14940, DOI 10.1021/ja206743v; Boyer N, 2012, CHEM SCI, V3, P1798, DOI 10.1039/c2sc20270k; Cheng DJ, 2014, ACS CATAL, V4, P743, DOI 10.1021/cs401172r; Vine KL, 2009, ANTI-CANCER AGENT ME, V9, P397; Fuchs JR, 2005, ORG LETT, V7, P677, DOI 10.1021/ol047532v; Miyamoto H, 2006, ANGEW CHEM INT EDIT, V45, P2274, DOI 10.1002/anie.200504247; Kitagawa O, 1997, TETRAHEDRON LETT, V38, P4447, DOI 10.1016/S0040-4039(97)00928-3; Ma S, 2009, ANGEW CHEM INT EDIT, V48, P8037, DOI 10.1002/anie.200902943; Ball-Jones NR, 2012, ORG BIOMOL CHEM, V10, P5165, DOI 10.1039/c2ob25184a; Nakazaki A, 2012, TETRAHEDRON LETT, V53, P7131, DOI 10.1016/j.tetlet.2012.10.092; Wang Y, 2012, ORG BIOMOL CHEM, V10, P2793, DOI 10.1039/c2ob00014h; Badillo JJ, 2010, CURR OPIN DRUG DISC, V13, P758; Tayu M, 2014, ORG LETT, V16, P3613, DOI 10.1021/ol5012373; Trost BM, 2011, J AM CHEM SOC, V133, P20611, DOI 10.1021/ja209244m; Dounay AB, 2003, J AM CHEM SOC, V125, P6261, DOI 10.1021/ja034525d; Beattie NJ, 2010, AUST J CHEM, V63, P445, DOI 10.1071/CH09479; Grant CD, 2009, ORG LETT, V11, P4485, DOI 10.1021/ol9018562; Hinman R. L., 1964, ORG CHEM, V29, P2431; Klein JEMN, 2011, EUR J ORG CHEM, P6821, DOI 10.1002/ejoc.201100836; Nakazaki A, 2012, SYNLETT, P1427, DOI 10.1055/s-0031-1290982; Hirano T, 2009, HETEROCYCLES, V79, P805, DOI 10.3987/COM-08-S(D)49; Marti C, 2003, EUR J ORG CHEM, P2209, DOI 10.1002/ejoc.200300050; Nakazaki A, 2008, J SYN ORG CHEM JPN, V66, P124; Shen K, 2012, CHEM SCI, V3, P327, DOI 10.1039/c1sc00544h; Takahashi I, 2014, ORG PREP PROCED INT, V46, P1, DOI 10.1080/00304948.2014.866467; Trost BM, 2009, SYNTHESIS-STUTTGART, P3003, DOI 10.1055/s-0029-1216975	43	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	MAY	2015	26	8					1116	1120		10.1055/s-0034-1380266		5	Chemistry, Organic	Chemistry	CH3GX	WOS:000353918600023		
J	Seki, M				Seki, Masahiko			Studies on the Cocatalyst in Ruthenium- Catalyzed C-H Arylation	SYNTHESIS-STUTTGART			English	Article						C-H activation; direct arylation; ruthenium; BrOnsted acids; biaryls; heterocycles	II RECEPTOR BLOCKERS; CARBON-HYDROGEN BONDS; PRACTICAL SYNTHESIS; ACTIVATION; SYSTEM	The performance of three types of BrOnsted acid potassium salts, potassium carboxylates, potassium phosphates, and potassium sulfonates, has been tested as the cocatalyst in ruthenium-catalyzed C-H arylation. Among them, dipotassium glutarate, potassium bis(2-ethylhexyl) phosphate, and potassium 2,4,6-trimethylbenzenesulfonate provided higher activity. Potassium 2,4,6-trimethylbenzenesulfonate was the most active even for less reactive substrates, such as electron-deficient azoles and sterically demanding aryl bromides.	API Corp, Healthcare Business Div 2, Proc R&D Dept, Chiyoda Ku, Tokyo 1010047, Japan	Seki, M (reprint author), API Corp, Healthcare Business Div 2, Proc R&D Dept, Chiyoda Ku, Kaiteki Bldg,1-13-4 Uchikanda, Tokyo 1010047, Japan.	seki.masahiko@mm.api-corp.co.jp					Anderson N. G., 2000, PRACTICAL PROCESS RE; [Anonymous], 2007, GREEN CHEM, DOI DOI 10.1039/B713736M; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Pozgan F, 2009, ADV SYNTH CATAL, V351, P1737, DOI 10.1002/adsc.200900350; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Ackermann L, 2011, ORG LETT, V13, P3332, DOI 10.1021/ol2010648; Negishi E, 2003, CHEM REV, V103, P1979, DOI 10.1021/cr020377i; Hatano M, 2008, J AM CHEM SOC, V130, P16858, DOI 10.1021/ja806875c; Arockiam P, 2009, GREEN CHEM, V11, P1871, DOI 10.1039/b913115a; Matheron ME, 2004, PLANT DIS, V88, P665, DOI 10.1094/PDIS.2004.88.6.665; Honjo T, 2012, ANGEW CHEM INT EDIT, V51, P9684, DOI 10.1002/anie.201205383; Seki M, 2011, J ORG CHEM, V76, P10198, DOI 10.1021/jo202041e; Ouellet SG, 2011, J ORG CHEM, V76, P1436, DOI 10.1021/jo1018574; Seki M, 2014, ACS CATAL, V4, P4047, DOI 10.1021/cs501328x; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Chiong HA, 2007, J AM CHEM SOC, V129, P9879, DOI 10.1021/ja071845e; Seki M, 2014, RSC ADV, V4, P29131, DOI 10.1039/c4ra03679d; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Seki M, 2011, ACS CATAL, V1, P607, DOI 10.1021/cs200044t; Liu L, 2014, J ORG CHEM, V79, P80, DOI 10.1021/jo402307x; BRINGMANN G, 1993, ANGEW CHEM INT EDIT, V32, P1190, DOI 10.1002/anie.199311901; Kocienski P, 2013, SYNFACTS, V9, P0006; Manfredi K. P., 1955, ANTIBIOT ANNU, V56, P606; Seki M., 2015, SCI SYNTHESIS CATALY; Seki M, 2014, [No title captured], Patent No. [WO 2014034868, 2014034868]; Seki M, 2012, SYNTHESIS-STUTTGART, V44, P3231, DOI 10.1055/s-0032-1317131; Seki M, 2012, J SYN ORG CHEM JPN, V70, P1295; Seki M., 2014, [No title captured], Patent No. [WO 2014051008, 2014051008]; Seki M, 2014, SYNTHESIS-STUTTGART, V46, P3249, DOI 10.1055/s-0034-1378585; Yasuda N., 2010, ART PROCESS CHEM	30	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	MAY	2015	47	10					1423	1435		10.1055/s-0034-1380159		13	Chemistry, Organic	Chemistry	CH5YM	WOS:000354112000008		
J	Moritani, S				Moritani, Sueyoshi			Surgical Management of Laryngeal Invasion by Papillary Thyroid Carcinoma: A Retrospective Analysis	THYROID			English	Article							PROGNOSTIC SCORING SYSTEM; DIFFERENTIATED CARCINOMA; LARYNGOTRACHEAL INVASION; AERODIGESTIVE TRACT; CANCER; RESECTION; RADIOTHERAPY; MODALITIES	Background: Papillary thyroid carcinoma (PTC) has an excellent prognosis. Although rare, PTC invasion into the upper aerodigestive tract can adversely affect patient prognosis and quality of life. This study investigated the impact of tumor excision on the prognosis and postoperative status of patients with PTC invasion of the larynx. Methods: Data on PTC patients who underwent surgery at the author's institution between April 1981 and March 2010 were retrospectively reviewed, and 55 patients with thyroid cartilage invasion were enrolled. Curative resection was performed for all patients, and laryngeal function was preserved or reconstructed when possible. Results: Of the 55 patients, 40 and 15 patients had superficial and intraluminal invasion of the larynx, respectively. The 10-year disease-specific survival rates were 81.0% and 61.4% in patients who underwent surgery for superficial and intraluminal invasion of the larynx, respectively. Only two patients (3.6%) had an isolated locoregional recurrence in the larynx. Four patients (7.3%) underwent total laryngectomy during the initial surgery or surgery for laryngeal recurrence. Permanent stoma remained in 26 patients (47%): 14 with laryngeal invasion, and 12 with invasion of other aerodigestive structures. The number of invaded aerodigestive structures including the larynx was correlated with the presence of permanent stoma. Conclusions: In many patients, PTC invasion of the larynx remained at the thyroid cartilage or paraglottic space. Most patients did not require total laryngectomy. Good locoregional control was achieved with surgical tumor excision in patients with laryngeal invasion. Distant metastases were the major cause of death in patients with PTC invasion of the larynx.	Kusatsu Gen Hosp, Ctr Head & Neck Surg, Kusatsu, Shiga 5258585, Japan	Moritani, S (reprint author), Kusatsu Gen Hosp, Ctr Head & Neck Surg, 1660 Yabase Cho, Kusatsu, Shiga 5258585, Japan.	suemoritani@gmail.com					SAMAAN NA, 1992, J CLIN ENDOCR METAB, V75, P714, DOI 10.1210/jc.75.3.714; Honings J, 2010, LARYNGOSCOPE, V120, P682, DOI 10.1002/lary.20800; McCarty TM, 1997, ANN SURG ONCOL, V4, P403, DOI 10.1007/BF02305553; ANDERSEN PE, 1995, AM J SURG, V170, P467, DOI 10.1016/S0002-9610(99)80331-6; Wada N, 2006, LANGENBECK ARCH SURG, V391, P545, DOI 10.1007/s00423-006-0106-9; Bayles SW, 1998, LARYNGOSCOPE, V108, P1402, DOI 10.1097/00005537-199809000-00029; Randolph GW, 2006, SURGERY, V139, P357, DOI 10.1016/j.surg.2005.08.009; MCCAFFREY TV, 1994, HEAD NECK-J SCI SPEC, V16, P165, DOI 10.1002/hed.2880160211; Czaja JM, 1997, ARCH OTOLARYNGOL, V123, P484; HAY ID, 1987, SURGERY, V102, P1088; CADY B, 1988, SURGERY, V104, P947; McCaffrey JC, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.MLG.0000200428.26975.86; MCCONAHEY WM, 1986, MAYO CLIN PROC, V61, P978; SHAH JP, 1992, AM J SURG, V164, P658, DOI 10.1016/S0002-9610(05)80729-9; Gaissert HA, 2007, ANN THORAC SURG, V83, P1952, DOI 10.1016/j.athoracsur.2007.01.056; Farahati J, 1996, CANCER, V77, P172, DOI 10.1002/(SICI)1097-0142(19960101)77:1<172::AID-CNCR28>3.0.CO;2-1; Giovanni A, 2001, LARYNGOSCOPE, V111, P663, DOI 10.1097/00005537-200104000-00020; Hay ID, 1993, SURGERY, V114, P7; Hay Ian D, 2002, Trans Am Clin Climatol Assoc, V113, P241; HAY ID, 1993, SURGERY, V114, P1050; Kasperbauer JL, 2004, ANN OTO RHINOL LARYN, V113, P749; Kebebew E, 2003, SURG ONCOL, V12, P91, DOI 10.1016/S0960-7404(03)00032-X; Kim KH, 2000, OTOLARYNG HEAD NECK, V122, P763, DOI 10.1016/S0194-5998(00)70212-9; Meadows KM, 2006, AM J OTOLARYNG, V27, P24, DOI 10.1016/j.amjoto.2005.05.017; Segal K, 2006, OTOLARYNG HEAD NECK, V134, P819, DOI 10.1016/j.otohns.2005.11.040	25	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	MAY 1	2015	25	5					528	533		10.1089/thy.2014.0485		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CH3ZL	WOS:000353969800010		
J	Fukushima, T; Suzuki, S; Ohira, T; Shimura, H; Midorikawa, S; Ohtsuru, A; Sakai, A; Abe, M; Yamashita, S; Suzuki, S				Fukushima, Toshihiko; Suzuki, Satoru; Ohira, Tetsuya; Shimura, Hiroki; Midorikawa, Sanae; Ohtsuru, Akira; Sakai, Akira; Abe, Masafumi; Yamashita, Shunichi; Suzuki, Shinichi		Radiation Med Ctr Fukushima Hlth	Prevalence of Ectopic Intrathyroidal Thymus in Japan: The Fukushima Health Management Survey	THYROID			English	Article							OF-THE-LITERATURE; THYROID-NODULE; SONOGRAPHIC APPEARANCE; PARATHYROID-GLAND; INVOLUTION; TISSUE; BOY	Background: Ectopic intrathyroidal thymus is thought to be a rare entity, often discovered incidentally, and is due to aberrant thymic migration during embryogenesis. Objective: The aim of this study was to determine the prevalence of ectopic intrathyroidal thymus in children using ultrasound screening. Methods: This study was cross-sectional and was conducted with the initial preliminary survey of the Fukushima Health Management Survey between October 9, 2011, and March 31, 2012, after the Fukushima Daiichi Nuclear Power Plant accident. A total of 37,816 children were examined in the survey. Results: Diagnostic criteria are based on the ultrasonographic appearance of ectopic intrathyroidal thymus, which were round, oval, or polygonal hypoechoic or hyperechoic areas, with multiple granular and punctate echogenic foci. A total of 375 (0.99%) cases (164 girls) with ectopic intrathyroidal thymus were observed. The mean age was 7.0 years (range 0-18 years). Ectopic intrathyroidal thymus was located in the right (n=180), left (n=178), or bilateral (n=17) thyroid lobes. The incidence of ectopic intrathyroidal thymus was inversely correlated with age and body mass index. Conclusion: The results reflect the prevalence of ectopic intrathyroidal thymus using ultrasonography in the general population. Further examination will be needed by way of longitudinal follow-up.	[Fukushima, Toshihiko; Suzuki, Satoru; Suzuki, Shinichi] Fukushima Med Univ, Sch Med, Dept Thyroid & Endocrinol, Fukushima, Fukushima 9601295, Japan; [Ohira, Tetsuya] Fukushima Med Univ, Sch Med, Dept Epidemiol, Fukushima, Fukushima 9601295, Japan; [Shimura, Hiroki] Fukushima Med Univ, Sch Med, Dept Lab Med, Fukushima, Fukushima 9601295, Japan; [Midorikawa, Sanae; Ohtsuru, Akira] Fukushima Med Univ, Sch Med, Dept Radiat Hlth Management, Fukushima, Fukushima 9601295, Japan; [Sakai, Akira] Fukushima Med Univ, Sch Med, Dept Radiat Life Sci, Fukushima, Fukushima 9601295, Japan; [Fukushima, Toshihiko; Suzuki, Satoru; Ohira, Tetsuya; Shimura, Hiroki; Midorikawa, Sanae; Ohtsuru, Akira; Sakai, Akira; Abe, Masafumi; Yamashita, Shunichi; Suzuki, Shinichi] Fukushima Med Univ, Radiat Med Sci Ctr Fukushima Hlth Management Surv, Fukushima, Fukushima 9601295, Japan; [Yamashita, Shunichi] Nagasaki Univ, Atom Bomb Dis Inst, Nagasaki 852, Japan	Fukushima, T (reprint author), Fukushima Med Univ, Sch Med, Dept Thyroid & Endocrinol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	fuku@fmu.ac.jp			national "Health Fund for Children and Adults Affected by the Nuclear Incident"	This survey was conducted as part of Fukushima Prefecture's post-disaster recovery plans and was supported by the national "Health Fund for Children and Adults Affected by the Nuclear Incident."	Ahsan F, 2010, J LARYNGOL OTOL, V124, P694, DOI 10.1017/S0022215109992180; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Boehm T, 2013, NAT REV IMMUNOL, V13, P831, DOI 10.1038/nri3534; Gui JG, 2012, AGING DIS, V3, P280; Nishino M, 2006, RADIOGRAPHICS, V26, P335, DOI 10.1148/rg.262045213; Hogan AR, 2009, J SURG RES, V156, P167, DOI 10.1016/j.jss.2009.03.098; Avula S, 2010, PEDIATR RADIOL, V40, P1774, DOI 10.1007/s00247-010-1684-9; Bellizzi MC, 1999, AM J CLIN NUTR, V70, p173S; Buyukyavuz I, 2002, EUR J PEDIATR SURG, V12, P327, DOI 10.1055/s-2002-35961; Calder AE, 2011, NEUROIMMUNOMODULAT, V18, P281, DOI 10.1159/000329496; Courcoutsakis N, 2009, THYROID, V19, P293, DOI 10.1089/thy.2008.0404; Durmaz E, 2012, J PEDIATR ENDOCR MET, V25, P997, DOI 10.1515/jpem-2012-0207; Gilmour JR, 1937, J PATHOL BACTERIOL, V45, P507, DOI 10.1002/path.1700450304; Gimm O, 1997, J PEDIATR SURG, V32, P1241, DOI 10.1016/S0022-3468(97)90691-6; HARACH HR, 1993, PEDIATR PATHOL, V13, P431; Hayashida N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083220; Ishida T, 2013, INT J PEDIATR OTORHI, V77, P1609, DOI 10.1016/j.ijporl.2013.06.030; Kim HG, 2012, J CLIN ULTRASOUND, V40, P266, DOI 10.1002/jcu.21898; Lignitz S, 2008, THYROID, V18, P1125, DOI 10.1089/thy.2008.0055; Loney DA, 1998, INT J PEDIATR OTORHI, V43, P77, DOI 10.1016/S0165-5876(97)00155-9; Megremis S, 2008, J CLIN ULTRASOUND, V36, P443, DOI 10.1002/jcu.20463; Nolder AR, 2013, ENT-EAR NOSE THROAT, V92, P41; Patel MN, 2013, J CLIN ULTRASOUND, V41, P319, DOI 10.1002/jcu.21930; Schramm JC, 2014, INT J PEDIATR OTORHI, V78, P163, DOI 10.1016/j.ijporl.2013.10.066; Segni M, 2011, HORM RES PAEDIAT, V75, P258, DOI 10.1159/000322441; Segni M, 2006, THYROID, V16, P1179, DOI 10.1089/thy.2006.16.1179	26	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	MAY 1	2015	25	5					534	537		10.1089/thy.2014.0367		4	Endocrinology & Metabolism	Endocrinology & Metabolism	CH3ZL	WOS:000353969800011		
J	Takemoto, N; Konagaya, S; Kuwabara, R; Iwata, H				Takemoto, Naohiro; Konagaya, Shuhei; Kuwabara, Rei; Iwata, Hiroo			Coaggregates of Regulatory T Cells and Islet Cells Allow Long-term Graft Survival in Liver Without Immunosuppression	TRANSPLANTATION			English	Article							PREVENT ALLOGRAFT-REJECTION; TRANSPLANTATION; PANCREAS; TOLERANCE; THERAPY; VIVO	Background. Transplantation of islets of Langerhans (islets) has been investigated in the clinic to treat patients with insulindependent diabetes mellitus. Islet grafts have been maintained by administering immunosuppressive drugs, which can lead to complications in the long term. Alternatives to immunosuppressive therapy are eagerly desired. In this study, we examined the transplantation of coaggregates of CD4(+)CD25(+) regulatory T (Treg) cells. Methods. Coaggregates of Treg cells from C57BL/6 mice and islet cells from BALB/c mice were prepared on agarose hydrogel with small round-bottomed wells. Four hundred coaggregates were transplanted into the livers of streptozotocin-induced diabetic C57BL/6 mice without systemic immunosuppression. Results. The Treg cells and islet cells were distributed randomly in the coaggregates. When 400 coaggregates were transplanted into 9 C57BL/6 mice via the portal vein, 6 of the 9 recipients demonstrated blood glucose less than 250 mg/dL for more than 100 days. A number of insulin-positive cells were observed in the livers at 120 days after transplantation. Conclusions. The Treg cells and islet cells were distributed randomly in the coaggregates. After intraportal transplantation of the coaggregates, Treg cells in the aggregates enabled the long-term survival of allogeneic islet cell grafts in the liver without the use of immunosuppressive drugs.	[Takemoto, Naohiro; Konagaya, Shuhei; Kuwabara, Rei; Iwata, Hiroo] Kyoto Univ, Dept Reparat Mat, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Iwata, H (reprint author), Kyoto Univ, Dept Reparat Mat, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	iwata@frontier.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24.3121];  [23107008];  [24240078];  [23650257]	This study was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23107008), Scientific Research (A) (No. 24240078), Challenging Exploratory Research (No. 23650257), and by the Japan Society for the Promotion of Science (JSPS) Fellows (No. 24.3121) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Karim M, 2005, BLOOD, V105, P4871, DOI 10.1182/blood-2004-10-3888; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Froud T, 2005, AM J TRANSPLANT, V5, P2037, DOI 10.1111/j.1600-6143.2005.00957.x; Teramura Y, 2010, ADV DRUG DELIVER REV, V62, P827, DOI 10.1016/j.addr.2010.01.005; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Feng G, 2008, TRANSPLANTATION, V86, P578, DOI 10.1097/TP.0b013e3181806a60; Feng G, 2011, METHODS MOL BIOL, V677, P281, DOI 10.1007/978-1-60761-869-0_20; LACY PE, 1967, DIABETES, V16, P35; Bart J, 2002, LANCET ONCOL, V3, P357, DOI 10.1016/S1470-2045(02)00776-3; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; BENHAMOU PY, 1995, HORM METAB RES, V27, P113, DOI 10.1055/s-2007-979921; IWATA H, 1992, J BIOMED MATER RES, V26, P967, DOI 10.1002/jbm.820260711; Kim JI, 2011, TRANSPLANTATION, V91, P707, DOI 10.1097/TP.0b013e31820e50b3; Luzi L, 1999, J MOL MED-JMM, V77, P49, DOI 10.1007/s001090050300; Marek N, 2011, ANN SURG, V254, P512, DOI 10.1097/SLA.0b013e31822c9ca7; RICORDI C, 1987, P NATL ACAD SCI USA, V84, P8080, DOI 10.1073/pnas.84.22.8080; STREILEIN JW, 1995, SCIENCE, V270, P1158, DOI 10.1126/science.270.5239.1158; Takemoto N, 2014, TRANSPLANTATION, V97, P287, DOI 10.1097/01.TP.0000438198.76531.03	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0041-1337	1534-6080		TRANSPLANTATION	Transplantation	MAY	2015	99	5					942	947		10.1097/TP.0000000000000579		6	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CH3WW	WOS:000353962700016		
J	Zaitsu, M; Yamashita, K; Shibasaki, S; Tsunetoshi, Y; Fukai, M; Ogura, M; Yoshida, T; Igarashi, R; Kobayashi, N; Umezawa, K; Todo, S				Zaitsu, Masaaki; Yamashita, Kenichiro; Shibasaki, Susumu; Tsunetoshi, Yusuke; Fukai, Moto; Ogura, Masaomi; Yoshida, Tadashi; Igarashi, Rumi; Kobayashi, Nozomi; Umezawa, Kazuo; Todo, Satoru			3-[(Dodecylthiocarbonyl)Methyl]-Glutarimide Attenuates Graft Arterial Disease by Suppressing Alloimmune Responses and Vascular Smooth Muscle Cell Proliferation	TRANSPLANTATION			English	Article							CARDIAC ALLOGRAFT VASCULOPATHY; TRANSPLANTED MOUSE HEARTS; INTERFERON-GAMMA; CHRONIC REJECTION; LONG-TERM; CORONARY ARTERIOSCLEROSIS; RETINOBLASTOMA PROTEIN; ADHESION MOLECULE-1; CYCLE REGULATION; EXPRESSION	Background. Graft arterial disease (GAD) is a major cause of late graft loss after organ transplantation. Alloimmune responses and vascular remodeling eventually cause the transplant organ to developGAD. In this study, we aimed to limit the development of GAD by inhibiting alloimmune responses and vascular smooth muscle cell (VSMC) proliferation with a new compound, 3-[(dodecylthiocarbonyl)methyl]-glutarimide ([DTCM]-glutarimide), in a murine cardiac model of GAD. Methods. The hearts from B6.CH-2(bm12) mice were transplanted into C57BL/6 mouse recipients to examine the extent of GAD. The recipients were treated with either vehicle or DTCM-glutarimide intraperitoneally (40 mg/kg per day) for 4 weeks. Results. The administration of DTCM-glutarimide attenuated GAD formation (luminal occlusion: 37.9 +/- 5.9% vs 14.8 +/- 5.4%, P < 0.05) by inhibiting the number of graft-infiltrating cells and decreasing alloreactive interferon (IFN)-gamma production compared with control mice, as measured by the Enzyme-linked ImmunoSpot assay. In vitro, VSMCs proliferated on stimulation with either basic fibroblast growth factor or IFN-gamma and splenocytes after transplantation, but the addition of DTCM-glutarimide resulted in the inhibition of VSMC proliferation. Moreover, DTCM-glutarimide suppressed cyclin D1 expression and inhibited cell cycle progression from G1 to S in VSMCs. Conclusions. The compound DTCM-glutarimide suppressed GAD development by inhibiting not only alloimmune responses but also VSMC proliferation in the graft.	[Zaitsu, Masaaki; Shibasaki, Susumu; Tsunetoshi, Yusuke; Ogura, Masaomi; Yoshida, Tadashi; Igarashi, Rumi; Kobayashi, Nozomi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Sapporo, Hokkaido 0608638, Japan; [Yamashita, Kenichiro; Fukai, Moto; Todo, Satoru] Hokkaido Univ, Grad Sch Med, Dept Transplant Surg, Sapporo, Hokkaido 0608638, Japan; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med Screening, Nagakude, Japan	Yamashita, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Transplant Surg, Kita Ku, N-15,W-7, Sapporo, Hokkaido 0608638, Japan.	kenchan@med.hokudai.ac.jp; s-todo@st-mary-med.or.jp			Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, Japan	This study was supported, in part, by funding from the Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, Japan.	Win TS, 2009, CIRC-HEART FAIL, V2, P361, DOI 10.1161/CIRCHEARTFAILURE.108.827139; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; Shi CW, 1996, P NATL ACAD SCI USA, V93, P4051, DOI 10.1073/pnas.93.9.4051; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; Nagano H, 1998, AM J PATHOL, V152, P1187; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Kibbe M, 1999, CARDIOVASC RES, V43, P650, DOI 10.1016/S0008-6363(99)00130-3; Yu LY, 2011, CIRC RES, V109, P418, DOI 10.1161/CIRCRESAHA.111.248245; Lodhi SA, 2011, AM J TRANSPLANT, V11, P1226, DOI 10.1111/j.1600-6143.2011.03539.x; Tellides G, 2007, CIRC RES, V100, P622, DOI 10.1161/01.RES.0000258861.72279.29; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; Peng YD, 2010, CELL BIOL INT, V34, P447, DOI 10.1042/CBI20090301; Goto R, 2012, TRANSPLANTATION, V93, P777, DOI 10.1097/TP.0b013e318248ca5f; Libby P, 2001, IMMUNITY, V14, P387, DOI 10.1016/S1074-7613(01)00119-4; Nagano H, 1997, J CLIN INVEST, V100, P550, DOI 10.1172/JCI119564; Ishikawa Y, 2009, BIOORG MED CHEM LETT, V19, P1726, DOI 10.1016/j.bmcl.2009.01.107; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Yang J, 2008, CIRCULATION, V117, P660, DOI 10.1161/CIRCULATIONAHA.107.741025; Moon SK, 2004, J CELL PHYSIOL, V198, P310, DOI 10.1002/jcp.10728; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Takeiri M, 2011, INFLAMM RES, V60, P879, DOI 10.1007/s00011-011-0348-z; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Moon SK, 2003, BIOCHEM BIOPH RES CO, V301, P1069, DOI 10.1016/S0006-291X(03)00091-3; Wang XK, 1996, J BIOL CHEM, V271, P24286; Shibasaki S, 2012, TRANSPLANTATION, V93, P1229, DOI 10.1097/TP.0b013e3182516c9f; Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; Shimizu K, 2000, J IMMUNOL, V165, P3506; BRAUN M, 1995, J MOL CELL CARDIOL, V27, P2571, DOI 10.1006/jmcc.1995.0044; Ensminger SM, 2002, TRANSPLANTATION, V73, P279, DOI 10.1097/00007890-200201270-00022; Espeillac C, 2011, J CLIN INVEST, V121, P2821, DOI 10.1172/JCI44203; Fischbein MP, 2000, J IMMUNOL, V165, P7316; Fischbein MP, 2001, TRANSPLANTATION, V71, P1146, DOI 10.1097/00007890-200104270-00023; Furukawa Y, 2004, CARDIOVASC RES, V63, P347, DOI 10.1016/j.cardiores.2004.04.004; Glysing-Jensen T, 1997, TRANSPLANTATION, V64, P1641, DOI 10.1097/00007890-199712270-00002; HANSSON GK, 1988, CIRC RES, V63, P712; Isobe M, 2006, ARTERIOSCL THROM VAS, V26, P1447, DOI 10.1161/01.ATV.0000222906.78307.7b; ISOBE M, 1992, SCIENCE, V255, P1125, DOI 10.1126/science.1347662; Kim KS, 2001, AM J PATHOL, V158, P977, DOI 10.1016/S0002-9440(10)64044-8; KLAGSBRUN M, 1989, ARTERIOSCLEROSIS, V9, P269; Koga N, 2004, ARTERIOSCL THROM VAS, V24, P2057, DOI 10.1161/01.ATV.0000145015.23656.e4; Koskinen PK, 2001, TRANSPLANTATION, V71, P1741, DOI 10.1097/00007890-200106270-00007; Lee JY, 2005, J CELL PHYSIOL, V203, P493, DOI 10.1002/jcp.20257; Mitchell RN, 2009, ANNU REV PATHOL-MECH, V4, P19, DOI 10.1146/annurev.pathol.3.121806.151449; Nozaki T, 2009, AM J TRANSPLANT, V9, P2251, DOI 10.1111/j.1600-6143.2009.02786.x; OROSZ CG, 1993, TRANSPLANTATION, V56, P453, DOI 10.1097/00007890-199308000-00039; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; Richter MHC, 2003, TRANSPLANT INT, V16, P26, DOI 10.1111/j.1432-2277.2003.tb00219.x; Saiki H, 2008, INT HEART J, V49, P105, DOI 10.1536/ihj.49.105; Sakihama H, 2004, CIRCULATION, V110, P2924, DOI 10.1161/01.CIR.0000146890.93172.6C; Shibasaki S, 2013, TRANSPLANTATION, V95, P542, DOI 10.1097/TP.0b013e31827b3d90; Sriram V, 2001, CIRCULATION, V103, P2414; Suzuki J, 2007, TRANSPLANTATION, V83, P1093, DOI 10.1097/01.tp.0000259650.67061.16; Szeto WY, 2002, TRANSPLANTATION, V73, P1116, DOI 10.1097/00007890-200204150-00019; Tiriveedhi V, 2010, BIOCHEM BIOPH RES CO, V399, P251, DOI 10.1016/j.bbrc.2010.07.063	55	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0041-1337	1534-6080		TRANSPLANTATION	Transplantation	MAY	2015	99	5					948	956		10.1097/TP.0000000000000576		9	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CH3WW	WOS:000353962700017		
J	Minamino, T; Imada, K				Minamino, Tohru; Imada, Katsumi			The bacterial flagellar motor and its structural diversity	TRENDS IN MICROBIOLOGY			English	Review						bacterial flagellum; rotary motor; flagellar assembly; protein export; stator assembly	III PROTEIN EXPORT; NA+-DRIVEN FLAGELLA; PROTON-MOTIVE FORCE; ESCHERICHIA-COLI; BASAL BODY; VIBRIO-ALGINOLYTICUS; FLII ATPASE; CRYOELECTRON TOMOGRAPHY; CRYSTAL-STRUCTURE; CHARGED RESIDUES	The bacterial flagellum is a reversible rotary motor powered by an electrochemical-potential difference of specific ions across the cytoplasmic membrane. The H+-driven motor of Salmonella spins at similar to 300 Hz, whereas the Na+-driven motor of marine Vibrio spp. can rotate much faster, up to 1700 Hz. A highly conserved motor structure consists of the MS ring, C ring, rod, and export apparatus. The C ring and the export apparatus show dynamic properties for exerting their functional activities. Various additional structures surrounding the conserved motor structure are observed in different bacterial species. In this review we summarize our current understanding of the structure, function, and assembly of the flagellar motor in Salmonella and marine Vibrio.	[Minamino, Tohru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Imada, Katsumi] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Toyonaka, Osaka 5600043, Japan	Minamino, T (reprint author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	tohru@fbs.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology	We gratefully thank Keiichi Namba for constant support and encouragement. Our research is supported in part by the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	AKIBA T, 1991, SCIENCE, V252, P1544, DOI 10.1126/science.2047860; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Zhou JD, 1998, J BACTERIOL, V180, P2729; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Nambu T, 1999, J BACTERIOL, V181, P1555; Vartanian AS, 2012, J BIOL CHEM, V287, P35779, DOI 10.1074/jbc.C112.378380; Abrusci P, 2013, NAT STRUCT MOL BIOL, V20, P99, DOI 10.1038/nsmb.2452; Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Lele PP, 2013, P NATL ACAD SCI USA, V110, P11839, DOI 10.1073/pnas.1305885110; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6; Kojima S, 2011, J MOL BIOL, V414, P62, DOI 10.1016/j.jmb.2011.09.019; Yuan JH, 2013, J MOL BIOL, V425, P1760, DOI 10.1016/j.jmb.2013.02.016; Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x; Terashima H, 2010, J BACTERIOL, V192, P5609, DOI 10.1128/JB.00720-10; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436; Tipping MJ, 2013, MOL MICROBIOL, V87, P338, DOI 10.1111/mmi.12098; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x; Terashima H, 2006, MOL MICROBIOL, V62, P1170, DOI 10.1111/j.1365-2958.2006.05435.x; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015; Minamino T, 2008, CURR OPIN STRUC BIOL, V18, P693, DOI 10.1016/j.sbi.2008.09.006; Minamino T, 2000, J BACTERIOL, V182, P3029, DOI 10.1128/JB.182.11.3029-3036.2000; Delalez NJ, 2010, P NATL ACAD SCI USA, V107, P11347, DOI 10.1073/pnas.1000284107; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Chevance FFV, 2007, GENE DEV, V21, P2326, DOI 10.1101/gad.1571607; Yuan JH, 2012, NATURE, V484, P233, DOI 10.1038/nature10964; Minamino T, 2009, MOL MICROBIOL, V74, P1471, DOI 10.1111/j.1365-2958.2009.06946.x; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Zhu SW, 2014, P NATL ACAD SCI USA, V111, P13523, DOI 10.1073/pnas.1324201111; Morimoto YV, 2014, MOL MICROBIOL, V91, P1214, DOI 10.1111/mmi.12529; Fukuoka H, 2010, BIOCHEM BIOPH RES CO, V394, P130, DOI 10.1016/j.bbrc.2010.02.129; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Fukuoka H, 2009, MOL MICROBIOL, V71, P825, DOI 10.1111/j.1365-2958.2008.06569.x; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Paul K, 2011, EMBO J, V30, P2962, DOI 10.1038/emboj.2011.188; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; Che YS, 2014, MOL MICROBIOL, V91, P175, DOI 10.1111/mmi.12453; Hara N, 2012, J BACTERIOL, V194, P5353, DOI 10.1128/JB.01028-12; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; Raddi G, 2012, J BACTERIOL, V194, P1299, DOI 10.1128/JB.06474-11; Kanbe M, 2007, J BACTERIOL, V189, P1083, DOI 10.1128/JB.01405-06; Lam KH, 2013, MOL MICROBIOL, V88, P798, DOI 10.1111/mmi.12222; Morimoto YV, 2010, FEBS LETT, V584, P1268, DOI 10.1016/j.febslet.2010.02.051; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Bai F, 2014, SCI REP-UK, V4, DOI 10.1038/srep06528; Belas R, 2014, TRENDS MICROBIOL, V22, P517, DOI 10.1016/j.tim.2014.05.002; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; BLOCK SM, 1984, NATURE, V309, P470, DOI 10.1038/309470a0; Branch RW, 2014, J MOL BIOL, V426, P3314, DOI 10.1016/j.jmb.2014.07.009; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Castillo D. J., 2013, BIOPHYSICS-USSR, V9, P173; Che YS, 2008, J BACTERIOL, V190, P6660, DOI 10.1128/JB.00503-08; Cohen EJ, 2014, J BACTERIOL, V196, P2387, DOI 10.1128/JB.01580-14; Delalez N. J., 2014, MBIO, V5; Fabela S, 2013, J BACTERIOL, V195, P5285, DOI 10.1128/JB.00760-13; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; Haya S, 2011, APPL ENVIRON MICROB, V77, P2799, DOI 10.1128/AEM.00286-11; HIROTA N, 1981, FEBS LETT, V132, P278, DOI 10.1016/0014-5793(81)81178-7; Hosking ER, 2006, J MOL BIOL, V364, P921, DOI 10.1016/j.jmb.2006.09.035; Ibuki T, 2013, J BACTERIOL, V195, P466, DOI 10.1128/JB.01711-12; Imada K, 2010, P NATL ACAD SCI USA, V107, P8812, DOI 10.1073/pnas.1001866107; Kanbe M., 2007, MICROBIOLOGY, V151, P433; Kawamoto A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03369; Kazetani K, 2009, BIOCHEM BIOPH RES CO, V388, P323, DOI 10.1016/j.bbrc.2009.08.004; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi0354051; Kojima S, 2008, P NATL ACAD SCI USA, V105, P7696, DOI 10.1073/pnas.0800308105; Kubori T, 1997, MOL MICROBIOL, V24, P399, DOI 10.1046/j.1365-2958.1997.3341714.x; Levenson R, 2012, BIOCHEMISTRY-US, V51, P5052, DOI 10.1021/bi3004582; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; Martinez RM, 2010, J BACTERIOL, V192, P2085, DOI 10.1128/JB.01562-09; Martinez RM, 2009, J BACTERIOL, V191, P5669, DOI 10.1128/JB.00632-09; Minamino T, 2004, J MOL MICROB BIOTECH, V7, P5, DOI 10.1149/000077865; Minamino T, 2014, BBA-MOL CELL RES, V1843, P1642, DOI 10.1016/j.bbamcr.2013.09.005; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 2012, MOL MICROBIOL, V83, P168, DOI 10.1111/j.1365-2958.2011.07924.x; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Morimoto YV, 2010, MOL MICROBIOL, V78, P1117, DOI 10.1111/j.1365-2958.2010.07391.x; Morimoto YV, 2013, J BACTERIOL, V195, P474, DOI 10.1128/JB.01971-12; Muller A, 2014, MICROBIOLOGYOPEN, V3, P702, DOI 10.1002/mbo3.200; Okabe M, 2005, J BIOL CHEM, V280, P25659, DOI 10.1074/jbc.M500263200; Sato K, 2000, J BIOL CHEM, V275, P5718, DOI 10.1074/jbc.275.8.5718; Sowa Y, 2014, P NATL ACAD SCI USA, V111, P3436, DOI 10.1073/pnas.1317741111; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P11699, DOI 10.1021/bi901517n; Suzuki H, 2004, J MOL BIOL, V337, P105, DOI 10.1016/j.jmb.2004.01.034; Takekawa N, 2014, J BACTERIOL, V196, P1377, DOI 10.1128/JB.01392-13; Takekawa N., 2014, J BIOCH, V153, P441; Terashima H, 2013, P NATL ACAD SCI USA, V110, P6133, DOI 10.1073/pnas.1222655110; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; Tipping M. J., 2013, MBIO, V4; UENO T, 1992, J MOL BIOL, V227, P672, DOI 10.1016/0022-2836(92)90216-7; Zhao XW, 2014, BIOCHEMISTRY-US, V53, P4323, DOI 10.1021/bi500059y; Zhao XW, 2013, P NATL ACAD SCI USA, V110, P14390, DOI 10.1073/pnas.1308306110	100	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0966-842X	1878-4380		TRENDS MICROBIOL	Trends Microbiol.	MAY	2015	23	5					267	274		10.1016/j.tim.2014.12.011		8	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CH6MS	WOS:000354151300005		
J	Iwai, H; Funatogawa, K; Matsumura, K; Kato-Miyazawa, M; Kirikae, F; Kiga, K; Sasakawa, C; Miyoshi-Akiyama, T; Kirikae, T				Iwai, Hiroki; Funatogawa, Keiji; Matsumura, Kazunori; Kato-Miyazawa, Masako; Kirikae, Fumiko; Kiga, Kotaro; Sasakawa, Chihiro; Miyoshi-Akiyama, Tohru; Kirikae, Teruo			MicroRNA-155 knockout mice are susceptible to Mycobacterium tuberculosis infection	TUBERCULOSIS			English	Article						Mycobacterium tuberculosis; microRNA; miR-155	IMMUNE FUNCTION; INDUCTION; MACROPHAGES; MIR-155; CLEARANCE; APOPTOSIS; CELLS	MicroRNAs (miRNAs) are short, conserved, non-coding RNA molecules that repress translation, followed by the decay of miRNA-targeted mRNAs that encode molecules involved in cell differentiation, development, immunity and apoptosis. At least six miRNAs, including microRNA-155 (miR-155), were upregulated when born marrow-derived macrophages from C57BL/6 mice were infected with Mycobacterium tuberculosis Erdman. C57BL/6 mice intravenously infected with Erdman showed up-regulation of miR-155 in livers and lungs. Following infection, miR-155-deficient C57BL/6 mice died significantly earlier and had significantly higher numbers of CFU in lungs than wild-type mice. Moreover, fewer CD4(+) T cells, but higher numbers of monocytes and neutrophils, were present in the lungs of Erdman-infected miR-155 knockout (miR-155(-/-)) than of wild-type mice. These findings indicated that miR-155 plays a critical role in immune responses to M. tuberculosis. (C) 2015 Elsevier Ltd. All rights reserved.	[Iwai, Hiroki; Matsumura, Kazunori; Kato-Miyazawa, Masako; Kirikae, Fumiko; Miyoshi-Akiyama, Tohru; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Dept Infect Dis, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan; [Funatogawa, Keiji] Tochigi Prefectural Inst Publ Hlth, Utsunomiya, Tochigi 3291196, Japan; [Sasakawa, Chihiro] Nippon Inst Biol Sci, Tokyo 1980024, Japan; [Kiga, Kotaro; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Div Bacterial Infect, Tokyo 1088639, Japan; [Sasakawa, Chihiro] Chiba Univ, Med Mycol Res Ctr, Chiba 2608673, Japan	Kirikae, T (reprint author), Natl Ctr Global Hlth & Med, Dept Infect Dis, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan.	tkirikae@ri.ncgm.go.jp			Grants for International Health Research from the Ministry of Health, Labor, and Welfare of Japan [27A-1102, 26A-103, 24A-93103]	This study was supported by Grants for International Health Research (27A-1102, 26A-103 and 24A-93103) from the Ministry of Health, Labor, and Welfare of Japan.	Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Seddiki N, 2014, IMMUNOLOGY, V142, P32, DOI 10.1111/imm.12227; Spinelli SV, 2013, MOL IMMUNOL, V53, P265, DOI 10.1016/j.molimm.2012.08.008; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Dorhoi A, 2013, J CLIN INVEST, V123, P4836, DOI 10.1172/JCI67604; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Koch M, 2012, P NATL ACAD SCI USA, V109, pE1153, DOI 10.1073/pnas.1116125109; Lind EF, 2013, J IMMUNOL, V190, P1210, DOI 10.4049/jimmunol.1202700; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Verschoor CP, 2014, INFECT IMMUN, V82, P4824, DOI 10.1128/IAI.02251-14; Ghorpade DS, 2012, MOL CELL BIOL, V32, P2239, DOI [10.1128/MCB.06597-11, 10.1125/MCB.06597-11]; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Yang K, 2014, J INFECT DIS, V210, P89, DOI 10.1093/infdis/jiu002; Kumar R, 2012, CELL MICROBIOL, V14, P1620, DOI 10.1111/j.1462-5822.2012.01827.x; Clare S, 2013, INFECT IMMUN, V81, P723, DOI 10.1128/IAI.00969-12; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Li JZ, 2014, TRANSPLANTATION, V97, P626, DOI 10.1097/TP.0000000000000061; Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180; Wang JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003697	21	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1472-9792			TUBERCULOSIS	Tuberculosis	MAY	2015	95	3					246	250		10.1016/j.tube.2015.03.006		5	Immunology; Microbiology; Respiratory System	Immunology; Microbiology; Respiratory System	CH6DK	WOS:000354126100003		
J	Hang, NTL; Maeda, S; Keicho, N; Thuong, PH; Endo, H				Hang, Nguyen T. L.; Maeda, Shinji; Keicho, Naoto; Thuong, Pham H.; Endo, Hiroyoshi			Sublineages of Mycobacterium tuberculosis Beijing genotype strains and unfavorable outcomes of anti-tuberculosis treatment	TUBERCULOSIS			English	Article						Beijing genotype; Sublineage; Recurrence; Treatment failure; Vietnam	POPULATION-STRUCTURE ANALYSIS; DRUG-RESISTANCE; RISK-FACTORS; GENETIC DIVERSITY; RELAPSE; ASSOCIATION; FAMILY; VIETNAM; EPIDEMIOLOGY; CHEMOTHERAPY	The influence of Mycobacterium tuberculosis (MTB) lineages/sublineages on unfavorable tuberculosis (TB) treatment outcomes is poorly understood. We investigated the effects of Beijing genotype sublineages and other factors contributing to treatment outcome. Patients newly diagnosed with sputum smear-positive and culture-positive TB in Hanoi, Vietnam, participated in the study. After receiving anti-TB treatment, they were intensively followed up for the next 16 months. MTB isolates collected before treatment were subjected to drug susceptibility testing, and further analyzed to determine MTB (sub) lineages and their clonal similarities. Of 430 patients, 17 had treatment failure and 30 had TB recurrence. Rifampicin resistance was associated with treatment failure {adjusted odds ratio = 6.64 [95% confidence interval (CI), 1.48-29.73]}. The modern Beijing genotype was significantly associated with recurrent TB within 16 months [adjusted hazard ratio = 3.29 (95% CI, 1.17-9.27)], particularly after adjustment for the relevant antibiotic resistance. Human immunodeficiency virus coinfection and severity on chest radiographs were not significantly associated with unfavorable outcomes. Our findings provide further understanding of the influence of MTB strains on unfavorable treatment outcomes. Multiple risk factors should be considered for the optimal management of TB. (C) 2015 Elsevier Ltd. All rights reserved.	[Hang, Nguyen T. L.; Endo, Hiroyoshi] Tokyo Womens Med Univ, Dept Int Affairs & Trop Med, Tokyo, Japan; [Hang, Nguyen T. L.] Bach Mai Hosp NCGM, Med Collaborat Ctr, Natl Ctr Global Hlth & Med, Hanoi, Vietnam; [Maeda, Shinji] Japan AntiTB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Kiyose, Tokyo 2048533, Japan; [Keicho, Naoto] Japan AntiTB Assoc, Res Inst TB, Dept Pathophysiol & Host Def, Kiyose, Tokyo 2048533, Japan; [Keicho, Naoto] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Thuong, Pham H.] Hanoi Lung Hosp, Hanoi, Vietnam	Keicho, N (reprint author), Japan AntiTB Assoc, Res Inst TB, Dept Pathophysiol & Host Def, 3-1-24 Matsuyama, Kiyose, Tokyo 2048533, Japan.	lehang0310@gmail.com; maeda@jata.or.jp; nkeicho-tky@umin.ac.jp; phamhuuthuong.hth@gmail.com; endoh@research.twmu.ac.jp			Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), MEXT, Japan	This work was supported by a grant from the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Huyen MNT, 2013, J INFECT DIS, V207, P1516, DOI 10.1093/infdis/jit048; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Hales Craig M, 2013, Ann Am Thorac Soc, V10, P18, DOI 10.1513/AnnalsATS.201207-038OC; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Yang CG, 2012, CLIN INFECT DIS, V55, P1179, DOI 10.1093/cid/cis670; Nakajima C, 2013, J CLIN MICROBIOL, V51, P2025, DOI 10.1128/JCM.03404-12; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Glynn JR, 2006, EMERG INFECT DIS, V12, P736; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907; Lew W, 2008, ANN INTERN MED, V149, P123; Burman WJ, 2009, EMERG INFECT DIS, V15, P1061, DOI 10.3201/eid1507.081253; [Anonymous], TREATM TUB GUID; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Allix-Beguec C, 2014, J CLIN MICROBIOL, V52, P164, DOI 10.1128/JCM.02519-13; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chen YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094296; Hang NTL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071867; Hang NTL, 2014, J INFECTION, V69, P616, DOI 10.1016/j.jinf.2014.06.007; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633; MACGREGOR RR, 1975, CHEST, V68, P518, DOI 10.1378/chest.68.4.518; Maeda S, 2014, TUBERCULOSIS, V94, P649, DOI 10.1016/j.tube.2014.09.005; Mokrousov I, 2006, ANTIMICROB AGENTS CH, V50, P2820, DOI 10.1128/AAC.00324-06; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Sun YJ, 2006, EPIDEMIOL INFECT, V134, P329, DOI 10.1017/S095026880500525X; van Laarhoven A, 2013, INFECT IMMUN, V81, P3750, DOI 10.1128/IAI.00282-13; Vree M, 2007, INT J TUBERC LUNG D, V11, P392; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	41	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1472-9792			TUBERCULOSIS	Tuberculosis	MAY	2015	95	3					336	342		10.1016/j.tube.2015.02.040		7	Immunology; Microbiology; Respiratory System	Immunology; Microbiology; Respiratory System	CH6DK	WOS:000354126100014		
J	Suzuki, S; Uchida, K; Harada, T; Nibe, K; Yamashita, M; Ono, K; Nakayama, H				Suzuki, S.; Uchida, K.; Harada, T.; Nibe, K.; Yamashita, M.; Ono, K.; Nakayama, H.			The Origin and Role of Autophagy in the Formation of Cytoplasmic Granules in Canine Lingual Granular Cell Tumors	VETERINARY PATHOLOGY			English	Article						autophagy; canine; cell culture; immunohistochemistry; lingual granular cell tumor; neural crest origin; transmission electron microscopy; xenotransplantation	NERVE; STEM; DOG	Granular cell tumors (GCTs) are histologically characterized by polygonal neoplastic cells with abundant eosinophilic cytoplasmic granules. In humans, these cells are considered to be derived from Schwann cells, and the cytoplasmic granules are assumed to be autophagosomes or autophagolysosomes. However, the origin and nature of the cytoplasmic granules in canine GCTs have not been well characterized. The present study examined 9 canine lingual GCTs using immunohistochemistry, transmission electron microscopy (TEM), and cell culture and xenotransplantation experiments. In some cases, the tumor cells expressed S100, CD133, and desmin. The cytoplasmic granules were positive for LC3, p62, NBR1, and ubiquitin. TEM revealed autophagosome-like structures in the cytoplasm of the granule-containing cells. The cultured GCT cells were round to spindle shaped and expressed S100, nestin, Melan-A, CD133, LC3, p62, NBR1, and ubiquitin, suggesting that they were of neural crest origin, redifferentiated into melanocytes, and exhibited upregulated autophagy. The xenotransplanted tumors consisted of spindle to polygonal cells. Only a few cells contained cytoplasmic granules, and some had melanin pigments in their cytoplasm. The xenotransplanted cells expressed S100, nestin, Melan-A, and CD133. P62 and ubiquitin were detected, regardless of the presence or absence of cytoplasmic granules, while LC3 and NBR1 were detected only in the neoplastic cells containing cytoplasmic granules. These findings suggest that some xenotransplanted cells redifferentiated into melanocytes and that autophagy was upregulated in the cytoplasmic granule-containing cells. In conclusion, canine lingual GCTs originate from the neural crest and develop cytoplasmic granules via autophagy. In addition, the microenvironment of GCT cells affects their morphology.	[Suzuki, S.; Uchida, K.; Harada, T.; Nakayama, H.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan; [Nibe, K.; Yamashita, M.; Ono, K.] Japan Anim Referral Med Ctr, Takatsu Ku, Kawasaki, Kanagawa, Japan	Uchida, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, I-1-1 Yayoi, Tokyo 1138657, Japan.	auchidak@mail.ecc.u-tokyo.ac.jp					Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Shintaku M, 2011, VIRCHOWS ARCH, V459, P315, DOI 10.1007/s00428-011-1104-z; Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x; Dupin E, 2007, CR BIOL, V330, P521, DOI 10.1016/j.crvi.2007.04.004; Crane JF, 2006, ANNU REV CELL DEV BI, V22, P267, DOI 10.1146/annurev.cellbio.22.010305.103814; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Rallis TS, 2001, VET CLIN PATH, V30, P62, DOI 10.1111/j.1939-165X.2001.tb00260.x; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056878; Head KW, 2003, WHO INT HISTOLOGICAL, V10; Lu JE, 2012, VET OPHTHALMOL, V15, P406, DOI 10.1111/j.1463-5224.2012.01001.x; Lu Si-Zhao, 2013, World J Biol Chem, V4, P64, DOI 10.4331/wjbc.v4.i3.64; MIWA K, 1986, Gastroenterologia Japonica, V21, P508; PATNAIK AK, 1993, VET PATHOL, V30, P176; Rao D, 2010, J VET DIAGN INVEST, V22, P638; Rejas RAG, 2011, MED ORAL PATOL ORAL, V16, pE6, DOI 10.4317/medoral.16.e6; Shimada S, 2007, PATHOL INT, V57, P60, DOI 10.1111/j.1440-1827.2006.02059.x; Spyra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021099; Suzuki S, 2013, VET PATHOL, V51, P722; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Xu YH, 2013, ONCOL LETT, V5, P411, DOI 10.3892/ol.2012.1015	20	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	MAY	2015	52	3					456	464		10.1177/0300985814546051		9	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CH3GB	WOS:000353915800004		
J	Watanabe, K; Uchida, K; Chambers, JK; Tei, M; Shoji, A; Ushio, N; Nakayama, H				Watanabe, K.; Uchida, K.; Chambers, J. K.; Tei, M.; Shoji, A.; Ushio, N.; Nakayama, H.			Experimental Transmission of AA Amyloidosis by Injecting the AA Amyloid Protein Into Interleukin-1 Receptor Antagonist Knockout (IL-1raKO) Mice	VETERINARY PATHOLOGY			English	Article						AA amyloidosis; amyloid-enhancing factor; animal model; IL-1raKO; rheumatoid arthritis; serum amyloid A; species barrier; transmission	ENHANCING FACTOR AEF; RHEUMATOID-ARTHRITIS; SYSTEMIC AMYLOIDOSIS; FIBRILS; INDUCTION; MECHANISM	The incidence of AA amyloidosis is high in humans with rheumatoid arthritis and several animal species, including cats and cattle with prolonged inflammation. AA amyloidosis can be experimentally induced in mice using severe inflammatory stimuli and a coinjection of AA amyloid; however, difficulties have been associated with transmitting AA amyloidosis to a different animal species, and this has been attributed to the species barrier. The interleukin-1 receptor antagonist knockout (IL-1raKO) mouse, a rodent model of human rheumatoid arthritis, has been used in the transmission of AA amyloid. When IL-1raKO and BALB/c mice were intraperitoneally injected with mouse AA amyloid together with a subcutaneous pretreatment of 2% AgNO3, all mice from both strains that were injected with crude or purified murine AA amyloid developed AA amyloidosis. However, the amyloid index, which was determined by the intensity of AA amyloid deposition, was significantly higher in IL-1raKO mice than in BALB/c mice. When IL-1raKO and BALB/c mice were injected with crude or purified bovine AA amyloid together with the pretreatment, 83% (5/6 cases) and 38% (3/8 cases) of IL-1raKO mice and 17% (1/6 cases) and 0% (0/6 cases) of BALB/c mice, respectively, developed AA amyloidosis. Similarly, when IL-1raKO and BALB/c mice were injected with crude or purified feline AA amyloid, 33% (2/6 cases) and 88% (7/8 cases) of IL-1raKO mice and 0% (0/6 cases) and 29% (2/6 cases) of BALB/c mice, respectively, developed AA amyloidosis. These results indicated that IL-1raKO mice are a useful animal model for investigating AA amyloidogenesis.	[Watanabe, K.; Uchida, K.; Chambers, J. K.; Tei, M.; Shoji, A.; Ushio, N.; Nakayama, H.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Tokyo 1138657, Japan	Uchida, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	auchidak@mail.ecc.u-tokyo.ac.jp					ALIZADEHKHIAVI K, 1992, VIRCHOWS ARCH A, V420, P139, DOI 10.1007/BF02358805; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; Solomon A, 1999, AM J PATHOL, V154, P1267, DOI 10.1016/S0002-9440(10)65378-3; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; PRAS M, 1968, J CLIN INVEST, V47, P924; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Iwakura Y, 2002, CYTOKINE GROWTH F R, V13, P341, DOI 10.1016/S1359-6101(02)00021-7; SNOW AD, 1991, J HISTOCHEM CYTOCHEM, V39, P1321; SKINNER M, 1977, LAB INVEST, V36, P420; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; AXELRAD MA, 1982, LAB INVEST, V47, P139; BENDITT EP, 1971, FEBS LETT, V19, P169, DOI 10.1016/0014-5793(71)80506-9; Cui D, 2002, PATHOL INT, V52, P40, DOI 10.1046/j.1440-1827.2002.01309.x; GERTZ MA, 1991, MEDICINE, V70, P246; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Horiuchi N, 2008, AMYLOID, V15, P84, DOI 10.1080/13506120802005882; Johnsin KH, 1996, AMYLOID, V4, P270; KINDY MS, 1995, LAB INVEST, V73, P469; Kisilevsky R, 1999, AMYLOID, V6, P98, DOI 10.3109/13506129909007309; MAINARDI CL, 1987, RHEUM DIS CLIN N AM, V13, P215; Omoto M, 2007, MED MOL MORPHOL, V40, P88, DOI 10.1007/s00795-007-0361-z; RAM JS, 1968, INT ARCH ALLER A IMM, V34, P201; Sasatomi Y, 2007, INTERNAL MED, V46, P213, DOI 10.2169/internalmedicine.46.1690; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; SIPE JD, 1982, ANN NY ACAD SCI, V389, P137, DOI 10.1111/j.1749-6632.1982.tb22132.x; Sponarova J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003308; Takase H, 2014, BIOCHEM BIOPH RES CO, V444, P92, DOI 10.1016/j.bbrc.2014.01.029	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	MAY	2015	52	3					505	512		10.1177/0300985814556154		8	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CH3GB	WOS:000353915800009		
J	Hirata, A; Hashimoto, K; Katoh, Y; Sakai, H; Bruce, AG; Rose, TM; Kaneko, A; Suzuki, J; Nikami, H; Yanai, T				Hirata, A.; Hashimoto, K.; Katoh, Y.; Sakai, H.; Bruce, A. G.; Rose, T. M.; Kaneko, A.; Suzuki, J.; Nikami, H.; Yanai, T.			Characterization of Spontaneous Malignant Lymphomas in Japanese Macaques (Macaca fuscata)	VETERINARY PATHOLOGY			English	Article						Epstein-Barr virus; Japanese macaque; lymphocryptovirus; lymphoma; T cell	EPSTEIN-BARR-VIRUS; INFECTED RHESUS MACAQUES; CYNOMOLGUS MONKEYS; CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISORDER; LYMPHOCRYPTOVIRUS; FASCICULARIS; HERPESVIRUS; DIAGNOSIS; HOMOLOGS	Lymphomas are common spontaneous tumors in nonhuman primates but remain poorly characterized in Japanese macaques (Macaca fuscata). This study examined 5 cases of spontaneous malignant lymphoma in Japanese macaques, focusing on the immunophenotypes and presence of simian lymphocryptoviruses, which are Epstein-Barr virus-related herpesviruses in nonhuman primates. The macaques with lymphoma were 5 to 28 years old, indicating that lymphomas develop over a wide age range. The common macroscopic findings were splenomegaly and enlargement of lymph nodes. Histologic and immunohistochemical analyses revealed that all cases were non-Hodgkin type and exhibited a T-cell phenotype, positive for CD3 but negative for CD20 and CD79. The lymphomas exhibited diverse cellular morphologies and were subdivided into 3 types according to the World Health Organization classification. These included 3 cases of peripheral T-cell lymphoma, not otherwise specified; 1 case of T-cell prolymphocytic leukemia; and 1 case of an unclassifiable T-cell lymphoma. Positive signals were detected by in situ hybridization in 2 of the 4 examined cases using probes for the Epstein-Barr virus-encoded small RNA (EBER). Furthermore, the presence of M. fuscata lymphocryptovirus 2, a macaque homolog of Epstein-Barr virus, was demonstrated in EBER-positive cases by polymerase chain reaction amplification followed by direct sequencing. Immunohistochemistry using antibody to the Epstein-Barr virus-encoded nuclear antigen 2 was negative, even in the EBER-positive cases. The present study suggests that T-cell lymphoma is more common than B-cell lymphoma in Japanese macaques and that M. fuscata lymphocryptovirus 2 is present in some cases.	[Hirata, A.; Nikami, H.] Gifu Univ, Div Anim Expt, Life Sci Res Ctr, Gifu 5011194, Japan; [Hashimoto, K.; Katoh, Y.; Sakai, H.; Yanai, T.] Gifu Univ, Lab Vet Pathol, Dept Vet Med, Fac Appl Biol Sci, Gifu 5011194, Japan; [Bruce, A. G.; Rose, T. M.] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA; [Kaneko, A.; Suzuki, J.] Kyoto Univ, Primate Res Inst, Ctr Human Evolut Modeling Res, Inuyama, Aichi 484, Japan	Hirata, A (reprint author), Gifu Univ, Div Anim Expt, Life Sci Res Ctr, Yanagido 1-1, Gifu 5011194, Japan.	akatsuki@gifu-u.ac.jp			Cooperation Research Program of the Primate Research Institute of Kyoto University; Ministry of Education, Culture, Sports, Science, and Technology of Japan	We thank Ms Chikako Iriyama at Laboratory of Veterinary Pathology, Gifu University, for her expert technical assistance and the Division of Genomics Research, Life Science Research Center, Gifu University, for its support in molecular analysis. This study was supported by the Cooperation Research Program of the Primate Research Institute of Kyoto University and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Carbone A, 2008, ONCOLOGIST, V13, P577, DOI 10.1634/theoncologist.2008-0036; Estep RD, 2013, J VIROL, V87, P512, DOI 10.1128/JVI.02194-12; Dupuis J, 2006, BLOOD, V108, P4163, DOI 10.1182/blood-2006-04-017632; HAYAMI M, 1984, INT J CANCER, V33, P179, DOI 10.1002/ijc.2910330205; BENIASHVILI DS, 1989, J MED PRIMATOL, V18, P423; Blaschke S, 2001, J MED VIROL, V65, P114, DOI 10.1002/jmv.2009.abs; Bruce AG, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-2; Bruce AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002962; Carville A, 2008, COMPARATIVE MED, V58, P57; Ehlers B, 2003, J VIROL, V77, P10695, DOI 10.1128/JVI.77.19.10695-10699.2003; FEICHTINGER H, 1992, J EXP MED, V176, P281, DOI 10.1084/jem.176.1.281; FEICHTINGER H, 1990, AM J PATHOL, V137, P1311; Gilardi KVK, 2000, J AM VET MED ASSOC, V217, P384, DOI 10.2460/javma.2000.217.384; Gulley ML, 2001, J MOL DIAGN, V3, P1, DOI 10.1016/S1525-1578(10)60642-3; Habis A, 1999, AIDS RES HUM RETROV, V15, P1389, DOI 10.1089/088922299310098; Hirata A, 2013, J COMP PATHOL, V148, P43, DOI 10.1016/j.jcpa.2012.05.001; Isa T, 2009, EXP ANIM TOKYO, V58, P451, DOI 10.1538/expanim.58.451; ISHIDA T, 1993, FOLIA PRIMATOL, V61, P228; ISHIDA T, 1983, MICROBIOL IMMUNOL, V27, P297; Marr-Belvin AK, 2008, VET PATHOL, V45, P914, DOI 10.1354/vp.45-6-914; McInnes EF, 2002, TRANSPLANTATION, V73, P44, DOI 10.1097/00007890-200201150-00008; Michishita M, 2003, EXP ANIM TOKYO, V52, P339, DOI 10.1538/expanim.52.339; Paramastri YA, 2002, VET PATHOL, V39, P399, DOI 10.1354/vp.39-3-399; Pingel S, 1997, INT J CANCER, V72, P160, DOI 10.1002/(SICI)1097-0215(19970703)72:1<160::AID-IJC23>3.3.CO;2-A; Rao P, 2000, J CLIN MICROBIOL, V38, P3219; REZIKYAN S, 1995, INT J CANCER, V61, P574, DOI 10.1002/ijc.2910610423; Rivadeneira ED, 1999, BLOOD, V94, P2090; Schmidtko J, 2002, TRANSPLANTATION, V73, P1431, DOI 10.1097/00007890-200205150-00012; Suzuki J, 2005, EXP ANIM TOKYO, V54, P101, DOI 10.1538/expanim.54.101	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	MAY	2015	52	3					566	572		10.1177/0300985814547389		7	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CH3GB	WOS:000353915800015		
J	Kesdangsakonwut, S; Sunden, Y; Yamada, K; Nishizono, A; Sawa, H; Umemura, T				Kesdangsakonwut, S.; Sunden, Y.; Yamada, K.; Nishizono, A.; Sawa, H.; Umemura, T.			Neurogenic Cardiomyopathy in Rabbits With Experimentally Induced Rabies	VETERINARY PATHOLOGY			English	Article						rabbits; heart; brain; cardiomyopathy; neurogenic; rabies; brain-heart syndrome; myocardial necrosis	MYOCARDITIS; HEART	Cardiomyopathies have been rarely described in rabbits. Here we report myocardial necrosis of the ventricular wall in rabbits with experimentally induced rabies. Myocardial lesions were found only in rabbits with brain lesions, and the severity of the cardiac lesions was proportional to that of the brain lesions. Neither the frequency nor the cumulative dose of anesthesia was related to the incidence or the severity of the myocardial lesions. The myocardial lesions were characterized by degeneration and/or necrosis of myocardial cells and were accompanied by contraction band necrosis, interstitial fibrosis, and infiltration of inflammatory cells. The brain lesions due to rabies virus infection were most prominent in the cerebral cortex, thalamus, hypothalamus, brainstem, and medulla. Rabies virus antigen was not found in the hearts of any rabbits. Based on these findings, the myocardial lesions were classified as neurogenic cardiomyopathy.	[Kesdangsakonwut, S.; Umemura, T.] Hokkaido Univ, Lab Comparat Pathol, Dept Vet Clin Sci, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kesdangsakonwut, S.] Chulalongkorn Univ, Dept Pathol, Fac Vet Sci, Bangkok, Thailand; [Sunden, Y.] Tottori Univ, Fac Agr, Lab Vet Pathol, Tottori 680, Japan; [Yamada, K.; Nishizono, A.] Oita Univ, Dept Microbiol, Fac Med, Oita 87011, Japan; [Sawa, H.] Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan	Sunden, Y (reprint author), Tottori Univ, Lab Vet Pathol, Fac Agr, Koyama Cho Minami 4-101, Tottori 6890945, Japan.	sunden@muses.tottori-u.ac.jp	Sawa, Hirofumi/F-6954-2012		Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [23380171, 23780306]; Global Center of Excellence Program; Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, Japan	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (23380171 to T.U. and 23780306 to Y.S.) and by the Global Center of Excellence Program and the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, Japan.	Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; CHEETHAM HD, 1970, LANCET, V1, P921; Cheung RTF, 2000, ARCH NEUROL-CHICAGO, V57, P1685, DOI 10.1001/archneur.57.12.1685; Feiden W, 2013, PATHOLOGE, V34, P165, DOI 10.1007/s00292-012-1720-7; HURLEY RJ, 1994, LAB ANIM SCI, V44, P472; Marini RP, 1999, LAB ANIM SCI, V49, P153; METZE K, 1991, NEW ENGL J MED, V324, P1814; Meyer Sascha, 2009, Wien Med Wochenschr, V159, P342, DOI 10.1007/s10354-009-0642-3; Pariaut Romain, 2009, Vet Clin North Am Exot Anim Pract, V12, P135, DOI 10.1016/j.cvex.2008.08.004	9	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	MAY	2015	52	3					573	575		10.1177/0300985814543197		3	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CH3GB	WOS:000353915800016		
J	Mikami, T; Maruyama, S; Abe, T; Kobayashi, T; Yamazaki, M; Funayama, A; Shingaki, S; Kobayashi, T; Jun, C; Saku, T				Mikami, Toshihiko; Maruyama, Satoshi; Abe, Tatsuya; Kobayashi, Takanori; Yamazaki, Manabu; Funayama, Akinori; Shingaki, Susumu; Kobayashi, Tadaharu; Jun, Cheng; Saku, Takashi			Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration	VIRCHOWS ARCHIV			English	Article						Oral squamous cell carcinoma; Carcinoma in situ; Keratin 17; 14-3-3 sigma; siRNA	EPITHELIAL DYSPLASIA; 2-PHASE APPEARANCE; SIRNA DELIVERY; BETA-CATENIN; TUMOR-GROWTH; EXPRESSION; PROTEIN; CYTOKERATIN-17; MTOR; DIAGNOSIS	Expression of keratin (K) 13 is replaced with that of K17 when squamous cells of the oral mucosa transform from normal and dysplastic epithelia to carcinoma in situ (CIS) and squamous cell carcinoma (SCC). Since 14-3-3 sigma is functionally associated with K17, we examined possible relationships between expression of K17 and 14-3-3 sigma in oral CIS and SCC tissues by immunohistochemistry. We furthermore examined whether or not K17 expression or knockdown by small interfering RNA (siRNA) modulates the behavior of SCC cells in culture in terms of cell proliferation and migration. In tissue specimens of oral SCC and CIS, the pattern of cytoplasmic expression of 14-3-3 sigma and K17 was similar but neither was expressed in normal or dysplastic epithelia. Both proteins were demonstrated in the cytoplasm of control oral SCC ZK-1 cells, but expression of 14-3-3 sigma changed from cytoplasmic to nuclear upon knockdown of K17. In carcinoma cells, therefore, cytoplasmic localization of 14-3-3 sigma seems to accompany expression of K17. In K17-knockdown cells, proliferation was significantly suppressed at 4 days after seeding. In addition, the cell size of K17-knockdown cells was significantly smaller than that of control cells; as a result of which in the migration experiments, we found delayed closure of scratch wounds but migration as such was not affected. We conclude that K17 expression promotes SCC cell growth and cell size but does not affect cell migration. K17 expression is accompanied by cytoplasmic expression of 14-3-3 sigma, indicative of their functional relationship.	[Mikami, Toshihiko; Maruyama, Satoshi; Abe, Tatsuya; Kobayashi, Takanori; Yamazaki, Manabu; Funayama, Akinori; Jun, Cheng; Saku, Takashi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Oral Pathol,Chuo Ku, Niigata 9518514, Japan; [Mikami, Toshihiko; Funayama, Akinori; Shingaki, Susumu; Kobayashi, Tadaharu] Niigata Univ, Grad Sch Med & Dent Sci, Div Reconstruct Surg Oral & Maxillofacial Reg, Dept Tissue Regenerat & Reconstruct, Niigata 9518514, Japan; [Maruyama, Satoshi; Abe, Tatsuya; Saku, Takashi] Niigata Univ Hosp, Dept Surg Pathol, Oral Pathol Sect, Niigata, Japan	Saku, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Oral Pathol,Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	tsaku@dent.niigata-u.ac.jp			Japan Society for the Promotion of Science; Promotion of Niigata University Research Projects	This work was supported in part by Grants-in-Aid for Scientific Research (to SM, JC, and TS) and for Young Scientists (to TM and SM) from the Japan Society for the Promotion of Science and by a grant for the Promotion of Niigata University Research Projects (to TM and SM).	Shegokar R, 2011, PHARMAZIE, V66, P313, DOI 10.1691/ph.2011.0301; TROYANOVSKY SM, 1992, EUR J CELL BIOL, V59, P127; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Santel A, 2010, CLIN CANCER RES, V16, P5469, DOI 10.1158/1078-0432.CCR-10-1994; Xu G, 2004, INT J ONCOL, V24, P893; Chan TA, 2000, GENE DEV, V14, P1584; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Funayama A, 2011, PATHOBIOLOGY, V78, P171, DOI 10.1159/000324926; Janus A, 2005, CELL MOL BIOL LETT, V10, P479; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Senzer N, 2012, MOL THER, V20, P679, DOI 10.1038/mt.2011.269; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Lyda MH, 2000, HUM PATHOL, V31, P980, DOI 10.1053/hupa.2000.9076; Strimpakos AS, 2009, CANCER TREAT REV, V35, P148, DOI 10.1016/j.ctrv.2008.09.006; Metwaly H, 2012, HUM PATHOL, V43, P1973, DOI 10.1016/j.humpath.2012.02.006; Sarbia M, 2007, AM J CLIN PATHOL, V128, P255, DOI 10.1309/EEML5CH79PWD0R2D; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Alvarado CG, 2011, HISTOPATHOLOGY, V59, P283, DOI 10.1111/j.1365-2559.2011.03929.x; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Wang Z, 2011, PHARM RES-DORDR, V28, P2983, DOI 10.1007/s11095-011-0604-5; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Carrilho C, 2004, HUM PATHOL, V35, P546, DOI 10.1016/j.humpath.2004.01.021; Cohen-Kerem R, 2004, ANN OTO RHINOL LARYN, V113, P821; Funayama A, 2012, VIRCHOWS ARCH, V460, P473, DOI 10.1007/s00428-012-1224-0; Hayashi E, 2009, PROTEOM CLIN APPL, V3, P1338, DOI 10.1002/prca.200900091; Ida-Yonemochi H, 2012, MODERN PATHOL, V25, P784, DOI 10.1038/modpathol.2011.218; Ikarashi T, 2004, J ORAL PATHOL MED, V33, P87, DOI 10.1111/j.1600-0714.2004.00026.x; Ikeda K, 2008, GYNECOL ONCOL, V108, P598, DOI 10.1016/j.ygyno.2007.11.042; Kirschner M, 2006, STEM CELLS DEV, V15, P556, DOI 10.1089/scd.2006.15.556; Kobayashi T, 2012, HISTOPATHOLOGY, V61, P910, DOI 10.1111/j.1365-2559.2012.04283.x; Kobayashi T, 2010, PATHOL INT, V60, P156, DOI 10.1111/j.1440-1827.2009.02499.x; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Maruyama S, 2010, CANCER GENET CYTOGEN, V195, P14; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Mikami T, 2011, ORAL ONCOL, V47, P497, DOI 10.1016/j.oraloncology.2011.03.015; Patnaik A, 2009, J CLIN ONCOL, V27; Saito M., 2012, ORAL MED PATHOLOGY, V16, P81; Smith FJD, 1998, HUM MOL GENET, V7, P1143, DOI 10.1093/hmg/7.7.1143; Syafriadi M, 2005, J ORAL PATHOL MED, V34, P140, DOI 10.1111/j.1600-0714.2004.00283.x; Takahashi Y, 2006, J CONTROL RELEASE, V116, P90, DOI 10.1016/j.jconrel.2006.09.002; Takanashi M, 2009, GENE THER, V16, P982, DOI 10.1038/gt.2009.66; Tilakaratne WM, 2009, J ORAL PATHOL MED, V38, P348, DOI 10.1111/j.1600-0714.2009.00750.x; TROYANOVSKY SM, 1989, J CELL SCI, V93, P419; Wei KJ, 2009, ORAL DIS, V15, P111, DOI 10.1111/j.1601-0825.2008.01501.x; Yoshikawa K, 1998, J DERMATOL SCI, V17, P15, DOI 10.1016/S0923-1811(97)00065-0	48	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	MAY	2015	466	5					559	569		10.1007/s00428-015-1735-6		11	Pathology	Pathology	CH6FD	WOS:000354130900010		
J	Pelekanos, V; Ban, H; Welchman, AE				Pelekanos, Vassilis; Ban, Hiroshi; Welchman, Andrew E.			Brightness masking is modulated by disparity structure	VISION RESEARCH			English	Article						Brightness estimation; Visual masking; Binocular depth perception; Filling-in	FIGURE-GROUND SEPARATION; VISUAL BACKWARD-MASKING; PERCEPTUAL FILLING-IN; LIGHTNESS PERCEPTION; NEURAL DYNAMICS; COMPLETION; CORTEX; CONSISTENT; INDUCTION; VISION	The luminance contrast at the borders of a surface strongly influences surface's apparent brightness, as demonstrated by a number of classic visual illusions. Such phenomena are compatible with a propagation mechanism believed to spread contrast information from borders to the interior. This process is disrupted by masking, where the perceived brightness of a target is reduced by the brief presentation of a mask (Paradiso & Nakayama, 1991), but the exact visual stage that this happens remains unclear. In the present study, we examined whether brightness masking occurs at a monocular-, or a binocular-level of the visual hierarchy. We used backward masking, whereby a briefly presented target stimulus is disrupted by a mask coming soon afterwards, to show that brightness masking is affected by binocular stages of the visual processing. We manipulated the 3-D configurations (slant direction) of the target and mask and measured the differential disruption that masking causes on brightness estimation. We found that the masking effect was weaker when stimuli had a different slant. We suggest that brightness masking is partly mediated by mid-level neuronal mechanisms, at a stage where binocular disparity edge structure has been extracted. (C) 2015 The Authors. Published by Elsevier Ltd.	[Pelekanos, Vassilis; Ban, Hiroshi; Welchman, Andrew E.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Pelekanos, Vassilis; Welchman, Andrew E.] Univ Cambridge, Dept Psychol, Cambridge CB2 1TN, England; [Ban, Hiroshi] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Osaka, Japan; [Ban, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan	Welchman, AE (reprint author), Univ Cambridge, Dept Psychol, Cambridge CB2 1TN, England.	aew69@cam.ac.uk	Welchman, Andrew/B-7542-2013	Welchman, Andrew/0000-0002-7559-3299	Japan Society for the Promotion of Science; JSPS KAKENHI [26870911]; Wellcome Trust [095183/Z/10/Z]	This project was supported by fellowships to H.B. from the Japan Society for the Promotion of Science, JSPS KAKENHI (26870911) and A.E.W. from the Wellcome Trust (095183/Z/10/Z).	Adelson E. H., 2000, NEW COGNITIVE NEUROS, P339; Anderson BL, 2005, NATURE, V434, P79, DOI 10.1038/nature03271; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; PARADISO MA, 1991, VISION RES, V31, P1221, DOI 10.1016/0042-6989(91)90047-9; ALPERN M, 1953, J OPT SOC AM, V43, P648, DOI 10.1364/JOSA.43.000648; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; Otazu X, 2008, VISION RES, V48, P733, DOI 10.1016/j.visres.2007.12.008; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; KNILL DC, 1991, NATURE, V351, P228, DOI 10.1038/351228a0; GROSSBERG S, 1985, PSYCHOL REV, V92, P173, DOI 10.1037/0033-295X.92.2.173; DEWEERD P, 1995, NATURE, V377, P731; Blakeslee B, 1999, VISION RES, V39, P4361, DOI 10.1016/S0042-6989(99)00119-4; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Anstis S, 2010, CURR BIOL, V20, pR664, DOI 10.1016/j.cub.2010.06.029; Breitmeyer B. G., 2006, VISUAL MASKING TIME; Davey MP, 1998, VISION RES, V38, P2037, DOI 10.1016/S0042-6989(97)00329-5; Green MF, 2005, J COGNITIVE NEUROSCI, V17, P13, DOI 10.1162/0898929052880011; GROSSBERG S, 1994, PERCEPT PSYCHOPHYS, V55, P48, DOI 10.3758/BF03206880; GROSSBERG S, 1988, PERCEPT PSYCHOPHYS, V43, P241, DOI 10.3758/BF03207869; Kelly F, 2000, PERCEPT PSYCHOPHYS, V62, P1596, DOI 10.3758/BF03212158; Komatsu H., 2008, SENSES COMPREHENSIVE, P45; McArthur JA, 1999, VISION RES, V39, P1199, DOI 10.1016/S0042-6989(98)00216-8; Polat Uri, 2007, Adv Cogn Psychol, V3, P153, DOI 10.2478/v10053-008-0021-4; WATT RJ, 1985, VISION RES, V25, P1661, DOI 10.1016/0042-6989(85)90138-5; Welchman AE, 2003, P ROY SOC B-BIOL SCI, V270, P83, DOI 10.1098/rspb.2002.2220	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	MAY	2015	110		A				87	92		10.1016/j.visres.2015.02.010		6	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CH6LW	WOS:000354149100010		
J	Yokoyama, O; Tsujimura, A; Akino, H; Segawa, N; Tamada, S; Oguchi, N; Kitagawa, Y; Tsuji, H; Watanabe, A; Inamoto, T; Shimizu, N; Fujiuchi, Y; Katsuoka, Y; Azuma, H; Matsuda, T; Namiki, M; Uemura, H; Okuyama, A; Nonomura, N; Fuse, H; Nakatani, T				Yokoyama, Osamu; Tsujimura, Akira; Akino, Hironobu; Segawa, Naoki; Tamada, Satoshi; Oguchi, Naoki; Kitagawa, Yasuhide; Tsuji, Hidenori; Watanabe, Akihiko; Inamoto, Teruo; Shimizu, Nobutaka; Fujiuchi, Yasuyoshi; Katsuoka, Yoji; Azuma, Haruhito; Matsuda, Tadashi; Namiki, Mikio; Uemura, Hirotsugu; Okuyama, Akihiko; Nonomura, Norio; Fuse, Hideki; Nakatani, Tatsuya			Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving alpha 1-blocker treatment: a multi-centre, prospective, randomised study	WORLD JOURNAL OF UROLOGY			English	Article						Anticholinergic; Nocturia; Nocturnal urine volume; Overactive bladder; Benign prostatic hyperplasia; Imidafenacin	OVERACTIVE BLADDER SYMPTOMS; QUALITY-OF-LIFE; BENIGN PROSTATIC HYPERPLASIA; ANTIMUSCARINIC AGENT; CONTROLLED-TRIAL; DOUBLE-BLIND; IMIDAFENACIN; POLYURIA; MEN; SOLIFENACIN	To evaluate the efficacy and safety of imidafenacin (IM), a novel short half-life anticholinergic, as add-on therapy for male LUTS with nocturia and nocturnal polyuria. This multicenter, prospective, randomized, open-labelled study was conducted and involved men who had frequency, urgency, and nocturia despite receiving a stable dose of alpha 1-blocker for a parts per thousand yen1 month. Subjects were randomised to control (alpha 1-blocker alone), IM twice/day (alpha 1-blocker +0.1 mg imidafenacin twice daily), or IM nightly (alpha 1-blocker plus 0.1 mg imidafenacin nightly) group; the treatment period was 8 weeks. Primary endpoints included improvements in night-time frequency and Nocturia Quality of Life Questionnaire (N-QOL) scores. Secondary endpoints included changes from the baseline in frequency volume chart variables, and post-void residual volume. Compared with the controls, IM twice/day and IM nightly patients had a significantly lower night-time frequency (changes from baseline: 0.1 +/- A 0.8 in control, -0.6 +/- A 0.9 in IM twice/day, and -0.4 +/- A 1.0 in IM nightly, p = 0.5227, 0.0006 and 0.0143, respectively). The hours of undisturbed sleep and N-QOL score were significantly improved in IM twice/day group, though not IM nightly group. Nocturnal urine volume was significantly reduced in IM nightly group, although total urine volume remained unchanged. A short half-life anticholinergic is suggested to be safe and effective as an add-on therapy for residual nocturia in patients with male LUTS receiving alpha 1-blocker treatment. Anticholinergic administration nightly could reduce the nocturnal urine volume.	[Yokoyama, Osamu; Akino, Hironobu] Univ Fukui, Fac Med Sci, Dept Urol, Fukui 910, Japan; [Tsujimura, Akira; Okuyama, Akihiko; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka, Japan; [Segawa, Naoki; Inamoto, Teruo; Katsuoka, Yoji; Azuma, Haruhito] Osaka Med Coll, Dept Urol, Osaka, Japan; [Tamada, Satoshi; Nakatani, Tatsuya] Osaka City Univ, Dept Urol, Osaka 558, Japan; [Oguchi, Naoki; Matsuda, Tadashi] Kansai Med Univ, Dept Urol & Androl, Osaka, Japan; [Kitagawa, Yasuhide; Namiki, Mikio] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa, Japan; [Tsuji, Hidenori; Shimizu, Nobutaka; Uemura, Hirotsugu] Kinki Univ, Sch Med, Dept Urol, Osaka 589, Japan; [Watanabe, Akihiko; Fujiuchi, Yasuyoshi; Fuse, Hideki] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Urol, Toyama 930, Japan	Yokoyama, O (reprint author), Univ Fukui, Fac Med Sci, Dept Urol, Fukui 910, Japan.	oyoko@u-fukui.ac.jp			Supporting Center for Clinical Research and Education (SCCRE)	This study was supported by the Supporting Center for Clinical Research and Education (SCCRE). The authors thank Dr. Urashima Mitsuyoshi at the Division of Molecular Epidemiology, Jikei University School of Medicine (Tokyo), for help with the random assignment, and the Osaka-Hokuriku male LUTS research study group for contributions to the success of this trial. We would like to express our sincere thanks to the following for their participation: Masato Kuribayashi and Takashi Shima, Kanazawa University Graduate School of Medical Science (Kanazawa); Masayuki Nakagawa, Kansai Medical University (Osaka); Hideo Tahara, Kinki University School of Medicine (Osaka); Katsuyuki Kuratsukuri, Osaka City University (Osaka); Yuto Nomi and Nobutaka Ubai, Osaka Medical College (Osaka); Yasushi Miyagawa and Tetsuya Takao, Osaka University Graduate School of Medicine (Osaka); Yoshitaka Aoki, Hideaki Ito, University of Fukui (Fukui); University of Toyama (Toyama); Fujita Memorial Hospital (Fukui); Fukui Social Insurance Hospital (Fukui); Hasegawa Hospital (Toyama); Hayashi Hospital (Fukui); Jujinkai Kimura Hospital (Fukui); Kimura Hospital (Fukui); Mimihara General Hospital (Osaka); and Nanto Municipal Hospital (Toyama).	Abraham L, 2004, UROLOGY, V63, P481, DOI 10.1016/j.urology.2003.10.019; Appell RA, 2008, NEUROUROL URODYNAM, V27, P34, DOI 10.1002/nau.20484; Nishizawa O, 2011, LUTS, V3, P29, DOI 10.1111/j.1757-5672.2010.00081.x; Maggiore ULR, 2013, EXPERT OPIN PHARMACO, V14, P1383, DOI 10.1517/14656566.2013.796930; Kaplan SA, 2006, JAMA-J AM MED ASSOC, V296, P2319, DOI 10.1001/jama.296.19.2319; Chang SC, 2006, UROLOGY, V67, P541, DOI 10.1016/j.urology.2005.09.037; Yamada S, 2011, J PHARMACOL EXP THER, V336, P365, DOI 10.1124/jpet.110.172288; Cornu JN, 2012, EUR UROL, V62, P877, DOI 10.1016/j.eururo.2012.07.004; Homma Y, 2006, UROLOGY, V68, P560, DOI 10.1016/j.urology.2006.03.035; Asplund R, 2004, J PSYCHOSOM RES, V56, P517, DOI 10.1016/j.jpsychores.2004.04.003; Stoevelaar HJ, 1999, J UROLOGY, V161, P133, DOI 10.1016/S0022-5347(01)62083-4; Yamaguchi O, 2011, UROLOGY, V78, P126, DOI 10.1016/j.urology.2011.02.055; van Kerrebroeck P, 2002, NEUROUROL URODYNAM, V21, P179, DOI 10.1002/nau.10053; Kupelian V, 2012, EUR UROL, V61, P78, DOI 10.1016/j.eururo.2011.05.065; Coyne KS, 2003, BJU INT, V92, P948, DOI 10.1046/j.1464-410X.2003.04527.x; Asplund R, 1999, BJU INT, V83, P591; Brubaker L, 2007, INT UROGYNECOL J, V18, P737, DOI 10.1007/s00192-006-0239-y; Homma Y, 2009, INT J UROL, V16, P499, DOI 10.1111/j.1442-2042.2009.02286.x; Homma Y, 2011, UROLOGY, V77, P60, DOI 10.1016/j.urology.2010.06.044; Smith AL, 2011, BJU INT, V107, P1550, DOI 10.1111/j.1464-410X.2010.09972.x; Takeuchi Takumi, 2013, Ther Adv Urol, V5, P43, DOI 10.1177/1756287212459549; Watanabe N, 2013, BJU INT, V112, P131, DOI 10.1111/j.1464-410X.2012.11747.x; Weiss JP, 2000, J UROLOGY, V163, P5, DOI 10.1016/S0022-5347(05)67961-X; Yokoyama O, 2010, NEUROUROL URODYNAM, V29, P587, DOI 10.1002/nau.20797; Yokoyama O, 2013, UROLOGY, V82, P515, DOI 10.1016/j.urology.2013.05.017	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-4983	1433-8726		WORLD J UROL	World J. Urol.	MAY	2015	33	5					659	667		10.1007/s00345-014-1399-x		9	Urology & Nephrology	Urology & Nephrology	CH2CL	WOS:000353832200008		
J	Kawada, T				Kawada, T.			Sleep by actigraphy in patients with remitted bipolar disorders	ACTA PSYCHIATRICA SCANDINAVICA			English	Letter							POLYSOMNOGRAPHY		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	kawada@nms.ac.jp					Kaplan KA, 2012, BIPOLAR DISORD, V14, P870, DOI 10.1111/bdi.12021; Geoffroy PA, 2014, J AFFECT DISORDERS, V158, P1, DOI 10.1016/j.jad.2014.01.012; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; Boudebesse C, 2014, CHRONOBIOL INT, V31, P698, DOI 10.3109/07420528.2014.895742; Geoffroy PA, 2015, ACTA PSYCHIAT SCAND, V131, P89, DOI 10.1111/acps.12367	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-690X	1600-0447		ACTA PSYCHIAT SCAND	Acta Psychiatr. Scand.	MAY	2015	131	5					399	400		10.1111/acps.12398		2	Psychiatry	Psychiatry	CG9PP	WOS:000353649200014		
J	Omichi, H; Ueda, T; Eguchi, T				Omichi, Hiroaki; Ueda, Takahiro; Eguchi, Taro			Molecular motion of alcohols adsorbed in ACF hydrophobic nanoslits as studied by solid-state NMR	ADSORPTION-JOURNAL OF THE INTERNATIONAL ADSORPTION SOCIETY			English	Article						Molecular motion; NMR; 2D porous materials; Amphipathic molecular system; Confinement; Hydrogen bond	ACTIVATED CARBON-FIBERS; X-RAY-DIFFRACTION; NUCLEAR-MAGNETIC-RESONANCE; GRAPHITIC MICROPORES; MONOHYDRIC ALCOHOLS; SELF-DIFFUSION; CLUSTER-GROWTH; PHASE-DIAGRAM; WATER; ETHANOL	The molecular motion and local structure of methanol-d(1) (CH3OD) and ethanol-d(1) (C2H5OD) in activated carbon fiber (ACF) with a slit width of 0.7 and 1.1 nm have been investigated by solid-state H-1 and H-2 NMR. H-2 NMR spectra for alcohols confined in ACF gave a so-called Pake doublet below 140 K, which were characterized by the H-2 quadrupole coupling constant (QCC) of 185 kHz and the asymmetric parameter of the electric-field-gradient tensor (eta) of 0.1. The QCC value of the deuteron was indicative of the hydrogen bond formation with the O center dot center dot center dot O distance of ca. 0.27 nm, suggesting the solid-like feature of alcohols in ACFs. The quadrupole broadening vanished on heating and the single isotropic resonance line was observed. Alcohol molecules were undergoing a rapid motion like as in the bulk liquid, indicating a transition from solid to liquid in ACFs. Temperature-dependent H-1 NMR spectra were used for evaluating the E (a) value for reorientation in solid-like alcohols, whereas the H-2 NMR spectra were used for obtaining the translation accompanying reorientation in liquid-like alcohols. Alcohols with a bilayered structure in ACF with a slit width of 1.1 nm gave similar E (a) values, whereas C2H5OD in ACF with a slit width of 0.7 nm, in which a monolayered structure is expected, exhibited a cross-over of two activation processes at 172 K. The variation in E (a) was probably caused by the structural relaxation concerning with the hydrogen bonding formation and/or excitation of the large amplitude local motion. The competition of the directionality of hydrogen bonds and a freedom of molecular orientation plays an important role to characterize the intermolecular structure as well as the physicochemical properties in amphipathic molecules in confinement.	[Omichi, Hiroaki; Ueda, Takahiro; Eguchi, Taro] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Ueda, Takahiro; Eguchi, Taro] Osaka Univ, Museum Osaka Univ, Toyonaka, Osaka 5600043, Japan	Ueda, T (reprint author), Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan.	ueda@museum.osaka-u.ac.jp					Abragam A., 1961, PRINCIPLES NUCL MAGN; KANEKO K, 1992, CARBON, V30, P1075, DOI 10.1016/0008-6223(92)90139-N; Radhakrishnan R, 1999, J CHEM PHYS, V111, P9058, DOI 10.1063/1.480261; Radhakrishnan R, 2000, J CHEM PHYS, V112, P11048, DOI 10.1063/1.481745; Kaneko K, 1999, J PHYS CHEM B, V103, P7061, DOI 10.1021/jp9907692; Radhakrishnan R, 2002, J CHEM PHYS, V116, P1147, DOI 10.1063/1.1426412; STEELE WA, 1973, SURF SCI, V36, P317, DOI 10.1016/0039-6028(73)90264-1; Ohba T, 2004, J AM CHEM SOC, V126, P1560, DOI 10.1021/ja038842w; Ohkubo T, 1999, J PHYS CHEM B, V103, P1859, DOI 10.1021/jp984261v; PRATT KC, 1977, J CHEM SOC FARAD T 2, V73, P997, DOI 10.1039/f29777300997; BERGLUND B, 1980, J CHEM PHYS, V73, P2037, DOI 10.1063/1.440423; Watanabe A, 1999, CHEM PHYS LETT, V305, P71, DOI 10.1016/S0009-2614(99)00362-0; Ohba T, 2005, CHEM-EUR J, V11, P4890, DOI 10.1002/chem.200400918; Mowla D, 2003, CHEM PHYS CARBON, V28, P229; Iiyama T, 2009, COLLOID SURFACE A, V347, P133, DOI 10.1016/j.colsurfa.2009.02.021; HURLE RL, 1985, J CHEM SOC FARAD T 1, V81, P769, DOI 10.1039/f19858100769; Nguyen TX, 2011, J PHYS CHEM C, V115, P16606, DOI 10.1021/jp2053162; Ohkubo T, 2001, COLLOID SURFACE A, V187, P177, DOI 10.1016/S0927-7757(01)00627-6; EGUCHI T, 1980, MOL PHYS, V40, P681, DOI 10.1080/00268978000101791; GARG SK, 1973, J CHEM PHYS, V58, P1898, DOI 10.1063/1.1679449; GOLDAMME.EV, 1970, J PHYS CHEM-US, V74, P3734; Henschel A, 2010, PHIL MAG LETT, V90, P481, DOI 10.1080/09500831003766999; JONSSON PG, 1976, ACTA CRYSTALLOGR B, V32, P232, DOI 10.1107/S0567740876002653; KANEKO K, 1994, LANGMUIR, V10, P4606, DOI 10.1021/la00024a036; Kaneko K, 1996, COLLOID SURFACE A, V109, P319, DOI 10.1016/0927-7757(95)03464-1; MORISHIGE K, 1992, J CHEM PHYS, V97, P2084, DOI 10.1063/1.463146; Nobusawa S, 2013, COLLOID SURFACE A, V419, P100, DOI 10.1016/j.colsurfa.2012.11.059; Ohba T, 2004, J PHYS CHEM B, V108, P14964, DOI 10.1021/jp048323v; Ohkubo T, 2000, STUD SURF SCI CATAL, V128, P411; Ohkubo T, 1999, CHEM PHYS LETT, V312, P191, DOI 10.1016/S0009-2614(99)01001-5; OLYMPIA PL, 1969, J CHEM PHYS, V51, P2976, DOI 10.1063/1.1672444; Omichi H, 2007, CHEM LETT, V36, P256, DOI 10.1246/cl.2007.256; Omichi H, 2008, MOL CRYST LIQ CRYST, V490, P91, DOI 10.1080/15421400802305772; OSHIDA K, 1995, J MATER RES, V10, P2507, DOI 10.1557/JMR.1995.2507; Radhakrishnan R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.076101; Ramos MA, 2006, J NON-CRYST SOLIDS, V352, P4769, DOI 10.1016/j.jnoncrysol.2006.02.143; Sato M, 1997, J PHYS CHEM B, V101, P1845, DOI 10.1021/jp962472z; Sliwinska-Bartkowiak M, 2012, PHYS CHEM CHEM PHYS, V14, P7145, DOI 10.1039/c2cp22111j; Sliwinska-Bartkowiak M, 2001, PHYS CHEM CHEM PHYS, V3, P1179, DOI 10.1039/b009792f; Torrie BH, 2002, J SOLID STATE CHEM, V166, P415, DOI 10.1006/jssc.2002.9615; Ueda T, 2006, B CHEM SOC JPN, V79, P237, DOI 10.1246/bcsj.79.237; Ueda T, 2010, PHYS CHEM CHEM PHYS, V12, P9222, DOI 10.1039/b922681h; Ueda T, 2010, B CHEM SOC JPN, V83, P1323, DOI 10.1246/bcsj.20100169	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5607	1572-8757		ADSORPTION	Adsorpt.-J. Int. Adsorpt. Soc.	MAY	2015	21	4					273	282		10.1007/s10450-015-9669-5		10	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CH1LV	WOS:000353784100003		
J	Lee, MP; Zhou, JL; Messerschmidt, L; Honda, M; Ditangco, R; Sirisanthana, T; Kumarasamy, N; Phanuphak, P; Chen, YMA; Zhang, FJ; Saphonn, V; Kiertiburanakul, S; Lee, CKC; Pujari, S; Choi, JY; Kamarulzaman, A; Yunihastuti, E; Merati, TP; Lim, PL; Li, PCK				Lee, Man Po; Zhou, Jialun; Messerschmidt, Liesl; Honda, Miwako; Ditangco, Rossana; Sirisanthana, Thira; Kumarasamy, Nagalingeswaran; Phanuphak, Praphan; Chen, Yi-Ming Arthur; Zhang, Fujie; Saphonn, Vonthanak; Kiertiburanakul, Sasisopin; Lee, Christopher K. C.; Pujari, Sanjay; Choi, Jun Yong; Kamarulzaman, Adeeba; Yunihastuti, Evy; Merati, Tuti Parwati; Lim, Poh-Lian; Li, Patrick C. K.		TREAT Asia HIV	Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database	AIDS PATIENT CARE AND STDS			English	Letter							SEX-DIFFERENCES; ADVERSE EVENTS; PHARMACOKINETICS; INFECTION; PROGRAM		[Lee, Man Po; Li, Patrick C. K.] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China; [Zhou, Jialun] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Messerschmidt, Liesl] TREAT Asia AmfAR, Bangkok, Thailand; [Honda, Miwako] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Ditangco, Rossana] Res Inst Trop Med, Manila, Philippines; [Sirisanthana, Thira] Res Inst Hlth Sci, Chiang Mai, Thailand; [Kumarasamy, Nagalingeswaran] YRG Ctr AIDS Res & Educ, Chennai, Tamil Nadu, India; [Phanuphak, Praphan] HIV NAT Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Chen, Yi-Ming Arthur] Taipei Vet Gen Hosp, Taipei, Taiwan; [Chen, Yi-Ming Arthur] Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan; [Zhang, Fujie] Beijing Ditan Hosp, Beijing, Peoples R China; [Saphonn, Vonthanak] Natl Ctr HIV AIDS Dermatol & STDs, Phnom Penh, Cambodia; [Kiertiburanakul, Sasisopin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Lee, Christopher K. C.] Hosp Sungai Buloh, Sungai Buloh, Malaysia; [Pujari, Sanjay] Inst Infect Dis, Pune, Maharashtra, India; [Choi, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Kamarulzaman, Adeeba] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Yunihastuti, Evy] Univ Indonesia, Ciptomangunkusumo Hosp, Working Grp AIDS Fac Med, Jakarta, Indonesia; [Merati, Tuti Parwati] Udayana Univ, Fac Med, Bali, Indonesia; [Merati, Tuti Parwati] Sanglah Hosp, Bali, Indonesia; [Lim, Poh-Lian] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Infect Dis, Singapore, Singapore	Lee, MP (reprint author), Queen Elizabeth Hosp, Dept Med, 30 Gascoigne Rd, Kowloon, Hong Kong, Peoples R China.	leemp@ha.org.hk			US National Institutes of Health as part of the International Epidemiologic Databases to Evaluate AIDS (NIAID/NICHD/NCI) [U01AI069907]; Dutch Ministry of Foreign Affairs through Stichting Aids Fonds; Australian Government Department of Health and Ageing	Study funders included the US National Institutes of Health as part of the International Epidemiologic Databases to Evaluate AIDS (NIAID/NICHD/NCI; U01AI069907), the Dutch Ministry of Foreign Affairs through Stichting Aids Fonds, and the Australian Government Department of Health and Ageing. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above.	Alibhai Arif, 2010, Int J Womens Health, V2, P45; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI 10.1146/annurev.pharmtox.44.101802.121453; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5; Le Coeur S, 2009, SOC SCI MED, V69, P846, DOI 10.1016/j.socscimed.2009.05.042; Clark R, 2005, DRUG SAFETY, V28, P1075, DOI 10.2165/00002018-200528120-00003; Currier JS, 2000, J ACQ IMMUN DEF SYND, V24, P316; Floridia M, 2008, PHARMACOL RES, V58, P173, DOI 10.1016/j.phrs.2008.07.007; Umeh OC, 2006, EXPERT OPIN DRUG MET, V2, P273, DOI 10.1517/17425255.2.2.273; UNAIDS, UNAIDS REP GLOB AIDS; Wen Y, 2011, AIDS CARE, V23, P1226, DOI 10.1080/09540121.2011.555748	11	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1087-2914	1557-7449		AIDS PATIENT CARE ST	Aids Patient Care STDS	MAY 1	2015	29	5					229	231		10.1089/apc.2014.0232		3	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CH0LF	WOS:000353710600001		
J	Matsui, Y; Shimatani, M; Kuzuhara, K; Miyazaki, Y; Horiuchi, T; Tajima, Y; Yano, K; Nagata, T				Matsui, Yasuko; Shimatani, Michitsugu; Kuzuhara, Kenta; Miyazaki, Yoshiko; Horiuchi, Tomoko; Tajima, Yasuhisa; Yano, Kunio; Nagata, Toshi			Three-year prospective, observational study of central line-associated bloodstream infections in a 600-bed Japanese acute care hospital	AMERICAN JOURNAL OF INFECTION CONTROL			English	Article						Central line-associated bloodstream infection; Central venous catheters; Surveillance	CENTRAL VENOUS CATHETERS; UNIT PATIENTS; SINGLE-LUMEN; RISK-FACTORS; SURVEILLANCE; METAANALYSIS; PREVENTION; ADULTS	Background: Central line-associated bloodstream infection (CLABSI) is an important concern associated with central venous catheter (CVC) use. The objective of this study was to determine the influences of CVC access sites, CVC types, and presumed causative microorganisms on CLABSI occurrence in an acute care hospital. Methods: We conducted a prospective, observational study of CLABSI occurrence for 3 consecutive years in a 600-bed Japanese acute care hospital. Data collected included patient characteristics, CVC access sites, CVC types, and microorganisms isolated by blood culture. Results: For 1,650 CVCs used for 1,237 patients, 39 cases of infection were identified. Most infections had occurred within 1 month of CVC insertion. Maximal sterile barrier precautions had been used for most cases (97.3%). The average CLABSI occurrence days with internal jugular vein access were shorter than those with subclavian vein access and femoral vein access. CLABSI rates were 1.1 and 0.7 for single- and multilumen CVCs, respectively. CLABSI occurrence tended to be shorter when gram-positive cocci were isolated and tended to be longer when fungi (Candida spp) were isolated. Conclusion: Most CLABSI cases had occurred within 1 month of CVC insertion. Longer CVC duration increased chance of fungal infection. Copyright (C) 2015 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.	[Matsui, Yasuko; Shimatani, Michitsugu; Kuzuhara, Kenta; Miyazaki, Yoshiko; Horiuchi, Tomoko; Tajima, Yasuhisa; Yano, Kunio] Hamamatsu Med Ctr, Dept Infect Control, Hamamatsu, Shizuoka, Japan; [Matsui, Yasuko; Nagata, Toshi] Hamamatsu Univ Sch Med, Dept Hlth Sci, Hamamatsu, Shizuoka 4313192, Japan	Nagata, T (reprint author), Hamamatsu Univ Sch Med, Dept Hlth Sci, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	tnagata@hama-med.ac.jp					Dudeck MA, 2013, AM J INFECT CONTROL, V41, P1148, DOI 10.1016/j.ajic.2013.09.002; RICHET H, 1990, J CLIN MICROBIOL, V28, P2520; Lorente L, 2005, CRIT CARE, V9, pR631, DOI 10.1186/cc3824; Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842; Kallen AJ, 2010, CLIN INFECT DIS, V51, P335, DOI 10.1086/653942; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Maki DG, 2006, MAYO CLIN PROC, V81, P1159; Fagan RP, 2013, INFECT CONT HOSP EP, V34, P893, DOI 10.1086/671724; Templeton A, 2008, INFECTION, V36, P322, DOI 10.1007/s15010-008-7314-x; Marik PE, 2012, CRIT CARE MED, V40, P2479, DOI 10.1097/CCM.0b013e318255d9bc; Dezfulian C, 2003, CRIT CARE MED, V31, P2385, DOI 10.1097/01.CCM.0000084843.31852.01; Parienti JJ, 2008, JAMA-J AM MED ASSOC, V299, P2413, DOI 10.1001/jama.299.20.2413; Pawar M, 2004, J CARDIOTHOR VASC AN, V18, P304, DOI 10.1053/j.jvca.2004.03.009; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Centers for Disease Control and Prevention, 2014, BLOODSTR INF EV CENT; Ge X, 2012, COCHRANE DB SYST REV, V3; Hu KK, 2004, CLIN INFECT DIS, V39, P1441, DOI 10.1086/425309; Krause R, 2013, INFECTION, V41, P49, DOI 10.1007/s15010-012-0391-x; LEE RB, 1988, J TRAUMA, V28, P1472, DOI 10.1097/00005373-198810000-00012; Maki DG, 2007, BENNETT BRACHMANS HO, P611; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c309; Schaberg DR, 1991, AM J MED S3B, V16, P72; Timsit JF, 2013, AM J RESP CRIT CARE, V188, P1232, DOI 10.1164/rccm.201303-0460OC	24	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-6553	1527-3296		AM J INFECT CONTROL	Am. J. Infect. Control	MAY 1	2015	43	5					494	498		10.1016/j.ajic.2015.01.011		5	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CH2XZ	WOS:000353890100015		
J	Sun, C; Fukui, H; Hara, K; Kitayama, Y; Eda, H; Yang, M; Yamagishi, H; Tomita, T; Oshima, T; Watari, J; Takasawa, S; Chiba, T; Miwa, H				Sun, Chao; Fukui, Hirokazu; Hara, Ken; Kitayama, Yoshitaka; Eda, Hirotsugu; Yang, Mo; Yamagishi, Hidetsugu; Tomita, Toshihiko; Oshima, Tadayuki; Watari, Jiro; Takasawa, Shin; Chiba, Tsutomu; Miwa, Hiroto			Expression of Reg family genes in the gastrointestinal tract of mice treated with indomethacin	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Article						Reg; nonsteroidal anti-inflammatory drug; proliferation; apoptosis; gastrointestinal mucosa	PANCREATITIS-ASSOCIATED PROTEIN; INFLAMMATORY-BOWEL-DISEASE; I-ALPHA PROTEIN; ULCERATIVE-COLITIS; COLORECTAL-CANCER; GASTRIC-CANCER; KNOCKOUT MICE; MUCOSAL; INJURY; CELLS	Regenerating gene (Reg) family proteins, which are classified into four types, commonly act as trophic and/or antiapoptotic factors in gastrointestinal (GI) diseases. However, it remains unclear how these proteins coordinate their similar roles under such pathophysiological conditions. Here, we investigated the interrelationships of Reg family gene expression with mucosal cell proliferation and apoptosis in nonsteroidal anti-inflammatory drug (NSAID)-induced GI injury. GI injury was induced by subcutaneous injection of indomethacin into Reg I knockout (KO) and wild-type (WT) mice, and its severity was scored histopathologically. Temporal changes in the expression of Reg family genes, mucosal proliferation, and apoptosis were evaluated throughout the GI tract by real-time RT-PCR, Ki-67 immunoreactivity, and TUNEL assay, respectively. Reg I, Reg III family, and Reg IV were predominantly expressed in the upper, middle, and lower GI mucosa, respectively. Expression of Reg I and Reg III family genes was upregulated in specific portions of the GI tract after indomethacin treatment. Ki-67-positive epithelial cells were significantly decreased in the gastric and small-intestinal mucosa of Reg I KO mice under normal conditions. After treatment with indomethacin, the number of TUNEL-positive cells was significantly greater throughout the GI mucosa in Reg I KO mice than in WT mice. Expression of Reg I was independent of that of other Reg family genes in, not only normal GI tissues, but also indomethacin-induced GI lesions. Members of the Reg gene family show distinct profiles of expression in the GI tract, and Reg I independently plays a role in protecting the GI mucosa against NSAID-induced injury.	[Sun, Chao; Fukui, Hirokazu; Hara, Ken; Kitayama, Yoshitaka; Eda, Hirotsugu; Yang, Mo; Tomita, Toshihiko; Oshima, Tadayuki; Watari, Jiro; Miwa, Hiroto] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo 6638501, Japan; [Sun, Chao; Yang, Mo] Tianjin Med Univ, Gen Hosp, Dept Digest Dis, Tianjin, Peoples R China; [Yamagishi, Hidetsugu] Dokkyo Univ, Sch Med, Dept Surg & Mol Pathol, Mibu, Tochigi, Japan; [Takasawa, Shin] Nara Med Univ, Dept Biochem, Kashihara, Nara 634, Japan; [Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan	Fukui, H (reprint author), Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan.	hfukui@hyo-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26460953]	This work was supported in part by Grants-in-Aid for Scientific Research 26460953 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Abe A, 2009, J PATHOL, V217, P42, DOI 10.1002/path.2431; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Unno M, 2002, DIABETES, V51, pS478, DOI 10.2337/diabetes.51.2007.S478; Sekikawa A, 2005, GASTROENTEROLOGY, V128, P642, DOI 10.1053/j.gastro.2004.12.045; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lieu HT, 2005, HEPATOLOGY, V42, P618, DOI 10.1002/hep.20845; Bishnupuri KS, 2010, GASTROENTEROLOGY, V138, P616, DOI 10.1053/j.gastro.2009.10.050; Ortiz EM, 1998, GASTROENTEROLOGY, V114, P808, DOI 10.1016/S0016-5085(98)70595-5; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Tarnawski A, 2001, J PHYSIOL-PARIS, V95, P337, DOI 10.1016/S0928-4257(01)00046-8; Laine L, 2006, ALIMENT PHARM THERAP, V24, P751, DOI 10.1111/j.1365-2036.2006.03043.x; Takeuchi K, 2010, J PHARMACOL SCI, V114, P248, DOI 10.1254/jphs.10R06CR; Sekikawa A, 2005, GUT, V54, P1437, DOI 10.1136/gut.2004.053587; Scarpignato C, 2010, GASTROENTEROL CLIN N, V39, P433, DOI 10.1016/j.gtc.2010.08.010; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Porterfield M, 2014, J PROTEOME RES, V13, P395, DOI 10.1021/pr400422g; Takaishi S, 2007, CANCER SCI, V98, P284, DOI 10.1111/j.1349-7006.2007.00392.x; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Fukui H, 2003, LAB INVEST, V83, P1777, DOI 10.1097/01.LAB.0000106501.56339.CE; Imaoka H, 2010, AM J PHYSIOL-GASTR L, V299, pG311, DOI 10.1152/ajpgi.00469.2009; Kim Kyong Rae, 2007, Korean J Gastroenterol, V49, P209; Kinoshita Y, 2004, J GASTROENTEROL, V39, P507, DOI 10.1007/s00535-004-1354-5; Sekikawa A, 2010, LAB INVEST, V90, P496, DOI 10.1038/labinvest.2009.147; van Ampting MTJ, 2009, DIGEST DIS SCI, V54, P2588, DOI 10.1007/s10620-008-0685-0; Yajima S, 2007, INT J ONCOL, V31, P1029	27	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	MAY 1	2015	308	9					G736	G744		10.1152/ajpgi.00362.2014		9	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	CH3WY	WOS:000353962900002		
J	Nakamura, U; Rudolf, FO; Pandey, K; Kadokawa, H				Nakamura, Urara; Rudolf, Faidiban O.; Pandey, Kiran; Kadokawa, Hiroya			The non-steroidal mycoestrogen zeranol suppresses luteinizing hormone secretion from the anterior pituitary of cattle via the estradiol receptor GPR30 in a rapid, non-genomic manner	ANIMAL REPRODUCTION SCIENCE			English	Article						Fusarium; Gonadotrope; G protein-coupled estrogen receptor-1; Non-genomic effect; Ruminant; Zearalenone	GONADOTROPIN-RELEASING-HORMONE; FOLLICLE-STIMULATING-HORMONE; GROWTH PROMOTER ZERANOL; ESTROGEN-RECEPTOR; REPRODUCTIVE FUNCTION; TRENBOLONE ACETATE; EPITHELIAL-CELLS; GENE-EXPRESSION; CORPUS-LUTEUM; MESSENGER-RNA	Picomolar concentrations of estradiol produce rapid suppression of GnRH-induced luteinizing hormone (LH) secretion from the anterior pituitary (AP) of cattle via G-protein-coupled receptor 30 (GPR30). Zeranol is a strong estrogenic metabolite derived from zearalenone, a non-steroidal mycoestrogen produced by Fusarium that induces reproductive disorders in domestic animals. The hypothesis was tested that zeranol suppresses GnRH-induced LH release from the AP of cattle via GPR30 in a rapid, non-genomic manner. The AP cells (n = 15) were cultured for 3 days in steroid-free conditions and then treated them with estradiol (0.001-10 nM) or zeranol (0.001-100 nM) for 5 min before GnRH stimulation. Pre-treatment with 0.001-0.1 nM estradiol suppressed GnRH-stimulated LH secretion. Pretreatment with zeranol at concentrations of 0.001 nM (P < 0.01), 0.01 nM (P < 0.01), 0.1 nM (P < 0.05), and 1 nM (P < 0.05), but not at concentrations of 10 and 100 nM, also inhibited GnRH-stimulated LH secretion from AP cells. Pre-treatment for 5 min with a GPR30-specific antagonist, G36, inhibited estradiol or zeranol suppression of LH secretion from cultured AP cells. Cyclic AMP measurements and quantitative PCR analyses revealed that pre-treatment with small amounts of estradiol (P < 0.05) or zeranol (P < 0.01) decreased CAMP, but not gene expressions of the LH alpha, LH beta, or FSH beta subunits in the AP cells. Hence, zeranol may suppress luteinizing hormone secretion from the AP of cattle via GPR30 in a rapid, non-genomic manner. (C) 2015 Elsevier B.V. All rights reserved.	[Nakamura, Urara; Rudolf, Faidiban O.; Pandey, Kiran; Kadokawa, Hiroya] Yamaguchi Univ, Fac Vet Med, Yamaguchi, Yamaguchi 16771, Japan	Kadokawa, H (reprint author), Yamaguchi Univ, Fac Vet Med, Yamaguchi, Yamaguchi 16771, Japan.	hiroya@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science (Tokyo, Japan) [23580440]	This research was partly supported by a Grant-in Aid for Scientific Research (JSPS Kakenhi Grant Number 23580440) from Japan Society for the Promotion of Science (Tokyo, Japan) to H. Kadokawa.	ADAMS TE, 1979, BIOL REPROD, V21, P735, DOI 10.1095/biolreprod21.3.735; Anchan D, 2014, NEUROENDOCRINOLOGY, V100, P71, DOI 10.1159/000365574; Arreguin-Arevalo JA, 2005, BIOL REPROD, V73, P115, DOI 10.1095/biolreprod.104.040329; Hewitt SC, 2003, REPRODUCTION, V125, P143, DOI 10.1530/rep.0.1250143; SPICER LJ, 1986, J ANIM SCI, V62, P428; Hazell GGJ, 2009, J ENDOCRINOL, V202, P223, DOI 10.1677/JOE-09-0066; Kadokawa H, 2007, J REPROD DEVELOP, V53, P121, DOI 10.1262/jrd.18058; MORAN C, 1990, J REPROD FERTIL, V89, P527; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Endo N, 2012, ANIM REPROD SCI, V134, P112, DOI 10.1016/j.anireprosci.2012.08.018; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; RIESEN JW, 1977, J ANIM SCI, V45, P293; ELSASSER TH, 1983, AM J VET RES, V44, P1068; Jacobi JS, 2007, NEUROENDOCRINOLOGY, V86, P260, DOI 10.1159/000107770; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Cortinovis C, 2013, THERIOGENOLOGY, V80, P557, DOI 10.1016/j.theriogenology.2013.06.018; Noel SD, 2009, MOL ENDOCRINOL, V23, P349, DOI 10.1210/me.2008-0299; Sanchez-Criado JE, 2012, REPRODUCTION, V143, P549, DOI 10.1530/REP-11-0214; ERASMUSON AF, 1994, J AGR FOOD CHEM, V42, P2721, DOI 10.1021/jf00048a014; Suzuki S, 2008, ANIM REPROD SCI, V103, P360, DOI 10.1016/j.anireprosci.2007.05.016; Li YR, 2013, J ASSIST REPROD GEN, V30, P227, DOI 10.1007/s10815-013-9942-z; Kamanga-Sollo E, 2014, DOMEST ANIM ENDOCRIN, V49, P20, DOI 10.1016/j.domaniend.2014.04.004; Minervini F, 2008, INT J MOL SCI, V9, P2570, DOI 10.3390/ijms9122570; Rudolf FO, 2013, ANIM REPROD SCI, V139, P9, DOI 10.1016/j.anireprosci.2013.04.003; Terasawa E, 2012, FRONT NEUROENDOCRIN, V33, P364, DOI 10.1016/j.yfrne.2012.08.001; Gieske MC, 2008, ENDOCRINOLOGY, V149, P20, DOI 10.1210/en.2007-1084; FABRY J, 1983, J ANIM SCI, V57, P1138; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Iqbal J, 2009, ENDOCRINOLOGY, V150, P4213, DOI 10.1210/en.2009-0092; PUSATERI AE, 1993, J ANIM SCI, V71, P415; Wang C, 2007, ENDOCRINOLOGY, V148, P4853, DOI 10.1210/en.2007-0727; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; ELSASSER TH, 1983, J ANIM SCI, V57, P443; Broselid S, 2014, J BIOL CHEM, V289, P22117, DOI 10.1074/jbc.M114.566893; CLARKE IJ, 1995, J ENDOCRINOL, V145, P271, DOI 10.1677/joe.0.1450271; COOPER RA, 1985, BRIT VET J, V141, P424; COOPER RA, 1981, BRIT VET J, V137, P621; CUPP AS, 1995, BIOL REPROD, V52, P288, DOI 10.1095/biolreprod52.2.288; EVANS NP, 1994, ENDOCRINOLOGY, V134, P1806, DOI 10.1210/en.134.4.1806; Garcia-Galiano D, 2012, J NEUROENDOCRINOL, V24, P22, DOI 10.1111/j.1365-2826.2011.02230.x; Iqbal J, 2007, ENDOCRINOLOGY, V148, P5794, DOI 10.1210/en.2007-0986; Kadokawa H, 2014, ANIM REPROD SCI, V150, P84, DOI 10.1016/j.anireprosci.2014.09.008; Mendez-Luna D., 2015, J BIOMOL STRUCT DYN, V14, P1; MERCER JE, 1993, J NEUROENDOCRINOL, V5, P591, DOI 10.1111/j.1365-2826.1993.tb00526.x; Mo ZQ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3581; Rekawiecki R, 2012, REPROD BIOL, V12, P362, DOI 10.1016/j.repbio.2012.10.010; Rudolf FO, 2014, J VET MED SCI, V76, P1623, DOI 10.1292/jvms.14-0179; Scaling AL, 2014, HORM CANCER-US, V5, P146, DOI 10.1007/s12672-014-0174-1; SIKDAR SK, 1989, BRAIN RES, V496, P113, DOI 10.1016/0006-8993(89)91057-3; Vaucher L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092425; Walker CG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-100; Wen SY, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-143	52	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4320	1873-2232		ANIM REPROD SCI	Anim. Reprod. Sci.	MAY	2015	156						118	127		10.1016/j.anireprosci.2015.03.009		10	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CG8YZ	WOS:000353602900014		
J	Daouk, J; Bailly, P; Kamimura, M; Sacksick, D; Jounieaux, V; Meyer, ME				Daouk, Joel; Bailly, Pascal; Kamimura, Mitsuhiro; Sacksick, David; Jounieaux, Vincent; Meyer, Marc-Etienne			Positron emission tomography-based evidence of low-amplitude respiratory motion in patients with chronic obstructive pulmonary disease	ANNALS OF NUCLEAR MEDICINE			English	Article						PET; F-18-fluorodeoxyglucose; Respiratory motion; Lung cancer	STANDARDIZED UPTAKE VALUE; LUNG-CANCER; ATTENUATION CORRECTION; F-18-FDG PET; DIAGNOSIS; METAANALYSIS; ACCURACY; NODULES; LESIONS; CT	Chronic obstructive pulmonary disease (COPD) is characterized by low vital capacity and tidal volume, which translate into smaller respiratory motions. We sought to demonstrate the limited respiratory motion in COPD by comparing respiratory-gated and free-breathing positron emission tomography (PET) images of lung nodules ("CT-based" and "Ungated" images) in patients with and without COPD. We studied 74 lung lesions (37 malignant) in 60 patients (23 patients with COPD; 37 without). An Ungated PET examination was followed by a CT-based acquisition. Maximum standard uptake value (SUVmax) for each lesion on PET images was measured. On CT images, we checked for the presence of emphysema and pleural adhesions or indentations associated with the nodules. Lastly, we used univariate and then multivariate analyses to determine the lung function parameters possibly affecting respiratory motion in patients with and without COPD. The mean "CT-based" vs. "Ungated" difference in SUVmax was 0.3 and 0.6 for patients with and without COPD, respectively. Statistical analysis revealed that lesion site, hyperinflation and pleural indentation were independently associated with a difference in SUVmax. PET lung lesion images in patients with COPD are barely influenced by respiratory motion. Thoracic hyperinflation in patients with COPD was found to be independently associated with an effect of respiratory motion on PET images. Moreover, pleural indentation limits the respiratory motion of lung nodules, regardless of the presence or absence of COPD.	[Daouk, Joel; Meyer, Marc-Etienne] Jules Verne Univ Picardie, Amiens, France; [Bailly, Pascal; Sacksick, David; Meyer, Marc-Etienne] Amiens Univ Hosp, Dept Nucl Med, Unite TEP, F-80054 Amiens, France; [Kamimura, Mitsuhiro] Natl Hosp Org Disaster Med Ctr, Dept Pulmonol, Tokyo, Japan; [Jounieaux, Vincent] Amiens Univ Hosp, Dept Resp Med, Amiens, France	Bailly, P (reprint author), Amiens Univ Hosp, Dept Nucl Med, Unite TEP, F-80054 Amiens, France.	bailly.pascal@chu-amiens.fr					Bernard S, 1998, AM J RESP CRIT CARE, V158, P629; Hashimoto Y, 2006, J NUCL MED, V47, P426; HOFFMAN EJ, 1982, J COMPUT ASSIST TOMO, V6, P987; Goerres GW, 2003, RADIOLOGY, V226, P906, DOI 10.1148/radiol.2263011732; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201; Laghi F, 2003, AM J RESP CRIT CARE, V168, P10, DOI 10.1164/rccm.2206020; Barger RL, 2012, ACAD RADIOL, V19, P153, DOI 10.1016/j.acra.2011.10.009; Osman MM, 2003, EUR J NUCL MED MOL I, V30, P603, DOI 10.1007/s00259-002-1024-x; Ahuja V, 1998, CANCER, V83, P918, DOI 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.0.CO;2-Y; Gould MK, 2001, JAMA-J AM MED ASSOC, V285, P914, DOI 10.1001/jama.285.7.914; Christensen JA, 2006, AM J ROENTGENOL, V187, P1361, DOI 10.2214/AJR.05.1166; Lee J, 2001, CHEST, V120, P1791, DOI 10.1378/chest.120.6.1791; DeTroyer A, 1997, EUR RESPIR J, V10, P708; Mac Manus MP, 2012, SEMIN NUCL MED, V42, P308, DOI 10.1053/j.semnuclmed.2012.04.003; Bar-Shalom R, 2008, CANCER, V113, P3213, DOI 10.1002/cncr.23928; Daouk J, 2009, ACTA RADIOL, V50, P144, DOI 10.1080/02841850802627437; Fin L, 2008, EUR J NUCL MED MOL I, V35, P1971, DOI 10.1007/s00259-008-0858-2; Dawood M, 2007, MED PHYS, V34, P3067, DOI 10.1118/1.2748104; Nehmeh SA, 2007, J NUCL MED, V48, P22; COHEN BH, 1977, LANCET, V2, P523; Daou D, 2008, EUR J NUCL MED MOL I, V35, P1961, DOI 10.1007/s00259-008-0931-x; Daouk J, 2011, ACTA RADIOL, V52, P651, DOI 10.1258/ar.2011.110018; Ding K, 2009, LECT NOTES COMPUT SC, V5761, P739; HUBMAYR RD, 1987, J APPL PHYSIOL, V63, P2467; Papathanassiou D, 2005, EUR J NUCL MED MOL I, V32, P1422, DOI 10.1007/s00259-005-1868-y; Raherison C, 2009, Eur Respir Rev, V18, P213, DOI 10.1183/09059180.00003609; RODARTE JR, 1985, J APPL PHYSIOL, V58, P164; Slater A, 2006, CHEST, V129, P545, DOI 10.1378/chest.129.3.545; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512; WADE OL, 1954, J PHYSIOL-LONDON, V124, P193; Zhang L, 2013, ACTA RADIOL, V54, P770, DOI 10.1177/0284185113481594	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	MAY	2015	29	4					319	324		10.1007/s12149-014-0945-3		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH2BO	WOS:000353829400001		
J	Hatano, K; Sekimata, K; Yamada, T; Abe, J; Ito, K; Ogawa, M; Magata, Y; Toyohara, J; Ishiwata, K; Biggio, G; Serra, M; Laquintana, V; Denora, N; Latrofa, A; Trapani, G; Liso, G; Suzuki, H; Sawada, M; Nomura, M; Toyama, H				Hatano, Kentaro; Sekimata, Katsuhiko; Yamada, Takashi; Abe, Junichiro; Ito, Kengo; Ogawa, Mikako; Magata, Yasuhiro; Toyohara, Jun; Ishiwata, Kiichi; Biggio, Giovanni; Serra, Mariangela; Laquintana, Valentino; Denora, Nunzio; Latrofa, Andrea; Trapani, Giuseppe; Liso, Gaetano; Suzuki, Hiromi; Sawada, Makoto; Nomura, Masahiko; Toyama, Hiroshi			Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [C-11]CB184 and [C-11]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [C-11](R)-PK11195	ANNALS OF NUCLEAR MEDICINE			English	Article						Positron emission tomography; TSPO; PBR; Neuroinflammation; Alzheimer's disease	PERIPHERAL BENZODIAZEPINE-RECEPTOR; POSITRON-EMISSION-TOMOGRAPHY; MICROGLIAL ACTIVATION; BINDING-SITES; PRIMATE BRAIN; MOUSE-BRAIN; LIGAND; RADIOLIGAND; CNS; NEUROINFLAMMATION	We report synthesis of two carbon-11 labeled imidazopyridines TSPO ligands, [C-11]CB184 and [C-11]CB190, for PET imaging of inflammatory process along with neurodegeneration, ischemia or brain tumor. Biodistribution of these compounds was compared with that of [C-11]CB148 and [C-11](R)-PK11195. Both [C-11]CB184 and [C-11]CB190 having C-11-methoxyl group on an aromatic ring were readily prepared using [C-11]methyl triflate. Biodistribution and metabolism of the compounds were examined with normal mice. An animal PET study using 6-hydroxydopamine treated rats as a model of neurodegeneration was pursued for proper estimation of feasibility of the radioligands to determine neuroinflammation process. [C-11]CB184 and [C-11]CB190 were obtained via O-methylation of corresponding desmethyl precursor using [C-11]methyl triflate in radiochemical yield of 73 % (decay-corrected). In vivo validation as a TSPO radioligand was carried out using normal mice and lesioned rats. In mice, [C-11]CB184 showed more uptake and specific binding than [C-11]CB190. Metabolism studies showed that 36 % and 25 % of radioactivity in plasma remained unchanged 30 min after intravenous injection of [C-11]CB184 and [C-11]CB190, respectively. In the PET study using rats, lesioned side of the brain showed significantly higher uptake than contralateral side after i.v. injection of either [C-11]CB184 or [C-11](R)-PK11195. Indirect Logan plot analysis revealed distribution volume ratio (DVR) between the two sides which might indicate lesion-related elevation of TSPO binding. The DVR was 1.15 +/- A 0.10 for [C-11](R)-PK11195 and was 1.15 +/- A 0.09 for [C-11]CB184. The sensitivity to detect neuroinflammation activity was similar for [C-11]CB184 and [C-11](R)-PK11195.	[Hatano, Kentaro; Sekimata, Katsuhiko; Yamada, Takashi; Abe, Junichiro; Ito, Kengo] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Clin & Expt Neuroimaging, Obu, Aichi 4748522, Japan; [Ogawa, Mikako; Magata, Yasuhiro] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Toyohara, Jun; Ishiwata, Kiichi] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo 1730015, Japan; [Biggio, Giovanni; Serra, Mariangela] Univ Cagliari, Dept Expt Biol, I-09100 Cagliari, Italy; [Laquintana, Valentino; Denora, Nunzio; Latrofa, Andrea; Trapani, Giuseppe; Liso, Gaetano] Univ Bari, Pharmacochem Dept, I-70125 Bari, Italy; [Suzuki, Hiromi; Sawada, Makoto] Nagoya Univ, Environm Med Res Inst, Nagoya, Aichi 4648601, Japan; [Nomura, Masahiko; Toyama, Hiroshi] Fujita Hlth Univ, Dept Radiol, Toyoake, Aichi 4701192, Japan	Hatano, K (reprint author), Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan.	hatanok@md.tsukuba.ac.jp			Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology, Japan [21-5]	The authors would like to thank the members of National Center for Geriatrics and Gerontology for their help. This work was supported by the Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology, Japan (21-5). All the authors disclose to have no potential conflict of interest.	LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; SZABO I, 1993, FEBS LETT, V330, P206, DOI 10.1016/0014-5793(93)80274-X; Bergeron M, 2009, IEEE T NUCL SCI, V56, P10, DOI 10.1109/TNS.2008.2010257; Yasuno F, 2012, PSYCHIAT RES-NEUROIM, V203, P67, DOI 10.1016/j.pscychresns.2011.08.013; James ML, 2005, BIOORGAN MED CHEM, V13, P6188, DOI 10.1016/j.bmc.2005.06.030; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Boutin H, 2007, J NUCL MED, V48, P573, DOI 10.2967/jnumed.106.036764; Zhang MR, 2003, NUCL MED BIOL, V30, P513, DOI 10.1016/S0969-8051(03)00016-7; Sekimata K, 2008, NUCL MED BIOL, V35, P327, DOI 10.1016/j.nucmedbio.2007.12.005; Wilson AA, 2008, NUCL MED BIOL, V35, P305, DOI 10.1016/j.nucmedbio.2007.12.009; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lockhart A, 2003, NUCL MED BIOL, V30, P199, DOI 10.1016/S0969-8051(02)00410-9; Zhang MR, 2004, J MED CHEM, V47, P2228, DOI 10.1021/jm0304919; Martin A, 2010, J CEREBR BLOOD F MET, V30, P230, DOI 10.1038/jcbfm.2009.205; Chen MK, 2004, BRAIN, V127, P1379, DOI 10.1093/brain/awh161; Belloli S, 2004, NEUROCHEM INT, V44, P433, DOI 10.1016/j.neuint.2003.08.006; Fujita M, 2008, NEUROIMAGE, V40, P43, DOI 10.1016/j.neuroimage.2007.11.011; Briard E, 2008, J MED CHEM, V51, P17, DOI 10.1021/jm0707370; Kropholler MA, 2005, J CEREBR BLOOD F MET, V25, P842, DOI 10.1038/sj.jcbfm.9600092; Zhang MR, 2007, J NUCL MED, V48, P1853, DOI 10.2967/jnumed.107.043505; Golani I, 2001, BIOCHEMISTRY-US, V40, P10213, DOI 10.1021/bi010431+; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834; Owen DR, 2010, J CEREBR BLOOD F MET, V30, P1608, DOI 10.1038/jcbfm.2010.63; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Beurdeley-Thomas A, 2000, J NEURO-ONCOL, V46, P45, DOI 10.1023/A:1006456715525; Converse AK, 2011, J NUCL MED, V52, P257, DOI 10.2967/jnumed.110.082743; Culty M, 1999, J STEROID BIOCHEM, V69, P123, DOI 10.1016/S0960-0760(99)00056-4; Denora N, 2008, J MED CHEM, V2008, P6876; Ito F, 2010, ANN NUCL MED, V24, P163, DOI 10.1007/s12149-009-0339-0; Mattner F, 2008, EUR J NUCL MED MOL I, V35, P779, DOI 10.1007/s00259-007-0645-5; PETITTABOUE MC, 1991, EUR J PHARMACOL, V200, P347, DOI 10.1016/0014-2999(91)90594-G; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Toyama H, 2008, ANN NUCL MED, V22, P417, DOI 10.1007/s12149-008-0136-1	35	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	MAY	2015	29	4					325	335		10.1007/s12149-015-0948-8		11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH2BO	WOS:000353829400002		
J	Beppu, T; Sasaki, T; Terasaki, K; Saura, H; Mtsuura, H; Ogasawara, K; Sasaki, M; Ehara, S; Iwata, R; Takai, Y				Beppu, Takaaki; Sasaki, Toshiaki; Terasaki, Kazunori; Saura, Hiroaki; Mtsuura, Hideki; Ogasawara, Kuniaki; Sasaki, Makoto; Ehara, Shigeru; Iwata, Ren; Takai, Yoshihiro			High-uptake areas on positron emission tomography with the hypoxic radiotracer F-18-FRP170 in glioblastomas include regions retaining proliferative activity under hypoxia	ANNALS OF NUCLEAR MEDICINE			English	Article						Glioblastoma; FRP170; PET; Hypoxia; Proliferation	F-18-LABELED 2-NITROIMIDAZOLE ANALOG; CELL LUNG-CANCER; IMAGING HYPOXIA; TUMOR HYPOXIA; RODENT MODEL; HUMAN HEAD; PET; F-18-FLUOROMISONIDAZOLE; VASCULATURE; GLIOMAS	The aim was to evaluate the proliferative activity of high-uptake areas on positron emission tomography (PET) with the hypoxic cell radiotracer, 1-(2-[F-18]fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole (FRP170). Thirteen patients with glioblastoma underwent FRP170 PET before tumor resection. During surgery, tumor specimens were stereotaxically obtained from regions corresponding to high (high-uptake areas, HUAs) and relatively low (low-uptake areas, LUAs) accumulation of FRP170. We compared immunohistochemical staining for Ki-67 and hypoxia-inducible factor (HIF)-1 alpha between HUA and LUA. HIF-1 alpha index was significantly higher in HUAs than in LUAs. In contrast, mean Ki-67 indices did not differ significantly between HUAs and LUAs. Findings for HIF-1 alpha index clearly indicated that HUAs on FRP170 PET represented hypoxic regions in glioblastoma. However, findings of Ki-67 index suggest that HUAs on FRP170 PET include regions retaining proliferative activity regardless of tissue hypoxia.	[Beppu, Takaaki; Saura, Hiroaki; Mtsuura, Hideki; Ogasawara, Kuniaki] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 0208505, Japan; [Sasaki, Toshiaki; Terasaki, Kazunori] Iwate Med Univ, Cyclotron Res Ctr, Morioka, Iwate 0208505, Japan; [Sasaki, Makoto] Iwate Med Univ, Inst Biomed Sci, Morioka, Iwate 0208505, Japan; [Ehara, Shigeru] Iwate Med Univ, Dept Radiol, Morioka, Iwate 0208505, Japan; [Iwata, Ren] Tohoku Univ, Cyclotron & Radioisotope Ctr CYRIC, Sendai, Miyagi 980, Japan; [Takai, Yoshihiro] Hirosaki Univ, Grad Sch Med, Dept Radiol & Radiat Oncol, Hirosaki, Aomori, Japan	Beppu, T (reprint author), Iwate Med Univ, Dept Neurosurg, Uchimaru 19-1, Morioka, Iwate 0208505, Japan.	tbeppu@iwate-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26462764, S1491001]; JSPS KAKENHI [26462764]; Ministry of Science, Education, Sports and Culture, Japan	This study was supported in part by Grant-in-Aid for JSPS KAKENHI (Grant no. 26462764, 2014-2016), and for Strategic Medical Science Research (Grant no. S1491001, 2014-2018) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This study was supported in part by JSPS KAKENHI (Grant no. 26462764) and a Grant-in-Aid for the Strategic Medical Science Research Center for Advanced Medical Science Research from the Ministry of Science, Education, Sports and Culture, Japan.	Mendichovszky I, 2011, BRIT J RADIOL, V84, pS145, DOI 10.1259/bjr/82292521; Ljungkvist ASE, 2002, INT J RADIAT ONCOL, V54, P215, DOI 10.1016/S0360-3016(02)02938-3; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Dence CS, 2008, NUCL MED BIOL, V35, P713, DOI 10.1016/j.nucmedbio.2008.06.001; Rajendran JG, 2004, CLIN CANCER RES, V10, P2245, DOI 10.1158/1078-0432.CCR-0688-3; WANG GL, 1995, J BIOL CHEM, V270, P1230; Eschmann SM, 2005, J NUCL MED, V46, P253; Heijmen L, 2014, CONTRAST MEDIA MOL I, V9, P237, DOI 10.1002/cmmi.1564; Cherk MH, 2006, J NUCL MED, V47, P1921; Hoogsteen IJ, 2005, CLIN CANCER RES, V11, P97; Evans SM, 2001, AM J CLIN ONCOL-CANC, V24, P467, DOI 10.1097/00000421-200110000-00011; Evans SM, 2008, RADIAT RES, V170, P677, DOI 10.1667/RR1207.1; Schmaltz C, 1998, MOL CELL BIOL, V18, P2845; Fischer I, 2005, BRAIN PATHOL, V15, P297; Tanaka T, 2006, NUCL MED BIOL, V33, P743, DOI 10.1016/j.nucmedbio.2006.05.005; Shibahara I, 2010, J NEUROSURG, V113, P358, DOI 10.3171/2009.10.JNS09510; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Evans SM, 2010, TRANSL ONCOL, V3, P160, DOI 10.1593/tlo.09265; Beppu T, 2014, MOL IMAGING BIOL, V16, P127, DOI 10.1007/s11307-013-0670-7; CHAPMAN JD, 1979, NEW ENGL J MED, V301, P1429, DOI 10.1056/NEJM197912273012606; Denekamp J, 1999, ACTA ONCOL, V38, P903; Hatano T, 2013, INT J ONCOL, V42, P823, DOI 10.3892/ijo.2013.1781; Ishikawa Y, 2005, APPL RADIAT ISOTOPES, V62, P705, DOI 10.1016/j.apradiso.2004.09.008; Jensen Randy L, 2006, Neurosurg Focus, V20, pE24, DOI 10.3171/foc.2006.20.4.16; Kaneta T, 2002, J NUCL MED, V43, P109; Kaneta T, 2007, ANN NUCL MED, V21, P101; Kawai N, 2011, EUR J NUCL MED MOL I, V38, P441, DOI 10.1007/s00259-010-1645-4; Krohn KA, 2008, J NUCL MED S2, V49, p129S, DOI DOI 10.2967/JNUMED.107.045914; Narita T, 2012, JPN J CLIN ONCOL, V42, P120, DOI 10.1093/jjco/hyr181; RALEIGH JA, 1995, ACTA ONCOL, V34, P345; Rasey JS, 1999, J NUCL MED, V40, P1072; Swanson KR, 2009, J NUCL MED, V50, P36, DOI 10.2967/jnumed.108.055467; Webster L, 1998, BRIT J CANCER, V77, P227, DOI 10.1038/bjc.1998.38	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	MAY	2015	29	4					336	341		10.1007/s12149-015-0951-0		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH2BO	WOS:000353829400003		
J	Ogino, Y; Horiguchi, Y; Ueda, T; Shiomori, T; Kanna, M; Kawaminami, T; Iinuma, N; Sudo, Y; Morita, Y				Ogino, Yutaka; Horiguchi, Yoriko; Ueda, Tomohiro; Shiomori, Tomofumi; Kanna, Masahiko; Kawaminami, Tomoko; Iinuma, Naoki; Sudo, Yuta; Morita, Yukiko			A myocardial perfusion imaging system using a multifocal collimator for detecting coronary artery disease: validation with invasive coronary angiography	ANNALS OF NUCLEAR MEDICINE			English	Article						Coronary angiography; Coronary artery disease; IQ-SPECT; Multifocal collimator; Myocardial perfusion imaging	FRACTIONAL FLOW RESERVE; INTERVENTION; TOMOGRAPHY; CARDIOLOGY; AGREEMENT; PROTOCOL	Myocardial perfusion imaging (MPI) systems using a multifocal collimator can reduce scan time substantially compared with conventional MPI systems. In this study, we evaluated the diagnostic accuracy of multifocal collimator SPECT/CT in coronary artery disease (CAD) detection by comparing it with coronary artery angiography (CAG). We retrospectively analyzed 50 consecutive patients who had undergone CAG and stress Tl-201 MPI multifocal collimator SPECT/CT within a 3-month period. A summed difference score (SDS) was calculated for each vascular territory from the MPI images. On CAG, a stenotic coronary artery was defined as one with luminal narrowing of a parts per thousand yen75 % with quantitative coronary angiography software. We analyzed the diagnostic accuracy of coronary artery stenosis detection using the definition that a coronary artery territory was ischemic when the SDS per vessel was a parts per thousand yen2. We generated receiver operating characteristic (ROC) curves to evaluate the usefulness of SDS per vascular territory to find coronary artery stenoses. The area under the ROC curve was 0.86 and cut-off value was 2. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy to detect stenoses were 85, 83, 66, 94 and 84 %, respectively. We confirmed the high accuracy of imaging with multifocal collimator SPECT/CT for detection of angiographically significant CAD.	[Ogino, Yutaka; Horiguchi, Yoriko; Kanna, Masahiko; Kawaminami, Tomoko; Iinuma, Naoki; Sudo, Yuta; Morita, Yukiko] Natl Hosp Org Sagamihara Natl Hosp, Dept Cardiol, Minami Ku, Sagamihara, Kanagawa 2520392, Japan; [Ueda, Tomohiro; Shiomori, Tomofumi] Natl Hosp Org Sagamihara Natl Hosp, Dept Radiol, Minami Ku, Sagamihara, Kanagawa 2520392, Japan	Ogino, Y (reprint author), Natl Hosp Org Sagamihara Natl Hosp, Dept Cardiol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa 2520392, Japan.	ogino@yokohama-cu.ac.jp					ALLMAN KC, 1992, J NUCL MED, V33, P2067; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Fiechter M, 2011, EUR J NUCL MED MOL I, V38, P2025, DOI 10.1007/s00259-011-1877-y; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Rajaram R, 2011, IEEE NUCL SCI CONF R, P2451, DOI 10.1109/NSSMIC.2011.6152666; Vija AH, 2010, IEEE NUCL SCI CONF R, P3433, DOI 10.1109/NSSMIC.2010.5874444; Caobelli F, 2013, NUKLEARMED-NUCL MED, V52, P178, DOI 10.3413/Nukmed-0570-13-03; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cuocolo A, 2005, Q J NUCL MED MOL IM, V49, P4; Forster S, 2010, INT J CARDIOVAS IMAG, V26, P203, DOI 10.1007/s10554-009-9510-x; Horiguchi Y, 2014, ANN NUCL MED, V28, P707; Nakajima K, 2010, ANN NUCL MED, V24, P99, DOI 10.1007/s12149-009-0331-8; Nakata T, 2008, SHINZOUKAKUIGAKU, V9, P6; Nakazato R, 2013, J NUCL MED, V54, P373, DOI 10.2967/jnumed.112.110601; OZAKI Y, 1995, AM HEART J, V129, P471, DOI 10.1016/0002-8703(95)90270-8; Tamaki N, 2005, Q J NUCL MED MOL IM, V49, P193	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	MAY	2015	29	4					366	370		10.1007/s12149-015-0955-9		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH2BO	WOS:000353829400007		
J	Okada, N; Tajima, K; Takami, Y; Kato, W; Fujii, K; Hibino, M; Munakata, H; Sakai, Y; Hirakawa, A; Usui, A				Okada, Noritaka; Tajima, Kazuyoshi; Takami, Yoshiyuki; Kato, Wataru; Fujii, Kei; Hibino, Makoto; Munakata, Hisaaki; Sakai, Yoshimasa; Hirakawa, Akihiro; Usui, Akihiko			Valve Selection for the Aortic Position in Dialysis Patients	ANNALS OF THORACIC SURGERY			English	Article							DISEASE REQUIRING DIALYSIS; VALVULAR HEART-DISEASE; STAGE RENAL-FAILURE; ACCELERATED PROGRESSION; PRACTICE GUIDELINES; UNITED-STATES; REPLACEMENT; PROSTHESIS; MORTALITY; SURGERY	Background. Prosthetic valve selection in dialysis patients remains controversial because of the limited data available. This study aimed to clarify late clinical outcomes and discuss strategies for optimal valve selection in dialysis patients. Methods. We retrospectively analyzed the data obtained from 406 consecutive patients who underwent aortic valve replacement between 1995 and 2010. We compared valve-related outcomes among 89 dialysis and 317 nondialysis patients. We selected bioprostheses for all patients older than 65 to 70 years, irrespective of the renal function. Results. Dialysis was found to be a significant risk factor for bleeding events (hazard ratio, 3.98; 95% confidence interval, 2.51 to 6.30; p < 0.001), however, no significant differences were observed according to the type of prosthesis. The overall survival was significantly worse in the dialysis patients (63% versus 85% at 5 years; p < 0.001), and freedom from structural valve deterioration was also lower in the dialysis patients (82% versus 100% at 5 years; p < 0.001). Among the dialysis patients, an advanced age (>= 70 years; hazard ratio, 3.53; p = 0.011), diabetes mellitus (hazard ratio, 2.48; p = 0.041), and concomitant coronary artery bypass grafting (hazard ratio, 1.99; p = 0.071) were independent predictors for late death based on a multivariate analysis. Conclusions. Our valve selection criteria in dialysis patients, which are the same as the current practice guidelines for nondialysis patients, are acceptable. Bioprostheses can be considered in all dialysis patients with diabetes or coronary artery disease. (C) 2015 by The Society of Thoracic Surgeons	Nagoya Univ, Dept Cardiac Surg, Grad Sch Med, Ctr Adv Med & Clin Res, Nagoya, Aichi 4668550, Japan; Nagoya Univ, Ctr Adv Med & Clin Res, Biostat Sect, Grad Sch Med, Nagoya, Aichi 4668550, Japan; Nagoya Daini Red Cross Hosp, Dept Cardiovasc Surg, Nagoya, Aichi, Japan	Okada, N (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiac Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	cvsoka@gmail.com	Usui, Akihiko/I-7251-2014				Boning A, 2011, THORAC CARDIOV SURG, V59, P454, DOI 10.1055/s-0030-1271028; Herzog CA, 2002, CIRCULATION, V105, P1336, DOI 10.1161/hc1102.100075; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Perkovic V, 2003, NEPHRON CLIN PRACT, V94, pC40, DOI 10.1159/000071280; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Akins CW, 2008, ANN THORAC SURG, V85, P1490, DOI 10.1016/j.athoracsur.2007.12.082; Chan V, 2006, ANN THORAC SURG, V81, P857, DOI 10.1016/j.athoracsur.2005.09.009; Tanaka K, 2010, ANN THORAC SURG, V89, P65, DOI 10.1016/j.athoracsur.2009.10.026; Bianchi G, 2012, INTERACT CARDIOV TH, V15, P473, DOI 10.1093/icvts/ivs236; Boeken U, 2010, THORAC CARDIOV SURG, V58, P23, DOI 10.1055/s-0029-1186201; BRADLEY JR, 1985, LANCET, V2, P1370; Chan V, 2011, HEART, V97, P2033, DOI 10.1136/heartjnl-2011-300727; Hahn HS, 2000, ANN INTERN MED, V132, P847; Jamieson WRE, 2004, CAN J CARDIOL, V20, p7E; Kaplon RJ, 2000, ANN THORAC SURG, V70, P438, DOI 10.1016/S0003-4975(00)01544-7; K/DOQI Workgroup, 2005, AM J KIDNEY DIS S, V45, pS1, DOI DOI 10.1053/J.AJKD.2005.02.002; Mao M, 2011, INT J NEPHROL, V2011; Ohara T, 2005, CIRC J, V69, P1535, DOI 10.1253/circj.69.1535; Thourani VH, 2011, ANN THORAC SURG, V91, P1127, DOI 10.1016/j.athoracsur.2010.12.056; Yan H, 2011, SURGERY, V150, P1095, DOI 10.1016/j.surg.2011.09.027	21	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1524	1531		10.1016/j.athoracsur.2014.11.055		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900017		
J	Suzuki, T; Asai, T; Nota, H; Kinoshita, T; Fujino, S; Takashima, N				Suzuki, Tomoaki; Asai, Tohru; Nota, Hiromitsu; Kinoshita, Takeshi; Fujino, Susumu; Takashima, Noriyuki			Similar Outcome in Insulin-Dependent and Noninsulin-Dependent Diabetic Patients After Off-Pump Coronary Artery Bypass Grafting With Multiple Skeletonized Arterial Conduits	ANNALS OF THORACIC SURGERY			English	Article							INTERNAL THORACIC ARTERY; STERNAL WOUND-INFECTION; LONG-TERM; FOLLOW-UP; GASTROEPIPLOIC ARTERY; MULTIVESSEL DISEASE; MAMMARY ARTERIES; SURGERY; REVASCULARIZATION; SURVIVAL	Background. We were interested in whether current multiarterial off-pump coronary artery bypass graft surgery can improve the clinical outcome for insulindependent diabetes mellitus patients. Methods. Between January 2002 and December 2013, 1,064 consecutive patients underwent isolated off-pump coronary artery bypass surgery at our hospital; 551 of these patients had diabetes. Of these 551 patients, 166 had insulin-dependent diabetes (IDM) and the remaining 385 had noninsulin-dependent diabetes (NIDM). The propensity score was calculated to achieve one-to-two matching sets (IDM 143 versus NIDM 286). Results. Ten patients (3.5%) in the NIDM group and 2 patients (1.4%) in the IDM group died in hospital (p = 0.18). Insulin dependency was not an independent risk factor for any early death or major complications. Followup was complete for 96.5% of the patients, with a mean follow-up of 4.6 +/- 3.8 years. Overall survival rate at 10 years was 76.3% for the NIDM group and 73.1% for the IDM group (p = 0.79). The rate of 10-year actuarial freedom from major adverse cardiac events was 89.6% in the NIDM group and 86.3% in the IDM group (p = 0.72). Multivariate Cox proportional hazard regression analysis revealed that female sex, congestive heart failure, previous myocardial infarction, lower ejection fraction, and at least one major complication were independent risk factors for combined cardiac events. Insulin dependency did not affect any outcome in the long term. Conclusions. Early and long-term outcomes after offpump skeletonized multiarterial coronary artery bypass graft surgery were similar among the IDM and NIDM patients. (C) 2015 by The Society of Thoracic Surgeons	[Suzuki, Tomoaki; Asai, Tohru; Nota, Hiromitsu; Kinoshita, Takeshi; Fujino, Susumu; Takashima, Noriyuki] Shiga Univ Med Sci, Dept Cardiovasc Surg, Otsu, Shiga 5202192, Japan	Suzuki, T (reprint author), Shiga Univ Med Sci, Dept Cardiovasc Surg, Otsu, Shiga 5202192, Japan.	suzukit@belle.shiga-med.ac.jp					Suzuki T, 2011, ANN THORAC SURG, V91, P1159, DOI 10.1016/j.athoracsur.2010.12.031; Zhang H, 2014, ANN THORAC SURG, V97, P2073, DOI 10.1016/j.athoracsur.2014.02.047; Goraya TY, 2002, J AM COLL CARDIOL, V40, P946, DOI 10.1016/S0735-1097(02)02065-X; Calafiore AM, 2003, J THORAC CARDIOV SUR, V125, P144, DOI 10.1067/mtc.2003.73; Saso S, 2010, ANN THORAC SURG, V89, P661, DOI 10.1016/j.athoracsur.2009.08.018; Suzuki T, 2013, ANN THORAC SURG, V96, P90, DOI 10.1016/j.athoracsur.2013.04.018; Renner A, 2013, ANN THORAC SURG, V96, P528, DOI 10.1016/j.athoracsur.2013.04.063; Tavilla G, 2004, ANN THORAC SURG, V77, P794, DOI 10.1016/S0003-4975(03)01659-X; Hirotani T, 1999, J AM COLL CARDIOL, V34, P532, DOI 10.1016/S0735-1097(99)00215-6; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Luciani N, 2003, ANN THORAC SURG, V76, P1149, DOI 10.1016/S0003-4975(03)00838-5; Emmert MY, 2011, EUR J CARDIO-THORAC, V40, P233, DOI 10.1016/j.ejcts.2010.11.003; Carson JL, 2002, J AM COLL CARDIOL, V40, P418, DOI 10.1016/S0735-1097(02)01969-1; Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X; Szabo Z, 2002, ANN THORAC SURG, V74, P712, DOI 10.1016/S0003-4975(02)03778-5; ElBardissi AW, 2012, J THORAC CARDIOV SUR, V143, P273, DOI 10.1016/j.jtcvs.2011.10.029; Deo SV, 2013, ANN THORAC SURG, V95, P862, DOI 10.1016/j.athoracsur.2012.11.068; Taggart DP, 2010, EUR HEART J, V31, P2470, DOI 10.1093/eurheartj/ehq318; Hwang HY, 2010, ANN THORAC SURG, V90, P1180, DOI 10.1016/j.athoracsur.2010.05.021; Puskas JD, 2012, ANN THORAC SURG, V94, P710, DOI 10.1016/j.athoracsur.2012.03.082; Schmidt SE, 1997, ANN THORAC SURG, V64, P9, DOI 10.1016/S0003-4975(97)00473-6; Dorman MJ, 2012, CIRCULATION, V126, P2935, DOI 10.1161/CIRCULATIONAHA.112.117606; Magee MJ, 2001, ANN THORAC SURG, V72, P776, DOI 10.1016/S0003-4975(01)02840-5; Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Gum Patricia A., 1997, Circulation, V96, pII7; Leavitt BJ, 2004, CIRCULATION, V110, pII41, DOI 10.1161/01.CIR.0000138197.07051.e7; Mohammadi S, 2007, CIRCULATION, V116; O'Keefe JH, 1998, EUR HEART J, V19, P1696, DOI 10.1053/euhj.1998.1153; Rajakaruna C, 2006, J THORAC CARDIOV SUR, V132, P802, DOI 10.1016/j.jtcvs.2006.05.056; Stewart RD, 1998, J SURG RES, V76, P124, DOI 10.1006/jsre.1998.5306; Suzuki T, 2008, HEART SURG FORUM, V11, P196; The Bari 2D Study Group, 2009, NEW ENGL J MED, V360, P2503	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1562	1567		10.1016/j.athoracsur.2014.12.014		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900025		
J	Kamohara, K; Furukawa, K; Koga, S; Yunoki, J; Morokuma, H; Noguchi, R; Takase, K; Tanaka, A; Morita, S				Kamohara, Keiji; Furukawa, Kojiro; Koga, Shugo; Yunoki, Junji; Morokuma, Hiroyuki; Noguchi, Ryo; Takase, Kojiro; Tanaka, Atsuhisa; Morita, Shigeki			Surgical Strategy for Retrograde Type A Aortic Dissection Based on Long-Term Outcomes	ANNALS OF THORACIC SURGERY			English	Article							ELEPHANT TRUNK PROCEDURE; DESCENDING AORTA; THERAPEUTIC CHALLENGE; ASCENDING AORTA; THORACIC AORTA; TEAR; DETERMINANTS; REPLACEMENT; PROGNOSIS	Background. The optimal management of a retrograde type A aortic dissection (RAAD) is controversial, and few reports have discussed the long-term outcomes of surgical strategies. To determine the most appropriate strategy, we studied the early and late outcomes of RAAD cases. Methods. From 1998 to 2014, 44 patients with RAAD (mean age of 63 +/- 11 years) underwent surgical repair. Ascending aortic replacement (AAR) was performed in 21 patients and ascending and total arch replacement (TAR) was performed in 23 patients. Eight of the patients who received TAR underwent complete resection of the primary tear in the distal arch or descending aorta (TAR-R[+]), whereas the remaining 15 patients received elephant trunk implantation as an alternative procedure for tear resection (TAR-R[-]). The early and late outcomes (mean follow-up, 86.5 months) were evaluated. Results. Hospital mortality occurred in 4 of the 44 (9.1%) patients, with no mortalities among the patients undergoing TAR-R[-]. There was a tendency toward a higher incidence of late aorta-related events in the AAR group, with a significantly higher patency rate of the false lumen in the proximal site of the residual aorta compared with the TAR group (p = 0.009). Furthermore, the 5-year rate of freedom from aortic growth greater than 50 mm was significantly lower after AAR than after TAR (p = 0.04). A multivariate analysis indicated that the initial ascending aortic diameter (odds ratio [OR], 1.5; p = 0.02) and AAR (OR, 29.1; p = 0.01) were independent predictors of late aortic expansion. Conclusions. The surgical outcomes were acceptable in both the AAR and TAR groups. The long-term outcomes potentially support the aggressive adoption of TAR in relatively younger patients with significant ascending aortic enlargement at presentation. (C) 2015 by The Society of Thoracic Surgeons.	[Kamohara, Keiji; Furukawa, Kojiro; Koga, Shugo; Yunoki, Junji; Morokuma, Hiroyuki; Noguchi, Ryo; Takase, Kojiro; Tanaka, Atsuhisa; Morita, Shigeki] Saga Med Sch, Dept Thorac & Cardiovasc Surg, Saga, Saga 8498501, Japan	Kamohara, K (reprint author), Saga Med Sch, Dept Thorac & Cardiovasc Surg, 5-1 Nabeshima, Saga, Saga 8498501, Japan.	keijikamohara@hotmail.com					ERBEL R, 1993, CIRCULATION, V87, P1604; MILLER DC, 1984, CIRCULATION, V70, P153; Kazui T, 1996, J THORAC CARDIOV SUR, V112, P973, DOI 10.1016/S0022-5223(96)70097-1; Sun LZ, 2009, ANN THORAC SURG, V87, P1177, DOI 10.1016/j.athoracsur.2009.01.042; Hanafusa Y, 2002, ANN THORAC SURG, V74, pS1836, DOI 10.1016/S0003-4975(02)04141-3; CARREL T, 1993, EUR J CARDIO-THORAC, V7, P146, DOI 10.1016/1010-7940(93)90037-C; CIPRIANO PR, 1979, AM J CARDIOL, V43, P520, DOI 10.1016/0002-9149(79)90008-0; GLOWER DD, 1991, ANN SURG, V214, P31; HAVERICH A, 1985, CIRCULATION, V72, P22; Kaji S, 2003, CIRCULATION, V108, P300, DOI 10.1161/01.cir.0000087424.32901.98; Katayama K, 2014, EUR J CARDIOTHORAC S; MASSIMO CG, 1988, ANN THORAC SURG, V46, P420; Shimono T, 2002, CIRCULATION S1, V106, P241; Shu C, 2012, J VASC INTERV RADIOL, V23, P453, DOI 10.1016/j.jvir.2011.12.023; Tamura K, 2014, J THORAC CARDIOV SUR, V148, P561, DOI 10.1016/j.jtcvs.2012.12.094; VONSEGESSER LK, 1994, J THORAC CARDIOV SUR, V108, P755	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1610	1615		10.1016/j.athoracsur.2014.12.059		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900032		
J	Sakurai, H; Nakagawa, K; Watanabe, S; Asamura, H				Sakurai, Hiroyuki; Nakagawa, Kazuo; Watanabe, Shun-ichi; Asamura, Hisao			Clinicopathologic Features of Resected Subcentimeter Lung Cancer	ANNALS OF THORACIC SURGERY			English	Article							GROUND-GLASS OPACITY; ONCOLOGY GROUP 0201; LIMITED RESECTION; PULMONARY NODULES; RANDOMIZED-TRIAL; 1 CM; ADENOCARCINOMA; LESS; DIAMETER; SIZE	Background. Subcentimeter lung cancers are still rare, and their pathobiologic behavior and management have not yet been fully clarified. Methods. From 1993 through 2011, 291 patients with resected lung cancers 1.0 cm or less in diameter were studied regarding their clinicopathologic characteristics. According to appearance on high-resolution computed tomography (HRCT), the tumors were classified into four types: type 1 (n = 50), nonsolid ground-glass opacity (GGO) lesion; type 2 (n = 89), part-solid GGO lesion including 50% or more GGO within the lesion; type 3 (n = 62), part-solid GGO lesion including less than 50% GGO within the lesion, and type 4 (n = 90), solid lesion. Results. Although none of types 1 to 3 tumors had lymph node metastases, these were found in 10% of type 4 tumors. Recurrence was observed in 13 patients, almost all of whom had type 4 tumors. The lone exception was a patient with a type 3 tumor in whom local recurrence developed on a surgical staple line. The 5-year overall survival rates were 100% in type 1 and type 2, 98% in type 3, and 88% in type 4. Type 4 had a significantly worse prognosis than the other types. Conclusions. Subcentimeter lung cancers with a GGO component on HRCT (types 1 to 3) can be considered "early" lung cancers. In these cases, limited resection may be warranted to achieve a cure because they had no lymph node metastasis. By contrast, lobectomy should still be considered the standard operation of choice for type 4 tumors. (C) 2015 by The Society of Thoracic Surgeons	Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan; Keio Univ, Grad Sch Med, Dept Gen Thorac Surg, Tokyo, Japan	Sakurai, H (reprint author), Natl Canc Ctr, Div Thorac Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	hsakurai@ncc.go.jp					Altorki Nasser K, 2005, Semin Thorac Cardiovasc Surg, V17, P123, DOI 10.1053/j.semtcvs.2005.04.002; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Suzuki K, 2006, ANN THORAC SURG, V81, P413, DOI 10.1016/j.athoracsur.2005.07.058; Okada M, 2005, J THORAC CARDIOV SUR, V129, P87, DOI 10.1016/j.jtcvs.2004.04.030; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; Ikeda N, 2004, ANN THORAC SURG, V78, P1011, DOI 10.1016/j.athorascur.2004.03.048; Watanabe S, 2001, EUR J CARDIO-THORAC, V20, P1007, DOI 10.1016/S1010-7940(01)00954-X; Kishi K, 2004, LUNG CANCER-J IASLC, V44, P43, DOI 10.1016/j.lungcan.2003.09.024; Seok Y, 2014, J THORAC ONCOL, V9, P818, DOI 10.1097/JTO.0000000000000169; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Suzuki K, 2002, ANN THORAC SURG, V74, P1635, DOI 10.1016/S0003-4975(02)03895-X; Asamura H, 2013, J THORAC CARDIOV SUR, V146, P24, DOI 10.1016/j.jtcvs.2012.12.047; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Kodama K, 2001, LUNG CANCER-J IASLC, V33, P17, DOI 10.1016/S0169-5002(01)00185-4; Asamura H, 2003, ANN THORAC SURG, V76, P1016, DOI 10.1016/S0003-4975(03)00835-X; HOLMES CE, 1995, ANN THORAC SURG, V60, P615; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Henschke CI, 2004, RADIOLOGY, V231, P164, DOI 10.1148/radiol.23111030634; Kondo D, 2003, ANN THORAC SURG, V76, P350, DOI 10.1016/S0003-4975(03)00340-0; Midthun DE, 2003, LUNG CANCER S4, V41, pS40, DOI 10.1016/S0169-5002(03)91785-5; Miller DL, 2002, ANN THORAC SURG, V73, P1545, DOI 10.1016/S0003-4975(02)03525-7; Moriya Y, 2004, THORAC CARDIOV SURG, V52, P196, DOI 10.1055/s-2004-820899; Sakurai Hiroyuki, 2014, Transl Lung Cancer Res, V3, P164, DOI 10.3978/j.issn.2218-6751.2014.06.11; Sobin LH, 2009, TNM CLASSIFICATION M, V7th, P138; Travis WD, 1999, HISTOLOGICAL TYPING; Zhou QJ, 2010, INTERACT CARDIOV TH, V10, P53, DOI 10.1510/icvts.2009.216119	27	3	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1731	1738		10.1016/j.athoracsur.2015.01.034		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900055		
J	Harada, H; Miyamoto, K; Yamashita, Y; Taniyama, K; Ohdan, H; Okada, M				Harada, Hiroaki; Miyamoto, Kazuaki; Yamashita, Yoshinori; Taniyama, Kiyomi; Ohdan, Hideki; Okada, Morihito			Methylated DLX4 Predicts Response to Pathologic Stage I Non-Small Cell Lung Cancer Resection	ANNALS OF THORACIC SURGERY			English	Article							DNA METHYLATION; HOMEOBOX GENE; BREAST-CANCER; TRANSLATIONAL IMPLICATIONS; BP1; EXPRESSION; METASTASIS; EPIGENOME; IDENTIFICATION; RECURRENCE	Background. Surgery with curative intent is the standard treatment for patients with stage I non-small cell lung cancer (NSCLC). Even after curative resection, however, many patients have recurrent disease. Thus, there is a need to identify molecular biomarkers for the biological characteristics and prognosis of tumors. Methods. Methylation-specific polymerase chain reaction analysis was performed for the distal-less homeobox 4 (DLX4) gene in cancer tissues from 109 patients who underwent curative resection for pathologic stage I NSCLC from June 2005 to November 2011. We investigated possible correlations between DLX4 methylation status and disease outcome. Results. Methylated DLX4 was detected in 54 of 109 patients (49.5%). No significant relationship between DLX4 methylation status and clinicopathologic features was found. Multivariate logistic regression analysis revealed that DLX4 methylation was an independent risk factor for recurrence (p < 0.0001). Patients with DLX4 methylation showed significantly poorer recurrence-free, cancer-specific, and overall survival than patients without DLX4 methylation (p < 0.0001, p=0.0001, p=0.0004, respectively). Cox's proportional hazard regression analysis revealed that DLX4 methylation was an independent risk factor for poor prognosis regarding recurrence-free, cancer-specific, and overall survival (p < 0.0001, p=0.0005, p =0.0018, respectively). Conclusions. Methylated DLX4 is a potential biomarker that predicts poor prognosis after curative resection of pathologic stage I NSCLC. Identification of patients with methylated DLX4 may assist stratification for appropriate adjuvant treatment strategies. (C) 2015 by The Society of Thoracic Surgeons	[Harada, Hiroaki; Yamashita, Yoshinori] Natl Hosp Org, Kure Med Ctr, Dept Resp Surg, Kure, Hiroshima 7370023, Japan; [Harada, Hiroaki; Miyamoto, Kazuaki; Yamashita, Yoshinori; Taniyama, Kiyomi] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Kure, Hiroshima 7370023, Japan; [Harada, Hiroaki; Miyamoto, Kazuaki; Yamashita, Yoshinori; Taniyama, Kiyomi] Chugoku Canc Ctr, Kure, Hiroshima, Japan; [Miyamoto, Kazuaki] Natl Hosp Org, Higashihiroshima Med Ctr, Dept Surg, Higashihiroshima, Japan; [Ohdan, Hideki] Hiroshima Univ, Dept Surg, Hiroshima, Japan; [Okada, Morihito] Hiroshima Univ, Dept Surg Oncol, Hiroshima, Japan	Harada, H (reprint author), Natl Hosp Org, Kure Med Ctr, 3-1 Aoyama Cho, Kure, Hiroshima 7370023, Japan.	haradah@kure-nh.go.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Science, Sports, and Technology of Japan; Kyowa Hakko and Daiwa Securities Health Foundation	We would like to thank Kazuko Mihara and Mitsuki Nishimura for their excellent technical assistance. We have no conflicts of interest to disclose. This work was supported in part by Grants-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Cancer Research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan; and by research funding from Kyowa Hakko and Daiwa Securities Health Foundation.	Fu SW, 2003, BREAST CANCER RES, V5, pR82, DOI 10.1186/bcr602; Sandoval J, 2013, J CLIN ONCOL, V31, P4140, DOI 10.1200/JCO.2012.48.5516; Weichenhan D, 2013, HUM MOL GENET, V22, pR1, DOI 10.1093/hmg/ddt348; Man YG, 2005, BREAST CANCER RES TR, V90, P241, DOI 10.1007/s10549-004-4492-9; Tomida S, 2007, ONCOGENE, V26, P4600, DOI 10.1038/sj.onc.1210242; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Quinn LM, 1998, PLACENTA, V19, P87, DOI 10.1016/S0143-4004(98)90103-5; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Okada M, 1998, J THORAC CARDIOV SUR, V115, P836, DOI 10.1016/S0022-5223(98)70364-2; Miyamoto K, 2005, INT J CANCER, V116, P407, DOI 10.1002/ijc.21054; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Fu SD, 2001, GENE, V278, P131, DOI 10.1016/S0378-1119(01)00716-8; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Walter K, 2014, EPIGENOMICS-UK, V6, P59, DOI 10.2217/epi.13.81; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Zhang LM, 2012, INT J BIOL SCI, V8, P1178, DOI 10.7150/ijbs.4458; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Rauch TA, 2012, TUMOR BIOL, V33, P287, DOI 10.1007/s13277-011-0282-2; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Baylin Stephen B, 2012, Proc Am Thorac Soc, V9, P64, DOI 10.1513/pats.201201-001MS; Baylin SB, 1998, ADV CANCER RES, V72, P141; Hara F, 2007, AM J PATHOL, V170, P1594, DOI 10.2353/ajpath.2007.061025; Harada H, 2013, CANCER-AM CANCER SOC, V119, P792, DOI 10.1002/cncr.27754; Stevenson HS, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1766; Trinh BQ, 2011, ONCOGENE, V30, P2718, DOI 10.1038/onc.2011.4; Yu M, 2008, CLIN BIOCHEM, V41, P824, DOI 10.1016/j.clinbiochem.2008.03.011	32	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1746	1754		10.1016/j.athoracsur.2014.12.058		9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900059		
J	Ikeda, K; Shiraishi, K; Koga, T; Motooka, Y; Fujino, K; Shibata, H; Mori, T; Suzuki, M				Ikeda, Koei; Shiraishi, Kenji; Koga, Takafumi; Motooka, Yamato; Fujino, Kosuke; Shibata, Hidekatsu; Mori, Takeshi; Suzuki, Makoto			Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma	ANNALS OF THORACIC SURGERY			English	Article							CANDIDATE TUMOR-SUPPRESSOR; PLASMA-MEMBRANE TRANSPORTER; SQUAMOUS-CELL CARCINOMA; PROMOTER HYPERMETHYLATION; SLC5A8; CANCER; CLASSIFICATION; SURVIVIN; SMOKERS	Background. Solute carrier family 5 member A8 (SLC5A8) is a sodium-coupled transporter for several chemicals. The SLC5A8 gene has been reported to function as a tumor suppressor gene that contributes to carcinogenesis and tumor progression. The expression of SLC5A8 is silenced in colon neoplasia by hypermethylation of CpG-rich islands located in exon 1. In this study, we assessed the significance of aberrant methylation of the SLC5A8 gene as a prognostic factor for lung adenocarcinoma (AD). Methods. We analyzed the methylation levels of a consecutive series of 143 node-negative stage I and II lung AD samples using pyrosequencing. Results. The methylation level of exon 1 in the SLC5A8 gene was significantly associated with poor prognosis in cases of node-negative stage I and II lung AD. Conclusions. Gene silencing of SLC5A8 by hypermethylation was associated with poor prognosis in cases of node-negative stage I and II lung AD. (C) 2015 by The Society of Thoracic Surgeons	[Ikeda, Koei; Shiraishi, Kenji; Koga, Takafumi; Motooka, Yamato; Fujino, Kosuke; Shibata, Hidekatsu; Mori, Takeshi; Suzuki, Makoto] Kumamoto Univ, Grad Sch Med Sci, Dept Thorac Surg, Kumamoto 8608556, Japan	Ikeda, K (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Thorac Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan.	koei@cg7.so-net.ne.jp			Ministry of Education, Science, Sports, Culture and Technology of Japan [2459209600]	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan (2459209600).	Ueno M, 2004, TUMOR BIOL, V25, P134, DOI 10.1159/000079145; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Groome PA, 2007, J THORAC ONCOL, V2, P694, DOI 10.1097/JTO.0b013e31812d05d5; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Elangovan S, 2013, MOL CELL BIOL, V33, P3920, DOI 10.1128/MCB.01702-12; Ganapathy V, 2005, BIOCHEM SOC T, V33, P237; Leng SG, 2012, CANCER RES, V72, P707, DOI 10.1158/0008-5472.CAN-11-3194; Rodriguez AM, 2002, J CLIN ENDOCR METAB, V87, P3500, DOI 10.1210/jc.87.7.3500; Park JY, 2008, PANCREAS, V36, pE32, DOI 10.1097/MPA.0b013e3181630ffe; Porra V, 2005, J CLIN ENDOCR METAB, V90, P3028, DOI 10.1210/jc.2004-1394; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Babu E, 2011, ONCOGENE, V30, P4026, DOI 10.1038/onc.2011.113; Coothankandaswamy V, 2013, BIOCHEM J, V450, P169, DOI 10.1042/BJ20121248; Gaikwad A, 2012, EUR J RADIOL, V81, P4146, DOI 10.1016/j.ejrad.2012.08.023; Nordquist LT, 2004, CHEST, V126, P347, DOI 10.1378/chest.126.2.347; Park JY, 2007, CANCER DETECT PREV, V31, P359, DOI 10.1016/j.cdp.2007.09.002; Park JY, 2013, LUNG CANCER, V79, P198, DOI 10.1016/j.lungcan.2012.11.019; Sakai T, 2011, ANN THORAC CARDIOVAS, V17, P539, DOI 10.5761/atcs.oa.11.01660; Sepulveda Antonia R, 2009, J Mol Diagn, V11, P266, DOI 10.2353/jmoldx.2009.080125; Sun PL, 2013, VIRCHOWS ARCH, V463, P427, DOI 10.1007/s00428-013-1462-9; Yoshino I, 2006, ANN THORAC SURG, V81, P1181	22	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1755	1759		10.1016/j.athoracsur.2015.02.013		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900061		
J	Sano, A; Tsuchiya, T				Sano, Atsushi; Tsuchiya, Takehiro			Thoracoscopic Surgery for Multiple Peripheral Pulmonary Arteriovenous Fistulas	ANNALS OF THORACIC SURGERY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; MALFORMATIONS	A 37-year-old woman with dyspnea was referred to our department with the diagnosis of multiple bilateral pulmonary arteriovenous fistulas. Computed tomography of the chest showed nine fistulas in the right lung and four in the left lung. Because the fistulas were small and located peripherally, we chose thoracoscopic surgery instead of transcatheter pulmonary artery embolization. Intraoperatively, we identified four additional fistulas in the left lung. We resected 15 abnormal vessels and ligated two vessels during thoracoscopic surgery. Postoperatively, her dyspnea decreased and arterial blood oxygenation improved. Thoracoscopic surgery is a good treatment option for multiple small peripheral pulmonary arteriovenous fistulas. (C) 2015 by The Society of Thoracic Surgeons	[Sano, Atsushi; Tsuchiya, Takehiro] Chigasaki Municipal Hosp, Dept Thorac Surg, Chigasaki, Kanagawa, Japan	Sano, A (reprint author), Honson 5-15-1, Chigasaki, Kanagawa 2530042, Japan.	sanoa-tky@umin.ac.jp					Nishida T, 2012, AM J MED GENET A, V158A, P2829, DOI 10.1002/ajmg.a.35622; Cottin V, 2004, AM J RESP CRIT CARE, V169, P994, DOI 10.1164/rccm.200310-1441OC; Cartin-Ceba R, 2013, CHEST, V144, P1033, DOI 10.1378/chest.12-0924; Kohno Mitsutomo, 2004, Interact Cardiovasc Thorac Surg, V3, P596, DOI 10.1016/j.icvts.2004.07.003; Nakajima Jun, 2006, Asian Cardiovasc Thorac Ann, V14, P412	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1808	1809		10.1016/j.athoracsur.2014.08.047		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900077		
J	Miyoshi, K; Oto, T; Konishi, Y; Hirano, Y; Okada, M; Iga, N; Hirayama, S; Sugimoto, S; Yamane, M; Kobayashi, M; Miyoshi, S				Miyoshi, Kentaroh; Oto, Takahiro; Konishi, Yusuke; Hirano, Yutaka; Okada, Masanori; Iga, Norichika; Hirayama, Shin; Sugimoto, Seiichiro; Yamane, Masaomi; Kobayashi, Motomu; Miyoshi, Shinichiro			Use of Extended-Criteria Lungs on a Lobe-by-Lobe Basis Through Ex Vivo Lung Perfusion Assessment	ANNALS OF THORACIC SURGERY			English	Article							TRANSPLANTATION	Initially rejected and extended-criteria lungs were partially used through an ex vivo lung perfusion (EVLP) assessment that was first clinically applied in Asia. The truly injured lobe (left lower lobe) was identified during 89-minute normothermic EVLP and was excised, and the remaining lobes were successfully transplanted into a patient with lymphangioleiomyomatosis. The lung lobes showed heterogeneous changes on the ex vivo rig, and a brief duration of EVLP helped differentiate lung quality on a lobe-by-lobe basis. (C) 2015 by The Society of Thoracic Surgeons	Okayama Univ Hosp, Dept Thorac Surg, Okayama 7008558, Japan; Okayama Univ Hosp, Dept Anesthesiol, Okayama 7008558, Japan	Oto, T (reprint author), Okayama Univ Hosp, Dept Thorac Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	oto@md.okayama-u.ac.jp					Aigner C, 2012, AM J TRANSPLANT, V12, P1839, DOI 10.1111/j.1600-6143.2012.04027.x; Cypel M, 2008, J HEART LUNG TRANSPL, V27, P1319, DOI 10.1016/j.healun.2008.09.003; Cypel M, 2012, J THORAC CARDIOV SUR, V144, P1200, DOI 10.1016/j.jtcvs.2012.08.009; Steen S, 2007, ANN THORAC SURG, V83, P2191, DOI 10.1016/j.athoracsur.2007.01.033	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1819	1821		10.1016/j.athoracsur.2014.06.115		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900082		
J	Kimura, T; Inagawa, K; Tanimoto, K; Takatsuki, S				Kimura, Takehiro; Inagawa, Kohei; Tanimoto, Kojiro; Takatsuki, Seiji			Huge Left Atrial Appendage After an Incomplete Surgical Ligation and Successful Catheter Ablation of Atrial Fibrillation	ANNALS OF THORACIC SURGERY			English	Editorial Material									[Kimura, Takehiro; Inagawa, Kohei; Tanimoto, Kojiro; Takatsuki, Seiji] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Kimura, T (reprint author), 35 Shinanomachi Shinjuku Ku, Tokyo 1608582, Japan.	kimura@z7.keio.jp					Katz ES, 2000, J AM COLL CARDIOL, V36, P468, DOI 10.1016/S0735-1097(00)00765-8	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1826	1826		10.1016/j.athoracsur.2014.12.056		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900085		
J	Tanaka, K; Nakajima, T; Morimoto, J; Yoshino, I				Tanaka, Kazuhisa; Nakajima, Takahiro; Morimoto, Junichi; Yoshino, Ichiro			Right Lower Sleeve LobectomyWith Double-Barreled Bronchoplasty for a Centrally Located Lung Cancer	ANNALS OF THORACIC SURGERY			English	Editorial Material									[Tanaka, Kazuhisa; Nakajima, Takahiro; Morimoto, Junichi; Yoshino, Ichiro] Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba 2608670, Japan	Nakajima, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	takahiro_nakajima@med.miyazaki-u.ac.jp					Cerfolio RJ, 1996, ANN THORAC SURG, V61, P1458, DOI 10.1016/0003-4975(96)00078-1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1829	1829		10.1016/j.athoracsur.2014.12.050		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900088		
J	Hamaji, M; Ali, SO; Burt, BM				Hamaji, Masatsugu; Ali, Syed Osman; Burt, Bryan M.			A Meta-Analysis of Induction Therapy for Advanced Thymic Epithelial Tumors	ANNALS OF THORACIC SURGERY			English	Review							LOCALLY ADVANCED THYMOMA; SINGLE-INSTITUTION EXPERIENCE; STAGE-IVA THYMOMA; PHASE-II TRIAL; MULTIDISCIPLINARY APPROACH; NEOADJUVANT CHEMOTHERAPY; EXTENDED RESECTIONS; SURGICAL RESECTION; MALIGNANT THYMOMA; INVASIVE THYMOMA	This meta-analysis was designed to determine the effect of induction therapy and surgical resection on overall survival in patients with advanced thymic epithelial tumors. PubMed and Scopus databases were queried, and 12 studies comprising 266 patients were analyzed. Meta-analysis using a random effect model revealed a pooled rate of response to induction therapy of 59%, a pooled rate of complete resection of 73%, and pooled 5-year and 10-year overall survival of 87% and 76% after induction therapy, respectively. Surgical resection after induction therapy for advanced thymic epithelial tumors can be undertaken with favorable outcomes. (C) 2015 by The Society of Thoracic Surgeons	Kyoto Univ Hosp, Dept Thorac Surg, Kyoto 6068507, Japan; Altru Hosp, Div Cardiothorac Surg, Grand Forks, ND USA; Baylor Coll Med, Dept Surg, Div Thorac Surg, Houston, TX 77030 USA	Hamaji, M (reprint author), Kyoto Univ Hosp, Dept Thorac Surg, Sakyo Ku, 54 Kawaracho, Kyoto 6068507, Japan.	mhamaji@kuhp.kyoto-u.ac.jp					Korst RJ, 2014, J THORAC CARDIOV SUR, V147, P36, DOI 10.1016/j.jtcvs.2013.08.061; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Park S, 2013, J THORAC ONCOL, V8, P959, DOI 10.1097/JTO.0b013e318292c41e; Ruffini E, 2014, J THORAC ONCOL, V9, P541, DOI 10.1097/JTO.0000000000000128; Venuta F, 2003, ANN THORAC SURG, V76, P1866, DOI 10.1016/S0003-4975(03)01020-8; Kunitoh H, 2010, BRIT J CANCER, V103, P6, DOI 10.1038/sj.bjc.6605731; Cardillo G, 2010, EUR J CARDIO-THORAC, V37, P819, DOI 10.1016/j.ejcts.2009.11.001; Wright CD, 2008, ANN THORAC SURG, V85, P385, DOI 10.1016/j.athoracsur.2007.08.051; Lucchi M, 2005, ANN THORAC SURG, V79, P1840, DOI 10.1016/j.athoracsur.2004.12.047; Rea F, 2011, LUNG CANCER, V72, P68, DOI 10.1016/j.lungcan.2010.07.006; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Berruti A, 1999, BRIT J CANCER, V81, P841, DOI 10.1038/sj.bjc.6690773; Bretti S, 2004, LUNG CANCER-J IASLC, V44, P69, DOI 10.1016/j.lungcan.2003.09.002; Huang J, 2007, J THORAC CARDIOV SUR, V134, P1477, DOI 10.1016/j.jtcvs.2007.07.049; Ioannidis JPA, 2007, BMJ-BRIT MED J, V78, P375; Kim ES, 2004, LUNG CANCER-J IASLC, V44, P369, DOI 10.1016/j.lungcan.2003.12.010; Litvak AM, 2014, J THORAC ONCOL, V9, P1810, DOI 10.1097/JTO.0000000000000363; Lucchi M, 2006, J THORAC ONCOL, V1, P308, DOI 10.1097/01243894-200605000-00007; Marulli Giuseppe, 2011, Eur J Cardiothorac Surg, V39, pe1, DOI 10.1016/j.ejcts.2010.11.026; Mineo TC, 2010, ANN SURG ONCOL, V17, P3022, DOI 10.1245/s10434-010-1134-9; Okereke IC, 2010, ANN THORAC SURG, V89, P1071, DOI 10.1016/j.athoracsur.2010.01.026; REA F, 1993, J THORAC CARDIOV SUR, V106, P543; Rena O, 2012, LUNG CANCER, V76, P89, DOI 10.1016/j.lungcan.2011.10.004; Riely GJ, 2010, J THORAC ONCOL, V5, pS323, DOI 10.1097/JTO.0b013e3181f20e90; Shapiro Mark, 2014, Front Oncol, V3, P332, DOI 10.3389/fonc.2013.00332; Shin DM, 1998, ANN INTERN MED, V129, P100; Venuta Federico, 2012, Gen Thorac Cardiovasc Surg, V60, P1, DOI 10.1007/s11748-011-0814-0; Wright CD, 2010, J THORAC ONCOL, V5, pS344, DOI 10.1097/JTO.0b013e3181f20eb3	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					1848	1856		10.1016/j.athoracsur.2014.12.048		9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900094		
J	Furutake, T; Koizumi, J; Iwase, T; Kamada, T; Takahashi, S; Oyama, K; Okabayashi, H; Ikai, A				Furutake, Tatsuya; Koizumi, Junichi; Iwase, Tomoyuki; Kamada, Takeshi; Takahashi, Shin; Oyama, Kotaro; Okabayashi, Hitoshi; Ikai, Akio			Artery Fistula Causing Aortic Regurgitation in Pulmonary Atresia With Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries	ANNALS OF THORACIC SURGERY			English	Article							CORONARY	We report a case of aortic regurgitation (AR), coronary artery-to-pulmonary artery (CAPA) fistula, pulmonary atresia with ventricular septal defect (PA/VSD), and major aortopulmonary collateral arteries (MAPCAS). As a result of coronary steal and AR, myocardial ischemia and ventricular dysfunction occurred. When the patient was 2 months old with a body weight of 2.7 kg, we performed fistula ligation, aortic valvuloplasty, unifocalization of the MAPCAS, and right ventricle-to-pulmonary artery shunting. After the operation, the AR volume reduced, and the patient was scheduled for repair. (C) 2015 by The Society of Thoracic Surgeons	[Ikai, Akio] Iwate Med Univ, Dept Cardiovasc Surg, Morioka, Iwate 0208505, Japan; Iwate Med Univ, Dept Pediat Cardiol, Morioka, Iwate 0208505, Japan	Ikai, A (reprint author), Iwate Med Univ, Dept Cardiovasc Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	ikai@iwate-med.ac.jp					Amin Z, 2000, ANN THORAC SURG, V70, P119, DOI 10.1016/S0003-4975(00)01284-4; Kaneko Y, 2001, ANN THORAC SURG, V71, P355, DOI 10.1016/S0003-4975(00)02143-3; Sathanandam SK, 2011, PEDIATR CARDIOL, V32, P1017, DOI 10.1007/s00246-011-0043-4; Seetharama Bhat P, 2014, ANN PEDIAT CARDIOL, V7, P142	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					E121	E123		10.1016/j.athoracsur.2015.02.059		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900006		
J	Iwaki, R; Oshima, Y; Maruo, A; Hasegawa, T; Matsuhisa, H; Noda, R; Matsushima, S				Iwaki, Ryuma; Oshima, Yoshihiro; Maruo, Ayako; Hasegawa, Tomomi; Matsuhisa, Hironori; Noda, Rei; Matsushima, Shunsuke			Staged Biventricular Repair for Absent Aortic Valve in a Neonate	ANNALS OF THORACIC SURGERY			English	Article							STENOSIS	Congenitally absent aortic valve is an extremely rare and fatal cardiac malformation. We report the case of a neonate with absent aortic valve, an interrupted aortic arch, and a normal-sized left ventricle. At age 9 hours, emergency aortic valve closure and a Norwood procedure were performed to maintain coronary circulation. The patient's postoperative course was complicated because of tracheomalacia and a severely dilated aorta that were treated with reduction aortoplasty at age 4 months. Finally, a staged Yasui procedure was performed at 26 months. To our knowledge, this is the first report of a successful biventricular repair for absent aortic valve. (C) 2015 by The Society of Thoracic Surgeons	[Iwaki, Ryuma; Oshima, Yoshihiro; Maruo, Ayako; Hasegawa, Tomomi; Matsuhisa, Hironori; Noda, Rei; Matsushima, Shunsuke] Kobe Childrens Hosp, Dept Cardiovasc Surg, Kobe, Hyogo 6540081, Japan	Iwaki, R (reprint author), Kobe Childrens Hosp, Dept Cardiovasc Surg, Suma Ku, 1-1-1 Takakura Dai, Kobe, Hyogo 6540081, Japan.	iwaki_kch@hp.pref.hyogo.jp					TOEWS WH, 1975, CHEST, V68, P381, DOI 10.1378/chest.68.3.381; Harada Y, 1998, ANN THORAC SURG, V66, P935, DOI 10.1016/S0003-4975(98)00623-7; Krasemann T, 2003, PEDIATR CARDIOL, V24, P304, DOI 10.1007/s00246-002-0322-1; Baker CJ, 2005, ANN THORAC SURG, V80, P1647, DOI 10.1016/j.athotacsur.2005.04.064; LAKIER JB, 1974, CIRCULATION, V50, P167	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	MAY	2015	99	5					E117	E119		10.1016/j.athoracsur.2014.10.026		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CH2TP	WOS:000353877900005		
J	Tsukimoto, A; Sugiyama, R; Abe, M; Nishitsuji, H; Shimizu, Y; Shimotohno, K; Kawai, G; Takaku, H				Tsukimoto, Atsuko; Sugiyama, Ryuichi; Abe, Makoto; Nishitsuji, Hironori; Shimizu, Yuko; Shimotohno, Kunitada; Kawai, Gota; Takaku, Hiroshi			A new role for PGA(1) in inhibiting hepatitis C virus-IRES-mediated translation by targeting viral translation factors	ANTIVIRAL RESEARCH			English	Article						HCV; Translation inhibition; Prostaglandin A(1); Small ribosomal subunit (40S); Eukaryotic initiation factors eIF3; HCV IRES RNA	RIBOSOME ENTRY SITE; PROSTAGLANDIN-A; FACTOR EIF3; CYCLOPENTENONE PROSTAGLANDINS; PROTEIN-SYNTHESIS; INITIATION; INFECTION; RNA; REPLICATION; SUBUNIT	Previous studies have demonstrated that cyclopentenone prostaglandins (cyPGs) inhibit the replication of a wide variety of DNA and RNA viruses in different mammalian cell types. We investigated a new role for prostaglandin A(1) (PGA(1)) in the inhibition of hepatitis C virus (HCV)-IRES-mediated translation. PGA(1) exhibited dose-dependent inhibitory effects on HCV translation in HCV replicon cells. Furthermore, repetitive PGA(1) treatment demonstrated the potential to safely induce the suppression of HCV translation. We also validated a new role for PGA(1) in the inhibition of HCV-IRES-mediated translation by targeting cellular translation factors, including the small ribosomal subunit (40S) and eukaryotic initiation factors (eIFs). In pull-down assays, biotinylated PGA(1) co-precipitated with the entire HCV IRES RNA/eIF3-40S subunit complex. Moreover, the interactions between PGA(1) and the elongation factors and ribosomal subunit were dependent upon HCV IRES RNA binding, and the PGA(1)/HCV IRES RNA/eIF3-40S subunit complex inhibited HCV-IRES-mediated translation. The novel mechanism revealed in this study may aid in the search for more effective anti-HCV drugs. (C) 2015 Elsevier B.V. All rights reserved.	[Tsukimoto, Atsuko; Sugiyama, Ryuichi; Abe, Makoto; Nishitsuji, Hironori; Kawai, Gota; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan; [Takaku, Hiroshi] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 2750016, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Res Inst, Narashino, Chiba 2750016, Japan; [Nishitsuji, Hironori; Shimizu, Yuko; Shimotohno, Kunitada] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba 2728516, Japan; [Sugiyama, Ryuichi] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan	Takaku, H (reprint author), Chiba Inst Technol, Res Inst, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	hiroshi.takaku@p.chibakoudai.jp			Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT); Ministry of Education, Science, Sports; Japan Society for the Promotion of Science (JSPS) [26860309]; Strategic Research Foundation	We are grateful to K. Kimizuka for excellent technical assistance. This work was supported by a Grant-in-Aid for HCV Research from the Ministry of Health, Labor, and Welfare of Japan; a Grant from the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT); a Grant-in-Aid for High Technology Research (HTR) from the Ministry of Education, Science, Sports; and a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS) (Grant Number 26860309).	AMICI C, 1991, J GEN VIROL, V72, P1877, DOI 10.1099/0022-1317-72-8-1877; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105; Soriano V, 2009, CLIN INFECT DIS, V48, P313, DOI 10.1086/595848; Santoro MG, 1997, TRENDS MICROBIOL, V5, P276, DOI 10.1016/S0966-842X(97)01066-4; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; Seth PP, 2005, J MED CHEM, V48, P7099, DOI 10.1021/jm050815o; Aoyagi K, 1999, J CLIN MICROBIOL, V37, P1802; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Gayarre J, 2005, FEBS LETT, V579, P5803, DOI 10.1016/j.febslet.2005.09.069; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Fontanes V, 2009, VIROLOGY, V394, P82, DOI 10.1016/j.virol.2009.08.012; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Ujino S, 2009, J BIOL CHEM, V284, P6841, DOI 10.1074/jbc.M806452200; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436; Pisarev AV, 2005, CR BIOL, V328, P589, DOI 10.1016/j.crvi.2005.02.004; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Lukavsky PJ, 2009, VIRUS RES, V139, P166, DOI 10.1016/j.virusres.2008.06.004; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Kieft JS, 2002, NAT STRUCT BIOL, V9, P370, DOI 10.1038/nsb781; Wang WY, 2000, BIOORG MED CHEM LETT, V10, P1151, DOI 10.1016/S0960-894X(00)00217-1; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Diez-Dacal B, 2011, CANCER RES, V71, P4161, DOI 10.1158/0008-5472.CAN-10-3816; Diez-Dacal B, 2012, CANCER LETT, V320, P150, DOI 10.1016/j.canlet.2012.03.003; Pudi R, 2005, J VIROL, V79, P9842, DOI 10.1128/JVI.79.15.9842-9853.2005; Buratti E, 1998, NUCLEIC ACIDS RES, V26, P3179, DOI 10.1093/nar/26.13.3179; Carnevali M, 2010, CHEMBIOCHEM, V11, P1364, DOI 10.1002/cbic.201000177; Degasperi Elisabetta, 2014, Hepat Med, V6, P25, DOI 10.2147/HMER.S44375; Dvory-Sobol H, 2010, VIRUSES-BASEL, V2, P2481, DOI 10.3390/v2112481; Ghobrial RM, 2001, ANN SURG, V234, P384, DOI 10.1097/00000658-200109000-00012; Hayes MM, 2002, J BIOL CHEM, V277, P16913, DOI 10.1074/jbc.M200875200; Jefferson EA, 2004, BIOORG MED CHEM LETT, V14, P5139, DOI 10.1016/j.bmcl.2004.07.066; Kalantari P, 2009, FASEB J, V23, P2366, DOI 10.1096/fj.08-124982; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kishine H, 2002, BIOCHEM BIOPH RES CO, V293, P993, DOI 10.1016/S0006-291X(02)00342-X; Melnikova I, 2011, NAT REV DRUG DISCOV, V10, P93, DOI 10.1038/nrd3361; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; SANTORO MG, 1980, SCIENCE, V209, P1032, DOI 10.1126/science.6157190; SANTORO MG, 1989, J GEN VIROL, V70, P789, DOI 10.1099/0022-1317-70-4-789; Ujino S, 2012, VIRUS RES, V163, P390, DOI 10.1016/j.virusres.2011.10.003; Zhou YF, 2005, ANTIMICROB AGENTS CH, V49, P4942, DOI 10.1128/AAC.49.12.4942-4949.2005	47	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	MAY	2015	117						1	9		10.1016/j.antiviral.2015.01.013		9	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	CH0TH	WOS:000353734800001		
J	Takashita, E; Meijer, A; Lackenby, A; Gubareva, L; Rebelo-de-Andrade, H; Besselaar, T; Fry, A; Gregory, V; Leang, SK; Huang, WJ; Lo, J; Pereyaslov, D; Siqueira, MM; Wang, DY; Mak, GC; Zhang, WQ; Daniels, RS; Hurt, AC; Tashiro, M				Takashita, Emi; Meijer, Adam; Lackenby, Angie; Gubareva, Larisa; Rebelo-de-Andrade, Helena; Besselaar, Terry; Fry, Alicia; Gregory, Vicky; Leang, Sook-Kwan; Huang, Weijuan; Lo, Janice; Pereyaslov, Dmitriy; Siqueira, Marilda M.; Wang, Dayan; Mak, Gannon C.; Zhang, Wenqing; Daniels, Rod S.; Hurt, Aeron C.; Tashiro, Masato			Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014	ANTIVIRAL RESEARCH			English	Article						Influenza virus; Antiviral resistance; Neuraminidase inhibitors; Oseltamivir; Global analysis; Reduced susceptibility	H275Y OSELTAMIVIR-RESISTANT; UNITED-STATES; COMMUNITY CLUSTER; A(H1N1) VIRUS; H1N1; MUTATIONS; SEASON; JAPAN	Four World Health Organization (WHO) Collaborating Centres for Reference and Research on Influenza and one WHO Collaborating Centre for the Surveillance, Epidemiology and Control of Influenza (WHO CCs) tested 10,641 viruses collected by WHO-recognized National Influenza Centres between May 2013 and May 2014 to determine 50% inhibitory concentration (IC50) data for neuraminidase inhibitors (NAIs) oseltamivir, zanamivir, peramivir and laninamivir. In addition, neuraminidase (NA) sequence data, available from the WHO CCs and from sequence databases (n = 3206), were screened for amino acid substitutions associated with reduced NAI susceptibility. Ninety-five per cent of the viruses tested by the WHO CCs were from three WHO regions: Western Pacific, the Americas and Europe. Approximately 2% (n = 172) showed highly reduced inhibition (HRI) against at least one of the four NAIs, commonly oseltamivir, while 0.3% (n = 32) showed reduced inhibition (RI). Those showing HRI were A(H1N1)pdm09 with NA H275Y (n = 169), A(H3N2) with NA E119V (n = 1), B/Victoria-lineage with NA E117G (n = 1) and B/Yamagata-lineage with NA H273Y (n = 1); amino acid position numbering is A subtype and B type specific. Although approximately 98% of circulating viruses tested during the 2013-2014 period were sensitive to all four NAIs, a large community cluster of A(H1N1)pdm09 viruses with the NA H275Y substitution from patients with no previous exposure to antivirals was detected in Hokkaido, Japan. Significant numbers of A(H1N1)pdm09 NA H275Y viruses were also detected in China and the United States: phylogenetic analyses showed that the Chinese viruses were similar to those from Japan, while the United States viruses clustered separately from those of the Hokkaido outbreak, indicative of multiple resistance-emergence events. Consequently, global surveillance of influenza antiviral susceptibility should be continued from a public health perspective. (C) 2015 The Authors. Published by Elsevier B.V.	[Takashita, Emi; Tashiro, Masato] Natl Inst Infect Dis, World Hlth Org Collaborating Ctr Reference & Res, Tokyo 2080011, Japan; [Meijer, Adam] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Lackenby, Angie] Publ Hlth England Colindale, London NW9 5EQ, England; [Gubareva, Larisa; Fry, Alicia] Ctr Dis Control & Prevent, World Hlth Org Collaborating Ctr Surveillance Epi, Atlanta, GA USA; [Rebelo-de-Andrade, Helena] Inst Nacl Saude, P-1649016 Lisbon, Portugal; [Rebelo-de-Andrade, Helena] Univ Lisbon, Fac Farm, P-1649003 Lisbon, Portugal; [Besselaar, Terry; Zhang, Wenqing] WHO, Global Influenza Programme, CH-1211 Geneva 27, Switzerland; [Gregory, Vicky; Daniels, Rod S.] Natl Inst Med Res, MRC, World Hlth Org Collaborating Ctr Reference & Res, London NW7 1AA, England; [Leang, Sook-Kwan; Hurt, Aeron C.] Peter Doherty Inst Infect & Immun, VIDRL, World Hlth Org Collaborating Ctr Reference & Res, Melbourne, Vic 3000, Australia; [Huang, Weijuan; Wang, Dayan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Chinese Natl Influenza Ctr, World Hlth Org Collaborating Ctr Reference & Res, Beijing 102206, Peoples R China; [Lo, Janice; Mak, Gannon C.] Publ Hlth Lab Ctr, Kowloon, Hong Kong, Peoples R China; [Pereyaslov, Dmitriy] WHO, Reg Off Europe, Div Communicable Dis Hlth Secur & Environm, DK-2100 Copenhagen O, Denmark; [Siqueira, Marilda M.] Fiocruz MS, Resp Viruses Lab IOC, BR-4365 Rio De Janeiro, Brazil; [Hurt, Aeron C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia	Tashiro, M (reprint author), Natl Inst Infect Dis, Influenza Virus Res Ctr, Gakuen 4-7-1, Tokyo 2080011, Japan.	emitaka@nih.go.jp; adam.meijer@rivm.nl; Angie.Lackenby@phe.gov.uk; LGubareva@CDC.gov; h.rebelo.andrade@insa.min-saude.pt; besselaart@who.int; agf1@cdc.gov; vgregor@nimr.mrc.ac.uk; leah.leang@influenzacentre.org; huangweijuan@cnic.org.cn; janicelo@dh.gov.hk; PDM@euro.who.int; mmsiq@ioc.fiocruz.br; dayanwang@cnic.org.cn; so_phls10@dh.gov.hk; zhangw@who.int; rdaniel@nimr.mrc.ac.uk; Aeron.Hurt@influenzacentre.org; mtashiro2@gmail.com	Rebelo-de-Andrade, Helena/E-1871-2014; iMed.ULisboa, iMed.ULisboa/C-6292-2014; iMed.ULisboa, HPI /B-4239-2014; 	Rebelo-de-Andrade, Helena/0000-0002-0138-0944; Hurt, Aeron/0000-0003-1826-4314	Ministry of Health, Labour, and Welfare, Japan; JSPS KAKENHI Grant [26460816]; British Medical Research Council [U117512723]; Australian Government Department of Health	We thank all laboratories, mostly NICs of the WHO GISRS (http://www.who.int/influenza/gisrs_laboratory/national_influenza_cen-tresflist/en/), which contributed to this global analysis by submitting influenza virus positive samples (clinical specimens or virus isolates) to WHO CCs for detailed characterisation. We gratefully acknowledge the authors, originating and submitting laboratories of the sequences submitted to the GISAID database (Supplementary Table 3), and the sequences retrieved from the NCBI-IVR, that were included in this global analysis. The Tokyo WHO CC is supported by Grants-in-Aid for Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour, and Welfare, Japan and by JSPS KAKENHI Grant number 26460816. The London WHO CC is funded by the British Medical Research Council through programme U117512723. The Melbourne WHO CC is supported by the Australian Government Department of Health.	Abed Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002431; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Collins PJ, 2009, VACCINE, V27, P6317, DOI 10.1016/j.vaccine.2009.07.017; Hurt AC, 2012, J INFECT DIS, V206, P148, DOI 10.1093/infdis/jis337; Kawai N, 2009, J INFECTION, V59, P207, DOI 10.1016/j.jinf.2009.07.002; Abed Y, 2014, J VIROL, V88, P1652, DOI 10.1128/JVI.02681-13; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Kitler ME, 2002, VACCINE, V20, pS5, DOI 10.1016/S0264-410X(02)00121-4; Dapat C, 2010, EMERG INFECT DIS, V16, P493, DOI 10.3201/eid1603.091321; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Oakley AJ, 2010, J MED CHEM, V53, P6421, DOI 10.1021/jm100621s; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.181280, 10.3201/eid1504.081280]; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Saito R, 2010, PEDIATR INFECT DIS J, V29, P898, DOI 10.1097/INF.0b013e3181de9d24; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P69, DOI 10.1111/j.1750-2659.2009.00072.x; Ujike M, 2010, EMERG INFECT DIS, V16, P926, DOI 10.3201/eid1606.091623; Garg S, 2013, J INFECT DIS, V207, P966, DOI 10.1093/infdis/jis776; Bouvier NM, 2012, J VIROL, V86, P7268, DOI 10.1128/JVI.07242-12; Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065; Dharan NJ, 2010, CLIN INFECT DIS, V50, P621, DOI 10.1086/650178; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Lackenby A., 2008, Eurosurveillance, V13, P8026; Matsuzaki Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-53; Meijer A, 2014, ANTIVIR RES, V110, P31, DOI 10.1016/j.antiviral.2014.07.001; Okomo-Adhiambo M, 2015, EMERG INFECT DIS, V21, P136, DOI [10.3201/eid2101.141006, 10.3201/eid2101/141006]; Rameix-Welti MA, 2011, ANTIVIR THER, V16, P597, DOI 10.3851/IMP1804; Takashita E, 2014, EUROSURVEILLANCE, V19, P4, DOI 10.2807/1560-7917.ES2014.19.1.20666; Tamura D, 2013, ANTIMICROB AGENTS CH, V57, P6141, DOI 10.1128/AAC.01364-13; Tan H, 2013, MOL BIOSYST, V9, P2764, DOI 10.1039/c3mb70253g; WHO, 2013, WKLY EPIDEMIOL REC, V88, P477; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P369	32	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	MAY	2015	117						27	38		10.1016/j.antiviral.2015.02.003		12	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	CH0TH	WOS:000353734800004		
J	Onishi, M; Kitano, M; Taniguchi, K; Homma, T; Kobayashi, M; Yoshinaga, T; Naito, A; Sato, A				Onishi, Motoyasu; Kitano, Mitsutaka; Taniguchi, Keiichi; Homma, Tomoyuki; Kobayashi, Masanori; Yoshinaga, Tomokazu; Naito, Akira; Sato, Akihiko			Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae	ANTIVIRAL RESEARCH			English	Article						Bacterial co-infection; Neuraminidase inhibitor; Peramivir; Influenza virus; Streptococcus pneumoniae	PLATELET-ACTIVATING-FACTOR; RESPIRATORY-TRACT; ORAL OSELTAMIVIR; FACTOR RECEPTOR; INFECTION; EFFICACY; NEURAMINIDASE; CHILDREN; DEFENSE; SAFETY	Introduction: Influenza virus infection increases susceptibility to bacterial infection and mortality in humans. Although the efficacy of approved intravenous peramivir, a neuraminidase (NA) inhibitor, against influenza virus infection has been reported, its efficacy against bacterial co-infection, which occurs during the period of viral shedding, was not fully investigated. To further understand the significance of treatment with peramivir, we assessed the efficacy of peramivir against a bacterial co-infection model in mice caused by clinically isolated influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae. Methods: Mice were infected with influenza A(H1N1)pdm09. Peramivir was intravenously administered after the viral infection. At 2 days post viral infection, the mice were infected with Streptococcus pneumoniae. Peramivir efficacy was measured by the survival rates and viral titers, bacterial titers, or proinflammatory cytokine concentrations in lung homogenates. Results: Peramivir treatment reduced the mortality of mice infected with influenza virus and Streptococcus pneumoniae. The survival rate in the peramivir-treated group was significantly higher than that in the oseltamivir-treated group. Viral titers and proinflammatory cytokine responses in the peramivir-treated group were significantly lower than those in the oseltamivir-treated group until at 2 days post viral infection. Bacterial titer was significantly lower in the peramivir-treated group than in the oseltamivir-treated group at 4 days post viral infection. Conclusion: These results demonstrated that peramivir inhibits viral replication, consequently leading to bacterial clearance and prevention of mortality during severe murine bacterial co-infection, which occurs during the period of viral shedding, with the efficacy of peramivir being superior to that of oseltamivir. (C) 2015 Elsevier B.V. All rights reserved.	[Onishi, Motoyasu; Kitano, Mitsutaka; Taniguchi, Keiichi; Homma, Tomoyuki; Kobayashi, Masanori; Yoshinaga, Tomokazu; Naito, Akira; Sato, Akihiko] Shionogi & Co Ltd, Discovery Res Lab, Core Therapeut Area, Infect Dis, Toyonaka, Osaka 5610825, Japan	Onishi, M (reprint author), Shionogi & Co Ltd, Discovery Res Lab, Core Therapeut Area, Infect Dis, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan.	motoyasu.oonishi@shionogi.co.jp		Onishi, Motoyasu/0000-0002-7660-2986	Shionogi Co., Ltd.	We thank Tetsuo Kase from the Osaka Prefectural Institute of Public Health for providing A/Osaka/129/2009. Also, we thank Takeshi Noshi, Yoshinori Ando, Tadashi Miyamoto, Hayato Matsuda, Rio Nakamura, Masakatsu Tsuji, Mitsunobu Matsumoto, and Takayuki Kanazawa from Shionogi & Co., Ltd. for their valuable comments about this study. This study was financially supported by Shionogi & Co., Ltd.	McCullers JA, 2004, J INFECT DIS, V190, P519, DOI 10.1086/421525; Kohno S, 2011, ANTIMICROB AGENTS CH, V55, P2803, DOI [10.1128/AAC.01718-10, 10.1128/AAC.00360-11]; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Joseph C, 2013, INFLUENZA OTHER RESP, V7, P105, DOI 10.1111/irv.12089; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; Chertow DS, 2013, JAMA-J AM MED ASSOC, V309, P275, DOI 10.1001/jama.2012.194139; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Birnkrant D, 2009, NEW ENGL J MED, V361, P2204, DOI 10.1056/NEJMp0910479; van der Sluijs KF, 2006, AM J PHYSIOL-LUNG C, V290, pL194, DOI 10.1152/ajplung.00050.2005; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Cox CM, 2011, CLIN INFECT DIS, V52, pS69, DOI 10.1093/cid/ciq011; Hernan MA, 2011, CLIN INFECT DIS, V53, P277, DOI 10.1093/cid/cir400; Kitano M, 2013, ANTIMICROB AGENTS CH, V57, P2286, DOI 10.1128/AAC.02324-12; Kohno S, 2010, ANTIMICROB AGENTS CH, V54, P4568, DOI 10.1128/AAC.00474-10; Seki M, 2009, JPN J INFECT DIS, V62, P6; Stegemann-Koniszewski S, 2013, J INNATE IMMUN, V5, P84, DOI 10.1159/000345112; Tanaka A., 2014, ANTIVIR THE IN PRESS; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	MAY	2015	117						52	59		10.1016/j.antiviral.2015.02.012		8	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	CH0TH	WOS:000353734800007		
J	Satomura, T; Ishikura, M; Koyanagi, T; Sakuraba, H; Ohshima, T; Suye, S				Satomura, Takenori; Ishikura, Masaru; Koyanagi, Takashi; Sakuraba, Haruhiko; Ohshima, Toshihisa; Suye, Shin-ichiro			Dye-linked D-amino acid dehydrogenase from the thermophilic bacterium Rhodothermus marinus JCM9785: characteristics and role in trans-4-hydroxy-L-proline catabolism	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						trans-4-hydroxy-L-proline catabolism; D-amino acid dehydrogenase; Dye-linked dehydrogenase; Thermophilic bacteria; Rhodothermus marinus	ESCHERICHIA-COLI; D-PROLINE; ALANINE DEHYDROGENASE; DAD OPERON; OXIDASE; ENZYME	A gene from the thermophilic Gram-negative bacterium Rhodothermus marinus JCM9785, encoding a dye-linked d-amino acid dehydrogenase homologue, was overexpressed in Escherichia coli, and its product was purified and characterized. The expressed enzyme was a highly thermostable dye-linked d-amino acid dehydrogenase that retained more than 80 % of its activity after incubation for 10 min at up to 70 A degrees C. When enzyme-catalyzed dehydrogenation of several d-amino acids was carried out using 2,6-dichloroindophenol as the electron acceptor, d-phenylalanine was the most preferable substrate among the d-amino acids tested. Immediately upstream of the dye-linked d-amino acid dehydrogenase gene (dadh) was a gene encoding a 4-hydroxyproline 2-epimerase homologue (hypE). That gene was successfully expressed in E. coli, and the gene product exhibited strong 4-hydroxyproline 2-epimerase activity. Reverse transcription PCR and quantitative real-time PCR showed that the six genes containing the dadh and hypE genes were arranged in an operon and were required for catabolism of trans-4-hydroxy-l-proline in R. marinus. This is the first description of a dye-linked d-amino acid dehydrogenase (Dye-DADH) with broad substrate specificity involved in trans-4-hydroxy-l-proline catabolism.	[Satomura, Takenori; Ishikura, Masaru; Koyanagi, Takashi; Suye, Shin-ichiro] Univ Fukui, Grad Sch Engn, Dept Appl Chem & Biotechnol, Fukui 9108507, Japan; [Satomura, Takenori; Suye, Shin-ichiro] Univ Fukui, Res & Educ Program Life Sci, Fukui 9108507, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan; [Ohshima, Toshihisa] Osaka Inst Technol, Dept Biomed Engn, Fac Engn, Asahi Ku, Osaka 5358585, Japan; [Suye, Shin-ichiro] Univ Fukui, Grad Sch Engn, Dept Frontier Fiber Technol & Sci, Fukui 9108507, Japan	Satomura, T (reprint author), Univ Fukui, Grad Sch Engn, Dept Appl Chem & Biotechnol, 3-9-1 Bunkyo, Fukui 9108507, Japan.	satomura@u-fukui.ac.jp			Japan Society for the Promotion of Science	This work was supported by a Grant-in-Aid for Young Scientific Research (B) to Takenori Satomura from the Japan Society for the Promotion of Science and a Grant-in-Aid for Scientific Research (A) to Toshihisa Ohshima.	He WQ, 2011, J BACTERIOL, V193, P2107, DOI 10.1128/JB.00036-11; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Sakuraba H, 2002, EXTREMOPHILES, V6, P275, DOI 10.1007/s00792-001-0254-3; LOBOCKA M, 1994, J BACTERIOL, V176, P1500; Satomura T, 2002, J BIOL CHEM, V277, P12861, DOI 10.1074/jbc.M112272200; Nagata Y, 2006, LIFE SCI, V78, P1677, DOI 10.1016/j.lfs.2005.08.009; JONES H, 1983, FEBS LETT, V151, P189, DOI 10.1016/0014-5793(83)80066-0; Watanabe S, 2012, J BIOL CHEM, V287, P32674, DOI 10.1074/jbc.M112.374272; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Hamase K, 2001, ANAL BIOCHEM, V298, P253, DOI 10.1006/abio.2001.5382; Boulette ML, 2009, J BACTERIOL, V191, P6329, DOI 10.1128/JB.00817-09; CHERKIN A, 1978, PHARMACOL BIOCHEM BE, V8, P623, DOI 10.1016/0091-3057(78)90399-4; Feng ZY, 2002, J BACTERIOL, V184, P5001, DOI 10.1128/JB.184.18.5001-5010.2002; FREESE E, 1963, BIOCHEMISTRY-US, V2, P1212, DOI 10.1021/bi00906a006; Frew JE, 1987, ANAL CHEM, V59, p933A; Mathew E, 1996, J BACTERIOL, V178, P7234; OHSHIMA T, 1993, EUR J BIOCHEM, V214, P37, DOI 10.1111/j.1432-1033.1993.tb17893.x; Olsiewski JP, 1980, J BIOL CHEM, V255, P4487; WILD J, 1974, MOL GEN GENET, V128, P131, DOI 10.1007/BF02654486	19	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	MAY	2015	99	10					4265	4275		10.1007/s00253-014-6263-9		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CH2AQ	WOS:000353826200011		
J	Wasaki, J; Taguchi, H; Senoura, T; Akasaka, H; Watanabe, J; Kawaguchi, K; Komata, Y; Hanashiro, K; Ito, S				Wasaki, Jun; Taguchi, Hidenori; Senoura, Takeshi; Akasaka, Hiroshi; Watanabe, Jun; Kawaguchi, Kazuki; Komata, Yosuke; Hanashiro, Kiyotoshi; Ito, Susumu			Identification and distribution of cellobiose 2-epimerase genes by a PCR-based metagenomic approach	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Metagenome; Environmental DNA; Cellobiose 2-epimerase; Mannobiose 2-epimerase; Mannan catabolism	RUMINOCOCCUS-ALBUS; MANNOSE METABOLISM; RUMEN; DIVERSITY; CLONING; ENZYME; PHOSPHORYLASE; EPILACTOSE; ALIGNMENT; TOOL	Cellobiose 2-epimerase (CE) catalyzes the reversible epimerization of cellobiose to 4-O-beta-d-glucopyranosyl-d-mannose. By using a PCR-based metagenomic approach, 71 ce-like gene fragments were obtained from wide-ranging environmental samples such as sheep rumen, soils, sugar beet extracts, and anaerobic sewage sludge. The frequency of isolation of the fragments similar to known sequences varied depending on the nature of the samples used. The ce-like genes appeared to be widely distributed in environmental bacteria belonging to the phyla Bacteroidetes, Chloroflexi, Dictyoglomi, Firmicutes, Proteobacteria, Spirochaetes, and Verrucomicrobia. The phylogenetic analysis suggested that the cluster of CE and CE-like proteins was functionally and evolutionarily separated from that of N-acetyl-d-glucosamine 2-epimerase (AGE) and AGE-like proteins. Two ce-like genes containing full-length ORFs, designated md1 and md2, were obtained by PCR and expressed in Escherichia coli. The recombinant mD1 and mD2 exhibited low K (m) values and high catalytic efficiencies (k (cat)/K (m)) for mannobiose compared with cellobiose, suggesting that they should be named mannobiose 2-epimerase, which is involved in a new mannan catabolic pathway we proposed.	[Wasaki, Jun] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398521, Japan; [Taguchi, Hidenori; Senoura, Takeshi; Akasaka, Hiroshi] Hokkaido Univ, CRIS, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Watanabe, Jun] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Kawaguchi, Kazuki; Komata, Yosuke; Hanashiro, Kiyotoshi; Ito, Susumu] Univ Ryukyus, Dept Biosci & Biotechnol, Fac Agr, Nishihara, Okinawa 9030213, Japan	Wasaki, J (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Kagamiyama 1-7-1, Higashihiroshima 7398521, Japan.	junw@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Mr. Tomohiro Hirose and Mr. Akira Miyao at the Center for Instrumental Analysis, Hokkaido University, determined the N-terminal amino acid sequences of mD1 and mD2. This research was partly supported by the Special Coordination Funds for Promoting Science and Technology and by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; AMEIN M, 1969, BIOCHEM BIOPH RES CO, V36, P223, DOI 10.1016/0006-291X(69)90318-0; Kim JE, 2012, BIOTECHNOL LETT, V34, P2061, DOI 10.1007/s10529-012-0999-z; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Ito S, 2007, BIOCHEM BIOPH RES CO, V360, P640, DOI 10.1016/j.bbrc.2007.06.091; Nishimukai M, 2008, J AGR FOOD CHEM, V56, P10340, DOI 10.1021/jf801556m; Ito S, 2008, APPL MICROBIOL BIOT, V79, P433, DOI 10.1007/s00253-008-1449-7; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Senoura T, 2009, BIOSCI BIOTECH BIOCH, V73, P400, DOI 10.1271/bbb.80691; Ojima T, 2011, BIOSCI BIOTECH BIOCH, V75, P2162, DOI 10.1271/bbb.110456; Park CS, 2013, BIOTECHNOL LETT, V35, P1873, DOI 10.1007/s10529-013-1267-6; Taguchi H, 2008, FEMS MICROBIOL LETT, V287, P34, DOI 10.1111/j.1574-6968.2008.01281.x; Lee YC, 2007, J MOL BIOL, V367, P895, DOI 10.1016/j.jmb.2006.11.001; Galbraith EA, 2004, ENVIRON MICROBIOL, V6, P928, DOI 10.1111/j.1462-2920.2004.00575.x; Watanabe J, 2008, J DAIRY SCI, V91, P4518, DOI 10.3168/jds.2008-1367; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Nakae S, 2013, J MOL BIOL, V425, P4468, DOI 10.1016/j.jmb.2013.08.002; Park CS, 2011, APPL MICROBIOL BIOT, V92, P1187, DOI 10.1007/s00253-011-3403-3; TYLER TR, 1967, ARCH BIOCHEM BIOPHYS, V119, P363, DOI 10.1016/0003-9861(67)90466-3; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Binet MRB, 1998, MICROBIOL-SGM, V144, P1113; Centeno MSJ, 2006, FEMS MICROBIOL LETT, V261, P123, DOI 10.1111/j.1574-6968.2006.00342.x; KAWAGUCHI K, 2014, ARCH MICROBIOL, V193, P17, DOI DOI 10.1007/S00203-013-0938-Y; Maru I, 1996, J BIOL CHEM, V271, P16294; Ogimoto K, 1981, ATLAS RUMEN MICROBIO; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Whitford MF, 1998, ANAEROBE, V4, P153, DOI 10.1006/anae.1998.0155	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	MAY	2015	99	10					4287	4295		10.1007/s00253-014-6265-7		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CH2AQ	WOS:000353826200013		
J	Miyakawa, T; Mizushima, H; Ohtsuka, J; Oda, M; Kawai, F; Tanokura, M				Miyakawa, Takuya; Mizushima, Hiroki; Ohtsuka, Jun; Oda, Masayuki; Kawai, Fusako; Tanokura, Masaru			Structural basis for the Ca2+-enhanced thermostability and activity of PET-degrading cutinase-like enzyme from Saccharomonospora viridis AHK190	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						PET hydrolase; Cutinase-type polyesterase; Ca2+ activation; Thermostability; Saccharomonospora viridis AHK190	LICHENIFORMIS ALPHA-AMYLASE; THERMOBIFIDA-CELLULOSILYTICA; CRYSTAL-STRUCTURE; DIFFRACTION DATA; BINDING SITE; POLY(ETHYLENE-TEREPHTHALATE); HYDROLYSIS; STABILITY; LIPASE; PROTEIN	A cutinase-like enzyme from Saccharomonospora viridis AHK190, Cut190, hydrolyzes the inner block of polyethylene terephthalate (PET); this enzyme is a member of the lipase family, which contains an alpha/beta hydrolase fold and a Ser-His-Asp catalytic triad. The thermostability and activity of Cut190 are enhanced by high concentrations of calcium ions, which is essential for the efficient enzymatic hydrolysis of amorphous PET. Although Ca2+-induced thermostabilization and activation of enzymes have been well explored in alpha-amylases, the mechanism for PET-degrading cutinase-like enzymes remains poorly understood. We focused on the mechanisms by which Ca2+ enhances these properties, and we determined the crystal structures of a Cut190 S226P mutant (Cut190(S226P)) in the Ca2+-bound and free states at 1.75 and 1.45 resolution, respectively. Based on the crystallographic data, a Ca2+ ion was coordinated by four residues within loop regions (the Ca2+ site) and two water molecules in a tetragonal bipyramidal array. Furthermore, the binding of Ca2+ to Cut190(S226P) induced large conformational changes in three loops, which were accompanied by the formation of additional interactions. The binding of Ca2+ not only stabilized a region that is flexible in the Ca2+-free state but also modified the substrate-binding groove by stabilizing an open conformation that allows the substrate to bind easily. Thus, our study explains the structural basis of Ca2+-enhanced thermostability and activity in PET-degrading cutinase-like enzyme for the first time and found that the inactive state of Cut190(S226P) is activated by a conformational change in the active-site sealing residue, F106.	[Miyakawa, Takuya; Mizushima, Hiroki; Ohtsuka, Jun; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Biophys Chem Lab, Sakyo Ku, Kyoto 6068522, Japan; [Kawai, Fusako] Kyoto Inst Technol, Ctr Fiber & Text Sci, Sakyo Ku, Kyoto 6068585, Japan	Tanokura, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	This work was supported by the Platform for Drug Design, Discovery and Development of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT). We would like to thank the scientists and staff at the Photon Factory. The synchrotron radiation experiments were conducted at the beamlines AR-NW12 and BL-17A at the Photon Factory, Tsukuba, Japan (Proposal No. 2013G658).	MACHIUS M, 1995, J MOL BIOL, V246, P545, DOI 10.1006/jmbi.1994.0106; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Ribitsch D, 2013, BIOMACROMOLECULES, V14, P1769, DOI 10.1021/bm400140u; Ronkvist AM, 2009, MACROMOLECULES, V42, P5128, DOI 10.1021/ma9005318; Machius M, 1998, STRUCTURE, V6, P281, DOI 10.1016/S0969-2126(98)00032-X; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Acero EH, 2013, BIOTECHNOL BIOENG, V110, P2581, DOI 10.1002/bit.24930; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Simons JWFA, 1999, BIOCHEMISTRY-US, V38, P2, DOI 10.1021/bi981869l; Thumarat U, 2012, APPL MICROBIOL BIOT, V95, P419, DOI 10.1007/s00253-011-3781-6; Kitadokoro K, 2012, POLYM DEGRAD STABIL, V97, P771, DOI 10.1016/j.polymdegradstab.2012.02.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Muller RJ, 2005, MACROMOL RAPID COMM, V26, P1400, DOI 10.1002/marc.200500410; Vertommen MAME, 2005, J BIOTECHNOL, V120, P376, DOI 10.1016/j.jbiotec.2005.06.015; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Kim MH, 2000, BIOSCI BIOTECH BIOCH, V64, P280, DOI 10.1271/bbb.64.280; Zhang Y, 2013, CARBOHYD POLYM, V97, P124, DOI 10.1016/j.carbpol.2013.04.042; Pio TF, 2009, ADV APPL MICROBIOL, V66, P77, DOI 10.1016/S0065-2164(08)00804-6; Amada K, 2001, FEBS LETT, V509, P17, DOI 10.1016/S0014-5793(01)03108-8; Arockiasamy A, 2011, PROTEIN SCI, V20, P827, DOI 10.1002/pro.607; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Kawai F, 2014, APPL MICROBIOL BIOT, V95, P419; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinsirodom P., 2001, CURRENT PROTOCOLS FO; Roth C, 2014, APPL MICROB IN PRESS; Sulaiman S, 2014, BIOCHEMISTRY-US, V53, P1858, DOI 10.1021/bi401561p; Wei R, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0044-9; Yadav JK, 2012, INT J BIOL MACROMOL, V51, P146, DOI 10.1016/j.ijbiomac.2012.04.013; Zimmermann W, 2011, ADV BIOCHEM ENG BIOT, V125, P97, DOI 10.1007/10_2010_87	34	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	MAY	2015	99	10					4297	4307		10.1007/s00253-014-6272-8		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CH2AQ	WOS:000353826200014		
J	Nagayama, H; Sugawara, T; Endo, R; Ono, A; Kato, H; Ohtsubo, Y; Nagata, Y; Tsuda, M				Nagayama, Hirofumi; Sugawara, Tomonori; Endo, Ryo; Ono, Akira; Kato, Hiromi; Ohtsubo, Yoshiyuki; Nagata, Yuji; Tsuda, Masataka			Isolation of oxygenase genes for indigo-forming activity from an artificially polluted soil metagenome by functional screening using Pseudomonas putida strains as hosts	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Metagenome; Biodegradation; Oxygenase; Aromatic compound; Indigo	ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; NAPHTHALENE OXIDATION; PHENOL HYDROXYLASE; DEGRADATION; MONOOXYGENASES; IDENTIFICATION; EXPRESSION; PLASMIDS; CLONING	Metagenomes contain the DNA from many microorganisms, both culturable and non-culturable, and are a potential resource of novel genes. In this study, a 5.2-Gb metagenomic DNA library was constructed from a soil sample (artificially polluted with four aromatic compounds, i.e., biphenyl, phenanthrene, carbazole, and 3-chlorobenzoate) in Escherichia coli by using a broad-host-range cosmid vector. The resultant library was introduced into naphthalene-degrading Pseudomonas putida-derived strains having deficiencies in their naphthalene dioxygenase components, and indigo-forming clones on the indole-containing agar plates were screened. Cosmids isolated from 29 positive clones were classified by their various properties (original screening hosts, hosts showing indigo-forming activity, and digestion patterns with restriction enzymes), and six representative cosmids were chosen. Sequencing and in vitro transposon mutagenesis of the six cosmids resulted in the identification of genes encoding putative class B and D flavoprotein monooxygenases, a multicomponent hydroxylase, and a reductase that were responsible for the indigo-forming activity in the host cells. Among them, the genes encoding the multicomponent hydroxylase were demonstrated to be involved in phenol degradation. Furthermore, two genes encoding ring-cleavage dioxygenases were also found adjacent to the genes responsible for the indigo formation, and their functions were experimentally confirmed.	[Nagayama, Hirofumi; Sugawara, Tomonori; Endo, Ryo; Ono, Akira; Kato, Hiromi; Ohtsubo, Yoshiyuki; Nagata, Yuji; Tsuda, Masataka] Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, Sendai, Miyagi 9808577, Japan	Nagata, Y (reprint author), Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	aynaga@ige.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Singh A, 2010, BIORESOURCE TECHNOL, V101, P8481, DOI 10.1016/j.biortech.2010.06.025; van Hellemond EW, 2007, APPL ENVIRON MICROB, V73, P5832, DOI 10.1128/AEM.02708-06; Ogawa N, 2003, CHEM REC, V3, P158, DOI 10.1002/tcr.10059; Lim HK, 2005, APPL ENVIRON MICROB, V71, P7768, DOI 10.1128/AEM.71.12.7768-7777.2005; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Lee CM, 2008, BIOCHEM BIOPH RES CO, V370, P322, DOI 10.1016/j.bbrc.2008.03.102; Chen Y, 2011, P NATL ACAD SCI USA, V108, P17791, DOI 10.1073/pnas.1112928108; Fernandez-Arrojo L, 2010, CURR OPIN BIOTECH, V21, P725, DOI 10.1016/j.copbio.2010.09.006; SHINGLER V, 1992, J BACTERIOL, V174, P711; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Iqbal HA, 2012, CURR OPIN CHEM BIOL, V16, P109, DOI 10.1016/j.cbpa.2012.02.015; Vilchez-Vargas R, 2010, ENVIRON MICROBIOL, V12, P3089, DOI 10.1111/j.1462-2920.2010.02340.x; Suenaga H, 2012, ENVIRON MICROBIOL, V14, P13, DOI 10.1111/j.1462-2920.2011.02438.x; Li YG, 2005, ENVIRON MICROBIOL, V7, P1927, DOI 10.1111/j.1462-2920.2005.00853.x; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Eltis LD, 1996, J BACTERIOL, V178, P5930; Wexler M, 2005, ENVIRON MICROBIOL, V7, P1917, DOI 10.1111/j.1462-2920.2005.00854.x; Drewlo S, 2001, APPL ENVIRON MICROB, V67, P1964, DOI 10.1128/AEM.67.4.1964-1969.2001; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Kimura N, 2010, MICROBES ENVIRON, V25, P133, DOI 10.1264/jsme2.ME10110; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Kim TM, 2013, WORLD J GASTROENTERO, V19, P6784, DOI 10.3748/wjg.v19.i40.6784; Ono A, 2007, APPL MICROBIOL BIOT, V74, P501, DOI 10.1007/s00253-006-0671-4; Lombard N, 2011, FEMS MICROBIOL ECOL, V78, P31, DOI 10.1111/j.1574-6941.2011.01140.x; TAYLOR LA, 1988, NUCLEIC ACIDS RES, V16, P358, DOI 10.1093/nar/16.1.358; DUNN NW, 1973, J BACTERIOL, V114, P974; ENSLEY BD, 1983, SCIENCE, V222, P167, DOI 10.1126/science.6353574; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; Kageyama C, 2005, ARCH MICROBIOL, V183, P56, DOI 10.1007/s00203-004-0746-5; KIMBARA K, 1989, J BACTERIOL, V171, P2740; Nakamura K, 2000, J BIOSCI BIOENG, V89, P47, DOI 10.1016/S1389-1723(00)88049-4; Nam JW, 2002, APPL ENVIRON MICROB, V68, P5882, DOI 10.1128/AEM.68.12.5882-5890.2002; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Powlowski J, 1997, J BIOL CHEM, V272, P945; Ringelberg DB, 2001, APPL ENVIRON MICROB, V67, P1542, DOI 10.1128/AEM.67.4.1542-1550.2001; Sambrook J., 1989, MOL CLONING LAB MANU; Sambrook J, 2001, MOL CLONING LAB MANU; Santos PM, 2007, OMICS, V11, P233, DOI 10.1089/omi.2007.0009; Shintani M, 2013, MANAGEMENT MICROBIAL; Silva CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061811; Sota M, 2006, J BACTERIOL, V188, P4057, DOI 10.1128/JB.00185-06; Urlacher VB, 2006, CURR OPIN CHEM BIOL, V10, P156, DOI 10.1016/j.cbpa.2006.02.001; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Yano H, 2010, J BACTERIOL, V192, P4337, DOI 10.1128/JB.00359-10; ZYLSTRA GJ, 1989, J BIOL CHEM, V264, P14940	48	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	MAY	2015	99	10					4453	4470		10.1007/s00253-014-6322-2		18	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CH2AQ	WOS:000353826200028		
J	Kumahara, H; Ayabe, M; Ichibakase, M; Tashima, A; Chiwata, M; Takashi, T				Kumahara, Hideaki; Ayabe, Makoto; Ichibakase, Misato; Tashima, Akari; Chiwata, Maiko; Takashi, Tomomi			Validity of activity monitors worn at multiple nontraditional locations under controlled and free-living conditions in young adult women	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM			English	Article						accelerometer; exercise intensity; Japanese; locomotion; pedometer; physical activity	AMERICAN-HEART-ASSOCIATION; PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; PUBLIC-HEALTH; PEDOMETER; VALIDATION; INACTIVITY; STEPS/DAY; ACCURACY; NAKANOJO	The purpose of this study was to examine the validity of counting steps and computing indices of moderate-to-vigorous physical activity (MVPA) using miniature activity monitors with 3-D technology worn at various locations under controlled (CON) and free-living conditions (FL). Kenz e-style2, Tanita Calorism Smart, and Omron Calori Scan HJA-306 activity monitors were assessed. Nine and 31 young adult women were assigned to the CON and FL studies, respectively. While walking or jogging on a treadmill at 5 different speeds, the subjects simultaneously carried the 3 different monitors in a pants pocket (PP), a chest shirt pocket, and a shoulder bag (B). Under the FL condition, the 3 monitors were placed only at the PP and B locations for practical reasons. Significant effects of monitor location and walking/jogging speed on the step count measured by the 3 monitors were evaluated under the CON condition. Monitors placed at both PP and B tended to underestimate the number of steps; however, there were no significant differences between the values obtained with the Kenz monitor and those obtained with a criterion accelerometer under the FL condition. Moreover, strong correlations were observed between steps measured by monitors placed at PP and steps measured by the criterion accelerometer. The amount of MVPA for the PP location and the non-carrying duration of the bag for the B location were considered to be important determinants of the accuracy of step counting under the FL condition. In conclusion, monitors placed at the PP location, especially the Kenz monitor, showed acceptable accuracy for young adult women in real-life settings. In contrast, MVPA indices assessed using these monitors showed limited validity.	[Kumahara, Hideaki; Ichibakase, Misato; Tashima, Akari; Chiwata, Maiko; Takashi, Tomomi] Nakamura Gakuen Univ, Fac Nutr Sci, Jounan Ku, Fukuoka 8140198, Japan; [Ayabe, Makoto] Okayama Prefectural Univ, Fac Comp Sci & Syst Engn, Soja, Okayama 7191197, Japan	Kumahara, H (reprint author), Nakamura Gakuen Univ, Fac Nutr Sci, Jounan Ku, 5-7-1 Befu, Fukuoka 8140198, Japan.	kumahara@nakamura-u.ac.jp			Suzuken Memorial Foundation	This study was supported in part by a research grant provided by the Suzuken Memorial Foundation.	American College of Sports Medicine, 2010, ACSMS GUID EX TEST P; Ayabe M, 2008, CIRC J, V72, P299, DOI 10.1253/circj.72.299; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1249/mss.0b013e3180616b27; Ishikawa-Takata K, 2007, J EPIDEMIOL, V17, P177; Tudor-Locke C, 2013, APPL PHYSIOL NUTR ME, V38, P100, DOI 10.1139/apnm-2012-0235; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Meijer EP, 2001, INT J OBESITY, V25, P935, DOI 10.1038/sj.ijo.0801644; Shephard RJ, 2013, J AM GERIATR SOC, V61, P1887, DOI 10.1111/jgs.12505; Schneider PL, 2004, MED SCI SPORT EXER, V36, P331, DOI 10.1249/01.MSS.0000113486.60548.E9; Ayabe M, 2009, J PHYS ACT HEALTH, V6, P419; Le Masurier GC, 2004, MED SCI SPORT EXER, V36, P905, DOI 10.1249/01.MSS.0000126777.50188.73; De Cocker KA, 2012, J SCI MED SPORT, V15, P418, DOI 10.1016/j.jsams.2012.02.002; Hasson RE, 2009, MED SCI SPORT EXER, V41, P805, DOI 10.1249/MSS.0b013e31818d9fc2; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Aoyagi Y, 2013, ARCH GERONTOL GERIAT, V56, P327, DOI 10.1016/j.archger.2012.11.006; Ayabe M, 2008, J SPORT SCI MED, V7, P249; Ayabe M, 2010, BRIT J SPORT MED, V44, P95, DOI 10.1136/bjsm.2007.045179; BLAND JM, 1986, LANCET, V1, P307; Holbrook EA, 2009, MED SCI SPORT EXER, V41, P669, DOI 10.1249/MSS.0b013e3181886095; Japanese Industrial Standards Committee, 1993, S7200 JIS; Kumahara H, 2010, PHYSIOL BEHAV, V100, P350, DOI 10.1016/j.physbeh.2010.03.015; Kumahara H., 2006, INT J SPORT HLTH SCI, V4, P380, DOI [10.5432/ijshs.4.380, DOI 10.5432/IJSHS.4.380]; McClain JJ, 2010, J PHYS ACT HEALTH, V7, P662; Rafamantanantsoa HH, 2002, J NUTR SCI VITAMINOL, V48, P517; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Silcott NA, 2011, MED SCI SPORT EXER, V43, P1791, DOI 10.1249/MSS.0b013e318212888c; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-79	31	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1715-5312	1715-5320		APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	MAY	2015	40	5					448	456		10.1139/apnm-2014-0183		9	Nutrition & Dietetics; Physiology; Sport Sciences	Nutrition & Dietetics; Physiology; Sport Sciences	CG9SQ	WOS:000353660800003		
J	Iwata, H; Yamaguchi, K; Takeshita, Y; Kubota, A; Hirakawa, S; Isobe, T; Hirano, M; Kim, EY				Iwata, Hisato; Yamaguchi, Keisuke; Takeshita, Yoko; Kubota, Akira; Hirakawa, Shusaku; Isobe, Tomohiko; Hirano, Masashi; Kim, Eun-Young			Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: Implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals	AQUATIC TOXICOLOGY			English	Article						Cytochrome P450; Aquatic mammal; Baikal seal; Alkoxyresorufin O-dealkylation; Estrogen hydroxylation; Conserved threonine	WHALE DELPHINAPTERUS-LEUCAS; PUSA-SIBIRICA; HYDROCARBON RECEPTOR; SIGNALING PATHWAYS; BIPHENYL CONGENERS; LIVER-MICROSOMES; TEMPORAL TRENDS; P450 1A1; DIOXINS; INDUCTION	This study aimed to elucidate the catalytic function of cytochrome P450 (CYP) 1 enzymes in aquatic mammals. Alkoxyresorufin O-dealkylation (AROD) activities including methoxy- (MROD), ethoxy- (EROD), pentoxy- (PROD), and benzyloxyresorufin O-deallcylation (BROD), and 2- and 4-hydroxylation activities of 17 beta-estradiol (E-2) were measured by using yeast-expressed Baikal seal (Pusa sibirica) CYP1A1, 1A2, and 1B1 proteins. Heterologous protein expression of the Baikal seal CYP1s (bsCYP1s) in yeast microsomes was confirmed by reduced CO-difference spectra and immunoblotting. Heterologously expressed human CYP1 enzyme (hCYP1) activities were simultaneously measured and compared with those of bsCYP1 isozymes. Recombinant bsCYP1A1 protein showed the highest V-max of EROD, followed by MROD, PROD, and BROD, similar to that of hCYP1A1. V-max/K-m ratios of all AROD activities catalyzed by bsCYP1A1 were lower than those catalyzed by hCYP1A1, suggesting less potential for AROD by bsCYP1A1. Enzymatic assays for bsCYP1A2 showed no or minimal AROD activities, while hCYP1A2 displayed MROD and EROD activities. bsCYP1B1 showed an AROD profile (EROD > BROD > MROD >> PROD) similar to that of hCYP1B1; however, Vmax/Km ratios of all AROD activities by bsCYP1B1 were higher. Yeast microsomes containing bsCYP1A1 and 1B1 and hCYP1A1, 1A2, and 1B1 metabolized E-2 to 2-OHE2 and 4-OHE2, whereas bsCYP1A2 showed no such activity. Comparison of 4- and 2-hydroxylations of E-2 by CYP1As suggests that bsCYP1A1, hCYP1A1, and 1A2 preferentially catalyze 2-rather than 4-hydroxylation. As for CYP1B1, the V-max/K-m ratios suggest that both Baikal seal and human CYPs catalyze 4- rather than 2-hydroxylation. Interspecies comparison showed that bsCYP1B1 has higher metabolic potencies for both E2 hydroxylations than does hCYP1B1, whereas the activity of bsCYP1A1 was lower than that of hCYP1A1. Messenger RNA expression levels of bsCYP1s in the liver of Baikal seals indicated that bsCYP1A1 and 1A2 enzymes contributed to 16.2% and 83.7% of total CYP1s, respectively; bsCYP1B1 accounted for only 0.06%. Addition of anti-human CYP1A1 antibody in seal liver microsomes suppressed EROD activity more than did antihuman CYP1A2 antibody. Therefore, EROD may be catalyzed by hepatic bsCYP1A1 but not bsCYP1A2, consistent with the results of yeast-expressed bsCYP1A1 and 1A2. In silico substrate-docking models of bsCYP1s suggested that the defect in bsCYP1A2 enzymatic activities may be accounted for by the Pro substitution of highly conserved Thr in the I-helix, which is involved in formation of a hydrogen bond with the hydroperoxy intermediate on the heme. This Thr-Pro substitution is evolutionarily conserved across aquatic mammals and could explain their lower metabolic potential for persistent organic pollutants. (C) 2015 Elsevier B.V. All rights reserved.	[Iwata, Hisato; Yamaguchi, Keisuke; Takeshita, Yoko; Hirano, Masashi] Ehime Univ, CMES, Matsuyama, Ehime 7908577, Japan; [Kubota, Akira] Obihiro Univ Agr & Vet Med, Diagnost Ctr Anim Hlth & Food Safety, Obihiro, Hokkaido 0808555, Japan; [Hirakawa, Shusaku] Fukuoka Inst Hlth & Environm Sci, Fukuoka 8180135, Japan; [Isobe, Tomohiko] Natl Inst Environm Studies, Ctr Environm Hlth Sci, Tsukuba, Ibaraki 3058506, Japan; [Kim, Eun-Young] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea; [Kim, Eun-Young] Kyung Hee Univ, Dept Biol, Seoul 130701, South Korea	Iwata, H (reprint author), Ehime Univ, CMES, Bunkyo Cho 2-5, Matsuyama, Ehime 7908577, Japan.	iwatah@agr.ehime-u.ac.jp; eykim08@khu.ac.kr			Japan Society for the Promotion of Science (JSPS) [21221004, 26220103, 25660228]; JSPS; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2A10010043, 2012K2A2A4021504]	This work was supported by Grants-in-Aid for Scientific Research (S) (Nos. 21221004 and 26220103) and Challenging Exploratory Research (No. 25660228) to H.I. from Japan Society for the Promotion of Science (JSPS). Financial assistance was also provided from Joint Research Project under the Japan-Korea Basic Scientific Cooperation Program for FY 2012 from JSPS. Funding support was also given to E-Y.K. from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2A10010043 and 2012K2A2A4021504).	SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Liu JG, 2004, ARCH BIOCHEM BIOPHYS, V424, P33, DOI 10.1016/j.abb.2003.12.040; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; White RD, 2000, COMP BIOCHEM PHYS C, V126, P267, DOI 10.1016/S0742-8413(00)00123-7; OMURA T, 1964, J BIOL CHEM, V239, P2370; Whitlock JP, 1996, FASEB J, V10, P809; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/k.bbcan.2006.03.001; Walsh AA, 2013, J BIOL CHEM, V288, P12932, DOI 10.1074/jbc.M113.452953; Chung WG, 2004, AQUAT TOXICOL, V70, P111, DOI 10.1016/j.aquatox.2004.07.007; Inouye K, 2002, J AGR FOOD CHEM, V50, P5496, DOI 10.1021/jf020415z; Kim EY, 2002, MAR ENVIRON RES, V54, P285, DOI 10.1016/S0141-1136(02)00180-0; Kim EY, 2011, ENVIRON SCI TECHNOL, V45, P1652, DOI 10.1021/es102991s; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Choudhary D, 2003, ARCH BIOCHEM BIOPHYS, V414, P91, DOI 10.1016/S0003-9861(03)00174-7; Hanna IH, 2000, CANCER RES, V60, P3440; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Kubota A, 2012, ENVIRON POLLUT, V168, P131, DOI 10.1016/j.envpol.2012.04.014; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; BURKE MD, 1994, BIOCHEM PHARMACOL, V48, P923, DOI 10.1016/0006-2952(94)90363-8; Hirakawa S, 2007, TOXICOL SCI, V97, P318, DOI 10.1093/toxsci/kfm066; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; Imaeda D, 2009, ENVIRON POLLUT, V157, P737, DOI 10.1016/j.envpol.2008.11.027; Hirakawa S, 2011, AQUAT TOXICOL, V105, P89, DOI 10.1016/j.aquatox.2011.05.007; Boon JP, 1997, ARCH ENVIRON CON TOX, V33, P298, DOI 10.1007/s002449900257; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Liehr JG, 1996, P NATL ACAD SCI USA, V93, P3294, DOI 10.1073/pnas.93.8.3294; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420; Isobe T, 2003, J CHROMATOGR A, V984, P195, DOI 10.1016/S0021-9673(02)01851-4; Zahid M, 2006, CHEM RES TOXICOL, V19, P164, DOI 10.1021/tx050229y; Goto J., 2008, J CHEM INF MODEL, V48, P583; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; Kubota A, 2009, COMP BIOCHEM PHYS C, V149, P544, DOI 10.1016/j.cbpc.2008.12.004; Kubota A, 2008, MAR ENVIRON RES, V66, P154, DOI 10.1016/j.marenvres.2008.02.047; Liu JG, 2003, DRUG METAB DISPOS, V31, P412, DOI 10.1124/dmd.31.4.412; lwata H., 2004, ENVIRON SCI TECHNOL, V38, P3505; McKinney MA, 2006, AQUAT TOXICOL, V77, P87, DOI 10.1016/j.aquatox.2005.08.016; Schlezinger J.J., 2000, COMP BIOCH PHYSL C, V125, P276; Shinkyo R, 2003, ARCH BIOCHEM BIOPHYS, V409, P180, DOI 10.1016/S0003-9861(02)00366-1; Thuruthippallil LM, 2013, ENVIRON SCI TECHNOL, V47, P6656, DOI 10.1021/es401155g; Thuruthippallil LM., 2012, ENVIRON SCI TECHNOL, V46, P525	47	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-445X	1879-1514		AQUAT TOXICOL	Aquat. Toxicol.	MAY	2015	162						138	151		10.1016/j.aquatox.2015.03.010		14	Marine & Freshwater Biology; Toxicology	Marine & Freshwater Biology; Toxicology	CH2NA	WOS:000353860700016		
J	Onodera, T; Kuriyama, I; Sakamoto, Y; Kawamura, M; Kuramochi, K; Tsubaki, K; Tabata, A; Naganune, H; Mizushina, Y				Onodera, Takefumi; Kuriyama, Isoko; Sakamoto, Yuka; Kawamura, Moe; Kuramochi, Kouji; Tsubaki, Kazunori; Tabata, Atsushi; Naganune, Hideaki; Mizushina, Yoshiyuki			5-O-Acyl plumbagins inhibit DNA polymerase activity and suppress the inflammatory response	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						5-O-Acyl plumbagins; C22:6-acyl plumbagin; DNA polymerase lambda; Enzyme inhibitor; Anti-inflammation	NF-KAPPA-B; INDUCED OXIDATIVE STRESS; BASE-EXCISION-REPAIR; FATTY-ACIDS; ESCHERICHIA-COLI; TUMOR PROMOTER; CANCER-CELLS; CALF THYMUS; IN-VITRO; LAMBDA	We previously found that vitamin K-3 (menadione, 2-methyl-1,4-naphthoquinone) inhibits the activity of human mitochondrial DNA polymerase (pol) gamma. In this study, we focused on plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), and chemically synthesized novel plumbagins conjugated with C2:0 to C22:6 fatty acids (5-O-acyl plumbagins). These chemically modified plumbagins displayed enhanced mammalian pol inhibition, with plumbagin conjugated to docosahexaenoic acid (C22:6-acyl plumbagin) exhibiting the strongest inhibition of pol lambda among the ten 5-O-acyl plumbagins synthesized. C22:6-acyl plumbagin selectively inhibited the activities of mammalian pol species, but did not influence the activities of other pols or DNA metabolic enzymes tested. The inhibition of pol lambda, a DNA repair/recombination pol, by these compounds was significantly correlated with both their suppression of lipopolysaccharide (LPS) induced tumor necrosis factor-alpha (TNF-alpha) production by mouse RAW264.7 macrophages and the reduction of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in the mouse ear. These data indicate that 5-O-acyl plumbagins act as anti-inflammatory agents by inhibiting mammalian pol gamma. These results further suggest that C22:6-acyl plumbagin is a promising anti-inflammatory candidate and that acylation could be an effective chemical modification to improve the anti-inflammatory activity of vitamin K-3 derivatives, such as plumbagin. (C) 2015 Elsevier Inc. All rights reserved.	[Onodera, Takefumi; Kuriyama, Isoko; Sakamoto, Yuka] Kobe Gakuin Univ, Fac Nutr, Lab Food & Nut Sci, Nishi Ku, Kobe, Hyogo 6512180, Japan; [Onodera, Takefumi; Tabata, Atsushi; Naganune, Hideaki; Mizushina, Yoshiyuki] Kobe Gakuin Univ, Cooperat Res Ctr Life Sci, Chuo Ku, Kobe, Hyogo 6518586, Japan; [Kawamura, Moe; Kuramochi, Kouji; Tsubaki, Kazunori] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan; [Tabata, Atsushi; Naganune, Hideaki] Univ Tokushima, Grad Sch, Inst Sci & Technol, Dept Biol Sci & Technol Life Syst, Tokushima 7708506, Japan; [Mizushina, Yoshiyuki] Shinshu Univ, Grad Sch Agr, Nagano 3994598, Japan	Mizushina, Y (reprint author), Shinshu Univ, Grad Sch Agr, Nagano 3994598, Japan.	mizushina@shinshu-u.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan)-Supported Program for the Strategic Research Foundation at Private Universities (Japan); MEXT (Japan) [24580205]; Cosmetology Research Foundation (Japan); JST (Japan Science and Technology Agency) (Japan)	This study was supported in part by the MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan)-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (Japan). Y.M. acknowledges Grants-in-Aid for Scientific Research (C) (No. 24580205) from MEXT (Japan), and the 25th (2014) Cosmetology Research Foundation (Japan). K.K and Y.M. acknowledge a Grant-in-Aid for A-STEP (Adaptable and Seamless Technology Transfer Program through target-driven R&D) (Exploratory Research) from JST (Japan Science and Technology Agency) (Japan).	Aggarwal B.B., 2003, REV IMMUNOL, V3, P745; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Mizushina Y, 1999, J BIOL CHEM, V274, P25599, DOI 10.1074/jbc.274.36.25599; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1365-2443.2004.00747.x; Sasaki R, 2008, CANCER SCI, V99, P1040, DOI 10.1111/j.1349-7006.2008.00771.x; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Checker R, 2011, FREE RADICAL RES, V45, P975, DOI 10.3109/10715762.2011.585647; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Kusumoto R, 2004, GENES CELLS, V9, P1139, DOI 10.1111/j.1365-2443.2004.00797.x; Nakamura Y, 1998, CANCER RES, V58, P4832; Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Srinivas P, 2004, MOL CARCINOGEN, V40, P201, DOI 10.1002/mc.20031; Luo P, 2010, J PHARMACOL EXP THER, V335, P735, DOI 10.1124/jpet.110.170852; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Ogawa A, 1998, JPN J CANCER RES, V89, P1154; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Bertocci B, 2002, J IMMUNOL, V168, P3702; Checker R, 2014, INFLAMMATION, V37, P542, DOI 10.1007/s10753-013-9768-y; DATE T, 1988, BIOCHEMISTRY-US, V27, P2983, DOI 10.1021/bi00408a048; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; Garcia-Diaz M, 2001, J BIOL CHEM, V276, P34659, DOI 10.1074/jbc.M106336200; GSCHWENDT M, 1984, CANCER LETT, V25, P177, DOI 10.1016/S0304-3835(84)80043-9; HIROSE F, 1989, EXP CELL RES, V181, P169, DOI 10.1016/0014-4827(89)90191-2; Kawamura M., 2014, PLOS ONE, V9; Kornberg K., 1992, DNA REPLICATION, P197; LU BC, 1991, J BIOL CHEM, V266, P21060; Mizushina Y, 1996, BBA-GENE STRUCT EXPR, V1308, P256, DOI 10.1016/0167-4781(96)00121-2; Mizushina Y., 2007, CURR ENZYME INHIB, V3, P61, DOI 10.2174/157340807779815422; Mizushina Y., 2011, Journal of Japanese Society of Nutrition and Food Science, V64, P377; Mizushina Y, 2007, BIOCHIMIE, V89, P581, DOI 10.1016/j.biochi.2007.01.009; Mizushina Y, 2002, BIOCHEMISTRY-US, V41, P14463, DOI 10.1021/bi020476q; Mizushina Y, 1997, BBA-GEN SUBJECTS, V1336, P509, DOI 10.1016/S0304-4165(97)00067-6; Mizushina Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1239, DOI 10.1271/bbb.90121; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAYAMA C, 1985, J BIOCHEM-TOKYO, V97, P1385; Ohsugi T, 2005, CARCINOGENESIS, V26, P1382, DOI 10.1093/carcin/bgi095; Oshige M, 2004, PROTEIN EXPRES PURIF, V35, P248, DOI 10.1016/j.pep.2004.02.001; Ramadan K, 2002, J BIOL CHEM, V277, P18454, DOI 10.1074/jbc.M200421200; SAKAGUCHI K, 1980, CELL STRUCT FUNCT, V5, P323; Shimazaki N, 2002, GENES CELLS, V7, P639, DOI 10.1046/j.1365-2443.2002.00547.x; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SOLTIS DA, 1982, J BIOL CHEM, V257, P1332; Takeuchi T, 2006, GENES CELLS, V11, P223, DOI 10.1111/j.1365-2443.2006.00937.x; TAMAI K, 1988, BIOCHIM BIOPHYS ACTA, V950, P263, DOI 10.1016/0167-4781(88)90122-4; TamiyaKoizumi K, 1997, BIOCHEM MOL BIOL INT, V41, P1179; Umeda S, 2000, EUR J BIOCHEM, V267, P200, DOI 10.1046/j.1432-1327.2000.00990.x; Wang TY, 2014, FOOD CHEM TOXICOL, V64, P177, DOI 10.1016/j.fct.2013.11.027; Zucca E, 2013, NUCLEIC ACIDS RES, V41, P229, DOI 10.1093/nar/gks1016	55	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	MAY 1	2015	573						100	110		10.1016/j.abb.2015.02.032		11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH2OI	WOS:000353864100012		
J	Ota, K; Murayama, N; Kasanuki, K; Kondo, D; Fujishiro, H; Arai, H; Sato, K; Iseki, E				Ota, Kazumi; Murayama, Norio; Kasanuki, Koji; Kondo, Daizo; Fujishiro, Hiroshige; Arai, Heii; Sato, Kiyoshi; Iseki, Eizo			Visuoperceptual Assessments for Differentiating Dementia with Lewy Bodies and Alzheimer's Disease: Illusory Contours and Other Neuropsychological Examinations	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Dementia with Lewy bodies; Alzheimer's disease; Visuoperceptual impairment; Visuoperceptual examinations; Illusory contours	POSTERIOR CORTICAL ATROPHY; DIAGNOSIS; AUTOPSY; ASSOCIATION; PERFORMANCE; TOMOGRAPHY; IMPAIRMENT; PERCEPTION; SYMPTOMS; BODY	We examined the utility of illusory contours (ICs) for the differentiation of dementia with Lewy bodies (DLB) from Alzheimer's disease (AD). Thirty-five probable DLB patients, 35 probable AD patients controlled by age, years of education, and Mini-Mental State Examination (MMSE) score, and 30 cognitively normal subjects controlled by age and years of education underwent visuoperceptual examinations including ICs, pentagon copying in MMSE, overlapping figures, clock drawing test, cube copying, and line orientation. Four items in ICs (ICs-4) were found to be significantly impaired in DLB compared with AD, and a sensitivity and a specificity of total score of ICs-4 were 88.6% and 37.1%, respectively. When a score of ICs-4 is combined with a 10-point scaled score of pentagon copying in MMSE, a sensitivity and a specificity were 77.1% and 82.9%, respectively. The present study suggests that ICs-4 can be included in neuropsychological examinations to assess visuoperceptual impairment in DLB.	[Ota, Kazumi; Murayama, Norio; Kasanuki, Koji; Kondo, Daizo; Fujishiro, Hiroshige; Sato, Kiyoshi; Iseki, Eizo] Juntendo Univ, Sch Med, Juntendo Tokyo Koto Geriatr Med Ctr, PET CT Dementia Res Ctr, Tokyo 1360075, Japan; [Murayama, Norio] Kitasato Univ, Sch Allied Hlth Sci, Dept Hlth Sci, Sagamihara, Kanagawa 2520373, Japan; [Kasanuki, Koji; Arai, Heii; Iseki, Eizo] Juntendo Univ, Dept Psychiat, Sch Med, Tokyo 1138431, Japan	Iseki, E (reprint author), 3-3-20 Shinsuna,Koto Ku, Tokyo 1360075, Japan.	iseki@juntendo.gmc.ac.jp			Juntendo University	This study was supported by project research funding from Juntendo University for research on the early detection of neuro-degenerative dementias using brain functional imaging examinations and neuropsychological examinations.	Ala TA, 2001, J NEUROL NEUROSUR PS, V70, P483, DOI 10.1136/jnnp.70.4.483; Hurt C, 2008, DEMENT GERIATR COGN, V26, P138, DOI 10.1159/000149584; Minoshima S, 2001, ANN NEUROL, V50, P358, DOI 10.1002/ana.1133; Mosimann UP, 2004, NEUROLOGY, V63, P2091; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Mori E, 2000, ARCH NEUROL-CHICAGO, V57, P489, DOI 10.1001/archneur.57.4.489; [Anonymous], 1987, PSYCHIATRY; Cormack F, 2004, INT J GERIATR PSYCH, V19, P371, DOI 10.1002/gps.1094; Walker Z, 2007, J NEUROL NEUROSUR PS, V78, P1176, DOI 10.1136/jnnp.2006.110122; Tang-Wai DF, 2004, NEUROLOGY, V63, P1168; Nelson PT, 2010, J NEUROL, V257, P1875, DOI 10.1007/s00415-010-5630-4; Tranel D, 2009, J CLIN EXP NEUROPSYC, V31, P219, DOI 10.1080/13803390802317542; Gilman S, 2005, EXP NEUROL, V191, pS95, DOI 10.1016/j.expneurol.2004.06.017; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Murray MM, 2013, TRENDS COGN SCI, V17, P471, DOI 10.1016/j.tics.2013.07.004; Donaghy PC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt274; Farina Elisabetta, 2009, Acta Biomed, V80, P57; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gnanalingham KK, 1996, LANCET, V347, P696, DOI 10.1016/S0140-6736(96)91254-4; Goto T., 2005, HDB SCI ILLUSION; Hirayama K., 2013, SHINKEI SHINRIGAKU Z, V29, P113; Huang Yue, 2013, Transl Neurodegener, V2, P4, DOI 10.1186/2047-9158-2-4; Iseki E., 2010, IGAKU AYUMI, V235, P719; Lezak MD, 1995, NEUROPSYCHOLOGICAL A, pXVIII; Maeshima S, 2004, BRAIN INJURY, V18, P889, DOI 10.1080/02699050410001671847; Metzler-Baddeley C, 2010, NEUROPSYCHOLOGY, V24, P35, DOI 10.1037/a0016834; Mohs R. C., 1994, ADM SCORING MANUAL A; Murayama N, 2007, DEMENT GERIATR COGN, V23, P258, DOI 10.1159/000100772; Nagahama Y, 2008, DEMENT GERIATR COGN, V25, P524, DOI 10.1159/000131665; Ota K, 2014, PSYCHOGERIATRICS, V14, P72, DOI 10.1111/psyg.12039; Palmqvist S, 2009, INT J GERIATR PSYCH, V24, P1405, DOI 10.1002/gps.2277; Rouleau N., 1992, BRAIN COGNITION, V18, P70; Shimomura T, 1998, ARCH NEUROL-CHICAGO, V55, P1547, DOI 10.1001/archneur.55.12.1547; Simard M, 2000, J NEUROPSYCH CLIN N, V12, P425, DOI 10.1176/appi.neuropsych.12.4.425; Simard M, 2003, INT J GERIATR PSYCH, V18, P387, DOI 10.1002/gps.839; The Committee for the Visual Perception Test Japanese Society of Aphasiology, 1997, VIS PERC TESTS AGN V; Yokoi K, 2014, NEUROPSYCHOLOGIA, V56, P245, DOI 10.1016/j.neuropsychologia.2014.01.017	37	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2015	30	3					256	263		10.1093/arclin/acv016		8	Psychology, Clinical; Psychology	Psychology	CH1ZO	WOS:000353822600010		
J	Shoda, H; Fujio, K; Sakurai, K; Ishigaki, K; Nagafuchi, Y; Shibuya, M; Sumitomo, S; Okamura, T; Yamamoto, K				Shoda, Hirofumi; Fujio, Keishi; Sakurai, Keiichi; Ishigaki, Kazuyoshi; Nagafuchi, Yasuo; Shibuya, Mihoko; Sumitomo, Shuji; Okamura, Tomohisa; Yamamoto, Kazuhiko			Autoantigen BiP-Derived HLA-DR4 Epitopes Differentially Recognized by Effector and Regulatory T Cells in Rheumatoid Arthritis	ARTHRITIS & RHEUMATOLOGY			English	Article							COLLAGEN-INDUCED ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; STRESS-PROTEIN BIP; TH17 CELLS; AUTOIMMUNE ARTHRITIS; PEPTIDE INTERACTION; AMERICAN-COLLEGE; II COLLAGEN; B-CELL; BINDING	Objective. The balance between effector and regulatory CD4+ T cells plays a key role in the pathogenesis of rheumatoid arthritis (RA). The aim of this study was to examine whether the RA autoantigen BiP has epitopes for both effector and regulatory immunities. Methods. The proliferation and cytokine secretion of peripheral blood mononuclear cells (PBMCs) from HLA-DR4-positive RA patients in response to BiP-derived peptides were examined by H-3-thymidine uptake and enzyme-linked immunosorbent assay. As a mouse therapeutic model, a BiP-derived peptide was administered orally to mice with collagen-induced arthritis (CIA). Results. Among the peptides examined, BiP336-355 induced the strongest proliferation of PBMCs from RA patients, but not from healthy donors. The proliferation of PBMCs in response to BiP336-355 showed a correlation with clinical RA activity and serum anti-BiP/citrullinated BiP antibodies. In contrast, BiP456-475 induced interleukin-10 (IL-10) secretion from CD25-positive PBMCs obtained from RA patients and healthy donors without inducing cell proliferation, and it actively suppressed the BiP336-355-induced proliferation and proinflammatory cytokine secretion by PBMCs. Oral administration of BiP456-475 to mice with CIA reduced the severity of arthritis and T cell proliferation and increased the secretion of IL-10 from T cells as well as the number of CD4+CD25+FoxP3+ regulatory T cells. Conclusion. Effector and regulatory T cells recognized different BiP epitopes. The deviated balance toward BiP-specific effector T cells in RA may be associated with disease activity; therefore, BiP-specific effector or regulatory T cells could be a target of new RA therapies.	[Shoda, Hirofumi; Fujio, Keishi; Sakurai, Keiichi; Ishigaki, Kazuyoshi; Nagafuchi, Yasuo; Shibuya, Mihoko; Sumitomo, Shuji; Okamura, Tomohisa; Yamamoto, Kazuhiko] Univ Tokyo, Tokyo, Japan	Fujio, K (reprint author), Univ Tokyo, Dept Allergy & Rheumatol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	kfujio-tky@umin.ac.jp			Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology (Kakenhi) [22790990, 23229007]; Japan Society for the Promotion of Science	Supported by the Ministry of Health, Labor, and Welfare, the Ministry of Education, Culture, Sports, Science, and Technology (Kakenhi Grant-in-Aid for Young Scientists 22790990 and Grant-in-Aid for Scientific Research 23229007), and the Japan Society for the Promotion of Science.	Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Ito Y, 2009, ARTHRITIS RHEUM, V60, P2294, DOI 10.1002/art.24687; HAMMER J, 1994, J EXP MED, V180, P2353, DOI 10.1084/jem.180.6.2353; von Delwig A, 2010, ARTHRITIS RHEUM-US, V62, P143, DOI 10.1002/art.25064; Brownlie RJ, 2006, ARTHRITIS RHEUM, V54, P854, DOI 10.1002/art.21654; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Schuler Mathias M., 2007, V409, P75; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hill JA, 2003, J IMMUNOL, V171, P538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; James EA, 2010, ARTHRITIS RHEUM-US, V62, P2909, DOI 10.1002/art.27594; Yoo SA, 2012, J EXP MED, V209, P871, DOI 10.1084/jem.20111783; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Falta MT, 2005, ARTHRITIS RHEUM, V52, P1885, DOI 10.1002/ART.21098; Blass S, 2001, ARTHRITIS RHEUM, V44, P761; Kotzin BL, 2000, P NATL ACAD SCI USA, V97, P291, DOI 10.1073/pnas.97.1.291; Mijnheer G, 2013, CURR OPIN RHEUMATOL, V25, P260, DOI 10.1097/BOR.0b013e32835d0ee4; Bodman-Smith MD, 2003, RHEUMATOLOGY, V42, P637, DOI 10.1093/rheumatology/keg204; Bayrak S, 1997, INT IMMUNOL, V9, P1687, DOI 10.1093/intimm/9.11.1687; Weber CK, 2010, RHEUMATOLOGY, V49, P2255, DOI 10.1093/rheumatology/keq272; Rosloniec EF, 2002, J IMMUNOL, V168, P253; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Lu MC, 2010, ARTHRITIS RHEUM-US, V62, P1213, DOI 10.1002/art.27386; Corrigall VM, 2001, J IMMUNOL, V166, P1492; Esensten JH, 2009, NAT REV RHEUMATOL, V5, P560, DOI 10.1038/nrrheum.2009.183; McGovern JL, 2012, ARTHRITIS RHEUM-US, V64, P3129, DOI 10.1002/art.34565; Kawai S, 1996, EUR J IMMUNOGENET, V23, P471, DOI 10.1111/j.1744-313X.1996.tb00137.x; Kotzin BL, 1998, ARTHRITIS RHEUM, V41, P1906; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Shoda H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3520; Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; YAMAMOTO K, 1992, INT IMMUNOL, V4, P1219, DOI 10.1093/intimm/4.11.1219; Yoshida K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3463	41	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	MAY	2015	67	5					1171	1181		10.1002/art.39054		11	Rheumatology	Rheumatology	CH1IV	WOS:000353775900007		
J	Kondo, M; Yamaoka, K; Sakata, K; Sonomoto, K; Lin, L; Nakano, K; Tanaka, Y				Kondo, Masahiro; Yamaoka, Kunihiro; Sakata, Kei; Sonomoto, Koshiro; Lin, Lin; Nakano, Kazuhisa; Tanaka, Yoshiya			Contribution of the Interleukin-6/STAT-3 Signaling Pathway to Chondrogenic Differentiation of Human Mesenchymal Stem Cells	ARTHRITIS & RHEUMATOLOGY			English	Article							HUMAN ARTICULAR-CARTILAGE; RHEUMATOID-ARTHRITIS; PROGENITOR CELLS; SYNOVIAL-FLUID; FACTOR SOX9; OSTEOARTHRITIS; MICE; IL-6; DESTRUCTION; INHIBITION	Objective. Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into chondrocytes. Articular cartilage contains MSC-like chondroprogenitor cells, which suggests their involvement in the maintenance of cartilage homeostasis by a self-repair mechanism. Interleukin-6 (IL-6) is a cytokine with a wide range of physiologic functions, which are produced by MSCs in a steady manner and in large quantities. The purpose of this study was to investigate the involvement of IL-6 signaling in MSC differentiation into chondrocytes. Methods. Human bone marrow-derived MSCs were cultured using a pellet culture system in medium containing transforming growth factor beta 3. Chondrogenic differentiation was detected by cartilage matrix accumulation and chondrogenic marker gene expression. Results. IL-6 was detected at a high concentration in culture supernatants during chondrogenic differentiation. The expression of the IL-6 receptor (IL-6R) was significantly increased, accompanied by markedly increased phosphorylation and expression of STAT-3. Addition of IL-6 and soluble IL-6R (sIL-6R) to the chondrogenic culture resulted in concentration-dependent increases in cartilage matrix accumulation and cartilage marker gene expression (type II collagen/aggrecan/type X collagen). Phosphorylation of the master transcription factor SOX9 was enhanced upon addition of IL-6 and sIL-6R. STAT-3 knockdown suppressed chondrogenic differentiation. IL-6 and the MSC markers CD166 and nestin were colocalized in macroscopically normal human cartilage taken from the lateral femoral compartment of knees with medial tibiofemoral osteoarthritis. Conclusion. During differentiation of human MSCs into chondrocytes, the activation of IL-6/STAT-3 signaling positively regulated chondrogenic differentiation. The presence of IL-6 around MSC-like cells in the cartilage tissue was identified, suggesting that IL-6 contributes to homeostasis and cartilage self-repair by promoting chondrogenic differentiation.	[Kondo, Masahiro; Yamaoka, Kunihiro; Sakata, Kei; Sonomoto, Koshiro; Lin, Lin; Nakano, Kazuhisa; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 8078555, Japan; [Kondo, Masahiro; Sakata, Kei] Mitsubishi Tanabe Pharma, Osaka, Japan	Tanaka, Y (reprint author), Univ Occupat & Environm Hlth, Dept Internal Med 1, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant for Advanced Research from the University of Occupational and Environmental Health, Japan; Pfizer; Chugai; Mitsubishi Tanabe Pharma; Takeda Industrial Pharma; GlaxoSmithKline; Nippon Shinyaku; Eli Lilly; Janssen; Eisai; Astellas; Actelion; Abbott Immunology; Santen; AstraZeneca; Asahi Kasei; UCB; AbbVie; Bristol-Myers Squibb; Mitsubishi Tanabe; MSD; Daiichi-Sankyo	Supported in part by Research Grants-In-Aid for Scientific Research from the Ministry of Health, Labor, and Welfare of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a Grant for Advanced Research from the University of Occupational and Environmental Health, Japan.; Dr. Yamaoka has received consulting fees and/or speaking fees from Pfizer, Chugai, Mitsubishi Tanabe Pharma, Takeda Industrial Pharma, GlaxoSmithKline, Nippon Shinyaku, Eli Lilly, Janssen, Eisai, Astellas, and Actelion (less than $10,000 each). Dr. Tanaka has received consulting fees, speaking fees, and/or honoraria from Mitsubishi Tanabe Pharma, Eisai, Pfizer, Abbott Immunology, Janssen, Takeda Industrial Pharma, Santen, AstraZeneca, Astellas, Asahi Kasei, UCB, and GlaxoSmithKline (less than $10,000 each) and from AbbVie and Chugai (more than $10,000 each) and has received research grant support from Bristol-Myers Squibb, Mitsubishi Tanabe, MSD, Takeda Industrial Pharma, Astellas, Eisai, Chugai, Pfizer, and Daiichi-Sankyo.	Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Ryu JH, 2011, ARTHRITIS RHEUM-US, V63, P2732, DOI 10.1002/art.30451; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307; de Hooge ASK, 2005, OSTEOARTHR CARTILAGE, V13, P66, DOI 10.1016/j.joca.2004.09.011; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Hashimoto J, 2011, MOD RHEUMATOL, V21, P10, DOI 10.1007/s10165-010-0325-3; Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bi WM, 1999, NAT GENET, V22, P85; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Doss F, 2007, SCAND J RHEUMATOL, V36, P136, DOI 10.1080/03009740701250785; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Livshits G, 2009, ARTHRITIS RHEUM, V60, P2037, DOI 10.1002/art.24598; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alsalameh S, 2004, ARTHRITIS RHEUM, V50, P1522, DOI 10.1002/art.20269; Smolen JS, 2013, ANN RHEUM DIS, V72, P482, DOI 10.1136/annrheumdis-2012-202469; Beekhuizen M, 2011, ARTHRITIS RHEUM-US, V63, P1918, DOI 10.1002/art.30364; Flannery CR, 2000, MATRIX BIOL, V19, P549, DOI 10.1016/S0945-053X(00)00111-6; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Kondo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079463; Livak KJ, 2001, METHODS, V25, P4028; MAROUDAS A, 1976, J ANAT, V122, P335; Naka Tetsuji, 2002, Arthritis Res, V4 Suppl 3, pS233, DOI 10.1186/ar565; Okada A, 2012, CLIN EXP RHEUMATOL, V30, P332; Ozbey O, 2010, HISTOL HISTOPATHOL, V25, P1437; Pretzel D, 2011, ARTHRITIS RES THER, V2, pR64; Tsuchida AI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4107; vandeLoo FAJ, 1997, AM J PATHOL, V151, P177; VANLENT PLEM, 1987, J RHEUMATOL, V14, P798; VANLENT PLEM, 1989, J RHEUMATOL, V16, P1295	40	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	MAY	2015	67	5					1250	1260		10.1002/art.39036		11	Rheumatology	Rheumatology	CH1IV	WOS:000353775900015		
J	Akamata, K; Asano, Y; Yamashita, T; Noda, S; Taniguchi, T; Takahashi, T; Ichimura, Y; Toyama, T; Trojanowska, M; Sato, S				Akamata, Kaname; Asano, Yoshihide; Yamashita, Takashi; Noda, Shinji; Taniguchi, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Trojanowska, Maria; Sato, Shinichi			Endothelin Receptor Blockade Ameliorates Vascular Fragility in Endothelial Cell-Specific Fli-1-Knockout Mice by Increasing Fli-1 DNA Binding Ability	ARTHRITIS & RHEUMATOLOGY			English	Article							TRANSCRIPTION FACTOR FLI1; PROTEIN-ASSOCIATED FACTOR; GROWTH-FACTOR-BETA; SYSTEMIC-SCLEROSIS; DIGITAL ULCERS; SCLERODERMA FIBROBLASTS; DEFICIENCY CONTRIBUTES; DERMAL FIBROBLASTS; BOSENTAN REVERSES; EXPRESSION	Objective. It is generally accepted that blockade of endothelin receptors has potentially beneficial effects on vasculopathy associated with systemic sclerosis (SSc). The aim of this study was to clarify the molecular mechanism underlying these effects using endothelial cell-specific Fli-1-knockout (Fli-1 ECKO) mice, an animal model of SSc vasculopathy. Methods. Levels of messenger RNA for target genes and the expression and phosphorylation levels of target proteins were determined in human and murine dermal microvascular endothelial cells by real-time quantitative reverse transcription-polymerase chain reaction and immunoblotting, respectively. The binding of Fli-1 to the target gene promoters was evaluated using chromatin immunoprecipitation. Expression levels of Fli-1 and alpha-smooth muscle actin in murine skin were evaluated using immunohistochemistry. Vascular structure and permeability were evaluated in mice injected with fluorescein isothiocyanate-dextran and Evans blue dye, respectively. Results. In human dermal microvascular endothelial cells, endothelin 1 induced phosphorylation of Fli-1 at Thr(312) through the sequential activation of c-Abl and protein kinase C delta, leading to a decrease in Fli-1 protein levels as well as a decrease in binding of Fli-1 to the target gene promoters, whereas bosentan treatment reversed those effects. In Fli-1 ECKO mice, 4 weeks of treatment with bosentan increased endothelial Fli-1 expression, resulting in vascular stabilization and the restoration of impaired leaky vessels. Conclusion. The vascular fragility of Fli-1 ECKO mice was improved by bosentan through the normalization of Fli-1 protein levels and activity in endothelial cells, which may explain, in part, the mechanism underlying the beneficial effects of endothelin receptor blockade on SSc vasculopathy.	[Akamata, Kaname; Asano, Yoshihide; Yamashita, Takashi; Noda, Shinji; Taniguchi, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Sato, Shinichi] Univ Tokyo, Grad Sch Med, Tokyo 1138655, Japan; [Trojanowska, Maria] Boston Univ, Sch Med, Boston, MA 02118 USA	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Japan Intractable Diseases Research Foundation; Rohto Dermatology Prize; Japanese Society for Investigative Dermatology Fellowship Shiseido Award; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Actelion Academia Award; NIH [AR-042334]; Actelion	Supported by the Ministry of Health, Labor, and Welfare of Japan (grants to Drs. Asano and Sato), the Japan Intractable Diseases Research Foundation, a Rohto Dermatology Prize, the Japanese Society for Investigative Dermatology Fellowship Shiseido Award, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and an Actelion Academia Award (to Dr. Asano). Dr. Trojanowska's work was supported by the NIH (grant AR-042334).; Dr. Asano has received honoraria (less than $10,000) as well as research funding from Actelion.	Abdelsaid M, 2014, LIFE SCI, V118, P268, DOI 10.1016/j.lfs.2014.01.008; Akamata K, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4529; von Tell D, 2006, EXP CELL RES, V312, P623, DOI 10.1016/j.yexcr.2005.10.019; Penn H, 2013, QJM-INT J MED, V106, P839, DOI 10.1093/qjmed/hct111; Noda S, 2013, RHEUMATOLOGY, V52, P790, DOI 10.1093/rheumatology/kes379; Ichimura Y, 2014, ARCH DERMATOL RES, V306, P331, DOI 10.1007/s00403-013-1431-9; Matucci-Cerinic M, 2011, ANN RHEUM DIS, V70, P32, DOI 10.1136/ard.2010.130658; Bujor AM, 2011, ARTHRITIS RHEUM-US, V63, P1729, DOI 10.1002/art.30284; VANCHEESWARAN R, 1994, J RHEUMATOL, V21, P1838; Distler JHW, 2006, RHEUMATOLOGY, V45, P26, DOI 10.1093/rheumatology/kel295; Dreau D, 2006, CLIN EXP METASTAS, V23, P41, DOI 10.1007/s10585-006-9016-z; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Korn JH, 2004, ARTHRITIS RHEUM-US, V50, P3985, DOI 10.1002/art.20676; Asano Y, 2010, J DERMATOL SCI, V59, P153, DOI 10.1016/j.jdermsci.2010.06.008; Hasegawa M, 2006, BRIT J DERMATOL, V155, P1159, DOI 10.1111/j.1365-2133.2006.07475.x; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Asano Y, 2007, J BIOL CHEM, V282, P34672, DOI 10.1074/jbc.M703907200; Asano Y, 2004, AM J PATHOL, V164, P1275, DOI 10.1016/S0002-9440(10)63215-4; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Guiducci S, 2012, CLIN RHEUMATOL, V31, P1723, DOI 10.1007/s10067-012-2074-5; Frerix M, 2012, RHEUMATOLOGY, V51, P735, DOI 10.1093/rheumatology/ker414; Ichimura Y, 2011, MOD RHEUMATOL, V21, P548, DOI 10.1007/s10165-011-0436-5; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Rabquer BJ, 2012, CURR RHEUMATOL REP, V14, P56, DOI 10.1007/s11926-011-0219-1; Cutolo M, 2013, J RHEUMATOL, V40, P40, DOI 10.3899/jrheum.120416; Wang YQ, 2006, ARTHRITIS RHEUM, V54, P2271, DOI 10.1002/art.21948; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Shah P, 2011, J RHEUMATOL, V38, P2079, DOI 10.3899/jrheum.110067; Asano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074930; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Hettema ME, 2009, CLIN RHEUMATOL, V28, P825, DOI 10.1007/s10067-009-1157-4; Ihn H, 2000, J INVEST DERMATOL, V114, P1011, DOI 10.1046/j.1523-1747.2000.00956.x; Mayes MD, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2189; Noda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032272; YAMANE K, 1992, J RHEUMATOL, V19, P1566	35	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	MAY	2015	67	5					1335	1344		10.1002/art.39062		10	Rheumatology	Rheumatology	CH1IV	WOS:000353775900023		
J	Shirai, Y; Kuwana, M				Shirai, Yuichiro; Kuwana, Masataka			Assessment of elevated pentraxin 3 levels in systemic sclerosis: comment on the article by Shirai et al Reply	ARTHRITIS & RHEUMATOLOGY			English	Letter									[Shirai, Yuichiro; Kuwana, Masataka] Nippon Med Sch, Grad Sch Med, Tokyo 113, Japan	Shirai, Y (reprint author), Nippon Med Sch, Grad Sch Med, 1-1-5 Sendagi, Tokyo 113, Japan.						Kahaleh MB, 1999, AUTOIMMUNITY, V31, P195, DOI 10.3109/08916939908994064; Hasegawa M, 2006, BRIT J DERMATOL, V155, P1159, DOI 10.1111/j.1365-2133.2006.07475.x; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Au K, 2011, ARTHRITIS RHEUM-US, V63, P2078, DOI 10.1002/art.30380; Herrick A, 2008, RHEUM DIS CLIN N AM, V34, P89, DOI 10.1016/j.rdc.2007.11.006	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	MAY	2015	67	5					1409	1410		10.1002/art.39032		3	Rheumatology	Rheumatology	CH1IV	WOS:000353775900037		
J	Li, DX; Ni, KK; Pang, HL; Wang, YP; Cai, YM; Jin, QS				Li, Dongxia; Ni, Kuikui; Pang, Huili; Wang, Yanping; Cai, Yimin; Jin, Qingsheng			Identification and Antimicrobial Activity Detection of Lactic Acid Bacteria Isolated from Corn Stover Silage	ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES			English	Article						Antimicrobial Activity; Corn Stover Silage; Identification; Lactic Acid Bacteria	FORAGE CROPS; FERMENTATION	A total of 59 lactic acid bacteria (LAB) strains were isolated from corn stover silage. According to phenotypic and chemotaxonomic characteristics, 16S ribosomal DNA (rDNA) sequences and recA gene polymerase chain reaction amplification, these LAB isolates were identified as five species: Lactobacillus (L.) plantarum subsp. plantarum, Pediococcus pentosaceus, Enterococcus mundtii, Weissella cibaria and Leuconostoc pseudomesenteroides, respectively. Those strains were also screened for antimicrobial activity using a dual-culture agar plate assay. Based on excluding the effects of organic acids and hydrogen peroxide, two L. plantarum subsp. plantarum strains ZZU 203 and 204, which strongly inhibited Salmonella enterica ATCC 43971(T), Micrococcus luteus ATCC 4698(T) and Escherichia coli ATCC 11775(T) were selected for further research on sensitivity of the antimicrobial substance to heat, pH and protease. Cell-free culture supernatants of the two strains exhibited strong heat stability (60 min at 100 degrees C), but the antimicrobial activity was eliminated after treatment at 121 degrees C for 15 min. The antimicrobial substance remained active under acidic condition (pH 2.0 to 6.0), but became inactive under neutral and alkaline condition (pH 7.0 to 9.0). In addition, the antimicrobial activities of these two strains decreased remarkably after digestion by protease K. These results preliminarily suggest that the desirable antimicrobial activity of strains ZZU 203 and 204 is the result of the production of a bacteriocin-like substance, and these two strains with antimicrobial activity could be used as silage additives to inhibit proliferation of unwanted microorganism during ensiling and preserve nutrients of silage. The nature of the antimicrobial substances is being investigated in our laboratory.	[Li, Dongxia; Ni, Kuikui; Pang, Huili; Wang, Yanping] Zhengzhou Univ, Henan Prov Key Lab Ion Beam Bioengn, Zhengzhou 450052, Peoples R China; [Cai, Yimin] Natl Inst Livestock & Grassland Sci, Anim Physiol & Nutr Div, Tsukuba, Ibaraki 3050901, Japan; [Jin, Qingsheng] Zhejiang Acad Agr Sci, Inst Crops & Utilizat Nucl Technol, Hangzhou 310021, Zhejiang, Peoples R China	Wang, YP (reprint author), Zhengzhou Univ, Henan Prov Key Lab Ion Beam Bioengn, Zhengzhou 450052, Peoples R China.	wyp@zzu.edu.cn			Foundation of Henan Science and Technology Committee [132300410054, 132300410123, 132300413205]; National Natural Science Foundation of China [41101244]; Exploration, Torch-plan Project grant from Henan Province [112102310069]; Special Fund for Agro-Scientific Research in the Public Interest of China [201103007]	This work was supported by Foundation of Henan Science and Technology Committee (Grant No. 132300410054, 132300410123 and 132300413205), National Natural Science Foundation of China (Grant No. 41101244) and an Exploration, Torch-plan Project grant (112102310069) from Henan Province, a grant from the Special Fund for Agro-Scientific Research in the Public Interest of China (201103007).	Pang HL, 2012, J MICROBIOL, V50, P63, DOI 10.1007/s12275-012-1284-5; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Karska-Wysocki B, 2010, MICROBIOL RES, V165, P674, DOI 10.1016/j.micres.2009.11.008; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Hata T, 2010, INT J FOOD MICROBIOL, V137, P94, DOI 10.1016/j.ijfoodmicro.2009.10.021; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; KRAUS E, 1976, H-S Z PHYSIOL CHEM, V357, P233; Ennahar S, 2003, APPL ENVIRON MICROB, V69, P444, DOI 10.1128/AEM.69.1.444-451.2003; Ennahar S, 2000, FEMS MICROBIOL REV, V24, P85, DOI 10.1016/S0168-6445(99)00031-5; Todorov SD, 2011, FOOD RES INT, V44, P1351, DOI 10.1016/j.foodres.2011.01.027; Torriani S, 2001, APPL ENVIRON MICROB, V67, P3450, DOI 10.1128/AEM.67.8.3450-3454.2001; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; AOAC, 1990, OFFICIAL METHODS ANA; Benitez LB, 2011, PARASITOL RES, V108, P687, DOI 10.1007/s00436-010-2114-5; Cai Y, 1997, J APPL MICROBIOL, V83, P307, DOI 10.1046/j.1365-2672.1997.00229.x; Cai YM, 1998, APPL ENVIRON MICROB, V64, P2982; Cai YM, 1999, J DAIRY SCI, V82, P2466; Cai YM, 1994, JPN J ZOOTECH SCI, V65, P788; Chaudhari AA, 2014, AVIAN DIS, V58, P25, DOI 10.1637/10536-032213-Reg.1; Eitan BD, 2006, APPL ENVIRON MICROB, V72, P6902; Hellal A, 2012, ANN MICROBIOL, V62, P177, DOI 10.1007/s13213-011-0244-3; Kozaki M., 1992, EXPT MANUAL LACTIC A; LIN CJ, 1992, J APPL BACTERIOL, V73, P375, DOI 10.1111/j.1365-2672.1992.tb04992.x; MUCK RE, 1989, GRASS FORAGE SCI, V44, P19, DOI 10.1111/j.1365-2494.1989.tb01905.x; Pang HL, 2011, ANIM SCI J, V82, P642, DOI 10.1111/j.1740-0929.2011.00894.x; Riley MA, 2009, ENCY MICROBIOLOGY, P32; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sharma Parvati, 2013, Pakistan Journal of Biological Sciences, V16, P1204, DOI 10.3923/pjbs.2013.1204.1207; Simova ED, 2008, J IND MICROBIOL BIOT, V35, P559, DOI 10.1007/s10295-008-0317-x; Smaoui S, 2010, APPL BIOCHEM BIOTECH, V162, P1132, DOI 10.1007/s12010-009-8821-7; Tohno M, 2012, ANIM SCI J, V83, P111, DOI 10.1111/j.1740-0929.2011.00923.x; Weinberg ZG, 2004, APPL BIOCHEM BIOTECH, V118, P1, DOI 10.1385/ABAB:118:1-3:001; Yang E, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-48	34	0	0	ASIAN-AUSTRALASIAN ASSOC ANIMAL PRODUCTION SOC	SEOUL	ROOM 708 SAMMO SPOREX, 1638-32, SEOWON-DONG, GWANAK-GU, SEOUL 151-730, SOUTH KOREA	1011-2367	1976-5517		ASIAN AUSTRAL J ANIM	Asian Australas. J. Anim. Sci.	MAY	2015	28	5					620	631		10.5713/ajas.14.0439		12	Agriculture, Dairy & Animal Science	Agriculture	CH2ID	WOS:000353848000003		
J	Kisaka, S; Ioka, K				Kisaka, Shota; Ioka, Kunihito			LONG-LASTING BLACK HOLE JETS IN SHORT GAMMA-RAY BURSTS	ASTROPHYSICAL JOURNAL LETTERS			English	Article						gamma-ray burst: general; stars: black holes; stars: magnetic field; stars: neutron	NEUTRON-STAR MERGERS; GRB LIGHT CURVES; EXTENDED EMISSION; MAGNETIC-FIELD; SPIN-DOWN; ACCRETION; AFTERGLOWS; FLARES; MACRONOVAE; SIGNATURES	Whether a short gamma-ray burst (GRB) is caused by a black hole (BH) or a neutron star (NS) after the merger of an NS binary is a crucial problem. We propose a BH model that explains short GRBs with long-lasting activities such as extended emission and plateau emission up to similar to 10,000 s. To extract the BH rotational energy, the topological evolution of the magnetic field should accompany the mass ejection, mass fallback, and magnetic field reconnection. The observations suggest magnetic field decay from similar to 10(14) to similar to 10(13) - 10(11) G at the BH, bounded below by the pre-merger strength and kept constant while the luminosity is constant, and the fallback mass of similar to 10(-4)-10(-2) M-circle dot, comparable to the ejecta mass implied by the macronova (or kilonova) in GRB 130603B. The BH model has implications for gravitational waves and the equation of state of NS matter.	[Kisaka, Shota; Ioka, Kunihito] KEK, Inst Particle & Nucl Studies, Ctr Theory, Tsukuba, Ibaraki 3050801, Japan; [Ioka, Kunihito] SOKENDAI Grad Univ Adv Studies, Dept Particle & Nucl Phys, Tsukuba, Ibaraki 3050801, Japan	Kisaka, S (reprint author), KEK, Inst Particle & Nucl Studies, Ctr Theory, Tsukuba, Ibaraki 3050801, Japan.	kisaka@post.kek.jp; kunihito.ioka@kek.jp			KAKENHI [24103006, 24000004, 26247042, 26287051]	We are grateful to the anonymous referee for helpful comments. We also thank K. Asano, K. Kiuchi, K. Kyutoku, T. Nakamura, Y. Sekiguchi, and H. Takami for fruitful discussions. This work is supported by KAKENHI 24103006 (S.K., K.I.), 24000004, 26247042, 26287051 (K.I.).	Margutti R, 2011, MON NOT R ASTRON SOC, V417, P2144, DOI 10.1111/j.1365-2966.2011.19397.x; Hotokezaka K, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.124008; Metzger BD, 2008, MON NOT R ASTRON SOC, V385, P1455, DOI 10.1111/J.1365-2966.2008.12923.X; Nakar E, 2011, NATURE, V478, P82, DOI 10.1038/nature10365; D'Avanzo P, 2009, ASTRON ASTROPHYS, V498, P711, DOI 10.1051/0004-6361/200811294; Gompertz BP, 2014, MON NOT R ASTRON SOC, V438, P240, DOI 10.1093/mnras/stt2165; Fernandez R, 2015, MON NOT R ASTRON SOC, V449, P390, DOI 10.1093/mnras/stv238; BISNOVATYIKOGAN GS, 1976, ASTROPHYS SPACE SCI, V42, P401, DOI 10.1007/BF01225967; Beckwith K, 2008, ASTROPHYS J, V678, P1180, DOI 10.1086/533492; Shibata M, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.064027; Rowlinson A, 2013, MON NOT R ASTRON SOC, V430, P1061, DOI 10.1093/mnras/sts683; Fan YZ, 2005, ASTROPHYS J, V635, pL129, DOI 10.1086/499489; Proga D, 2006, MON NOT R ASTRON SOC, V370, pL61, DOI 10.1111/j.1745-3933.2006.00189.x; Lyne AG, 2004, SCIENCE, V303, P1153, DOI 10.1126/science.1094645; Narayan R, 2003, PUBL ASTRON SOC JPN, V55, pL69; Hotokezaka K, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.024001; Gompertz BP, 2013, MON NOT R ASTRON SOC, V431, P1745, DOI 10.1093/mnras/stt293; Tchekhovskoy A, 2011, MON NOT R ASTRON SOC, V418, pL79, DOI 10.1111/j.1745-3933.2011.01147.x; Ioka K, 2005, ASTROPHYS J, V631, P429, DOI 10.1086/432567; Tchekhovskoy A, 2015, MON NOT R ASTRON SOC, V447, P327, DOI 10.1093/mnras/stu2229; Zhang B, 2007, ASTROPHYS J, V655, P989, DOI 10.1086/510110; Dessart L, 2009, ASTROPHYS J, V690, P1681, DOI 10.1088/0004-637X/690/2/1681; Kyutoku K, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.041503; Tanvir NR, 2013, NATURE, V500, P547, DOI 10.1038/nature12505; Barthelmy SD, 2005, ASTROPHYS J, V635, pL133, DOI 10.1086/499432; Berger E, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L23; Berger E, 2014, ANNU REV ASTRON ASTR, V52, P43, DOI 10.1146/annurev-astro-081913-035926; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433; Ciolfi R, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/2/L36; Fong W, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/118; Foucart F., 2015, ARXIV150204146; Gao H, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/86; Kisaka S, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/119; Kiuchi K, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.041502; Kyutoku K, 2014, MON NOT R ASTRON SOC, V437, pL6, DOI 10.1093/mnrasl/slt128; Kyutoku K., 2015, ARXIV150205402; Lee WH, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/1/017; Lu H.-J., 2015, ARXIV150102589; Nagakura H, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/2/L28; Rezzolla L, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/95; Rosswog S, 2007, MON NOT R ASTRON SOC, V376, pL48, DOI 10.1111/j.1745-3933.2007.00284.x; Sekiguchi Y, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.064059; Shibata M, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/2/L36; Takami H, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/1/L6; Takami H, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.063006; Zhang B, 2004, INT J MOD PHYS A, V19, P2385, DOI 10.1142/S0217751X0401746X	46	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	MAY 1	2015	804	1							L16	10.1088/2041-8205/804/1/L16		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CH1YK	WOS:000353819400016		
J	Kobayashi, C; Nomoto, K; Hachisu, I				Kobayashi, Chiaki; Nomoto, Ken'ichi; Hachisu, Izumi			SUBCLASSES OF TYPE IA SUPERNOVAE AS THE ORIGIN OF [alpha/FE] RATIOS IN DWARF SPHEROIDAL GALAXIES	ASTROPHYSICAL JOURNAL LETTERS			English	Article						galaxies: abundances; galaxies: dwarf; galaxies: evolution; Local Group; stars: abundances; supernovae: general	WHITE-DWARFS; SYNTHETIC OBSERVABLES; CHEMICAL EVOLUTION; EXPLOSION MODELS; ELECTRON-CAPTURE; MASS MODELS; ABUNDANCES; PROGENITOR; STARS; NUCLEOSYNTHESIS	Recent extensive observations of Type Ia Supernovae (SNe Ia) have revealed the existence of a diversity of SNe Ia, including SNe lax. We introduce two possible channels in the single degenerate scenario: (1) double detonations in sub-Chandrasekhar (Ch) mass CO white dwarfs (WDs), where a thin He envelope is developed with relatively low accretion rates after He novae even at low metallicities, and (2) carbon deflagrations in Chmass, possibly hybrid C+O+Ne WDs, where WD winds occur at [Fe/H] similar to -2.5 at high accretion rates. These subclasses of SNe Ia are rarer than "normal" SNe Ia and do not affect the chemical evolution in the solar neighborhood, but can be very important in metal-poor systems with stochastic star formation. In dwarf spheroidal galaxies in the Local Group, the decrease of [alpha/Fe] ratios at [Fe/H] similar to -2 to -1.5 can be produced depending on the star formation history. SNe lax give high [Mn/Fe], while sub-Ch-mass SNe Ia give low [Mn/Fe], and thus a model including a mix of the two is favored by the available observations.	[Kobayashi, Chiaki] Univ Hertfordshire, Sch Phys Astron & Math, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Kobayashi, Chiaki] Australian Natl Univ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Kobayashi, Chiaki; Nomoto, Ken'ichi] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Hachisu, Izumi] Univ Tokyo, Coll Arts & Sci, Dept Earth Sci & Astron, Meguro Ku, Tokyo 1538902, Japan	Kobayashi, C (reprint author), Univ Hertfordshire, Sch Phys Astron & Math, Ctr Astrophys Res, Coll Lane, Hatfield AL10 9AB, Herts, England.	c.kobayashi@herts.ac.uk			WPI Initiative, MEXT, Japan; JSPS [23224004, 23540262, 24540227, 26400222]	We thank K. Venn, A. Karakas, S. Jones, R. Scalzo, I. Seitenzahl, A. Ruiter, and A. Bunker for fruitful discussion. This work has been supported in part by the WPI Initiative, MEXT, Japan, and by the Grants-in-Aid for Scientific Research of the JSPS (23224004, 23540262, 24540227, and 26400222).	Hillebrandt W, 2000, ANNU REV ASTRON ASTR, V38, P191, DOI 10.1146/annurev.astro.38.1.191; NOMOTO K, 1991, ASTROPHYS J, V367, pL19, DOI 10.1086/185922; Kraft RP, 1997, ASTRON J, V113, P279, DOI 10.1086/118251; Tolstoy E, 2003, ASTRON J, V125, P707, DOI 10.1086/345967; Seitenzahl IR, 2015, MON NOT R ASTRON SOC, V447, P1484, DOI 10.1093/mnras/stu2537; Fink M, 2014, MON NOT R ASTRON SOC, V438, P1762, DOI 10.1093/mnras/stt2315; Scalzo RA, 2014, MON NOT R ASTRON SOC, V445, P2535, DOI 10.1093/mnras/stu1808; Koch A, 2008, ASTROPHYS J LETT, V688, pL13, DOI 10.1086/595001; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Hachisu I, 2001, ASTROPHYS J, V558, P323, DOI 10.1086/321601; NOMOTO K, 1982, NATURE, V299, P803, DOI 10.1038/299803a0; Kobayashi C, 1998, ASTROPHYS J, V503, pL155, DOI 10.1086/311556; KAWAI Y, 1987, ASTROPHYS J, V315, P229, DOI 10.1086/165126; Li WD, 2011, MON NOT R ASTRON SOC, V412, P1441, DOI 10.1111/j.1365-2966.2011.18160.x; Shen KJ, 2009, ASTROPHYS J, V699, P1365, DOI 10.1088/0004-637X/699/2/1365; Nomoto K, 2013, ANNU REV ASTRON ASTR, V51, P457, DOI 10.1146/annurev-astro-082812-140956; Maoz D, 2014, ANNU REV ASTRON ASTR, V52, P107, DOI 10.1146/annurev-astro-082812-141031; IBEN I, 1991, ASTROPHYS J, V370, P615, DOI 10.1086/169848; Denissenkov PA, 2015, MON NOT R ASTRON SOC, V447, P2696, DOI 10.1093/mnras/stu2589; Umeda H, 1999, ASTROPHYS J, V513, P861, DOI 10.1086/306887; SHIGEYAMA T, 1992, ASTROPHYS J, V386, pL13, DOI 10.1086/186281; Kobayashi C, 2006, ASTROPHYS J, V653, P1145, DOI 10.1086/508914; Kromer M, 2013, MON NOT R ASTRON SOC, V429, P2287, DOI 10.1093/mnras/sts498; Tolstoy E, 2009, ANNU REV ASTRON ASTR, V47, P371, DOI 10.1146/annurev-astro-082708-101650; Kromer M, 2010, ASTROPHYS J, V719, P1067, DOI 10.1088/0004-637X/719/2/1067; Hachisu I, 1996, ASTROPHYS J, V470, pL97, DOI 10.1086/310303; Cayrel R, 2004, ASTRON ASTROPHYS, V416, P1117, DOI 10.1051/0004-6361:20034074; Kobayashi C, 2011, MON NOT R ASTRON SOC, V414, P3231, DOI 10.1111/j.1365-2966.2011.18621.x; Foley RJ, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/57; GRATTON RG, 1989, ASTRON ASTROPHYS, V211, P41; Hachisu I, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/69; Hoflich P, 1996, ASTROPHYS J, V457, P500; Jones S, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/83; Kobayashi C, 2000, ASTROPHYS J, V539, P26, DOI 10.1086/309195; Kobayashi C, 2009, ASTROPHYS J, V707, P1466, DOI 10.1088/0004-637X/707/2/1466; Kroupa P, 2008, ASTR SOC P, V390, P3; McWilliam A., 2003, APJ, V592, P21; Meng XC, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/2/L45; NOMOTO K, 1984, ASTROPHYS J, V277, P791, DOI 10.1086/161749; Nomoto K, 1997, NUCL PHYS A, V621, pC467; NOMOTO KI, 1982, ASTROPHYS J, V257, P780, DOI 10.1086/160031; NOMOTO K, 1982, ASTROPHYS J, V253, P798, DOI 10.1086/159682; North P., 2012, ASTRON ASTROPHYS, V541, P45; Nugent P, 1997, ASTROPHYS J, V485, P812, DOI 10.1086/304459; Romano D, 2011, MON NOT R ASTRON SOC, V418, P696, DOI 10.1111/j.1365-2966.2011.19521.x; Seitenzahl IR, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322599; Sim SA, 2010, ASTROPHYS J LETT, V714, pL52, DOI 10.1088/2041-8205/714/1/L52; Starkenburg E, 2010, ASTRON ASTROPHYS, V513, P34; Woosley SE, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/38; Yamaguchi H, 2015, ASTROPHYS J LETT, V801, DOI 10.1088/2041-8205/801/2/L31; YUNGELSON L, 1995, ASTROPHYS J, V447, P656, DOI 10.1086/175908	51	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	MAY 1	2015	804	1							L24	10.1088/2041-8205/804/1/L24		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CH1YK	WOS:000353819400024		
J	Stefanutti, C; D'Alessandri, G; Petta, A; Harada-Shiba, M; Julius, U; Soran, H; Moriarty, PM; Romeo, S; Drogari, E; Jaeger, BR				Stefanutti, C.; D'Alessandri, G.; Petta, A.; Harada-Shiba, M.; Julius, U.; Soran, H.; Moriarty, P. M.; Romeo, S.; Drogari, E.; Jaeger, B. R.		MightyMedic Multidisciplinary Int	First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias	ATHEROSCLEROSIS SUPPLEMENTS			English	Article						Coronary artery disease; Dyslipidemia; Lipoprotein apheresis; Multicenter study; Survey	DENSITY-LIPOPROTEIN-APHERESIS; ASSOCIATION EXPERT PANEL; CORONARY-HEART-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; ITALIAN REGISTRY; MANAGEMENT; GUIDELINES; SOCIETY; RECOMMENDATIONS; POPULATION	The MightyMedic (Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsturbances Contrast) Working Group has been founded in 2013. The leading idea was to establish an international network of interdisciplinary nature aimed at working to cross national borders research projects, clinical trials, educational initiatives (meetings, workshops, summer schools) in the field of metabolic diseases, namely hyperlipidemias, and diabetes, preventive cardiology, and atherosclerosis. Therapeutic apheresis, its indications and techniques, is a parallel field of investigation. The first on-line survey of the Group has been completed in the first half of 2014. The survey included # 24 Centers in Italy, Germany, Greece, UK, Sweden, Japan and USA. Relevant data have been collected on current practice in diagnosis, therapy and follow-up of dyslipidemias. 240 subjects with hyperlipidemia and treated with lipoprotein apheresis have been reported in the survey, but a large percentage of patients (35%) who could benefit from this therapeutic option are still treated by conventional drug approach. Genetic molecular diagnosis is performed in only 33% of patients while Lipoprotein(a) (Lp(a)) is included in cardiovascular disease risk assessment in 71% of participating Centers. New detailed investigations and prospective multicenter studies are needed to evaluate changes induced by the impact of updated indications and strategies, as well as new treatment options, targeting standardization of therapeutic and diagnostic approaches. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Stefanutti, C.] Univ Roma La Sapienza, Umberto Hosp 1, Lipid Clin, Extracorporeal Therapeut Tech Unit, I-00185 Rome, Italy; [Stefanutti, C.] Univ Roma La Sapienza, Umberto Hosp 1, Atherosclerosis Prevent Ctr, Dept Mol Med, I-00185 Rome, Italy; [D'Alessandri, G.] ASL3, Immunohematol & Transfus Med, Pistoia, Italy; [Petta, A.] Kaneka Pharma Europe NV, Brussels, Belgium; [Harada-Shiba, M.] Natl Cerebral & Cardiovasc Ctr, Res Inst, Osaka, Japan; [Julius, U.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, Dresden, Germany; [Soran, H.] Cent Manchester Fdn Trust, Univ Dept Med, Manchester, Lancs, England; [Moriarty, P. M.] Univ Kansas, Med Ctr, Dept Internal Med, Div Clin Pharmacol, Kansas City, KS 66103 USA; [Romeo, S.] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Drogari, E.] Aghia Sophia Childrens Hosp, Sch Med, Dept Pediat 1, Athens, Greece; [Jaeger, B. R.] Lipid Ctr Nordrhein, Mulheim, Germany	Stefanutti, C (reprint author), Univ Roma La Sapienza, Extracorporeal Therapeut Tech Unit, Lipid Clin, Rome, Italy.	claudia.stefanutti@uniroma1.it	刘, 李陆/H-8469-2015; Romeo, Stefano/L-6861-2015; 	Romeo, Stefano/0000-0001-9168-4898; perrone, giuseppina/0000-0002-9152-3047; Parasassi, Tiziana/0000-0002-9795-0568	Kaneka Pharma Europe NV Belgium; B.Braun Avitum Italy; Fresenius Medical Care Italy	This work was supported by grants from Kaneka Pharma Europe NV Belgium, B.Braun Avitum Italy and Fresenius Medical Care Italy.	Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Stefanutti C, 2013, THER APHER DIAL, V17, P169, DOI 10.1111/j.1744-9987.2012.01142.x; Kavey REW, 2006, CIRCULATION, V114, P2710, DOI 10.1161/CIRCULATIONAHA.106.179568; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028; Harada-Shiba M, 2012, J ATHEROSCLER THROMB, V19, P1043; Schwartz J, 2013, J CLIN APHERESIS, V28, P145, DOI 10.1002/jca.21276; Bundesministerium fur Gesundheit und Soziale Sicherung, 2003, BANZ, V123, P14; Civiera F, 2004, ATHEROSCLEROSIS, V173, P55; De Silvestro G, 2009, J CLIN APHERESIS, V24, P1, DOI 10.1002/jca.20184; Gemeinsamer-Bundesausschuss, 2009, BANZ, V128, P3005; Ito MK, 2011, J CLIN LIPIDOL, V5, pS38, DOI 10.1016/j.jacl.2011.04.001; Korach J M, 2000, Ther Apher, V4, P207, DOI 10.1046/j.1526-0968.2000.00201.x; Masaki N, 2005, INT HEART J, V46, P833, DOI 10.1536/ihj.46.833; Matsunaga T, 2004, INTERNAL MED, V43, P760, DOI 10.2169/internalmedicine.43.760; Matsuzaki M, 2002, J AM COLL CARDIOL, V40, P220, DOI 10.1016/S0735-1097(02)01955-1; National Cholesterol Education Program (NCEP); Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002, CIRCULATION, V106, P3143, DOI DOI 10.1001/ARCHINTE.1991.00400060019005; Norda R, 2001, TRANSFUS APHER SCI, V24, P49, DOI 10.1016/S0955-3886(00)00132-6; Palcoux JB, 2008, THER APHER DIAL, V12, P195, DOI 10.1111/j.1744-9987.2008.00574.x; Passalacqua S, 2005, J CLIN APHERESIS, V20, P101, DOI 10.1002/jca.20037; Patti AM, 2014, ANGIOLOGY; Schettler V, 2002, THER APHER, V6, P381, DOI 10.1046/j.1526-0968.2002.00426.x; Stefanutti C, 2013, J LIFE SCI, V7, P941; Stefanutti C, 2010, NUTR METAB CARDIOVAS, V20, P761, DOI 10.1016/j.numecd.2010.04.007; Stefanutti C, 2009, LIPIDS, V44, P1141, DOI 10.1007/s11745-009-3368-5; Stefanutti C., 2007, THER APHER DIAL, V14, P79; Stegmayr BG, 2005, THER APHER DIAL, V9, pA37, DOI 10.1111/j.1744-9987.2005.00324_2.x; Wood D, 1998, EUR HEART J, V19, P1434	27	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1567-5688	1878-5050		ATHEROSCLEROSIS SUPP	Atheroscler. Suppl.	MAY	2015	18						241	250		10.1016/j.atherosclerosissup.2015.02.036		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH1QI	WOS:000353796000036		
J	Kuraishi, Y				Kuraishi, Yasushi			Methods for Preclinical Assessment of Antipruritic Agents and Itch Mechanisms Independent of Mast-Cell Histamine	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Review						pruritus; animal model; scratching; biting; keratinocyte; itch mediator	MU-OPIOID RECEPTORS; DORSAL-HORN NEURONS; PROTEASE-ACTIVATED RECEPTORS; SPINOTHALAMIC TRACT NEURONS; LEUKOTRIENE B-4 ACTION; ATOPY-LIKE DERMATITIS; SUBSTANCE-P; SCRATCHING BEHAVIOR; SPINAL-CORD; MOSQUITO ALLERGY	Itch is a sensation that provokes a desire to scratch. Mast-cell histamine was thought to be a key itch mediator. However, histamine and mast-cell degranulation were reported not to elicit scratching in animals. It was difficult to investigate the pathophysiology of itching and to evaluate the antipruritic efficacy of chemical agents in the early 1990s. We showed that hind-paw scratching and biting were elicited by stimulation with pruritogenic agents in mice. Those results demonstrated for the first time that cutaneous itching could be evaluated behaviorally in animals. We established various animal models of pathological itch of the skin (dry skin, mosquito allergy, surfactant-induced pruritus, and herpes zoster) and mucus membranes (pollen allergy). Mast-cell histamine did not play a key role in itching in any animal model examined except for the pollen allergy model. Histamine is not an exclusive itch mediator of mast cells; tryptase and leukotriene B-4 released from mast cells also act as itch mediators. Epidermal keratinocytes release several itch mediators, such as leukotriene B-4, sphingosylphosphorylcholine, thromboxane A(2), nociceptin, nitric oxide, and histamine, which may play important roles in pathological itching. Appropriate animal models of pathological itching are needed for pharmacological evaluation of the antipruritic efficacy of chemical agents.	Toyama Univ, Lab Appl Pharmacol, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan	Kuraishi, Y (reprint author), Toyama Univ, Lab Appl Pharmacol, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan.	kuraisiy@pha.u-toyama.ac.jp			Japan Society for the Promotion of Science	I would like to express sincere gratitude to all the collaborators contributing to our research described here, many of whom are cited in this review. I also express cordial thanks to all the members of our research group. This work was supported financially by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Abbott FV, 1996, NEUROPHARMACOLOGY, V35, P99, DOI 10.1016/0028-3908(95)00136-0; Adhikari S, 2013, ACTA DERM-VENEREOL, V91, p616P; Akiyama T, 2010, NEUROSCI LETT, V484, P62, DOI 10.1016/j.neulet.2010.08.020; Akiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022665; Ananthapadmanabhan K P, 2004, Dermatol Ther, V17 Suppl 1, P16, DOI 10.1111/j.1396-0296.2004.04S1002.x; Andoh T, 2004, J PHARMACOL SCI, V94, P207, DOI 10.1254/jphs.94.207; Andoh T, 2013, J PHARMACOL SCI, V123, P199, DOI 10.1254/jphs.13122SC; Andoh T, 2014, J DERMATOL SCI, V76, P206, DOI 10.1016/j.jdermsci.2014.10.005; Andoh T, 2004, J INVEST DERMATOL, V123, P196, DOI 10.1111/j.0022-202X.2004.22704.x; Andoh T, 2008, J PHARMACOL SCI, V106, P667, DOI 10.1254/jphs.08004SC; Andoh T, 2014, PHARMACOL REP, V66, P699, DOI 10.1016/j.pharep.2014.01.003; Andoh T, 2001, J INVEST DERMATOL, V117, P1621, DOI 10.1046/j.0022-202x.2001.01585.x; Andoh T, 2000, EUR J PHARMACOL, V406, P149, DOI 10.1016/S0014-2999(00)00637-3; Andoh T, 2014, EXP DERMATOL, V23, P359, DOI 10.1111/exd.12377; Andoh T, 2011, ACTA DERM-VENEREOL, V91, P638; Andoh T, 1998, EUR J PHARMACOL, V353, P93, DOI 10.1016/S0014-2999(98)00440-3; Andoh T, 2012, EXP EYE RES, V98, P97, DOI 10.1016/j.exer.2012.03.021; Andoh T, 2002, EUR J PHARMACOL, V436, P235, DOI 10.1016/S0014-2999(01)01617-X; Andoh T, 1996, MOL BRAIN RES, V35, P329, DOI 10.1016/0169-328X(95)00244-M; Andoh T, 2006, EUR J PHARMACOL, V547, P59, DOI 10.1016/j.ejphar.2006.07.009; Andoh T, 2011, EXP DERMATOL, V20, P894, DOI 10.1111/j.1600-0625.2011.01346.x; Andoh T, 2005, MOL BRAIN RES, V137, P263, DOI 10.1016/j.molbrainres.2005.02.029; Andoh T, 2004, FASEB J, V18, P182, DOI 10.1096/fj.02-1169fje; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Gotoh Y, 2011, NEUROPHARMACOLOGY, V61, P825, DOI 10.1016/j.neuropharm.2011.05.030; Thomsen JS, 2002, BRIT J DERMATOL, V146, P792, DOI 10.1046/j.1365-2133.2002.04722.x; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; Tsujii K, 2009, J PHARMACOL SCI, V109, P388, DOI 10.1254/jphs.08332FP; O'Brien PJ, 2001, ONCOGENE, V20, P1570, DOI 10.1038/sj.onc.1204194; Yamaguchi T, 2001, J DERMATOL SCI, V25, P20, DOI 10.1016/S0923-1811(00)00099-2; SHELLEY WB, 1957, ARCH DERMATOL, V76, P296; Tominaga M, 2013, BIOL PHARM BULL, V36, P1241; Sherrington CS, 1903, J PHYSIOL-LONDON, V29, P58; BALLANTYNE JC, 1988, PAIN, V33, P149, DOI 10.1016/0304-3959(88)90085-1; Johanek LM, 2007, J NEUROSCI, V27, P7490, DOI 10.1523/JNEUROSCI.1249-07.2007; Akiyama T, 2009, J NEUROPHYSIOL, V102, P2176, DOI 10.1152/jn.00463.2009; Reddy VB, 2008, J NEUROSCI, V28, P4331, DOI 10.1523/JNEUROSCI.0716-08.2008; Andoh T, 1998, J PHARMACOL EXP THER, V286, P1140; Kumagai H, 2010, NEPHROL DIAL TRANSPL, V25, P1251, DOI 10.1093/ndt/gfp588; REUNALA T, 1991, CLIN EXP ALLERGY, V21, P617, DOI 10.1111/j.1365-2222.1991.tb00855.x; Maekawa T, 2002, JPN J PHARMACOL, V90, P193, DOI 10.1254/jjp.90.193; Bergasa NV, 1999, J AM ACAD DERMATOL, V41, P431, DOI 10.1016/S0190-9622(99)70117-9; Nakano T, 2008, NEUROREPORT, V19, P723, DOI 10.1097/WNR.0b013e3282fdf6c5; Andoh T, 2007, J INVEST DERMATOL, V127, P2042, DOI 10.1038/sj.jid.5700810; Peer G, 1996, LANCET, V348, P1552, DOI 10.1016/S0140-6736(96)04176-1; Ui H, 2006, EUR J PHARMACOL, V530, P172, DOI 10.1016/j.ejphar.2005.11.021; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; DUBUISSON D, 1977, PAIN, V4, P161; Andoh T, 2009, J INVEST DERMATOL, V129, P2854, DOI 10.1038/jid.2009.155; Belghiti M, 2013, J BIOL CHEM, V288, P9675, DOI 10.1074/jbc.M113.455162; Ohtsuka E, 2001, JPN J PHARMACOL, V86, P97, DOI 10.1254/jjp.86.97; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; Inami Y, 2013, J PHARMACOL EXP THER, V344, P459, DOI 10.1124/jpet.112.200063; Togashi Y, 2002, EUR J PHARMACOL, V435, P259, DOI 10.1016/S0014-2999(01)01588-6; Yamaguchi T, 1999, NEUROSCI RES, V35, P77, DOI 10.1016/S0168-0102(99)00070-X; Akman A, 1998, OCUL IMMUNOL INFLAMM, V6, P179, DOI 10.1076/ocii.6.3.179.4042; Kuraishi Y, 2013, BIOL PHARM BULL, V36, P1228; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Inami Y, 2013, J PHARMACOL SCI, V121, P242, DOI 10.1254/jphs.12267SC; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Umeuchi H, 2003, EUR J PHARMACOL, V477, P29, DOI 10.1016/j.ejphar.2003.08.007; Okubo Kimihiro, 2011, Allergology International, V60, P171, DOI [10.2332/allergolint. 11-RAI-0334, 10.2332/allergolint.11-RAI-0334]; BERGASA NV, 1995, ANN INTERN MED, V123, P161; Andoh T, 2003, BRIT J PHARMACOL, V138, P202, DOI 10.1038/sj.bjp.0705004; MONROE EW, 1989, J AM ACAD DERMATOL, V21, P135, DOI 10.1016/S0190-9622(89)80353-6; Yanai K, 2007, PHARMACOL THERAPEUT, V113, P1, DOI 10.1016/j.pharmthera.2006.06.008; HYLDEN JLK, 1981, BRAIN RES, V217, P212, DOI 10.1016/0006-8993(81)90203-1; Morton CA, 1996, NEPHROL DIAL TRANSPL, V11, P2031; ARTHUR RP, 1955, J INVEST DERMATOL, V25, P341, DOI 10.1038/jid.1955.138; BERGASA NV, 1995, AM J PHYSIOL-GASTR L, V268, pG346; BERGASA NV, 1993, LIFE SCI, V53, P1253; BERGASA NV, 1992, J HEPATOL, V15, P220, DOI 10.1016/0168-8278(92)90040-V; Bergasa NV, 1997, LIFE SCI, V61, P1169, DOI 10.1016/S0024-3205(97)00658-9; BERNSTEIN JE, 1982, J INVEST DERMATOL, V78, P82, DOI 10.1111/1523-1747.ep12497974; BHALA BB, 1988, CLIN J PAIN, V4, P169, DOI 10.1097/00002508-198809000-00007; DECASTROCOSTA M, 1987, PAIN, V29, P123, DOI 10.1016/0304-3959(87)90186-2; DEGROOT AC, 1987, INT J COSMETIC SCI, V9, P255; FJELLNER B, 1981, ACTA DERM-VENEREOL, V61, P245; Gotoh Y, 2011, J PHARMACOL SCI, V115, P417, DOI 10.1254/jphs.10305SC; Gotoh Y, 2011, EUR J PHARMACOL, V650, P215, DOI 10.1016/j.ejphar.2010.10.011; GREAVES MW, 1992, NEW ENGL J MED, V326, P1016, DOI 10.1056/NEJM199204093261509; HAGERMAR.O, 1972, ACTA DERM-VENEREOL, V52, P125; HAGERMAR.O, 1974, ACTA DERM-VENEREOL, V54, P397; HAGERMARK O, 1978, J INVEST DERMATOL, V71, P233, DOI 10.1111/1523-1747.ep12515092; Hagiwara K, 1999, PAIN RES, V14, P53; Ikoma A, 2013, BIOL PHARM BULL, V36, P1235; Inami Y, 2014, ACTA DERM-VENEREOL, V94, P645, DOI 10.2340/00015555-1834; Jinquan Tan, 1995, Journal of Allergy and Clinical Immunology, V95, P979, DOI 10.1016/S0091-6749(95)70098-6; JOKURA Y, 1995, J INVEST DERMATOL, V104, P806, DOI 10.1111/1523-1747.ep12607005; Kato A, 2000, AM J NEPHROL, V20, P437, DOI 10.1159/000046196; Keele CA, 1964, SUBSTANCES PRODUCING; Kuraishi Y, 2008, BIOL PHARM BULL, V31, P2143, DOI 10.1248/bpb.31.2143; Kuraishi Y, 2000, J BIOMED SCI, V7, P248, DOI 10.1159/000025455; Kuraishi Y, 2013, PAIN MODELS TRANSLAT, P391; Kuraishi Y, 2007, J PHARMACOL SCI, V105, P41, DOI 10.1254/jphs.FP0070404; LANG E, 1990, J NEUROPHYSIOL, V63, P887; LOWMAN M A, 1988, Journal of Allergy and Clinical Immunology, V81, P590, DOI 10.1016/0091-6749(88)90199-6; Maekawa T, 2000, JPN J PHARMACOL, V84, P462, DOI 10.1254/jjp.84.462; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; MELLANBY K, 1946, NATURE, V158, P554, DOI 10.1038/158554c0; MITCHELL JC, 1964, J INVEST DERMATOL, V43, P177; MOUSLI M, 1990, FEBS LETT, V259, P260, DOI 10.1016/0014-5793(90)80023-C; Nakano T, 2007, ACTA DERM-VENEREOL, V87, P473; Nojima H, 2003, NEUROSCI LETT, V347, P62, DOI 10.1016/S0304-3940(03)00609-8; Ohtsuka E, 2003, J PHARMACOL SCI, V91, P263, DOI 10.1254/jphs.91.263; Omori Y, 2009, NEUROREPORT, V20, P478, DOI 10.1097/WNR.0b013e3283293725; SAKURADA T, 1987, NEUROPEPTIDES, V9, P197, DOI 10.1016/0143-4179(87)90039-4; Sasaki A, 2008, J PHARMACOL SCI, V108, P266, DOI 10.1254/jphs.08154FP; Sasaki A, 2013, NEUROREPORT, V24, P652, DOI 10.1097/WNR.0b013e32836352d8; SCHWARTZ.RM, 1965, J INVEST DERMATOL, V44, P39; Shii D, 2009, J OCUL PHARMACOL TH, V25, P321, DOI 10.1089/jop.2009.0009; Shinkado T, 2001, SOC NEUR NEUR M PLAN; SWAIN MG, 1992, GASTROENTEROLOGY, V103, P630; Takasaki I, 2000, PAIN, V86, P95, DOI 10.1016/S0304-3959(00)00240-2; Tohda C, 1997, JPN J PHARMACOL, V74, P77, DOI 10.1254/jjp.74.77; Tsujii K, 2008, J PHARMACOL SCI, V108, P385, DOI 10.1254/jphs.08200SC; TUCKETT RP, 1987, BRAIN RES, V413, P95, DOI 10.1016/0006-8993(87)90157-0; TUCKETT RP, 1987, BRAIN RES, V413, P87, DOI 10.1016/0006-8993(87)90156-9; VARADI DP, 1974, ARCH DERMATOL, V109, P678, DOI 10.1001/archderm.109.5.678; Yamashita M, 2000, BRIT J PHARMACOL, V129, P367, DOI 10.1038/sj.bjp.0703044	121	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					635	644				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800001		
J	Miura, M				Miura, Masatomo			Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients with Chronic Myeloid Leukemia	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Review						imatinib; nilotinib; dasatinib; therapeutic drug monitoring	CHRONIC MYELOGENOUS LEUKEMIA; STANDARD-DOSE IMATINIB; ACUTE LYMPHOBLASTIC-LEUKEMIA; EXPOSURE-RESPONSE ANALYSIS; PHASE-3 TRIAL DASISION; CLINICAL-RESPONSE; TROUGH CONCENTRATION; PLASMA-LEVELS; KINASE INHIBITORS; FOLLOW-UP	Imatinib, nilotinib, and dasatinib are tyrosine kinase inhibitors (TKIs) that have become first-line treatments for Philadelphia chromosome-positive chronic myeloid leukemia (CML). According to European LeukemiaNet recommendations, the clinical response of CML patients receiving TKI therapy should be evaluated after 3, 6, and 12 months. For patients not achieving a satisfactory response within 3 months, the mean plasma concentration for the three months of TKI administration must be considered. In TKI therapy for CML patients, therapeutic drug monitoring is a new strategy for dosage optimization to obtain a faster and more effective clinical response. The imatinib plasma trough concentration (C-0) should be set above 1000 ng/mL to obtain a response and below 3000 ng/mL to avoid serious adverse events such as neutropenia. For patients with a UGT1A1*6/*6, *6/*28, or *28/*28 genotype initially administered 300-400 mg/d, a target nilotinib C-0 of 500 ng/mL is recommended to prevent elevation of bilirubin levels, whereas for patients with the UGT1A1*1 allele initially administered 600 mg/d, a target nilotinib C-0 of 800 ng/mL is recommended. For dasatinib, it is recommended that a higher C-max or C-2 (above 50 ng/mL) to obtain a clinical response and a lower C-0 (less than 2.5ng/mL) to avoid pleural effusion be maintained by once daily administration of dasatinib. Although at present clinicians consider the next pharmacotherapy from clinical responses (efficacy/toxicity) obtained by a fixed dosage of TKI, the TKI dosage should be adjusted based on target plasma concentrations to maximize the efficacy and to minimize the incidence of adverse events.	Akita Univ Hosp, Dept Pharm, Akita 0108543, Japan	Miura, M (reprint author), Akita Univ Hosp, Dept Pharm, 1-1-1 Hondo, Akita 0108543, Japan.	m-miura@hos.akita-u.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [26460188, 26461414, 23590168]	I would like to express my thanks to Dr. Mitsuhiro Takeshita (presently at Tokiwa Hospital, Fukushima, Japan, previously professor of Tohoku Pharmaceutical University), Dr. Tadashi Ohkubo (presently at Shichifuku Pharmacy, Aomori, Japan; previously assistant professor of Hirosaki University Hospital), Dr. Naoto Takahashi (Professor of the Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine) and Dr. Kenichi Sawada (Akita University, previously professor of the Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine) for their valuable guidance and suggestions. I would also like to thank the late Dr. Takanori Hishinuma (previously professor of the Division of Pharmacotherapy, Tohoku University Graduate School of Pharmaceutical Sciences) for leading me into the field of pharmaceutical sciences. This work was supported by Grant Nos. 26460188, 26461414, and 23590168 from the Japan Society for the Promotion of Science, Tokyo, Japan.	Abumiya M, 2014, DRUG METAB PHARMACOK, V29, P449, DOI 10.2133/dmpk.DMPK-14-RG-031; Ai LM, 2014, XENOBIOTICA, V44, P320, DOI 10.3109/00498254.2013.840750; Ieiri I, 2012, DRUG METAB PHARMACOK, V27, P85, DOI 10.2133/dmpk.DMPK-11-RV-098; White DL, 2012, HAEMATOL-HEMATOL J, V97, P907, DOI 10.3324/haematol.2011.056457; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kawaguchi T, 2009, INT J HEMATOL, V89, P642, DOI 10.1007/s12185-009-0315-4; Petain A, 2008, CLIN CANCER RES, V14, P7102, DOI 10.1158/1078-0432.CCR-08-0950; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Goldman JM, 2007, BLOOD, V110, P2828, DOI 10.1182/blood-2007-04-038943; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Seong SJ, 2013, ANN ONCOL, V24, P756, DOI 10.1093/annonc/mds532; Kobayashi D, 2005, DRUG METAB DISPOS, V33, P94, DOI 10.1124/dmd.104.001628; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Quintas-Cardama A, 2007, J CLIN ONCOL, V25, P3908, DOI 10.1200/JCO.2007.12.0329; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Kim DH, 2009, CLIN CANCER RES, V15, P4750, DOI 10.1158/1078-0432.CCR-09-0145; Fukui T, 2011, ONCOL LETT, V2, P923, DOI 10.3892/ol.2011.346; Zhong JS, 2012, ACTA HAEMATOL-BASEL, V127, P221, DOI 10.1159/000336244; Gschwind HP, 2005, DRUG METAB DISPOS, V33, P1503, DOI 10.1124/dmd.105.004283; Giles FJ, 2013, EUR J CLIN PHARMACOL, V69, P813, DOI 10.1007/s00228-012-1385-4; Au A, 2014, BIOMED PHARMACOTHER, V68, P343, DOI 10.1016/j.biopha.2014.01.009; Shibata T, 2014, INT J CLIN ONCOL, V19, P391, DOI 10.1007/s10147-013-0562-5; Takahashi N, 2010, J HUM GENET, V55, P731, DOI 10.1038/jhg.2010.98; van Erp NR, 2007, CLIN CANCER RES, V13, P7394, DOI 10.1158/1078-0432.CCR-07-0346; Forrest DL, 2009, LEUKEMIA RES, V33, P271, DOI 10.1016/j.leukres.2008.07.015; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Larson RA, 2012, EUR J CLIN PHARMACOL, V68, P723, DOI 10.1007/s00228-011-1200-7; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; O'Brien SG, 2003, BRIT J CANCER, V89, P1855, DOI 10.1038/sj.bjc.6601152; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405; Brave M, 2008, CLIN CANCER RES, V14, P352, DOI 10.1158/1078-0432.CCR-07-4175; Shinohara Y, 2013, HAEMATOLOGICA, V98, P1407, DOI 10.3324/haematol.2013.085167; Yu HX, 2014, CLIN PHARMACOKINET, V53, P305, DOI 10.1007/s40262-014-0137-2; Ohnishi K, 2012, CANCER SCI, V103, P1071, DOI 10.1111/j.1349-7006.2012.02253.x; Jabbour E, 2014, BLOOD, V123, P494, DOI 10.1182/blood-2013-06-511592; Rousselot P, 2014, J CLIN ONCOL, V32, P424, DOI 10.1200/JCO.2012.48.5797; Matsuoka A, 2012, CANCER CHEMOTH PHARM, V70, P351, DOI 10.1007/s00280-012-1900-4; Picard S, 2007, BLOOD, V109, P3496, DOI 10.1182/blood-2006-07-036012; Fujita K, 2011, CANCER CHEMOTH PHARM, V67, P237, DOI 10.1007/s00280-010-1445-3; Singer JB, 2007, LEUKEMIA, V21, P2311, DOI 10.1038/sj.leu.2404827; Ando Y, 2000, CANCER RES, V60, P6921; Singh N, 2009, EUR J CLIN PHARMACOL, V65, P545, DOI 10.1007/s00228-009-0621-z; Peng B, 2004, J CLIN PHARMACOL, V44, P158, DOI 10.1177/0091270003262101; Awidi A, 2010, LEUKEMIA RES, V34, P1573, DOI 10.1016/j.leukres.2010.07.014; Baccarani M, 2009, BLOOD, V114, P142; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Bouchet S, 2013, FUND CLIN PHARMACOL, V27, P690, DOI 10.1111/fcp.12007; Chuah CT, 2014, LEUKEMIA LYMPHOMA, V55, P2093, DOI 10.3109/10428194.2013.866663; Faber E, 2012, ANN HEMATOL, V91, P923, DOI 10.1007/s00277-011-1394-x; Guilhot F, 2012, HAEMATOL-HEMATOL J, V97, P731, DOI 10.3324/haematol.2011.045666; Hazarika M, 2008, CLIN CANCER RES, V14, P5325, DOI 10.1158/1078-0432.CCR-08-0308; Ishikawa Y, 2010, CANCER SCI, V101, P2186, DOI 10.1111/j.1349-7006.2010.01643.x; Kim Min Kyoung, 2009, Leuk Res, V33, pe159, DOI 10.1016/j.leukres.2009.04.013; Koren-Michowitz M, 2012, HEMATOL ONCOL, V30, P200, DOI 10.1002/hon.2005; Li QB, 2010, ACTA PHARMACOL SIN, V31, P999, DOI 10.1038/aps.2010.79; Miura Masatomo, 2013, Rinsho Ketsueki, V54, P1720; Mo Wei, 2012, Int J Biochem Mol Biol, V3, P1; Porkka K, 2010, CANCER, V116, P377, DOI 10.1002/cncr.24734; Rousselot P, 2014, C EUR HEM ASS EHA; Saeki M, 2006, PHARMACOGENOMICS J, V6, P63, DOI 10.1038/sj.tpj.6500335; Sakai M, 2009, INT J HEMATOL, V89, P319, DOI 10.1007/s12185-009-0263-z; Sohn SK, 2011, LEUKEMIA LYMPHOMA, V52, P1024, DOI 10.3109/10428194.2011.563885; Takahashi N, 2012, CANCER CHEMOTH PHARM, V69, P999, DOI 10.1007/s00280-011-1797-3; Takahashi N, 2012, BLOOD, V120; Takahashi N, 2011, PHARMACOLOGY, V87, P241, DOI 10.1159/000324900; Takahashi N, 2010, CLIN PHARMACOL THER, V88, P809, DOI 10.1038/clpt.2010.186; Takahashi N, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-23; Takahashi Naoto, 2014, Biomark Res, V2, P6, DOI 10.1186/2050-7771-2-6; Vainstein V, 2013, BLOOD, V122, P3331, DOI 10.1182/blood-2012-08-452409; Wang Xiaoning, 2013, Clin Pharmacol, V5, P85, DOI 10.2147/CPAA.S42796; Wang YF, 2009, THER DRUG MONIT, V31, P579, DOI 10.1097/FTD.0b013e3181b2c8cf; Yoshida C, 2011, INT J HEMATOL, V93, P618, DOI 10.1007/s12185-011-0838-3	76	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					645	654				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800002		
J	Ishikawa, T				Ishikawa, Tomohisa			Foreword	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Editorial Material									Univ Shizuoka, Dept Pharmacol, Grad Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Ishikawa, T (reprint author), Univ Shizuoka, Dept Pharmacol, Grad Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	ishikat@u-shizuoka-ken.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					655	655				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800003		
J	Takahashi, N				Takahashi, Noriko			Imaging Analysis of Insulin Secretion with Two-Photon Microscopy	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						exocytosis; imaging; secretion; soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE); membrane fusion; insulin	PANCREATIC BETA-CELLS; DENSE-CORE VESICLES; GRANULE EXOCYTOSIS; FUSION PORE; SEQUENTIAL EXOCYTOSIS; REGULATED EXOCYTOSIS; COMPOUND EXOCYTOSIS; CUMULATIVE FUSION; CHROMAFFIN CELLS; SINGLE VESICLES	High-resolution deep tissue imaging is possible with two-photon excitation microscopy. With the combined application of two-photon imaging and perfusion with a polar fluorescent tracer, we have established a method to detect exocytic events inside secretory tissues. This method displays the spatiotemporal distribution of exocytic sites, dynamics of fusion pores, and modes of exocytosis. In glucose-stimulated pancreatic islets, exocytic events were observed to be synchronized with an increase in cytosolic Ca2+ concentrations. Full fusion of a single secretory granule is the typical mode of exocytosis and compound exocytosis is inhibited. Because two-photon excitation enables simultaneous multicolor imaging due to the broadened excitation spectra, the distributions and conformational changes in fluorescent-labeled molecules can be simultaneously visualized with exocytic events. Therefore, we can analyze the dynamics of the molecules involved in membrane fusion and their association with exocytosis in living tissues.	Univ Tokyo, Ctr Dis Biol & Integrat Med, Lab Struct Physiol, Fac Med,Bunkyo Ku, Tokyo 1130033, Japan	Takahashi, N (reprint author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Lab Struct Physiol, Fac Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	norikomd@m.u-tokyo.ac.jp					An SJ, 2004, SCIENCE, V306, P1042, DOI 10.1126/science.1102559; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Zhou Z, 1996, BIOPHYS J, V70, P1543; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Lam PPL, 2013, DIABETES, V62, P2416, DOI 10.2337/db12-1380; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397; Yasuda T, 2010, CELL METAB, V12, P117, DOI 10.1016/j.cmet.2010.05.017; MacDonald PE, 2005, PHILOS T ROY SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Michael DJ, 2006, DIABETES, V55, P600, DOI 10.2337/diabetes.55.03.06.db05-1054; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Low JT, 2014, DIABETOLOGIA, V57, P1655, DOI 10.1007/s00125-014-3252-6; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001; Hoppa MB, 2012, DIABETOLOGIA, V55, P1001, DOI 10.1007/s00125-011-2400-5; Takahashi N, 2002, SCIENCE, V297, P1349, DOI 10.1126/science.1073806; Zhao Y, 2013, P NATL ACAD SCI USA, V110, P14249, DOI 10.1073/pnas.1306699110; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Takahashi N, 2004, J CELL BIOL, V165, P255, DOI 10.1083/jcb.200312033; Takahashi N, 2010, CELL METAB, V12, P19, DOI 10.1016/j.cmet.2010.05.013; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Benninger RK, 2013, CURR PROTOC CELL BIO, V11, P1; Cochilla AJ, 2000, J CELL BIOL, V150, P839, DOI 10.1083/jcb.150.4.839; Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3; Hafez I, 2003, J BIOL CHEM, V278, P44921, DOI 10.1074/jbc.M306013200; Hatakeyama H, 2006, J PHYSIOL-LONDON, V570, P271, DOI 10.1113/jphysiol.2005.096560; INTVELD PA, 1984, DIABETES, V33, P101, DOI 10.2337/diabetes.33.1.101; Kasai H, 2006, ADV DRUG DELIVER REV, V58, P850, DOI 10.1016/j.addr.2006.07.008; Kishimoto T, 2006, EMBO J, V25, P673, DOI 10.1038/sj.emboj.7600983; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Liu TT, 2005, J PHYSIOL-LONDON, V568, P917, DOI 10.1113/jphysiol.2005.094011; Ma L, 2004, P NATL ACAD SCI USA, V101, P9266, DOI 10.1073/pnas.0403201101; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; SCEPEK S, 1993, EMBO J, V12, P1811; Speidel D, 2008, CELL METAB, V7, P57, DOI 10.1016/j.cmet.2007.11.009; Takahashi N, 2002, DIABETES, V51, pS25, DOI 10.2337/diabetes.51.2007.S25; Oliveira AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052874	45	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					656	662				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800004		
J	Yamaoka, M; Ishizaki, T; Kimura, T				Yamaoka, Mami; Ishizaki, Toshimasa; Kimura, Toshihide			GTP- and GDP-Dependent Rab27a Effectors in Pancreatic Beta-Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						small guanosine triphosphatase (GTPase); Rab27a; insulin; pancreatic beta-cell; diabetes	SECRETORY GRANULES; ACTIVATING PROTEIN; INSULIN GRANULES; BINDING PROTEINS; PLASMA-MEMBRANE; ACTIN; IQGAP1; EXOCYTOSIS; CDC42; RAC1	Small guanosine triphosphatases (GTPases) participate in a wide variety of cellular functions including proliferation, differentiation, adhesion, and intracellular transport. Conventionally, only the guanosine 5'-triphosphate (GTP)-bound small GTPase interacts with effector proteins, and the resulting downstream signals control specific cellular functions. Therefore, the GTP-bound form is regarded as active, and the focus has been on searching for proteins that bind the GTP form to look for their effectors. The Rab family small GTPase Rab27a is highly expressed in some secretory cells and is involved in the control of membrane traffic. The present study reviews recent progress in our understanding of the roles of Rab27a and its effectors in pancreatic beta-cells. In the basal state, GTP-bound Rab27a controls insulin secretion at pre-exocytic stages via its GTP-dependent effectors. We previously identified novel guanosine 5'-diphosphate (GDP)-bound Rab27-interacting proteins. Interestingly, GDP-bound Rab27a controls endocytosis of the secretory membrane via its interaction with these proteins. We also demonstrated that the insulin secretagogue glucose converts Rab27a from its GTP- to GDP-bound forms. Thus, GTP- and GDP-bound Rab27a regulate pre-exocytic and endocytic stages in membrane traffic, respectively. Since the physiological importance of GDP-bound GTPases has been largely overlooked, we consider that the investigation of GDP-dependent effectors for other GTPases is necessary for further understanding of cellular function.	[Yamaoka, Mami; Ishizaki, Toshimasa; Kimura, Toshihide] Oita Univ, Fac Med, Dept Pharmacol, Oita 8795593, Japan	Kimura, T (reprint author), Oita Univ, Fac Med, Dept Pharmacol, 1-1 Idaigaoka, Oita 8795593, Japan.	t-kimura@oita-u.ac.jp			KAKENHI; Takeda Science Foundation; Suzuken Memorial Foundation; Novo Nordisk Pharma; Oita Broadcasting System Cultural Foundation; Research Fund at the Discretion of the President, Oita University	We thank all members of our laboratory for helpful suggestions. This work was supported by the grant KAKENHI, Takeda Science Foundation, Suzuken Memorial Foundation, Novo Nordisk Pharma, Oita Broadcasting System Cultural Foundation and Research Fund at the Discretion of the President, Oita University.	Kimura T, 2010, ARCH BIOCHEM BIOPHYS, V496, P33, DOI 10.1016/j.abb.2010.01.017; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Kimura T, 2008, J CELL SCI, V121, P3092, DOI 10.1242/jcs.030544; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Kimura T, 2011, ENDOCR J, V58, P1, DOI 10.1507/endocrj.K10E-391; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Hart MJ, 1996, EMBO J, V15, P2997; Wang H, 2013, MOL BIOL CELL, V24, P319, DOI 10.1091/mbc.E12-04-0265; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Takai Y, 2001, PHYSIOL REV, V81, P153; Rittmeyer EN, 2008, J CELL SCI, V121, P391, DOI 10.1242/jcs.016881; Yang SN, 2007, CELL METAB, V6, P217, DOI 10.1016/j.cmet.2007.08.002; Mizuno K, 2011, MOL BIOL CELL, V22, P1716, DOI 10.1091/mbc.E10-05-0404; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Brozzi F, 2012, TRAFFIC, V13, P54, DOI 10.1111/j.1600-0854.2011.01301.x; Brozzi F, 2012, MOL BIOL CELL, V23, P4444, DOI 10.1091/mbc.E12-05-0369; DIRACSVEJSTRUP AB, 1994, J BIOL CHEM, V269, P15427; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Fukui K, 1997, J BIOL CHEM, V272, P4655; Galletta BJ, 2008, PLOS BIOL, V6, P72, DOI 10.1371/journal.pbio.0060001; Goehring AS, 2007, J BIOL CHEM, V282, P33155, DOI 10.1074/jbc.M705167200; Hasse A, 2005, EUR J NEUROSCI, V21, P1155, DOI 10.1111/j.1460-9568.2005.03917.x; Hou YA, 2013, J BIOL CHEM, V288, P19548, DOI 10.1074/jbc.M113.472134; Iizaka M, 2000, CYTOGENET CELL GENET, V88, P221, DOI 10.1159/000015555; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Izumi T, 2007, ENDOCR J, V54, P649, DOI 10.1507/endocrj.KR-78; Kimura T, 2010, BIOCHEM BIOPH RES CO, V395, P318, DOI 10.1016/j.bbrc.2010.03.173; Kimura T, 2013, MOL CELL BIOL, V33, P4834, DOI 10.1128/MCB.00895-13; Kimura T, 2011, PROG BIOPHYS MOL BIO, V107, P219, DOI 10.1016/j.pbiomolbio.2011.06.016; Kuroda S, 1996, J BIOL CHEM, V271, P23363; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Pouli AE, 1998, BIOCHEM J, V333, P193; Rosentreter A, 2007, EXP CELL RES, V313, P878, DOI 10.1016/j.yexcr.2006.12.015; Spoerl Z, 2002, J BIOL CHEM, V277, P48858, DOI 10.1074/jbc.M205136200; Torii S, 2002, MOL CELL BIOL, V22, P5518, DOI 10.1128/MCB.22.15.5518-5526.2002; Ullrich O, 1994, NATURE, V368, P157; Vo YP, 2004, BIOCHEM BIOPH RES CO, V324, P1004, DOI 10.1016/j.bbrc.2004.09.147; Wang J, 1999, J BIOL CHEM, V274, P28542, DOI 10.1074/jbc.274.40.28542; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022	47	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					663	668				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800005		
J	Kaneko, YK; Ishikawa, T				Kaneko, Yukiko K.; Ishikawa, Tomohisa			Diacylglycerol Signaling Pathway in Pancreatic beta-Cells: An Essential Role of Diacylglycerol Kinase in the Regulation of Insulin Secretion	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						diacylglycerol kinase; diacylglycerol; pancreatic beta-cell; insulin secretion; diabetes	C ACTIVATION; GLUCOSE; PROTEIN; ISLETS; GAMMA; LOCALIZATION; RELEASE; ACID; COMPLICATIONS; INHIBITION	Diacylglycerol (DAG) is a lipid signal messenger and plays a physiological role in beta-cells. Since defective glucose homeostasis increases de novo DAG synthesis, DAG may also contribute to beta-cell dysfunction in type 2 diabetes. Although the primary function of DAG is to activate protein kinase C (PKC), the role of PKC in insulin secretion is controversial: PKC has been reported to act as both a positive and negative regulator of insulin secretion. In addition to the PKC pathway, DAG has also been shown to mediate other pathways such as the Munc-13-dependent pathway in beta-cells. The intracellular levels of DAG are strictly regulated by diacylglycerol kinase (DGK); however, the role of DGK in beta-cells and their involvement in beta-cell failure in type 2 diabetes remain to be fully elucidated. We have recently reported the roles of type I DGK, DGK alpha and gamma, in insulin secretion from beta-cells. DGK alpha and gamma were activated by glucose or high K+ stimulation in beta-cells, and the inhibition of the DGKs by a type I DGK inhibitor or by knockdown with small interfering RNA (siRNA) decreased insulin secretion. Thus, DGK alpha and gamma are suggested to be activated in response to elevated [Ca2+](i) in beta-cells and to act as positive regulators of insulin secretion. In this article, we review the current understanding of the roles of DAG and DGK in beta-cell function and their involvement in the development of beta-cell dysfunction in type 2 diabetes.	[Kaneko, Yukiko K.; Ishikawa, Tomohisa] Univ Shizuoka, Dept Pharmacol, Grad Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Kaneko, YK (reprint author), Univ Shizuoka, Dept Pharmacol, Grad Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	ykaneko@u-shizuoka-ken.ac.jp			JSPS KAKENHI [26750336]; Suzuken Memorial Foundation	This work was supported in part by JSPS KAKENHI Grant number 26750336 and the Suzuken Memorial Foundation.	Adachi N, 2005, MOL BRAIN RES, V139, P288, DOI 10.1016/j.molbrainres.2005.06.007; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Zawalich WS, 2001, MOL CELL ENDOCRINOL, V177, P95, DOI 10.1016/S0303-7207(01)00422-1; Yamada K, 1997, BIOCHEM J, V321, P59; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Topham MK, 1998, NATURE, V394, P697; Baldanzi Gianluca, 2014, Advances in Biological Regulation, V55, P39, DOI 10.1016/j.jbior.2014.02.001; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Tian YM, 1996, MOL CELL ENDOCRINOL, V119, P185, DOI 10.1016/0303-7207(96)03811-7; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Carpenter L, 2004, DIABETES, V53, P53; Cazzolli R, 2007, DIABETOLOGIA, V50, P1732, DOI 10.1007/s00125-007-0709-x; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Goto Kaoru, 2014, Adv Biol Regul, V54, P242; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Kaneko YK, 2013, ENDOCRINOLOGY, V154, P4089, DOI 10.1210/en.2013-1356; KONRAD RJ, 1994, BIOCHEMISTRY-US, V33, P13284, DOI 10.1021/bi00249a015; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; McDonald P, 2007, AM J PHYSIOL-CELL PH, V292, pC1216, DOI 10.1152/ajpcell.00467.2006; PETERRIESCH B, 1988, J CLIN INVEST, V81, P1154, DOI 10.1172/JCI113430; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rodriguez de Turco EB, 2001, P NATL ACAD SCI USA, V98, P4740; Sakai H, 2014, J BIOL CHEM, V289, P26607, DOI 10.1074/jbc.M114.590950; Sakuma M, 2014, BIOCHEM BIOPH RES CO, V445, P340, DOI 10.1016/j.bbrc.2014.01.197; Shirai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011602; Takeshita E, 2014, BIOCHEM BIOPH RES CO, V444, P617, DOI 10.1016/j.bbrc.2014.01.116; THOMAS TP, 1992, ENDOCRINOLOGY, V131, P1985, DOI 10.1210/en.131.4.1985; Yamada K, 2003, BIOCHEM BIOPH RES CO, V305, P101, DOI 10.1016/S0006-291X(03)00713-7; Zawalich WS, 2000, METABOLISM, V49, P1156, DOI 10.1053/meta.2000.8613	35	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					669	673				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800006		
J	Kojima, I; Nakagawa, Y; Hamano, K; Medina, J; Li, LF; Nagasawa, M				Kojima, Itaru; Nakagawa, Yuko; Hamano, Kunihisa; Medina, Johan; Li, Longfei; Nagasawa, Masahiro			Glucose-Sensing Receptor T1R3: A New Signaling Receptor Activated by Glucose in Pancreatic beta-Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						insulin secretion; beta-cell; glucose; sweet taste receptor; glucose-sensing receptor; calcium	SWEET TASTE RECEPTOR; INSULIN-SECRETION; MAMMALIAN SWEET; UMAMI TASTE; CALCIUM; BITTER; EXPRESSION; RESPONSES; GUSTDUCIN; PATTERNS	Subunits of the sweet taste receptors T1R2 and T1R3 are expressed in pancreatic beta-cells. Compared with T1R3, mRNA expression of T1R2 is considerably lower. At the protein level, expression of T1R2 is un-detectable in beta-cells. Accordingly, a major component of the sweet taste-sensing receptor in beta-cells may be a homodimer of T1R3 rather than a heterodimer of T1R2/T1R3. Inhibition of this receptor by gurmarin or deletion of the T1R3 gene attenuates glucose-induced insulin secretion from beta-cells. Hence the T1R3 homodimer functions as a glucose-sensing receptor (GSR) in pancreatic beta-cells. When GSR is activated by the T1R3 agonist sucralose, elevation of intracellular ATP concentration ([ATP](i)) is observed. Sucralose increases [ATP](i) even in the absence of ambient glucose, indicating that sucralose increases [ATP](i) not simply by activating glucokinase, a rate-limiting enzyme in the glycolytic pathway. In addition, sucralose augments elevation of [ATP](i) induced by methylsuccinate, suggesting that sucralose activates mitochondrial metabolism. Nonmetabolizable 3-O-methylglucose also increases [ATP](i) and knockdown of T1R3 attenuates elevation of [ATP](i) induced by high concentration of glucose. Collectively, these results indicate that the T1R3 homodimer functions as a GSR; this receptor is involved in glucose-induced insulin secretion by activating glucose metabolism probably in mitochondria.	[Kojima, Itaru; Nakagawa, Yuko; Hamano, Kunihisa; Medina, Johan; Li, Longfei; Nagasawa, Masahiro] Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gumma 3718512, Japan	Kojima, I (reprint author), Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gumma 3718512, Japan.	ikojima@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by Grants-in-Aid for Scientific Research and Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors thank Mayumi Odagiri for secretarial assistance during preparation of the manuscript.	Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Komatsu M, 2013, J DIABETES INVEST, V4, P511, DOI 10.1111/jdi.12094; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/ng0501-58; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Nakagawa Y, 2014, ENDOCR J, V61, P119; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; Medina A, 2014, ENDOCR J, V61, P797, DOI 10.1507/endocrj.EJ14-0221; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Tateyama M, 2006, P NATL ACAD SCI USA, V103, P1124, DOI 10.1073/pnas.0505925103; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Temussi PA, 2009, TRENDS BIOCHEM SCI, V34, P296, DOI 10.1016/j.tibs.2009.02.005; Nakagawa Y, 2013, ENDOCR J, V60, P1191, DOI 10.1507/endocrj.EJ13-0282; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Kojima I, J DIABETES IN PRESS; Kojima Itaru, 2011, Diabetes Metab J, V35, P451, DOI 10.4093/dmj.2011.35.5.451; Kojima I, 2014, ENDOCRINOL METAB, V29, P1, DOI 10.3803/EnM.2014.29.1.12; Lee RJ, 2014, CELL MOL LIFE SCI, V72, P217; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Ohtsu Y, 2014, MOL CELL ENDOCRINOL, V394, P70, DOI 10.1016/j.mce.2014.07.004; Ren Xueying, 2009, Front Integr Neurosci, V3, P12, DOI 10.3389/neuro.07.012.2009; Shigemura N, 2008, BIOCHEM BIOPH RES CO, V367, P356, DOI [10.1016/j.bbrc.2007.12.146, 10.1016/j.bbre.2007.12.146]; Temussi PA, 2011, INT REV CEL MOL BIO, V291, P191, DOI 10.1016/B978-0-12-386035-4.00006-9; Tordoff MG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00496	35	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					674	679				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800007		
J	Suzuki, Y; Suzuki, H; Umetsu, R; Uranishi, H; Abe, J; Nishibata, Y; Sekiya, Y; Miyamura, N; Hara, H; Tsuchiya, T; Kinosada, Y; Nakamura, M				Suzuki, Yukiya; Suzuki, Honami; Umetsu, Ryogo; Uranishi, Hiroaki; Abe, Junko; Nishibata, Yuri; Sekiya, Yasuaki; Miyamura, Nobuteru; Hara, Hideaki; Tsuchiya, Teruo; Kinosada, Yasutomi; Nakamura, Mitsuhiro			Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						clopidogrel; adverse event reporting system; aspirin; proton pump inhibitor	DRUG-DRUG INTERACTIONS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACUTE CORONARY SYNDROME; CONCOMITANT USE; SIGNAL-DETECTION; PUBLIC VERSION; RISK; DISPROPORTIONALITY; PHARMACOVIGILANCE; OMEPRAZOLE	Clopidogrel is an antiplatelet agent widely used in combination with aspirin to limit the occurrence of cardiovascular (embolic/thrombotic) events. Consensus guidelines recommend proton pump inhibitors (PPIs) as a gastrointestinal (GI) prophylactic measure for all patients receiving dual antiplatelet therapy with clopidogrel and aspirin. The objective of this study was to analyze the effect of the simultaneous use of clopidogrel, aspirin, and PPIs on hemorrhagic and embolic/thrombotic events using the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database. Reports of hemorrhagic and embolic/thrombotic events between 2004 and 2013 were analyzed with a reporting odds ratio (ROR) algorithm and logistic regression methods. The Medical Dictionary for Regulatory Activities Preferred Terms was used to identify such events. Regarding hemorrhagic events, the adjusted RORs of the concomitant use of aspirin and clopidogrel and those of PPIs prescribed with aspirin and clopidogrel were 4.40 (95% confidence interval [CI], 4.02-4.81) and 3.40 (95% CI, 2.84-4.06), respectively. For embolic/thrombotic events, the adjusted RORs of the concomitant use of aspirin and clopidogrel and those of PPIs prescribed with aspirin and clopidogrel were 2.37 (95% CI, 2.16-2.59) and 2.38 (95% CI, 2.00-2.84), respectively. Among patients included in the FAERS database, the concurrent use of aspirin and clopidogrel with PPIs reduced the adjusted ROR of GI hemorrhagic events. PPIs had little influence on the adjusted ROR of embolic/thrombotic events. These results support the use of PPIs as a preventive measure against GI hemorrhagic events for patients receiving clopidogrel and aspirin.	[Suzuki, Yukiya; Suzuki, Honami; Umetsu, Ryogo; Uranishi, Hiroaki; Abe, Junko; Nishibata, Yuri; Nakamura, Mitsuhiro] Gifu Pharmaceut Univ, Lab Drug Informat, Gifu 5011196, Japan; [Suzuki, Yukiya; Hara, Hideaki] Gifu Pharmaceut Univ, Mol Pharmacol, Dept Biofunct Evaluat, Gifu 5011196, Japan; [Sekiya, Yasuaki; Miyamura, Nobuteru; Kinosada, Yasutomi] Gifu Univ, Grad Sch Med, Dept Biomed Informat, Gifu 5011194, Japan; [Tsuchiya, Teruo] Gifu Pharmaceut Univ, Lab Hosp Pharm, Gifu 5011196, Japan	Nakamura, M (reprint author), Gifu Pharmaceut Univ, Lab Drug Informat, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	mnakamura@gifu-pu.ac.jp			JSPS KAKENHI [24390126]	This research was partially supported by JSPS KAKENHI Grant Number, 24390126.	Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Abraham NS, 2010, J AM COLL CARDIOL, V56, P2051, DOI 10.1016/j.jacc.2010.09.010; Szarfman A, 2002, DRUG SAFETY, V25, P381, DOI 10.2165/00002018-200225060-00001; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Gould AL, 2003, PHARMACOEPIDEM DR S, V12, P559, DOI 10.1002/pds.771; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; van Puijenbroek EP, 2000, EUR J CLIN PHARMACOL, V56, P733, DOI 10.1007/s002280000215; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Ng FH, 2008, AM J GASTROENTEROL, V103, P865, DOI 10.1111/j.1572-0241.2007.01715.x; Ray WA, 2010, ANN INTERN MED, V152, P337, DOI 10.7326/0003-4819-152-6-201003160-00003; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Tamura T, 2012, INT J MED SCI, V9, P441, DOI 10.7150/ijms.4549; Stockl KM, 2010, ARCH INTERN MED, V170, P704, DOI 10.1001/archinternmed.2010.34; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Kwok CS, 2010, ALIMENT PHARM THER, V31, P810, DOI 10.1111/j.1365-2036.2010.04247.x; Skrondal A, 2003, AM J EPIDEMIOL, V158, P251, DOI 10.1093/aje/kwg113; Rassen JA, 2009, CIRCULATION, V120, P2322, DOI 10.1161/CIRCULATIONAHA.109.873497; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; Egberts ACG, 2002, DRUG SAFETY, V25, P453, DOI 10.2165/00002018-200225060-00010; Depta JP, 2010, CLEV CLIN J MED, V77, P113, DOI 10.3949/ccjm.77a.09173; Evans SJ, 2001, DRUG SAFETY, V10, P483; Food and Drug Administration, FUT DRUG SAF PROM PR; Food and Drug Administration, RED EFF PLAV CLOP PA; Hauben Manfred, 2005, Expert Opin Drug Saf, V4, P929, DOI 10.1517/14740338.4.5.929; Hoffman KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042866; Hosmer DW, 2013, APPL LOGISTIC REGRES, V3rd, P182; Kadoyama K, 2012, BIOL PHARM BULL, V35, P967, DOI 10.1248/bpb.35.967; MedDRA Maintenance and Support Services Organization, 2012, INTR GUID STAND MEDD; Moayyedi P, 2009, CAN J GASTROENTEROL, V23, P251; Qian YF, 2010, BRIT J CLIN PHARMACO, V69, P67, DOI 10.1111/j.1365-2125.2009.03557.x; Sibbing D, 2009, LANCET, V374, P952, DOI 10.1016/S0140-6736(09)61562-2; Umetsu R, 2014, YAKUGAKU ZASSHI, V134, P299; van Puijenbroek EP, 1999, BRIT J CLIN PHARMACO, V47, P689, DOI 10.1046/j.1365-2125.1999.00957.x; van Werkum JW, 2009, AM HEART J, V157, DOI 10.1016/j.ahj.2009.03.014; van Werkum JW, 2009, AM HEART J, V157, pe45	37	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					680	686				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800008		
J	Masuda, Y; Ohta, H; Morita, Y; Nakayama, Y; Miyake, A; Itoh, N; Konishi, M				Masuda, Yuki; Ohta, Hiroya; Morita, Yumiko; Nakayama, Yoshiaki; Miyake, Ayumi; Itoh, Nobuyuki; Konishi, Morichika			Expression of Fgf23 in Activated Dendritic Cells and Macrophages in Response to Immunological Stimuli in Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						fibroblast growth factor (Fgf); Fgf23; macrophage; dendritic cell; inflammation	FIBROBLAST-GROWTH-FACTOR; VITAMIN-D METABOLISM; DISEASE; PROLIFERATION; PHOSPHATE; RECEPTOR; FGF-23; ROLES	Fibroblast growth factors (Fgfs) are polypeptide growth factors with diverse biological activities. While several studies have revealed that Fgf23 plays important roles in the regulation of phosphate and vitamin D metabolism, the additional physiological roles of Fgf23 remain unclear. Although it is believed that osteo-blasts/osteocytes are the main sources of Fgf23, we previously found that Fgf23 mRNA is also expressed in the mouse thymus, suggesting that it might be involved in the immune system. In this study we examined the potential roles of Fgf23 in immunological responses. Mouse serum Fgf23 levels were significantly increased following inoculation with Escherichia coli or Staphylococcus aureus or intraperitoneal injection of lipopolysaccharide. We also identified activated dendritic cells and macrophages that potentially contributed to increased serum Fgf23 levels. Nuclear factor-kappa B (NF-kappa B) signaling was essential for the induction of Fgf23 expression in dendritic cells in response to immunological stimuli. Moreover, we examined the effects of recombinant Fgf23 protein on immune cells in vitro. Fgfr1c, a potential receptor for Fgf23, was abundantly expressed in macrophages, suggesting that Fgf23 might be involved in signal transduction in these cells. Our data suggest that Fgf23 potentially increases the number in macrophages and induces expression of tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine. Collectively, these data suggest that Fgf23 might be intimately involved in inflammatory processes.	[Masuda, Yuki; Morita, Yumiko; Nakayama, Yoshiaki; Konishi, Morichika] Kobe Pharmaceut Univ, Dept Microbial Chem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Ohta, Hiroya; Miyake, Ayumi; Itoh, Nobuyuki] Kyoto Univ, Dept Biochem Genet, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Konishi, M (reprint author), Kobe Pharmaceut Univ, Dept Microbial Chem, Higashinada Ku, 4-19-1 Motoyama Kitamachi, Kobe, Hyogo 6588558, Japan.	mkonishi@kobepharma-u.ac.jp					Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Takeshita F, 2001, J IMMUNOL, V167, P3555; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Masuda Y, 2012, J LEUKOCYTE BIOL, V91, P547, DOI 10.1189/jlb.0711386; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Bhattacharyya N, 2012, TRENDS ENDOCRIN MET, V23, P610, DOI 10.1016/j.tem.2012.07.002; Masuda Y, 2010, CANCER IMMUNOL IMMUN, V59, P1531, DOI 10.1007/s00262-010-0880-7; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; KRAAL G, 1992, INT REV CYTOL, V132, P31; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Saji F, 2010, AM J PHYSIOL-RENAL, V299, pF1212, DOI 10.1152/ajprenal.00169.2010; Fukumoto S, 2005, THER APHER DIAL, V9, P319, DOI 10.1111/j.1744-9987.2005.00289.x; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Katoh Y, 2005, INT J MOL MED, V16, P355; Kawai M, 2013, J BIOL CHEM, V288, P2414, DOI 10.1074/jbc.M112.410043; Meir T, 2014, KIDNEY INT, V86, P1106, DOI 10.1038/ki.2014.215; Olauson H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003975; Tsolmongyn B, 2013, IMMUNOLOGY, V140, P352, DOI 10.1111/imm.12147	23	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					687	693				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800009		
J	Sato, Y; Sasaki, N; Saito, M; Endo, N; Kugawa, F; Ueno, A				Sato, Yasunori; Sasaki, Naoto; Saito, Megu; Endo, Nao; Kugawa, Fumihiko; Ueno, Akemichi			Luteolin Attenuates Doxorubicin-Induced Cytotoxicity to MCF-7 Human Breast Cancer Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						luteolin; MCF-7 human breast cancer cell; doxorubicin; cytotoxicity	FLAVONOID LUTEOLIN; LINE MCF-7; INDEPENDENT MECHANISMS; ANTICANCER DRUGS; APOPTOSIS; DEATH; ACTIVATION; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; DYSFUNCTION	Luteolin, a flavone found in some vegetables, has been reported to exhibit antioxidant, antiinflammatory, and anticancer activities. In the present study, we found that luteolin has biphasic effects on the viability of the human breast cancer cell line MCF-7. That is, cell viability increased at relatively low luteolin concentrations and decreased at relatively high concentrations. Focusing on the proliferative effect at low concentrations, we showed that luteolin has a cytoprotective effect on MCF-7 cells when administered with doxorubicin. Moreover, luteolin attenuated doxorubicin-induced cytotoxicity even in the presence of the estrogen receptor (ER) antagonist ICI 182,780 and the ER-negative MDA-MB-453 human breast cancer cell line. Reactive oxygen species (ROS) were generated after doxorubicin treatment of MCF-7 cells. In contrast, luteolin attenuated doxorubicin-induced ROS generation. Levels of the antiapoptotic protein Bcl-2 in luteolin-treated MCF-7 cells were significantly higher than those in doxorubicin-treated MCF-7 cells. Our results suggest that a low concentration of luteolin attenuates doxorubicin-induced cytotoxicity to MCF-7 cells through a combination of antioxidant activity and an increase in levels of Bcl-2 protein.	[Sato, Yasunori; Sasaki, Naoto; Saito, Megu; Endo, Nao; Ueno, Akemichi] Ohu Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Fukushima 9638611, Japan; [Kugawa, Fumihiko] Hyogo Univ Hlth Sci, Sch Pharmaceut Sci, Dept Biopharmaceut, Kobe, Hyogo 6508530, Japan	Ueno, A (reprint author), Ohu Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Fukushima 9638611, Japan.	a-ueno@pha.ohu-u.ac.jp			Ohu University; Ohu University General Individual Research Grant	This study was supported by the Young Investigator Grant from Ohu University (to Y.S.) and by the Ohu University General Individual Research Grant (to Y.S. and A.U).	Adina AB, 2014, IRAN J PHARM RES, V13, P919; Zand RSR, 2000, BREAST CANCER RES TR, V62, P35, DOI 10.1023/A:1006422302173; Neilan TG, 2007, CIRCULATION, V116, P506, DOI 10.1161/CIRCULATIONAHA.106.652339; Choi EM, 2011, TOXICOL IN VITRO, V25, P1671, DOI 10.1016/j.tiv.2011.07.004; Skildum A, 2011, BREAST CANCER RES TR, V129, P785, DOI 10.1007/s10549-010-1268-2; Vibet S, 2008, FREE RADICAL BIO MED, V44, P1483, DOI 10.1016/j.freeradbiomed.2008.01.009; Collins-Burow BM, 2000, NUTR CANCER, V38, P229, DOI 10.1207/S15327914NC382_13; Wang SQ, 2010, BIOORG MED CHEM LETT, V20, P6411, DOI 10.1016/j.bmcl.2010.09.086; Kang KP, 2011, NEPHROL DIAL TRANSPL, V26, P814, DOI 10.1093/ndt/gfq528; Seelinger G, 2008, MOLECULES, V13, P2628, DOI 10.3390/molecules13102628; Dutta C, 2012, CANCER RES, V72, P4193, DOI 10.1158/0008-5472.CAN-11-4204; Selvendiran K, 2006, CANCER RES, V66, P4826, DOI 10.1158/0008-5472.CAN-05-4062; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31; Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0; Wolfle U, 2011, FREE RADICAL BIO MED, V50, P1081, DOI 10.1016/j.freeradbiomed.2011.01.027; Long XH, 2008, MOL CANCER THER, V7, P2096, DOI 10.1158/1535-7163.MCT-07-2350; Berthiaume JM, 2005, CARDIOVASC TOXICOL, V5, P257, DOI 10.1385/CT:5:3:257; Chitambar CR, 2006, INT J CANCER, V119, P2200, DOI 10.1002/ijc.22079; Kugawa F, 2012, PHARMAZIE, V67, P862, DOI 10.1691/ph.2012.1165; Kugawa F, 2004, LIFE SCI, V75, P287, DOI 10.1016/j.lfs.2003.11.032; Kugawa F, 2004, BIOL PHARM BULL, V27, P392, DOI 10.1248/bpb.27.392; Kugawa F, 2010, J HEALTH SCI, V56, P81; Landis-Piwowar KR, 2008, J CELL BIOCHEM, V105, P514, DOI 10.1002/jcb.21853; Lim Y, 2012, BMC GASTROENTEROL, V12, P9; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Meiyanto E, 2014, ASIAN PAC J CANCER P, V15, P179, DOI 10.7314/APJCP.2014.15.1.179; Nagar S, 2010, ADV EXP MED BIOL, V678, P124; Perez E, 2005, ONCOLOGY-NY, V19, P1759; Resende FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074881; Roca-Alonso L, 2012, CARDIOLOGY, V122, P253, DOI 10.1159/000339858; Saika K., 2009, JMAJ - Japan Medical Association Journal, V52, P39; Hardwick JM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008722; Yang RY, 2008, ASIA PAC J CLIN NUTR, V17, P275	33	0	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					703	709				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800011		
J	Oh-hashi, K; Norisada, J; Hirata, Y; Kiuchi, K				Oh-hashi, Kentaro; Norisada, Junpei; Hirata, Yoko; Kiuchi, Kazutoshi			Characterization of the Role of MANF in Regulating the Secretion of CRELD2	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						endoplasmic reticulum; chaperone; 78 kDa glucose-regulated protein (GRP78); cysteine-rich with epidermal growth factor (EGF)-like domains 2 (CRELD2); mesencephalic astrocyte-derived neurotrophic factor (MANF)	UNFOLDED PROTEIN RESPONSE; NEUROTROPHIC FACTOR; ER STRESS; CYSTEINE-RICH; DOPAMINERGIC-NEURONS; KDEL RECEPTORS; MESSENGER-RNA; CELL-DEATH; DOMAINS 2; ATF6	We recently demonstrated that the secretion of two novel endoplasmic reticulum (ER) stress-inducible proteins, cysteine-rich with epidermal growth factor (EGF)-like domains 2 (CRELD2) and mesencephalic astrocyte-derived neurotrophic factor (MANF), are oppositely regulated by the overexpression of 78 kDa glucose-regulated protein (GRP78). In the present study, we found that the co-transfection of CRELD2 and MANF remarkably enhanced the secretion of CRELD2 without affecting the expression level of GRP78. To identify the structural features of CRELD2 and MANF involved in this process, we generated several CRELD2 and MANF expression constructs. The deletion of the four C-terminal amino acids, either REDL in CRELD2 or RTDL in MANF, abolished the increased secretion of CRELD2 induced by the co-expression of MANF. The deleted mutation of MANF partially abolished the increased secretion of wild type CRELD2 (wtCRELD2) as a positive action of wild type MANF (wtMANF), even when we added the amino acid sequence RTDL at the C-terminus of each mutated MANF construct. Enhanced green fluorescent protein (EGFP), which was tagged with the signal peptide sequence at the N-terminus and four C-terminal amino acids (KEDL, REDL or RTDL), were retained intracellularly, but they did not enhance the secretion of wtCRELD2. Taken together, our data demonstrate that MANF is a factor in regulating the secretion of CRELD2 through four C-terminal amino acids, RTDL and REDL, and the fluctuation of intracellular MANF seems to potentiate the secretion of CRELD2.	[Oh-hashi, Kentaro; Norisada, Junpei; Hirata, Yoko; Kiuchi, Kazutoshi] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan; [Oh-hashi, Kentaro; Norisada, Junpei; Hirata, Yoko; Kiuchi, Kazutoshi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011193, Japan	Oh-hashi, K (reprint author), Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, 1-1 Yanagido, Gifu 5011193, Japan.	oohashi@gifu-u.ac.jp			Research Foundation for the Electrotechnology of Chubu; Suzuken Memorial Foundation	This work is in part supported by the Research Foundation for the Electrotechnology of Chubu and the Suzuken Memorial Foundation.	Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Shridhar R, 1996, CANCER RES, V56, P5576; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Zhu C, 1997, MOL CELL BIOL, V17, P4957; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Oh-Hashi K, 2013, CELL MOL BIOL LETT, V18, P398, DOI 10.2478/s11658-013-0096-x; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Nohara K, 2012, TOXICOL SCI, V129, P293, DOI 10.1093/toxsci/kfs203; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Harding HP, 1999, NATURE, V397, P271; Airavaara M, 2010, EXP NEUROL, V225, P104, DOI 10.1016/j.expneurol.2010.05.020; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Evron E, 1997, CANCER RES, V57, P2888; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Norisada J, 2014, BIOCHEM BIOPH RES CO, V449, P483, DOI 10.1016/j.bbrc.2014.05.031; Oh-hashi K, 2012, MOL CELL BIOCHEM, V363, P35, DOI 10.1007/s11010-011-1155-0; Oh-hashi K, 2014, CELL BIOL TOXICOL, V30, P127, DOI 10.1007/s10565-014-9274-5; Oh-hashi K, 2011, FEBS LETT, V585, P2481, DOI 10.1016/j.febslet.2011.06.029; Oh-hashi K, 2013, MOL CELL BIOCHEM, V380, P97, DOI 10.1007/s11010-013-1663-1; Oh-hashi K, 2009, BIOCHEM BIOPH RES CO, V387, P504, DOI 10.1016/j.bbrc.2009.07.047; Ortiz JA, 2005, J NEUROCHEM, V95, P1585, DOI 10.1111/j.1471-4159.2005.03473.x; Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073086	39	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					722	731				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800014		
J	Nagahama, M; Ohkubo, A; Kinouchi, Y; Kobayashi, K; Miyamoto, K; Takehara, M; Sakurai, J				Nagahama, Masahiro; Ohkubo, Akiko; Kinouchi, Yoshihito; Kobayashi, Keiko; Miyamoto, Kazuaki; Takehara, Masaya; Sakurai, Jun			Clostridium perfringens TpeL Induces Formation of Stress Fibers via Activation of RhoA-ROCK Signaling Pathway	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						Clostridium perfringens TpeL; stress fiber; RhoA; Rho A-Rho kinase (ROCK)	III SECRETION SYSTEM; INTRACELLULAR TRAFFICKING; LIVING CELLS; BETA-TOXIN; ACTIN; RAS; CYTOTOXINS	Clostridium perfringens TpeL belongs to a family of large clostridial glucosylating cytotoxins. TpeL modifies Rac1 and Ras subfamily proteins. Herein we report TpeL-induced formation of stress fibers via RhoA-Rho kinase (ROCK) signaling. A recombinant protein (TpeL1-525) derived from the TpeL N-terminal catalytic domain in the presence of streptolysin 0 (SLO) induced the formation of actin stress fibers in Madin-Darby canine kidney (MDCK) cells in a dose-dependent manner. The RhoA/ROCK pathway is known to control the formation of stress fibers. We examined the role of the RhoA/ROCK pathway in TpeL-induced formation of stress fibers. TpeL1-525-induced formation of stress fibers was inhibited by the ROCK inhibitor, Y27632 and Rho protein inhibitor, C3 transferase. TpeL1-525 activated RhoA and ROCK in a dose-dependent manner. C3 transferase blocked TpeL1-525-induced activation of RhoA and ROCK whereas Y27632 inhibited TpeL-induced activation of ROCK. These results demonstrate for the first time that TpeL induces the formation of stress fibers by activating the RhoA/ROCK signaling pathway.	[Nagahama, Masahiro; Ohkubo, Akiko; Kinouchi, Yoshihito; Kobayashi, Keiko; Miyamoto, Kazuaki; Takehara, Masaya; Sakurai, Jun] Tokushima Bunri Univ, Dept Microbiol, Fac Pharmaceut Sci, Yamashiro, Tokushima 7708514, Japan	Nagahama, M (reprint author), Tokushima Bunri Univ, Dept Microbiol, Fac Pharmaceut Sci, Yamashiro, Tokushima 7708514, Japan.	nagahama@ph.bunri-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank M. Satoh and H. Nakamura for their technical assistance. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 2013	Nagahama M, 2015, TOXINS, V7, P396, DOI 10.3390/toxins7020396; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Nagahama M, 2011, INFECT IMMUN, V79, P905, DOI 10.1128/IAI.01019-10; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Amimoto K, 2007, MICROBIOL-SGM, V153, P1198, DOI 10.1099/mic.0.2006/002287-0; Sakurai J, 2006, TOXIN REV, V25, P89, DOI 10.1080/15569540500320979; Guttenberg G, 2012, J BIOL CHEM, V287, P24929, DOI 10.1074/jbc.M112.347773; Nagahama M, 2012, INFECT IMMUN, V80, P3410, DOI 10.1128/IAI.00483-12; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Pauillac S, 2013, TOXICON, V75, P136, DOI 10.1016/j.toxicon.2013.07.003; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/micro1150; Tweten RK, 2001, VET MICROBIOL, V82, P1, DOI 10.1016/S0378-1135(01)00372-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Coursodon CF, 2012, ANAEROBE, V18, P117, DOI 10.1016/j.anaerobe.2011.10.001; Bailey MA, 2013, ISRN VET SCI, V2013; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Giesemann T, 2008, J MED MICROBIOL, V57, P690, DOI 10.1099/jmm.0.47742-0; Gurtner C, INFECT IMMUN; Nagahama M, 2014, TOXICON, V82, P76, DOI 10.1016/j.toxicon.2014.02.009; Shojadoost B., 2012, VET RES, V43, P43, DOI DOI 10.1186/1297-9716-43-74; Smedley J G 3rd, 2004, Rev Physiol Biochem Pharmacol, V152, P183	29	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					732	739				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800015		
J	Hayashi, T; Nagamatsu, T; Matsushita, A; Mizuno, T; Nishibe, S; Noguchi, A; Kato, R; Toda, T; Tanaka, J; Takahashi, H; Hayashi, H; Yuzawa, Y; Yamada, S				Hayashi, Takahiro; Nagamatsu, Tadashi; Matsushita, Ayako; Mizuno, Tomohiro; Nishibe, Seira; Noguchi, Ayaka; Kato, Rina; Toda, Takahiro; Tanaka, Junko; Takahashi, Hiroshi; Hayashi, Hiroki; Yuzawa, Yukio; Yamada, Shigeki			Comparison between Long- and Short-Acting Erythropoiesis-Stimulating Agents in the Period Required for Haemoglobin Stabilisation in Treatment of Anaemia in Patients with Chronic Kidney Disease	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						erythropoiesis-stimulating agent; haemoglobin stabilization; risk factor; anaemia; chronic kidney disease	CHRONIC-RENAL-FAILURE; DARBEPOETIN ALPHA; HEMODIALYSIS-PATIENTS; EPOETIN-ALPHA; THERAPY; HYPORESPONSIVENESS; LEVEL	Comparative studies of the potency of long- and short-acting erythropoiesis-stimulating agents (L-ESAs and S-ESAs) on erythropoietic activity in patients with chronic kidney disease without dialysis have not been performed, although L-ESAs are used in many countries. We performed a retrospective analysis of non-dialysis (ND) patients who had received L-ESA or S-ESA. More days were needed for the S-ESA-treated group (368d) to reach the haemoglobin (lib) reference range than for the L-ESA-treated group (126d). Therefore, we investigated risk factors that influence the period until the Hb level reaches the reference range. Patients were classified into two groups by the period until the fib level was stabilised within the reference range: the short- and long-term group. Two risk factors for delayed Hb stabilisation were identified: age >= 60 years; and administration of an S-ESA for initial treatment. These findings suggest that the fib level should be carefully monitored during ESA therapy in elderly ND patients, and that the ESA dose should be increased or L-ESA therapy should be utilised to treat renal anaemia.	[Hayashi, Takahiro; Nishibe, Seira; Toda, Takahiro; Tanaka, Junko; Yamada, Shigeki] Fujita Hlth Univ, Sch Med, Dept Clin Pharm, Toyoake, Aichi 4701192, Japan; [Hayashi, Takahiro; Nagamatsu, Tadashi; Matsushita, Ayako; Mizuno, Tomohiro; Noguchi, Ayaka; Kato, Rina] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Mizuno, Tomohiro; Hayashi, Hiroki; Yuzawa, Yukio] Fujita Hlth Univ, Sch Med, Dept Nephrol, Toyoake, Aichi 4701192, Japan; [Takahashi, Hiroshi] Fujita Hlth Univ, Div Med Stat, Toyoake, Aichi 4701192, Japan	Hayashi, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Clin Pharm, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	taka-h@fujita-hu.ac.jp					Akizawa T, 2007, THER APHER DIAL, V11, P220, DOI 10.1111/j.1744-9987.2007.00474.x; Minutolo R, 2012, NEPHROL DIAL TRANSPL, V27, P2880, DOI 10.1093/ndt/gfs007; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Rossert J, 2007, NEPHROL DIAL TRANSPL, V22, P794, DOI 10.1093/ndt/gf1716; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Gouva C, 2004, KIDNEY INT, V66, P753, DOI 10.1111/j.1523-1755.2004.00797.x; Kuriyama S, 1997, NEPHRON, V77, P176; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Hayashi T, 2000, AM J KIDNEY DIS, V35, P250, DOI 10.1016/S0272-6386(00)70334-9; Bernieh B, 2014, INT UROL NEPHROL, V46, P453, DOI 10.1007/s11255-013-0640-7; Canaud B, 2008, NEPHROL DIAL TRANSPL, V23, P3654, DOI 10.1093/ndt/gfn320; Hirai T, 2010, INT J ARTIF ORGANS, V33, P283; Iwasaki M, 2011, J JPN SOC DIAL THER, V44, P137; Kuroda Y, 2008, J JPN SOC DIAL THER, V41, P843; MACDOUGALL IC, 1995, BRIT MED J, V310, P1424; Tsubakihara Y, 2011, KIDNEY DIAL, V70, P953; Van Wyck DB, 2007, AM J KIDNEY DIS, V50, P471	18	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					740	745				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800016		
J	Shimizu, T; Kijima, A; Masuo, Y; Ishimoto, T; Sugiura, T; Takahashi, S; Nakamichi, N; Kato, Y				Shimizu, Takuya; Kijima, Ai; Masuo, Yusuke; Ishimoto, Takahiro; Sugiura, Tomoko; Takahashi, Saki; Nakamichi, Noritaka; Kato, Yukio			Gene Ablation of Carnitine/Organic Cation Transporter 1 Reduces Gastrointestinal Absorption of 5-Aminosalicylate in Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						organic cation transporter; 5-aminosalicylate; gastrointestinal absorption	ORGANIC CATION/CARNITINE TRANSPORTERS; ULCERATIVE-COLITIS; COLORECTAL-CANCER; OCTN1; ACID; CELLS; BIOAVAILABILITY; OCTN1/SLC22A4; PROGRESSION; POPULATION	5-Aminosalicylic acid (5-ASA) is an orally administered therapeutic agent for inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. We hypothesized that the absorption of 5-ASA is mediated by the polyspecific carnitine/organic cation transporter (OCTN1/SLC22A4), based on the similarity of chemical structure between 5-ASA and other OCTN1 substrates. Therefore, we examined the involvement of this transporter in the disposition of 5-ASA in vivo by using octn1 gene knockout (octn1(-/-)) mice. After oral administration of 5-ASA, the plasma concentrations of 5-ASA and its primary metabolite, N-acetyl-5-aminosalicylate (Ac-5-ASA), in octn1(-/-) mice were much lower than those in wild-type mice. The time required to reach maximum plasma concentration was also delayed in octn1(-/-) mice. On the other hand, the plasma concentration profiles of both 5-ASA and Ac-5-ASA after intravenous administration of 5-ASA (bolus or infusion) were similar in the two strains. Uptake of 5-ASA from the apical to the basal side of isolated small-intestinal tissues of octn1(-/-) mice, determined in an Ussing-type chamber, was lower than that in wild-type mice. Further, uptake of 5-ASA in HEK293 cells stably transfected with the OCTN1 gene, assessed as the sum of cell-associated 5-ASA and Ac-5-ASA, was higher than that in HEK293 cells transfected with the vector alone. Overall, these results indicate that OCTN1 is involved, at least in part, in the gastrointestinal absorption of 5-ASA.	[Shimizu, Takuya; Kijima, Ai; Masuo, Yusuke; Ishimoto, Takahiro; Sugiura, Tomoko; Takahashi, Saki; Nakamichi, Noritaka; Kato, Yukio] Kanazawa Univ, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Kato, Y (reprint author), Kanazawa Univ, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan.	ykato@p.kanazawa-u.ac.jp	KATO, Yukio/D-8396-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan; Hoansha Foundation (Osaka, Japan); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO)	We thank Dr. Tsuyoshi Taniguchi, Faculty of Pharmacy, Kanazawa University, for synthesis of Ac-5-ASA. We also thank Ms. Lica Ishida for technical assistance. This study was supported by a Grant-in-Aid for Scientific Research provided by the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant from Hoansha Foundation (Osaka, Japan) and a Grant from the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO).	Jong NN, 2011, J PHARMACOL EXP THER, V338, P537, DOI 10.1124/jpet.111.181297; Urban TJ, 2008, CLIN PHARMACOL THER, V83, P416, DOI 10.1038/sj.clpt.6100271; [Anonymous], 2013, ULC COL MAN AD CHILD; Sugiura T, 2010, DRUG METAB DISPOS, V38, P1665, DOI 10.1124/dmd.110.032763; Pochini L, 2012, LIFE SCI, V91, P1013, DOI 10.1016/j.lfs.2012.04.027; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Reinacher-Schick A, 2003, CARCINOGENESIS, V24, P443, DOI 10.1093/carcin/24.3.443; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Nakamura T, 2010, MOL PHARMACEUT, V7, P187, DOI 10.1021/mp900206j; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Baan B, 2012, GUT, V61, P1708, DOI 10.1136/gutjnl-2011-301626; Kato Y, 2010, PHARM RES-DORDR, V27, P832, DOI 10.1007/s11095-010-0076-z; Shugarts S, 2009, PHARM RES-DORDR, V26, P2039, DOI 10.1007/s11095-009-9924-0; Imanaga J, 2011, PHARMACOGENET GENOM, V21, P84, DOI 10.1097/FPC.0b013e32834300cc; Hussain FN, 1998, J CHROMATOGR B, V716, P257, DOI 10.1016/S0378-4347(98)00323-5; Benet LZ, 2011, AAPS J, V13, P519, DOI 10.1208/s12248-011-9290-9; Yabuuchi H, 1999, J PHARMACOL EXP THER, V289, P768; Ieiri I, 2012, J CLIN PHARMACOL, V52, P1078, DOI 10.1177/0091270011408612; Rousseaux C, 2013, CARCINOGENESIS, V34, P2580, DOI 10.1093/carcin/bgt245; YU DK, 1990, CLIN PHARMACOL THER, V48, P26; Caliendo G, 2001, EUR J MED CHEM, V36, P517, DOI 10.1016/S0223-5234(01)01251-X; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; GREENFIELD SM, 1992, ALIMENT PHARM THERAP, V6, P671; Griindemann D, 2005, P NATL ACAD SCI USA, V102, P5256; HAWKEY CJ, 1983, GUT, V24, P213, DOI 10.1136/gut.24.3.213; Kawasaki Y, 2004, J PHARM SCI-US, V93, P2920, DOI 10.1002/jps.20190; Konig J, 2011, DRUG METAB DISPOS, V39, P1097, DOI 10.1124/dmd.110.034991; Munding J, 2012, CARCINOGENESIS, V33, P637, DOI 10.1093/carcin/bgr306; Nakamichi N, 2013, J PHARM SCI-US, V102, P3407, DOI 10.1002/jps.23595; Nishimura T, 2007, DRUG METAB DISPOS, V35, P1275, DOI 10.1124/dmd.106.013037; Shimizu T, DRUG METAB IN PRESS; Taubert D, 2009, GUT, V58, P312, DOI 10.1136/gut.2008.164418; Zhao LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094208; Zhou SY, 1999, DRUG METAB DISPOS, V27, P479	34	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					774	780				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800020		
J	Hisajima, N; Hata, Y; Kinoshita, K; Fukushima, T; Nishida, N; Kano, M; Tabata, T				Hisajima, Nozomi; Hata, Yukiko; Kinoshita, Koshi; Fukushima, Toshiki; Nishida, Naoki; Kano, Masanobu; Tabata, Toshihide			The Susceptibilities of Human Ether-a-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						arrhythmia; Kv(11.1); KCNH2; single-nucleotide polymorphism; class III antiarrhythmic drug; pharmacogenomic	HERG POTASSIUM CHANNELS; K+ CHANNELS	The human ether-a-go-go-related gene (hERG) channel mediates the rapid delayed rectifier potassium current (I-Kr) responsible for shaping the repolarization phase of cardiac action potentials. hERG mutation may cause hERG channel malfunction, leading to long QT syndrome and other arrhythmic disorders. Elucidation of the genotype phenotype relationships of individual hERG mutations is key to the development of treatment for such arrhythmic disorders. We previously identified hERG(G487R), a missense mutant with a glycine-to-arginine substitution at position 487. In the absence of arrhythmogenic factors, hERG(G487R) subunit-containing channels show normal surface expression and gating kinetics. However, it remains unknown whether the mutation exacerbates hERG channel malfunction induced by arrhythmogenic factors. Here we used a voltage-clamp technique to compare the effects of the major arrythmogenic factors on wildtype hERG IhERG(WT)] and hERG(G487R) channel currents (I-hERG) in HEK-293T cells. The extent of I-hERG blockade by the antiarrhythmic drug dofetilide or E4031 was not different between these channels. On the other hand, the extracellular K+ concentration ([K+](ex))-dependent changes in the rates of recovery from inactivation and deactivation of I-hERG were rather less obvious for hERG(G487R) channel than for hERG(WT) channel. These findings suggest that the inheritance of hERG(G487R) does not increase the risk of arrhythmic disorders induced by antiarrhythmic drugs or hypokalemia.	[Hisajima, Nozomi; Fukushima, Toshiki; Tabata, Toshihide] Toyama Univ, Grad Sch Sci & Engn, Lab Neural Informat Technol, Toyama 9308555, Japan; [Hata, Yukiko; Kinoshita, Koshi; Nishida, Naoki] Toyama Univ, Dept Legal Med, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Kano, Masanobu] Univ Tokyo, Dept Neurophysiol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	Tabata, T (reprint author), Toyama Univ, Grad Sch Sci & Engn, Lab Neural Informat Technol, 3190 Gofuku, Toyama 9308555, Japan.	ttabata@eng.u-toyama.ac.jp			Toyama First Bank Foundation; University of Toyama's presidential office	This work was supported by grants from Toyama First Bank Foundation and University of Toyama's presidential office.	Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; He FZ, 2013, TRENDS MOL MED, V19, P227, DOI 10.1016/j.molmed.2012.12.006; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1992, PFLUG ARCH EUR J PHY, V420, P180, DOI 10.1007/BF00374988; Kinoshita K, 2012, CARDIOVASC ELECTROPH, V23, P1246; Liu L, 2013, HEART RHYTHM, V10, P61, DOI 10.1016/j.hrthm.2012.09.053; Maekawa K, 2005, ANN HUM GENET, V69, P413, DOI 10.1046/j.1529-8817.2005.00167.x; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; Yamaguchi Y, 2014, CIRC J, V78, P610, DOI 10.1253/circj.CJ-13-1126	10	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					781	784				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800021		
J	Keyamura, Y; Nagano, C; Kohashi, M; Niimi, M; Nozako, M; Koyama, T; Itabe, H; Yoshikawa, T				Keyamura, Yuka; Nagano, Chifumi; Kohashi, Masayuki; Niimi, Manabu; Nozako, Masanori; Koyama, Takashi; Itabe, Hiroyuki; Yoshikawa, Tomohiro			Dietary Cholesterol Atherogenic Changes in Juvenile Rabbits	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						atherosclerosis; juvenile; rabbit; cholesterol	MATERNAL HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; PREGNANCY; CHILDHOOD	Atherosclerotic lesion formation starts during fetal development and progresses with age after adolescence. However, atherogenesis during the juvenile period has not been studied thoroughly. In this study, we examined the atherogenic susceptibility of juvenile rabbits to cholesterol feeding. Male New Zealand White rabbits aged 8 (younger group) and 12 (older group) weeks were fed a 0.5% cholesterol-containing diet for 8 weeks, and then their aortic atherosclerotic lesion areas were evaluated. Plasma concentrations of total cholesterol, triglycerides, and phospholipids did not differ between the two groups; however, plasma concentrations of high-density lipoprotein cholesterol were 23% lower in the younger than in the older group. Atherosclerotic lesion areas were significantly larger in the younger group (32 +/- 21%). However, only moderate changes were observed in these areas in the older group (3.3 +/- 0.3%). Histological examination showed marked intimal thickening and macrophage accumulation in the aortic lesions of rabbits in the younger group. To the best of our knowledge, this is the first study to show that dietary cholesterol-induced atherogenic changes markedly occur during a short period in juvenile rabbits.	[Keyamura, Yuka; Nagano, Chifumi; Kohashi, Masayuki; Niimi, Manabu; Nozako, Masanori; Koyama, Takashi; Yoshikawa, Tomohiro] Otsuka Pharmaceut Co Ltd, Free Rad Res Project, Tokushima 7710192, Japan; [Keyamura, Yuka; Itabe, Hiroyuki] Showa Univ, Sch Pharm, Div Biol Chem, Dept Mol Biol,Shinagawa Ku, Tokyo 1428555, Japan	Yoshikawa, T (reprint author), Otsuka Pharmaceut Co Ltd, Free Rad Res Project, 463-10 Kagasuno,Kawauchi Cho, Tokushima 7710192, Japan.	yoshikawa.tomohiro.a@otsuka.jp					Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; Palinski W, 2002, FASEB J, V16, P1348, DOI 10.1096/fj.02-0226rev; Williams CL, 2002, CIRCULATION, V106, P143, DOI 10.1161/01.CIR.0000019555.61092.9E; BERGER M, 1982, ACTA ENDOCRINOL-COP, V99, P459; Bjorkegren JL, 2014, PLOS GENET, V10, DOI DOI 10.1371/JOURNAL.PGEN.1004201.S019; Frantz E, 2012, ACTA CIR BRAS, V27, P7, DOI 10.1590/S0102-86502012000100002; Herring MJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000271; Keyamura Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096929; Yanni AE, 2004, LAB ANIM-UK, V38, P246, DOI 10.1258/002367704323133628	9	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					785	788				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800022		
J	Takagaki, A; Nanjo, F				Takagaki, Akiko; Nanjo, Fumio			Bioconyersion of (-)-Epicatechin, (+)-Epicatechin, (-)-Catechin, and (+)-Catechin by (-)-Epigallocatechin-Metabolizing Bacteria	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						catechin; metabolite; bacterium; Adlercreutzia equolifaciens; Eggerthella lenta; Flavonifractor plautii	HUMAN INTESTINAL BACTERIUM; METABOLIC-FATE; TEA CATECHINS; RAT; DEHYDROXYLATION; POLYPHENOLS; GALLATE; RING	Bioconversion of (-)-epicatechin (-EC), (+)-epicatechin (+EC), (-)-catechin (-C), and (+)-catechin (+C) by (-)-epigallocatechin (-EGC)-metabolizing bacteria, Adlercreutzia equolifaciens MT4s-5, Eggerthella lenta JCM 9979, and Flavonifractor plautii MT42, was investigated. A. equolifaciens MT4s-5 could catalyze C ring cleavage to form (2S)-1-(3,4-dihydroxypheny1)-3-(2,4,6-trihydroxyphenyl)propan-2-ol (1S) from -EC and -C, and (2R)-1-(3,4-dihydroxypheny1)-3-(2,4,6-trihydroxyphenyl)propan-2-ol (1R) from +C. The C ring cleavage by A. equolifaciens MT4s-5 was accelerated in the presence of hydrogen. E. lenta JCM 9979 also catalyzed C ring cleavage of -EC and +C to produce 1S and 1R, respectively. In the presence of hydrogen or formate, strain JCM 9979 showed not only stimulation of C ring cleavage but also subsequent 4'-dehydroxylation of 1S and 1R to produce (2S)-1-(3-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)propan-2-ol (2S) and (2R)-1-(3-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)propan-2-ol (2R), respectively. On the other hand, A. equolifaciens MT4s-5 did not show any 4'-dehydroxylation ability even in the presence of hydrogen. F. plautii MT42 could convert 1S, 1R, 2S, and 2R into their corresponding 4-hydroxy-5-hydroxyphenylvaleric acids and 5-hydroxyphenyl-gamma-valerolactones simultaneously. Similar bioconversion was observed by F. plautii ATCC 29863 and F. plautii ATCC 49531.	[Takagaki, Akiko; Nanjo, Fumio] Mitsui Norin Co Ltd, Food Res Labs, Fujieda, Shizuoka 4260133, Japan	Nanjo, F (reprint author), Mitsui Norin Co Ltd, Food Res Labs, 223-1 Miyabara, Fujieda, Shizuoka 4260133, Japan.	fnanjo@mitsui-norin.co.jp					Kohri T, 2003, J AGR FOOD CHEM, V51, P5561, DOI 10.1021/jf034450x; Yang CS, 2006, MOL CARCINOGEN, V45, P431, DOI 10.1002/mc.20228; Seto R, 1997, BIOSCI BIOTECH BIOCH, V61, P1434; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Kutschera M, 2011, J APPL MICROBIOL, V111, P165, DOI 10.1111/j.1365-2672.2011.05025.x; Wang LQ, 2001, CHEM PHARM BULL, V49, P1640, DOI 10.1248/cpb.49.1640; Kohri T, 2001, J AGR FOOD CHEM, V49, P4102, DOI 10.1021/jf001491+; Takagaki A, 2013, J AGR FOOD CHEM, V61, P4927, DOI 10.1021/jf304431v; Clifford M.N., 2013, AM J CLIN NUTR, V98, P1619; Hara Y, 2001, GREEN TEA HLTH BENEF; Jin JS, 2012, BIOL PHARM BULL, V35, P2252; Komatsu K, 1993, BIOSCI BIOTECH BIOCH, V57, P907; Takagaki A, 2014, ARCH MICROBIOL, V196, P681, DOI 10.1007/s00203-014-1006-y	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAY	2015	38	5					789	794				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2LD	WOS:000353855800023		
J	Ishida, T; Naito, T; Kawakami, J				Ishida, Takuya; Naito, Takafumi; Kawakami, Junichi			Simultaneous determination of erlotinib and its isomeric major metabolites in human plasma using isocratic liquid chromatography-tandem mass spectrometry and its clinical application	BIOMEDICAL CHROMATOGRAPHY			English	Article						erlotinib; isomeric metabolites; LC-MS; MS; pharmacokinetics; human plasma	RECEPTOR TYROSINE KINASE; OSI-774; INHIBITOR; OSI-420; QUANTIFICATION	This study developed a method for the simultaneous determination of erlotinib and its isomeric major metabolites, OSI-413 and OSI-420, in human plasma using an isocratic liquid chromatography-tandem mass spectrometry. Plasma specimens deproteinized with acetonitrile were separated using a 3-mu m particle size octadecylsilyl column. The m/z values of the precursor and product ions for the analytes were as follows: erlotinib, 394.2/278.2; and OSI-413 and OSI-420, 380.2/278.2. The total run time was 21 min and no peaks interfering with the analytes and internal standard (d(6)-erlotinib) in human plasma were observed. The calibration curves of erlotinib, OSI-413 and OSI-420 were linear over the concentration ranges of 10-3000, 2-500 and 2-100 ng/mL, respectively. The pretreatment recovery ratios were >86.1%. The intra- and inter-assay precisions and accuracies were <12.7 and 89.0-108.9% for all analytes. This validated method was applied to the determination of plasma samples in lung cancer patients receiving 150 mg of oral erlotinib. The plasma concentration ranges of erlotinib, OSI-413 and OSI-420 were 373-2354, 15.7-379 and 2.5-43.6 ng/mL, respectively. In conclusion, the present method can be helpful for evaluating the plasma exposures of erlotinib and its major isomeric metabolites in clinical settings. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ishida, Takuya; Naito, Takafumi; Kawakami, Junichi] Hamamatsu Univ Sch Med, Dept Hosp Pharm, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Naito, T (reprint author), Hamamatsu Univ Sch Med, Dept Hosp Pharm, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	naitou@hama-med.ac.jp			JSPS KAKENHI [24927001, 25926002]	This work was supported by JSPS KAKENHI grant numbers 24927001 and 25926002.	Masters AR, 2007, J CHROMATOGR B, V848, P379, DOI 10.1016/j.jchromb.2006.10.046; Rodriguez J, 2014, ELECTROPHORESIS, V35, P1489, DOI 10.1002/elps.201300573; Zhang WJ, 2005, J CHROMATOGR B, V814, P143, DOI 10.1016/j.jchromb.2004.10.016; Lankheet NAG, 2013, BIOMED CHROMATOGR, V27, P466, DOI 10.1002/bmc.2814; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Lepper ER, 2003, J CHROMATOGR B, V796, P181, DOI 10.1016/j.jchromb.2003.08.015; Ling J, 2006, DRUG METAB DISPOS, V34, P420, DOI 10.1124/dmd.105.007765; Jiongweis P, 2010, PHARMACEUTICS, V2, P105; Lis J, 2007, CLIN CANCER RES, V13, P3731; U.S. Food and Drug Administration (FDA), 2001, GUID IND BIOAN METH; Zhao M, 2003, J CHROMATOGR B, V793, P413, DOI 10.1016/S1570-0232(03)00356-8	11	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-3879	1099-0801		BIOMED CHROMATOGR	Biomed. Chromatogr.	MAY	2015	29	5					643	646		10.1002/bmc.3357		4	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	CH2UK	WOS:000353880000003		
J	Togami, K; Kanehira, Y; Tada, H				Togami, Kohei; Kanehira, Yukimune; Tada, Hitoshi			Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy	BIOPHARMACEUTICS & DRUG DISPOSITION			English	Article						pirfenidone; pirfenidone metabolites; idiopathic pulmonary fibrosis; tissue distribution; Calu-3 cell monolayers	BLEOMYCIN HAMSTER MODEL; EPITHELIAL LINING FLUID; CALU-3 CELL MONOLAYERS; FUNCTIONAL-ACTIVITY; ANTIFIBROTIC AGENT; LUNG FIBROSIS; IN-VITRO; EXPRESSION; DRUGS; DETERMINANT	Pirfenidone is the first and only clinically used anti-fibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF). It was reported previously that pirfenidone metabolites (5-hydroxypirfenidone and 5-carboxypirfenidone) also have anti-fibrotic effects. The present study evaluated the distribution of pirfenidone and its metabolites in the lung, liver and kidney tissues in rats. The time course for the different concentrations of pirfenidone, 5-hydroxypirfenidone and 5-carboxypirfenidone in the lung tissue following oral administration (30mg/kg) to rats was lower than that in plasma, and the area under the drug concentration-time curve (AUC) ratios of lung/plasma for pirfenidone, 5-hydroxypirfenidone and 5-carboxypirfenidone were 0.52, 0.40 and 0.61, respectively. In in vitro transport experiments, the basolateral-to-apical transport of pirfenidone and its metabolites through the model of lung epithelial cell (Calu-3) monolayers was not significantly different from their apical-to-basolateral transport. In binding experiments, the binding rate of these drugs to the lung tissue was lower than that to the plasma protein. These findings suggest that the low distribution of pirfenidone and its metabolites in the lungs was based on their low affinities with lung tissue and not the transport characteristics of lung epithelial cells. On the other hand, the AUC ratios of liver/plasma for pirfenidone and 5-carboxypirfenidone were 2.3 and 6.5 and the AUC ratios of kidney/plasma were 1.5 and 20, respectively. The binding rates to the liver and kidney tissues were higher than those to the plasma protein. These results suggest that high concentrations of these drugs were found in the liver and kidney tissues. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Togami, Kohei; Kanehira, Yukimune; Tada, Hitoshi] Hokkaido Pharmaceut Univ, Sch Pharm, Div Pharmaceut, Otaru, Hokkaido 0470264, Japan; [Togami, Kohei; Kanehira, Yukimune; Tada, Hitoshi] Ohu Univ, Sch Pharmaceut Sci, Dept Biopharmaceut, Koriyama, Fukushima 9638611, Japan	Tada, H (reprint author), Hokkaido Pharmaceut Univ, Sch Pharm, Div Pharmaceut, 7-1 Katsuraoka Cho, Otaru, Hokkaido 0470264, Japan.	h-tada@hokuyakudai.ac.jp			Japan Society for the Promotion of Science [24790167]	This work was supported by Grants-in-Aid (No. 24790167) for Young Scientists (B) provided by Japan Society for the Promotion of Science.	Adamali HI, 2012, DRUG DES DEV THER, V6, P261, DOI 10.2147/DDDT.S29928; Grattendick KJ, 2008, INT IMMUNOPHARMACOL, V8, P679, DOI 10.1016/j.intimp.2008.01.013; Scheffer GL, 2002, J CLIN PATHOL, V55, P332; Gurujeyalakshmi G, 1999, AM J PHYSIOL-LUNG C, V276, pL311; Peng ZZ, 2009, NEPHROLOGY, V14, P565, DOI 10.1111/j.1440-1797.2009.01129.x; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Sakagami M, 2006, ADV DRUG DELIVER REV, V58, P1030, DOI 10.1016/j.addr.2006.07.012; KURZ H, 1983, DRUG METAB REV, V14, P467, DOI 10.3109/03602538308991397; Iyer SN, 1999, J PHARMACOL EXP THER, V291, P367; Miric G, 2001, BRIT J PHARMACOL, V133, P687, DOI 10.1038/sj.bjp.0704131; Shitara Y, 2006, EUR J PHARM SCI, V27, P425, DOI 10.1016/j.ejps.2005.12.003; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061; MacDonald C, 2013, J DRUG TARGET, V21, P97, DOI 10.3109/1061186X.2012.731068; Huang N-Y, 2013, Drug Res (Stuttg), V63, P388, DOI 10.1055/s-0033-1341478; Hamilton KO, 2001, J PHARMACOL EXP THER, V298, P1199; Forbes B, 2005, EUR J PHARM BIOPHARM, V60, P193, DOI 10.1016/j.ejpb.2005.02.010; Zhang JY, 2006, CURR DRUG METAB, V7, P939, DOI 10.2174/138920006779010575; Rubino CM, 2009, PULM PHARMACOL THER, V22, P279, DOI 10.1016/j.pupt.2009.03.003; Aoki M, 2009, BIOL PHARM BULL, V32, P1095; Belkin A, 2013, CURR OPIN PULM MED, V19, P474, DOI 10.1097/MCP.0b013e328363f479; Endter S, 2007, CELL TISSUE RES, V328, P77, DOI 10.1007/s00441-006-0346-6; FENG NH, 1992, J APPL PHYSIOL, V72, P1081; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Lins JH, 1982, J PHARMACOKINET BIOP, V10, P637; Mikkaichi Tsuyoshi, 2004, Drug Metab Pharmacokinet, V19, P171, DOI 10.2133/dmpk.19.171; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Taniyama M, 1997, EUR J CLIN PHARMACOL, V52, P77, DOI 10.1007/s002280050252; Togami K, 2013, BIOL PHARM BULL, V36, P1525; Togami K, 2012, PHARMAZIE, V67, P389, DOI 10.1691/ph.2012.1699; Widdicombe J, 1997, J APPL PHYSIOL, V82, P3; YATA N, 1990, PHARMACEUT RES, V7, P1019, DOI 10.1023/A:1015935031933; Zhao XY, 2009, CLIN EXP PHARMACOL P, V36, P963, DOI 10.1111/j.1440-1681.2009.05194.x	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2782	1099-081X		BIOPHARM DRUG DISPOS	Biopharm. Drug Dispos.	MAY	2015	36	4					205	215		10.1002/bdd.1932		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH3WH	WOS:000353961000001		
J	Orikiasa, T; Roy, P; Tokuyasu, K; Nakamura, N; Koide, S; Shiina, T				Orikiasa, Takahiro; Roy, Poritosh; Tokuyasu, Ken; Nakamura, Nobutaka; Koide, Shoji; Shiina, Takeo			Effect of bioethanol conversion efficiency and ratio of rice paddy area to flatland on energy consumption and CO2 emission of rice straw transport process in Japan	BIOSYSTEMS ENGINEERING			English	Article						Rice straw; Biomass transport; Ethanol conversion efficiency; Ratio of the rice paddy area to flatland; Energy consumption; CO2 emission	CACCO PROCESS; FUEL ETHANOL; PRETREATMENT; BIOMASS; CHALLENGES; TRENDS	In Japan, rice straw is recognised as the most promising biomass for bioethanol production based on the amount and availability. This study examined the energy consumption and the CO2 emissions of the rice straw transport process. Specifically, we investigated the effects of the ethanol conversion efficiency (epsilon) and the ratio of the rice paddy area to flatland (gamma) on the CO2 emission and energy consumption of the rice straw transport process. The energy consumption and the CO2 emissions (epsilon: 0.60-1.0; gamma: 0.050-0.20) were determined to be 0.17-0.37 MJ L-1 and 0.012-0.025 kg L-1, respectively. The predicting model for the energy consumption and the CO2 emissions of the rice straw transport process was constructed, and the energy consumption and the CO2 emissions were proportional to the ethanol conversion efficiency raised to the -1.5 power and gamma raised to the -0.5 power. These results showed that the lower gamma, the higher the energy consumption of the rice straw transport process. Furthermore, the energy consumption of the rice straw transport process increased at large-scale plants because of the higher value of average transportation distance. (C) 2015 IAgrE. Published by Elsevier Ltd. All rights reserved.	[Orikiasa, Takahiro; Koide, Shoji] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Roy, Poritosh] Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada; [Tokuyasu, Ken; Nakamura, Nobutaka; Shiina, Takeo] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Shiina, Takeo] Chiba Univ, Grad Sch Hort, Matsudo, Chiba 2718510, Japan	Orikiasa, T (reprint author), Iwate Univ, Fac Agr, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.	orikasa@iwate-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (Rural Biofuel Research Project) [310, 311]	The authors thank the careful reviews and constructive feedback by the anonymous reviewers. This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Rural Biofuel Research Project; 310, 311).	Park JY, 2010, BIORESOURCE TECHNOL, V101, P6805, DOI 10.1016/j.biortech.2010.03.098; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Cardona CA, 2007, BIORESOURCE TECHNOL, V98, P2415, DOI 10.1016/j.biortech.2007.01.002; Galbe M, 2007, ADV BIOCHEM ENG BIOT, V108, P41, DOI 10.1007/10_2007_070; Shiroma R, 2011, BIORESOURCE TECHNOL, V102, P2943, DOI 10.1016/j.biortech.2010.11.086; Goh CS, 2010, BIORESOURCE TECHNOL, V101, P4834, DOI 10.1016/j.biortech.2009.08.080; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Matsumura Y, 2005, BIOMASS BIOENERG, V29, P347, DOI 10.1016/j.biombioe.2004.06.015; Roy P, 2012, BIOMASS BIOENERG, V37, P188, DOI 10.1016/j.biombioe.2011.12.013; Asano K., 2007, J JAPAN I ENERGY, V86, P957; GSI (Geospatial Information Authority of Japan), 2013, AR MUN JAP; Huang HJ, 2009, BIOMASS BIOENERG, V33, P234, DOI 10.1016/j.biombioe.2008.05.007; Imou K., 2008, ETHANOL PRODUCTION B, P12; Kanai G., 2010, J SOC AGR STRUCTURES, V40, P249; Licht F. O, 2009, F O LICHTS WORLD ETH, V7, P365; MAFF (Ministry of Agriculture Forestry and Fisheries of Japan), 2007, CROP ACR EXP PROD RI; MOE (Ministry of Environment of Japan), 2003, GUID LIN CALC METH G; Ogino C., 2009, Japanese Journal of Grassland Science, V55, P270; Orikasa T., 2009, Journal of the Japanese Society of Agricultural Machinery, V71, P45; Orikasa T., 2015, ENG AGR ENV IN PRESS; Park JY, 2010, BIOSCI BIOTECH BIOCH, V74, P50, DOI 10.1271/bbb.90535; Saga K., 2008, J JPN SOC ENE RESO, V29, P8; Sanchez OJ, 2008, BIORESOURCE TECHNOL, V99, P5270, DOI 10.1016/j.biortech.2007.11.013; Ueda T., 2011, FEASIBILITY STUDY PR, V211, P131; Yanagida T, 2011, J JPN PETROL INST, V54, P215, DOI 10.1627/jpi.54.215	25	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1537-5110	1537-5129		BIOSYST ENG	Biosyst. Eng.	MAY	2015	133						95	101		10.1016/j.biosystemseng.2015.03.002		7	Agricultural Engineering; Agriculture, Multidisciplinary	Agriculture	CH0ZG	WOS:000353750300010		
J	Miyoshi, Y; Noguchi, K; Yanagisawa, M; Taguri, M; Morita, S; Ikeda, I; Fujinami, K; Miura, T; Kobayashi, K; Uemura, H				Miyoshi, Yasuhide; Noguchi, Kazumi; Yanagisawa, Masahiro; Taguri, Masataka; Morita, Satoshi; Ikeda, Ichiro; Fujinami, Kiyoshi; Miura, Takeshi; Kobayashi, Kazuki; Uemura, Hiroji			Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer	BMC CANCER			English	Article						Prostate cancer; Nomogram; Prognostic tool; Bone metastasis	CASTRATION; MEN; MITOXANTRONE; ABIRATERONE; PREDNISONE; DOCETAXEL; THERAPY	Background: We analyzed the relationship between prostate cancer outcomes and pretreatment clinical factors and developed a prognostic nomogram of overall survival (OS) of patients with bone metastasis. Methods: From 1993 to 2011, 463 consecutive patients were treated for bone-metastatic prostate cancer. Data sets from 361 patients were used to develop a nomogram (training data), and data sets of 102 patients were used for validation of the nomogram (validation data). Using the external validation data set, the nomogram was assessed for discriminatory ability, and the predictions were assessed for calibration accuracy by plotting actual survival against predicted risk. Results: Of the 361 patients in the training data set, 205 (56.8%) patients died, 169 (46.8%) deaths of which were due to prostate cancer. The median follow-up period was 55.2 months. In the multivariate analysis, patient age, serum prostate-specific antigen level, clinical T stage, extent of disease on bone scan, and biopsy Gleason sum were independent prognostic factors. We developed a prognostic model comprising these five factors for patients with bone-metastatic prostate cancer. This nomogram can be used to estimate 1-, 3-, and 5-year survival probability. External validation of this model using 102 validation data sets showed reasonable accuracy (concordance index, 0.719). Conclusion: Our pretreatment prognostic nomogram might be useful for Japanese patients with bone-metastatic prostate cancer.	[Miyoshi, Yasuhide; Noguchi, Kazumi; Fujinami, Kiyoshi] Yokohama City Univ, Med Ctr, Dept Urol, Yokohama, Kanagawa 232, Japan; [Yanagisawa, Masahiro; Uemura, Hiroji] Yokohama City Univ, Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan; [Taguri, Masataka; Morita, Satoshi] Yokohama City Univ, Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Ikeda, Ichiro] Yokohama Minami Kyosai Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Miura, Takeshi] Kanagawa Canc Ctr, Dept Urol, Yokohama, Kanagawa 2410815, Japan; [Kobayashi, Kazuki] Yokosuka Kyosai Hosp, Dept Urol, Yokosuka, Kanagawa, Japan	Miyoshi, Y (reprint author), Yokohama City Univ, Med Ctr, Dept Urol, Yokohama, Kanagawa 232, Japan.	miyoyasu@med.yokohama-cu.ac.jp			MEXT/JSPS KAKENHI Grant	This work was supported by a MEXT/JSPS KAKENHI Grant.	Sternberg CN, 2009, J CLIN ONCOL, V27, P5431, DOI 10.1200/JCO.2008.20.1228; Dalesio O, 2000, LANCET, V355, P1491; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Oh WK, 1998, J UROLOGY, V160, P1220, DOI 10.1016/S0022-5347(01)62501-1; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Huggins C, 1941, CANCER RES, V1, P293; Droz JP, 2010, BJU INT, V106, P462, DOI 10.1111/j.1464-410X.2010.09334.x; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Small EJ, 1997, J CLIN ONCOL, V15, P382; Armstrong AJ, 2007, CLIN CANCER RES, V13, P6396, DOI 10.1158/1078-0432.CCR-07-1036; Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021; Halabi S, 2003, J CLIN ONCOL, V21, P1232, DOI 10.1200/JCO.2003.06.100; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Dellis A, 2014, EXPERT REV PHARM OUT, V14, P175, DOI 10.1586/14737167.2014.891444; Tewari A, 2006, UROLOGY, V68, P1268, DOI 10.1016/j.urology.2006.08.1059; Armstrong AJ, 2010, CLIN CANCER RES, V16, P203, DOI 10.1158/1078-0432.CCR-09-2514; Cooperberg MR, 2009, J CLIN ONCOL, V27, P4306, DOI 10.1200/JCO.2008.21.5228; SOLOWAY MS, 1988, CANCER, V61, P195, DOI 10.1002/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y; Halabi S, 2009, J CLIN ONCOL, V27, P2766, DOI 10.1200/JCO.2008.18.9159; Matsuda A, 2013, JPN J CLIN ONCOL, V44, P388; Mikkola A, 2009, SCAND J UROL NEPHROL, V43, P265, DOI 10.1080/00365590902836500; Miyoshi Yasuhide, 2005, Int J Clin Oncol, V10, P182, DOI 10.1007/s10147-005-0490-0; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318	25	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2407			BMC CANCER	BMC Cancer	MAY 1	2015	15								338	10.1186/s12885-015-1330-x		7	Oncology	Oncology	CH4PY	WOS:000354016600001		
J	Furukawa, Y; Kish, SJ				Furukawa, Yoshiaki; Kish, Stephen J.			Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia	BRAIN			English	Letter							TYROSINE-HYDROXYLASE; BRAIN BIOPTERIN; I GENE; MUTATION; DISEASE; FAMILY; ONSET; PET		[Furukawa, Yoshiaki] Juntendo Tokyo Koto Geriatr Med Ctr, Dept Neurol, Tokyo 1360075, Japan; [Furukawa, Yoshiaki] Univ & Postgrad Univ Juntendo, Fac Med, Dept Neurol, Tokyo, Japan; [Kish, Stephen J.] Ctr Addict & Mental Hlth, Res Imaging Ctr, Human Brain Lab, Toronto, ON, Canada; [Kish, Stephen J.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Kish, Stephen J.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada	Furukawa, Y (reprint author), Juntendo Tokyo Koto Geriatr Med Ctr, Dept Neurol, Koto Ku, 3-3-20 Shinsuna, Tokyo 1360075, Japan.	furukawa@juntendo.gmc.ac.jp					Friedman J, 2012, ANN NEUROL, V71, P520, DOI 10.1002/ana.22685; Opladen T, 2012, J INHERIT METAB DIS, V35, P963, DOI 10.1007/s10545-012-9506-x; Lee WT, 2009, J INHERIT METAB DIS, V32, P361, DOI 10.1007/s10545-009-1106-z; Cilia R, 2014, NEUROLOGY, V83, P1155, DOI 10.1212/WNL.0000000000000821; De la Fuente-Fernandez R, 2003, SYNAPSE, V49, P20, DOI 10.1002/syn.10199; Furukawa Y, 1999, NEUROLOGY, V53, P1032; Furukawa Y, 1998, ANN NEUROL, V44, P10, DOI 10.1002/ana.410440107; Furukawa Y, 2002, ANN NEUROL, V51, P637, DOI 10.1002/ana.10175; Furukawa Y, 2013, MOVEMENT DISORDER EM, P319; Furukawa Y, 1998, NEUROLOGY, V51, P632; Kang JH, 2004, BRAIN DEV-JPN, V26, P287, DOI 10.1016/S0387-7604(03)00167-0; Mencacci NE, 2014, BRAIN, V137, P2480, DOI 10.1093/brain/awu179; NYGAARD TG, 1992, ANN NEUROL, V32, P603, DOI 10.1002/ana.410320502; O'Sullivan JD, 2001, NEUROLOGY, V56, P266; Tatsch K, 2002, EUR J NUCL MED MOL I, V29, P711, DOI 10.1007/s00259-002-0814-5	15	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAY 1	2015	138		5				E351	U18		10.1093/brain/awu325		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH2DB	WOS:000353834100006		
J	Niino, M; Miyazaki, Y				Niino, Masaaki; Miyazaki, Yusei			Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis	CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Review						genetics; cytokine; risk factor; vitamin D receptor; therapy	D-RECEPTOR GENE; PLACEBO-CONTROLLED TRIAL; GENOME-WIDE ASSOCIATION; D-BINDING PROTEIN; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D; RELAPSE RISK; DOUBLE-BLIND; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; SERUM 25-HYDROXYVITAMIN-D	Vitamin D receptors (VDRs), which are responsible for most vitamin D functions, are expressed on various immune cells. Vitamin D is considered to be a potent immunomodulator. A variety of cells in the central nervous system (CNS) also express VDRs; thus, vitamin D may play a role in the regulation of neurodegeneration and repair processes within the CNS. Considered together with epidemiological studies, low vitamin D status is reckoned to be one of the risk factors for multiple sclerosis (MS). Further, vitamin D is considered to be a possible treatment for MS. However, previous clinical trials with small cohorts have not demonstrated significant effects of vitamin D in MS. Current ongoing clinical trials with large cohorts could provide answers with respect to the clinical effects of vitamin D in MS. However, genetic studies have suggested that genes associated with vitamin D, including VDRs, are susceptible genes for MS. Vitamin D needs to be considered from the perspective of the interaction between vitamin-D-related genetic factors and environmental factors affecting vitamin D levels.	[Niino, Masaaki; Miyazaki, Yusei] Hokkaido Med Ctr, Dept Clin Res, Sapporo, Hokkaido, Japan; [Miyazaki, Yusei] Hokkaido Med Ctr, Dept Neurol, Sapporo, Hokkaido, Japan	Niino, M (reprint author), Hokkaido Med Ctr, Dept Clin Res, Sapporo, Hokkaido, Japan.	niino@hok-mc.hosp.go.jp					Allen AC, 2012, MULT SCLER J, V18, P1797, DOI 10.1177/1352458512442992; Alzahrani AS, 2010, J CLIN ENDOCR METAB, V95, P4176, DOI 10.1210/jc.2009-2278; Kampman MT, 2012, MULT SCLER J, V18, P1144, DOI 10.1177/1352458511434607; Huang J, 2012, J NEUROL SCI, V313, P79, DOI 10.1016/j.jns.2011.09.024; Smolders J, 2009, ANN NY ACAD SCI, V1173, P515, DOI 10.1111/j.1749-6632.2009.04656.x; Kimball S, 2011, J CLIN ENDOCR METAB, V96, P2826, DOI 10.1210/jc.2011-0325; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Dickinson JL, 2009, MULT SCLER, V15, P563, DOI 10.1177/1352458509102459; Stewart N, 2012, NEUROLOGY, V79, P254, DOI 10.1212/WNL.0b013e31825fded9; Liu PT, 2007, J IMMUNOL, V179, P2060; Smolders J, 2009, J NEUROIMMUNOL, V207, P117, DOI 10.1016/j.jneuroim.2008.12.011; Loken-Amsrud KI, 2012, NEUROLOGY, V79, P267, DOI 10.1212/WNL.0b013e31825fdf01; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; Runia TF, 2012, NEUROLOGY, V79, P261, DOI 10.1212/WNL.0b013e31825fdec7; Wingerchuk DM, 2005, J NEUROL NEUROSUR PS, V76, P1294, DOI 10.1136/jnnp.2004.056499; Mowry EM, 2012, ANN NEUROL, V72, P234, DOI 10.1002/ana.23591; Simon KC, 2010, MULT SCLER, V16, P133, DOI 10.1177/1352458509355069; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Agliardi C, 2011, BRAIN BEHAV IMMUN, V25, P1460, DOI 10.1016/j.bbi.2011.05.015; Gelfand JM, 2011, NEUROLOGY, V76, P1824, DOI 10.1212/WNL.0b013e31821cccf5; Griffin MD, 2000, BIOCHEM BIOPH RES CO, V270, P701, DOI 10.1006/bbrc.2000.2490; Munger KL, 2011, MULT SCLER J, V17, P1405, DOI 10.1177/1352458511425366; Shinpo K, 2000, J NEUROSCI RES, V62, P374, DOI 10.1002/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7; Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Soilu-Hanninen M, 2008, J NEUROL NEUROSUR PS, V79, P152, DOI 10.1136/jnnp.2006.105320; Piemonti L, 2000, J IMMUNOL, V164, P4443; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; Alloza I, 2012, GENES IMMUN, V13, P253, DOI 10.1038/gene.2011.81; Salzer J, 2012, NEUROLOGY, V79, P2140, DOI 10.1212/WNL.0b013e3182752ea8; Smolders J, 2011, J NEUROL SCI, V311, P37, DOI 10.1016/j.jns.2011.07.033; Tajouri L, 2005, J NEUROGENET, V19, P25, DOI 10.1080/01677060590949692; Mosayebi G, 2011, IMMUNOL INVEST, V40, P627, DOI 10.3109/08820139.2011.573041; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Gorman S, 2007, J IMMUNOL, V179, P6273; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Boonstra A, 2001, J IMMUNOL, V167, P4974; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Fukazawa T, 1999, J NEUROL SCI, V166, P47, DOI 10.1016/S0022-510X(99)00112-4; Simon KC, 2011, J NEUROL, V258, P1676, DOI 10.1007/s00415-011-6001-5; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; Chen S, 2007, J IMMUNOL, V179, P1634; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; James E, 2013, MULT SCLER J, V19, P1571, DOI 10.1177/1352458513489756; Stein MS, 2011, NEUROLOGY, V77, P1611, DOI 10.1212/WNL.0b013e3182343274; Mowry EM, 2010, ANN NEUROL, V67, P618, DOI 10.1002/ana.21972; Orton SM, 2008, AM J CLIN NUTR, V88, P441; Penna G, 2000, J IMMUNOL, V164, P2405; Hewer S, 2013, J CLIN NEUROSCI, V20, P634, DOI 10.1016/j.jocn.2012.10.005; Steffensen LH, 2011, J NEUROL, V258, P1624, DOI 10.1007/s00415-011-5980-6; Irizar H, 2012, MULT SCLER J, V18, P569, DOI 10.1177/1352458511426813; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Amezcua L, 2012, J NEUROL, V259, P2565, DOI 10.1007/s00415-012-6537-z; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Taniura H, 2006, J NEUROSCI RES, V83, P1179, DOI 10.1002/jnr.20824; The Australia and New Zealand Multiple Sclerosis Genetics Consortium, 2009, Nature Genetics, V41, P824, DOI 10.1038/ng.396; Colin EM, 2000, CLIN ENDOCRINOL, V52, P211, DOI 10.1046/j.1365-2265.2000.00909.x; Cox MB, 2012, MULT SCLER J, V18, P16, DOI 10.1177/1352458511415562; Disanto G, 2011, J NEUROL, V258, P353, DOI 10.1007/s00415-010-5797-8; Handel AE, 2012, MULT SCLER J, V18, P2, DOI 10.1177/1352458511418353; Handunnetthi L, 2010, NEUROLOGY, V74, P1905, DOI 10.1212/WNL.0b013e3181e24124; Kim CJ, 2007, J CLIN ENDOCR METAB, V92, P3177, DOI 10.1210/jc.2006-2664; Kimball SM, 2007, AM J CLIN NUTR, V86, P645; Mamutse G, 2008, MULT SCLER J, V14, P1280, DOI 10.1177/1352458508094643; Meehan TF, 2002, ARCH BIOCHEM BIOPHYS, V408, P200, DOI 10.1016/S0003-9861(02)00580-5; NEVEU I, 1994, MOL BRAIN RES, V24, P70, DOI 10.1016/0169-328X(94)90119-8; Niino M, 2010, DRUG TODAY, V46, P279, DOI 10.1358/dot.2010.46.4.1476498; Niino Masaaki, 2007, Expert Rev Neurother, V7, P1175, DOI 10.1586/14737175.7.9.1175; Niino M, 2002, J NEUROIMMUNOL, V127, P177, DOI 10.1016/S0165-5728(02)00099-1; Niino M., 2013, CLIN EXP NEUROIMMUNO, V4, P193, DOI DOI 10.1111/CEN3.12031; Niino M, 2000, J NEUROL SCI, V177, P65, DOI 10.1016/S0022-510X(00)00336-1; Orton SM, 2011, J NEUROL SCI, V305, P116, DOI 10.1016/j.jns.2011.02.032; Pandit L, 2013, MULT SCLER J, V19, P1592, DOI 10.1177/1352458513482375; Partridge JM, 2004, NEUROLOGY, V62, P2323; Ramagopalan SV, 2011, ANN NEUROL, V70, P881, DOI 10.1002/ana.22678; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Shaygannejad Vahid, 2010, Int J Prev Med, V1, P195; Shaygannejad V, 2012, MULT SCLER INT, V2012, DOI DOI 10.1155/2012/452541; Sioka Chrissa, 2011, J Negat Results Biomed, V10, P3, DOI 10.1186/1477-5751-10-3; Smolders J, 2011, J NEUROL SCI, V311, P44, DOI 10.1016/j.jns.2011.04.013; Smolders J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015235; Soilu-Hanninen M, 2012, J NEUROL NEUROSUR PS, V83, P566, DOI 10.1136/jnnp-2011-301876; Steckley JL, 2000, NEUROLOGY, V54, P729; Sundqvist E, 2010, EUR J HUM GENET, V18, P1349, DOI 10.1038/ejhg.2010.113; Weinstock-Guttman B, 2011, J NEUROL NEUROSUR PS, V82, P189, DOI 10.1136/jnnp.2010.227942	85	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4212	1205-7541		CAN J PHYSIOL PHARM	Can. J. Physiol. Pharmacol.	MAY	2015	93	5	1				319	325		10.1139/cjpp-2014-0374		7	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CH1KW	WOS:000353781300003		
J	Hagino, H				Hagino, Hiroshi			Vitamin D-3 analogs for the treatment of osteoporosis	CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Review						eldecalcitol; 2MD; vitamin D receptor ligand; vitamin-D-binding protein; mini-modeling	BONE-MINERAL DENSITY; OVARIECTOMIZED RATS; BIOLOGICAL EVALUATION; POSTMENOPAUSAL WOMEN; TRABECULAR BONE; DOUBLE-BLIND; D-RECEPTOR; D-3 ED-71; IN-VIVO; ELDECALCITOL	Vitamin D supplementation is recommended whenever patients are given therapeutic drugs for osteoporosis, to make their calcium (Ca) balance positive. Vitamin D is converted to 25-hydroxyvitamin D in the liver, and then activated to become 1 alpha,25-dihydroxyvitamin D in the kidneys. The active vitamin D acts in the intestine to stimulate Ca absorption and maintain the Ca balance. 2 beta-(3-Hydroxypropyloxy)-1 alpha,25-dihydroxyvitamin D-3 (eldecalcitol) and 2-methylene-19-nor-(20S)-1 alpha,25-dihydroxyvitamin D-3 (2MD) are newly developed vitamin D analogs, with a substitution at the 2 position of 1 alpha,25-dihydroxyvitamin D-3 (calcitriol). Eldecalcitol and 2MD share common structural and biological characteristics. Both compounds increase serum Ca levels more markedly than calcitriol, increase bone mineral density (BMD), and improve bone strength in ovariectomized (OVX) rats. In a randomized, placebo-controlled, double-blind, 1 year clinical trial, eldecalcitol dose-dependently increased lumbar and hip BMD and suppressed bone turnover markers in patients with osteoporosis. Whereas, 2MD markedly increased the bone turnover markers, but it did not change the BMD of postmenopausal women with osteopenia in a 1 year clinical trial. After a randomized, double-blind, 3 year fracture-prevention trial comparing it with alfacalcidol, eldecalcitol was approved for the treatment of osteoporosis in Japan. On the other hand, the manufacturer discontinued the clinical development of 2MD. In this review, we discuss the similarities and differences between these 2 compounds, and the reasons why different outcomes resulted from their clinical trials.	[Hagino, Hiroshi] Tottori Univ, Fac Med, Sch Hlth Sci, Tottori 680, Japan; [Hagino, Hiroshi] Tottori Univ, Fac Med, Rehabil Div, Tottori 680, Japan	Hagino, H (reprint author), Tottori Univ, Fac Med, Sch Hlth Sci, Tottori 680, Japan.	hagino@med.tottori-u.ac.jp			Asahi Kasei Pharma Corporation; Astellas Pharma Incorporated; Banyu Pharmaceutical Company, Ltd.; Chugai Pharmaceutical Company, Ltd.; Eisai Company, Ltd.; Eli Lilly Japan; Mitsubishi Tanabe Pharma Corporation; Ono Pharmaceutical Company, Ltd.; Pfizer Incorporated; Takeda Pharmaceutical Company, Ltd.; Teijin Pharma Ltd.	Conflict of Interest: H.H. has received consulting fees from the Asahi Kasei Pharma Corporation, Astellas Pharma Incorporated, the Banyu Pharmaceutical Company, Ltd., the Chugai Pharmaceutical Company, Ltd., the Eisai Company, Ltd., Eli Lilly Japan K.K., the Mitsubishi Tanabe Pharma Corporation, the Ono Pharmaceutical Company, Ltd., Pfizer Incorporated, the Takeda Pharmaceutical Company, Ltd., and Teijin Pharma Ltd.	Abe M., 2011, JPN PHARMACOL THER, V39, P261; de Freitas PHL, 2011, BONE, V49, P335, DOI 10.1016/j.bone.2011.05.022; OKANO T, 1989, BIOCHEM BIOPH RES CO, V163, P1444, DOI 10.1016/0006-291X(89)91140-6; Matsumoto T, 2007, J STEROID BIOCHEM, V103, P584, DOI 10.1016/j.jsbmb.2006.12.088; Sicinski RR, 1998, J MED CHEM, V41, P4662, DOI 10.1021/jm9802618; MIYAMOTO K, 1993, CHEM PHARM BULL, V41, P1111; Matsumoto T, 2005, J CLIN ENDOCR METAB, V90, P5031, DOI 10.1210/jc.2004-2552; Hatakeyama S, 2007, J STEROID BIOCHEM, V103, P222, DOI 10.1016/j.jsbmb.2006.12.025; Sakai S, 2009, J BONE MINER METAB, V27, P643, DOI 10.1007/s00774-009-0084-4; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Yamamoto Y, 2013, ENDOCRINOLOGY, V154, P1008, DOI 10.1210/en.2012-1542; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Choi M, 2009, EXPERT OPIN THER PAT, V19, P593, DOI 10.1517/13543770902877717; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Kikuta J, 2013, P NATL ACAD SCI USA, V110, P7009, DOI [10.1073/pnas.1218799110, 10.1073/1218799110]; Barycki R, 2009, BIOORGAN MED CHEM, V17, P7658, DOI 10.1016/j.bmc.2009.09.047; DeLuca HF, 2011, J BONE MINER RES, V26, P538, DOI 10.1002/jbmr.256; Erben RG, 2002, J BONE MINER RES, V17, P1498, DOI 10.1359/jbmr.2002.17.8.1498; Furuichi Tatsuya, 1998, Life Sciences, V62, P453; Harada S, 2010, J STEROID BIOCHEM, V121, P281, DOI 10.1016/j.jsbmb.2010.04.001; Ke HZ, 2005, J BONE MINER RES, V20, P1742, DOI 10.1359/JBMR.050605; Matsumoto T, 2010, J STEROID BIOCHEM, V121, P261, DOI 10.1016/j.jsbmb.2010.03.035; NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy, 2001, JAMA-J AM MED ASSOC, V285, P785, DOI [10.1001/jama.285.6.785, DOI 10.1001/JAMA.285.6.785]; Ritter CS, 2011, J CELL BIOCHEM, V112, P1348, DOI 10.1002/jcb.23051; Saito H, 2014, J STEROID BIOCHEM, V144, P189, DOI 10.1016/j.jsbmb.2013.11.013; Papadimitropoulos E, 2002, ENDOCR REV, V23, P560, DOI 10.1210/er.2001-8002; TSURUKAMI H, 1994, CALCIFIED TISSUE INT, V54, P142, DOI 10.1007/BF00296065; Uchiyama Y, 2002, BONE, V30, P582, DOI 10.1016/S8756-3282(02)00682-8; Ueno Y, 2003, J CELL BIOCHEM, V90, P267, DOI 10.1002/jcb.10623; Vanhooke JL, 2007, ARCH BIOCHEM BIOPHYS, V460, P161, DOI 10.1016/j.abb.2006.11.029; Zella JB, 2014, AM J NEPHROL, V39, P476, DOI 10.1159/000362846	33	2	2	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4212	1205-7541		CAN J PHYSIOL PHARM	Can. J. Physiol. Pharmacol.	MAY	2015	93	5	1				327	332		10.1139/cjpp-2014-0419		6	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CH1KW	WOS:000353781300004		
J	Matsumoto, Y; Kittaka, A; Chen, TC				Matsumoto, Yotaro; Kittaka, Atsushi; Chen, Tai C.			19-Norvitamin D analogs for breast cancer therapy	CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Review						1 alpha,25-dihydroxyvitamin D-3; vitamin D receptor; MART-10; synthesis; CYP24A1	VITAMIN-D-RECEPTOR; CELLS IN-VITRO; 1-ALPHA,25-DIHYDROXY-19-NORVITAMIN D-3 COMPOUNDS; HORMONE 1-ALPHA,25-DIHYDROXYVITAMIN D-3; ENHANCED CHEMOTHERAPEUTIC POTENCY; EPIDERMAL-GROWTH-FACTOR; DIFFERENT SIDE-CHAINS; A-RING CONFORMATION; PROSTATE-CANCER; BIOLOGICAL EVALUATION	The active form of vitamin D-3, 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25(OH)(2)D-3 or calcitriol), is known to inhibit the proliferation and invasiveness of many types of cancer cells, including breast, colon, pancreatic, prostate, and liver cancer cells. These findings support the use of 1 alpha,25(OH)(2)D-3 for the treatment of these types of cancer. However, 1 alpha,25(OH)(2)D-3 can cause hypercalcemia, so analogs of 1 alpha,25(OH)(2)D-3 that are less calcemic but exhibit more potent anti-tumor activity would be good candidates as therapeutic agents. Therefore, a series of 19-norvitamin D analogs, in which the methylidene group on C19 is replaced with 2 hydrogen atoms, have been synthesized by several laboratories. In our laboratory, we have designed and synthesized a series of 2 alpha-functional group substituted 19-norvitamin D-3 analogs and examined their anti-proliferative activity. Among them, 2 alpha- and 2 alpha-(3-hydroxypropyl)-1 alpha,25-dihydroxy-19-norvitamin D-3 (MART-10 and MART-11) were found to be the most promising. Here, we review the rationale and approaches for the synthesis of different 19-norvitamin D analogs, and the pre-clinical studies using these analogs in breast cancer cells, in particular, we chose MART-10 for its potential application to the prevention and treatment of breast cancer.	[Matsumoto, Yotaro; Kittaka, Atsushi] Teikyo Univ, Fac Pharmaceut Sci, Itabashi Ku, Tokyo 1738605, Japan; [Chen, Tai C.] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA	Kittaka, A (reprint author), Teikyo Univ, Fac Pharmaceut Sci, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	akittaka@pharm.teikyo-u.ac.jp; taichen@bu.edu			MEXT KAKENHI [24790004]; JSPS KAKENHI [24590021]; CREST, JST; Clinical Translational Science Award (CTSA) from US National Institutes of Health [UL1-TR000157]	The authors thank MEXT KAKENHI (grant number 24790004 to Y.M.), JSPS KAKENHI (grant number 24590021 to A.K.), CREST, JST, and Clinical Translational Science Award (CTSA) from the US National Institutes of Health (grant UL1-TR000157) for partial support in the preparation of this manuscript.	Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Getzenberg RH, 1997, UROLOGY, V50, P999, DOI 10.1016/S0090-4295(97)00408-1; Verlinden L, 2000, CANCER RES, V60, P2673; Bao BY, 2006, CARCINOGENESIS, V27, P1883, DOI 10.1093/carcin/bgl041; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Chung I, 2006, CANCER RES, V66, P8565, DOI 10.1158/0008-5472.CAN-06-0905; Rygiel AM, 2008, CANCER EPIDEM BIOMAR, V17, P1380, DOI 10.1158/1055-9965.EPI-07-2734; Chiang KC, 2011, STEROIDS, V76, P1513, DOI 10.1016/j.steroids.2011.08.006; COLSTON K, 1981, ENDOCRINOLOGY, V108, P1083; Shimizu M, 2008, BIOORGAN MED CHEM, V16, P6949, DOI 10.1016/j.bmc.2008.05.043; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; El Abdaimi K, 2000, CANCER RES, V60, P4412; Pendas-Franco N, 2007, DIFFERENTIATION, V75, P193, DOI 10.1111/j.1432-0436.2006.00131.x; Kittaka A, 2012, FUTURE MED CHEM, V4, P2049, DOI [10.4155/fmc.12.130, 10.4155/FMC.12.130]; Shinkyo R, 2004, BIOCHEM BIOPH RES CO, V324, P451, DOI 10.1016/j.bbrc.2004.09.073; Komagata S, 2009, MOL PHARMACOL, V76, P702, DOI 10.1124/mol.109.056986; CHEN TC, 1989, IN VITRO CELL DEV B, V25, P714; Lopes N, 2012, ANTICANCER RES, V32, P249; Sicinski RR, 1998, J MED CHEM, V41, P4662, DOI 10.1021/jm9802618; Chiang KC, 2014, J STEROID BIOCHEM, V139, P54, DOI 10.1016/j.jsbmb.2013.10.005; Flanagan JN, 2009, ANTICANCER RES, V29, P3547; CHEN KS, 1993, P NATL ACAD SCI USA, V90, P4543, DOI 10.1073/pnas.90.10.4543; Sakaki T, 2014, ANTI-CANCER AGENT ME, V14, P97, DOI 10.2174/18715206113139990307; Ellfolk M, 2009, MOL PHARMACOL, V75, P1392, DOI 10.1124/mol.108.053660; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Chiang KC, 2013, CELL CYCLE, V12, P1316, DOI 10.4161/cc.24445; James SY, 1996, J STEROID BIOCHEM, V58, P395, DOI 10.1016/0960-0760(96)00048-9; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Jiang F, 2004, J BIOL CHEM, V279, P53213, DOI 10.1074/jbc.M410395200; Liu G, 2002, CLIN CANCER RES, V8, P2820; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hobaus J, 2013, ANTI-CANCER AGENT ME, V13, P20; Nakagawa K, 2005, CARCINOGENESIS, V26, P1044, DOI 10.1093/carcin/bgi049; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449; Chiang KC, 2013, J STEROID BIOCHEM, V138, P427, DOI 10.1016/j.jsbmb.2013.09.002; McCollum EV, 1922, J BIOL CHEM, V53, P293; Flanagan JN, 2006, ANTICANCER RES, V26, P2567; Chiang KC, 2013, ANTI-CANCER AGENT ME, V13, P126; Liu G, 2003, CLIN CANCER RES, V9, P4077; FRASER DR, 1970, NATURE, V228, P764, DOI 10.1038/228764a0; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rahman MT, 2012, CANCER-AM CANCER SOC, V118, P2846, DOI 10.1002/cncr.26598; Iglesias-Gato D, 2011, J STEROID BIOCHEM, V127, P269, DOI 10.1016/j.jsbmb.2011.08.010; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Friedrich M, 2003, RECENT RES CANCER, V164, P239; Cordero JB, 2002, J BIOL CHEM, V277, P38965, DOI 10.1074/jbc.M203736200; Sicinski RR, 2007, J MED CHEM, V50, P6154, DOI 10.1021/jm070635; STUMPF WE, 1979, SCIENCE, V206, P1188, DOI 10.1126/science.505004; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016; Hidaka S, 2000, CLIN CANCER RES, V6, P2712; Luo W, 2010, CANCER RES, V70, P5953, DOI 10.1158/0008-5472.CAN-10-0617; Schwartz GG, 2005, CLIN CANCER RES, V11, P8680, DOI 10.1158/1078-0432.CCR-05-1237; ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; PERLMAN KL, 1990, TETRAHEDRON LETT, V31, P1823, DOI 10.1016/S0040-4039(00)98795-1; Chen TC, 2000, CLIN CANCER RES, V6, P901; HANSEN CM, 1994, CLIN EXP METASTAS, V12, P195, DOI 10.1007/BF01753887; Chiang KC, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/310872; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Meijer GA, 1998, J CLIN PATHOL, V51, P901; Ono K, 2003, J ORG CHEM, V68, P7407, DOI 10.1021/jo034787y; Blutt SE, 2000, ENDOCRINOLOGY, V141, P10, DOI 10.1210/en.141.1.10; Bouillon R., 2000, US patent, Patent No. 6017907; Bouillon R., 1993, patent, Patent No. [PCT/ EP 93202037, 93202037]; Brosseau C, 2012, APOPTOSIS, V17, P164, DOI 10.1007/s10495-011-0670-5; BROWN A, 2008, LANDSCOPE, V23, P29; BURMESTER JK, 1988, P NATL ACAD SCI USA, V85, P1005, DOI 10.1073/pnas.85.4.1005; Carlberg C, 1998, CRIT REV EUKAR GENE, V8, P19; Chen T. C., 2011, ISRN UROL, V2011, DOI 10.5402/2011/301490; Chen TC, 2003, J CELL BIOCHEM, V88, P315, DOI 10.1002/jcb.10342; Chen TC, 2007, J STEROID BIOCHEM, V103, P717, DOI 10.1016/j.jsbmb.2006.12.009; Chen TC, 2012, ANTICANCER RES, V32, P291; Courtney LF, 1998, TETRAHEDRON LETT, V39, P3363, DOI 10.1016/S0040-4039(98)00682-0; Dalhoff K, 2003, BRIT J CANCER, V89, P252, DOI 10.1038/sj.bjc.6601104; Deeb KK, 2011, EPIGENETICS-US, V6, P994, DOI 10.4161/epi.6.8.16536; DELUCA HF, 1973, NEW ENGL J MED, V289, P359; Eelen G, 2005, MOL PHARMACOL, V67, P1566, DOI 10.1124/mol.104.008730; Flores A, 2012, J MED CHEM, V55, P4352, DOI 10.1021/jm300187x; Garay E, 2007, BIOORGAN MED CHEM, V15, P4444, DOI 10.1016/j.bmc.2007.04.034; Glebocka A, 2006, J MED CHEM, V49, P2909, DOI 10.1021/jm051082a; Glebocka A, 2009, J MED CHEM, V52, P3496, DOI 10.1021/jm9001583; Hanazawa T, 2001, ORG LETT, V3, P3975, DOI 10.1021/ol016908r; Hilpert H, 2001, TETRAHEDRON, V57, P681, DOI 10.1016/S0040-4020(00)01035-8; Howarth DL, 2008, ENDOCRINOLOGY, V149, P2411, DOI 10.1210/en.2007-1256; HUANG PQ, 1995, TETRAHEDRON LETT, V36, P8299, DOI 10.1016/0040-4039(95)01730-6; Mozolowski W, 1939, NATURE, V143, P121, DOI 10.1038/143121a0; Jones G., 2011, VITAMIN D, V3rd, P23; Kahraman M, 2004, J MED CHEM, V47, P6854, DOI 10.1021/jm040129; KAMEI Y, 1995, GENE, V152, P281, DOI 10.1016/0378-1119(94)00735-B; Karlgren Maria, 2005, Toxicol Appl Pharmacol, V207, P57, DOI 10.1016/j.taap.2004.12.022; Kawata H, 2006, J CELL PHYSIOL, V207, P793, DOI 10.1002/jcp.20618; Kittaka A, 2009, ANTICANCER RES, V29, P3563; KOLI K, 1995, CANCER RES, V55, P1540; Li YC, 1997, ENDOCRINOLOGY, V138, P2347, DOI 10.1210/en.138.6.2347; Luo WJ, 2009, CANCER INVEST, V27, P29, DOI 10.1080/07357900802438569; Maehr H, 2004, J MED CHEM, V47, P6476, DOI 10.1021/jm0496340b; Mathiasen IS, 1999, CANCER RES, V59, P4848; MCDONNELL DP, 1987, SCIENCE, V235, P1214, DOI 10.1126/science.3029866; Mellanby E, 1919, LANCET, V1, P407; Mikami K, 1998, TETRAHEDRON LETT, V39, P3359, DOI 10.1016/S0040-4039(98)00272-X; Nagai Y., 2014, J ORG CHEM, V3, P994, DOI [10. 1002/ ajoc. 201402109, DOI 10.1002/AJOC.201402109]; Ohyama Y, 2004, FRONT BIOSCI, V9, P3007, DOI 10.2741/1455; OHYAMA Y, 1991, FEBS LETT, V278, P195, DOI 10.1016/0014-5793(91)80115-J; PAAREN HE, 1980, J ORG CHEM, V45, P3253, DOI 10.1021/jo01304a022; PERLMAN KL, 1991, TETRAHEDRON LETT, V32, P7663, DOI 10.1016/0040-4039(91)80559-O; Posner GH, 2004, J STEROID BIOCHEM, V89-90, P5, DOI 10.1016/j.jsbmb.2004.03.044; Resendes AR, 2004, J GEN VIROL, V85, P2837, DOI 10.1099/vir.0.80221-0; Sakaki T, 1999, EUR J BIOCHEM, V262, P43, DOI 10.1046/j.1432-1327.1999.00375.x; Sanchez-Abella L, 2009, J MED CHEM, V52, P6158, DOI 10.1021/jm900711d; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; SHEVES M, 1975, J AM CHEM SOC, V97, P6249, DOI 10.1021/ja00854a053; Shimizu M, 2003, BIOORG MED CHEM LETT, V13, P809, DOI 10.1016/S0960-894X(03)00005-2; Shimizu M, 2005, BIOORG MED CHEM LETT, V15, P1451, DOI 10.1016/j.bmcl.2004.12.090; Sicinski RR, 2002, J MED CHEM, V45, P3366, DOI 10.1021/jm020007m; SICINSKI RR, 1994, J MED CHEM, V37, P3730, DOI 10.1021/jm00048a009; Sikervar V, 2012, CHEM COMMUN, V48, P9077, DOI 10.1039/c2cc33054g; SimboliCampbell M, 1996, J STEROID BIOCHEM, V58, P367, DOI 10.1016/0960-0760(96)00055-6; Suhara Y, 2001, J ORG CHEM, V66, P8760, DOI 10.1021/jo010375i; Sundaram S, 2006, MOL CANCER THER, V5, P2806, DOI 10.1158/1535-7163.MCT-06-0092; Takaku H, 2008, BIOORGAN MED CHEM, V16, P1796, DOI 10.1016/j.bmc.2007.11.013; Toyoda A, 2009, TETRAHEDRON, V65, P10002, DOI 10.1016/j.tet.2009.09.115; Urushino N, 2007, DRUG METAB DISPOS, V35, P1482, DOI 10.1124/dmd.107.015602; Wang L, 2008, ANTICANCER RES, V28, P2009; Wang LL, 2004, J STEROID BIOCHEM, V89-90, P127, DOI 10.1016/j.jsbmb.2004.03.091; Whitfield GK, 2003, ENDOCRINOLOGY, V144, P2704, DOI 10.1210/en.2002-221101; Windaus A, 1936, LIEBIGS ANN CHEM, V521, P160; Windaus A., 1936, Z PHYSL CHEM, V241, P100, DOI 10.1515/bchm2.1936.241.1-3.100; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Wu YH, 1999, BIOCHEMISTRY-US, V38, P2654, DOI 10.1021/bi981944s; Xie SP, 1999, EUR J CANCER, V35, P1717, DOI 10.1016/S0959-8049(99)00200-2; Yoshida A, 2003, SYNLETT, P1175; Young MV, 2004, CARCINOGENESIS, V25, P967, DOI 10.1093/carcin/bgh082; Zhou SZ, 1996, TETRAHEDRON LETT, V37, P7637, DOI 10.1016/0040-4039(96)01700-5	138	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4212	1205-7541		CAN J PHYSIOL PHARM	Can. J. Physiol. Pharmacol.	MAY	2015	93	5	1				333	348		10.1139/cjpp-2014-0452		16	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CH1KW	WOS:000353781300005		
J	Sakao, K; Vyas, AR; Chinni, SR; Amjad, AI; Parikh, R; Singh, SV				Sakao, Kozue; Vyas, Avani R.; Chinni, Sreenivasa R.; Amjad, Ali I.; Parikh, Rahul; Singh, Shivendra V.			CXCR4 Is a Novel Target of Cancer Chemopreventative Isothiocyanates in Prostate Cancer Cells	CANCER PREVENTION RESEARCH			English	Article							CHEMOKINE RECEPTOR CXCR4; NF-KAPPA-B; PHENETHYL ISOTHIOCYANATE; BENZYL ISOTHIOCYANATE; IN-VIVO; DIETARY ISOTHIOCYANATES; CRUCIFEROUS VEGETABLES; ANDROGEN RECEPTOR; INDUCED APOPTOSIS; GENE-EXPRESSION	Isothiocyanates (ITCs) derived from cruciferous vegetables, including phenethyl isothiocyanate (PEITC) and sulforaphane (SFN), exhibit in vivo activity against prostate cancer in a xenograft and transgenic mouse model, and thus are appealing for chemoprevention of this disease. Watercress constituent PEITC and SFN-rich broccoli sprout extract are under clinical investigations but the molecular mechanisms underlying their cancer chemopreventive effects are not fully understood. The present study demonstrates that chemokine receptor CXCR4 is a novel target of ITCs in prostate cancer cells. Exposure of prostate cancer cells (LNCaP, 22Rv1, C4-2, and PC-3) to pharmacologically applicable concentrations of PEITC, benzyl isothiocyanate (BITC), and SFN (2.5 and 5 mu mol/L) resulted in downregulation of CXCR4 expression. None of the ITCs affected secretion of CXCR4 ligand (stromal-derived factor-1). In vivo inhibition of PC-3 xenograft growth upon PEITC treatment was associated with a significant decrease in CXCR4 protein level. A similar trend was discernible in the tumors from SFN-treated TRAMP mice compared with those of control mice, but the difference was not significant. Stable overexpression of CXCR4 in PC-3 cells conferred significant protection against wound healing, cell migration, and cell viability inhibition by ITCs. Inhibition of cell migration resulting from PEITC and BITC exposure was significantly augmented by RNAi of CXCR4. This study demonstrates, for the first time, that cancer chemopreventive ITCs suppress CXCR4 expression in prostate cancer cells in vitro as well as in vivo. These results suggest that CXCR4 downregulation may be an important pharmacodynamic biomarker of cancer chemopreventative ITCs in prostate adenocarcinoma. (C) 2015 AACR.	[Sakao, Kozue] Kagoshima Univ, Dept Biochem Sci & Technol, Kagoshima 890, Japan; [Vyas, Avani R.; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Vyas, Avani R.; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA; [Chinni, Sreenivasa R.] Wayne State Univ, Sch Med, Dept Urol, Detroit, MI USA; [Chinni, Sreenivasa R.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Chinni, Sreenivasa R.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Amjad, Ali I.; Parikh, Rahul] Univ Pittsburgh, Dept Med, Sch Med, Div Hematol & Oncol, Pittsburgh, PA 15213 USA; [Amjad, Ali I.; Parikh, Rahul] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA	Singh, SV (reprint author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr Res Pavil 2 32A, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	singhs@upmc.edu			National Cancer Institute [RO1 CA101753-11, CA115498-09]; National Cancer Institute at the NIH [P30 CA047904]	This work was supported by the grant RO1 CA101753-11 and CA115498-09 awarded by the National Cancer Institute (to S.V. Singh). This research used the Animal Facility supported in part by a grant from the National Cancer Institute at the NIH (P30 CA047904).	Keum YS, 2009, PHARM RES-DORD, V26, P2324, DOI 10.1007/s11095-009-9948-5; Powolny AA, 2011, JNCI-J NATL CANCER I, V103, P571, DOI 10.1093/jnci/djr029; van Poppel G, 1999, ADV EXP MED BIOL, V472, P159; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Wang LG, 2006, CARCINOGENESIS, V27, P2124, DOI 10.1093/carcin/bgl075; Kolonel LN, 2000, CANCER EPIDEM BIOMAR, V9, P795; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Shen PF, 2014, PROSTATE, V74, P756, DOI 10.1002/pros.22795; Singh SV, 2012, CARCINOGENESIS, V33, P1833, DOI 10.1093/carcin/bgs216; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; WATTENBERG LW, 1977, J NATL CANCER I, V58, P395; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Maroni P, 2007, CARCINOGENESIS, V28, P267, DOI 10.1093/carcin/bgl129; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Hudson TS, 2012, INT J ONCOL, V40, P1113, DOI 10.3892/ijo.2012.1335; Sun YX, 2003, J CELL BIOCHEM, V89, P462, DOI 10.1002/jcb.10522; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Kim SH, 2009, MOL CANCER THER, V8, P1946, DOI 10.1158/1535-7163.MCT-09-0104; Chinni SR, 2008, MOL CANCER RES, V6, P446, DOI 10.1158/1541-7786.MCR-07-0117; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Xiao D, 2010, PHARM RES-DORDR, V27, P722, DOI 10.1007/s11095-010-0079-9; Cohen JH, 2000, J NATL CANCER I, V92, P61, DOI 10.1093/jnci/92.1.61; Liu B, 2012, INT J UROL, V19, P134, DOI 10.1111/j.1442-2042.2011.02906.x; Akashi T, 2008, CANCER SCI, V99, P539, DOI 10.1111/j.1349-7006.2007.00712.x; Vyas AR, 2013, CANCER RES, V73, P5985, DOI 10.1158/0008-5472.CAN-13-0755; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Ketterer B, 1998, CANCER EPIDEM BIOMAR, V7, P645; Arya Manit, 2004, J Exp Ther Oncol, V4, P291; Cai JA, 2010, TRANSL ONCOL, V3, P195, DOI 10.1593/tlo.09328; Conley-LaComb MK, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-85; Drudge-Coates L, 2012, BR J NURS S, V21, P23; Hahm ER, 2010, CANCER PREV RES, V3, P484, DOI 10.1158/1940-6207.CAPR-09-0250; Hecht SS, 1999, J NUTR, V129, P768; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Labsch S, 2014, INT J ONCOL, V44, P1470, DOI 10.3892/ijo.2014.2335; Roobol MJ, 2013, NAT REV UROL, V10, P38, DOI 10.1038/nrurol.2012.225; Sehrawat A, 2013, CARCINOGENESIS, V34, P864, DOI 10.1093/carcin/bgs397; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singareddy R, 2013, MOL CANCER RES, V11, P1349, DOI 10.1158/1541-7786.MCR-12-0705; Spans L, 2013, INT J MOL SCI, V14, P10822, DOI 10.3390/ijms140610822; Uchida D, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-62; Uygur B, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-139; Xiao D, 2005, CLIN CANCER RES, V11, P2670, DOI 10.1158/1078-0432.CCR-04-1545; Xiao D, 2006, CARCINOGENESIS, V27, P2223, DOI 10.1093/carcin/bgl087; Zhu Y, 2014, ASIAN PAC J CANCER P, V15, P8225, DOI 10.7314/APJCP.2014.15.19.8225	50	0	2	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1940-6207	1940-6215		CANCER PREV RES	Cancer Prev. Res.	MAY	2015	8	5					365	374		10.1158/1940-6207.CAPR-14-0386		10	Oncology	Oncology	CH0IY	WOS:000353704300005		
J	Zhou, MS; Liu, C; Tian, RX; Nishiyama, A; Raij, L				Zhou, Ming-Sheng; Liu, Chang; Tian, Runxia; Nishiyama, Akira; Raij, Leopoldo			Skeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NF kappa B	CARDIOVASCULAR DIABETOLOGY			English	Article						Angiotensin II; Hypertension; Insulin resistance; NF kappa B; Skeletal muscle	OXIDATIVE STRESS; RECEPTOR BLOCKERS; CARDIOVASCULAR-DISEASE; ALDOSTERONE SYSTEM; METABOLIC SYNDROME; DIABETES-MELLITUS; BLOOD-PRESSURE; NADPH OXIDASE; NITRIC-OXIDE; IKK-BETA	Background: We have previously shown that in hypertensive Dahl salt-sensitive (DS) rats, impaired endothelium-dependent relaxation to acetylcholine and to insulin is mechanistically linked to up-regulation of angiotensin (Ang) II actions and the production of reactive oxygen species (ROS) and to activation of the proinflammatory transcription factor (NF)kappa B. Here we investigated whether Ang II activation of NF kappa B contributed to insulin resistance in the skeletal muscle of this animal model. Methods: DS rats were fed either a normal (NS, 0.5% NaCl) or high (HS, 4% NaCl) salt diet for 6 weeks. In addition, 3 separate groups of HS rats were given angiotensin receptor 1 blocker candesartan (ARB, 10 mg/kg/day in drinking water), antioxidant tempol (1 mmol/L in drinking water) or NF kappa B inhibitor PDTC (150 mg/kg in drinking water). Results: DS rats manifested an increase in soleus muscle Ang II content, ROS production and phosopho-I kappa Ba/I kappa Ba ratio, ARB or tempol reduced ROS and phospho-I kappa Ba/I kappa Ba ratio. Hypertensive DS rats also manifested a reduction in glucose infusion rate, impaired insulin-induced Akt phosphorylation and Glut-4 translocation in the soleus muscle, which were prevented with treatment of either ARB, tempol, or PDTC. Data from the rat diabetes signaling pathway PCR array showed that 8 genes among 84 target genes were altered in the muscle of hypertensive rats with the increase in gene expression of ACE1 and 5 proinflammatory genes, and decrease of 2 glucose metabolic genes. Incubation of the muscle with NF kappa B SN50 (a specific peptide inhibitor of NF kappa B) ex vivo reversed changes in hypertension-induced gene expression. Conclusion: The current findings strongly suggest that the activation of NF kappa B inflammatory pathway by Ang II play a critical role in skeletal muscle insulin resistance in salt-sensitive hypertension.	[Zhou, Ming-Sheng] Liaoning Med Univ, Dept Physiol, Jinzhou, Peoples R China; [Liu, Chang] Liaoning Med Univ, Dept Endocrinol, Jinzhou, Peoples R China; [Zhou, Ming-Sheng; Tian, Runxia; Raij, Leopoldo] Miami VA Med Ctr, Hypertens Nephrol Sect, Miami, FL USA; [Nishiyama, Akira] Kagawa Univ, Sch Med, Dept Pharmacol, Kagawa, Japan; [Raij, Leopoldo] Univ Miami, Miller Sch Med, Hypertens Nephrol Sect, Vasc Biol Inst, Miami, FL 33136 USA	Zhou, MS (reprint author), Liaoning Med Univ, Dept Physiol, Jinzhou, Peoples R China.	zhoums1963@163.com			National Natural Science Foundation of China [81470532]; American Heart Association National Scientist Development Award; South Florida Veterans Affairs Foundation for Research and Education	This work was supported by the grant from the National Natural Science Foundation of China (No. 81470532) and American Heart Association National Scientist Development Award to Ming-Sheng Zhou, and by funds from the South Florida Veterans Affairs Foundation for Research and Education to Leopoldo Raij.	Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/0785390600888413; Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Underwood PC, 2013, CURR HYPERTENS REP, V15, P59, DOI 10.1007/s11906-012-0323-2; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Kiechl S, 2013, NAT MED, V19, P358, DOI 10.1038/nm.3084; Chu KY, 2006, DIABETES, V55, P367, DOI 10.2337/diabetes.55.02.06.db05-1022; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1068/nm1185; Cooper SA, 2007, AM J PHYSIOL-HEART C, V293, pH2009, DOI 10.1152/ajpheart.00522.2007; Sriwijitkamol A, 2006, DIABETES, V55, P760, DOI 10.2337/diabetes.55.03.06.db05-0677; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; De Boer MP, 2012, MICROCIRCULATION, V19, P5, DOI 10.1111/j.1549-8719.2011.00130.x; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011; Chen J, 2009, LANCET, V373, P829, DOI 10.1016/S0140-6736(09)60144-6; He JH, 2015, PEPTIDES, V64, P49, DOI 10.1016/j.peptides.2014.12.012; Zhou MS, 2012, VASC MED, V17, P330, DOI 10.1177/1358863X12450094; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Zhou MS, 2010, J HYPERTENS, V28, P527, DOI 10.1097/HJH.0b013e3283340da8; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Zhou MS, 2009, AM J PHYSIOL-HEART C, V296, pH833, DOI 10.1152/ajpheart.01096.2008; Wei Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE345, DOI 10.1152/ajpendo.00456.2007; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Folli F, 1997, J CLIN INVEST, V100, P2158, DOI 10.1172/JCI119752; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Bonner JS, 2013, DIABETES, V62, P572, DOI 10.2337/db12-0354; Chang CH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-91; Clark MG, 2008, AM J PHYSIOL-ENDOC M, V295, pE732, DOI 10.1152/ajpendo.90477.2008; De Filippo G, 2014, J ENDOCRINOL INVEST; Jiang YD, 2014, J BIOL CHEM, V289, P26395, DOI 10.1074/jbc.M114.583880; Jones A, 2003, INT J BIOCHEM CELL B, V35, P855, DOI 10.1016/S1357-2725(02)00342-4; Lastra G, 2010, NAT REV CARDIOL, V7, P577, DOI 10.1038/nrcardio.2010.123; Lastra-Lastra G, 2009, CLIN ENDOCRINOL, V71, P1, DOI 10.1111/j.1365-2265.2008.03498.x; Liu M, 2015, MOL CELL BIOCHEM, V400, P233, DOI 10.1007/s11010-014-2280-3; Lu JX, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-58; Nasser M, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-40; Nishiyama A, 2004, KIDNEY INT, V65, P972, DOI 10.1111/j.1523-1755.2004.00476.x; Ogihara T, 2004, DIABETOLOGIA, V47, P794, DOI 10.1007/s00125-004-1391-x; Pan Y, 2015, EXP CLIN ENDOCR DIAB, V123, P170, DOI 10.1055/s-0034-1395658; STEINBERG HO, 1994, J CLIN INVEST, V94, P1172, DOI 10.1172/JCI117433; Wang NS, 2013, AM J PHYSIOL-ENDOC M, V304, pE538, DOI 10.1152/ajpendo.00537.2012; Zhou MS, 2006, HYPERTENSION, V47, P81, DOI 10.1161/01.HYP.0000197182.65554.c7; Zhou MS, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-12; Zhou MS, 2003, HYPERTENSION, V42, P945, DOI 10.1161/01.HYP.0000094220.06020.C8	48	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2840			CARDIOVASC DIABETOL	Cardiovasc. Diabetol.	MAY 1	2015	14								45	10.1186/s12933-015-0211-6		9	Cardiac & Cardiovascular Systems; Endocrinology & Metabolism	Cardiovascular System & Cardiology; Endocrinology & Metabolism	CH3SC	WOS:000353949600001		
J	Miyamoto, Y; Sakane, F; Hashimoto, K				Miyamoto, Yasunori; Sakane, Fumi; Hashimoto, Kei			N-cadherin-based adherens junction regulates the maintenance, proliferation, and differentiation of neural progenitor cells during development	CELL ADHESION & MIGRATION			English	Review						adherens junction; -catenin; apico-basal polarity; N-cadherin; neural progenitor cells; AJ; adherens junction; aPKC; atypical protein kinase C; EC; extracellular; Fox; forkhead box; Frz; frizzled; GFAP; glial fibrillary acidic protein; GSK3; glycogen synthase kinase 3; Hes; hairly; enhancer of split; Hh; hedgehog; IP; intermediate progenitor; iPSC; induced pluripotent stem cell; KO; knockout; LEF; lymphocyte enhancer factor; ngn2; neurogenin 2; NPC; neural progenitor cell; Par; partition defective complex protein; Ptc; Pached; shRNA; short hairpin RNA; Smo; smoothened; Sox2; sry (sex determining region Y)-box containing gene 2; TCF; T-cell factor; TA cell; transient amplifying cell; ZO-1; Zonula Occludens-1	ALPHA-E-CATENIN; MIDBRAIN DOPAMINE NEURONS; CEREBRAL CORTICAL SIZE; PLURIPOTENT STEM-CELLS; ADULT MAMMALIAN BRAIN; BETA-CATENIN; RADIAL GLIA; SUBVENTRICULAR ZONE; ADHESION MOLECULES; EPITHELIAL-CELLS	This review addresses our current understanding of the regulatory mechanism by which N-cadherin, a classical cadherin, affects neural progenitor cells (NPCs) during development. N-cadherin is responsible for the integrity of adherens junctions (AJs), which develop in the sub-apical region of NPCs in the neural tube and brain cortex. The apical domain, which contains the sub-apical region, is involved in the switching from symmetric proliferative division to asymmetric neurogenic division of NPCs. In addition, N-cadherin-based AJ is deeply involved in the apico-basal polarity of NPCs and the regulation of Wnt--catenin, hedgehog (Hh), and Notch signaling. In this review, we discuss the roles of N-cadherin in the maintenance, proliferation, and differentiation of NPCs through components of AJ, -catenin and E-catenin.	[Miyamoto, Yasunori; Sakane, Fumi; Hashimoto, Kei] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 112, Japan	Miyamoto, Y (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 112, Japan.	miyamoto.yasunori@ocha.ac.jp					AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ajioka I, 2005, DEV BRAIN RES, V160, P106, DOI 10.1016/j.devbrainres.2005.08.004; Alvarez-Medina R, 2009, DEVELOPMENT, V136, P3301, DOI 10.1242/dev.041772; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Wisniewska MB, 2013, NEUROCHEM RES, V38, P1144, DOI 10.1007/s11064-013-0980-9; SUZUKI S, 1991, CELL REGUL, V2, P261; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Kang WF, 2009, J NEUROSCI, V29, P14571, DOI 10.1523/JNEUROSCI.3844-09.2009; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; Kosodo Y, 2009, DEV GROWTH DIFFER, V51, P251, DOI 10.1111/j.1440-169X.2009.01101.x; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Yagita Y, 2009, J NEUROSCI RES, V87, P3331, DOI 10.1002/jnr.22044; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Draganova K, 2015, STEM CELLS, V33, P170, DOI 10.1002/stem.1820; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Porlan E, 2014, NAT CELL BIOL, V16, P629, DOI 10.1038/ncb2993; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Locker M, 2006, GENE DEV, V20, P3036, DOI 10.1101/gad.391106; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; Zuccotti A, 2014, P NATL ACAD SCI USA, V111, P10726, DOI 10.1073/pnas.1320290111; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Sato K, 2011, MOL BIOL CELL, V22, P3103, DOI 10.1091/mbc.E11-03-0274; Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Morita H, 2010, DEVELOPMENT, V137, P1315, DOI 10.1242/dev.043190; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Nagashima M, 2013, DEVELOPMENT, V140, P4510, DOI 10.1242/dev.090738; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Rago L, 2014, EMBO J, V33, P906, DOI 10.1002/embj.201386591; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Yamaguchi M, 2010, MECH DEVELOP, V127, P247, DOI 10.1016/j.mod.2010.03.004; Tucci V, 2014, J CLIN INVEST, V124, P1468, DOI 10.1172/JCI70372; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Dong ZQ, 2012, NEURON, V74, P65, DOI 10.1016/j.neuron.2012.01.031; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Hatakeyama J, 2014, DEVELOPMENT, V141, P1671, DOI 10.1242/dev.102988; Luo Y, 2001, DEVELOPMENT, V128, P459; Tetsu O, 1999, NATURE, V398, P422; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Klingener M, 2014, J NEUROSCI, V34, P9590, DOI 10.1523/JNEUROSCI.3699-13.2014; Nelson BR, 2013, J NEUROSCI, V33, P9122, DOI 10.1523/JNEUROSCI.0791-13.2013; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Tang MZ, 2009, DEVELOPMENT, V136, P2027, DOI 10.1242/dev.034330; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Orsulic S, 1999, J CELL SCI, V112, P1237; OZAWA M, 1989, EMBO J, V8, P1711; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447; Ghosh S, 2008, P NATL ACAD SCI USA, V105, P335, DOI 10.1073/pnas.0705713105; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; Shitamukai A, 2012, DEV GROWTH DIFFER, V54, P277, DOI 10.1111/j.1440-169X.2012.01345.x; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Higginbotham H, 2013, NAT NEUROSCI, V16, P1000, DOI 10.1038/nn.3451; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Chalasani K, 2011, MOL BIOL CELL, V22, P1505, DOI 10.1091/mbc.E10-08-0675; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chauvet N, 2003, MOL CELL NEUROSCI, V22, P467, DOI 10.1016/S1044-7431(03)00030-7; Culver JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053546; Dady A, 2012, DEV DYNAM, V241, P1333, DOI 10.1002/dvdy.23813; Das RM, 2014, SCIENCE, V343, P200, DOI 10.1126/science.1247521; Dave RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014680; DUFOUR S, 1994, J CELL BIOL, V127, P521, DOI 10.1083/jcb.127.2.521; Erdmann B, 2003, DEV DYNAM, V226, P570, DOI 10.1002/dvdy.10266; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Frade JM, 2002, PROG BRAIN RES, V136, P67; Ganzler-Odenthal SII, 1998, J NEUROSCI, V18, P5415; Haque A, 2012, BIOMATERIALS, V33, P5094, DOI 10.1016/j.biomaterials.2012.04.003; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; INUZUKA H, 1991, DEVELOPMENT, V113, P959; Junghans D, 2005, DEV DYNAM, V233, P528, DOI 10.1002/dvdy.20365; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kasemeier-Kulesa JC, 2006, DEVELOPMENT, V133, P4839, DOI 10.1242/dev.02662; Kim S, 2007, NAT NEUROSCI, V10, P812, DOI 10.1038/nn0707-812; Kurusu M, 2012, DEV BIOL, V366, P204, DOI 10.1016/j.ydbio.2012.04.006; Liu Q, 2014, BIOMATERIALS, V35, P6206, DOI 10.1016/j.biomaterials.2014.04.068; Matsumata M, 2005, DEV BIOL, V286, P601, DOI 10.1016/j.ydbio.2005.08.005; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Meyers JR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-30; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noles SR, 2007, MOL CELL NEUROSCI, V35, P549, DOI 10.1016/j.mcn.2007.04.012; Oro AE, 2007, CURR OPIN CELL BIOL, V19, P691, DOI 10.1016/j.ceb.2007.10.008; Ozaki C, 2010, CELL STRUCT FUNCT, V35, P81; Piven OO, 2011, EXP BIOL MED, V236, P816, DOI 10.1258/ebm.2011.010362; Pujic Z, 2001, DEV BIOL, V234, P454, DOI 10.1006/dbio.2001.0251; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; Sakane F, 2013, DEV NEUROBIOL, V73, P518, DOI 10.1002/dneu.22077; Stocker AM, 2006, BRAIN RES, V1073, P151, DOI 10.1016/j.brainres.2005.12.057; Su HX, 2013, STEM CELL RES, V10, P338, DOI 10.1016/j.scr.2013.01.003; Tanabe K, 2004, DEV DYNAM, V229, P899, DOI 10.1002/dvdy.10493; Tang M, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-8; TANIHARA H, 1994, CELL ADHES COMMUN, V2, P15, DOI 10.3109/15419069409014199; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Wang ZZ, 2009, EMBO J, V28, P2360, DOI 10.1038/emboj.2009.190; Wong GKW, 2012, J NEUROSCI, V32, P223, DOI 10.1523/JNEUROSCI.2596-11.2012; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Zhang JN, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-7	141	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1933-6918	1933-6926		CELL ADHES MIGR	Celll Adhes. Migr.	MAY-JUN	2015	9	3					183	192		10.1080/19336918.2015.1005466		10	Cell Biology	Cell Biology	CH3IC	WOS:000353922800003		
J	Nakagawa, K; Goto, Y				Nakagawa, Kyuya; Goto, Yuki			Preparation of alpha-amylase-immobilized freeze-dried poly(vinyl alcohol) foam and its application to microfluidic enzymatic reactor	CHEMICAL ENGINEERING AND PROCESSING			English	Article						Freeze-drying; Poly(vinyl alcohol); Enzyme immobilization; Microreactor	IN-SITU POLYMERIZATION; PROTEOME ANALYSIS; SYSTEMS; CRYOGELS; CRYOSTRUCTURATION; SUSPENSION; MONOLITHS; CELL	Freeze-drying aqueous poly(vinyl alcohol) (PVA) solutions affords porous foam materials that show potential as an interesting entrapping matrix for enzyme immobilization. When an enzyme-PVA solution is freeze-dried, the enzymes are automatically entrapped in the architecture of the PVA matrix. The obtained PVA foams barely disperse in aqueous solution because of physically cross-linked PVA cryogel formation. This method is an in situ immobilization technique such that supporting materials can be produced in any space where the precursor solutions can be loaded. In this study, an attempt was made to prepare freeze-dried PVA foams in a microchannel to prepare an alpha-amylase-immobilized microreactor. Freeze-dried foams for amylase immobilization were demonstrated to be successfully prepared in microreactors with a ca. 18-mu L microchannel volume, and were evaluated by conducting continuous starch hydrolysis reactions over 8 d. The macroscopic pore structures seemed to be only minimally affected by the apparent activities of the immobilized enzymes; however, the cryogel structures, affected by the freezing protocol, and the microchannel materials employed were suggested as the key to determining reaction performances. (c) 2015 Elsevier B.V. All rights reserved.	[Nakagawa, Kyuya] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan; [Goto, Yuki] Univ Hyogo, Dept Mech & Syst Engn, Himeji, Hyogo 6712280, Japan	Nakagawa, K (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan.	kyuya@kais.kyoto-u.ac.jp					Brady D, 2009, BIOTECHNOL LETT, V31, P1639, DOI 10.1007/s10529-009-0076-4; Yu C, 2001, ANAL CHEM, V73, P5088, DOI 10.1021/ac0106288; Thongprachan N, 2008, MATER CHEM PHYS, V112, P262, DOI 10.1016/j.matchemphys.2008.05.067; Lozinsky VI, 1998, ENZYME MICROB TECH, V23, P227, DOI 10.1016/S0141-0229(98)00036-2; Ma JF, 2009, ANAL CHIM ACTA, V632, P1, DOI 10.1016/j.aca.2007.08.045; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; Nakagawa K, 2011, CHEM ENG PROCESS, V50, P22, DOI 10.1016/j.cep.2010.10.010; Hedstrom M, 2008, ANAL BIOANAL CHEM, V390, P907, DOI 10.1007/s00216-007-1745-6; Tischer W, 1999, TOP CURR CHEM, V200, P95; Lozinsky VI, 2008, RUSS CHEM B+, V57, P1015, DOI 10.1007/s11172-008-0131-7; Nakagawa K, 2007, AICHE J, V53, P1362, DOI 10.1002/aic.11147; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Damshkaln LG, 1999, J APPL POLYM SCI, V74, P1978, DOI 10.1002/(SICI)1097-4628(19991121)74:8<1978::AID-APP11>3.0.CO;2-L; Hahn R, 2001, ANAL CHEM, V73, P5126, DOI 10.1021/ac0103165; Josic D, 2001, J BIOCHEM BIOPH METH, V49, P153, DOI 10.1016/S0165-022X(01)00195-6; Lion N, 2003, ELECTROPHORESIS, V24, P3533, DOI 10.1002/elps.200305629; Liu HH, 2011, MATER CHEM PHYS, V129, P488, DOI 10.1016/j.matchemphys.2011.04.043; Liu Y, 2008, ANAL BIOANAL CHEM, V390, P227, DOI 10.1007/s00216-007-1664-6; LOZINSKY VI, 1986, ACTA POLYM, V37, P142, DOI 10.1002/actp.1986.010370303; Lozinsky VI, 2001, J APPL POLYM SCI, V82, P1609, DOI 10.1002/app.2000; Ma J, 2007, J SEP SCI, V30, P3050, DOI 10.1002/jssc.200700362; Nakagawa K, 2014, CHEM ENG SCI, V119, P22, DOI 10.1016/j.ces.2014.07.054; Nakagawa K, 2010, CHEM ENG SCI, V65, P1438, DOI 10.1016/j.ces.2009.10.014; Nakagawa K., 2012, P 16 INT C MIN SYST, P1765; Nakagawa Kyuya, 2011, CARBON NANOTUBES RES; Svec Frantisek, 2006, Anal Chem, V78, P2101	26	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0255-2701	1873-3204		CHEM ENG PROCESS	Chem. Eng. Process.	MAY	2015	91						35	42		10.1016/j.cep.2015.03.010		8	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CH0SR	WOS:000353733200004		
J	Fujii, K; Izutsu, K; Kume, M; Yoshino, T; Yoshihashi, Y; Sugano, K; Terada, K				Fujii, Kahori; Izutsu, Ken-ichi; Kume, Migiwa; Yoshino, Takeshi; Yoshihashi, Yasuo; Sugano, Kiyohiko; Terada, Katsuhide			Physical Characterization of meso-Erythritol as a Crystalline Bulking Agent for Freeze-Dried Formulations	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						meso-erythritol; crystallization; freeze-drying; sugar alcohol; thermal analysis	FROZEN AQUEOUS-SOLUTIONS; PROTEIN LYOPHILIZATION; MIXTURES; MANNITOL; COLLAPSE; SYSTEMS; BEHAVIOR; WATER; STABILIZATION; DENATURATION	The purpose of this study was to identify and characterize new crystalline bulking agents applicable to freeze-dried pharmaceuticals. Thermal analysis of heat-melt sugar and sugar alcohol solids as well as their frozen aqueous solutions showed high crystallization propensity of meso-erythritol and D-mannitol. Experimental freeze-drying of the aqueous meso-erythritol solutions after their cooling by two different methods (shelf-ramp cooling and immersion of vials into liquid nitrogen) resulted in cylindrical crystalline solids that varied in appearance and microscopic structure. Powder X-ray diffraction and thermal analysis indicated different crystallization processes of meso-erythritol depending on the extent of cooling. Cooling of the frozen nzeso-erythritol solutions at temperatures lower than their T-g' (glass transition temperature of maximally freeze-concentrated phase, -59.7 degrees C) induced a greater number of nuclei in the highly concentrated solute phase. Growth of multiple meso-erythritol anhydride crystals at around -40 degrees C explains the powder-like fine surface texture of the solids dried after their immersion in liquid nitrogen. Contrarily, shelf-ramp cooling of the frozen solution down to -40 degrees C induced an extensive growth of the solute crystal from a small number of nuclei, leading to scale-like patterns in the dried solids. An early transition of the freezing step into primary drying induced collapse of the non-crystalline region in the cakes. Appropriate process control should enable the use of meso-erythritol as an alternative crystalline bulking agent in freeze-dried formulations.	[Fujii, Kahori; Kume, Migiwa; Yoshino, Takeshi; Yoshihashi, Yasuo; Sugano, Kiyohiko; Terada, Katsuhide] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan; [Fujii, Kahori] POLA Pharma Inc, R&D Labs, Totsuka Ku, Yokohama, Kanagawa 2440812, Japan; [Izutsu, Ken-ichi] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan	Fujii, K (reprint author), Toho Univ, Fac Pharmaceut Sci, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.	kaporinfujii3@yahoo.co.jp					Adams GDJ, 1996, J PHARM SCI, V85, P1301, DOI 10.1021/js960146p; Al-Hussein A, 2012, J PHARM SCI-US, V101, P2534, DOI 10.1002/jps.23173; Baird JA, 2010, J PHARM SCI-US, V99, P3787, DOI 10.1002/jps.22197; Shalaev EY, 1996, CRYOBIOLOGY, V33, P14, DOI 10.1006/cryo.1996.0002; Morishige K, 2009, J PHYS CHEM C, V113, P3056, DOI 10.1021/jp8088935; CARPENTER JF, 1993, ARCH BIOCHEM BIOPHYS, V303, P456, DOI 10.1006/abbi.1993.1309; Fonseca F, 2004, BIOTECHNOL PROGR, V20, P229, DOI 10.1021/bp034136n; Malkin TL, 2012, P NATL ACAD SCI USA, V109, P1041, DOI 10.1073/pnas.1113059109; Nail Steven L, 2002, Pharm Biotechnol, V14, P281; Tang XL, 2004, PHARM RES, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75; Mohammed-Saeid W, 2012, J PHARM PHARM SCI, V15, P548; AKERS MJ, 1995, PHARMACEUT RES, V12, P1457, DOI 10.1023/A:1016223101872; Liu JS, 2006, PHARM DEV TECHNOL, V11, P3, DOI 10.1080/10837450500463729; Patel SM, 2009, AAPS PHARMSCITECH, V10, P1406, DOI 10.1208/s12249-009-9338-7; Chen CJ, 2010, J CONTROL RELEASE, V142, P299, DOI 10.1016/j.jconrel.2009.10.024; CHANG BS, 1992, CRYOBIOLOGY, V29, P632, DOI 10.1016/0011-2240(92)90067-C; Uchida T, 2010, PHYS CHEM CHEM PHYS, V12, P15034, DOI 10.1039/c0cp01059f; Bernt WO, 1996, REGUL TOXICOL PHARM, V24, pS191, DOI 10.1006/rtph.1996.0098; Cavatur RK, 2002, PHARMACEUT RES, V19, P894, DOI 10.1023/A:1016177404647; Costantino HR, 1998, INT J PHARM, V166, P211, DOI 10.1016/S0378-5173(98)00050-7; EFSA Panel on Food Additives and Nutrient Sources (ANS), 2010, EFSA J, V8, P1650; GEKKO K, 1982, J BIOCHEM-TOKYO, V91, P1197; Hasegawa G, 2009, INT J PHARM, V369, P12, DOI 10.1016/j.ijpharm.2008.10.018; Heller MC, 1999, ARCH BIOCHEM BIOPHYS, V363, P191, DOI 10.1006/abbi.1998.1078; International Pharmaceutical Excipients Council Japan, 2007, JAP PHARM EXC 2007, P41; IZUTSU K, 1994, CHEM PHARM BULL, V42, P5; Jesus AJL, 2010, INT J PHARMACEUT, V388, P129, DOI 10.1016/j.ijpharm.2009.12.043; Johnson RE, 2002, J PHARM SCI, V91, P914, DOI 10.1002/jps.10094; Makinen K. K., 2010, INT J DENT, V2010; Mehta M, 2013, EUR J PHARM BIOPHARM, V85, P207, DOI 10.1016/j.ejpb.2013.04.010; Meister E, 2009, J PHARM SCI-US, V98, P3072, DOI 10.1002/jps.21586; Milton N, 2007, J PHARM SCI-US, V96, P1848, DOI 10.1002/jps.20854; Munro IC, 1998, FOOD CHEM TOXICOL, V36, P1139, DOI 10.1016/S0278-6915(98)00091-X; Tyapkova O., 2012, Journal of Food Research, V1, P207; Wallen AJ, 2009, J PHARM SCI-US, V98, P997, DOI 10.1002/jps.21491; Yamaki T, 2012, CHEM PHARM BULL, V60, P1176	36	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	MAY	2015	63	5					311	317				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CH2LF	WOS:000353856000001		
J	Inoue, Y; Sekiya, N; Yamamoto, M; Iohara, D; Hirayama, F; Uekama, K				Inoue, Yasuo; Sekiya, Noboru; Yamamoto, Masanobu; Iohara, Daisuke; Hirayama, Fumitoshi; Uekama, Kaneto			Formation of the Ternary Inclusion Complex of Limaprost with alpha- and beta-Cyclodextrins in Aqueous Solution	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Limaprost alfadex; alpha-cyclodextrin; beta-cyclodextrin; ternary inclusion complex; NMR spectroscopy; kinetics	PHARMACEUTICAL APPLICATIONS; DISSOLUTION RATE; HUMID CONDITIONS; ORAL BIOAVAILABILITY; ANTIOXIDANT ACTIVITY; IMPROVED STABILITY; DRUG-DELIVERY; SOLID-STATE; SOLUBILITY; STABILIZATION	The inclusion mode of Limaprost in the presence of alpha- and beta-cyclodextrins (CDs) was investigated to gain insight into the stabilization mechanism of Limaprost-alfadex upon the addition of beta-CD in the solid state. The inclusion sites of a- and beta-CDs were studied by NMR spectroscopic and kinetic methods. With the addition of alpha- and beta-CDs, displacements in C-13 chemical shifts of prostaglandin F-2 alpha (PGF(2 alpha)) were observed in the omega-chain and the five-membered ring, respectively, of the drug. Similar shift changes were observed with the addition of both alpha- and beta-CDs. In two-dimensional (2D) H-1-NMR spectra, intermolecular correlation peaks were observed between protons of PGF(2 alpha) and protons of both alpha- and beta-CDs, suggesting that PGF(2 alpha) interacts with alpha- and beta-CDs to form a ternary complex by including the omega-chain with the former CD and the five-membered ring with the latter. In kinetic studies in aqueous solution, Limaprost was degraded to 17S,20-dimethyl-trans-Delta(2)-PGA(1) (11-deoxy-Delta(10)) and 17S,20-dimethyl-trans-Delta(2)-8-iso-PGE1 (8-iso). The addition of alpha-CD promoted the dehydration to 11-deoxy-Delta(10), while beta-CD promoted the isomerization to 8-iso, under these conditions. In the presence of both alpha- and beta-CDs, dehydration and isomerization were also accelerated, supporting the formation of the ternary Limaprost/alpha-CD/beta-CD complex.	[Inoue, Yasuo] Ono Pharmaceut Co Ltd, CMC Regulatory & Analyt R&D, Shimamoto, Osaka 6188585, Japan; [Sekiya, Noboru; Yamamoto, Masanobu] Ono Pharmaceut Co Ltd, Pharmaceut R&D, Shimamoto, Osaka 6188585, Japan; [Iohara, Daisuke; Hirayama, Fumitoshi] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto 8600082, Japan; [Uekama, Kaneto] Sojo Univ, DDS Res Inst, Nishi Ku, Kumamoto 8600082, Japan	Inoue, Y (reprint author), Ono Pharmaceut Co Ltd, CMC Regulatory & Analyt R&D, 3-1-1 Sakurai, Shimamoto, Osaka 6188585, Japan.	ya.inoue@ono.co.jp					ADACHI H, 1992, CHEM PHARM BULL, V40, P1586; Al Omari AA, 2011, J PHARMACEUT BIOMED, V54, P503, DOI 10.1016/j.jpba.2010.09.027; Rajewski RA, 1996, J PHARM SCI, V85, P1142, DOI 10.1021/js960075u; Miyake K, 2000, PHARM DEV TECHNOL, V5, P399, DOI 10.1081/PDT-100100556; Nagase Y, 2001, INT J PHARM, V229, P163, DOI 10.1016/S0378-5173(01)00851-1; Jansook P, 2010, J PHARM PHARM SCI, V13, P336; Miletic T, 2013, CARBOHYD POLYM, V98, P122, DOI 10.1016/j.carbpol.2013.05.084; Nguyen TA, 2013, FOOD CHEM, V136, P186, DOI 10.1016/j.foodchem.2012.07.104; Liu M, 2013, SPECTROCHIM ACTA A, V115, P854, DOI 10.1016/j.saa.2013.07.008; Uekama K, 2004, CHEM PHARM BULL, V52, P900, DOI 10.1248/cpb.52.900; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; Bourkaib N, 2013, DRUG DEV IND PHARM, V39, P918, DOI 10.3109/03639045.2012.718785; HIBI T, 1984, YAKUGAKU ZASSHI, V104, P990; HIRAYAMA F, 1986, CHEM PHARM BULL, V34, P5093; HIRAYAMA F, 1980, CHEM PHARM BULL, V28, P1975; HORIUCHI Y, 1991, YAKUGAKU ZASSHI, V111, P592; IKEDA Y, 1982, YAKUGAKU ZASSHI, V102, P83; INABA K, 1986, Yakuzaigaku, V46, P58; Inaba K., 1984, J INCLUSION PHENOM, V2, P467, DOI 10.1007/BF00662213; Inoue Y, 2014, CHEM PHARM BULL, V62, P786; Jansook P, 2008, INT J PHARMACEUT, V363, P217, DOI 10.1016/j.ijpharm.2008.07.011; Lin-Hui T., 1995, J INCL PHENOM MACRO, V23, P119, DOI 10.1007/BF00707889; Loftsson T, 1996, J PHARM SCI, V85, P1017, DOI 10.1021/js950534b; Malaekeh-Nikouei B, 2007, J INCL PHENOM MACRO, V59, P245, DOI 10.1007/s10847-007-9321-4; MONKHOUS.DC, 1973, J PHARM SCI, V62, P576, DOI 10.1002/jps.2600620406; Moribe K, 2007, INT J PHARM, V338, P1, DOI 10.1016/j.ijpharm.2006.12.047; Ozdemir N, 2012, DRUG DEV IND PHARM, V38, P331, DOI 10.3109/03639045.2011.604327; Palem Chinna Reddy, 2009, PDA J Pharm Sci Technol, V63, P217; Sekiya N., 2006, JPN J PHARM HLTH CAR, V32, P482; Sekiya Noboru, 2006, Yakuzaigaku, V66, P160; Sekiya N, 2008, CHEM PHARM BULL, V56, P7, DOI 10.1248/cpb.56.7; Sekiya N, 2007, CHEM PHARM BULL, V55, P546, DOI 10.1248/cpb.55.546; Priya AS, 2013, INT J BIOL MACROMOL, V62, P472, DOI 10.1016/j.ijbiomac.2013.09.006; UEKAMA K, 1978, CHEM PHARM BULL, V26, P1195; Uekama K, 2004, YAKUGAKU ZASSHI, V124, P909, DOI 10.1248/yakushi.124.909; UEKAMA K, 1981, YAKUGAKU ZASSHI, V101, P857; Uekama K, 2001, PHARMACEUT RES, V18, P1578, DOI 10.1023/A:1013034615464	37	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	MAY	2015	63	5					318	325				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CH2LF	WOS:000353856000002		
J	Takao, K; Miyashiro, T; Sugita, Y				Takao, Koichi; Miyashiro, Takaki; Sugita, Yoshiaki			Synthesis and Biological Evaluation of Piperic Acid Amides as Free Radical Scavengers and alpha-Glucosidase Inhibitors	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						piperine; alpha-glucosidase inhibitor; antioxidant; structure-activity relationship	ANTIOXIDANT ACTIVITY; OXIDATIVE STRESS; BLACK PEPPER; TYROSINASE; SEROTONIN; CELLS; DERIVATIVES	A series of piperic acid amides (4-24, 29, 30) were synthesized and their 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging and a-glucosidase inhibitory activities were evaluated. Among the synthesized compounds, the amides 11, 13 and 15, which contain o-methoxyphenol, catechol or 5-hydroxyindole moieties, showed potent DPPH free radical scavenging activity (11: EC50 140,mu m; 13: EC50 28 mu m; 15: EC50 20 mu m). The amides 10, 18 and 23 showed higher inhibitory activity of a-glucosidase (10: IC50 21 mu m; 18: IC50 21 mu m; 23: IC50 12 mu m). These data suggest that the hydrophobicity of the conjugated amines is an important determinant of alpha-glucosidase inhibitory activity. In addition, the amides 13 and 15 showed both potent DPPH free radical scavenging activity and a-glucosidase inhibitory activity (13: IC50 46 mu m; 15: IC50 46 mu m). This is the first report identifying the DPPH free radical scavenging and a-glucosidase inhibitory activities of piperic acid amides and suggests that these amides may serve as lead compounds for the development of novel a-glucosidase inhibitors with antioxidant activity.	[Takao, Koichi; Miyashiro, Takaki; Sugita, Yoshiaki] Josai Univ, Fac Pharmaceut Sci, Dept Pharmaceut & Hlth Sci, Bioorgan Chem Lab, Sakado, Saitama 3500295, Japan	Takao, K (reprint author), Josai Univ, Fac Pharmaceut Sci, Dept Pharmaceut & Hlth Sci, Bioorgan Chem Lab, 1-1 Keyaki Dai, Sakado, Saitama 3500295, Japan.	ktakao@josai.ac.jp					Shimada C, 2014, ANTICANCER RES, V34, P4877; Takahashi T, 2011, BIOORG MED CHEM LETT, V21, P1983, DOI 10.1016/j.bmcl.2011.02.028; Do MT, 2013, FOOD CHEM, V141, P2591, DOI 10.1016/j.foodchem.2013.04.125; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Bhardwaj RK, 2002, J PHARMACOL EXP THER, V302, P645, DOI 10.1124/jpet.102.034728; McNamara FN, 2005, BRIT J PHARMACOL, V144, P781, DOI 10.1038/sj.bjp.0706040; Wu ZR, 2012, FOOD CHEM, V134, P1128, DOI 10.1016/j.foodchem.2012.02.152; Kim JS, 2011, J AGR FOOD CHEM, V59, P138, DOI 10.1021/jf103130a; Ansari FL, 2005, CHEM BIODIVERS, V2, P487, DOI 10.1002/cbdv.200590029; Ying XZ, 2013, CELL IMMUNOL, V285, P49, DOI 10.1016/j.cellimm.2013.09.001; Kumar S, 2013, EXPERT OPIN PHARMACO, V14, P1723, DOI 10.1517/14656566.2013.815725; Mittal R, 2000, METHOD FIND EXP CLIN, V22, P271, DOI 10.1358/mf.2000.22.5.796644; Singh IP, 2010, EUR J MED CHEM, V45, P3439, DOI 10.1016/j.ejmech.2010.04.033; Fagerlund A, 2009, FOOD CHEM, V113, P550, DOI 10.1016/j.foodchem.2008.07.101; Okombi S, 2006, BIOORG MED CHEM LETT, V16, P2252, DOI 10.1016/j.bmcl.2006.01.022; Chadwick J, 2010, BIOORGAN MED CHEM, V18, P2586, DOI 10.1016/j.bmc.2010.02.035; Choi JY, 2010, FITOTERAPIA, V81, P1134, DOI 10.1016/j.fitote.2010.07.015; Christhudas IVSN, 2013, CURR MICROBIOL, V67, P69, DOI 10.1007/s00284-013-0329-2; GEISLER JG, 1990, PHYTOCHEMISTRY, V29, P489, DOI 10.1016/0031-9422(90)85102-L; Kang S, 2006, PLANT PHYSIOL, V140, P704, DOI 10.1104/pp.105.071514; Kumar GS, 2010, J ASIAN NAT PROD RES, V12, P978, DOI 10.1080/10286020.2010.511190; Le Mellay-Hamon V, 2009, BIOL PHARM BULL, V32, P301; Mu LH, 2012, BIOORG MED CHEM LETT, V22, P3343, DOI 10.1016/j.bmcl.2012.02.090; Najar IA, 2011, CHEM-BIOL INTERACT, V190, P84, DOI 10.1016/j.cbi.2011.02.011; Nile SH, 2013, BIOMED RES INT, V2013; Okwute S. K., 2013, INT J CHEM, V5, P99; Raju BC, 2010, BIOORGAN MED CHEM, V18, P358, DOI 10.1016/j.bmc.2009.10.047; Rao RR, 2009, BIOORGAN MED CHEM, V17, P5170, DOI 10.1016/j.bmc.2009.05.051; Takahashi T, 2012, BIOORG MED CHEM LETT, V22, P2494, DOI 10.1016/j.bmcl.2012.02.002; Takahashi T, 2012, MED CHEM RES, V21, P1762, DOI 10.1007/s00044-011-9699-9; Yao Y, 2010, J AGR FOOD CHEM, V58, P770, DOI 10.1021/jf903234c	31	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	MAY	2015	63	5					326	333				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CH2LF	WOS:000353856000003		
J	Uchino, T; Murata, A; Miyazaki, Y; Oka, T; Kagawa, Y				Uchino, Tomonobu; Murata, Akiko; Miyazaki, Yasunori; Oka, Toshihiko; Kagawa, Yoshiyuki			Glyceryl Monooleyl Ether-Based Liquid Crystalline Nanoparticles as a Transdermal Delivery System of Flurbiprofen: Characterization and in Vitro Transport	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						lyotropic liquid crystal; liquid crystalline nanoparticle; hexosome; skin permeation; flurbiprofen; NMR	BUPIVACAINE-LOADED FORMULATIONS; AQUEOUS DISPERSIONS; PHASE-BEHAVIOR; SODIUM DICLOFENAC; TOPICAL DELIVERY; SKIN PENETRATION; DRUG-DELIVERY; WATER SYSTEM; OLEIC-ACID; VESICLES	Liquid crystalline nanoparticles (LCNs) were prepared using glyceryl monooleyl ether (GME) by the modified film rehydration method. Hydrogenated lecithin (HL), 1,3-butylene glycol (1,3-BG), and Poloxamer 407 were used as additives. The prepared LCN formulations were evaluated based on particle size, small-angle X-ray diffraction (SAXS) analysis, H-1- and F-19-NMR spectra, and in vitro skin permeation across Yucatan micropig skin. The Composition (weight percent) of the LCN formulations were GME HL-1,3-BG (4:1:15), 4% GME-based LCN and GME HL-1,3-BG (8:1 :15), 8% GME-based LCN and their mean particle sizes were 130-175nm. Flurbiprofen 5 and 10mg was loaded into 4% GME-based LCN and 8% GME-based LCN systems, respectively. The results of SAXS and NMR suggested that both flurbiprofen-loaded formulations consist of particles with reverse type hexagonal phase (formation of hexosome) and flurbiprofen molecules were localized in the lipid domain through interaction of flurbiprofen with the lipid components. Flurbiprofen transport from the LCN systems across the Yucatan micropig skin was increased compared to flurbiprofen in citric buffer (pH=3.0). The 8% GME-based LCN systems was superior to the 4% GME-based LCN for flurbiprofen transport. Since the internal hexagonal phase in the 8% GME-based LCN systems had a higher degree of order compared to the 4% GME-based LCN in SAXS patterns, the 8% GME-based LCN system had a larger surface area, which might influence flurbiprofen permeation. These results indicated that the GME-based LCN system is effective in improving the skin permeation of flurbiprofen across the skin.	[Uchino, Tomonobu; Murata, Akiko; Miyazaki, Yasunori; Kagawa, Yoshiyuki] Univ Shizuoka, Sch Pharmaceut Sci, Dept Clin Pharmaceut, Suruga Ku, Shizuoka 4228526, Japan; [Uchino, Tomonobu; Miyazaki, Yasunori; Kagawa, Yoshiyuki] Shizuoka Prefectural Gen Hosp, Clin Pharmacokinet Lab, Aoi Ku, Shizuoka 4208527, Japan; [Oka, Toshihiko] Shizuoka Univ, Grad Sch Sci, Dept Phys, Suruga Ku, Shizuoka 4228529, Japan; [Oka, Toshihiko] Shizuoka Univ, Elect Res Inst, Nanomat Res Div, Suruga Ku, Shizuoka 4228529, Japan	Uchino, T (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Clin Pharmaceut, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	uchinot@u-shizuoka-ken.ac.jp	Oka, Toshihiko/C-3757-2015	Oka, Toshihiko/0000-0002-1676-9231	Japan Society for the Promotion of Sciences [26460225]	This study was partially supported by Grant-in-Aid for Scientific Research (C) (JSPS, 26460225) from the Japan Society for the Promotion of Sciences. SAXS measurements were carried out at the Center for Instrumental Analysis of Shizuoka University.	Amar-Yuli I, 2007, LANGMUIR, V23, P3637, DOI 10.1021/la062851b; ANDERSON BD, 1985, J PHARM SCI, V74, P815, DOI 10.1002/jps.2600740803; Guo CY, 2010, DRUG DISCOV TODAY, V15, P1032, DOI 10.1016/j.drudis.2010.09.006; Lopes LB, 2006, PHARM RES, V23, P1332, DOI 10.1007/s11095-006-0143-7; de Campo L, 2004, LANGMUIR, V20, P5254, DOI 10.1021/la0499416; Caboi F, 2001, CHEM PHYS LIPIDS, V109, P47, DOI 10.1016/S0009-3084(00)00200-0; Fang JY, 2003, INT J PHARM, V250, P313, DOI 10.1016/S0378-5173(02)00540-9; Cohen-Avrahami M, 2011, J PHYS CHEM B, V115, P10189, DOI 10.1021/jp112067v; Lopes LB, 2007, EUR J PHARM SCI, V32, P209, DOI 10.1016/j.ejps.2007.07.006; Yaghmur A, 2011, PHYS CHEM CHEM PHYS, V13, P3115, DOI 10.1039/c0cp01036g; Yaghmur A, 2009, ADV COLLOID INTERFAC, V147-48, P333, DOI 10.1016/j.cis.2008.07.007; Uchino T, 2014, INT J PHARMACEUT, V464, P75, DOI 10.1016/j.ijpharm.2013.12.051; ENGSTROM S, 1992, INT J PHARM, V79, P113, DOI 10.1016/0378-5173(92)90102-8; Yariv D, 2010, COLLOID SURFACE B, V78, P185, DOI 10.1016/j.colsurfb.2010.02.029; Esposito E, 2005, PHARM RES, V22, P2163, DOI 10.1007/s11095-005-8176-x; Barauskas J, 2005, COLLOID SURFACE B, V41, P49, DOI 10.1016/j.colsurfb.2004.11.008; Borne J, 2002, J PHYS CHEM B, V106, P10492, DOI 10.1021/jp021023y; Borne J, 2002, LANGMUIR, V18, P8972, DOI 10.1021/la020377d; Chang CM, 1997, INT J PHARM, V147, P135, DOI 10.1016/S0378-5173(96)04805-3; Cohen-Avrahami M, 2014, COLLOID SURFACE B, V122, P231, DOI 10.1016/j.colsurfb.2014.04.026; Cohen-Avrahami M, 2010, COLLOID SURFACE B, V77, P131, DOI 10.1016/j.colsurfb.2010.01.013; Cohen-Avrahami M, 2014, J PHYS CHEM B, V118, P6277, DOI 10.1021/jp412739p; Engstrom S, 2007, LANGMUIR, V23, P10020, DOI 10.1021/la701217b; Evenbratt H, 2013, INT J PHARMACEUT, V452, P270, DOI 10.1016/j.ijpharm.2013.05.047; Larsson K, 2000, CURR OPIN COLLOID IN, V5, P64, DOI 10.1016/S1359-0294(00)00040-6; Monduzzi M, 2000, LANGMUIR, V16, P7355, DOI 10.1021/la0000872; Nguyen TH, 2011, DRUG DELIV TRANSL RE, V1, P429, DOI 10.1007/s13346-011-0045-z; Uchino T, 2011, INT J PHARMACEUT, V412, P142, DOI 10.1016/j.ijpharm.2011.04.016; Uchino T, 2014, EUR J PHARM BIOPHARM, V86, P156, DOI 10.1016/j.ejpb.2013.02.009; Williams A., 2003, TRANSDERMAL TOPICAL; Yaghmur A, 2012, LANGMUIR, V28, P2881, DOI 10.1021/la203577v; Yaghmur A, 2011, SOFT MATTER, V7, P8291, DOI 10.1039/c1sm05854a; Yamada KMT, 2011, SPRINGER TRAC MOD PH, V241, P1, DOI 10.1007/978-3-642-16268-8_1	33	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	MAY	2015	63	5					334	340				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CH2LF	WOS:000353856000004		
J	Nakajima, Y; Tojo, T; Morita, M; Hatanaka, K; Shirakami, S; Tanaka, A; Sasaki, H; Nakai, K; Mukoyoshi, K; Hamaguchi, H; Takahashi, F; Moritomo, A; Higashi, Y; Inoue, T				Nakajima, Yutaka; Tojo, Takashi; Morita, Masataka; Hatanaka, Keiko; Shirakami, Shohei; Tanaka, Akira; Sasaki, Hiroshi; Nakai, Kazuo; Mukoyoshi, Koichiro; Hamaguchi, Hisao; Takahashi, Fumie; Moritomo, Ayako; Higashi, Yasuyuki; Inoue, Takayuki			Synthesis and Evaluation of 1H-Pyrrolo[2,3-b]pyridine Derivatives as Novel Immunomodulators Targeting Janus Kinase 3	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Janus kinase 3 inhibitor; immunomodulator; docking calculation; WaterMap	RHEUMATOID-ARTHRITIS; CALCINEURIN INHIBITORS; TRANSPLANT REJECTION; LYMPHOID DEVELOPMENT; LIGAND-BINDING; JAK3; DISCOVERY; INTERLEUKIN-2; CP-690550; DISEASES	Janus kinases (JAKs) have been known to play crucial roles in modulating a number of inflammatory and immune mediators. Here, we describe a series of 1H-pyrrolo[2,3-b]pyridine derivatives as novel immunomodulators targeting JAK3 for use in treating immune diseases such as organ transplantation. In the chemical modification of compound 6, the introduction of a carbamoyl group to the C5-position and substitution of a cyclohexylamino group at the C4-position of the 1H-pyrrolo[2,3-b]pyridine ring led to a large increase in JAK3 inhibitory activity. Compound 14c was identified as a potent, moderately selective JAK3 inhibitor, and the immunomodulating effect of 14c on interleukin-2-stimulated T cell proliferation was shown. Docking calculations and Water Map analysis of the 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives were conducted to confirm the substituent effects on JAK3 inhibitory activity.	[Nakajima, Yutaka; Tojo, Takashi; Morita, Masataka; Hatanaka, Keiko; Shirakami, Shohei; Tanaka, Akira; Sasaki, Hiroshi; Nakai, Kazuo; Mukoyoshi, Koichiro; Hamaguchi, Hisao; Takahashi, Fumie; Moritomo, Ayako; Higashi, Yasuyuki; Inoue, Takayuki] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Nakajima, Y (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	yutaka.nakajima@astellas.com; inoue_eck@mii.maruho.co.jp					Gomez-Puerta JA, 2013, CURR TOP MED CHEM, V13, P760; Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; Hirayama F, 2011, J MED CHEM, V54, P8051, DOI 10.1021/jm200868m; Flanagan ME, 2010, J MED CHEM, V53, P8468, DOI 10.1021/jm1004286; Safa K, 2013, CURR OPIN NEPHROL HY, V22, P689, DOI 10.1097/MNH.0b013e328365b3e6; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; West K, 2009, CURR OPIN INVEST DR, V10, P491; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Bechstein WO, 2000, TRANSPLANT INT, V13, P313, DOI 10.1111/j.1432-2277.2000.tb01004.x; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Norman P, 2012, EXPERT OPIN THER PAT, V22, P1233, DOI 10.1517/13543776.2012.723693; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Clark JD, 2014, J MED CHEM, V57, P5023, DOI 10.1021/jm401490p; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Dymock BW, 2013, EXPERT OPIN THER PAT, V23, P449, DOI 10.1517/13543776.2013.765862; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Denton MD, 1999, LANCET, V353, P1083, DOI 10.1016/S0140-6736(98)07493-5; Abel R, 2008, J AM CHEM SOC, V130, P2817, DOI 10.1021/ja0771033; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Liptak P, 2006, NAT CLIN PRACT NEPHR, V2, P398, DOI 10.1038/ncpneph0225; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; L'Heureux A, 2004, TETRAHEDRON LETT, V45, P2317, DOI 10.1016/j.tetlet.2004.01.122; Milici AJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2365; Wilson LJ, 2010, EXPERT OPIN THER PAT, V20, P609, DOI 10.1517/13543771003709767; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Yang Y, 2013, EXPERT OPIN DRUG DIS, V8, P277, DOI 10.1517/17460441.2013.749853	31	2	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	MAY	2015	63	5					341	353				13	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CH2LF	WOS:000353856000005		
J	Uchida, S; Hiraoka, S; Namiki, N				Uchida, Shinya; Hiraoka, Shogo; Namiki, Noriyuki			Development of Gummi Drugs of Aripiprazole as Hospital Formulations	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						gummi drug; aripiprazole; adherence; hospital formulation	DISINTEGRATING TABLETS; SCHIZOPHRENIA; RECEPTORS; MANNITOL; RELAPSE	About half of patients with schizophrenia have poor adherence to taking medication, so many have recurrence, therefore, providing formulations that enable patients to continue their medication without interruption is important. We aimed to develop a gummi drug that contains aripiprazole (which can reduce schizophrenia and manic symptoms in bipolar disorder). We were able to develop gummi drugs (OD-G, PW-G and OS-G) using three commercially available aripiprazole products (Abilify (R) orally disintegrating tablets, powder formulation, and oral solutions, respectively) as hospital formulations. Furthermore, we developed improved OD-G (iOD-G), which contained high aripiprazole content. Pharmaceutical characteristics of iOD-G were demonstrated to be suitable for hospital formulations, and iOD-G could be stored for <= 1 month. No significant differences in the dissolution and pharmacokinetics of divided portions of iOD-G were observed when compared with commercially available aripiprazole products. This study confirmed that new dosage forms of aripiprazole in gummi drugs can be developed as hospital formulations, which will contribute to improve medication adherence of patients.	[Uchida, Shinya; Hiraoka, Shogo; Namiki, Noriyuki] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharm Practice & Sci, Suruga Ku, Shizuoka 4228526, Japan; [Hiraoka, Shogo] Otsuka Pharmaceut Co Ltd, Kawaguchi, Tokushima 7710182, Japan	Uchida, S (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharm Practice & Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	uchidas@u-shizuoka-ken.ac.jp					Stoltenberg I, 2011, EUR J PHARM BIOPHARM, V78, P462, DOI 10.1016/j.ejpb.2011.02.005; HANAWA T, 1995, CHEM PHARM BULL, V43, P284; Park EJ, 2013, ARCH PHARM RES, V36, P651, DOI 10.1007/s12272-013-0105-7; Shu T, 2002, CHEM PHARM BULL, V50, P193, DOI 10.1248/cpb.50.193; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Yan YD, 2010, BIOL PHARM BULL, V33, P1364; Deb S, 2014, RES DEV DISABIL, V35, P711, DOI 10.1016/j.ridd.2013.12.004; Fleischhacker WW, 2009, BIOL PSYCHIAT, V65, P510, DOI 10.1016/j.biopsych.2008.07.033; Valenstein M, 2006, J CLIN PSYCHIAT, V67, P1542; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Koizumi K, 1997, INT J PHARM, V152, P127, DOI 10.1016/S0378-5173(97)04924-7; Stark AD, 2007, PSYCHOPHARMACOLOGY, V190, P373, DOI 10.1007/s00213-006-0621-y; Pigott TA, 2003, J CLIN PSYCHIAT, V64, P1048; [Anonymous], 2006, ICH HARM TRIP GUID I; Ereshefsky L, 2003, J CLIN PSYCHIAT, V64, P18; HOGARTY GE, 1991, ARCH GEN PSYCHIAT, V48, P340; Jacob S, 2009, DRUG DEV IND PHARM, V35, P321, DOI 10.1080/03639040802337021 ; Kathpalia H, 2013, CURR DRUG DELIV, V10, P667; Namiki N., 1997, YAKUZAIGAKU, V57, P87; Namiki N, 1998, BIOL PHARM BULL, V21, P87; Namiki N., 2003, JPN J PHARM HLTH CAR, V29, P92; Shimoda H, 2009, EUR J PHARM BIOPHARM, V73, P361, DOI 10.1016/j.ejpb.2009.08.010	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	MAY	2015	63	5					354	360				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CH2LF	WOS:000353856000006		
J	Onuki, Y; Funatani, C; Yokawa, T; Yamamoto, Y; Fukami, T; Koide, T; Obata, Y; Takayama, K				Onuki, Yoshinori; Funatani, Chiaki; Yokawa, Takashi; Yamamoto, Yoshihisa; Fukami, Toshiro; Koide, Tatsuo; Obata, Yasuko; Takayama, Kozo			Magnetic Resonance Imaging of the Phase Separation in Mixed Preparations of Moisturizing Cream and Steroid Ointment after Centrifugation	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						mixed external preparation; magnetic resonance (MR) spectroscopy; MR imaging (MRI); chemical shift selective image; quantitative T-2 map; clobetasone butyrate ointment	NONINVASIVE LOCALIZATION; EMULSION STABILITY; WATER; OIL; NMR; MICROEMULSIONS; SCATTERING; PLANTS; MICE	A mixed preparation consisting of a water-in-oil emulsion-type moisturizing cream and a steroid ointment is frequently prescribed for the treatment of atopic dermatitis. We have investigated the compatibility of moisturizing creams and ointments because there are concerns regarding the physical stability of these mixed preparations. The key technology used in this study was magnetic resonance imaging (MRI). A commercial moisturizing cream and white petrolatum or clobetasone butyrate (CLB) ointment samples were mixed in a weight ratio of 1:1. A centrifugation test protocol (20000xg for 3min) was implemented to accelerate the destabilization processes in the samples. After centrifugation, the mixed preparations separated into three distinct layers (upper, middle, and lower), while no phase separation was observed using moisturizing cream alone. The phase separation was monitored using chemical shift selective images of water and oil and quantitative T-2 maps. In addition, MR and near-infrared spectroscopy were employed for component analysis of each phase-separated layer. Collectively, it was confirmed that the lower layer contained water, oils, and organic solvent, while the upper and middle layers were composed solely of oils. Furthermore, this study investigated the distribution of CLB in the phase-separated samples and showed that a heterogeneous distribution existed. From our results, it was confirmed that the mixed preparation became unstable because of the incompatibility of the moisturizing cream and ointment.	[Onuki, Yoshinori; Funatani, Chiaki; Obata, Yasuko; Takayama, Kozo] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan; [Yokawa, Takashi] Bio View Corp, Chiyoda Ku, Tokyo 1010032, Japan; [Yamamoto, Yoshihisa] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan; [Fukami, Toshiro] Meiji Pharmaceut Univ, Dept Mol Pharmaceut, Kiyose, Tokyo 2048588, Japan; [Koide, Tatsuo] Natl Inst Hlth Sci, Div Drugs, Setagaya Ku, Tokyo 1588501, Japan	Onuki, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Pharmaceut Technol, 2630 Sugitani, Toyama 9300194, Japan.	onuki@pha.u-toyama.ac.jp			Japan Society for the Promotion of Science [25460045]; research foundation for pharmaceutical sciences; MEXT [S1411019]	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#25460045), the research foundation for pharmaceutical sciences, and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1411019). The authors thank PerkinElmer Japan Co., Ltd. for their technical support.	LaTorraca GA, 1998, MAGN RESON IMAGING, V16, P659, DOI 10.1016/S0730-725X(98)00030-7; McClements DJ, 2007, CRIT REV FOOD SCI, V47, P611, DOI 10.1080/10408390701289292; HAASE A, 1985, PHYS MED BIOL, V30, P341, DOI 10.1088/0031-9155/30/4/008; Onuki Y, 2014, DRUG DEV IND PHARM, V40, P937, DOI 10.3109/03639045.2013.790903; Hirasaki GJ, 2003, MAGN RESON IMAGING, V21, P269, DOI 10.1016/S0730-725X(03)00135-8; Gersbach PV, 2002, ANN BOT-LONDON, V90, P253, DOI 10.1093/aob/mcf179; Peng XG, 2013, RADIOLOGY, V269, P748, DOI 10.1148/radiol.13122860; Nishikawa M, 2011, CHEM PHARM BULL, V59, P332, DOI 10.1248/cpb.59.332; Hessien M, 2011, LANGMUIR, V27, P2299, DOI 10.1021/la104728r; Song MG, 2000, J COLLOID INTERF SCI, V230, P213, DOI 10.1006/jcis.2000.7090; Aulton M. E., 2013, AULTONS PHARM DESIGN; HALLOIN JM, 1993, J AM OIL CHEM SOC, V70, P1259, DOI 10.1007/BF02564238; Hashemi RH, 2010, MRI THE BASICS; Morriss C. E., 1997, LOG ANAL, V38, P44; Peng XG, 2013, AM J PHYSIOL-ENDOC M, V304, pE160, DOI 10.1152/ajpendo.00401.2012; RUMPEL H, 1992, MAGN RESON IMAGING, V10, P187, DOI 10.1016/0730-725X(92)90479-J; Shukla A, 2002, PHARMACEUT RES, V19, P881, DOI 10.1023/A:1016173303738; Shukla A, 2003, J PHARM PHARMACOL, V55, P741, DOI 10.1211/0022357021017; Straley C., 1997, LOG ANAL, V38, P84; Tan BL, 2005, HORTSCIENCE, V40, P720; Tse TY, 1996, PROTOPLASMA, V194, P54, DOI 10.1007/BF01273167; Yamamoto Y, 2014, INT J PHARMACEUT, V463, P62, DOI 10.1016/j.ijpharm.2013.12.054	22	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	MAY	2015	63	5					377	383				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CH2LF	WOS:000353856000009		
J	Okutani, M; Mori, Y				Okutani, Masaru; Mori, Yuji			Synthesis of Alkynes from Vinyl Triflates Using Tetrabutylammonium Fluoride	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						tetrabutylammonium fluoride; vinyl triflate; elimination; alkyne	N-BUTYLAMMONIUM FLUORIDE; DECARBOXYLATIVE ELIMINATION; GENERAL-SYNTHESIS; ORGANIC-SYNTHESIS; MICHAEL ADDITION; DERIVATIVES; ACETYLENES; ESTERS; 1,3-DICARBONYL; ANALOGS	A convenient method for the preparation of alkynes and alkynyl esters from ketones and beta-keto esters is described which involves the formation of vinyl triflates, followed by elimination with tetrabutylammonium fluoride trihydrate, to give alkynes. Unlike established elimination methods, the method requires neither a strong base nor anhydrous conditions.	[Okutani, Masaru; Mori, Yuji] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan	Mori, Y (reprint author), Meijo Univ, Fac Pharm, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	mori@meijo-u.ac.jp					COMINS DL, 1992, TETRAHEDRON LETT, V33, P6299, DOI 10.1016/S0040-4039(00)60957-7; CLARK JH, 1980, CHEM REV, V80, P429, DOI 10.1021/cr60327a004; Moritz BJ, 2014, ANGEW CHEM INT EDIT, V53, P2988, DOI 10.1002/anie.201310060; Chassaing S, 2012, TETRAHEDRON, V68, P7245, DOI 10.1016/j.tet.2012.05.107; Wei LL, 2001, TETRAHEDRON, V57, P459, DOI 10.1016/S0040-4020(00)01014-0; Schultz MK, 2010, ORG LETT, V12, P2398, DOI 10.1021/ol100774p; Asano M, 2006, J ORG CHEM, V71, P6942, DOI 10.1021/jo0610208; Brummond KM, 1996, J ORG CHEM, V61, P6096, DOI 10.1021/jo9610265; Brummond KM, 1998, TETRAHEDRON LETT, V39, P8613, DOI 10.1016/S0040-4039(98)01928-5; D'hooghe M, 2004, J ORG CHEM, V69, P2703, DOI 10.1021/jo035759i; DULCERE JP, 1993, J ORG CHEM, V58, P5709, DOI 10.1021/jo00073a033; Fleming I, 1999, CHEM COMMUN, P1113, DOI 10.1039/a901921i; Fleming I., 1998, J CHEM SOC P1, V1998, P1237; Fleming I, 2004, ORG BIOMOL CHEM, V2, P1504, DOI 10.1039/b401435a; Hamajima A, 2009, ANGEW CHEM INT EDIT, V48, P2941, DOI 10.1002/anie.200805996; Hanessian S, 1996, TETRAHEDRON LETT, V37, P987, DOI 10.1016/0040-4039(95)02359-3; HARGROVE RJ, 1976, TETRAHEDRON, V32, P37, DOI 10.1016/0040-4020(76)80018-X; HARGROVE RJ, 1974, J ORG CHEM, V39, P581, DOI 10.1021/jo00918a042; Ikeuchi Y, 2005, J ORG CHEM, V70, P756, DOI 10.1021/jo048860b; Ito Y, 2000, HETEROCYCLES, V52, P91; Katritzky AR, 2000, ORG LETT, V2, P3789, DOI 10.1021/ol0002370; Kudyba I, 2004, HELV CHIM ACTA, V87, P1724, DOI 10.1002/hlca.200490156; Liitjens H., 1995, TETRAHEDRON-ASYMMETR, V6, P2675; Ma Y, 2006, J AM CHEM SOC, V128, P15399, DOI 10.1021/ja060964b; Maity P, 2009, J ORG CHEM, V74, P158, DOI 10.1021/jo801563x; MATSUMOTO K, 1981, ANGEW CHEM INT EDIT, V20, P770, DOI 10.1002/anie.198107701; Myers AG, 2004, J ORG CHEM, V69, P2516, DOI 10.1021/jo030368p; Ohno H, 1998, TETRAHEDRON-ASYMMETR, V9, P3929, DOI 10.1016/S0957-4166(98)00406-6; Okutani M, 2009, J ORG CHEM, V74, P442, DOI 10.1021/jo802101a; Okutani M, 2007, TETRAHEDRON LETT, V48, P6856, DOI 10.1016/j.tetlet.2007.07.174; Perez-Garcia X, 2003, ORG LETT, V5, P4033, DOI 10.1021/ol0351246; Ramharter J, 2010, J AM CHEM SOC, V132, P14338, DOI 10.1021/ja107533m; Sharma GVM, 2002, TETRAHEDRON-ASYMMETR, V13, P21, DOI 10.1016/S0957-4166(02)00047-2; Sosa JR, 2008, ORG LETT, V10, P5091, DOI 10.1021/ol802147h; Specklin S, 2008, J ORG CHEM, V73, P7845, DOI 10.1021/jo8015049; Tarraga A, 2000, TETRAHEDRON LETT, V41, P4895, DOI 10.1016/S0040-4039(00)00756-5	36	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	MAY	2015	63	5					393	396				4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CH2LF	WOS:000353856000012		
J	Nagy, AD; Iwamoto, A; Kawai, M; Goda, R; Matsuo, H; Otsuka, T; Nagasawa, M; Furuse, M; Yasuo, S				Nagy, Andras David; Iwamoto, Ayaka; Kawai, Misato; Goda, Ryosei; Matsuo, Haruka; Otsuka, Tsuyoshi; Nagasawa, Mao; Furuse, Mitsuhiro; Yasuo, Shinobu			Melatonin adjusts the expression pattern of clock genes in the suprachiasmatic nucleus and induces antidepressant-like effect in a mouse model of seasonal affective disorder	CHRONOBIOLOGY INTERNATIONAL			English	Article						C57BL/6J mice; circadian clock; dorsal raphe nucleus; melatonin; seasonal affective disorder; serotonin; suprachiasmatic nucleus	CIRCADIAN-RHYTHMS; SEROTONERGIC SYSTEM; LABORATORY MICE; DAY LENGTH; DEPRESSION; LIGHT; BEHAVIOR; AGOMELATINE; RECEPTORS; RESPONSES	Recently, we have shown that C57BL/6J mice exhibit depression-like behavior under short photoperiod and suggested them as an animal model for investigating seasonal affective disorder (SAD). In this study, we tested if manipulations of the circadian clock with melatonin treatment could effectively modify depression-like and anxiety-like behaviors and brain serotonergic system in C57BL/6J mice. Under short photoperiods (8-h light/16-h dark), daily melatonin treatments 2 h before light offset have significantly altered the 24-h patterns of mRNA expression of circadian clock genes (per1, per2, bmal1 and clock) within the suprachiasmatic nuclei (SCN) mostly by increasing amplitude in their expressional rhythms without inducing robust phase shifts in them. Melatonin treatments altered the expression of genes of serotonergic neurotransmission in the dorsal raphe (tph2, sert, vmat2 and 5ht1a) and serotonin contents in the amygdala. Importantly, melatonin treatment reduced the immobility in forced swim test, a depression-like behavior. As a key mechanism of melatonin-induced antidepressant-like effect, the previously proposed phase-advance hypothesis of the circadian clock could not be confirmed under conditions of our experiment. However, our findings of modest adjustments in both the amplitude and phase of the transcriptional oscillators in the SCN as a result of melatonin treatments may be sufficient to associate with the effects seen in the brain serotonergic system and with the improvement in depression-like behavior. Our study confirmed a predictive validity of C57BL/6J mice as a useful model for the molecular analysis of links between the clock and brain serotonergic system, which could greatly accelerate our understanding of the pathogenesis of SAD, as well as the search for new treatments.	[Nagy, Andras David; Iwamoto, Ayaka; Kawai, Misato; Goda, Ryosei; Matsuo, Haruka; Otsuka, Tsuyoshi; Nagasawa, Mao; Furuse, Mitsuhiro; Yasuo, Shinobu] Kyushu Univ, Fac Agr, Lab Regulat Metab & Behav, Higashi Ku, Fukuoka 812, Japan; [Nagy, Andras David] Univ Pecs, Fac Med, Dept Anat, H-7624 Pecs, Hungary	Nagy, AD (reprint author), Univ Pecs, Fac Med, Dept Anat, Szigeti Ut 12, H-7624 Pecs, Hungary.	andras.d.nagy@aok.pte.hu			Japanese Society for the Promotion of Science [24780286, 24650490, 23248046]; Matsumae International Foundation; Hungarian Scientific Research Fund [OTKA-PD100927]	Authors declare no conflicts of interest. This work was, in part, supported by Grants-in-Aid for Young Scientists (B) (No.24780286) to S. Y., Challenging Exploratory Research (No.24650490) and Scientific Research (A) (No. 23248046) to M. F. from the Japanese Society for the Promotion of Science. Contribution of A. D. N. to this work was supported by the Matsumae International Foundation, and the Hungarian Scientific Research Fund (OTKA-PD100927).	Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Micale V, 2006, EUR NEUROPSYCHOPHARM, V16, P538, DOI 10.1016/j.euroneuro.2006.01.005; Heils A, 1997, J NEURAL TRANSM, V104, P1005, DOI 10.1007/BF01273314; Meijer JH, 2010, EUR J NEUROSCI, V32, P2143, DOI 10.1111/j.1460-9568.2010.07522.x; Foster RG, 2013, PROG MOL BIOL TRANSL, V119, P325, DOI 10.1016/B978-0-12-396971-2.00011-7; MCARTHUR AJ, 1991, BRAIN RES, V565, P158, DOI 10.1016/0006-8993(91)91748-P; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; Bourin M, 2004, J PSYCHIATR NEUROSCI, V29, P126; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; EBIHARA S, 1980, PHYSIOL BEHAV, V24, P523, DOI 10.1016/0031-9384(80)90246-2; Tataroglu O, 2004, BRAIN RES, V1001, P118, DOI 10.1016/j.brainres.2003.11.063; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; Goto M, 2013, GEN COMP ENDOCR, V186, P33, DOI 10.1016/j.ygcen.2013.02.028; Benloucif S, 1996, J BIOL RHYTHM, V11, P113, DOI 10.1177/074873049601100204; McClung CA, 2011, EUR NEUROPSYCHOPHARM, V21, pS683, DOI 10.1016/j.euroneuro.2011.07.008; Kronfeld-Schor N, 2012, NEUROPHARMACOLOGY, V62, P101, DOI 10.1016/j.neuropharm.2011.08.020; Otsuka T, 2014, PSYCHONEUROENDOCRINO, V40, P37, DOI 10.1016/j.psyneuen.2013.10.013; Wan Q, 1999, NAT NEUROSCI, V2, P401; Prendergast BJ, 2005, PSYCHONEUROENDOCRINO, V30, P438, DOI 10.1016/j.psyneuen.2004.08.008; CASSONE VM, 1987, NEUROSCI LETT, V81, P29, DOI 10.1016/0304-3940(87)90335-1; Lam RW, 2000, J PSYCHIATR NEUROSCI, V25, P469; Leach G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057115; Leppamaki S, 2003, EUR NEUROPSYCHOPHARM, V13, P137, DOI 10.1016/S0924-977X(02)00175-X; Lesch KP, 2005, HANDB EXP PHARM, V169, P71; Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364; Otsuka T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039090; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Sack RL, 1997, J BIOL RHYTHM, V12, P595, DOI 10.1177/074873049701200615; SHIBATA S, 1989, NEUROSCI LETT, V97, P140, DOI 10.1016/0304-3940(89)90153-5; Steinlechner S, 2002, J BIOL RHYTHM, V17, P202, DOI 10.1177/07430402017003003; Sumova A, 2003, J BIOL RHYTHM, V18, P134, DOI 10.1177/0748730403251801; Sumova A, 1996, NEUROSCI LETT, V218, P181, DOI 10.1016/S0304-3940(96)13159-1; Tuma J, 2005, EUR NEUROPSYCHOPHARM, V15, P545, DOI 10.1016/j.euroneuro.2005.02.004; VANECEK J, 1987, BRAIN RES, V435, P359, DOI 10.1016/0006-8993(87)91625-8; Watanabe K, 1998, BRAIN RES, V801, P216, DOI 10.1016/S0006-8993(98)00543-5; Ying SW, 1996, EUR J PHARMACOL, V296, P33, DOI 10.1016/0014-2999(95)00684-2	37	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	MAY	2015	32	4					447	457		10.3109/07420528.2014.992525		11	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CH3IZ	WOS:000353925700001		
J	Nakao, R; Yamamoto, S; Horikawa, K; Yasumoto, Y; Nikawa, T; Mukai, C; Oishi, K				Nakao, Reiko; Yamamoto, Saori; Horikawa, Kazumasa; Yasumoto, Yuki; Nikawa, Takeshi; Mukai, Chiaki; Oishi, Katsutaka			Atypical expression of circadian clock genes in denervated mouse skeletal muscle	CHRONOBIOLOGY INTERNATIONAL			English	Article						Circadian rhythm; DNA microarray; gastrocnemius muscle; muscle atrophy; peripheral clock; sciatic denervation; soleus muscle	PERIPHERAL-TISSUES; REV-ERB; DIFFERENTIAL CONTROL; TRANSCRIPTION; ATROPHY; RHYTHMS; MICE; OSCILLATIONS; FIBROBLASTS; METABOLISM	The central circadian clock in the suprachiasmatic nucleus of the hypothalamus synchronizes peripheral clocks through neural and humoral signals in most mammalian tissues. Here, we analyzed the effects of unilateral sciatic denervation on the expression of circadian clock-and clock-controlled genes in the gastrocnemius muscles of mice twice per day on days 0, 3, 7, 9, 11 and 14 after denervation and six times on each of days 7 and 28 after denervation to assess the regulation mechanism of the circadian clock in skeletal muscle. Sciatic denervation did not affect systemic circadian rhythms since core body temperature (Day 7), corticosterone secretion (Days 7 and 28), and hepatic clock gene expression remained intact (Days 7 and 28). Expression levels of most circadian clock-related genes such as Arntl, Per1, Rora, Nr1d1 and Dbp were reduced in accordance with the extent of muscle atrophy, although circadian Per2 expression was significantly augmented (Day 28). Cosinor analysis revealed that the circadian expression of Arntl (Days 7 and 28) and Dbp (Day 28) was phase advanced in denervated muscle. The mRNA expression of Clock was significantly increased in denervated muscle on Day 3 when the severe atrophy was absent, and it was not affected by atrophic progression for 28 days. Sciatic denervation did not affect the expression of these genes in the contralateral muscle (Days 7 and 28), suggesting that humoral changes were not involved in denervation-induced muscle clock disruption. We then analyzed genome-wide gene expression using microarrays to determine the effects of disrupting the molecular clock in muscle on circadian rhythms at Day 7. Among 478 circadian genes, 313 lost rhythmicity in the denervated muscles. These denervation-sensitive genes included the lipid metabolism-related genes, Nrip1, Bbs1, Ptgis, Acot1, Scd2, Hpgd, Insig1, Dhcr24, Ldlr and Mboat1. Our findings revealed that sciatic denervation disrupts the circadian expression of clock and clock-controlled genes either directly or indirectly via muscle atrophy in the gastrocnemius muscles of mice in a gene-specific manner.	[Nakao, Reiko; Yamamoto, Saori; Horikawa, Kazumasa; Yasumoto, Yuki; Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Tsukuba, Ibaraki, Japan; [Yasumoto, Yuki; Oishi, Katsutaka] Tokyo Univ Sci, Grad Sch Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Nikawa, Takeshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nutr Physiol, Tokushima 770, Japan; [Mukai, Chiaki] Japan Aerosp Explorat Agcy JAXA, Ctr Appl Space Med & Human Res, Tsukuba, Ibaraki, Japan; [Oishi, Katsutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan	Oishi, K (reprint author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-ooishi@aist.go.jp			AIST; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25350179, 24620015]	The authors have no conflicts of interest to report. The authors are solely responsible for the content and writing of this paper. This study was supported by operational subsidies from AIST and Grant-in-Aid for Scientific Research (C) KAKENHI to R. Nakao (24620015) and K. Oishi (25350179) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Schroder EA, 2013, EXERC SPORT SCI REV, V41, P224, DOI 10.1097/JES.0b013e3182a58a70; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; DAVIS TA, 1988, BIOCHEM J, V254, P667; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Oishi K, 1998, NEUROSCI LETT, V256, P117, DOI 10.1016/S0304-3940(98)00765-4; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1153/ajpcell.00565.2004; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Quy PN, 2013, J BIOL CHEM, V288, P1125, DOI 10.1074/jbc.M112.399949; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Chaves I, 2014, CURR BIOL, V24, P1248, DOI 10.1016/j.cub.2014.04.018; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Buhr ED, 2013, HDB EXP PHARM, V217, P3, DOI DOI 10.1007/978-3-642-25950-0_1; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Nakao R, 2014, MUSCLE NERV IN PRESS; Ohkura N, 2007, CHRONOBIOL INT, V24, P651, DOI 10.1080/0742520701534673; Roy RL, 2000, MUSCLE NERVE, V23, P735, DOI 10.1002/(SICI)1097-4598(200005)23:5<735::AID-MUS11>3.0.CO;2-T; Sakamoto K, 2004, EXP ANIM TOKYO, V53, P471, DOI 10.1538/expanim.53.471; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Tang H, 2014, SCI SIGNAL, V7, P1; TOMANEK RJ, 1973, J ANAT, V116, P395	36	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	MAY	2015	32	4					486	496		10.3109/07420528.2014.1003350		11	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CH3IZ	WOS:000353925700005		
J	Mikoya, T; Shibukawa, T; Susami, T; Sato, Y; Tengan, T; Katashima, H; Oyama, A; Matsuzawa, Y; Ito, Y; Funayama, E				Mikoya, Tadashi; Shibukawa, Toyoko; Susami, Takafumi; Sato, Yoshiaki; Tengan, Toshimoto; Katashima, Hirotaka; Oyama, Akihiko; Matsuzawa, Yusuke; Ito, Yumi; Funayama, Emi			Dental Arch Relationship Outcomes in One- and Two-Stage Palatoplasty for Japanese Patients With Complete Unilateral Cleft Lip and Palate	CLEFT PALATE-CRANIOFACIAL JOURNAL			English	Article						5-Year-Olds' Index; dental arch relationships; Huddart/Bodenham Index; Japanese infants; unilateral cleft lip and palate	CLASS-III MALOCCLUSION; HARD PALATE; GOSLON YARDSTICK; 5-YEAR-OLD PATIENTS; PRIMARY VELOPLASTY; CRANIOFACIAL FORM; BEAGLE DOGS; PART 2; REPAIR; CHILDREN	Objective: To compare dental arch relationship outcomes following one-and two-stage palatal repair. Design: Nonrandomized, clinical trial with concurrent control. Setting: Hokkaido University Hospital. Patients: Sixty-eight consecutively treated Japanese patients with complete unilateral cleft lip and palate. Interventions: Thirty-one of the 68 patients underwent two-stage palatoplasty with delayed hard palate closure, and 37 patients underwent one-stage pushback palatoplasty. Main Outcome Measures: Dental casts were taken at 4.9 to 6.3 (mean: 5.2) years of age in the two-stage group and at 4.0 to 6.3 (mean: 5.1) years of age in the one-stage group, and dental arch relationships were assessed using the 5-Year-Olds' Index (5-Y) by four raters and the Huddart/Bodenham Index (HB) by two raters. Results: Intrarater and interrater reliabilities evaluated using weighted kappa statistics were good or better for the 5-Y and HB ratings. The mean 5-Y score was 2.94 in the two-stage group and 3.13 in the one-stage group (P value was not significant). However, there was a significant difference in distributions between the groups (P < .05). The HB scores of molars were significantly greater in the two-stage group than in the one-stage group (P < .05). The rank correlation coefficients between the 5-Y and total HB score (rho = -0.840, P < .01) and between the 5-Y and the score of the incisors in the HB (rho = -0.814, P < .01) were significantly increased. Conclusions: These results suggest that the anteroposterior relationship was not significantly different between the groups, but the transversal relationship was better in the two-stage group than in the one-stage group.	[Mikoya, Tadashi] Hokkaido Univ Hosp, Ctr Adv Oral Med, Stomatognath Funct, Sapporo, Hokkaido 0608648, Japan; [Matsuzawa, Yusuke; Ito, Yumi] Hokkaido Univ, Dept Oral & Maxillofacial Surg, Grad Sch Dent, Sapporo, Hokkaido, Japan; [Sato, Yoshiaki] Hokkaido Univ, Dept Orthodont, Grad Sch Dent, Sapporo, Hokkaido, Japan; [Oyama, Akihiko; Funayama, Emi] Hokkaido Univ Hosp, Plast & Reconstruct Surg, Sapporo, Hokkaido 0608648, Japan; [Susami, Takafumi] Tokyo Univ Hosp, Dept Oral Maxillofacial Surg Dent & Orthodont, Tokyo 113, Japan; [Katashima, Hirotaka] Univ Ryukyus, Grad Sch Med, Dept Oral & Maxillofacial Funct Rehabil, Okinawa, Japan	Mikoya, T (reprint author), Hokkaido Univ Hosp, Ctr Adv Oral Med, Clin Stomatognath Funct, Kita Ku, Kita 14,Nishi 5, Sapporo, Hokkaido 0608648, Japan.	mikoya@den.hokudai.ac.jp			JSPS KAKENHI Grant [23592911]	This research was supported by JSPS KAKENHI Grant 23592911.	Altman D, 1991, PRACTICAL STAT MED R, P404; Brattstrom V, 2005, CLEFT PALATE-CRAN J, V42, P69, DOI 10.1597/02-119.2.1; BARDACH J, 1984, PLAST RECONSTR SURG, V73, P207, DOI 10.1097/00006534-198402000-00007; Lilja J, 2006, CLEFT PALATE-CRAN J, V43, P606, DOI 10.1597/05-069; Williams AC, 2001, CLEFT PALATE-CRAN J, V38, P24, DOI 10.1597/1545-1569(2001)038<0024:CLAPCI>2.0.CO;2; Rohrich RJ, 1996, PLAST RECONSTR SURG, V98, P236, DOI 10.1097/00006534-199608000-00005; MOORREES CF, 1969, AMER J ORTHODONTICS, V55, P600, DOI 10.1016/0002-9416(69)90037-2; Molsted K, 2005, CLEFT PALATE-CRAN J, V42, P78, DOI 10.1597/02-119.3.1; Atack NE, 1997, CLEFT PALATE-CRAN J, V34, P242, DOI 10.1597/1545-1569(1997)034<0242:ANIFAS>2.3.CO;2; Pigott RW, 2002, CLEFT PALATE-CRAN J, V39, P383, DOI 10.1597/1545-1569(2002)039<0383:ACOTMO>2.0.CO;2; HOTZ MM, 1979, J MAXILLOFAC SURG, V7, P201, DOI 10.1016/S0301-0503(79)80041-7; Friede H, 2001, CLEFT PALATE-CRAN J, V38, P323, DOI 10.1597/1545-1569(2001)038<0323:LTEFFM>2.0.CO;2; KNOTT VB, 1972, ANGLE ORTHOD, V42, P387; FURLOW LT, 1986, PLAST RECONSTR SURG, V78, P724; Kim T, 2002, CLEFT PALATE-CRAN J, V39, P425, DOI 10.1597/1545-1569(2002)039<0425:COTMDA>2.0.CO;2; WIJDEVELD MGMM, 1991, ARCH ORAL BIOL, V36, P837, DOI 10.1016/0003-9969(91)90033-Q; Bongaarts CAM, 2004, CLEFT PALATE-CRAN J, V41, P633, DOI 10.1597/03-051.1; Nollet PJPM, 2005, CLEFT PALATE-CRAN J, V42, P512, DOI 10.1597/04-129.1; SCHWECKENDIEK W, 1978, CLEFT PALATE J, V15, P268; MARS M, 1987, CLEFT PALATE J, V24, P314; Atack N, 1997, EUR J ORTHODONT, V19, P165, DOI 10.1093/ejo/19.2.165; Mossey PA, 2003, EUR J ORTHODONT, V25, P251, DOI 10.1093/ejo/25.3.251; Atack N E, 1998, Br J Orthod, V25, P181; Baik H S, 2000, Int J Adult Orthodon Orthognath Surg, V15, P119; Bartzela T, 2011, CLEFT PALATE-CRAN J, V48, P455, DOI 10.1597/09-208; CHAN GK, 1974, AM J ORTHOD DENTOFAC, V65, P152, DOI 10.1016/0002-9416(74)90176-6; Clark SA, 2007, CLEFT PALATE-CRAN J, V44, P235, DOI 10.1597/06-044; COSMAN B, 1980, CLEFT PALATE J, V17, P27; DiBiase AT, 2002, CLEFT PALATE-CRAN J, V39, P635, DOI 10.1597/1545-1569(2002)039<0635:TRBADA>2.0.CO;2; DORF DS, 1982, PLAST RECONSTR SURG, V70, P74, DOI 10.1097/00006534-198207000-00015; Enlow DH, 1990, FACIAL GROWTH, P198; Flinn W, 2006, CLEFT PALATE-CRAN J, V43, P253; Fudalej P, 2009, CLEFT PALATE-CRAN J, V46, P648, DOI 10.1597/09-010.1; Hirano Y, 2007, J JPN CLEFT PALATE A, V32, P68; Huddart A G, 1972, Cleft Palate J, V9, P194; Ishii N, 2002, EUR J ORTHODONT, V24, P493, DOI 10.1093/ejo/24.5.493; Kajii TS, 2013, CLEFT PALATE-CRAN J, V50, P466, DOI 10.1597/11-150; KAPLAN EN, 1975, PLAST RECONSTR SURG, V56, P129, DOI 10.1097/00006534-197508000-00002; KOBUS K, 1984, PLAST RECONSTR SURG, V73, P895, DOI 10.1097/00006534-198406000-00006; Kremenak C R Jr, 1970, Cleft Palate J, V7, P817; Lehner B, 2003, CLEFT PALATE-CRAN J, V40, P126, DOI 10.1597/1545-1569(2003)040<0126:IOEHPC>2.0.CO;2; Lohmander-Agerskov A, 1998, SCAND J PLAST RECONS, V32, P63; MARS M, 1992, CLEFT PALATE-CRAN J, V29, P405, DOI 10.1597/1545-1569(1992)029<0405:ASCISO>2.3.CO;2; Mars M, 1990, CLEFT PALATE J, V1, P7; Mars M, 2006, CLEFT PALATE-CRAN J, V43, P557, DOI 10.1597/05-074; Mars M, 1985, 5 INT C CLEFT PAL CR; Meng T, 2007, J CRANIOFAC SURG, V18, P391, DOI 10.1097/01.scs.0000235109.15860.f7; MEREDITH HOWARD V., 1956, JOUR DENTAL RES, V35, P879, DOI 10.1177/00220345560350060801; MOLSTED K, 1992, CLEFT PALATE-CRAN J, V29, P398, DOI 10.1597/1545-1569(1992)029<0398:ASCISO>2.3.CO;2; MORRIS T, 1994, CLEFT PALATE-CRAN J, V31, P142, DOI 10.1597/1545-1569(1994)031<0142:IOAAOM>2.3.CO;2; Nollet PJPM, 2005, PLAST RECONSTR SURG, V116, P1255, DOI 10.1097/01.prs.0000181652.84855.a3; Perko M A, 1979, J Maxillofac Surg, V7, P46; Ross R B, 1987, Cleft Palate J, V24, P5; Ross R B, 1970, Cleft Palate J, V7, P37; Sandy J, 2012, 5 YEAR OLDS INDEX CO; SCHMID E, 1974, J MAXILLOFAC SURG, V2, P92, DOI 10.1016/S0301-0503(74)80020-2; SHAW WC, 1992, CLEFT PALATE-CRAN J, V29, P393, DOI 10.1597/1545-1569(1992)029<0393:ASCISO>2.3.CO;2; SHAW WC, 1992, CLEFT PALATE-CRAN J, V29, P413, DOI 10.1597/1545-1569(1992)029<0413:ASCISO>2.3.CO;2; Shaw WC, 2000, EUROCLEFT PROJECT 19; SILLMAN JH, 1964, AM J ORTHOD DENTOFAC, V50, P824, DOI 10.1016/0002-9416(64)90040-5; Sommerlad BC., 2009, COMPREHENSIVE CLEFT, P399; Susami T, 2006, CLEFT PALATE-CRAN J, V43, P96, DOI 10.1597/04-117R.1; Suzuki A, 2007, CLEFT PALATE-CRAN J, V44, P434, DOI 10.1597/06-069.1; WIJDEVELD MGMM, 1987, INT J ORAL MAX SURG, V16, P729, DOI 10.1016/S0901-5027(87)80060-7	64	0	0	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1545-1569	1055-6656		CLEFT PALATE-CRAN J	Cleft Palate-Craniofac. J.	MAY	2015	52	3					277	286		10.1597/13-285		10	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CH2YG	WOS:000353890900007		
J	Uto, T; Akagi, T; Akashi, M; Baba, M				Uto, Tomofumi; Akagi, Takami; Akashi, Mitsuru; Baba, Masanori			Induction of Potent Adaptive Immunity by the Novel Polyion Complex Nanoparticles	CLINICAL AND VACCINE IMMUNOLOGY			English	Article							POLY(GAMMA-GLUTAMIC ACID) NANOPARTICLES; DENDRITIC CELLS; BIODEGRADABLE NANOPARTICLES; VACCINE; INNATE; HYDROPHOBICITY; ADJUVANTS; RESPONSES; ANTIGEN; RECOGNITION	The development of effective and simple methods of vaccine preparation is desired for the prophylaxis and treatment of a variety of infectious diseases and cancers. We have created novel polyion complex (PIC) nanoparticles (NPs) composed of amphiphilic anionic biodegradable poly(gamma-glutamic acid) (gamma-PGA) and cationic polymers as a vaccine adjuvant. PIC NPs can be prepared by mixing gamma-PGA-graft-L-phenylalanine ethylester (gamma-PGA-Phe) polymer with cationic polymer in phosphate-buffered saline. We examined the efficacy of PIC NPs for antigen delivery and immunostimulatory activity in vitro and in vivo. PIC NPs enhanced the uptake of ovalbumin (OVA) by dendritic cells (DCs) and subsequently induced DC maturation. The immunization of mice with OVA-carrying PIC NPs induced potent and antigen-specific cellular and humoral immunity. Since PIC NPs can be created with water-soluble anionic gamma-PGA-Phe and a cationic polymer by simple mixing in the absence of any organic solvents, PIC NPs may have potential as a novel candidate for an effective antigen carrier and vaccine adjuvant.	[Uto, Tomofumi; Baba, Masanori] Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Div Antiviral Chemotherapy, Kagoshima 890, Japan; [Akagi, Takami; Akashi, Mitsuru] Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka, Japan; [Uto, Tomofumi; Akagi, Takami; Akashi, Mitsuru; Baba, Masanori] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Tokyo, Japan	Baba, M (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Div Antiviral Chemotherapy, Kagoshima 890, Japan.	m-baba@m2.kufm.kagoshima-u.ac.jp	Baba, Masanori/G-3867-2011		Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency (JST)	This work was supported by Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency (JST).	Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Shima F, 2013, BIOMATERIALS, V34, P9709, DOI 10.1016/j.biomaterials.2013.08.064; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Uto T, 2007, J IMMUNOL, V178, P2979; Murthy N, 1999, J CONTROL RELEASE, V61, P137, DOI 10.1016/S0168-3659(99)00114-5; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Saimura M, 2008, BIOTECHNOL LETT, V30, P377, DOI 10.1007/s10529-007-9563-7; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Akagi T, 2006, BIOMACROMOLECULES, V7, P297, DOI 10.1021/bm050657i; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Uto T, 2011, BIOMATERIALS, V32, P5206, DOI 10.1016/j.biomaterials.2011.03.052; Sorgi FL, 1997, GENE THER, V4, P961, DOI 10.1038/sj.gt.3300484; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x; Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Akagi T, 2010, LANGMUIR, V26, P2406, DOI 10.1021/la902868g; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; KREUTER J, 1988, VACCINE, V6, P253, DOI 10.1016/0264-410X(88)90220-4; Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Smith DM, 2013, NAT REV IMMUNOL, V13, P592, DOI 10.1038/nri3488; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Akagi T, 2005, J CONTROL RELEASE, V108, P226, DOI 10.1016/j.jconrel.2005.08.003; Akagi T, 2007, BIOMATERIALS, V28, P3427, DOI 10.1016/j.biomaterials.2007.04.023; Cohn L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00255; De Gregorio E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00214; Rosenthal JA, 2014, CURR OPIN BIOTECH, V7, P51; Sahdev P, 2014, PHARM RES-DORDR, V31, P2563, DOI 10.1007/s11095-014-1419-y; Sato Katsuaki, 2007, Allergol Int, V56, P183, DOI 10.2332/allergolint.R-06-139; Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8; Uto T, 2009, BIOCHEM BIOPH RES CO, V379, P600, DOI 10.1016/j.bbrc.2008.12.122; Wang X, 2007, J VIROL, V81, P10009, DOI 10.1128/JVI.00489-07	38	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	1556-6811	1556-679X		CLIN VACCINE IMMUNOL	Clin. Vaccine Immunol.	MAY	2015	22	5					578	585		10.1128/CVI.00080-15		8	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CG8OS	WOS:000353568300014		
J	Yokote, H; Shinmura, Y				Yokote, Hiroyuki; Shinmura, Yasuhiko			Reply to "Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky"	CLINICAL AND VACCINE IMMUNOLOGY			English	Letter							SAFETY		[Yokote, Hiroyuki; Shinmura, Yasuhiko] Chemo Sero Therapeut Res Inst KAKETSUKEN, Vaccine Div, Dept Dev, Kita Ku, Kumamoto, Kumamoto, Japan	Yokote, H (reprint author), Chemo Sero Therapeut Res Inst KAKETSUKEN, Vaccine Div, Dept Dev, Kita Ku, Kumamoto, Kumamoto, Japan.	yokote@kaketsuken.or.jp					Gordon SN, 2011, J INFECT DIS, V203, P1043, DOI 10.1093/infdis/jiq162; Yokote H, 2014, CLIN VACCINE IMMUNOL, V21, P1261, DOI 10.1128/CVI.00199-14; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Danon YL, 2015, CLIN VACCINE IMMUNOL, V22, P604, DOI 10.1128/CVI.00782-14	4	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	1556-6811	1556-679X		CLIN VACCINE IMMUNOL	Clin. Vaccine Immunol.	MAY	2015	22	5					605	605		10.1128/CVI.00055-15		1	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CG8OS	WOS:000353568300018		
J	Srisawasdi, P; Vanavanan, S; Rochanawutanon, M; Kruthkul, K; Kotani, K; Kroll, MH				Srisawasdi, Pornpen; Vanavanan, Somlak; Rochanawutanon, Mana; Kruthkul, Khanat; Kotani, Kazuhiko; Kroll, Martin H.			Small-dense LDL/large-buoyant LDL ratio associates with the metabolic syndrome	CLINICAL BIOCHEMISTRY			English	Article						Cardiovascular disease; Metabolic syndrome; Atherogenic dyslipidemia; Lipoprotein subpopulation; Small-dense low density lipoprotein; Large-buoyant low density lipoprotein	CARDIOMETABOLIC RISK; DEVELOPING-COUNTRIES; DIABETES-MELLITUS; LIPOPROTEIN; DEFINITION; MANAGEMENT; DISEASE; METAANALYSIS; CHOLESTEROL; GUIDELINES	Objective: Heterogeneous particles of intermediate-density lipoprotein (IDL) and low-density lipoprotein (LDL) vary in atherogenesis. We investigated the association between the metabolic syndrome (MetS) score and lipoprotein subclasses. Design and methods: A total of 260 outpatients were scored into six groups, based on their number of MetS components. Lipoprotein subclass determined by polyacrylamide tube gel electrophoresis separates IDL particles into three midbands (MID-A to C) and LDL into larger-buoyant (LDL1 and LDL2) and small-dense LDL (LDL3 to LDL6). Results: Mean concentrations of VLDL, MIDC, LDL2, and LDL3 to LDL6 positively correlated with increasing MetS score, but those of MIDA, LDL1 and HDL-C inversely correlated. LDL2 and LDL3 to LDL6 increased while MIDA and LDL1 decreased with increasing visceral fat, HOMA-IR, and triglycerides, with a reverse pattern for HDL-C. MIDB and MIDC were unchanged. By logistic regression, LDL1 and LDL3 to LDL6 significantly associates with the MetS score (odds ratio = 0.957 and 1.077, respectively). The ratio of (LDL3 to LDL6)/LDL1 in the presence of HDL-C, showed the strongest association with MetS. Conclusions: Respective subpopulations of IDL and LDL particles can vary in their ability to identify MetS. Because of the most strongly associated with MetS, (LDL3 to LDL6)/LDL1 ratio is proposed as an excellent marker for evaluating lipid metabolic status in patient with MetS. (C) 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Srisawasdi, Pornpen; Vanavanan, Somlak; Rochanawutanon, Mana] Mahidol Univ, Ramathibodi Hosp, Dept Pathol, Fac Med, Bangkok 10400, Thailand; [Kruthkul, Khanat] Mahidol Univ, Ramathibodi Hosp, Dept Med, Fac Med, Bangkok 10400, Thailand; [Kotani, Kazuhiko] Jichi Med Univ, Dept Clin Lab Med, Shimotsuke 3290498, Japan; [Kroll, Martin H.] Quest Diagnost, Madison, NJ 07940 USA	Vanavanan, S (reprint author), Ramathibodi Hosp, Fac Med, Dept Pathol, Div Clin Chem, Rama 6 Rd, Bangkok 10400, Thailand.	svanavanan47@gmail.com			Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand [56076]	This study was supported by a Research Grant from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand (56076).	Smith JD, 2012, J CLIN ENDOCR METAB, V97, P1517, DOI 10.1210/jc.2011-2550; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Sachdeva A, 2009, AM HEART J, V157, P111, DOI 10.1016/j.ahj.2008.08.010; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Diffenderfer MR, 2014, CURR OPIN LIPIDOL, V25, P221, DOI 10.1097/MOL.0000000000000067; Krentz AJ, 2003, DIABETES OBES METAB, V5, pS19, DOI 10.1046/j.1462-8902.2003.0310.x; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Rizzo M, 2009, TRANSL RES, V153, P217, DOI 10.1016/j.trsl.2009.01.008; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Mikhailidis DP, 2011, CURR VASC PHARMACOL, V9, P533; AUSTIN MA, 1990, CIRCULATION, V82, P495; Dashty M, 2014, THROMB HAEMOSTASIS, V111, P518, DOI 10.1160/TH13-02-0178; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI 10.1093/eurheartj/ehr158; Kathiresan S, 2006, CIRCULATION, V113, P20, DOI 10.1161/CIRCULATINAHA.105.567107; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Shiina Y, 2013, INTERNAL MED, V52, P1775, DOI 10.2169/internalmedicine.52.9190; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bancells C, 2010, J LIPID RES, V51, P3508, DOI 10.1194/jlr.M009258; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; King RI, 2011, ANN CLIN BIOCHEM, V48, P166, DOI 10.1258/acb.2010.010185; Kuk JL, 2010, DIABETES CARE, V33, P2457, DOI 10.2337/dc10-0942; National Cholesterol Education Program (NCEP); Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002, CIRCULATION, V106, P3143, DOI DOI 10.1001/ARCHINTE.1991.00400060019005; Pease RJ, 1996, CURR OPIN LIPIDOL, V7, P132, DOI 10.1097/00041433-199606000-00004; Srisawasdi P, 2013, CLIN BIOCHEM, V46, P1509, DOI 10.1016/j.clinbiochem.2013.06.021; Srisawasdi P, 2013, AM J CLIN PATHOL, V140, P506, DOI 10.1309/AJCPE5I3KELTBXEJ	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	MAY	2015	48	7-8					495	502		10.1016/j.clinbiochem.2015.01.011		8	Medical Laboratory Technology	Medical Laboratory Technology	CH2UB	WOS:000353879100007		
J	Weykamp, C; John, G; Gillery, P; English, E; Ji, LN; Lenters-Westra, E; Little, RR; Roglic, G; Sacks, DB; Takei, I				Weykamp, Cas; John, Garry; Gillery, Philippe; English, Emma; Ji, Linong; Lenters-Westra, Erna; Little, Randie R.; Roglic, Gojka; Sacks, David B.; Takei, Izumi		IFCC Task Force Implementation HbA	Investigation of 2 Models to Set and Evaluate Quality Targets for Hb A(1c): Biological Variation and Sigma-Metrics	CLINICAL CHEMISTRY			English	Article							ANALYTICAL BIAS; IMPRECISION; HBA(1C); NUMBER; LIMITS; GOALS	BACKGROUND: A major objective of the IFCC Task Force on Implementation of HbA(1c) Standardization is to develop a model to define quality targets for glycated hemoglobin (Hb A(1c)). METHODS: Two generic models, biological variation and sigma-metrics, are investigated. We selected variables in the models for Hb A(1c) and used data of external quality assurance/proficiency testing programs to evaluate the suitability of the models to set and evaluate quality targets within and between laboratories. RESULTS: In the biological variation model, 48% of individual laboratories and none of the 26 instrument groups met the minimum performance criterion. In the sigma-metrics model, with a total allowable error (TAE) set at 5 mmol/mol (0.46% NGSP), 77% of the individual laboratories and 12 of 26 instrument groups met the 2 sigma criterion. CONCLUSIONS: The biological variation and sigma-metrics models were demonstrated to be suitable for setting and evaluating quality targets within and between laboratories. The sigma-metrics model is more flexible, as both the TAE and the risk of failure can be adjusted to the situation for example, requirements related to diagnosis/monitoring or international authorities. With the aim of reaching (inter)national consensus on advice regarding quality targets for Hb A,5, the Task Force suggests the sigma-metrics model as the model of choice, with default values of 5 mmol/mol (0.46%) for TAE and risk levels of 2 sigma and 4 sigma for routine laboratories and laboratories performing clinical trials, respectively. These goals should serve as a starting point for discussion with international stakeholders in the field of diabetes. (C) 2015 American Association for Clinical Chemistry	[Weykamp, Cas] Locat Queen Beatrix Hosp, Dept Clin Chem, Winterswijk, Netherlands; [Weykamp, Cas] Locat Queen Beatrix Hosp, European Reference Lab, Winterswijk, Netherlands; [John, Garry] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England; [Gillery, Philippe] Univ Hosp Reims, Lab Pediat Biol & Res, Reims, France; [English, Emma] Univ Nottingham, Royal Derby Hosp, Sch Med, Derby, England; [Ji, Linong] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Lenters-Westra, Erna] Isala Clin, Dept Clin Chem, Zwolle, Netherlands; [Lenters-Westra, Erna] European Reference Lab, Location Isala, Zwolle, Netherlands; [Little, Randie R.] Univ Missouri, Sch Med, Dept Pathol, Columbia, MO 65212 USA; [Little, Randie R.] Univ Missouri, Sch Med, Dept Child Hlth, Columbia, MO 65212 USA; [Roglic, Gojka] WHO, Dept Management Noncommunicable Dis, CH-1211 Geneva, Switzerland; [Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA; [Takei, Izumi] Ichikawa Gen Hosp, Diabet & Endocrine Dept, Ichikawa, Japan	Weykamp, C (reprint author), Queen Beatrix Hosp, Dept Clin Chem, Beatrixpk 1, NL-7101 BN Winterswijk, Netherlands.	c.w.weykamp@skbwinterswijk.nl			Intramural Research Program of the NIH	D.B. Sacks, Intramural Research Program of the NIH.	Aarsand AK, 2015, CLIN CHEM LAB MED, V53, P153, DOI 10.1515/cclm-2014-1141; American Diabetes Association, 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011; American Diabetes Association, 2010, DIABETES CARE S1, V33, pS23; Roraas T, 2012, CLIN CHEM, V58, P1306, DOI 10.1373/clinchem.2012.187781; Bais R, 2013, CLIN CHEM LAB MED, V51, P973, DOI 10.1515/cclm-2013-0122; Braga F, 2011, CLIN CHIM ACTA, V412, P1412, DOI 10.1016/j.cca.2011.04.014; Miller WG, 2011, CLIN CHEM, V57, P1670, DOI 10.1373/clinchem.2011.168641; Lenters-Westra E, 2014, CLIN CHEM, V60, P1570, DOI 10.1373/clinchem.2014.227983; Fraser CG, 1997, ANN CLIN BIOCHEM, V34, P8; Weykamp CW, 2011, CLIN CHEM, V57, P1204, DOI 10.1373/clinchem.2011.162719; Carlsen S, 2011, CLIN CHEM LAB MED, V49, P1501, DOI 10.1515/CCLM.2011.233; Consensus Committee, 2007, Diabetes Care, V30, P2399, DOI 10.2337/dc07-9925; Kenny D, 1999, SCAND J CLIN LAB INV, V59, P585; National Institute for Health and Clinical Excellence, TYP 2 DIAB NEW AG; Nielsen AA, 2014, CLIN CHEM LAB MED, V52, P1069, DOI 10.1515/cclm-2013-0337; Petersen PH, 2014, CLIN CHIM ACTA, V430, P1, DOI 10.1016/j.cca.2013.12.014; WESTGARD JO, 1974, CLIN CHEM, V20, P825; Westgard JO, TOTAL ANAL ERROR CON; Westgard QC, QUALITY REQUIREMENTS	19	4	4	AMER ASSOC CLINICAL CHEMISTRY	WASHINGTON	2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA	0009-9147	1530-8561		CLIN CHEM	Clin. Chem.	MAY	2015	61	5					752	759				8	Medical Laboratory Technology	Medical Laboratory Technology	CH2GR	WOS:000353844200015		
J	Nakajima, S; Okada, T; Yamamoto, A; Kanagaki, M; Fushimi, Y; Okada, T; Arakawa, Y; Takagi, Y; Miyamoto, S; Togashi, K				Nakajima, Satoshi; Okada, Tomohisa; Yamamoto, Akira; Kanagaki, Mitsunori; Fushimi, Yasutaka; Okada, Tsutomu; Arakawa, Yoshiki; Takagi, Yasushi; Miyamoto, Susumu; Togashi, Kaori			Primary central nervous system lymphoma and glioblastoma: differentiation using dynamic susceptibility-contrast perfusion-weighted imaging, diffusion-weighted imaging, and F-18-fluorodeoxyglucose positron emission tomography	CLINICAL IMAGING			English	Article						Primary central nervous system lymphoma; Glioblastoma; Dynamic susceptibility-contrast perfusion-weighted imaging; Diffusion-weighted imaging F-18-fluorodeoxyglucose positron emission tomography	BRAIN-TUMORS; F-18-FDG PET; COMPUTED-TOMOGRAPHY; MALIGNANT-LYMPHOMA; GLIOMA; GRADE; MAPS	Objective: The objective was to evaluate diagnostic performance of dynamic susceptibility-contrast perfusion-weighted imaging, diffusion-weighted imaging, and F-18-fluorodeoxyglucose positron emission tomography in differentiating primary central nervous system lymphoma (PCNSL) and glioblastoma. Materials and methods: Twenty-three glioblastomas and 11 PCNSLs were analyzed with uncorrected cerebral blood volume (CBV) ratio, fifth percentile value of cumulative apparent diffusion coefficient histogram (ADC(5%)), and maximum standardized uptake value (SUVmax) using regions of interest created semiautomatically on enhancing areas. Results: Uncorrected CBV ratio was highly capable of differentiating PCNSL from glioblastoma, as well as SUVmax and ADC(5%). Conclusions: Uncorrected CBV ratio demonstrates high diagnostic performance comparable to SUVmax. (C) 2015 Elsevier Inc. All rights reserved.	[Nakajima, Satoshi; Okada, Tomohisa; Yamamoto, Akira; Kanagaki, Mitsunori; Fushimi, Yasutaka; Okada, Tsutomu; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan; [Arakawa, Yoshiki; Takagi, Yasushi; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan	Okada, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	tomokada@kuhp.kyoto-u.ac.jp					Ellingson BM, 2014, RADIOLOGY, V271, P200, DOI 10.1148/radiol.13131305; Olson JE, 2002, CANCER, V95, P1504, DOI 10.1002/cncr.10851; Benard F, 2003, SEMIN NUCL MED, V33, P148, DOI 10.1053/snuc.2003.127304; Kosaka N, 2008, AM J ROENTGENOL, V190, pW365, DOI 10.2214/AJR.07.2660; Yamaguchi S, 2014, ANN NUCL MED, V28, P603, DOI 10.1007/s12149-014-0851-8; Chu HH, 2013, RADIOLOGY, V269, P831, DOI 10.1148/radiol.13122024; Hartmann M, 2003, NEUROSCI LETT, V338, P119, DOI 10.1016/S0304-3940(02)01367-8; ROSENFELD SS, 1992, J NUCL MED, V33, P532; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Makino K, 2011, ANN NUCL MED, V25, P432, DOI 10.1007/s12149-011-0483-1; Willats L, 2013, NMR BIOMED, V26, P913, DOI 10.1002/nbm.2833; Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Matsushima N, 2012, ANN NUCL MED, V26, P262, DOI 10.1007/s12149-012-0570-y; Bhagavathi S, 2008, ARCH PATHOL LAB MED, V132, P1830, DOI 10.1043/1543-2165-132.11.1830; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Giese A, 2001, J CANCER RES CLIN, V127, P217, DOI 10.1007/s004320000188; Kadoch Cigall, 2006, Neurosurg Focus, V21, pE1; Koeller KK, 1997, RADIOGRAPHICS, V17, P1497; Louis ON, 2007, WHO CLASSIFICATION T, V4th, P188; Molnár P P, 1999, Neuro Oncol, V1, P89, DOI 10.1215/15228517-1-2-89; Okada Y, 2012, CLIN NUCL MED, V37, P843, DOI 10.1097/RLU.0b013e318262af48; Raoux D, 2010, NEUROPATHOLOGY, V30, P232, DOI 10.1111/j.1440-1789.2009.01074.x; Schultz CJ, 2010, INT J RADIAT ONCOL, V76, P666, DOI 10.1016/j.ijrobp.2009.10.011; Toh CH, 2013, AM J NEURORADIOL, V34, P1145, DOI 10.3174/ajnr.A3383; WATANABE M, 1992, NEURORADIOLOGY, V34, P36; Wesseling P, 1997, J NEURO-ONCOL, V32, P253, DOI 10.1023/A:1005746320099	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-7071	1873-4499		CLIN IMAG	Clin. Imaging	MAY-JUN	2015	39	3					390	395		10.1016/j.clinimag.2014.12.002		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CG9VT	WOS:000353668900008		
J	Iwata, K; Fukuchi, T; Yoshimura, K				Iwata, Kentaro; Fukuchi, Takahiko; Yoshimura, Kenichi			Is the Quality of Sushi Ruined by Freezing Raw Fish and Squid? A Randomized Double-Blind Trial With Sensory Evaluation Using Discrimination Testing	CLINICAL INFECTIOUS DISEASES			English	Article						sushi; anisakidosis; freezing; sensory evaluation	ANISAKIASIS; JAPAN	Background. Sushi is a traditional Japanese cuisine enjoyed worldwide. However, using raw fish to make sushi may pose risk of certain parasitic infections, such as anisakidosis, which is most reported in Japan. This risk of infection can be eliminated by freezing fish; however, Japanese people are hesitant to freeze fish because it is believed that freezing ruins sushi's taste. Methods. A randomized double-blind trial with discrimination testing was conducted to examine the ability of Japanese individuals to distinguish between frozen and unfrozen sushi. A pair of mackerel and squid sushi, one once frozen and the other not, was provided to the participants, and they were asked to answer which one tasted better. Results. Among 120 rounds of discrimination testing involving the consumption of 240 pieces of mackerel sushi, unfrozen sushi was believed to taste better in 42.5% (51 dishes) of cases, frozen sushi was thought to taste better in 49.2% (59 dishes), and the participants felt the taste was the same in 8.3% (10 dishes). The odds ratio for selecting unfrozen sushi as "tastes better" over frozen sushi was 0.86 (95% confidence interval [CI],.59-1.26; P=.45). For squid, unfrozen sushi was believed to be superior 48.3% of the time (58 dishes), and frozen sushi, 35.0% of the time (42 dishes). They were felt to be the same in 16.7% (20 dishes) (odds ratio, 1.38; 95% CI,.93-2.05; P=.11). Conclusions. Freezing raw fish did not ruin sushi's taste. These findings may encourage the practice of freezing fish before using it in sushi, helping to decrease the incidence of anisakidosis.	[Iwata, Kentaro; Fukuchi, Takahiko] Kobe Univ, Grad Sch Med, Div Infect Dis Therapeut, Kobe, Hyogo 6500017, Japan; [Yoshimura, Kenichi] Kanazawa Univ Hosp, Innovat Clin Res Ctr iCREK, Kanazawa, Ishikawa, Japan	Iwata, K (reprint author), Kobe Univ, Grad Sch Med, Div Infect Dis Therapeut, Chuo Ku, Kusunokicho 7-5-2, Kobe, Hyogo 6500017, Japan.	kiwata@med.kobe-u.ac.jp					Nawa Y, 2005, CLIN INFECT DIS, V41, P1297, DOI 10.1086/496920; Kawai T, 2012, CLIN INFECT DIS, V54, P1046, DOI 10.1093/cid/cir1040; Hochberg NS, 2010, CLIN INFECT DIS, V51, P806, DOI 10.1086/656238; COX DR, 1972, J R STAT SOC B, V34, P187; Bucci C, 2013, INT J INFECT DIS, V17, pE1071, DOI 10.1016/j.ijid.2013.05.008; Clayton D, 1993, STAT METHODS EPIDEMI; Fisher RA, 1956, WORLD MATH, V3; Kasumi W T, 1993, Int J Technol Assess Health Care, V9, P416; National Institute of Infectious Diseases, ON AN; Organisation for Economic Cooperation and Development, HLTH GLANC 2009 OECD; OSHIMA T, 1987, PARASITOL TODAY, V3, P44, DOI 10.1016/0169-4758(87)90212-2; US Food and Drug Administration, FISH FISH PROD HAZ C; Wallop H, 2007, TELEGRAPH; What's up with Amsterdam, RAW HERR; Yasunaga H, 2010, AM J TROP MED HYG, V83, P104, DOI 10.4269/ajtmh.2010.09-0780; Zarembka P., 1974, FRONTIERS ECONOMETRI, P105	16	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1058-4838	1537-6591		CLIN INFECT DIS	Clin. Infect. Dis.	MAY 1	2015	60	9					E43	E48		10.1093/cid/civ057		6	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CH0NS	WOS:000353718400001		
J	Uchiyama, M; Konno, N; Shibuya, S; Nogami, S				Uchiyama, Minoru; Konno, Norifumi; Shibuya, Sachika; Nogami, Satoshi			Cloning and expression of the epithelial sodium channel and its role in osmoregulation of aquatic and estivating African lungfish Protopterus annectens	COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY			English	Article						Aldosterone; Dipnoi; Estivation; Plasma sodium concentration; Plasma urea concentration; Sodium channel	MESSENGER-RNA EXPRESSION; NA+ CHANNEL; NEOCERATODUS-FORSTERI; AUSTRALIAN LUNGFISH; METABOLISM; DOLLOI; WATER; FISH; FAMILY; KIDNEY	The epithelial sodium channel (ENaC) is a sodium (Na+)-selective aldosterone-stimulated ion channel involved in Na+ transport homeostasis of tetrapods. We examined full-length cDNA sequences and tissue distributions of ENaC alpha, ENaC beta, and ENaC gamma subunits in the African lungfish Protopterus annectens. Protopterus ENaC (pENaC) comprises 3 subunits: pENaC alpha, pENaC beta, and pENaC gamma. pENaC alpha, pENaC beta, and pENaC gamma subunits are closely related to alpha, beta, and gamma subunits of the Australian lungfish Neoceratodus forsteri ENaC (nENaC), respectively. Three ENaC subunit mRNAs were highly expressed in the gills and moderately expressed in the kidney and rectum of P. annectens. During estivation for 2-4 weeks and 2-3 months, plasma Na+ concentration was relatively stable, but plasma urea concentration significantly increased in comparison with the control fish kept in a freshwater environment. Plasma aldosterone concentration and mRNA expression of the ENaCa. subunit gradually and significantly decreased in the gills and kidney after 2 months of estivation. Thus, aldosterone-dependent Na+ absorption via ENaC probably exists in the epithelial cells of osmoregulatory organs of lungfish kept in fresh water, whereas plasma Na+ concentration may be maintained by a mechanism independent of aldosterone-ENaC axis during estivation in lungfish. (C) 2014 Elsevier Inc All rights reserved.	[Uchiyama, Minoru; Konno, Norifumi; Shibuya, Sachika; Nogami, Satoshi] Toyama Univ, Grad Sch Sci & Engn, Dept Life & Environm Sci, Toyama 9308555, Japan	Uchiyama, M (reprint author), Toyama Univ, Grad Sch Sci & Engn, Dept Life & Environm Sci, 3190 Gofuku, Toyama 9308555, Japan.	uchiyama@sci.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [2440164]; Salt Science Research Foundation [1131]	This work was supported, in part, by a Grant-in-Aid for Scientific Research (No. 2440164) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to M.U. and The Salt Science Research Foundation (No. 1131) to N.K.	Konno N, 2010, ENDOCRINOLOGY, V151, P1089, DOI 10.1210/en.2009-1070; Loong AM, 2012, J COMP PHYSIOL B, V182, P367, DOI 10.1007/s00360-011-0626-7; Chew SF, 2004, J EXP BIOL, V207, P777, DOI 10.1242/jeb.00813; Garty H, 1997, PHYSIOL REV, V77, P359; Studer RA, 2011, PHYSIOL GENOMICS, V43, P844, DOI 10.1152/physiolgenomics.00002.2011; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Ji HL, 2012, AM J PHYSIOL-LUNG C, V303, pL1013, DOI 10.1152/ajplung.00206.2012; Ojeda JL, 2008, ANAT REC, V291, P1156, DOI 10.1002/ar.20729; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Smith HW, 1930, J BIOL CHEM, V88, P97; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Icardo JM, 2012, ANAT REC, V295, P60, DOI 10.1002/ar.21476; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Brinkmann H, 2004, P NATL ACAD SCI USA, V101, P4900, DOI 10.1073/pnas.0400609101; Wright PA, 2007, FISH PHYSIOL, V26, P283, DOI 10.1016/S1546-5098(07)26006-6; Bentley P.J, 2002, ZOOPHYSIOLOGY, V39; BLAIRWEST JR, 1977, J ENDOCRINOL, V74, P137, DOI 10.1677/joe.0.0740137; Cartledge VA, 2008, PHYSIOL BIOCHEM ZOOL, V81, P43, DOI 10.1086/523856; Fishman AP, 1986, J MORPHOL S, V190, P237; Graham JB, 1997, AIR BREATHING FISHES; Greenwood P.H., 1986, J MORPHOL S, V190, P163, DOI DOI 10.1002/JMOR.1051900412; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P96; IP YK, 2010, NITROGEN METABOLISM, V49, P63; Konno N, 2007, CELL TISSUE RES, V328, P583, DOI 10.1007/s00441-007-0383-9; Kumai Y, 2012, RESP PHYSIOL NEUROBI, V184, P249, DOI 10.1016/j.resp.2012.06.009; MERKLE S, 1988, COMP BIOCHEM PHYS B, V89, P719, DOI 10.1016/0305-0491(88)90314-8; Reynolds SJ, 2011, COMP BIOCHEM PHYS A, V160, P348, DOI 10.1016/j.cbpa.2011.06.028; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Sturia M, 2002, J EXP ZOOL, V292, P26, DOI 10.1002/jez.1139; Uchiyama M, 2012, P ROY SOC B-BIOL SCI, V279, P4795, DOI 10.1098/rspb.2012.1945; Uchiyama M, 2011, J EXP ZOOL PART B, V316B, P135, DOI 10.1002/jez.b.21384; Wilkie MP, 2007, PHYSIOL BIOCHEM ZOOL, V80, P99, DOI 10.1086/508837	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1095-6433	1531-4332		COMP BIOCHEM PHYS A	Comp. Biochem. Physiol. A-Mol. Integr. Physiol.	MAY	2015	183						1	8		10.1016/j.cbpa.2014.12.028		8	Biochemistry & Molecular Biology; Physiology; Zoology	Biochemistry & Molecular Biology; Physiology; Zoology	CH0TB	WOS:000353734200001		
J	Okubo, H; Miyamoto, T; Yoshida, S; Mori, K; Kitamura, S; Izui, Y				Okubo, Hironori; Miyamoto, Toshiyuki; Yoshida, Satoshi; Mori, Kazuyuki; Kitamura, Shoichi; Izui, Yoshio			Project scheduling under partially renewable resources and resource consumption during setup operations	COMPUTERS & INDUSTRIAL ENGINEERING			English	Article						Project scheduling; Energy saving; RCPSP; Partially renewable resources; Setup operations	TARDINESS PENALTY; DECISION-SUPPORT; CONSTRAINT; ALGORITHM; CLASSIFICATION; EXTENSIONS	There has been an increasing pressure on manufacturing industries to reduce energy consumption. In this study, we propose a new variant of RCPSP called RCPSP/pi RC, which can deal with realistic energy constraints such as power restriction during peak hours, contract demand, and energy consumption during setup operations. First, we present an integer programming (IP) model and a constraint programming (CP) model of the RCPSP/pi RC. Next, we present a heuristic mode restriction method called a mask calculation algorithm to achieve efficient searching by restricting selectable modes. Finally, through computational experiments, we evaluate the proposed methods and show their effectiveness. (c) 2015 Elsevier Ltd. All rights reserved.	[Okubo, Hironori; Miyamoto, Toshiyuki; Yoshida, Satoshi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Mori, Kazuyuki; Kitamura, Shoichi; Izui, Yoshio] Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo 6618661, Japan	Miyamoto, T (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	miyamoto@eei.eng.osaka-u.ac.jp					Alvarez-Valdes R, 2008, EUR J OPER RES, V189, P1153, DOI 10.1016/j.ejor.2006.06.073; BLAZEWICZ J, 1983, DISCRETE APPL MATH, V5, P11, DOI 10.1016/0166-218X(83)90012-4; Brucker P, 1999, EUR J OPER RES, V112, P3, DOI 10.1016/S0377-2217(98)00204-5; Drexl A, 2000, EUR J OPER RES, V125, P59, DOI 10.1016/S0377-2217(99)00205-2; Delgado A, 2012, EUR J OPER RES, V220, P251, DOI 10.1016/j.ejor.2012.01.028; Coelho J, 2011, EUR J OPER RES, V213, P73, DOI 10.1016/j.ejor.2011.03.019; Fang KT, 2013, COMPUT IND ENG, V64, P224, DOI 10.1016/j.cie.2012.10.002; Zhu GD, 2006, INFORMS J COMPUT, V18, P377, DOI 10.1287/ijoc.1040.0121; Bouleimen K, 2003, EUR J OPER RES, V149, P268, DOI 10.1016/S0377-2217(02)00761-0; Hartmann S, 2010, EUR J OPER RES, V207, P1, DOI 10.1016/j.ejor.2009.11.005; Bartsch T, 2006, COMPUT OPER RES, V33, P1907, DOI 10.1016/j.cor.2004.09.037; Battcher J., 1999, MANAGE SCI, V45, P543; Das K, 2009, COMPUT IND ENG, V56, P283, DOI 10.1016/j.cie.2008.06.001; Demassey S, 2005, INFORMS J COMPUT, V17, P52, DOI 10.1287/ijoc.1030.0043; Dietmair A, 2009, INT J SUSTAINABLE EN, V2, P123, DOI DOI 10.1080/19397030902947041; Hartmann S, 1998, NAV RES LOG, V45, P733, DOI 10.1002/(SICI)1520-6750(199810)45:7<733::AID-NAV5>3.3.CO;2-7; IBM, 2012, IBM ILOG CPLEX OPT S; Johnson D. S., 1979, COMPUTERS INTRACTABI; Brucker P, 2012, GOR-PUBL, P1, DOI 10.1007/978-3-642-23929-8; Kolisch R., 1995, MANAGE SCI, V41, P1693; Lova A., 2006, INTELIGENCIA ARTIFIC, V30, P69; Nonobe K, 2002, OPERAT RES COMP SCI, V15, P557; Ranjbar M, 2012, COMPUT IND ENG, V62, P264, DOI 10.1016/j.cie.2011.09.013; Smith LD, 2004, INFOR, V42, P79; Trojet M, 2011, COMPUT IND ENG, V61, P357, DOI 10.1016/j.cie.2010.08.014; Wierkle D., 2002, IEEE T EVOLUTIONARY, V6, P333; Williams H. P., 2013, MODEL BUILDING MATH; Zeng LS, 2012, COMPUT OPER RES, V39, P1692, DOI 10.1016/j.cor.2011.10.004	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0360-8352	1879-0550		COMPUT IND ENG	Comput. Ind. Eng.	MAY	2015	83						91	99		10.1016/j.cie.2015.02.006		9	Computer Science, Interdisciplinary Applications; Engineering, Industrial	Computer Science; Engineering	CH0XX	WOS:000353746800007		
J	Hidaka, N; Murata, M; Sasahara, J; Ishii, K; Mitsuda, N				Hidaka, Nobuhiro; Murata, Masaharu; Sasahara, Jun; Ishii, Keisuke; Mitsuda, Nobuaki			Correlation between lung to thorax transverse area ratio and observed/expected lung area to head circumference ratio in fetuses with left- sided diaphragmatic hernia	CONGENITAL ANOMALIES			English	Article						congenital diaphragmatic hernia; lung hypoplasia; lung to thorax transverse area ratio; observed; expected lung area to head circumference ratio	SURVIVAL; HYPOPLASIA; PREDICTION; TERM	Observed/expected lung area to head circumference ratio (o/e LHR) and lung to thorax transverse area ratio (LTR) are the sonographic indicators of postnatal outcome in fetuses with congenital diaphragmatic hernia (CDH), and they are not influenced by gestational age. We aimed to evaluate the relationship between these two parameters in the same subjects with fetal left-sided CDH. Fetuses with left-sided CDH managed between 2005 and 2012 were included. Data of LTR and o/e LHR values measured on the same day prior to 33 weeks' gestation in target fetuses were retrospectively collected. The correlation between the two parameters was estimated using the Spearman's rank-correlation coefficient, and linear regression analysis was used to assess the relationship between them. Data on 61 measurements from 36 CDH fetuses were analyzed to obtain a Spearman's rank-correlation coefficient of 0.74 with the following linear equation: LTR=0.002x(o/e LHR) + 0.005. The determination coefficient of this linear equation was sufficiently high at 0.712, and the prediction accuracy obtained with this regression formula was considered satisfactory. A good linear correlation between the LTR and the o/e LHR was obtained, suggesting that we can translate the predictive parameters for each other. This information is expected to be useful to improve our understanding of different investigations focusing on LTR or o/e LHR as a predictor of postnatal outcome in CDH.	Osaka Med Ctr, Dept Maternal Fetal Med, Izumi, Japan; Res Inst Maternal & Child Hlth, Izumi, Japan	Hidaka, N (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hidaka.nobuhiro.484@m.kyushu-u.ac.jp					Alfaraj MA, 2011, AM J OBSTET GYNECOL, V205, pe1; Victoria T, 2012, PRENATAL DIAG, V32, P715, DOI 10.1002/pd.3890; Peralta CFA, 2005, ULTRASOUND OBST GYN, V26, P718, DOI 10.1002/uog.2651; DeKoninck P, 2011, EARLY HUM DEV, V87, P619, DOI 10.1016/j.earlhumdev.2011.08.001; Lipshutz GS, 1997, J PEDIATR SURG, V32, P1634, DOI 10.1016/S0022-3468(97)90471-1; Metkus AP, 1996, J PEDIATR SURG, V31, P148, DOI 10.1016/S0022-3468(96)90338-3; Hayakawa M, 2013, PEDIATR INT, V55, P190, DOI 10.1111/ped.12059; Jani J, 2007, ULTRASOUND OBST GYN, V30, P67, DOI 10.1002/uog.4052; HASEGAWA T, 1990, J CLIN ULTRASOUND, V18, P705; Hidaka N, 2014, J OBSTET GYNAECOL RE, V40, P429, DOI 10.1111/jog.12210; Jani J, 2008, ULTRASOUND OBST GYN, V31, P37, DOI 10.1002/uog.5198; KAMATA S, 1992, EARLY HUM DEV, V29, P375, DOI 10.1016/0378-3782(92)90195-M; Nakata M, 2003, EARLY HUM DEV, V72, P75, DOI 10.1016/S0378-3782(03)00026-4; Tsukimori K, 2008, J ULTRAS MED, V27, P707; Usui N, 2014, J PEDIATR SURG, V49, P1191, DOI 10.1016/j.jpedsurg.2013.10.021; Usui N, 2011, PEDIATR SURG INT, V27, P39, DOI 10.1007/s00383-010-2725-z	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	MAY	2015	55	2					81	84		10.1111/cga.12092		4	Pediatrics	Pediatrics	CH2ZQ	WOS:000353895300002		
J	Hirawatari, K; Hanzawa, N; Kuwahara, M; Aoyama, H; Miura, I; Wakana, S; Gotoh, H				Hirawatari, Keitaro; Hanzawa, Naoto; Kuwahara, Maki; Aoyama, Hiroaki; Miura, Ikuo; Wakana, Shigeharu; Gotoh, Hideo			Polygenic expression of teratozoospermia and normal fertility in B10.MOL-TEN1 mouse strain	CONGENITAL ANOMALIES			English	Article						genetics; male fertility; reproduction	2-GENERATION REPRODUCTION TOXICITY; DOMINANT LETHAL; RATS; MUTATION; MICE	Subfertility and infertility are two major reproductive health problems in human and domestic animals. The contribution of the genotype to these conditions is poorly understood. To examine the genetic basis of male subfertility, we analyzed its relationship to sperm morphology in B10.MOL-TEN1 mice, which shows high-frequencies (about 50%) of morphologically abnormal sperm. Drastic histological changes were also found in the testis of the B10.MOL-TEN1. Segregation analysis showed that the abnormal sperm phenotype in B10.MOL-TEN1 was inherited and was predictably controlled by at least three loci. We also found that male fertility of this strain was normal. These findings indicate a complicated relationship between sperm morphology and male subfertility.	[Hirawatari, Keitaro; Gotoh, Hideo] Natl Inst Agrobiol Sci, Anim Genome Res Unit, Agrogen Res Ctr, Tsukuba, Ibaraki 3050851, Japan; [Hirawatari, Keitaro; Hanzawa, Naoto] RIKEN BioResource Ctr, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki, Japan; [Kuwahara, Maki; Aoyama, Hiroaki] Yamagata Univ, Grad Sch Sci & Engn, Yamagata 990, Japan; [Miura, Ikuo; Wakana, Shigeharu] Inst Environm Toxicol, Toxicol Div, Joso, Ibaraki, Japan	Gotoh, H (reprint author), Natl Inst Agrobiol Sci, Anim Genome Res Unit, Agrogen Res Ctr, 1-2 Owashi, Tsukuba, Ibaraki 3050851, Japan.	gotoh@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries, Japan	The authors acknowledge the assistance of Mr Masayuki Araki and Mr Heiichi Uchiyama with the experiments. We thank Dr Shiroishi for providing us B10.MOL-TEN1 strain of mouse. This work was supported by the Ministry of Agriculture, Forestry, and Fisheries, Japan.	Jamsai D, 2011, ASIAN J ANDROL, V13, P139, DOI 10.1038/aja.2010.101; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Massart A, 2012, ASIAN J ANDROL, V14, P40, DOI 10.1038/aja.2011.67; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Lewis SEM, 2007, REPRODUCTION, V134, P31, DOI 10.1530/REP-07-0152; Gotoh H, 2010, REPROD FERT DEVELOP, V22, P1066, DOI 10.1071/RD09295; Aoyama H, 2012, CONGENIT ANOM, V52, P28, DOI 10.1111/j.1741-4520.2011.00344.x; Aitken RJ, 2006, INT J ANDROL, V29, P69, DOI 10.1111/j.1365-2605.2005.00630.x; Flachs P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003044; Gotoh H, 2012, MAMM GENOME, V23, P399, DOI 10.1007/s00335-012-9395-1; Gotoh H, 2012, CONGENIT ANOM, V52, P186, DOI 10.1111/j.1741-4520.2012.00379.x; Handel MA, 2006, MOL CELL ENDOCRINOL, V250, P201, DOI 10.1016/j.mce.2005.12.046; Hojo Hitoshi, 2006, Congenital Anomalies, V46, P105, DOI 10.1111/j.1741-4520.2006.00110.x; Peripato AC, 2004, J EVOLUTION BIOL, V17, P593, DOI 10.1111/j.1420-9101.2004.00702.x; Russel RD, 1990, HISTOLOGICAL HISTOPA, V1st, P119; SHIROISHI T, 1982, NATURE, V300, P370, DOI 10.1038/300370a0; TERAMOTO S, 1980, MUTAT RES, V77, P71, DOI 10.1016/0165-1218(80)90122-6; TEZUKA H, 1978, MUTAT RES, V57, P201, DOI 10.1016/0027-5107(78)90269-5; Visser L, 2010, REPRODUCTION, V139, P230	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	MAY	2015	55	2					92	98		10.1111/cga.12102		7	Pediatrics	Pediatrics	CH2ZQ	WOS:000353895300004		
J	Taketani, K; Yamada, S; Uwabe, C; Okada, T; Togashi, K; Takakuwa, T				Taketani, Kaori; Yamada, Shigehito; Uwabe, Chigako; Okada, Tomohisa; Togashi, Kaori; Takakuwa, Tetsuya			Morphological features and length measurements of fetal lateral ventricles at 16-25 weeks of gestation by magnetic resonance imaging	CONGENITAL ANOMALIES			English	Article						fetal lateral ventricles; length measurements; magnetic resonance imaging; morphology; three-dimensional reconstruction	3-DIMENSIONAL ULTRASOUND; BRAIN DEVELOPMENT; FETUSES; MRI; EMBRYOS; ATLAS	Normal growth of the lateral ventricles (LVs) was characterized three-dimensionally using magnetic resonance imaging (MRI) data from 16 human fetuses at 16-25 weeks of gestation. The LV was differentiated into four primary regions, the anterior horn, central parts, posterior horn, and inferior horn, at 16 weeks of gestation. The LV changed shape mainly by elongation and narrowing, which corresponded to the external and internal growth of the surrounding cerebrum. Six length parameters measured in the LV correlated with biparietal diameter by simple regression analysis (R-2 range, 0.56-0.93), which may be valuable for establishing a standardized prenatal protocol to assess fetal well-being and development across intrauterine periods. No correlation was found between biparietal diameter and LV volume (R-2=0.13).	[Taketani, Kaori; Yamada, Shigehito; Takakuwa, Tetsuya] Kyoto Univ, Human Hlth Sci, Kyoto 6068507, Japan; [Yamada, Shigehito; Uwabe, Chigako] Kyoto Univ, Congenital Anomaly Res Ctr, Kyoto 6068507, Japan; [Okada, Tomohisa; Togashi, Kaori] Kyoto Univ, Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto 6068507, Japan	Takakuwa, T (reprint author), Kyoto Univ, Human Hlth Sci, Grad Sch Med, Sakyo Ku, Shogoin Kawahara Cyo 53, Kyoto 6068507, Japan.	tez@hs.med.kyoto-u.ac.jp			Japan Society for the Promotion of Science [22591199, 24119002, 24790195, 25461642]	This study was supported by grants #22591199, #24119002, #24790195 and #25461642 from the Japan Society for the Promotion of Science.	Gholipour A, 2012, NEUROIMAGE, V60, P1819, DOI 10.1016/j.neuroimage.2012.01.128; Mailath-Pokorny M, 2012, SEMIN FETAL NEONAT M, V17, P278, DOI 10.1016/j.siny.2012.06.002; Girard NJ, 2012, J MAGN RESON IMAGING, V36, P788, DOI 10.1002/jmri.23596; Studholme C, 2011, ANNU REV BIOMED ENG, V13, P345, DOI [10.1146/annurev-bioeng-071910-124654, 10.1146/annurev-biocng-071910-124654]; Hikishima K, 2013, NEUROSCIENCE, V230, P102, DOI 10.1016/j.neuroscience.2012.09.053; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Pooh RK, 2012, SEMIN FETAL NEONAT M, V17, P261, DOI 10.1016/j.siny.2012.05.008; Blaas HG, 1998, LANCET, V352, P1182, DOI 10.1016/S0140-6736(98)03227-9; Blaas HGK, 2014, BEST PRACT RES CL OB, V28, P341, DOI 10.1016/j.bpobgyn.2013.11.004; Blaas HGK, 2009, PRENATAL DIAG, V29, P312, DOI 10.1002/pd.2170; Bulas Dorothy, 2007, Ultrasound Q, V23, P3, DOI 10.1097/01.ruq.0000263841.69689.a7; Corliss CE, 1976, PATTENS HUMAN EMBRYO, P199; Fukunishi K, 2011, ACTA NEUROBIOL EXP, V71, P381; Glenn OA, 2009, SEMIN PERINATOL, V33, P208, DOI 10.1053/j.semperi.2009.04.009; Hamabe Y, 2013, HEPATOL RES, V43, P639, DOI 10.1111/hepr.12000; Hata T, 2011, J OBSTET GYNAECOL RE, V37, P1748, DOI 10.1111/j.1447-0756.2011.01595.x; Kinoshita Y, 2001, AM J NEURORADIOL, V22, P382; Li Y, 2011, AM J ROENTGENOL, V196, P1457, DOI 10.2214/AJR.10.5422; NISHIMUR.H, 1968, TERATOLOGY, V1, P281, DOI 10.1002/tera.1420010306; Pooh RK, 2012, SEMIN FETAL NEONAT M, V17, P269, DOI 10.1016/j.siny.2012.06.003; Pooh RK, 2011, J PERINAT MED, V39, P3, DOI 10.1515/JPM.2010.118; Scott JA, 2013, BRAIN STRUCT FUNCT, V218, P645, DOI 10.1007/s00429-012-0418-1; SHIOTA K, 1991, Congenital Anomalies, V31, P67, DOI 10.1111/j.1741-4520.1991.tb00360.x; Shiraishi N, 2013, ANAT REC, V296, P692, DOI 10.1002/ar.22662; vans Duijns S, 2011, MAGN RESON MED, V65, P1750; Wyldes M, 2004, ARCH DIS CHILD, V89, pF9, DOI 10.1136/fn.89.1.F9; Yamada S, 2004, BIRTH DEFECTS RES A, V70, P495, DOI 10.1002/bdra.20048	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	MAY	2015	55	2					99	102		10.1111/cga.12076		4	Pediatrics	Pediatrics	CH2ZQ	WOS:000353895300005		
J	Saito, S; Sawada, K; Mori, Y; Yoshioka, Y; Murase, K				Saito, Shigeyoshi; Sawada, Kazuhiko; Mori, Yuki; Yoshioka, Yoshichika; Murase, Kenya			Brain and arterial abnormalities following prenatal X-ray irradiation in mice assessed by magnetic resonance imaging and angiography	CONGENITAL ANOMALIES			English	Article						brain abnormalities; cerebral artery malformation; magnetic resonance angiography; magnetic resonance imaging; prenatal radiation exposure	BOMB SURVIVORS; RADIATION; RATS; EXPOSURE; DAMAGE	The present study aimed to quantitatively characterize changes in the whole brain and arterial morphology in response to prenatal ionizing irradiation. Magnetic resonance imaging (MRI) and angiography (MRA) were used to evaluate brain and arterial abnormalities in 8-week-old male mice prenatally exposed to X-ray radiation at a dose of 0.5 or 1.0 Gy on embryonic day (E) 13. Irradiated mice demonstrated decreased brain volume, increased ventricular volume, and arterial malformation. Additionally, MRA signal intensity and arterial thickness in the anterior cerebral artery, middle cerebral artery, and basilar artery were lower in radiation-exposed mice than in control mice. MRI and MRA are useful tools for assessing brain and arterial abnormalities after prenatal exposure to radiation.	[Saito, Shigeyoshi; Murase, Kenya] Osaka Univ, Dept Med Engn, Div Hlth Sci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Saito, Shigeyoshi; Mori, Yuki; Yoshioka, Yoshichika; Murase, Kenya] Osaka Univ, Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks CiNet, Osaka, Japan; [Mori, Yuki; Yoshioka, Yoshichika] Osaka Univ, Biofunct Imaging Lab, Immunol Frontier Res Ctr WPI IFReC, Osaka, Japan; [Sawada, Kazuhiko] Tsukuba Int Univ, Fac Med & Hlth Sci, Dept Phys Therapy, Ibaraki, Japan	Saito, S (reprint author), Osaka Univ, Div Med Technol & Sci, Dept Med Phys & Engn, Fac Hlth Sci,Grad Sch Med, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	saito@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24791299, 24300167, 26870339]	This work was supported by Grants-in-Aid for Scientific Research (Kakenhi no. 24791299, no. 24300167 and no. 26870339) from the Japan Society for the Promotion of Science (JSPS).	Otake M, 1998, INT J RADIAT BIOL, V74, P159, DOI 10.1080/095530098141555; Fajardo LF, 2005, ACTA ONCOL, V44, P13, DOI 10.1080/0284186051007440; Hayashi T, 2003, INT J RADIAT BIOL, V79, P129, DOI 10.1080/0955300021000038662; Autio J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024056; BLOT W J, 1975, Journal of Radiation Research, V16, P82, DOI 10.1269/jrr.16.SUPPLEMENT_82; Bolaris S, 2001, INT J RADIAT BIOL, V77, P71; HOSHINO K, 1988, TERATOLOGY, V37, P257, DOI 10.1002/tera.1420370311; Kitamura Makiko, 2001, Kobe Journal of Medical Sciences, V47, P59; MIKI T, 1995, NEUROSCI RES, V23, P241, DOI 10.1016/0168-0102(95)00947-7; OTAKE M, 1991, J RADIAT RES, V32, P249, DOI 10.1269/jrr.32.SUPPLEMENT_249; Saito S, 2011, RADIAT RES, V175, P1, DOI 10.1667/RR2134.1; Saito S, 2012, NMR BIOMED, V25, P75, DOI 10.1002/nbm.1715; Saito S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107368; Sawada K, 2013, CONGENIT ANOM, V53, P127, DOI 10.1111/cga.12016; Sawada K, 2014, CONGENIT ANOM, V54, P87, DOI 10.1111/cga.12028; Sun XZ, 2002, J RADIAT RES, V43, P89, DOI 10.1269/jrr.43.89; Takai N, 2004, J RADIAT RES, V45, P563, DOI 10.1269/jrr.45.563	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	MAY	2015	55	2					103	106		10.1111/cga.12101		4	Pediatrics	Pediatrics	CH2ZQ	WOS:000353895300006		
J	Kaga, A; Murotsuki, J; Kamimura, M; Kimura, M; Saito-Hakoda, A; Kanno, J; Hoshi, K; Kure, S; Fujiwara, I				Kaga, Akimune; Murotsuki, Jun; Kamimura, Miki; Kimura, Masato; Saito-Hakoda, Akiko; Kanno, Junko; Hoshi, Kazuhiko; Kure, Shigeo; Fujiwara, Ikuma			Association of achondroplasia with Down syndrome: Difficulty in prenatal diagnosis by sonographic and 3-D helical computed tomographic analyses	CONGENITAL ANOMALIES			English	Article						achondroplasia; Down syndrome; fibroblast growth factor receptor 3; prenatal 3-D helical computed tomographic analysis; prenatal sonographic analysis	SKELETAL DYSPLASIAS; FEMUR; ULTRASOUND; MUTATION; MARKERS; HUMERUS	Achondroplasia and Down syndrome are relatively common conditions individually. But co-occurrence of both conditions in the same patient is rare and there have been no reports of fetal analysis of this condition by prenatal sonographic and three-dimensional (3-D) helical computed tomography (CT). Prenatal sonographic findings seen in persons with Down syndrome, such as a thickened nuchal fold, cardiac defects, and echogenic bowel were not found in the patient. A prenatal 3-D helical CT revealed a large head with frontal bossing, metaphyseal flaring of the long bones, and small iliac wings, which suggested achondroplasia. In a case with combination of achondroplasia and Down syndrome, it may be difficult to diagnose the co-occurrence prenatally without typical markers of Down syndrome.	[Kaga, Akimune; Kamimura, Miki; Kimura, Masato; Saito-Hakoda, Akiko; Kanno, Junko; Kure, Shigeo; Fujiwara, Ikuma] Tohoku Univ, Grad Sch Med, Tohoku Univ Hosp, Dept Pediat, Sendai, Miyagi 9808574, Japan; [Murotsuki, Jun] Tohoku Univ, Grad Sch Med, Dept Maternal & Fetal Med, Sendai, Miyagi 9808574, Japan; [Murotsuki, Jun] Miyagi Childrens Hosp, Dept Obstet, Sendai, Miyagi, Japan; [Hoshi, Kazuhiko] Suzuki Mem Hosp, Dept Obstet, Iwanuma, Miyagi, Japan	Fujiwara, I (reprint author), Tohoku Univ, Sch Med, Dept Pediat, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	ifujiwara-endo@umin.ac.jp					Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Chitty LS, 2011, ULTRASOUND OBST GYN, V37, P283, DOI 10.1002/uog.8893; Ruano R, 2004, ULTRASOUND OBST GYN, V24, P134, DOI 10.1002/uog.1113; Hawkins A, 2011, EUR J PEDIATR, V170, P915, DOI 10.1007/s00431-010-1378-1; KURTZ AB, 1990, RADIOLOGY, V177, P197; Bellus GA, 1999, AM J MED GENET, V85, P53, DOI 10.1002/(SICI)1096-8628(19990702)85:1<53::AID-AJMG10>3.3.CO;2-6; Benacerraf BR, 2010, PRENATAL DIAG, V30, P644, DOI 10.1002/pd.2531; Bethune M, 2007, AUSTRALAS RADIOL, V51, P218, DOI 10.1111/j.1440-1673.2007.01713.x; Carakushansky G, 1998, AM J MED GENET, V77, P168, DOI 10.1002/(SICI)1096-8628(19980501)77:2<168::AID-AJMG12>3.0.CO;2-L; Chen H, 2000, SOUTHERN MED J, V93, P622; Dabir T, 2008, NEONATOLOGY, V94, P68, DOI 10.1159/000113310; Hickey Fran, 2012, Adv Pediatr, V59, P137, DOI 10.1016/j.yapd.2012.04.006; LOCKWOOD C, 1987, AM J OBSTET GYNECOL, V157, P803; Modaff P, 1996, PRENATAL DIAG, V16, P525, DOI 10.1002/(SICI)1097-0223(199606)16:6<525::AID-PD909>3.0.CO;2-N; Moreira LMD, 2010, BIRTH DEFECTS RES A, V88, P228, DOI 10.1002/bdra.20653; NYBERG DA, 1993, AM J OBSTET GYNECOL, V168, P534; Ramalho C, 2011, FETAL DIAGN THER, V30, P207, DOI 10.1159/000329309; Sánchez O, 1999, Invest Clin, V40, P143; Shinozuka N, 2000, J MED ULTRASOUND, V8, P87; SOMMER A, 1970, Journal of Medical Genetics, V7, P63, DOI 10.1136/jmg.7.1.63	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	MAY	2015	55	2					116	120		10.1111/cga.12097		5	Pediatrics	Pediatrics	CH2ZQ	WOS:000353895300009		
J	Ikami, K; Tokue, M; Sugimoto, R; Noda, C; Kobayashi, S; Hara, K; Yoshida, S				Ikami, Kanako; Tokue, Moe; Sugimoto, Ryo; Noda, Chiyo; Kobayashi, Satoru; Hara, Kenshiro; Yoshida, Shosei			Hierarchical differentiation competence in response to retinoic acid ensures stem cell maintenance during mouse spermatogenesis	DEVELOPMENT			English	Article						Retinoic acid receptor gamma; Spermatogenesis; Spermatogonia; Stem cell niche	UNDIFFERENTIATED SPERMATOGONIA; SERTOLI-CELLS; SEMINIFEROUS EPITHELIUM; GERM-CELLS; VITAMIN-A; RECEPTOR-GAMMA; IN-VIVO; TESTIS; IDENTIFICATION; EXPRESSION	Stem cells ensure tissue homeostasis through the production of differentiating and self-renewing progeny. In some tissues, this is achieved by the function of a definitive stem cell niche. However, the mechanisms that operate in mouse spermatogenesis are unknown because undifferentiated spermatogonia (A(undiff)) are motile and intermingle with differentiating cells in an 'open' niche environment of seminiferous tubules. A(undiff) include glial cell line-derived neurotrophic factor receptor alpha 1 (GFR alpha 1)(+) and neurogenin 3 (NGN3)(+) subpopulations, both of which retain the ability to self-renew. However, whereas GFR alpha 1(+) cells comprise the homeostatic stem cell pool, NGN3(+) cells show a higher probability to differentiate into KIT+ spermatogonia by as yet unknown mechanisms. In the present study, by combining fate analysis of pulse-labeled cells and a model of vitamin A deficiency, we demonstrate that retinoic acid (RA), which may periodically increase in concentration in the tubules during the seminiferous epithelial cycle, induced only NGN3(+) cells to differentiate. Comparison of gene expression revealed that retinoic acid receptor gamma (Rarg) was predominantly expressed in NGN3(+) cells, but not in GFR alpha 1(+) cells, whereas the expression levels of many other RA response-related genes were similar in the two populations. Ectopic expression of RAR gamma was sufficient to induce GFR alpha 1(+) cells to directly differentiate to KIT+ cells without transiting the NGN3(+) state. Therefore, RAR gamma plays key roles in the differentiation competence of NGN3(+) cells. We propose a novel mechanism of stem cell fate selection in an open niche environment whereby undifferentiated cells show heterogeneous competence to differentiate in response to ubiquitously distributed differentiation-inducing signals.	[Ikami, Kanako; Tokue, Moe; Sugimoto, Ryo; Hara, Kenshiro; Yoshida, Shosei] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Germ Cell Biol, Okazaki, Aichi 4448787, Japan; [Ikami, Kanako; Tokue, Moe; Kobayashi, Satoru; Hara, Kenshiro; Yoshida, Shosei] Grad Univ Adv Studies Sokendai, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Noda, Chiyo; Kobayashi, Satoru] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Div Germ Cell Biol, Okazaki, Aichi 4448787, Japan	Yoshida, S (reprint author), Natl Inst Nat Sci, Natl Inst Basic Biol, Div Germ Cell Biol, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	shosei@nibb.ac.jp			KAKENHI [20116004, 24247041, 25114004]; Mitsubishi Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research [KAKENHI; grant numbers 20116004, 24247041 and 25114004] and by the Mitsubishi Foundation (S.Y.). Deposited in PMC for immediate release.	Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Chiarini-Garcia H, 2003, REPRODUCTION, V126, P669, DOI 10.1530/reprod/126.5.669; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; VANPELT AMM, 1990, BIOL REPROD, V43, P363, DOI 10.1095/biolreprod43.3.363; De Rooij DG, 2000, J ANDROL, V21, P776; Grasso M, 2012, REPRODUCTION, V143, P325, DOI 10.1530/REP-11-0385; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Sugimoto R, 2012, MECH DEVELOP, V128, P610, DOI 10.1016/j.mod.2011.12.003; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Shirakawa T, 2013, DEVELOPMENT, V140, P3565, DOI 10.1242/dev.094045; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795; Gely-Pernot A, 2012, ENDOCRINOLOGY, V153, P438, DOI 10.1210/en.2011-1102; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; Uesaka T, 2007, DEVELOPMENT, V134, P2171, DOI 10.1242/dev.001388; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; LEBLOND CP, 1952, ANN NY ACAD SCI, V55, P548, DOI 10.1111/j.1749-6632.1952.tb26576.x; MORALES C, 1987, ENDOCRINOLOGY, V121, P432; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Yoshida S, 2012, REPRODUCTION, V144, P293, DOI 10.1530/REP-11-0320; Vernet N, 2006, EMBO J, V25, P5816, DOI 10.1038/sj.emboj.7601447; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Stine RR, 2013, TRENDS CELL BIOL, V23, P357, DOI 10.1016/j.tcb.2013.03.001; Yomogida K, 2003, BIOL REPROD, V69, P1303, DOI 10.1095/biolreprod.103.015958; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; ASTROM A, 1990, BIOCHEM BIOPH RES CO, V173, P339, DOI 10.1016/S0006-291X(05)81062-9; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; GIGUERE V, 1990, MOL CELL BIOL, V10, P2335; Hara K, 2014, CELL STEM CELL, V14, P658, DOI 10.1016/j.stem.2014.01.019; Hasegawa K, 2012, DEVELOPMENT, V139, P4347, DOI 10.1242/dev.080119; Hogarth CA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126326; HUCKINS C, 1978, ANAT REC, V192, P519, DOI 10.1002/ar.1091920406; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biloreprod.103.017012; Obrochta KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099435; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Russell L.D., 1990, HISTOLOGICAL HISTOPA; Snyder EM, 2011, BIOL REPROD, V84, P886, DOI 10.1095/biolreprod.110.089755; Tagelenbosch R., 1993, MUTAT RES, V290, P193, DOI [10.1016/0027-5107(93)90159-D, DOI 10.1016/0027-5107(93)90159-D]; Yoshida S, 2001, DEV BIOL, V240, P517, DOI 10.1006/dbio.2001.0473; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	60	3	3	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	MAY 1	2015	142	9					1582	1592		10.1242/dev.118695		11	Developmental Biology	Developmental Biology	CG8UY	WOS:000353591300004		
J	Morishita, Y; Kuroiwa, A; Suzuki, T				Morishita, Yoshihiro; Kuroiwa, Atsushi; Suzuki, Takayuki			Quantitative analysis of tissue deformation dynamics reveals three characteristic growth modes and globally aligned anisotropic tissue deformation during chick limb development	DEVELOPMENT			English	Article						Bayesian inference; Limb development; Quantitative analysis; Tensor analysis; Tissue deformation dynamics	SONIC HEDGEHOG FUNCTION; VERTEBRATE LIMB; GENE-EXPRESSION; FEEDBACK LOOP; MOUSE LIMB; CELL FATE; BUD; PROLIFERATION; SPECIFICATION; GRADIENTS	Tissue-level characterization of deformation dynamics is crucial for understanding organ morphogenetic mechanisms, especially the interhierarchical links among molecular activities, cellular behaviors and tissue/organ morphogenetic processes. Limb development is a well-studied topic in vertebrate organogenesis. Nevertheless, there is still little understanding of tissue-level deformation relative to molecular and cellular dynamics. This is mainly because live recording of detailed cell behaviors in whole tissues is technically difficult. To overcome this limitation, by applying a recently developed Bayesian approach, we here constructed tissue deformation maps for chick limb development with high precision, based on snapshot lineage tracing using dye injection. The precision of the constructed maps was validated with a clear statistical criterion. From the geometrical analysis of the map, we identified three characteristic tissue growth modes in the limb and showed that they are consistent with local growth factor activity and cell cycle length. In particular, we report that SHH signaling activity changes dynamically with developmental stage and strongly correlates with the dynamic shift in the tissue growth mode. We also found anisotropic tissue deformation along the proximal-distal axis. Morphogenetic simulation and experimental studies suggested that this directional tissue elongation, and not local growth, has the greatest impact on limb shaping. This result was supported by the novel finding that anisotropic tissue elongation along the proximal-distal axis occurs independently of cell proliferation. Our study marks a pivotal point for multi-scale system understanding in vertebrate development.	[Morishita, Yoshihiro] RIKEN Quantitat Biol Ctr, Lab Dev Morphogeometry, Kobe, Hyogo 6500047, Japan; [Morishita, Yoshihiro] RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Kuroiwa, Atsushi; Suzuki, Takayuki] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Morishita, Y (reprint author), RIKEN Quantitat Biol Ctr, Lab Dev Morphogeometry, Kobe, Hyogo 6500047, Japan.	yoshihiro.morishita@riken.jp; suzuki.takayuki@j.mbox.nagoya-u.ac.jp			Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency (PRESTO JST); Ministry of Education, Culture, Sports, Science and Technology of Japan [23124510, 25111735, 25124709, 25111710, 23127504]	This work was supported by grants from Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency (PRESTO JST) (to Y.M. and T.S.) and from the Ministry of Education, Culture, Sports, Science and Technology of Japan [23124510, 25111735 and 25124709 to Y.M.; 25111710 and 23127504 to T.S.]. Deposited in PMC for immediate release.	Nissim S, 2007, DEV BIOL, V304, P9, DOI 10.1016/j.ydbio.2006.12.010; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Wyngaarden LA, 2010, DEVELOPMENT, V137, P2551, DOI 10.1242/dev.046987; Sato K, 2007, DEVELOPMENT, V134, P1397, DOI 10.1242/dev.02822; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Taniguchi K, 2011, SCIENCE, V333, P339, DOI 10.1126/science.1200940; Raspopovic J, 2014, SCIENCE, V345, P566, DOI 10.1126/science.1252960; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Arques CG, 2007, DEVELOPMENT, V134, P3713, DOI 10.1242/dev.02873; Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Xu JS, 2000, DEVELOPMENT, V127, P1833; Honda H, 2004, J THEOR BIOL, V226, P439, DOI 10.1016/j.jtbi.2003.10.001; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; NISWANDER L, 1993, DEVELOPMENT, V119, P287; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Vargesson N, 1997, DEVELOPMENT, V124, P1909; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Prusinkiewicz P, 2012, NEW PHYTOL, V193, P549, DOI 10.1111/j.1469-8137.2011.04009.x; Sheth R, 2012, SCIENCE, V338, P1476, DOI 10.1126/science.1226804; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Pearse RV, 2007, DEV BIOL, V310, P388, DOI 10.1016/j.ydbio.2007.08.002; Boehm B., 2010, PLOS BIOL, V8; Christ B, 2002, INT J DEV BIOL, V46, P905; Clarke JDW, 1999, NAT CELL BIOL, V1, pE103, DOI 10.1038/12105; Filas BA, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979866; Graner F, 2008, EUR PHYS J E, V25, P349, DOI 10.1140/epje/i2007-10298-8; Hopyan S, 2011, DEV DYNAM, V240, P1054, DOI 10.1002/dvdy.22601; Ide Hiroyuki, 1998, Wound Repair and Regeneration, V6, pS398; Li SG, 1999, DEV BIOL, V211, P335, DOI 10.1006/dbio.1999.9317; Marcon L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001071; Morishita Y, 2014, J THEOR BIOL, V357, P74, DOI 10.1016/j.jtbi.2014.04.027; Prykhozhij SV, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-91; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sato K, 2010, J EXP ZOOL PART B, V314B, P539, DOI 10.1002/jez.b.21359; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Bonet J, 2008, NONLINEAR CONTINUUM MECHANICS FOR FINITE ELEMENT ANALYSIS, 2ND EDITION, P1, DOI 10.1017/CBO9780511755446	48	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	MAY 1	2015	142	9					1672	1683		10.1242/dev.109728		12	Developmental Biology	Developmental Biology	CG8UY	WOS:000353591300012		
J	Hamai, Y; Hihara, J; Taomoto, J; Yamakita, I; Ibuki, Y; Okada, M				Hamai, Y.; Hihara, J.; Taomoto, J.; Yamakita, I.; Ibuki, Y.; Okada, M.			Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer	DISEASES OF THE ESOPHAGUS			English	Article						complication; esophagectomy; esophageal cancer; neoadjuvant therapy; survival	TRANSTHORACIC ESOPHAGECTOMY; PERIOPERATIVE COMPLICATIONS; TRANSHIATAL ESOPHAGECTOMY; SURGICAL COMPLICATIONS; SURGERY; METAANALYSIS; CARCINOMA; CHEMORADIATION; CHEMOTHERAPY; OUTCOMES	We compared the surgical outcomes between 114 patients who did not receive neoadjuvant therapy (group 1) and 92 others who received neoadjuvant chemoradiotherapy (nCRT) (group 2), and assessed the preoperative and surgical factors that influence postoperative morbidity to determine the impact of nCRT on morbidity and mortality after esophagectomy via cervical, right transthoracic, and abdominal approaches. The overall postoperative morbidity rates were 44.7% and 55.4% in groups 1 and 2, respectively (P=0.13). Rates of anastomotic leak (8.8% vs. 16.3%; P=0.10), pneumonia (9.6% vs. 13.0%; P=0.44), recurrent nerve palsy (15.8% vs. 10.9%; P=0.31), and all other complications did not significantly differ between the groups. Multivariable analysis revealed cervical lymph node dissection (odds ratio [OR], 1.97; 95% confidence interval [CI], 1.01-3.84; P=0.047) as the sole independent covariate for overall morbidity. Furthermore, a history of cardiovascular disease (OR, 2.90; 95% CI, 1.03-8.24; P=0.045), the retrosternal reconstruction route (OR, 15.15; 95% CI, 3.56-62.50; P=0.0002), and a longer surgical duration (OR, 1.01; 95% CI, 1.002-1.02; P=0.01) were independent covariates for anastomotic leakage, and advanced age (OR, 1.08; 95% CI, 1.01-1.15; P=0.02) and lower body mass index (OR, 1.16; 95% CI, 1.01-1.33; P=0.04) were independent covariates for pneumonia. However, whether or not patients received nCRT was irrelevant. We found that nCRT is safe for three-incision esophagectomy and it does not increase the incidence of postoperative morbidity and mortality relative to esophagectomy alone.	[Hamai, Y.; Hihara, J.; Taomoto, J.; Yamakita, I.; Ibuki, Y.; Okada, M.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Surg Oncol, Hiroshima 7348551, Japan	Hihara, J (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Surg Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	hihara@hiroshima-u.ac.jp					Fiorica F, 2004, GUT, V53, P925, DOI 10.1136/gut.2003.025080; BRINKMAN GL, 1963, AM REV RESPIR DIS, V87, P684; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; [Anonymous], 2009, ESOPHAGUS, V6, P71; Reynolds JV, 2006, J THORAC CARDIOV SUR, V132, P549, DOI 10.1016/j.jtcvs.2006.05.015; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Emi M, 2012, CANCER CHEMOTH PHARM, V69, P1499, DOI 10.1007/s00280-012-1853-7; Killeen SD, 2005, BRIT J SURG, V92, P389, DOI 10.1002/bjs.4954; Holscher AH, 2006, BEST PRACT RES CL GA, V20, P907, DOI 10.1016/j.bpg.2006.05.002; Boshier PR, 2011, ANN SURG, V254, P894, DOI 10.1097/SLA.0b013e3182263781; Bailey SH, 2003, ANN THORAC SURG, V75, P217, DOI 10.1016/S0003-4975(02)04368-0; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Avendano CE, 2002, ANN THORAC SURG, V73, P922, DOI 10.1016/S0003-4975(01)03584-6; Urschel JD, 2003, AM J SURG, V185, P538, DOI 10.1016/S0002-9610(03)00066-7; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Chang AC, 2008, ANN THORAC SURG, V85, P424, DOI 10.1016/j.athoracsur.2007.10.007; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; Berger AC, 2005, SEMIN ONCOL, V32, pS16, DOI 10.1053/j.seminoncol.2005.04.017; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Colvin H, 2011, INTERACT CARDIOV TH, V12, P265, DOI 10.1510/icvts.2010.252148; Hihara J, 2007, ANTICANCER RES, V27, P2597; Hirao M, 2011, BRIT J SURG, V98, P1735, DOI 10.1002/bjs.7683; Kelley ST, 2004, J GASTROINTEST SURG, V8, P227, DOI 10.1016/j.gassur.2003.11.024; Lin FCF, 2004, ANN THORAC SURG, V78, P1783, DOI 10.1016/j.athorscur.2004.04.081; Low DE, 2007, BRIT J SURG, V94, P655, DOI 10.1002/bjs.5853; Merritt RE, 2011, ANN THORAC SURG, V92, P2034, DOI 10.1016/j.athoracsur.2011.05.121; SATO N, 1993, BRIT J SURG, V80, P1413, DOI 10.1002/bjs.1800801119; vansHagen P, 2012, NEW ENGL J MED, V366, P2074; Viklund P, 2006, ANN SURG, V243, P204, DOI 10.1097/01.sla.0000197698.17794.eb	31	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1120-8694	1442-2050		DIS ESOPHAGUS	Dis. Esophagus	MAY-JUN	2015	28	4					358	364		10.1111/dote.12207		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH3CA	WOS:000353902700008		
J	Stickley, A; Koyanagi, A; Roberts, B; Murphy, A; Kizilova, K; McKee, M				Stickley, Andrew; Koyanagi, Ai; Roberts, Bayard; Murphy, Adrianna; Kizilova, Kseniya; McKee, Martin			Male solitary drinking and hazardous alcohol use in nine countries of the former Soviet Union	DRUG AND ALCOHOL DEPENDENCE			English	Article						Solitary drinking; Former Soviet Union; Alcohol problems; Heavy episodic drinking; HITT survey	MOTIVATIONAL MODEL; MULTILEVEL DATA; HEAVY DRINKING; CONSUMPTION; PATTERNS; RUSSIA; POPULATION; MORTALITY; DRINKERS; CONTEXTS	Background: Despite evidence that many people engage in solitary drinking and that it might be associated with negative consequences, to date, little research has focused on this form of drinking behaviour. This study examined the prevalence and factors associated with solitary drinking, and assessed whether it is linked with hazardous alcohol use among males in nine countries of the former Soviet Union (fSU). Methods: Data came from a cross-sectional population-based survey undertaken in 2010/11 in Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, and Ukraine. Information was obtained on the frequency of solitary drinking among male regular drinkers (i.e., those consuming alcoholic drinks at least once a month), and on problem drinking (CAGE) and heavy episodic drinking (HED). Logistic regression analysis was used to examine associations between the variables. Results: The prevalence of occasional and frequent solitary drinking ranged from 8.4% (Georgia) to 42.4% (Azerbaijan), and 3.1% (Kazakhstan) to 8.2% (Armenia), respectively. Solitary drinking was associated with being older, divorced/widowed, living alone, having a bad/very bad household financial situation, lower levels of social support, and poor self-rated health. Occasional solitary drinking was linked to problem drinking and HED, while frequent solitary alcohol use was related to problem drinking. Conclusions: Solitary drinking is relatively common among male regular drinkers in the fSU and is linked to older age, social and economic disadvantage, and hazardous alcohol use. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Stickley, Andrew; Roberts, Bayard; Murphy, Adrianna; McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England; [Stickley, Andrew] Sodertorn Univ, Stockholm Ctr Hlth Soc Transit SCOHOST, S-14189 Huddinge, Sweden; [Stickley, Andrew] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo, Japan; [Koyanagi, Ai] Fundacio St Joan de Deu, Res & Dev Unit, Parc Sanitari St Joan de Deu, Barcelona, Spain; [Koyanagi, Ai] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, CIBERSAM, Madrid, Spain; [Kizilova, Kseniya] Kharkov Natl Univ, Social & Humanitarian Res Inst, Kharkov, Ukraine	Stickley, A (reprint author), Sodertorn Univ, Stockholm Ctr Hlth Soc Transit SCOHOST, S-14189 Huddinge, Sweden.	andrew.stickley@sh.se			European Union [HEALTH-F2-2009-223344]; Miguel Servet contract [CP13/00150]; ISCIII-General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF)	This work was supported by the European Union's 7th Framework Programme, project HEALTH-F2-2009-223344. The European Commission cannot accept any responsibility for any information provided or views expressed. AK's work was supported by the Miguel Servet contract financed by the CP13/00150 project, integrated into the National R+ D + I and funded by the ISCIII-General Branch Evaluation and Promotion of Health Research-and the European Regional Development Fund (ERDF).	Mohr CD, 2001, J PERS SOC PSYCHOL, V80, P489, DOI 10.1037//0022-3514.80.3.489; Murphy A, 2014, EUR J PUBLIC HEALTH, V24, P572, DOI 10.1093/eurpub/ckt213; Nordlund S, 2013, ADDICT RES THEORY, V21, P402, DOI 10.3109/16066359.2012.732630; Stickley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067978; Stickley A, 2007, EUR J PUBLIC HEALTH, V17, P444, DOI 10.1093/eurpub/ckl275; Stickley A, 2009, PUBLIC HEALTH, V123, P20, DOI 10.1016/j.puhe.2008.07.009; Murphy A, 2014, HEALTH PLACE, V27, P205, DOI 10.1016/j.healthplace.2014.02.015; Gaunekar G, 2005, SOC PSYCH PSYCH EPID, V40, P267, DOI 10.1007/s00127-005-0886-1; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Pomerleau J, 2008, ALCOHOL ALCOHOLISM, V43, P351, DOI 10.1093/alcalc/agm167; Abbott PA, 2006, SOC SCI MED, V62, P228, DOI 10.1016/j.socscimed.2005.05.019; Gonzalez VM, 2009, ADDICT BEHAV, V34, P993, DOI 10.1016/j.addbeh.2009.06.001; San Jose B, 1999, SUBST USE MISUSE, V34, P1085; Christiansen M, 2002, ADDICT BEHAV, V27, P393, DOI 10.1016/S0306-4603(01)00180-0; Andreev E, 2013, ALCOHOL ALCOHOLISM, V48, P215, DOI 10.1093/alcalc/ags132; Assanangkornchai S, 2000, ALCOHOL ALCOHOLISM, V35, P263, DOI 10.1093/alcalc/35.3.263; Assanangkornchai S, 2010, ALCOHOL ALCOHOLISM, V45, P278, DOI 10.1093/alcalc/agq018; Bourgault C, 1997, ADDICTION, V92, P303; COOPER ML, 1995, J PERS SOC PSYCHOL, V69, P990, DOI 10.1037/0022-3514.69.5.990; Cooper M. L., 1992, PSYCHOL ASSESSMENT, V4, P123, DOI [10.1037/1040-3590.4.2.123, DOI 10.1037/1040-3590.4.2.123]; COX WM, 1988, J ABNORM PSYCHOL, V97, P168, DOI 10.1037//0021-843X.97.2.168; Creswell KG, 2014, CLIN PSYCHOL SCI, V2, P602; Demers A, 1996, ADDICTION, V91, P1505; Field M. G., 2000, RUSSIAS TORN SAFETY; Footman K, 2013, NICOTINE TOB RES, V15, P1628, DOI 10.1093/ntr/ntt034; Gonzalez VM, 2012, PSYCHOL ADDICT BEHAV, V26, P609, DOI 10.1037/a0026916; Greenfield TK, 1997, ADDICTION, V92, P33; Gronkjaer M, 2013, SCAND J PUBLIC HEALT, V41, P221, DOI 10.1177/1403494812472266; Gronkjaer M, 2010, ADDICT RES THEORY, V18, P359, DOI 10.3109/16066350903145056; Makela P, 2012, DRUG ALCOHOL REV, V31, P831, DOI 10.1111/j.1465-3362.2012.00479.x; MARTIN C, 1987, J STUD ALCOHOL, V48, P109; Neff JA, 1997, ALCOHOL ALCOHOLISM, V32, P33; Pomerleau J, 2005, ADDICTION, V100, P1647, DOI 10.1111/j.1360-0443.2005.01233.x; Roberts B, 2013, SIGHT SOUND, V23, P22; VictorioEstrada A, 1997, ADDICT BEHAV, V22, P557, DOI 10.1016/S0306-4603(96)00061-5; World Health Organisation, 2011, GLOB STAT REP ALC HL	37	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0376-8716	1879-0046		DRUG ALCOHOL DEPEN	Drug Alcohol Depend.	MAY 1	2015	150						105	111		10.1016/j.drugalcdep.2015.02.017		7	Substance Abuse; Psychiatry	Substance Abuse; Psychiatry	CG8YF	WOS:000353600900014		
J	Kobayashi, C; Matsuo, K; Watanabe, K; Nagata, N; Suzuki-Ohno, Y; Kawata, M; Kato, M				Kobayashi, Chisato; Matsuo, Kazunori; Watanabe, Kyohei; Nagata, Nobuaki; Suzuki-Ohno, Yukari; Kawata, Masakado; Kato, Makoto			Arms race between leaf rollers and parasitoids: diversification of plant-manipulation behavior and its consequences	ECOLOGICAL MONOGRAPHS			English	Article						Attelabidae; community structure; host plant; Japan; leaf miners; leaf rollers; parasitoids; phylogeny; plant manipulation; weevils	TROPHIC ASSOCIATIONS; POPULATION-DYNAMICS; WEEVILS COLEOPTERA; MINING INSECTS; FOOD-WEB; COMMUNITY; LEAFMINER; HOST; ABSCISSION; HERBIVORE	Understanding the determinants of community structure remains a challenging ecological task; the plant-host insect-parasitoid community is a particularly important community because of its overwhelming biomass in terrestrial ecosystems. Some ecological and phylogenetic factors are determinants of community structure; however, the relative importance of these factors remains to be entirely elucidated because we cannot separately analyze individual factors. Here, we compared parasitoid communities among 23 weevil species. We demonstrated that the parasitoid community structures were significantly influenced by types of maternal plant manipulation and larval feeding, but not by the phylogeny of the host plant or weevil, which has diverse feeding niches even within closely related species, through maternal plant manipulation for immature weevils (e.g., shoot/petiole/seed borers, leaf miners, and leaf roll feeders). Weevil phylogenetic data indicate that although plant-cutting behavior may have evolved as an adaptation to plant chemical defenses, some manipulation behaviors, such as cutting off plants with eggs or open and closed leaf roll construction, may be an innovative adaptation against parasitoids. However, we expect that an evolutionary arms race would exist between weevils with specific manipulations (e.g., constructing wrapped leaf rolls) and their specific parasitoids.	[Kobayashi, Chisato; Nagata, Nobuaki; Suzuki-Ohno, Yukari; Kawata, Masakado] Tohoku Univ, Grad Sch Life Sci, Dept Ecol & Evolutionary Biol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Matsuo, Kazunori] Kagawa Prefectural Livestock Hyg Serv Ctr, Zentsuji, Kagawa 7650022, Japan; [Watanabe, Kyohei] Kanagawa Prefectural Museum Nat Hist, Odawara, Kanagawa 2500031, Japan; [Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Kobayashi, C (reprint author), Tohoku Univ, Grad Sch Life Sci, Dept Ecol & Evolutionary Biol, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	chisato.ck@gmail.com	Kawata, Masakado/E-3962-2012		JSPS; Ministry of Education, Science, Sports and Culture [18207002, 22405009]	We thank Toru Kato for offering weevil samples. We are also grateful to Tommi Nyman and Takashi Makino for their technical advice regarding phylogenetic signal analyses. We thank Megumi Katori and Yu Fukasawa for their field assistance. This study was supported by the JSPS Research Fellowship for Young Scientists. This research was partly supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (A) 2006-2009 (18207002, M. Kato) and 2010-2014 (22405009, M. Kato).	Alonso-Zarazaga M.A., 1999, WORLD CATALOGUE FAMI; GRAFEN A, 1989, PHILOS T ROY SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Van Hezewijk BH, 2003, ECOL ENTOMOL, V28, P593, DOI 10.1046/j.1365-2311.2003.00553.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Stireman JO, 2003, OECOLOGIA, V135, P629, DOI 10.1007/s00442-003-1235-2; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; Price PW, 2002, ECOL RES, V17, P241, DOI 10.1046/j.1440-1703.2002.00483.x; Sugiura S, 2007, BASIC APPL ECOL, V8, P544, DOI 10.1016/j.baae.2006.09.006; Oishi M, 2007, ENVIRON ENTOMOL, V36, P1504, DOI 10.1603/0046-225X(2007)36[1504:IOPLAB]2.0.CO;2; Lewis OT, 2002, J ANIM ECOL, V71, P855, DOI 10.1046/j.1365-2656.2002.00651.x; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Leppanen SA, 2013, EVOLUTION, V67, P1493, DOI 10.1111/evo.12028; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; ASKEW RR, 1974, BIOL J LINN SOC, V6, P289, DOI 10.1111/j.1095-8312.1974.tb00727.x; CASAS J, 1989, ECOL ENTOMOL, V14, P257, DOI 10.1111/j.1365-2311.1989.tb00954.x; Kobayashi C, 2004, POPUL ECOL, V46, P193, DOI 10.1007/s10144-004-0179-7; PSCHORNWALCHER H, 1989, ZOOL ANZ, V222, P37; HESPENHEIDE HA, 1991, ANNU REV ENTOMOL, V36, P535; Fernandes GW, 2008, ARTHROPOD-PLANT INTE, V2, P93, DOI 10.1007/s11829-008-9031-x; Ives AR, 2006, AM NAT, V168, pE1, DOI 10.1086/505157; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KAHN DM, 1989, ECOLOGY, V70, P1219, DOI 10.2307/1938179; KATO M, 1994, OECOLOGIA, V97, P17, DOI 10.1007/BF00317904; Askew R.R., 1986, P225; Ayabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032594; Bailey R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000179; DOUTT R L, 1968, Proceedings of the California Academy of Sciences, V35, P477; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fursov V. N., 2007, KEYS INSECTS RUSSIAN, VIV, P981; Gonget H., 2003, NEMONYCHIDAE ANTHRIB; Hamback PA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-92; HAMILTON RW, 1994, COLEOPTS BULL, V48, P331; Hawkins B. A., 1994, PARASITOID COMMUNITY; HAWKINS BA, 1984, ECOL ENTOMOL, V9, P271, DOI 10.1111/j.1365-2311.1984.tb00851.x; Hawkins B.A., 1994, PATTERN PROCESS HOST; Hayashi M., 1984, COLEOPTERA JAPAN COL, VIV; Hirose Yoshimi, 1994, P19; Hirose Y, 1968, KONTYU, V36, P377; Hirose Y., 1963, Acta Hymenopterologica, V2, P29; HOFFMEISTER T, 1992, OECOLOGIA, V89, P288; HUBER J T, 1986, Entomography, V4, P185; JERVIS MA, 1980, ECOL ENTOMOL, V5, P123, DOI 10.1111/j.1365-2311.1980.tb01133.x; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kato M, 1996, RES POPUL ECOL, V38, P27, DOI 10.1007/BF02514968; Kobayashi C, 2012, MOL PHYLOGENET EVOL, V64, P318, DOI 10.1016/j.ympev.2012.04.006; Kobayashi Chisato, 2004, Contributions from the Biological Laboratory Kyoto University, V29, P431; Lou J. X., 1996, J SHENYANG AGR U, V27, P43; Midford P. E., 2011, PDAP PDTREE TRANSLAT; Mills N. J., 1994, PATTERN PROCESS HOST, P31; Mittelbach GG, 2012, COMMUNITY ECOLOGY, P1; Morimoto K., 1964, INSECT J, V1, P15; Noyes JS, 2014, UNIVERSAL CHALCIDOID; Nyman T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-49; Owen AK, 2007, SYST ENTOMOL, V32, P227, DOI 10.1111/j.1365-3113.2006.00361.x; PRICE PW, 1988, ECOL ENTOMOL, V13, P195, DOI 10.1111/j.1365-2311.1988.tb00347.x; Price P.W., 1987, P287; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rott AS, 2000, J ANIM ECOL, V69, P274, DOI 10.1046/j.1365-2656.2000.00390.x; Salvo A, 2004, J ANIM ECOL, V73, P494, DOI 10.1111/j.0021-8790.2004.00824.x; Sawada Yoshihisa, 1993, Humans and Nature, V2, P1; Subba Rao B. R., 1969, ORIENT INSECTS, V3, P319; Thompson W. R., 1958, CATALOGUE PARASITES; Trjapitzin V. A., 1978, OPREDELITELI NASEKOM, V3, P506; Viggiani G., 1974, Bollettino Lab Ent agr Filippi Silvestri, V31, P192; Vogt George B., 1992, P392; Waage J., 1986, INSECT PARASITOIDS	70	0	0	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	0012-9615	1557-7015		ECOL MONOGR	Ecol. Monogr.	MAY	2015	85	2					253	268		10.1890/14-0280.1		16	Ecology	Environmental Sciences & Ecology	CH2HI	WOS:000353845900006		
J	Akiba, M; Senba, H; Otagiri, H; Prabhasankar, VP; Taniyasu, S; Yamashita, N; Lee, K; Yamamoto, T; Tsutsui, T; Joshua, DI; Balakrishna, K; Bairy, I; Iwata, T; Kusumoto, M; Kannan, K; Guruge, KS				Akiba, Masato; Senba, Hironobu; Otagiri, Haruna; Prabhasankar, Valipparambil P.; Taniyasu, Sachi; Yamashita, Nobuyoshi; Lee, Ken-ichi; Yamamoto, Takehisa; Tsutsui, Toshiyuki; Joshua, Derrick Ian; Balakrishna, Keshava; Bairy, Indira; Iwata, Taketoshi; Kusumoto, Masahiro; Kannan, Kurunthachalam; Guruge, Keerthi S.			Impact of wastewater from different sources on the prevalence of antimicrobial-resistant Escherichia coli in sewage treatment plants in South India	ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY			English	Article						Hospital effluent; Sewage treatment plant; India; Environmental contamination; Antimicrobial resistance; E coli	IN-HOSPITAL WASTEWATERS; ANTIBIOTIC-RESISTANCE; BACTERIA; ENVIRONMENT; MUNICIPAL	The sewage treatment plant (STP) is one of the most important interfaces between the human population and the aquatic environment, leading to contamination of the latter by antimicrobial-resistant bacteria. To identify factors affecting the prevalence of antimicrobial-resistant bacteria, water samples were collected from three different STPs in South India. STP1 exclusively treats sewage generated by a domestic population. STP2 predominantly treats sewage generated by a domestic population with a mix of hospital effluent. STP3 treats effluents generated exclusively by a hospital. The water samples were collected between three intermediate treatment steps including equalization, aeration, and clarification, in addition to the outlet to assess the removal rates of bacteria as the effluent passed through the treatment plant. The samples were collected in three different seasons to study the effect of seasonal variation. Escherichia coli isolated from the water samples were tested for susceptibility to 12 antimicrobials. The results of logistic regression analysis suggest that the hospital wastewater inflow significantly increased the prevalence of antimicrobial-resistant E. coli, whereas the treatment processes and sampling seasons did not affect the prevalence of these isolates. A bias in the genotype distribution of E. coli was observed among the isolates obtained from STP3. In conclusion, hospital wastewaters should be carefully treated to prevent the contamination of Indian environment with antimicrobial-resistant bacteria. (C) 2015 Elsevier Inc. All rights reserved.	[Akiba, Masato; Lee, Ken-ichi; Iwata, Taketoshi; Kusumoto, Masahiro] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 3050856, Japan; [Akiba, Masato] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan; [Senba, Hironobu] Anim Quarantine Serv, Quarantine Dept, Anim Inspect Div, Yokohama, Kanagawa, Japan; [Otagiri, Haruna] Tobu Livestock Hyg Serv Ctr, Fuefuki, Yamanashi, Japan; [Prabhasankar, Valipparambil P.; Joshua, Derrick Ian; Balakrishna, Keshava] Manipal Univ, Manipal Inst Technol, Dept Civil Engn, Manipal, Karnataka, India; [Taniyasu, Sachi; Yamashita, Nobuyoshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Yamamoto, Takehisa; Tsutsui, Toshiyuki] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 3050856, Japan; [Bairy, Indira] Manipal Univ, Dept Microbiol, Melaka Manipal Med Coll, Manipal, Karnataka, India; [Kannan, Kurunthachalam] SUNY Albany, Wadsworth Ctr, New York State Dept Hlth, Albany, NY 12222 USA; [Kannan, Kurunthachalam] SUNY Albany, Dept Environm Hlth Sci, Albany, NY 12222 USA; [Guruge, Keerthi S.] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Pathol & Pathophysiol Res Div, Tsukuba, Ibaraki 3050856, Japan	Akiba, M (reprint author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	akiba@affrc.go.jp; guruge@affrc.go.jp		Balakrishna, K/0000-0002-5399-0808	Japan Society for the Promotion of Science [24256004]	This work was supported by the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research (A), 2012 to 2015 (24256004). Dr TMA Pai Endowment Chair of Manipal University is thanked for supporting this study at Manipal.	Al-Ahmad A, 2009, ARCH ENVIRON CON TOX, V57, P264, DOI 10.1007/s00244-008-9259-6; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Bouki C, 2013, ECOTOX ENVIRON SAFE, V91, P1, DOI 10.1016/j.ecoenv.2013.01.016; Minh TB, 2009, MAR POLLUT BULL, V58, P1052, DOI 10.1016/j.marpolbul.2009.02.004; Kumar R, 2008, J CLIN PHARM THER, V33, P625, DOI 10.1111/j.1365-2710.2008.00960.x; Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014; Galvin S, 2010, APPL ENVIRON MICROB, V76, P4772, DOI 10.1128/AEM.02898-09; Diwan V, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-414; Ganguly NK, 2011, INDIAN J MED RES, V134, P281; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Gundogdu A, 2013, CAN J MICROBIOL, V59, P737, DOI 10.1139/cjm-2013-0515; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Berrazeg M., 2014, Eurosurveillance, V19, P20809, DOI 10.2807/1560-7917.ES2014.19.20.20809; Clinical and Laboratory Standards Institute, 2007, M100S17 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2007, M2A9 CLIN LAB STAND; Garcia S, 2007, WATER ENVIRON RES, V79, P2387, DOI 10.2175/106143007X183826; Guardabassi L, 2002, WATER RES, V36, P1955, DOI 10.1016/S0043-1354(01)00429-8; Mathew JL, 2009, VACCINE, V27, P4247, DOI 10.1016/j.vaccine.2009.04.031; R Core Team, 2014, R LANG ENV STAT COMP; Rice DH, 1999, EPIDEMIOL INFECT, V122, P479, DOI 10.1017/S0950268899002496; Thompson JM, 2013, J APPL MICROBIOL, V114, P44, DOI 10.1111/jam.12037; Zhang XX, 2010, PROTEIN CELL, V1, P1051, DOI 10.1007/s13238-010-0134-7	22	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0147-6513	1090-2414		ECOTOX ENVIRON SAFE	Ecotox. Environ. Safe.	MAY	2015	115						203	208		10.1016/j.ecoenv.2015.02.018		6	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CG1YX	WOS:000353073200027		
J	Zhou, SY; Watanabe, H; Wei, C; Wang, DZ; Zhou, J; Tatarazako, N; Masunaga, S; Zhang, Y				Zhou, Siyun; Watanabe, Haruna; Wei, Chang; Wang, Dongzhou; Zhou, Jiti; Tatarazako, Norihisa; Masunaga, Shigeki; Zhang, Ying			Reduction in toxicity of coking wastewater to aquatic organisms by vertical tubular biological reactor	ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY			English	Article						Acute toxicity; Bio-toxicity; Daphnia; Phenol removal; Toxicity removal; Toxicity unit (TU)	SWIMMING BEHAVIOR; TREATMENT-PLANT; BIODEGRADATION; WASTEWATERS; EFFLUENTS; SYSTEM; FISH	We conducted a battery of toxicity tests using photo bacterium, algae, crustacean and fish to evaluate acute toxicity profile of coking wastewater, and to evaluate the performance of a novel wastewater treatment process, vertical tubular biological reactor (VTBR), in the removal of toxicity and certain chemical pollutants. A laboratory scale VTBR system was set up to treat industrial coking wastewater, and investigated both chemicals removal efficiency and acute bio-toxicity to aquatic organisms. The results showed that chemical oxygen demand (COD) and phenol reductions by VTBR were approximately 93% and 100%, respectively. VTBR also reduced the acute toxicity of coking wastewater significantly: Toxicity Unit (TU) decreased from 21.2 to 0.4 for Photobacterium phosphoreum, from 9.5 to 0.6 for Isochrysis galbana, from 31.9 to 1.3 for Daphnia magna, and from 30.0 to nearly 0 for Danio rerio. VTBR is an efficient treatment method for the removal of chemical pollutants and acute bio-toxicity from coking wastewater. (C) 2015 Elsevier Inc. All rights reserved.	[Zhou, Siyun; Wei, Chang; Wang, Dongzhou; Zhou, Jiti; Zhang, Ying] Dalian Univ Technol, Sch Environm Sci & Technol, Lab Ind Ecol & Environm Engn MOE, Dalian 116024, Peoples R China; [Watanabe, Haruna; Tatarazako, Norihisa] Natl Inst Environm Studies, Endocrine Disrupters & Dioxin Res Project, Tsukuba, Ibaraki 3048506, Japan; [Masunaga, Shigeki] Yokohama Natl Univ, Fac Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Zhang, Y (reprint author), Dalian Univ Technol, Sch Environm Sci & Technol, Lab Ind Ecol & Environm Engn MOE, Dalian 116024, Peoples R China.	yzhang@dlut.edu.cn	Masunaga, Shigeki/F-1315-2011	Masunaga, Shigeki/0000-0003-0608-2337	Natural Science Foundation of China (NSFC-JST) [21261140334]; Open Project of State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology [ESK201408]	It was supported by Natural Science Foundation of China (NSFC-JST, 21261140334), and Open Project of State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology (ESK201408).	Zhang WH, 2012, CHEMOSPHERE, V88, P174, DOI 10.1016/j.chemosphere.2012.02.076; Zhu N, 2013, J ENVIRON SCI-CHINA, V25, P2123, DOI 10.1016/S1001-0742(12)60261-7; LITTLE EE, 1990, ENVIRON TOXICOL CHEM, V9, P13, DOI 10.1897/1552-8618(1990)9[13:SBAAIO]2.0.CO;2; Han M, 2011, ECOTOX ENVIRON SAFE, V74, P1050, DOI 10.1016/j.ecoenv.2011.01.023; Zheng N, 2007, SCI TOTAL ENVIRON, V383, P81, DOI 10.1016/j.scitotenv.2007.05.002; Dong YR, 2010, ECOTOX ENVIRON SAFE, V73, P944, DOI 10.1016/j.ecoenv.2009.12.026; Kim YM, 2008, J HAZARD MATER, V152, P915, DOI 10.1016/j.jhazmat.2007.07.065; Lai P, 2007, J HAZARD MATER, V147, P232, DOI 10.1016/j.jhazmat.2006.12.075; Zhu XB, 2013, ENVIRON SCI-PROC IMP, V15, P1391, DOI 10.1039/c3em00064h; Lu Y, 2009, J HAZARD MATER, V165, P1091, DOI 10.1016/j.jhazmat.2008.10.091; Zhao WT, 2009, SEP PURIF TECHNOL, V66, P279, DOI 10.1016/j.seppur.2008.12.028; Persoone G, 2003, ENVIRON TOXICOL, V18, P395, DOI 10.1002/tox.10141; Lai P, 2008, PROCESS BIOCHEM, V43, P229, DOI 10.1016/j.procbio.2007.11.012; BP, 2013, BP STAT REV WORLD EN; Fang YX, 2012, ECOTOX ENVIRON SAFE, V76, P143, DOI 10.1016/j.ecoenv.2011.10.003; ISO, 1996, 7346 ISO; Jin XW, 2013, J ENVIRON SCI-CHINA, V25, P1565, DOI 10.1016/S1001-0742(12)60212-5; Kang IJ, 2009, J FAC AGR KYUSHU U, V54, P209; Lu Y, 2010, WATER SCI TECHNOL, V62, P1784, DOI 10.2166/wst.2010.543; Ma XY, 2013, WATER SCI TECHNOL, V67, P2221, DOI 10.2166/wst.2013.113; OECD, 2004, GUID TEST CHEM DAPHN; OECD (Organisation for Economic Cooperation and Development), 2006, GUID TEST CHEM FRESH; SEPA (State Environmental Protection Administration), 1996, 89781996 SEPA GB; SEPA (State Environmental Protection Administration), 1995, 154411995 SEPA GBT; Wei XX, 2012, J HAZARD MATER, V239, P135, DOI 10.1016/j.jhazmat.2012.08.042; Xu YL, 2010, CHEM ENG J, V156, P92, DOI 10.1016/j.cej.2009.10.002; Yang M, 2007, B ENVIRON CONTAM TOX, V79, P66, DOI 10.1007/s00128-007-9150-6; Yuan XY, 2012, DESALINATION, V289, P45, DOI 10.1016/j.desal.2012.01.002; Zhao JL, 2014, ENVIRON TOXICOL CHEM, V33, P1967, DOI 10.1002/etc.2638; Zitova A, 2009, ENVIRON TOXICOL, V24, P116, DOI 10.1002/tox.20387	30	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0147-6513	1090-2414		ECOTOX ENVIRON SAFE	Ecotox. Environ. Safe.	MAY	2015	115						217	222		10.1016/j.ecoenv.2015.02.017		6	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CG1YX	WOS:000353073200029		
J	Sasahira, N; Kawakami, H; Isayama, H; Uchino, R; Nakai, Y; Ito, Y; Matsubara, S; Ishiwatari, H; Uebayashi, M; Yagioka, H; Togawa, O; Toda, N; Sakamoto, N; Kato, J; Koike, K				Sasahira, Naoki; Kawakami, Hiroshi; Isayama, Hiroyuki; Uchino, Rie; Nakai, Yousuke; Ito, Yukiko; Matsubara, Saburo; Ishiwatari, Hirotoshi; Uebayashi, Minoru; Yagioka, Hiroshi; Togawa, Osamu; Toda, Nobuo; Sakamoto, Naoya; Kato, Junji; Koike, Kazuhiko			Early use of double-guidewire technique to facilitate selective bile duct cannulation: the multicenter randomized controlled EDUCATION trial	ENDOSCOPY			English	Article							POST-ERCP PANCREATITIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; DIFFICULT BILIARY CANNULATION; PRECUT SPHINCTEROTOMY; DEEP CANNULATION; WIRE PLACEMENT; RISK; METAANALYSIS; COMPLICATIONS; PREVENTION	Background and study aims: There are no guidelines for the timing of conversion from a single-guidewire to a double-guidewire technique to facilitate selective bile duct cannulation and reduce post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), when using wire-guided cannulation. We investigated whether early conversion to the double-guidewire method, at first unintentional insertion of a guidewire into the pancreatic duct, facilitated selective bile duct cannulation and reduced PEP compared with repeated single-guidewire attempts. Patients and methods: A multicenter prospective randomized controlled trial included 274 patients with a naive papilla, undergoing endoscopic retrograde cholangiography (ERC) using wire-guided cannulation in whom there was unintentional insertion of the guidewire into the pancreatic duct. With the guidewire still in the duct, patients were randomly assigned to undergo the double-guidewire technique or repeated single-wire cannulation. Main outcomes were success rates for selective bile duct cannulation and PEP frequency. Results: Success rates for selective bile duct cannulation within 10 attempts and 10 minutes were 75% and 70%, respectively, for the early double-guidewire (EDG) and repeated single-guidewire (RSG) cannulation groups (relative rate 1.07, 95% confidence interval [95 %CI] 0.93-1.24, P=0.42). Corresponding final selective bile duct cannulation rates were 98% and 97% (relative rate 1.01, 95% CI 0.97-1.05, P=1.00). PEP rates were 20% and 17%, respectively, for the EDG and RSG cannulation groups (relative risk 1.17, 95% CI 0.71-1.94, P=0.53). Double-guidewire cannulation was more effective in patients with malignant biliary stricture (relative rate 1.36, 95% CI 1.05-1.77, P=0.02). Conclusions: During therapeutic ERC using wire-guided cannulation, converting to a double-guidewire technique neither facilitated selective bile duct cannulation nor decreased PEP incidence compared with repeated use of a single-wire technique.	[Sasahira, Naoki; Isayama, Hiroyuki; Uchino, Rie; Nakai, Yousuke; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Sasahira, Naoki] Sempo Tokyo Takanawa Hosp, Dept Gastroenterol, Tokyo, Japan; [Kawakami, Hiroshi; Sakamoto, Naoya] Hokkaido Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Uchino, Rie] Kanto Cent Hosp, Dept Gastroenterol, Tokyo, Japan; [Ito, Yukiko] Japanese Red Cross Med Ctr, Dept Gastroenterol, Tokyo, Japan; [Matsubara, Saburo] Tokyo Metropolitan Police Hosp, Dept Gastroenterol, Tokyo, Japan; [Ishiwatari, Hirotoshi; Kato, Junji] Sapporo Med Univ, Dept Gastroenterol & Metab, Sapporo, Hokkaido, Japan; [Uebayashi, Minoru] Japanese Red Cross Kitami Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Yagioka, Hiroshi] JR Tokyo Gen Hosp, Dept Gastroenterol, Tokyo, Japan; [Togawa, Osamu] Saitama Med Univ, Int Med Ctr, Dept Gastroenterol, Saitama, Japan; [Toda, Nobuo] Mitsui Mem Hosp, Dept Gastroenterol, Tokyo 101, Japan	Isayama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	isayama-tky@umin.ac.jp					Angsuwatcharakon P, 2012, J GASTROEN HEPATOL, V27, P356, DOI 10.1111/j.1440-1746.2011.06927.x; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Tse F, 2013, ENDOSCOPY, V45, P605, DOI 10.1055/s-0032-1326640; Freeman ML, 2004, GASTROINTEST ENDOSC, V59, P845, DOI 10.1016/S0016-5107(04)00353-0; Maeda S, 2003, ENDOSCOPY, V35, P721; Freeman ML, 2005, GASTROINTEST ENDOSC, V61, P112, DOI 10.1016/S0016-5107(04)02463-0; Cote GA, 2012, DIGEST DIS SCI, V57, P3271, DOI 10.1007/s10620-012-2269-2; Kawakami H, 2012, GASTROINTEST ENDOSC, V75, P362, DOI 10.1016/j.gie.2011.10.012; Artifon ELA, 2007, AM J GASTROENTEROL, V102, P2147, DOI 10.1111/j.1572-0241.2007.01378.x; Bailey AA, 2008, ENDOSCOPY, V40, P296, DOI 10.1055/s-2007-995566; de Tejada AH, 2009, GASTROINTEST ENDOSC, V70, P700, DOI 10.1016/j.gie.2009.03.031; Kobayashi G, 2013, DIGEST ENDOSC, V25, P295, DOI 10.1111/j.1443-1661.2012.01372.x; Cennamo V, 2009, AM J GASTROENTEROL, V104, P2343, DOI 10.1038/ajg.2009.269; Cennamo V, 2010, ENDOSCOPY, V42, P381, DOI 10.1055/s-0029-1243992; Testoni PA, 2010, AM J GASTROENTEROL, V105, P1753, DOI 10.1038/ajg.2010.136; Katsinelos P, 2008, ENDOSCOPY, V40, P302, DOI 10.1055/s-2007-995483; Yoo YW, 2013, WORLD J GASTROENTERO, V19, P108, DOI 10.3748/wjg.v19.i1.108; Lee TH, 2012, GASTROINTEST ENDOSC, V76, P578, DOI 10.1016/j.gie.2012.05.001; Halttunen J, 2014, SCAND J GASTROENTERO, V49, P752, DOI 10.3109/00365521.2014.894120; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Dumonceau JM, 1998, ENDOSCOPY, V30, pS80, DOI 10.1055/s-2007-1001379; Nambu T, 2011, SCAND J GASTROENTERO, V46, P109, DOI 10.3109/00365521.2010.521889; Bailey AA, 2010, GASTROINTEST ENDOSC, V71, P266, DOI 10.1016/j.gie.2009.09.024; Manes G, 2009, AM J GASTROENTEROL, V104, P2412, DOI 10.1038/ajg.2009.345; Gotoh Y, 2001, GASTROINTEST ENDOSC, V53, P820, DOI 10.1067/mge.2001.113387; Bourke MJ, 2009, ENDOSCOPY, V41, P612, DOI 10.1055/s-0029-1214859; Gyokeres T, 2003, ENDOSCOPY, V35, P95, DOI 10.1055/s-2003-36403; Ito K, 2010, J GASTROENTEROL, V45, P1183, DOI 10.1007/s00535-010-0268-7; Kawakami H, 2009, J GASTROENTEROL, V44, P1140, DOI 10.1007/s00535-009-0107-x; Lee TH, 2009, GASTROINTEST ENDOSC, V69, P444, DOI 10.1016/j.gie.2008.04.064; Nakai Y, 2011, J GASTROEN HEPATOL, V26, P1552, DOI 10.1111/j.1440-1746.2011.06788.x; Parlak E, 2007, DIGEST DIS SCI, V52, P845, DOI 10.1007/s10620-006-9546-x; SIEGEL JH, 1987, GASTROINTEST ENDOSC, V33, P438, DOI 10.1016/S0016-5107(87)71683-6; Tsujino T, 2005, CLIN GASTROENTEROL H, V3, P376, DOI 10.1053/S1542-3565(04)00671-8	34	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	MAY	2015	47	5					421	429		10.1055/s-0034-1391228		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG8MP	WOS:000353562400006		
J	Uraoka, T; Tanaka, S; Oka, S; Matsuda, T; Saito, Y; Moriyama, T; Higashi, R; Matsumoto, T				Uraoka, Toshio; Tanaka, Shinji; Oka, Shiro; Matsuda, Takahisa; Saito, Yutaka; Moriyama, Tomohiko; Higashi, Reiji; Matsumoto, Takayuki			Feasibility of a novel colonoscope with extra-wide angle of view: a clinical study	ENDOSCOPY			English	Article							MISS-RATE; TANDEM COLONOSCOPY; COLORECTAL-CANCER; POLYPECTOMY; PREVENTION; EFFICACY; POLYPS; MODELS; TRIAL; COLON	Background and study aims: Lesions may be missed during colonoscopy because of anatomical features such as mucosal folds. This feasibility study assessed the safety and efficacy of a novel colonoscope with extra-wide angle of view, which provides a simultaneous lateral-backward view to complement the forward view. Patients and methods: Consecutive patients undergoing colonoscopy using the prototype colonoscope were enrolled in this multicenter, single-arm study. The number of adverse events, and the first detection of adenomas during withdrawal by the lateral-backward view and the forward view were evaluated. Results: A total of 47 patients underwent colonoscopy examination to the cecum. The mean insertion and withdrawal times were 6.4 +/- 4.9 minutes and 8.6 +/- 4.2 minutes, respectively. Of 47 detected polyps, 28 adenomatous polyps were found (mean size 3.3 +/- 3.1mm). A total of 29 polyps (61.7 %) and 16 adenomatous polyps (57.1 %) were first detected with the lateral-backward view. The lateral-backward view first detected 5/6 adenomatous polyps (83.3 %) in the ascending colon and all (2/2) adenomatous polyps in the sigmoid colon. No adverse events occurred during the study. Conclusions: This exploratory study suggested that a novel colonoscope with extra-wide angle of view is safe and feasible, and has the potential to improve colorectal adenoma detection.	[Uraoka, Toshio] Natl Hosp Org Tokyo Med Ctr, Dept Gastroenterol, Tokyo 1528902, Japan; [Uraoka, Toshio] Okayama Univ Hosp, Dept Endoscopy, Okayama, Japan; [Tanaka, Shinji; Oka, Shiro] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Matsuda, Takahisa; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Moriyama, Tomohiko; Matsumoto, Takayuki] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Higashi, Reiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008530, Japan; [Matsumoto, Takayuki] Iwate Med Univ, Dept Med, Disis Gastroenterol, Morioka, Iwate 020, Japan	Uraoka, T (reprint author), Natl Hosp Org Tokyo Med Ctr, Dept Gastroenterol, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528902, Japan.	turaoka@a3.keio.jp					Rex DK, 2000, GASTROINTEST ENDOSC, V51, P33, DOI 10.1016/S0016-5107(00)70383-X; Hewett DG, 2011, GASTROINTEST ENDOSC, V74, P246, DOI 10.1016/j.gie.2011.04.005; Ng SC, 2012, AM J GASTROENTEROL, V107, P1165, DOI 10.1038/ajg.2012.135; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352; Rex DK, 2003, AM J GASTROENTEROL, V98, P2000, DOI 10.1016/S0002-9270(03)00625-7; Leufkens AM, 2011, GASTROINTEST ENDOSC, V73, P480, DOI 10.1016/j.gie.2010.09.004; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Matsushita M, 1998, ENDOSCOPY, V30, P444, DOI 10.1055/s-2007-1001305; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; HIXSON LJ, 1991, GASTROINTEST ENDOSC, V37, P125, DOI 10.1016/S0016-5107(91)70668-8; Gralnek IM, 2014, LANCET ONCOL, V15, P353, DOI 10.1016/S1470-2045(14)70020-8; Triadafilopoulos G, 2007, GASTROINTEST ENDOSC, V65, P139, DOI 10.1016/j.gie.2006.07.044; Uraoka T, 2013, GASTROINTEST ENDOSC, V77, P480, DOI 10.1016/j.gie.2012.08.037	14	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	MAY	2015	47	5					444	448		10.1055/s-0034-1390870		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG8MP	WOS:000353562400009		
J	Itoi, T; Sofuni, A; Tsuchiya, T; Ishii, K; Ikeuchi, N; Tanaka, R; Umeda, J; Tonozuka, R; Honjo, M; Mukai, S; Takayama, T; Moriyasu, F				Itoi, Takao; Sofuni, Atsushi; Tsuchiya, Takayoshi; Ishii, Kentaro; Ikeuchi, Nobuhito; Tanaka, Reina; Umeda, Junko; Tonozuka, Ryosuke; Honjo, Mitsuyoshi; Mukai, Shuntaro; Takayama, Takako; Moriyasu, Fuminori			Initial evaluation of a new plastic pancreatic duct stent for endoscopic ultrasonography-guided placement	ENDOSCOPY			English	Article							PANCREATICOGASTROSTOMY	There are currently no plastic pancreatic duct stents that have been designed for endoscopic ultrasonography (EUS)-guided placement. This study prospectively evaluated the feasibility and efficacy of a new, single-pigtail, plastic stent. Eight patients with main pancreatic duct stricture or stenotic pancreatojejunostomy underwent EUS-guided placement of the pancreatic duct stent. The stent was placed successfully in all cases (8/8). Treatment success was achieved in all cases (8/8). A mild adverse event associated with the procedure was observed in one patient but there were no other adverse events during a mean follow-up of 7.4 months. This new pancreatic duct stent appears to be feasible and effective for EUS-guided stenting.	[Itoi, Takao; Sofuni, Atsushi; Tsuchiya, Takayoshi; Ishii, Kentaro; Ikeuchi, Nobuhito; Tanaka, Reina; Umeda, Junko; Tonozuka, Ryosuke; Honjo, Mitsuyoshi; Mukai, Shuntaro; Moriyasu, Fuminori] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1600023, Japan; [Takayama, Takako] Tokyo Womens Med Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan	Itoi, T (reprint author), Tokyo Med Univ, Internal Med, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	itoi@tokyo-med.ac.jp					Kahaleh M, 2007, GASTROINTEST ENDOSC, V65, P224, DOI 10.1016/j.gie.2006.05.008; Fujii LL, 2013, GASTROINTEST ENDOSC, V78, P854, DOI 10.1016/j.gie.2013.05.016; Tessier G, 2007, GASTROINTEST ENDOSC, V65, P233, DOI 10.1016/j.gie.2006.06.029; Francois E, 2002, GASTROINTEST ENDOSC, V56, P128, DOI 10.1067/mge.2002.125547; Itoi T, 2013, DIGEST ENDOSC, V25, P241, DOI 10.1111/den.12048; Kurihara T, 2013, DIGEST ENDOSC, V25	6	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	MAY	2015	47	5					462	465		10.1055/s-0034-1391083		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG8MP	WOS:000353562400013		
J	Jayawardana, DT; Pitawala, HMTGA; Ishiga, H				Jayawardana, D. T.; Pitawala, H. M. T. G. A.; Ishiga, H.			Geochemical evidence for the accumulation of vanadium in soils of chronic kidney disease areas in Sri Lanka	ENVIRONMENTAL EARTH SCIENCES			English	Article						Vanadium; Kidney patients; Soil; Geochemistry	PRINCIPAL COMPONENT ANALYSIS; CHRONIC-RENAL-FAILURE; SEDIMENTS; GROUNDWATER; SPECIATION; SINGLE; ROCKS; BASIN; BELT	Chronic kidney disease (CKD) is a major health problem in the dry zone of Sri Lanka. Although the precise figures are not known, number of patients suffering from CKD has reached a crisis level during the last decade. This study describes soil geochemistry of the affected region to establish the etiology for the unresolved problem of CKD. A field survey was carried out in 88 localities, and concentrations of 16 major and trace elements from soil samples were determined using X-ray fluorescence spectroscopy. It was revealed that the number of CKD patients is high where elevated concentrations of soil vanadium were observed. Further, V levels in nonagricultural soils of CKD-reported sites have significantly exceeded the risk level (200 mg/kg) given by the Canadian Environmental Council. The strong enrichment of V in soil indicates that its bioavailable fraction is also high. Besides the V of soils studied, Fe and Cr contents are also contained to be high. However, the values have not reached up to the threshold levels. Moreover, the presence of lower concentrations of other harmful trace elements (F, As, Pb, Zn, Cu and Ni) in the hotspots does not exhibit a significant impact on CKD. Strong positive correlations of V with Fe, Cr, Ti and Ni indicate that they may have derived from mineral phases of weathered basement rocks. Further, ratios of the immobile trace elements in soils studied illustrate that V is mainly derived from parent meta-igneous rocks of basaltic composition.	[Jayawardana, D. T.] Univ Sri Jayewardenepura, Nugegoda, Sri Lanka; [Jayawardana, D. T.] Univ Sri Jayewardenepura, Fac Sci, Nugegoda, Sri Lanka; [Pitawala, H. M. T. G. A.] Univ Peradeniya, Dept Geol, Peradeniya 20400, Sri Lanka; [Ishiga, H.] Shimane Univ, Grad Sch Sci & Engn, Dept Geosci, Matsue, Shimane 6908504, Japan	Jayawardana, DT (reprint author), Univ Sri Jayewardenepura, Fac Sci, Nugegoda, Sri Lanka.	daham@sci.sjp.ac.lk; apitawala@pdn.ac.lk; Ishiga@riko.shimane-u.ac.jp			MEXT (Monbukagakusho) graduate scholarship	We thank divisional secretary of Padaviya for his great support during the field study. Professor Namal Priyantha from Peradeniya University, Sri Lanka and Dr N. Attanayake from Uva Wellassa University, Sri Lanka are highly acknowledged for the constructive reviewing, which improved the study considerably. We also thank the staff of the Shimane University Japan for their constructive suggestions. This study was supported by a MEXT (Monbukagakusho) graduate scholarship to DTJ from Shimane University.	Agnieszka J, 2012, J HAZARD MATER, V237, P315, DOI 10.1016/j.jhazmat.2012.08.048; Ahmed F, 2012, ENVIRON MONIT ASSESS, V184, P4383, DOI 10.1007/s10661-011-2271-8; Ahmed F, 2006, ATMOS ENVIRON, V40, P3835, DOI 10.1016/j.atmosenv.2006.03.004; Prytulak J, 2013, EARTH PLANET SC LETT, V365, P177, DOI 10.1016/j.epsl.2013.01.010; COORAY PG, 1994, PRECAMBRIAN RES, V66, P3, DOI 10.1016/0301-9268(94)90041-8; Wright MT, 2014, APPL GEOCHEM, V48, P41, DOI 10.1016/j.apgeochem.2014.06.025; Ouyang Y, 2005, WATER RES, V39, P2621, DOI 10.1016/j.watres.2005.04.024; Zuo RG, 2011, J GEOCHEM EXPLOR, V111, P13, DOI 10.1016/j.gexplo.2011.06.012; Tankersley KB, 2010, J ARCHAEOL SCI, V37, P133, DOI 10.1016/j.jas.2009.09.023; Evangelou AM, 2002, CRIT REV ONCOL HEMAT, V42, P249, DOI 10.1016/S1040-8428(01)00221-9; Pourret O, 2012, CHEM GEOL, V294, P89, DOI 10.1016/j.chemgeo.2011.11.033; Almeida M, 2001, PHYTOCHEMISTRY, V57, P633, DOI 10.1016/S0031-9422(01)00094-2; Poledniok J, 2003, TALANTA, V59, P1, DOI 10.1016/S0039-9140(02)00322-3; Bandara JMRS, 2008, ENVIRON GEOCHEM HLTH, V30, P465, DOI 10.1007/s10653-007-9129-6; Teng YG, 2011, ENVIRON MONIT ASSESS, V176, P605, DOI 10.1007/s10661-010-1607-0; Parsons C, 2013, J HAZARD MATER, V262, P1213, DOI 10.1016/j.jhazmat.2012.07.001; BHATIA MR, 1986, CONTRIB MINERAL PETR, V92, P181, DOI 10.1007/BF00375292; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; Wanigasuriya KP, 2007, T ROY SOC TROP MED H, V101, P1013, DOI 10.1016/j.trstmh.2007.05.006; API (American Petroleum Institute), 1985, VAN ENV COMM HLTH IM; Assem FL, 2009, J TOXICOL ENV HEAL B, V12, P289, DOI 10.1080/10937400903094166; Bloomfield C, 1981, CHEM SOIL PROCESSES; Bong WSK, 2012, FORENSIC SCI INT, V220, P33, DOI 10.1016/j.forsciint.2012.01.024; Brooks RR, 1972, GEOBOTANY BIOGEOCHEM; CCME (Canadian Council of Ministers of the Environment), 1991, INT CAN ENV QUAL CRI; Chan Erwin P. H., 2010, Toxicological and Environmental Chemistry, V92, P359, DOI 10.1080/02772240902863848; Chandrajith R, 2010, ENVIRON EARTH SCI, V60, P193, DOI 10.1007/s12665-009-0179-1; Chandrajith R, 2011, SCI TOTAL ENVIRON, V409, P671, DOI 10.1016/j.scitotenv.2010.10.046; Chandrajith R, 2011, ENVIRON GEOCHEM HLTH, V33, P267, DOI 10.1007/s10653-010-9339-1; Chandrapala L, 2003, AGR WATER MANAGE, V58, P89, DOI 10.1016/S0378-3774(02)00127-0; Cooray PG, 1984, INTRO GEOLOGY SRI LA, p[81, 256, 289]; De Silva N, 2011, TECH REP, V63, P1; DISSANAYAKE CB, 1984, CHEM GEOL, V47, P221, DOI 10.1016/0009-2541(84)90127-X; Dissanayake CB, 1985, J NATL SCI CON SRI L, V13, P147; Evans HT, 1978, HDB GEOCHEMISTRY, VII, P23; Gad SC, 2014, ENCY TOXICOLOGY, V3rd, P909; Gummow B, 2006, PREV VET MED, V76, P167, DOI 10.1016/j.prevetmed.2006.05.003; Gummow B, 2011, REFERENCE MODULE EAR, P628; Herath JW, 1973, EC B, V1, p[1, 67, 96]; Herath JW, 1984, J NATL SCI COUNCIL S, V12, P257; Hernandez H, 2012, ENVIRON MONIT ASSESS, V184, P5327, DOI 10.1007/s10661-011-2343-9; Ileperuma O. A., 2000, Journal of the National Science Foundation of Sri Lanka, V28, P301; Jayasekera JMKB, 2012, P INT S WAT QUAL HUM, P56; Jayasumana C, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-124; Jayawardana DT, 2012, J GEOCHEM EXPLOR, V114, P118, DOI 10.1016/j.gexplo.2012.01.004; Jayawardana D. T., 2010, International Journal of Environmental Science and Development, V1, P244; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, VXXIX, P487; Kubova J, 2008, TALANTA, V75, P1110, DOI 10.1016/j.talanta.2008.01.002; Lepp NW, 1995, HEAVY METALS SOIL; Lin TS, 2004, B ENVIRON CONTAM TOX, V73, P781, DOI 10.1007/s00128-004-0495-9; Lopez-Lopez G, 2012, J ENVIRON MANAGE, V113, P517, DOI 10.1016/j.jenvman.2012.03.010; Mapa RB, 2010, SPECIAL PUBLICATION, V7, p[1, 59]; MULLER G, 1981, CHEM ZTG, V105, P157; MUNASINGHE T, 1980, PRECAMBRIAN RES, V12, P459, DOI 10.1016/0301-9268(80)90040-6; Narwal RP, 1998, WATER AIR SOIL POLL, V102, P313; Norrish K, 1975, TRACE ELEMENTS SOIL; Novotny EH, 2006, ORG GEOCHEM, V37, P1562, DOI 10.1016/j.orggeochem.2006.06.015; Nriagu JO, 1998, ADV ENV SCI, V30, P1; O'seaghdha CM, 2011, NEPHRON CLIN PRACT, V118, P55; Panabokke CR, 1996, SOILS AGROECOLOGICAL, P220; Pohl J.G., 1991, CRYSTALLINE CRUST 1, P94; Ranasinghe PN, 2008, J GEOCHEM EXPLOR, V99, P1, DOI 10.1016/j.gexplo.2008.02.001; Rehder Dieter, 2013, Met Ions Life Sci, V13, P139, DOI 10.1007/978-94-007-7500-8_5; Roser BP, 2000, MEM GEOL SOC JPN, V57, P73; Rudnick RL, 2005, CRUSTACEANA, V3, P17; Scibior A, 2007, J TOXICOL ENV HEAL A, V70, P696, DOI 10.1080/15287390601187906; Suwa K, 1996, J SOUTHE ASIAN EARTH, V14, P299, DOI 10.1016/S0743-9547(96)00066-9; Takeno N, 2005, GEOL SOC JPN OPEN FI, V419, P11; Tian LY, 2014, CHEMOSPHERE, V111, P89, DOI 10.1016/j.chemosphere.2014.03.051; Tokalioglu S, 2005, B ENVIRON CONTAM TOX, V75, P180, DOI 10.1007/s00128-005-0736-6; Venkataraman BV, 2005, ASIAN J EXPT SCI, V19, P117; Wanigasuriya KP, 2012, J COLL COMMUNITY PHY, V17, P15; WHO, 1988, ENV HLTH CRIT	73	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	MAY	2015	73	9					5415	5424		10.1007/s12665-014-3796-2		10	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CH1TE	WOS:000353803600053		
J	Acharya, KP; Bhandary, NP; Dahal, RK; Yatabe, R				Acharya, Kiran Prasad; Bhandary, Netra Prakash; Dahal, Ranjan Kumar; Yatabe, Ryuichi			Numerical analysis on influence of principal parameters of topography on hillslope instability in a small catchment	ENVIRONMENTAL EARTH SCIENCES			English	Article						Unsaturated hillslopes; Instability; Numerical modeling; Subsurface hillslope hydrologica response to rainfall; Factor of safety	PHYSICALLY-BASED MODEL; TRIGGERED SHALLOW LANDSLIDES; STORAGE BOUSSINESQ MODEL; SLOPE STABILITY ANALYSIS; RESIDUAL SOIL SLOPE; COMPLEX HILLSLOPES; SUBSURFACE FLOW; NOVEMBER 2000; RAINFALL; INFILTRATION	This study was conducted to identify the influence of three principal parameters constituting topography (slope inclination, soil depth, and slope length) on hillslope instability in a small catchment, known as Higashifukubegawa of Shikoku Island, western Japan. The typhoon rainfall of 19-20 October 2004 was significant in causing a total of seven slope failures in the catchment, though other rainfall events of various intensities in the same year did not cause failure. To understand the influence of the three principal parameters, numerical modeling of seepage and slope stability was performed in slope profiles constructed by varying the three parameters across their permissible range prepared from the seven slope failures of Higashifukubegawa in GeoStudio (GeoStudio Tutorials includes student edition lessons, Geo-Slope International Ltd., Calgary, 2005 v.4). The change in porewater pressure and slope mass weight due to variation in values of principal parameters was used to interpret the change in factor of safety or instability. The results showed that (1) instability increases with increase in the values of all three selected parameters across their range in Higashifukubegawa with remarkable decreasing trend in factors of safety, (2) slope inclination and soil depth were observed to affect instability through change in both unsaturated zone moisture content and mobilizing force of slope mass, (3) but with slope length, the unsaturated zone moisture content was not found to change considerably which implies that the instability due to slope length is mainly governed by change in slope mass weight. Overall, this study has dealt in great detail with how hillslope instability changes with principal parameters of topography under the same simulating conditions of hydrological and geo-mechanical parameters.	[Acharya, Kiran Prasad] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Acharya, Kiran Prasad] Pokhara Univ, Nepal Engn Coll, Dept Civil Engn, Changunarayan, Bhaktapur, Nepal; [Bhandary, Netra Prakash; Yatabe, Ryuichi] Ehime Univ, Grad Sch Sci & Engn, Dept Civil & Environm Engn, Matsuyama, Ehime 7908577, Japan; [Dahal, Ranjan Kumar] Tribhuvan Univ, Dept Geol, Kathmandu, Nepal	Acharya, KP (reprint author), Ehime Univ, Grad Sch Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	kiran_acharya60@yahoo.com; netra@ehime-u.ac.jp; ranjan@ranjan.net.np; yatabe@cee.ehime-u.ac.jp					Acharya KP, 2014, GEOMAT NAT HAZ RISK, DOI [10.1080/19475705.2014.954150, DOI 10.1080/19475705.2014.954150]; Acharya KP, 2014, GEOMAT NAT HAZ RISK, DOI [10.1080/19475705.2014.880856, DOI 10.1080/19475705.2014.880856]; Rigon R, 2006, J HYDROMETEOROL, V7, P371, DOI 10.1175/JHM497.1; Iida T, 1999, CATENA, V34, P293, DOI 10.1016/S0341-8162(98)00093-9; FREDLUND DG, 1994, CAN GEOTECH J, V31, P533, DOI 10.1139/t94-062; Rahimi A, 2010, ENG GEOL, V114, P135, DOI 10.1016/j.enggeo.2010.04.010; Iverson RM, 2000, WATER RESOUR RES, V36, P1897, DOI 10.1029/2000WR900090; Borga M, 2002, HYDROL PROCESS, V16, P2833, DOI 10.1002/hyp.1074; Montgomery DR, 2002, WATER RESOUR RES, V38, DOI 10.1029/2002WR001429; Griffiths DV, 2011, INT J NUMER ANAL MET, V35, P569, DOI 10.1002/nag.909; Aryal SK, 2005, ADV WATER RESOUR, V28, P99, DOI 10.1016/j.advwatres.2004.10.008; Puigdefabregas J, 1998, GEOMORPHOLOGY, V23, P337, DOI 10.1016/S0169-555X(98)00014-2; Simoni S, 2008, HYDROL PROCESS, V22, P532, DOI 10.1002/hyp.6886; Zhan TLT, 2013, INT J NUMER ANAL MET, V37, P1737, DOI 10.1002/nag.2106; Troch PA, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001728; Giannecchini R, 2012, NAT HAZARD EARTH SYS, V12, P829, DOI 10.5194/nhess-12-829-2012; Hsu SM, 2010, NAT HAZARD EARTH SYS, V10, P535; Dahal RK, 2009, ENVIRON GEOL, V58, P567, DOI 10.1007/s00254-008-1531-6; Burton A, 1998, ENVIRON GEOL, V35, P89; MONTGOMERY DR, 1994, WATER RESOUR RES, V30, P1153, DOI 10.1029/93WR02979; Troch P, 2002, ADV WATER RESOUR, V25, P637, DOI 10.1016/S0309-1708(02)00017-9; von Ruette J, 2013, WATER RESOUR RES, V49, P6266, DOI 10.1002/wrcr.20418; McNamara JP, 2005, HYDROL PROCESS, V19, P4023, DOI 10.1002/hyp.5869; Lu N, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006976; Salciarini D, 2008, ENG GEOL, V102, P227, DOI 10.1016/j.enggeo.2008.03.013; WU WM, 1995, WATER RESOUR RES, V31, P2097, DOI 10.1029/95WR01136; Rahardjo H, 2005, CAN GEOTECH J, V42, P340, DOI 10.1139/t04-101; D'Odorico P, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001595; Tsaparas I, 2002, COMPUT GEOTECH, V29, P1, DOI 10.1016/S0266-352X(01)00019-2; Godt JW, 2008, ENG GEOL, V102, P214, DOI 10.1016/j.enggeo.2008.03.019; Casagli N, 2006, LANDSLIDES, V3, P13, DOI 10.1007/s10346-005-0007-y; Gasmo JM, 2000, COMPUT GEOTECH, V26, P145, DOI 10.1016/S0266-352X(99)00035-X; Tofani V, 2006, NAT HAZARD EARTH SYS, V6, P1025; Rahardjo H, 2007, J GEOTECH GEOENVIRON, V133, P1532, DOI 10.1061/(ASCE)1090-0241(2007)133:12(1532); Hilberts AGJ, 2004, J HYDROL, V291, P160, DOI 10.1016/j.jhydrol.2003.12.043; ASTM, 1999, ANN BOOK ASTM STAND; Boussinesq J., 1877, MEMOIRES PRESENTES D, V23, P1; Cascini L, 2010, J GEOTECH GEOENVIRON, P85; Cha KS, 2011, KSCE J CIV ENG, V15, P251, DOI 10.1007/s12205-011-0930-5; Claessens L, 2007, GEOMORPHOLOGY, V87, P16, DOI 10.1016/j.geomorph.2006.06.039; Dahal RK, 2011, J NEPAL GEOL SOC, V42, P127; Dahal RK, 2008, ENVIRON GEOL, V54, P314, DOI 10.1007/s00254-007-0818-3; Daitou Techno Green, 2009, HAS SIT PERM TEST OP; Dapporto S, 2005, ADV GEOSCI, V2, P305, DOI DOI 10.5194/ADGE0-2-305-2005; De Bryan RB, 1989, EARTH SURF PROC LAND, V14, P211; de Campos TMP, 1991, P 6 INT S LANDSL CHR, P1357; De Giesen NV, 2011, AGR ECOSYST ENVIRON, V142, P95, DOI DOI 10.1016/J.AGEE.2010.06.006; Dhakal AS, 2003, EARTH SURF PROC LAND, V28, P853, DOI 10.1002/esp.499; Dietrich WE, 2008, 4 INT C DEBR FLOW HA; Dietrich WE, 1987, IAHS PUBL, V165; Fox DM, 1997, GEODERMA, V80, P81; Fredlund D. G., 1993, SOIL MECH UNSATURATE; Fredlund DG, 1987, CAN GEOTECH J, V24, P323; Garg A, 2010, INT J EARTH SCI ENG, V3, P40; GeoStudio, 2005, V 4 GEOSTUDIO TUT IN, V1st; Gofar N, 2009, STUDY DEV SATURATION; Harp EL, 2009, ENG GEOL, V104, P295, DOI 10.1016/j.enggeo.2008.11.010; Harris SJ, 2012, LANDSLIDES, V9, P349, DOI 10.1007/s10346-011-0309-1; Hilberts AGJ, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR004964; Huang J, 2013, CATENA, V104, P93, DOI 10.1016/j.catena.2012.10.013; Iverson RM, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002077; Kassim A, 2012, ENG GEOL, V131, P70, DOI 10.1016/j.enggeo.2012.02.005; Lanni C, 2012, THESIS, P80; Lee LM, 2014, NAT HAZARDS, V70, P353; Lee LM, 2009, ENG GEOL, V108, P272, DOI 10.1016/j.enggeo.2009.06.011; Loague K, 2005, HYDROL PROCESS, V19, P1373, DOI 10.1002/hyp.5566; LUK SH, 1993, CATENA SUPP, V24, P29; Milledge DG, 2012, EARTH SURF PROC LAND, V37, P1158, DOI 10.1002/esp.3235; MORGENST.NR, 1965, GEOTECHNIQUE, V15, P79; Pack RT, 1998, SINMAP STABILITY IND; Poesens J, 1984, Z GEOMORPHOL S, V49, P117; Sidle R.C., 2006, WATER RESOURCES MONO, V18; Talebi A, 2008, EARTH SURF PROC LAND, V33, P1964, DOI 10.1002/esp.1648; Talebi A, 2007, NAT HAZARD EARTH SYS, V7, P523; Travis QB, 2010, J GEOTECH GEOENVIRON, V136, P963, DOI 10.1061/(ASCE)GT.1943-5606.0000301; van Schalkwyk A, 1991, P 3 INT C TROP RES S, P57; VanderKwaak J.E., 1999, THESIS U WATERLOO; WEST LT, 1992, ADV SOIL S, P73; Zhan T. L. T., 2004, International Journal of Geomechanics, V4, P273, DOI 10.1061/(ASCE)1532-3641(2004)4:4(273)	79	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	MAY	2015	73	9					5643	5656		10.1007/s12665-014-3819-z		14	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CH1TE	WOS:000353803600073		
J	Sone, D; Ito, K; Taniguchi, G; Murata, Y; Nakata, Y; Watanabe, Y; Okazaki, M; Sato, N; Matsuda, H; Watanabe, M				Sone, Daichi; Ito, Kimiteru; Taniguchi, Go; Murata, Yoshiko; Nakata, Yasuhiro; Watanabe, Yutaka; Okazaki, Mitsutoshi; Sato, Noriko; Matsuda, Hiroshi; Watanabe, Masako			Evaluation of amygdala pathology using C-11-methionine positron emission tomography/computed tomography in patients with temporal lobe epilepsy and amygdala enlargement	EPILEPSY RESEARCH			English	Article						C-11-methionine; PET; PET/CT; Amygdala enlargement; Temporal lobe epilepsy; Brain neoplasms	BRAIN-TUMORS; DIFFERENTIAL-DIAGNOSIS; CORTICAL DYSPLASIA; F-18-FDG PET; GLIOMAS; SEIZURES	Objective: The association between amygdala enlargement (AE) and temporal lobe epilepsy (TLE) has increasingly been reported. However, the pathology of AE remains poorly understood. The purpose of this study was to explore AE pathology using C-11-methionine (Met) positron emission tomography (PET)/computed tomography (CT) in patients who have TLE with AE. Materials and methods: Twenty-six TLE patients with AE and 18 TLE patients without AE underwent C-11-Met PET/CT and magnetic resonance imaging (MRI). C-11-Met uptake in amygdala was evaluated by both visual inspection and semi-quantitative measurement. MRI was assessed visually and semi-quantitatively for AE. Laterality index (LI) was obtained by comparing the amygdala volumes of ipsilateral and contralateral sides. The clinical course and histopathological findings of all patients were also analyzed. Results: On C-11-Met PET/CT images, visual examination detected increased uptake in the enlarged amygdala in 7 of 26 (27%) TLE patients with AE, and the results were confirmed by semi-quantitative analysis. Among six TLE patients with AE who underwent surgery, histopathology revealed neoplasms (low grade astrocytoma and gangliocytoma) in two patients and focal cortical dysplasia in one patient with increased C-11-Met uptake, but non-neoplastic lesions (focal cortical dysplasia, vacuolar degeneration, and hamartoma) in all three patients with no increased C-11-Met uptake. On MRI, volume of the affected amygdala was significantly larger compared to the contralateral amygdala. LI was significantly higher in the group with AE than in the group without AE. Conclusions: This study revealed that some TLE patients with AE showed increased C-11-Met uptake in the enlarged amygdala. C-11-Met PET/CT is potentially useful for the evaluation of AE pathology, and may provide beneficial information for appropriate decision-making. (C) 2015 Elsevier B.V. All rights reserved.	[Sone, Daichi; Ito, Kimiteru; Nakata, Yasuhiro; Sato, Noriko] Natl Ctr Neurol & Psychiat, Dept Radiol, Kodaira, Tokyo 1878551, Japan; [Sone, Daichi] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo 1138654, Japan; [Taniguchi, Go] Tokyo Univ Hosp, Dept Neuropsychiat, Tokyo, Japan; [Murata, Yoshiko; Watanabe, Yutaka; Okazaki, Mitsutoshi; Watanabe, Masako] Natl Ctr Neurol & Psychiat, Dept Psychiat, Kodaira, Tokyo 1878551, Japan; [Nakata, Yasuhiro] Tokyo Metropolitan Neurol Hosp, Dept Neuroradiol, Tokyo, Japan; [Matsuda, Hiroshi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Kodaira, Tokyo 1878551, Japan	Ito, K (reprint author), Natl Ctr Neurol & Psychiat, Dept Radiol, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878551, Japan.	daichisone@gmail.com; itoukimiteru@yahoo.co.jp; taniguchi-jes@umin.ac.jp; ymurata@ncnp.go.jp; nakatay-tky@umin.ac.jp; wata-yt@ncnp.go.jp; okazakim@ncnp.go.jp; snoriko@ncnp.go.jp; matsudah@ncnp.go.jp; wata2ms@gmail.com					Pirotte B, 2004, J NEUROSURG, V101, P476, DOI 10.3171/jns.2004.101.3.0476; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; Bower SPC, 2003, J NEUROL NEUROSUR PS, V74, P1245, DOI 10.1136/jnnp.74.9.1245; Pirotte B, 2004, J NUCL MED, V45, P1293; Kaschten B, 1998, J NUCL MED, V39, P778; Soeder BM, 2009, J NEUROL NEUROSUR PS, V80, P894, DOI 10.1136/jnnp.2008.165860; Singhal T, 2012, J NUCL MED, V53, P1709, DOI 10.2967/jnumed.111.102533; Rowan AJ, 2005, NEUROLOGY, V64, P1868, DOI 10.1212/01.WNL.0000167384.68207.3E; Mandonnet E, 2003, ANN NEUROL, V53, P524, DOI 10.1002/ana.10528; Phi JH, 2009, CANCER, V115, P5771, DOI 10.1002/cncr.24666; Chung JK, 2002, EUR J NUCL MED MOL I, V29, P176, DOI 10.1007/s00259-001-0690-4; Herholz K, 1998, NEUROLOGY, V50, P1316; Besocke AG, 2013, EPILEPSY BEHAV, V27, P29, DOI 10.1016/j.yebeh.2012.11.041; Danfors T, 2009, EUR J NEUROL, V16, P823, DOI 10.1111/j.1468-1331.2009.02599.x; Hildebrand J, 2005, NEUROLOGY, V65, P212, DOI 10.1212/01.wnl.0000168903.09277.8f; Isohashi K, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-27; Kim DW, 2012, J CLIN NEUROSCI, V19, P509, DOI 10.1016/j.jocn.2011.05.042; Kimura Y, 2015, J NEUROIMAGING, V25, P175, DOI 10.1111/jon.12106; Madakasira PV, 2002, AM J NEURORADIOL, V23, P844; Maehara T, 2004, EPILEPSIA, V45, P41, DOI 10.1111/j.0013-9580.2004.20703.x; Mitsueda-Ono T, 2011, J NEUROL NEUROSUR PS, V82, P652, DOI 10.1136/jnnp.2010.206342; Phi JH, 2010, J NUCL MED, V51, P728, DOI 10.2967/jnumed.109.070920; Rosenberg DS, 2005, J NEUROL NEUROSUR PS, V76, P1686, DOI 10.1136/jnnp.2004.051607; Sasaki M, 1998, J NUCL MED, V39, P974; Tabatabaei SS, 2013, NEUROL SCI, V34, P1441, DOI 10.1007/s10072-012-1261-0; Takaya S, 2014, J NEUROIMAGING, V24, P54, DOI 10.1111/j.1552-6569.2011.00694.x; Whittle IR, 2004, J NEUROL NEUROSUR PS, V75, P31, DOI 10.1136/jnnp.2004.040501	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	MAY	2015	112						114	121		10.1016/j.eplepsyres.2015.02.018		8	Clinical Neurology	Neurosciences & Neurology	CH2HD	WOS:000353845400014		
J	Kanemura, H; Sano, F; Ohyama, T; Aoyagi, K; Sugita, K; Aihara, M				Kanemura, Hideaki; Sano, Fumikazu; Ohyama, Tetsuo; Aoyagi, Kakuro; Sugita, Kanji; Aihara, Masao			Sequential prefrontal lobe volume changes and cognitive dysfunctions in children with Panayiotopoulos syndrome presenting with status epilepticus	EPILEPSY RESEARCH			English	Article						Panayiotopoulos syndrome; Prefrontal lobe; Brain volumetry; Cognition; Behavior	BENIGN CHILDHOOD EPILEPSY; RECURRENT SEIZURES; DEVELOPING BRAIN; NEUROPSYCHOLOGICAL FINDINGS; BEHAVIOR PROBLEMS; GROWTH; VULNERABILITY; HARMFUL; DAMAGE	Panayiotopoulos syndrome (PS) is usually not associated with neurodevelopmental problems. However, neuropsychological impairments may also be present in at least some of the patients with PS. On the other hand, several degrees of neuronal damage due to status epilepticus (SE) may occur in the cortex. We prospectively measured frontal and prefrontal lobe volumes using three-dimensional magnetic resonance imaging (3D-MRI)-based volumetry in patients with PS with and without SE. Moreover, the neuropsychological outcome in relation to the presence of SE in children with PS is also discussed. We studied six patients with a final diagnosis of PS, including three cases with SE and cognitive impairments/behavioral problems (SE group) and three cases without SE (non-SE group). Serial 3D-MRI studies were performed five times (at onset of clinical symptoms and 1-4 years after onset) in both the SE and non-SE patients. All patients were studied with a set of Wechsler Intelligence Scale for Children, version III (WISC-III) or Wechsler Preschool and Primary Scale of Intelligence tests and the Kaufman Assessment Battery for Children (K-ABC). Growth of the frontal and prefrontal lobes was slightly decreased for some time after SE episodes in the SE patients. Moreover, the prefrontal-to-frontal lobe volume ratio was stagnant for some time after SE in the SE patients. The scores on the neuropsychological tests were decreased in the SE patients. Moreover, the average WISC and K-ABC scores in the SE group remained low and did not reach the levels of the initial examinations. Occurrence of SE in patients with PS at least in some patients may be associated with retarded prefrontal lobe growth, which was related to neuropsychological problems and ultimately, neuropsychological outcomes. Treatment management may be required to prevent SE as much as possible to achieve optimal prognosis in PS at least in some patients. (C) 2015 Elsevier B.V. All rights reserved.	[Kanemura, Hideaki; Sano, Fumikazu; Ohyama, Tetsuo; Aoyagi, Kakuro; Sugita, Kanji] Univ Yamanashi, Fac Med, Dept Pediat, Yamanashi 4093898, Japan; [Aihara, Masao] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Yamanashi 4093898, Japan	Kanemura, H (reprint author), Univ Yamanashi, Fac Med, Dept Pediat, 1110 Chuo, Yamanashi 4093898, Japan.	ykimu@yamanashi.ac.jp			Japan Epilepsy Research Foundation [22591123]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [25-6]	This research was supported in part by the Japan Epilepsy Research Foundation, a Grant-in-Aid for Scientific Research (22591123), and an Intramural Research Grant (25-6) for Neurological and Psychiatric Disorders of NCNP. The funding sources had no involvement such as study design, the collection, analysis and interpretation of data, the writing of the report, and the decision to submit the article for publication.	Bailet LL, 2000, EPILEPSIA, V41, P426, DOI 10.1111/j.1528-1157.2000.tb00184.x; AUSTIN JK, 1992, EPILEPSIA, V33, P1115, DOI 10.1111/j.1528-1157.1992.tb01768.x; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; Austin JK, 2002, EPILEPSIA, V43, P1564, DOI 10.1046/j.1528-1157.2002.26002.x; Kanemura H, 2012, DEV MED CHILD NEUROL, V54, P912, DOI 10.1111/j.1469-8749.2012.04358.x; MITCHELL WG, 1994, PEDIATRICS, V94, P471; Kanemura H, 2011, BRAIN DEV-JPN, V33, P106, DOI 10.1016/j.braindev.2010.03.005; Kanemura H, 2012, BRAIN DEV-JPN, V34, P175, DOI 10.1016/j.braindev.2011.04.009; DOBBING J, 1971, BIOL NEONATE, V19, P363; Mandelbaum DE, 1997, DEV MED CHILD NEUROL, V39, P731; HOARE P, 1984, DEV MED CHILD NEUROL, V26, P3; Germano E, 2005, EPILEPSY RES, V64, P137, DOI 10.1016/j.eplepsyres.2005.03.004; Camfield PR, 1997, EPILEPSIA, V38, P735, DOI 10.1111/j.1528-1157.1997.tb01245.x; Caraballo R, 2000, NEUROLOGY, V55, P1096; Chiappedi M, 2011, EPILEPSY BEHAV, V20, P79, DOI 10.1016/j.yebeh.2010.10.029; Chilosi AM, 2006, EPILEPSIA, V47, P76, DOI 10.1111/j.1528-1167.2006.00696.x; Fejerman N., 2007, BENIGN FOCAL EPILEPS, P115; Fejerman N, 2008, EPILEPSY COMPREHENSI, Vsecond, P2379; Fountain NB, 2005, CUR CLIN NEUROL, P181; FOWLER M, 1957, ARCH DIS CHILD, V32, P67; Garcia C, 2009, EPILEPSY RES, V85, P318, DOI 10.1016/j.eplepsyres.2009.03.024; Kanemura H, 2003, BRAIN DEV-JPN, V25, P195, DOI 10.1016/S0387-7604(02)00214-0; Kanemura H, 2009, NEUROPEDIATRICS, V40, P192, DOI 10.1055/s-0029-1243224; Marks JD, 1996, DEV BRAIN RES, V97, P194, DOI 10.1016/S0165-3806(96)00149-6; Oguni H, 2001, PEDIATR NEUROL, V25, P312, DOI 10.1016/S0887-8994(01)00323-X; Schmidt G, 2012, EPILEPTIC DISORD, V14, P426, DOI 10.1684/epd.2012.0536; Schoenfeld J, 1999, DEV MED CHILD NEUROL, V41, P724, DOI 10.1017/S0012162299001486; Caviness VS, 1999, BRAIN DEV-JPN, V21, P289; Wasterlain CG, 1997, EPILEPSIA, V38, P728, DOI 10.1111/j.1528-1157.1997.tb01244.x	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	MAY	2015	112						122	129		10.1016/j.eplepsyres.2015.02.019		8	Clinical Neurology	Neurosciences & Neurology	CH2HD	WOS:000353845400015		
J	Gomez, F; Onuma, R; Artigas, LF; Horiguchi, T				Gomez, Fernando; Onuma, Ryo; Artigas, Luis F.; Horiguchi, Takeo			A new definition of Adenoides eludens, an unusual marine sand-dwelling dinoflagellate without cingulum, and Pseudadenoides kofoidii gen. & comb. nov for the species formerly known as Adenoides eludens	EUROPEAN JOURNAL OF PHYCOLOGY			English	Article						Adenoides kofoidii; Dinophyta; microphytobenthos; molecular phylogeny; new genus; psammophilic Dinophyceae	MOLECULAR PHYLOGENY; HETEROTROPHIC DINOFLAGELLATE; DINOPHYCEAE; PERIDINIALES; DIVERSITY	The species Amphidinium eludens, as described by Herdman (1922; Proc. Trans. Liverpool Biol. Soc. 36: 18) based on her drawing in fig. 1, has been investigated for the first time by scanning electron microscopy and phylogenetic analysis. The morphological and molecular data reveal that this species is distantly related to other known dinoflagellates. Balech [1956, Rev. Algol., n. ser. 2(1-2): 30] cited Amphidinium eludens Herdman (1922, fig. 1) as the basionym of the type of Adenoides, while he described and illustrated Amphidinium kofoidii Herdman (1922, fig. 2) as Adenoides eludens. As the nomenclatural rules do not allow the change of basionym, we have re-defined the genus Adenoides based on the characteristics of Amphidinium eludens Herdman (1922, fig. 1). The thecal plate formula of Adenoides eludens is Po, 5, 6, 0c, 3+s, 5, 3p, 1. This species lacks a cingulum. The apical pore complex resembles that of peridinioid dinoflagellates, while the absence of a cingular groove is reminiscent of desmokont prorocentroids. We also propose Pseudadenoides kofoidii gen. & comb. nov. based on Herdman's 1922 fig. 2 of Amphidinium kofoidii which was described by Balech in 1956 and re-named Adenoides eludens.	[Gomez, Fernando] Univ Sao Paulo, Oceanog Inst, Lab Plankton Syst, BR-05508900 Sao Paulo, Brazil; [Onuma, Ryo] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Gomez, Fernando; Artigas, Luis F.] Univ Littoral Cote dOpale, CNRS UMR 8187, Labo Oceanol & Geosci, MREN ULCO, F-62930 Wimereux, France; [Horiguchi, Takeo] Hokkaido Univ, Dept Nat Hist Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Gomez, F (reprint author), Univ Sao Paulo, Oceanog Inst, Lab Plankton Syst, Sala 100,Praca Oceanog 191,Cidade Univ, BR-05508900 Sao Paulo, Brazil.	fernando.gomez@fitoplancton.com	Gomez, Fernando/B-2495-2009; Horiguchi, Takeo/D-7612-2012	Gomez, Fernando/0000-0002-5886-3488; 	UL1 post-doctoral grant; CNRS; Universite Littoral-Cote Opale; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [BJT 370646/2013-14]	F.G. was supported by a UL1 post-doctoral grant and a CNRS convention of research, and an invited lecturer grant from Universite Littoral-Cote Opale. F.G. is currently supported by the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant number BJT 370646/2013-14).	Yamaguchi A, 2006, PHYCOL RES, V54, P317, DOI 10.1111/j.1440-1835.2006.00438.x; Yamaguchi A, 2011, EUR J PHYCOL, V46, P98, DOI 10.1080/09670262.2011.564517; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Tillmann U, 2009, EUR J PHYCOL, V44, P63, DOI 10.1080/09670260802578534; Gomez F, 2010, PHYCOLOGIA, V49, P212, DOI 10.2216/09-29.1; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Balech E., 1956, REV ALGOL N, V2, P29; Dodge J.D., 1982, MARINE DINOFLAGELLAT; DODGE JD, 1986, PROTISTOLOGICA, V22, P221; Gomez F, 2012, SYST BIODIVERS, V10, P267, DOI 10.1080/14772000.2012.721021; Gomez F, 2014, J MAR BIOL ASSOC UK, V94, P443, DOI 10.1017/S0025315413001744; Gomez F, 2011, ACTA PROTOZOOL, V50, P255; Herdman E. C., 1923, P T LIVERPOOL BIOL S, V38, P58; Herdman E. C., 1922, Proceedings and Transactions of the Liverpool Biological Society, V36, P15; Hoppenrath M, 2003, EUR J PHYCOL, V38, P385, DOI 10.1080/09670260310001613717; McNeill J, 2012, REGNUM VEG, V154, P1; Murray S, 2004, EUR J PHYCOL, V39, P229, DOI 10.1080/0967026042000202154; Paulmier G., 1992, RV92007RH IFREMER; Posada MA, 1998, BIOINFORMATICS, V14, P817; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Saldarriaga JF, 2003, J PHYCOL, V39, P368; Swofford D. L., 2003, PAUP PHYLOGENETIC AN	23	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0967-0262	1469-4433		EUR J PHYCOL	Eur. J. Phycol.	MAY	2015	50	2					125	138		10.1080/09670262.2015.1009174		14	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CH3JU	WOS:000353927800001		
J	Sato, R; Noma, R; Tokuyama, H				Sato, Ryuichi; Noma, Ryoko; Tokuyama, Hideaki			Preparation of macroporous poly(N-isopropylacrylamide) hydrogels using a suspension-gelation method	EUROPEAN POLYMER JOURNAL			English	Article						Macroporous hydrogel; Composite hydrogel; N-isopropylacrylamide; Thermosensitive polymer; Calcium alginate	HEAVY-METAL IONS; ADSORPTION PROPERTIES; GEL ADSORBENTS; DRUG-RELEASE; POLYMER GELS; KINETICS; ATOMIZATION; MORPHOLOGY; NETWORKS; WATER	A macroporous hydrogel, consisting of a homogeneous cross-linked polymer network and linear polymers containing randomly distributed sphere-like cavities, was developed using a suspension-gelation method. This method involves the synthesis of composite hydrogels containing distributed microcapsules as a pore template (porogen) by free radical polymerization, followed by a chemical treatment to break down the structure of the microcapsules within the hydrogels. Macroporous hydrogels were successfully synthesized in a model system consisting of thermosensitive N-isopropylacrylamide hydrogels and physically cross-linked microcapsules of calcium alginate, which were prepared using an electrostatic atomization method. Observation of the internal structure of the hydrogels using scanning electron microscopy revealed that the composite hydrogels contain microcapsules and the macroporous hydrogels have non-interconnected macropores created by the microcapsules as the template. The thermosensitive swelling properties and the mechanical properties of the hydrogels were characterized. (C) 2015 Elsevier Ltd. All rights reserved.	[Sato, Ryuichi; Noma, Ryoko; Tokuyama, Hideaki] Tokyo Univ Agr & Technol, Dept Chem Engn, Koganei, Tokyo 1848588, Japan	Tokuyama, H (reprint author), Tokyo Univ Agr & Technol, Dept Chem Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	htoku@cc.tuat.ac.jp	Tokuyama, Hideaki/C-3876-2013		JSPS (Japan Society for the Promotion of Science) [26289284]	The authors wish to acknowledge the support of a Grant-in-Aid for Scientific Research (B) from JSPS (Japan Society for the Promotion of Science) (Grant No. 26289284).	Tokuyama H, 2013, REACT FUNCT POLYM, V73, P550, DOI 10.1016/j.reactfunctpolym.2012.12.006; Tokuyama H, 2007, LANGMUIR, V23, P11246, DOI 10.1021/la701492u; Antonietti M, 1999, MACROMOLECULES, V32, P1383, DOI 10.1021/ma9812478; Tokuyama H, 2010, SEP PURIF TECHNOL, V71, P83, DOI 10.1016/j.seppur.2009.11.005; Tokuyama H, 2007, EUR POLYM J, V43, P4975, DOI 10.1016/j.eurpolymj.2007.09.016; Tokuyama H, 2005, SEP PURIF TECHNOL, V44, P152, DOI 10.1016/j.seppur.2005.01.004; Zhang XZ, 2001, LANGMUIR, V17, P6094, DOI 10.1021/la010105v; Zamecnik C, 2012, J MACROMOL SCI A, V49, P906, DOI 10.1080/10601325.2012.714692; Muniz EC, 2001, MACROMOLECULES, V34, P4480, DOI 10.1021/ma001192l; Zhang XZ, 2004, BIOMATERIALS, V25, P3793, DOI 10.1016/j.biomaterials.2003.10.065; TANAKA T, 1979, J CHEM PHYS, V70, P1214, DOI 10.1063/1.437602; HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548; Zhao Q, 2008, J POLYM SCI POL CHEM, V46, P6594, DOI 10.1002/pola.22969; Fukui Y, 2010, COLLOID SURFACE A, V370, P28, DOI 10.1016/j.colsurfa.2010.08.039; Takeoka Y, 2002, LANGMUIR, V18, P5977, DOI 10.1021/la020133t; Varaprasad K, 2010, J APPL POLYM SCI, V116, P3593, DOI 10.1002/app.31917; Tokuyama H, 2011, IND ENG CHEM RES, V50, P10270, DOI 10.1021/ie201179n; YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0; Apohan NK, 2001, MACROMOL CHEM PHYS, V202, P1182; BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609; Delaney JT, 2010, SOFT MATTER, V6, P866, DOI 10.1039/b922888h; Dogu Y, 2006, J APPL POLYM SCI, V99, P37, DOI 10.1002/app.22140; Flory P. J., 1953, PRINCIPLES POLYM CHE; Harmon ME, 2003, POLYMER, V44, P6927, DOI 10.1016/j.polymer.2003.07.006; Hogan CJ, 2007, COLLOID SURFACE A, V311, P67, DOI 10.1016/j.colsurfa.2007.05.072; Kaneko T, 2005, MACROMOL CHEM PHYSIC, V206, P566, DOI 10.1002/macp.200400405; KANEKO Y, 1995, J MEMBRANE SCI, V101, P13, DOI 10.1016/0376-7388(94)00268-4; Krajnc P, 2005, MACROMOL RAPID COMM, V26, P1289, DOI 10.1002/marc.200500353; Sakohara S, 2003, KAGAKU KOGAKU RONBUN, V29, P62; Sato R, 2014, REACT FUNCT POLYM, V76, P8, DOI 10.1016/j.reactfunctpolym.2014.01.001; Studenovska H, 2008, J MATER SCI-MATER M, V19, P6151; Tokuyama H, 2009, SEP PURIF TECHNOL, V68, P417, DOI 10.1016/j.seppur.2009.06.023; Zhang XZ, 2003, J APPL POLYM SCI, V89, P1935, DOI 10.1002/app.12378; Zhao Q, 2009, LANGMUIR, V25, P3249, DOI 10.1021/la8038939	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0014-3057	1873-1945		EUR POLYM J	Eur. Polym. J.	MAY	2015	66						91	97		10.1016/j.eurpolymj.2015.01.051		7	Polymer Science	Polymer Science	CH2KL	WOS:000353854000009		
J	Javadi, A; Shockravi, A; Koohgard, M; Malek, A; Shourkaei, FA; Ando, S				Javadi, Ali; Shockravi, Abbas; Koohgard, Mehdi; Malek, Ali; Shourkaei, Fateme Ahmadi; Ando, Shinji			Nitro-substituted polyamides: A new class of transparent and highly refractive materials	EUROPEAN POLYMER JOURNAL			English	Article						Nitro-substituted polyamide; Thiazole; Solubility; High refractive index; Low birefringence	CONTAINING AROMATIC DIAMINES; DIRECT POLYCONDENSATION; LOW-BIREFRINGENCE; INDEX POLYIMIDE; PENDANT GROUPS; BEARING ETHER; DIANHYDRIDES; SULFUR; UNITS; POLYMERS	High-refractive-index polyamides (PAs) were developed by introducing nitro groups, thiazole rings, and thioether linkages. The PAs were prepared by the polycondensation of a novel diamine monomer, 5,5'-thiobis(2-amino-4-(3-nitrophenyl)thiazole) (DA), with various aromatic diacids. The bulky pendant nitrophenyl units, as well as the flexible thioether linkage in the diamine, endowed the resulting PAs with excellent solubilities in both amide-type polar aprotic solvents and less polar solvents. The obtained polymers exhibited high heat resistance, with 10% weight loss temperatures exceeding 472 degrees C under nitrogen and 427 degrees C in air atmosphere, while their glass transition temperatures were in the range 210-244 degrees C. The combination of the nitro substituents, thiazole units, and thioether linkages provided PAs with high refractive indices of up to 1.7660 at 632.8 nm, along with high transparency in the visible region and low birefringences (<0.0081). The structure-property relationships of these PAs due to the presence of nitro groups were also studied by comparing the results with the previously reported analogous polymers. (C) 2015 Elsevier Ltd. All rights reserved.	[Javadi, Ali] Univ Akron, Dept Polymer Engn, Akron, OH 44325 USA; [Shockravi, Abbas; Koohgard, Mehdi; Shourkaei, Fateme Ahmadi] Kharazmi Univ, Fac Chem, Tehran 1571914911, Iran; [Malek, Ali] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Ando, Shinji] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528552, Japan	Shockravi, A (reprint author), Kharazmi Univ, Fac Chem, Mofatteh Ave 49, Tehran 1571914911, Iran.	abbas_shockravi@yahoo.co.uk	ANDO, Shinji/D-6280-2011	ANDO, Shinji/0000-0002-3508-035X	Kharazmi University	This work was mainly supported by Kharazmi University. A.J. is thankful to Dr. Mahmood Kamali for helpful discussions.	Shockravi A, 2013, RSC ADV, V3, P6717, DOI 10.1039/c3ra22418j; Shockravi A, 2009, EUR POLYM J, V45, P1599, DOI 10.1016/j.eurpolymj.2009.01.014; Zhang G, 2011, REACT FUNCT POLYM, V71, P775, DOI 10.1016/j.reactfunctpolym.2011.04.008; Liu JG, 2008, MACROMOL CHEM PHYSIC, V209, P195, DOI 10.1002/macp.200700305; You NH, 2010, MACROMOLECULES, V43, P4613, DOI 10.1021/ma100448d; Ma T, 2010, POLYM DEGRAD STABIL, V95, P1244, DOI 10.1016/j.polymdegradstab.2010.03.026; Okutsu R, 2008, CHEM MATER, V20, P4017, DOI 10.1021/cm800432p; GROH W, 1991, MACROMOLECULES, V24, P6660, DOI 10.1021/ma00025a016; Zhang G, 2013, POLYMER, V54, P601, DOI 10.1016/j.polymer.2012.12.008; Berti C, 2007, EUR POLYM J, V43, P2453, DOI 10.1016/j.eurpolymj.2007.03.044; Liu JG, 2007, MACROMOLECULES, V40, P7902, DOI 10.1021/ma0713714; You NH, 2009, POLYMER, V50, P789, DOI 10.1016/j.polymer.2008.12.001; Hsiao SH, 2010, EUR POLYM J, V46, P1878, DOI 10.1016/j.eurpolymj.2010.06.010; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Shockravi A, 2011, POLYM J, V43, P816, DOI 10.1038/pj.2011.74; Sharma GD, 2012, ORG ELECTRON, V13, P252, DOI 10.1016/j.orgel.2011.10.022; Ma H, 2002, ADV MATER, V14, P1339, DOI 10.1002/1521-4095(20021002)14:19<1339::AID-ADMA1339>3.0.CO;2-O; Song Y, 2008, POLYMER, V49, P4995, DOI 10.1016/j.polymer.2008.09.003; Ando S, 2002, JPN J APPL PHYS 2, V41, pL105, DOI 10.1143/JJAP.41.L105; WOODBRIDGE RG, 1949, J AM CHEM SOC, V71, P1744, DOI 10.1021/ja01173a057; Liaw DJ, 2005, MACROMOLECULES, V38, P4024, DOI 10.1021/ma048559x; Simpson JO, 1997, THIN SOLID FILMS, V308, P480, DOI 10.1016/S0040-6090(97)00481-1; Zhou M, 2002, OPT ENG, V41, P1631, DOI 10.1117/1.1481895; Javadi A, 2013, J POLYM SCI POL CHEM, V51, P3505, DOI 10.1002/pola.26752; Ando S, 2006, J PHOTOPOLYM SCI TEC, V19, P351, DOI 10.2494/photopolymer.19.351; Suzuki Y, 2008, POLYM J, V40, P414, DOI 10.1295/polymj.PJ2007233; Liu JG, 2007, POLYM J, V39, P543, DOI 10.1295/polymj.PJ2006232; YAMAZAKI N, 1975, J POLYM SCI POL CHEM, V13, P1373, DOI 10.1002/pol.1975.170130609; Garcia JM, 2010, PROG POLYM SCI, V35, P623, DOI 10.1016/j.progpolymsci.2009.09.002; Su HW, 2008, J MATER CHEM, V18, P1139, DOI 10.1039/b717069f; Liu JG, 2009, J MATER CHEM, V19, P8907, DOI 10.1039/b909690f; YANG CJ, 1995, CHEM MATER, V7, P1276, DOI 10.1021/cm00055a002; Zhang G, 2011, J POLYM RES, V18, P1261, DOI 10.1007/s10965-010-9528-8; Pal RR, 2009, EUR POLYM J, V45, P953, DOI 10.1016/j.eurpolymj.2008.11.034; Edler M, 2013, J MATER CHEM C, V1, P3931, DOI 10.1039/c3tc00006k; Maier G, 2001, PROG POLYM SCI, V26, P3, DOI 10.1016/S0079-6700(00)00043-5; Shockravi A, 2012, J APPL POLYM SCI, V125, P1521, DOI 10.1002/app.36363; Okutsu R, 2008, MACROMOLECULES, V41, P6165, DOI 10.1021/ma800797p; Zhang G, 2010, J MACROMOL SCI A, V47, P892, DOI 10.1080/10601325.2010.501305; Tojo Y, 2013, POLYM CHEM-UK, V4, P3807, DOI 10.1039/c3py00377a; BOESE D, 1992, J POLYM SCI POL PHYS, V30, P1321, DOI 10.1002/polb.1992.090301203; Zhang G, 2013, POLYM INT, V62, P1358, DOI 10.1002/pi.4431; You NH, 2009, J POLYM SCI POL CHEM, V47, P4886, DOI 10.1002/pola.23538; You NH, 2008, MACROMOLECULES, V41, P6361, DOI 10.1021/ma800982x; Fukuzaki N, 2010, MACROMOLECULES, V43, P1836, DOI 10.1021/ma902013y; You NH, 2009, J POLYM SCI POL CHEM, V47, P4428, DOI 10.1002/pola.23497; Terui Y, 2005, J PHOTOPOLYM SCI TEC, V18, P337; Balcar H, 1998, POLYMER, V39, P4443, DOI 10.1016/S0032-3861(98)00050-0; Binran K., 2004, HDB CHEM PURE CHEM; Born M., 1999, PRINCIPLES OPTICS EL; Castanon-Alonso SL, 2012, MATER CHEM PHYS, V133, P528, DOI 10.1016/j.matchemphys.2012.01.079; Dean J A, 1998, LANGES HDB CHEM; Fushimi T, 2009, DALTON T, P2477, DOI 10.1039/b819826h; Javadi A, 2014, POLYM INT; JIN JI, 1995, POLYMER, V36, P193, DOI 10.1016/0032-3861(95)90692-U; Kiani H., 2013, J POLYM RES, V20, P1; Li Z, 2010, HIGH PERFORM POLYM, V22, P468, DOI 10.1177/0954008309104955; Liaw DJ, 1998, J POLYM SCI POL CHEM, V36, P2301, DOI 10.1002/(SICI)1099-0518(19980930)36:13<2301::AID-POLA17>3.0.CO;2-E; MINNS RA, 1992, J MACROMOL SCI PURE, V29, P19, DOI 10.1080/10101329208054104; Ohkita H, 2003, MRS ONLINE P LIB, V771; Patil PS, 2007, EUR POLYM J, V43, P5047, DOI 10.1016/j.eurpolymj.2007.08.016; ROSENTHAL MV, 1985, J ELECTROANAL CHEM, V185, P297, DOI 10.1016/0368-1874(85)80137-4; Shobha HK, 2001, J POLYM SCI POL CHEM, V39, P2904, DOI 10.1002/pola.1270; Terraza CA, 2008, J POLYM SCI POL CHEM, V46, P1510, DOI 10.1002/pola.22492; Yen HJ, 2013, RSC ADV, V3, P17048, DOI 10.1039/c3ra42180e; Zulfiqar S, 2007, COLLOID POLYM SCI, V285, P1749, DOI 10.1007/s00396-007-1768-8	66	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0014-3057	1873-1945		EUR POLYM J	Eur. Polym. J.	MAY	2015	66						328	341		10.1016/j.eurpolymj.2015.02.032		14	Polymer Science	Polymer Science	CH2KL	WOS:000353854000034		
J	Zhao, Y; Koizumi, S				Zhao, Yue; Koizumi, Satoshi			Combining small-angle and intermediate-angle neutron scattering to study the hierarchical structure in microbial cellulose	EUROPEAN POLYMER JOURNAL			English	Article						Small-angle neutron scattering; Intermediate-angle neutron scattering; Contrast variation; Incoherent scattering; Microbial cellulose; Water-exchange	X-RAY-SCATTERING; BACTERIAL CELLULOSE; MECHANICAL-PROPERTIES; NATIVE CELLULOSES; AGITATED CULTURE; C-13 NMR; MEMBRANES	In this study, we employed intermediate angle neutron scattering (IANS) technique to correct the small angle neutron scattering (SANS) data of the water-swollen microbial cellulose (MC) sample, the system of which has a significant incoherent contribution from the water solvent, and we described the effects that the corrections have on the structural analysis. In order to elucidate the structure efficiently, the solvent was exchanged in situ between protonated water and deuterated water to give different scattering contrasts, and the water-exchange processes were followed by time-resolved SANS and IANS simultaneously. Our results showed that: (1) after incoherent correction, the microstructure of MC sample was proved to be invariant with solvents; (2) the scattering intensity depended only on the contrast factor, revealing a two-phase system composed of water-resistant crystalline cellulose phase and hydrated amorphous phase; (3) the cellulose crystallites have a constant scattering length density of 2.0 x 10(10) cm(-2), determined by the matching point at which the scattering contrast between the two phases is minimum. This value was consistent with that of 1.9 x 10(10) cm(-2) estimated from its chemical structure. (C) 2015 Elsevier Ltd. All rights reserved.	[Zhao, Yue; Koizumi, Satoshi] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki 3191195, Japan; [Koizumi, Satoshi] Ibaraki Univ, Dept Engn, Hitachi, Ibaraki 3168511, Japan	Zhao, Y (reprint author), Ibaraki Univ, Dept Engn, Hitachi, Ibaraki 3168511, Japan.	zhao.yue@jaea.go.jp; skoizumi@mx.ibaraki.ac.jp					Alvarez OM, 2004, WOUNDS, V16, P224; SUGIYAMA J, 1991, MACROMOLECULES, V24, P2461, DOI 10.1021/ma00009a050; LEGGE RL, 1990, BIOTECHNOL ADV, V8, P303, DOI 10.1016/0734-9750(90)91067-Q; Sokolnicki AM, 2006, J MEMBRANE SCI, V272, P15, DOI 10.1016/j.memsci.2005.06.065; Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149; Park PJ, 2004, J MICROBIOL BIOTECHN, V14, P317; SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123; FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250; OKIYAMA A, 1993, FOOD HYDROCOLLOID, V6, P503; Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3; OKIYAMA A, 1992, FOOD HYDROCOLLOID, V6, P471; Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6; Czaja W, 2004, CELLULOSE, V11, P403, DOI 10.1023/B:CELL.0000046412.11983.61; ROSS P, 1991, MICROBIOL REV, V55, P35; Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1; VANDERHART DL, 1984, MACROMOLECULES, V17, P1465, DOI 10.1021/ma00138a009; YAMAMOTO H, 1993, MACROMOLECULES, V26, P1313, DOI 10.1021/ma00058a020; Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175; Jakob HF, 1995, MACROMOLECULES, V28, P8782, DOI 10.1021/ma00130a010; Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582; Evans BR, 2003, BIOSENS BIOELECTRON, V18, P917, DOI 10.1016/S0956-5663(02)00212-9; BATCHELOR G. K., 1967, INTRO FLUID DYNAMICS; Brown A.J., 1886, J CHEM SOC, V49, P432, DOI 10.1039/ct8864900432; FINK HP, 1990, ACTA POLYM, V41, P131, DOI 10.1002/actp.1990.010410213; Fontana JD, 1997, APPL BIOCHEM BIOTECH, V63-5, P327, DOI 10.1007/BF02920434; Higgins J. S., 1994, POLYM NEUTRON SCATTE; Keshk SM, 2014, BIOPROCES BIOTECHNIQ, V4; Klemm D., 1999, POLYM NEWS, V24, P377; Koizumi S, 2007, J APPL CRYSTALLOGR, V40, pS474, DOI 10.1107/S0021889807014392; Koizumi S, 2009, MACROMOL SYMP, V279, P110, DOI 10.1002/masy.200950517; Koizumi S, 2008, EUR PHYS J E, V26, P137, DOI 10.1140/epje/i2007-10259-3; Matyjaszewski K., 2012, POLYM SCI COMPREHENS; Muller M, 1998, MACROMOLECULES, V31, P3953, DOI 10.1021/ma980004c; NISHI Y, 1990, J MATER SCI, V25, P2997, DOI 10.1007/BF00584917; Ring D.F., 1987, United States patent, Patent No. [US4655758. A, 4655758]; Roe R. J., 2000, METHODS XRAY NEUTRON; SCHOTT H, 1988, J MACROMOL SCI PHYS, VB27, P119, DOI 10.1080/00222348808212315; SCHRAMM M, 1954, BIOCHEM J, V56, P163; Sun CQ, 2005, J PHARM SCI-US, V94, P2132, DOI 10.1002/jps.20459; Tarte R, 2009, INGREDIENTS MEAT PRO; Zhang CJ, 2011, ADV MATER RES-SWITZ, V239-242, P2667, DOI 10.4028/www.scientific.net/AMR.239-242.2667; Zhao Y, 2014, EUR PHYS J E, V37, DOI 10.1140/epje/i2014-14129-7	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0014-3057	1873-1945		EUR POLYM J	Eur. Polym. J.	MAY	2015	66						437	443		10.1016/j.eurpo1ymj.2015.03.012		7	Polymer Science	Polymer Science	CH2KL	WOS:000353854000044		
J	Enomoto-Rogers, Y; Iio, N; Takemura, A; Iwata, T				Enomoto-Rogers, Yukiko; Iio, Narihiro; Takemura, Akio; Iwata, Tadahisa			Synthesis and characterization of pullulan alkyl esters	EUROPEAN POLYMER JOURNAL			English	Article						Pullulan; Alkyl ester; Thermal and mechanical properties; Film; Nanofiber	FATTY-ACID ESTERS; THERMAL-ANALYSIS; CHEMICAL-MODIFICATION; MECHANICAL-PROPERTIES; GLUCOMANNAN ACETATE; MIXED ESTERS; CELLULOSE; STARCH; POLYSACCHARIDES; BIODEGRADABILITY	Fully substituted pullulan (PL) esters with carbon number of acyl group (n) of 2-14 were prepared in carboxylic acid/trifluoroacetic anhydride (TFAA) system. Thermal properties of PL esters were analyzed by differential scanning calorimetry (DSC) and thermogravimetric analyses (TGA). The decomposition temperatures of the PL esters were higher than that of neat PL DSC measurements revealed that the PL esters did not exhibit melting peaks, indicating that PL esters were amorphous. The glass transition temperatures (T(g)s) of PL esters increased from 35 degrees C for PL myristate (PLMy, n = 14) to 174 degrees C for PL acetate (PLAc, n = 2) as the chain length decreased. WAXD diffractogram of the PL esters showed the reflection at small-angle region, indicating alignment of the PL main-chain caused by side-chains which are extended perpendicular to the main-chain. Colorless and transparent PL ester films were obtained by solvent casting and melt-pressing method. DMA analyses indicated a beta-relaxation of alkyl side-chains below room temperature. Tensile strength of the PL ester films decreased with increase in alkyl carbons from 23.4 MPa for PLAc to 1.4 MPa for PLMy. The elongation at break of the PL esters increased with increase in alkyl carbons from 8% for PLAc to 1090% for PLMy. The PL esters exhibited extremely high elongation at break. PL esters could be electrospun into nanofibers. (C) 2015 Elsevier Ltd. All rights reserved.	[Enomoto-Rogers, Yukiko; Iio, Narihiro; Takemura, Akio; Iwata, Tadahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Sci Polymer Mat,Bunkyo Ku, Tokyo 1138657, Japan	Iwata, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Sci Polymer Mat,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atiwata@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [22245026, 26248044]	This study was supported by a Grant-in-Aid for Scientific Research (A) (Nos. 22245026 and 26248044) (to T.I.) from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-Aid for JSPS Fellows (to Y.E-R).	Crepy L, 2011, CARBOHYD POLYM, V83, P1812, DOI 10.1016/j.carbpol.2010.10.045; AKIYOSHI K, 1993, MACROMOLECULES, V26, P3062, DOI 10.1021/ma00064a011; Edgar KJ, 2001, PROG POLYM SCI, V26, P1605, DOI 10.1016/S0079-6700(01)00027-2; Zong Z, 2000, POLYMER, V41, P899, DOI 10.1016/S0032-3861(99)00270-0; Teramoto Y, 2006, BIOMACROMOLECULES, V7, P190, DOI 10.1021/bm050580y; Yang BY, 2006, STARCH-STARKE, V58, P520, DOI 10.1002/star.200600540; Sealey JE, 1996, J POLYM SCI POL PHYS, V34, P1613, DOI 10.1002/(SICI)1099-0488(19960715)34:9<1613::AID-POLB10>3.0.CO;2-A; Fundador NGV, 2012, CARBOHYD POLYM, V87, P170, DOI 10.1016/j.carbpol.2011.07.034; Fundador NGV, 2012, POLYMER, V53, P3885, DOI 10.1016/j.polymer.2012.06.038; Marubayashi H, 2014, CARBOHYD POLYM, V103, P427, DOI 10.1016/j.carbpol.2013.12.015; Enomoto-Rogers Y, 2014, CARBOHYD POLYM, V101, P592, DOI 10.1016/j.carbpol.2013.09.103; Vaca-Garcia C, 2003, J POLYM SCI POL PHYS, V41, P281, DOI 10.1002/polb.10378; BENDER H, 1959, BIOCHIM BIOPHYS ACTA, V36, P309, DOI 10.1016/0006-3002(59)90172-6; Aburto J, 1999, J APPL POLYM SCI, V74, P1440, DOI 10.1002/(SICI)1097-4628(19991107)74:6<1440::AID-APP17>3.0.CO;2-V; Singh RS, 2008, CARBOHYD POLYM, V73, P515, DOI 10.1016/j.carbpol.2008.01.003; TSUZUKI M, 1980, J APPL POLYM SCI, V25, P2567, DOI 10.1002/app.1980.070251113; MORITA H, 1956, ANAL CHEM, V28, P64, DOI 10.1021/ac60109a019; Leathers TD, 2003, APPL MICROBIOL BIOT, V62, P468, DOI 10.1007/s00253-003-1386-4; Billmeyer Jr F. W., 1984, TXB POLYM SCI; BOURNE EJ, 1949, J CHEM SOC, P2976, DOI 10.1039/jr9490002976; BRUNEEL D, 1994, POLYMER, V35, P2656, DOI 10.1016/0032-3861(94)90395-6; Danjo T, 2014, POLYM DEGRAD STABIL, V109, P373, DOI 10.1016/j.polymdegradstab.2014.05.023; Enomoto-Rogers Y, 2013, CARBOHYD POLYM, V92, P1827, DOI 10.1016/j.carbpol.2012.11.043; Farris S, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40539; Krochta JM, 1997, FOOD TECHNOL-CHICAGO, V51, P61; Ma GP, 2009, CARBOHYD POLYM, V75, P390, DOI 10.1016/j.carbpol.2008.07.035; Mark J.E., 1996, PHYS PROPERTIES POLY; Mihai D, 2001, EUR POLYM J, V37, P541, DOI 10.1016/S0014-3057(00)00142-7; MOROOKA T, 1984, J APPL POLYM SCI, V29, P3981, DOI 10.1002/app.1984.070291230; MOTOZATO Y, 1986, J CHROMATOGR, V355, P434, DOI 10.1016/S0021-9673(01)97349-2; SAGAR AD, 1995, J APPL POLYM SCI, V58, P1647, DOI 10.1002/app.1995.070580927; Shibata M, 2001, POLYMER, V42, P59, DOI 10.1016/S0032-3861(00)00321-9; Shibata M, 2002, EUR POLYM J, V38, P497, DOI 10.1016/S0014-3057(01)00198-7; Teramoto N, 2006, CARBOHYD POLYM, V63, P476, DOI 10.1016/j.carbpol.2005.10.008; Tezuka Y, 1997, CARBOHYD RES, V305, P155, DOI 10.1016/S0008-6215(97)10036-2; Yang BY, 2008, STARCH-STARKE, V60, P146, DOI 10.1002/star.200700692	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0014-3057	1873-1945		EUR POLYM J	Eur. Polym. J.	MAY	2015	66						470	477		10.1016/j.eurpolymj.2015.03.007		8	Polymer Science	Polymer Science	CH2KL	WOS:000353854000048		
J	Kamezawa, N; Nagao, D; Ishii, H; Konno, M				Kamezawa, Nao; Nagao, Daisuke; Ishii, Haruyuki; Konno, Mikio			Transparent, highly dielectric poly(vinylidene fluoride) nanocomposite film homogeneously incorporating BaTiO3 nanoparticles with fluoroalkylsilane surface modifier	EUROPEAN POLYMER JOURNAL			English	Article						Barium titanate; Dielectric constant; Nanocomposite; Poly(vinyldene fluoride); Transparent	BARIUM-TITANATE NANOPARTICLES; POLYMER MATRIX; HIGH-PERMITTIVITY; COMPOSITE FILMS; THIN-FILMS; FABRICATION; NANOFIBERS; CONSTANT; SIZE	Incorporation of barium titanate (BT) nanoparticles surface-modified with a fluoroalkylsilane into poly(vinyldene fluoride) (PVDF) was performed to fabricate transparent nanocomposite films with high permittivity. The BT nanoparticles were prepared in a sol-gel Method using 2-methoxyehanol solvent. They were surface-modified with the fluoroalkylsilane to disperse them into N-methyl-2-pyrrolidone that was used in the successive process of dissolving PVDF. The surface modification with the fluoroalkylsilane was allowed to homogeneously incorporate the nanoparticles into PVDF films up to the BT content of 67 vol%. No distinct decrease in film transparency by the incorporation was observed for the films at the high loadings of BT nanoparticles. The transparent nanocomposite film could attain a permittivity as high as 44 at a ST content of 67 vol% with maintenance of dissipation factors lower than 0.06. (C) 2015 Elsevier Ltd. All rights reserved.	[Kamezawa, Nao; Nagao, Daisuke; Ishii, Haruyuki; Konno, Mikio] Tohoku Univ, Grad Sch Engn, Dept Chem Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Nagao, D (reprint author), Tohoku Univ, Grad Sch Engn, Dept Chem Engn, Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.	nagao@mickey.che.tohoku.ac.jp; konno@mickey.che.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (JSPS KAKENHI) [24651112, 25600001, 26286019]	This research was supported by the Ministry of Education, Culture, Sports, Science, and Technology (JSPS KAKENHI Grant Numbers 24651112, 25600001 and 26286019).	Abe K, 2013, EUR POLYM J, V49, P3455, DOI 10.1016/j.eurpolymj.2013.07.023; Song Y, 2012, J MATER CHEM, V22, P8063, DOI 10.1039/c2jm30297g; Choudhury A, 2012, POLYM INT, V61, P696, DOI 10.1002/pi.4181; Nagao D, 2011, POLYM INT, V60, P1180, DOI 10.1002/pi.3057; Choudhury A, 2010, MATER CHEM PHYS, V121, P280, DOI 10.1016/j.matchemphys.2010.01.035; Abe K, 2013, POLYM INT, V62, P141, DOI 10.1002/pi.4285; Almadhoun MN, 2012, J MATER CHEM, V22, P11196, DOI 10.1039/c2jm30542a; Chon J, 2010, CHEM MATER, V22, P5445, DOI 10.1071/cm100729d; Zhang XH, 2014, APPL SURF SCI, V305, P531, DOI 10.1016/j.apsusc.2014.03.131; Dang ZM, 2008, J ELECTROCERAM, V21, P381, DOI 10.1007/s10832-007-9201-8; Huang LM, 2010, ADV FUNCT MATER, V20, P554, DOI 10.1002/adfm.200901258; Kim P, 2009, ACS NANO, V3, P2581, DOI 10.1021/nn9006412; Song Y, 2012, J MATER CHEM, V22, P16491, DOI 10.1039/c2jm32579a; Dang ZM, 2012, PROG MATER SCI, V57, P660, DOI 10.1016/j.pmatsci.2011.08.001; Chen WC, 1999, J MATER CHEM, V9, P2999, DOI 10.1039/a906157f; Dang ZM, 2013, J ADV DIELECTRICS, V3; Jang KW, 2008, J APPL POLYM SCI, V110, P798, DOI 10.1002/app.28515; Kobayashi Y, 2011, THIN SOLID FILMS, V519, P1971, DOI 10.1016/j.tsf.2010.10.037; Kobayashi Y, 2010, POLYM COMPOSITE, V31, P1179, DOI 10.1002/pc.20904; Kobayashi Y, 2004, J SOL-GEL SCI TECHN, V29, P49, DOI 10.1023/B:JSST.0000016137.82633.52; Kobayashi Y, 2008, J EUR CERAM SOC, V28, P117, DOI 10.1016/j.jeurceramsoc.2007.05.007; Wu XZ, 2013, COMPOS SCI TECHNOL, V81, P48, DOI 10.1016/j.compscitech.2013.03.021; Zha JW, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866269	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0014-3057	1873-1945		EUR POLYM J	Eur. Polym. J.	MAY	2015	66						528	532		10.1016/j.eurpolymj.2015.03.021		5	Polymer Science	Polymer Science	CH2KL	WOS:000353854000054		
J	Kamiya, K; Koda, M; Furuya, T; Kato, K; Takahashi, H; Sakuma, T; Inada, T; Ota, M; Maki, S; Okawa, A; Ito, Y; Takahashi, K; Yamazaki, M				Kamiya, Koshiro; Koda, Masao; Furuya, Takeo; Kato, Kei; Takahashi, Hiroshi; Sakuma, Tsuyoshi; Inada, Taigo; Ota, Mitsutoshi; Maki, Satoshi; Okawa, Akihiko; Ito, Yasuo; Takahashi, Kazuhisa; Yamazaki, Masashi			Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control	EUROPEAN SPINE JOURNAL			English	Article						Spinal cord injury; Neuroprotective therapy; G-CSF; High-dose methylprednisolone; Clinical trial	PROMOTES FUNCTIONAL RECOVERY; G-CSF; COMPLICATIONS; CELLS; MICE	We performed a phase I/IIa clinical trial and confirmed the safety and feasibility of granulocyte colony-stimulating factor (G-CSF) as neuroprotective therapy in patients with acute spinal cord injury (SCI). In this study, we retrospectively analyzed the clinical outcome in SCI patients treated with G-CSF and compared these results to a historical cohort of SCI patients treated with high-dose methylprednisolone sodium succinate (MPSS). In the G-CSF group (n = 28), patients were treated from August 2009 to July 2012 within 48 h of the injury, and G-CSF (10 mu g/kg/day) was administered intravenously for five consecutive days. In the MPSS group (n = 34), patients underwent high-dose MPSS therapy from August 2003 to July 2005 following the NASCIS II protocol. We evaluated the ASIA motor score and the AIS grade elevation between the time of treatment and 3-month follow-up and adverse events. The Delta ASIA motor score was significantly higher in the G-CSF group than in the MPSS group (p < 0.01). When we compared AIS grade elevation in patients with AIS grades B/C incomplete paralysis, 17.9 % of patients in the G-CSF group had an AIS grade elevation of two steps compared to 0 % of patients in the MPSS group (p < 0.05), and the incidence of pneumonia was significantly higher in the MPSS group (42.9 %) compared to the G-CSF group (8.3 %) (p < 0.05). These results suggest that G-CSF administration is safe and effective, but a prospective randomized controlled clinical trial is needed to compare the efficacy of MPSS versus G-CSF treatment in patients with SCI.	[Kamiya, Koshiro; Koda, Masao; Furuya, Takeo; Kato, Kei; Inada, Taigo; Ota, Mitsutoshi; Maki, Satoshi; Okawa, Akihiko; Takahashi, Kazuhisa] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chuo Ku, Chiba 2608670, Japan; [Takahashi, Hiroshi] Toho Univ, Sakura Med Ctr, Dept Orthopaed Sci, Chiba 2748510, Japan; [Sakuma, Tsuyoshi] Seirei Sakura Citizen Hosp, Chiba, Japan; [Ito, Yasuo] Japanese Red Cross Kobe Hosp, Kobe, Hyogo, Japan; [Yamazaki, Masashi] Univ Tsukuba, Dept Med, Tsukuba, Ibaraki, Japan	Koda, M (reprint author), Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	masaokod@gmail.com					Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Matsumoto T, 2001, SPINE, V26, P426, DOI 10.1097/00007632-200102150-00020; JACKSON AB, 1994, ARCH PHYS MED REHAB, V75, P270, DOI 10.1016/0003-9993(94)90027-2; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Kliesch WF, 1996, PARAPLEGIA, V34, P82; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Bauchet L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P330, DOI 10.1016/j.annrmp.2008.10.004; BRACKEN MB, 2012, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Kadota R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050391; Kawabe J, 2011, J NEUROSURG-SPINE, V15, P414, DOI 10.3171/2011.5.SPINE10421; Koda M, 2007, BRAIN RES, V1149, P223, DOI 10.1016/j.brainres.2007.02.058; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; Takahashi H, 2012, EUR SPINE J, V21, P2580, DOI 10.1007/s00586-012-2213-3	16	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	MAY	2015	24	5					963	967		10.1007/s00586-014-3373-0		5	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CH2AN	WOS:000353825700008		
J	Ohtsubo, Y; Yagi, A				Ohtsubo, Yohsuke; Yagi, Ayano			Relationship value promotes costly apology-making: testing the valuable relationships hypothesis from the perpetrator's perspective	EVOLUTION AND HUMAN BEHAVIOR			English	Article						Valuable relationships hypothesis; Costly signaling theory; Reconciliation; Costly apology; Compensation	SOCIAL INTERACTIONS; FORGIVENESS; RECONCILIATION; PSYCHOLOGY; EXCHANGE; ACCOUNTS; PRIMATES; REMORSE; REGRET; TRUST	The valuable relationships hypothesis posits that people are inclined to reconcile with their valuable-relationship partners. Focusing on a particular type of credible conciliatory signal (i.e., costly apology), the present study tested this hypothesis from the perpetrator's perspective. In studies 1 and 2, after imagining that they had committed an interpersonal transgression against one of their real friends, participants (N = 529 and 311 in studies 1 and 2, respectively) rated their willingness to incur a cost in order to apologize to the victim. Apology cost was operationalized as "canceling plans to make an apology as soon as possible" in study 1, and as "offering compensation" in study 2. The results showed that the instrumentality of the partner to achieving the participants' goals would increase their willingness to make a costly apology, after controlling for the participants' sex, version of the transgression scenario, closeness to the victim, and expected forgiveness of the victim. To ensure the extemal validity of this finding, studies 3 and 4 asked participants to recall one of their interpersonal transgression experiences, and to report whether they had offered compensation for it (N = 190 and 224 in studies 3 and 4, respectively). Study 3 confirmed the hypothesis, while study 4 did not directly support it. However, study 4 did show that participants were more willing to reconcile with their valuable partners. Taken together, these results indicate that the valuable relationships hypothesis applies not only to victims, but also to their perpetrators as well. (C) 2015 Elsevier Inc. All rights reserved.	[Ohtsubo, Yohsuke; Yagi, Ayano] Kobe Univ, Kobe, Hyogo 6578501, Japan	Ohtsubo, Y (reprint author), Kobe Univ, Dept Psychol, Grad Sch Humanities, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	yohtsubo@lit.kobe-u.ac.jp			Japan Society for the Promotion of Science [21683006]; Murata Science Foundation	We are grateful to Ayumi Masuchi, Nobuhiro Mifune, Kumiko Mori, Daisuke Nakanishi, Sayaka Suga and Kazuho Yamaura for their generous support in the data collection. We thank Asami Kogire and Megumi Suzuki for their help with conducting the research. Our gratitude is also extended to Robert Kurzban, Adam Smith, Daniel Sznycer, and an anonymous reviewer for their insightful comments on earlier versions of this article. This research was supported by the Japan Society for the Promotion of Science (Grant no. 21683006) and the Murata Science Foundation.	Zeelenberg M, 2008, EMOTION, V8, P589, DOI 10.1037/a0012894; Desmet PTM, 2011, PERS INDIV DIFFER, V51, P267, DOI 10.1016/j.paid.2010.05.027; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; Exline JJ, 2007, J SOC CLIN PSYCHOL, V26, P479, DOI 10.1521/jscp.2007.26.4.479; Ohtsubo Y, 2014, EVOL HUM BEHAV, V35, P237, DOI 10.1016/j.evolhumbehav.2014.02.004; Fitzsimons GM, 2008, J PERS SOC PSYCHOL, V95, P319, DOI 10.1037/0022-3514.95.2.319; Leunissen JM, 2013, J EXP SOC PSYCHOL, V49, P315, DOI 10.1016/j.jesp.2012.12.005; Shnabel N, 2008, J PERS SOC PSYCHOL, V94, P116, DOI 10.1037/0022-3514.94.1.116; Schweitzer ME, 2006, ORGAN BEHAV HUM DEC, V101, P1, DOI 10.1016/j.obhdp.2006.05.005; Ohtsubo Y, 2009, EVOL HUM BEHAV, V30, P114, DOI 10.1016/j.evolhumbehav.2008.09.004; Davis JR, 2011, PERS INDIV DIFFER, V50, P392, DOI 10.1016/j.paid.2010.10.031; McCullough ME, 2010, EMOTION, V10, P358, DOI 10.1037/a0019349; Darley JM, 2003, PERS SOC PSYCHOL REV, V7, P324, DOI 10.1207/S15327957PSPR0704_05; Silk JB, 2002, ANNU REV ANTHROPOL, V31, P21, DOI 10.1146/annurev.anthro.31.032902.101743; Fehr R, 2010, ORGAN BEHAV HUM DEC, V113, P37, DOI 10.1016/j.obhdp.2010.04.002; Gold GJ, 2000, BASIC APPL SOC PSYCH, V22, P291, DOI 10.1207/15324830051035992; McCullough ME, 2013, BEHAV BRAIN SCI, V36, P1, DOI 10.1017/S0140525X11002160; Tabak BA, 2012, J PERS, V80, P503, DOI 10.1111/j.1467-6494.2011.00728.x; Fehr R, 2010, PSYCHOL BULL, V136, P894, DOI 10.1037/a0019993; CLARK MS, 1979, J PERS SOC PSYCHOL, V37, P12, DOI 10.1037//0022-3514.37.1.12; Zechmeister JS, 2004, J SOC CLIN PSYCHOL, V23, P532, DOI 10.1521/jscp.23.4.532.40309; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037//0022-3514.63.4.596; Baumeister F., 1994, PSYCHOL BULL, V115, P243; Blatz C. W., 2010, SOCIAL PERSONALITY P, V4, P995, DOI [10.1111/j.1751-9004.2010.00318.x, DOI 10.1111/J.1751-9004.2010.00318.X]; Bliege Bird Rebecca, 2005, CURR ANTHROPOL, V46, P221, DOI DOI 10.1086/427115; Bottom WP, 2002, ORGAN SCI, V13, P497, DOI 10.1287/orsc.13.5.497.7816; Burnette JL, 2012, PERS SOC PSYCHOL B, V38, P345, DOI 10.1177/0146167211424582; DARBY BW, 1982, J PERS SOC PSYCHOL, V43, P742, DOI 10.1037//0022-3514.43.4.742; De Cremer D, 2010, J ECON PSYCHOL, V31, P843, DOI 10.1016/j.joep.2010.05.006; Desmet PTM, 2010, J BUS ETHICS, V95, P105, DOI 10.1007/s10551-011-0791-3; GONZALES MH, 1990, J PERS SOC PSYCHOL, V58, P610, DOI 10.1037/0022-3514.58.4.610; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Hodgins HS, 2003, J EXP SOC PSYCHOL, V39, P297, DOI 10.1016/S0022-1031(03)00024-6; John O. P., 2000, HDB RES METHODS SOCI, P339; Long WJ, 2003, WAR AND RECONCILIATION: REASON AND EMOTION IN CONFLICT RESOLUTION, P1; Lydon JE, 1997, J PERS SOC PSYCHOL, V73, P536, DOI 10.1037/0022-3514.73.3.536; McCullough M. E., 2008, REVENGE EVOLUTION FO; Nelissen RMA, 2014, J PERS SOC PSYCHOL, V106, P257, DOI 10.1037/a0034711; OHBUCHI K, 1989, J PERS SOC PSYCHOL, V56, P219, DOI 10.1037//0022-3514.56.2.219; Ohtsubo Y., 2012, J EVOLUTIONARY PSYCH, V10, P187; Pinker S., 2011, BETTER ANGELS OUR NA; Pokorny J. J., 2005, HDB FORGIVENESS, P17; Sherif M., 1961, INTERGROUP CONFLICT, V10; Skarlicki DP, 2004, J APPL SOC PSYCHOL, V34, P322, DOI 10.1111/j.1559-1816.2004.tb02550.x; Tangney J. P., 2002, SHAME GUILT; Verbeek P., 2001, PEACE CONFLICT J PEA, V7, P5, DOI 10.1207/S15327949PAC0701_02; Zahavi A., 1997, HANDICAP PRINCIPLE M	47	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1090-5138	1879-0607		EVOL HUM BEHAV	Evol. Hum. Behav.	MAY	2015	36	3					232	239		10.1016/j.evolhumbehav.2014.11.008		8	Psychology, Biological; Behavioral Sciences; Social Sciences, Biomedical	Psychology; Behavioral Sciences; Biomedical Social Sciences	CH0ZZ	WOS:000353752200010		
J	Kihara, Y; Mizuno, H; Chun, J				Kihara, Yasuyuki; Mizuno, Hirotaka; Chun, Jerold			Lysophospholipid receptors in drug discovery	EXPERIMENTAL CELL RESEARCH			English	Review						Multiple sclerosis; Idiopathic pulmonary fibrosis; FTY720; Fingolimod; GPCR; LPA; S1P; LPS; Cannabinoids	PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR; SPHINGOSINE 1-PHOSPHATE RECEPTOR; MULTIPLE-SCLEROSIS; IMMUNOSUPPRESSANT FTY720; PULMONARY-FIBROSIS; SYSTEMIC-SCLEROSIS; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION; ACTIVATION	Lysophospholipids (LPs), including lysophosphatidic acid (LPA), sphingosine 1-phospate (S1P), lysophosphatidylinositol (LPI), and lysophosphatidylserine (LysoPS), are bioactive lipids that transduce signals through their specific cell-surface G protein-coupled receptors, LPA(1-6), S1P(1-5), LPI1, and LysoPS(1-3), respectively. These LPs and their receptors have been implicated in both physiological and pathophysiological processes such as autoimmune diseases, neurodegenerative diseases, fibrosis, pain, cancer, inflammation, metabolic syndrome, bone formation, fertility, organismal development, and other effects on most organ systems. Advances in the LP receptor field have enabled the development of novel small molecules targeting LP receptors for several diseases. Most notably, fingolimod (FTY720, Gilenya, Novartis), an S1P receptor modulator, became the first FDA-approved medicine as an orally bioavailable drug for treating relapsing forms of multiple sclerosis. This success is currently being followed by multiple, mechanistically related compounds targeting SIP receptor subtypes, which are in various stages of clinical development. In addition, an LPA(1) antagonist, BMS-986020 (Bristol-Myers Squibb), is in Phase 2 clinical development for treating idiopathic pulmonary fibrosis, as a distinct compound, SAR100842 (Sanofi) for the treatment of systemic sclerosis and related fibrotic diseases. This review summarizes the current state of drug discovery in the LP receptor field. (C) 2014 Elsevier Inc. All rights reserved.	[Kihara, Yasuyuki; Mizuno, Hirotaka; Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Mizuno, Hirotaka] Ono Pharmaceut Co Ltd, Exploratory Res Labs, Ibaraki 3004247, Japan	Chun, J (reprint author), Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, DNC-118,10550 N,Torrey Pines Rd, La Jolla, CA 92037 USA.	jchun@scripps.edu			Abbott; Amira Pharmaceuticals; Biogen-Idec; Celgene; GlaxoSmithKline; Johnson and Johnson; Merck; Mitsubishi Tanabe Pharma Corporation; Novartis; Ono Pharmaceutical Co.; Pfizer; Taisho Pharmaceutical Co.; National Institutes of Health [MH051699, NS048478, DA019674]; Human Frontier Science Program	J.C. has received honoraria, consulting fees and/or grant support from: Abbott, Amira Pharmaceuticals, Biogen-Idec, Celgene, GlaxoSmithKline, Johnson and Johnson, Merck, Mitsubishi Tanabe Pharma Corporation, Novartis, Ono Pharmaceutical Co., Pfizer, and Taisho Pharmaceutical Co. This work was supported by the National Institutes of Health (MH051699, NS048478, DA019674; JC), the Human Frontier Science Program (YK) and a research grants from Novartis and Ono Pharmaceutical Co. (JC). The authors wish to thank Ms Danielle Jones for editorial assistance.	Adachi Kunitomo, 2008, Perspect Medicin Chem, V1, P11; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C220176200; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Salvadori M, 2006, AM J TRANSPLANT, V6, P2912, DOI 10.1111/j.1600-6143.2006.01552.x; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; HLA T, 1990, J BIOL CHEM, V265, P9308; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Tokumura A, 2009, INT J MED SCI, V6, P168; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Castelino FV, 2011, ARTHRITIS RHEUM-US, V63, P1405, DOI 10.1002/art.30262; Yamashita A, 2013, PROSTAG OTH LIPID M, V107, P103, DOI 10.1016/j.prostaglandins.2013.05.004; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Rommer PS, 2014, CLIN EXP IMMUNOL, V175, P397, DOI 10.1111/cei.12206; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Hu JC, 2014, J IMMUNOL, V193, P85, DOI 10.4049/jimmunol.1300429; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Khanna C. P. D. Dinesh, 2014, AM COLL RHEUM ANN M; Kitamura H, 2012, J BIOCHEM, V151, P511, DOI 10.1093/jb/mvs011; Klabunde Thomas, 2002, Chembiochem, V3, P928, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Oda SK, 2013, CANCER IMMUNOL RES, V1, P245, DOI 10.1158/2326-6066.CIR-13-0043-T; Pattanaik D, 2010, DISCOV MED, V51, P161; Shinkuma S, 2010, HUM MUTAT, V31, P602, DOI 10.1002/humu.21235; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095	64	3	3	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	MAY 1	2015	333	2					171	177		10.1016/j.yexcr.2014.11.020		7	Oncology; Cell Biology	Oncology; Cell Biology	CG9UR	WOS:000353666100003		
J	Ohashi, K; Nagata, Y; Wada, E; Zammit, PS; Shiozuka, M; Matsuda, R				Ohashi, Kazuya; Nagata, Yosuke; Wada, Eiji; Zammit, Peter S.; Shiozuka, Masataka; Matsuda, Ryoichi			Zinc promotes proliferation and activation of myogenic cells via the PI3K/Akt and ERK signaling cascade	EXPERIMENTAL CELL RESEARCH			English	Article						Skeletal muscle; C2C12; Reserve cells; Zinc; Insulin	FIBROBLAST-GROWTH-FACTOR; MUSCLE SATELLITE CELLS; SKELETAL-MUSCLE; FACTOR-I; MYOBLAST DIFFERENTIATION; CYCLE PROGRESSION; MAMMALIAN TARGET; MURINE 3T3-CELLS; INSULIN-RECEPTOR; DNA-SYNTHESIS	Skeletal muscle stem cells named muscle satellite cells are normally quiescent but are activated in response to various stimuli, such as injury and overload. Activated satellite cells enter the cell cycle and proliferate to produce a large number of myogenic progenitor cells, and these cells then differentiate and fuse to form myofibers. Zinc is one of the essential elements in the human body, and has multiple roles, including cell growth and DNA synthesis. However, the role of zinc in myogenic cells is not well understood, and is the focus of this study. We first examined the effects of zinc on differentiation of murine C2C12 myoblasts and found that zinc promoted proliferation, with an increased number of cells incorporating EdU, but inhibited differentiation with reduced myogenin expression and myotube formation. Furthermore, we used the C2C12 reserve cell model of myogenic quiescence to investigate the role of zinc on activation of myogenic cells. The number of reserve cells incorporating BrdU was increased by zinc in a dose dependent manner, with the number dramatically further increased using a combination of zinc and insulin. Akt and extracellular signal-regulated kinase (ERK) are downstream of insulin signaling, and both were phosphorylated after zinc treatment. The zinc/insulin combination-induced activation involved the phosphoinositide 3-kinase (PI3K)/Akt and ERK cascade. We conclude that zinc promotes activation and proliferation of myogenic cells, and this activation requires phosphorylation of PI3K/Akt and ERK as part of the signaling cascade. (C) 2015 Elsevier Inc. All rights reserved.	[Ohashi, Kazuya; Nagata, Yosuke; Wada, Eiji; Shiozuka, Masataka; Matsuda, Ryoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Zammit, Peter S.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	Matsuda, R (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	asuno10k@yahoo.co.jp; cynagata@mail.ecc.u-tokyo.ac.jp; gacchu1@yahoo.co.jp; peter.zammit@kcl.ac.uk; cmuscle@mail.ecc.u-tokyo.ac.jp; cmatsuda@mail.ecc.u-tokyo.ac.jp			Intramural Research Grant for Neurological and Psychiatric Disorder of National Center of Neurology and Psychiatry [26-8]; Ministry of Education, Culture, Sports, Science and Technology-Japan [25650106]; Ichiro Kanehara Foundation [25-3]; Sasakawa Scientific Research Grant from The Japan Science Society [13-209];  [H22-016]	This work was supported in part by a Grant-in-Aid for a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare (H22-016); Intramural Research Grant (26-8) for Neurological and Psychiatric Disorder of National Center of Neurology and Psychiatry; a grant-in aid #25650106 from Ministry of Education, Culture, Sports, Science and Technology-Japan; the Ichiro Kanehara Foundation (25-3) and the Sasakawa Scientific Research Grant (13-209) from The Japan Science Society.	Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Tang XH, 2001, J NUTR, V131, P1414; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Yablonka-Reuveni Z, 1999, J HISTOCHEM CYTOCHEM, V47, P23; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Park IH, 2005, EXP CELL RES, V309, P211, DOI 10.1016/j.yexcr.2005.05.17; Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Suliburska J, 2013, EUR REV MED PHARMACO, V17, P2396; Kim S, 2000, J BIOL CHEM, V275, P25979, DOI 10.1074/jbc.M001975200; Sharples AP, 2011, CURR OPIN CLIN NUTR, V14, P230, DOI 10.1097/MCO.0b013e3283457ade; ROSENTHAL SM, 1995, P NATL ACAD SCI USA, V92, P10307, DOI 10.1073/pnas.92.22.10307; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Wu WD, 1999, AM J PHYSIOL-LUNG C, V277, pL924; Ramalingam L, 2013, CELL MOL LIFE SCI, V70, P2815, DOI 10.1007/s00018-012-1176-1; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; McClung JP, 2007, BIOL TRACE ELEM RES, V118, P65, DOI 10.1007/s12011-007-0018-8; BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; PETRIE L, 1991, BIOCHEM J, V276, P109; Barthel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P175, DOI 10.1016/j.abb.2007.04.015; ISAACSON A, 1963, J GEN PHYSIOL, V46, P655, DOI 10.1085/jgp.46.4.655; KOBUSCH AB, 1990, BIOCHEM PHARMACOL, V39, P555, DOI 10.1016/0006-2952(90)90063-Q; Krotkiewski M., ACTA PHYSL SCAND, V116; Mac Donald R.S, 2000, J NUTR S, V130, P1500; MacDonald RS, 1998, J NUTR, V128, P1600; Miranda ER, 2004, BIOL TRACE ELEM RES, V101, P19, DOI 10.1385/BTER:101:1:19; MOONEY RA, 1992, J BIOL CHEM, V267, P14054; Nagata Y, 2010, CELL STRUCT FUNCT, V35, P63; Nagata Y, 2014, EXP CELL RES, V326, P112, DOI 10.1016/j.yexcr.2014.06.009; O'Dell BL, 2011, J NUTR, V141, P1036, DOI 10.3945/jn.110.137042; Pandey NR, 2010, J BIOL INORG CHEM, V15, P399, DOI 10.1007/s00775-009-0612-7; Petrie L, 1996, J NUTR BIOCHEM, V7, P670, DOI 10.1016/S0955-2863(96)00129-5; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Tameyasu T, 2002, JPN J PHYSIOL, V52, P449, DOI 10.2170/jjphysiol.52.449; Tameyasu T, 2002, JPN J PHYSIOL, V52, P111, DOI 10.2170/jjphysiol.52.111; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001	42	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	MAY 1	2015	333	2					228	237		10.1016/j.yexcr.2015.03.003		10	Oncology; Cell Biology	Oncology; Cell Biology	CG9UR	WOS:000353666100011		
J	Doi, N; Ogawa, R; Cui, ZG; Morii, A; Watanabe, A; Kanayama, S; Yoneda, Y; Kondo, T				Doi, Nobutaka; Ogawa, Ryohei; Cui, Zheng-Guo; Morii, Akihiro; Watanabe, Akihiko; Kanayama, Shinji; Yoneda, Yuko; Kondo, Takashi			The acquired radioresistance in HeLa cells under conditions mimicking hypoxia was attenuated by a decreased expression of HIF subunit genes induced by RNA interference	EXPERIMENTAL CELL RESEARCH			English	Article						Hypoxia; Radiation; Cancer stem cell; HIF; shRNA; Cobalt chloride	INDUCIBLE FACTORS; CANCER-CELLS; TUMOR-GROWTH; STEM-CELLS; OXYGEN-TENSIONS; TARGET GENES; HIF-2-ALPHA; PROMOTES; PLURIPOTENCY; HIF-1-ALPHA	The cancer cells residing in the hypoxic layer are resistant to radiation and these are ones responsible for cancer recurrence after radiation therapy. One of the reasons why hypoxic cancer cells acquire radioresistance may be attributable to changes in the gene expression profile by the activation of hypoxia inducible factors (HIFs). However, the details underlying this process remain unknown. In this study, we investigated the effects of knockdown of HIF subunit genes to elucidate how HIF subunit genes may be involved in the radioresistance acquired by HeLa cells following exposure to a hypoxia mimic. Interestingly, HIF-1 alpha and HIF-2 alpha seemed mutually complementary for each other when either of them was suppressed. We thus suppressed the expression of both genes simultaneously. To do this, we developed a short hairpin RNA (shRNA) targeting a high homology region between HIF-1 alpha and HIF-2 alpha. It was shown that the expression of the shRNA effectively suppressed the acquisition of radioresistance following the hypoxia mimic. Moreover, it was confirmed that suppression of both subunits resulted in the down-regulation of stem cell markers and the suppression of spheroid formation during the hypoxia mimicking-conditions. This shRNA-mediated knockdown method targeting a common region shared by a family of genes may offer a new candidate cancer treatment. (C) 2015 Elsevier Inc. All rights reserved.	[Doi, Nobutaka; Ogawa, Ryohei; Kondo, Takashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan; [Doi, Nobutaka; Kanayama, Shinji; Yoneda, Yuko] NIPPON GENE Co Ltd, Gene Engn Div, New Prod Res & Dev, Toyama, Japan; [Cui, Zheng-Guo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Publ Hlth, Toyama, Toyama, Japan; [Morii, Akihiro; Watanabe, Akihiko] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Urol, Toyama, Toyama, Japan	Ogawa, R (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan.	ogawa@med.u-toyama.ac.jp			Japan Society for the Promotion of Science [26461882]	This study was supported, in part, by Grants-in-Aid for Scientific Research (C) (26461882) from the Japan Society for the Promotion of Science. The authors thank Dr. Go Kagiya for his critical reading of the manuscript.	Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Bertout JA, 2009, P NATL ACAD SCI USA, V106, P14391, DOI 10.1073/pnas.0907357106; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Lin Q, 2011, MOL CANCER RES, V9, P757, DOI 10.1158/1541-7786.MCR-11-0053; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Yu EZ, 2004, LAB INVEST, V84, P553, DOI 10.1038/labinvest.3700071; Sowter HM, 2003, CANCER RES, V63, P6130; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Comerford KM, 2002, CANCER RES, V62, P3387; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Furusawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029012; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Keith B., 2011, NAT REV CANCER, V12, P9, DOI DOI 10.1038/NRC3183; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Krishnamachary B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044078; Liang DM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-201; Lopez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-48; Ogawa R, 2012, J GENE MED, V14, P316, DOI 10.1002/jgm.2625; Patrick van Uden P., 2011, PLOS GENET, V7; Sambrook J, 2001, MOL CLONING LAB MANU; Szablowska-Gadomska I, 2011, ACTA NEUROBIOL EXP, V71, P86; Tomari Y, 2011, JPA, P4708, Patent No. 20114708; Wang JL, 2014, WORLD J GASTROENTERO, V20, P18296, DOI 10.3748/wjg.v20.i48.18296; Weigand JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042697; Yoshimura M, 2013, BIOMED RES INT, DOI 10.1155/2013/685308	35	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	MAY 1	2015	333	2					249	260		10.1016/j.yexcr.2015.03.009		12	Oncology; Cell Biology	Oncology; Cell Biology	CG9UR	WOS:000353666100013		
J	Ozeki, N; Hase, N; Yamaguchi, H; Hiyama, T; Kawai, R; Kondo, A; Nakata, K; Mogi, M				Ozeki, Nobuaki; Hase, Naoko; Yamaguchi, Hideyuki; Hiyama, Taiki; Kawai, Rie; Kondo, Ayami; Nakata, Kazuhiko; Mogi, Makio			Polyphosphate induces matrix metalloproteinase-3-mediated proliferation of odontoblast-like cells derived from induced pluripotent stem cells	EXPERIMENTAL CELL RESEARCH			English	Article						Inorganic polyphosphate; Matrix metalloproteinase-3; Induced pluripotent stem cell; Odontoblast; Cell proliferation	INORGANIC POLYPHOSPHATE; OSTEOBLASTIC DIFFERENTIATION; TNF-ALPHA; EXPRESSION; ACTIVATION; INDUCTION; PERIODONTITIS; CYTOKINES; RAT; PROCOLLAGENASE	Inorganic polyphosphate [Poly(P)] may represent a physiological source of phosphate and has the ability to induce bone differentiation in osteoblasts. We previously reported that cytokine-induced matrix metalloproteinase (MMP)-3 accelerates the proliferation of purified odontoblast-like cells. In this study, MMP-3 small interfering RNA (siRNA) was transfected into odontoblast-like cells derived from induced pluripotent stem cells to investigate whether MMP-3 activity is induced by Poly(P) and/or is associated with cell proliferation and differentiation into odontoblast-like cells. Treatment with Poly(P) led to an increase in both cell proliferation and additional odontoblastic differentiation. Poly(P)-treated cells showed a small but significant increase in dentin sialophosphoprotein (DSPP) and dentin matrix protein-1 (DMP-1) mRNA expression, which are markers of mature odontoblasts. The cells also acquired additional odontoblast-specific properties including adoption of an odontoblastic phenotype typified by high alkaline phosphatase (ALP) activity and a calcification capacity. In addition, Poly(P) induced expression of MMP-3 mRNA and protein, and increased MMP-3 activity. MMP-3 siRNA-mediated disruption of the expression of these effectors potently suppressed the expression of odontoblastic biomarkers ALP, DSPP, and DMP-1, and blocked calcification. Interestingly, upon siRNA-mediated silencing of MMP-3, we noted a potent and significant decrease in cell proliferation. Using specific siRNAs, we revealed that a unique signaling cascade, Poly(P)-->MMP-3-->DSPP and/or DMP-1, was intimately involved in the proliferation of odontoblast-like cells. (C) 2015 Elsevier Inc. All rights reserved.	[Ozeki, Nobuaki; Hase, Naoko; Yamaguchi, Hideyuki; Hiyama, Taiki; Kawai, Rie; Nakata, Kazuhiko] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Chikusa Ku, Nagoya, Aichi 4648651, Japan; [Kondo, Ayami; Mogi, Makio] Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Chikusa Ku, Nagoya, Aichi 4648650, Japan	Mogi, M (reprint author), Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan.	makio@dpc.agu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25253101, 23592818, 26462904]	We thank Dr. Randall H. Kramer for supplying reagents and contributing to helpful discussions. This work was supported by a Grant-in-Aid-for Scientific Research (A) (Grant no. 25253101; to SY), a Grant-in-Aid-for Scientific Research (C) (Grant no. 23592818; to KN) and a Grant-in-Aid-for Scientific Research (C) (Grant no. 26462904; to NO) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Ozeki N, 2002, ARCH ORAL BIOL, V47, P511, DOI 10.1016/S0003-9969(02)00035-3; Orriss IR, 2012, BONE, V51, P389, DOI 10.1016/j.bone.2012.06.013; Noguchi F, 2009, J ENDODONT, V35, P668, DOI 10.1016/j.joen.2009.01.016; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Abd-Elmeguid A, 2012, J ENDODONT, V38, P75, DOI 10.1016/j.joen.2011.10.005; Paula-Silva FWG, 2010, J ENDODONT, V36, P231, DOI 10.1016/j.joen.2009.10.030; Ozeki N, 2014, ORAL DIS, V20, P505, DOI 10.1111/odi.12165; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Hayami T, 2008, MATRIX BIOL, V27, P682, DOI 10.1016/j.matbio.2008.07.005; Zheng L, 2009, AM J PATHOL, V175, P1905, DOI 10.2353/ajpath.2009.080705; Kim RH, 2013, J ENDODONT, V39, P57, DOI 10.1016/j.joen.2012.09.006; Yamaguchi H, 2014, J ENDODONT, V40, P89, DOI 10.1016/j.joen.2013.09.029; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Koyama Y, 2008, BIOCHEM BIOPH RES CO, V371, P659, DOI 10.1016/j.bbrc.2008.04.064; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Tian J, 2013, RHEUMATOL INT, V33, P1829, DOI 10.1007/s00296-012-2657-0; Huang CYC, 2009, REGEN MED, V4, P809, DOI [10.2217/rme.09.55, 10.2217/RME.09.55]; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Xu JP, 2009, STEM CELLS DEV, V18, P487, DOI 10.1089/scd.2008.0113; BIRKEDALHANSEN H, 1993, J PERIODONTOL, V64, P474, DOI 10.1902/jop.1993.64.5s.474; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Azuma Y, 2007, EUR J PHARMACOL, V568, P260, DOI 10.1016/j.ejphar.2007.05.001; BRINCKERHOFF CE, 1990, J BIOL CHEM, V265, P22262; de Araujo RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066391; Eba H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052523; Emingil G, 2014, J PERIODONTOL, V85, P1070, DOI 10.1902/jop.2013.130365; Hiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083563; Kawano Michio M, 2006, Haematologica, V91, p1154A; Kawazoe Y, 2004, J DENT RES, V83, P613; Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803; Ozeki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080026; Ozeki N, 2014, J BIOL CHEM, V289, P14380, DOI 10.1074/jbc.M113.526772; Ozeki N., 2013, ORAL DIS; Ozeki N., 2014, EXP CELL RES; Schroder HC, 2000, BIOCHEMISTRY-MOSCOW+, V65, P296; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Teles J C, 1967, Rev Bras Odontol, V25, P305; Tseng WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063963; Tsutsumi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086834; Usui Y, 2010, J DENT RES, V89, P504, DOI 10.1177/0022034510363096	45	1	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	MAY 1	2015	333	2					303	315		10.1016/j.yexcr.2015.01.007		13	Oncology; Cell Biology	Oncology; Cell Biology	CG9UR	WOS:000353666100017		
J	Okada-Ogawa, A; Nakaya, Y; Imamura, Y; Kobayashi, M; Shinoda, M; Kita, K; Sessle, BJ; Iwata, K				Okada-Ogawa, Akiko; Nakaya, Yuka; Imamura, Yoshiki; Kobayashi, Masayuki; Shinoda, Masamichi; Kita, Kozue; Sessle, Barry J.; Iwata, Koichi			Involvement of medullary GABAergic system in extraterritorial neuropathic pain mechanisms associated with inferior alveolar nerve transection	EXPERIMENTAL NEUROLOGY			English	Article						GABA; Ectopic neuropathic pain; Trigeminal nerve injury; Trigeminal spinal subnucleus caudalis; KCC2	SPINAL SUBNUCLEUS CAUDALIS; CORD DORSAL-HORN; GABA-TRANSPORTER GAT-1; CENTRAL SENSITIZATION; TRIGEMINAL NERVE; MESSENGER-RNAS; RAT MODEL; THERMAL HYPERALGESIA; NOCICEPTIVE NEURONS; RECEPTOR ACTIVATION	In order to determine if the functional changes in the GABAergic system in the trigeminal spinal subnucleus caudalis (Vc) are involved in the mechanisms underlying extraterritorial neuropathic pain in the orofacial region following inferior alveolar nerve transection (IANX), mechanical noxious behavior, phosphoiylated extracellular signal-regulated kinase (pERK) immunohistochemistry and single neuronal activity were analyzed in vesicular GABA transporter (VGAT)-VenusA rats expressing fluorescent protein and the VGAT in Vc neurons. The number of VGAT-VenusA positive neurons was significantly reduced in IANX rats than naive and sham rats at 7 days after nerve transection. The number of VGAT-VenusA positive pERK-immunoreactive (IR) cells was significantly increased in IANX rats at 21 days after IAN transection compared with naive and sham rats. The background activity and mechanical-evoked responses of Vc nociceptive neurons were significantly depressed after intrathecal application of the GABA receptor agonist muscimol in sham rats but not in IANX rats. Furthermore, the expression of potassium-chloride co-transporter 2 (KCC2) in the Vc was significantly reduced in IANX rats compared with sham rats. The head-withdrawal threshold (HWT) to mechanical stimulation of the whisker pad skin was significantly decreased in IANX rats compared with sham rats on days 7 and 21 after IANX. The significant reduction of the HINT and significant increase in the number of VGAT-VenusA negative pERK-IR cells were observed in KCC2 blocker R-DIOA-injected rats compared with vehicle-injected rats on day 21 after sham treatment. These findings revealed that GABAergic Vc neurons might be reduced in their number at the early period after IANX and the functional changes might occur in GABAergic neurons from inhibitory to excitatory at the late period after IANX, suggesting that the neuroplastic changes occur in the GABAergic neuronal network in the Vc due to morphological and functional changes at different time periods following IANX and resulting in the extraterritorial neuropathic pain in the orofacial region following trigeminal nerve injury. (C) 2015 Elsevier Inc. All rights reserved.	[Okada-Ogawa, Akiko; Nakaya, Yuka; Imamura, Yoshiki] Nihon Univ, Sch Dent, Dept Oral Diag Sci, Tokyo 101, Japan; [Okada-Ogawa, Akiko; Imamura, Yoshiki; Shinoda, Masamichi; Kita, Kozue; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Tokyo 101, Japan; [Kobayashi, Masayuki] Nihon Univ, Sch Dent, Dept Pharmacol, Tokyo 101, Japan; [Shinoda, Masamichi; Iwata, Koichi] Nihon Univ, Sch Dent, Dent Res Ctr, Div Funct Morphol, Tokyo 101, Japan; [Sessle, Barry J.] Univ Toronto, Fac Dent, Dept Oral Physiol, Toronto, ON, Canada; [Sessle, Barry J.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Iwata, Koichi] Nihon Univ, Grad Sch Med Sci, Adv Med Res Ctr, Div Appl Syst Neurosci, Tokyo 1018310, Japan	Okada-Ogawa, A (reprint author), Nihon Univ, Sch Dent, Dept Oral Diag Sci, Chiyoda Ku, 1-8-13 Kandasurugadai, Tokyo 1018310, Japan.	okada.akiko1@nihon-u.ac.jp			JSPS KAKENHI Grant [25463151]	VGAT-Venus transgenic rats were generated by Drs. Y. Yanagawa, M. Hirabayashi, and Y. Kawaguchi in National Institute for Physiological Sciences, Okazaki, Japan, using pCS2-Venus provided by Dr. A. Miyawaki. This study was supported in part by JSPS KAKENHI Grant Number 25463151 to A.O.	Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Shih A, 2008, ANESTH ANALG, V106, P1296, DOI 10.1213/ane.0b013e318164f1e9; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Yan XS, 2013, J PHYSIOL-LONDON, V591, P2001, DOI 10.1113/jphysiol.2012.250522; Tsuboi Y, 2011, EUR J NEUROSCI, V34, P292, DOI 10.1111/j.1460-9568.2011.07747.x; Morgado C, 2011, DIABETES OBES METAB, V13, P150, DOI 10.1111/j.1463-1326.2010.01333.x; Melin C, 2013, EUR J NEUROSCI, V37, P417, DOI 10.1111/ejn.12048; Yamada MH, 2012, MOL PHARMACOL, V81, P610, DOI 10.1124/mol.111.076083; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; Miletic G, 2008, PAIN, V137, P532, DOI 10.1016/j.pain.2007.10.016; TREVINO DL, 1973, J NEUROPHYSIOL, V36, P750; Saito K, 2008, J NEUROPHYSIOL, V99, P2251, DOI 10.1152/jn.00794.2007; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Moore KA, 2002, J NEUROSCI, V22, P6724; Ng CH, 2001, PAIN, V92, P29, DOI 10.1016/S0304-3959(00)00468-1; Uematsu M, 2008, CEREB CORTEX, V18, P315, DOI 10.1093/cercor/bhm056; Paul J, 2012, J COMP NEUROL, V520, P3895, DOI 10.1002/cne.23129; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Xu YF, 2008, J NEUROSCI RES, V86, P465, DOI 10.1002/jnr.21499; Daemen MARC, 2008, NEUROSCI LETT, V444, P112, DOI 10.1016/j.neulet.2008.08.001; Rafati DS, 2008, J NEUROSCI RES, V86, P566, DOI 10.1002/jnr.21508; Asiedu MN, 2012, J PAIN, V13, P546, DOI 10.1016/j.jpain.2012.03.002; Bardoni R, 2013, ANN NY ACAD SCI, V1279, P90, DOI 10.1111/nyas.12056; Iwata K, 2001, J NEUROPHYSIOL, V86, P2868; Dougherty KJ, 2008, J NEUROPHYSIOL, V100, P212, DOI 10.1152/jn.01104.2007; MAO J, 1992, BRAIN RES, V598, P271, DOI 10.1016/0006-8993(92)90193-D; Fukuoka T, 1998, PAIN, V78, P13, DOI 10.1016/S0304-3959(98)00111-0; Kayser V, 2011, EUR J PAIN, V15, P451, DOI 10.1016/j.ejpain.2010.09.012; Bao F, 2003, NEUROSCIENCE, V116, P59, DOI 10.1016/S0306-4522(02)00571-7; Ogawa A, 2005, EXP NEUROL, V192, P310, DOI 10.1016/j.expneurol.2004.11.010; Nomura H, 2002, PAIN, V95, P225, DOI 10.1016/S0304-3959(01)00403-1; Miletic G, 2003, PAIN, V105, P347, DOI 10.1016/S0304-3959(03)00250-1; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainsrev.2004.03.003; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830; Gwak YS, 2011, NEUROPHARMACOLOGY, V60, P799, DOI 10.1016/j.neuropharm.2010.12.030; Hu JH, 2003, J NEUROSCI RES, V73, P565, DOI 10.1002/jnr.10677; Tsuboi Y, 2004, PAIN, V111, P323, DOI 10.1016/j.pain.2004.07.014; Austin TM, 2011, ANESTH ANALG, V113, P1509, DOI 10.1213/ANE.0b013e31822e0a5d; Biggs JE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-44; Chiang CY, 2007, J NEUROSCI, V27, P9068, DOI 10.1523/JNEUROSCI.2260-07.2007; Daniele CA, 2009, J NEUROSCI, V29, P686, DOI 10.1523/JNEUROSCI.5120-08.2009; Dubner R, 1997, J DENT RES, V76, P730; GARRISON CJ, 1993, BRAIN RES, V607, P205, DOI 10.1016/0006-8993(93)91508-P; Hiura A, 1996, ARCH HISTOL CYTOL, V59, P55, DOI 10.1679/aohc.59.55; Janssen SP, 2012, NEUROCHEM INT, V60, P21, DOI 10.1016/j.neuint.2011.11.006; Kiyomoto M, 2013, J NEUROSCI, V33, P7667, DOI 10.1523/JNEUROSCI.4968-12.2013; Li YQ, 2010, BRAIN RES BULL, V81, P561, DOI 10.1016/j.brainresbull.2010.01.002; MELDRUM BS, 1992, CURR OPIN NEUROL NEU, V5, P508; Okada-Ogawa A, 2009, J NEUROSCI, V29, P11161, DOI 10.1523/JNEUROSCI.3365-09.2009; OTSUKA M, 1990, CELL MOL NEUROBIOL, V10, P293, DOI 10.1007/BF00711176; Pu L, 2012, EVID-BASED COMPL ALT, V2012, P1; Renton T, 2012, INT J ORAL MAX SURG, V41, P1509, DOI 10.1016/j.ijom.2012.06.025; Sah R, 2002, J NEUROCHEM, V80, P383, DOI 10.1046/j.0022-3042.2001.00706.x; Sharma HS, 2002, AMINO ACIDS, V23, P261, DOI 10.1007/s00726-001-0137-z; Shibuta K, 2012, BRAIN RES, V1451, P74, DOI 10.1016/j.brainres.2012.02.023; Shimizu K, 2006, BRAIN RES, V1072, P99, DOI 10.1016/j.brainres.2005.12.040; SOMMER C, 1995, ACTA NEUROPATHOL, V90, P478; Soudijn W, 2000, CURR MED CHEM, V7, P1063; Suzuki I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057278; Suzuki I, 2007, J OROFAC PAIN, V21, P225; THOMPSON SWN, 1994, J NEUROSCI, V14, P3672; Toyoda H, 2005, MOL BRAIN RES, V133, P12, DOI 10.1016/j.molbrainres.20043.09.015; Wei B, 2013, NEUROSCIENCE, V228, P334, DOI 10.1016/j.neuroscience.2012.10.043; Wiesenfeld-Hallin Z., 1997, BEHAV BRAIN SCI, V20, P435; Wiesenfeld-Hallin Z, 1997, BEHAV BRAIN SCI, V20, P420; Wu LA, 2009, NEUROSCI LETT, V457, P36, DOI 10.1016/j.neulet.2009.03.107; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	67	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2015	267						42	52		10.1016/j.expneurol.2015.02.030		11	Neurosciences	Neurosciences & Neurology	CH1AZ	WOS:000353754800005		
J	Matsushita, T; Lankford, KL; Arroyo, EJ; Sasaki, M; Neyazi, M; Radtke, C; Kocsis, JD				Matsushita, Takashi; Lankford, Karen L.; Arroyo, Edgardo J.; Sasaki, Masanori; Neyazi, Milad; Radtke, Christine; Kocsis, Jeffery D.			Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells	EXPERIMENTAL NEUROLOGY			English	Article						Spinal cord injury; Blood spinal cord barrier; Pericytes; Mesenchymal stem cell	QUANTITATIVE SPATIAL-ANALYSIS; BRAIN-BARRIER; ANTIGEN EBA; CEREBRAL-ISCHEMIA; STROMAL CELLS; PERMEABILITY; PERICYTES; MICE; ANGIOGENESIS; ENCEPHALOMYELITIS	Intravenous infusion of mesenchymal stem cells (MSCs) has been shown to reduce the severity of experimental spinal cord injury (SCI), but mechanisms are not fully understood. One important consequence of SCI is damage to the microvasculature and disruption of the blood spinal cord barrier (BSCB). In the present study we induced a contusive SCI at T9 in the rat and studied the effects of intravenous MSC infusion on BSCB permeability, microvascular architecture and locomotor recovery over a 10 week period. Intravenously delivered MSCs could not be identified in the spinal cord, but distributed primarily to the lungs where they survived for a couple of days. Spatial and temporal changes in BSCB integrity were assessed by intravenous infusions of Evans blue (EvB) within vivo and ex vivo optical imaging and spectrophotometric quantitation of EvB leakage into the parenchyma. SCI resulted in prolonged BSCB leakage that was most severe at the impact site but disseminated extensively rostral and caudal to the lesion over 6 weeks. Contused spinal cords also showed an increase in vessel size, reduced vessel number, dissociation of pericytes from microvessels and decreases in von Willebrand factor (vWF) and endothelial barrier antigen (EBA) expression. In MSC-treated rats, BSCB leakage was reduced, vWF expression was increased and locomotor function improved beginning 1 week post-MSC infusion, i.e., 2 weeks post-SCI. These results suggest that intravenously delivered MSCs have important effects on reducing BSCB leakage which could contribute to their therapeutic efficacy. (C) 2015 Published by Elsevier Inc.	[Matsushita, Takashi; Lankford, Karen L.; Arroyo, Edgardo J.; Sasaki, Masanori; Neyazi, Milad; Radtke, Christine; Kocsis, Jeffery D.] Yale Univ, Sch Med, Dept Neurol, VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Matsushita, Takashi; Lankford, Karen L.; Arroyo, Edgardo J.; Sasaki, Masanori; Neyazi, Milad; Radtke, Christine; Kocsis, Jeffery D.] VA Connecticut Healthcare Syst, Ctr Neurosci Regenerat Res, West Haven, CT 06516 USA; [Matsushita, Takashi; Sasaki, Masanori] Sapporo Med Univ, Res Inst Frontier Med, Dept Neural Regenerat Med, Sapporo, Hokkaido, Japan; [Neyazi, Milad; Radtke, Christine] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany	Kocsis, JD (reprint author), Yale Univ, Sch Med, Neurosci Res Ctr 127A, Dept Vet Affairs Med Ctr, West Haven, CT 06516 USA.	jeffery.kocsis@yale.edu			Rehabilitation Research and Development (RR&D) Service of the Department of Veterans Affairs [B7335R, B9260L]; CT Stem Cell Research Program [12-SCB-Yale-05]; Japanese Ministry of Education, Culture, Sports, Science and Technology [24890181, 25462227]; Boehringer Ingelheim Foundation; National Multiple Sclerosis Society	This work was supported in part by Rehabilitation Research and Development (RR&D) Service of the Department of Veterans Affairs (B7335R, B9260L), the National Multiple Sclerosis Society and the CT Stem Cell Research Program (12-SCB-Yale-05) to J.K., The Japanese Ministry of Education, Culture, Sports, Science and Technology to M.S. (24890181; 25462227), and Boehringer Ingelheim Foundation to C.R.	Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Al Ahmad A, 2011, J CEREBR BLOOD F MET, V31, P693, DOI 10.1038/jcbfm.2010.148; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Matthes SM, 2013, BIOMED RES INT, DOI 10.1155/2013/573169; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Cohen DM, 2009, NMR BIOMED, V22, P332, DOI 10.1002/nbm.1343; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ryan LA, 2008, RADIAT RES, V169, P188, DOI 10.1667/RR1141.1; ROSENSTEIN JM, 1992, DEV BRAIN RES, V66, P47, DOI 10.1016/0165-3806(92)90138-M; Lemmon VP, 2014, J NEUROTRAUM, V31, P1354, DOI 10.1089/neu.2014.3400; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Attwell D., 2010, FRONT NEUROENERGETIC, V2, P5, DOI DOI 10.3389/FNENE.2010.00005; Byun JS, 2013, J KOREAN NEUROSURG S, V54, P467, DOI 10.3340/jkns.2013.54.6.467; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Ghabriel MN, 2000, BRAIN RES, V878, P127, DOI 10.1016/S0006-8993(00)02721-9; Hatzi VI, 2015, CANCER LETT, V356, P34, DOI 10.1016/j.canlet.2013.11.018; Horner PJ, 1996, EXP NEUROL, V142, P226, DOI 10.1006/exnr.1996.0194; Kaptanoglu E, 2004, J CLIN NEUROSCI, V11, P879, DOI 10.1016/j.jocn.2004.04.005; Kilpinen L, 2013, J EXTRACELL VESICLES, V10, P2; Lin BW, 2000, BRAIN RES, V865, P237, DOI 10.1016/S0006-8993(00)02228-9; Nakano N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073494; Noubade R, 2008, AM J PATHOL, V173, P892, DOI 10.2353/ajpath.2008.080001; Ohshima M, 2015, BRAIN DEV-JPN, V37, P376, DOI 10.1016/j.braindev.2014.06.010; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Randi AM, 2013, MEDITERR J HEMATOL I, V5; Rastogi S, 2013, RADIAT RES, V179, P135, DOI 10.1667/RR2969.1; Suidan GL, 2013, ARTERIOSCL THROM VAS, V33, P2112, DOI 10.1161/ATVBAHA.113.301362; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; Yilmaz G, 2011, STROKE, V42, P806, DOI 10.1161/STROKEAHA.110.597088	49	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2015	267						152	164		10.1016/j.expneurol.2015.03.001		13	Neurosciences	Neurosciences & Neurology	CH1AZ	WOS:000353754800016		
J	Nishimura, Y				Nishimura, Yasuzo			Solving quintic equations by two-fold origami	FORUM MATHEMATICUM			English	Article						Origami; paper folding; quintic equation; geometric construction		It is known that a general quintic equation cannot be solved by an ordinary origami construction. Alperin and Lang showed that three simultaneous folds leads to a solution of the general quintic equation. In this paper we improve their result and show that two simultaneous folds are sufficient to solve the general quintic equation.	Univ Fukui, Fac Educ & Reg Studies, Fukui 9108507, Japan	Nishimura, Y (reprint author), Univ Fukui, Fac Educ & Reg Studies, 3-9-1 Bunkyo, Fukui 9108507, Japan.	y-nishi@u-fukui.ac.jp					Abe H., 1980, POSSIBILITY TRISECTI; Alperin R. C., 2009, ORIGAMI, P371; Alperin R.C., 2000, NEW YORK J MATH, V6, P119; Beloch M. P., 1936, SCRITTI MATEMATICI O, P93; Cow T. Y., 2009, ORIGAMI4, P395; Geretschlager R., 1995, MATH MAG, V68, P357, DOI DOI 10.2307/2690924; Hull TC, 2011, AM MATH MON, V118, P307, DOI 10.4169/amer.math.monthly.118.04.307; Huzita H., 1989, P 1 INT M OR SCI TEC, P143; Huzita H., 1989, P 1 INT M OR SCI TEC, P215; Justin J., 1989, P 1 INT M OR SCI TEC, P263; Lang R. J., 2004, ANGLE QUINTISECTION; Messer P., 1986, CRUX MATH, V12, P188; Nishimura Y., PREPRINT	13	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0933-7741	1435-5337		FORUM MATH	Forum Math.	MAY	2015	27	3					1379	1387		10.1515/forum-2012-0123		9	Mathematics, Applied; Mathematics	Mathematics	CG9SR	WOS:000353660900004		
J	Hada, K; Nagasaki, K; Masuda, K; Kobayashi, S; Ide, S; Isayama, A; Kajiwara, K				Hada, Kazuyoshi; Nagasaki, Kazunobu; Masuda, Kai; Kobayashi, Shinji; Ide, Shunsuke; Isayama, Akihiko; Kajiwara, Ken			ONE-DIMENSIONAL ANALYSIS OF ECRH-ASSISTED PLASMA START-UP IN JT-60SA	FUSION SCIENCE AND TECHNOLOGY			English	Article						one-dimensional model; ECRH-assisted start-up; JT-60SA	PREIONIZATION; TOKAMAK	By using a one-dimensional model, we analyze plasma start-up assisted by second-harmonic extraordinary-mode electron cyclotron (EC) resonance heating (ECRH). The model leads to energy transport equations for electrons and ions, particle transport equations for electrons and hydrogen atoms, and a toroidal current equation. These equations are solved for a cylindrically symmetrical plasma; that is, a torus straightened to a cylinder with a circular cross section and on-axis ECRH power absorption. The calculation indicates that ECRH has a threshold power for plasma start-up in JT-60SA. For example, approximately 1 MW of ECRH power is required for plasma start-up for an initial hydrogen atom density n(H)(t=0)=3.0 x 10(18) m(-3), an error field B-err = 1 mT, carbon and oxygen impurity fractions n(C)/n(e) = n(O)/n(e) = 0.1%, and an EC beam radius of approximately 5 cm. This estimated ECRH power is less than the planned power and increases sublinearly with the initial hydrogen atom density. The threshold power depends weakly on the error field and carbon impurity concentration. This is especially prominent for plasma start-up with a low initial hydrogen atom density. This result implies that suppressing the error field and carbon impurity density is helpful for reliable plasma start-up.	[Hada, Kazuyoshi] Kyoto Univ, Grad Sch Energy Sci, Kyoto, Japan; [Nagasaki, Kazunobu; Masuda, Kai; Kobayashi, Shinji] Kyoto Univ, Inst Adv Energy, Kyoto, Japan; [Ide, Shunsuke; Isayama, Akihiko; Kajiwara, Ken] Japan Atom Energy Agcy, Ibaraki, Japan	Hada, K (reprint author), Kyoto Univ, Grad Sch Energy Sci, Kyoto, Japan.	hada.880@iae.kyoto-u.ac.jp			Global COB program of Kyoto University;  [JT-60SA]	The authors are grateful to Y. S. Bae for useful discussions. This study was supported by collaboration research of JT-60SA and in part by the Global COB program of Kyoto University toward a CO<INF>2</INF> zero-emission energy system.	Lloyd B, 1996, PLASMA PHYS CONTR F, V38, P1627, DOI 10.1088/0741-3335/38/9/007; Darbos C, 2009, FUSION ENG DES, V84, P651, DOI 10.1016/j.fusengdes.2009.02.007; Wauters T, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/12/125003; HUGHES MH, 1978, J COMPUT PHYS, V28, P43, DOI 10.1016/0021-9991(78)90045-1; Gribov Y, 2007, NUCL FUSION, V47, pS385, DOI 10.1088/0029-5515/47/6/S08; Mueller D, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4804416; Kamada Y, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104010; BAE Y. S., 2003, IEEE T PLASMA SCI, V31, P4; Bae YS, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/2/022001; Bae YS, 2007, J KOREAN PHYS SOC, V51, P1313; Bucallossi J, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/5/054005; CHEN F. F., 1984, INTRO PLASMA PHYS CO, P43; Goswami R, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4818988; HADA K., 2012, PLASMA FUSION RES, V7; HAWRYLUK RJ, 1976, NUCL FUSION, V16, P775, DOI 10.1088/0029-5515/16/5/005; Jackson GL, 2007, NUCL FUSION, V47, P257, DOI 10.1088/0029-5515/47/4/003; Jackson GL, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3374242; JANEV R. K., 1987, ELEMENTRAY PROCESSES; Kajiwara K, 2005, NUCL FUSION, V45, P694, DOI 10.1088/0029-5515/45/7/019; Kim HT, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083024; Kim HT, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/10/103016; KULCHAR A. G., 1984, PHYS FLUIDS, V27, P7; PAPOULAR R, 1976, NUCL FUSION, V16, P37, DOI 10.1088/0029-5515/16/1/004; WATANABE K., 2002, J PLASMA FUSION RES, V5, P124	24	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAY	2015	67	4					693	704				12	Nuclear Science & Technology	Nuclear Science & Technology	CH3LH	WOS:000353931700001		
J	Takahashi, K; Kajiwara, K; Oda, Y; Sakamoto, K; Omori, T; Henderson, M				Takahashi, K.; Kajiwara, K.; Oda, Y.; Sakamoto, K.; Omori, T.; Henderson, M.			DEVELOPMENT OF ITER EQUATORIAL EC LAUNCHER COMPONENTS TOWARD THE FINAL DESIGN	FUSION SCIENCE AND TECHNOLOGY			English	Article						equatorial EC launcher; ITER	CURRENT DRIVE; PROGRESS; TOKAMAK; PLASMA	Development of an electron cyclotron equatorial launcher has proceeded with a series of prototype tests and design enhancements intended to improve reliability and functionality of the launcher. The design enhancements include adaptation of the launcher steering angles such that one of three beam rows of the launcher is necessarily flipped to perform counter current drive to conform to a new ITER physics requirement. Also, the top and bottom steering rows have been tilted at an angle of 5 deg so that the top and bottom beam rows can be accessed from on-axis to near midradius. Furthermore, the position of the fixed focusing mirror that forms a quasi-optical in-vessel millimeter-wave (mm-wave) transmission line is modified to increase the nuclear shielding capability. A high-power experiment of the mm-wave launching system mock-up fabricated based on the design confirmed a successful steering capability of 20 to 40 deg. It was measured that some stray radio-frequency power propagated in the beam duct and generated some heat on the duct. Prototype tests also include the fabrication of the blanket shield module and partial port plug mock-up and have shown no serious technological issue regarding the fabrication and cooling functionality.	[Takahashi, K.; Kajiwara, K.; Oda, Y.; Sakamoto, K.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Omori, T.; Henderson, M.] ITER Org, F-13067 St Paul Les Durance, France	Takahashi, K (reprint author), Japan Atom Energy Agcy, 801-1 Mukoyama, Naka, Ibaraki 3110193, Japan.	takahashi.koji@jaea.go.jp					Omori T, 2011, FUSION ENG DES, V86, P951, DOI 10.1016/j.fusengdes.2011.02.040; Isayama A, 2007, NUCL FUSION, V47, P773, DOI 10.1088/0029-5515/47/8/007; Sauter O, 2000, PHYS REV LETT, V84, P3322, DOI 10.1103/PhysRevLett.84.3322; Strauss D, 2014, FUSION ENG DES, V89, P1669, DOI 10.1016/j.fusengdes.2014.02.045; Chapman IT, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/6/063006; CIRANT S., 2009, 061403 EFDA; Maraschek M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/7/074007; NISHIO S, 1990, IEEE T MAGN, V26, P865, DOI 10.1109/20.106454; Ridolfini VP, 2003, NUCL FUSION, V43, P469, DOI 10.1088/0029-5515/43/6/309; ROCCELL R., 2012, P IAEA FUS EN C 2012; Takahashi K, 2007, FUSION SCI TECHNOL, V52, P266; ZOHM H., 1999, NUCL FUSION, V39, P577	12	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	MAY	2015	67	4					718	731				14	Nuclear Science & Technology	Nuclear Science & Technology	CH3LH	WOS:000353931700003		
J	Bonney, ME; Moriya, H; Amon, A				Bonney, Megan E.; Moriya, Hisao; Amon, Angelika			Aneuploid proliferation defects in yeast are not driven by copy number changes of a few dosage-sensitive genes	GENES & DEVELOPMENT			English	Article						aneuploidy; dosage-sensitive genes; Down syndrome; proliferation	DOWN-SYNDROME PHENOTYPES; SYNDROME CRITICAL REGION; OF-WAR METHOD; SACCHAROMYCES-CEREVISIAE; ALZHEIMER-DISEASE; TUBULIN GENE; OVEREXPRESSION; IDENTIFICATION; GROWTH; EXPRESSION	Aneuploidy-the gain or loss of one or more whole chromosome-typically has an adverse impact on organismal fitness, manifest in conditions such as Down syndrome. A central question is whether aneuploid phenotypes are the consequence of copy number changes of a few especially harmful genes that may be present on the extra chromosome or are caused by copy number alterations of many genes that confer no observable phenotype when varied individually. We used the proliferation defect exhibited by budding yeast strains carrying single additional chromosomes (disomes) to distinguish between the "few critical genes" hypothesis and the "mass action of genes" hypothesis. Our results indicate that subtle changes in gene dosage across a chromosome can have significant phenotypic consequences. We conclude that phenotypic thresholds can be crossed by mass action of copy number changes that, on their own, are benign.	[Bonney, Megan E.; Amon, Angelika] MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Biol, Cambridge, MA 02142 USA; [Bonney, Megan E.; Amon, Angelika] MIT, Dept Biol, Cambridge, MA 02142 USA; [Moriya, Hisao] Okayama Univ, Res Core Interdisciplinary Sci, Okayama 7008530, Japan	Amon, A (reprint author), MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Biol, Cambridge, MA 02142 USA.	angelika@mit.edu			National Institutes of Health [GM056800]	We thank Frank Solomon and members of the Amon laboratory for suggestions and critical reading of this manuscript. This work was supported by the National Institutes of Health (GM056800 to A.A). A.A is also an investigator of the Howard Hughes Medical Institute.	Olson LE, 2004, DEV DYNAM, V230, P581, DOI 10.1002/dvdy.20079; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/nmeth.1318, 10.1038/NMETH.1318]; Thorburn RR, 2013, MOL BIOL CELL, V24, P1274, DOI 10.1091/mbc.E12-07-0520; Makanae K, 2013, GENOME RES, V23, P300, DOI 10.1101/gr.146662.112; Moriya H, 2012, MOL BIOSYST, V8, P2513, DOI 10.1039/c2mb25100k; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Douglas AC, 2012, G3-GENES GENOM GENET, V2, P1279, DOI 10.1534/g3.112.003400; Rachidi M, 2007, NEUROSCI RES, V59, P349, DOI 10.1016/j.neures.2007.08.007; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; LINDSLEY DL, 1972, GENETICS, V71, P157; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; FUTCHER B, 1986, MOL CELL BIOL, V6, P2213; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Boyer J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r72; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Blank HM, 2015, MOL BIOL CELL, V26, P1440, DOI 10.1091/mbc.E14-10-1442; Chen GB, 2015, CELL, V160, P771, DOI 10.1016/j.cell.2015.01.026; Dang VT, 2008, EUR J HUM GENET, V16, P1350, DOI 10.1038/ejhg.2008.111; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; KATZ W, 1990, MOL CELL BIOL, V10, P5286; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; LIU HP, 1992, GENETICS, V132, P665; Munshi R, 2001, GENETICS, V157, P1425; NEFF NF, 1983, CELL, V33, P211, DOI 10.1016/0092-8674(83)90350-1; RAHMANI Z, 1990, AM J MED GENET, P98; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203	34	4	4	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	MAY 1	2015	29	9					898	903		10.1101/gad.261743.115		6	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	CH0LD	WOS:000353710400002		
J	Nukaya, D; Minami, K; Hoshikawa, R; Yokoi, N; Seino, S				Nukaya, Daiki; Minami, Kohtaro; Hoshikawa, Ritsuko; Yokoi, Norihide; Seino, Susumu			Preferential gene expression and epigenetic memory of induced pluripotent stem cells derived from mouse pancreas	GENES TO CELLS			English	Article							INSULIN-SECRETING CELLS; BETA-CELLS; EMBRYOID BODIES; ACINAR-CELLS; RAT PANCREAS; ADULT-RAT; IN-VITRO; DIFFERENTIATION; GENERATION; LIVER	Induced pluripotent stem cells (iPSCs) have been established from various somatic cell types. Accumulating evidence suggests that iPSCs from different cell sources have distinct molecular and functional properties. Here, we establish iPSC derived from mouse pancreas (Panc-iPSC) and compared their properties with those of iPSC derived from tail-tip fibroblast (TTF-iPSC). The metabolic profile differs between Panc-iPSC and TTF-iPSC, indicating distinct cell properties in these iPSCs. Expression of Pdx1, a marker of pancreas differentiation, is increased through formation of embryoid body (EB) in Panc-iPSC, but the level is similar to that in TTF-iPSC. In contrast, EBs derived from Panc-iPSC express liver-specific albumin (Alb) and alpha-fetoprotein (Afp) genes much more strongly than those from TTF-iPSC. Epigenetic analysis shows a different histone modification pattern between Panc-iPSC and TTF-iPSC. Promoter regions of Alb and Afp genes in Panc-iPSC are suggested to have a more open chromatin structure than those in TTF-iPSC, which also is seen in primary cultured pancreatic cells. Our data suggest that Panc-iPSC possesses distinct differentiation capacity from that of TTF-PSC, which may be influenced by epigenetic memory.	[Nukaya, Daiki; Minami, Kohtaro] Kobe Univ, Div Cellular & Mol Med, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nukaya, Daiki] Sumitomo Dainippon Pharma Co Ltd, Regenerat & Cellular Med Off, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Hoshikawa, Ritsuko; Yokoi, Norihide; Seino, Susumu] Kobe Univ, Div Mol & Metab Med, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Minami, K (reprint author), Kobe Univ, Div Cellular & Mol Med, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kminami@harbor.kobe-u.ac.jp; seino@med.kobe-u.ac.jp			CREST grant from the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Haruyo Maeda for her technical assistance. This work was supported by a CREST grant from the Japan Science and Technology Agency and Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; YEUNG RS, 1993, CANCER, V72, P2124, DOI 10.1002/1097-0142(19931001)72:7<2124::AID-CNCR2820720711>3.0.CO;2-C; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Asahina K, 2004, GENES CELLS, V9, P1297, DOI 10.1111/j.1365-2443.2004.00809.x; Ding XL, 2014, STEM CELLS DEV, V23, P931, DOI 10.1089/scd.2013.0267; des Portes V, 1998, CELL, V92, P51; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Abe K, 1996, EXP CELL RES, V229, P27, DOI 10.1006/excr.1996.0340; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; McGraw TE, 2010, NAT CHEM BIOL, V6, P176; REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; RAO MS, 1988, BIOCHEM BIOPH RES CO, V156, P131, DOI 10.1016/S0006-291X(88)80814-3; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Shiraki N, 2008, GENES CELLS, V13, P731, DOI 10.1111/j.1365-2443.2008.01201.x; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Dabeva MD, 1997, P NATL ACAD SCI USA, V94, P7356, DOI 10.1073/pnas.94.14.7356; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; GREEN RP, 1992, DNA CELL BIOL, V11, P31, DOI 10.1089/dna.1992.11.31; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245; Lardon J, 2004, HEPATOLOGY, V39, P1499, DOI 10.1002/hep.20213; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Minami K, 2008, J BIOL CHEM, V283, P13753, DOI 10.1074/jbc.M710034200; Minami K, 2008, FRONT BIOSCI, V13, P5824; Minami K, 2011, J DIABETES INVEST, V2, P271, DOI 10.1111/j.2040-1124.2010.00095.x; Okuno M, 2007, AM J PHYSIOL-ENDOC M, V292, pE158, DOI 10.1152/ajpendo.00180.2006; SCHATTEMAN GC, 1992, DEVELOPMENT, V115, P123; Wu SY, 2010, GASTROENTEROLOGY, V138, P2519, DOI 10.1053/j.gastro.2010.02.011	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	MAY	2015	20	5					367	381		10.1111/gtc.12227		15	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CH3YG	WOS:000353966500001		
J	Saeki, N; Ono, H; Yanagihara, K; Aoyagi, K; Sasaki, H; Sakamoto, H; Yoshida, T				Saeki, Norihisa; Ono, Hiroe; Yanagihara, Kazuyoshi; Aoyagi, Kazuhiko; Sasaki, Hiroki; Sakamoto, Hiromi; Yoshida, Teruhiko			rs2294008T, a risk allele for gastric and gallbladder cancers, suppresses the PSCA promoter by recruiting the transcription factor YY1	GENES TO CELLS			English	Article							STEM-CELL ANTIGEN; YIN YANG 1; GENETIC-VARIATION; STOMACH-CANCER; SUSCEPTIBILITY; ASSOCIATION; CARCINOMA; LINES; CARCINOGENESIS; AMPLIFICATION	Previous genomewide association studies identified prostate stem cell antigen (PSCA) as a gastric cancer (GC) susceptibility gene and showed an association between GC and the T allele of the single nucleotide polymorphism rs2294008 (C/T) in this gene. The protein product of this gene inhibits cell growth, and the T allele significantly suppresses the transcriptional activity of the -3.2kb PSCA upstream region. However, the mechanism remains unknown. In this study, we conducted reporter assays using the PSCA upstream region containing the C allele and identified the region from -200 to +38bp of the transcription initiation site of the gene as a critical region of the -3.2kb PSCA upstream region. We found that introducing the T allele at rs2294008 generated a consensus binding sequence for the Polycomb group transcription factor Yin Yang 1 (YY1) and that disruption of the consensus sequence restored the transcriptional activity to the -3.2kb PSCA upstream region. These findings imply that the T allele significantly suppresses PSCA expression in vivo by recruiting YY1 to its promoter, which eventually predisposes gastric epithelial cells to GC development.	[Saeki, Norihisa; Ono, Hiroe; Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Chuo Ku, Tokyo 1040045, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr Hosp East, Div Translat Res, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan; [Aoyagi, Kazuhiko; Sasaki, Hiroki] Natl Canc Ctr, Res Inst, Dept Translat Oncol, Chuo Ku, Tokyo 1040045, Japan	Saeki, N (reprint author), Natl Canc Ctr, Res Inst, Div Genet, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	nsaeki@ncc.go.jp			JST; JSPS KAKENHI [23501327]	This work was supported by a JST grant for the personalized medicine project and by JSPS KAKENHI (No. 23501327).	Rai R, 2013, GENE, V530, P172, DOI 10.1016/j.gene.2013.08.058; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Ou JF, 2010, DNA CELL BIOL, V29, P319, DOI 10.1089/dna.2009.0960; Fock KM, 2010, J GASTROEN HEPATOL, V25, P479, DOI 10.1111/j.1440-1746.2009.06188.x; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Saeki N, 2013, CANCER SCI, V104, P1, DOI 10.1111/cas.12042; Lu Y, 2010, INT J CANCER, V127, P2183, DOI 10.1002/ijc.25228; Lochhead P, 2011, GASTROENTEROLOGY, V140, P435, DOI 10.1053/j.gastro.2010.11.001; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Yasui W, 2006, SCAND J SURG, V95, P225; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Zeng ZR, 2011, MOL CARCINOGEN, V50, P353, DOI 10.1002/mc.20718; Aoyagi K, 2003, BIOCHEM BIOPH RES CO, V300, P915, DOI 10.1016/S0006-291X(02)02697-4; Atchison ML, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00045; Ghosh M, 2004, INT J ONCOL, V24, P1189; Homma S, 1988, Hum Cell, V1, P95; Kang W, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-80; Koike N, 1998, INT J ONCOL, V13, P1269; Matsuo K, 2009, INT J CANCER, V125, P1961, DOI 10.1002/ijc.24519; Ono H, 2012, GENE CHROMOSOME CANC, V51, P30, DOI 10.1002/gcc.20928; Ono Hiroe, 2013, J Carcinog, V12, P4, DOI 10.4103/1477-3163.109030; Sala N, 2012, INT J CANCER, V130, P2417, DOI 10.1002/ijc.26243; Sharom FJ, 2004, SUB CELL BIOCHEM, V37, P285; Song HR, 2011, MOL CARCINOGEN, V50, P871, DOI 10.1002/mc.20796; Wu C, 2009, MOL CARCINOGEN, V48, P1131, DOI 10.1002/mc.20565; YANAGIHARA K, 1991, CANCER RES, V51, P381	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	MAY	2015	20	5					382	391		10.1111/gtc.12228		10	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CH3YG	WOS:000353966500002		
J	Oda, A; Takemata, N; Hirata, Y; Miyoshi, T; Suzuki, Y; Sugano, S; Ohta, K				Oda, Arisa; Takemata, Naomichi; Hirata, Yoshito; Miyoshi, Tomoichiro; Suzuki, Yutaka; Sugano, Sumio; Ohta, Kunihiro			Dynamic transition of transcription and chromatin landscape during fission yeast adaptation to glucose starvation	GENES TO CELLS			English	Article							SCHIZOSACCHAROMYCES-POMBE; INTERGENIC TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; NONCODING RNAS; S. POMBE; STRESS; CELLS; INITIATION; TERMINATION	Shortage of glucose, the primary energy source for all organisms, is one of the most critical stresses influencing cell viability. Glucose starvation promptly induces changes in mRNA and noncoding RNA (ncRNA) transcription. We previously reported that glucose starvation induces long ncRNA (lncRNA) transcription in the 5 segment of a fission yeast gluconeogenesis gene (fbp1(+)), which leads to stepwise chromatin alteration around the fbp1(+) promoter and to subsequent robust gene activation. Here, we analyzed genomewide transcription by strand-specific RNA sequencing, together with chromatin landscape by immunoprecipitation sequencing (ChIP-seq). Clustering analysis showed that distinct mRNAs and ncRNAs are induced at the early, middle and later stages of cellular response to glucose starvation. The starvation-induced transcription depends substantially on the stress-responsive transcription factor Atf1. Using a new computer program that examines dynamic changes in expression patterns, we identified ncRNAs with similar behavior to the fbp1(+) lncRNA. We confirmed that there are continuous lncRNAs associated with local reduction of histone density. Overlapping with the regions for transcription of these lncRNAs, antisense RNAs are antagonistically transcribed under glucose-rich conditions. These results suggest that Atf1-dependent integrated networks of mRNA and lncRNA govern drastic changes in cell physiology in response to glucose starvation.	[Oda, Arisa; Ohta, Kunihiro] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; [Takemata, Naomichi; Miyoshi, Tomoichiro; Ohta, Kunihiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Hirata, Yoshito] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778561, Japan	Ohta, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.	kohta@bio.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science [23114003, 21241046, 26291018, 221S0002]; Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan;  [12J02844];  [13J08245]	We thank Galipon Josephine, Atsuko Miki, Takatomi Yamada, Kazuto Kugo, Shintaro Yamada and Masaru Ito for discussions and technical supports, and Terumi Horiuchi and Kasumi Abe for sequencing. This work was supported by a grant from the Japan Society for the Promotion of Science (23114003, 21241046, 26291018) to K.O, (221S0002) to Y.S. and S.S, and Grant-in-Aid for JSPS Fellows (12J02844 to A.O. and 13J08245 to N.T.). This work was also supported by the Grant-in-Aid for Scientific Research on Innovative Areas (221S0002) and by the Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Computational resources for the basic deep sequencing analyses were provided by the Data Integration and Analysis Facility, National Institute for Basic Biology.	Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Galipon J, 2013, GENES CELLS, V18, P353, DOI 10.1111/gtc.12042; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Nadal-Ribelles M, 2014, MOL CELL, V53, P549, DOI 10.1016/j.molcel.2014.01.006; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Gullerova M, 2012, NAT STRUCT MOL BIOL, V19, P1193, DOI 10.1038/nsmb.2392; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Bitton DA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.90; Chen HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029917; Hirota K, 2007, EUKARYOT CELL, V6, P2072, DOI 10.1128/EC.00246-07; Hirota K, 2004, NUCLEIC ACIDS RES, V32, P855, DOI 10.1093/nar/gkh251; HOFFMAN CS, 1989, GENE, V84, P473, DOI 10.1016/0378-1119(89)90523-4; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Leong HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4947; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Thorvaldsdottir H., 2012, BRIEF BIOINFORM, V14, P178, DOI DOI 10.1093/BIB/BBS017; vansDijk E L., 2011, NATURE, V475, P114; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	MAY	2015	20	5					392	407		10.1111/gtc.12229		16	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CH3YG	WOS:000353966500003		
J	Omori, Y; Kitamura, T; Yoshida, S; Kuwahara, R; Chaya, T; Irie, S; Furukawa, T				Omori, Yoshihiro; Kitamura, Tamiki; Yoshida, Satoyo; Kuwahara, Ryusuke; Chaya, Taro; Irie, Shoichi; Furukawa, Takahisa			Mef2d is essential for the maturation and integrity of retinal photoreceptor and bipolar cells	GENES TO CELLS			English	Article							AUTOSOMAL-DOMINANT CONE; HYPOKALEMIC PERIODIC PARALYSIS; STATIONARY NIGHT BLINDNESS; TRANSCRIPTION FACTOR MEF2C; THYROID-HORMONE RECEPTOR; SYNDROME TYPE 1F; GENE-EXPRESSION; MOUSE RETINA; PHOSPHOGLYCERATE MUTASE; FATE DETERMINATION	Mef2 transcription factors play a crucial role in cardiac and skeletal muscle differentiation. We found that Mef2d is highly expressed in the mouse retina and its loss causes photoreceptor degeneration similar to that observed in human retinitis pigmentosa patients. Electroretinograms (ERGs) were severely impaired in Mef2d(-/-) mice. Immunohistochemistry showed that photoreceptor and bipolar cell synapse protein levels severely decreased in the Mef2d(-/-) retina. Expression profiling by microarray analysis showed that Mef2d is required for the expression of various genes in photoreceptor and bipolar cells, including cone arrestin, Guca1b, Pde6h and Cacna1s, which encode outer segment and synapse proteins. We also observed that Mef2d synergistically activates the cone arrestin (Arr3) promoter with Crx, suggesting that functional cooperation between Mef2d and Crx is important for photoreceptor cell gene regulation. Taken together, our results show that Mef2d is essential for photoreceptor and bipolar cell gene expression, either independently or cooperatively with Crx.	[Omori, Yoshihiro; Kitamura, Tamiki; Yoshida, Satoyo; Chaya, Taro; Irie, Shoichi; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 5650871, Japan; [Omori, Yoshihiro; Kitamura, Tamiki; Yoshida, Satoyo; Chaya, Taro; Irie, Shoichi; Furukawa, Takahisa] JST, CREST, Suita, Osaka 5650871, Japan; [Kuwahara, Ryusuke] Osaka Univ, Res Ctr Ultrahigh Voltage Electron Microscopy, Osaka 5670047, Japan	Furukawa, T (reprint author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takahisa.furukawa@protein.osaka-u.ac.jp			CREST from Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Uehara Memorial Foundation; Research Foundation for Opto-Science and Technology; Suzuken Memorial Foundation; Japan Foundation for Applied Enzymology; 'Nanotechnology Platform' of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [12024046]	We thank Dr R. Molday for the anti-ROM1 antibody, A. Tani, M. Kadowaki, A. Ishimaru, Y. Tojima, K. Hasegawa, H. Abe and S. Kennedy for technical assistance. This work was supported by CREST from Japan Science and Technology Agency, Grants-in-Aid for Scientific Research on Innovative Areas, Grant-in-Aid for Scientific Research (B), Specially Designated Research Promotion and Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Takeda Science Foundation, the Uehara Memorial Foundation, Research Foundation for Opto-Science and Technology, Suzuken Memorial Foundation and Japan Foundation for Applied Enzymology. A part of this work was supported by 'Nanotechnology Platform' (project No. 12024046) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Morrow EM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-5; Haider NB, 2000, NAT GENET, V24, P127; Katoh K, 2010, J NEUROSCI, V30, P6515, DOI 10.1523/JNEUROSCI.0771-10.2010; Tummala SR, 2014, INVEST OPHTH VIS SCI, V55, P1483, DOI 10.1167/iovs.13-13766; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; JURKATROTT K, 1994, HUM MOL GENET, V3, P1415, DOI 10.1093/hmg/3.8.1415; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837; Rodriguez CI, 2000, NAT GENET, V25, P139; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Ng L, 2001, NAT GENET, V27, P94; PTACEK LJ, 1994, CELL, V77, P863; Hao H, 2011, J BIOL CHEM, V286, P34893, DOI 10.1074/jbc.M111.271072; Kohl S, 2012, AM J HUM GENET, V91, P527, DOI 10.1016/j.ajhg.2012.07.006; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; Agarwal P, 2011, DEVELOPMENT, V138, P2555, DOI 10.1242/dev.056804; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; KAUSHAL S, 1994, SCIENCE, V266, P1236, DOI 10.1126/science.7973707; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Singh RK, 2014, MOL CELL, V55, P592, DOI 10.1016/j.molcel.2014.06.035; Nakamura M, 2010, MOL VIS, V16, P425; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; LYONS GE, 1995, J NEUROSCI, V15, P5727; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Muranishi Y, 2010, BIOCHEM BIOPH RES CO, V392, P317, DOI 10.1016/j.bbrc.2010.01.007; Sebastian S, 2013, GENE DEV, V27, P1247, DOI 10.1101/gad.215400.113; Lee Y, 1997, MOL CELL BIOL, V17, P2745; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; DesLuca A., 2003, BIOCHEM J, V369, P477; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P96; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; LAVAIL MM, 1973, J CELL BIOL, V58, P650, DOI 10.1083/jcb.58.3.650; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647; Omori Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019685; Pickrell SW, 2004, INVEST OPHTH VIS SCI, V45, P3877, DOI 10.1167/iovs.04-0663; SHANSKE S, 1987, J BIOL CHEM, V262, P14612; TSUJINO S, 1993, AM J HUM GENET, V52, P472; vansGenderen M. M., 2009, AM J HUM GENET, V85, P730; Wada Y, 2001, INVEST OPHTH VIS SCI, V42, P2395; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Zhu XM, 2002, FEBS LETT, V524, P116, DOI 10.1016/S0014-5793(02)03014-4	71	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	MAY	2015	20	5					408	426		10.1111/gtc.12233		19	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CH3YG	WOS:000353966500004		
J	Kametani, Y; Chi, NC; Stainier, DYR; Takada, S				Kametani, Yoshiko; Chi, Neil C.; Stainier, Didier Y. R.; Takada, Shinji			Notch signaling regulates venous arterialization during zebrafish fin regeneration	GENES TO CELLS			English	Article							EMBRYONIC VASCULAR DEVELOPMENT; ENDOTHELIAL-CELLS; SAPHENOUS-VEIN; DIFFERENTIATION; MORPHOGENESIS; IDENTIFICATION; EXPRESSION; IDENTITY; MUTANTS; VESSELS	To protect against blood pressure, a mature artery is supported by mural cells which include vascular smooth muscle cells and pericytes. To regenerate a functional vascular system, arteries should be properly reconstructed with mural cells although the mechanisms underlying artery reconstruction remain unclear. In this study, we examined the process of artery reconstruction during regeneration of the zebrafish caudal fin as a model to study arterial formation in an adult setting. During fin regeneration, the arteries and veins form a net-like vasculature called the vascular plexus, and this plexus undergoes remodeling to form a new artery and two flanking veins. We found that the new vascular plexus originates mainly from venous cells in the stump but very rarely from the arterial cells. Interestingly, these vein-derived cells contributed to the reconstructed arteries. This arterialization was dependent on Notch signaling, and further analysis showed that Notch signaling was required for the initiation of arterial gene expression. In contrast, venous remodeling did not require Notch signaling. These results provide new insights toward understanding mechanisms of vascular regeneration and illustrate the utility of the adult zebrafish fin to study this process.	[Kametani, Yoshiko; Chi, Neil C.; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94158 USA; [Kametani, Yoshiko; Chi, Neil C.; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, Program Genet, San Francisco, CA 94158 USA; [Kametani, Yoshiko; Chi, Neil C.; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94158 USA; [Kametani, Yoshiko; Takada, Shinji] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kametani, Yoshiko; Takada, Shinji] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448787, Japan; [Chi, Neil C.] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Chi, Neil C.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Dept Dev Genet, D-61231 Bad Nauheim, Germany; [Takada, Shinji] SOKENDAI Grad Sch Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan	Kametani, Y (reprint author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94158 USA.	ykametani@gmail.com; Didier.Stainier@mpi-bn.mpg.de			National Institutes of Health [HL54737, HL104239, HD069305]; Packard Foundation; Human Frontier Science Program Organization; Okazaki Institute for Integrative Bioscience	We thank Ms H. Utsumi, K. Takashiro, A. Ayala, K. Brand and M. Alva for fish care; Functional Genomics Facility Spectrography and Bioimaging Facility, NIBB Core Research Facilities for technical support; Ms S. Ukai and Ms K. Yamamoto for assistant-secretary support; and all members of the laboratories of S.T. and D.Y.R.S for helpful discussions. This work was supported in part by grants from the National Institutes of Health to D.Y.R.S (HL54737) and N.C.C (HL104239, HD069305), Packard Foundation to D.Y.R.S, Human Frontier Science Program Organization to Y.K and a grant for scientific research from the Okazaki Institute for Integrative Bioscience to S.T. The authors declare no competing financial interests.	Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Huang CC, 2003, DEV BIOL, V264, P263, DOI 10.1016/j.ydbio.2003.08.016; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Bussmann J, 2011, DEVELOPMENT, V138, P4327, DOI 10.1242/dev.068080; Ehling M, 2013, DEVELOPMENT, V140, P3051, DOI 10.1242/dev.093351; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; JOHNSON SL, 1995, GENETICS, V141, P1583; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Krebs LT, 2000, GENE DEV, V14, P1343; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Kudo FA, 2007, ARTERIOSCL THROM VAS, V27, P1562, DOI 10.1161/ATVBAHA.107.143032; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Moyon D, 2001, DEVELOPMENT, V128, P3359; Roman BL, 2002, DEVELOPMENT, V129, P3009; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Cheung C, 2011, J MOL CELL CARDIOL, V51, P651, DOI 10.1016/j.yjmcc.2011.07.014; IesNoble F., 2004, DEVELOPMENT, V131, P361; Jin Suk-Won, 2005, Development, V132, P5199, DOI 10.1242/dev.02087; Micchelli Craig A., 2003, FASEB Journal, V17, P79; Othman-Hassan K, 2001, DEV BIOL, V237, P398, DOI 10.1006/dbio.2001.0383; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Wakabayashi T, 2013, INVEST OPHTH VIS SCI, V54, P6686, DOI 10.1167/iovs.13-12342	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	MAY	2015	20	5					427	438		10.1111/gtc.12234		12	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CH3YG	WOS:000353966500005		
J	Aoki, H; Hara, A; Kunisada, T				Aoki, Hitomi; Hara, Akira; Kunisada, Takahiro			White spotting phenotype induced by targeted REST disruption during neural crest specification to a melanocyte cell lineage	GENES TO CELLS			English	Article							RESTRICTIVE SILENCER FACTOR; NEURONAL DEVELOPMENT; GENE-EXPRESSION; TRANSGENIC MICE; KNOCKOUT MICE; STEM-CELLS; REPRESSOR; NEUROGENESIS; PROTEIN; DIFFERENTIATION	Neural crest cells (NCCs) emerge from the dorsal region of the neural tube of vertebrate embryos and have the pluripotency to differentiate into both neuronal and non-neuronal lineages including melanocytes. Rest, also known as NRSF (neuro-restrictive silencer factor), is a regulator of neuronal development and function and suggested to be involved in the lineage specification of NCCs. However, further investigations of Rest gene functions in vivo have been hampered by the fact that Rest null mice show early embryonic lethality. To investigate the function of Rest in NCC development, we recently established NCC-specific Rest conditional knockout (CKO) mice and observed their neonatal death. Here, we have established viable heterozygous NCC-specific Rest CKO mice to analyze the function of Rest in an NCC-derived melanocyte cell lineage and found that the white spotting phenotype was associated with the reduction in the number of melanoblasts in the embryonic skin. The Rest deletion induced after the specification to melanocytes did not reduce the number of melanoblasts; therefore, the expression of REST during the early neural crest specification stage was necessary for the normal development of melanoblasts to cover all of the skin.	[Aoki, Hitomi; Kunisada, Takahiro] Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev Regenerat & Adv Med Sci, Gifu 5011194, Japan; [Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu 5011194, Japan	Kunisada, T (reprint author), Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev Regenerat & Adv Med Sci, 1-1 Yanagido, Gifu 5011194, Japan.	tkunisad@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Gifu University; JSPS; Gifu University KASSEIKA-KEIHI	We would like to thank Dr IJ. Jackson for the Dct-lacZ mice, Dr P Soriano for the RosaR26R-LacZ mice, Dr L. Larue for the Tyr-CreA mice, Dr S. Iseki for the Wnt1-Cre mice, Dr F. Beermann for the Dct-Cre mice, Dr M. Osawa for the K14-Cre mice and Dr H Yamazaki for the P0-Cre mice. This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from Gifu University. This study was supported in part by grants-in-aid for Scientific Research of JSPS and a grant supported by Gifu University KASSEIKA-KEIHI.	Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Lee MJ, 2001, DEV DYNAM, V222, P40, DOI 10.1002/dvdy.1165; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mcb.E05-07-0687; Nitzan E, 2013, DEVELOPMENT, V140, P2269, DOI 10.1242/dev.093294; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Kallunki P, 1997, J CELL BIOL, V138, P1343, DOI 10.1083/jcb.138.6.1343; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Rodenas-Ruano A, 2012, NAT NEUROSCI, V15, P1382, DOI 10.1038/nn.3214; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Jorgensen HF, 2009, NATURE, V457, pE4, DOI 10.1038/nature07783; Covey MV, 2012, DEVELOPMENT, V139, P2878, DOI 10.1242/dev.074765; Yoshida H, 1996, DEVELOPMENT, V122, P1207; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Aoki H, 2014, GENES CELLS, V19, P723, DOI 10.1111/gtc.12172; Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Armisen R, 2002, J NEUROSCI, V22, P8347; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403-2004; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kok FO, 2012, DEVELOPMENT, V139, P3838, DOI 10.1242/dev.080994; LesDouarin N, 1999, NEURAL CREST; Liang HZ, 2011, MOL CELL BIOL, V31, P955, DOI 10.1128/MCB.01062-10; Okamura D, 2012, DEV BIOL, V372, P190, DOI 10.1016/j.ydbio.2012.09.013; Olguin P, 2006, J NEUROSCI, V26, P2820, DOI 10.1523/JNEUROSCI.5037-05.2006; Thiel G, 2015, CELL TISSUE RES, V359, P99, DOI 10.1007/s00441-014-1963-0; Yoshimura N, 2013, DEV GROWTH DIFFER, V55, P270, DOI 10.1111/dgd.12034	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	MAY	2015	20	5					439	449		10.1111/gtc.12235		11	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CH3YG	WOS:000353966500006		
J	Noorollahi, Y; Pourarshad, M; Jalilinasrabady, S; Yousefi, H				Noorollahi, Younes; Pourarshad, Meysam; Jalilinasrabady, Saeid; Yousefi, Hossein			Numerical simulation of power production from abandoned oil wells in Ahwaz oil field in southern Iran	GEOTHERMICS			English	Article						Geothermal energy; Abandoned oil wells; Heat transfer; Power generation; Binary cycle	GEOTHERMAL-ENERGY; OPTIMIZATION; FLUIDS	Abandoned oil and gas wells can be used as low temperature geothermal resources for heat extraction from geological formations. They can provide valuable potential sources of heat without the extra cost of deep drilling required in traditional geothermal projects. In this study, two oil wells (AZ and DQ) in southern Iran were numerically simulated using a 3D technique for heat extraction. The bottom-hole temperature of wells AZ and DQ were 138.7 degrees C and 159.8 degrees C, respectively. Heat transfer between the fluid injected into the well and the surrounding hot rock was simulated. Well casing geometry and an exact thermal gradient for two abandoned oil wells were considered. The shnulation results were optimized for parameters such as input and output fluid flow rates and temperatures. The results revealed that, in addition to thermal gradient and input mass flow rate, well casing geometry and the size of injection and extraction pipes were essential to the output heat extraction rate. The small internal diameter of the wells and design of the injection and extraction pipes were limited, resulting in lower mass flow rate and higher power consumption by the injection pump. Total extractable rate of heat from wells AZ-II and DQ-II was 967 kW and 1842 kW, respectively, and net electricity generation using a geothermal binary cycle was 138 kW and 364 kW, respectively. (C) 2015 Elsevier Ltd. All rights reserved.	[Noorollahi, Younes; Pourarshad, Meysam; Yousefi, Hossein] Univ Tehran, Fac New Sci & Technol, Dept Renewable Energies Engn, Tehran, Iran; [Jalilinasrabady, Saeid] Akita Univ, Fac Int Resource Sci, Akita 010, Japan	Noorollahi, Y (reprint author), Fac New Sci & Technol, North Karegar St, Tehran, Iran.	Noorollahi@ut.ac.ir					[Anonymous], 2011, ANSYS FLUENT TUT GUI; Ghasemi H, 2013, ENERGY, V50, P412, DOI 10.1016/j.energy.2012.10.039; Davis AP, 2009, ENERGY, V34, P866, DOI 10.1016/j.energy.2009.03.017; Yousefi H, 2010, GEOTHERMICS, V39, P140, DOI 10.1016/j.geothermics.2009.11.001; Quick H, 2013, RENEW ENERG, V49, P133, DOI 10.1016/j.renene.2012.01.047; Kohl T, 2002, GEOTHERMICS, V31, P687, DOI 10.1016/S0375-6505(02)00031-7; Cheng WL, 2013, ENERGY, V59, P248, DOI 10.1016/j.energy.2013.07.008; Franco A, 2009, GEOTHERMICS, V38, P379, DOI 10.1016/j.geothermics.2009.08.001; Guo T, 2011, ENERG CONVERS MANAGE, V52, P2384, DOI 10.1016/j.enconman.2010.12.038; Walraven D, 2013, ENERG CONVERS MANAGE, V66, P220, DOI 10.1016/j.enconman.2012.10.003; Guo T, 2011, ENERGY, V36, P2639, DOI 10.1016/j.energy.2011.02.005; Hung TC, 2010, ENERGY, V35, P1403, DOI 10.1016/j.energy.2009.11.025; Shirazi AS, 2013, ENERG BUILDINGS, V67, P352, DOI 10.1016/j.enbuild.2013.08.023; Asaad Y., 1955, THESIS U CALIFORNIA; Bu XB, 2012, RENEW ENERG, V41, P80, DOI 10.1016/j.renene.2011.10.009; Chen Z. S., 2008, ADV ENG THERMODYNAMI; Emirov SN, 2007, HIGH TEMP+, V45, P317, DOI 10.1134/S0018151X07030066; Gehringer M., 2012, GEOTHERMAL HDB PLANN; George A., 2013, ENERG POLICY, V62, P118; Ghasemi H, 2013, COMPUT-AIDED CHEM EN, V32, P391; Ghoreishi Madiseh S. A., 2013, NUMERICAL EXPT STUDY; Ghoreishi-Madiseh S. A., 2013, AM SOL EN SOC ASES C, P1; Hellstrom G., 2002, IMPLEMENTING AGREEME, V2; Hellstrom G., 1998, 2 STOCKT INT GEOTH C; IEA, 2012, WORLD EN OUTL 2012; Incropera F.P., 2007, FUNDAMENTALS HEAT MA; Jalilinasrabady S., 2012, GRC 2012 T, V36, P1079; Kujawa T, 2006, ENERGY, V31, P650, DOI 10.1016/j.energy.2005.05.002; Madhawa H.D., 2007, ENERGY, V32, P1698, DOI DOI 10.1016/J.ENERGY.2007.01.005; Moghaddam MK, 2014, GEOTHERMICS, V50, P189, DOI 10.1016/j.geothermics.2013.09.004; Moody L.F., 1944, Transactions of the ASME, V66; Noorollahi Y, 2011, ENERGY, V36, P4552, DOI 10.1016/j.energy.2011.03.046; Paschen H., 2003, 84 TAB; Richard A., 2014, GEOTHERMICS, V51, P470; Richard A., 2013, APPL ENERG, V102, P665; Saffarzadeh A. H., 2005, P WORLD GEOTH C, P1; Seyed Ali G. M., 2013, QUTAR FDN ANN RES FO, V2013; Tester JW, 2006, FUTURE GEOTHERMAL EN; Wu Z. J., 2006, NEW ENERGY RENEWABLE; Yavuzturk C, 2002, ASHRAE T, V108, P925	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0375-6505	1879-3576		GEOTHERMICS	Geothermics	MAY	2015	55						16	23		10.1016/j.geothermics.2015.01.008		8	Energy & Fuels; Geosciences, Multidisciplinary	Energy & Fuels; Geology	CH0YI	WOS:000353747900002		
J	Ohno, S				Ohno, Shuichi			WEIGHTED COMPOSITION OPERATORS ON H-infinity boolean AND B-o	GLASGOW MATHEMATICAL JOURNAL			English	Article							INNER FUNCTIONS; BLOCH SPACE	We will characterize the boundedness and compactness of weighted composition operators on the closed subalgebra H-infinity boolean AND B-o between the disk algebra and the space of bounded analytic functions on the open unit disk.	Nippon Inst Technol, Miyashiro, Minami Saitama 3458501, Japan	Ohno, S (reprint author), Nippon Inst Technol, Miyashiro, Minami Saitama 3458501, Japan.	ohno@nit.ac.jp			Japan Society for the Promotion of Science [24540190]	We are grateful to the referee for several thoughtful comments and helpful suggestions that improved our manuscript. The author is partially supported by Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science (No. 24540190).	Aleksandrov AB, 1999, P LOND MATH SOC, V79, P318, DOI 10.1112/S002461159901196X; Ohno S, 2001, B AUST MATH SOC, V63, P177; MADIGAN K, 1995, T AM MATH SOC, V347, P2679, DOI 10.2307/2154848; Contreras M. D., 1999, CONT MATH, V232, P111; Cowen C., 1995, COMPOSITION OPERATOR; Garnett J., 2007, BOUNDED ANAL FUNCTIO; Izuchi KJ, 2013, GLASGOW MATH J, V55, P229, DOI 10.1017/S0017089512000511; Sarason D., 1999, FUNCTION THEORY UNIT; SHAPIRO J. H., 1993, COMPOSITION OPERATOR; Smith W, 1998, MICH MATH J, V45, P103; Zhu K., 2007, OPERATOR THEORY FUNC	11	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0017-0895	1469-509X		GLASGOW MATH J	Glasg. Math. J.	MAY	2015	57	2					475	480		10.1017/S0017089514000469		6	Mathematics	Mathematics	CH0HN	WOS:000353700500015		
J	Tatara, Y; Kakizaki, I; Suto, S; Ishioka, H; Negishi, M; Endo, M				Tatara, Yota; Kakizaki, Ikuko; Suto, Shinichiro; Ishioka, Haruna; Negishi, Mika; Endo, Masahiko			Chondroitin sulfate cluster of epiphycan from salmon nasal cartilage defines binding specificity to collagens	GLYCOBIOLOGY			English	Article						chondroitin sulfate; collagen; epiphycan; glycosaminoglycan; proteoglycan	CHICK-EMBRYO CARTILAGE; HEPARAN-SULFATE; AFFINITY-CHROMATOGRAPHY; MONOMERIC TROPOCOLLAGEN; EXTRACELLULAR-MATRIX; SUBSTITUTED AGAROSE; FIBRIL FORMATION; IN-VITRO; PROTEOGLYCAN; GLYCOSAMINOGLYCANS	Epiphycan (EPY) from salmon nasal cartilage has a glycosaminoglycan (GAG) domain that is heavily modified by chondroitin 4-sulfate and chondroitin 6-sulfate. The functional role of the GAG domain has not been investigated. The interaction of EPY with collagen was examined in vitro using surface plasmon resonance analysis. EPY was found to bind to type I collagen via clustered chondroitin sulfate (CS), while a single chain of CS was unable to bind. Types I, Ill, VII, VIII and X collagen showed high binding affinity with EPY, whereas types 11, IV, V, VI and IX showed low binding affinities. Chemical modification of lysine residues in collagen decreased the affinity with the clustered CS. These results suggest that lysine residues of collagen are involved in the interaction with the clustered CS, and the difference in lysine modification defines the binding affinity to EPY. The clustered CS was also involved in an inter-saccharide interaction, and formed self-associated EPY. CS of EPY promoted fibril formation of type I collagen.	[Tatara, Yota; Kakizaki, Ikuko; Suto, Shinichiro; Ishioka, Haruna; Negishi, Mika] Hirosaki Univ, Grad Sch Med, Dept Glycotechnol, Ctr Adv Med Res, Hirosaki, Aomori 0368562, Japan; [Tatara, Yota; Kakizaki, Ikuko; Suto, Shinichiro; Ishioka, Haruna; Negishi, Mika; Endo, Masahiko] Hirosaki Univ, Grad Sch Med, Dept Glycobiomed, Hirosaki, Aomori 0368562, Japan	Tatara, Y (reprint author), Hirosaki Univ, Grad Sch Med, Dept Glycotechnol, Ctr Adv Med Res, Hirosaki, Aomori 0368562, Japan.	ytatara@cc.hirosaki-u.ac.jp		Tatara, Yota/0000-0001-8114-3289	Ministry of Education, Culture, Sports, Science and Technology of Japan [23570157]; Hirosaki University Grant for Exploratory Research by Young Scientists; Sunstar Inc. (Takatsuki, Japan)	This work was supported by the Regional Innovation Strategy Support Program (City Area Type) and Grants-in-Aid for Scientific Research (No. 23570157 to I. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Hirosaki University Grant for Exploratory Research by Young Scientists and by Sunstar Inc. (Takatsuki, Japan).	Kvist AJ, 2006, J BIOL CHEM, V281, P33127, DOI 10.1074/jbc.M607892200; HASSELL JR, 1986, ANNU REV BIOCHEM, V55, P539; Raspanti M, 2008, J STRUCT BIOL, V164, P134, DOI 10.1016/j.jsb.2008.07.001; SCOTT JE, 1988, BIOCHEM J, V253, P607; Nguyen TKN, 2013, ACS CHEM BIOL, V8, P939, DOI 10.1021/cb400132r; SANDERSON RD, 1988, P NATL ACAD SCI USA, V85, P9562, DOI 10.1073/pnas.85.24.9562; Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945; VOGEL KG, 1984, BIOCHEM J, V223, P587; Bank RA, 1998, BIOCHEM J, V330, P345; MOORE S, 1948, J BIOL CHEM, V176, P367; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; SCOTT JE, 1988, BIOCHEM J, V252, P313; Noble GT, 2009, ORG BIOMOL CHEM, V7, P5245, DOI 10.1039/b910976e; de Paz JL, 2007, CHEM BIOL, V14, P879, DOI 10.1016/j.chembiol.2007.07.007; Rawat M, 2008, J AM CHEM SOC, V130, P2959, DOI 10.1021/ja709993p; WOOD GC, 1960, BIOCHEM J, V75, P588; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Hocking AM, 1998, MATRIX BIOL, V17, P1; OBRINK B, 1973, EUR J BIOCHEM, V34, P129, DOI 10.1111/j.1432-1033.1973.tb02739.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; HARDINGHAM TE, 1992, FASEB J, V6, P861; SCOTT JE, 1995, J ANAT, V187, P259; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; FISHER LW, 1983, J BIOL CHEM, V258, P6588; FRANSSON LA, 1976, BIOCHIM BIOPHYS ACTA, V437, P106, DOI 10.1016/0304-4165(76)90351-2; FRANSSON LA, 1981, J BIOL CHEM, V256, P3039; Hayashida O, 2003, J AM CHEM SOC, V125, P594, DOI 10.1021/ja0275663; Kakizaki I, 2011, ARCH BIOCHEM BIOPHYS, V506, P58, DOI 10.1016/j.abb.2010.10.025; KODA JE, 1984, J BIOL CHEM, V259, P1763; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; LAST JA, 1984, ENVIRON HEALTH PERSP, V55, P169, DOI 10.2307/3429701; Mammen MS, 1998, ANGEW CHEM INT EDIT, V37, P2754, DOI DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3; MATHEWS MB, 1968, BIOCHEM J, V109, P517; Munakata H, 1999, GLYCOBIOLOGY, V9, P1023, DOI 10.1093/glycob/9.10.1023; Nareyeck G, 2004, EUR J BIOCHEM, V271, P3389, DOI 10.1111/j.1432-1033.2004.04273.x; OBRINK B, 1973, EUR J BIOCHEM, V33, P387, DOI 10.1111/j.1432-1033.1973.tb02695.x; OBRINK B, 1971, BIOCHEM J, V121, P227; OBRINK B, 1973, EUR J BIOCHEM, V37, P226, DOI 10.1111/j.1432-1033.1973.tb02979.x; OEGEMA TR, 1975, ARCH BIOCHEM BIOPHYS, V170, P698, DOI 10.1016/0003-9861(75)90167-8; Rademaker GJ, 1998, ANAL BIOCHEM, V257, P149, DOI 10.1006/abio.1997.2548; Rühland Claus, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Scott J.E., 1992, J OFF PUBL FED AM SO, V6, P2639; SHINOMURA T, 1983, J BIOL CHEM, V258, P9314; SNOWDEN JM, 1980, BIOPOLYMERS, V19, P767, DOI 10.1002/bip.1980.360190405; Takagaki K, 2002, J BIOL CHEM, V277, P8882, DOI 10.1074/jbc.M106479200; Tatara Y, 2013, GLYCOBIOLOGY, V23, P993, DOI 10.1093/glycob/cwt038; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; Theis ER, 1944, J BIOL CHEM, V154, P87; TOOLE BP, 1968, BIOCHEM J, V109, P857; TOOLE BP, 1976, J BIOL CHEM, V251, P895; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200	56	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	MAY	2015	25	5					557	569		10.1093/glycob/cwu186		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH3BU	WOS:000353902000009		
J	Sawada, T; Ohji, M				Sawada, Tomoko; Ohji, Masahito			Reply to the letter to the editor: bimonthly injections of ranibizumab for age-related macular degeneration	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Letter									[Sawada, Tomoko; Ohji, Masahito] Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga 5202192, Japan	Sawada, T (reprint author), Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga 5202192, Japan.	tsawada@belle.shiga-med.ac.jp					Muether PS, 2012, OPHTHALMOLOGY, V119, P2082, DOI 10.1016/j.ophtha.2012.07.041; Sawada T, 2014, GRAEF ARCH CLIN EXP, V252, P1545, DOI 10.1007/s00417-014-2612-8	2	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	MAY	2015	253	5					825	825		10.1007/s00417-014-2878-x		1	Ophthalmology	Ophthalmology	CH1RZ	WOS:000353800400024		
J	Yanwachirakul, W; Fujii, H; Toprasertpong, K; Watanabe, K; Sugiyama, M; Nakano, Y				Yanwachirakul, Warakorn; Fujii, Hiromasa; Toprasertpong, Kasidit; Watanabe, Kentaroh; Sugiyama, Masakazu; Nakano, Yoshiaki			Effect of Barrier Thickness on Carrier Transport Inside Multiple Quantum Well Solar Cells Under High-Concentration Illumination	IEEE JOURNAL OF PHOTOVOLTAICS			English	Article						Charge carrier processes; photovoltaic cells; quantum wells; superlattices; tunneling; III-V semiconductor materials	TEMPERATURE-DEPENDENCE; COLLECTION EFFICIENCY; MOVPE	Carrier transport inside InGaAs/GaAs/GaAsP multiple quantum well (MQW) solar cells was discussed under high-concentrated sunlight illumination up to 338 suns. Current-voltage (I-V) characteristic curves for a GaAs reference cell and MQW cells with GaAsP barrier thickness of 2, 4, and 6 nm were investigated under dark and high-concentration illumination. Carrier collection efficiency (CCE) was estimated by net photocurrent, which is the difference between illuminated current and dark current density at each bias voltage normalized by the value at the saturated point. For the 2-nm barrier, CCE exhibited almost no degradation compared with the GaAs reference cell. On the other hand, CCE for the 6-nm barrier degraded with forward biases as the sunlight concentration ratio increased. The degradation in CCE under a high-concentration ratio is shown to be the result of carrier accumulation in quantum wells. Thin barriers seemed to eliminate such accumulation with the help of the carrier tunneling effect through the barriers.	[Yanwachirakul, Warakorn; Fujii, Hiromasa; Toprasertpong, Kasidit; Sugiyama, Masakazu; Nakano, Yoshiaki] Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Watanabe, Kentaroh] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Yanwachirakul, W (reprint author), Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan.	warakorn@hotaka.t.u-tokyo.ac.jp; fujii@hotaka.t.u-tokyo.ac.jp; toprasertpong@hotaka.t.u-tokyo.ac.jp; kentaroh@hotaka.t.u-tokyo.ac.jp; sugiyama@ee.t.u-tokyo.ac.jp; nakano@rcast.u-tokyo.ac.jp	Sugiyama, Masakazu/P-9616-2015	Sugiyama, Masakazu/0000-0002-4303-4038	Research and Development of Innovative Solar Cell program, New Energy and Industrial Technology Development Organization, Japan	Manuscript received July 11, 2014; revised November 10, 2014 and January 15, 2015; accepted February 7, 2015. Date of publication March 16, 2015; date of current version April 17, 2015. This work was supported by Research and Development of Innovative Solar Cell program, New Energy and Industrial Technology Development Organization, Japan.	Algora C, 2001, IEEE T ELECTRON DEV, V48, P840, DOI 10.1109/16.918225; Perez-Higueras P, 2011, RENEW SUST ENERG REV, V15, P1810, DOI 10.1016/j.rser.2010.11.046; Toprasertpong K, 2014, IEEE J PHOTOVOLT, V4, P607, DOI 10.1109/JPHOTOV.2013.2293877; Singh P, 2012, SOL ENERG MAT SOL C, V101, P36, DOI 10.1016/j.solmat.2012.02.019; King RR, 2012, PROG PHOTOVOLTAICS, V20, P801, DOI 10.1002/pip.1255; Brown AS, 2002, PHYSICA E, V14, P121, DOI 10.1016/S1386-9477(02)00375-2; Fujii H, 2014, IEEE J PHOTOVOLT, V4, P237, DOI 10.1109/JPHOTOV.2013.2287994; Dimroth F, 2014, PROG PHOTOVOLTAICS, V22, P277, DOI 10.1002/pip.2475; Barnham KWJ, 2002, PHYSICA E, V14, P27, DOI 10.1016/S1386-9477(02)00356-9; Barnham K, 1996, J APPL PHYS, V80, P1201, DOI 10.1063/1.362857; Stan M, 2008, J CRYST GROWTH, V310, P5204, DOI 10.1016/j.jcrysgro.2008.07.024; King RR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734507; Ohshita Y, 2011, J CRYST GROWTH, V318, P328, DOI 10.1016/j.jcrysgro.2010.11.082; Wang YP, 2012, J CRYST GROWTH, V352, P194, DOI 10.1016/j.jcrysgro.2011.12.049; Philipps SP, 2010, SOL ENERG MAT SOL C, V94, P869, DOI 10.1016/j.solmat.2010.01.010; Law DC, 2010, SOL ENERG MAT SOL C, V94, P1314, DOI 10.1016/j.solmat.2008.07.014; Asgari A, 2011, SOL ENERG MAT SOL C, V95, P3124, DOI 10.1016/j.solmat.2011.07.001; Ding Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10ND08; Ekins-Daukes NJ, 2002, PHYSICA E, V14, P132, DOI 10.1016/S1386-9477(02)00378-8; Fujii H, 2013, J APPL PHYS, V114, DOI 10.1063/1.4820396; Kinsey GS, 2009, SOL ENERG MAT SOL C, V93, P950, DOI 10.1016/j.solmat.2008.11.053; Queisser HJ, 2009, MATER SCI ENG B-ADV, V159-60, P322, DOI 10.1016/j.mseb.2008.06.033; Raisky OY, 2001, APPL PHYS LETT, V79, P430, DOI 10.1063/1.1386402; Rey-Stolle I, 2007, J CRYST GROWTH, V298, P762, DOI 10.1016/j.jcrysgro.2006.10.093; Sugiyama M., 2013, J PHYS D, V46	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	MAY	2015	5	3					846	853		10.1109/JPHOTOV.2015.2407159		8	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CG8IJ	WOS:000353550500020		
J	Ahsan, N; Miyashita, N; Yu, KM; Walukiewicz, W; Okada, Y				Ahsan, Nazmul; Miyashita, Naoya; Yu, Kin Man; Walukiewicz, Wladek; Okada, Yoshitaka			Electron Barrier Engineering in a Thin-Film Intermediate-Band Solar Cell	IEEE JOURNAL OF PHOTOVOLTAICS			English	Article						Dilute nitride; intermediate-band (IB) solar cell; molecular beam epitaxy (MBE); thin-film solar cell	EFFICIENCY; GAINNAS; GAAS	Improved open-circuit voltages have been achieved in dilute nitride thin-film intermediate-band solar cells by optimizing intermediate-band barrier layers. The blocking properties of the AlGaAs electron barrier are found to critically depend on the barrier-doping level. Open-circuit voltages V-OC improved when electron-doping levels in the AlGaAs barriers were reduced. This is ascribed to the increased association of V-OC with the larger gap defined by the valence and conduction bands due to the improved electrical isolation of the intermediate band.	[Ahsan, Nazmul; Miyashita, Naoya; Okada, Yoshitaka] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan; [Yu, Kin Man; Walukiewicz, Wladek] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	Ahsan, N (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan.	ahsan@mbe.rcast.u-tokyo.ac.jp; miyashita@mbe.rcast.u-tokyo.ac.jp; KMYu@lbl.gov; W_Walukiewicz@lbl.gov; okada@mbe.rcast.u-tokyo.ac.jp	Yu, Kin Man/J-1399-2012	Yu, Kin Man/0000-0003-1350-9642	New Energy and Industrial Technology Development Organization; Ministry of Economy, Trade, and Industry, Japan; U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences, and Engineering Division [DE-AC02-05CH11231]	Manuscript received June 30, 2014; revised January 30, 2015; accepted February 23, 2015. Date of publication April 1, 2015; date of current version April 17, 2015. This work was performed under SOLAR QUEST Program supported by the New Energy and Industrial Technology Development Organization and Ministry of Economy, Trade, and Industry, Japan. A part of this work was performed at the Lawrence Berkeley National Laboratory that was supported by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences, and Engineering Division under Contract DE-AC02-05CH11231.	Ahsan N, 2013, IEEE J PHOTOVOLT, V3, P730, DOI 10.1109/JPHOTOV.2012.2228296; Lopez N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028701; Shan W, 2004, J PHYS-CONDENS MAT, V16, pS3355, DOI 10.1088/0953-8984/16/31/024; Ahsan N, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4709405; Zhang SB, 2001, PHYS REV LETT, V86, P1789, DOI 10.1103/PhysRevLett.86.1789; Kurtz SR, 1999, APPL PHYS LETT, V74, P729, DOI 10.1063/1.123105; Cuadra L, 2004, THIN SOLID FILMS, V451, P593, DOI 10.1016/j.tsf.2003.11.047; Burgelman M, 2000, THIN SOLID FILMS, V361, P527, DOI 10.1016/S0040-6090(99)00825-1; ASPNES DE, 1973, SURF SCI, V37, P418, DOI 10.1016/0039-6028(73)90337-3; King RR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734507; Luque A, 2001, PROG PHOTOVOLTAICS, V9, P73, DOI 10.1002/pip.354; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Walukiewicz W, 2000, PHYS REV LETT, V85, P1552, DOI 10.1103/PhysRevLett.85.1552; Antolin E, 2010, J APPL PHYS, V108, DOI 10.1063/1.3468520; Antolin E., 2010, P 35 IEEE PHOT SPEC; Fujii H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10ND04; Harris JS, 2005, J CRYST GROWTH, V278, P3, DOI 10.1016/j.jcrysgro.2004.12.050; Islam MM, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895940; Islam MM, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793430; King RR, 2011, PROG PHOTOVOLTAICS, V19, P797, DOI 10.1002/pip.1044; Krispin P, 2003, J APPL PHYS, V93, P6095, DOI 10.1063/1.1568523; Kurtz SR, 2002, APPL PHYS LETT, V80, P1379, DOI 10.1063/1.1453480; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Marti A., 2013, P SPIE, V8620; Marti A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247701; Miyashita N., 2015, GENERATION IN PRESS; Miyashita N, 2013, SOL ENERG MAT SOL C, V111, P127, DOI 10.1016/j.solmat.2012.12.036; Ohmae A, 2003, J CRYST GROWTH, V251, P412, DOI [10.1016/S0022-0248(02)02331-X, 10.1016/S0022-02331-X]; Sellers DG, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4881181; Tomic S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.245305; Verschraegen J., 2007, THIN SOLID FILMS, V515, P6276	31	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	MAY	2015	5	3					878	884		10.1109/JPHOTOV.2015.2412451		7	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CG8IJ	WOS:000353550500024		
J	Koida, T; Kamikawa-Shimizu, Y; Yamada, A; Shibata, H; Niki, S				Koida, Takashi; Kamikawa-Shimizu, Yukiko; Yamada, Akimasa; Shibata, Hajime; Niki, Shigeru			Cu(In,Ga)Se-2 Solar Cells With Amorphous Oxide Semiconducting Buffer Layers	IEEE JOURNAL OF PHOTOVOLTAICS			English	Article						Amorphous semiconductors; chalcopyrite compound; heterojunctions; oxide semiconductor; photovoltaic cells	THIN-FILM; ELECTRONIC-STRUCTURE; PERFORMANCE; DEPOSITION; TRANSPORT; DEFECTS; VOLTAGE; MODULES	A transparent amorphous oxide semiconductor (TAOS) layer for the suppression of interface recombination and enhancement of open-circuit voltage (V-oc) in Cu(In,Ga)Se-2 (CIGS) solar cells is demonstrated. A 60-nm-thick n-type a-In2-2xGa2xO3 (x = 0.6, 0.7, 0.8, 0.9, 1) or a-Ga2-2y Al2yO3 (y = 0.1, 0.2) layer was introduced between the CIGS film and the ZnO transparent front contact. The solar cell performance systematically varied as a function of x and y, and CIGS solar cells with a-In2-2xGa2xO3 (x = 0.9, 1) buffer layers showed V-oc values comparable with those of a reference cell with standard i-ZnO/CdS buffer layers. Current density-voltage (J-V) curve behavior can be explained by conduction band discontinuity at the TAOS/CIGS interface and the carrier density of the TAOS layer.	[Koida, Takashi; Kamikawa-Shimizu, Yukiko; Yamada, Akimasa; Shibata, Hajime; Niki, Shigeru] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058568, Japan	Koida, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058568, Japan.	t-koida@aist.go.jp; yukiko-kamikawa@aist.go.jp; a.yamada@aist.go.jp; h.shibata@aist.go.jp; shigeru-niki@aist.go.jp			New Energy and Industrial Technology Development Organization under the Ministry of Economy, Trade, and Industry, Japan	Manuscript received December 18, 2014; revised January 13, 2015; accepted January 14, 2015. Date of publication February 16, 2015; date of current version April 17, 2015. This work was supported in part by the New Energy and Industrial Technology Development Organization under the Ministry of Economy, Trade, and Industry, Japan.	Schmid D, 1996, SOL ENERG MAT SOL C, V41-2, P281, DOI 10.1016/0927-0248(95)00107-7; Kamiya T, 2009, J DISP TECHNOL, V5, P273, DOI 10.1109/JDT.2009.2021582; Zunger A, 2003, APPL PHYS LETT, V83, P57, DOI 10.1063/1.1584074; Furue S, 2013, SOL ENERG MAT SOL C, V119, P163, DOI 10.1016/j.solmat.2013.05.058; Minami T, 2014, SOL ENERGY, V105, P206, DOI 10.1016/j.solener.2014.03.036; Hultqvist A, 2011, PROG PHOTOVOLTAICS, V19, P478, DOI 10.1002/pip.1039; Hosono H, 1996, J NON-CRYST SOLIDS, V203, P334, DOI 10.1016/0022-3093(96)00367-5; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P701, DOI 10.1002/pip.2525; Minemoto T, 2001, SOL ENERG MAT SOL C, V67, P83, DOI 10.1016/S0927-0248(00)00266-X; Lee YS, 2014, ADV MATER, V26, P4704, DOI 10.1002/adma.201401054; Takagi A, 2005, THIN SOLID FILMS, V486, P38, DOI 10.1016/j.tsf.2004.11.223; Lindahl J, 2013, PROG PHOTOVOLTAICS, V21, P1588, DOI 10.1002/pip.2239; Hariskos D, 2005, THIN SOLID FILMS, V480, P99, DOI 10.1016/j.tsf.2004.11.118; Eisgruber IL, 1998, SOL ENERG MAT SOL C, V53, P367, DOI 10.1016/S0927-0248(98)00035-X; Orita M, 2002, THIN SOLID FILMS, V411, P134, DOI 10.1016/S0040-6090(02)00202-X; Burgelman M, 1997, PROG PHOTOVOLTAICS, V5, P121, DOI 10.1002/(SICI)1099-159X(199703/04)5:2<121::AID-PIP159>3.0.CO;2-4; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; Klenk R, 2001, THIN SOLID FILMS, V387, P135, DOI 10.1016/S0040-6090(00)01736-3; Murat A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155101; Dona JM, 1997, J ELECTROCHEM SOC, V144, P4081; Herberholz R, 1997, SOL ENERG MAT SOL C, V49, P227, DOI 10.1016/S0927-0248(97)00199-2; Koida T., 2010, J APPL PHYS, V107; Koida T., 2014, 6 WORLD C PHOT EN CO; Koida T., 2014, JPN J APPL PHYS, V53; Koida T., 2007, J APPL PHYS, V101; Lee K., 2012, J APPL PHYS, V112; Lee K, 2011, ELECTROCHEM SOLID ST, V14, pH346, DOI 10.1149/1.3595741; Minemoto T, 2009, PHYS STATUS SOLIDI C, V6, P1225, DOI 10.1002/pssc.200881143; Naghavi N, 2010, PROG PHOTOVOLTAICS, V18, P411, DOI 10.1002/pip.955; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Nomura K., 2008, APPL PHYS LETT, V92; Nomura K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035212; Orita M, 2001, PHILOS MAG B, V81, P501, DOI 10.1080/13642810110045923; Pudov A. O., 2005, J APPL PHYS, V97; Siebentritt S, 2004, SOL ENERGY, V77, P767, DOI 10.1016/j.solener.2004.06.018	35	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	MAY	2015	5	3					956	961		10.1109/JPHOTOV.2015.2396356		6	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CG8IJ	WOS:000353550500035		
J	Adachi, K; Takei, A; Suzuki, T; Tanaka, S; Nakanishi, A; Naoe, K				Adachi, Koichiro; Takei, Aki; Suzuki, Takanori; Tanaka, Shigehisa; Nakanishi, Akira; Naoe, Kazuhiko			Large-Tolerant Direct Coupling to an SMF Array With a Lens-Integrated Surface-Emitting Laser	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Surface-emitting laser; optical interconnects; integrated optics		As a solution to provide a small-size and low-cost 100-Gb/s optical module, direct optical coupling between a lens-integrated surface-emitting DFB laser (LISEL) array and a single-mode fiber (SMF) array is demonstrated. A very-small far-field angle (similar to 2 degrees) was obtained by monolithic integration of an InP lens with a laser chip. As a result, each channel of the LISEL array can directly couple to an SMF without any additional external optical components. The measured misalignment tolerance between the LISEL array and an SMF array was sufficiently large, namely, +/- 5.5 mu m, at excess loss of 1 dB over all four channels with the maximum coupling efficiency of 8.4 dB. These measurement results are in good agreement with a theoretical calculation based on Gaussian optics. These results demonstrate that high coupling efficiency (-3 dB) can be achieved while large misalignment tolerance (+/- 4.5 mu m) at excess loss of only 1 dB is maintained.	[Adachi, Koichiro; Takei, Aki; Suzuki, Takanori; Tanaka, Shigehisa] Hitachi Ltd, Cent Res Lab, Tokyo 1850033, Japan; [Nakanishi, Akira; Naoe, Kazuhiko] Oclaro Japan Inc, Oyama 2520205, Japan	Adachi, K (reprint author), Hitachi Ltd, Cent Res Lab, Tokyo 1850033, Japan.	koichiro.adachi.rq@hitachi.com; aki.takei.gk@hitachi.com; takanori.suzuki.ym@hitachi.com; shigehisa.tanaka.pn@hitachi.com; akira.nakanishi@oclaro.com; kazuhiko.naoe@oclaro.com					Adachi K., 2009, P OPT FIBER C, P1; ADACHI K, 2010, P 22 IEEE INT SEM LA, P63; Adachi K, 2011, J LIGHTWAVE TECHNOL, V29, P2899, DOI 10.1109/JLT.2011.2163814; Fujisawa T, 2013, IEEE J QUANTUM ELECT, V49, P1001, DOI 10.1109/JQE.2013.2284242; Saeki T., 2013, P IPC SEP, P307; Shimizu T., 2011, P 8 IEEE INT C GROUP, P181; Shinoda K, 2009, CONF P INDIUM PHOSPH, P343, DOI 10.1109/ICIPRM.2009.5012434; SIMOYAMA T, 2012, P 23 IEEE INT SEM LA, P54; Yamatoya T., 2013, P 18 OPTOELECTRON CO, P1	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	MAY 1	2015	27	9					939	942		10.1109/LPT.2015.2399922		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CG9JZ	WOS:000353632600004		
J	Kishine, K; Inaba, H; Inoue, H; Nakamura, M; Tsuchiya, A; Katsurai, H; Onodera, H				Kishine, Keiji; Inaba, Hiromi; Inoue, Hiroshi; Nakamura, Makoto; Tsuchiya, Akira; Katsurai, Hiroaki; Onodera, Hidetoshi			A Multi-Rate Burst-Mode CDR Using a GVCO With Symmetric Loops for Instantaneous Phase Locking in 65-nm CMOS	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						Burst-mode; clock and data recovery (CDR); communication IC; GVCO; high speed; instantaneous phase locking; multi-rate; symmetric loop; 65 nm CMOS	DATA RECOVERY CIRCUIT; RING OSCILLATORS; JITTER; CLOCK; TRANSCEIVER	A multi-rate burst-mode clock and data recovery ( BCDR) circuit based on a simple gated voltage-controlled oscillator (GVCO) is presented. A simple symmetric circuit topology makes the area for the GVCO smaller and leads to an easier timing design. The GVCO consists of two loops that operate complementarily. Circuit configurations of the same type are adopted for AND and OR in the loops to reduce the difficulties in the timing alignment of the signals from the loops. To confirm the validity of the proposed topology, we fabricated a BCDR IC with the 65-nm-MOSFET process. It can extract the 12.5-GHz clock signal from 12.5-Gb/s, 6.25-Gb/s, 3.125-Gb/s, 1.5625-Gb/s, and 781.25-Mb/s input data. Without a circuit for precise timing adjustment for the signals in the two loops, the IC provides instantaneous phase locking of 1 bit for burst data input of 12.5 Gb/s. The measured jitter is lower than 2 ps rms. The area and the power consumption for the core GVCO are 0.03 mm(2) and 60 mW.	[Kishine, Keiji; Inaba, Hiromi; Inoue, Hiroshi] Univ Shiga Prefecture, Shiga 2500, Japan; [Nakamura, Makoto] Gifu Univ, Gifu 5011193, Japan; [Tsuchiya, Akira; Onodera, Hidetoshi] Kyoto Univ, Kyoto 6068501, Japan; [Katsurai, Hiroaki] NTT Labs, Tokyo 1808585, Japan	Kishine, K (reprint author), Univ Shiga Prefecture, 2500 Hassaka, Shiga 2500, Japan.	kishine.k@e.usp.ac.jp			Japan Society for the Promotion of Science; VLSI Design and Education Center (VDEC); University of Tokyo; CADENCE Corporation; SYNOPSYS Corporation	A part of this research was supported by Grants-in-Aid for Scientific Research, The Japan Society for the Promotion of Science. This work is supported by VLSI Design and Education Center (VDEC), the University of Tokyo with collaborations with CADENCE and SYNOPSYS Corporations. This paper was recommended by Associate Editor G. Setti.	Ahmed S. I., 2004, P IEEE ISCAS, V4, P365; McNeill JA, 1997, IEEE J SOLID-ST CIRC, V32, P870, DOI 10.1109/4.585289; Kromer C, 2005, IEEE J SOLID-ST CIRC, V40, P2667, DOI 10.1109/JSSC.2005.856575; [Anonymous], 8023AE IEEE; Lee J, 2008, IEEE J SOLID-ST CIRC, V43, P619, DOI 10.1109/JSSC.2007.916598; Hajimiri A, 1999, IEEE J SOLID-ST CIRC, V34, P790, DOI 10.1109/4.766813; BARRASS H, 2007, P IEEE LEOS ANN M OC, P362; Cavendish D, 2004, IEEE COMMUN MAG, V42, P72, DOI 10.1109/MCOM.2004.1273776; Cho L.-C., 2007, IEEE INT SOL STAT CI, P48; Han PS, 2007, IEEE T CIRCUITS-II, V54, P38, DOI 10.1109/TCSII.2006.884120; Lee BJ, 2003, ISSCC DIG TECH PAP I, V46, P76; Liang C. F., 2008, IEEE ISSCC, P224, DOI DOI 10.1109/ISSCC.2008.4523138; Liang C.-F., 2007, IEEE ASSCC NOV, P457; Maruyama T., 2008, P SPIE, V6921; Nogawa M., 2005, IEEE INT SOL STAT CI, P228, DOI 10.1109/ISSCC.2005.1493952; Ohta Y., 1994, LIGHTWAVE TECHNOL, V12, P325; Pius N., 1996, IEEE J SOLID-ST CIRC, V31, P841; Rogers J. E., 2002, IEEE INT SOL STAT CI, P254; Schow CL, 2009, IEEE J SOLID-ST CIRC, V44, P301, DOI 10.1109/JSSC.2008.2007439; Suzuki N., 2011, P ECOC, P1; Woo J.-K., 2006, ASSCC NOV, P411; YOU KD, 2009, P IEEE ISCAS, P1899; Zhang RY, 2006, IEEE J SOLID-ST CIRC, V41, P1016, DOI 10.1109/JSSC.2006.872705	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	MAY	2015	62	5					1288	1295		10.1109/TCSI.2015.2416812		8	Engineering, Electrical & Electronic	Engineering	CH2XC	WOS:000353887300009		
J	Sato, K; Itoh, T; Kato, T; Kitamura, Y; Kaul, SC; Wadhwa, R; Sato, F; Ohneda, O				Sato, Kazutoshi; Itoh, Takehiro; Kato, Toshiki; Kitamura, Yukiko; Kaul, Sunil C.; Wadhwa, Renu; Sato, Fujio; Ohneda, Osamu			Serum-free isolation and culture system to enhance the proliferation and bone regeneration of adipose tissue-derived mesenchymal stem cells	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL			English	Article						Serum-free; Proliferation; Bone regeneration; Mesenchymal stem cells; Cell therapy	FETAL CALF SERUM; PLATELET-RICH PLASMA; STROMAL CELLS; IN-VITRO; FRACTURE REPAIR; CORD BLOOD; MARROW; THERAPY; DIFFERENTIATION; EXPRESSION	Cell therapy using human mesenchymal stem cells (MSCs) is an attractive approach for many refractory diseases. Adipose tissue-derived mesenchymal stem cells (AT-MSCs) are considered as a favorable tool due to its abundance in the body, easy proliferation, and high cytokine production potency. In order to avoid the risks associated with the use of fetal bovine serum (FBS) in culture that includes batch variations and contamination with pathogens, development of serum-free culture system has been initiated. We have formulated a completely serum-free culture medium (SFM) that could be used not only for the expansion of AT-MSCs but also for initial isolation. We demonstrate that the AT-MSCs isolated and cultured in serum-free medium (AT-MSCs/SFM) possess high proliferation capacity and differentiation potency to osteoblast, adipocyte, and chondrocyte lineages in vitro. In in vivo bone fraction model analysis, AT-MSCs/SFM showed higher bone repair potency and quality of the regenerated bone than the cells cultured in serum-containing medium (AT-MSCs/SCM). This was attributed to the (i) presence of translated cells in the bone, as evidenced by in vivo imaging of the illuminated translated cells and (ii) high level of expression and induction capacity of AT-MSCs/SFM for cytokine BMP2, CCL2, and CCL5. Taken together, we report a new serum-free culture system for AT-MSCs that is suitable for cell therapy.	[Sato, Kazutoshi; Kato, Toshiki; Ohneda, Osamu] Univ Tsukuba, Dept Regenerat Med & Stem Cell Biol, Tsukuba, Ibaraki 3058575, Japan; [Sato, Fujio] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Cardiovasc Surg, Tsukuba, Ibaraki 3058575, Japan; [Sato, Kazutoshi; Itoh, Takehiro; Kitamura, Yukiko] Cell Sci & Technol Inst Inc, Aoba Ku, Sendai, Miyagi 9820262, Japan; [Kaul, Sunil C.; Wadhwa, Renu] AIST, Tsukuba, Ibaraki 3058562, Japan; [Ohneda, Osamu] Univ Tsukuba, Grad Sch Comprehens Human Sci, Lab Regenerat Med & Stem Cell Biol, Tsukuba, Ibaraki 3058575, Japan	Sato, K (reprint author), Univ Tsukuba, Dept Regenerat Med & Stem Cell Biol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	sato-k@cstimedia.com; oohneda@md.tsukuba.ac.jp					Amable PR, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt442; Goedecke A, 2011, J TISSUE ENG REGEN M, V5, P648, DOI 10.1002/term.359; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.y,the.2004.02.012; Taguchi K, 2005, BIOCHEM BIOPH RES CO, V331, P31, DOI 10.1016/j.bbrc.2006.03.119; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081; Peng LY, 2008, STEM CELLS DEV, V17, P761, DOI 10.1089/scd.2007.0217; Fan YX, 2013, GENET MOL RES, V12, P6067, DOI 10.4238/2013.December.2.5; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Li HW, 2007, BIOCHEM BIOPH RES CO, V356, P836, DOI 10.1016/j.bbrc.2007.02.165; Tran TC, 2011, J CELL PHYSIOL, V226, P224, DOI 10.1002/jcp.22329; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Chase LG, 2012, STEM CELL TRANSL MED, V1, P750, DOI 10.5966/sctm.2012-0072; Dimarakis I, 2006, STEM CELLS, V24, P1407, DOI 10.1634/stemcells.2005-0577; Ohyabu Y, 2009, HUM GENE THER, V20, P217, DOI 10.1089/hum.2008.100; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eom YW, 2014, BIOCHEM BIOPH RES CO, V445, P16, DOI 10.1016/j.bbrc.2014.01.084; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Pak J, 2012, PAIN PHYSICIAN, V15, P75; Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Suffee N, 2011, BIOCHEM SOC T, V39, P1649, DOI 10.1042/BST20110651; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Aplin AC, 2010, ANGIOGENESIS, V13, P219, DOI 10.1007/s10456-010-9179-8; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Chen WJ, 2004, J BONE MINER METAB, V22, P303, DOI 10.1007/s00774-004-0487-6; FRIEDENS.AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Galindo L. T., 2011, NEUROL RES INT, V2011, DOI DOI 10.1155/2011/564089; Gimble JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt19; Gottipamula S, 2013, J TISSUE ENG REGEN M, DOI [10.1002/term.1713, DOI 10.1002/TERM.1713]; Hosoya A, 2005, HISTOCHEM CELL BIOL, V123, P639, DOI 10.1007/s00418-005-0791-4; Kimura K, 2014, STEM CELLS DEV, V23, P488, DOI 10.1089/scd.2013.0307; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Linero I, 2014, PLOS ONE, V8, P9; Liu L, 2013, STEM CELLS DEV, V22, P1670, DOI 10.1089/scd.2012.0548; Pak J, 2012, J MED CASE REP, V5, P296; Parker A, 2007, CYTOTHERAPY, V7, P637; Patrikoski M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt175; Pietila M, 2013, EXP CELL RES, V319, P2770, DOI 10.1016/j.yexcr.2013.07.023; Ra JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-181; Rajala K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010246; Shetty Prathibha, 2010, Asian J Transfus Sci, V4, P14, DOI 10.4103/0973-6247.59386; Yoshioka T, 2011, J TISSUE ENG REGEN M, V5, P437, DOI 10.1002/term.329	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-2690	1543-706X		IN VITRO CELL DEV-AN	In Vitro Cell. Dev. Biol.-Anim.	MAY	2015	51	5					515	529		10.1007/s11626-014-9860-0		15	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CH2GF	WOS:000353843000011		
J	Goubard, A; Loiez, C; Abe, J; Fichel, C; Herwegh, S; Faveeuw, C; Porte, R; Cayet, D; Sebbane, F; Penet, S; Foligne, B; Desreumaux, P; Saito, H; Sirard, JC; Simonet, M; Carnoy, C				Goubard, Agathe; Loiez, Caroline; Abe, Jun; Fichel, Caroline; Herwegh, Stephanie; Faveeuw, Christelle; Porte, Remi; Cayet, Delphine; Sebbane, Florent; Penet, Sylvie; Foligne, Benoit; Desreumaux, Pierre; Saito, Hirohisa; Sirard, Jean-Claude; Simonet, Michel; Carnoy, Christophe			Superantigenic Yersinia pseudotuberculosis Induces the Expression of Granzymes and Perforin by CD4(+) T Cells	INFECTION AND IMMUNITY			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; BACTERIAL SUPERANTIGEN; IN-VIVO; GAMMA-INTERFERON; KAWASAKI-DISEASE; GENE-EXPRESSION; MITOGEN YPM; TNF-ALPHA; NKT CELLS; INFECTION	Bacterial superantigens (SAgs) are immunostimulatory toxins that induce acute diseases mainly through the massive release of inflammatory cytokines. Yersinia pseudotuberculosis is the only Gram-negative bacterium known to produce a SAg (Y. pseudotuberculosis-derived mitogen [YPM]). This SAg binds major histocompatibility complex class II molecules on antigen-presenting cells and T cell receptors (TcR) bearing the variable region V beta 3, V beta 9, V beta 13.1, or V beta 13.2 (in humans) and V beta 7 or V beta 8 (in mice). We have previously shown that YPM exacerbates the virulence of Y. pseudotuberculosis in mice. With a view to understanding the mechanism of YPM's toxicity, we compared the immune response in BALB/c mice infected with a YPM-producing Y. pseudotuberculosis or the corresponding isogenic, SAg-deficient mutant. Five days after infection, we observed strong CD4(+) V beta 7(+) T cell expansion and marked interleukin-4 (IL-4) production in mice inoculated with SAg-producing Y. pseudotuberculosis. These phenomena were correlated with the activation of ypm gene transcription in liver and spleen. A transcriptomic analysis revealed that the presence of YPM also increased expression of granzyme and perforin genes in the host's liver and spleen. This expression was attributed to a CD4(+) T cell subset, rather than to natural killer T (NKT) cells that display a TcR with a V beta region that is potentially recognized by YPM. Increased production of cytotoxic molecules was correlated with hepatotoxicity, as demonstrated by an increase in plasma alanine aminotransferase activity. Our results demonstrate that YPM activates a potentially hepatotoxic CD4(+) T cell population.	[Goubard, Agathe; Fichel, Caroline; Faveeuw, Christelle; Porte, Remi; Cayet, Delphine; Sebbane, Florent; Foligne, Benoit; Sirard, Jean-Claude; Simonet, Michel; Carnoy, Christophe] Univ Lille Nord de France, INSERM U1019, CNRS UMR 8204, Lille, France; [Goubard, Agathe; Fichel, Caroline; Faveeuw, Christelle; Porte, Remi; Cayet, Delphine; Sebbane, Florent; Foligne, Benoit; Sirard, Jean-Claude; Simonet, Michel; Carnoy, Christophe] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Loiez, Caroline; Herwegh, Stephanie; Simonet, Michel] CHRU Lille, Inst Microbiol, Ctr Biol Pathol, Lab Bacteriol Hyg, F-59037 Lille, France; [Abe, Jun; Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Penet, Sylvie] CHRU Lille, Ctr Biol Pathol, Biochim Lab, F-59037 Lille, France; [Desreumaux, Pierre] INSERM, U995, F-59045 Lille, France	Carnoy, C (reprint author), Univ Lille Nord de France, INSERM U1019, CNRS UMR 8204, Lille, France.	christophe.carnoy@univ-lille2.fr	SIRARD, Jean-Claude/B-5932-2011	SIRARD, Jean-Claude/0000-0001-9854-4652	Fondation pour la Recherche Medicale (FRM); Region Nord-Pas de Calais, France	Agathe Goubard was funded by a grant from the Fondation pour la Recherche Medicale (FRM). This work was also funded by the Region Nord-Pas de Calais, France.	Macias ES, 2011, J AM ACAD DERMATOL, V64, P455, DOI 10.1016/j.jaad.2010.03.044; Jellison ER, 2005, J IMMUNOL, V174, P614; Abe J, 1997, J CLIN INVEST, V99, P1823, DOI 10.1172/JCI119349; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; AUTENRIETH IB, 1994, INFECT IMMUN, V62, P2590; Swain MG, 2008, CLIN SCI, V114, P457, DOI 10.1042/CS20070328; Nakajima T, 2001, BLOOD, V98, P1127, DOI 10.1182/blood.V98.4.1127; Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; HEDLUND G, 1993, CANCER IMMUNOL IMMUN, V36, P89, DOI 10.1007/BF01754407; Rieder SA, 2011, INFECT IMMUN, V79, P3141, DOI 10.1128/IAI.00177-11; Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127; Lauw FN, 2000, J INFECT DIS, V182, P206, DOI 10.1086/315642; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Zaunders JJ, 2004, BLOOD, V103, P2238, DOI 10.1182/blood-2003-08-2765; Fukushima H, 2001, J CLIN MICROBIOL, V39, P3541, DOI 10.1128/JCM.39.10.3541-3547.2001; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Carnoy C, 2000, INFECT IMMUN, V68, P2553, DOI 10.1128/IAI.68.5.2553-2559.2000; HERRMANN T, 1992, EUR J IMMUNOL, V22, P1935, DOI 10.1002/eji.1830220739; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; ABE J, 1993, J IMMUNOL, V151, P4183; Llewelyn M, 2002, LANCET INFECT DIS, V2, P156, DOI 10.1016/S1473-3099(02)00222-0; SATO K, 1983, PEDIATR INFECT DIS J, V2, P123, DOI 10.1097/00006454-198303000-00011; Aslan N, 2006, J VIRAL HEPATITIS, V13, P505, DOI 10.1111/j.1365-2893.2006.00723.x; BABA K, 1991, CONTRIB TO MICROBIOL, V12, P292; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Xu SX, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00052; Zhang Y, 2010, INFECT IMMUN, V78, P2329, DOI 10.1128/IAI.00094-10; Pastacaldi C, 2011, ALLERGY, V66, P549, DOI 10.1111/j.1398-9995.2010.02502.x; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Konishi N, 1997, ACTA PAEDIATR, V86, P661, DOI 10.1111/j.1651-2227.1997.tb08952.x; UCHIYAMA T, 1993, J IMMUNOL, V151, P4407; Desreumaux P, 1999, GASTROENTEROLOGY, V117, P73, DOI 10.1016/S0016-5085(99)70552-4; Auerbuch V, 2007, INFECT IMMUN, V75, P3561, DOI 10.1128/IAI.01497-06; Boland A, 1998, INFECT IMMUN, V66, P1878; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; Carnoy C, 2002, J BACTERIOL, V184, P4489, DOI 10.1128/JB.184.16.4489-4499.2002; Chen LQ, 2002, J IMMUNOL, V168, P3817; Donadini R, 2004, STRUCTURE, V12, P145, DOI 10.1016/j.str.2003.12.002; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56; GARCIASANZ JA, 1990, J IMMUNOL, V145, P3111; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; ITO Y, 1995, J IMMUNOL, V154, P5896; Kaito H, 2012, PEDIATR INT, V54, P926, DOI 10.1111/j.1442-200X.2012.03615.x; Kano H, 2004, CLIN IMMUNOL, V110, P159, DOI 10.1016/j.clim.2003.10.009; Kansal RG, 2005, J INFECT DIS, V191, P2121, DOI 10.1086/430386; Marshall NB, 2011, J BIOMED BIOTECHNOL, V2011, DOI [10.1155/2011/954602, DOI 10.1155/2011/954602]; MiyoshiAkiyama T, 1997, MICROBIOL IMMUNOL, V41, P345; MIYOSHIAKIYAMA T, 1995, J IMMUNOL, V154, P5228; Muller-Alouf H, 2001, TOXICON, V39, P1691, DOI 10.1016/S0041-0101(01)00156-8; Ragin MJ, 2006, INFECT IMMUN, V74, P282, DOI 10.1128/IAI.74.1.282-288.2006; Shinbori T, 2004, EUR J IMMUNOL, V34, P1762, DOI 10.1002/eji.200425097; Sirard JC, 1997, J IMMUNOL, V159, P4435; Uchiyama T, 1999, JPN J INFECT DIS, V52, P141; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Yagi J, 1999, J IMMUNOL, V163, P3083	58	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	MAY	2015	83	5					2053	2064		10.1128/IAI.02339-14		12	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CG0TJ	WOS:000352982600029		
J	Inoue, S; Igarashi, Y; Yoneda, Y; Kawai, S; Okamura, H; Nishida, T				Inoue, Satoshi; Igarashi, Yuta; Yoneda, Yuko; Kawai, Shingo; Okamura, Hideo; Nishida, Tomoaki			Elimination and detoxification of fungicide miconazole and antidepressant sertraline by manganese peroxidase-dependent lipid peroxidation system	INTERNATIONAL BIODETERIORATION & BIODEGRADATION			English	Article						Miconazole; Sertraline; Elimination; Manganese peroxidase; Unsaturated fatty acids; Lipid peroxidation	SEROTONIN REUPTAKE INHIBITORS; WHITE-ROT FUNGI; ENDOCRINE-DISRUPTING CHEMICALS; TANDEM MASS-SPECTROMETRY; MUNICIPAL WASTE-WATER; LIGNINOLYTIC ENZYMES; IN-VITRO; PHANEROCHAETE-CHRYSOSPORIUM; IMIDAZOLE ANTIMYCOTICS; LIQUID-CHROMATOGRAPHY	The imidazole fungicide miconazole (MCZ) and the antidepressant sertraline (SER) have the potential to adversely affect aquatic organisms when they are released into the environment. To assess if they could be broken down, MCZ and SER were treated with laccase and manganese peroxidase (MnP) from lignin-degrading white-rot fungi. The MnP-dependent lipid peroxidation system with Tween 80 containing unsaturated fatty acid was effective in eliminating MCZ and SER; the MnP-Tween 80 system helped eliminate 88% of MCZ and 85% of SER after 24 h of treatment. Furthermore, this system eliminated a metabolite of SER (desmethylsertraline or DSER), and no differences between the elimination rates of DSER and SER were observed throughout the treatment period. It was also confirmed that the MnP-Tween 80 system caused a complete loss of growth inhibition by MCZ of the gram-positive bacterium Bacillus subtilis and reduced the growth inhibition by SER of the green alga Pseudokirchneriella sub-capitate by 78% after 24 h of treatment. On the other hand, no appreciable elimination of MCZ and SER was obtained by treatment with laccase, MnP, or the laccase-mediator system with 1-hydroxybenzotriazole. (C) 2015 Elsevier Ltd. All rights reserved.	[Inoue, Satoshi; Igarashi, Yuta; Yoneda, Yuko; Kawai, Shingo; Nishida, Tomoaki] Shizuoka Univ, Grad Sch Agr, Suruga Ku, Shizuoka 4228529, Japan; [Okamura, Hideo] Kobe Univ, Grad Sch Maritime Sci, Higashinada Ku, Kobe, Hyogo 6580022, Japan	Nishida, T (reprint author), Shizuoka Univ, Grad Sch Agr, Suruga Ku, Ohya 836, Shizuoka 4228529, Japan.	nishida.tomoaki@shizuoka.ac.jp					Aguiar A, 2010, INT BIODETER BIODEGR, V64, P588, DOI 10.1016/j.ibiod.2010.06.011; Inoue Y, 2010, J HAZARD MATER, V180, P764, DOI 10.1016/j.jhazmat.2010.04.024; Roberts PH, 2006, J CHROMATOGR A, V1134, P143, DOI 10.1016/j.chroma.2006.08.093; Brooks BW, 2005, ENVIRON TOXICOL CHEM, V24, P464, DOI 10.1897/04-081R.1; Marco-Urrea E, 2010, BIORESOURCE TECHNOL, V101, P2159, DOI 10.1016/j.biortech.2009.11.019; Murugesan K, 2010, WATER RES, V44, P298, DOI 10.1016/j.watres.2009.09.058; Backhaus T, 2014, WATER RES, V49, P157, DOI 10.1016/j.watres.2013.11.005; Lindberg RH, 2010, WATER RES, V44, P649, DOI 10.1016/j.watres.2009.10.034; Lajeunesse A, 2008, ANAL CHEM, V80, P5325, DOI 10.1021/ac800162q; Zhang YJ, 2010, J HAZARD MATER, V176, P1089, DOI 10.1016/j.jhazmat.2009.10.133; Touahar IE, 2014, SCI TOTAL ENVIRON, V481, P90, DOI 10.1016/j.scitotenv.2014.01.132; Mester T, 2000, INT BIODETER BIODEGR, V46, P51, DOI 10.1016/S0964-8305(00)00071-8; Zarn JA, 2003, ENVIRON HEALTH PERSP, V111, P255, DOI 10.1289/ehp.5785; Georgopapadakou NH, 1998, CURR OPIN MICROBIOL, V1, P547, DOI 10.1016/S1369-5274(98)80087-8; Eibes G, 2011, BIODEGRADATION, V22, P539, DOI 10.1007/s10532-010-9426-0; Fujisawa M, 2001, J POLYM ENVIRON, V9, P103, DOI 10.1023/A:1020472426516; Wen XH, 2010, J HAZARD MATER, V177, P924, DOI 10.1016/j.jhazmat.2010.01.005; Metcalfe CD, 2010, ENVIRON TOXICOL CHEM, V29, P79, DOI 10.1002/etc.27; Tamagawa Y, 2005, FEMS MICROBIOL LETT, V244, P93, DOI 10.1016/j.femsle.2005.01.023; Huang QX, 2010, J CHROMATOGR A, V1217, P3481, DOI 10.1016/j.chroma.2010.03.022; Vasskog T, 2006, J CHROMATOGR A, V1115, P187, DOI 10.1016/j.chroma.2006.02.091; Tsutsumi Y, 2001, CHEMOSPHERE, V42, P271, DOI 10.1016/S0045-6535(00)00081-3; Queiroz FB, 2012, WATER SCI TECHNOL, V66, P2562, DOI 10.2166/wst.2012.482; Minagh E, 2009, ECOTOX ENVIRON SAFE, V72, P434, DOI 10.1016/j.ecoenv.2008.05.002; Lajeunesse A, 2012, WATER RES, V46, P5600, DOI 10.1016/j.watres.2012.07.042; Tamagawa Y, 2007, ENVIRON TOXICOL, V22, P281, DOI 10.1002/tox.20258; McKinlay R, 2008, SCI TOTAL ENVIRON, V398, P1, DOI 10.1016/j.scitotenv.2008.02.056; Vasskog T, 2008, J CHROMATOGR A, V1185, P194, DOI 10.1016/j.chroma.2008.01.063; Cabana H, 2007, CHEMOSPHERE, V67, P770, DOI 10.1016/j.chemosphere.2006.10.037; Fabbrini M, 2002, J MOL CATAL B-ENZYM, V18, P169, DOI 10.1016/S1381-1177(02)00082-6; Weng SS, 2012, BIORESOURCE TECHNOL, V113, P259, DOI 10.1016/j.biortech.2011.12.111; Suzuki K, 2003, WATER RES, V37, P1972, DOI 10.1016/S0043-1354(02)00533-X; BAO WL, 1994, FEBS LETT, V354, P297, DOI 10.1016/0014-5793(94)01146-X; Richards SM, 2006, ECOTOXICOLOGY, V15, P647, DOI 10.1007/s10646-006-0102-4; Bogan BW, 1996, APPL ENVIRON MICROB, V62, P1788; JosephHorne T, 1997, FEMS MICROBIOL LETT, V149, P141, DOI 10.1016/S0378-1097(97)00043-8; Schultz MM, 2010, ENVIRON SCI TECHNOL, V44, P1918, DOI 10.1021/es9022706; Peng XZ, 2012, SCI TOTAL ENVIRON, V426, P311, DOI 10.1016/j.scitotenv.2012.03.067; McClellan K, 2010, WATER RES, V44, P658, DOI 10.1016/j.watres.2009.12.032; Henry TB, 2004, ENVIRON TOXICOL CHEM, V23, P2229, DOI 10.1897/03-278; Trosken ER, 2004, ENDOCR RES, V30, P387, DOI 10.1081/ERC-200035093; Araujo A.N., 2010, J HAZARD MATER, V175, P745; Christensen AM, 2007, ENVIRON TOXICOL CHEM, V26, P85, DOI 10.1897/06-219R.1; EspinelIngroff A, 1997, INFECT DIS CLIN N AM, V11, P929, DOI 10.1016/S0891-5520(05)70398-6; Hata T, 2010, J HAZARD MATER, V181, P1175, DOI 10.1016/j.jhazmat.2010.05.103; Henry TB, 2007, ENVIRON TOXICOL CHEM, V26, P1751, DOI 10.1897/06-265R.1; International Organization for Standardization, 1989, 86921989E ISO; Jensen KA, 1996, APPL ENVIRON MICROB, V62, P3679; Johnson DJ, 2007, ECOTOX ENVIRON SAFE, V67, P128, DOI 10.1016/j.ecoenv.2006.03.016; Lee PS, 2006, COMP BIOCHEM PHYS A, V145, P195, DOI 10.1016/j.cbpa.2006.06.013; MASON J I, 1987, Steroids, V50, P179, DOI 10.1016/0039-128X(83)90070-3; MASON JI, 1985, BIOCHEM PHARMACOL, V34, P1087; Mizuno H, 2009, BIODEGRADATION, V20, P533, DOI 10.1007/s10532-008-9242-y; MOEN MA, 1994, APPL ENVIRON MICROB, V60, P1956; OSPAR Commission, 2014, LIST SUBST POSS; Quatresooz P, 2008, EXPERT OPIN PHARMACO, V9, P1927, DOI [10.1517/14656566.9.11.1927 , 10.1517/14656560802268609]; Rozman D, 2002, MOL CELL ENDOCRINOL, V187, P179, DOI 10.1016/S0303-7207(01)00693-1; SAWYER PR, 1975, DRUGS, V9, P406, DOI 10.2165/00003495-197509060-00002; SCHAR G, 1976, CHEMOTHERAPY, V22, P211; Sei K, 2008, J ENVIRON SCI HEAL A, V43, P53, DOI 10.1080/10934520701750397; Suda T, 2012, BIORESOURCE TECHNOL, V103, P498, DOI 10.1016/j.biortech.2011.10.041; VANCUTSE.JM, 1972, CHEMOTHERAPY, V17, P392; Tran NH, 2010, J WATER ENV TECHNOL, V8, P125; Trosken ER, 2006, TOXICOLOGY, V228, P24, DOI 10.1016/j.tox.2006.08.007	64	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-8305	1879-0208		INT BIODETER BIODEGR	Int. Biodeterior. Biodegrad.	MAY	2015	100						79	84		10.1016/j.ibiod.2015.02.017		6	Biotechnology & Applied Microbiology; Environmental Sciences	Biotechnology & Applied Microbiology; Environmental Sciences & Ecology	CG8ZW	WOS:000353605200010		
J	Ramkumar, S; Thankappan, B; Fujii, N; Natarajaseenivasan, K; Anbarasu, K				Ramkumar, Srinivasagan; Thankappan, Bency; Fujii, Noriko; Natarajaseenivasan, Kalimuthusamy; Anbarasu, Kumarasamy			Interaction of alpha A-crystallin F71L mutant with wild type alpha A- and alpha B-crystallins by mammalian two hybrid assay	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						alpha-Crystallin, F71L mutation; Mammalian two hybrid system; Protein-protein interaction	PROTEIN-PROTEIN INTERACTIONS; RESONANCE ENERGY-TRANSFER; CHAPERONE-LIKE FUNCTION; CONGENITAL CATARACT; LENS CRYSTALLINS; FUNCTIONAL-CHANGES; MISSENSE MUTATION; INTERACTION SITES; SUBUNIT EXCHANGE; BETA-CRYSTALLIN	Incidence of age related cataract (ARC) increases by a variety of factors including metabolic and environmental factors. Nonetheless, genetic mutations are responsible for the altered structural stability of the proteins, especially; the F71L mutation in alpha A-crystallin has been shown to be responsible for the incidence of cataracts. However, structural characteristics and chaperone function of this mutant and its interaction with wild type (WT) crystallins may aid to decipher its role in cataractogenesis. The aim of the present study is to show the interaction of F71L mutant protein with the WT alpha-crystallins. The F71L mutant used in this study was created by site-directed mutagenesis, overexpressed and purified. Biophysical characteristics determined by size exclusion HPLC, DLS, CD spectrometry, tryptophan fluorescence and surface hydrophobicity did not show significant structural changes in the mutant protein compared to WT counterpart. Interestingly, the F71L mutant displayed a significant loss in homogenous interaction with WT alpha A-crystallin and F71L mutant as well as heterogeneous interaction with alpha B-crystallin as evaluated by mammalian two hybrid system. Our findings suggest that F71L loses the ability to form homo and hetero-oligomers seems to result in the loss in chaperone like activity (CIA) and refractive index resulting in the development of cataracts. (C) 2015 Elsevier B.V. All rights reserved.	[Ramkumar, Srinivasagan; Thankappan, Bency; Anbarasu, Kumarasamy] Bharathidasan Univ, Dept Marine Biotechnol, Tiruchchirappalli 620024, Tamil Nadu, India; [Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Natarajaseenivasan, Kalimuthusamy] Bharathidasan Univ, Dept Microbiol, Tiruchchirappalli 620024, Tamil Nadu, India	Anbarasu, K (reprint author), Bharathidasan Univ, Dept Marine Biotechnol, Tiruchchirappalli 620024, Tamil Nadu, India.	anbubdu@gmail.com			Department of Science and Technology (DST), New Delhi [SR/FT/LS-153/2008/(2010-2013)]; Indo-Japan international collaboration projects [DST/INT/JSPS/P-119/(2011-2013)]; DST-INSPIRE	The authors gratefully acknowledge the financial assistance from Department of Science and Technology (DST), New Delhi for Young Scientist (SR/FT/LS-153/2008/(2010-2013)) and Indo-Japan international collaboration projects (DST/INT/JSPS/P-119/(2011-2013)) sanctioned to the corresponding author (Dr. KA). We would like to thank Prof. S. Swamy Mruthinti, Associate Dean and Professor of Biology, College of Science and Mathematics, University of West Georgia, Carrollton, GA 30118, USA and the reviewers for their very constructive comments to revise the manuscript. The author (BT) acknowledges DST-INSPIRE for financial support as fellowship.	Abraham EC, 2008, MOL CELL BIOCHEM, V310, P235, DOI 10.1007/s11010-007-9685-1; Sun TX, 1998, J BIOL CHEM, V273, P286, DOI 10.1074/jbc.273.1.286; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Liu BF, 2007, MOL VIS, V13, P854; Kore R, 2012, MOL CELL BIOCHEM, V362, P93, DOI 10.1007/s11010-011-1131-8; Yang ZF, 2013, CURR EYE RES, V38, P1221, DOI 10.3109/02713683.2013.811260; Fu L, 2003, INVEST OPHTH VIS SCI, V44, P1155, DOI 10.1167/iovs.02-0950; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Srinivas P, 2010, IUBMB LIFE, V62, P693, DOI 10.1002/iub.373; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Kanade SR, 2009, MOL CELL BIOCHEM, V322, P185, DOI 10.1007/s11010-008-9956-5; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Srinivas PN, 2011, BIOCHEM BIOPH RES CO, V405, P486, DOI 10.1016/j.bbrc.2011.01.058; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Liang JJ, 2006, PROTEIN SCI, V15, P1619, DOI 10.1110/ps.062216006; Smulders RHPH, 1997, FEBS LETT, V409, P101, DOI 10.1016/S0014-5793(97)00498-5; Cobb BA, 2000, BIOCHEMISTRY-US, V39, P15791, DOI 10.1021/bi001453j; Kundu M, 2007, BIOPOLYMERS, V86, P177, DOI 10.1002/bip.20716; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Laurie KJ, 2013, HUM MUTAT, V34, P435, DOI 10.1002/humu.22260; Gupta R, 2009, J BIOL CHEM, V284, P18481, DOI 10.1074/jbc.M109.013789; Li H, 2008, BBA-MOL BASIS DIS, V1782, P303, DOI [10.1016/j.bbadis.2008.01.011, 10.1016/i.bbadis.2008.01.011]; Bhagyalaxmi SG, 2009, BBA-MOL BASIS DIS, V1792, P974, DOI 10.1016/j.bbadis.2009.06.011; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; Putilina T, 2003, J BIOL CHEM, V278, P13747, DOI 10.1074/jbc.M208157200; Devi RR, 2008, MOL VIS, V14, P1157; Horwitz J, 1999, EYE, V13, P403; Rao GN, 2011, CURR OPIN OPHTHALMOL, V22, P4, DOI 10.1097/ICU.0b013e3283414fc8; Liu BF, 2005, MOL VIS, V11, P321; Reddy GB, 2006, IUBMB LIFE, V58, P632, DOI 10.1080/15216540601010096; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Shroff NP, 2000, BIOCHEMISTRY-US, V39, P1420, DOI 10.1021/bi991656b; Bhattacharyya J, 2002, J PROTEIN CHEM, V21, P65, DOI 10.1023/A:1014187300930; Kallur LS, 2008, MOL CELL BIOCHEM, V308, P85, DOI 10.1007/s11010-007-9615-2; Liu BF, 2007, FEBS LETT, V581, P3936, DOI 10.1016/j.febslet.2007.07.022; Validandi V, 2011, FEBS LETT, V585, P3884, DOI 10.1016/j.febslet.2011.10.049; Datta SA, 2000, J BIOL CHEM, V275, P41004; Su DM, 2012, MOL VIS, V18, P3057; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Sun WM, 2011, MOL VIS, V17, P2197; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; Singh D, 2006, MOL VIS, V12, P1372; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Liu BF, 2006, J BIOL CHEM, V281, P2624, DOI 10.1074/jbc.M0509017200; Saha S, 2004, PROTEINS, V57, P610, DOI 10.1002/prot.20230; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Ponce A, 2006, MOL VIS, V12, P879; Xu JZ, 2010, MOL VIS, V16, P438; Chen QA, 2010, BIOL CHEM, V391, P1391, DOI 10.1515/BC.2010.143; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Datskevich PN, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1500, DOI 10.1134/S0006297912130081; Kumarasamy A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003175; Petrash JM, 2013, INVEST OPHTH VIS SCI, V54, P54; Pratheepakumari R., 2015, STUD CORNEA LENS, P287; Raju I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031421; Ramkumar S., 2014, MOL VIS, V20, P1602; Santhiya ST, 2004, INVEST OPHTH VIS SCI, V45, P3599, DOI 10.1167/iovs.040207; Santhoshkumar P, 2001, J BIOL CHEM, V276, P47094, DOI 10.1074/jbc.M107737200; Xia Q. Y., 2014, BMC OPHTHALMOL, V8, P108	64	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	MAY	2015	76						102	108		10.1016/j.ijbiomac.2015.02.025		7	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CG8ZK	WOS:000353604000014		
J	Raveendran, S; Palaninathan, V; Nagaoka, Y; Fukuda, T; Iwai, S; Higashi, T; Mizuki, T; Sakamoto, Y; Mohanan, PV; Maekawa, T; Kumar, DS				Raveendran, Sreejith; Palaninathan, Vivekanandan; Nagaoka, Yutaka; Fukuda, Takahiro; Iwai, Seiki; Higashi, Toshiaki; Mizuki, Toru; Sakamoto, Yasushi; Mohanan, P. V.; Maekawa, Toru; Kumar, D. Sakthi			Extremophilic polysaccharide nanoparticles for cancer nanotherapy and evaluation of antioxidant properties	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						Extremophiles; Mauran; Nanoparticles; Cancer therapy; Antioxidant mechanism; Polysaccharides	HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX-VIRUS; SULFATED POLYSACCHARIDES; HALOMONAS-MAURA; GLUTATHIONE-REDUCTASE; ENVELOPED VIRUSES; DELIVERY; BACTERIUM; ACID	Polysaccharides that show finest bioactivities and physicochemical properties are always promising for bionanoscience applications. Mauran is such a macromolecule extracted from halophilic bacterium, Halomonas maura for biotechnology and nanoscience applications. Antioxidant properties of MR/CH nanoparticles were studied using biochemical assays to prove the versatility of these test nanoparticles for biomedical applications. Here, we demonstrate the prospects of extremophilic polysaccharide, mauran based nanoparticles for scavenging reactive oxygen species in both in vitro and ex vivo conditions. 5-fluorouracil loaded MR/CH nanoparticles were tested for anticancer proliferation and compared their therapeutic efficiency using breast adenocarcinoma and glioma cells. Fluorescently labeled nanoparticles were employed to show the cellular uptake of these nanocarriers using confocal microscopic imaging and flow cytometry. (C) 2015 Elsevier B.V. All rights reserved.	[Raveendran, Sreejith; Palaninathan, Vivekanandan; Nagaoka, Yutaka; Fukuda, Takahiro; Iwai, Seiki; Higashi, Toshiaki; Mizuki, Toru; Maekawa, Toru; Kumar, D. Sakthi] Toyo Univ, Grad Sch Interdisciplinary New Sci, Bionano Elect Res Ctr, Kawagoe, Saitama 3508585, Japan; [Sakamoto, Yasushi] Saitama Med Univ, Biomed Res Ctr, Div Analyt Sci, Saitama 3500495, Japan; [Mohanan, P. V.] Govt India, Div Toxicol, Sree Chitra Tirunal Inst Med Sci & Technol, BMT Wing, Thiruvananthapuram 695012, Kerala, India	Kumar, DS (reprint author), Toyo Univ, Grad Sch Interdisciplinary New Sci, Bionano Elect Res Ctr, Kawagoe, Saitama 3508585, Japan.	sakthi@toyo.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; program of the strategic research foundation at private universities by the MEXT, Japan [S1101017]	Sreejith Raveendran and Vivekanandan Palaninathan would like to acknowledge their sincere gratitude to the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan for the financial support under the Monbukagakusho fellowship during the research. Also, part of this study has been supported by a grant for the program of the strategic research foundation at private universities S1101017, organized by the MEXT, Japan since April 2012.	SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Tan Q, 2011, INT J NANOMED, V6, P929, DOI 10.2147/IJN.S18753; NANDI A, 1988, J BIOSCIENCE, V13, P305, DOI 10.1007/BF02712155; Sinha VR, 2001, INT J PHARM, V224, P19, DOI 10.1016/S0378-5173(01)00720-7; PearcePratt R, 1996, BIOL REPROD, V54, P173, DOI 10.1095/biolreprod54.1.173; Yuk SH, 2011, BIOMACROMOLECULES, V12, P2335, DOI 10.1021/bm200413a; Pomin VH, 2009, BIOPOLYMERS, V91, P601, DOI 10.1002/bip.21200; Bouchotroch S, 2001, INT J SYST EVOL MICR, V51, P1625; Raveendran S, 2013, CARBOHYD POLYM, V98, P108, DOI 10.1016/j.carbpol.2013.04.050; Santo VE, 2010, J SUPERCRIT FLUID, V54, P320, DOI 10.1016/j.supflu.2010.05.021; Arias S, 2003, EXTREMOPHILES, V7, P319, DOI 10.1007/s00792-003-0325-8; Liu Y, 2009, EUR J PHARM SCI, V37, P306, DOI 10.1016/j.ejps.2009.02.022; HASUI M, 1995, INT J BIOL MACROMOL, V17, P293, DOI 10.1016/0141-8130(95)98157-T; Raveendran S, 2013, NANOMED-NANOTECHNOL, V9, P605, DOI 10.1016/j.nano.2012.12.006; Wijesekara I, 2011, CARBOHYD POLYM, V84, P14, DOI 10.1016/j.carbpol.2010.10.062; Costa LS, 2010, BIOMED PHARMACOTHER, V64, P21, DOI 10.1016/j.biopha.2009.03.005; Lin YH, 2009, BIOMATERIALS, V30, P3332, DOI 10.1016/j.biomaterials.2009.02.036; BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742; Ge YQ, 2009, NANOSCALE RES LETT, V4, P287, DOI 10.1007/s11671-008-9239-9; Grenha A, 2010, J BIOMED MATER RES A, V92A, P1265, DOI 10.1002/jbm.a.32466; Keppeler S, 2009, CARBOHYD POLYM, V78, P973, DOI 10.1016/j.carbpol.2009.07.029; McCarron PA, 2000, J PHARM PHARMACOL, V52, P1451, DOI 10.1211/0022357001777658; Raveendran S, 2013, PART PART SYST CHAR, V30, P573, DOI 10.1002/ppsc.201200126; Rohan LC, 2009, AAPS J, V11, P78, DOI 10.1208/s12248-009-9082-7; Park K, 2004, LANGMUIR, V20, P11726, DOI 10.1021/la048646i; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; MIZE CE, 1962, J BIOL CHEM, V237, P1589; Chen Y, 2003, LETT PEPT SCI, V10, P621, DOI 10.1007/BF02442596; Lee ES, 2007, BIOMATERIALS, V28, P2754, DOI 10.1016/j.biomaterials.2007.01.049; Lira MCB, 2011, EUR J PHARM BIOPHARM, V79, P162, DOI 10.1016/j.ejpb.2011.02.013; Mori Y, 2010, INT J NANOMED, V5, P147; Murugesan S, 2006, LANGMUIR, V22, P3461, DOI 10.1021/la0534468; Nair K Lekha, 2011, Int J Nanomedicine, V6, P1685, DOI 10.2147/IJN.S20165; Ohkawa H., 1979, ANAL BIOCHEM, V193, P265; Parish R.C., 1999, CANCER RES, V59, P3433; Raveendran S., 2003, CARBOHYD POLYM, V91, P22; Raveendran S, 2013, CARBOHYD POLYM, V92, P1225, DOI 10.1016/j.carbpol.2012.10.033; Raveendran S, 2014, ACS SUSTAIN CHEM ENG, V2, P1551, DOI 10.1021/sc500002g; Toshihiko T., 2003, TRENDS GLYCOSCI GLYC, V15, P29; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wu XZ, 2006, W INDIAN MED J, V55, P270; Zhu W, 2006, PHYTOMEDICINE, V13, P695, DOI 10.1016/j.phymed.2005.11.003	43	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	MAY	2015	76						310	319		10.1016/j.ijbiomac.2015.03.001		10	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CG8ZK	WOS:000353604000040		
J	Shimokawa, A; Kawasaki, Y; Miyaoka, E				Shimokawa, Asanao; Kawasaki, Yohei; Miyaoka, Etsuo			Comparison of Splitting Methods on Survival Tree	INTERNATIONAL JOURNAL OF BIOSTATISTICS			English	Article						survival tree; CART; recursive partitioning	MODELS	We compare splitting methods for constructing survival trees that are used as a model of survival time based on covariates. A number of splitting criteria on the classification and regression tree (CART) have been proposed by various authors, and we compare nine criteria through simulations. Comparative studies have been restricted to criteria that suppose the survival model for each terminal node in the final tree as a non-parametric model. As the main results, the criteria using the exponential log-likelihood loss, log-rank test statistics, the deviance residual under the proportional hazard model, or square error of martingale residual are recommended when it appears that the data have constant hazard with the passage of time. On the other hand, when the data are thought to have decreasing hazard with passage of time, the criterion using the two-sample test statistic, or square error of deviance residual would be optimal. Moreover, when the data are thought to have increasing hazard with the passage of time, the criterion using the exponential log-likelihood loss, or impurity that combines observed times and the proportion of censored observations would be the best. We also present the results of an actual medical research to show the utility of survival trees.	[Shimokawa, Asanao] Tokyo Univ Sci, Dept Math Informat Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Kawasaki, Yohei; Miyaoka, Etsuo] Tokyo Univ Sci, Dept Math, Tokyo 1628601, Japan	Shimokawa, A (reprint author), Tokyo Univ Sci, Dept Math Informat Sci, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	a.shimokawa0226@gmail.com; ykawasaki@ma.kagu.tus.ac.jp; miyaoka@rs.kagu.tus.ac.jp					CIAMPI A, 1988, COMPUT METH PROG BIO, V26, P239, DOI 10.1016/0169-2607(88)90004-1; LEBLANC M, 1992, BIOMETRICS, V48, P411, DOI 10.2307/2532300; Graf E, 1999, STAT MED, V18, P2529; SEGAL MR, 1988, BIOMETRICS, V44, P35, DOI 10.2307/2531894; Keles S, 2002, STAT MED, V21, P313, DOI 10.1002/sim.981; GORDON L, 1985, CANCER TREAT REP, V69, P1065; COX DR, 1972, J R STAT SOC B, V34, P187; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; HJORTH U, 1980, TECHNOMETRICS, V22, P99, DOI 10.2307/1268388; COPELAN EA, 1991, BLOOD, V78, P838; DAVIS RB, 1989, STAT MED, V8, P947, DOI 10.1002/sim.4780080806; Bou-Hamad I., 2011, STAT SURVEYS, V5, P44, DOI DOI 10.1214/09-SS047; Moeschberger M. L., 2003, SURVIVAL ANAL TECHNI; Radespiel-Troger M, 2003, ARTIF INTELL MED, V28, P323, DOI 10.1016/S0933-3657(03)00060-5; Radespiel-Troger M, 2006, METHOD INFORM MED, V45, P548; Zhang HP, 1995, P 10 INT WORKSH STAT, P305	16	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	2194-573X	1557-4679		INT J BIOSTAT	Int. J. Biostat.	MAY	2015	11	1					175	188		10.1515/ijb-2014-0029		14	Mathematical & Computational Biology; Statistics & Probability	Mathematical & Computational Biology; Mathematics	CG9QC	WOS:000353650900010		
J	Nakamura, M; Jinnai, W; Hamano, S; Nakamura, S; Koyano, K; Chiba, Y; Kanenishi, K; Yasuda, S; Ueno, M; Miki, T; Hata, T; Kusaka, T				Nakamura, Makoto; Jinnai, Wataru; Hamano, Satoshi; Nakamura, Shinji; Koyano, Kosuke; Chiba, Yoichi; Kanenishi, Kenji; Yasuda, Saneyuki; Ueno, Masaki; Miki, Takanori; Hata, Toshiyuki; Kusaka, Takashi			Cerebral blood volume measurement using near-infrared time-resolved spectroscopy and histopathological evaluation after hypoxic-ischemic insult in newborn piglets	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Amplitude-integrated electroencephalography; Animal model; Brain histology; Cerebral blood volume; Near-infrared spectroscopy; Hypoxia-ischemia	AMPLITUDE-INTEGRATED EEG; LAYERED TURBID MEDIA; BIRTH ASPHYXIA; OXYGEN-SATURATION; PREDICTIVE-VALUE; TERM INFANTS; FETAL SHEEP; BRAIN; ENCEPHALOPATHY; HYPOTHERMIA	The aim of this study was to assess the relationship between the cerebral blood volume (CBV) measured by near-infrared time-resolved spectroscopy (TRS) and pathological change of the brain in a hypoxicischemic (HI) piglet model. Twenty-one anesthetized newborn piglets, including three sham controls, were studied. An HI event was induced by low inspired oxygen. CBV was measured using TRS (Hamamatsu TRS-10). Data were collected before, during, and 6 h after the insult. CBV was calculated as the change from the end of the insult. The piglets were allowed to recover from anesthesia for 6 h after the insult. At the age of 5 days, the brains of the piglets were perfusion-fixed, and histologic evaluations of brain tissue were performed. The extent of histopathological damage was graded in 0.5-unit intervals on a 9-step scale. CBV increments were well correlated with histopathological scores, especially at 1 and 3 h after resuscitation. Spearman's rank-correlation coefficients at 1, 3, and 6 h after resuscitation in the gray matter were 0.9016, 0.9127, and 0.6907, respectively. We conclude that an increased CBV after HI insult indicates more marked histological brain damage. CBV measurement immediately after resuscitation provides a more precise prediction of the histological outcome. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakamura, Makoto; Hamano, Satoshi; Nakamura, Shinji; Kusaka, Takashi] Kagawa Univ, Fac Med, Dept Pediat, Takamatsu, Kagawa 760, Japan; [Nakamura, Makoto] Natl Hosp Org, Okayama Med Ctr, Dept Neonatol, Okayama, Japan; [Jinnai, Wataru; Koyano, Kosuke; Kanenishi, Kenji; Yasuda, Saneyuki] Kagawa Univ, Fac Med, Maternal Perinatal Ctr, Takamatsu, Kagawa 760, Japan; [Chiba, Yoichi; Ueno, Masaki] Kagawa Univ, Fac Med, Dept Pathol, Takamatsu, Kagawa 760, Japan; [Chiba, Yoichi; Ueno, Masaki] Kagawa Univ, Fac Med, Dept Host Def, Takamatsu, Kagawa 760, Japan; [Miki, Takanori] Kagawa Univ, Fac Med, Dept Anat, Takamatsu, Kagawa 760, Japan; [Miki, Takanori] Kagawa Univ, Fac Med, Dept Neurobiol, Takamatsu, Kagawa 760, Japan; [Hata, Toshiyuki] Kagawa Univ, Fac Med, Dept Perinatol, Takamatsu, Kagawa 760, Japan; [Hata, Toshiyuki] Kagawa Univ, Fac Med, Dept Gynecol, Takamatsu, Kagawa 760, Japan	Kusaka, T (reprint author), Kagawa Univ, Fac Med, Dept Pediat, Takamatsu, Kagawa 760, Japan.				Kagawa University Faculty of Medicine School of Medicine Alumni Association Sanjukai Research Aid [21-1, 25-2]; 22nd Research Aid for Pediatrics (Mother and Child Health Foundation);  [22,591,201];  [25,461,645];  [25,461,646];  [25,461,647];  [243,759];  [26,860,847];  [26,860,846];  [25,860,911];  [25,860,866];  [B0124119004]	This study was carried out with Grants-in-Aid for Scientific Research (C) 22,591,201, 25,461,645, 25,461,646, 25,461,647, and 243,759, Grants-in-Aid for Young Scientists (B) 26,860,847, 26,860,846, 25,860,911, and 25,860,866 and a Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)B0124119004, Kagawa University Faculty of Medicine School of Medicine Alumni Association Sanjukai Research Aid 21-1, 25-2 and the 22nd Research Aid for Pediatrics (Mother and Child Health Foundation).	PRYDS O, 1990, J PEDIATR-US, V117, P119, DOI 10.1016/S0022-3476(05)72459-8; Pichler G, 2013, J PEDIATR-US, V163, P1558, DOI 10.1016/j.jpeds.2013.07.007; Iwata O, 2007, BRAIN RES, V1154, P173, DOI 10.1016/j.brainres.2007.03.083; Ancora G, 2013, BRAIN DEV-JPN, V35, P26, DOI 10.1016/j.braindev.2011.09.008; Hoshi Y, 2011, PHILOS T R SOC A, V369, P4425, DOI 10.1098/rsta.2011.0262; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Toet MC, 1999, ARCH DIS CHILD, V81, pF19; Meek JH, 1999, ARCH DIS CHILD, V81, pF110; ALTMAN DI, 1988, ANN NEUROL, V24, P218, DOI 10.1002/ana.410240208; WILLIAMS CE, 1992, ANN NEUROL, V31, P14, DOI 10.1002/ana.410310104; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Kusaka T, 2009, PEDIATR RES, V65, P317, DOI 10.1203/PDR.0b013e318194fa73; Binder C, 2013, J PEDIATR-US, V163, P394, DOI 10.1016/j.jpeds.2013.01.026; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD, V72, pF34, DOI 10.1136/fn.72.1.F34; Isobe K, 2002, COMP BIOCHEM PHYS A, V132, P133, DOI 10.1016/S1095-6433(01)00539-6; Toet MC, 2006, PEDIATRICS, V117, P333, DOI 10.1542/peds.2005-0987; Shankaran S, 2011, PEDIATRICS, V128, pE112, DOI 10.1542/peds.2010-2036; Thoresen M, 1996, PEDIATR RES, V40, P738, DOI 10.1203/00006450-199611000-00014; Nakamura S, 2013, BRAIN DEV-JPN, V35, P614, DOI 10.1016/j.braindev.2012.10.007; VANBEL F, 1993, PEDIATRICS, V92, P365; Marks KA, 1996, PEDIATR RES, V39, P48, DOI 10.1203/00006450-199601000-00007; Sato C, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2136312; BRIERLEY JB, 1971, BRAIN RES, V25, P483, DOI 10.1016/0006-8993(71)90456-2; DEHAAN HH, 1993, AM J OBSTET GYNECOL, V169, P1493; Gunn AJ, 2008, CURR OPIN OBSTET GYN, V20, P175, DOI 10.1097/GCO.0b013e3282f4ef9e; Hielscher AH, 1996, APPL OPTICS, V35, P719, DOI 10.1364/AO.35.000719; Ijichi S., 2005, J BIOMED OPT, V10; Ijichi S., 2005, PEDIATR RES, V58, P568, DOI [10.1203/01PDR.;1;0000175638.98041.0E, DOI 10.1203/01PDR.;1;0000175638.98041.0E]; LOBERG EM, 1994, APMIS, V102, P771; MALLARD EC, 1992, AM J OBSTET GYNECOL, V167, P1423; Nakamura S, 2014, BRAIN DEV-JPN, V36, P563, DOI 10.1016/j.braindev.2013.08.005; Pichler G, 2013, RESUSCITATION, V84, P974, DOI 10.1016/j.resuscitation.2012.12.025; Rosenbaum JL, 1997, NEUROLOGY, V49, P1035	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	MAY	2015	42						1	9		10.1016/j.ijdevneu.2015.02.009		9	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CG9CK	WOS:000353611800001		
J	Iwasa, T; Matsuzaki, T; Munkhzaya, M; Tungalagsuvd, A; Yamasaki, M; Kuwahara, A; Yasui, T; Irahara, M				Iwasa, Takeshi; Matsuzaki, Toshiya; Munkhzaya, Munkhsaikhan; Tungalagsuvd, Altankhuu; Yamasaki, Mikio; Kuwahara, Akira; Yasui, Toshiyuki; Irahara, Minoru			The effects of prenatal undernutrition and postnatal high-fat diet on hypothalamic Kiss1 mRNA and serum leptin levels	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Kisspeptin; Kiss1; Leptin; IUGR; High-fat diet	FEMALE RATS; EXPRESSION; LIPOPOLYSACCHARIDE; KISSPEPTIN; EXPOSURE; PUBERTY; SIGNAL; SURGE	Prenatal undernutrition and postnatal overnutrition increase the risk of some metabolic disorders in adulthood, and hypothalamic leptin resistance makes an important contribution to these effects. Leptin plays important roles in the maintenance of reproductive function, and its actions might be partially mediated by kisspeptin, which is a potent positive regulator of gonadotropin-releasing hormone. In this study, the effects of prenatal undernutrition and postnatal overnutrition on reproductive parameters and sexual maturation during the peripubertal period were evaluated. Rats subjected to prenatal undernutrition (IUGR) and fed a postnatal high-fat diet (HFD) (n = 7) exhibited 40% higher serum leptin levels and 30% lower hypothalamic Kiss1 (the gene encoding kisspeptin) mRNA levels than those subjected to prenatal undernutrition (IUGR) and fed a normal diet (n = 7). No such HFD-induced postnatal alterations were observed in the rats fed a normal diet during the prenatal period (control) (n = 7 per group). Although the consumption of the HFD did not affect the serum luteinizing hormone levels or body weight of the IUGR or control rats, it did promote vaginal opening in both groups (evaluated in 14 rats per group). These findings indicate that hypothalamic leptin resistance might occur in IUGR-HFD rats, but these changes do not influence downstream effectors of the reproductive endocrinological system. They also suggest that the relationships between nutritional conditions, body weight, reproductive factors, and sexual maturation are complex. (C) 2015 Elsevier Ltd. All rights reserved.	[Iwasa, Takeshi; Matsuzaki, Toshiya; Munkhzaya, Munkhsaikhan; Tungalagsuvd, Altankhuu; Yamasaki, Mikio; Kuwahara, Akira; Irahara, Minoru] Univ Tokushima, Grad Sch, Dept Obstet & Gynecol, Inst Hlth Biosci, Tokushima 7708503, Japan; [Yasui, Toshiyuki] Univ Tokushima, Grad Sch, Dept Reprod Technol, Inst Hlth Biosci, Tokushima 7708503, Japan	Iwasa, T (reprint author), Univ Tokushima, Grad Sch, Dept Obstet & Gynecol, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	iwasa.takeshi@tokushima-u.ac.jp					Iwasa T, 2014, INT J DEV NEUROSCI, V34, P76, DOI 10.1016/j.ijdevneu.2014.02.001; Lie MEK, 2013, REPROD BIOL, V13, P298, DOI 10.1016/j.repbio.2013.08.001; Iwasa T, 2014, HORM BEHAV, V66, P309, DOI 10.1016/j.yhbeh.2014.06.007; Quennell JH, 2011, ENDOCRINOLOGY, V152, P1541, DOI 10.1210/en.2010-1100; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; True C, 2011, J NEUROENDOCRINOL, V23, P1099, DOI 10.1111/j.1365-2826.2011.02144.x; Li XF, 2012, ENDOCRINOLOGY, V153, P4422, DOI 10.1210/en.2012-1223; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Iwasa T, 2014, INT J DEV NEUROSCI, V36, P1, DOI 10.1016/j.ijdevneu.2014.03.011; Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144; Godfrey K. M., 2000, AM J CLIN NUTR, V71, P1344; Iwasa T, 2014, INT J DEV NEUROSCI, V35, P52, DOI 10.1016/j.ijdevneu.2014.03.007; Iwasa T, 2015, INT J DEV NEUROSCI, V40, P12, DOI 10.1016/j.ijdevneu.2014.10.002; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Poiling M.C., 2014, NEUROENDOCR IN PRESS	15	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	MAY	2015	42						76	79		10.1016/j.ijdevneu.2015.03.001		4	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CG9CK	WOS:000353611800009		
J	Boulay, AM; Bare, J; De Camillis, C; Doll, P; Gassert, F; Gerten, D; Humbert, S; Inaba, A; Itsubo, N; Lemoine, Y; Margni, M; Motoshita, M; Nunez, M; Pastor, AV; Ridoutt, B; Schencker, U; Shirakawa, N; Vionnet, S; Worbe, S; Yoshikawa, S; Pfister, S				Boulay, Anne-Marie; Bare, Jane; De Camillis, Camillo; Doell, Petra; Gassert, Francis; Gerten, Dieter; Humbert, Sebastien; Inaba, Atsushi; Itsubo, Norihiro; Lemoine, Yann; Margni, Manuele; Motoshita, Masaharu; Nunez, Montse; Pastor, Amandine V.; Ridoutt, Brad; Schencker, Urs; Shirakawa, Naoki; Vionnet, Samuel; Worbe, Sebastien; Yoshikawa, Sayaka; Pfister, Stephan			Consensus building on the development of a stress-based indicator for LCA-based impact assessment of water consumption: outcome of the expert workshops	INTERNATIONAL JOURNAL OF LIFE CYCLE ASSESSMENT			English	Article						Consensus-based; Water consumption; WULCA	INTEGRATED MODEL; PART; SCALE	The WULCA group, active since 2007 on Water Use in LCA, commenced the development of consensus-based indicators in January 2014. This activity is planned to last 2 years and covers human health, ecosystem quality, and a stress-based indicator. This latter encompasses potential deprivation of both ecosystem and human, hence aiming to represent potential impacts more comprehensively than any other available LCA-oriented method assessing the "water scarcity footprint" (ISO 2014). A series of three expert workshops, including non-LCA experts from hydrology, eco-hydrology, and water supply science, was organized specifically on the topic of this generic midpoint indicator. They were held in Zurich on 10th September, in San Francisco on 5th October and in Tsukuba on 27th October 2014. In total 49 experts attended. The specific objectives of the workshops were twofold. First, it was to present the identified options of the stress-based indicator narrowed down by the active members of WULCA during the first 8 months of the project and to receive comments on the relevance, usefulness, acceptability, and focus of the selected indicator. Second, the workshop covered different challenges in the modeling of the indicator and presented the experts with background information and specific questions. This paper summarizes the discussions and outcome of these workshops. Where no agreement was reached, the working group of active members is considering all inputs received and continues the work. The discussion covered first the question to be answered by such indicator, resulting on an agreement on the evaluation of the potential to deprive other users of water, independently of who the user is (i.e., human or ecosystems). Special attention was given to the special case of arid areas as well as the definition of environmental water requirements. Specific modeling challenges were then addressed: definition and quantification of human and ecosystem water demand, consideration of green water and terrestrial ecosystems, sources of data, distinction of groundwater and surface water, and temporal and geographical resolution. The input, decisions, and points of discussion were compiled and brought back within the group of active members. The group is using the recommendations and works further on the harmonization of the points of disagreement. It is expected that a selection of indicators representing different ways to address the most important issues will be produced and tested in spring 2015. The analysis of the result should lead to a provisional recommendation by summer 2015.	[Boulay, Anne-Marie; Margni, Manuele] Ecole Polytech, Dept Chem Engn, CIRAIG, Montreal, PQ H3C 3A7, Canada; [Bare, Jane] US EPA, Washington, DC USA; [De Camillis, Camillo] United Nations FAO, Agr & Consumer Protect Dept, Rome, Italy; [Doell, Petra] Goethe Univ Frankfurt, Inst Phys Geog, D-60054 Frankfurt, Germany; [Gassert, Francis] World Resources Inst, Washington, DC 20006 USA; [Gerten, Dieter] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Humbert, Sebastien; Vionnet, Samuel] Ecole Polytech Fed Lausanne, Quantis, CH-1015 Lausanne, Switzerland; [Inaba, Atsushi] Kogakuin Univ, Fac Engn, Tokyo, Japan; [Itsubo, Norihiro] Tokyo City Univ, Dept Environm Management, Tokyo, Japan; [Lemoine, Yann] EDF, DPIH, Water Management Unit, Lyon, France; [Motoshita, Masaharu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Nunez, Montse] ELSA, Res Grp Environm Life Cycle Sustainabil Assessmen, Irstea, UMR ITAP, Montpellier, France; [Pastor, Amandine V.] Wageningen Univ, Earth Syst Sci, NL-6700 AP Wageningen, Netherlands; [Ridoutt, Brad] CSIRO, Agr Flagship, Clayton, Vic 3168, Australia; [Schencker, Urs] Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland; [Shirakawa, Naoki] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan; [Worbe, Sebastien] Veolia Res & Innovat, Maisons Laffitte, France; [Yoshikawa, Sayaka] Tokyo Inst Technol, Dept Civil Engn, Tokyo 152, Japan; [Pfister, Stephan] ETH, Zurich, Switzerland	Boulay, AM (reprint author), Ecole Polytech, Dept Chem Engn, CIRAIG, POB 6079, Montreal, PQ H3C 3A7, Canada.	anne-marie.boulay@polymtl.ca	Pfister, Stephan/B-1317-2011; Ridoutt, Bradley/D-3329-2011; 	Pfister, Stephan/0000-0001-8984-2041; Ridoutt, Bradley/0000-0001-7352-0427; Schenker, Urs/0000-0002-9437-0904	Hydro-Quebec; Veolia Environnement; Danone; ExxonMobil; Cascades; Unilever; Cottons Inc; GDF-Suez; Mitacs, the Canadian funding agency	We acknowledge the contribution of the hosting institutions (ETH Zurich, ACLCA and the National Institute of Advanced Industrial Science and Technology of Tsukuba) as well as the financial support of the industrial sponsors supporting WULCA: Hydro-Quebec, Veolia Environnement, Danone, ExxonMobil, Cascades, Unilever, Cottons Inc, GDF-Suez, and Mitacs, the Canadian funding agency.	Hanasaki N, 2008, HYDROL EARTH SYST SC, V12, P1027; Bayart JB, 2010, INT J LIFE CYCLE ASS, V15, P439, DOI 10.1007/s11367-010-0172-7; Hanasaki N, 2008, HYDROL EARTH SYST SC, V12, P1007; Hanasaki N, 2010, J HYDROL, V384, P232, DOI 10.1016/j.jhydrol.2009.09.028; Gerten D, 2013, CURR OPIN ENV SUST, V5, P551, DOI 10.1016/j.cosust.2013.11.001; Boulay AM, 2015, INT J LIFE CYCLE ASS, V20, P865, DOI 10.1007/s11367-015-0868-9; Kounina A, 2013, INT J LIFE CYCLE ASS, V18, P707, DOI 10.1007/s11367-012-0519-3; Berger M, 2014, ENVIRON SCI TECHNOL, V48, P4521, DOI 10.1021/es404994t; Boulay AM, 2015, INT J LIFE CYCLE ASS, V20, P139, DOI 10.1007/s11367-014-0814-2; Gassert F., 2013, AQUEDUCT GLOBAL MAPS; Jolliet O, 2014, INT J LIFE CYCLE ASS, V19, P962, DOI 10.1007/s11367-014-0703-8; Loubet P, 2013, ENVIRON SCI TECHNOL, V47, P14242, DOI 10.1021/es403056x; Muller Schmied H, 2014, HYDROL EARTH SYST SC, V18, P3511, DOI 10.5194/hess-18-3511-2014; Pastor AV, 2013, HYDROL EARTH SYST SC, V10, P14987; Rockstrom J, 2009, ECOL SOC, V14; Rost S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006331; van Zelm R, 2011, ENVIRON SCI TECHNOL, V45, P629, DOI 10.1021/es102383v; Verones F, 2013, ENVIRON SCI TECHNOL, V47, P9799, DOI 10.1021/es400266v	18	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-3349	1614-7502		INT J LIFE CYCLE ASS	Int. J. Life Cycle Assess.	MAY	2015	20	5					577	583		10.1007/s11367-015-0869-8		7	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CG8QF	WOS:000353573800001		
J	Matsushita, Y; Yanamoto, S; Takahashi, H; Yamada, S; Naruse, T; Sakamoto, Y; Ikeda, H; Shiraishi, T; Fujita, S; Ikeda, T; Asahina, I; Umeda, M				Matsushita, Y.; Yanamoto, S.; Takahashi, H.; Yamada, S.; Naruse, T.; Sakamoto, Y.; Ikeda, H.; Shiraishi, T.; Fujita, S.; Ikeda, T.; Asahina, I.; Umeda, M.			A clinicopathological study of perineural invasion and vascular invasion in oral tongue squamous cell carcinoma	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						oral tongue squamous cell carcinoma (OTSCC); perineural invasion; vascular invasion; intermediate risk	LYMPH-NODE METASTASIS; LOCALLY ADVANCED HEAD; TUMOR THICKNESS; NECK-CANCER; POSTOPERATIVE IRRADIATION; CERVICAL METASTASIS; RADIATION-THERAPY; CAVITY; CHEMOTHERAPY; RISK	The risk factors for recurrence of head and neck cancer are classified as being of high or intermediate risk. Those of intermediate risk include multiple positive nodes without extracapsular nodal spread, perineural/vascular invasion, pT3/T4 primary tumours, and positive level IVN nodes. However, little evidence is available to validate these intermediate risk factors. We analyzed perineural/vascular invasion in 89 patients who underwent radical surgery for oral tongue squamous cell carcinoma, whose records were reviewed retrospectively. Perineural invasion was found in 27.0% of cases and vascular invasion in 23.6%; both had a strong relationship with histopathological nodal status (P = 0.005). The 5-year disease-specific survival (DSS) and overall survival rates of patients with perineural invasion were significantly lower than those of patients without perineural invasion (P < 0.001 and P = 0.002, respectively). The 5-year DSS of UICC stage I and II cases with perineural/vascular invasion was significantly lower than those without (P < 0.001 and P = 0.008, respectively). Perineural invasion and vascular invasion are risk factors for regional metastasis and a poor prognosis. We recommend elective neck dissection when perineural/vascular invasion is found in clinical stage I and II cases. The accumulation of further evidence to consider intermediate risks is required.	[Matsushita, Y.; Yanamoto, S.; Takahashi, H.; Yamada, S.; Naruse, T.; Sakamoto, Y.; Umeda, M.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki 852, Japan; [Ikeda, H.; Shiraishi, T.; Asahina, I.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 852, Japan; [Fujita, S.; Ikeda, T.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Pathol, Nagasaki 852, Japan	Matsushita, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Clin Oral Oncol, 1-7-1 Sakamoto, Nagasaki 852, Japan.	matsushita@nagasaki-u.ac.jp	Matsushita, Yuki/H-3188-2015	Matsushita, Yuki/0000-0001-9577-3249			Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Liebig C, 2009, CANCER, V115, P3379, DOI 10.1002/cncr.24396; Huang SH, 2009, CANCER, V115, P1489, DOI 10.1002/cncr.24161; Ganly I, 2013, CANCER-AM CANCER SOC, V119, P1168, DOI 10.1002/cncr.27872; Parsons JT, 1997, INT J RADIAT ONCOL, V39, P137, DOI 10.1016/S0360-3016(97)00152-1; Govers TM, 2013, ORAL ONCOL, V49, P726, DOI 10.1016/j.oraloncology.2013.04.006; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Rodolico V, 2004, ORAL ONCOL, V40, P92, DOI 10.1016/S1368-8375(03)00141-6; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Kurtz KA, 2005, ARCH PATHOL LAB MED, V129, P354; Langerman A, 2007, ARCH OTOLARYNGOL, V133, P1289, DOI 10.1001/archotol.133.12.1289; Bapat AA, 2011, NAT REV CANCER, V11, P695, DOI 10.1038/nrc3131; Lim SC, 2004, CLIN CANCER RES, V10, P166, DOI 10.1158/1078-0432.CCR-0533-3; Fagan JJ, 1998, ARCH OTOLARYNGOL, V124, P637; Langius JAE, 2013, CLIN NUTR, V32, P671, DOI 10.1016/j.clnu.2013.06.012; Speight PM, 2009, BRIT J ORAL MAX SURG, V47, P587, DOI 10.1016/j.bjoms.2009.03.017; Cooper JS, 2012, INT J RADIAT ONCOL, V84, P1198, DOI 10.1016/j.ijrobp.2012.05.008; Asakage T, 1998, CANCER, V82, P1443, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1443::AID-CNCR2>3.0.CO;2-A; BRYNE M, 1992, J PATHOL, V166, P375, DOI 10.1002/path.1711660409; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Chatzistefanou I, 2014, ORAL ONCOL, V50, P753, DOI 10.1016/j.oraloncology.2014.05.005; Liao CT, 2008, INT J RADIAT ONCOL, V71, P371, DOI 10.1016/j.ijrobp.2007.10.015; Magnano M, 1999, J EXP CLIN CANC RES, V18, P79; McMahon JD, 2011, BRIT J ORAL MAX SURG, V49, P92, DOI 10.1016/j.bjoms.2009.12.013; National Comprehensive Cancer Network Inc, 2014, NCCN CLIN PRACT GUID; Sobin LH, 2009, TNM CLASSIFICATION M; Tai SK, 2012, HEAD NECK-J SCI SPEC, V34, P994, DOI 10.1002/hed.21846; WOOLGAR JA, 1995, HEAD NECK-J SCI SPEC, V17, P463, DOI 10.1002/hed.2880170603	28	1	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	MAY	2015	44	5					543	548		10.1016/j.ijom.2015.01.018		6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CH2NC	WOS:000353860900001		
J	Takahashi, K; Ogura, N; Tomoki, R; Eda, T; Okada, H; Kato, R; Iwai, S; Ito, K; Kuyama, K; Kondoh, T				Takahashi, K.; Ogura, N.; Tomoki, R.; Eda, T.; Okada, H.; Kato, R.; Iwai, S.; Ito, K.; Kuyama, K.; Kondoh, T.			Applicability of human dental follicle cells to bone regeneration without dexamethasone: an in vivo pilot study	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						dental follicle; osteogenic differentiation; bone regeneration	OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; RAT CALVARIA; ANGIOGENESIS; APOPTOSIS; CARTILAGE; PROTEINS; INSULIN; REPAIR	The aim of this study was to investigate the capacity of human dental follicle cells (hDFCs) for bone formation in vivo. hDFCs were obtained from wisdom teeth extracted from patients aged 14 and 22 years. hDFCs from the 5th to 8th passages were grown in three-dimensional (3D) culture using gelatin sponges. Cells were transplanted onto the calvaria of F344/NIcl-rnu/rnu male rats (immunodeficient rats). Haematoxylin and eosin (BE) staining and immunohistochemistry were performed, and newly formed bone was evaluated by micro-computed tomography (micro-CT). HE staining showed newly formed bone in 3D culture. Immunohistochemistry showed bone morphogenetic protein 2 (BMP-2), runt-related transcription factor 2 (RUNX2), and osterix staining in areas with newly formed bone. Furthermore, micro-CT showed that, in comparison to controls, transplanted hDFCs promoted better bone quality and bone mineral density (BMD 582 +/- 131.1 vs. 300.5 +/- 77.7 mg/cm(3); P = 0.039), bone mineral content (BMC 5.6 +/- 1.1 vs. 2.1 +/- 0.4 mg; P = 0.006), bone volume (BV 9.7 +/- 0.5 x 10(-3) vs. 7.0 +/- 0.4 x 10(-3) cm(3); P = 0.002), BMC/total volume (TV) (399.9 +/- 76.3 vs. 147.7 +/- 30.8 mg/cm(3); P = 0.006), and BV/TV (69.1 +/- 3.6% vs. 49.6 +/- 3.1%; P = 0.002). This suggests that human dental follicles are potentially useful for regenerative therapy.	[Takahashi, K.; Ogura, N.; Tomoki, R.; Eda, T.; Okada, H.; Kato, R.; Iwai, S.; Ito, K.; Kuyama, K.; Kondoh, T.] Nihon Univ, Sch Dent Matsudo, Dept Maxillofacial Surg, Dept Oral Pathol,Res Inst Oral Sci, Matsudo, Chiba 2718587, Japan	Takahashi, K (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Maxillofacial Surg, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	takahashi.kosuke@nihon-u.ac.jp			Japan Society for the Promotion of Science [16592024, 20592347]	This study was supported by a Grant-in Aid for Scientific Research (C) (16592024 and 20592347) from the Japan Society for the Promotion of Science.	Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Wang FS, 2008, ENDOCRINOLOGY, V149, P1793, DOI 10.1210/en.2007-0910; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012; Gerber HP, 1999, NAT MED, V5, P623; Morsczeck C, 2005, CELL BIOL INT, V29, P567, DOI 10.1016/j.cellbi.2005.03.020; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Burghardt AJ, 2011, CLIN ORTHOP RELAT R, V469, P2179, DOI 10.1007/s11999-010-1766-x; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Felthaus O, 2014, CELL TISSUE RES, V357, P695, DOI 10.1007/s00441-014-1891-z; Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004; Kang SH, 2014, CELL TISSUE RES, V355, P81, DOI 10.1007/s00441-013-1738-z; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; Nkenke E, 2004, INT J ORAL MAX SURG, V33, P157, DOI 10.1054/ijom.2003.0465; Liu Y, 2004, J BONE MINER RES, V19, P479, DOI 10.1359/JBMR.0301242; Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X; Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3; Aonuma H, 2008, INT J ORAL MED SCI, V7, P91; Glueck C J, 2003, Curr Hematol Rep, V2, P417; Hollinger JO, 1998, ADV DRUG DELIV REV, V31, P303; Ibrahim N, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120075; Iwai S, 2013, J HARD TISSUE BIOL, V22, P95; Jin ZL, 2008, ACTA PHARMACOL SIN, V29, P1013, DOI 10.1111/j.1745-7254.2008.00834.x; Jones J P Jr, 1999, Acta Orthop Belg, V65 Suppl 1, P5; Langenbach F, 2013, STEM CELL RES THER, V4, DOI 10.1186/1757-6512-4-117; Li J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.348; Li P, 2013, J BONE MINER METAB; Reddi AH, 2001, J BONE JOINT SURG AM, V83A, pS1; Takahashi K, 2013, ARCH ORAL BIOL, V58, P690, DOI 10.1016/j.archoralbio.2012.10.018; Takiguchi S, 2009, J HARD TISSUE BIOL, V18, P149	31	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	MAY	2015	44	5					664	669		10.1016/j.ijom.2014.11.006		6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CH2NC	WOS:000353860900017		
J	Ito, O; Kawazoe, T; Park, S				Ito, Osamu; Kawazoe, Takeshi; Park, Susam			Letter to the Editor regarding "The 70-degree telescope as a teaching tool for cleft palate repair and pharyngoplasty surgery"	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Letter						Endoscope; Endoscopic surgery; Cleft palate; Plastic surgery; Maxillofacial surgery			[Ito, Osamu] Yokohama City Minato Red Cross Hosp, Dept Plast Surg, Naka Ku, Yokohama, Kanagawa 2318682, Japan; [Kawazoe, Takeshi] Kyoto Univ, Dept Plast Surg, Sakyo Ku, Kyoto, Kyoto 6068507, Japan; [Park, Susam] Shizuoka Childrens Hosp, Div Plast Surg, Shizuoka, Shizuoka 4200953, Japan	Ito, O (reprint author), Yokohama City Minato Red Cross Hosp, Dept Plast Surg, Naka Ku, 3-12-1 Shinyamashita, Yokohama, Kanagawa 2318682, Japan.	osaito1005@yahoo.co.jp					HENNINGSSON G, 1991, CLEFT PALATE-CRAN J, V28, P413, DOI 10.1597/1545-1569(1991)028<0413:CBMVAN>2.3.CO;2; LAMONT A, 1981, S AFR MED J, V60, P657; Park S, 2000, PLAST RECONSTR SURG, V105, P12, DOI 10.1097/00006534-200001000-00002; Park S, 2000, SCAND J PLAST RECONS, V34, P131; PROSCHEL U, 1994, LARYNGO RHINO OTOL, V73, P603, DOI 10.1055/s-2007-997205; Raurell A, 2000, ANN PLAS SURG, V45, P677	6	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	MAY	2015	79	5					778	780		10.1016/j.ijporl.2015.02.022		3	Otorhinolaryngology; Pediatrics	Otorhinolaryngology; Pediatrics	CG8ZQ	WOS:000353604600031		
J	Iida, T				Iida, Tetsuo			Benefits of leadtime information and of its combination with demand forecast information	INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS			English	Article						Inventory; Stochastic leadtimes; Demand forecasts; Leadtime information	DYNAMIC INVENTORY MODEL; BASE-STOCK LEVELS; PRODUCTION/INVENTORY SYSTEMS; APPROXIMATE SOLUTIONS; PRODUCTION CAPACITY; ORDER INFORMATION; UNCERTAIN DEMAND; OPTIMAL POLICIES; SAFETY STOCK; TIMES	This paper studies both the benefits of leadtime information and the interrelationships among demand forecast information, leadtime uncertainty, and leadtime information, for improving inventory control performance. To this end, it explicitly incorporates both leadtime information and demand forecast information into an inventory model although they have conventionally been dealt with individually in the literature. Specifically, it considers a periodic-review inventory model with uncertain leadtimes, in which both leadtime information and demand forecast information are available. The leadtime information is modeled as the information of the arrival of outstanding orders and the demand forecast information as the Martingale Model of Forecast Evolution (MMFE). The paper analyzes the way to use both leadtime information and demand forecast information for inventory control operations. Specifically, under certain conditions, the optimality of the state-dependent base-stock policy is shown, and an effective heuristic policy is developed. It also derives some managerial insights for exploiting both leadtime information and demand forecast information in the case where leadtimes are uncertain. For instance, while leadtime information itself significantly improves inventory control performance, it also enhances the benefits of demand forecast information. Specifically, the benefits of demand forecast information may significantly decrease as leadtime uncertainty increases. However, the decrease of the benefits of demand forecast information may be alleviated with leadtime information. (C) 2015 Elsevier B.V. All rights reserved.	Komazawa Univ, Fac Business Adm, Tokyo, Tokyo 1548525, Japan	Iida, T (reprint author), Komazawa Univ, Fac Business Adm, 1-23-1 Komazawa, Tokyo, Tokyo 1548525, Japan.	iida@komazawa-u.ac.jp					Altug MS, 2011, INT J PROD ECON, V129, P302, DOI 10.1016/j.ijpe.2010.11.005; HEATH DC, 1994, IIE TRANS, V26, P17, DOI 10.1080/07408179408966604; NAHMIAS S, 1979, OPER RES, V27, P904, DOI 10.1287/opre.27.5.904; Muharremoglu A, 2008, OPER RES, V56, P1089, DOI 10.1287/opre.1080.0620; Song JS, 1996, MANAGE SCI, V42, P1409, DOI 10.1287/mnsc.42.10.1409; Lee H, 2007, PROD OPER MANAG, V16, P40; Chen F, 2003, HDBK OPER R, V11, P341; Aviv Y, 2001, MANAGE SCI, V47, P1326, DOI 10.1287/mnsc.47.10.1326.10260; EPPEN GD, 1988, MANAGE SCI, V34, P1380, DOI 10.1287/mnsc.34.11.1380; Federgruen A, 1999, OPER RES, V47, P454, DOI 10.1287/opre.47.3.454; KAPLAN RS, 1970, MANAGE SCI, V16, P491, DOI 10.1287/mnsc.16.7.491; EHRHARDT R, 1984, OPER RES, V32, P121, DOI 10.1287/opre.32.1.121; Chen FR, 2001, OPER RES, V49, P226, DOI 10.1287/opre.49.2.226.13528; AVIV Y, 2004, HDB QUANTATIVE SUPPL, V74, P393; Ball MO, 2004, INT SER OPER RES MAN, V74, P447; Bertsekas D., 1996, STOCHASTIC OPTIMAL C; Chen F., 2005, MANUFACTURING SERVIC, V7, P144, DOI 10.1287/msom.1040.0060; CIARALLO FW, 1994, MANAGE SCI, V40, P320, DOI 10.1287/mnsc.40.3.320; Dong LX, 2003, OPER RES, V51, P969, DOI 10.1287/opre.51.6.969.24920; Gallego G., 2003, Manufacturing & Service Operations Management, V5, DOI 10.1287/msom.5.2.157.16072; Gallego G, 2001, MANAGE SCI, V47, P1344, DOI 10.1287/mnsc.47.10.1344.10261; Graves S. C., 1998, Operations Research, V46, DOI 10.1287/opre.46.3.S35; GRAVES SC, 1986, LECT NOTES ECON MATH, V266, P9; Gullu R, 1996, NAV RES LOG, V43, P289; Gullu R, 1999, INT J PROD ECON, V59, P377, DOI 10.1016/S0925-5273(98)00024-3; Hariharan R, 1995, MANAGE SCI, V41, P1599, DOI 10.1287/mnsc.41.10.1599; Iida T, 2006, M&SOM-MANUF SERV OP, V8, P407, DOI 10.1287/msom.1060.0116; Iida T., 2010, KOMAZAWA BUS REV, V41, P427; Iida T, 2002, EUR J OPER RES, V140, P670, DOI 10.1016/S0377-2217(01)00218-1; Jaksic M, 2015, INT J PROD ECON, V159, P254, DOI 10.1016/j.ijpe.2014.09.015; Jaksic M, 2011, NAV RES LOG, V58, P355, DOI 10.1002/nav.20450; Karaesmen F, 2004, ANN OPER RES, V126, P135, DOI 10.1023/B:ANOR.0000012278.41301.24; Karaesmen F, 2002, IIE TRANS, V34, P649, DOI 10.1080/07408170208928902; Karaesmen F, 2003, INT SER OPER RES MAN, V63, P243; Liberopoulos G, 2005, INT J PROD ECON, V96, P213, DOI 10.1016/j.ijpe.2004.04.006; Liberopoulos G, 2008, EUR J OPER RES, V190, P136, DOI 10.1016/j.ejor.2007.06.011; Lu XW, 2006, OPER RES, V54, P1079, DOI 10.1287/opre.1060.0338; Lu YD, 2003, OPER RES, V51, P292, DOI 10.1287/opre.51.2.292.12781; Rockafellar R T, 1970, CONVEX ANAL; Schoenmeyr T, 2009, M&SOM-MANUF SERV OP, V11, P657, DOI 10.1287/msom.1080.0245; Toktay LB, 2001, MANAGE SCI, V47, P1268, DOI 10.1287/mnsc.47.9.1268.9787; Wijngaard J, 2007, OR SPECTRUM, V29, P643, DOI 10.1007/s00291-006-0076-x; ZIPKIN P, 1986, NAV RES LOG, V33, P763, DOI 10.1002/nav.3800330419; Zipkin P H., 2000, FDN INVENTORY MANAGE	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-5273	1873-7579		INT J PROD ECON	Int. J. Prod. Econ.	MAY	2015	163						146	156		10.1016/j.ijpe.2015.02.010		11	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Engineering; Operations Research & Management Science	CH0UB	WOS:000353736800012		
J	Yokota, Y; Funayama, T; Mutou-Yoshihara, Y; Ikeda, H; Kobayashi, Y				Yokota, Yuichiro; Funayama, Tomoo; Mutou-Yoshihara, Yasuko; Ikeda, Hiroko; Kobayashi, Yasuhiko			The bystander cell-killing effect mediated by nitric oxide in normal human fibroblasts varies with irradiation dose but not with radiation quality	INTERNATIONAL JOURNAL OF RADIATION BIOLOGY			English	Article						Bystander effect; cell killing; co-culture; nitric oxide; radiation quality; carbon ion	HEAVY-ION IRRADIATION; DOUBLE-STRAND BREAKS; X-RAYS; INTERCELLULAR COMMUNICATION; MICROBEAM IRRADIATION; SYNTHASE EXPRESSION; IONIZING-RADIATION; HUMAN GLIOBLASTOMA; ALPHA-PARTICLES; INDUCTION	Purpose : To investigate the dependence of the bystander cell-killing effect on radiation dose and quality, and to elucidate related molecular mechanisms. Materials and methods : Normal human fibroblast WI-38 cells were irradiated with 0.125 - 2 Gy of gamma-rays or carbon ions and were co-cultured with non-irradiated cells. Survival rates of bystander cells were investigated using the colony formation assays, and nitrite concentrations in the medium were measured using the modified Saltzman method. Results : Survival rates of bystander cells decreased with doses of gamma-rays and carbon ions of <= 0.5 Gy. Treatment of the specific nitric oxide (NO) radical scavenger prevented reductions in survival rates of bystander cells. Moreover, nitrite concentrations increased with doses of less than 0.25 Gy (gamma-rays) and 1 Gy (carbon ions). The dose responses of increased nitrite concentrations as well as survival reduction were similar between gamma-rays and carbon ions. In addition, negative relationships were observed between survival rates and nitrite concentrations. Conclusion : The bystander cell-killing effect mediated by NO radicals in normal human fi broblasts depends on irradiation doses of up to 0.5 Gy, but not on radiation quality. NO radical production appears to be an important determinant of gamma-ray-and carbon-ion-induced bystander effects.	[Yokota, Yuichiro; Funayama, Tomoo; Mutou-Yoshihara, Yasuko; Ikeda, Hiroko; Kobayashi, Yasuhiko] Japan Atom Energy Agcy, Microbeam Radiat Biol Grp, Takasaki, Gunma 3701292, Japan; [Ikeda, Hiroko; Kobayashi, Yasuhiko] Gunma Univ, Grad Sch Med, Maebashi, Gunma 371, Japan	Yokota, Y (reprint author), Japan Atom Energy Agcy, Microbeam Radiat Biol Grp, 1233 Watanuki, Takasaki, Gunma 3701292, Japan.	yokota.yuichiro@jaea.go.jp			JAEA; Japan Society for the Promotion of Science KAKENHI [25740019, 24310073]	This work was financially supported by JAEA and Japan Society for the Promotion of Science KAKENHI [grant number 25740019 to Y. Y. and 24310073 to T. F.]. The authors thank Drs T. Sakashita and M. Suzuki for their useful comments. The authors are also grateful to the operators of the Takasaki Ion Accelerators for Advanced Radiation Application, and to the operators of the Cobalt-60 irradiation facility in JAEA-Takasaki for their technical cooperation.	Ambs S, 1998, P NATL ACAD SCI USA, V95, P8823, DOI 10.1073/pnas.95.15.8823; Tomita M, 2010, RADIAT RES, V173, P380, DOI 10.1667/RR1995.1; SALTZMAN BE, 1954, ANAL CHEM, V26, P1949, DOI 10.1021/ac60096a025; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1; Fournier C, 2007, RADIAT RES, V167, P194, DOI 10.1667/RR0760.1; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Sokolov MV, 2005, ONCOGENE, V24, P7257, DOI 10.1038/sj.onc.1208886; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Rastogi S, 2012, RADIAT RES, V177, P244, DOI 10.1667/RR2805.1; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; NAGASAWA H, 1992, CANCER RES, V52, P6394; Matsumoto H, 2001, RADIAT RES, V155, P387, DOI 10.1667/0033-7587(2001)155[0387:IORBAN]2.0.CO;2; Mothersill C, 2001, RADIAT RES, V155, P759, DOI 10.1667/0033-7587(2001)155[0759:RIBEPH]2.0.CO;2; Schettino G, 2003, RADIAT RES, V160, P505, DOI 10.1667/RR3060; Schettino G, 2005, RADIAT RES, V163, P332, DOI 10.1667/RR3319; Gow MD, 2010, RADIAT RES, V173, P769, DOI 10.1667/RR1895.1; Shao CL, 2003, FASEB J, V17, P1422, DOI 10.1096/fj.02-1115com; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Anzenberg V, 2008, RADIAT RES, V170, P467, DOI 10.1667/RR1312.1; Autsavapromporn N, 2013, RADIAT RES, V180, P367, DOI 10.1667/RR3111.1; Hamada Nobuyuki, 2011, Curr Mol Pharmacol, V4, P79; Kanasugi Y, 2007, INT J RADIAT BIOL, V83, P73, DOI 10.1080/09553000601121116; Kiefer J., 1990, BIOL RAD EFFECTS, P55; Maeda M, 2010, RADIAT RES, V174, P37, DOI 10.1667/RR2086.1; Matsumoto H, 2000, INT J RADIAT BIOL, V76, P1649; Matsumoto H, 2002, METHOD ENZYMOL, V359, P280; AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; Shao C, 2002, INT J RADIAT BIOL, V78, P837, DOI 10.1080/09553000210149786; Shao CL, 2006, NUCL INSTRUM METH B, V251, P177, DOI 10.1016/j.nimb.2006.06.009; Shao CL, 2004, J RADIAT RES, V45, P97, DOI 10.1269/jrr.45.97; Shao CL, 2001, J RADIAT RES, V42, P305, DOI 10.1269/jrr.42.305; Shao CL, 2003, RADIAT ENVIRON BIOPH, V42, P183, DOI 10.1007/s00411-003-0202-y; Su XM, 2010, INT J RADIAT ONCOL, V77, P559, DOI 10.1016/j.ijrobp.2009.12.059; Tomita M, 2012, J RADIAT RES, V53, P482, DOI 10.1269/jrr.11055; Yokota Y, 2003, INT J RADIAT BIOL, V79, P681, DOI 10.1080/09553000310001622832; Yokota Y, 2005, RADIAT RES, V163, P520, DOI 10.1667/RR3355	36	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0955-3002	1362-3095		INT J RADIAT BIOL	Int. J. Radiat. Biol.	MAY	2015	91	5					383	388		10.3109/09553002.2015.1021960		6	Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CH3GQ	WOS:000353917700001		
J	Liu, Z; Uchiyama, T; Sakakibara, R; Yamamoto, T				Liu, Zhi; Uchiyama, Tomoyuki; Sakakibara, Ryuji; Yamamoto, Tatsuya			Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease	INTERNATIONAL UROLOGY AND NEPHROLOGY			English	Article						Parkinson's disease; Bladder disorder; Detrusor weakness; Overactive bladder; Quality of life	LOWER URINARY-TRACT; IMPAIRED CONTRACTILE FUNCTION; VENTRAL TEGMENTAL AREA; DETRUSOR HYPERACTIVITY; VOIDING DYSFUNCTION; SYMPTOMS; PREVALENCE; SINGLE; CATS; RATS	Overactive bladder occurs in up to 70 % and underactive bladder in up to 50 % of patients with Parkinson's disease (PD), which is thought to reflect an altered frontal-basal ganglia circuit. However, it is not clear how bladder disorder is related to motor function and to quality of life (QOL) in PD. We studied these relationships by conducting multiple regression (MR) and bivariate correlation (BV) statistical analyses. We recruited 58 PD patients, irrespective of the presence of bladder disorder: 35 men and 23 women of mean age 66.8 years, mean duration of the disease 5.4 years, and median score of Hoehn-Yahr stage 3. We administered a bladder questionnaire including two major types of lower urinary tract symptoms, 'overactive bladder (OAB)' and 'voiding difficulty,' in addition to a QOL index and a pressure-flow urodynamic study to detect detrusor overactivity (DO) during filling; and detrusor weakness, outlet obstruction, and post-void residuals (PVR) during voiding. We analyzed the results using the MR and BV methods. (1) Motor impairment (by HY grades) was significantly related to detrusor weakness (P < 0.05 MR); voiding difficulty, OAB (P < 0.05 BV) (by de novo, levodopa honeymoon, and wearing-off); and voiding difficulty (P < 0.05 MR). (2) Bladder QOL was significantly related to OAB, increased bladder sensation (P < 0.05 MR) and voiding difficulty (P < 0.05 BV). (3) Male gender was significantly related to outlet obstruction, DO (P < 0.05 MR). (4) Age was significantly related to DO and PVR (P < 0.05 MR). Disease duration was significantly related to OAB (P < 0.05 MR). From these results, detrusor weakness (relevant to motor impairment) and OAB (relevant to bladder QOL) are thought to be fundamental in PD. In contrast to the mechanism of OAB, the mechanism of detrusor weakness in PD remains unclear and warrants further exploration.	[Liu, Zhi] Jilin City Cent Hosp, Neurol, Jilin, Jilin, Peoples R China; [Liu, Zhi; Uchiyama, Tomoyuki; Sakakibara, Ryuji; Yamamoto, Tatsuya] Chiba Univ, Neurol, Chiba, Japan; [Uchiyama, Tomoyuki] Dokkyo Med Coll, Continence Ctr, Mibu, Tochigi, Japan; [Sakakibara, Ryuji] Toho Univ, Div Neurol, Dept Internal Med, Sakura Med Ctr, Sakura, Chiba 2858741, Japan	Sakakibara, R (reprint author), Chiba Univ, Neurol, Chiba, Japan.	sakakibara@sakura.med.toho-u.ac.jp					MALONELEE J, 1993, BRIT J UROL, V72, P873, DOI 10.1111/j.1464-410X.1993.tb16289.x; Sakakibara R, 2014, PARKINSONISM RELAT D, V20, P267, DOI 10.1016/j.parkreldis.2013.11.001; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; Tsunoyama K, 2011, NEUROUROL URODYNAM, V30, P339, DOI 10.1002/nau.20953; Sakakibara R, 2012, NEUROBIOL DIS, V46, P565, DOI 10.1016/j.nbd.2011.10.002; SCHAFER W, 1990, UROL CLIN N AM, V17, P553; Hindle JV, 2010, AGE AGEING, V39, P156, DOI 10.1093/ageing/afp223; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Uchiyama T, 2003, MOVEMENT DISORD, V18, P573, DOI 10.1002/mds.10403; Madersbacher S, 1998, UROLOGY, V51, P206, DOI 10.1016/S0090-4295(97)00616-X; Araki I, 2000, J UROLOGY, V164, P1640, DOI 10.1016/S0022-5347(05)67048-6; Schulz JB, 2004, CELL TISSUE RES, V318, P135, DOI 10.1007/s00441-004-0954-y; Araki I, 2000, J NEUROL NEUROSUR PS, V68, P429, DOI 10.1136/jnnp.68.4.429; Campos-Sousa RN, 2003, ARQ NEURO-PSIQUIAT, V61, P359, DOI 10.1590/S0004-282X2003000300007; Chaliha C, 2006, INT UROGYNECOL J, V17, P215, DOI 10.1007/s00192-005-1363-9; Chancellor MB, 2014, INT UROL NEPHROL, V46, pS1, DOI 10.1007/s11255-014-0789-8; Chang SJ, 2013, NEUROUROL URODYNAM, V32, P1014, DOI 10.1002/nau.22342; Defreitas GA, 2003, UROLOGY, V62, P651, DOI 10.1016/S0090-4295(03)00507-7; Goldstein DS, 2011, J NEUROL SCI; Hashimoto K, 2003, J PHARMACOL SCI, V92, P143; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lemack GE, 2000, UROLOGY, V56, P250, DOI 10.1016/S0090-4295(00)00641-5; Matsui H, 2006, PARKINSONISM RELAT D, V12, P284, DOI 10.1016/j.parkreldis.2005.12.008; RESNICK NM, 1987, JAMA-J AM MED ASSOC, V257, P3076, DOI 10.1001/jama.257.22.3076; Sakakibara R, 2002, AUTON NEUROSCI-BASIC, V102, P30, DOI 10.1016/S1566-0702(02)00180-7; Sakakibara R, 2001, AUTON NEUROSCI-BASIC, V9, P276; Terayama K, 2012, MOVEMENT DISORD, V27, P1775, DOI 10.1002/mds.25225; Winge K, 2006, NEUROUROL URODYNAM, V25, P116, DOI 10.1002/nau.20193; Yamamoto T, 2012, NEUROUROL URODYNAM, V31, P1128, DOI 10.1002/nau.22208; Yamamoto T, 2009, NEUROUROL URODYNAM, V28, P549, DOI 10.1002/nau.20682; Yamamoto T, 2006, NEUROUROL URODYNAM, V25, P356, DOI 10.1002/nau.20224; Yoshimura N, 2003, BRIT J PHARMACOL, V139, P1425, DOI 10.1038/sj.bjp.0705388	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-1623	1573-2584		INT UROL NEPHROL	Int. Urol. Nephrol.	MAY	2015	47	5					751	757		10.1007/s11255-015-0951-y		7	Urology & Nephrology	Urology & Nephrology	CH2AS	WOS:000353826400008		
J	Ishibashi, Y; Shiraishi, Y; Takahashi, A				Ishibashi, Yoshihisa; Shiraishi, Yuuki; Takahashi, Atsushi			A uniqueness theorem for Frobenius manifolds and Gromov-Witten theory for orbifold projective lines	JOURNAL FUR DIE REINE UND ANGEWANDTE MATHEMATIK			English	Article							QUANTUM COHOMOLOGY; SPACES	We prove that the Frobenius structure constructed from the Gromov-Witten theory for an orbifold projective line with at most three orbifold points is uniquely determined by the Witten-Dijkgraaf-Verlinde-Verlinde equations with certain natural initial conditions.	[Ishibashi, Yoshihisa; Shiraishi, Yuuki; Takahashi, Atsushi] Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan	Ishibashi, Y (reprint author), Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan.	y-ishibashi@cr.math.sci.osaka-u.ac.jp; sm5021sy@ecs.cmc.osaka-u.ac.jp; takahashi@math.sci.osaka-u.ac.jp			JSPS International Training Program (ITP); Ministry of Education, Culture, Sports, Science and Technology, Japan [24684005]	The second named author is deeply grateful to Claus Hertling and Christian Sevenheck for their valuable discussions and encouragement. He is supported by the JSPS International Training Program (ITP). The third named author is supported by Grant-in Aid for Scientific Research grant numbers 24684005 from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Finally, we thank the referees for their careful reading of our paper and for valuable comments.	Abramovich D, 2008, AM J MATH, V130, P1337; Milanov TE, 2008, J REINE ANGEW MATH, V622, P189, DOI 10.1515/CRELLE.2008.069; Mann E, 2008, J ALGEBRAIC GEOM, V17, P137; Chen Weimin, 2002, CONT MATH, V310, P25, DOI 10.1090/conm/310/05398; Dubrovin B., 1996, LECT NOTES MATH, V1620, P120; KONTSEVICH M, 1994, COMMUN MATH PHYS, V164, P525, DOI 10.1007/BF02101490; Manin Y. I., 1999, AM MATH SOC C PUBL, V47; Rossi P., 2008, PREPRINT; Saito K, 2008, P SYMP PURE MATH, V78, P31; Satake I., 2011, PREPRINT	10	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0075-4102	1435-5345		J REINE ANGEW MATH	J. Reine Angew. Math.	MAY	2015	702						143	171		10.1515/crelle-2013-0030		29	Mathematics	Mathematics	CH1VM	WOS:000353809900006		
J	Moteki, N; Mori, T				Moteki, Nobuhiro; Mori, Tatsuhiro			Theoretical analysis of a method to measure size distributions of solid particles in water by aerosolization	JOURNAL OF AEROSOL SCIENCE			English	Article						Colloid; Size distribution; Nebulizer; Black carbon	BLACK CARBON; SCATTERING	Reliable measurement of the size-resolved number concentration (size distribution) of solid particles dispersed in water or melted ice is of critical importance in many geoscientific observational studies. Because physical and chemical properties of particles can be measured more unambiguously and accurately in rarefied media (air) than in condensed media (water), particle measurement after aerosolization using a nebulizer is a significant method for the observation of solid particles dispersed in water. We propose a mathematical theory for estimating the original size distribution of solid particles in water from the measured size distribution of aerosolized particles. We assume that the size distribution of water droplets produced by a nebulizer is given. The size distribution of solid particles in water can be estimated by solving a system of nonlinear equations. The complexity in solving the equations increases rapidly with the computational resolution of particle size and the assumed maximum number of particles within each droplet. For such a system of equations, we found rigorous error bounds of a true solution using INTLAB, an interval arithmetic package. Our theoretical framework will be useful in many fields in geoscience as a fundamental scheme to quantify solid particles in water. In particular, an application of the proposed theoretical method is shown to be useful for the quantitative observations of the size distribution of black carbon particles in rainwater. (C) 2015 Elsevier Ltd. All rights reserved.	[Moteki, Nobuhiro; Mori, Tatsuhiro] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	Moteki, N (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	moteki@eps.s.u-tokyo.ac.jp			Japan Society for the Promotion of Science [23221001]; Global Environment Research Fund of the Ministry of the Environment, Japan [2-1403]	This study was funded by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (23221001) and the Global Environment Research Fund of the Ministry of the Environment, Japan (2-1403). We would like to thank S. Ohata and Y. Kondo for useful discussions. Program code for solving inverse and forward problems will be available on request to N. Moteki.	Rump SM, 2010, ACTA NUMER, V19, P287, DOI 10.1017/S096249291000005X; MCCARTHY JF, 1989, ENVIRON SCI TECHNOL, V23, P496, DOI 10.1021/es00063a602; Moteki N, 2010, AEROSOL SCI TECH, V44, P663, DOI 10.1080/02786826.2010.484450; WELLS ML, 1992, MAR CHEM, V40, P5, DOI 10.1016/0304-4203(92)90045-C; Stramski D, 2004, PROG OCEANOGR, V61, P27, DOI 10.1016/j.pocean.2004.07.001; Ohata S, 2011, AEROSOL SCI TECH, V45, P1326, DOI 10.1080/02786826.2011.593590; Flanner M.G., 2007, J GEOPHYS RES-ATMOS, V112, pD11; KERKER M, 1983, CYTOMETRY, V4, P1, DOI 10.1002/cyto.990040102; Miroslaw J., 2011, LIGHT SCATTERING PAR; Moore R.E., 2009, INTRO INTERVAL ANAL; Mori T, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2014JD022103; Riley KJ, 2006, MATH METHODS PHYS EN; Rump S. M., 1999, DEV RELIABLE COMPUTI; Schwarz JP, 2013, SCI REP-UK, V3, DOI 10.1038/srep01356; WANG DS, 1980, APPL OPTICS, V19, P2315, DOI 10.1364/AO.19.002315	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-8502	1879-1964		J AEROSOL SCI	J. Aerosol. Sci.	MAY	2015	83						25	31		10.1016/j.jaerosci.2015.02.002		7	Engineering, Chemical; Engineering, Mechanical; Environmental Sciences; Meteorology & Atmospheric Sciences	Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CH2IX	WOS:000353850000003		
J	Sasaki, H; Hayashi, Y				Sasaki, Hiroyuki; Hayashi, Yoichiro			Regulatory fit in framing strategy of parental persuasive messages to young children	JOURNAL OF APPLIED SOCIAL PSYCHOLOGY			English	Article							NEGATIVE ROLE-MODELS; FEAR APPEALS; INDIVIDUAL-DIFFERENCES; IMMIGRANT CHINESE; SELF-REGULATION; STYLES; FOCUS; BEHAVIOR; TEMPERAMENT; MOTIVATION	The present research examined regulatory fit in parental messages aimed at young children. Study 1 measured parents' chronic regulatory focus, asking them to select either positively or negatively framed messages for promotion- and prevention-focused outcomes. The results showed that parents preferred positive frames for promotion-focused messages and negative frames for prevention-focused messages. Furthermore, parents with a chronic promotion focus favored a positively framed strategy more than parents with a prevention focus. Study 2 found that parents adopted different message strategies depending on whether they favored an active responsive or an active restrictive parenting style. Together, these findings demonstrate for the first time the applicability of regulatory focus/fit theory to explain parents' preferences for positively and negatively framed messages targeting children.	[Sasaki, Hiroyuki] Niigata Chuoh Jr Coll, Dept Child Educ, Kamo, Niigata 9591322, Japan; [Hayashi, Yoichiro] Keio Univ, Grad Sch Business Adm, Tokyo 108, Japan	Sasaki, H (reprint author), Niigata Chuoh Jr Coll, Dept Child Educ, 16-18 Gakko Cho, Kamo, Niigata 9591322, Japan.	sasakihi89@gmail.com			JSPS KAKENHI [24730560]	This work was supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B) Number 24730560. We would like to thank Johannes Keller for enabling us to access materials used in Keller (2008).	Higgins ET, 2000, AM PSYCHOL, V55, P1217, DOI 10.1037/0003-066X.55.11.1217; Higgins ET, 2001, EUR J SOC PSYCHOL, V31, P3, DOI 10.1002/ejsp.27; Lockwood P, 2002, J PERS SOC PSYCHOL, V83, P854, DOI 10.1037//0022-3514.83.4.854; MEYEROWITZ BE, 1987, J PERS SOC PSYCHOL, V52, P500, DOI 10.1037/0022-3514.52.3.500; Lee AY, 2004, J PERS SOC PSYCHOL, V86, P205, DOI 10.1037/0022-3514.86.2.205; Coolahan K, 2002, EARLY CHILD RES Q, V17, P356, DOI 10.1016/S0885-2006(02)00169-2; Cesario J, 2004, J PERS SOC PSYCHOL, V86, P388, DOI 10.1037/0022-3514.86.3.388; Levin IP, 2002, ORGAN BEHAV HUM DEC, V88, P411, DOI 10.1006/obhd.2001.2983; BAUMRIND D, 1967, GENET PSYCHOL MONOGR, V75, P43; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Forster J, 1998, J PERS SOC PSYCHOL, V75, P1115, DOI 10.1037/0022-3514.75.5.1115; LIN CYC, 1990, CHILD DEV, V61, P429, DOI 10.1111/j.1467-8624.1990.tb02789.x; Kuhberger A, 1998, ORGAN BEHAV HUM DEC, V75, P23, DOI 10.1006/obhd.1998.2781; Keller H, 2004, CHILD DEV, V75, P1745, DOI 10.1111/j.1467-8624.2004.00814.x; Lockwood P, 2005, PERS SOC PSYCHOL B, V31, P379, DOI 10.1177/0146167204271598; Idson LC, 2004, PERS SOC PSYCHOL B, V30, P926, DOI 10.1177/0146167204264334; CHAO RK, 1994, CHILD DEV, V65, P1111, DOI 10.1111/j.1467-8624.1994.tb00806.x; Keller J, 2008, EUR J SOC PSYCHOL, V38, P354, DOI 10.1002/ejsp.460; Kochanska G, 2008, CHILD DEV, V79, P30, DOI 10.1111/j.1467-8624.2007.01109.x; Spiegel S, 2004, EUR J SOC PSYCHOL, V34, P39, DOI 10.1002/ejsp.180; Higgins ET, 2003, J PERS SOC PSYCHOL, V84, P1140, DOI 10.1037/0022-3514.84.6.1140; Hamamura T, 2009, PERS SOC PSYCHOL B, V35, P454, DOI 10.1177/0146167208329512; Lee AY, 2000, J PERS SOC PSYCHOL, V78, P1122, DOI 10.1037//0022-3514.78.6.1122; Keller PA, 1996, J CONSUM RES, V22, P448, DOI 10.1086/209461; Higgins ET, 2005, CURR DIR PSYCHOL SCI, V14, P209; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; MARWELL G, 1967, SOCIOMETRY, V30, P350, DOI 10.2307/2786181; Shi RS, 2001, PSYCHOL SCI, V12, P70, DOI 10.1111/1467-9280.00312; Manian N, 2006, J PERS, V74, P1619, DOI 10.1111/j.1467-6494.2006.00422.x; Smith GE, 1996, J ADVERTISING RES, V36, P49; Chao RK, 2000, J APPL DEV PSYCHOL, V21, P233, DOI 10.1016/S0193-3973(99)00037-4; Russell A, 2003, INT J BEHAV DEV, V27, P74, DOI 10.1080/01650250244000038; Appelt KC, 2010, J EXP SOC PSYCHOL, V46, P1138, DOI 10.1016/j.jesp.2010.05.010; Blount S, 2000, ORGAN BEHAV HUM DEC, V81, P43, DOI 10.1006/obhd.1999.2866; Brislin R., 1973, CROSS CULTURAL RES M; Cesario J., 2008, SOCIAL PERSONALITY P, V2, P444, DOI [10.1111/j.1751-9004.2007.00055.x, DOI 10.1111/J.1751-9004.2007.00055.X]; desTurck M. A., 1983, J MARRIAGE FAM, V45, P543; Dijkstra A, 2009, BASIC APPL SOC PSYCH, V31, P234, DOI 10.1080/01973530903058441; Hart CH, 1998, DEV PSYCHOL, V34, P687, DOI 10.1037/0012-1649.34.4.687; Higgins E. T., 1998, MOTIVATION SELF REGU, P78, DOI DOI 10.1017/CB09780511527869.005; Latimer A.E., 2007, J EXPT SOCIAL PSYCHO, V44, P826; Lee A. Y., 2009, SOCIAL PSYCHOL CONSU, P319; Manian N, 1998, J PERS SOC PSYCHOL, V75, P1321, DOI 10.1037//0022-3514.75.5.1321; McBride B. A., 1993, EARLY CHILDHOOD RES, V8, P457, DOI DOI 10.1016/S0885-2006(05)80080-8; McElroy T, 2003, J EXP SOC PSYCHOL, V39, P610, DOI 10.1016/S0022-1031(03)00036-2; MAHESWARAN D, 1990, J MARKETING RES, V27, P361, DOI 10.2307/3172593; O'Keefe D. J., 2008, COMMUNICATION STUDIE, V59, P51, DOI DOI 10.1080/10510970701849388; Presaghi F., 2007, PSICOLOGIA SOCIALE, V1, P149; Risley T. R., 1995, MEANINGFUL DIFFERENC; ROBBERSON MR, 1988, J APPL SOC PSYCHOL, V18, P277, DOI 10.1111/j.1559-1816.1988.tb00017.x; Salovey P, 2004, AM BEHAV SCI, V47, P488, DOI 10.1177/0002764203259293; STERNTHAL B, 1974, J CONSUM RES, V1, P22, DOI 10.1086/208597; Steward WT, 2003, J APPL SOC PSYCHOL, V33, P2439, DOI 10.1111/j.1559-1816.2003.tb02775.x; Trommsdorff G., 2009, SOCIAL PERSONALITY P, V3, P687, DOI DOI 10.1111/J.1751-9004.2009.00209.X; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Van 't Riet J., 2008, EUROPEAN J SOCIAL PS, V38, P800; Yi SW, 2008, PSYCHOL MARKET, V25, P1007, DOI 10.1002/mar.20250	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9029	1559-1816		J APPL SOC PSYCHOL	J. Appl. Soc. Psychol.	MAY	2015	45	5					253	262		10.1111/jasp.12292		10	Psychology, Social	Psychology	CG8MU	WOS:000353562900001		
J	Pataky, TC; Vanrenterghem, J; Robinson, MA				Pataky, Todd C.; Vanrenterghem, Jos; Robinson, Mark A.			Zero- vs. one-dimensional, parametric vs. non-parametric, and confidence interval vs. hypothesis testing procedures in one-dimensional biomechanical trajectory analysis	JOURNAL OF BIOMECHANICS			English	Article						Bootstrap confidence interval; Kinematics; Ground reaction force; Statistical parametric mapping; Random field theory; Time series analysis	GAIT ANALYSIS; BOOTSTRAP; COORDINATION; PREDICTION; FORCES; BANDS	Biomechanical processes are often manifested as one-dimensional (1D) trajectories. It has been shown that 1D confidence intervals (CIs) are biased when based on OD statistical procedures, and the non-parametric 1D bootstrap CI has emerged in the Biomechanics literature as a viable solution. The primary purpose of this paper was to clarify that, for 1D biomechanics datasets, the distinction between OD and 1D methods is much more important than the distinction between parametric and non-parametric procedures. A secondary purpose was to demonstrate that a parametric equivalent to the 1D bootstrap exists in the form of a random field theory (RFT) correction for multiple comparisons. To emphasize these points we analyzed six datasets consisting of force and kinematic trajectories in one-sample, paired, two-sample and regression designs. Results showed, first, that the 1D bootstrap and other 1D non-parametric CIs were qualitatively identical to RFT CIs, and all were very different from OD CIs. Second, 10 parametric and 1D non-parametric hypothesis testing results were qualitatively identical for all six datasets. Last, we highlight the limitations of 1D CIs by demonstrating that they are complex, design-dependent, and thus non-generalizable. These results suggest that (i) analyses of 1D data based on OD models of randomness are generally biased unless one explicitly identifies OD variables before the experiment, and (ii) parametric and non-parametric 1D hypothesis testing provide an unambiguous framework for analysis when one's hypothesis explicitly or implicitly pertains to whole 1D trajectories. (C) 2015 Elsevier Ltd. All rights reserved.	[Pataky, Todd C.] Shinshu Univ, Dept Bioengn, Matsumoto, Nagano, Japan; [Vanrenterghem, Jos; Robinson, Mark A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England	Pataky, TC (reprint author), Shinshu Univ, Dept Bioengn, Matsumoto, Nagano, Japan.	tpataky@shinshu-u.ac.jp		Vanrenterghem, Jos/0000-0002-1682-8430			Neptune RR, 1999, MED SCI SPORT EXER, V31, P294, DOI 10.1097/00005768-199902000-00014; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1&lt;74::AID-HBM5&gt;3.0.CO;2-M; Besier TF, 2009, J BIOMECH, V42, P898, DOI 10.1016/j.jbiomech.2009.01.032; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Lenhoff MW, 1999, GAIT POSTURE, V9, P10, DOI 10.1016/S0966-6362(98)00043-5; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; Duhamel A, 2004, GAIT POSTURE, V20, P204, DOI 10.1016/j.gaitpost.2003.09.010; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Batterham AM, 2006, INTJ SPORT PHYSIOL, V1, P50; Dorn TW, 2012, J EXP BIOL, V215, P1944, DOI 10.1242/jeb.064527; Cutti AG, 2014, J BIOMECH, V47, P1035, DOI 10.1016/j.jbiomech.2013.12.028; Dixon PC, 2013, GAIT POSTURE, V38, P870, DOI 10.1016/j.gaitpost.2013.04.010; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Good P. I., 2005, PERMUTATION PARAMETR; Gravel P, 2010, J NEUROSCI METH, V190, P279, DOI 10.1016/j.jneumeth.2010.05.006; Kristianslund E., 2013, J BIOMECH, V45, P666; OLSHEN RA, 1989, ANN STAT, V17, P1419, DOI 10.1214/aos/1176347372; Pataky TC, 2012, COMPUT METHOD BIOMEC, V15, P295, DOI 10.1080/10255842.2010.527837; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Peterson M. G. E., 2000, Proceedings 13th IEEE Symposium on Computer-Based Medical Systems. CBMS 2000, DOI 10.1109/CBMS.2000.856876; Robinson MA, 2015, J ELECTROMYOGR KINES, V25, P14, DOI 10.1016/j.jelekin.2014.10.018; Sadeghi H, 2003, IEEE T NEUR SYS REH, V11, P24, DOI 10.1109/TNSRE.2003.810428; Schwartz MH, 2004, GAIT POSTURE, V20, P196, DOI 10.1016/j.gaitpost.2003.09.011; Silverman B. W., 2005, FUNCTIONAL DATA ANAL; Taylor J., 2007, RANDOM FIELDS GEOMET	29	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAY 1	2015	48	7					1277	1285		10.1016/j.jbiomech.2015.02.051		9	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CH0ZP	WOS:000353751200007		
J	Endo, N; Goto, A; Suzuki, T; Matsuda, S; Yasumura, S				Endo, Noriko; Goto, Aya; Suzuki, Tomoko; Matsuda, Shin; Yasumura, Seiji			Factors Associated With Enrollment and Adherence in Outpatient Cardiac Rehabilitation in Japan	JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION			English	Article						cardiac rehabilitation; patient adherence; patient enrollment	CHRONIC HEART-FAILURE; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; NON-ATTENDANCE; DROP-OUT; EXERCISE; PREDICTORS; PROGRAMS	PURPOSE: Despite the effectiveness of cardiac rehabilitation (CR), the participation percentage is low in Japan. Therefore, we investigated factors associated with enrollment and adherence in outpatient cardiac rehabilitation (OCR) in Japan. METHODS: This was a single-hospital, case-controlled study. During a 2-year study period, 544 patients were hospitalized for ischemic heart disease, heart failure, or open heart surgery, and recommended for in-hospital CR. Among them, 78 OCR participants and 179 randomly selected nonparticipants were included in the study. These 2 groups were compared to examine factors associated with OCR enrollment. In addition, OCR participants were divided into those who continued OCR for 3 months (adherence group) and those who did not (nonadherence group), and these 2 groups were compared to examine factors associated with OCR adherence. Univariate and multivariate logistic regression analyses were conducted for both objectives and included sociodemographic, clinical, and OCR-related variables. RESULTS: OCR enrollment was significantly associated with younger age (OR, 0.96; 95% CI, 0.93-0.98) and shorter distance to the hospital (OR, 0.97; 95% CI, 0.95-0.99). OCR adherence was significantly associated with a history of ischemic heart disease (OR, 6.03; 95% CI, 1.62-22.5) and prescription of antidepressants and/or sleeping pills (OR, 4.14; 95% CI, 1.07-16.0). CONCLUSIONS: The main factors associated with OCR enrollment and adherence were sociodemographic factors related to easier hospital access and clinical conditions that reflected high disease awareness, respectively.	[Endo, Noriko; Goto, Aya; Suzuki, Tomoko; Yasumura, Seiji] Fukushima Med Univ, Dept Publ Hlth, Sch Med, Koriyama, Fukushima, Japan; [Endo, Noriko; Matsuda, Shin] Ohta Nishinouchi Hosp, Ohta Gen Hosp Fdn, Koriyama, Fukushima, Japan	Endo, N (reprint author), Fukushima Med Univ, Ohta Nishinouchi Hosp, Ohta Gen Hosp Fdn, Sch Med,Cardiovasc Ctr, 2-5-21 Nishinouchi, Koriyama, Fukushima 9638554, Japan.	nopi@fmu.ac.jp					Goto Y, 2007, CIRC J, V71, P173, DOI 10.1253/circj.71.173; Clark AM, 2007, EUR J CARDIOV PREV R, V14, P538, DOI 10.1097/HJR.0b013e328013f11a; Evangelista LS, 2001, HEART LUNG, V30, P294, DOI 10.1067/mhl.2001.116011; Ramm C, 2001, NEW ZEAL MED J, V114, P227; Deskur-Smielecka E, 2009, KARDIOL POL, V67, P632; Belardinelli R, 1999, CIRCULATION, V99, P1173; ADES PA, 1992, ARCH INTERN MED, V152, P1033, DOI 10.1001/archinte.152.5.1033; Jackson L, 2005, HEART, V91, P10, DOI 10.1136/hrt.2004.045559; Bauer LK, 2012, AM J CARDIOL, V109, P1266, DOI 10.1016/j.amjcard.2011.12.017; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Ueshima K, 2004, JPN HEART J, V45, P789, DOI 10.1536/jhj.45.789; Grace SL, 2012, J CARDIOPULM REHABIL, V32, P41, DOI 10.1097/HCR.0b013e31823be13b; Menezes AR, 2014, PROG CARDIOVASC DIS, V56, P522, DOI 10.1016/j.pcad.2013.09.018; OLDRIDGE NB, 1983, AM J CARDIOL, V51, P70, DOI 10.1016/S0002-9149(83)80013-7; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Clark AM, 2012, AM HEART J, V164, P835, DOI 10.1016/j.ahj.2012.08.020; Brual J, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-27; De Vos C, 2013, EUR J PREV CARDIOL, V20, P341, DOI 10.1177/2047487312437057; Yohannes AM, 2007, CLIN REHABIL, V21, P222, DOI 10.1177/0269215506070771; Pack QR, 2013, CIRCULATION, V127, P349, DOI 10.1161/CIRCULATIONAHA.112.121996; Belardinelli R, 2001, J AM COLL CARDIOL, V37, P1891, DOI 10.1016/S0735-1097(01)01236-0; Worcester MUC, 2004, EUR J CARDIOV PREV R, V11, P328, DOI 10.1097/01.hjr.0000137083.20844.54; Bunker S, 1999, J Cardiopulm Rehabil, V19, P334, DOI 10.1097/00008483-199911000-00001; Clark AM, 2011, J CARDIOPULM REHABIL, V31, P42, DOI 10.1097/HCR.0b013e3181f68aa6; Davis MG, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-116; Du HY, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-63; Evans J, 2011, J CARDIOPULM REHABIL, V31, P181, DOI 10.1097/HCR.0b013e3181fc0970; Girolami B, 1999, ARCH INTERN MED, V159, P337, DOI 10.1001/archinte.159.4.337; Goto Y, 2014, PROG CARDIOVASC DIS, V56, P557, DOI 10.1016/j.pcad.2013.12.001; Goto Y, 2009, J CARDIOL JPN ED, V3, P195; Hansen D, 2009, J CARDIOPULM REHABIL, V29, P179, DOI 10.1097/HCR.0b013e3181a333ba; Ishii N, 2009, JPN J CARD REHABIL, V14, P145; JCS Joint Working Group, 2012, GUID REH PAT CARD DI; Kusunoki S, 2008, J JPN CORON ASS, V14, P206; Mak Y. M. W., 2005, Hong Kong Medical Journal, V11, P472; Motulsky H, 1995, INTUITIVE BIOSTATIST, P195; Nakanishi M, 2011, JPN J CARD REHABIL, V16, P188; Takeyama J, 2000, JPN CIRC J, V64, P809, DOI 10.1253/jcj.64.809	38	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1932-7501	1932-751X		J CARDIOPULM REHABIL	J. Cardiopulm. Rehabil. Prev.	MAY-JUN	2015	35	3					186	192		10.1097/HCR.0000000000000103		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG9GU	WOS:000353623700004		
J	Rajkumar, H; Kumar, M; Das, N; Kumar, SN; Challa, HR; Nagpal, R				Rajkumar, Hemalatha; Kumar, Manoj; Das, Nilita; Kumar, S. Nishanth; Challa, Hanumanth R.; Nagpal, Ravinder			Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers: A Randomized Controlled Single-Blind Pilot Study	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article						fructo-oligosaccharides; inflammation; insulin resistance; Lactobacillus salivarius; prebiotics; probiotics; synbiotics	DENSITY-LIPOPROTEIN CHOLESTEROL; DIET-INDUCED OBESITY; IMMUNE-RESPONSE; CONVENTIONAL YOGURT; ADIPOSE-TISSUE; MICROBIOTA; DISEASE; PLASMA; RATS; ACIDOPHILUS	This study investigated the effect of 6-week supplementation of a probiotic strain Lactobacillus salivarius UBL S22 with or without prebiotic fructo-oligosaccharide (FOS) on serum lipid profiles, immune responses, insulin sensitivity, and gut lactobacilli in 45 healthy young individuals. The patients were divided into 3 groups (15/group), that is, placebo, probiotic, and synbiotic. After 6 weeks, a significant reduction (P < .05) in total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides and increase in high-density lipoprotein cholesterol was observed in the probiotic as well as in the synbiotic group when compared to placebo; however, the results of total cholesterol and LDL-cholesterol were more pronounced in the synbiotic group. Similarly, when compared to the placebo group, the serum concentrations of inflammatory markers such as high sensitivity C-reactive protein, interleukin (IL) 6, IL-1 beta, and tumor necrosis factor a were significantly (P < .05) reduced in both the experimental groups, but again the reduction in the synbiotic group was more pronounced. Also, an increase (P < .05) in the fecal counts of total lactobacilli and a decrease (P < .05) in coliforms and Escherichia coil was observed in both the experimental groups after 6 weeks of ingestion. Overall, the combination of L salivarius with FOS was observed to be more beneficial than L salivarius alone, thereby advocating that such synbiotic combinations could be therapeutically exploited for improved health and quality of life.	[Rajkumar, Hemalatha; Kumar, Manoj; Das, Nilita; Kumar, S. Nishanth; Challa, Hanumanth R.] Natl Inst Nutr, Dept Microbiol & Immunol, Hyderabad 500007, Andhra Pradesh, India; [Nagpal, Ravinder] Juntendo Univ, Grad Sch Med, Div Labs Probiot Res, Tokyo, Japan	Kumar, M (reprint author), Natl Inst Nutr ICMR, Dept Microbiol & Immunol, Hyderabad, Andhra Pradesh, India.	manoj15micro@yahoo.co.in			NIN	The work was supported by and executed at NIN. This work was carried out at the Department of Microbiology and Immunology, National Institute of Nutrition, Hyderabad (Andhra Pradesh), India.	Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Guigoz Y, 2002, NUTR RES, V22, P13, DOI 10.1016/S0271-5317(01)00354-2; DiRienzo DB, 2014, NUTR REV, V72, P18, DOI 10.1111/nure.12084; GIBSON GR, 1995, J NUTR, V125, P1401; Roller M, 2004, J NUTR, V134, P153; Kajander K, 2008, ALIMENT PHARM THERAP, V27, P48, DOI 10.1111/j.1365-2036.2007.03542.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; Klein A, 2008, EUR J CLIN NUTR, V62, P584, DOI 10.1038/sj.ejcn.1602761; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Yadav H, 2007, NUTRITION, V23, P62, DOI 10.1016/j.nut.2006.09.002; Carol M, 2006, J LEUKOCYTE BIOL, V79, P917, DOI 10.1189/jlb.0405188; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Neville BA, 2010, FUTURE MICROBIOL, V5, P759, DOI [10.2217/fmb.10.35, 10.2217/FMB.10.35]; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Ng SC, 2009, INFLAMM BOWEL DIS, V15, P300, DOI 10.1002/ibd.20602; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Castellazzi AM, 2007, IMMUNOL INVEST, V36, P413, DOI 10.1080/08820130701361160; Tinrat S, 2011, J GEN APPL MICROBIOL, V57, P365; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Sanders ME, 2013, GUT, V62, P787, DOI 10.1136/gutjnl-2012-302504; [Anonymous], 2012, BR J NUTR, V107, P601; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Diaz-Ropero MP, 2007, J APPL MICROBIOL, V102, P337, DOI 10.1111/j.1365-2672.2006.03102.x; Meyer AL, 2007, J HUM NUTR DIET, V20, P590, DOI 10.1111/j.1365-277X.2007.00807.x; Yadav H, 2013, J BIOL CHEM, V288, P25088, DOI 10.1074/jbc.M113.452516; Nagpal R, 2012, FEMS MICROBIOL LETT, V334, P1, DOI 10.1111/j.1574-6968.2012.02593.x; Salminen SJ, 2005, J NUTR, V135, P1294; Kumar M, 2012, EXP DIABETES RES, DOI 10.1155/2012/902917; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Messaoudi S, 2013, FOOD MICROBIOL, V36, P296, DOI 10.1016/j.fm.2013.05.010; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Vyas U, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/872716; Videlock EJ, 2012, ALIMENT PHARM THER, V35, P1355, DOI 10.1111/j.1365-2036.2012.05104.x; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Vulevic J, 2008, AM J CLIN NUTR, V88, P1438, DOI 10.3945/ajcn.2008.26242; Chuang L, 2007, J AGR FOOD CHEM, V55, P11080, DOI 10.1021/jf071786o; Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Cani PD, 2013, CURR OPIN PHARMACOL, V13, P935, DOI 10.1016/j.coph.2013.09.008; Bodera Pawel, 2009, Recent Pat Inflamm Allergy Drug Discov, V3, P58; Canani RB, 2007, BMJ-BRIT MED J, V335, P335; Cani PD, 2012, CLIN MICROBIOL INFEC, V18, P50, DOI 10.1111/j.1469-0691.2012.03866.x; Childs CE, 2014, BR J NUTR, V24, P1; Fabian E, 2006, ANN NUTR METAB, V50, P387, DOI 10.1159/000094304; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; FULLER R, 1991, GUT, V32, P439, DOI 10.1136/gut.32.4.439; Hemalatha R, 2014, MEDIAT INFLAMM, V2014, DOI [10.1155/2014/348959, DOI 10.1155/2014/348959]; Hsieh PS, 2012, HELICOBACTER, V17, P466, DOI 10.1111/j.1523-5378.2012.00992.x; Ji Y, 2011, CURR OPIN CLIN NUTR, V14, P315, DOI 10.1097/MCO.0b013e3283476e74; Kumar M, 2012, BRIT J NUTR, V107, P1006, DOI 10.1017/S0007114511003953; Kumar R, 2011, BRIT J NUTR, V105, P561, DOI 10.1017/S0007114510003740; Mohania D, 2013, J CARDIOVASC PHARM T, V18, P490, DOI 10.1177/1074248413487431; Nadhazi Z., 2002, Acta Microbiologica et Immunologica Hungarica, V49, P151, DOI 10.1556/AMicr.49.2002.1.15; Nagpal R, 2007, INT J PROBIOTICS PRE, V2, P75; Nakarai H, 2011, INNATE IMMUN, V18, P164; Ooi LG, 2010, J DAIRY SCI, V93, P5048, DOI 10.3168/jds.2010-3311; Respondek F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071026; Schaafsma G, 1998, EUR J CLIN NUTR, V52, P436, DOI 10.1038/sj.ejcn.1600583; Toh ZQ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00171; Tsai YT, 2014, APPL MICROBIOL BIOT, V98, P1, DOI 10.1007/s00253-013-5346-3; Tumbaugh PJ, 2006, NATURE, V444, P1027; Turnbaugh PJ, 2009, NATURE, V22, p[457, 480]; Wu SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030440	68	3	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1074-2484	1940-4034		J CARDIOVASC PHARM T	J. Cardiovasc. Pharmacol. Ther.	MAY	2015	20	3					289	298		10.1177/1074248414555004		10	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CG5EZ	WOS:000353315200005		
J	Liang, GF; He, LM; Cheng, HY; Zhang, C; Li, XR; Fujita, S; Zhang, B; Arai, M; Zhao, FY				Liang, Guanfeng; He, Limin; Cheng, Haiyang; Zhang, Chao; Li, Xiaoru; Fujita, Shin-ichiro; Zhang, Bin; Arai, Masahiko; Zhao, Fengyu			ZSM-5-supported multiply-twinned nickel particles: Formation, surface properties, and high catalytic performance in hydrolytic hydrogenation of cellulose	JOURNAL OF CATALYSIS			English	Article						Ni catalyst; Multiply-twinned particles; Cellulose; Hydrogenation; Hexitol	SUPPORTED NI CATALYSTS; GOLD PARTICLES; INDUCED GROWTH; CONVERSION; NANOPARTICLES; WATER; TRANSITION; CHEMISTRY; HEXITOLS; SORBITOL	Nickel multiply-twinned particles (Ni MTPs) imbedded onto ZSM-5 were prepared, and their formation and chemical and electronic properties were characterized by HRTEM, XPS, CO-FTIR, and H-2-TPD. HRTEM showed the formation of Ni MTPs with triangular, square, hexagonal, and spherical shapes. The multiply-twinned particles were composed of f.c.c. nanocrystals dominated by (111) crystal face. Ni MTPs indicate an enhanced CO adsorption capability as compared with ordinary Ni particles. Ni MTPs were electron deficient and inherently strained, which is responsible for high catalytic activity in the hydrolytic hydrogenation of cellulose. (C) 2015 Elsevier Inc. All rights reserved.	[Liang, Guanfeng; He, Limin; Cheng, Haiyang; Zhang, Chao; Li, Xiaoru; Zhang, Bin; Zhao, Fengyu] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Peoples R China; [Liang, Guanfeng; He, Limin; Cheng, Haiyang; Zhang, Chao; Li, Xiaoru; Zhang, Bin; Zhao, Fengyu] Chinese Acad Sci, Changchun Inst Appl Chem, Lab Green Chem & Proc, Changchun 130022, Peoples R China; [Liang, Guanfeng; He, Limin; Li, Xiaoru; Zhang, Bin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Fujita, Shin-ichiro; Arai, Masahiko] Hokkaido Univ, Div Chem Proc Engn, Fac Engn, Sapporo, Hokkaido 0608628, Japan	Arai, M (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, Lab Green Chem & Proc, Changchun 130022, Peoples R China.	marai@eng.hokudai.ac.jp; zhaofy@ciac.ac.cn			National Natural Science Foundation of China (NNSFC) [21273222, 20086036]; Jilin Provincial Science and Technology Department, China [20100562]	The authors gratefully acknowledge the financial support from the National Natural Science Foundation of China (NNSFC) (Grant Nos. 21273222 and 20086036). The authors thanks the research grant from Jilin Provincial Science and Technology Department, China (Grant No. 20100562).	Ruban A, 1997, J MOL CATAL A-CHEM, V115, P421, DOI 10.1016/S1381-1169(96)00348-2; Pawelec B, 2007, APPL CATAL A-GEN, V323, P188, DOI 10.1016/j.apcata.2007.02.017; Palkovits R, 2011, CHEM COMMUN, V47, P576, DOI 10.1039/c0cc02263b; Corma A, 2007, CHEM REV, V107, P2411, DOI 10.1021/cr050989d; INO S, 1966, J PHYS SOC JPN, V21, P346, DOI 10.1143/JPSJ.21.346; Zhang QB, 2009, ACS NANO, V3, P139, DOI 10.1021/nn800531q; Algra RE, 2008, NATURE, V456, P369, DOI 10.1038/nature07570; Wang AQ, 2013, ACCOUNTS CHEM RES, V46, P1377, DOI 10.1021/ar3002156; Geboers J, 2010, CHEM COMMUN, V46, P3577, DOI 10.1039/c001096k; Mohr C, 2003, J CATAL, V213, P86, DOI 10.1016/S0021-9517(02)00043-X; Luo C, 2007, ANGEW CHEM INT EDIT, V46, P7636, DOI 10.1002/anie.200702661; Pang JF, 2012, GREEN CHEM, V14, P614, DOI 10.1039/c2gc16364k; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; MARKS LD, 1979, NATURE, V282, P196, DOI 10.1038/282196a0; Vogel W, 1998, J PHYS CHEM B, V102, P10853, DOI 10.1021/jp9827274; Resini C, 2009, APPL CATAL A-GEN, V353, P137, DOI 10.1016/j.apcata.2008.10.042; Lim B, 2009, ANGEW CHEM INT EDIT, V48, P6304, DOI 10.1002/anie.200902235; Walsh MJ, 2012, NANO LETT, V12, P2027, DOI 10.1021/nl300067q; Van de Vyver S, 2010, CHEMSUSCHEM, V3, P698, DOI 10.1002/cssc.201000087; Hadjiivanov KI, 2002, ADV CATAL, V47, P307, DOI 10.1016/S0360-0564(02)47008-3; Wang XC, 2012, GREEN CHEM, V14, P758, DOI 10.1039/c2gc15946e; Deng WP, 2010, J CATAL, V271, P22, DOI 10.1016/j.jcat.2010.01.024; Norskov JK, 2011, P NATL ACAD SCI USA, V108, P937, DOI 10.1073/pnas.1006652108; Hadjiivanov K, 2002, J PHYS CHEM B, V106, P2618, DOI 10.1021/jp0132782; Casillas G, 2012, J PHYS CHEM C, V116, P8844, DOI 10.1021/jp3011475; Dieguez M. G., 2010, J CATAL, V274, P11; GILLET MF, 1989, Z PHYS D ATOM MOL CL, V12, P107; GRIGERA JR, 1988, J CHEM SOC FARAD T 1, V84, P2603, DOI 10.1039/f19888402603; INO S, 1967, J PHYS SOC JPN, V22, P1365, DOI 10.1143/JPSJ.22.1365; Li Q, 2002, J CRYST GROWTH, V243, P327, DOI 10.1016/S0022-0248(02)01531-2; Liang GF, 2014, J CATAL, V309, P468, DOI 10.1016/j.jcat.2013.10.022; LU DL, 1995, SURF SCI, V325, pL397, DOI 10.1016/0039-6028(94)00806-X; Nepijko SA, 2000, J CRYST GROWTH, V213, P129, DOI 10.1016/S0022-0248(00)00337-7; Parizotto NV, 2009, APPL CATAL A-GEN, V366, P122, DOI 10.1016/j.apcata.2009.06.039; vandeWaal BW, 1996, J CRYST GROWTH, V158, P153, DOI 10.1016/0022-0248(95)00419-X	35	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	MAY	2015	325						79	86		10.1016/j.jcat.2015.02.014		8	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CH0ZH	WOS:000353750400009		
J	Gajavelli, S; Kentaro, S; Diaz, J; Yokobori, S; Spurlock, M; Diaz, D; Jackson, C; Wick, A; Zhao, WZ; Leung, LY; Shear, D; Tortella, F; Bullock, MR				Gajavelli, Shyam; Kentaro, Shimoda; Diaz, Julio; Yokobori, Shoji; Spurlock, Markus; Diaz, Daniel; Jackson, Clayton; Wick, Alexandra; Zhao, Weizhao; Leung, Lai Y.; Shear, Deborah; Tortella, Frank; Bullock, M. Ross			Glucose and oxygen metabolism after penetrating ballistic-like brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						2-deoxy glucose; cerebral metabolism; Fluorojade B; glucose; neurodegeneration; oxygen	ISCHEMIC PENUMBRA; GUNSHOT WOUNDS; UNITED-STATES; RAT MODEL; ACTIVATION; HEMORRHAGE; EXPRESSION; BIOMARKERS; SEVERITY	Traumatic brain injury (TBI) is a major cause of death and disability in all age groups. Among TBI, penetrating traumatic brain injuries (PTBI) have the worst prognosis and represent the leading cause of TBI-related morbidity and death. However, there are no specific drugs/interventions due to unclear pathophysiology. To gain insights we looked at cerebral metabolism in a PTBI rat model: penetrating ballistic-like brain injury (PBBI). Early after injury, regional cerebral oxygen tension and consumption significantly decreased in the ipsilateral cortex in the PBBI group compared with the control group. At the same time point, glucose uptake was significantly reduced globally in the PBBI group compared with the control group. Examination of Fluorojade B-stained brain sections at 24 hours after PBBI revealed an incomplete overlap of metabolic impairment and neurodegeneration. As expected, the injury core had the most severe metabolic impairment and highest neurodegeneration. However, in the peri-lesional area, despite similar metabolic impairment, there was lesser neurodegeneration. Given our findings, the data suggest the presence of two distinct zones of primary injury, of which only one recovers. We anticipate the peri-lesional area encompassing the PBBI ischemic penumbra, could be salvaged by acute therapies.	[Gajavelli, Shyam; Kentaro, Shimoda; Diaz, Julio; Spurlock, Markus; Diaz, Daniel; Jackson, Clayton; Wick, Alexandra; Zhao, Weizhao; Bullock, M. Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Leung, Lai Y.; Shear, Deborah; Tortella, Frank] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD USA	Bullock, MR (reprint author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Room 3-20,1095 NW 14th Terrace, Miami, FL 33136 USA.	RBullock@med.miami.edu			Department of Defense [PT074521W81XWH-08-1-0419]	This work was supported by Department of Defense Grant #PT074521W81XWH-08-1-0419 to RB.	KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; ASTRUP J, 1981, STROKE, V12, P723; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Heiss WD, 2011, CEREBROVASC DIS, V32, P307, DOI 10.1159/000330462; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Murakami Y, 2012, J NEUROSCI METH, V203, P115, DOI 10.1016/j.jneumeth.2011.09.025; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; BACK T, 1995, J CEREBR BLOOD F MET, V15, P566; Cartagena CM, 2014, MOL CELL NEUROSCI, V60, P81, DOI 10.1016/j.mcn.2014.04.005; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; De Fazio M, 2011, NEUROCRIT CARE, V14, P91, DOI 10.1007/s12028-010-9494-3; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Henry Boret, 2012, J Emerg Trauma Shock, V5, P103, DOI 10.4103/0974-2700.93101; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Kalesan B, 2014, AM J EPIDEMIOL, V179, P303, DOI 10.1093/aje/kwt255; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Tsukada H, 2014, J CEREBR BLOOD F MET, V34, P708, DOI 10.1038/jcbfm.2014.5; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Yao CP, 2011, J NEUROTRAUM, V28, P1237, DOI 10.1089/neu.2010.1678; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI 10.1089/neu.2008-0811; ZHAO WZ, 1995, J CEREBR BLOOD F MET, V15, P552	40	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2015	35	5					773	780		10.1038/jcbfm.2014.243		8	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CH1GK	WOS:000353769100012		
J	Takenouchi, T; Sugiura, Y; Morikawa, T; Nakanishi, T; Nagahata, Y; Sugioka, T; Honda, K; Kubo, A; Hishiki, T; Matsuura, T; Hoshino, T; Takahashi, T; Suematsu, M; Kajimura, M				Takenouchi, Toshiki; Sugiura, Yuki; Morikawa, Takayuki; Nakanishi, Tsuyoshi; Nagahata, Yoshiko; Sugioka, Tadao; Honda, Kurara; Kubo, Akiko; Hishiki, Takako; Matsuura, Tomomi; Hoshino, Takao; Takahashi, Takao; Suematsu, Makoto; Kajimura, Mayumi			Therapeutic hypothermia achieves neuroprotection via a decrease in acetylcholine with a concurrent increase in carnitine in the neonatal hypoxia-ischemia	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						acetylcholine (ACh); carnitine; cerebral metabolism; hypoxia-ischemia (H-I); neonate; therapeutic hypothermia; quantitative imaging mass spectrometry (Q-IMS)	CEREBRAL GLUCOSE-UTILIZATION; IMAGING MASS-SPECTROMETRY; KETONE-BODY UTILIZATION; BRAIN-DAMAGE; IMMATURE RAT; ENERGY-METABOLISM; MILD HYPOTHERMIA; IN-VIVO; SYSTEM; SLEEP	Although therapeutic hypothermia is known to improve neurologic outcomes after perinatal cerebral hypoxia-ischemia, etiology remains unknown. To decipher the mechanisms whereby hypothermia regulates metabolic dynamics in different brain regions, we used a two-step approach: a metabolomics to target metabolic pathways responding to cooling, and a quantitative imaging mass spectrometry to reveal spatial alterations in targeted metabolites in the brain. Seven-day postnatal rats underwent the permanent ligation of the left common carotid artery followed by exposure to 8% O-2 for 2.5 hours. The pups were returned to normoxic conditions at either 38 degrees C or 30 degrees C for 3 hours. The brain metabolic states were rapidly fixed using in situ freezing. The profiling of 107 metabolites showed that hypothermia diminishes the carbon biomass related to acetyl moieties, such as pyruvate and acetyl-CoA; conversely, it increases deacetylated metabolites, such as carnitine and choline. Quantitative imaging mass spectrometry demarcated that hypothermia diminishes the acetylcholine contents specifically in hippocampus and amygdala. Such decreases were associated with an inverse increase in carnitine in the same anatomic regions. These findings imply that hypothermia achieves its neuroprotective effects by mediating the cellular acetylation status through a coordinated suppression of acetyl-CoA, which resides in metabolic junctions of glycolysis, amino-acid catabolism, and ketolysis.	[Takenouchi, Toshiki; Sugiura, Yuki; Morikawa, Takayuki; Nakanishi, Tsuyoshi; Nagahata, Yoshiko; Sugioka, Tadao; Honda, Kurara; Kubo, Akiko; Hishiki, Takako; Matsuura, Tomomi; Hoshino, Takao; Suematsu, Makoto; Kajimura, Mayumi] Keio Univ, Dept Biochem, Sch Med, Tokyo 1608582, Japan; [Takenouchi, Toshiki; Takahashi, Takao] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Sugiura, Yuki; Honda, Kurara] JST Precursory Res Embryon Sci & Technol PRESTO P, Tokyo, Japan; [Morikawa, Takayuki; Nagahata, Yoshiko; Kubo, Akiko; Hishiki, Takako; Matsuura, Tomomi; Suematsu, Makoto; Kajimura, Mayumi] JST Exploratory Res Adv Technol ERATO Suematsu Ga, Tokyo, Japan; [Nakanishi, Tsuyoshi] Shimadzu Co Ltd, MS Business Unit, Tokyo, Japan	Kajimura, M (reprint author), Keio Univ, Dept Biochem, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	gasbiology@z6.keio.jp; myk30@z5.keio.jp	Suematsu, Makoto/I-8135-2013	Suematsu, Makoto/0000-0002-7165-6336	Japan Society for the Promotion of Science from Japan Society for the Promotion of Science [24791121, 26860854, 24500448]; Precursory Research for Embryonic Science and Technology (PRESTO) program from Japan Science and Technology Agency (JST); Exploratory Research for Advanced Technology (ERATO), Suematsu Gas Biology Project in Tokyo; Core Research for Evolutional Science and Technology (CREST) program from JST	The authors thank Ms. Eri Torikai for her help with the illustration in Figure 1. Preliminary results have been presented at the Society for Neuroscience 2013 and the Experimental Biology 2014. This work was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (24791121 and 26860854 to T.Take., 24500448 to MK) from the Japan Society for the Promotion of Science, the Precursory Research for Embryonic Science and Technology (PRESTO) program (to YS) from the Japan Science and Technology Agency (JST), and the Exploratory Research for Advanced Technology (ERATO), Suematsu Gas Biology Project, in Tokyo, 160-8582 (to MS), the Core Research for Evolutional Science and Technology (CREST) program (to MS) from JST.	Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; VANNUCCI RC, 1989, PEDIATR RES, V26, P208, DOI 10.1203/00006450-198909000-00011; WILLIAMS JA, 1994, J NEUROSCI, V14, P5236; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; WAWRZENCZYK A, 1995, NEUROCHEM INT, V26, P635, DOI 10.1016/0197-0186(94)00162-N; Hishiki T, 2012, J MOL MED, V90, P245, DOI 10.1007/s00109-012-0875-2; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; HAWKINS RA, 1971, BIOCHEM J, V122, P13; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Sugiura Y, 2012, ANAL BIOANAL CHEM, V403, P1851, DOI 10.1007/s00216-012-5988-5; Harada T, 2009, ANAL CHEM, V81, P9153, DOI 10.1021/ac901872n; Sugiura Y, 2014, PROTEOMICS, V14, P829, DOI 10.1002/pmic.201300047; VANNUCCI RC, 1990, PEDIATR RES, V27, P317, DOI 10.1203/00006450-199004000-00001; Shintani T, 2009, HEPATOLOGY, V49, P141, DOI 10.1002/hep.22604; Thoresen M, 2009, J CEREBR BLOOD F MET, V29, P707, DOI 10.1038/jcbfm.2008.163; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Hobbs C, 2008, STROKE, V39, P1307, DOI 10.1161/STROKEAHA.107.499822; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; NEHLIG A, 1993, PROG NEUROBIOL, V40, P163, DOI 10.1016/0301-0082(93)90022-K; Yamazoe S, 2014, ACS NANO, V8, P5622, DOI 10.1021/nn4065692; KAMETANI H, 1990, LIFE SCI, V47, P421, DOI 10.1016/0024-3205(90)90300-G; Cai YY, 2004, EMBO J, V23, P2047, DOI 10.1038/sj.emboj.7600221; CREMER JE, 1981, EARLY HUM DEV, V5, P117, DOI 10.1016/0378-3782(81)90043-8; Cronin CN, 1998, J BIOL CHEM, V273, P24465, DOI 10.1074/jbc.273.38.24465; GRIGOR MR, 1986, BIOCHEM J, V233, P917; HAGERDAL M, 1975, J NEUROCHEM, V24, P743; Hattori K, 2010, ANTIOXID REDOX SIGN, V13, P1157, DOI 10.1089/ars.2010.3290; Lee JC, 2011, METHOD ENZYMOL, P185, DOI 10.1016/B978-0-12-381268-1.00008-2; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; MATTHIEU JM, 1973, BRAIN RES, V55, P391, DOI 10.1016/0006-8993(73)90304-1; NALECZ KA, 1992, ARCH BIOCHEM BIOPHYS, V297, P162; PALMER C, 1990, J CEREBR BLOOD F MET, V10, P227; Roth Mark B, 2005, Sci Am, V292, P48; Takenouchi T, 2011, J PEDIATR-US, V159, P232, DOI 10.1016/j.jpeds.2011.01.006; VANNUCCI RC, 1988, STROKE, V19, P245; Vannucci RC, 1999, DEV BRAIN RES, V118, P147, DOI 10.1016/S0165-3806(99)00142-X; Wainwright MS, 2003, PEDIATR RES, V54, P688, DOI 10.1203/01.PDR.0000085036.07561.9C; YAGER J, 1993, PEDIATR RES, V34, P525, DOI 10.1203/00006450-199310000-00029; YAGER JY, 1992, AM J PHYSIOL, V262, pH672; Yamamoto T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4480	42	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2015	35	5					794	805		10.1038/jcbfm.2014.253		12	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CH1GK	WOS:000353769100014		
J	Shirao, S; Yoneda, H; Shinoyama, M; Sugimoto, K; Koizumi, H; Ishihara, H; Oka, F; Sadahiro, H; Nomura, S; Fujii, M; Tamechika, M; Kagawa, Y; Owada, Y; Suzuki, M				Shirao, Satoshi; Yoneda, Hiroshi; Shinoyama, Mizuya; Sugimoto, Kazutaka; Koizumi, Hiroyasu; Ishihara, Hideyuki; Oka, Fumiaki; Sadahiro, Hirokazu; Nomura, Sadahiro; Fujii, Masami; Tamechika, Masakatsu; Kagawa, Yoshiteru; Owada, Yuji; Suzuki, Michiyasu			A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Hyperlipidemia; lipid rafts; Rho-kinase; sphingosylphosphorylcholine; vasospasm	MYOSIN LIGHT-CHAIN; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CHRONIC CEREBRAL VASOSPASM; PLACEBO-CONTROLLED TRIAL; CA2+ SENSITIZATION; PROTEIN-KINASE; ENDOTHELIAL-CELLS; CORONARY-DISEASE; DOUBLE-BLIND; PHOSPHORYLATION	Hyperlipidemia is a risk factor for abnormal cerebrovascular events. Rafts are cholesterol-enriched membrane microdomains that influence signal transduction. We previously showed that Rho-kinase-mediated Ca2+ sensitization of vascular smooth muscle (VSM) induced by sphingosylphosphorylcholine (SPC) has a pivotal role in cerebral vasospasm. The goals of the study were to show SPC-Rho-kinase-mediated VSM contraction in vivo and to link this effect to cholesterol and rafts. The SPC-induced VSM contraction measured using a cranial window model was reversed by Y-27632, a Rho-kinase inhibitor, in rats fed a control diet. The extent of SPC-induced contraction correlated with serum total cholesterol. Total cholesterol levels in the internal carotid artery (ICA) were significantly higher in rats fed a cholesterol diet compared with a control diet or a beta-cyclodextrin diet, which depletes VSM cholesterol. Western blotting and real-time PCR revealed increases in flotillin-1, a raft marker, and flotillin-1 mRNA in the ICA in rats fed a cholesterol diet, but not in rats fed the beta-cyclodextrin diet. Depletion of cholesterol decreased rafts in VSM cells, and prevention of an increase in cholesterol by beta-cyclodextrin inhibited SPC-induced contraction in a cranial window model. These results indicate that cholesterol potentiates SPC-Rho-kinase-mediated contractions of importance in cerebral vasospasm and are compatible with a role for rafts in this process.	[Shirao, Satoshi; Yoneda, Hiroshi; Shinoyama, Mizuya; Sugimoto, Kazutaka; Koizumi, Hiroyasu; Ishihara, Hideyuki; Oka, Fumiaki; Sadahiro, Hirokazu; Nomura, Sadahiro; Fujii, Masami; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg & Clin Neurosci, Ube, Yamaguchi 7558505, Japan; [Tamechika, Masakatsu; Kagawa, Yoshiteru; Owada, Yuji] Yamaguchi Univ, Sch Med, Dept Organ Anat, Ube, Yamaguchi 7558505, Japan	Shirao, S (reprint author), Yamaguchi Univ, Sch Med, Dept Neurosurg & Clin Neurosci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	shirao@yamaguchi-u.ac.jp			Japan Ministry of Education, Culture, Sports, Science, and Technology; MEXT of Japan [22791346]; Kanae Foundation for the Promotion of Medical Science; Mitsubishi Pharma Research Foundation;  [20001008]	This work was supported (in part) by a Grant-in-Aid for Specially Promoted Research (Project No. 20001008) granted in 2008 to Kyushu Institute of Technology, Yamaguchi University, and Shizuoka University by the Japan Ministry of Education, Culture, Sports, Science, and Technology; a Grant-in-Aid for Scientific Research (Project No. 22791346) granted by MEXT of Japan; the Kanae Foundation for the Promotion of Medical Science; and the Mitsubishi Pharma Research Foundation.	Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Nakao F, 2002, CIRC RES, V91, P953, DOI 10.1161/01.RES.0000042702.04920.BF; Sato M, 2000, CIRC RES, V87, P195; Shirao S, 2002, CIRC RES, V91, P112, DOI 10.1161/01.RES.0000026057.13161.42; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; U-King-Im JM, 2009, LANCET NEUROL, V8, P569, DOI 10.1016/S1474-4422(09)70092-4; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Iida M, 1998, STROKE, V29, P1656; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Sterzer P, 2001, STROKE, V32, P2817, DOI 10.1161/hs1201.099663; SHIBUYA M, 1992, J NEUROSURG, V76, P571, DOI 10.3171/jns.1992.76.4.0571; LACOSTE L, 1995, CIRCULATION, V92, P3172; Amin E, 2013, BIOL CHEM, V394, P1399, DOI 10.1515/hsz-2013-0181; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; BROWN BG, 1993, CIRCULATION, V87, P1781; Das M, 2008, CELL PHYSIOL BIOCHEM, V21, P325, DOI 10.1159/000129391; FINDLAY JM, 1991, CEREBROVAS BRAIN MET, V3, P336; GONG MC, 1992, J BIOL CHEM, V267, P21492; Hartshorne DJ, 1987, PHYSL GASTROINTESTIN, P423; Heringdorf DMZ, 1996, N-S ARCH PHARMACOL, V354, P397; Jensen PE, 1996, BIOCHEM J, V318, P469; Kaewprasert S, 2001, J NUTR SCI VITAMINOL, V47, P335; Miyagi Y, 2000, J NEUROSURG, V93, P471, DOI 10.3171/jns.2000.93.3.0471; MIZUGUCHI K, 1992, JPN J PHARMACOL, V59, P307, DOI 10.1254/jjp.59.307; Mogami K, 1999, FEBS LETT, V457, P375, DOI 10.1016/S0014-5793(99)01076-5; Morikage N, 2006, CIRC RES, V99, P299, DOI 10.1161/01.RES.0000235877.33682.e9; Nagata J, 2007, GASTROENTEROLOGY, V133, P256, DOI 10.1053/j.gastro.2007.03.115; SATOH S, 1992, EUR J PHARMACOL, V220, P243; Schweitzer JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005193; Shirao S, 2008, CEREBROVASC DIS, V26, P30, DOI 10.1159/000135650; SPIEGEL S, 1995, J MEMBRANE BIOL, V146, P225; Tseng MY, 2007, J NEUROSURG, V107, P1092, DOI 10.3171/JNS-07/12/1092; Turan TN, 2010, STROKE, V41, P1636, DOI 10.1161/STROKEAHA.110.584672; WALSH MP, 1994, CAN J PHYSIOL PHARM, V72, P1392	38	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2015	35	5					835	842		10.1038/jcbfm.2014.260		8	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CH1GK	WOS:000353769100018		
J	Ahmad, S; de Oliveira, JAP				Ahmad, Sohail; Puppim de Oliveira, Jose A.			Fuel switching in slum and non-slum households in urban India	JOURNAL OF CLEANER PRODUCTION			English	Article						Cooking energy; Fuel switching; LPG; Slum; India	DEVELOPING-COUNTRIES; ENERGY USE; CO-BENEFITS; COOKING; CHOICE; HEALTH; PREFERENCES; COMBUSTION; CLIMATE; SECTOR	Improving access to modern fuels is essential in developing countries for reducing adverse human health and environmental impacts caused by traditional fuels. Fuels use in developing countries is heterogeneous across households. This paper estimates drivers of fuel switching in non-slum and slum households in urban India, using a discrete choice model on a nationally representative micro data. The choices considered are three categories of cooking fuels: traditional firewood, dung, crop residue and coal/charcoal; modern kerosene and liquefied petroleum gas (LPG); and mixed fuels. The results suggest that the patterns of fuels use are consistent with the energy ladder theory in urban India. In addition to income, the major determinants of modern fuels uptake are fuels prices, access to electricity and water supply, and education attainment. The increasing price of LPG affects the willingness to change fuels for low-income non-slum and the high-income slum households negatively. The analyses make a strong case for applying differential subsidies on modern fuels employing multidimensional aspects of poverty. Moreover, there is a need for partial diversion of existing fuels subsidies on improving physical and social capitals, which will result in uptake of modern fuels, particularly among disadvantaged communities. (C) 2015 Elsevier Ltd. All rights reserved.	[Ahmad, Sohail; Puppim de Oliveira, Jose A.] United Nations Univ Inst Adv Study Sustainabil UN, Shibuya Ku, Tokyo 1508925, Japan; [Ahmad, Sohail] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Tokyo 152, Japan; [Puppim de Oliveira, Jose A.] Getulio Vargas Fdn FGV, Brazilian Sch Publ & Business Adm EBAPE, Rio De Janeiro, Brazil	Ahmad, S (reprint author), Lab Integrated Res & Act Human Settlements Lab, D92,Second Floor, New Delhi 110025, India.	architectsohail@gmail.com			Japan Society for the Promotion of Science (JSPS); Ministry of the Environment, Japan (MOEJ)	The authors wish to thank the following people and the organizations: the Japan Society for the Promotion of Science (JSPS) for supporting the work of S. Ahmad through Grants-in-Aid for Scientific Research; the School of Planning and Architecture, Vijayawada (SPAV), and the Mercator Research Institute on Global Commons and Climate Change (MCC), Berlin, where S. Ahmad was affiliated while revising the manuscript; Prof. Manmohan Kapshe, Dr. Ping Jiang, and anonymous reviewers for their constructive and helpful comments on the manuscript. The article is the sole responsibility to the authors and does not express the views of the institutions that they are affiliated with. The research for the article was part of a larger research project, Urban Development with the Co-Benefits Approach, conducted by the United Nations University Institute for the Advanced Study of Sustainability (UNU-IAS) with the support of the Ministry of the Environment, Japan (MOEJ).	HOSIER RH, 1987, RESOUR ENERG, V9, P347, DOI 10.1016/0165-0572(87)90003-X; SMITH KR, 1993, ANNU REV ENERG ENV, V18, P529, DOI 10.1146/annurev.energy.18.1.529; Farsi M, 2007, ENVIRON DEV ECON, V12, P757, DOI 10.1017/S1355770X07003932; Purohit P, 2009, J CLEAN PROD, V17, P181, DOI 10.1016/j.jclepro.2008.04.004; Heltberg R, 2005, ENVIRON DEV ECON, V10, P337, DOI 10.1017/S1355770X04001858; Kowsari R, 2011, ENERG POLICY, V39, P7505, DOI 10.1016/j.enpol.2011.06.030; Heltberg R, 2004, ENERG ECON, V26, P869, DOI 10.1016/j.eneco.2004.04.018; van der Kroon B, 2013, RENEW SUST ENERG REV, V20, P504, DOI 10.1016/j.rser.2012.11.045; Roy A, 2005, J AM PLANN ASSOC, V71, P147, DOI 10.1080/01944360508976689; Masera OR, 2000, WORLD DEV, V28, P2083, DOI 10.1016/S0305-750X(00)00076-0; DEKONING HW, 1985, B WORLD HEALTH ORGAN, V63, P11; Reddy BS, 2009, ENERGY, V34, P992, DOI 10.1016/j.energy.2009.01.004; Alam M, 1998, ENERG POLICY, V26, P885, DOI 10.1016/S0301-4215(98)00008-1; Smith KR, 2000, ANNU REV ENERG ENV, V25, P741, DOI 10.1146/annurev.energy.25.1.741; Smith KR, 2008, ANNU REV PUBL HEALTH, V29, P11, DOI 10.1146/annurev.publhealth.29.020907.090759; Ahmad S, 2013, CITIES, V31, P641, DOI 10.1016/j.cities.2012.12.006; Jerneck A, 2013, J CLEAN PROD, V60, P208, DOI 10.1016/j.jclepro.2012.09.026; Gautam R., 2000, J CLEAN PROD, V8, P225, DOI 10.1016/S0959-6526(00)00006-8; Guptaa G, 2006, ECOL ECON, V57, P107, DOI 10.1016/j.ecolecon.2005.03.010; Holdren J.P., 2000, ENERGY ENV HLTH; Israel D, 2002, ECON DEV CULT CHANGE, V50, P865, DOI 10.1086/342846; Long J. S., 2006, REGRESSION MODELS CA; McMichael A., 2000, SPECIAL REPORT METHO, P329; Moreno E.L., 2003, SLUMS WORLD FACE URB; NBO, 2010, REP COMM SLUM STAT C; Ouedraogo B, 2006, ENERG POLICY, V34, P3787, DOI 10.1016/j.enpol.2005.09.006; Planning Commission, 2012, REP EXP GROUP REC DE; de Oliveira JAP, 2013, J CLEAN PROD, V58, P7, DOI 10.1016/j.jclepro.2013.08.009; Rao N., 2007, ENERGY, V32, P143; REDDY BS, 1995, ENERGY, V20, P929; UNDP/ESMAP, 2003, ACC POOR CLEAN HOUSE, P94	31	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-6526	1879-1786		J CLEAN PROD	J. Clean Prod.	MAY 1	2015	94						130	136		10.1016/j.jclepro.2015.01.072		7	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CH0VV	WOS:000353741400013		
J	Liao, MI; Chen, PC; Ma, HW; Nakamura, S				Liao, Meng-i; Chen, Pi-cheng; Ma, Hwong-wen; Nakamura, Shinichiro			Identification of the driving force of waste generation using a high-resolution waste input-output table	JOURNAL OF CLEANER PRODUCTION			English	Article						Waste input-output table; Waste generation; Sustainable consumption and production; Final demand	MATERIAL FLOW-ANALYSIS; SUSTAINABILITY ASSESSMENT; ENVIRONMENTAL IMPACTS; SUPPLY CHAIN; MODEL; CONSUMPTION; METALS; APPLIANCES; ECONOMY	Effective strategic planning for industrial waste management requires sound knowledge of the waste streams in an economy. Based on an input output analysis with an extended function to consider the entire life cycle of a product, waste input output (WIO) analysis plays an important role in describing the driving forces behind the generation of industrial waste. In this study, we compile a high-resolution WIO table for Taiwan that traces the flow of waste streams covering almost all types of waste emitted from industries into corresponding wake treatments and that identifies the driving force of waste in the economic system. In addition, we generate a detailed breakdown of the final demand categories into sub-categories to clarify consumption patterns or lifestyles that produce specific waste streams. The results show that export is the main driving force generating industrial waste. This dominance is obvious for "waste acidic etchants" and "copper and copper compounds", of which the electronic parts and components sector is the largest generator. In addition, this study reveals the industries that create the substantial demand for incinerators and landfills. This article illuminates the diagnostic features of the high-resolution WIO table and provides useful insights for linking the WIO and supply chain analysis approaching sustainable consumption and production. (C) 2015 Elsevier Ltd. All rights reserved.	[Liao, Meng-i; Chen, Pi-cheng; Ma, Hwong-wen] Natl Taiwan Univ, Grad Inst Environm Engn, Taipei 106, Taiwan; [Nakamura, Shinichiro] Waseda Univ, Grad Sch Econ, Tokyo 1698050, Japan	Ma, HW (reprint author), Natl Taiwan Univ, Grad Inst Environm Engn, 71 Chou Shan Rd, Taipei 106, Taiwan.	hwma@ntu.edu.tw		MA, HWONG-WEN/0000-0002-7595-2343			Nakamura S, 2005, MATER TRANS, V46, P2550, DOI 10.2320/matertrans.46.2550; Nakamura S, 2006, ECOL ECON, V57, P494, DOI 10.1016/j.ecolecon.2005.05.002; Vergragt P, 2014, J CLEAN PROD, V63, P1, DOI 10.1016/j.jclepro.2013.09.028; Hertwich EG, 2005, ENVIRON SCI TECHNOL, V39, P4673, DOI 10.1021/es0497375; LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294; Seppala J, 2011, J CLEAN PROD, V19, P1833, DOI 10.1016/j.jclepro.2011.04.021; Egilmez G, 2013, J CLEAN PROD, V53, P91, DOI [10.1016/j.jclepro.2013.03.037, 10.1016/j.jclepro,2013.03.037]; Nakamura S, 2007, J IND ECOL, V11, P50, DOI 10.1162/jiec.2007.1290; Huppes G, 2006, J IND ECOL, V10, P129, DOI 10.1162/jiec.2006.10.3.129; Nakamura S, 2009, J IND ECOL, V13, P706, DOI 10.1111/j.1530-9290.2009.00153.x; Kondo Y, 2004, INT J LIFE CYCLE ASS, V9, P236, DOI 10.1065/lca2004.033.153; Clift R, 2000, TECHNOL FORECAST SOC, V65, P281, DOI 10.1016/S0040-1625(99)00055-4; Court C.D., 2014, EUR J OPER RES; Hendrickson C.T., 2006, RESOURCES FUTURE; Jensen C. D., 2011, REG STUD, V47, P913; Jiang QH, 2014, J CLEAN PROD, V78, P131, DOI 10.1016/j.jclepro.2014.04.003; Kagawa S, 2007, RESOUR CONSERV RECY, V51, P141, DOI 10.1016/j.resconrec.2006.09.001; Kucukvar M, 2014, J CLEAN PROD, V81, P234, DOI 10.1016/j.jclepro.2014.06.033; Lee CH, 2012, RESOUR CONSERV RECY, V68, P29, DOI 10.1016/j.resconrec.2012.07.007; Nakajima K, 2011, ISIJ INT, V51, P1934, DOI 10.2355/isijinternational.51.1934; Nakajima K, 2013, ENVIRON SCI TECHNOL, V47, P4653, DOI 10.1021/es3043559; Nakamura S., 2002, J MATER CYCLES WASTE, V4, P2; Nakamura Shinichiro, 2002, Journal of Industrial Ecology, V6, P39, DOI 10.1162/108819802320971632; Nakamura S, 2009, ECO-EFFIC IND SCI, V26, P1; Nakamura S, 2012, ENVIRON SCI TECHNOL, V46, P9266, DOI 10.1021/es3013529; Takase K, 2005, J IND ECOL, V9, P201, DOI 10.1162/1088198054084653; UNEP (United Nations Environment Program), 2002, SUST CONS GLOB STAT	27	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-6526	1879-1786		J CLEAN PROD	J. Clean Prod.	MAY 1	2015	94						294	303		10.1016/j.jclepro.2015.02.002		10	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CH0VV	WOS:000353741400029		
J	Nihashi, S; Ohshima, KI				Nihashi, Sohey; Ohshima, Kay I.			Circumpolar Mapping of Antarctic Coastal Polynyas and Landfast Sea Ice: Relationship and Variability	JOURNAL OF CLIMATE			English	Article							BOTTOM WATER FORMATION; SOUTHERN WEDDELL SEA; NOVA BAY POLYNYA; EAST ANTARCTICA; AMSR-E; ROSS-SEA; ARCTIC-OCEAN; FRAZIL ICE; PACK ICE; THICKNESS	Sinking of dense water from Antarctic coastal polynyas produces Antarctic Bottom Water (AABW), which is the densest water in the global overturning circulation and is a key player in climate change as a significant sink for heat and carbon dioxide. Very recent studies have suggested that landfast sea ice (fast ice) plays an important role in the formation and variability of the polynyas and possibly AABW. However, they have been limited to regional and case investigations only. This study provides the first coincident circumpolar mapping of Antarctic coastal polynyas and fast ice. The map reveals that most of the polynyas are formed on the western side of fast ice, indicating an important role of fast ice in the polynya formation. Winds diverging from a boundary comprising both coastline and fast ice are the primary determinant of polynya formation. The blocking effect of fast ice on westward sea ice advection by the coastal current would be another key factor. These effects on the variability in sea ice production for 13 major polynyas are evaluated quantitatively. Furthermore, it is demonstrated that a drastic change in fast ice extent, which is particularly vulnerable to climate change, causes dramatic changes in the polynyas and possibly AABW formation that can potentially contribute to further climate change. These results suggest that fast ice and precise polynya processes should be addressed by next-generation models to produce more accurate climate projections. This study provides the boundary and validation data of fast ice and sea ice production for such models.	[Nihashi, Sohey] Natl Inst Technol, Dept Mech Engn, Tomakomai Coll, Tomakomai, Hokkaido 0591275, Japan; [Ohshima, Kay I.] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan	Nihashi, S (reprint author), Natl Inst Technol, Dept Mech Engn, Tomakomai Coll, 443 Nishikioka, Tomakomai, Hokkaido 0591275, Japan.	sohey@me.tomakomai-ct.ac.jp	Ohshima, Kay/D-6909-2012		Ministry of Education, Culture, Sports, Science and Technology in Japan [20221001, 21740337, 24740322, 25241001]; research fund for Global Change Observation Mission-Water 1 (GCOM-W1) of the Japan Aerospace Exploration Agency (JAXA)	The AMSR-E data were provided by the National Snow and Ice Data Center (NSIDC), University of Colorado. We thank Robert A. Massom and Alexander D. Fraser for their valuable comments, and Takeshi Tamura for helping with the development of the AMSR-E algorithms. Comments from the editor and three reviewers were very helpful. This work was supported by Grants-in-Aids for Scientific Research (20221001, 21740337, 24740322, and 25241001) of the Ministry of Education, Culture, Sports, Science and Technology in Japan. This work was also supported by a research fund for Global Change Observation Mission-Water 1 (GCOM-W1) of the Japan Aerospace Exploration Agency (JAXA).	ADOLPHS U, 1995, ANTARCT SCI, V7, P307; Nihashi S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005222; Galton-Fenzi BK, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008214; Yu Y, 1996, J GEOPHYS RES-OCEANS, V101, P25753, DOI 10.1029/96JC02242; MARTIN S, 1981, ANNU REV FLUID MECH, V13, P379, DOI 10.1146/annurev.fl.13.010181.002115; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Drucker R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048668; Shadwick EH, 2013, GEOPHYS RES LETT, V40, P904, DOI 10.1002/grl.50178; Iwamoto K, 2013, INT J REMOTE SENS, V34, P468, DOI 10.1080/01431161.2012.712229; Tamura T, 2007, J ATMOS OCEAN TECH, V24, P1757, DOI 10.1175/JTECH2113.1; Scambos TA, 2006, ANN GLACIOL, V44, P345, DOI 10.3189/172756406781811457; Massom RA, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006083; Tamura T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032903; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Drucker R, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001213; Dragon AC, 2014, J MARINE SYST, V130, P46, DOI 10.1016/j.jmarsys.2013.06.006; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; KILLWORTH PD, 1983, REV GEOPHYS, V21, P1, DOI 10.1029/RG021i001p00001; Massom RA, 2001, ANN GLACIOL, V33, P391, DOI 10.3189/172756401781818518; FOSTER TD, 1976, DEEP-SEA RES, V23, P301, DOI 10.1016/0011-7471(76)90872-X; Rintoul Sr, 1998, ANTARCT RES SER, V75, P151; MARKUS T, 1995, J GEOPHYS RES-OCEANS, V100, P4473, DOI 10.1029/94JC02278; Jeffries MO, 1997, ANTARCT SCI, V9, P188; BROMWICH DH, 1984, J GEOPHYS RES-OCEANS, V89, P3561, DOI 10.1029/JC089iC03p03561; Tamura T, 2006, ANN GLACIOL, V44, P269, DOI 10.3189/172756406781811745; Markus T, 2000, IEEE T GEOSCI REMOTE, V38, P1387, DOI 10.1109/36.843033; Iwamoto K, 2014, J GEOPHYS RES-OCEANS, V119, P3574, DOI 10.1002/2013JC009749; JACOBS SS, 1970, DEEP-SEA RES, V17, P935, DOI 10.1016/0011-7471(70)90046-X; [Anonymous], 1998, ANTAR RES S; THORNDIKE AS, 1982, J GEOPHYS RES-OC ATM, V87, P5845, DOI 10.1029/JC087iC08p05845; Martin S, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002428; Tamura T, 2011, SOLA, V7, P17, DOI 10.2151/sola.2011-005; Massom RA, 1998, ANN GLACIOL, V27, P420; Comiso JC, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006391; Miles BWJ, 2013, NATURE, V500, P563, DOI 10.1038/nature12382; Kern S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038062; Fraser AD, 2012, J CLIMATE, V25, P1137, DOI 10.1175/JCLI-D-10-05032.1; Petrelli P, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC004048; Renfrew IA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000720; Hall DK, 2004, IEEE T GEOSCI REMOTE, V42, P1076, DOI 10.1109/TGRS.2004.825587; Ohshima KI, 2013, NAT GEOSCI, V6, P235, DOI 10.1038/NGEO1738; [Anonymous], 1998, ANTAR RES S; Key JR, 1997, REMOTE SENS ENVIRON, V61, P302, DOI 10.1016/S0034-4257(97)89497-7; Scott KA, 2014, IEEE T GEOSCI REMOTE, V52, P2726, DOI 10.1109/TGRS.2013.2265091; Toyota T, 2007, J OCEANOGR, V63, P393, DOI 10.1007/s10872-007-0037-2; Aoki S, 2013, J GEOPHYS RES-OCEANS, V118, P6046, DOI 10.1002/2013JC009009; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001739; Ashcroft P., 2003, AMSR E AQUA L2A GLOB; CAVALIERI DJ, 1994, J GEOPHYS RES-OCEANS, V99, P18343, DOI 10.1029/94JC01169; Cavalieri DJ, 2004, AMSR E AQUA DAILY L3; FEDOTOV VI, 1998, ANTAR RES S, V74, P343; Fusco G, 2002, MAR ECOL-P S Z N I, V23, P201, DOI 10.1111/j.1439-0485.2002.tb00019.x; Giles AB, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004139; GORDON AL, 1993, SCIENCE, V262, P95, DOI 10.1126/science.262.5130.95; Haran T., 2005, MODIS MOSAIC ANTARCT; Hwang BJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003703; Kern S, 2007, ANN GLACIOL, V46, P409, DOI 10.3189/172756407782871585; Kitade Y, 2014, GEOPHYS RES LETT, V41, P3528, DOI 10.1002/2014GL059971; Kondo J., 1975, Boundary-Layer Meteorology, V9; Konig-Langlo G., 1994, Meteorologische Zeitschrift, V3; Kottmeier C., 1996, J GEOPHYS RES, V101, P824, DOI DOI 10.1029/96JC01293; Kovacs A., 1996, CRREL MONOGR; Kozlovsky A. M., 1977, P SOV ANTARCT EXPED, V63, P1; Kurtz DD, 1985, ANTARCT RES SER, V43, P177, DOI DOI 10.1029/AR043P0177; Kusahara K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1156; Lacarra M, 2014, J GEOPHYS RES-OCEANS, V119, P5203, DOI 10.1002/2013JC009124; Jones PD, 2015, INT J CLIMATOL, V35, P1354, DOI 10.1002/joc.4061; Massom RA, 2003, ANTARCT SCI, V15, P303, DOI 10.1017/S0954102003001299; MAYKUT GA, 1987, J GEOPHYS RES-OCEANS, V92, P7032, DOI 10.1029/JC092iC07p07032; MAYKUT GA, 1978, J GEOPHYS RES-OC ATM, V83, P3646, DOI 10.1029/JC083iC07p03646; MILLER LA, 2007, POLYNYAS WINDOWS WOR, V74, P163, DOI 10.1016/S0422-9894(06)74005-3; Maqueda MAM, 2004, REV GEOPHYS, V42, DOI 10.1029/2002RG000116; Nakayama Y, 2014, OCEAN MODEL, V84, P26, DOI 10.1016/j.ocemod.2014.09.007; Nihashi S, 2012, J CLIMATE, V25, P2261, DOI 10.1175/JCLI-D-11-00022.1; Nihashi S, 2001, J GEOPHYS RES-OCEANS, V106, P16767, DOI 10.1029/2000JC000399; Ohshima KI, 2003, J METEOROL SOC JPN, V81, P653, DOI 10.2151/jmsj.81.653; PEASE CH, 1987, J GEOPHYS RES-OCEANS, V92, P7049, DOI 10.1029/JC092iC07p07049; REED RK, 1977, J PHYS OCEANOGR, V7, P482, DOI 10.1175/1520-0485(1977)007<0482:OEIOTO>2.0.CO;2; Riggs G. A., 2006, MODIS SEA ICE PRODUC; Saha S., 2010, NCEP CLIMATE FORECAS, DOI [http://dx.doi.org/10.5065/D69K487J, DOI 10.5065/D69K487J]; Tamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1820; Tamura T, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006586; Uotila J, 2000, J GEOPHYS RES-OCEANS, V105, P1135, DOI 10.1029/1999JC900265; Vihma T, 1996, J GEOPHYS RES-OCEANS, V101, P18279, DOI 10.1029/96JC01441; COX GFN, 1983, J GLACIOL, V29, P306; Williams GD, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004346; Williams GD, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005812; WMO, 1970, 259 WMOOMMBMO; Zillman J. W., 1972, METEOROLOGICAL STUDI, V26; Zwally H.J., 1985, ANTARCT RES SER, V43, P203	90	1	2	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	MAY 1	2015	28	9					3650	3670		10.1175/JCLI-D-14-00369.1		21	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CH2EJ	WOS:000353838200013		
J	Nagura, M; Terao, T; Hashizume, M				Nagura, Motoki; Terao, Toru; Hashizume, Masahiro			The Role of Temperature Inversions in the Generation of Seasonal and Interannual SST Variability in the Far Northern Bay of Bengal	JOURNAL OF CLIMATE			English	Article							INDIAN-OCEAN DIPOLE; SEA-SURFACE TEMPERATURE; EAST ASIAN TELECONNECTION; LAYER HEAT-BUDGET; EL-NINO; MIXED-LAYER; SUMMER MONSOON; ARABIAN SEA; LA-NINA; CLIMATE VARIABILITY	The northern Bay of Bengal is characterized by freshwater supply from the Ganges and Brahmaputra Rivers. The resulting shallow haline stratification and thick barrier layer lead to temperature inversions in fall and winter, that is, cool surface water overlaying warm subsurface water. This study examines sea surface temperature (SST) variability off Bangladesh and shows that temperature inversions play an essential role in generating seasonal and interannual SST variability there. Two satellite SST datasets reveal that the magnitude of SST variability has a local peak near the coast of Bangladesh on seasonal and interannual time scales. Output from a high-resolution ocean general circulation model, which is validated by satellite SST and Argo float observations, is used to calculate the mixed layer heat budget. Results show that inverted temperature profiles lead to SST warming on the seasonal time scale via heat exchange at the bottom of the mixed layer, which balances climatological atmospheric cooling in fall and winter. On interannual time scales, surface heat flux tends to damp SST variability, whereas heat exchange at the base of the mixed layer contributes to the growth of SST anomalies. SST off Bangladesh tends to be anomalously high in the year after an El Nino event and in the year of negative Indian Ocean dipole and La Nina events. The atmospheric circulations related to these climate modes force anomalous Ekman pumping, which advects more subsurface warm water to the surface in fall and winter, resulting in anomalous mixed layer warming. The deepening of the mixed layer entrains more subsurface warm water, which also contributes to anomalous warming.	[Nagura, Motoki] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Terao, Toru] Kagawa Univ, Fac Educ, Kagawa, Japan; [Hashizume, Masahiro] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 852, Japan	Nagura, M (reprint author), Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	nagura@jamstec.go.jp			NEKKEN	The authors thank the OFES team of JAMSTEC for their dedication in developing the model. We also thank H. Annamalai for his helpful comments. We would like to acknowledge the careful and insightful comments from three anonymous reviewers as well. The study is partly supported by the Cooperative Research Grant of NEKKEN, 2013.	Akhil VP, 2014, J GEOPHYS RES-OCEANS, V119, P3926, DOI 10.1002/2013JC009632; DAVIS RE, 1976, J PHYS OCEANOGR, V6, P249, DOI 10.1175/1520-0485(1976)006<0249:POSSTA>2.0.CO;2; ROSATI A, 1988, J PHYS OCEANOGR, V18, P1601, DOI 10.1175/1520-0485(1988)018<1601:AGCMFU>2.0.CO;2; Ogata T, 2013, J CLIMATE, V26, P2145, DOI 10.1175/JCLI-D-11-00615.1; Wang B, 2000, J CLIMATE, V13, P1517, DOI 10.1175/1520-0442(2000)013<1517:PEATHD>2.0.CO;2; Gentemann CL, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002092; Luo JJ, 2007, J CLIMATE, V20, P2178, DOI 10.1175/JCLI4132.1; Girishkumar MS, 2013, J GEOPHYS RES-OCEANS, V118, P2426, DOI 10.1002/jgrc.20192; Klein SA, 1999, J CLIMATE, V12, P917, DOI 10.1175/1520-0442(1999)012<0917:RSSTVD>2.0.CO;2; Emery WJ, 2001, J GEOPHYS RES-OCEANS, V106, P2387, DOI 10.1029/2000JC000246; GADGIL S, 1984, NATURE, V312, P141, DOI 10.1038/312141a0; Roemmich D, 2009, PROG OCEANOGR, V82, P81, DOI 10.1016/j.pocean.2009.03.004; SPRINTALL J, 1992, J GEOPHYS RES-OCEANS, V97, P7305, DOI 10.1029/92JC00407; Lau NC, 2003, J CLIMATE, V16, P3, DOI 10.1175/1520-0442(2003)016<0003:AOVITI>2.0.CO;2; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Hoerling MP, 1997, J CLIMATE, V10, P1769, DOI 10.1175/1520-0442(1997)010<1769:ENOLNA>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Pacanowski RC, 1998, MON WEATHER REV, V126, P3248, DOI 10.1175/1520-0493(1998)126<3248:TRIAZL>2.0.CO;2; Thadathil P, 2002, DEEP-SEA RES PT I, V49, P1801, DOI 10.1016/S0967-0637(02)00044-4; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Barnston AG, 1999, B AM METEOROL SOC, V80, P217, DOI 10.1175/1520-0477(1999)080<0217:PSOSAD>2.0.CO;2; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Huang BH, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001278; Larkin NK, 2002, J CLIMATE, V15, P1118, DOI 10.1175/1520-0442(2002)015<1118:EWENOA>2.0.CO;2; Shetye SR, 1996, J GEOPHYS RES-OCEANS, V101, P14011, DOI 10.1029/95JC03307; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Wallace JM, 1998, J GEOPHYS RES-OCEANS, V103, P14241, DOI 10.1029/97JC02905; Xie SP, 2009, J CLIMATE, V22, P730, DOI 10.1175/2008JCLI2544.1; Ashok K, 2001, GEOPHYS RES LETT, V28, P4499, DOI 10.1029/2001GL013294; Du Y, 2009, J CLIMATE, V22, P2023, DOI 10.1175/2008JCLI2590.1; Xie SP, 2002, J CLIMATE, V15, P864, DOI 10.1175/1520-0442(2002)015<0864:SAMOSI>2.0.CO;2; Han WQ, 2002, J PHYS OCEANOGR, V32, P216, DOI 10.1175/1520-0485(2002)032<0216:FMOSLI>2.0.CO;2; McBride JL, 2003, J CLIMATE, V16, P2905, DOI 10.1175/1520-0442(2003)016<2905:RBTMCH>2.0.CO;2; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Wang B, 2002, J CLIMATE, V15, P3252, DOI 10.1175/1520-0442(2002)015<3252:PEATPI>2.0.CO;2; An SI, 2004, J CLIMATE, V17, P2399, DOI 10.1175/1520-0442(2004)017<2399:NAAOE>2.0.CO;2; Hashizume M, 2011, ENVIRON HEALTH PERSP, V119, P239, DOI 10.1289/ehp.1002302; MCCREARY JP, 1993, PROG OCEANOGR, V31, P181, DOI 10.1016/0079-6611(93)90002-U; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Han WQ, 2001, J GEOPHYS RES-OCEANS, V106, P859, DOI 10.1029/2000JC000316; CLARKE AJ, 1994, J PHYS OCEANOGR, V24, P1224, DOI 10.1175/1520-0485(1994)024<1224:ISLITN>2.0.CO;2; Boyer T. P., 1998, SALINITY INDIAN OCEA, V6; Boyer T. P., 1998, SALINITY PACIFIC OCE, V5; Boyer T.P., 1998, NOAA ATLAS NESDIS, V30; Bryan K., 1969, Journal of Computational Physics, V4, DOI 10.1016/0021-9991(69)90004-7; Castro SL, 2010, REMOTE SENS ENVIRON, V114, P2666, DOI 10.1016/j.rse.2010.06.003; de Boyer Montegut C, 2007, J CLIMATE, V20, P3249, DOI 10.1175/JCLI4148.1; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Emery WJ, 2004, DATA ANAL METHODS PH; Han WQ, 2001, J GEOPHYS RES-OCEANS, V106, P6895, DOI 10.1029/2000JC000403; Howden SD, 2001, J GEOPHYS RES-OCEANS, V106, P19825, DOI 10.1029/2000JC000656; Janowiak JE, 1998, J CLIMATE, V11, P2960, DOI 10.1175/1520-0442(1998)011<2960:ACOTNN>2.0.CO;2; Kessler WS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015924; Kim SB, 2006, J ATMOS OCEAN TECH, V23, P840, DOI 10.1175/JTECH1883.1; Terao T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023010; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Nagura M, 2005, J CLIMATE, V18, P1942, DOI 10.1175/JCLI3378.1; Nagura M, 2014, J PHYS OCEANOGR, V44, P343, DOI 10.1175/JPO-D-13-0141.1; Pacanowski R. C., 1999, 4 GFDL; RAO RR, 1989, J GEOPHYS RES-OCEANS, V94, P10801, DOI 10.1029/JC094iC08p10801; Rao RR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000907; Rao SA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014645; Rasmusson EM, 1990, J MARINE SYST, V1, P71, DOI 10.1016/0924-7963(90)90153-2; Sasaki H, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P157, DOI 10.1007/978-0-387-49791-4_10; Sasaki H., 2006, J EARTH SIMULATOR, V6, P35; Sengupta D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015340; Shenoi SSC, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000679; Shenoi SSC, 2005, J PHYS OCEANOGR, V35, P395, DOI 10.1175/JPO-2678.1; Terao T, 2013, J METEOROL SOC JPN, V91, P1, DOI 10.2151/jmsj.2013-101; Thadathil P, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003651; Tokinaga H, 2004, J METEOROL SOC JPN, V82, P1007, DOI 10.2151/jmsj.2004.1007; Vinayachandran PN, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000831; Fomby TB, 2002, J CLIMATE, V15, P117, DOI 10.1175/1520-0442(2002)015<0117:TAOSRT>2.0.CO;2; Wang JW, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008373; Wang WM, 2001, J GEOPHYS RES-OCEANS, V106, P837, DOI 10.1029/1999JC000076; Zaron ED, 2009, J PHYS OCEANOGR, V39, P2652, DOI 10.1175/2009JPO4133.1	76	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	MAY 1	2015	28	9					3671	3693		10.1175/JCLI-D-14-00553.1		23	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CH2EJ	WOS:000353838200014		
J	Abbassy, MA; Watari, I; Bakry, AS; Hamba, H; Hassan, AH; Tagami, J; Ono, T				Abbassy, M. A.; Watari, I.; Bakry, A. S.; Hamba, H.; Hassan, Ali H.; Tagami, J.; Ono, T.			Diabetes detrimental effects on enamel and dentine formation	JOURNAL OF DENTISTRY			English	Article						Enamel thickness; Dentine thickness; Type 1 Diabetes Mellitus; Micro CT; Histomorphometry; Tooth mineral density	MICRO-COMPUTED TOMOGRAPHY; X-RAY MICROTOMOGRAPHY; BONE-MINERAL DENSITY; ANIMAL-MODELS; RATS; MELLITUS; GROWTH; TEETH; INSULIN; PREGNANCY	Objectives: Understanding morphological changes and mineral content of tooth hard tissues may influence dental treatment. In this study, the effect of Type 1 Diabetes Mellitus (T1DM) on tooth structure was examined. Methods: Experimental T1DM was induced in 3-week old male Wistar rats (n = 10) by a single dose of 60 mg/kg body weight of Streprozotocin. All rats were injected with calcein twice during the experiment and sacrificed at the age of 7 weeks old. Micro-computed tomography (micro-CT) was used to determine the mineral density and thickness of enamel and dentine. Also, a histomorphometery study was conducted to detect the rates of dentine mineral apposition and formation. The examined area was in the crown analogue of the rat mandibular incisor parallel to the long axis of the mesial surface of the first molar. All results were compared using Students' t-test (p < 0.05). Results: Results showed that the enamel and dentine thickness were significantly reduced (hypoplasia) and there was a significant reduction of the rate of dentine mineral apposition and formation, while there was no significant effect of the T1DM condition on the mineral density of enamel and dentine. Conclusions: T1DM has a detrimental influence on the formation of enamel and dentine in the early growth stage. Clinical significance: T1DM condition may alter treatment planning of orthodontic treatment as it is associated with decreased enamel and dentin thickness that may affect teeth size and their resistance to caries. (C) 2015 Elsevier Ltd. All rights reserved.	[Abbassy, M. A.; Hassan, Ali H.] King Abdulaziz Univ, Fac Dent, Dept Orthodont, Jeddah 21589, Saudi Arabia; [Abbassy, M. A.; Watari, I.; Ono, T.] Tokyo Med & Dent Univ, Grad Sch, Dept Orofacial Dev & Funct, Orthodont Sci,Div Oral Hlth Sci,Bunkyo Ku, Tokyo 1138549, Japan; [Abbassy, M. A.] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Bunkyo Ku, Tokyo 1138549, Japan; [Abbassy, M. A.] Univ Alexandria, Alexandria, Egypt; [Bakry, A. S.] King Abdulaziz Univ, Fac Dent, Dept Operat Dent, Jeddah 21589, Saudi Arabia; [Bakry, A. S.] Univ Alexandria, Fac Dent, Conservat Dent Dept, Alexandria, Egypt; [Hamba, H.; Tagami, J.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Cariol & Operat Dent Dept, Bunkyo Ku, Tokyo, Tokyo 1138549, Japan	Bakry, AS (reprint author), King Abdulaziz Univ, Fac Dent, Dept Operat Dent, POB 80209, Jeddah 21589, Saudi Arabia.	drahmedbakry@gmail.com			NSTIP Strategic Technologies Program in the Kingdom of Saudi Arabia [12-MED2735-03]	This project was supported by the NSTIP Strategic Technologies Program in the Kingdom of Saudi Arabia - Project No. (12-MED2735-03). The authors also, acknowledge with thanks Science and Technology Unit, King Abdulaziz University for technical support.	Abbassy MA, 2008, ARCH ORAL BIOL, V53, P819, DOI 10.1016/j.archoralbio.2008.02.008; Vital SO, 2012, BONE, V50, P989, DOI 10.1016/j.bone.2012.01.010; PARFITT AM, 1988, BONE, V9, P67, DOI 10.1016/8756-3282(88)90029-4; Cochrane NJ, 2012, J DENT RES, V91, P185, DOI 10.1177/0022034511429570; Nazarian A, 2008, BONE, V43, P302, DOI 10.1016/j.bone.2008.04.009; Hamba H, 2012, J DENT RES, V91, P586, DOI 10.1177/0022034512444127; Gutowska I, 2011, BIOL TRACE ELEM RES, V139, P332, DOI 10.1007/s12011-010-8666-5; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Yeh CK, 2012, LAB INVEST, V92, P868, DOI 10.1038/labinvest.2012.60; McCracken MS, 2006, CLIN ORAL IMPLAN RES, V17, P495, DOI 10.1111/j.1600-0501.2006.01266.x; Pautke C, 2007, J ANAT, V210, P117, DOI 10.1111/j.1469-7580.2006.00660.x; Davis GR, 1996, PHYSIOL MEAS, V17, P121, DOI 10.1088/0967-3334/17/3/001; Siudikiene J, 2006, EUR J ORAL SCI, V114, P8, DOI 10.1111/j.1600-0722.2006.00277.x; Shimomoto Y, 2007, J DENT RES, V86, P47; Balint E, 2001, BONE, V28, P21, DOI 10.1016/S8756-3282(00)00426-9; ELLIOTT JC, 1982, J MICROSC-OXFORD, V126, P211; Lo ECM, 2010, J DENT, V38, P352, DOI 10.1016/j.jdent.2010.01.001; Burghardt AJ, 2008, CALCIFIED TISSUE INT, V83, P129, DOI 10.1007/s00223-008-9158-x; Abbassy MA, 2010, EUR J ORAL SCI, V118, P364, DOI 10.1111/j.1600-0722.2010.00739.x; Atar M, 2004, Int J Paediatr Dent, V14, P301, DOI 10.1111/j.1365-263X.2004.00562.x; Durand LAH, 2010, BIOL TRACE ELEM RES, V135, P242, DOI 10.1007/s12011-009-8512-9; Giglio MJ, 2001, EUR J ORAL SCI, V109, P193, DOI 10.1034/j.1600-0722.2001.00032.x; Hamba H, 2011, J DENT, V39, P405, DOI 10.1016/j.jdent.2011.03.005; KESHAWARZ NM, 1986, BONE, V7, P83, DOI 10.1016/8756-3282(86)90678-2; LOSKEN A, 1994, CLEFT PALATE-CRAN J, V31, P17, DOI 10.1597/1545-1569(1994)031<0017:CCSONC>2.3.CO;2; Ozbek M, 2009, J VET MED SCI, V71, P1273, DOI 10.1292/jvms.001273; Sato K, 1996, Adv Dent Res, V10, P216; Sheng MHC, 1999, BONE, V25, P421, DOI 10.1016/S8756-3282(99)00184-2; Sheng ZF, 2010, ARCH ORAL BIOL, V55, P288, DOI 10.1016/j.archoralbio.2010.02.007; SIEGEL MI, 1990, CLEFT PALATE J, V27, P18, DOI 10.1597/1545-1569(1990)027<0018:AAMFCB>2.3.CO;2; Silva-Sousa Yara Teresinha Corrêa, 2003, Braz Dent J, V14, P162, DOI 10.1590/S0103-64402003000300004; Siudikiene J, 2008, CARIES RES, V42, P354, DOI 10.1159/000151582; Splieth CH, 2011, CLIN ORAL INVEST, V16, P1395; Tein MSC, 1998, EXP PHYSIOL, V83, P165; Välikangas L, 2001, Adv Dent Res, V15, P72	35	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	MAY	2015	43	5					589	596		10.1016/j.jdent.2015.01.005		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CH2YC	WOS:000353890500014		
J	Nakao, A; Takeda, A; Ogasawara, S; Yanai, J; Sano, O; Ito, T				Nakao, Atsushi; Takeda, Akira; Ogasawara, Sho; Yanai, Junta; Sano, Oki; Ito, Toyoaki			Relationships between Paddy Soil Radiocesium Interception Potentials and Physicochemical Properties in Fukushima, Japan	JOURNAL OF ENVIRONMENTAL QUALITY			English	Article							NUCLEAR-POWER-PLANT; ORGANIC-MATTER; CLAY-MINERALS; ROOT UPTAKE; CS-137; CESIUM; ADSORPTION; SEDIMENTS; SORPTION; CS	The radiocesium interception potential (RIP) of bulk soil (RIPsoil) can reliably be used to predict the magnitude of soil-to-plant radiocesium transfer. There has been some controversy about which soil properties control the RIPsoil, although the RIP is theoretically proportional to the amount of frayed edge sites in micaceous clay minerals. The RIPsoil was determined for 97 paddy soils in three regions (Hama-dori, Naka-dori, and Aizu) in Fukushima Prefecture, Japan, and the relationships between selected physicochemical properties and the RIP were analyzed. The mean (+/- standard deviation) of the RIPsoil for the 97 soils was 1.67 (+/- 0.87) mol kg(-1), and the range was 0.34 to 5.36 mol kg(-1). Pearson correlation analysis revealed that the RIPsoil positively correlated best (P < 0.01) with the clay fraction K content as a mass fraction of the bulk soil (clay-K-soil) and negatively correlated with the total C content and the phosphate absorption coefficient (P < 0.05). Therefore, clay-K-soil, an indicator of the amount of micaceous clay minerals in a soil, was confirmed as being useful for estimating the magnitude of the RIPsoil for paddy soils in Fukushima. The RIPsoil was invariably low if either the total C content exceeded 6.0% or the phosphate absorption coefficient exceeded 1500 mg kg(-1), suggesting that these parameters could be useful for screening soils with particularly low RIPsoil values.	[Nakao, Atsushi; Ogasawara, Sho; Yanai, Junta] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan; [Takeda, Akira] Inst Environm Sci, Dept Radioecol, Aomori 0393212, Japan; [Sano, Oki; Ito, Toyoaki] Tohoku Univ, Grad Sch Agr Sci, Field Sci Ctr, Osaki, Miyagi 9896711, Japan	Nakao, A (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, 1-5 Hangi Cho, Kyoto 6068522, Japan.	na_4_ka_triplochiton@kpu.ac.jp			Kyoto Prefectural University	We thank the Fukushima Agricultural Technology Centre for providing soil samples that were collected for the Soil Conservation Measures Project. This work was financially supported by a Strategic Research Project Grant from Kyoto Prefectural University.	INOUE K, 1987, SOIL SCI PLANT NUTR, V33, P327; Yamashita J, 2014, J PLANT RES, V127, P11, DOI 10.1007/s10265-013-0605-z; SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; Rigol A, 2002, J ENVIRON RADIOACTIV, V58, P191, DOI 10.1016/S0265-931X(01)00066-2; Fan QH, 2014, GEOCHIM COSMOCHIM AC, V135, P49, DOI 10.1016/j.gca.2014.02.049; Dumat C, 1997, EUR J SOIL SCI, V48, P675, DOI 10.1046/j.1365-2389.1997.00114.x; Kruyts N, 2002, J ENVIRON RADIOACTIV, V58, P175, DOI 10.1016/S0265-931X(01)00065-0; Tsukada H, 2008, J ENVIRON RADIOACTIV, V99, P875, DOI 10.1016/j.jenvrad.2007.11.014; Delvaux B, 2000, ENVIRON SCI TECHNOL, V34, P1489, DOI 10.1021/es990658g; Staunton S, 1997, CLAY CLAY MINER, V45, P251, DOI 10.1346/CCMN.1997.0450213; CREMERS A, 1988, NATURE, V335, P247, DOI 10.1038/335247a0; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Dahlgren R.A., 1994, VOLCANIC ASH SOILS G, P101; de Koning A, 2007, APPL GEOCHEM, V22, P219, DOI 10.1016/j.apgeochem.2006.07.013; Eguchi T, 2012, SOIL SCI PLANT NUTR, V58, P191, DOI 10.1080/00380768.2012.672926; International Atomic Energy Agency, 2010, 472 IAEA; IUSS Working Group WRB, 2007, 103 FAO IUSS WORK GR; Jackson M. L., 1963, CLAYS CLAY MINER, V11, P29, DOI DOI 10.1346/CCMN.1962.0110104; Jackson M.L., 1958, SOIL CHEM ANAL ADV C; Kawaguchi K., 1974, SE ASIAN STUD, V12, P3; MIZOTA C, 1985, SOIL SCI PLANT NUTR, V31, P369; Nakao A, 2014, SCI TOTAL ENVIRON, V468, P523, DOI 10.1016/j.scitotenv.2013.08.062; Nakao A, 2008, SOIL SCI PLANT NUTR, V54, P479, DOI 10.1111/j.1747-0765.2008.00262.x; Saito T, 2014, J ENVIRON RADIOACTIV, V138, P11, DOI 10.1016/j.jenvrad.2014.07.025; Sano O., 2010, Pedologist, V54, P83; SHAW G, 1993, SCI TOTAL ENVIRON, V137, P119, DOI 10.1016/0048-9697(93)90381-F; SWEECK L, 1990, TRANSFER OF RADIONUCLIDES IN NATURAL AND SEMI-NATURAL ENVIRONMENTS, P249; Takahashi J, 2015, J ENVIRON RADIOACTIV, V139, P351, DOI 10.1016/j.jenvrad.2014.07.004; Takeda A, 2014, J ENVIRON RADIOACTIV, V137, P119, DOI 10.1016/j.jenvrad.2014.06.022; Thompson M.L., 2002, SSSA BOOK SERIES, V7, P431, DOI 10.2136/sssabookser7.c14; Tsukada H., 2012, PEDOLOGIST, V55, P435; Tsukada H, 2002, J ENVIRON RADIOACTIV, V59, P351, DOI 10.1016/S0265-931X(01)00083-2; Vandebroek L, 2012, J ENVIRON RADIOACTIV, V104, P87, DOI 10.1016/j.jenvrad.2011.09.002; Waegeneers N, 1999, J ENVIRON QUAL, V28, P1005; Wampler JM, 2012, ENVIRON SCI TECHNOL, V46, P3837, DOI 10.1021/es2035834; Wauters J, 1996, APPL GEOCHEM, V11, P589, DOI 10.1016/0883-2927(96)00027-3; WAUTERS J, 1994, SCI TOTAL ENVIRON, V157, P239	37	0	0	AMER SOC AGRONOMY	MADISON	677 S SEGOE RD, MADISON, WI 53711 USA	0047-2425	1537-2537		J ENVIRON QUAL	J. Environ. Qual.	MAY-JUN	2015	44	3					780	788		10.2134/jeq2014.10.0423		9	Environmental Sciences	Environmental Sciences & Ecology	CG9LP	WOS:000353637200029		
J	Yabuki, A; Tame, A				Yabuki, Akinori; Tame, Akihiro			Phylogeny and Reclassification of Hemistasia phaeocysticola (Scherffel) Elbrachter & Schnepf, 1996	JOURNAL OF EUKARYOTIC MICROBIOLOGY			English	Article						Diplonemid; Euglenozoa; kinetoplastid; phylogenetic analysis; taxonomy	CLASSIFICATION; REDESCRIPTION; DIPLONEMIDS; FLAGELLATE; EUGLENOZOA; AUSTRALIA; GEN.	Hemistasia phaeocysticola is a marine flagellate that preys on diatoms and dinoflagellates among others. Although its morphology and ultrastructure were previously observed and characterized, its phylogenetic position has not been analyzed using molecular sequence data. This flagellate was classified as a kinetoplastid on the basis of the presence of a kinetoplast in the mitochondrion. However, several morphological characteristics similar to those of diplonemids, a sister group of kinetoplastids, have also been noted. Herein, we report that H. phaeocysticola branches within the diplonemid clade in the phylogenetic tree reconstructed by analyzing 18S rRNA gene sequences. Its systematic placement based on this finding is also discussed.	[Yabuki, Akinori] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan; [Tame, Akihiro] Marine Works Japan Ltd, Yokosuka, Kanagawa 2370063, Japan	Yabuki, A (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, 2-15 Natsushima, Yokosuka, Kanagawa 2370061, Japan.	yabukia@jamstec.go.jp			JSPS [26840133]; Japanese Society for the Promotion of Science (JSPS) [236484]	We are grateful to Mr. Katsuyuki Uematsu (Marine Work Japan Ltd.) for his technical help with electron microscopy and Dr. Alastair G. B. Simpson (Dalhousie University) for valuable comments. This study was supported by a grant from the JSPS (no. 26840133). AY was supported by a Research Fellowship from the Japanese Society for the Promotion of Science (JSPS) for Young Scientists (no. 236484).	Al-Qassab S, 2002, ACTA PROTOZOOL, V41, P91; SOGIN ML, 1987, ANN NY ACAD SCI, V503, P125, DOI 10.1111/j.1749-6632.1987.tb40603.x; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Simpson AGB, 1997, ARCH PROTISTENKD, V148, P318; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Moreira D, 2004, INT J SYST EVOL MICR, V54, P1861, DOI 10.1099/ijs.0.63081-0; Marande W, 2005, EUKARYOT CELL, V4, P1137, DOI 10.1128/EC.4.6.1137-1146.2005; Lee WJ, 2002, ACTA PROTOZOOL, V41, P375; Brandt nee Tong S. M., 2000, ESTUAR COAST SHELF S, V51, P91; Elbrachter M, 1996, ARCH PROTISTENKD, V147, P125; Elbrachter M, 1998, PHYSL ECOLOGY HARMFU, P351; Kasai F., 2009, JPN J PHYCOL S, V57, P1; Lara E, 2009, ENVIRON MICROBIOL, V11, P47, DOI 10.1111/j.1462-2920.2008.01737.x; Maddison W. P., 2011, MESQUITE MODULAR SYS; MONTEGUTFELKNER AE, 1994, EUR J PROTISTOL, V30, P227; Scherffel A, 1900, ABT HELGOLAND, V4, P1; Simpson AGB, 2004, MOL PHYLOGENET EVOL, V30, P201, DOI 10.1016/S1055-7903(03)00177-5; Tong SM, 1998, EUR J PROTISTOL, V34, P162; Vlcek C., 2010, NUCLEIC ACIDS RES, V39, P979; Yabuki A, 2013, PROTIST, V164, P75, DOI 10.1016/j.protis.2012.04.005	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5234	1550-7408		J EUKARYOT MICROBIOL	J. Eukaryot. Microbiol.	MAY-JUN	2015	62	3					426	429		10.1111/jeu.12191		4	Microbiology	Microbiology	CG8IQ	WOS:000353551300017		
J	Verbitsky, M				Verbitsky, Misha			Degenerate twistor spaces for hyperkahler manifolds	JOURNAL OF GEOMETRY AND PHYSICS			English	Article						Twistor space; Hyperkahler manifold; Lagrangian fibration; Holomorphically symplectic manifold; Special Lagrangian submanifold	KAHLER-MANIFOLDS; AUTOMORPHISMS	Let M be a hyperkahler manifold, and eta a closed, positive (1, 1)-form with rk eta < dim M. We associate to eta a family of complex structures on M, called a degenerate twistor family, and parametrized by a complex line. When eta is a pullback of a Kahler form under a Lagrangian fibration L, all the fibers of degenerate twistor family also admit a Lagrangian fibration, with the fibers isomorphic to that of L. Degenerate twistor families can be obtained by taking limits of twistor families, as one of the Kahler forms in the hyperkahler triple goes to eta. (C) 2014 Elsevier B.V. All rights reserved.	[Verbitsky, Misha] NRU HSE, Fac Math, Lab Algebra Geometry, Moscow, Russia; [Verbitsky, Misha] Univ Tokyo, Kavli IPMU WPI, Tokyo 1138654, Japan	Verbitsky, M (reprint author), NRU HSE, Fac Math, Lab Algebra Geometry, 7 Vavilova Str, Moscow, Russia.	verbit@mccme.ru			RSCF [14-21-00053]	Partially supported by RSCF, grant number 14-21-00053.	Huybrechts D, 1999, INVENT MATH, V135, P63, DOI 10.1007/s002220050280; Verbitsky M, 1996, GEOM FUNCT ANAL, V6, P601, DOI 10.1007/BF02247112; Matsushita D, 2001, TOPOLOGY, V40, P431, DOI 10.1016/S0040-9383(99)00048-8; SALAMON S, 1982, INVENT MATH, V67, P143, DOI 10.1007/BF01393378; Verbitsky M, 2013, DUKE MATH J, V162, P2929, DOI 10.1215/00127094-2382680; Kontsevich M, 2006, PROG MATH, V244, P321; Hassett B, 2001, GEOM FUNCT ANAL, V11, P1201; BEAUVILLE A, 1983, J DIFFER GEOM, V18, P755; Besse A.L., 1987, EINSTEIN MANIFOLDS; Bogomolov F. A., 1974, MATH USSR SB, V22, P580, DOI 10.1070/SM1974v022n04ABEH001706; Cantat S, 2001, ACTA MATH-DJURSHOLM, V187, P1, DOI 10.1007/BF02392831; Cantat Serge, 2012, FRONTIERS COMPLEX DY; Demailly Jean-Pierre, 1993, U SERIES MATH; Demailly J.-P., 1994, J ALGEBRAIC GEOM, V3, P295; Dinh TC, 2005, J AM MATH SOC, V18, P291, DOI 10.1090/S0894-0347-04-00474-6; Fujiki A., 1987, ADV STUDIES PURE MAT, V10, P105; Gross Mark, ARXIV12124220, P67; Huybrechts Daniel, 2003, UNIVERSITEXT, P161; Hwang Jun-Muk, INVENT MATH, V174, P625; Kaledin D., 1998, SELECTA MATH, V4, P271, DOI 10.1007/s000290050032; KAWAMATA Y, 1985, INVENT MATH, V79, P567, DOI 10.1007/BF01388524; Kontsevich M., 2001, SYMPLECTIC GEOMETRY, P203, DOI DOI 10.1142/9789812799821_0007; Markman Eyal, ARXIV13016584, P34; Matsushita D., 2005, AM J MATH, V127; Sawon Justin, 2003, TURKISH J MATH, V27, P197; Verbitsky M., COHOMOLOGY COMPACT H; Verbitsky M, 2010, GEOM FUNCT ANAL, V19, P1481, DOI 10.1007/s00039-009-0037-z; Verbitsky Misha, ARXIV09074217, P22	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0393-0440	1879-1662		J GEOM PHYS	J. Geom. Phys.	MAY	2015	91						2	11		10.1016/j.geomphys.2014.08.010		10	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CG8XX	WOS:000353600100002		
J	Fujiki, A; Pontecorvo, M				Fujiki, Akira; Pontecorvo, Massimiliano			Numerically anticanonical divisors on Kato surfaces	JOURNAL OF GEOMETRY AND PHYSICS			English	Article						Non Kahler surfaces; Kato surfaces; Holomorphic vector fields	CLASS VII0; CURVES	The compact curves of an intermediate Kato surface S form a basis of H-2(S, Q). We present a way to compute the associated rational coefficients of the first Chern class c(1) (S). We get in particular a simple geometric obstruction for c(1) (S) to be an integral class, or equivalently index (S) = 1. In the final part we discuss relations with some recent work of Dloussky (2011) and Oeljeklaus and Toma (2009). (C) 2015 Elsevier B.V. All rights reserved.	[Fujiki, Akira] Kyoto Univ, Math Sci Res Inst, Kyoto 6068501, Japan; [Pontecorvo, Massimiliano] Univ Rome Tre, Dipartimento Matemat & Fis, I-00146 Rome, Italy	Pontecorvo, M (reprint author), Univ Rome Tre, Dipartimento Matemat & Fis, I-00146 Rome, Italy.	max@mat.uniroma3.it					Apostolov V, 1999, P LOND MATH SOC, V79, P414, DOI 10.1112/S0024611599012058; Apostolov V, 2001, MATH Z, V238, P555, DOI 10.1007/s002090100266; Dloussky G., 2011, ANN FAC SCI TOULOUSE; Dloussky G, 2006, AM J MATH, V128, P639, DOI 10.1353/ajm.2006.0021; Dloussky G., 2014, COMPLEX MANIFOLDS, V1, P1; Dloussky G., 1984, MEMOIRES SMF, V112, P14; Dloussky G, 1999, ANN I FOURIER, V49, P1503; Dloussky G., ARXIV12062518V1MATHC; Favre C, 2000, J MATH PURE APPL, V79, P475, DOI 10.1016/S0021-7824(00)00162-8; Kato Ma., 1978, P INT S ALG GEOM KYO, P45; Nakamura I., 1984, SUGAKU EXPOSITIONS, V36, p[110, 209]; NAKAMURA I, 1990, TOHOKU MATH J, V42, P475, DOI 10.2748/tmj/1178227571; Oeljeklaus K., 2009, MATH ANN, V341, P323; Teleman A, 2010, ANN MATH, V172, P1749; Teleman A., ARXIV13090350	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0393-0440	1879-1662		J GEOM PHYS	J. Geom. Phys.	MAY	2015	91						117	130		10.1016/j.geomphys.2015.01.001		14	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CG8XX	WOS:000353600100011		
J	Gambioli, A; Nagatomo, Y; Salamon, S				Gambioli, A.; Nagatomo, Y.; Salamon, S.			Special geometries associated to quaternion-Kahler 8-manifolds	JOURNAL OF GEOMETRY AND PHYSICS			English	Article						Kahler quotient; Holonomy G(2); Half-flat metric	YANG-MILLS FIELDS; MANIFOLDS; HYPERKAHLER; METRICS; CONSTRUCTION; REDUCTION; HOLONOMY; DUALITY; SPACES	We develop a calculus of differential forms on a quaternion-Kahler manifold M-4n admitting an isometric circle action. This is used to study three fundamental examples of such actions on the quatemionic projective plane and the construction of G(2) and half-flat structures on quotients of M-8 and its hypersurfaces. (C) 2014 Elsevier B.V. All rights reserved.	[Gambioli, A.] Dawson Coll, Dept Math, Westmount, PQ H3Z 1A4, Canada; [Nagatomo, Y.] Meiji Univ, Dept Math, Tama Ku, Kawasaki, Kanagawa 2148571, Japan; [Salamon, S.] Kings Coll London, Dept Math, London WC2R 2LS, England	Salamon, S (reprint author), Kings Coll London, Dept Math, London WC2R 2LS, England.	agambioli@dawsoncollege.qc.ca; yasunaga@meiji.ac.jp; simon.salamon@kcl.ac.uk			CIRGET postdoctoral fellowship; JSPS KAKENHI Grant (Japan) [26400074]; MIUR (Italy)	Andrea Gambioli's work was supported by a CIRGET postdoctoral fellowship held at the Universite du Quebec a Montreal (Canada). Yasuyuki Nagatomo is supported by JSPS KAKENHI Grant Number 26400074 (Japan). Simon Salamon was supported by the PRIN07 project 'Differential Geometry and Global Analysis' financed by MIUR (Italy).	Acharya B., HEPTH0106034; Alekseevsky DV, 1998, ANN GLOB ANAL GEOM, V16, P419, DOI 10.1023/A:1006574700453; ALEKSEEVSKY DV, 1968, FUNNKCIONAL ANAL PRI, V2, P1; SALAMON S, 1982, INVENT MATH, V67, P143, DOI 10.1007/BF01393378; BRYANT RL, 1989, DUKE MATH J, V58, P829, DOI 10.1215/S0012-7094-89-05839-0; ATIYAH MF, 1978, P ROY SOC LOND A MAT, V362, P425, DOI 10.1098/rspa.1978.0143; Moroianu A, 2011, ADV MATH, V228, P940, DOI 10.1016/j.aim.2011.06.006; HITCHIN NJ, 1987, COMMUN MATH PHYS, V108, P535, DOI 10.1007/BF01214418; ATIYAH MF, 1984, TOPOLOGY, V23, P1, DOI 10.1016/0040-9383(84)90021-1; Conti D, 2007, T AM MATH SOC, V359, P5319, DOI 10.1090/S0002-9947-07-04307-3; Hitchin N, 2013, COMMUN MATH PHYS, V324, P77, DOI 10.1007/s00220-013-1689-y; Haydys A, 2008, J GEOM PHYS, V58, P293, DOI 10.1016/j.geomphys.2007.11.004; Apostolov V, 2004, COMMUN MATH PHYS, V246, P43, DOI 10.1007/s00220-003-1014-2; Arnold V., 1999, P STEKLOV I MATH, V224, P46; Atiyah M., 2002, ADV THEOR MATH PHYS, V6, P1; Atiyah M F, 2003, SURVEYS DIFFERENTIAL, VVIII, P1; Battaglia F, 1999, J LOND MATH SOC, V59, P345, DOI 10.1112/S0024610798006930; Battaglia F, 1996, P AM MATH SOC, V124, P2185, DOI 10.1090/S0002-9939-96-03208-X; Besse A., 1987, ERGEBNISSE MATH IHRE, V10; Bryant R., 1989, J AM MATH SOC, V2, P1, DOI 10.2307/1990911; Capria MM, 1988, NONLINEARITY, V1, P517, DOI 10.1088/0951-7715/1/4/002; Conti D, 2011, DIFFER GEOM APPL, V29, P493, DOI 10.1016/j.difgeo.2011.04.030; Conti D., ARXIV13084083; Eells J., 1985, ANN SCUOLA NORM PI S, V12, P589; Fino A, 2008, INT J MATH, V19, P1147, DOI 10.1142/S0129167X08005072; Fulton W., 1991, GTM, V129; GALICKI K, 1988, MATH ANN, V282, P1, DOI 10.1007/BF01457009; GALICKI K, 1991, J MATH PHYS, V32, P1263, DOI 10.1063/1.529501; GALICKI K, 1987, COMMUN MATH PHYS, V108, P117, DOI 10.1007/BF01210705; Gambioli A, 2008, ANN GLOB ANAL GEOM, V34, P77, DOI 10.1007/s10455-007-9097-1; Grav A., 1980, ANN MAT PUR APPL, V123, P35; Hitchin N., 2001, CONT MATH, V288, P70; JOYCE D, 1991, MATH ANN, V290, P323, DOI 10.1007/BF01459248; Kostant B., 1955, T AM MATH SOC, V80, P528, DOI 10.2307/1993001; KRAINES VY, 1966, T AM MATH SOC, V122, P357, DOI 10.2307/1994553; Macia O., ARXIV14040785; Miyaoka R., MATHPH0605074; Nagatomo Y, 1997, B LOND MATH SOC, V29, P359, DOI 10.1112/S0024609396002470; PONTECORVO M, 1992, T AM MATH SOC, V331, P653, DOI 10.2307/2154133; Salamon S., 2003, MILAN J MATH, V71, P59, DOI 10.1007/s00032-003-0015-0; Salamon S., 2007, WORKSH GEN GEOM FLUX; SALAMON S, 1985, LECT NOTES MATH, V1164, P161; Salamon S. M., 1989, PITMAN RES NOTES MAT, V201; Salamon S.M., 2001, CONT MATH, V288, P162; SWANN A, 1991, MATH ANN, V289, P421, DOI 10.1007/BF01446581; Swann A., 1997, ARCH MATH, V33, P349; WOLF JA, 1984, ACTA MATH-DJURSHOLM, V152, P141, DOI 10.1007/BF02392195	47	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0393-0440	1879-1662		J GEOM PHYS	J. Geom. Phys.	MAY	2015	91						146	162		10.1016/j.geomphys.2014.11.007		17	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CG8XX	WOS:000353600100014		
J	Sakai, M				Sakai, Masamichi			Dharmottara's Re-Use of Arguments from the Ksanabhangasiddhi in the Pramanaviniscayatika	JOURNAL OF INDIAN PHILOSOPHY			English	Article						Dharmottara; Dharmakirti; Textual reuse; Commentary; Monograph/Essay		Dharmottara, one of the most outstanding commentators of Dharmakirti, re-uses arguments in the Pramanaviniscayatika, his broad commentary on Dharmakirti's Pramanaviniscaya, from his independent essay, the Ksanabhangasiddhi. By analyzing contents of re-used arguments in the Pramanaviniscayatika, this paper clarifies Dharmottara's intention of paraphrasing his arguments in his commentarial work on Dharmakirti. I argue that, in terms of content, such arguments are original and never fit into Dharmakirti's own system. It can be said that Dharmottara has a clear intention to display his new innovations not only in his independent monograph, but also in his commentarial work. For Dharmottara, a commentary on Dharmakirti is a better place than an independent monograph for showing off his advanced notions, since it is only in a commentary that his ideas can stand out directly against those of Dharmakirti. In this sense, Dharmottara writes his commentary strategically. At the end of the article I discuss the significance of composing independent monographs or essays in the intellectual history of medieval India in the case of Dharmottara.	Kansai Univ, Suita, Osaka, Japan	Sakai, M (reprint author), Kansai Univ, Suita, Osaka, Japan.	msakai@kansai-u.ac.jp					Frauwallner E., 1935, WIENER ZEITSCHRIFT F, V42, P217; Ishida H., 2011, THESIS; Iwata T., 1991, SAHOPALAMBHANIYAMA S; KRASSER H, 1995, J INDIAN PHILOS, V23, P247, DOI 10.1007/BF01850500; Krasser H., 1991, DHARMOTTARAS KURZE U; McCrea LJ, 2006, J INDIAN PHILOS, V34, P303, DOI 10.1007/s10781-005-5739-4; Sakai M., 2012, JOURNAL OF INDIAN AN, V60-3, P130; Sakai M., 2011, RELIGION AND LOGIC I, P407; Sakai M., 2012, WIENER ZEITSCHRIFT F, V54, P187; Sakai M., 2010, BUDDHIST STUDIES, V58-3, P125; Sakai M., 2013, STUDIES OF INDIAN PH, V20, P77; Sakai M., 2010, THESIS; Steinkellner E., 2006, WIENER ZEITSCHRIFT F, V50, P199; Steinkellner E., 2006, THE COLOPHON OF DHAR; Steinkellner E., 1971, WIENER Z KUNDE SUDAS, V15, P179; von Rospatt A., 1995, THE BUDDHIST DOCTRIN; Yoshimizu C., 1999, WZKS, V43, P231	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0022-1791	1573-0395		J INDIAN PHILOS	J. Indian Philos.	MAY	2015	43	2-3			SI		171	182		10.1007/s10781-014-9235-6		12	Asian Studies; Philosophy	Asian Studies; Philosophy	CG4BM	WOS:000353225800004		
J	MacDonald, R; Nagayasu, J				MacDonald, Ronald; Nagayasu, Jun			Currency forecast errors and carry trades at times of low interest rates: Evidence from survey data on the yen/dollar exchange rate	JOURNAL OF INTERNATIONAL MONEY AND FINANCE			English	Article						Currency forecast errors; Uncovered interest parity; Forward premium puzzle; Carry trade; Markov-switching model; STAR model	EXPECTATIONS FORMATION; SWITCHING APPROACH; MONETARY-POLICY; ASYMMETRIC LOSS; PREMIUM PUZZLE; SHORT-RUN; MARKETS; DOLLAR; MODEL; RISK	Using survey expectations data and a variant of the uncovered interest rate parity (UIRP), this paper evaluates the relationship between interest rates and investors' forecast errors about the yen/dollar exchange rate. This study therefore is related to the forward premium puzzle and the currency carry trade strategy. Using relatively short (i.e., 1 to 6 month-ahead) forecast data, we obtain the following results. First, with the same forecast horizon, exchange rate forecasts are homogeneous among different industry types, but within the same industry, exchange rate forecasts differ if the forecast time horizon is different. Second, while forecast errors are found to be partly driven by interest rate spreads, evidence against the UIRP is provided. Consistent with this finding, our coefficients on interest rate spreads obtained from nonlinear models provide indirect evidence of the yen carry trade. In particular, unlike theoretical predictions, the carry trade is found to be active during financial turmoil and when there is a clear indication that the interest rate will be low in the future. (C) 2015 Elsevier Ltd. All rights reserved.	[MacDonald, Ronald] Univ Glasgow, Adam Smith Business Sch, Glasgow G12 8QQ, Lanark, Scotland; [Nagayasu, Jun] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 305, Japan	Nagayasu, J (reprint author), Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 305, Japan.	nagayasu@sk.tsukuba.ac.jp					Fernandez C, 2001, J APPL ECONOM, V16, P563, DOI 10.1002/jae.623; Batchelor R, 1998, ECON LETT, V61, P49, DOI 10.1016/S0165-1765(98)00157-8; Evans MDD, 2002, J POLIT ECON, V110, P170, DOI 10.1086/324391; Peria MSM, 2002, EMPIR ECON, V27, P299; Bansal R, 2000, J INT ECON, V51, P115, DOI 10.1016/S0022-1996(99)00039-2; Clarida R, 2009, J INT MONEY FINANC, V28, P1375, DOI 10.1016/j.jimonfin.2009.08.010; FROOT KA, 1989, J INT MONEY FINANC, V8, P487, DOI 10.1016/0261-5606(89)90032-6; ENGEL C, 1990, AM ECON REV, V80, P689; Chinn MD, 2004, IMF STAFF PAPERS, V51, P409; Macdonald R, 1996, J INT MONEY FINANC, V15, P665, DOI 10.1016/0261-5606(96)00030-7; Ottaviani M, 2006, J FINANC ECON, V81, P441, DOI 10.1016/j.jfineco.2005.08.002; Lo MC, 2005, J MONEY CREDIT BANK, V37, P865, DOI 10.1353/mcb.2005.0054; Raymond JE, 1997, J MONEY CREDIT BANK, V29, P193, DOI 10.2307/2953675; Christoffersen PF, 1997, ECONOMET THEOR, V13, P808; Menkhoff L, 2012, J FINANC, V67, P681, DOI 10.1111/j.1540-6261.2012.01728.x; Hattori M, 2009, IMF STAFF PAPERS, V56, P384, DOI 10.1057/imfsp.2009.2; KIM CJ, 1994, J ECONOMETRICS, V60, P1, DOI 10.1016/0304-4076(94)90036-1; Elliott G, 2005, REV ECON STUD, V72, P1107, DOI 10.1111/0034-6527.00363; Ranaldo A, 2010, REV FINANC, V14, P385, DOI 10.1093/rof/rfq007; Bhansali V., 2007, J FIXED INCOME, V17, P72, DOI 10.3905/jfi.2007.700219; Breedon Francis, 2014, WORKING PAPER; Brunnermeier M. K., 2009, NBER MACROECON ANNU, V23, P313; Burnside C, 2009, AM ECON J-MACROECON, V1, P127, DOI 10.1257/mac.1.2.127; Curcuru Stephanie, 2010, MEASURING CARRY TRAD; Diebold F. X., 1994, NONSTATIONARY TIME S, P283; DURLAND JM, 1994, J BUS ECON STAT, V12, P279, DOI 10.2307/1392084; Engel C., 1996, INT J FINANC ECON, V1, P55, DOI 10.1002/(SICI)1099-1158(199601)1:1<55::AID-IJFE5>3.0.CO;2-C; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; FAMA EF, 1984, J MONETARY ECON, V14, P319, DOI 10.1016/0304-3932(84)90046-1; FILARDO AJ, 1994, J BUS ECON STAT, V12, P299, DOI 10.2307/1392086; Frances P. H., 2000, NONLINEAR TIME SERIE; Fratzscher Marcel, 2006, EUROPEAN CENTRAL BAN, V695; FROOT KA, 1989, Q J ECON, V104, P139, DOI 10.2307/2937838; Habib Maurizio Michael, 2011, 1288 EUR CENTR BANK; ITO T, 1994, J JPN INT ECON, V8, P119, DOI 10.1006/jjie.1994.1008; ITO T, 1990, AM ECON REV, V80, P434; KAMINSKY G, 1993, AM ECON REV, V83, P450; Kawai Masahiro, 2009, EXCHANGE RATES BALAN; Koop Gary, 2006, BAYESIAN ECONOMETRIC; Lamont OA, 2002, J ECON BEHAV ORGAN, V48, P265, DOI 10.1016/S0167-2681(01)00219-0; MACDONALD R, 1990, OXFORD ECON PAP, V42, P544; MacDonald R, 2000, J ECON SURV, V14, P69, DOI 10.1111/1467-6419.00105; Menkhoff Lukas, 2013, J FINANCE; Ruelke JC, 2010, J JPN INT ECON, V24, P355, DOI 10.1016/j.jjie.2010.01.002; TERASVIRTA T, 1994, J AM STAT ASSOC, V89, P208, DOI 10.2307/2291217	45	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0261-5606	1873-0639		J INT MONEY FINANC	J. Int. Money Finan.	MAY	2015	53						1	19		10.1016/j.jimonfin.2014.12.011		19	Business, Finance	Business & Economics	CG8YT	WOS:000353602300001		
J	Shirota, T				Shirota, Toyoichiro			What is the major determinant of cross-border banking flows?	JOURNAL OF INTERNATIONAL MONEY AND FINANCE			English	Article						International capital flows; Global banking; Bayesian estimation	DEVELOPING-COUNTRIES; CAPITAL FLOWS; GLOBAL BANKS; TRANSMISSION; CRISIS; INFLOWS; POLICY; PULL; PUSH	This study examines the major determinant of cross-border credit flows through global banks across 70 countries. Employing a Bayesian dynamic latent factor model, we decompose volatilities of banking flows into the contribution of a global common factor, regional common factor, and country-specific factor. The results indicate that the global and regional common factor explains about 40-50 percent of volatility in overall cross-border banking flows. In particular, the contribution of the global common factor increased in the 2000s. Simultaneously, main determinants are largely heterogeneous across countries: this implies that the desirable policy response to credit inflows may differ for each host country. (C) 2015 Elsevier Ltd. All rights reserved.	Bank Japan, Chuo Ku, Tokyo, Japan	Shirota, T (reprint author), Bank Japan, Chuo Ku, 2-1-1 Hongokucho Nihonbashi, Tokyo, Japan.	toyoichirou.shirota@boj.or.jp					Peek J, 2000, AM ECON REV, V90, P30, DOI 10.1257/aer.90.1.30; Lane PR, 2008, AM ECON REV, V98, P327, DOI 10.1257/aer.98.2.327; Adrian T, 2010, J FINANC INTERMED, V19, P418, DOI 10.1016/j.jfi.2008.12.002; Shin HS, 2012, IMF ECON REV, V60, P155, DOI 10.1057/imfer.2012.6; Bekaert G, 2013, J MONETARY ECON, V60, P771, DOI 10.1016/j.jmoneco.2013.06.003; Taylor MP, 1997, WORLD BANK ECON REV, V11, P451; Cetorelli N, 2012, J INT ECON, V88, P299, DOI 10.1016/j.jinteco.2012.05.001; Peek J, 1997, AM ECON REV, V87, P495; Fratzscher M, 2012, J INT ECON, V88, P341, DOI 10.1016/j.jinteco.2012.05.003; Kalemli-Ozcan S, 2013, J INT ECON, V89, P495, DOI 10.1016/j.jinteco.2012.07.001; Chuhan P, 1998, J DEV ECON, V55, P439, DOI 10.1016/S0304-3878(98)00044-3; Borio C, 2012, J FINANC STABIL, V8, P236, DOI 10.1016/j.jfs.2011.12.003; Forbes KJ, 2012, J INT ECON, V88, P235, DOI 10.1016/j.jinteco.2012.03.006; Calvo GA, 1996, J ECON PERSPECT, V10, P123; Baba N., 2009, BIS Q REV; Bank for International Settlements, 2012, GUID INT LOC BANK ST; Borio C., 2011, 402 BIS; Brunnermeier M., 2012, BANKS CROSS BORDER C; Bruno V., 2015, REV EC STUD IN PRESS; Chinn Menzie, 2008, J COMP POLICY ANAL, V10, P309, DOI DOI 10.1080/13876980802231123; Cihak M., 2012, POLICY RES WORKING P, V6175; Committee on the Global Financial System, 2010, CGFS PUBL, V37; Eickmeier S, 2014, EUR ECON REV, V68, P1, DOI 10.1016/j.euroecorev.2014.01.015; FernandezArias E, 1996, J DEV ECON, V48, P389, DOI 10.1016/0304-3878(95)00041-0; Hernandez L, 2001, WP0164 IMF; Herrmann S., 2010, 315 BIS; Ilzetzki EO, 2008, EXCHANGE RATE ARRANG; Jeanneau S., 2002, 112 BIS; Kim Y, 2000, J INT MONEY FINANC, V19, P235, DOI 10.1016/S0261-5606(00)00001-2; Kose Ayhan M., 2003, AM ECON REV, V93, P1216; MUNDELL RA, 1963, CAN J ECON POLIT SCI, V29, P475, DOI 10.2307/139336; REY H, 2013, P EC POL S JACKS HOL, P1; Rose A., 2008, J INT ECON, V75, P110; Shirota T., 2013, BOJ WORKING PAPER SE, V13-E-5	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0261-5606	1873-0639		J INT MONEY FINANC	J. Int. Money Finan.	MAY	2015	53						137	147		10.1016/j.jimonfin.2015.01.001		11	Business, Finance	Business & Economics	CG8YT	WOS:000353602300007		
J	Nagashima, S; Yagyu, H; Tozawa, R; Tazoe, F; Takahashi, M; Kitamine, T; Yamamuro, D; Sakai, K; Sekiya, M; Okazaki, H; Osuga, J; Honda, A; Ishibashi, S				Nagashima, Shuichi; Yagyu, Hiroaki; Tozawa, Ryuichi; Tazoe, Fumiko; Takahashi, Manabu; Kitamine, Tetsuya; Yamamuro, Daisuke; Sakai, Kent; Sekiya, Motohiro; Okazaki, Hiroaki; Osuga, Jun-ichi; Honda, Akira; Ishibashi, Shun			Plasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liver	JOURNAL OF LIPID RESEARCH			English	Article						cholesterol/biosynthesis; enzymology/enzyme regulation; lipoproteins/metabolism; very low density lipoprotein; inborn errors of metabolism; Cre recombinase; gene targeting; knockout	FATTY-ACID SYNTHESIS; RECEPTOR LXR-ALPHA; APOLIPOPROTEIN-B; EMBRYONIC LETHALITY; STEROL SYNTHESIS; RAT HEPATOCYTES; IN-VITRO; INHIBITOR; HYPERCHOLESTEROLEMIA; BIOSYNTHESIS	Squalene synthase (SS) catalyzes the biosynthesis of squalene, the first specific intermediate in the cholesterol biosynthetic pathway. To test the feasibility of lowering plasma cholesterol by inhibiting hepatic SS, we generated mice in which SS is specifically knocked out in the liver (L-SSKO) using Cre-loxP technology. Hepatic SS activity of L-SSKO mice was reduced by > 90%. In addition, cholesterol biosynthesis in the liver slices was almost eliminated. Although the hepatic squalene contents were markedly reduced in L-SSKO mice, the hepatic contents of cholesterol and its precursors distal to squalene were indistinguishable from those of control mice, indicating the presence of sufficient centripetal flow of cholesterol and/or its precursors from the extrahepatic tissues. L-SSKO mice showed a transient liver dysfunction with moderate hepatomegaly presumably secondary to increased farnesol production. In a fed state, the plasma total cholesterol and triglyceride were significantly reduced in L-SSKO mice, primarily owing to reduced hepatic VLDL secretion. In a fasted state, the hypolipidemic effect was lost. mRNA expression of liver X receptor alpha target genes was reduced, while that of sterol-regulatory element binding protein 2 target genes was increased. In conclusion, liver-specific ablation of SS inhibits hepatic cholesterol biosynthesis and induces hypolipidemia without increasing significant mortality.	[Nagashima, Shuichi; Yagyu, Hiroaki; Tazoe, Fumiko; Takahashi, Manabu; Yamamuro, Daisuke; Sakai, Kent; Osuga, Jun-ichi; Ishibashi, Shun] Jichi Med Univ, Sch Med, Div Endocrinol & Metab, Shimotsuke, Tochigi 3290498, Japan; [Tozawa, Ryuichi; Kitamine, Tetsuya; Sekiya, Motohiro; Okazaki, Hiroaki] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo 1138655, Japan; [Honda, Akira] Tokyo Med Univ, Ibaraki Med Ctr, Joint Res Ctr, Ibaraki 3000395, Japan	Ishibashi, S (reprint author), Jichi Med Univ, Sch Med, Div Endocrinol & Metab, Shimotsuke, Tochigi 3290498, Japan.	ishibash@jichi.ac.jp			Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; JKA through its promotion funds from KEIRIN RACE; Jichi Medical University Young Investigator Award; Japan Heart Foundation; Astellas/Pfizer Grant for Research on Atherosclerosis Update; Banyu Life Science Foundation International; MSD; Pfizer; Eli Lilly	This work was supported by a Grant-in-Aid for Scientific Research and the Program for the Strategic Research Foundation at Private Universities 2011-2015 "Cooperative Basic and Clinical Research on Circadian Medicine" and 2013-2017 "Non-communicable disease (NCD)" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, JKA through its promotion funds from KEIRIN RACE, Jichi Medical University Young Investigator Award, Japan Heart Foundation & Astellas/Pfizer Grant for Research on Atherosclerosis Update, Banyu Life Science Foundation International, and unrestricted grants of from MSD, Pfizer, and Eli Lilly.	Amano Y, 2003, EUR J PHARMACOL, V466, P155, DOI 10.1016/S0014-2999(03)01549-8; Okazaki H, 2006, J LIPID RES, V47, P1950, DOI 10.1194/jlr.M600224-JLR200; Wong J, 2008, J BIOL CHEM, V283, P700, DOI 10.1074/jbc.M706416200; Nishimoto T, 2003, BRIT J PHARMACOL, V139, P911, DOI 10.1038/sj.bjp.0705332; Nagashima S, 2012, ARTERIOSCL THROM VAS, V32, P1824, DOI 10.1161/ATVBAHA.111.240754; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Joo JH, 2010, CANCER LETT, V287, P123, DOI 10.1016/j.canlet.2009.05.015; Kocarek TA, 1998, MOL PHARMACOL, V54, P474; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; FARESE RV, 1995, P NATL ACAD SCI USA, V92, P1774, DOI 10.1073/pnas.92.5.1774; Tansey TR, 2000, BBA-MOL CELL BIOL L, V1529, P49, DOI 10.1016/S1388-1981(00)00137-2; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1194, DOI 10.1073/pnas.78.2.1194; Stein EA, 2011, CIRCULATION, V123, P1974, DOI 10.1161/CIRCULATIONAHA.110.975284; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Do R, 2009, CLIN GENET, V75, P19, DOI 10.1111/j.1399-0004.2008.01099.x; Wiersma H, 2010, J LIPID RES, V51, P544, DOI 10.1194/jlr.M000844; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843; Basciano H, 2009, AM J PHYSIOL-GASTR L, V297, pG323, DOI 10.1152/ajpgi.90546.2008; Bedi M, 2008, ARCH BIOCHEM BIOPHYS, V470, P116, DOI 10.1016/j.abb.2007.11.011; Hiyoshi H, 2003, J LIPID RES, V44, P128, DOI 10.1194/jlr.M200316-JLR200; JIANG GJ, 1993, J BIOL CHEM, V268, P12818; Lopez D, 1998, ARCH BIOCHEM BIOPHYS, V351, P159, DOI 10.1006/abbi.1997.0556; Malerod L, 2002, BIOCHEM BIOPH RES CO, V299, P916, DOI 10.1016/S0006-291X(02)02760-2; Memon RA, 1997, J LIPID RES, V38, P1620; NESS GC, 1994, ARCH BIOCHEM BIOPHYS, V311, P277, DOI 10.1006/abbi.1994.1238; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; STRANDBERG TE, 1981, SCAND J GASTROENTERO, V16, P801; TOMKINS GM, 1952, J BIOL CHEM, V196, P569; TURLEY SD, 1981, J LIPID RES, V22, P551; Vaidya S, 1998, ARCH BIOCHEM BIOPHYS, V355, P84, DOI 10.1006/abbi.1998.0704; Wasko BM, 2011, J LIPID RES, V52, P1957, DOI 10.1194/jlr.M016089; Xie CL, 2009, J LIPID RES, V50, P1316, DOI 10.1194/jlr.M900024-JLR200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013	39	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	MAY	2015	56	5					998	1005		10.1194/jlr.M057406		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH1FT	WOS:000353767200005		
J	Ichikawa, S; Motosugi, U; Nakazawa, T; Morisaka, H; Sano, K; Ichikawa, T; Enomoto, N; Matsuda, M; Fujii, H; Onishi, H				Ichikawa, Shintaro; Motosugi, Utaroh; Nakazawa, Tadao; Morisaka, Hiroyuki; Sano, Katsuhiro; Ichikawa, Tomoaki; Enomoto, Nobuyuki; Matsuda, Masanori; Fujii, Hideki; Onishi, Hiroshi			Hepatitis Activity Should Be Considered a Confounder of Liver Stiffness Measured With MR Elastography	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						magnetic resonance elastography; hepatic fibrosis; liver stiffness; activity of hepatitis	MAGNETIC-RESONANCE ELASTOGRAPHY; FORCE IMPULSE ELASTOGRAPHY; PLATELET RATIO INDEX; C VIRUS-INFECTION; TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; HEPATOCELLULAR-CARCINOMA; PORTAL-HYPERTENSION; SPLENIC STIFFNESS; FIBROSIS	PurposeTo evaluate the effect of hepatitis activity on liver stiffness measurements and the role of serum alanine aminotransferase (ALT) in liver fibrosis staging by MR elastography (MRE). Materials and MethodsWe measured liver stiffness (kPa) in 135 patients by MRE and histologically assessed fibrosis and hepatitis activity within 2 months. Stepwise multiple linear regression was performed to determine the maximum adjusted R-2 against liver stiffness, after adjusting for nothing (model 1), ALT/upper limit of normal categories (model 2), and hepatitis activity (A grade) by METAVIR (model 3). Logistic regression was used to identify independent factors associated with pathologically proven cirrhosis. ResultsPlatelet count and METAVIR F score were strongly associated with liver stiffness. The adjusted R-2 value of model 3 (0.7026) was higher than those of models 1 (0.6472) and 2 (0.6564), showing that hepatitis activity affected liver stiffness measurement. High ALT levels (odds ratio, 0.0066; P=0.0003) as well as MRE (odds ratio, 9.91; P<0.0001) were independently associated with cirrhosis. ConclusionHepatitis activity may be a confounder of liver stiffness measurement during liver fibrosis staging using MRE. MRE can potentially make an overdiagnosis of liver cirrhosis if the patient has high ALT levels. J. Magn. Reson. Imaging 2015;41:1203-1208. (c) 2014 Wiley Periodicals, Inc.	[Ichikawa, Shintaro; Motosugi, Utaroh; Morisaka, Hiroyuki; Sano, Katsuhiro; Ichikawa, Tomoaki; Onishi, Hiroshi] Univ Yamanashi, Dept Radiol, Chuo, Yamanashi 4093898, Japan; [Motosugi, Utaroh] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Nakazawa, Tadao] Univ Yamanashi, Dept Pathol, Chuo, Yamanashi 4093898, Japan; [Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Chuo, Yamanashi 4093898, Japan; [Matsuda, Masanori; Fujii, Hideki] Univ Yamanashi, Dept Surg 1, Chuo, Yamanashi 4093898, Japan	Motosugi, U (reprint author), Univ Yamanashi, Dept Radiol, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	utaroh-motosugi@nifty.com					Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Motosugi U, 2011, MAGN RESON IMAGING, V29, P1047, DOI 10.1016/j.mri.2011.05.007; Bohte AE, 2014, EUR RADIOL, V24, P638, DOI 10.1007/s00330-013-3046-0; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Regev A, 2002, AM J GASTROENTEROL, V97, P2614; Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x; Talwalkar JA, 2009, AM J ROENTGENOL, V193, P122, DOI 10.2214/AJR.07.3504; Huwart L, 2007, RADIOLOGY, V245, P458, DOI 10.1148/radiol.2452061673; Tapper EB, 2012, CLIN GASTROENTEROL H, V10, P932, DOI 10.1016/j.cgh.2012.01.015; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Kim BH, 2011, J MAGN RESON IMAGING, V34, P1110, DOI 10.1002/jmri.22723; Shire NJ, 2011, J MAGN RESON IMAGING, V34, P947, DOI 10.1002/jmri.22716; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Kanematsu M, 2012, MAGN RESON MED SCI, V11, P151; Chen J, 2011, RADIOLOGY, V259, P749, DOI 10.1148/radiol.11101942; Wang QB, 2012, HEPATOLOGY, V56, P239, DOI 10.1002/hep.25610; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Hines CDG, 2010, J MAGN RESON IMAGING, V31, P725, DOI 10.1002/jmri.22066; Motosugi U, 2013, MAGN RESON MED SCI, V12, P161, DOI 10.2463/mrms.2012-0085; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; Bensamoun SF, 2013, ALCOHOL CLIN EXP RES, V37, P811, DOI 10.1111/acer.12025; Yoshida H, 1999, ANN INTERN MED, V131, P174; Taouli B, 2009, AM J ROENTGENOL, V193, P14, DOI 10.2214/AJR.09.2601; Venkatesh SK, 2014, EUR RADIOL, V24, P70, DOI 10.1007/s00330-013-2978-8; Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731; Nedredal GI, 2011, J MAGN RESON IMAGING, V34, P79, DOI 10.1002/jmri.22610; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chen SH, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-105; Dzyubak B, 2013, J MAGN RESON IMAGING, V38, P371, DOI 10.1002/jmri.23980; European Association for Study of Liver, 2014, J HEPATOL, V60, P392, DOI DOI 10.1016/J.JHEP.2013.11.003; Fraquelli M, 2007, HEPATOLOGY, V46, P282, DOI 10.1002/hep.21653; Glaser KJ, 2003, MAGNET RESON MED, V50, P1256, DOI 10.1002/mrm.10641; Ichikawa S, 2012, MAGN RESON MED SCI, V11, P291; Morisaka H, 2013, MAGN RESON MED SCI, V12, P77, DOI 10.2463/mrms.2012-0052; Motosugi U, 2011, JPN J RADIOL, V29, P639, DOI 10.1007/s11604-011-0607-5; Motosugi U, 2010, JPN J RADIOL, V28, P623, DOI 10.1007/s11604-010-0478-1; Mueller Sebastian, 2010, Hepat Med, V2, P49; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Wang Yi, 2011, AJR Am J Roentgenol, V196, P553, DOI 10.2214/AJR.10.4580	46	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	MAY	2015	41	5					1203	1208		10.1002/jmri.24666		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CG9ND	WOS:000353641600006		
J	Han, MS; Chiba, K; Banerjee, S; Carballido-Gamio, J; Krug, R				Han, Misung; Chiba, Ko; Banerjee, Suchandrima; Carballido-Gamio, Julio; Krug, Roland			Variable Flip Angle Three-Dimensional Fast Spin-Echo Sequence Combined With Outer Volume Suppression for Imaging Trabecular Bone Structure of the Proximal Femur	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						trabecular bone structure; 3D fast spin echo; variable flip angle; proximal femur; outer volume suppression	CONFIRMATION BIAS	BackgroundTo demonstrate the feasibility of using a variable flip angle three-dimensional fast spin-echo (3D VFA-FSE) sequence combined with outer volume suppression for imaging trabecular bone structure at the proximal femur in vivo at 3 Tesla. MethodsThe 3D VFA-FSE acquisition was optimized to minimize blurring and to provide high signal-to-noise ratio (SNR) from bone marrow. Outer volume suppression was achieved by applying three quadratic-phase radio-frequency pulses. The SNR and trabecular bone structures from 3D VFA-FSE were compared with those from previously demonstrated multiple-acquisition 3D balanced steady-state free precision (bSSFP) using theoretical simulations, ex vivo experiments, and in vivo experiments. ResultsOur simulation demonstrated that 3D VFA-FSE can provide at least 35% higher SNR than 3D bSSFP, which was confirmed by the ex vivo and in vivo experiments. The ex vivo experiments demonstrated a good correlation and agreement between bone structural paramters obtained with the two sequences. The proposed sequence depicted trabecular bone structure at the proxiaml femur in vivo well without visible suppression artifacts and provided a mean SNR of 11.0. ConclusionThe 3D VFA-FSE sequence combined with outer volume suppression can depict the trabecular bone structure of the proximal femur in vivo with minimal blurring and high SNR efficiency. J. Magn. Reson. Imaging 2015;41:1300-1310. (c) 2014 Wiley Periodicals, Inc.	[Han, Misung; Carballido-Gamio, Julio; Krug, Roland] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Chiba, Ko] Nagasaki Univ, Sch Med, Dept Orthopaed Surg, Nagasaki 852, Japan; [Banerjee, Suchandrima] GE Healthcare, Appl Sci Lab, Menlo Pk, CA USA	Han, MS (reprint author), China Basin Landing, 185 Berry St,Suite 350,Box 0946, San Francisco, CA 94107 USA.	misung.han@ucsf.edu			NIH [R01AR057336, P30AR058899]; UCSF-Gladstone Institute of Virology and Immunology Center for AIDS Research	Contract grant sponsor: NIH; Contract grant number: R01AR057336, Contract grant number: P30AR058899; Contract grant sponsor: the UCSF-Gladstone Institute of Virology and Immunology Center for AIDS Research.	Doll BB, 2014, COGN AFFECT BEHAV NE, V14, P715, DOI 10.3758/s13415-014-0250-6; Carlin CS, 2014, STAT MED; Guimond Mary Elizabeth, 2014, Nurs Womens Health, V18, P28, DOI 10.1111/1751-486X.12091; Kukucka J, 2014, LAW HUMAN BEHAV, V38, P256, DOI 10.1037/lhb0000066	4	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	MAY	2015	41	5					1300	1310		10.1002/jmri.24673		148	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CG9ND	WOS:000353641600001		
J	Lee, J; Shin, Y; Murota, H				Lee, JeongBeom; Shin, YoungOh; Murota, Hiroyuki			Oligonol Supplementation Modulates Plasma Volume and Osmolality and Sweating After Heat Load in Humans	JOURNAL OF MEDICINAL FOOD			English	Article						temperature; plasma osmolality; Oligonol; sweat; sodium; diuretic; aldosterone; plasma volume	BLOOD-VOLUME; BODY-TEMPERATURE; ANGIOTENSIN-II; STRESS; MECHANISMS; EXERCISE; WATER; THERMOREGULATION; DEHYDRATION; ACCLIMATION	Oligonol is a low-molecular-weight polyphenol that possesses antioxidant and anti-inflammatory properties. This study investigated the effects of Oligonol supplementation on sweating response, plasma volume (PV), and osmolality (Osm) after heat load in human volunteers. We conducted a placebo-controlled crossover trial. Participants took a daily dose of 200 mg Oligonol or placebo for 1 week. After a 2-week washout period, the subjects were switched to the other study arm. As a heat load, half-body immersion into hot water (42 degrees C +/- 0.5 degrees C for 30 min) was performed in an automated climate chamber. Tympanic and mean body temperature (Tty, mTb) and whole-body sweat loss volume (WBSLV) were measured. Changes in PV, Osm, and serum levels of aldosterone and sodium were analyzed. Oligonol intake attenuated increases in Tty, mTb, and WBSLV after heat load compared with the placebo (P<.01, P<.05, and P<.01, respectively). In addition, serum aldosterone was maintained at a relatively low degree and serum sodium was maintained at a relatively high degree with Oligonol compared to the placebo (PP<.05, respectively). However, PV decreased and Osm increased significantly with Oligonol compared to the placebo (PP<.05, respectively). This study demonstrates that Oligonol supplementation for 1 week can attenuate elevation of body temperature and excessive sweating under heat load in healthy humans, but interpretation of the results requires caution due to the potent diuretic effect of Oligonol.	[Lee, JeongBeom] Soonchunhyang Univ, Dept Physiol, Coll Med, Cheonan, South Korea; [Shin, YoungOh] Soonchunhyang Univ, Global Grad Sch, Dept Healthcare, Asan, South Korea; [Murota, Hiroyuki] Osaka Univ, Grad Sch Med, Course Integrated Med, Dept Dermatol, Osaka, Japan	Shin, Y (reprint author), Soonchunhyang Univ, Global Grad Sch, Dept Healthcare, 646 Eupnae Ri Shinchang Myun, Asan 336745, Chungnam, South Korea.	syo99@nate.com					Chawla R, 2012, J ETHNOPHARMACOL, V143, P116, DOI 10.1016/j.jep.2012.06.014; Sunderland C, 2005, J SPORT SCI, V23, P531, DOI 10.1080/02640410410001730197; Quispe C, 2012, PLANT FOOD HUM NUTR, V67, P242, DOI 10.1007/s11130-012-0302-4; Lee JB, 2010, NUTR RES PRACT, V4, P203, DOI 10.4162/nrp.2010.4.3.203; Wimer GS, 1997, CAN J APPL PHYSIOL, V22, P479; DILL DB, 1974, J APPL PHYSIOL, V37, P247; Shin YO, 2013, J MED FOOD, V16, P318, DOI 10.1089/jmf.2012.2543; Lee JB, 2014, NUTRIENTS, V6, P2466, DOI 10.3390/nu6062466; Cheuvront SN, 2010, J APPL PHYSIOL, V109, P1989, DOI 10.1152/japplphysiol.00367.2010; EDELMAN IS, 1959, AM J MED, V27, P256, DOI 10.1016/0002-9343(59)90346-8; Shibasaki M, 2006, J APPL PHYSIOL, V100, P1692, DOI 10.1152/japplphysiol.01124.2005; dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236; Fujii H, 2007, FOOD CHEM TOXICOL, V45, P378, DOI 10.1016/j.fct.2006.08.026; HARRISON MH, 1983, J APPL PHYSIOL, V54, P515; Horowitz M, 1999, AM J PHYSIOL-REG I, V277, pR47; HOROWITZ M, 1988, PFLUG ARCH EUR J PHY, V412, P354, DOI 10.1007/BF01907551; Kim TW, 2013, APPL BIOCHEM BIOTECH, V171, P1253, DOI 10.1007/s12010-013-0296-x; Kim TW, 2011, J MED FOOD, V14, P1448, DOI 10.1089/jmf.2010.1534; KOSUNEN KJ, 1976, J APPL PHYSIOL, V41, P323; Landis EM, 1933, J CLIN INVEST, V12, P105, DOI 10.1172/JCI100482; Lee JB, 2014, FOOD FUNCT, V5, P2516, DOI 10.1039/c4fo00521j; Lee Jeong-Beom, 2007, Korean Journal of Physiology & Pharmacology, V11, P233; MIKI K, 1983, J APPL PHYSIOL, V55, P300; Muhammad N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-59; Nielsen B, 1998, INT J SPORTS MED, V19, pS154, DOI 10.1055/s-2007-971984; Okazaki K, 2009, J PHYSIOL-LONDON, V587, P5585, DOI 10.1113/jphysiol.2009.180562; Policegoudra RS, 2011, J BIOSCIENCES, V36, P739, DOI 10.1007/s12038-011-9106-1; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531; Shibasaki Manabu, 2010, Front Biosci (Schol Ed), V2, P685; Shilpi JA, 2012, ADV PHARM SCI, V2012, DOI 10.1155/2012/576086; Shin YO, 2011, FOOD SCI BIOTECHNOL, V20, P659, DOI 10.1007/s10068-011-0093-7; Starling E H, 1894, J Physiol, V16, P224; Starling E H, 1896, J Physiol, V19, P312	33	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-620X	1557-7600		J MED FOOD	J. Med. Food	MAY 1	2015	18	5					578	583		10.1089/jmf.2014.3184		6	Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics	Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics	CH0PV	WOS:000353725500010		
J	Matsushita, Y; Yamamura, K; Morimoto, S; Bao, Z; Kurose, D; Sato, I; Yoshida, S; Tsushima, S				Matsushita, Yuko; Yamamura, Kohji; Morimoto, Sho; Bao, Zhihua; Kurose, Daisuke; Sato, Ikuo; Yoshida, Shigenobu; Tsushima, Seiya			Analysis of variations in band positions for normalization in across-gel denaturing gradient gel electrophoresis	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						DGGE; Band position; Between-gel variation; Within-gel variation; Marker; Normalization	16S RIBOSOMAL-RNA; 18S RDNA PRIMERS; FUNGAL COMMUNITIES; SOIL COMMUNITY; AGRICULTURAL SOILS; DGGE; BACTERIAL; DIVERSITY; PCR; POPULATIONS	Variation in band position between gels is a well-known problem in denaturing gradient gel electrophoresis (DGGE). However, few reports have evaluated the degree of variation in detail. In this study, we investigated the variation in band positions of DNA samples extracted from soil, normalized using reference positions within marker lanes for DGGE in three organismal (bacterial, fungal, and nematode) conditions. For sample lanes, marker DNA (as a control) and sample DNA were used. The test for normality of distribution showed that the position data of a large percentage of bands were normally distributed but not for certain bands. For the normally-distributed data, their variations [standard deviation of marker bands (SDM) and standard deviation of sample bands (SDS), respectively] were assessed. For all organismal conditions, the degree of within-gel variation were similar between SDMs and SDSs, while between-gel variations in SDSs were larger than those in SDMs. Due to the large effect of between-gel variations, the total variations in SDSs were more varied between sample bands, and the mean variations of all sample bands were higher than those in the markers. We found that the total variation in the fungal and nematode SDSs decreased when the intervals between marker bands were narrowed, suggesting that band interval is important for reducing total variation in normalized band positions. For the non-normally distributed data, the distribution was examined in detail. This study provided detailed information on the variation of band positions, which could help to optimize markers for reducing band position variation, and could aid in the accurate identification of bands in across-gel DGGE analyses. (C) 2015 Elsevier B.V. All rights reserved.	[Matsushita, Yuko; Yamamura, Kohji; Morimoto, Sho; Bao, Zhihua; Kurose, Daisuke; Sato, Ikuo; Yoshida, Shigenobu; Tsushima, Seiya] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan	Tsushima, S (reprint author), Natl Inst Agroenvironm Sci, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan.	seya@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	This study was supported by a Grant-in-Aid (Soil eDNA project) from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Nakatsu CH, 2007, SOIL SCI SOC AM J, V71, P562, DOI 10.2136/sssaj2006.0080; Fromin N, 2002, ENVIRON MICROBIOL, V4, P634, DOI 10.1046/j.1462-2920.2002.00358.x; Bao ZH, 2012, MICROBES ENVIRON, V27, P72, DOI 10.1264/jsme2.ME11281; Anderson IC, 2004, ENVIRON MICROBIOL, V6, P769, DOI 10.1111/j.1462-2920.2004.00675.x; Yamamura K, 1999, RES POPUL ECOL, V41, P229; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; Okada H, 2008, NEMATOLOGY, V10, P689, DOI 10.1163/156854108785787280; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233; Suzuki C, 2012, SOIL SCI PLANT NUTR, V58, P288, DOI 10.1080/00380768.2012.694119; May LA, 2001, CAN J MICROBIOL, V47, P829, DOI 10.1139/cjm-47-9-829; Hoshino YT, 2010, MICROBES ENVIRON, V25, P281, DOI 10.1264/jsme2.ME10136; Suzuki C, 2009, SOIL SCI PLANT NUTR, V55, P80, DOI 10.1111/j.1747-0765.2008.00344.x; Hoshino YT, 2008, SOIL SCI PLANT NUTR, V54, P701, DOI 10.1111/j.1747-0765.2008.00289.x; Ferrari VC, 1999, HYDROBIOLOGIA, V401, P55, DOI 10.1023/A:1003773907789; Sekiguchi H, 2002, APPL ENVIRON MICROB, V68, P5142, DOI 10.1128/AEM.68.10.5142-5150.2002; Waite IS, 2003, SOIL BIOL BIOCHEM, V35, P1165, DOI 10.1016/S0038-0717(03)00177-9; Muyzer G, 1999, CURR OPIN MICROBIOL, V2, P317, DOI 10.1016/S1369-5274(99)80055-1; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Nakatsu CH, 2000, SOIL SCI SOC AM J, V64, P1382; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Classification Committee of Cultivated Soils, 1995, CLASS CULT SOILS JAP; Foucher ALJL, 2004, SOIL BIOL BIOCHEM, V36, P2027, DOI 10.1016/j.soilbio.2004.05.021; Fujii T., 2009, MARC S 2009 WORKSH 5; Huber F, 2004, APPL ENVIRON MICROB, V70, P4390, DOI 10.1128/AEM.70.7.4390-4392.2004; Matsushita Y., 2010, SOIL MICROORG, V64, P107; Morimoto S., 2008, Soil Microorganisms, V62, P63; Navidi W, 2006, STAT ENG SCI; NIAES, 2010, TECHN REP PCR DGGE A; Oba H., 2008, Soil Microorganisms, V62, P69; R Development Core Team, 2012, R LANG ENV STAT COMP; Takemoto S, 2010, J NEMATOL, V42, P324; Tourlomousis P, 2010, MICROB ECOL, V59, P776, DOI 10.1007/s00248-009-9613-x; Tsushima S, 2014, J GEN PLANT PATHOL, V80, P389, DOI 10.1007/s10327-014-0538-y; Valaskova V, 2009, PLANT SOIL ENVIRON, V55, P413; Valentin-Vargas A, 2013, J MICROBIOL METH, V92, P173, DOI 10.1016/j.mimet.2012.12.001	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	MAY	2015	112						11	20		10.1016/j.mimet.2015.02.011		10	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CG6QL	WOS:000353426900003		
J	Dong, L; Zhu, XY; Cui, HC; Ojika, M; Wang, RG; Liu, HR				Dong, Lei; Zhu, Xiangyuan; Cui, Haichen; Ojika, Makoto; Wang, Ruigang; Liu, Huirong			Establishment of the straightforward electro-transformation system for Phytophthora infestans and its comparison with the improved PEG/CaCl2 transformation	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Phytophthora; Transformation; Electroporation; Zoospore; Protoplast	GREEN FLUORESCENT PROTEIN; TRANSIENT EXPRESSION; OOMYCETE PATHOGEN; VITAL MARKER; GFP; RESISTANCE; GENE; REPORTER; SINGLE	Phytophthora infestans is the most devastating pathogen of potato. For the biology study of P. infestans at the molecular level, one of the difficulties is the technique for the genetic transformation. In this study, the straightforward electro-transformation system was established for P. infestans with a green fluorescent protein expression vector and compared with the improved PEG/CaCl2 mediated protoplast transformation system. The results showed that the straightforward electro-transformation could work in P. infestans and 32 positive transformants were obtained per about 1.10 x 10(6) zoospores. The transformants per mu g of vector DNA were 1.08. The transformation efficiency of the straightforward electro-transformation was approximately 2 times higher than that of the improved PEG/CaCl2 mediated protoplast transformation (17 positive transformants per about 1.05 x 10(6) protoplasts, 0.58 transformants per mu g of vector DNA) according to the reported procedures. Furthermore, compared with the improved PEG/CaCl2 transformation, the straightforward electroporation is simpler and requires less starting materials and operating time from collecting material to obtaining the resistant transformants. Our work will lay a foundation for the biology study of P. infestans in the future. (C) 2015 Elsevier B.V. All rights reserved.	[Dong, Lei; Zhu, Xiangyuan; Cui, Haichen; Wang, Ruigang; Liu, Huirong] Inner Mongolia Agr Univ, Coll Life Sci, Dept Biochem & Mol Biol, Hohhot 010018, Inner Mongolia, Peoples R China; [Ojika, Makoto] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Liu, HR (reprint author), Inner Mongolia Agr Univ, Coll Life Sci, Dept Biochem & Mol Biol, 306 Zhaowuda Rd, Hohhot 010018, Inner Mongolia, Peoples R China.	huirong_liu@imau.edu.cn			National Natural Science Foundation of China (NSFC) [31060126, 31260217]	We thank H. Zhou and G. Li, Inner Mongolia Agricultural University, China, for providing the isolate HQK8-3 of P. infestans and the vector pCAMBIA1302, and Y. Wang, Nanjing Agricultural University, China, for supplying the vector pHam34 and pHSPN. This work was supported by grants from the National Natural Science Foundation of China (NSFC) (Grant Nos. 31060126 and 31260217).	CATEN CE, 1968, CAN J BOTANY, V46, P329; GOODWIN SB, 1992, CURR GENET, V22, P107, DOI 10.1007/BF00351469; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Si-Ammour A, 2003, MOL PLANT PATHOL, V4, P237, DOI [10.1046/j.1364-3703.2003.00168.x, 10.1046/J.1364-3703.2003.00168.X]; Kroon LPNM, 2012, PHYTOPATHOLOGY, V102, P348, DOI 10.1094/PHYTO-01-11-0025; Sanju Suman, 2013, Physiology and Molecular Biology of Plants, V19, P165, DOI 10.1007/s12298-012-0157-z; Vijn I, 2003, MOL PLANT PATHOL, V4, P459, DOI [10.1046/j.1364-3703.2003.00191.x, 10.1046/J.1364-3703.2003.00191.X]; Bottin A, 1999, FEMS MICROBIOL LETT, V176, P51, DOI 10.1016/S0378-1097(99)00218-9; Chen XiaoRen, 2012, Journal of Agricultural Biotechnology, V20, P568; Cvitanich C, 2003, CURR GENET, V42, P228, DOI 10.1007/s00294-002-0354-3; Dubresson R, 2008, VITIS, V47, P235; Hammer TR, 2007, PLANT PATHOL, V56, P177, DOI 10.1111/j.1365-3059.2006.01494.x; Huitema E, 2011, METHODS MOL BIOL, V712, P129, DOI 10.1007/978-1-61737-998-7_11; JUDELSON HS, 1991, CURR GENET, V19, P453, DOI 10.1007/BF00312736; JUDELSON HS, 1993, CURR GENET, V23, P211, DOI 10.1007/BF00351498; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Latijnhouwers M, 2003, EUKARYOT CELL, V2, P971, DOI 10.1128/EC.2.5.971-977.2003; Mcleod A, 2008, J EUKARYOT MICROBIOL, V55, P103, DOI 10.1111/j.1550-7408.2008.00304.x; MortBontemps M, 1997, CURR GENET, V31, P272, DOI 10.1007/s002940050205; van West P, 1999, FEMS MICROBIOL LETT, V178, P71, DOI 10.1016/S0378-1097(99)00320-1; Weiland JJ, 2003, CURR GENET, V42, P344, DOI 10.1007/s00294-002-0359-y	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	MAY	2015	112						83	86		10.1016/j.mimet.2015.03.013		4	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CG6QL	WOS:000353426900016		
J	Reale, L; Bonfigli, F; Lai, A; Flora, F; Albertano, P; Di Giorgio, ML; Mezi, L; Montereali, RM; Faenov, A; Pikuz, T; Almaviva, S; Francucci, M; Gaudio, P; Martellucci, S; Richetta, M; Poma, A				Reale, L.; Bonfigli, F.; Lai, A.; Flora, F.; Albertano, P.; Di Giorgio, M. L.; Mezi, L.; Montereali, R. M.; Faenov, A.; Pikuz, T.; Almaviva, S.; Francucci, M.; Gaudio, P.; Martellucci, S.; Richetta, M.; Poma, A.			Contact X-ray microscopy of living cells by using LiF crystal as imaging detector	JOURNAL OF MICROSCOPY			English	Article						Contact X-ray microscopy; lithium fluoride detectors; algae; Chlamydomonas; Leptolyngbya; Macrophage RAW 264.7	MONONUCLEAR PHAGOCYTE SYSTEM; FREE-ELECTRON LASER; LITHIUM-FLUORIDE; IMMUNOHISTOCHEMICAL LOCALIZATION; SPATIAL-RESOLUTION; PLASMA SOURCE; POINT-DEFECTS; ANTIGEN F4/80; COLOR-CENTERS; WATER WINDOW	In this paper, the use of lithium fluoride (LiF) as imaging radiation detector to analyse living cells by single-shot soft X-ray contact microscopy is presented. High resolved X-ray images on LiF of cyanobacterium Leptolyngbya VRUC135, two unicellular microalgae of the genus Chlamydomonas and mouse macrophage cells (line RAW 264.7) have been obtained utilizing X-ray radiation in the water window energy range from a laser plasma source. The used method is based on loading of the samples, the cell suspension, in a special holder where they are in close contact with a LiF crystal solid-state X-ray imaging detector. After exposure and sample removal, the images stored in LiF by the soft X-ray contact microscopy technique are read by an optical microscope in fluorescence mode. The clear image of the mucilaginous sheath the structure of the filamentous Leptolyngbya and the visible nucleolus in the macrophage cells image, are noteworthiness results. The peculiarities of the used X-ray radiation and of the LiF imaging detector allow obtaining images in absorption contrast revealing the internal structures of the investigated samples at high spatial resolution. Moreover, the wide dynamic range of the LiF imaging detector contributes to obtain high-quality images. In particular, we demonstrate that this peculiar characteristic of LiF detector allows enhancing the contrast and reveal details even when they were obscured by a nonuniform stray light. Lay Description The possibility of detecting images by X-ray of materials, devices and biological samples with high spatial resolution is a topical task nowadays. The great and fast development of radiation sources, optics and detectors, makes X-ray imaging applications very attractive in physics as well as in life sciences. For biological investigations, when compared with traditional microscopy techniques, single-exposure X-ray microscopy has the potential to obtain high spatial resolution images while still keeping a sample alive. In particular, in the (2.2-4.4) nm wavelength interval, known as water-window, water is much less absorbing than organic compounds. Thus images of specimens containing water can be obtained with a natural contrast. X-ray contact microscopy represents the simplest X imaging technique: the sample is placed in direct contact with a sensitive material and exposed to radiation. The image is formed in an absorption contrast process. This process doesn't need coherent radiation and compact polychromatic laboratory X-ray sources, such as soft X-ray laser plasma sources, can be used. Single-shot experiments are possible in this experimental configuration, allowing in vivo investigation (without the need of any cryogenic or chemical process). The performances of lithium fluoride (LiF) detectors have renewed the interest in such imaging technique and in the development of X-ray imaging laboratory tools. We present the use of LiF as imaging radiation detector to analyze living cells by single-shot soft X-ray contact microscopy. High resolved X-ray images on LiF of cyanobacterium Leptolyngbya VRUC135, two unicellular microalgae of the genus Chlamydomonas and mouse macrophage cells (line RAW 264.7) have been obtained utilizing X-ray radiation in the water window energy range from a laser plasma source. The used method is based on loading of the samples, the cell suspension, in a special holder where they are in close contact with a LiF crystal solid-state X-ray imaging detector. After exposure and sample removal, the images stored in LiF are read by an optical microscope in fluorescence mode. We showed that the peculiarities of LiF detector (wide dynamic range and very high spatial resolution) are particularly suitable for single-shot soft X-ray contact microscopy of in vivo biological samples. In particular, images revealing the internal structures of the investigated samples at high spatial resolution have been obtained. Furthermore, an image reconstruction technique for stray light removal to enhance the contrast and reveal details has been shown.	[Reale, L.] Campus Biomed, Rome, Italy; [Bonfigli, F.; Lai, A.; Flora, F.; Mezi, L.; Montereali, R. M.; Almaviva, S.; Francucci, M.] ENEA CR Frascati, UTAPRAD, Tech Unit Dev & Applicat Radiat, I-00044 Rome, Italy; [Albertano, P.] Univ Roma Tor Vergata, Dipartimento Biol, Lab Biol Alghe, I-00173 Rome, Italy; [Di Giorgio, M. L.; Poma, A.] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Faenov, A.] Osaka Univ, Inst Acad Initiat, Suita, Osaka 565, Japan; [Faenov, A.; Pikuz, T.] Russian Acad Sci, Joint Inst High Temp, Moscow, Russia; [Pikuz, T.] Osaka Univ, Grad Sch Engn, Suita, Osaka 565, Japan; [Gaudio, P.; Martellucci, S.; Richetta, M.] Univ Roma Tor Vergata, Dept Engn, Rome, Italy	Bonfigli, F (reprint author), ENEA CR Frascati, UTAPRAD, Tech Unit Dev & Applicat Radiat, V Enrico Fermi 45, I-00044 Rome, Italy.	francesca.bonfigli@enea.it	Gaudio, Pasqualino/B-3009-2014	Gaudio, Pasqualino/0000-0003-0861-558X	RIA grants of University of L'Aquila; Russian Science Foundation [14-50-00124]	Authors thank Prof. Armando Reale for his continuous support and precious suggestions on this research activity. The work was partially supported by RIA grants of University of L'Aquila to A. Poma. Work of T. Pikuz and A. Faenov were partly supported by Russian Science Foundation, grant # 14-50-00124.	Albertano P., 1988, ALGOLOGICAL STUDIES, V50-53, P47; Albertano P, 2000, MICRON, V31, P27, DOI 10.1016/S0968-4328(99)00063-3; Bollanti S, 1998, NUOVO CIMENTO D, V20, P1685; Albertano P., 1988, ALGOLOGICAL STUDIES, V50-53, P55; Albertano P, 1997, J MICROSC-OXFORD, V187, P96, DOI 10.1046/j.1365-2818.1997.2120768.x; Albertano P., 1991, ARCH HYDROBIOL ALGOL, V64, P199; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Laskin DL, 2001, J LEUKOCYTE BIOL, V70, P163; Almaviva S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2236283; Ackermann W, 2007, NAT PHOTONICS, V1, P336, DOI 10.1038/nphoton.2007.76; HUME DA, 1984, P NATL ACAD SCI-BIOL, V81, P4174, DOI 10.1073/pnas.81.13.4174; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; Bellezza S, 2003, J APPL PHYCOL, V15, P193, DOI 10.1023/A:1023811311686; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Chao WL, 2005, NATURE, V435, P1210, DOI 10.1038/nature03719; Voitovich AP, 2013, J LUMIN, V143, P207, DOI 10.1016/j.jlumin.2013.04.004; Wachulak PW, 2011, OPT EXPRESS, V19, P9541, DOI 10.1364/OE.19.009541; Sekatskii SK, 1996, APPL PHYS B-LASERS O, V63, P525; Sakdinawat A, 2010, NAT PHOTONICS, V4, P840, DOI 10.1038/nphoton.2010.267; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; LOHMANNMATTHES ML, 1994, EUR RESPIR J, V7, P1678; ATHANASOU NA, 1995, ANN RHEUM DIS, V54, P392, DOI 10.1136/ard.54.5.392; Baldacchini G., 2005, REV SCI INSTRUM, V76; Bellucci I., 2000, P 40 ANN LAS FIR 200, P159; BOLD HAROLD C., 1949, BULL TORREY BOT CLUB, V76, P101, DOI 10.2307/2482218; Bonfigli F, 2008, MICROSC RES TECHNIQ, V71, P35, DOI 10.1002/jemt.20523; Bonfigli F, 2005, PHYS STATUS SOLIDI A, V202, P250, DOI 10.1002/pssa.200460236; Bonfigli F, 2009, J LUMIN, V129, P1964, DOI 10.1016/j.jlumin.2009.04.035; Bonfigli F, 2003, P SOC PHOTO-OPT INS, V5181, P194, DOI 10.1117/12.502707; Bruno L., 1999, ARCH HYDROBIOL ALGOL, V94, P89; Cotton R, 1995, P SOC PHOTO-OPT INS, V2523, P184, DOI 10.1117/12.220977; HUME DA, 1984, J CELL SCI, V66, P189; HUME DA, 1983, J EXP MED, V157, P1704, DOI 10.1084/jem.157.5.1704; HUME DA, 1987, J LEUKOCYTE BIOL, V42, P474; Larsen EC, 2002, J CELL BIOL, V159, P939, DOI 10.1083/jcb.200205140; Montereali R. M., 2002, HDB THIN FILM MAT, V3, P399, DOI 10.1016/B978-012512908-4/50043-6; Oldenhof H, 2006, EUR J PHYCOL, V41, P313, DOI 10.1080/09670260600699920; PETROCELLI G, 1993, APPL PHYS LETT, V63, P3402, DOI 10.1063/1.110154; PETROCELLI G, 1993, J OPT SOC AM B, V10, P918, DOI 10.1364/JOSAB.10.000918; Pickett-Heaps J., 1975, GREEN ALGAE, P27; Reale L, 2008, MICROSC RES TECHNIQ, V71, P839, DOI 10.1002/jemt.20625; Renaut S, 2006, EVOLUTION, V60, P2272; Richetta M., 2006, J PHYS CONDENS MATT, V18, P2039; TerMikirtychev VV, 1997, CAN J PHYS, V75, P813, DOI 10.1139/cjp-75-11-813; Ustione A., 2006, APPL PHYS LETT, V88; VansFurth R., 1972, B WORLD HEALTH ORGAN, V46, P845	49	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-2720	1365-2818		J MICROSC-OXFORD	J. Microsc..	MAY	2015	258	2					127	139		10.1111/jmi.12226		13	Microscopy	Microscopy	CH2GA	WOS:000353842500005		
J	Maeno, S; Zhu, QQ; Sasaki, M; Miyamoto, T; Fukushima, M				Maeno, Shohei; Zhu, Qianqian; Sasaki, Masahide; Miyamoto, Takafumi; Fukushima, Masami			Monopersulfate oxidation of tetrabromobisphenol A by an iron(III)-phthalocyaninetetrasulfate catalyst coordinated to imidazole functionalized silica particles	JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL			English	Article						Iron(III)-phthalocyanine-4,4 ',4 '',4 '''-tetrasulfonic acid; Imidazole functionalized silica; Iron(III)-tetrakis(p-sulfonatephenyl)porphyrin; Catalytic oxidation	HYDROXYPROPYL-BETA-CYCLODEXTRIN; CONTAMINATED SOIL SUSPENSIONS; HUMIC-ACID; POTASSIUM MONOPERSULFATE; FORMALDEHYDE POLYCONDENSATION; PORPHYRIN COMPLEX; IRON(III)-PHTHALOCYANINE-TETRASULFONIC ACID; BIOMIMETIC CATALYSTS; HYDROGEN-PEROXIDE; FLAME RETARDANTS	An iron(III)-phthalocyaninetetrasulfate (FePcTS) was axially coordinated to a series of imidazole functionalized silica, 3-(1-imidazolyl)propylcarbamoyl-3'-aminopropylsilica (IPS) particles. Among the prepared FePcTS/IPS catalysts, catalytic activity for the oxidation of tetrabromobisphenol A (TBBPA) for the smallest sized particle (<30 mu m) was more effective than larger sizes (145 mu m< and 45-145 mu m). The catalytic activity of FePcTS/IPS was compared with that of a structural analogue, iron(III)-tetrakis(p-sulfonatephenyl)porphyrin (FeTPPS) supported IPS (FeTPPS/IPS). The TOF values for the oxidation of TBBPA by FePcTS/IPS (11-17 h(-1)) were much larger than the corresponding values for FeTPPS/IPS (0.7-3.5 h(-1)) in the absence and presence of humic acid, a major coexistent substance in landfill leachates. To investigate the reasons for the differences in catalytic activities between the FePcTS and FeTPPS systems, the influence of ethanol, a SO4 center dot- scavenger, on the oxidation of TBBPA oxidation was tested. The TOF values for FePcTS/IPS decreased with increasing ethanol concentration, while the catalytic activities for FeTPPS/IPS were not affected by adding ethanol. These results suggest that the higher catalytic activity of the FePcTS catalytic system can be attributed to the contribution of radical species, which can be generated via the homolysis of O-O bonding in the Fe(III)-peroxo species. (C) 2015 Elsevier B.V. All rights reserved.	[Maeno, Shohei; Zhu, Qianqian; Miyamoto, Takafumi; Fukushima, Masami] Hokkaido Univ, Div Sustainable Resources Engn, Lab Chem Resources, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Sasaki, Masahide] Natl Inst Advanced Ind Sci & Technol, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan	Fukushima, M (reprint author), Hokkaido Univ, Div Sustainable Resources Engn, Lab Chem Resources, Fac Engn, Sapporo, Hokkaido 0608628, Japan.	m-fukush@eng.hokudai.ac.jp	Fukushima, Masami/D-6150-2012		Japan Society for Promotion of Science [25241017]	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for Promotion of Science (25241017).	Fang GD, 2013, APPL CATAL B-ENVIRON, V129, P325, DOI 10.1016/j.apcatb.2012.09.042; Osako M, 2004, CHEMOSPHERE, V57, P1571, DOI 10.1016/j.chemosphere.2004.08.076; Christoforidis KC, 2010, APPL CATAL B-ENVIRON, V95, P297, DOI 10.1016/j.apcatb.2010.01.007; Ranguelova K, 2012, FREE RADICAL BIO MED, V52, P1264, DOI 10.1016/j.freeradbiomed.2012.01.016; Shigetatsu S, 2010, J ENVIRON SCI HEAL A, V45, P1536, DOI 10.1080/10934529.2010.506110; Miyamoto T, 2014, J MOL CATAL B-ENZYM, V110, P147, DOI 10.1016/j.molcatb.2014.10.003; Zhu QQ, 2015, APPL CATAL B-ENVIRON, V163, P459, DOI 10.1016/j.apcatb.2014.08.035; Miyamoto T, 2014, J MOL CATAL B-ENZYM, V99, P150, DOI 10.1016/j.molcatb.2013.11.002; Zhu QQ, 2013, J ENVIRON SCI HEAL A, V48, P1593, DOI 10.1080/10934529.2013.815078; Liang CJ, 2009, IND ENG CHEM RES, V48, P5558, DOI 10.1021/ie9002848; Zou J, 2013, ENVIRON SCI TECHNOL, V47, P11685, DOI 10.1021/es4019145; Zhu QQ, 2014, J MOL CATAL A-CHEM, V385, P31, DOI 10.1016/j.molcata.2014.01.013; Fukushima M, 2009, J ANAL APPL PYROL, V86, P200, DOI 10.1016/j.jaap.2009.06.005; Zucca P, 2007, J MOL CATAL A-CHEM, V278, P220, DOI 10.1016/j.molcata.2007.09.017; Nishimoto R, 2013, COLLOID SURFACE A, V418, P117, DOI 10.1016/j.colsurfa.2012.11.032; Fukushima M, 2011, J ANAL APPL PYROL, V91, P323, DOI 10.1016/j.jaap.2011.03.008; Nam W, 2000, J AM CHEM SOC, V122, P8677, DOI 10.1021/ja994403e; Rismayani S, 2004, J HAZARD MATER, V114, P175, DOI 10.1016/j.jhazmat.2004.08.006; Tan CQ, 2014, J HAZARD MATER, V276, P452, DOI 10.1016/j.jhazmat.2014.05.068; Rismayani S, 2004, J MOL CATAL A-CHEM, V217, P13, DOI 10.1016/j.molcata.2004.03.030; Timmins GS, 1999, FREE RADICAL BIO MED, V27, P329, DOI 10.1016/S0891-5849(99)00049-0; Zhu QQ, 2013, MOLECULES, V18, P5360, DOI 10.3390/molecules18055360; Zucca P, 2009, J MOL CATAL A-CHEM, V306, P89, DOI 10.1016/j.molcata.2009.02.029; SOROKIN A, 1995, SCIENCE, V268, P1163, DOI 10.1126/science.268.5214.1163; Fukushima M, 2007, BIOMACROMOLECULES, V8, P386, DOI 10.1021/bm060829r; Christoforidis KC, 2011, APPL CATAL B-ENVIRON, V101, P417, DOI 10.1016/j.apcatb.2010.10.011; Fukushima M, 2011, ENVIRON CHEM LETT, V9, P223, DOI 10.1007/s10311-009-0269-z; Fukushima M, 2003, ENVIRON SCI TECHNOL, V37, P386, DOI 10.1021/es020747k; Fukushima M, 2008, J MOL CATAL A-CHEM, V286, P47, DOI 10.1016/j.molcata.2008.01.041; Fukushima M, 2006, J MOL CATAL A-CHEM, V245, P178, DOI 10.1016/j.molcata.2005.09.051; Fukushima M, 2012, MOLECULES, V17, P48, DOI 10.3390/molecules17010048; Fukushima M, 2006, BIORESOURCE TECHNOL, V97, P1605, DOI 10.1016/j.biortech.2005.07.032; Fukushima M, 2005, ENVIRON SCI TECHNOL, V39, P9337, DOI 10.1021/es051355r; Fukushima M, 1999, ANAL SCI, V15, P185, DOI 10.2116/analsci.15.185; Fukushima M, 2010, CHEMOSPHERE, V80, P860, DOI 10.1016/j.chemosphere.2010.05.041; Fukushima M, 2008, J MOL CATAL A-CHEM, V293, P103, DOI 10.1016/j.molcata.2008.07.014; Fukushima M, 2003, ENVIRON SCI TECHNOL, V37, P1031, DOI 10.1021/es020681t; Fukushima M, 2009, J ENVIRON SCI HEAL A, V44, P1088, DOI 10.1080/10934520903005079; Fukushima M, 2007, J HAZARD MATER, V144, P222, DOI 10.1016/j.jhazmat.2006.10.013; Kawasaki M, 2003, J PORPHYR PHTHALOCYA, V7, P645; Maeno S, 2014, J ENVIRON SCI HEAL A, V49, P981, DOI 10.1080/10934529.2014.894810; Mizutani Y, 2014, J ENVIRON SCI HEAL A, V49, P365, DOI 10.1080/10934529.2014.854148; Nam W, 2000, INORG CHEM, V39, P5572, DOI 10.1021/ic000502d; Nam WO, 2000, J AM CHEM SOC, V122, P6641, DOI 10.1021/ja000289k; Nishimoto R, 2015, J MOL CATAL A-CHEM, V396, P84, DOI 10.1016/j.molcata.2014.09.035; Ozawa T, 1996, FREE RADICAL BIO MED, V20, P837, DOI 10.1016/0891-5849(95)02092-6; Shukla RS, 1996, J MOL CATAL A-CHEM, V113, P45, DOI 10.1016/S1381-1169(96)00105-7; Zucca P, 2014, J MOL CATAL A-CHEM, V388, P2, DOI 10.1016/j.molcata.2013.09.010; Zucca P, 2008, J MOL CATAL A-CHEM, V288, P97, DOI 10.1016/j.molcata.2008.04.001; Zucca P, 2014, J MOL CATAL A-CHEM, V394, P129, DOI 10.1016/j.molcata.2014.07.013; Zucca P, 2010, J MOL CATAL A-CHEM, V321, P27, DOI 10.1016/j.molcata.2010.01.015	51	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1169	1873-314X		J MOL CATAL A-CHEM	J. Mol. Catal. A-Chem.	MAY 1	2015	400						56	63		10.1016/j.molcata.2015.02.003		8	Chemistry, Physical	Chemistry	CG4IE	WOS:000353248000008		
J	Gadge, ST; Kusumawati, EN; Harada, K; Sasaki, T; Nishio-Hamane, D; Bhanage, BM				Gadge, Sandip T.; Kusumawati, Etty Nurlia; Harada, Kei; Sasaki, Takehiko; Nishio-Hamane, Daisuke; Bhanage, Bhalchandra M.			Synthesis of oxamate and urea by oxidative single and double carbonylation of amines using immobilized palladium metal-containing ionic liquid@SBA-15	JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL			English	Article						Oxamate; Carbonylation; Amine; Heterogeneous catalysis; Palladium; Ligand-free	CATALYSTS; EFFICIENT; CARBON	A promising route for the synthesis of oxamate and urea by oxidative carbonylation of amine is described using immobilized palladium metal-containing ionic liquid onto mesoporous silica (ImmPd-IL-@SBA-15). Adequate adjustments of the different reaction parameters such as solvent, additives temperature, and substrate to achieve optimal catalyst performance were made using ImmPd-IL@SBA-15 as a catalytic system. The ImmPd-IL@SBA-15 catalyst along with NaI promoter showed high selectivity to the desired products over several amine compounds such as aliphatic, aromatic, allylic etc. The secondary amines selectively cross double carbonylated with alcohol to give the oxamate derivatives and the primary amines provided the urea as a product by the single carbonylation. The fresh and recycled catalyst was characterized using XPS and TEM-EDX analysis. The carbonylation route proposed here eliminates the need for corrosive, moisture-sensitive, thermally unstable monoesters of oxalyl chlorides and provides a cleaner synthetic route for the synthesis of oxamates using ImmPd-IL@SBA-15 as a heterogeneous and reusable catalyst. Notably reaction does not require air/moisture sensitive phosphine ligands, co-catalyst and dehydrating agent with an additional advantage of palladium catalyst recovery and reuse for up to six consecutive cycles without loss in activity and selectivity. (C) 2015 Elsevier B.V. All rights reserved.	[Gadge, Sandip T.; Bhanage, Bhalchandra M.] Inst Chem Technol, Dept Chem, Bombay 400019, Maharashtra, India; [Kusumawati, Etty Nurlia] Univ Tokyo, Grad Sch Sci, Dept Chem, Kashiwa, Chiba 2778561, Japan; [Harada, Kei; Sasaki, Takehiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Nishio-Hamane, Daisuke] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	Bhanage, BM (reprint author), Inst Chem Technol, Dept Chem, N Parekh Marg, Bombay 400019, Maharashtra, India.	bm.bhanage@gmail.com	Sasaki, Takehiko/E-8160-2014	Sasaki, Takehiko/0000-0001-6190-4087	CSIR (Council of Scientific and Industrial Research, India); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; JSPS; DST under the Japan-India Science Cooperative Program [DST/INT/JSPS/P-152/2013]	The author (Sandip T. Gadge) is greatly thankful to CSIR (Council of Scientific and Industrial Research, India) for providing Senior Research Fellowship. XPS measurements were conducted in Research Hub for Advanced Nano Characterization, the University of Tokyo, supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work is supported by JSPS and DST under the Japan-India Science Cooperative Program (Project No.DST/INT/JSPS/P-152/2013).	Gadge ST, 2012, ADV SYNTH CATAL, V354, P2049, DOI 10.1002/adsc.201200041; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; [Anonymous], KIRK OTHMER ENCY CHE, V4, P774; LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812; Gabriele B, 2004, J ORG CHEM, V69, P4741, DOI 10.1021/jo0494634; Gadge ST, 2014, RSC ADV, V4, P10367, DOI 10.1039/c3ra46273k; BURROWS EP, 1982, J ORG CHEM, V47, P892, DOI 10.1021/jo00344a029; Didgikar MR, 2011, J MOL CATAL A-CHEM, V334, P20, DOI 10.1016/j.molcata.2010.10.018; FUKUOKA S, 1984, J CHEM SOC CHEM COMM, P399, DOI 10.1039/c39840000399; KELKAR AA, 1992, IND ENG CHEM RES, V31, P172, DOI 10.1021/ie00001a024; MURAHASHI S, 1987, J CHEM SOC CHEM COMM, P125, DOI 10.1039/c39870000125; PRIBAR I, 1990, CAN J CHEM, V68, P1544, DOI 10.1139/v90-238; RHOADS SJ, 1963, J AM CHEM SOC, V85, P585, DOI 10.1021/ja00888a023; Sartori G., 2005, SCI SYNTHESIS, V18, P665; Sasaki T, 2005, CHEM COMMUN, P2506, DOI 10.1039/b500349k; Shi F, 2001, TETRAHEDRON LETT, V42, P2161, DOI 10.1016/S0040-4039(01)00124-1; Toochinda P, 2004, IND ENG CHEM RES, V43, P1192, DOI 10.1021/ie0305768; vonGeldern TW, 1996, J MED CHEM, V39, P968, DOI 10.1021/jm950592+; Wang YM, 2005, MICROPOR MESOPOR MAT, V84, P127, DOI 10.1016/j.micromeso.2005.05.024	19	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1169	1873-314X		J MOL CATAL A-CHEM	J. Mol. Catal. A-Chem.	MAY 1	2015	400						170	178		10.1016/j.molcata.2015.01.009		9	Chemistry, Physical	Chemistry	CG4IE	WOS:000353248000022		
J	Kurinomaru, T; Kameda, T; Shiraki, K				Kurinomaru, Takaaki; Kameda, Tomoshi; Shiraki, Kentaro			Effects of multivalency and hydrophobicity of polyamines on enzyme hyperactivation of alpha-chymotrypsin	JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC			English	Article						alpha-Chymotrypsin; Enzyme hyperactivation; Hydrophobicity; Multivalency; Polyamine	AQUEOUS-SOLUTIONS; SUBSTRATE SELECTIVITY; INDUCED AGGREGATION; COMPLEX MICELLES; BLOCK IONOMERS; AMMONIUM-SALTS; IONIC LIQUID; PROTEIN; SUPERACTIVITY; SURFACTANTS	Enzyme hyperactivation using a complementary charged modulator/substrate pair has potential for enzyme applications in a wide range of research fields. Here, we report that amine compounds as well as naturally occurring polyamines, putrescine, spermidine, and spermine, enhance the enzyme activity of alpha-chymotrypsin (ChT) toward anionic substrates. The enzyme activity of ChT was increased by 1.6-6.9-fold in the presence of 50 mM amine compounds at pH 7.5. Analysis of the enzyme kinetics indicated that the catalytic constant (k(cat)) and specific constant (k(cat)/K-M) increased in the presence of amine compounds depending on both the multivalency and hydrophobicity of the amine compounds, whereas the Michaelis constant (K-M) remained constant. Molecular dynamics simulation suggested that the enhancement of enzyme activity of ChT was induced by weak interactions between amine compounds and ChT. These results provide extended design parameters for artificial activators for enzyme hyperactivation as well as an understanding of enzyme activity in the crude complex condition in vivo. (C) 2015 Elsevier B.V. All rights reserved.	[Kurinomaru, Takaaki; Shiraki, Kentaro] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Kameda, Tomoshi] AIST, CBRC, Koto Ku, Tokyo 1350064, Japan	Shiraki, K (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	shiraki@bk.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; University of Tsukuba	The theoretical calculations were performed using the Research Center for Computational Science, Okazaki, Japan, and super computer system, National Institute of Genetics (NIG), Research Organization of Information and Systems (ROIS). The authors acknowledge financial support from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, for grant-in-aid for JSPS Fellows and University of Tsukuba.	Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hong R, 2004, J AM CHEM SOC, V126, P13572, DOI 10.1021/ja0461163; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0; Celej MS, 2004, BIOCHEM J, V378, P1059, DOI 10.1042/BJ20031536; Jin LL, 2012, ACS NANO, V6, P4864, DOI 10.1021/nn300217z; PACE CN, 1995, PROTEIN SCI, V4, P2411; Iyer PV, 2008, PROCESS BIOCHEM, V43, P1019, DOI 10.1016/j.procbio.2008.06.004; Yasui K, 2010, PROTEIN SCI, V19, P486, DOI 10.1002/pro.326; Kusano T, 2007, J PLANT RES, V120, P345, DOI 10.1007/s10265-007-0074-3; Harada A, 2003, J AM CHEM SOC, V125, P15306, DOI 10.1021/ja038572h; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Murata H, 2013, BIOMACROMOLECULES, V14, P1919, DOI 10.1021/bm4002816; Kudou M, 2003, EUR J BIOCHEM, V270, P4547, DOI 10.1046/j.1432-1033.2003.03850.x; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Harada A, 2001, J CONTROL RELEASE, V72, P85, DOI 10.1016/S0168-3659(01)00264-4; Naushad M, 2012, INT J BIOL MACROMOL, V51, P555, DOI 10.1016/j.ijbiomac.2012.06.020; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Kurinomaru T, 2014, LANGMUIR, V30, P3826, DOI 10.1021/la500575c; Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Biasutti MA, 2008, ADV COLLOID INTERFAC, V136, P1, DOI 10.1016/j.cis.2007.07.001; Hamada H, 2008, BIOTECHNOL PROGR, V24, P436, DOI 10.1021/bp070350q; Harada A, 2007, MACROMOL BIOSCI, V7, P339, DOI 10.1002/mabi.200600199; IMOTO T, 1994, PROTEIN ENG, V7, P743, DOI 10.1093/protein/7.6.743; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalac P., 2005, FOOD CHEM, V90, P219; Kawamura A, 2005, BIOMACROMOLECULES, V6, P627, DOI 10.1021/bm049198w; Kawamura A, 2007, BIOCONJUGATE CHEM, V18, P1555, DOI 10.1021/bc070029t; Kumari M, 2014, SPECTROCHIM ACTA A, V124, P349, DOI 10.1016/j.saa.2014.01.012; Murata H, 2014, BIOMACROMOLECULES, V15, P2817, DOI 10.1021/bm5008629; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Roy R, 2006, LANGMUIR, V22, P7695, DOI 10.1021/la060496j; Sandanaraj BS, 2005, J AM CHEM SOC, V127, P10693, DOI 10.1021/ja051947+; Shiraki K, 2002, J BIOCHEM, V131, P213; Sintra TE, 2014, J MOL CATAL B-ENZYM, V107, P140, DOI 10.1016/j.molcatb.2014.06.001; Spreti N, 2001, EUR J BIOCHEM, V268, P6491, DOI 10.1046/j.0014-2956.2001.02604.x; Spreti N, 2008, J MOL CATAL B-ENZYM, V50, P1, DOI 10.1016/j.molcatb.2007.09.012; Spreti N, 1999, J MOL CATAL B-ENZYM, V6, P99, DOI 10.1016/S1381-1177(98)00139-8; Viparelli P, 1999, BIOCHEM J, V344, P765, DOI 10.1042/0264-6021:3440765; Viparelli P, 2004, J MOL CATAL B-ENZYM, V28, P101, DOI 10.1016/j.molcatb.2004.02.002; Viparelli P, 2003, J MOL CATAL B-ENZYM, V21, P175, DOI 10.1016/S1381-1177(02)00125-X; Wang J., 2004, J COMPUT CHEM, V25; You CC, 2006, J AM CHEM SOC, V128, P14612, DOI 10.1021/ja064433z	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1177	1873-3158		J MOL CATAL B-ENZYM	J. Mol. Catal. B-Enzym.	MAY	2015	115						135	139		10.1016/j.molcatb.2015.02.010		5	Biochemistry & Molecular Biology; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	CG8XP	WOS:000353599300019		
J	Marumoto, S; Okuno, Y; Miyamoto, Y; Miyazawa, M				Marumoto, Shinsuke; Okuno, Yoshiharu; Miyamoto, Yohei; Miyazawa, Mitsuo			Biotransformation of (+)-(1R,2S,4R)-borneol and (-)-(1S,2R,4S)-borneol by Spodoptera litura (common cutworm) larvae	JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC			English	Article						Borneol biotransformation; Larvae, Spodoptera litura; Fatty acid conjugation reaction; Glucose conjugation reaction	CHIRAL CROWN-ETHERS; ENANTIOSELECTIVE THIOLYSIS; (-)-BORNYL ACETATE; ESTER SALTS; ALPHA-AMINO; CONSTITUENTS; ACID; OXIDATION; MONOTERPENE; DERIVATIVES	In this study, we investigated the use of insects as biocatalysts for the biotransformation of monoterpenoids such as (+)-(1R,2S,4R)-bomeol (1) and (-)-(1S,2R,4S)-borneol (2) by the larvae of Spodoptera litura. The substrates were administrated to the fourth instar larvae of S. litura through food, and the metabolites were collected in the feces. Analysis showed that substrate 1 was converted into the following 12 metabolites: (+)-(1R,2S,4R)-bomeol linoleate (1-1), (+)-(1R,2S,4R)-bomeol linolenate (1-2), (+)-(1R,25,4R)-bomeol-2-O-beta-D-glucopyranoside (1-3), (+)-(1R,2S,4R,5S)-5-endo-hydroxyborneol (1-4), (+)-(1R,4R,5S)-5-endo-hydroxycamphor (1-5), (+)-(1R,2S,4R,5R)-5-exo-hydroxybomeol (1-6), (+)-(1R,4R,5R)-5-exo-hydroxycamphor (1-7), (+)-(1R,2S,4R,7R)-8-hydroxybomeol (1-8), (+)-(1R,4R,7R)-8-hydroxy camphor (1-9), (+)-(1R,2S,4R,7S)-9-hydroxyborneol (1-10), (+)-(1R,2S,4R)-10-hydroxyborneol (1-11), and (+)-(1R,2R,3S,4S)-3-endo-hydroxybomeol (1-12). The metabolism of substrate 2 generated 12 enantiomers of the above metabolites, namely 2-1 to 2-12. Compounds 1-1,1-2,1-3,2-1,2-2,2-8, 2-10, and 2-12 are novel compounds. The main metabolites were generated by phase II reactions such as esterification or glucosidation of the parent substrates. The minor metabolites originated from phase I reactions such as hydroxylation or oxidation, probably by cytochrome P450 enzymes. These fatty acid and glucose conjugation reactions are new metabolic pathways, compared with those reported in previous studies on monoterpenoids in S. litura. (C) 2015 Elsevier B.V. All rights reserved.	[Marumoto, Shinsuke] Kinki Univ, Joint Res Ctr, Higashiosaka, Osaka 5778502, Japan; [Okuno, Yoshiharu] Wakayama Coll, Natl Inst Technol, Dept Mat Sci, Wakayama 6440023, Japan; [Miyamoto, Yohei; Miyazawa, Mitsuo] Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 5778502, Japan	Miyazawa, M (reprint author), Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 5778502, Japan.	miyazawa@apch.kindai.ac.jp					Ackermann I. E., 1989, LIEBIGS ANN CHEM, V1, P79; AHMED AA, 1991, PHYTOCHEMISTRY, V30, P1207, DOI 10.1016/S0031-9422(00)95203-8; ALLEN MS, 1978, TETRAHEDRON LETT, P2255; ALLEN MS, 1977, J CHEM SOC CHEM COMM, P358, DOI 10.1039/c39770000358; ALLEN MS, 1979, CAN J CHEM, V57, P733, DOI 10.1139/v79-120; ANET FA, 1961, CAN J CHEM, V39, P789, DOI 10.1139/v61-096; ANGYAL SJ, 1984, AUST J CHEM, V37, P661; FUJITA T, 1995, CHEM PHARM BULL, V43, P920; MAHMOOD U, 1983, PHYTOCHEMISTRY, V22, P774, DOI 10.1016/S0031-9422(00)86984-8; ASANO T, 1993, CHEM PHARM BULL, V41, P566; GUNAWARDANA YAGP, 1988, J NAT PROD, V51, P142, DOI 10.1021/np50055a022; BOHLMANN F, 1982, PHYTOCHEMISTRY, V21, P2317, DOI 10.1016/0031-9422(82)85198-4; COULOMBE.C, 1970, B SOC CHIM FR, P1199; DENG JG, 1991, SYNTHESIS-STUTTGART, P963; HAMADA H, 1988, B CHEM SOC JPN, V61, P869, DOI 10.1246/bcsj.61.869; Harborne J.B., 1993, PHYTOCHEMICAL DICT H; HAYASHI T, 1969, Nippon Nogeikagaku Kaishi, V43, P583; HUNECK S, 1986, PHYTOCHEMISTRY, V25, P883; ITOKAWA H, 1977, CHEM PHARM BULL, V25, P1941; KANEDA N, 1983, YAKUGAKU ZASSHI, V103, P1133; MARQUET A, 1967, B SOC CHIM FR, P128; Meyer L. W., 1967, J ORG CHEM, V32, P1754; Miyazawa M, 2009, J AGR FOOD CHEM, V57, P7800, DOI 10.1021/jf9009069; Miyazawa M, 2010, J AGR FOOD CHEM, V58, P3855, DOI 10.1021/jf903301v; Miyazawa M, 2004, J MOL CATAL B-ENZYM, V27, P83, DOI 10.1016/j.molcatb.2003.09.012; Ono T, 2013, J OLEO SCI, V62, P313, DOI 10.5650/jos.62.313; Orihara Y., 1993, PHYTOCHEMISTRY, P1045; Partanen T., 1990, J CHEM SOC P2, V5, P777; PAWLOWICZ P, 1988, PHYTOCHEMISTRY, V27, P2809, DOI 10.1016/0031-9422(88)80667-8; SASAKI S, 1985, CHEM PHARM BULL, V33, P4247; SASAKI S, 1979, HETEROCYCLES, V12, P1305; SUGA T, 1983, Plant Cell Reports, V2, P186, DOI 10.1007/BF00270099; TAKESHITA T, 1959, B CHEM SOC JPN, V32, P985, DOI 10.1246/bcsj.32.985; UCHIDA T, 1990, J ORG CHEM, V55, P2938, DOI 10.1021/jo00296a069; VASANTH S, 1990, J NAT PROD, V53, P354, DOI 10.1021/np50068a013; Weyerstahl P., 1987, LIEBIGS ANN CHEM, V1, P21	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1177	1873-3158		J MOL CATAL B-ENZYM	J. Mol. Catal. B-Enzym.	MAY	2015	115						160	167		10.1016/j.molcatb.2015.01.006		8	Biochemistry & Molecular Biology; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	CG8XP	WOS:000353599300023		
J	Zhang, S; Tan, IB; Sapari, NS; Grabsch, HI; Okines, A; Smyth, EC; Aoyama, T; Hewitt, LC; Inam, I; Bottomley, D; Nankivell, M; Stenning, SP; Cunningham, D; Wotherspoon, A; Tsuburaya, A; Yoshikawa, T; Soong, R; Tan, P				Zhang, Shenli; Tan, Iain B.; Sapari, Nur S.; Grabsch, Heike I.; Okines, Alicia; Smyth, Elizabeth C.; Aoyama, Toru; Hewitt, Lindsay C.; Inam, Imran; Bottomley, Dan; Nankivell, Matthew; Stenning, Sally P.; Cunningham, David; Wotherspoon, Andrew; Tsuburaya, Akira; Yoshikawa, Takaki; Soong, Richie; Tan, Patrick			Technical Reproducibility of Single-Nucleotide and Size-Based DNA Biomarker Assessment Using DNA Extracted from Formalin-Fixed, Paraffin-Embedded Tissues	JOURNAL OF MOLECULAR DIAGNOSTICS			English	Article							THYMIDYLATE SYNTHASE GENE; S-TRANSFERASE M1; MALDI-TOF MS; COLORECTAL-CANCER; GASTRIC-CANCER; COLON-CARCINOMA; EXCISION-REPAIR; POLYMORPHISMS; CHEMOTHERAPY; SUSCEPTIBILITY	DNA extracted from formalin-fixed, paraffin-embedded (FFPE) tissues has been used in the past to analyze genetic polymorphisms. We evaluated the technical reproducibility of different types of assays for gene polymorphisms using DNA extracted from FFPE material. By using the MassARRAY iPLEX system, we investigated polymorphisms in DPYD (rs1801159 and rs3918290), UMPS (rs1801019), ERCC1 (rs11615), ERCC1 (rs3212986), and ERCC2 (rs13181) in 56 FFPE DNA samples. By using PCR, followed by size-based gel electrophoresis, we also examined TYMS 5' untranslated region 2R/3R repeats and GSTT1 deletions in 50 FFPE DNA samples and 34 DNAs extracted from fresh-frozen tissues and cell lines. Each polymorphism was analyzed by two independent runs. We found that iPLEX biomarker assays measuring single-nucleotide polymorphisms provided consistent concordant results. However, by using FFPE DNA, size-based PCR biomarkers (GSTT1 and TYMS 5' untranslated region) were discrepant in 32.7% (16/49, with exact 95% CI, 19.9%-47.5%; exact binomial confidence limit test) and 4.2% (2/48, with exact 95% CI, 0.5%-14.3%) of cases, respectively, whereas no discrepancies were observed using intact genomic DNA. Our findings suggest that DNA from FFPE material can be used to reliably test single-nucleotide polymorphisms. However, results based on size-based PCR biomarkers, and particularly GSTT1 deletions, using FFPE DNA need to be interpreted with caution. Independent repeated assays should be performed on all cases to assess potential discrepancies.	[Zhang, Shenli; Tan, Patrick] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Tan, Iain B.] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Tan, Patrick] Natl Canc Ctr, Dept Cellular & Mol Res, Singapore, Singapore; [Sapari, Nur S.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Hewitt, Lindsay C.; Inam, Imran; Bottomley, Dan] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Okines, Alicia; Smyth, Elizabeth C.; Cunningham, David] Royal Marsden Hosp, Dept Gastrointestinal Oncol, Sutton, Surrey, England; [Wotherspoon, Andrew] Royal Marsden Hosp, Dept Pathol, Sutton, Surrey, England; [Aoyama, Toru; Yoshikawa, Takaki] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2410815, Japan; [Nankivell, Matthew; Stenning, Sally P.] UCL, Med Res Council Clin Trials Unit, London, England; [Tsuburaya, Akira] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; [Soong, Richie] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore; [Tan, Patrick] Genome Inst Singapore, Canc Therapeut & Stratified Oncol Grp, Singapore, Singapore	Tan, P (reprint author), Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, 8 Coll Rd, Singapore 169857, Singapore.	gmstanp@duke-nus.edu.sg			National University of Singapore Graduate School for Integrative Sciences and Engineering Scholarship; National Institute for Health Research (NIHR), Royal Marsden (RM)/The Institute of Cancer Research (ICR) Biomedical Research Centre; Cancer Research UK [C26441/A8944, C20023/A7217]; Medical Research Council (MRC) through the MRC Clinical Trials Unit; Kanagawa Standard Anti-Cancer Therapy Support System;  [NMRC/TCR/009-NUHS/2013];  [BMRC 10/1/24/19/655]	Supported by the National University of Singapore Graduate School for Integrative Sciences and Engineering Scholarship (I.B.T.), The National Institute for Health Research (NIHR), Royal Marsden (RM)/The Institute of Cancer Research (ICR) Biomedical Research Centre (E.C.S., D.C., and A.W.), and grants NMRC/TCR/009-NUHS/2013 and BMRC 10/1/24/19/655 (P.T.). Collection and analysis of samples from the OEO2 and MAGIC trials was funded by Cancer Research UK grants C26441/A8944 and C20023/A7217, respectively, with support from the Medical Research Council (MRC) through the MRC Clinical Trials Unit, which sponsored and coordinated the MAGIC trial. JUST study was funded by a non-profit organization, Kanagawa Standard Anti-Cancer Therapy Support System.	Ahern Thomas P, 2010, Clin Epidemiol, V2, P241, DOI 10.2147/CLEP.S13811; Katoh T, 1996, CARCINOGENESIS, V17, P1855, DOI 10.1093/carcin/17.9.1855; Relling MV, 2001, NAT REV CANCER, V1, P99, DOI 10.1038/35101056; Hahnvajanawong C, 2012, WORLD J GASTROENTERO, V18, P3955, DOI 10.3748/wjg.v18.i30.3955; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Shiraishi K, 2010, J CLIN ONCOL, V28, P4945, DOI 10.1200/JCO.2010.30.5334; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Schwab M, 2008, J CLIN ONCOL, V26, P2131, DOI 10.1200/JCO.2006.10.4182; Graziano F, 2004, INT J CANCER, V112, P1010, DOI 10.1002/ijc.20489; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Cheng J, 2012, J CANCER RES CLIN, V138, P231, DOI 10.1007/s00432-011-1090-1; Lecomte T, 2004, CLIN CANCER RES, V10, P5880, DOI 10.1158/1078-0432.CCR-04-0169; Horn H, 2010, PHARMACOGENET GENOM, V20, P598, DOI 10.1097/FPC.0b013e32833deb16; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Kawakami K, 2003, CANCER RES, V63, P6004; Marchetti A, 2006, NEW ENGL J MED, V354, P526; Agell L, 2008, MODERN PATHOL, V21, P1470, DOI 10.1038/modpathol.2008.145; PAABO S, 1990, J BIOL CHEM, V265, P4718; Jaremko M, 2005, HUM MUTAT, V25, P232, DOI 10.1002/humu.20141; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Salgado J, 2007, ONCOL REP, V17, P325; Syrmis MW, 2011, CLIN MICROBIOL INFEC, V17, P1804, DOI 10.1111/j.1469-0691.2011.03521.x; Bouakaze C, 2011, J CLIN MICROBIOL, V49, P3292, DOI 10.1128/JCM.00744-11; Koh WP, 2011, CARCINOGENESIS, V32, P1507, DOI 10.1093/carcin/bgr175; Antonacopoulou AG, 2011, CELL ONCOL, V34, P381, DOI 10.1007/s13402-011-0038-4; Armitage P, 1987, STAT METHODS MED RES, V2, P117; Burchard PR, 2013, CANCER GENET-NY, V206, P130, DOI 10.1016/j.cancergen.2013.03.002; Cote ML, 2012, INT J GYNECOL CANCER, V22, P1367, DOI 10.1097/IGC.0b013e31826b1110; Deakin M, 1996, CARCINOGENESIS, V17, P881, DOI 10.1093/carcin/17.4.881; Farina-Sarasqueta A, 2010, CANCER CHEMOTH PHARM, V66, P1167, DOI 10.1007/s00280-010-1403-0; Ferguson AE, 2012, DIAGN MOL PATHOL, V21, P105, DOI 10.1097/PDM.0b013e3182340a78; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Imyanitov EN, 2001, BIOTECHNIQUES, V31, P1000; Jennings BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078053; Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363; Peng JP, 2013, J CLIN MICROBIOL, V51, P402, DOI 10.1128/JCM.01170-12; Perkins G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047020; Quach N, 2004, BMC CLIN PATHOL, V4, P1, DOI DOI 10.1186/1472-6890-4-1; Rae JM, 2013, JNCI-J NATL CANCER I, V105, P1332, DOI 10.1093/jnci/djt204; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Santos LS, 2013, ONCOL REP, V30, P2458, DOI 10.3892/or.2013.2702; Shitara K, 2010, CANCER EPIDEM BIOMAR, V19, P1311, DOI 10.1158/1055-9965.EPI-09-1257; Singh S, 2009, ENVIRON TOXICOL PHAR, V28, P25, DOI 10.1016/j.etap.2009.01.010; Soong R, 2003, CLIN CHEM, V49, P973, DOI 10.1373/49.6.973; Wang Z, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-137; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529; Wright WT, 2008, CLIN GENET, V74, P463, DOI 10.1111/j.1399-0004.2008.01071.x; Zhang H, 2007, MED ONCOL, V24, P251, DOI 10.1007/BF02698048	48	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-1578	1943-7811		J MOL DIAGN	J. Mol. Diagn.	MAY	2015	17	3					242	250		10.1016/j.jmoldx.2014.12.001		9	Pathology	Pathology	CH2GO	WOS:000353843900004		
J	Feig, M; Harada, R; Mori, T; Yu, I; Takahashi, K; Sugita, Y				Feig, Michael; Harada, Ryuhei; Mori, Takaharu; Yu, Isseki; Takahashi, Koichi; Sugita, Yuji			Complete atomistic model of a bacterial cytoplasm for integrating physics, biochemistry, and systems biology	JOURNAL OF MOLECULAR GRAPHICS & MODELLING			English	Article						Mycoplasma genitalium; Metabolic reaction network; Protein structure prediction; Crowding	GENOME-REDUCED BACTERIUM; PROTEIN-STRUCTURE; FORCE-FIELD; MYCOPLASMA-GENITALIUM; STRUCTURE PREDICTION; ESCHERICHIA-COLI; CELL; SIMULATION; CHARMM; OPTIMIZATION	A model for the cytoplasm of Mycoplasma genitalium is presented that integrates data from a variety of sources into a physically and biochemically consistent model. Based on gene annotations, core genes expected to be present in the cytoplasm were determined and a metabolic reaction network was reconstructed. The set of cytoplasmic genes and metabolites from the predicted reactions were assembled into a comprehensive atomistic model consisting of proteins with predicted structures, RNA, protein/RNA complexes, metabolites, ions, and solvent. The resulting model bridges between atomistic and cellular scales, between physical and biochemical aspects, and between structural and systems views of cellular systems and is meant as a starting point for a variety of simulation studies. (C) 2015 Elsevier Inc. All rights reserved.	[Feig, Michael] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Feig, Michael] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Feig, Michael; Harada, Ryuhei; Mori, Takaharu; Sugita, Yuji] RIKEN, Quantitat Biol Ctr, IMDA, Kobe, Hyogo 6500047, Japan; [Harada, Ryuhei; Sugita, Yuji] RIKEN, Adv Inst Computat Sci, Kobe, Hyogo 6500047, Japan; [Mori, Takaharu; Yu, Isseki; Sugita, Yuji] RIKEN, Theoret Mol Sci Lab, Wako, Saitama 3510198, Japan; [Mori, Takaharu; Yu, Isseki; Sugita, Yuji] RIKEN, iTHES, Wako, Saitama 3510198, Japan; [Takahashi, Koichi] RIKEN, Quantitat Biol Ctr, Lab Biochem Simulat, Suita, Osaka 5650874, Japan; [Takahashi, Koichi] Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa 2528520, Japan	Feig, M (reprint author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,BCH 218, E Lansing, MI 48824 USA.	feig@msu.edu	Sugita, Yuji/L-6726-2014	Sugita, Yuji/0000-0001-9738-9216	RIKEN-QBIC; NIH [GM092949, GM084953]; NSF MCB [1330560]; MEXT SPIRE Supercomputational Life Science	Funding from RIKEN-QBIC, NIH GM092949, NIH GM084953, and NSF MCB 1330560 (to MF) and by MEXT SPIRE Supercomputational Life Science (to YS) is acknowledged. Computer resources were used at RIKEN-RICC (RIKEN Integrated Cluster of Clusters).	Ando T, 2010, P NATL ACAD SCI USA, V107, P18457, DOI 10.1073/pnas.1011354107; Macklin DN, 2014, CURR OPIN BIOTECH, V28, P111, DOI 10.1016/j.copbio.2014.01.012; Ridgway D, 2008, BIOPHYS J, V94, P3748, DOI 10.1529/biophysj.107.116053; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karr JR, 2013, NUCLEIC ACIDS RES, V41, pD787, DOI 10.1093/nar/gks1108; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Fiser A, 2002, ACCOUNTS CHEM RES, V35, P413, DOI 10.1021/ar010061h; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Fiser A, 2000, PROTEIN SCI, V9, P1753; Kihara D, 2002, P NATL ACAD SCI USA, V99, P5993, DOI 10.1073/pnas.092135699; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Feig M, 2013, J MOL GRAPH MODEL, V45, P144, DOI 10.1016/j.jmgm.2013.08.017; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Huang YJP, 2014, PROTEINS, V82, P43, DOI 10.1002/prot.24488; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct3004000x; Huynen M, 1998, J MOL BIOL, V280, P323, DOI 10.1006/jmbi.1998.1884; Shabala L, 2009, ENVIRON MICROBIOL, V11, P137, DOI 10.1111/j.1462-2920.2008.01748.x; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Consortium TU, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI DOI 10.1093/NAR/GKT1140; Cossins BP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002066; Frembgen-Kesner Tamara, 2013, Biophysical Reviews, V5, DOI 10.1007/s12551-013-0110-6; Hasnain S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106466; Li Y.H., 2010, BMC STRUCT BIOL, V10; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Pollack J. Dennis, 2002, OMICS A Journal of Integrative Biology, V6, P247, DOI 10.1089/15362310260256909; Sánchez R, 1997, Proteins, VSuppl 1, P50; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285	47	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1093-3263	1873-4243		J MOL GRAPH MODEL	J. Mol. Graph.	MAY	2015	58						1	9		10.1016/j.jmgm.2015.02.004		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Computer Science, Interdisciplinary Applications; Crystallography; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Computer Science; Crystallography; Mathematical & Computational Biology	CH0SB	WOS:000353731600001		
J	Dattani, NS				Dattani, Nikesh S.			Beryllium monohydride (BeH): Where we are now, after 86 years of spectroscopy	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						Ultra-high precision; Interstellar chemistry & astrochemistry; Fundamental molecules; Early universe chemistry; Big Bang physics; Potentiology & potential energy curves and surfaces; Halo nucleonic molecules; Theory vs experiment; Exoplanet atmosphere; Cool stars; Stellar chemistry and the Sun; Isotope effect; Dispersion constants	AB-INITIO CALCULATIONS; CONFIGURATION-INTERACTION METHODS; TRANSFORM EMISSION-SPECTROSCOPY; DENSITY-FUNCTIONAL THEORY; HARTREE-FOCK CALCULATIONS; SUCHER-FEINBERG IDENTITY; ROW DIATOMIC HYDRIDES; GAUSSIAN-BASIS SETS; OPEN-SHELL SYSTEMS; GROUND-STATES	BeH is one of the most important benchmark systems for ab initio methods and for studying Born-Oppenheimer breakdown. However the best empirical potential and best ab initio potential for the ground electronic state to date give drastically different predictions in the long-range region between where the highest measurements have been made, and the dissociation energy; a region which is about similar to 1000 cm(-1) for (BeH)-Be-9, similar to 3000 cm(-1) for (BeD)-Be-9, and similar to 13 000 cm(-1) for (BeT)-Be-9. Improved empirical potentials and Born-Oppenheimer breakdown corrections have now been built in this work for the ground electronic states X(1(2)Sigma(+)) of all three isotopologues. The predicted dissociation energy for (BeH)-Be-9 from the new empirical potential is now in agreement with the current best ab initio prediction in all 5 digits of the former's precision, while the previous best empirical potential was in disagreement by 74 cm(-1). The previous best empirical potential predicted the existence of unobserved vibrational levels for all three isotopologues, and the current best ab initio study also predicted the existence of all of these levels, and 7 more in total. With the exception of two, the present empirical potential agrees with the existence of all of the ab initio potentials' extra levels not predicted by the earlier empirical potential. With one exception, all energy spacings between vibrational energy levels for which measurements have been made, are predicted with an agreement of better than 1 cm(-1) between the new empirical potential and the current best ab initio potential, but some predictions for unobserved levels are still in great disagreement, and the equilibrium bond lengths are different by orders of magnitude. (C) 2014 Elsevier Inc. All rights reserved.	[Dattani, Nikesh S.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Dattani, Nikesh S.] Kyoto Univ, Dept Chem, Quantum Chem Lab, Kyoto 6068502, Japan	Dattani, NS (reprint author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England.	dattani.nike@gmail.com			JSPS	It is with pleasure that the author thanks Bob Le Roy of University of Waterloo (Canada) for suggesting BeH as an interesting molecule for testing extrapolation with analytic models. The author also gratefully thanks Jim Mitroy of Charles Darwin University (Australia) for providing his unpublished calculated values for the constants appearing in Table 1 and used for the models to which the data was fitted, Jacek Koput of Adam Mickiewicz University (Poland) for his very prompt supply of his pointwise ab initio potentials for <SUP>9</SUP>BeH, <SUP>9</SUP>BeD, and <SUP>9</SUP>BeT which were discussed but not presented in [78], Yoshitaka Tanimura of Kyoto University (Japan) for his generous hospitality, and last but indubitably not least, Staszek Welsh of Oxford University (UK) for assistance with running many fits at a preliminary stage of this project. Financial support was generously provided by JSPS.	Nakajima T, 1999, CHEM PHYS LETT, V300, P1, DOI 10.1016/S0009-2614(98)01363-3; Li H, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3476465; Machado FBC, 1998, CHEM PHYS LETT, V284, P293, DOI 10.1016/S0009-2614(97)01380-8; Li H, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4826595; Stein A, 2010, EUR PHYS J D, V57, P171, DOI 10.1140/epjd/e2010-00058-y; Bubin S, 2013, CHEM REV, V113, P36, DOI 10.1021/cr200419d; Wang LC, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4813527; Le Roy RJ, 1998, J MOL SPECTROSC, V191, P223, DOI 10.1006/jmsp.1998.7646; Koput J, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3671610; Dattani NS, 2011, J MOL SPECTROSC, V268, P199, DOI 10.1016/j.jms.2011.03.030; Bubin S, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2736699; Petsalakis ID, 1999, J PHYS B-AT MOL OPT, V32, P3225, DOI 10.1088/0953-4075/32/13/312; Le Roy RJ, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2354502; HENRIET C, 1986, PHYS SCRIPTA, V33, P299, DOI 10.1088/0031-8949/33/4/004; Szalay PG, 2000, J CHEM PHYS, V112, P4027, DOI 10.1063/1.480952; FRANK A, 1989, J CHEM PHYS, V91, P29, DOI 10.1063/1.457516; BENDER CF, 1969, PHYS REV, V183, P23, DOI 10.1103/PhysRev.183.23; MEYER W, 1975, J CHEM PHYS, V63, P2356, DOI 10.1063/1.431665; Martin JML, 1998, CHEM PHYS LETT, V283, P283, DOI 10.1016/S0009-2614(97)01400-0; Salami H, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2734973; Le Roy RJ, 2011, MOL PHYS, V109, P435, DOI 10.1080/00268976.2010.527304; Semczuk M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.052505; Xie F, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3606397; COOPER DL, 1984, J CHEM PHYS, V80, P1961, DOI 10.1063/1.446957; MARTIN JML, 1989, CHEM PHYS LETT, V163, P387, DOI 10.1016/0009-2614(89)85155-3; BAGUS PS, 1973, J CHEM PHYS, V58, P1886, DOI 10.1063/1.1679448; PETSALAKIS ID, 1992, J CHEM PHYS, V97, P7623, DOI 10.1063/1.463482; CADE PE, 1967, J CHEM PHYS, V47, P614, DOI 10.1063/1.1711938; Pitarch-Ruiz J, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2953584; Hirata S, 1999, CHEM PHYS LETT, V302, P375, DOI 10.1016/S0009-2614(99)00137-2; Li G, 2013, J QUANT SPECTROSC RA, V130, P284, DOI 10.1016/j.jqsrt.2013.07.019; Bacchus-Montabonel M. C., 1999, THEOCHEM, V463, DOI 10.1016/S0166-1280(98)00397-2; BIRD S, 1984, J CHEM SOC FARAD T 2, V80, P851, DOI 10.1039/f29848000851; BISHOP DM, 1986, CHEM PHYS LETT, V127, P377, DOI 10.1016/0009-2614(86)80299-8; Bruna PJ, 2003, PHYS CHEM CHEM PHYS, V5, P3140, DOI 10.1039/b303698g; CANTARELLA E, 1992, PHYS SCRIPTA, V46, P489, DOI 10.1088/0031-8949/46/6/003; CHAN ACH, 1968, J CHEM PHYS, V49, P727, DOI 10.1063/1.1670130; CHANG TC, 1992, J COMPUT CHEM, V13, P268, DOI 10.1002/jcc.540130303; CLAXTON TA, 1980, J CHEM SOC FARAD T 2, V76, P1655, DOI 10.1039/f29807601655; CLERBAUX C, 1991, MOL PHYS, V72, P471, DOI 10.1080/00268979100100361; COLIN R, 1975, CAN J PHYS, V53, P2142; COLIN R, 1983, CAN J PHYS, V61, P641; Cooper DL, 1996, INT J QUANTUM CHEM, V57, P501, DOI 10.1002/(SICI)1097-461X(1996)57:3<501::AID-QUA24>3.0.CO;2-4; Corongiu G, 2006, J PHYS CHEM A, V110, P11584, DOI 10.1021/jp064065l; Coxon JA, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3319739; Dattani N. S., 2014, P INT S MOL SPECTR, pRD01; Dattani N. S., 2014, PHYS CHEM PH; DEGREEF D, 1974, J MOL SPECTROSC, V53, P455, DOI 10.1016/0022-2852(74)90082-4; Dong YR, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/8/083104; Duxbury G, 1998, PLASMA PHYS CONTR F, V40, P361, DOI 10.1088/0741-3335/40/3/002; ELLISON FO, 1984, J CHEM PHYS, V81, P5855, DOI 10.1063/1.447586; Fast PL, 1999, J CHEM PHYS, V110, P11679, DOI 10.1063/1.479112; FERNANDEZ B, 1995, CHEM PHYS LETT, V232, P463, DOI 10.1016/0009-2614(94)01394-B; Fiilscher M. P., 2002, MOL PHYS, V100, P903; Fiser J, 1996, CHEM PHYS, V205, P351, DOI 10.1016/0301-0104(96)00004-3; Focsa C, 1998, J MOL SPECTROSC, V192, P348, DOI 10.1006/jmsp.1998.7700; Focsa C, 1998, J CHEM PHYS, V109, P5795, DOI 10.1063/1.477201; FUENTEALBA P, 1987, J CHEM PHYS, V87, P5338, DOI 10.1063/1.453653; GADEA FX, 1992, CHEM PHYS LETT, V191, P77, DOI 10.1016/0009-2614(92)85371-G; GERRATT J, 1980, P ROY SOC LOND A MAT, V371, P525, DOI 10.1098/rspa.1980.0095; Glushkov VN, 2004, INT J QUANTUM CHEM, V99, P903, DOI 10.1002/qua.20143; Glushkov VN, 1997, CHEM PHYS LETT, V273, P122, DOI 10.1016/S0009-2614(97)00603-9; GLUSHKOV VN, 1995, CHEM PHYS LETT, V244, P1, DOI 10.1016/0009-2614(95)00910-V; Guan J, 2000, J MOL STRUC-THEOCHEM, V527, P229, DOI 10.1016/S0166-1280(00)00496-6; Gunton W, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.062510; Henriet C, 1984, J MOL STR THEOCHEM, V107, P63, DOI 10.1016/0166-1280(84)80038-X; HINKLEY RK, 1972, J PHYS PT B ATOM M P, V5, P204, DOI 10.1088/0022-3700/5/2/016; HINKLEY RK, 1972, J PHYS PT B ATOM M P, V5, P2016, DOI 10.1088/0022-3700/5/11/006; Home R., 1972, B SOC CHIM BELG, V81, P93; ISHIDA K, 1990, CHEM PHYS LETT, V175, P133, DOI 10.1016/0009-2614(90)85531-G; ISHIDA K, 1989, CHEM PHYS LETT, V158, P217, DOI 10.1016/0009-2614(89)87324-5; Ivanova M, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3652755; JUNGEN M, 1970, THEOR CHIM ACTA, V17, P339, DOI 10.1007/BF00528569; Klein RA, 2006, CHEM PHYS LETT, V421, P595, DOI 10.1016/j.cplett.2006.02.039; Klein RA, 2006, CHEM PHYS LETT, V419, P254, DOI 10.1016/j.cplett.2005.11.083; Knockel H, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4792725; Kobayashi T, 1997, INT J QUANTUM CHEM, V65, P665; Koontz PG, 1935, PHYS REV, V48, P707, DOI 10.1103/PhysRev.48.707; KVASNICKA V, 1981, MOL PHYS, V42, P1345, DOI 10.1080/00268978100101011; LAAKSONEN L, 1988, J CHEM PHYS, V89, P4903, DOI 10.1063/1.455660; LARSSON M, 1985, PHYS SCRIPTA, V32, P97, DOI 10.1088/0031-8949/32/2/001; LARSSON M, 1984, J CHEM PHYS, V81, P6409, DOI 10.1063/1.447558; Le Roy R. J., 2013, CP667 U WAT; Le Roy R. J., 2014, CP668 U WAT; Le Roy RJ, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3264688; LEFEBVREBRION H, 1977, J MOL SPECTROSC, V65, P33, DOI 10.1016/0022-2852(77)90356-3; Le Roy RJ, 2006, J MOL SPECTROSC, V236, P178, DOI 10.1016/j.jms.2006.01.010; Li H, 2008, PHYS CHEM CHEM PHYS, V10, P4128, DOI 10.1039/b800718g; Li X., 2005, COMMUNICATION; LI XZ, 1995, J CHEM PHYS, V102, P2013, DOI 10.1063/1.468766; Luchow A, 1996, J CHEM PHYS, V105, P7573, DOI 10.1063/1.472584; Lushington GH, 1996, Z PHYS D ATOM MOL CL, V36, P301, DOI 10.1007/BF01426416; Ma YT, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4879956; Machado FBC, 1999, CHEM PHYS LETT, V305, P156, DOI 10.1016/S0009-2614(99)00364-4; MAEDER F, 1979, CHEM PHYS, V42, P95, DOI 10.1016/0301-0104(79)85171-X; MAROULIS G, 1988, J PHYS B-AT MOL OPT, V21, P3819, DOI 10.1088/0953-4075/21/23/004; Martin JML, 1997, CHEM PHYS LETT, V273, P98, DOI 10.1016/S0009-2614(97)00538-1; Martinazzo R, 2001, J CHEM PHYS, V115, P2917, DOI 10.1063/1.1388043; Meifiner H., 2000, J CHEM PHYS, V113, P2622; Meshkov VV, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4864355; Mitroy J., 2014, COMMUNICATION; Mitroy J, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.062710; Mitroy J, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.019903; Mulliken R. S., 1971, INT J QUANTUM CHEM, V5, P95; Nakajima T, 1999, CHEM PHYS, V242, P177, DOI 10.1016/S0301-0104(99)00004-X; Olsson E, 1932, Z PHYS, V73, P732, DOI 10.1007/BF01344221; Peterson M., 1928, PHYS REV, V31; Petsalakis ID, 1997, J PHYS B-AT MOL OPT, V30, P4935, DOI 10.1088/0953-4075/30/21/026; Pitarch-Ruiz J, 2008, J COMPUT CHEM, V29, P523, DOI 10.1002/jcc.20811; Piticco L, 2010, J MOL SPECTROSC, V264, P83, DOI 10.1016/j.jms.2010.08.007; POLASEK M, 1995, INT J QUANTUM CHEM, V54, P93, DOI 10.1002/qua.560540204; Pollet R, 2002, J CHEM PHYS, V116, P1250, DOI 10.1063/1.1430739; POPKIE HE, 1971, J CHEM PHYS, V54, P4597, DOI 10.1063/1.1674728; Quiney HM, 2004, INT J QUANTUM CHEM, V99, P950, DOI 10.1002/qua.20146; RICHMAN KW, 1987, CHEM PHYS LETT, V141, P186, DOI 10.1016/0009-2614(87)85006-6; ROSMUS P, 1980, J MOL STRUCT, V60, P405, DOI 10.1016/0022-2860(80)80099-8; Roy R. J., 2007, MOL PHYS, V105, P663, DOI 10.1080/00268970701241656; SEKINO H, 1985, J CHEM PHYS, V82, P4225, DOI 10.1063/1.448837; Shanmugavel R., 2008, SERB ASTRON J, V51; Shanmugavel R., 2008, SERB ASTRON J, V83; Shayesteh A, 2003, J CHEM PHYS, V118, P1158, DOI 10.1063/1.1528606; Shayesteh A, 2007, J PHYS CHEM A, V111, P12495, DOI 10.1021/jp075704a; STANDARD JM, 1985, J CHEM PHYS, V83, P3002, DOI 10.1063/1.449203; STEPHENS ME, 1983, MOL PHYS, V49, P65, DOI 10.1080/00268978300101041; TAGUE TJ, 1993, J AM CHEM SOC, V115, P12111, DOI 10.1021/ja00078a057; TINO J, 1979, J CHEM SOC FARAD T 2, V75, P1307, DOI 10.1039/f29797501307; Tritzant-Martinez Y, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4810006; Velasco AM, 2008, CHEM PHYS LETT, V462, P344, DOI 10.1016/j.cplett.2008.07.099; Watson WW, 1929, PHYS REV, V34, P372, DOI 10.1103/PhysRev.34.372; Watson WW, 1937, PHYS REV, V52, P0318, DOI 10.1103/PhysRev.52.318; Watson WW, 1931, PHYS REV, V37, P167, DOI 10.1103/PhysRev.37.167; Watson WW, 1928, PHYS REV, V32, P0600, DOI 10.1103/PhysRev.32.600; Watson WW, 1930, PHYS REV, V36, P1019, DOI 10.1103/PhysRev.36.1019; Wenthold PG, 2000, INT J MASS SPECTROM, V195, P319, DOI 10.1016/S1387-3806(99)00179-7; WOHL H, 1971, SOL PHYS, V16, P362, DOI 10.1007/BF00162477; Yadin B, 2012, MON NOT R ASTRON SOC, V425, P34, DOI 10.1111/j.1365-2966.2012.21367.x; Yukiya T, 2013, J MOL SPECTROSC, V283, P32, DOI 10.1016/j.jms.2012.12.006	137	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	MAY	2015	311				SI		76	83		10.1016/j.jms.2014.09.005		8	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CH0XP	WOS:000353746000012		
J	Fukunaga, H; Nagano, A; Oshikiri, S; Kajita, M; Kambara, H; Komatsu, K; Shinichiro, S; Hino, A; Kasahara, H				Fukunaga, H.; Nagano, A.; Oshikiri, S.; Kajita, M.; Kambara, H.; Komatsu, K.; Shinichiro, S.; Hino, A.; Kasahara, H.			Preclinical evaluation of a novel integrin-targeting non-RGD small molecular radioligand, Ga-67-/Y-90-FF58, for tumor imaging and radionuclide therapy	JOURNAL OF NUCLEAR MEDICINE			English	Meeting Abstract	3rd Theranostics World Congress on Gallium-68 and PRRT	MAR 12-14, 2015	Johns Hopkins Med Campus, Baltimore, MD	Soc Nucl Med & Mol Imaging, Johns Hopkins Univ	Johns Hopkins Med Campus				[Fukunaga, H.; Komatsu, K.; Shinichiro, S.] FUJIFILM Corp, Yokohama, Kanagawa, Japan; [Nagano, A.; Oshikiri, S.; Kajita, M.; Kambara, H.; Hino, A.; Kasahara, H.] FUJIFILM RI Pharma Co Ltd, Chiba, Japan								0	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	MAY 1	2015	56			2		26						1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH1XO	WOS:000353816700027		
J	Nakamoto, Y; Sano, K; Ishimori, T; Togashi, K				Nakamoto, Y.; Sano, K.; Ishimori, T.; Togashi, K.			Clinical efficacy of PET/CT with Ga-68-DOTATOC for detecting suspected or unknown primary neuroendocrine tumors: the Japan experience	JOURNAL OF NUCLEAR MEDICINE			English	Meeting Abstract	3rd Theranostics World Congress on Gallium-68 and PRRT	MAR 12-14, 2015	Johns Hopkins Med Campus, Baltimore, MD	Soc Nucl Med & Mol Imaging, Johns Hopkins Univ	Johns Hopkins Med Campus				[Nakamoto, Y.; Sano, K.; Ishimori, T.; Togashi, K.] Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	MAY 1	2015	56			2		54						1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH1XO	WOS:000353816700055		
J	Wu, S; Tokuda, M; Kashiwagi, A; Henmi, A; Okada, Y; Tachibana, S; Nomura, M				Wu, Shuhsien; Tokuda, Megumi; Kashiwagi, Ayaka; Henmi, Atsushi; Okada, Yoshiharu; Tachibana, Shinya; Nomura, Masato			Evaluation of the Fatty Acid Composition of the Seeds of Mangifera indica L. and Their Application	JOURNAL OF OLEO SCIENCE			English	Article						mango seed oil; deodorizing effect; washing effect	VOLATILE COMPONENTS; COCOA BUTTER; MANGO; MOISTURIZERS; ADSORPTION; CHOCOLATE; KERNEL; SKIN	Mango (Mangifera indica L.), an edible fruit, is one of the main agricultural products in many tropical regions. Mango varieties differ in not only fruit shape but also aroma, which is an important characteristic. Although the fruit has many uses, the seeds are discarded as waste. Therefore, this study aimed to estimate the fatty acid content of seed oil of mangoes from different cultivation areas (Miyazaki, Japan, and Taiwan), and to evaluate their application in cosmetics. Five fatty acids were identified in the mango seed oil. Oleic acid and stearic acid were the principal components of mango seed oil obtained from Miyazaki (46.1% and 39.8%, respectively) and Taiwan (43.7% and 40.1%, respectively). As a cosmetic ingredient, mango seed oil showed good deodorizing effect on both 2-nonenal and isovaleric acid. The results indicated the potential applications of mango seed oil in the cosmetic industry.	[Wu, Shuhsien; Nomura, Masato] Kinki Univ, Major Syst Engn, Grad Sch Syst Engn, Higashihiroshima, Hiroshima 7392116, Japan; [Tokuda, Megumi; Kashiwagi, Ayaka; Okada, Yoshiharu] Kinki Univ, Fac Engn, Dept Biotechnol & Chem, Higashihiroshima, Hiroshima 7392116, Japan; [Henmi, Atsushi] Rilis Co Ltd, Yodogawa, Osaka 5320035, Japan; [Tachibana, Shinya] Konan Chem Ind Co Ltd, Takasuki, Osaka 5690066, Japan	Wu, S (reprint author), Kinki Univ, Major Syst Engn, Grad Sch Syst Engn, 1 Umenobe, Higashihiroshima, Hiroshima 7392116, Japan.	1344830002r@hiro.kindai.ac.jp					Abd-El-Baki M. M., 1981, Deutsche Lebensmittel-Rundschau, V77, P139; Flynn TC, 2001, CLIN DERMATOL, V19, P387, DOI 10.1016/S0738-081X(01)00199-7; SAKHO M, 1985, J FOOD SCI, V50, P548; Vermaak I, 2011, S AFR J BOT, V77, P920, DOI 10.1016/j.sajb.2011.07.003; [Anonymous], 1990, HDB OIL CHEM, V3<SUP>rd</SUP>, P282; Srivastava R, 2011, INDIAN J CHEM TECHN, V18, P67; Byun HJ, 2012, J DERMATOL SCI, V65, P110, DOI 10.1016/j.jdermsci.2011.12.005; Muchiri DR, 2012, J AM OIL CHEM SOC, V89, P1567, DOI 10.1007/s11746-012-2054-6; Murugan T, 2010, E-J CHEM, V7, P669; Kumar S, 2005, TECHNOVATION, V25, P1263, DOI 10.1016/j.technovation.2004.07.003; Simoneau C, 1999, FOOD CHEM, V65, P111, DOI 10.1016/S0308-8146(98)00106-X; Leifert WR, 2008, NUTR RES, V28, P729, DOI [10.1016/j.nutres.2008.08.007, 10.1016/j.nutres.2008.09.001]; Esteves EA, 2011, FOOD RES INT, V44, P2357, DOI 10.1016/j.foodres.2010.12.005; Arogba SS, 1997, J SCI FOOD AGR, V73, P321, DOI 10.1002/(SICI)1097-0010(199703)73:3<321::AID-JSFA722>3.0.CO;2-4; BANDYOPA.C, 1973, J SCI FOOD AGR, V24, P1497, DOI 10.1002/jsfa.2740241205; Haneba M, 2001, JPN RES SOC DET ENV, V25, P17; Hirota H, 1997, FRAGRANCE J LTD, P190; HUNTER GLK, 1974, J FOOD SCI, V39, P900, DOI 10.1111/j.1365-2621.1974.tb07271.x; HYMAN EL, 1991, WORLD DEV, V19, P1247, DOI 10.1016/0305-750X(91)90071-O; Lipp M, 1998, FOOD CHEM, V62, P73, DOI 10.1016/S0308-8146(97)00160-X; MACLEOD AJ, 1984, PHYTOCHEMISTRY, V23, P361, DOI 10.1016/S0031-9422(00)80333-7; MACLEOD AJ, 1982, PHYTOCHEMISTRY, V21, P117, DOI 10.1016/0031-9422(82)80025-3; Maribel R. S., 2011, FOOD RES INT, V44, P1386; Mimura Kunihiro, 2007, Rinsho Byori, V55, P35; Moharib Sorial A., 2012, Advances in Food Sciences, V34, P14; Oya M., 1989, JPN RES ASS TEXT END, V30, P87; PATTABHIRAMAN T. R., 1969, Perfumery and Essential Oil Record, V60, P233; Prakash D., 2009, OPEN NUTRACEUTICALS, V2, P20; Rider A. J., 1997, CURR THER RES, V58, P955; Sackier JM, 1998, J HOSP INFECT, V40, P97, DOI 10.1016/S0195-6701(98)90088-3; Scalia S, 1998, J CHROMATOGR A, V795, P219, DOI 10.1016/S0021-9673(97)00973-4; STECK AJ, 1983, J NEUROIMMUNOL, V5, P145, DOI 10.1016/0165-5728(83)90005-X; Suss J, 2004, INT J MED MICROBIOL, V293, P69, DOI 10.1016/S1433-1128(04)80011-1	33	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	MAY	2015	64	5					479	484		10.5650/jos.ess14238		6	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CG9BO	WOS:000353609600002		
J	Shimotori, Y; Hoshi, M; Miyakoshi, T				Shimotori, Yasutaka; Hoshi, Masayuki; Miyakoshi, Tetsuo			Combination of Novozym 435-catalyzed Enantioselective Hydrolysis and Amidation for the Preparation of Optically Active delta-Hexadecalactone	JOURNAL OF OLEO SCIENCE			English	Article						delta-hexadecalactone; lipase-catalyzed resolution; hydrolysis; amidation	LIPASE-CATALYZED RESOLUTION; ALPHA/BETA HYDROLASE FOLD; CANDIDA-ANTARCTICA; KINETIC RESOLUTION; VESPA-ORIENTALIS; FLAVOR COMPOUNDS; LACTONES; IMMOBILIZATION; CONSTITUENTS; ENANTIOMERS	A new enzymatic method for synthesis of enantiomerically enriched delta-hexadecalactone (3) based on the enzymatic kinetic resolution of N-methyl-5-acetoxyhexadecanamide (1) is described. A combination of lipase-catalyzed hydrolysis and amidation improved enantioselectivity. Lipase-catalyzed amidation was also investigated. Detailed screening of solvents and additive amines was performed. The addition of cyclohexylamine to lipase-catalyzed hydrolysis afforded the best results to give both enantiomers of 3 with more than 90% enantiomeric excess.	[Shimotori, Yasutaka; Hoshi, Masayuki] Kitami Inst Technol, Dept Biotechnol & Environm Chem, Kitami, Hokkaido 0908507, Japan; [Miyakoshi, Tetsuo] Meiji Univ, Dept Appl Chem, Sch Sci & Technol, Tama Ku, Kawasaki, Kanagawa, Japan	Shimotori, Y (reprint author), Kitami Inst Technol, Dept Biotechnol & Environm Chem, 165 Koen Cho, Kitami, Hokkaido 0908507, Japan.	yasu@mail.kitami-it.ac.jp					Shimotori Y, 2012, SYNTHETIC COMMUN, V42, P694, DOI 10.1080/00397911.2010.529230; LEHMANN D, 1995, Z LEBENSM UNTERS FOR, V201, P55, DOI 10.1007/BF01193201; Tamogami S, 2001, FLAVOUR FRAG J, V16, P161, DOI 10.1002/ffj.969; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Tomiyama K, 2012, FLAVOUR FRAG J, V27, P341, DOI 10.1002/ffj.3104; UM KW, 1992, J AGR FOOD CHEM, V40, P1641, DOI 10.1021/jf00021a033; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; IKAN R, 1969, J INSECT PHYSIOL, V15, P1709, DOI 10.1016/0022-1910(69)90003-1; VANDEWEGHE P, 1990, J AGR FOOD CHEM, V38, P1549, DOI 10.1021/jf00097a026; MOSANDL A, 1988, Z LEBENSM UNTERS FOR, V187, P40, DOI 10.1007/BF01454321; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Yamamoto T, 2002, TETRAHEDRON LETT, V43, P9081, DOI 10.1016/S0040-4039(02)02312-2; Tanaka H, 2007, LIFE SCI, V80, P1851, DOI 10.1016/j.lfs.2007.02.028; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Pilissao C, 2009, PROCESS BIOCHEM, V44, P1352, DOI 10.1016/j.procbio.2009.07.012; Banoth L, 2012, TETRAHEDRON-ASYMMETR, V23, P1272, DOI 10.1016/j.tetasy.2012.08.002; Bernreuther A, 1991, PHYTOCHEM ANALYSIS, V2, P43, DOI 10.1002/pca.2800020109; CAPORASO F, 1977, J AGR FOOD CHEM, V25, P1230, DOI 10.1021/jf60214a040; Castro M. S., 2000, TETRAHEDRON, V56, P1387; Chavez-Flores D, 2012, TETRAHEDRON-ASYMMETR, V23, P237, DOI 10.1016/j.tetasy.2012.02.014; El-Behairy MF, 2013, TETRAHEDRON-ASYMMETR, V24, P285, DOI 10.1016/j.tetasy.2013.02.006; Leuven I. van, 2008, International Dairy Journal, V18, P790, DOI 10.1016/j.idairyj.2008.01.001; Marszall MP, 2012, CATAL COMMUN, V24, P80, DOI 10.1016/j.catcom.2012.03.027; MORI K, 1985, TETRAHEDRON, V41, P547, DOI 10.1016/S0040-4020(01)96498-1; Ollis D. L., 1992, PROTEIN ENG, V5, P197; Onayade OA, 1998, FLAVOUR FRAG J, V13, P409, DOI 10.1002/(SICI)1099-1026(199811/12)13:6<409::AID-FFJ771>3.3.CO;2-E; Paivio M, 2012, TETRAHEDRON-ASYMMETR, V23, P230, DOI 10.1016/j.tetasy.2012.02.008; Prasad AK, 2005, TETRAHEDRON LETT, V46, P4511, DOI 10.1016/j.tetlet.2005.04.121; SUZUKI J, 1985, J AGR FOOD CHEM, V33, P343, DOI 10.1021/jf00063a006; Torres-Gavilan A, 2006, J MOL CATAL B-ENZYM, V41, P136, DOI 10.1016/j.molcatb.2006.06.001; Watanabe A, 2010, J FOOD SCI, V75, pC774, DOI 10.1111/j.1750-3841.2010.01870.x	31	1	1	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	MAY	2015	64	5					561	575		10.5650/jos.ess14232		15	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CG9BO	WOS:000353609600010		
J	Motooka, R; Usami, A; Nakahashi, H; Koutari, S; Nakaya, S; Shimizu, R; Tsuji, K; Marumoto, S; Miyazawa, M				Motooka, Ryota; Usami, Atsushi; Nakahashi, Hiroshi; Koutari, Satoshi; Nakaya, Satoshi; Shimizu, Ryoyu; Tsuji, Kaoru; Marumoto, Shinsuke; Miyazawa, Mitsuo			Characteristic Odor Components of Essential Oils from Eurya japonica	JOURNAL OF OLEO SCIENCE			English	Article						Eurya japonica; essential oil; GC-MS; GC-O; AEDA; OAV	IMPACT ODORANTS; AROMA; VARIETIES; OMISSION; WINE	The chemical compositions of essential oils from the flower and aerial parts (i.e., leaf and branch) of Eurya japonica were determined and quantified using gas chromatography-mass spectrometry (GC-MS). A total of 87 and 50 compounds were detected in the oils from the flower and aerial parts, respectively. The main compounds of the flower oil were linalool (14.0%), (9Z)-tricosene (12.0%), and nonanal (7.4%). In the oil from the aerial parts, linalool (37.7%), alpha-terpineol (13.5%), and geraniol (9.6%) were detected. In the oils from the flower and aerial parts, 13 and 8 aroma-active compounds were identified by GC-olfactometry (GC-O) analysis, respectively. The key aroma-active compounds of the flower oil were heptanal 1 fatty, green, flavor dilution (FD) = 128, odor activity value (OAV) = 3461, nonanal (sweet, citrus, FD = 128, OAV = 491), and eugenol (sweet, spicy, FD = 64, OAV = 62): in the oil from the aerial parts, the key aroma-active compounds were linalool (sweet, citrus, FD = 64, OAV = 95), (E)-beta-damascenone (sweet, FD = 256, OAV = 4000), and (E)-beta-ionone (floral, violet, FD = 128, OAV = 120). This study revealed that nonanal and eugenol impart the sweet, citrus, and spicy odor of the flower oil, while (E)-beta-damascenone and (E)-beta-ionone contribute the floral and sweet odor of the oil from the aerial parts.	[Motooka, Ryota; Usami, Atsushi; Nakahashi, Hiroshi; Koutari, Satoshi; Nakaya, Satoshi; Shimizu, Ryoyu; Miyazawa, Mitsuo] Kindai Univ, Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 5778502, Japan; [Tsuji, Kaoru] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Marumoto, Shinsuke] Kindai Univ, Kinki Univ, Joint Res Ctr, Higashiosaka, Osaka 5778502, Japan	Miyazawa, M (reprint author), Kindai Univ, Kinki Univ, Fac Sci & Engn, Dept Appl Chem, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	miyazawa@apch.kindai.ac.jp					Adams R.P., 2007, IDENTIFICATION ESSEN; Kuo LMY, 2013, J NAT PROD, V76, P580, DOI 10.1021/np3007638; Escudero A, 2007, J AGR FOOD CHEM, V55, P4501, DOI 10.1021/jf0636418; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; Miyazawa M, 2001, J AGR FOOD CHEM, V49, P5433, DOI 10.1021/jf010219c; Guth H, 1997, J AGR FOOD CHEM, V45, P3027, DOI 10.1021/jf970280a; Noudogbessi JP, 2008, REC NAT PROD, V2, P33; Dharmawan J, 2009, J AGR FOOD CHEM, V57, P239, DOI 10.1021/jf801070r; Buettner A, 1999, J AGR FOOD CHEM, V47, P5189, DOI 10.1021/jf990071l; Castro-Vazquez L, 2007, FOOD CHEM, V103, P601, DOI 10.1016/j.foodchem.2006.08.031; Miyazawa M, 2012, PHYTOCHEM ANALYSIS, V23, P208, DOI 10.1002/pca.1344; Arctander S., 1969, PERFUME FLAVOR CHEM, V1; Bairamian S, 2004, J ESSENT OIL RES, V16, P461; Boonbumrung S., 2001, Food Science and Technology Research, V7, P200, DOI 10.3136/fstr.7.200; Flanzy C, 2003, ENOLOGIA FUNDAMENTOS, P137; Guth H, 1999, FLAVOR CHEMISTRY, P377; Jorge A. P., 2006, FLAVOUR FRAG J, V21, P207; Miyazawa M, 2010, J OLEO SCI, V59, P527, DOI 10.5650/jos.59.527; Rosalind T., 2011, J PURE APPL MICROBIO, V5, P909; Rosalind Th., 2013, ASIAN J PHARM CLIN R, V6, P152; SEFTON MA, 1990, J AGR FOOD CHEM, V38, P2045, DOI 10.1021/jf00101a009; Takei S., 1934, NIPPON NOGEI KAGAKU, V14, P709; Yang DS, 2008, J AGR FOOD CHEM, V56, P235, DOI 10.1021/jf072360c	23	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	MAY	2015	64	5					577	584		10.5650/jos.ess14225		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CG9BO	WOS:000353609600011		
J	Ono, T; Usami, A; Nakaya, S; Shinpuku, H; Yonejima, Y; Ikeda, A; Miyazawa, M				Ono, Toshirou; Usami, Atsushi; Nakaya, Satoshi; Shinpuku, Hideto; Yonejima, Yasunori; Ikeda, Atsushi; Miyazawa, Mitsuo			Agroecosystem Development of Industrial Fermentation Waste - Characterization of Aroma-active Compounds from the Cultivation Medium of Lactobacillus brevis-	JOURNAL OF OLEO SCIENCE			English	Article						media after incubation (MAI); utilizing waste liquid; aroma extract dilution analysis (AEDA); Lactobacillus brevis	EXTRACT DILUTION ANALYSIS; CHARACTERISTIC ODOR COMPONENTS; GC-MS ANALYSIS; VOLATILE COMPOUNDS; ESSENTIAL OILS; AMINO-ACIDS; CHARACTERISTIC FLAVOR; CHEMICAL-COMPOSITION; ANALYSIS AEDA; PEEL OIL	Volatile oils obtained from both the liquid medium after incubation (MAI) and liquid medium before incubation (MBI) during the cultivation process of Lactobacillus brevis were isolated by hydrodistillation (HD) and analyzed to determine the utility of the liquid waste. The composition of the volatile oils was analyzed by capillary gas chromatography (GC) and gas chromatography-mass spectrometry (GC-MS). In total, 55 and 36 compounds were detected in the volatile oils from MAI (MAI oil) and MBI (MBI oil), respectively. The principle components of MAI oil were N-containing compounds, including 2,3-dimethylpyrazine (16, 37.1 %), methylpyrazine (4, 17.1 %). The important aroma-active compounds in the oils were detected by GC-Olfactometry (GC-O), and their intensity of aroma were measured by aroma extract dilution analysis (AEDA). Expressly, pyrazine compounds were determined as key aroma components; in particular, 2,5-dimethylpyrazine and 2,3-dimethylpyrazine were the most primary aroma-active compound in MAI oil. These results imply that the waste medium after incubation of L. brevis may be utilized as a source of volatile oils.	[Ono, Toshirou; Usami, Atsushi; Nakaya, Satoshi; Shinpuku, Hideto; Miyazawa, Mitsuo] Kindai Univ, Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 5778502, Japan; [Ono, Toshirou] Narasangyo Univ, Res Inst Publ Affairs, Nara 6368503, Japan; [Yonejima, Yasunori; Ikeda, Atsushi] Nitto Pharmaceut Ind Ltd, Kyoto 6170006, Japan	Miyazawa, M (reprint author), Kindai Univ, Kinki Univ, Fac Sci & Engn, Dept Appl Chem, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	miyazawa@apch.kindai.ac.jp					Adams R.P., 2007, IDENTIFICATION ESSEN; Choi HS, 2003, J AGR FOOD CHEM, V51, P2687, DOI 10.1021/jf021069o; SPADONE JC, 1990, J AGR FOOD CHEM, V38, P226, DOI 10.1021/jf00091a050; Kaneko S, 2012, J AGR FOOD CHEM, V60, P3831, DOI 10.1021/jf300150d; Alissandrakis E, 2007, J AGR FOOD CHEM, V55, P8152, DOI 10.1021/jf071442y; Song HS, 2000, FLAVOUR FRAG J, V15, P245, DOI 10.1002/1099-1026(200007/08)15:4<245::AID-FFJ904>3.0.CO;2-V; Zhang M, 2008, WORLD J MICROB BIOT, V24, P7, DOI 10.1007/s11274-007-9431-6; Javidnia K, 2004, FLAVOUR FRAG J, V19, P213, DOI 10.1002/ffj.1277; ITO T, 1987, NIPPON NOGEIK KAISHI, V61, P963; Sreekumar R, 2009, LETT APPL MICROBIOL, V48, P777, DOI 10.1111/j.1472-765X.2009.02610.x; SUGAWARA E, 1985, AGR BIOL CHEM TOKYO, V49, P311; Rezazadeh S, 2006, FLAVOUR FRAG J, V21, P290, DOI 10.1002/ffj.1587; Kawata J, 2008, J NAT MED, V62, P239, DOI 10.1007/s11418-007-0221-0; Kim JS, 2009, J KOREAN SOC APPL BI, V52, P516, DOI 10.3839/jksabc.2009.088; Nakamura A, 2013, J ESSENT OIL RES, V25, P497, DOI 10.1080/10412905.2013.809320; Pino J, 2011, FOOD CHEM, V125, P860, DOI 10.1016/j.foodchem.2010.08.073; Ye M, 2012, INT DAIRY J, V23, P68, DOI 10.1016/j.idairyj.2011.09.014; Radulovic NS, 2012, CHEM BIODIVERS, V9, P1320, DOI 10.1002/cbdv.201100430; Fang Y, 2005, FLAVOUR FRAG J, V20, P22, DOI 10.1002/ffj.1551; Yasar A, 2005, PHARM BIOL, V43, P108, DOI 10.1080/13880200590919384; Methven L, 2007, J AGR FOOD CHEM, V55, P1427, DOI 10.1021/jf0625611; Xie JC, 2008, FOOD CHEM, V109, P506, DOI 10.1016/j.foodchem.2007.12.074; Miyazato H, 2013, FOOD CHEM, V138, P2346, DOI 10.1016/j.foodchem.2012.12.013; Miyazawa M, 2011, REC NAT PROD, V5, P221; Saroglou V, 2006, J CHROMATOGR A, V1104, P313, DOI 10.1016/j.chroma.2005.11.087; ITO T, 1989, J JPN SOC FOOD SCI, V36, P762; Miyazawa M, 2006, J NAT MED, V60, P89, DOI 10.1007/s11418-005-009-z; Schwambach SL, 2006, J AGR FOOD CHEM, V54, P502, DOI 10.1021/jf0519764; Perez RA, 2007, FLAVOUR FRAG J, V22, P265, DOI 10.1002/ffj.1791; Miyazawa M, 2012, J ESSENT OIL RES, V24, P441, DOI 10.1080/10412905.2012.703475; DEMAIN AL, 1967, J BACTERIOL, V94, P323; Riu-Aumatell M, 2005, J AGR FOOD CHEM, V53, P7837, DOI 10.1021/jf051397z; Miyazawa M, 2012, PHYTOCHEM ANALYSIS, V23, P208, DOI 10.1002/pca.1344; SUGAWARA E, 1990, J JPN SOC FOOD SCI, V37, P520; Kashima Y, 2012, CHEM NAT COMPD+, V47, P998, DOI 10.1007/s10600-012-0128-1; Risticevic S, 2008, ANAL CHIM ACTA, V617, P72, DOI 10.1016/j.aca.2008.04.009; Miyazawa M, 2008, J ESSENT OIL RES, V20, P420; Qian M, 2003, FLAVOUR FRAG J, V18, P252, DOI 10.1002/ffj.1194; Brozozowski B., 2009, J SCI FOOD AGR, V89, P2467; Clery RA, 2005, J ESSENT OIL RES, V17, P591; Dong XY, 2012, EUR J LIPID SCI TECH, V114, P277, DOI 10.1002/ejlt.201100059; Fokialakis N, 2003, FLAVOUR FRAG J, V18, P39, DOI 10.1002/ffj.1148; Fujii H., 1963, NIPPON NOGEIKAGAKU K, V37, P615; FULLER R, 1991, GUT, V32, P439, DOI 10.1136/gut.32.4.439; Jordan MJ, 2002, J AGR FOOD CHEM, V50, P1523, DOI 10.1021/jf011077p; LIDBECK A, 1987, SCAND J INFECT DIS, V19, P531, DOI 10.3109/00365548709032419; Liu J, 1993, Zhongguo Zhong Yao Za Zhi, V18, P25; Miyazawa M., 2004, J OLEO SCI, V53, P511; Ono T, 2014, J OLEO SCI, V63, P971, DOI 10.5650/jos.ess14083; Paraskevopoulou A, 2012, FOOD RES INT, V48, P568, DOI 10.1016/j.foodres.2012.05.028; Rizzi P. G, 1988, J AGR FOOD CHEM, V36, P349; Sartoratto A, 2004, BRAZ J MICROBIOL, V35, P275, DOI 10.1590/S1517-83822004000300001; Seo H. M., 2007, HANGUK SIKPUM YONGYA, V36, P332; da Silva UF, 1999, PHYTOCHEMISTRY, V50, P31, DOI 10.1016/S0031-9422(98)00459-2; Surburg H., 1988, Developments in Food Science, V18, P505	55	1	1	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	MAY	2015	64	5					585	594		10.5650/jos.ess14257		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CG9BO	WOS:000353609600012		
J	Thubthimthong, B; Hane, K				Thubthimthong, Borriboon; Hane, Kazuhiro			Group velocity enhancement for guided lightwave by band-pulling effect in single-mode silicon comb photonic crystal wires	JOURNAL OF OPTICS			English	Article						photonic crystal waveguide; dispersion engineering; silicon nanophotonics; optical pulse propagation; ring resonators; optical interconnects	WAVE-GUIDES; SLOW-LIGHT; OPTICAL INTERCONNECTS; DELAY-LINES; CHALLENGES	Photonic crystal waveguides (PCWs), which usually exhibit the slow-light effect near the band edge frequency, may in fact be used to induce higher group velocity (nu(g)). The presence of the band edge, due to periodically carving a strip waveguide (SW) into a PCW of a comb-shape dielectric wire, results in the band-pulling effect. The band-pulling effect, which lifts the fundamental photonic band toward the band gap, not only enhances nu(g) by reducing the effective index but also prevents the band from bending toward the light cone of the core material, leading to additional nu(g) enhancement. The maximum PCW nu(g) (0.43c; c = vacuum light speed) found from numerical modeling was higher than SW nu(g) at all widths and thicknesses, except for extremely low thickness below 80 nm. We found by numerical modeling and experiments that up to 75% enhancement at the 1550 nm wavelength may be achieved in a fabricated single-mode PCW (0.38c) compared with an SW (0.21c) of the same width and thickness. The higher nu(g) was confirmed by measuring the PCW's group index using ring resonators. The PCW propagation loss of 2.1 dB mm(-1) and the bandwidth-distance product of 100 Gb/s-cm were deduced from experimental results. Our findings seemed encouraging for employing PCWs in optical interconnect applications.	[Thubthimthong, Borriboon; Hane, Kazuhiro] Tohoku Univ, Grad Sch Engn, Dept Nanomech, Sendai, Miyagi 9808579, Japan	Thubthimthong, B (reprint author), Tohoku Univ, Grad Sch Engn, Dept Nanomech, 6-6-1 Aoba, Sendai, Miyagi 9808579, Japan.	borriboon@hane.mech.tohoku.ac.jp			KAKENHI [A24246019]; MNC, Tohoku University, Japan	We thank the Nanostructures and Computation research group at Massachusetts Institute of Technology for making available to the public its fantastic computation packages and comprehensive documentation. We thank Professor Yoshiaki Kanamori and Professor Takashi Sasaki for helpful comments. Many thanks to Mr Mustafa Ordu, Dr Yasushi Munemasa, and Dr Ryohei Hokari for facility training and discussions on waveguides and ring resonators. This work was supported by KAKENHI(A24246019) and MNC, Tohoku University, Japan.	Agrawal G P, 2002, FIBER OPTIC COMMUNIC, P38; Haurylau M, 2006, IEEE J SEL TOP QUANT, V12, P1699, DOI 10.1109/JSTQE.2006.880615; Oskooi AF, 2010, COMPUT PHYS COMMUN, V181, P687, DOI 10.1016/j.cpc.2009.11.008; Benner AF, 2005, IBM J RES DEV, V49, P755; Khan S, 2011, OPT EXPRESS, V19, P11780, DOI 10.1364/OE.19.011780; Khan S, 2012, OPT EXPRESS, V20, P19859, DOI 10.1364/OE.20.019859; Baba T, 2008, NAT PHOTONICS, V2, P465, DOI 10.1038/nphoton.2008.146; Li JT, 2011, OPT EXPRESS, V19, P4458, DOI 10.1364/OE.19.004458; Schulz SA, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/10/104004; Burla M, 2013, OPT EXPRESS, V21, P25120, DOI 10.1364/OE.21.025120; Akihama Y, 2011, OPT EXPRESS, V19, P23658, DOI 10.1364/OE.19.023658; Johnson SG, 2001, OPT EXPRESS, V8, P173; Miller DAB, 2000, P IEEE, V88, P728, DOI 10.1109/5.867687; Belotti M, 2010, OPT EXPRESS, V18, P1450, DOI 10.1364/OE.18.001450; Jacobsen RS, 2005, OPT EXPRESS, V13, P7861, DOI 10.1364/OPEX.13.007861; Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1; Klocek P, 1991, HDB INFRARED OPTICAL; Kondo K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.053902; Lee KKY, 2008, OPT EXPRESS, V16, P15170, DOI 10.1364/OE.16.015170; Makino S, 2013, J LIGHTWAVE TECHNOL, V31, P2565, DOI 10.1109/JLT.2013.2269994; Monat C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4246; Okamoto K., 2006, FUNDAMENTALS OPTICAL; Oskooi A, 2012, OPT EXPRESS, V20, P21558, DOI 10.1364/OE.20.021558; Palik E. D., 1998, HDB OPTICAL CONSTANT; Sancho J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2092	25	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2040-8978	2040-8986		J OPTICS-UK	J. Opt.	MAY	2015	17	5							055104	10.1088/2040-8978/17/5/055104		9	Optics	Optics	CG8XG	WOS:000353598400010		
J	Igarashi, T; Abe, K; Miura, T; Tagami, K; Motonaga, S; Ichida, Y; Hasuo, H; Matsumoto, Y; Saito, S; Kinoshita, H				Igarashi, Takashi; Abe, Kentaro; Miura, Tomofumi; Tagami, Keita; Motonaga, Shinya; Ichida, Yasuhiko; Hasuo, Hideaki; Matsumoto, Yoshihisa; Saito, Shinichiro; Kinoshita, Hiroya			Oxycodone Frequently Induced Nausea and Vomiting in Oxycodone-Naive Patients with Hepatic Dysfunction	JOURNAL OF PALLIATIVE MEDICINE			English	Letter									[Igarashi, Takashi; Abe, Kentaro; Motonaga, Shinya; Ichida, Yasuhiko; Saito, Shinichiro] Natl Canc Ctr Hosp East, Dept Pharm, Kashiwa, Chiba 2778577, Japan; [Miura, Tomofumi; Tagami, Keita; Hasuo, Hideaki; Matsumoto, Yoshihisa; Kinoshita, Hiroya] Natl Canc Ctr Hosp East, Dept Palliat Med, Kashiwa, Chiba 2778577, Japan	Miura, T (reprint author), Natl Canc Ctr Hosp East, Dept Palliat Med, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	tomiura@east.ncc.go.jp					Tallgren M, 1997, CLIN PHARMACOL THER, V61, P655, DOI 10.1016/S0009-9236(97)90100-4	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	MAY 1	2015	18	5					399	399		10.1089/jpm.2015.0012.18.5		1	Health Care Sciences & Services	Health Care Sciences & Services	CH0LC	WOS:000353710300003		
J	Kikuchi, R; Kamibeppu, K				Kikuchi, Ryota; Kamibeppu, Kiyoko			Parents' Quality of Life and Family Functioning in Pediatric Organ Transplantation	JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES			English	Article						Family functioning; Parents; Pediatric organ transplantation; QOL; Review	POSTTRAUMATIC-STRESS-DISORDER; DONOR LIVER-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; INTESTINAL TRANSPLANTATION; HEART-TRANSPLANTATION; PSYCHOSOCIAL IMPACT; SOCIAL SUPPORT; HEALTH; CHILDREN; OUTCOMES	Solid organ transplantation is an important treatment option for pediatric patients in end-stage organ failure. The impact of pediatric organ transplantation on parents' quality of life and family functioning has been found to be substantial, but findings on this topic have not previously been consolidated. Thirty-one studies were selected for analysis after a database search on this topic. We present future research questions and suggestions to improve clinical practice based on the integration of this knowledge. (C) 2015 Elsevier Inc. All rights reserved.	[Kikuchi, Ryota; Kamibeppu, Kiyoko] Univ Tokyo, Grad Sch Med, Dept Family Nursing, Div Hlth Sci & Nursing, Tokyo 1138654, Japan	Kamibeppu, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Family Nursing, Div Hlth Sci & Nursing, Tokyo 1138654, Japan.	kkamibeppu-tky@umin.ac.jp					Abidin R. R., 1990, PARENTING STRESS IND; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Taylor RM, 2011, QUAL LIFE RES, V20, P1715, DOI 10.1007/s11136-011-9904-9; LaRosa C, 2011, PEDIATR TRANSPLANT, V15, P128, DOI 10.1111/j.1399-3046.2010.01434.x; Isotani S, 2002, UROLOGY, V60, P588, DOI 10.1016/S0090-4295(02)01865-4; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; Alonso EM, 2008, LIVER TRANSPLANT, V14, P460, DOI 10.1002/lt.21352; Perry KT, 2003, J UROLOGY, V169, P2018, DOI 10.1097/01.ju.0000067975.59772.b6; ROBERTS CS, 1982, NURS RES, V31, P231; Cole CR, 2004, PEDIATR TRANSPLANT, V8, P222, DOI 10.1111/j.1399-3046.2004.00126.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155; OBERST MT, 1989, CANCER NURS, V12, P209; Fredericks EM, 2007, AM J TRANSPLANT, V7, P1974, DOI 10.1111/j.1600-6143.2007.01878.x; Parikh ND, 2010, LIVER TRANSPLANT, V16, P1352, DOI 10.1002/lt.22181; Bucuvalas JC, 2003, LIVER TRANSPLANT, V9, P62, DOI 10.1053/jlts.2002.50012; Alonso EM, 2003, J PEDIATR GASTR NUTR, V37, P155, DOI 10.1097/00005176-200308000-00014; Anthony SJ, 2010, PEDIATR TRANSPLANT, V14, P249, DOI 10.1111/j.1399-3046.2009.01214.x; Beck A. T., 1996, BECK DEPRESSION INVE; Brown KL, 2009, J HEART LUNG TRANSPL, V28, P1267, DOI 10.1016/j.healun.2009.05.023; Carey P J, 1991, Oncol Nurs Forum, V18, P1341; Crowley-Matoka M, 2004, AM J TRANSPLANT, V4, P744, DOI 10.1111/j.1600-6143.2004.00377.x; Dazord A., 2001, MENTAL HLTH QUALITY; DEBOLT AJ, 1995, CHILD HEALTH CARE, V24, P79, DOI 10.1207/s15326888chc2402_1; Derogatis L. R., 1990, PSYCHOSOCIAL ADJUSTM; Derogatis LR, 1993, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diseth TH, 2011, PEDIATR NEPHROL, V26, P1881, DOI 10.1007/s00467-011-1887-9; Douglas JE, 1998, CHILD CARE HLTH DEV, V24, P73; Farley LM, 2007, J HEART LUNG TRANSPL, V26, P120, DOI 10.1016/j.healun.2006.11-013; FEDEWA MM, 1996, PEDIAT NURS, V22, P417; Foa E. B., 1995, POSTTRAUMATIC STRESS; FOULKES LM, 1993, PEDIATR NEPHROL, V7, P185; Goldberg D. P., 1988, USERS GUIDE GEN HLTH; Green A, 2009, PROG TRANSPLANT, V19, P122; Hasegawa A., 2004, TRANSPLANTATION TODA, V17, P456; Kroencke S, 2006, LIVER TRANSPLANT, V12, P1661, DOI 10.1002/lt.20862; Landgraf J., 1994, INFANT TODDLER QUALI; Landgraf J. L., 1996, THE CHQ USERS MANUAL; LoBiondo-Wood Geri, 2004, J Spec Pediatr Nurs, V9, P59, DOI 10.1111/j.1088-145X.2004.00059.x; Manificat S, 2003, PEDIATR TRANSPLANT, V7, P228, DOI 10.1034/j.1399-3046.2003.00065.x; McCubbin H., 1981, FIRM FAMILY INVENTOR; McCubbin M. A., 1987, FAMILY ASSESSMENT IN, P41; McNair D. M., 1992, PROFILE MOOD STATES; Moos R. H., 1986, FAMILY ENV SCALE MAN; Morimoto T., 1994, J TRANSPL COORD, V4, P126; Neuhaus TJ, 2005, PEDIATR NEPHROL, V20, P205, DOI 10.1007/s00467-004-1749-9; Ngo KD, 2011, PEDIATR TRANSPLANT, V15, P849, DOI 10.1111/j.1399-3046.2011.01590.x; Organ Procurement and Transplantation Network (OPTN), 2012, NAT DAT 2011; Price D P, 1998, Ann Transplant, V3, P34; Rossi A, 2011, TRANSPL P, V43, P1164, DOI 10.1016/j.transproceed.2011.01.119; Schulz KH, 2001, TRANSPLANT P, V33, P1496, DOI 10.1016/S0041-1345(00)02567-7; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Spielberger C. D., 1983, MANUAL STATE TRAIT A; Spurkland I, 2001, CARDIOL YOUNG, V11, P277, DOI 10.1017/S1047951101000294; STEIN REK, 1980, MED CARE, V18, P465, DOI 10.1097/00005650-198004000-00010; Stubblefield C, 2000, J Pediatr Health Care, V14, P280, DOI 10.1067/mph.2000.109186; Stubblefield C, 2001, QUAL HEALTH RES, V11, P58, DOI 10.1177/104973201129118939; Sudan D, 2004, AM J TRANSPLANT, V4, P407, DOI 10.1111/j.1600-6143.2004.00330.x; Sundaram SS, 2007, AM J TRANSPLANT, V7, P982, DOI 10.1111/j.1600-6143.2006.01722.x; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Uzark K, 1989, Prog Cardiovasc Nurs, V4, P23; UZARK KC, 1992, J HEART LUNG TRANSPL, V11, P1160; Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55; Weiss D, 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1007/978-0-387-70990-1_10; World Health Organization, 1948, CONST WHO BAS DOC; Young GS, 2003, PEDIATRICS, V111, pE725, DOI 10.1542/peds.111.6.e725; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	69	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0882-5963			J PEDIATR NURS	J. Pediatr. Nurs.	MAY-JUN	2015	30	3					463	477		10.1016/j.pedn.2014.12.013		15	Nursing; Pediatrics	Nursing; Pediatrics	CH2BL	WOS:000353829000007		
J	El-Agamey, A; El-Hagrasy, MA; Suenobu, T; Fukuzumi, S				El-Agamey, Ali; El-Hagrasy, Maha A.; Suenobu, Tomoyoshi; Fukuzumi, Shunichi			Influence of pH on the decay of beta-carotene radical cation in aqueous Triton X-100: A laser flash photolysis study	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY			English	Article							DENSITY-FUNCTIONAL THEORY; PROTON-TRANSFER REACTIONS; RETINYL POLYENES; PULSE-RADIOLYSIS; TRANSIENT PHENOMENA; ELECTRON-TRANSFER; REACTIVITY; ANTIOXIDANT; IONS; NUCLEOPHILES	The identification of the spectral information of carotenoid neutral radicals is essential for studying their reactivities towards O-2 and thereby evaluating their role in the antioxidant-prooxidant properties of the corresponding carotenoid. Recently, it was reported that beta-carotene neutral radical (beta-CAR(center dot)) has an absorption maximum at 750 nm. This contradicts the results of many reports that show carotenoid neutral radicals (CAR(center dot)) absorb in the same or near to the spectral region as their parent carotenoids. In this manuscript, the influence of pH on the decay of beta-carotene radical cation (beta-CAR-H center dot+), generated in an aqueous solution of 2% Triton X-100 (TX-100), was investigated, employing laser flash photolysis (LFP) coupled with kinetic absorption spectroscopy, to identify the absorption bands of the beta-carotene neutral radicals. By increasing the pH value of the solution, the decay of beta-CAR-H center dot+ is enhanced and this enhancement is not associated with the formation of any positive absorption bands over the range 550-900 nm. By comparing these results with the literature, it can be concluded that beta-carotene neutral radicals most probably absorb within the same spectral range as that of beta-carotene. The reaction pathways of the reaction of beta-CAR-H center dot+ with -OH have been discussed. (C) 2015 Elsevier B.V. All rights reserved.	[El-Agamey, Ali; Suenobu, Tomoyoshi; Fukuzumi, Shunichi] Osaka Univ, Japan Sci & Technol Agcy JST, Grad Sch Engn, Dept Mat & Life Sci,ALCA, Suita, Osaka 5650871, Japan; [El-Agamey, Ali; El-Hagrasy, Maha A.] Damietta Univ, Fac Sci, Dept Chem, Dumyat, Egypt	El-Agamey, A (reprint author), Osaka Univ, Japan Sci & Technol Agcy JST, Grad Sch Engn, Dept Mat & Life Sci,ALCA, Suita, Osaka 5650871, Japan.		Fukuzumi, Shunichi /E-4728-2010		JSPS (Japan Society for the Promotion of Science); Global COE program, "the Global Education and Research Center for Bio-Environmental Chemistry" from the MEXT, Japan; WCU Program from NRF/MEST, Korea [R31-2008-000-10010-0]; GRL Program from NRF/MEST, Korea [2010-00353];  [20108010]	Dr. El-Agamey is grateful to JSPS (Japan Society for the Promotion of Science) for financial support. Also, this work was supported by a Grant-in-Aid (No. 20108010) and a Global COE program, "the Global Education and Research Center for Bio-Environmental Chemistry" from the MEXT, Japan and WCU (R31-2008-000-10010-0) and GRL (2010-00353) Programs from NRF/MEST, Korea.	ALAM MM, 1995, J ORG CHEM, V60, P3440, DOI 10.1021/jo00116a033; Alam MM, 1996, PHOTOCHEM PHOTOBIOL, V63, P53, DOI 10.1111/j.1751-1097.1996.tb02991.x; ALMGREN M, 1980, PHOTOCHEM PHOTOBIOL, V31, P329, DOI 10.1111/j.1751-1097.1980.tb02549.x; Mortensen A, 1997, FEBS LETT, V418, P91, DOI 10.1016/S0014-5793(97)01355-0; Liu DZ, 2000, J ELECTROANAL CHEM, V488, P140, DOI 10.1016/S0022-0728(00)00205-9; MIMOUN H, 1986, J AM CHEM SOC, V108, P3711, DOI 10.1021/ja00273a027; El-Agamey Ali, 2008, V4, P119, DOI 10.1007/978-3-7643-7499-0_7; MORDI RC, 1993, TETRAHEDRON, V49, P911, DOI 10.1016/S0040-4020(01)80333-1; MORDI RC, 1991, TETRAHEDRON LETT, V32, P4203, DOI 10.1016/S0040-4039(00)79905-9; BURTON GW, 1984, SCIENCE, V224, P569, DOI 10.1126/science.6710156; El-Agamey A, 2004, ARCH BIOCHEM BIOPHYS, V430, P37, DOI 10.1016/j.abb.2004.03.007; DeMatteo MP, 2005, J AM CHEM SOC, V127, P7094, DOI 10.1021/ja043692q; Sporn MB, 2013, CANCER PREV RES, V6, P384, DOI 10.1158/1940-6207.CAPR-13-0026; Tanaka T, 2012, MOLECULES, V17, P3202, DOI 10.3390/molecules17033202; Gao YL, 2006, J PHYS CHEM B, V110, P24750, DOI 10.1021/jp0643707; Jeevarajan JA, 1996, J ELECTROANAL CHEM, V411, P57, DOI 10.1016/0022-0728(96)04572-X; Bohm F, 1997, J AM CHEM SOC, V119, P621, DOI 10.1021/ja962512c; AVELINE BM, 1995, J AM CHEM SOC, V117, P9699, DOI 10.1021/ja00143a013; Aveline BM, 1996, J AM CHEM SOC, V118, P10113, DOI 10.1021/ja961988t; BOBROWSKI K, 1985, J PHYS CHEM-US, V89, P5733, DOI 10.1021/j100272a032; BOBROWSKI K, 1987, J PHYS CHEM-US, V91, P1210, DOI 10.1021/j100289a035; BOBROWSKI K, 1985, J PHYS CHEM-US, V89, P5079, DOI 10.1021/j100269a038; Buxton GV, 1988, PHYS CHEM REF DATA, V17, P513; CHAUVET JP, 1983, J PHYS CHEM-US, V87, P592, DOI 10.1021/j100227a016; Chen CH, 2011, J PHYS CHEM B, V115, P2082, DOI 10.1021/jp1100889; CHESSIN M, 1966, T FARADAY SOC, V62, P1519, DOI 10.1039/tf9666201519; Chew BP, 2004, J NUTR, V134, P257; Edge R, 2007, ARCH BIOCHEM BIOPHYS, V458, P104, DOI 10.1016/j.abb.2006.10.008; El-Agamey A, 2003, J AM CHEM SOC, V125, P3330, DOI 10.1021/ja027986s; El-Agamey A, 2011, ORG BIOMOL CHEM, V9, P1459, DOI 10.1039/c0ob00799d; El-Agamey A, 2011, ORG BIOMOL CHEM, V9, P6437, DOI 10.1039/c1ob05814b; El-Agamey A, 2006, ORG LETT, V8, P4255, DOI 10.1021/ol061484s; El-Agamey A, 2007, FREE RADICAL RES, V41, P295, DOI 10.1080/10715760601087558; El-Agamey A, 2005, ORG LETT, V7, P3957, DOI 10.1021/ol051436s; EVERETT SA, 1995, BIOCHEM SOC T, V23, pS230; Everett SA, 1996, J BIOL CHEM, V271, P3988, DOI 10.1074/jbc.271.8.3988; Focsan AL, 2009, J PHYS CHEM B, V113, P6087, DOI 10.1021/jp810604s; Focsan AL, 2008, J PHYS CHEM B, V112, P1806, DOI 10.1021/jp0765650; Gao YL, 2003, J PHYS CHEM B, V107, P13237, DOI 10.1021/jp0358679; Gao YL, 2009, J PHYS CHEM B, V113, P9901, DOI 10.1021/jp8075832; HILL TJ, 1995, J AM CHEM SOC, V117, P8322, DOI 10.1021/ja00137a004; Jeevarajan JA, 1996, J CHEM SOC FARADAY T, V92, P1757, DOI 10.1039/ft9969201757; JOHNSTON LJ, 1995, PURE APPL CHEM, V67, P71, DOI 10.1351/pac199567010071; JOHNSTON LJ, 1993, J AM CHEM SOC, V115, P6564, DOI 10.1021/ja00068a013; Konovalova TA, 2000, FREE RADICAL BIO MED, V28, P1030, DOI 10.1016/S0891-5849(00)00192-1; LAND EJ, 1978, J CHEM SOC FARAD T 1, V74, P538, DOI 10.1039/f19787400538; Lawrence J, 2008, J PHYS CHEM B, V112, P5449, DOI 10.1021/jp711310u; Liu D., 1999, RECENT RES DEV ELECT, V2, P139; Magyar A, 2013, J PHYS CHEM B, V117, P2239, DOI 10.1021/jp306387e; MATHIS P, 1973, PHOTOCHEM PHOTOBIOL, V18, P343, DOI 10.1111/j.1751-1097.1973.tb06431.x; PARKER VD, 1987, J AM CHEM SOC, V109, P2521, DOI 10.1021/ja00242a052; Polyakov NE, 2010, J PHYS CHEM B, V114, P16968, DOI 10.1021/jp109039v; RAGHAVAN NV, 1981, J AM CHEM SOC, V103, P4569, DOI 10.1021/ja00405a045; REITSTOEN B, 1990, J AM CHEM SOC, V112, P4968, DOI 10.1021/ja00168a057; REITSTOEN B, 1991, J AM CHEM SOC, V113, P6954, DOI 10.1021/ja00018a037; Rozanowska M, 2005, FREE RADICAL BIO MED, V39, P1399, DOI 10.1016/j.freeradbiomed.2005.07.018; XUE J, 1994, J ORG CHEM, V59, P6564, DOI 10.1021/jo00101a015; Yamazaki M, 2001, J PHOTOCH PHOTOBIO A, V140, P139, DOI 10.1016/S1010-6030(01)00401-4; Zhao YX, 2001, J CHEM SOC PERK T 2, P1481, DOI 10.1039/b102320a	59	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1011-1344			J PHOTOCH PHOTOBIO B	J. Photochem. Photobiol. B-Biol.	MAY	2015	146						68	73		10.1016/j.jphotobiol.2015.02.026		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH0SP	WOS:000353733000009		
J	Kiya, K; Oyama, T; Sone, Y; Ishii, N; Hosokawa, K				Kiya, Koichiro; Oyama, Tomoki; Sone, Yumiko; Ishii, Nobuyuki; Hosokawa, Ko			A novel active intraoral appliance for presurgical orthopaedic treatment in patients with complete bilateral cleft lip and palate	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Complete bilateral cleft lip and palate; Presurgical orthopaedic treatment; Active appliance; Intraoral appliance; Protruding premaxilla	PREMAXILLA	Background: Management of the protruding/deviated premaxilla in patients with complete bilateral cleft lip and palate is a challenging problem for surgeons and orthodontists. Various passive and active methods have been developed for the presurgical orthopaedic treatment. However, most of these treatments are complicated and laborious for the patient's parents and clinicians. Here, we describe our original active intraoral appliance comprising two components, that is, the premaxillary and palatine process plates, connected with two elastic chains, and we assess its therapeutic efficacy. Patients and methods: We retrospectively evaluated 15 patients treated using this appliance during 2006-2012, followed up for an average of 60.3 months (range, 18-97 months). We analysed the cleft widths and maxillary size, obtained pretreatment, post-treatment and pre-palatoplasty. Results: Cleft widths and premaxillary protrusion were significantly decreased post treatment; however, the transverse dimensions were not significantly altered. In all cases, the protruding/deviated premaxilla was set into a suitable position within 1 month, and we could perform one-stage cheiloplasty using the modified Mulliken method with low tension. Conclusion: Our appliance is technically simple to use, less invasive to the skin and bone and cost-effective, with reliable and predictable outcomes. In the follow-up period, we observed no detrimental growth of the maxilla or dentition. Therefore, we consider our appliance to be useful for application in presurgical orthopaedic treatments of complete bilateral cleft lip and palate. (C) 2014 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Kiya, Koichiro; Oyama, Tomoki] Kobe Childrens Hosp, Dept Plast Surg, Suma Ku, Kobe, Hyogo, Japan; [Sone, Yumiko] Kobe Childrens Hosp, Dept Dent, Suma Ku, Kobe, Hyogo, Japan; [Ishii, Nobuyuki] Kanomi Dent Clin, Himeji, Hyogo, Japan; [Hosokawa, Ko] Osaka Univ, Grad Sch Med, Dept Plast Surg, Suita, Osaka, Japan	Kiya, K (reprint author), 1-1-1 Takakuradai Suma Ku, Kobe, Hyogo, Japan.	kiyapsurg@yahoo.co.jp					Millard DR, 1999, PLAST RECONSTR SURG, V103, P1630, DOI 10.1097/00006534-199905060-00009; Choo H, 2012, PLAST RECONSTR SURG, V129, P244, DOI 10.1097/PRS.0b013e318230c84c; Uzel A, 2011, CLEFT PALATE-CRAN J, V48, P587, DOI 10.1597/10-008; Berkowitz S, 2004, PLAST RECONSTR SURG, V113, P1, DOI 10.1097/01.PRS.0000096710.08123.93; BITTER K, 1992, J CRANIO MAXILL SURG, V20, P99, DOI 10.1016/S1010-5182(05)80091-5; Figueroa AA, 1996, CLEFT PALATE-CRAN J, V33, P497, DOI 10.1597/1545-1569(1996)033<0497:IAMTRT>2.3.CO;2; GEORGIADE NG, 1989, PLAST RECONSTR SURG, V83, P32, DOI 10.1097/00006534-198901000-00007; Kojo H, 1988, Shoni Shikagaku Zasshi, V26, P112; Konst EM, 2003, CLEFT PALATE-CRAN J, V40, P32, DOI 10.1597/1545-1569(2003)040<0032:PDOTWU>2.0.CO;2; Mishima K, 1998, CLEFT PALATE-CRAN J, V35, P227, DOI 10.1597/1545-1569(1998)035<0227:EOPOTI>2.3.CO;2; Oosterkamp BCM, 2005, CLEFT PALATE-CRAN J, V42, P239, DOI 10.1597/03-109.1; PAPAY FA, 1994, CLEFT PALATE-CRAN J, V31, P494, DOI 10.1597/1545-1569(1994)031<0494:POPAIC>2.3.CO;2; REISBERG DJ, 1988, CLEFT PALATE J, V25, P53; Robertson N, 1977, Plast Reconstr Surg, V59, P87	14	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	MAY	2015	68	5					632	637		10.1016/j.bjps.2014.12.022		6	Surgery	Surgery	CH1UT	WOS:000353807700009		
J	Kimura, H; Yasuoka, T; Nagao, M; Kudoh, S; Kobayashi, S				Kimura, Hiroaki; Yasuoka, Tomoyuki; Nagao, Munetomo; Kudoh, Shin; Kobayashi, Seiichiro			Oblique lateral incision and subpectoral dissection in modified Nuss procedure minimize future breast deformity	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Pectus excavatum; Nuss procedure; Breast deformity; Complications	INFRAMAMMARY FOLD; PECTUS EXCAVATUM; LIGAMENT	Background: We experienced the occurrence of breast deformity in some young female patients who underwent a modified Nuss procedure before breast development. We studied the causes of and preventive measures for this complication. Methods: We classified 13 prepubescent female patients who underwent our modified Nuss procedure into three groups according to the direction of the skin incision and the dissection layer for bar insertion. Four patients who underwent transverse lateral thoracic skin incision and bar insertion through a subpectoral dissection were assigned to the T/SP group, five who underwent oblique skin incision along the rib and bar insertion through a suprapectoral dissection were assigned to the O/IP group, and four who underwent oblique skin incision and subpectoral dissection were assigned to the O/SP group. Each patient in the T/SP group underwent the operation by a different surgeon, two of whom were the authors, including the first author; the first author performed all operations in the O/IP and O/SP groups. The first author evaluated the shape of the developed breasts using the frontal-and oblique-view photographs. We also investigated the location of the lateral border of the mammary gland in seven other adolescent and adult female patients using three-dimensional computed tomography images. Results: Lateral depression of the breast occurred in four of eight breasts with a transverse incision, and flattening of the lowermost portion of the inframammary fold occurred in six of 10 breasts with suprapectoral dissection. None of the eight breasts with an oblique incision and subpectoral dissection exhibited deformities. The lateral border of the mammary gland was on the fifth rib in five patients and on the fifth intercostal space in two patients. Conclusion: An oblique lateral thoracic skin incision along the sixth rib and subpectoral dissection may reduce the occurrence of breast deformity. (C) 2014 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Kimura, Hiroaki; Yasuoka, Tomoyuki; Nagao, Munetomo; Kudoh, Shin; Kobayashi, Seiichiro] Iwate Med Univ, Sch Med, Dept Plast Reconstruct & Aesthet Surg, Morioka, Iwate 0208505, Japan	Kimura, H (reprint author), Iwate Med Univ, Sch Med, Dept Plast Reconstruct & Aesthet Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	hkimura@iwate-med.ac.jp					Kim DH, 2005, ANN THORAC SURG, V80, P1073, DOI 10.1016/j.athoracsur.2005.03.070; Muntan CD, 2000, PLAST RECONSTR SURG, V105, P549, DOI 10.1097/00006534-200002000-00011; Boutros S, 1998, PLAST RECONSTR SURG, V102, P1030, DOI 10.1097/00006534-199809040-00017; Nava M, 1998, PLAST RECONSTR SURG, V102, P1034, DOI 10.1097/00006534-199809040-00018; BAYATI S, 1995, PLAST RECONSTR SURG, V95, P501, DOI 10.1097/00006534-199503000-00010; Olbrecht VA, 2008, ANN THORAC SURG, V86, P402, DOI 10.1016/j.athoracsur.2008.04.038; Hebra André, 2009, Semin Thorac Cardiovasc Surg, V21, P76, DOI 10.1053/j.semtcvs.2009.04.005; Imanishi N, 2011, JPN J BREAST CANC, V26, P649; Kimura H, 2010, JPN J PLAST SURG, V53, P957; Nuss D, 1998, PEDIAT ENDOSURG INNO, V2, P205, DOI 10.1089/pei.1998.2.205; Olbrecht VA, 2008, ANN THORAC SURG, V86; Ostlie DJ, 2003, J PEDIATR SURG, V38, P953, DOI 10.1016/S022-3468(03)00132-5; VANSTRAALEN WR, 1995, ANN PLAS SURG, V35, P237, DOI 10.1097/00000637-199509000-00003	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	MAY	2015	68	5					692	697		10.1016/j.bjps.2014.12.016		6	Surgery	Surgery	CH1UT	WOS:000353807700018		
J	Sakamoto, Y; Nakajima, H; Imanishi, N; Okumoto, T; Kato, T; Kishi, K				Sakamoto, Yoshiaki; Nakajima, Hideo; Imanishi, Nobuaki; Okumoto, Takayuki; Kato, Tatsuya; Kishi, Kazuo			A hammock flap: A modified backflip flap for the surgical correction of cicatricial entropion	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							GRAFTS		[Sakamoto, Yoshiaki; Nakajima, Hideo; Kato, Tatsuya; Kishi, Kazuo] Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Shinjuku Ward, Tokyo 1608582, Japan; [Imanishi, Nobuaki] Keio Univ, Sch Med, Dept Anat, Shinjuku Ward, Tokyo 1608582, Japan; [Okumoto, Takayuki] Fujita Hlth Univ, Sch Med, Dept Plast & Reconstruct Surg, Toyoake, Aichi 4701192, Japan	Sakamoto, Y (reprint author), Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Shinjuku Ward, 35 Shinanomachi, Tokyo 1608582, Japan.	ysakamoto@z8.keio.jp					SIEGEL RJ, 1985, PLAST RECONSTR SURG, V76, P411, DOI 10.1097/00006534-198509000-00013; BAYLIS HI, 1979, OPHTHALMIC SURG LAS, V10, P42; Goldberg RA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1255; Hintschich Christoph, 2008, Dev Ophthalmol, V41, P85, DOI 10.1159/000131075; Sakamoto Y, 2010, PLAST RECONSTR SURG, V126, p179E, DOI 10.1097/PRS.0b013e3181ea91f7	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	MAY	2015	68	5					738	740		10.1016/j.bjps.2014.12.043		4	Surgery	Surgery	CH1UT	WOS:000353807700026		
J	Matsutani, H; Hayashi, A; Yamamoto, T				Matsutani, Hitomi; Hayashi, Akitatsu; Yamamoto, Takumi			All-star lymphatic supermicrosurgery: Multiple lymph flow diversion using end-to-end, end-to-side, side-to-end, and side-to-side lymphaticovenular anastomoses in a surgical field	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter									[Matsutani, Hitomi; Hayashi, Akitatsu; Yamamoto, Takumi] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan	Matsutani, H (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2014, ANN PLAS SURG, V72, P67, DOI 10.1097/SAP.0b013e3182605580; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Yamamoto T, 2014, J PLAST RECONSTR AES, V67, pE142, DOI 10.1016/j.bjps.2013.12.045; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P812, DOI 10.1016/j.bjps.2010.10.011; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059523	7	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	MAY	2015	68	5					E107	E108		10.1016/j.bjps.2015.02.022		2	Surgery	Surgery	CH1UT	WOS:000353807700002		
J	Xu, C; Xiao, WL; Zhao, WT; Wang, WH; Hanada, S; Yamagata, H; Ma, CL				Xu Cong; Xiao Wenlong; Zhao Weitao; Wang Wenhong; Hanada, Shuji; Yamagata, Hiroshi; Ma Chaoli			Microstructure and formation mechanism of grain-refining particles in Al-Ti-C-RE grain refiners	JOURNAL OF RARE EARTHS			English	Article						Al-Ti-C-RE; core-shell structure; grain refinement; formation mechanism; rare earths	MASTER ALLOY; ALUMINUM; EFFICIENCY; SOLIDIFICATION; PERFORMANCE; ZIRCONIUM; BEHAVIOR; MELTS; SIZE	The Al-5Ti-0.2C-based grain refiners with different contents of rare earth (RE) were successfully prepared via powder metallurgy and vacuum casting. The microstructural evolution has been studied by X-ray diffraction (XRD), differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The results showed that the RE addition resulted in the formation of TiAl3/Ti2Al20RE core-shell structured primary particles, and the size of TiAl3 core decreased, while the thickness of Ti2Al20RE increased with increase of RE contents. As compared to Al-5Ti-0.2C grain refiner, the grain refining efficiency was gradually improved with increase of RE contents, which was mainly attributed to the TiAl3/Ti2Al20RE core-shell structured primary particles and insoluble TiC nuclei formed in alpha-Al matrix. The formation mechanism of core-shell structure was further investigated based on Ginstling-Brounstein model.	[Xu Cong; Xiao Wenlong; Ma Chaoli] Beihang Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Aerosp Adv Mat & Performance, Beijing 100191, Peoples R China; [Zhao Weitao; Wang Wenhong] Hebei Sitong New Met Mat Co Ltd, Baoding 071105, Peoples R China; [Hanada, Shuji] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Yamagata, Hiroshi] Gifu Univ, Ctr Adv Die Engn & Technol, Gifu, Gifu 5011193, Japan	Ma, CL (reprint author), Beihang Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Aerosp Adv Mat & Performance, Beijing 100191, Peoples R China.	machaoli@buaa.edu.cn	Xiao, Wenlong/B-4765-2008		National High Technology Research and Development Program of China [2013AA031001]; National Basic Research Program of China [2012CB619503]; International Science & Technology Cooperation Program of China [2012DFA50630]	Project supported by National High Technology Research and Development Program of China (2013AA031001), the National Basic Research Program of China (2012CB619503) and International Science & Technology Cooperation Program of China (2012DFA50630)	Alamdari HD, 2013, METALL MATER TRANS A, V44A, P388, DOI 10.1007/s11661-012-1388-x; Kandalova EG, 2002, MATER LETT, V54, P131, DOI 10.1016/S0167-577X(01)00550-X; Greer AL, 2000, ACTA MATER, V48, P2823, DOI 10.1016/S1359-6454(00)00094-X; Wang T, 2013, MATER CHARACT, V83, P13, DOI 10.1016/j.matchar.2013.06.002; Qian M, 2007, ACTA MATER, V55, P943, DOI 10.1016/j.actamat.2006.09.016; Quested TE, 2004, ACTA MATER, V52, P3859, DOI 10.1016/j.actamat.2004.04.035; Kumar GSV, 2005, J ALLOY COMPD, V396, P143, DOI 10.1016/j.jallcom.2004.12.039; Li YL, 2008, MAT SCI ENG A-STRUCT, V487, P518, DOI 10.1016/j.msea.2007.11.067; Paik JG, 2005, THERMOCHIM ACTA, V425, P131, DOI 10.1016/j.tca.2004.06.012; MOHANTY PS, 1995, ACTA METALL MATER, V43, P2001, DOI 10.1016/0956-7151(94)00405-7; Quested TE, 2005, ACTA MATER, V53, P4643, DOI 10.1016/j.actamat.2005.06.018; BALAZ P, 1991, THERMOCHIM ACTA, V180, P117, DOI 10.1016/0040-6031(91)80380-2; BANERJI A, 1994, J MATER SCI, V29, P1958, DOI 10.1007/BF00351320; Birol Y, 2006, J ALLOY COMPD, V422, P128, DOI 10.1016/j.jallcom.2005.11.059; Bunn AM, 1999, MATER SCI TECH SER, V15, P1115; Cisse J., 1972, Journal of Crystal Growth, V13-14, DOI 10.1016/0022-0248(72)90558-1; Fu GS, 2003, J RARE EARTH, V21, P571; Ginstling A. M., 1950, J APPL CHEM-USSR, V23, P1327; Krishnan TS, 1998, J ALLOY COMPD, V269, P138, DOI 10.1016/S0925-8388(98)00217-5; Liu XF, 2002, MAT SCI ENG A-STRUCT, V332, P70; Liu Y, 2011, T NONFERR METAL SOC, V21, P1435, DOI 10.1016/S1003-6326(11)60878-9; Ma TF, 2013, J RARE EARTH, V31, P622, DOI 10.1016/S1002-0721(12)60331-7; Mohanty P S, 1995, 124 TMS ANN M LAS VE, P859; Nafisi S, 2006, J MATER PROCESS TECH, V174, P371, DOI 10.1016/j.jmatprotec.2006.02.012; Nie ZR, 2002, MATER SCI FORUM, V396-4, P1731; Small C, 1998, ICAA 6 6 INT C AL AL, P213; STEINBERG M, 1985, THERMOCHIM ACTA, V84, P357, DOI 10.1016/0040-6031(85)85402-2; Wang K, 2012, MATER LETT, V85, P153, DOI 10.1016/j.matlet.2012.06.072; Wang K, 2013, J RARE EARTH, V31, P313, DOI 10.1016/S1002-0721(12)60278-6; Xu CX, 2008, J RARE EARTH, V26, P604, DOI 10.1016/S1002-0721(08)60146-5; Xu CX, 2006, J RARE EARTH, V24, P596, DOI 10.1016/S1002-0721(06)60171-3; Yu LN, 2006, J ALLOY COMPD, V425, P245, DOI 10.1016/j.jallcom.2006.08.257; Zhao HL, 2010, J ALLOY COMPD, V508, P206, DOI 10.1016/j.jallcom.2010.08.047	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1002-0721			J RARE EARTH	J. Rare Earths	MAY	2015	33	5					553	560		10.1016/S1002-0721(14)60455-5		8	Chemistry, Applied	Chemistry	CH4IR	WOS:000353997700016		
